029,400,ADP,ATM,BACKGROUND,BRCA1,BRCA2,CHEK2,CRUK,EVALUATION,FANCONI,LABEL,METHODS,NEXT,OVERALL,PARP,RESULTS,SIXTEEN,SOLID,TREATMENT
000,2011,ABOUT,ANATOMICAL,FAVORABLE,III,METABOLIC,PSA,PSMA,THESE
ANALYSING,FINALLY,THEN
NIMBLEGEN,SNP,SNPS,USING
001,114,2015,2283,243,BACKGROUND,BASED,COLORECTAL,CONCLUSION,COX,CXR,GOVERNMENT,HRS,INTERVIEW,LABEL,LDCT,LUNG,METHODS,NEXT,NHIS,OVARIAN,PLCO,PRESS,PUBLISHED,RESULTS,SCREENING,TRIAL,UNIVERSITY
AGE,CURRENTLY,GLEASON,LABEL,METHODS,MOST,OBJECTIVE,PSA,PSAD,RESULTS,THEIR,TRUS
001,2014,202,348,496,824,ACCORDING,BEGG,CHINESE,CNKI,CONCLUSION,EGGER,LABEL,LIBRARY,METHODS,NINE,OBJECTIVE,RESULTS,STATA,VIP,WANFANG
BPH,CONCLUSION,LABEL,METHODS,OBJECTIVE,PCA,PSA,RESULTS,TRP,USING
11CM,177,1MM,300,307,356,3MM,4MM,5MM,6MM,726,8MM,931,963,ACCORDING,BMI,CTV,EACH,HERK,LABEL,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS
008,047,2014,296,ASIAN,CAUCASIAN,HOWEVER,LABEL,METHODS,OBJECTIVE,OCTOBER,OVERALL,PURPOSE,RESULTS,SCIENCE,STRATIFIED,WEB
1300,160,2009,2014,207,210,300,360,AFTER,AMICO,BETWEEN,CONTINENCE,JULY,LABEL,METHODS,OBJECTIVE,OVERALL,PATIENT,PURPOSE,RADICAL,RARP,RARPS,RESULTS,ROMANIA,VINCI
100,113,132,150,2004,2012,ADT,AFTER,ART,BETWEEN,DEPARTMENT,DISTANT,DSS,FIFTY,LABEL,LHRH,LNI,LVI,MEIER,METHODS,OBJECTIVE,PCA,PSA,PURPOSE,RESULTS,SPLIT,UNIVERSITY
007,008,018,024,030,136,177,596,BASED,CEA,COLORECTAL,CONCLUSION,CRC,CRCS,EMERGENCY,HOWEVER,LABEL,METHODS,MPV,NLR,OBJECTIVE,PURPOSE,RDW,RESULTS,THERE
1461,EVALUATION,MAXIMAL,METASTASES
232,ABOUT,BACKGROUND,CASES,CONCLUSION,LABEL,LITTR,METHODS,PRIMARY,THERE
145,293,AFTER,CONCLUSION,FOXM1,GFP,LABEL,METHODS,MTT,OBJECTIVE,PCR,PURO,REAL,RESULTS,THREE,WESTERN,ZSGREEN
128,PATENTS,THESE,URINARY
ACE,BPH,GLEASON,INDICATORS,PCA
ANALYZING,C30,CURRENTLY,EORTC,HIFU,MOST,QLQ
HOWEVER
0064,169,2015,COPYRIGHT,CTCS,ECTOPIC,SCIENCE,SEQ,THUS,WNT,WNT5A
8202,GLYCOMICS,THEREFORE
2009,BASED,CALIFORNIA,INTERVIEW,PSA
2016,280,AGREEMENT,ALSO,BACKGROUND,END,LABEL,METHODS,PATHOLOGIC,RESULTS,TNM
169,2015,COPYRIGHT,INC
001,003,006,009,022,169,2015,32X10,35X10,467,591,72X10,BACKGROUND,CH12Q24,GAME,GECCO,GWAS,INSTITUTE,LABEL,METHODS,NETWORK,PRESS,PUBLISHED,RESULTS,SH2B3,UNIVERSITY
169,2015,COPYRIGHT,FORCE,INC,PREVENTIVE,PSA,TASK,WIDESPREAD
600,ALSO,BACKGROUND,BASED,BRAF,EGFR,G12V,G13D,HOWEVER,INSTITUTE,IRAN,KRAS,LABEL,METHODS,MODEL,MUTATIONS,NETPHOS,REGARDING,RESULTS,SWISS
MEN,THUS
DESPITE,INTENSE
DRE,PSA
001,0069,0263,149,169,185,2015,378,399,807,8804,BACKGROUND,CD3,CONCLUSION,COX,EPIC,FOXP3,HEIDELBERG,HOWEVER,HRS,IMMUNOCRIT,LABEL,LABORATORY,METHODS,PRESS,PUBLISHED,REGARDING,RESULTS,UNIVERSITY
044,100,101,954,AUC,BOTH,CONCLUSION,GLEASON,HOWEVER,LABEL,MATERIALS,METHODS,MRI,NONE,OBJECTIVE,RESPECTIVE,RESULTS,ROC,T3A,T3B
CONCLUSION,GLEASON,LABEL,MATERIALS,METHODS,OBJECTIVE,PSA,RESULTS,SIX,STUDENT,THREE
078,2014,299,517,563,8202,956,APRIL,CHINESE,CIS,ENGLISH,HOWEVER,PCA,REMOVAL,RRS,STATA,STUDIES,WILEY
084,144,169,1980,1986,2010,2015,269,7571,853,8805,881,CAO,CONCLUSION,HOWEVER,LABEL,LIGHT,MAIN,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SETTING
MALIGNANT,REGARDING,THERE,THUS
133,1625,169,172,2005,2010,2015,2312,2336,2337,2339,2354,6927,ACUTE,ADVERSE,COPYRIGHT,EBRT,GRADE,INC,INSTITUTE,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCORE,SYMPTOM,TOXICITIES
001,2008,2012,CGS,COMPARING,GLEASON,GRADE,GSS,HGS,RPGS
160,193,2015,523,8233,CONCLUSION,HOWEVER,LABEL,LITERATURE,MARCH,META,METHODS,OBJECTIVE,RESULTS
2001AND,2004,2009,509,95TH,AFTER,COX,GLM,HISPANICS,HOWEVER,PATTERN,PROPENSITY,SEER,STEP
CONGENITAL,ECTOPIC,WHILE
AKT,CAP,LNCAP,MYC,SP1,STAT3,THESE
AMONG,BROAD,GENDICINE,THEREFORE
053,126,1595,5ML,HOWEVER,PCR,RFLP,SIMILAR,TRAIL
UNILATERAL
001,1940S,790,ADT,AFTER,BACKGROUND,INSTITUTE,LABEL,METHODS,RESULTS,SIX
BELONGING,BOTH,EVEN,FINALLY,HOWEVER
956,A549,ADDITIONAL,ASPC,FOUR,GI50,HEP3B,IC50,STAT3
ALSO,AMONG,DESPITE,DUE
BASED,HOWEVER,MAJOR,RADICAL
DIFERELIN
CIP2A,PP2A,PROTEIN,SET
100,177,BACKGROUND,ECG,ECGS,HOWEVER,LABEL,MEAN,METHODS,OBJECTIVE,OBJECTIVES,PROLONGED,QTC,RESULTS,SEVERAL,UNLABELLED
169,2015,COPYRIGHT,CURRENTLY,HOWEVER,IGF,IRELAND,LTD,PCA
215,219RN,223RA,DOSES,FDA,THESE,THREE,USING
GCS
CURRENT,WHETHER
169,2015,705,COPYRIGHT,DU145,ERK,INC,MEG2,NOTABLY,ROS,STAT3,THEREFORE,TYR
001,0016,002,005,169,173,2015,ADT,BACKGROUND,CONCLUSION,COPYRIGHT,CRPC,LABEL,LTD,METHODS,PFS,PSA,PUBLISHED,RESULTS,THERE
169,1MM,2015,231,233,286,3MM,5MM,8MM,95TH,CBCT,CONCLUSION,COPYRIGHT,EACH,LABEL,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SAS,SFRO,SOCI
001,8201,8804,CONCLUSION,CTS,DVH,KNOWLEDGE,LABEL,MEAN,METHODS,OBJECTIVE,RESULTS,THEN
169,2010,2015,COPYRIGHT,DEFICIENCY,DESPITE,EDUCATION,ENDOCRINE,FOUNDATION,GUIDELINE,GUIDELINES,INC,JANUARY,MARCH,MAYO,MEDICAL,MEN,PUBLISHED,SEVERAL,SOCIETY,SYNDROMES,THERAPY,USING
LOW,MEN,METS,T2DM,THERE,TRT
001,003,215,ADC,ADCS,AUCS,CONCLUSION,DIAGNOSIS,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,RESULTS,ROC
100,AMERICA,CLAVIEN,CONCLUSION,DINDO,FOCAL,FOUR,FURTHER,GLEASON,LABEL,METHODS,MRI,NORTH,OBJECTIVE,ONCOLOGIC,PSA,QUALITY,RESULTS,UNDER
001,002,1042,1119,1138,1154,1166,123,129,134,141,1429,1579,177,180,197,215,217,225,ADC,ADCS,AUC,AWARENESS,CONCLUSION,GLEASON,HOWEVER,LABEL,MATERIALS,MEAN,METHODS,MRI,OBJECTIVE,RESULTS,ROC,ROI
ANOMALOUS,COLORECTAL,CONCLUSION,LABEL,LUNG,NLST,OBJECTIVE,OVARIAN,SCREENING,TRIAL
008,542,BACKGROUND,HES1,INHIBITION,LABEL,METHODS,NOTCH,OBJECTIVE,RESULTS,SCS
001,142,165,183,190,198,325,488,956,FACTORS,HPLC,WHILE
169,2015,APMIS,HMWCK,JOHN,LTD,P63,PSA,PUBLISHED,SONS,WILEY
169,2015,AE1,AE3,CDX2,COPYRIGHT,DEEP,EMA,EPITHELIAL,IDH1,INC,R132,SUBSEQUENT
000,099,100,1261,181,193,1997,2002,2005,2012,236,449,453,464,507,AMONG,CALIFORNIA,COHORTS,CRUDE,EVER,EXPOSURES,HODGKIN,IMPORTANCE,JUNE,LABEL,MAIN,METHODS,OBJECTIVE,PERMANENTE,RELEVANCE,RESULTS,SETTING,STUDIES
111,2009,2012,394,437,631,AFFAIRS,AMONG,BACKGROUND,BECAUSE,FSH,FY09,FY12,LABEL,METHODS,OBJECTIVE,PROMOTING,PROPORTION,RESULTS,SETTING
001,160,169,177,2015,475,513,CONCLUSION,COPYRIGHT,CTV,D99,INC,LABEL,MATERIALS,METHODS,MLC,MULTILEAF,OBJECTIVE,PTV,PURPOSE,RESULTS,THESE,V65
112,160,169,2015,AREA,AREAS,CONCLUSION,COPYRIGHT,ECE,GLEASON,INC,KETTERING,LABEL,MEAN,METHODS,MRI,MSK,OBJECTIVE,PREDICTIVE,REGRESSION,RESULTS,SLOAN
100,956,AMP,AMPELOPSIN,ANNEXIN,CCK,CDK2,CIP1,FCM,FITC,WESTERN,WHETHER
CONCLUSION,FCH,FIRST,GLEASON,LABEL,PET,PSA,UNLABELLED
001,084,088,094,169,2005,2014,378,547,926,956,BMI,BMIS,COPYRIGHT,FREQUENCY,GLEASON,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERWEIGHT,PATHOLOGY,PSA,PSAD,RESULTS,SERUM,SOCIETY,THUS,WHILE
013,038,046,140,169,2009,2013,2015,AFFILIATED,BOTH,FIBULIN,HOWEVER,LABEL,METHODS,NANTONG,OBJECTIVE,PRESS,PUBLISHED,RESULTS,UNIVERSITY,WESTERN
169,2015,ADT,AUTHORS,COPYRIGHT,HOWEVER,IRELAND,LTD,PUBLISHED
001,169,181,2015,531,8201,886,ACUTE,BACKGROUND,CHRONIC,CONCLUSION,INC,LABEL,METHODS,POISSON,PSA,REDUCTION,RESULTS,WILEY
160,169,2015,BACKGROUND,CELL,COPYRIGHT,CRPC,DOCETAXEL,HOWEVER,INC,LABEL,LNCAP,METHODS,MMP,MTS,PC3,RESULTS
001,030,061,138,164,177,2006,2007,280,307,606,8202,825,8805,ACCORDING,BCR,COX,JANUARY,JULY,MEAN,MEIER,PSA,SERUM,SHBG
123,145,169,2015,916,936,945,BACKGROUND,BCL,BESIDES,BOTH,CDK1,CELL,CFSE,CRPC,DRUG,INC,LABEL,METHODS,MITOTIC,PROTEIN,RESULTS,RHODAMINE,SEVERAL,WESTERN,WILEY
223,ADVERSE,III
001,169,200,2005,2013,2015,8201,821,8804,AGE,BACKGROUND,DCA,GLEASON,INC,LABEL,METHODS,OVERALL,PCA,PSA,PSAD,RESULTS,SIMILARLY,WILEY
112,169,2015,BACKGROUND,CRPC,FRESH,INC,KI67,LABEL,METHODS,MICE,PDX,PDXS,PRIMARY,RESULTS,SELECTING,TURP,WILEY
000,0012,169,2015,239,370,8201,AFTER,AUC,BACKGROUND,INC,INCLUSION,INITIALLY,LABEL,METHODS,POLYGENIC,RESULTS,SIX,WILEY
160,169,2015,COPYRIGHT,FURTHER,INC,PKCS
001,004,034,169,2015,242,652,8201,AMICO,BACKGROUND,COLD,COX,COXPH,CRYO,GLEASON,INC,LABEL,LINE,LPCA,MEIER,METHODS,OVERALL,PTPSA,RESULTS,STRATIFIED,WILEY
8201,937,BACKGROUND,GADD45A,LABEL,METHODS,PSA,RESULTS,SERUM,THERE
945,GLUCOSE,GLUTS,PET,SGLT,SGLT1,SGLT2,SGLTS,THREE
016,104,169,2015,945,ADT,AIM,COPYRIGHT,CRPC,HIGH,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,SRD5A,THEN
001,006,169,2015,6735,7830,AIM,ASCO,CIS,COPYRIGHT,LABEL,LIBRARY,LTD,MEDLINE,MEETING,METHODS,OBJECTIVE,RESULTS,RRS
126,160,169,171,193,2015,277,290,AFFAIRS,ANGELES,CONCLUSION,COPYRIGHT,FURTHER,GREATER,HEALTHCARE,INC,LABEL,LOS,MAPS,METHODS,OBJECTIVE,PATIENT,RESULTS
001,1000,2000,2011,238,8202,946,AFTER,BETWEEN,CIS,COX,FURTHER,HOWEVER,INSURANCE,JANUARY
169,2015,ACUTE,COPYRIGHT,INC,OPERATIVE
CEA,CURRENT,HOWEVER,TABLE
169,2015,2B15,376C,COPYRIGHT,GIVEN,LNCAP,SOCIETY,UDP,UGT,UGT2B15,UGT2B17,UGTS,UTRS
10878,169,2015,754,COPYRIGHT,DATA,ECOG,IRELAND,LABEL,LENT,LTD,METHODS,OBJECTIVE,PC1,PEAK,PURPOSE,RADAR,RESULTS,SOMA,SUSTAINED,TROG,URINARY
215,809,951,A2780,ATM,DOWNSTREAM,I257V,L517P,N447S,NADH,ND5,PF6,ROS,SUPEROXIDE,TIME,WHOLE
169,2015,945,946,AFTER,COPYRIGHT,FRET,HIF,HIFS,HYPOXIA,INC,PC3,WHILE
169,2015,AMONG,BIOLOGY,INC,MOLECULAR,SIAH2,SOCIETY
169,2015,223,945,ARC,BIOLOGY,CK2,CKIP,EGF,HOWEVER,INC,MOLECULAR,PAK1,PI3K,SER,SOCIETY,TAKEN,UPON
MRI,SINCE,STUMP
ALSO,THEN
169,2015,946,BIOLOGY,HECT,INC,MOLECULAR,SMAD7,SOCIETY,TGF,TIUL1,UPON,WWP1
1983,EGIST,GIST,MAZUR,THOSE
177,201,2011,APRIL,BACKGROUND,EARLY,GLEASON,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PSA,RESULTS,SEPTEMBER,SPECT,TRUS
0001,0003,0018,0330,100,100MG,169,177,2010,2013,212,AGE,AIMS,ASA,AVERAGE,BHP,BPH,BTCC,CONTROL,DEPARTMENT,GROUP,JUNE,LABEL,LESS,MATERIALS,METHODS,MOST,OBJECTIVE,RESULTS,SECONDARY,SELECTION,SIMILAR,UROLOGY,VTUR
CONTROL,LOCALLY,T4A,THEIR,THEREFORE,TNM
00001,0001,0008,5047,FURTHER,III,LABEL,LARGE,MATERIALS,METHODS,OBJECTIVE,RESULTS,SECONDARY,TEN,THESE
1832,2003,2014,956,FIVE,GLEASON,JANUARY,LABEL,MARCH,MEIER,METHODS,OBJECTIVE,PSA,RESULTS,SIX,T2C,T3A,T3B,THREE
000,CVD,DATA,FRUIT,HIGH,INVERSE,ITALIAN,SIMILAR,SUGGESTIVE,SWISS
954,HOWEVER,IL1A,IL6,MTOR,RAPAMYCIN,REDUCED,SASP,THUS,TOR,TORC1
169,2012,2014,2015,316,8805,AFTERWARD,AMONG,CONCLUSION,COPYRIGHT,DOPPLER,GLEASON,INC,JANUARY,LABEL,METHODS,MRI,OBJECTIVE,PBX,PCA,RADS,REAL,RESULTS,TRUS
0001,169,2015,CONCLUSION,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,USING
169,2015,215,COPYRIGHT,INC,PUBLISHED,SOCIETY
000,093,100,161,169,2004,2008,2009,2015,231,889,982,ASR,CASE,EAST,KENYA,NAIROBI,PBCR,UICC
001,169,2015,536,BACKGROUND,BCR,COPYRIGHT,FIVE,GLEASON,IRELAND,LABEL,LTD,MATERIALS,METHODS,NXR1,OBJECTIVE,PSA,PSM,PURPOSE,RESULTS,SCORE,THESE,UROLOGY
786T,894G,CAUCASIANS,CHINESE,CIS,HAN,III,ODDS,ORS,STRATIFIED,THUS
1996,2011,4259,876,8805,AGE,BASED,COPD,CRC,INSURANCE,SIR,SIRS,SPM,SPMS
003,004,005,019,021,023,025,026,1000,160,169,2015,ADC,AIM,AUC,COLLEGE,CONCLUSION,COPYRIGHT,DWI,FIFTY,GLEASON,LABEL,LTD,MATERIALS,METHODS,MRI,OBJECTIVE,PUBLISHED,REGIONS,RESULTS,ROIS,ROYAL,THEREFORE
GENOMIC
139,169,2011,2015,AIM,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,CRC,INSTITUTE,JOHN,LABEL,MATERIALS,METHODS,MOST,OBJECTIVE,RESULTS,SMALL,TNM
104,169,2015,AFTER,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,INSTITUTE,JOHN,LABEL,METHODS,OBJECTIVE,RESULTS
000,169,1992,2001,2004,2011,2015,378,470,582,AAIR,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,CSS,INSTITUTE,JOHN,LABEL,METHODS,NEC,NEPC,OBJECTIVE,OVERALL,RESULTS,SCC,USING
169,197,2015,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,ETNA,HODGKIN,INSTITUTE,IRR,JOHN,LABEL,MATERIALS,METHODS,RESULTS,SEVERAL,WHETHER,WORLDWIDE
007,169,2015,AIM,ANTICANCER,BACKGROUND,BPH,CONCLUSION,COPYRIGHT,HOWEVER,INHIBITOR,INSTITUTE,JOHN,KAZAL,LABEL,MATERIALS,METHODS,OBJECTIVE,PCA,RESULTS,SEVERAL,SNP,SNPS,TYPE
169,2015,2D3,945,AIM,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,CYP27B1,INSTITUTE,JOHN,LABEL,LNCAP,MATERIALS,METHODS,OBJECTIVE,OHASE,RESULTS,THERE
HORMONE,RESULTANT,RNAS,SEX,SHOT,THESE,TRNA
AKT,MOLECULAR,PI3K,THEREFORE
000,400,FOURIER,FTIR,MEV,PCA,PRINCIPAL
000,230,ABOUT,EACH,ELEVATIONS,PCA,PSA
ESPECIALLY,GYNECOLOGY,UNIVERSITY,UROLOGY
100,EARLY
PCA,RNAS
164,177,689,722,747,896,CD25,CD4,CONCLUSION,ELISA,FBG,FINS,FOXP3,HOMA,IGF,III,LABEL,MEANWHILE,METHODS,OBJECTIVE,PBMC,PBMCS,PCA,RESULTS,TNM,USING
001,002,027,391,BPH,CONCLUSION,CRPC,FOXA1,GLEASON,LABEL,METHODS,OBJECTIVE,PCA,RESULTS,THEN,TNM,USING
182,308,334,396,444,675,769,8804,8805,CONCLUSION,FIFTY,LABEL,METHODS,OBJECTIVE,PCR,PEARSON,RESULTS,TOTALLY,USING
169,2015,INSURANCE,KOREA,PRESS,PUBLISHED,THROUGHOUT,UNIVERSITY
954,DU45,MICHAEL,NRF2,STAT3,THESE,VERNOLIDE
007,169,200,2015,282,389,941,946,AUTHORS,BOTH,CORTACTIN,COX,HDAC6,HGPIN,HOWEVER,IA8,JOURNAL,PATHOLOGY,PFCA,THEIR,THEREFORE,WALD
035,169,2015,312,353,355,ACCORDING,ALLELIC,AMONG,ASIAN,BPH,COPYRIGHT,DUE,GENOTYPING,HRM,INC,MINOR,PCA,PCR,PSA,RFLP,SAME,SERBIAN
001,169,177,2015,AHX,APRIL,CONCLUSION,GLU,HISTOLOGIC,IMAGING,INC,JANUARY,LABEL,LYS,METHODS,MOLECULAR,NUCLEAR,PET,PSA,PSMA,RESULTS,SOCIETY,THERE,UNLABELLED
100,2025,229,470,ADVISER,BACKGROUND,GWAS,LABEL,METHODS,MGRS,MGRSS,MULTILOCUS,MULTIPLEX,NUCLEOTIDE,PCR,PYRO,RESULTS,RISK,SENATOR,SNP,SNPS,STUDIES,TAT,THESE,TIME,TURNAROUND,USING,WHILE,WIDE
169,2015,ADDITIONAL,HOWEVER,IARC,LIFESTYLE,MODE,PRESS,PROGRAMME,PUBLISHED,UNIVERSITY,WORLD
169,2015,HOWEVER,PRESS,PUBLISHED,THESE,UNDER,UNIVERSITY
169,2015,PRESS,PUBLISHED,THEREFORE,UNIVERSITY,WHEREAS
0924,169,2015,ACCORDING,COPYRIGHT,DMAX,DMEAN,DMIN,DVHS,GROUP,IMRT,INC,LABEL,MATERIALS,METHODS,OARS,OBJECTIVE,OHS,PCA,PELVIMETRY,PURPOSE,RADIATION,REGARDING,RESULTS,SIX,THERAPY,WPRT
169,2015,256,287,310,326,ALONE,BECAUSE,BEM,COPYRIGHT,CTV,CTVS,EVALUATION,FOUR,GROUP,INC,JACCARD,LABEL,LOCALLY,MARSDEN,MATERIALS,MEAN,METHODS,OBJECTIVE,PIVOTAL,PTV,PURPOSE,RADIATION,RESULTS,RMH,ROYAL,RTOG,SEVEN,THERAPY
169,1979,2015,398,433,831,8804,8805,ACCORDING,COPYRIGHT,GLEASON,GROUP,INC,LABEL,LHRH,MATERIALS,METHODS,OBJECTIVE,PRIOR,PURPOSE,RADIATION,RESULTS,T1B,T2B,TAS,THERAPY
169,177,2015,COPYRIGHT,CSS,CYBERKNIFE,D1CC,DMEAN,ERASMUS,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PLAN,PLANS,PURPOSE,RESULTS,USING,V40GYEQ,V60GYEQ
BACKGROUND,HOWEVER,LABEL,MAOA,METHODS,MMP,PCA,PTEN,RESULTS,SC144,THERE,YM155
2000,2003,585,761,967,BACKGROUND,CAPRA,CCP,CCR,FULL,GLEASON,KINGDOM,LABEL,METHODS,PSA,RESULTS
001,122,132,153,285,AFTER,CONCLUSION,GLEASON,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,RESULTS
0001,004,317,954,AMONG,AUC,CONCLUSION,ECE,INITIAL,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,RESULTS,ROC
CONCLUSION,DWI,EPI,FOVS,LABEL,METHODS,MRI,OBJECTIVE,RESULTS
041,CONCLUSION,LABEL,METHODS,MRI,MRL,NORMALIZED,OBJECTIVE,PLND,RESULTS,THREE
102,128,132,138,141,176,202,277,872,ANOVA,CANCERS,CONCLUSION,INCLUSION,LABEL,MATERIALS,METHODS,MOST,MRI,OBJECTIVE,PERIPHERAL,PSA,RESULTS,THEREAFTER,TRUS
003,155,169,2015,379,383,BACKGROUND,CONCLUSION,COPYRIGHT,GIVEN,GLEASON,GROUP,INC,LABEL,LYMPHOCELE,MEAN,METHODS,PLND,RARP,RESULTS,STRATEGIC,TECHNICAL
205,215,500,652,ASIA,ASIAN,ATM,CANCERS,EUROPEANS,GASTRIC,GWAS,MAF,MUC1,PSCA
423,431,854,BACKGROUND,CURRENTLY,FOUNDATION,HEART,LABEL,METHODS,RESULTS,ROUTINE,THERE
2PROPSA,PCA,PHI,RUSSIAN
MRI
001,ANOTHER,BFB,EMG,RPE,URINARY
160,169,2015,ANTI,COPYRIGHT,DU145,HGF,HGFS,INC,MET,RABMABS,THROUGH
CAD,CELL,CTR,EWING,MC3T3,THESE
223,FINALLY,THERE
0CM,125,145,169,1CM,2015,250,BACKGROUND,COPYRIGHT,CTV,DOSE,DVH,GTV,IRELAND,LABEL,LDR,LTD,METHODS,MRI,MULTI,OBJECTIVE,PLAN,PURPOSE,RESULTS,TRANS
169,2015,AUTHORS,BACKGROUND,COPYRIGHT,CRPC,HOWEVER,HRQOL,IRELAND,LABEL,LOWER,LTD,LUTS,METHODS,OBJECTIVE,PPRT,PRIMARY,PUBLISHED,PURPOSE,RESULTS,THERE
1964,2000,2001,2009,2011,2012,INSTITUTE,JOINPOINT,OVERALL,PANAMANIAN,REGRESSION,STATISTICS
169,2015,ADP,COPYRIGHT,INC,PARP,PARP1,POLY
169,177,2015,CONCLUSION,FIRST,III,IMAGING,INC,INITIAL,LABEL,LNCAP,METHODS,MOLECULAR,NUCLEAR,PET,PSMA,RESULTS,SOCIETY,UNLABELLED
169,2015,ACC,ACCS,ADENOID,COPYRIGHT,FOUR,HOPKINS,INC,JOHNS,MYB,NFIB,PBCC,PBCCS,TRUE
180,199,240,311,33258,440,480,956,ACCORDING,ANNEXIN,BESIDES,BIC,CHINESE,CYTOMETRY,ELISA,FITC,HOECHST,IC50,LNCAP,MEANWHILE,MTT,PCR,PSA,R1881,SPES,WESTERN
2007,ANATOMY,CASE,CONCLUSION,DEPARTMENT,LABEL,METHODS,OBJECTIVE,PSA,PSAP,SETTING,SKENE
HOWEVER,OTHER,PLANT,REDUCTIONS
12TH,169,18TH,2015,8764,ACCORDING,BESIDES,HOWEVER,INCIDENCE,INDONESIA,INDONESIAN,NON,PRESS,PUBLISHED,RADICAL,THEREFORE,UNIVERSITY
003,004,1986,2010,2015,731,909,ADIPOSITY,ALPHA,BETA,BLOOMBERG,COLORECTAL,GOVERNMENT,HOPKINS,INCIDENCE,JOHNS,LUNG,NUTRITION,OVARIAN,OVERALL,PRESS,PREVENTION,PUBLISHED,SCREENING,SEX,THERE,TOCOPHEROL,TRIAL,UNIVERSITY
8201,COMBINING,DAILY,HOWEVER,IDEALLY,IMRT,OVERALL,TCP
ACCORDING,COX,FLAVONOIDS,THEIR
223,PI3K,SAR,THESE
169,2015,946,BIOLOGY,CCL4,CONSISTENT,DOWN,HCC,HOWEVER,INC,KNOCKDOWN,MOLECULAR,MYC,PCNA,SOCIETY,SRC,STEROID,WNT
ADAR,PCA3,THESE
1986,2004,ALGORITHM,ASIAN,BACKGROUND,ENGLAND,GROUP,LABEL,METHODS,NAMES,RESULTS,SOUTH

169,1996,2010,2015,459,461,816,AFTER,AIDS,CONCLUSION,COX,DESPITE,HIV,HODGKIN,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SOCIETY
001,019,112,169,2008,2011,2015,477,8201,8805,BACKGROUND,BCR,COX,ESPECIALLY,FINALLY,INC,JANUARY,LABEL,MEIER,METHODS,MFS,OVERALL,RESULTS,THERE,THREE,UNI,WILEY
144,169,1996,2009,2015,537,617,ASPIRIN,BACKGROUND,COX,FINNISH,GROWING,HOWEVER,INC,LABEL,METHODS,NSAID,PCA,RESULTS,SCREENING,TRIAL,WILEY
169,2015,945,BACKGROUND,BMSC,BONE,CTE9908,CTX,CXCR4,HPSC,INC,LABEL,MEIER,METHODS,MMP,PC3,PCA,PCB2,PLERIXAFOR,RESULTS,SDF,SDF1,STROMAL,THEREFORE,WILEY
2010,COMMITTEE,CONTROL,DESPITE,GLEASON,JOINT,PSA,STAGE,STAGING,TNM,UNION
PCA,PSA

AAI,EXPRESSION,GLEASON,TREATMENT,WHILE
APART,GLEASON,UNUSUAL
001,10878,169,177,2015,BACKGROUND,COMPOSITE,CONCLUSION,COPYRIGHT,CRUDE,FINE,GRAY,HDRB,IRELAND,LABEL,LTD,MEN,METHODS,POST,PSA,RADAR,RDE,RESULTS,TROG
169,2015,CONSISTENT,EGFR,HOWEVER
005,100,11E,15E,22RV1,DISSECTED,IBP,INHIBITION,INHIBITORS,PCA,RAP1A,SCID,THREE,WESTERN
000,006,0212,0445,169,2015,223,306,475,681,990,CONCLUSION,FORTY,FTV10,IMAGING,INC,LABEL,METHODS,MOLECULAR,NUCLEAR,OVERALL,PET,RESULTS,SECONDARY,SOCIETY,SRE,SUV,TLF10,UNLABELLED
004,169,2015,961,CONCLUSION,DCFBC,GLEASON,HOWEVER,IMAGING,INC,LABEL,METHODS,MOLECULAR,NUCLEAR,PET,PSMA,RESULTS,SOCIETY,THERE,UNLABELLED
169,2015,HOWEVER,LNCAP,NOTABLY,PREDICTIVE,STRIKINGLY
116,128,160,169,183,2011,9736,ABOUT,CONCLUSION,DCE,DEDICATED,DRG,DWI,GEORG,GERMANY,HDS,KEY,LABEL,MATERIALS,METHODS,MRI,MRP,MRPS,MRS,OBJECTIVE,PPS,PURPOSE,RADIOLOGY,REPORTS,RESULTS,SOCIETY,STRUCTURED,STUTTGART,T2WI,YORK
0008,1354,1988,2007,215,AFTER,BACKGROUND,BLOOD,BONFERRONI,JUNE,KLK3,LABEL,METHODS,PCA,PSA,RESULTS,SEVEN,SNPS
101,169,2015,AKT,BCL,BCL2,COPYRIGHT,DU145,HOWEVER,INC,MTT,PC3,PI3K,RAL,TAKEN,TEM
331,8230,MEN
169,2010,2015,223,BECAUSE,COPYRIGHT,HOWEVER,LTD,UNTIL
BACKGROUND,CASE,COLLISION,CONCLUSION,LABEL,METHODS,THREE
141,AFTER,CONCLUSION,LABEL,LNCAP,METHODS,OBJECTIVE,PCR,RESULTS,UTR,WESTERN
169,2015,COPYRIGHT,ERG,HIPPO,INC,TEAD,THESE,YAP1
140,145,916,BECAUSE,LEINAMYCIN,LNCAP,LNM,PREVIOUSLY,ROS,UPON
169,2005,2010,2012,2013,2015,CONCLUSION,FORCE,INTERVIEW,LABEL,METHODS,OBJECTIVE,PREVENTIVE,PSA,PURPOSE,RESULTS,SCREENING,SOCIETY,TASK,THEREFORE
2008,2013,8201,ACCURAY,ACUTE,CONCLUSION,CYBERKNIFE,EBRT,FOUR,GROUP,KNOWLEDGE,LABEL,LATE,METHODS,NADIR,OBJECTIVE,OCTOBER,PHOENIX,RADIATION,RESULTS,SUNNYVALE,THERAPY,TREATMENT
1709,2636,GNRH,LABEL,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS,SWITCHING,THREE,UNIVARIATE
0001,160,169,177,2015,222,AUTHORS,COPYRIGHT,INC,INCREASED,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,OVERALL,PERIRECTAL,PRE,PUBLISHED,PURPOSE,RESULTS,THERE,V70
145,169,2015,BPEI,COPYRIGHT,FAM,HENCE,IRELAND,LTD,R11,SSPEI
006,007,023,079,169,2015,8201,945,948,AAS,AFRICAN,BACKGROUND,CAP,CIS,DIETARY,EAS,INC,INVERSE,LABEL,METHODS,ODDS,ORS,RESULTS,WILEY
2011,8201,8805,ADVERSE,AES,APRIL,BOTH,CBZ,CTCAE,DESPITE,HOWEVER,INSTITUTE,NCI,THEREFORE
127,169,2015,302,369,425,50MG,5MG,623,730,858,ADT,ADVERSE,BACKGROUND,CENTRAL,COPYRIGHT,CRPC,LABEL,LTD,METHODS,PRIMARY,PSA,RANDALL,RESULTS,TDP,THERE,WHITE
001,007,022,043,060,169,2012,2014,2015,342,366,AUS,BETWEEN,COMPOSITE,CONCLUSION,COPYRIGHT,EPIC,FORM,HRQOL,INC,INDEX,INVENTORY,IQR,JANUARY,JUNE,LABEL,MEN,METHODS,OBJECTIVE,QOL,RESULTS,SHORT,UDI,URINARY,UROGENITAL
169,2015,COPYRIGHT,HOWEVER,INC
169,2015,ANDROLOGY,COPYRIGHT,FINALLY,INC,PUBLISHED,SOCIETY
0004,0017,169,172,2015,674,8201,848,881,946,BACKGROUND,CASES,CONCLUSION,GLEASON,IFNG,IL1,IL10,IL12,IL2,IL4,IL6,IL8,INC,LABEL,METHODS,MSR1,NONE,PREVENTION,PSA,RESULTS,SINCE,SNPS,THESE,TLR4,TNFA,TRIAL,VARIATION,WILEY
054,055,169,2000,2015,8201,AFRICAN,BACKGROUND,BLOCK,BRIEF,CASE,CONCLUSION,FOOD,FREQUENCY,FURTHER,HUH,INC,LABEL,METHODS,PCA,RESULTS,THESE,UNIVERSITY,VITD,WILEY
169,2015,BACKGROUND,BODY,C57BL,CAPSAICIN,CONCLUSION,INC,KIP,LABEL,METHODS,MICE,PC3,PIN,RESULTS,TRAMP,WILEY
001,003,074,117,125,162,2006,2012,AIMS,AMERICANS,ART,BACKGROUND,EUROPEANS,FINALLY,FORTY,JUNE,LABEL,LATIN,MAY,METHODS,OBJECTIVE,OVERALL,RESULTS
169,1978,1990,1994,2005,2006,2009,2010,2015,237,294,BACKGROUND,COPYRIGHT,EARLY,LABEL,LIFE,LITHUANIA,LTD,METHODS,PSA,PUBLISHING,RESULTS
100,AIMS,BMJ,CHK,CHKA,GROUP,IHC,INCREASED,KI67,LABEL,LIMITED,MALIGNANT,METHODS,OBJECTIVE,PCR,PUBLISHED,PUBLISHING,RESULTS,THERE
BOTH,CAR,CARS,CD19,CRLF2,FINALLY,SHORT,TSLPR
0001,400,AIM,BACKGROUND,CD31,CONCLUSION,GLEASON,LABEL,METHODS,OBJECTIVE,PSA,RESULTS,THERE
169,19TH,2015,AMYGDALIN,B17,MOST,SINCE
AIMS,BMJ,CSC,EPITHELIAL,GROUP,HOLOCLONES,LABEL,LIMITED,LNCAP,METHODS,OBJECTIVE,PC3,PCA,PUBLISHED,PUBLISHING,RESULTS,TARGETING,TRANSITION
100,2005,2011,5YCSS,5YPRFSS,8807,ADT,AMICO,EBRT,FIFTY,GLEASON,PSA,THEIR,THERE,THESE
2005,2010,2858,3244,AFTER,CARIBBEAN,CONCLUSION,DEEP,JUAN,LABEL,METHODS,REGARDING,RESULTS,SAN,SECONDARY,UNLABELLED,VTE
125,145,COIN,D100,D90,DHI,FOUR,LDR,LSS,MRI,PRO,SPOT,V100,V150,V200,V90
125,1484,162,2012,2014,2015,2018,229,239,4812,539,678,901,9235,ACCORDING,BETWEEN,FORTY,FURTHER,HDR,HUNGARIAN,HUNGARY,IGRT,IMRT,INCLUDING,INSTITUTE,JANUARY,MOC,MUNICIPIAL,NIO,THERE,TREATMENT,UNION
001,004,018,042,1442,145,169,2001,2010,2015,8201,8805,ADJUSTING,BACKGROUND,BMI,CAP,COX,CSM,INCREASING,LABEL,METHODS,RESULTS,SOCIETY,T1B
700
100,160,169,2015,450,BLOOD,COPYRIGHT,HNSCC,INC,LABEL,MATERIALS,METHODS,MOST,OBJECTIVE,PROCESSES,PURPOSE,RESULTS
017,111,143,151,169,183,2015,206,207,8805,ADT,AVENTIS,BACKGROUND,COPYRIGHT,DOCETAXEL,EARLY,FUNDING,GLEASON,IQR,LABEL,LIGUE,LOCAL,LTD,METHODS,NEITHER,RESULTS
169,2015,231,233,CLINICIANS,COPYRIGHT,DENOSUMAB,DESPITE,FRAN,PUBLISHED,SAS,SINCE,SOCI,THESE
169,2015,231,233,CASTRATION,COPYRIGHT,FRAN,PUBLISHED,SAS,SOCI,THUS
10878,133,140,169,200,2003,2013,2015,756,945,946,BED,BEDS,CFRT,COPYRIGHT,DOSE,DOSES,FFBF,HDR,INCREASES,INCREASING,IRELAND,LABEL,LTD,MATERIALS,METHODS,MIXED,OBJECTIVE,PURPOSE,RESULTS
CAUSATION,CONTROLFOR,HPV,SEVERAL,THERE

100,BPH,CONCLUSION,EPCAM,LABEL,METHODS,OBJECTIVE,PCA,PIN,RESULTS
8804,BPH,CONCLUSION,GLEASON,LABEL,METHODS,OBJECTIVE,PCA,PIN,RESULTS,TFF1,TFF3,USING
BASED,CONCLUSION,LABEL,METHODS,OBJECTIVE,PMMT,RESULTS
946,947,AE37,DRB1,HLA,IFN,TGF,THESE,VACCINE
169,2015,202,381,AFTERWARDS,AMONG,ANTICANCER,COPYRIGHT,COULTER,DEPARTMENT,ESPECIALLY,FREE,INSTITUTE,JOHN,PCA,PSA,PSAV
169,2007,2009,2015,946,947,AIM,ANTICANCER,BETWEEN,CONCLUSION,COPYRIGHT,CSF,EGF,FGF2,FIFTEEN,FURTHER,GRO,IFN,INSTITUTE,JOHN,LABEL,MAY,METHODS,MOST,OBJECTIVE,PCA,RESULTS,SEVENTEEN,TGF,VEGF
169,2015,ANTICANCER,BACKGROUND,CD4,CD8,CONCLUSION,COPYRIGHT,DCS,H11,HYPER,INSTITUTE,JOHN,LABEL,MATERIALS,METHODS,RESULTS,TRAMP,WHOLE
169,2015,AIM,ANTICANCER,BACKGROUND,CDK2,CDK6,CELL,CONCLUSION,COPYRIGHT,CXC,CXCR2,HOWEVER,IL8,INSTITUTE,JOHN,LABEL,MATERIALS,METHODS,OBJECTIVE,PCR,PROFILING,RESULTS
169,2015,945,ANTICANCER,CELL,COPYRIGHT,EFFECTIVE,INSTITUTE,JOHN,NATURAL,SANDALWOOD,SANTLOL,SKH
169,2015,947,ADC,ADCS,CARLO,CONCLUSION,COPYRIGHT,D02,D50,D95,DOSE,INC,LABEL,METHODS,MONTE,OBJECTIVE,PURPOSE,RESULTS,TCP
BACKGROUND,CONTEXT,LABEL,METHODS,OBJECTIVE,RESULTS,SHORT,SIPULEUCEL,SYNTHESIS,THEREFORE,TREATMENT
001,007,169,201,2015,231,233,509,ARN,COPYRIGHT,FRAN,ODM,PARP,PUBLISHED,SAS,SEVERAL,SOCI,TAK,TOK
1000,700,8201,900,COHORTS,DLT,DLTS,DURABLE,MTD
169,2015,946,FURTHER,TMPRSS2
8209,BPH,GLEASON,PCA,PSA,THEREFORE
22RV1,LABEL,LNCAP,METHODS,OBJECTIVE,PURPOSE,RESULTS,TMFOL,TRAMP
105,192,2005,2011,RTOG,TREATMENT
1992,1M1B,2005,205,4N0,EBRT
100,104,115,189,D10,D2CC,D90,HDR,THERE,V100
427,616,CRR,GENERAL,THEREFORE
110
PASSING
BASIC,IMRT,JOINING,ODS,PSA,SOD
169,2015,946,ADT,BACKGROUND,CASTRATION,CHIP,CHROMATIN,CLINICALLY,CONCLUSION,CRPC,DHT,HDPC,INC,INCREASED,KNOCKDOWN,LABEL,LUCIFERASE,METHODS,MTS,PCA,PCR,REAL,RESISTANT,RESULTS,SOX4,THESE,WESTERN,WHILE,WILEY
100,103,169,2015,215,244,8805,BACKGROUND,CHIP,CPG,CTCF,DHSS,DNASE,ENRICHMENT,ERG,FOXA1,GENOMIC,GWAS,H3K27AC,H3K4ME1,H3K4ME2,H3K4ME3,HMS,HOWEVER,IIA,INC,LABEL,METHODS,NR3C1,PCA,POLYMERASE,RESULTS,SEQ,SNPS,TFS,UCSC,WILEY
169,2015,ACADEMY,CROSS,FOURIER,METABOLIC,NOVEL,RAMAN,TECHNIQUES,THESE,THUS,YORK
001,003,008,028,169,2015,205,ADT,ASSESSMENT,CONCLUSION,CORE,CTG,FUNCTIONAL,HRQOL,III,LABEL,MEAN,METHODS,MRC,NCIC,OBJECTIVE,PR07,PR3,PURPOSE,RESULTS,SOCIETY,THERAPY,TREATMENT
091,107,169,2002,2009,2010,2015,324,570,8201,BACKGROUND,BETWEEN,COMMUNITY,CONFIDENCE,COX,GLEASON,INC,LABEL,METHODS,PSA,RATIO,RESULTS,SCCS,TEN,WILEY
18F,BESIDES,HOWEVER,SINCE
27G,BULGARIAN,ERG,GSTP1,IVS1,KLF6,LABEL,METASTATIC,METHODS,NONE,OBJECTIVE,PCA,PCA3,PCR,PURPOSE,RESULTS,TMPRSS2,TNM
160,177,8734,AUC0,CMAX,CONCLUSION,CTCAE,FDA,FOLLOWING,FOOD,LABEL,MEGESTROL,METHODS,NCI,OBJECTIVE,PURPOSE,RESULTS,THESE,THUS
100,177,956,ALSO,CALLIANDRA,CAM,CONCLUSION,DETECTION,DPPH,EFFECTS,HOWEVER,LABEL,LDH,LNCAP,METHODS,OBJECTIVE,PCA,PRECISELY,RESULTS,XTT
100,401,8804,COMPARING,CONCLUSION,EPSTEIN,GLEASON,HOWEVER,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,T1C
1544,8805,AFRICAN,BRAZILIAN,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PSA,RESULTS
125,125I,2003,2013,227,233,429,830,CASES,CHLC,EORTC,GLEASON,IOG,JOS,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PHOENIX,PSA,PURPOSE,RESULTS,SEPTEMBER,THROUGH
029,130,148,278,CONCLUSION,INSERTION,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
106,8805,CONCLUSION,DPSA,EMPIRICAL,LABEL,MATERIALS,METHODS,OBJECTIVE,PCA,PSA,PURPOSE,RESULTS
001,042,177,2003,2012,272,292,390,421,642,743,8805,910,CONTROL,EVEN,GLEASON,IIEF,INDEX,LABEL,LOW,LOWER,MATERIALS,MAY,MEN,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS,THUS
004,177,229,633,AUC,CONCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,PSA,RESULTS,THERE,THUS
CNA,CNAS,GLEASON,MULTIFOCAL,MYCL,SNVS,THESE,TP53
169,2015,COPYRIGHT,CRPC,DIFFERENT,HOWEVER,INC,MICRORNAS,PCA,SINCE
145,150,177,956,CUR,DU145,ETOPOSIDE,ETP,PC3,WHILE
150,169,2015,946,APC,ATM,BRAF,BRCA1,BRCA2,COPYRIGHT,ETS,INC,PLZF,PTEN,RAF1,TP53
100,169,2015,BACKGROUND,BASEL,BRAIN,CASE,CONCLUSION,III,INTRADURAL,LABEL,METHODS,THESE,UNDER
BACKGROUND,LABEL,RESULTS,SET,VENN
002,123,158,169,1994,2007,2015,233,2771,297,3771,AFTER,ALCOHOL,BACKGROUND,CONCLUSION,COX,HOWEVER,LABEL,METHODS,MIN,NUTRITION,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,SOCIETY,SUPPL,VITAMINES
145,945,HDAC,HDACI,HDACS,MCF,OBHS,SAHA,THESE
10A,10H,145,946,947,AKT,BIOLOGICAL,CDDO,DDQ,FINALLY,HOWEVER
2010,2013,CONCLUSION,FRANKEL,JANUARY,JULY,KARNOFSKY,LABEL,LOG,MAIN,METHODS,RANK,RESULTS,SCORE,SIXTY,SPINE,UNLABELLED,VERTEBRAL
AIDED,CAD,DCE,DEVELOPING,DIAGNOSIS,DIFFUSION,DWI,DYNAMIC,IMAGING,MRI,TRUS,ULTRASOUND
169,2015,35FR,BACKGROUND,COPYRIGHT,FORM,HRQOL,INDEX,IPSS,IRELAND,ITEM,KNOWLEDGE,LABEL,LTD,LUTS,MATERIALS,METHODS,OBJECTIVE,PCI,PURPOSE,QOL,RESULTS,SCORE,SHORT,SRT,SYMPTOM,UCLA
004,169,2015,215,25TH,383,740,75TH,803,8201,827,AUC,BACKGROUND,CELL,ERG,GLEASON,HOWEVER,INC,LABEL,MEAN,METHODS,PCA,RESULTS,ROC,TK1,TMPRSS2,TRANSCRIPT,WILEY
169,2015,239,BACKGROUND,BDC,BDCS,INC,LABEL,MET,METHODS,MIC,MICS,NRP1,RANK,RANKL,RESULTS,TURP,WILEY
000,169,2015,AFTER,BACKGROUND,DLT,DLTS,DOSE,EACH,LABEL,MDSCS,METHODS,PSA,RESULTS,SOCIETY,THERAPY,WBM
AFTER,MOST,THERE
956,COMPOUNDS,IC50,LNCAP,NMR,QUEENSLAND,SAR
ACADEMY,ACP,BACKGROUND,COLLEGE,DATA,FORCE,HIGH,INSTITUTE,LABEL,METHODS,PHYSICIAN,PHYSICIANS,PREVENTIVE,QUERY,SCREENING,SOCIETY,TASK,UROLOGICAL
CHIP,CLUSTER,CTC,CTCS,EFFICIENT,USING
169,2015,233,471,ALTOGETHER,ASE,COPYRIGHT,EXPRESSION,INC,OVERALL,PUBLISHED,SNPS,SOCIETY,USING
073,169,178,2015,ADULT,AFTER,ATP,BACKGROUND,CRPC,III,INC,LABEL,METABOLIC,METHODS,PANEL,PFS,RESULTS,SIXTY,TREATMENT,WILEY
169,2015,946,COPYRIGHT,INC,SD208,SMADS,TGF
001,003,037,1017,1227,169,2015,244,BACKGROUND,CGEMS,COLORECTAL,DRE,GERM,INC,LABEL,LUNG,MARKERS,METHODS,OVARIAN,PCA,PGS,PLCO,PSA,RESULTS,SCREENING,SNPS,TRIAL,WILEY
292,502,862,CSF,GRADEB3,RATES
HOWEVER
0356,108,169,2005,2011,2015,814,851,994,AMONG,BETWEEN,HOWEVER,JANUARY,LABEL,MEIER,METHODS,OBJECTIVE,PRESS,PUBLISHED,RESULTS,UNIVERSITY
169,2015,206,8807,CONCLUSION,HOWEVER,LABEL,METHODS,OBJECTIVE,PEARSON,PHASE,PRESS,PUBLISHED,RESULTS,SECONDARY,UNIVERSITY
169,2015,CASTRATION,COPYRIGHT,CRPC,HOWEVER,HSP27,LTD,MOST
001,169,2008,2012,2015,3241,400,8804,8805,AVERAGE,BCR,BOARD,CCI,COPYRIGHT,FULL,INTRA,JANUARY,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RARP,RESULTS,THESE
1993,1ST,2000,FOOT,HAND,HODGKIN,MOUTH,MRI,MYELOMA,NON,PET,RAY,SCAN,SINCE,SOFT,THERE,VISIBLE

169,2006,2012,2015,3680,529,8804,ADDITIONAL,AMONG,GLEASON,JANUARY,LABEL,MARCH,METHODS,OBJECTIVE,PRESS,PUBLISHED,RESULTS,RISK,UNIVERSITY
EFFECTIVE,FOLLOWING,RADICAL
007,111,169,2015,310,ANTI,CONCLUSION,DTPA,IMAGING,INC,JVZ,LABEL,LNCAP,METHODS,MOLECULAR,NANOBODIES,NUCLEAR,PCA,PDXS,PSMA,RENAL,RESULTS,SCN,SOCIETY,SPECT,UNLABELLED,VHH
169,2015,ERG,ETS,LOSS,NKX3,TMPRSS2
006,028,042,169,2015,BACKGROUND,CONCLUSION,COPYRIGHT,DENOSUMAB,END,FEWER,HCM,III,LABEL,LTD,METHODS,PATIENT,RESULTS
135,141,186,8804,8805,BPH,LABEL,METHODS,OBJECTIVE,PCA,PCA3,RESULTS,SHORT,STR,TAAA,THERE
177,25OHD,8805,ANOVA,BACKGROUND,BMI,BPH,BULGARIAN,FURTHER,GLEASON,HPLC,KRUSKAL,LABEL,METHODS,OTHER,PCA,PSA,RESULTS
145,1522B,AG0,H460,IMRT,MCT,RIBES,SCT,THESE,UNDER
7402,7901,946,A549,AMONG,BEL,IC50S,PC3,SAR,SGC
BACKGROUND,ISOPURE,LABEL,REPLACING,RESULTS
COMPOUNDS,HCT,NMR,THEIR,THREE,VALERIANA
169,2015,CHIP,ELISA,IL6,INC,KNOCK,LABEL,METHODS,MYC,OBJECTIVE,PCR,PSA,PURPOSE,RESULTS,STAT3,WESTERN,WILEY,WOUND
100,8201,CONCLUSION,EPID,EPL,IMRT,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,RESULTS,TPS
145,169,2015,AGO2,PRESS,PSA,PUBLISHED,THESE,TMPRSS2,UNIVERSITY
169,2015,BIOLOGY,MICRORNAS,RNAS,SOCIETY
169,2015,3280,BMS,COPYRIGHT,CTLA,CYTOTOXIC,INC,MPDL
169,2015,250,750,8805,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,CRPC,INSTITUTE,JOHN,LABEL,METHODS,OBJECTIVE,PSA,REDUCED,RESULTS
100,158,169,174,177,2010,2013,2015,ADT,AIM,ANTICANCER,BETWEEN,CONCLUSION,COPYRIGHT,CRPC,EXCLUSION,GLEASON,INCLUSION,INSTITUTE,JANUARY,JOHN,LABEL,MEAN,METHODS,OBJECTIVE,PCA,PCA3,PSA,RESULTS,SAMPLES,THERE
169,2015,3DCRT,8805,945,946,ACCORDING,AFTER,AIM,ANTICANCER,BACKGROUND,BASED,CONCLUSION,CONFORMAL,COPYRIGHT,EARLY,EORTC,IGRT,IMRT,INSTITUTE,IPSS,JOHN,LABEL,METHODS,NCCN,NETWORK,OBJECTIVE,PCA,PHOENIX,RESULTS,RTOG,TREATMENT
169,2004,2007,2015,313,553,678,737,796,AIM,ANTICANCER,AUC,BCH,CONCLUSION,COPYRIGHT,INSTITUTE,JANUARY,JOHN,LABEL,METHODS,OBJECTIVE,PCA,RESULTS,ROC
169,2015,468,946,ANTICANCER,APPARENTLY,BACKGROUND,CONCLUSION,COPYRIGHT,GAL,H1975,H469,INSTITUTE,JOHN,LABEL,MATERIALS,MCF7,MDA,MEL28,METHODS,MUC1,MULTIPLEX,NCI,PCR,PRIMARY,PROBE,RESULTS,SCGB2A2,SW962,TP53
169,1TKB,2015,AIM,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,GBC,IL1,IL1RN,IL8,INSTITUTE,JOHN,LABEL,MATERIALS,METHODS,OBJECTIVE,PCR,PSCA,RESULTS,S100,TGBC,USING
021,077,156,169,2015,233,294,619,935,AFRICAN,AIM,AMERICANS,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,DNASE,INSTITUTE,JOHN,LABEL,MATERIALS,METHODS,NINE,OBJECTIVE,PCA,PSA,RESULTS,SNPS,USING
169,2015,AIM,ANTICANCER,APOPTOSIS,BACKGROUND,CONCLUSION,COPYRIGHT,DUAL,GFP,H2B,HOWEVER,INDUCTION,INSTITUTE,JOHN,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,RFP
169,2015,ANTICANCER,CONCERNING,COPYRIGHT,HOWEVER,HPV,INSTITUTE,JOHN
001,169,2015,8805,ADT,AGE,CONCLUSION,GNB3,LABEL,MEAN,MEN,METHODS,OBJECTIVE,PURPOSE,RESULTS,SOCIETY
001,008,169,2000,2011,2015,8201,HODGKIN,INC,NHL,SEER,USING,WILEY
BECAUSE,CLASS,GRADE
169,2015,ACT,BACKGROUND,COMPLEXING,FIVE,HUVEC,INC,LABEL,METHODS,NONE,PSA,RESULTS,WILEY
001,003,014,015,100,169,2015,220,248,8805,BACKGROUND,DISCUSSION,EPE,GLEASON,IDC,INC,ITALY,LABEL,METHODS,RESULTS,RUSSIAN,SMALL,WILEY
135,169,174,2005,2014,2015,COPYRIGHT,EDUCATION,HOWEVER,INC,LABEL,MASON,MATERIALS,MEN,METHODS,MOST,NCCN,OBJECTIVE,OUTCOME,PUBLISHED,PURPOSE,RESULTS,UNIVERSITY,UROLOGICAL,WELCH
045,125,169,2015,303,723,774,BACKGROUND,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,MATERIALS,METHODS,MRI,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THERE,WHEREAS
125,144,169,1989,1996,2007,2015,8805,ADVERSE,COPYRIGHT,DMFS,INC,LABEL,LATE,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PCSM,PURPOSE,RESULTS
ALKYL,BIS,FORTY,MOST,WADSWORTH
169,2015,DESPITE,FINALLY,INC,SINCE,SOCIETY
001,169,2004,2006,2011,2015,318,3540,ADT,AFTER,BACKGROUND,BASE,CLINICALLY,COX,DATA,FIVE,GLEASON,HRS,LABEL,METHODS,PCA,PRESS,PROPENSITY,PSA,PUBLISHED,RESULTS,THESE,UNIVERSITY,USING
GLEASON,TNM
ACC,CONCLUSION,CONTOURED,CONTOURING,FOLLOWING,IMRT,INTENSITY,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,PARTICULAR,RESULTS,SIDE,TECHNIQUES
169,2015,COPYRIGHT,DIFFUSION,DWI,INC

III,THEREFORE
145,DU145,LNCAP,PC3,PCA,PNT1A,SOX2
187,204,555,MACHINE,RESULTS,ROACH
176,8201,CONCLUSION,D95,EVEN,HOWEVER,INTER,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,PTV1,PTV2,PTVS,RBE,RESULTS,TOTAL
178,AFRICAN,ANY,BACKGROUND,CONCLUSION,EIGHT,LABEL,METHODS,RESULTS,SEVERAL
0001,001,028,2014,407,APRIL,CENTRAL,OVID,SIMILAR,SMD
169,2015,COPYRIGHT,FINALLY,LTD,SILIBININ,SILYBUM,STAT3
169,2015,ARAB,BAHRAIN,COPYRIGHT,COUNCIL,DESPITE,GULF,HODGKIN,LTD,OMAN,QATAR,SAUDI
100,160,169,2015,946,956,ACC,AMP,AMPK,ASPIRIN,AUTHORS,COA,LIMITED,MEFS,MRC,PNT1A,PRE,PRESS,SALICYLATE
169,191,2015,726,945,946,956,COPYRIGHT,HSC70,HSP90,INHIBITING,KU675,OVERALL,SOCIETY,WESTERN
000,001,003,007,052,150,169,2015,BACKGROUND,BASED,BPH,CONCLUSION,DHEA,DHEAS,DHT,HOWEVER,INC,LABEL,METHODS,METS,PSA,RESULTS,WILEY
003,007,025,032,041,047,048,169,2015,8201,8805,AMONG,BACKGROUND,DECREASED,ERG,INC,LABEL,LOG,METHODS,PSA,PTEN,RANK,RESULTS,THERE,TMPRSS2,WILEY
0001,0002,0008,001,009,112,169,189,2015,406,612,8201,AUTHORS,BACKGROUND,CONCLUSION,FISH,GLEASON,HEMIZYGOUS,HER2,INC,LABEL,LOSS,METHODS,MICROARRAY,PSA,PTEN,RESULTS,THERE,TMA,WILEY
104,1992,2001,2009,2015,208,8721,BDE,BDES,BLOOMBERG,CASES,COLORECTAL,GOVERNMENT,HOPKINS,INCREASING,JOHNS,LUNG,ODDS,OVARIAN,PBDE,PBDES,PRESS,PUBLISHED,SCREENING,TRIAL,UNIVERSITY
011,013,10877,10878,169,2015,348,4GY,99A,BACKGROUND,BASED,CONCLUSION,COPYRIGHT,FOUR,IRELAND,KU80,LABEL,LATE,LTD,MATERIALS,METHODS,MOST,OBJECTIVE,PBLS,PURPOSE,RESULTS,THEN
001,169,2015,COPYRIGHT,CTV,FIFTEEN,GTV,INC,LABEL,MATERIALS,METHODS,NTCP,OBJECTIVE,PGI,PTV,PURPOSE,RESULTS,RGI,TCP
100,107,145,169,181,191,195,2015,205,218,CARLO,COPYRIGHT,D10,D90,DOSE,FOCAL,INC,ISA,LABEL,LDR,MATERIALS,MEAN,METHODS,MONTE,MRI,NINE,OBJECTIVE,PLAN,PURPOSE,RESULTS,TPM,TREATMENT,V100
169,19A,2015,ADPC,BTG1,COPYRIGHT,CRPC,FEDERATION,MICRORNAS,PCA,PUBLISHED,SOCIETIES
169,2015,8805,CONCLUSION,COPYRIGHT,ELDERLY,FOUR,INC,LABEL,MATERIALS,MEN,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCALE,SIXTEEN,THERE,TREATMENT,VES,VULNERABLE
169,2015,23CM,4CM,AUTHORS,BACKGROUND,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,MRI,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SINCE,SIX,SIXTY,SUFFICIENT
169,2015,ACIDS,FINALLY,GCN5,HOWEVER,MDC1,NUCLEIC,PCA,PRESS,PUBLISHED,THESE,UNIVERSITY
169,182,2015,780,945,946,956,COPYRIGHT,ERE,ICI,LTD
MDV3100
BPH,CONCLUSION,LABEL,METHODS,OBJECTIVE,PBL,PCA,RESULTS
169,2015,946,956,COPYRIGHT,GENISTEIN,HOWEVER,INHIBITORY,LAPC,LNCAP,LTD,PCA,THEREFORE
1047,169,2001,2011,2015,6112,BACKGROUND,END,ESOPHAGEAL,GIST,GISTS,HODGKIN,HOWEVER,LABEL,METHODS,MOST,OVARIAN,RESULTS,SIR,SIRS,SOCIETY,SPR,SPRS,THERE,THESE
8202,CIS,FURTHER,INSURANCE,MDS,NHI,ORS,OVERALL,TAIWANESE
161,169,2015,690,8201,8805,AFTER,BACKGROUND,BMI,BODY,CONCLUSION,COX,HIGH,HOWEVER,INC,LABEL,MASS,METHODS,OBJECTIVE,RESULTS,WILEY
347,369,376,443,499,8804,954,ADDITIONAL,AMONG,DESPITE,DIGITAL,EACH,GLEASON,GP5,HOWEVER,REMAINING,THESE
1211,1961,2009,3645,5512,602,616,9157,BACKGROUND,BARR,CONCLUSION,EPSTEIN,FIRST,GENERATION,LABEL,METHODS,MULTI,NPC,POISSON,RESULTS,RRS,SWEDISH
0001,144,157,355,8805,DRE,GLEASON,GROUP,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,OVERALL,PCA,PSA,PURPOSE,RESULTS,STUDENT
0058,103,2008,2012,672,811,AMONG,CONTINUED,III,JANUARY,JUNE,LABEL,METHODS,OBJECTIVE,OVERALL,PSM,PURPOSE,RESULTS,TRUS
001,004,016,8805,BACKGROUND,BPH,BRAZILIAN,GLEASON,IGF,IGFBP,LABEL,MATERIALS,METHODS,NON,OBJECTIVE,PCA,PSA,RESULTS,THERE
500,AFTER,CONCLUSION,EIGHT,FEVER,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,SIXTEEN,THERE
2011,2013,APRIL,COMPOSITE,EPIC,HDR,HRQOL,INDEX,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIX,SIXTY,THERE
000,2015,280,ADT,DUE,HOWEVER,PCA,PSA
169,1902,1997,2013,2015,2510,366,608,ADT,AFTER,BACKGROUND,FINE,GRAY,LABEL,METHODS,PCSM,RESULTS,SOCIETY,THERE,TREATMENT
APOPTOSIS,BAX,BCL,CELL,CYTOCHROME,DESPITE,DETECTION,DOCETAXEL,DTX,ELISA,IAPS,KIT,LABEL,METHODS,OBJECTIVE,OCT,OCTREOTIDE,PLUS,PURPOSE,RESULTS,SSTR2,SSTR5,THESE,THUS,XTT
1000,GCPII,III
0001,122,ANOVA,BONFERRONI,BPH,CONCLUSION,III,IMAGE,LABEL,MEANS,METHODS,OBJECTIVE,PAC,PRO,PURPOSE,RESULTS,SMC,THERE
1000,11WEEKS,29WEEKS,956,ALDH1A1,CASE,CPG,CTPE,DECREASED,FOUR,HYAL1,INC,INCREASED,NES,NEXT,NTM,PUBLISHED,RWPE,S100P
169,2015,231,233,COPYRIGHT,MECHANISMS,PUBLISHED,SAS,SFRO,SOCI
128,169,2015,DUAL,HOWEVER,KNOCKDOWN,LABEL,METHODS,OBJECTIVE,PRESS,PUBLISHED,RESULTS,UNIVERSITY
956,A549,DU145,IC50,NTUB1,SOLANUM
ANTITUMOR,MCI,MTT,NYMPHOIDES,PC3,SCREENING,U2OS
002,169,2001,2004,2015,378,8201,8805,945,BACKGROUND,ESTRADIOL,FREE,GEOMETRIC,INC,LABEL,MEN,METHODS,NUTRITION,PSA,RESULTS,SERUM,SHBG,WILEY
0001,0005,1170,123,169,2012,2013,2015,588,AIM,BACKGROUND,BRITISH,CONCLUSION,DESPITE,GENERAL,JOURNAL,LABEL,METHODS,OBJECTIVE,RANDOMISED,RESULTS,SETTING
0001,135,195,230,239,272,281,292,314,329,375,65308,65309,DATA,ELND,LLND,LND,LYMPH,RALP,THERE,TOTAL
169,2015,AKT1,BAX,BCL,CHANGES,CONCLUSION,COPYRIGHT,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PC3,RESULTS
058,079,101,169,2015,286,781,8805,ADJUSTING,COLORECTAL,CONCLUSION,COPYRIGHT,DATA,GLEASON,HOWEVER,INC,LABEL,LUNG,METHODS,OBJECTIVE,OVARIAN,PSA,RESULTS,RISKS,SCREENING,TRIAL
0001,118,169,1994,2004,2011,2015,381,6036,665,901,ASIAN,CONCLUSION,COPYRIGHT,COX,HEART,INC,JANUARY,KOREA,LABEL,METHODS,OBJECTIVE,PSA,RESULTS
000,004,022,114,169,2015,568,967,ADT,BACKGROUND,CRPC,DETECTION,IDC,INC,LABEL,METHODS,PSA,PSADT,RESULTS,WILEY
0001,0003,029,100,169,177,2015,300,500,8201,8804,BACKGROUND,BPH,CD3,CONCLUSION,ECS,IELS,INC,LABEL,METHODS,NIH,PALT,PIN,RESULTS,THERE,WILEY
001,169,2007,2010,2015,688,794,AMONG,BACKGROUND,END,INSURANCE,LABEL,LUNG,METHODS,PATIENT,RATES,RESULTS,SEER,SOCIETY,VARIATION
169,1COMPARED,2015,BACKGROUND,DU145,GELATIN,HPAD,HPADS,INC,LABEL,LNCAP,MCP,METHODS,MMP,MTT,OBESITY,RESULTS,WESTERN,WILEY

BONE,GASTRIC
169,2015,AHR,ARVS,BIC,COOH,CRPC,ICT,KLK3,KNOCKDOWN,MDV,PERSISTENT,PRESS,PSA,PUBLISHED,THEREFORE,UBE2C,UNIVERSITY
0001,002,AIMS,BACKGROUND,GLEASON,LABEL,METHODS,OBJECTIVE,RESULTS,YAP
124,176,177,186,AIMS,BACKGROUND,CBCT,DAILY,IGRT,LABEL,METHODS,OBJECTIVE,PTV,RESULTS,TREATMENT,VISICOILS
1993,1997,1998,2005,2010,2011,283,656,8805,AHS,AMONG,BMJ,GROUP,IOWA,LABEL,LIMITED,METHODS,NEWLY,NORTH,OBJECTIVE,POISSON,PUBLISHED,PUBLISHING,RESULTS,RRS
100,169,1993,2010,2015,295,3670,590,7149,8805,BACKGROUND,BETWEEN,CIS,COLORECTAL,CONCLUSION,DBP,FURTHER,LABEL,LUNG,METHODS,NUTRITION,OBJECTIVE,ORS,OVARIAN,RESULTS,SOCIETY,VITAMIN
002,004,010,014,018,021,025,039,041,100,169,200,2015,626,ALPHA,AUTHORS,BETA,BOTH,DESPITE,INC,PREVENTION,PSA,PUBLISHED,SERUM,TOCOPHEROL,UICC,ULTRAHIGH,WILEY
169,2015,COLD,DLX2,LABORATORY,LIU,PRESS,PUBLISHED,RNAS,SHAD1,SOCIETY,YB1
100,169,2015,240,8804,8805,ADT,ADVERSE,BACKGROUND,BCR,EIGHT,INSTITUTE,LABEL,METHODS,PSA,RESULTS,SIXTEEN,SOCIETY,TREATMENT
125,13YEARS,169,1930,1969,2015,208,60YEARS,630,ADULT,BACKGROUND,BMI,CHILDHOOD,CONCLUSION,COPENHAGEN,COPYRIGHT,COX,HRZ,LABEL,LINKAGE,LTD,METHODS,RECORDS,RESULTS,THEREFORE,THESE
001,177,8201,AFTER,CCS,CONCLUSION,DATA,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,PCA,RESULTS,T2WI,TEXTURE
000,250,300,8804,HCT,HDL,MOST,PSA,SERUM,SEVERAL,TREATMENT,TRT,WHILE
AFTER,HOWEVER
HOWEVER,PCA,PSA
0001,0004,0014,0021,0026,0085,0129,0450,10878,BACKGROUND,CNV,CNVS,CRPC,CYP17A1,LABEL,MEIER,METHODS,PFS,PSA,RESULTS,SERUM
169,2015,8805,ADVANTAGES,ANEUPLOIDY,BACKGROUND,CHEMISTRY,FAST,HOWEVER,LABEL,METHODS,RESULTS,SCREENING,SEQ,SEQS,SEQUENCING,TEST,THEREFORE
169,177,2015,531,700,AMICO,COPYRIGHT,EDUCATION,INC,LABEL,LYMPH,MATERIALS,MEAN,METASTASES,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SINCE,SUPER,THREE,UROLOGICAL
169,2015,22RV1,BACKGROUND,BOTH,CELL,CHIP,CHROMATIN,FITC,INC,LABEL,LNCAP,METFORMIN,METHODS,MTT,PCR,PSA,RESULTS,WILEY
053,125B,169,177,181,2009,2014,2015,600,8201,92A,956,AFTER,AGILENT,ASAP,BACKGROUND,CONCLUSION,GTCS,HGPIN,INC,IPSS,LABEL,MEAN,METHODS,PCA,PR25,PREVENTION,PSA,PTEN,RAW,RESULTS,SAMPLES,TRIAL,UPON,VISIBLE,VITAMIN,WILEY
169,2015,8201,BACKGROUND,CONVERSELY,FISH,INC,LABEL,MEN,METHODS,PREVENTION,RESULTS,TELOMERES,THESE,TRIAL,WILEY
169,2015,423,8201,8804,BACKGROUND,BASED,DISCUSSION,GLEASON,INC,LABEL,METHODS,PCA,RESULTS,SSAT,TMA,TMAS,WILEY
169,2014,2015,21ST,FOUNDATION,INC,OCTOBER,PCF,RETREAT,SCIENTIFIC,WILEY
001,145,169,2015,8201,945,946,AKT,ALDH,BACKGROUND,CSC,DEPLETION,DISCUSION,DU145,ERK1,FMISO,HIF,HOWEVER,ID1,INC,LABEL,LNCAP,METHODS,PCNA,PDGFR,RESULTS,SUNITINIB,UNASSIGNED,WILEY
056,1218,150MG,169,2015,239,28NG,428,438,607,611,6YEAR,866,991,BACKGROUND,COPYRIGHT,COX,GROUP,HOWEVER,LABEL,LTD,MEIER,METHODS,OVERALL,PCA,PSA,RESULTS,SPCG,THROUGHOUT,WORLD
160,169,2015,250,956,AUTONOMIC,BACKGROUND,CONCLUSION,COPYRIGHT,DVF,EXCELLENT,FASCIAE,FOUR,GIFT,LABEL,LEEDS,LTD,METHODS,MILLERS,OPTIMAL,PROGRAMME,RESULTS,TME
169,2015,ADC,COPYRIGHT,DIFFUSION,LTD,MRI
100,169,2015,AEROBIC,BACKGROUND,CHANGES,EFFECTS,HRQOL,LABEL,METHODS,MODERATION,QOL,RESULTS,SOCIETY
013,037,169,177,2015,8805,ACUTE,COPYRIGHT,GROUP,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RADIATION,RESULTS,RTOG,SERUM,THERAPY,VITAMIN
169,1YEAR,2015,365,649,990,APRIL,BACKGROUND,CIS,COPYRIGHT,HRS,LABEL,LTD,METHODS,RESULTS,THOSE
145,146,169,2015,4D4,956,ASSAY,CDR,COPYRIGHT,DUE,FAB,FIVE,LYS,MAB,PSA
0003,0004,0008,020,028,123,125,169,2004,2009,2015,242,8805,LABEL,METHODS,OBJECTIVE,OCTOBER,PHOENIX,PRESS,PUBLISHED,RESULTS,THEIR,TIME,UNIVERSITY
169,945,946,CD133,CD44,CXCR4,FASEB,INHIBITION,USING
0001,068,106,135,160,169,181,183,2015,218,220,224,225,257,278,309,327,360,603,610,623,705,769,790,803,812,826,845,872,ASSESSMENT,BACKGROUND,BPI,BRIEF,COPYRIGHT,FACT,FORM,FUNCTIONAL,FUNDING,HRQOL,INVENTORY,IQR,LABEL,LTD,MEDIVATION,METHODS,PAIN,PREVAIL,RESULTS,SHORT,THERAPY
169,2015,BACKGROUND,COPYRIGHT,DU145,HIGH,INC,LABEL,LC3A,MATERIALS,METHODS,PC3,RESULTS,USING
945,BACKGROUND,DEF,ERG,ERK,ERK2,ETS,ETS1,HOWEVER,JNK1,LABEL,MAPK,RAS,RESULTS,S215,THEREFORE
169,2015,AREAS,COPYRIGHT,INC,LUR,NO2,NOX,ORS,THESE
DIETARY
128,148,150,169,177,2015,AFTER,CONCLUSION,EUK,EXM,FDG,FIVE,IMAGING,INC,INJECTION,LABEL,MBQ,MEAN,METHODS,MOLECULAR,NUCLEAR,PET,PSMA,RESULTS,SOCIETY,THERAPY,TIME,UNLABELLED,WHOLE
058,113,169,177,2015,529,617,BALB,CONCLUSION,DESPITE,DOTA,HOWEVER,IMAGING,INC,LABEL,LNCAP,METHODS,MOLECULAR,NUCLEAR,ORGAN,PET,PSMA,RESULTS,SOCIETY,SPECT,SUBSEQUENT,THEREFORE,UNLABELLED
169,2015,COPYRIGHT,HOWEVER,INC,TUR
169,2015,CLINICIANS,CONCLUSION,COPYRIGHT,INC,INVENTORY,LABEL,MEN,METHODS,OBJECTIVE,RESULTS,SCORE,STUDIES,SYMPTOM,UROLOGICAL,WHETHER
160,169,2015,8805,BECLIN1,CONCLUSION,COPYRIGHT,EXPRESSION,GLEASON,INC,LABEL,METHODS,OBJECTIVE,RESULTS,ULK1,UNC
000,100,152,2007,2011,312,330,CDC,CENTRAL,CESSATION,LABEL,METHODS,POPULATION,RICAN,RICO,STATISTICS,UNLABELLED,USCS
002,010,150,169,2015,8201,8805,AUSTRALIA,AUTHORS,BACKGROUND,COHEN,FURTHER,INC,LABEL,MELBOURNE,METHODS,RESULTS,SOCIETY,WILEY
169,2015,22RV1,946,ADN,BACKGROUND,BPH,CHINESE,CHIP,CONCLUSION,EMT,EPIGENETIC,EPITHELIAL,GLEASON,H3K4ME3,IHC,INC,LABEL,LNCAP,METHODS,MSP,MTS,PCA,PCR,PROSTATIC,REAL,RESULTS,SILENCING,TGF,TRANSITION,TSA,WESTERN,WILEY
169,2015,AUTHORS,BRITAIN,FINALLY,GREAT,IRELAND,JOHN,JOURNAL,LTD,MCT,MCTS,METABOLIC,PATHOLOGY,PCA,SOCIETY,SONS,USING,WILEY
8201,ACUTE,CONCLUSION,DOSIMETRIC,HOWEVER,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,POST,RESULTS,V10,WPRT
PSA,ULTIMATELY
FIVE,LABEL,METHODS,OBJECTIVE,RESULTS,RUNNING,SENSE,YET
0001,009,169,2015,333,369,6000,GLEASON,PRESS,PUBLISHED,RPS,TURP,TURPS,UNIVERSITY,USING,ZONE
169,2015,BASAL,COPYRIGHT,EGFR,ERBB2,ERG,INC,KIT,PTEN,TMPRSS2
ACCORDING
002,1RA,8764,946,947,BACKGROUND,CRPC,DOCETAXEL,EARLY,HOWEVER,IFN,LABEL,METHODS,MIC1,PC3,PC3RX,PSA,RESULTS,U937
150,EACH,ELISA,LOW,MANN,VITAMIN,WHITNEY
001,127,169,2015,CHOL,COPYRIGHT,DICE,DSC,FACTORS,INC,IPL,IPLS,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PET,PURPOSE,RESULTS,SUV,SUV60,T2W
169,2015,8322,ALPP,BOTH,CONCLUSION,COPYRIGHT,INC,INTRINSIC,ISD,LABEL,METHODS,OBJECTIVE,RARP,RESULTS,SIXTY
001,0NG,1000,119,133,1364,169,2015,428,4765,6129,617,634,651,704,716,719,734,738,761,802,820,838,8805,AREA,AUC,BACKGROUND,FREE,GLEASON,LABEL,METHODS,PRESS,PSA,PUBLISHED,RESULTS,TESTING,TREATMENT,UNIVERSITY,USING
0001,001,006,169,2015,866,ADIPOR2,BMI,COX,GLEASON,HOWEVER,PHYSICIANS,PRESS,PSA,PUBLISHED,RESULTS,THESE,TUNEL,UNIVERSITY,USING
100MG,169,2015,AEF,CONTRARILY,FEF,GLE,HENCE,HOWEVER,ISOLATION,ORAL,PRESS,PUBLISHED,UNIVERSITY
169,2015,ANTICANCER,BACKGROUND,CLINICIANS,CONCLUSION,COPYRIGHT,INSTITUTE,JOHN,LABEL,METHODS,RESULTS,SUBSEQUENT
108,169,179,2015,428,793,796,975,AMONG,ANTICANCER,ASAP,BACKGROUND,BPH,COMPARISON,CONCLUSION,COPYRIGHT,DRE,INSTITUTE,ITALIAN,JOHN,LABEL,METHODS,PCA,PCA3,PIN,PSA,RESULTS
001,005,169,1780,2015,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,INSTITUTE,JOHN,LABEL,METHODS,OBJECTIVE,PCA,PFR,PSA,PVOL,PVRUV,RESULTS
169,2015,ANTICANCER,COPYRIGHT,ENGLISH,FDG,HISTOLOGIC,INSTITUTE,JOHN,QUADRUPLE,SUBSEQUENT,SUV
015,169,2015,956,ABCB1,ANTICANCER,ATP,BACKGROUND,BOTH,CONCLUSION,COPYRIGHT,EVEN,INSTITUTE,JOHN,LABEL,LNCAP,MATERIALS,METHODS,RESISTANCE,RESULTS,STEROID
169,2015,ANTICANCER,BACKGROUND,CD133,CD44,CELLS,CONCLUSION,COPYRIGHT,EXPRESSION,INSTITUTE,ITGA6,JOHN,LABEL,MATERIALS,METHODS,PCR,RESULTS,THUS
169,2015,ANTICANCER,COPYRIGHT,INHIBITION,INSTITUTE,JOHN,KALLIKREIN,KLK4,OSCC,OSCCS,THEREFORE
145,169,2015,AKT,ANTICANCER,COPYRIGHT,ERK,INSTITUTE,JOHN,JUN,LNCAP,STATINS,THESE
001,140,169,2004,2011,2015,8805,CONSORTIUM,GRADE,LABEL,MEDICAL,METHODS,OBJECTIVE,PRESS,PUBLISHED,RESULTS,SAPPORO,THERE,UNIVERSITY
000,032,100,150,2002,2011,243,263,BACKGROUND,CRUDE,CUMULATIVE,LABEL,METHODS,OBJECTIVE,PERCENTAGE,RESULTS,RZESZ,THERE
160,169,2015,AKT,AMP,BECAUSE,COPYRIGHT,ERK1,HOWEVER,IGF,INC,METFORMIN
005,160,BLOOD,FILI,LABEL,MATE1,METHODS,MICROARRAY,OBJECTIVE,PCR,PURPOSE,RESULTS,SEVENTEEN,SLC47A1
147,148,CHILEAN,HOWEVER,NORTH
2013,CAR,EFFECTIVE,HOWEVER,INCLUSION,OPTIMAL,OTHER,SCIENCE,YEAR
169,2015,231,233,COPYRIGHT,DESPITE,NINE,PUBLISHED,SAS,SFRO,SOCI,THROUGH
169,2015,BMP,BMP4,EPIGENETIC,IL6,PROSTATIC,SOSTDC1,SYNTHESIS,THESE,WNT
169,2015,945,ALDH,ALTERED,FUNCTIONAL,PCSC,PCSCS,TAKEN
MANAGEMENT,PSA,SPOTLIGHT,SPR,VICKERS
169,2015,8794,BACKGROUND,COMPETING,CONCLUSION,COPYRIGHT,DUE,GROUP,HOWEVER,IRELAND,LABEL,LTD,METHODS,MFS,RESULTS,SOUTHWEST,SWOG,TRIAL
COLORECTAL,ERSPC,FOUR,GROUP,LUNG,OVARIAN,PIVOT,PLCO,PSA,RANDOMIZED,SCREENING,SPCG,TRIAL
169,2015,BIOLOGY,E131Q,EXPRESSION,GTPASES,HYAL1,HYALURONAN,INC,LIVE,MOLECULAR,OVERALL,RAB,SOCIETY,USING,Y202F
169,2015,CCL5,CROSS
0009,0027,0046,0052,155,169,2015,209,8201,BACKGROUND,ELISA,FGF,FGF19,FGFS,FIBROBLAST,GLEASON,INC,LABEL,LNCAP,METHODS,MTT,PC3,PCA,PSA,RESULTS,SERUM,UNDER,WESTERN,WILEY
169,1993,1996,2002,2005,2015,563,8805,BLOOMBERG,BMI,COMPARING,ERG,ETS,HOPKINS,JOHNS,KING,PRESS,PUBLISHED,T2E,TMPRSS2,UNIVERSITY,WASHINGTON
1000,1410,2009,781,CALCULATOR,CURRENT,DUTCH,ERSPC,PSA,RISK
169,1960S,1987,2005,2015,COPYRIGHT,DESPITE,EDUCATION,EFFORTS,ENGLISH,GLEASON,INC,LABEL,LARGE,MATERIALS,MEMBERS,METHODS,OBJECTIVE,POPULATION,PUBLISHED,PURPOSE,RESULTS,SOCIETY,THERE,THESE,UROLOGICAL,YOUNG
133,169,2015,CONCLUSION,DATA,EPE,ESUR,FEATURE,IMAGING,LABEL,LESIONS,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RADIOLOGY,RADS,REPORTING,RESULTS,RSNA,SOCIETY,UROGENITAL,ZONAL
REDUCED,S203,S211
036,105,169,180,2015,210,8804,8805,967,A12,CONCLUSION,CTC,CTCS,IGF,IMC,LABEL,LOWER,METHODS,OBJECTIVE,PATIENT,PSA,PURPOSE,RESULTS,SECONDARY,SOCIETY
177,326,8805,BESIDES,CLINICALLY,CONCERNING,GLEASON,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PCA,RCP,RESULTS
0126,169,2015,505,551,577,595,763,BACKGROUND,CHANGES,CRT,DESPITE,FACE,FUNCTIONAL,GROUP,IIEF,IMRT,INDEX,LABEL,METHODS,PROS,RADIATION,RESULTS,SOCIETY,THERAPY,THERE
129,165,169,2001,2013,2015,335,8201,AIM,ASSESSMENT,BACKGROUND,DATA,INDEX,LABEL,MAIN,METHODS,OBJECTIVE,ORDINAL,OUTCOME,POST,PRIOR,RESULTS,SIX,SOCIETY
146,169,2015,290,CONCLUSION,COPYRIGHT,CTV,DAILY,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PTV,RESULTS,THESE
0126,160,169,2015,219,8805,90TH,CONVERTING,COPYRIGHT,DVH,DVHS,GROUP,IMRT,INC,KUTCHER,LABEL,LKB,LYMAN,MATERIALS,METHODS,NTCP,NTCPS,OBJECTIVE,PLAN,PTV,PURPOSE,RADIATION,REPLANNING,RESULTS,RTOG,THERAPY
169,2015,210,221,BIC,COPYRIGHT,DHT,HOWEVER,IRELAND,LNCAP,LTD,MIB,PCR,POST,THUS,TREATMENT
169,2009,2013,2015,COPYRIGHT,EDUCATION,HOWEVER,INC,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,OCTOBER,PUBLISHED,PURPOSE,RESULTS,STRICTURES,SUCCESS,UROLOGICAL
169,2015,8201,AUC,BACKGROUND,CDH1,DISCUSSION,FDA,GOLM,HGPIN,HIGH,INC,KLK3,LABEL,MEN,METHODS,MULTIPLEX,PCA,PCA3,PCR,PPV,PSGR,PSMA,RESULTS,UNI,USING,WILEY
169,2015,744,810,890,ACIDS,BOTH,KNOCK,MICRORNAS,NUCLEIC,PRESS,PUBLISHED,THESE,UNIVERSITY,WEE1,XPC
0001,001,015,016,044,169,2006,2015,280,8201,APL,BACKGROUND,LABEL,METHODS,REPORTS,RESULTS,SOCIETY,TREATMENT
169,2007,2015,228,8804,BACKGROUND,BEGINNING,COMPOSITE,DISEASE,HRQOL,INDEX,LABEL,MEAN,MEDICAL,METHODS,PCA,RAND,RESULTS,SOCIETY,THESE
947,AFTER,CONVERSELY,DSBS,FOCI,H2AX,LOCAL
002,1999,2008,AIDS,ART,BACKGROUND,CONVERSELY,HIV,HODGKIN,IRR,JOINT,KAMPALA,LABEL,METHODS,NATIONS,POISSON,PROGRAM,RESULTS,SAHARAN,THESE
169,2015,BARR,COPYRIGHT,EBV,EPSTEIN,HHV8,HIV,HODGKIN,INC,NHL,OTHER,SCC,TRANSPLANT,VIRUS
024,169,2015,ASIAN,C677T,COPYRIGHT,MTHFR,OVERALL,PCA,RECESSIVE,TAKEN
169,1980S,1990S,2010,2011,2015,858,COPYRIGHT,END,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PSA,PURPOSE,RADIATION,RESULTS,SEER,THESE
001,169,177,2015,CONCLUSION,FDG,IMAGING,INC,LABEL,METHODS,MOLECULAR,NAF,NUCLEAR,PET,RESULTS,SOCIETY,SUV,SUVS,UNLABELLED
169,177,2015,947,AFTER,CLI,CONCLUSION,DOTA,GRPR,HOWEVER,IMAGING,INC,LABEL,MBQ,METHODS,MICE,MOLECULAR,NUCLEAR,OTHER,RESULTS,SOCIETY,UNLABELLED,USING
0001,001,111,130,169,177,2015,468,BALB,CLAUDIN,CONCLUSION,GST,IMAGING,INC,LABEL,MAMMARY,MDA,METHODS,MOLECULAR,NUCLEAR,OVERT,RESULTS,SOCIETY,SPECT,SQ20B,TAKEN,UNLABELLED
AFRICAN,CAUCASIAN,CONCLUSION,FDG,FECH,FIFTEEN,FIFTY,GLEASON,IMAGING,LABEL,METHODS,OBJECTIVE,PET,PSA,RESULTS,SUBJECT
BACKGROUND,BPH,GLEASON,H2O2,LABEL,LOW,LTP,METHODS,RESULTS
004,223,262,262T,8202,9777,FURTHER,LITERATURE,MANAGER,META,STATA
8197,AUTOPSY,BMJ,BOTH,BRCA2,GLEASON,GROUP,LIMITED,PUBLISHED,PUBLISHING
169,2015,COPYRIGHT,ETHANOLIC,GMBH,PSA,PUBLISHED,WCE,WEDELIA
1930S,1950S,PAP,SINCE
169,2007,2012,2015,2184,442,CONCLUSION,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE
169,2015,ASPECTS,COPYRIGHT,DESPITE,INC,ITALIAN,MEDICAL,PHYSICS,SEVERAL
1950,1967,1974,1985,2014,2500,ADDITIONAL,AMED,ANXIETY,AUTHORS,BACKGROUND,CENTRAL,COLLECTION,CONTROLLED,DATA,DEPRESSION,GROUP,ICTRP,LABEL,MAIN,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,RANDOMISED,REIKI,RESULTS,SELECTION,THERE,THESE,TREATMENTS,WORLD
017,035,042,499,571,BACKGROUND,CAUCASIANS,HOWEVER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,THR241MET,XRCC3
160,169,177,2015,2STP,4STP,7STP,COPYRIGHT,DRBE,FTP,INC,LABEL,LETD,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,STP
100,102,103,108,160,169,177,2015,ADAPTATION,BOTH,CBCT,COPYRIGHT,CORRECTION,CTV,DAILY,EUD,EVALUATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS,THREE,TREATMENT
001,100,105,160,169,2015,8805,945,946,COPYRIGHT,IDL,INC,LABEL,MATERIALS,METHODS,NTCP,OBJECTIVE,PET,PLAN,PLAN100,PURPOSE,RESULTS,TCP,THERE,VMAT
169,2015,BASEL,FUNCTIONAL,TREATMENT
120,1230,190,300,310,630,AIM,BACKGROUND,CONCERNING,CONCLUSION,LABEL,METHODS,OBJECTIVE,RADICAL,RESULTS,T3A,T3B,T4A
100,DQA,INCUBATION
2012,COLLEGE,CONCLUSION,DOPPLER,IQBAL,JANUARY,LABEL,MEDICAL,METHODS,OBJECTIVE,POWER,RESULTS,SIX
001,169,2015,8805,993,ADL,AMERICA,ASSESSMENT,BACKGROUND,CGA,COLORECTAL,CONCLUSION,COX,EASTERN,ECOG,GERIATRIC,GROUP,GUG,LABEL,METHODS,MORTALITY,PRESS,PUBLISHED,RESULTS,SOCIETY,UNIVERSITY
CANCEROUS,CIP2A,INHIBITOR,PP2A,THUS,USING
169,2015,367,945,BACKGROUND,CONCLUSION,FSP,GLEASON,HOWEVER,INC,LABEL,METHODS,RESULTS,SINCE,SMA,THESE,WILEY
169,2015,BACKGROUND,CCL2,DU145,INC,INTRA,LABEL,LPS,LYLU,MAT,METHODS,PC3,PCA,RESULTS,TAKEN,TLR4,TOLL,ULTIMATELY,WILEY
160,1600,169,1898,2015,20TH,223,226,921,945,947,COPYRIGHT,INC,RESULTS
11R,169,2015,945,BACKGROUND,BMTP,FINALLY,LABEL,LIMITED,METHODS,PREVIOUSLY,RECEPTORS,RESULTS,SOCIETY,THESE
2012,2014,BETWEEN,CYBERKNIFE,FOUR,JANUARY,OCTOBER,PRESCRIBED
CANCERS,DARWINIAN,HOWEVER,INTEGRATED,LESIONS,METASTASIS,USING
22RV1,945,CROSSTALK,CRPC,FKBP5,GIVEN,GOVERNMENT,HIF,KLK3,LNCAP,SIMILARLY,TMPRSS2,TREATMENT
945,EGFR,EP2,HIF,LNCAP,PC3,PGE2,THESE
169,2015,2327,ALSO,BACKGROUND,DATA,FNA,LABEL,MEDICAL,METHODS,PANCREATIC,RESULTS,SOCIETY,THERE
006,007,008,009,169,2015,AFTER,AUTHORS,BJU,CECT,CONCLUSION,GAINS,GIVEN,LABEL,MAINTAINED,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THESE,UNASSIGNED,YOUNGER
169,2015,ALTOGETHER,COPYRIGHT,INITIALLY,NGS,POLY,WHOLE
169,2015,400,BOTH,COPYRIGHT,ERASMUS,GIGA,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SHORTER,WORST
22RV1,AFTER,DUPA,IC50,PSMA
CRPC,MENIN,MLL,RESISTANCE,TAKEN,TREATMENT
945,INHIBITION
169,1948,2013,2015,8201,AUTHORS,GLEASON,INC,INCIDENTAL,MEDLINE,PUBLISHED,THERE,UICC,WILEY
169,2015,COPYRIGHT,DOSE,HDR,HIGH,IRELAND,LTD,RATE
8304,8310,947,CONCLUSION,FLOW,IGG,LABEL,METHODS,MTS,NCSHRNA,OBJECTIVE,PC3,PCR,RESULTS,WESTERN
945,947,BARRETT,DUOX1,DUOX2,KNOWLEDGE,NADPH,NOX,NOX1,NOX4,NOX5,NOXS,ROS
10878,169,2002,2010,2015,BACKGROUND,BIOLOGICAL,CNV,CNVS,CONCLUSION,COPYRIGHT,CROSS,FIFTY,GRADE,IRELAND,KUTCHER,LABEL,LKB,LTD,LYMAN,MATERIALS,MAXIMUM,METHODS,NTCP,OBJECTIVE,PURPOSE,RESULTS,SIXTY,SNP,SNPS
1254,126,134,137,144,169,2015,204,AROCLOR,COPYRIGHT,CPF,DU145,EDS,EMT,ENDOCRINE,EPITHELIAL,INC,MMP
169,194,2015,210,241,267,333,385,916,C4BP,C5B,CD55,COPYRIGHT,CRYSTAL,GPI,INC,MVS
001,160,169,2010,2011,2015,876,AFTER,AMONG,CONCLUSION,COPYRIGHT,INC,LABEL,LNS,METHODS,OBJECTIVE,OVERALL,PLND,RESULTS,USING
8201,BACKGROUND,DMQ,EBRT,FINALLY,LABEL,MATERIALS,MEN,METHODS,RARP,REASONS,RESULTS
1087,169,178,2015,AIM,BMI,LABEL,MATERIALS,MEDICAL,METHODS,OBJECTIVE,RESULTS
1941,ADT,ASIA,CRPC,HOWEVER,HUGGINS,LHRH,OPTIONS
100,169,2015,250,53BP1,8805,956,A549,CAPSAICIN,COPYRIGHT,DU145
032,045,139,141,143,169,2015,8804,COCHRAN,CONCLUSION,COPYRIGHT,DBT,ENCOUNTER,FOUR,GREATER,INC,LABEL,METHODS,MORNING,OAD,OBJECTIVE,PRN,PROFILE,RESULTS,SECONDARY,SEP,SEP1,SEP2,SEP3,SPL,THESE
145,169,2015,COPYRIGHT,HEAT,HSP90,IRELAND,LNCAP,LTD,SEVERAL,SLUG,THUS,TREATMENT,ZEB1
180,AMONG,SMALL,THERE,THREE
223,LOW,OSSEOUS
102,1268,169,2015,225,3668,720,8418,956,CONTROL,HYPOCCS,LABEL,METHODS,OBJECTIVE,RESULTS,SIR,SIRS,SOCIETY,STUDIES,THERE,USING
169,2015,458,ABSI,AUSTRALIAN,BMI,BODY,COX,HARRELL,HIP,HOWEVER,INDEX,OBESITY,SHAPE,STRONGEST,UICC,WHR,WTHR,ZEALAND
0001,0008,0030,0041,169,2015,6MWT,8201,ADT,AGGREGATE,BACKGROUND,FORM,GRIP,ITEM,LABEL,MEDICAL,METHODS,MIXED,PREVIOUSLY,QOL,RESULTS,SHORT,SOCIETY,TIMED,TUG
COMPETING,GRAPHICAL,MRE,MRES,RNAS,THEREFORE,UTR,UTRS,VIA,WHILE
032,038,041,150,169,180,1990,2011,2015,537,610,8201,8230,967,ADVERSE,BACKGROUND,CONCLUSION,GLEASON,INC,LABEL,METHODS,PSA,RESULTS,WILEY
017,121,169,2015,8201,8764,AMONG,AUTHORS,BACKGROUND,BRAF,CAUCASIAN,CHINESE,ERG,ETS,ETV1,ETV4,FFPE,FISH,IHC,INC,INCIDENCE,INDIA,ISH,LABEL,METHODS,MOLECULAR,NORTH,PCA,PTEN,RAF,RAF1,RESULTS,WILEY
169,2015,AUTHORS,INC,IRE,JOULE,NUMERICAL,WHERE,WHILE,WILEY
169,2015,945,946,CSC,CSCS,CXCR4,HOWEVER,PDLN,TAKEN,TNC
169,2015,ALSO,BACKGROUND,BRDU,EAF2,ELL,FOXA1,GFP,HOWEVER,INC,LABEL,LNCAP,METHODS,PCR,RESULTS,RNAI,THESE,USING,WILEY
169,2015,969,975,AMACR,AUTHORS,BACKGROUND,CAP,CELLS,COMPARISON,CYTOCLEAR,DRE,ERG,ICC,INC,LABEL,LNCAP,METHODS,PANEL,PCA3,PHI,PSA,RESULTS,TMPRSS2,UCMP,URINE,VCAP,WILEY
169,2015,888,ABT,MAR,MARS,PARP,PC3,PCA,THUS,UICC
8482,APC,CDH1,CURRENTLY,ERG,FGFR3,GSTP1,PCA,PCA3,PTGS2,RARB2,SFRP2,TERT,THUS,TMPRSS2,VHL
369,660,674,BPH,GLEASON,MMP,TIMP
189,2009,2013
102,FIVE,HIFU,NADIR,PSA,RPE
MRI,MRS,THESE,THUS,UPON
131I,945,HEAT,HSP90,IMAGING,LABEL,METHODS,OBJECTIVE,RESULTS
000,100,300,BESIDES,PSA,SEVERAL
1400,160,ARGENTINA,COLUMBIAN,CUEVA,DIFFERENT,JUJUY,MOST,NORTHWEST,SOUTH
1425,169,2000,2009,2013,2015,875,AMONG,ANGELES,BETWEEN,CALIFORNIA,CONCLUSION,COPYRIGHT,IMPROVING,INC,JANUARY,LABEL,LOS,MARCH,METHODS,OBJECTIVE,OVERALL,PATIENT,RESULTS,UNIVERSITY,URINARY
169,2012,2015,AFTER,DESPITE,DISCUSSION,LABEL,METHODS,MEXICAN,NUTRITION,OBJECTIVE,PAP,POPULAR,RESULTS
BACKGROUND,BLUE,CASE,CONCLUSION,EVEN,LABEL,METHODS,OURS,SUPRAPUBIC
956,LNCAP,PLASMODIUM
169,2015,BONE,COPYRIGHT,ECTOPIC,ERK,SOCIETY,SRC
ARCAP,AUGMENTED,CXCL1,CXCL2,CXCR2,INCREASED,PC3
001,147,169,2015,295,772,8201,8804,8805,AFFAIRS,AIMS,BACKGROUND,CLINICALLY,COMPOSITE,INDEX,LABEL,MAIN,MEDICAL,MET,METHODS,OBJECTIVE,OUTCOME,OVERALL,RESULTS,SOCIETY,THERE
001,034,169,2015,250,301,711,8805,ADDITIONAL,CONCLUSION,COU,CRPC,CTC,CTCS,EXAMINING,III,LABEL,LDH,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,SOCIETY
BASED,XIX
PRESENTED
1000,114,12TH,177,6TH,ART,PSA,START,TOTAL
110,122,2010,ACCORDING,CURRENTLY,DEPARTMENT,DUE,FIRST,FOCAL,HIFU,MARCH,MSMSU,PCA,SINCE,UROLOGY
2ND,6TH,AWARENESS,GOLD
001,003,008,010,013,169,2015,239,254,486,8805,ADDED,ADT,AMICO,CONCLUSION,COPYRIGHT,CRYO,GLEASON,INC,LABEL,LINE,METHODS,OBJECTIVE,PHOENIX,RESULTS
CBCT,CTV,DAILY,DISCUSSION,HOWEVER,LABEL,MATERIALS,METHODS,NTCP,OBJECTIVE,PURPOSE,RESULTS,SIXTEEN,TCP,THEN
100,109,169,2015,430,8764,920,AFTER,C5B,COPYRIGHT,INC,MVS,PC3,PKC,RHO,USING
016,017,058,074,091,169,2015,471,945,CARB,COPYRIGHT,CRPC,DHT,DIETARY,ENZYMES,HSD17B2,IGF,LNCAP,LOW,LTD,PCA,PSA,STEROID,THERE,WESTERN
LAST,PCSCS,THEREFORE
002,003,005,013,014,055,177,206,321,674,8805,CONCLUSION,GLEASON,GSS,LABEL,METHODS,OBJECTIVE,RESULTS,THOSE
169,2015,949,COPYRIGHT,IRELAND,LNCAP,LTD,NOTCH,PC3,PCA,PLC
169,2015,COPYRIGHT,CTV,GTV,IRELAND,LABEL,LTD,MATERIALS,METHODS,MULTIFOCAL,OBJECTIVE,PURPOSE,RESULTS,SATELLITES,THERE,THUS,VOLUMES
005,007,100,169,2011,2013,2015,355,8805,COPYRIGHT,GLEASON,INCIDENTAL,IRELAND,LABEL,LTD,METHODS,MRI,NPV,OBJECTIVE,OBJECTIVES,PPV,PSA,RESULTS,ROUTINE,SEPTEMBER
0001,0010,0028,0127,169,2015,400,9744,COPYRIGHT,ERG,GLEASON,HDAC1,HDACS,HIGH,HISTONE,INC,PSA,PTEN,RESULTS,TMPRSS2
001,130,140,165,166,169,1991,2007,2015,313,529,852,977,AMERICANS,ASIAN,BACKGROUND,BECAUSE,CHINESE,CSM,DESPITE,END,FINE,GRAY,HAWAIIANS,KOREANS,LABEL,METHODS,PACIFIC,PAKISTANI,PRESS,PROGRAM,PUBLISHED,RESULTS,SOUTH,THESE,UNIVERSITY,VIETNAMESE
169,2015,205,946,956,ABROGATION,ANTICANCER,COLO,COPYRIGHT,DIM,GRP78,IC50,IRELAND,LTD,MIAPACA,MMP,NGD16
10877,10878,169,2015,2096,ADT,BACKGROUND,CAPSURE,CONCLUSION,COPYRIGHT,ENDEAVOUR,GLEASON,LABEL,LTD,MEAN,METHODS,PSA,RESULTS,STRATEGIC
CONCLUSION,LABEL,MRI,OBJECTIVE
072,074,079,084,085,091,099,103,108,111,119,2013,AUC,BOTH,CONCLUSION,DCE,DWI,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,RESULTS,ROC,SEPTEMBER
0164,2007,2012,293,954,AIMS,ASSESSMENT,BMJ,FIVE,GROUP,JANUARY,LABEL,LIMITED,METHODS,OBJECTIVE,PUBLISHED,PUBLISHING,RESULTS
0001,0007,2004,2010,3018,339,8201,APM,COX,DATABASES,DPIN,DRUG,GNRH,JANUARY,NETWORK,PROGRAM,USING
0190,0783,100,155,169,177,2015,393,8804,8805,AHX,CONCLUSION,GLEASON,GLU,HBED,IMAGING,INC,LABEL,LYS,MBQ,METHODS,MOLECULAR,MOST,NUCLEAR,PET,PSA,PSMA,RESULTS,SOCIETY,UNLABELLED,WHEREAS
000,2040,8201,830,BACKGROUND,BRITISH,CONCLUSION,INCIDENCE,KINGDOM,LABEL,METHODS,PSA,RESULTS,SUCCESSFUL,THERE
001,169,2015,8804,COPYRIGHT,DAILY,EDUCATION,FLASH,GROUP,HOT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RELATED,RESULTS,SCALE,SEVERAL,THREE,UROLOGICAL
001,002,045,2012,2013,BESIDES,BMI,DATA,JUNE,LABEL,METHODS,OBJECTIVE,PURPOSE,RARP,RESULTS,ROBOT,SEPTEMBER,THERE,THESE
2014,AMONG,BLOOD,DIETARY,PCA,PUFA,PUFAS
169,2015,956,BIOLOGY,INC,MOLECULAR,NMR,SOCIETY,ZINC
169,2015,8201,956,BACKGROUND,BCL,CONCLUSION,DU145,HOWEVER,HRPC,INC,KIT,LABEL,METHODS,MTS,PC3,PCR,RESULTS,VEGF,WILEY
169,2015,COPYRIGHT,GREAT,HOWEVER,LTD,WHILE
001,160,169,177,2015,232,CONVERSELY,COPYRIGHT,EDUCATION,GLEASON,INC,LABEL,MATERIALS,MEAN,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
001,140,184,304,AIM,CHOLINE,LABEL,LESIONS,METHODS,OBJECTIVE,PET,PSA,RESULTS
169,2015,BACKGROUND,CONCLUSION,ELISA,INC,LABEL,METHODS,PROSTATIC,RESULTS,THESE,WESTERN,WILEY
169,2015,231,BONE,BOTH,COPYRIGHT,IRELAND,LNCAP,LTD,MCF7,MDA,PC3,PRDX,PRDX4,THESE,USING
1ST,2014,APRIL,ASIAN,CAUCASIAN,CIS,CRUDE,ESR1,HCC,LABEL,MEANWHILE,METHODS,OBJECTIVE,ORS,PURPOSE,PVUII,RESULTS,T594T,XBAI
2013,2014,947,ARETAIEION,CONCLUSION,DEVIATION,IMRT,INTENSITY,JANUARY,LABEL,LINAC,MAY,MEDICAL,METHODS,MODULATED,OBJECTIVE,PRE,PURPOSE,RADIATION,RESULTS,SIEMENS,THERAPY,TREATMENT,UNIVERSITY
005,006,010,150,CONCLUSION,COX,DFS,HIGH,LABEL,METHODS,OBJECTIVE,PCR,PURPOSE,RESULTS,WESTERN
001,002,004,169,2015,AUC,BRIER,CAL,CONCLUSION,CONTINUOUS,COPYRIGHT,FP1,FP2,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RCS,RCS3,RCS5,RESULTS,SETTING
3100,945,946,AMD,AMONG,CELL,CXCR4,MMP,MSC,RPMI,STROMAL,WESTERN
001,8201,BPH,PCA,PCR,QRT,RWPE,SOX,SOX11
169,2015,3377,8201,AMERICA,BECAUSE,NORTH,RESULTS,SOCIETY,TEAMS
169,2015,COPYRIGHT,INC,LABEL,LHRHA,MATERIALS,METHODS,OBJECTIVE,OPTIMIZING,PCA,PSA,PURPOSE,RADIATION,RESULTS,SERA,SIXTEEN,THERE
169,2015,231,2780,8PN,946,AFB1,ANOTHER,BVDV,CHINESE,COPYRIGHT,DU145,HSV1,HSV2,HUVEC,IXN,JAK,MAIN,MCF,MDA,P450,PSA,SOPHORA,STAT,SW620,TGF
0001,100,123,169,183,2015,995,BACKGROUND,CONCLUSION,COPYRIGHT,EBRT,FAILURE,HDR,IRELAND,LABEL,LTD,MEIER,METHODS,NADIR,OBJECTIVE,PSA,PURPOSE,RESULTS,ROC
001,10878,132,159,169,2004,2009,2011,2014,2015,506,AIM,BACKGROUND,CONCLUSION,COPYRIGHT,EAU,END,GERMANY,IRELAND,LABEL,LTD,MATERIALS,METHODS,NAT,RESULTS,THEREOF,THROUGH,USA
169,2015,CHD1,DUAL,ERG,ETS,GLEASON,LNCAP,PRP
000,169,2015,CRE,CRPC,CXCL,DACH1,ENDOGENOUS,IL6,IL8,USING
2000,DECREASES,LAPC,PCR,SIMILARLY,TFO,TFOS,THREE
CD69,CD95,KI67,PSA,ROS
000,100,120,151,160,180,2012,350,359,368,407,CONCLUSION,ICER,LABEL,METHODS,OBJECTIVE,QALY,QALYS,RESULTS,ROBOTIC,THAI,WHILE,WTP
025,045,186,242,776,BASED,HUMANEXOME,ILLUMINAM,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PCA,RESULTS,SNPS,THESE
FURTHER,MAJOR,MEN,MRI,THERE
11C,2014,CHOLINE,INSURANCE,MARCH,PET
MRI,MRS,PET
006,015,027,10TH,169,2015,215,247,251,657,90TH,AFTER,BACKGROUND,BONFERRONI,COLORECTAL,LABEL,LUNG,METHODS,NUTRITION,OBJECTIVE,OBJECTIVES,OVARIAN,PEARSON,RESULTS,SCREENING,SERUM,SOCIETY,TRIAL,USUAL
001,195,2010,2011,8197,8805,954,AIMS,BMJ,END,FURTHER,GLEASON,GROUP,LABEL,LIMITED,METHODS,OBJECTIVE,OVERALL,PUBLISHED,PUBLISHING,RESULTS,UNIVARIATE
CRPC,ONGOING,WHILE
223,CONVERSELY,CTC,DAILY,FOLLOWING,GIVEN,HOWEVER,PSA
945,GRP78,PKRGFQD,SNTRVAP,THESE
006,160,169,177,2015,511,8201,AUTHORS,BMI,FOLLOWING,INC,IQR,MEN,PROTECT,PUBLISHED,SIMILARLY,TESTING,TREATMENT,UICC,WILEY
000,036,058,100,154,1976,2009,2010,2014,2015,289,295,347,433,531,533,543,587,600,624,741,CRS,ESTIMATES,FIVE,HODGKIN,ITALIAN,ITALY,LABEL,MATERIALS,MEN,METHODS,MORTALITY,OBJECTIVE,OBJECTIVES,PREVALENCE,REGISTRIES,RESULTS,TIME,VALIDATED
0002,4559,833,947,954,CHINA,DATA,EVALUATION,HIFU,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SOLID
001,169,2014,2015,ADIPOSITY,ADULT,BACKGROUND,DOSE,HRT,LABEL,METHODS,PRESS,PUBLISHED,RESULTS,SEPTEMBER,UNIVERSITY,WHILE
126,2010,2011,AFTER,JULY,MARCH,MAY,PATHOLOGY,PSA
100,2008,2013,ADVERSE,ALP,CONCLUSION,CRPC,DOC,FORTY,LABEL,METHODS,OBJECTIVE,OCTOBER,PSA,PURPOSE,RESULTS,SEPTEMBER
102,412,IDC,LABEL,MAPPING,MATERIALS,METHODS,OBJECTIVE,RESULTS,THERE
345,946,950,BACKGROUND,EMT,ENDOGENOUS,HIGH,INCREASED,LABEL,METHODS,PAR,PAR3,PAR6,PAR6SER,RESULTS,RWPE1,TGF
ALSO,CONCLUSION,DATA,FPS,HOWEVER,LABEL,MEDLINE,METHODS,NOMOGRAMS,OBJECTIVE,RESULTS,SELECTION,SOURCES,SYNTHESIS
CARE,COMMITTEE,CONCLUSION,DISEASE,FPS,GROUP,LABEL,METHODS,NETWORK,OBJECTIVE,ONTARIO,PRIMARY,PROVINCIAL,SITE,THESE,UNASSIGNED
2013,8211,APRIL,GIVEN,JANUARY,USA
169,171,2009,2015,3506,AFRICAN,BACKGROUND,COX,HOWEVER,INITIATIVE,LABEL,METHODS,RESULTS,RISK,SOCIETY,THERE,THESE,WOMEN
00026,001,006,011,014,039,146,169,2015,375,8201,ANTIGEN,BPH,COX,DSS,ELISA,GLEASON,PCA,PCR,UICC
169,2015,BACKGROUND,CASTRATION,CD31,ELISA,INC,LABEL,LNCAP,METHODS,RESULTS,RESURGENT,TUNEL,WILEY
0001,0112,169,2000,2010,2015,275,406,642,8201,BACKGROUND,GLEASON,HOWEVER,INC,LABEL,METHODS,PSA,RESULTS,THEREFORE,UNIVERSITY,WILEY
1999,2012,208,234,242,255,308,484,526,602,APRIL,EBL,GLEASON,HOWEVER,LABEL,LRP,MAY,MEAN,METHODS,MINIMALLY,OBJECTIVE,OPERATION,ORP,PSA,RAL,RALRP,RESULTS,RPS,SHORTER,WHILE
169,2015,A549,ADP,ALSO,BAX,BCL,COPYRIGHT,EGFR,GBA,H460,HOWEVER,JOHN,LEWIS,LTD,MCL,MYELOID,NSCLC,OVERALL,PARP,SONS,THUS,TUNEL,WESTERN,WILEY
BEGINNING,PRE
179,195,2002,208,244,507,BACKGROUND,CONCLUSION,GENERAL,LABEL,METHODS,MOOD,PROFILE,RESULTS,SELF,SOCIETY
602,GHRH,MIA,MMP,PAPILLARY,PTC,SIMILARLY,SV1,THYROID
169,2015,946,AKT,ARRESTIN2,CRPC,FOXO1,IGF,INC,PP2A,THUS,WILEY
169,2015,945,946,CONCLUSION,COPYRIGHT,CSC,CSCS,DCC,DCCS,DLQ,FITTING,GBM,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SLQ,SMALLER
0001,001,169,2015,CBCT,CBCTS,CONCLUSION,COPYRIGHT,CTS,CTV,FOUR,HOWEVER,INC,IPMS,LABEL,MATERIALS,METHODS,NODAL,OBJECTIVE,PURPOSE,RESULTS,SBRT,SIXTY,THESE,V100
001,169,2003,2009,2015,2176,7700,9876,CARE,CONCLUSION,COPYRIGHT,COX,HOWEVER,INC,ITALIAN,LABEL,METHODS,OBJECTIVE,OUTCOME,PURPOSE,RADIATION,RATES,REGIONE,RESULTS,ROMAGNA
108,109,169,1998,2008,2015,2223,COPYRIGHT,DRE,DRES,INC,LABEL,LDR,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PHOENIX,RESULTS
001,002,009,169,2015,215,260,8805,COPYRIGHT,CRT,DOSE,GROUP,HOWEVER,IDENTICAL,IMAGE,IMRT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RADIATION,RESULTS,RTOG,THERAPY,THEREFORE,UNIVARIATE
169,177,2010,2012,2015,ACUTE,ADVERSE,COPYRIGHT,GRADE,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,TOLERANCE
001,1422,2011,2012,711,967,APRIL,EFFORTS,IMPORTANCE,LABEL,MAIN,METHODS,OBJECTIVE,PEARSON,RELEVANCE,RESULTS,SETTING,SIMILAR
100,108,112,120,148,169,1999,2005,2006,2012,2015,327,458,8804,8805,AIM,AMICO,ANTICANCER,CONCLUSION,COPYRIGHT,EBRT,GLEASON,HDR,HOWEVER,INSTITUTE,JOHN,LABEL,METHODS,OBJECTIVE,PSA,RECURRENCE,REGARDING,RESULTS,T1C,T2A,T2B,T2C,T3A,T3B,T3BN0M0,UNIVERSITY
100,169,200,2008,2011,2015,AIM,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,GLEASON,HOWEVER,INSTITUTE,JOHN,LABEL,MATERIALS,METHODS,OBJECTIVE,OHDG,PEDF,PIGMENT,PSA,RESULTS
169,2015,AFRICAN,AIM,ANTICANCER,ASIAN,BACKGROUND,CONCLUSION,COPYRIGHT,GLEASON,HAPLOTYPE,INSTITUTE,JOHN,LABEL,MATERIALS,METHODS,OBJECTIVE,PCA,PSA,RESULTS,SEVERAL,SNPS,THESE,VDR
145,169,2015,2YL,AIM,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,CWR,INSTITUTE,JOHN,LABEL,LNCAP,MATERIALS,METHODS,MTT,OBJECTIVE,PC3,RESULTS,ROOTS,THESE,WEST
169,2015,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,ERK1,INSTITUTE,JOHN,LABEL,MATERIALS,MCF,MEK,METHODS,MTT,OBJECTIVE,PCK3145,RESULTS,USING
001,8201,8226,AREA,CONCLUSION,DIFFUSION,KEP,KEY,LABEL,LDA,METHODS,MRI,MRIS,MRSI,OBJECTIVE,OBJECTIVES,RESULTS,ROC,TUMOURS
000,150,2006,2010,2011,3400,3800,4300,5000,800,8300,900,CORRECTED,COSTS,GAMMA,HODGKIN,LABEL,METHODS,OBJECTIVE,PER,RESULTS,VOTE,ZEALAND
CD20,CURRENTLY,HER2,SIMILAR,THUS
145,169,2015,BOTH,COPYRIGHT,CPG,DNMTS,IRELAND,LTD,PC3,RESPONSES,UTR
021,103,151,2007,2012,209,236,339,564,599,938,AMONG,BIOMEDICAL,CONCLUSION,INNOVATION,INSTITUTE,JANUARY,JUNE,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,SMOKING,THYROID,UPPER
169,2015,COPYRIGHT,DU145,IRELAND,LTD,PC3,TFF3,THESE,TREFOIL
101,102,105,107,116,124,177,8201,AIFM,CONCLUSION,CRT,CTV,CYBERKNIFE,D95,D98,DIFFERENT,DOSE,DOSES,DVH,FIELD,IMPORTANT,IMRT,ITALIAN,LABEL,MATERIALS,MEDICAL,METHODS,OAR,OARS,OBJECTIVE,PHYSICS,PLANS,PTV,PURPOSE,REPLANNING,RESULTS,SBRT,SIMILAR,VMAT
163,169,2015,281,COPYRIGHT,CURRENT,EDUCATION,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PATIENT,PUBLISHED,PURPOSE,RESULTS,SUSPICIOUS,UROLOGICAL
169,2015,946,COPYRIGHT,DU145,EFFECTS,EMT,IPA,MAPK,MOLECULAR,P21,P38,PAK1,PC3,RAC1,SELECTIVE,SNAIL,TGF,TRAF6
169,2015,945,ACCORDING,COPYRIGHT,IGFBP,INC,RESULTS,SERUM,VARIATIONS
001,005,008,044,169,2015,290,332,945,CONCLUSION,CONTINENCE,COPYRIGHT,FORM,H2O,HOWEVER,INC,LABEL,MAXIMAL,METHODS,OBJECTIVE,RESULTS,SHORT,SOCIETY
119,169,2015,AAPM,COPYRIGHT,GROUP,IGRT,IMRT,IRELAND,LTD,MRI,PHYSICISTS,TASK
169,2008,2010,2015,227,781,ALZHEIMER,AMERICA,AMERICANS,BACKGROUND,CENTERS,CMS,DESPITE,DOES,FILES,FOUR,LABEL,LIFE,LLFS,METHODS,PRESS,PUBLISHED,QUALITY,RESULTS,SEVEN,SOCIETY,SUMMARY,UNIVERSITY
166,169,2015,204,CADMIUM,CDCL2,COPYRIGHT,ECC,EGFR,ERK1,HEPG2,HOWEVER,INSTEAD,IRELAND,LTD,MAPK,MAPKS,MCF,MDM2,MEK,RAF,SER,TYR
0017,1046,1059,109,114,129,169,183,2009,2011,2012,2015,221,303,381,521,525,526,533,BACKGROUND,CELGENE,CLINICIANS,COPYRIGHT,EASTERN,FUNDING,FURTHER,GRADE,GROUP,IQR,JAN,LABEL,LTD,METHODS,NOV,OVERALL,RESULTS
FURTHER,HEAVY
000,2014,20TH,CHIBA,CURRENTLY,DAV,HEAVY,HIMAC,HOWEVER,HSP90,INSTITUTE,IONS,NIRS,PARP,PROJECT
215,233,ADC,BCG,CONCLUSION,DWI,DWIS,GADOLINIUM,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,T2WI
169,2015,CASTRATION,COPYRIGHT,FURTHER,HOWEVER,IMPORTANCE,LABEL,MPE,OBJECTIVE,PRIMARY,PTEN,SOCIETY,STAT1,THERE,THESE,UNLABELLED,VSV
169,2015,947,950,AM1,CAR,CARS,CD3,COPYRIGHT,DAP12,DNAX,FURTHER,HLA,IFN,INC,ITAM,KIR,NOTABLY,PSCA,YTS,ZAP
169,2015,348,446,794,AFRICAN,AMERICANS,BACKGROUND,CAP,CAUCASIAN,DECISIONAL,INCREASED,LABEL,METHODS,POTENTIAL,RESULTS,SOCIETY,TREATMENT,YOUNGER
JOINT,MONOLIX,PSA,STOCHASTIC
ADC,CONCLUSION,DAILY,DIFFUSION,DWI,EPI,GERMANY,HEALTHCARE,HOWEVER,IMPORTANT,KNOWLEDGE,LABEL,LIVERPOOL,METHODS,OBJECTIVE,OVERALL,PHANTOM,RESOLVE,RESULTS,SIEMENS,THERAPY,THREE
169,1996,2010,2015,7322,8411,BACKGROUND,BECAUSE,BLADDER,BOTH,HIV,LABEL,METHODS,ODDS,ORS,RESULTS,SOCIETY
185,8312,NAF,PET
CIP2A,INHIBITOR,PP2A,SGOL1,THUS,Y2H,YEAST
169,2014,2015,AFTER,APRIL,BACKGROUND,CONCLUSION,COPYRIGHT,DATA,DESPITE,EXTRACTION,FEW,HODGKIN,LABEL,LTD,MEDLINE,METHODS,NOMOGRAMS,OBJECTIVE,PURPOSE,RESULTS,SELECTION,SIX,SOURCES,STUDIES,SYNTHESIS,THREE
169,2015,ABT,CSF1,CSF1R,GROWING,INHIBITORS,TAM,TAMS
1000,113,169,2015,313,BRUEL,KINGDOM,LABEL,MAIN,METHODS,OBJECTIVE,OBJECTIVES,OUTCOME,RESULTS,SETTING,THERE,VAN,WOMEN
ADDITIONAL,BIOMARKERS,DISEASE,EARLY,PSA,TREATMENT
FDA,HOWEVER
ADT,BCR,BECAUSE,DEPENDING,INITIAL,LOCALIZED,MEN,THESE
0001,003,007,020,034,037,057,065,136,139,166,191,199,2000,2009,2011,213,216,219,297,298,302,323,505,508,521,554,583,594,630,788,821,890,942,987,AFRICAN,BACKGROUND,CAS,CIS,HYST,INPATIENT,LABEL,METHODS,NATIONWIDE,ORS,PROST,RADICAL,RESULTS,SMALL,UNI
145,AKT,ALTOGETHER,BAX,BCL,FLOW,HUVEC,LOTUS,LUP,LUPINUS,PARP
CEUS,HOWEVER,JAPAN,PCA,PSA
001,650,698,8201,CONCLUSION,KNOWLEDGE,LABEL,METHODS,MLC,MLCS,OBJECTIVE,RESULTS,VMAT
2012,2013,BACKGROUND,ENGLAND,FURTHER,LABEL,METHODS,NCRS,RESULTS,SERVICE,STAGE
AIMS,BACKGROUND,GLEASON,HOWEVER,LABEL,METHODS,MMP,OBJECTIVE,PSA,RESULTS,SERUM
160,169,2015,8804,CONCLUSION,COPYRIGHT,CSAG2,CTAS,GLEASON,INC,LABEL,METHODS,NOL4,OBJECTIVE,PAGE4,RESULTS,USING
169,2011,2014,2015,CONCLUSION,COPYRIGHT,DATA,EIGHT,FOUR,INC,JANUARY,JUNE,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,TEN,THREE
169,2002,2009,2015,465,594,595,870,8797,AMONG,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,ONTARIO,PROPENSITY,RESULTS,THESE
169,2015,317,353,945,CONCLUSION,COPYRIGHT,DHT,GLEASON,INC,LABEL,METHODS,OBJECTIVE,PREVENTION,RESULTS,SIMILAR,THERE,TRIAL
169,2015,COPYRIGHT,CRITICS,INC,PSA,RANDOMIZED,SCREENING,SIMILARLY,ULTIMATELY
169,187,2006,2012,2015,362,656,747,785,959,ADT,CONCLUSION,COX,CVD,GNRH,LABEL,MEN,METHODS,OBJECTIVE,PCA,PURPOSE,RESULTS,SOCIETY,SWEDISH
015,169,2015,8804,8805,CAD,CONCLUSION,COX,CSS,LABEL,LOW,MAXIMUM,METHODS,OBJECTIVE,PURPOSE,RESULTS,SOCIETY,THERE,THREE
002,1169,169,2015,264,27A1,2986,3577,496,518,8201,945,BACKGROUND,CIS,CYP24A1,CYP27A1,CYP27B1,GENOTYPING,LABEL,METHODS,ORS,P450,PCA,RESULTS,SNP,SNPS,SOCIETY,THERE
003,100,103,1245A,1245C,169,2004,2011,2015,8201,946,ADT,BACKGROUND,CONCLUSION,CRPC,DESPITE,DHT,FURTHER,GLEASON,HSD1,INC,LABEL,METHODS,PSA,RESULTS,WILEY
003,024,032,125,130,293,8201,ESCC,HIGH,HOWEVER,NSCLC,PCAT,PCR,RNAS
1247,1249,1269A,1271,1290,1291,1299,169,2015,BACKGROUND,CONCLUSION,CRPC,FUNCTIONAL,INC,LABEL,LNCAP,METHODS,PCR,RESULTS,SEVERAL,WESTERN,WILEY
ERG,MUTATIONS,SUBSETS
AAA,AIM,BLOT,CONCLUSION,LABEL,METHODS,MUC18,OBJECTIVE,PCR,RESULTS,TEA,USING,WESTERN
2001,2010,474,8805,AMONG,ENDOCRINE,LABEL,MEN,METHODS,OBJECTIVE,OBJECTIVES,PSA,RESULTS,SOCIETY
145,169,2015,22RV1,AMONG,BACKGROUND,CELL,CONCLUSION,ELISA,EMT,ERK,HOWEVER,INC,KNOCKDOWN,LABEL,LCN2,LIPOCALIN,LNCAP,METASTASIS,METHODS,PC3,PCA,RESULTS,ROLE,SLUG,THEREFORE,U0126,WILEY
125B2,133B,169,2015,AFTER,APEX1,BACKGROUND,CHIP,CONCLUSION,H3K4ME2,INC,KDM1A,KLK3,LABEL,METHODS,OGG1,OXIDATION,RESULTS,TMPRSS2,WILEY
169,196,2002,2005,2015,ASIAN,BACKGROUND,DATA,GLEASON,INC,JAPAN,JULY,LABEL,MEDICAL,METHODS,MOST,NINE,PCS,RESULTS,UNIVERSITY,WILEY
169,2015,22RV1,907,916,AKT,BACKGROUND,CHIP,CONCLUSION,DU145,EXPRESSION,INC,LABEL,METHODS,PCR,PTEN,RESULTS,SLUG,SNAIL,WESTERN,WILEY
169,2015,239,ADT,BACKGROUND,CIS,COX,ERG,GLEASON,HARBORING,HRS,INC,LABEL,METHODS,PHYSICIANS,RESULTS,ROUGHLY,THERE,TMPRSS2,WILEY
121,169,2015,BCI,CRC,H3K4ME2,INC,MOST,RNAI,SMYD3,THESE,WILEY
169,2015,22RV1,946,BACKGROUND,E74,ELF5,EMT,HOWEVER,INC,LABEL,LNCAP,METHODS,RESULTS,RNAS,SMAD3,TGF,THESE,WILEY
169,185,2007,2012,2015,574,667,BACKGROUND,CONCLUSION,COPYRIGHT,GLEASON,HIGH,LABEL,LTD,MEN,METHODS,PCA,PSA,RESULTS,STOCKHOLM,THERE
945,BPA,H3K4,HOXC6,MLL,PUBLISHED,SPRAGUE
002,006,009,035,169,2015,COPYRIGHT,EDUCATION,GLEASON,INC,LABEL,MATERIALS,MEAN,MEN,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THERE,UROLOGICAL
169,2015,945,COPYRIGHT,EPHB4,GFP,INC,LEF1,NLS,THESE
169,178,179,2015,AUTHORS,BACKGROUND,CONCLUSION,COPYRIGHT,CRUCIALLY,EPHB4,INC,KLK,KLK2,KLK3,KLK4,LABEL,METHODS,MOUSE,PAGE,PSA,PUBLISHED,RESULTS,SDS,THESE,WESTERN
0001,111,169,194,2015,COPYRIGHT,ERG,GLEASON,INC,INTER,NBX,NBXS,PCA,PTEN,YET
001,003,028,063,169,200,2000,2015,252,452,CAUCASIANS,CHINESE,COX,GLEASON,LABEL,MEIER,METHODS,OBJECTIVE,POTENTIAL,PRESS,PUBLISHED,RESULTS,THERE,UNIVERSITY,UPON
9KDA,EGF,EGFR,EPIDERMAL,ERBB,KNOWLEDGE,PUBLISHED,SEPW1,THUS
139,169,2015,603,675,CAGA,CAUCASIAN,CAUCASIANS,COX,FINALLY,GENOMIC,INFECTION,PCR,PSCA,SINCE,SPAIN,SPANISH,UICC
AFTER,RADIATION,THREE,THUS
068,169,171,2015,683,BACKGROUND,BASEL,DOCETAXEL,HOWEVER,LABEL,METHODS,RESULTS,THERE
169,2015,CROSS,FEDERATION,GYNECOLOGY,NEOVAGINAS,OBSTETRICS,PATHOLOGY,SEX,SHORTENING,SOCIETIES
169,2015,945,ATP,BIOLOGY,CH3,COA,GLUT,GRP78,INC,MOLECULAR,RNAI,SOCIETY
BACKGROUND,CD45,CELLSEARCH,CRPC,CTC,CTCS,LABEL,METHODS,OWING,PRIOR,RESULTS
001,191,2001,2007,2039,954,ABORIGINAL,AFTER,CONCLUSION,CROSS,LABEL,MAIN,MEASURE,METHODS,NSW,OBJECTIVE,OUTCOME,OVERALL,RESULTS,RRR,SETTING,SOUTH,WALES
19Q13,674,8804,8805,AFRICAN,AFTER,CASES,GLEASON,GROUP,GWAS,KLK3,NCI,PSA,SIMILAR,SNP,SNPS,SPORE,WORKING
ACCORDING,AMONG,GLEASON,HOWEVER,PSA,RADS
002,011,013,054,1000,106,177,2000,636,8804,8805,ADC,CONCLUSION,DCE,DWI,MATERIALS,METHODS,MRI,OBJECTIVE,OTHER,RESULTS,THREE
001,003,012,042,1600,215,800,ADC,ANOVA,AUC,CONCLUSION,DECREASING,GLEASON,LESIONS,METHODS,MRI,OBJECTIVE,RESULTS,ROC
169,2015,BCPT,EVEN,INSTITUTE,JNCI,JOURNAL,PCPT,PRESS,PREVENTION,PUBLISHED,THESE,TRIAL,UNIVERSITY,VITAMIN
169,2015,946,947,BRITAIN,CAP,COPYRIGHT,EMT,GREAT,H2AX,IRELAND,JOHN,LINEAGE,LTD,PREVIOUSLY,PTEN,PUBLISHED,SOCIETY,SONS,WILEY
146,146A,169,2015,954,FOXP3,IRAK1,NOTABLY,TARGETING,TRAF6
169,2015,ACIDS,CELL,E2F,E2F3,E2F4,ETS,EWING,EWS,FLI1,NUCLEIC,PRESS,PUBLISHED,RNAI,UNIVERSITY,USING
169,2015,COPYRIGHT,EPRE,INC
001,035,100,160,169,177,2015,COPYRIGHT,EDUCATION,GLEASON,HAUSDORFF,IMAGING,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,TESLA,THREE,UROLOGICAL
069,107,169,2004,2009,2015,827,COMPETING,CONFORMAL,COPYRIGHT,COX,EDUCATION,INC,INTENSITY,LABEL,LOCAL,MATERIALS,METHODS,OBJECTIVE,PROPENSITY,PUBLISHED,PURPOSE,RADICAL,RESULTS,SEER,SHR,UROLOGICAL
169,2010,2015,COPYRIGHT,CRPC,DESPITE,FINALLY,INC
160,169,2015,CONCLUSION,COPYRIGHT,INC,LABEL,MEN,METHODS,OBJECTIVE,RESULTS,THERE
001,002,004,005,009,051,122,8482,8805,CELLSEARCH,COMPARING,CTC,CTCS,LABEL,METHODS,OBJECTIVE,PURPOSE,RADIOLOGIC,RESULTS
ADT,BASED,ONGOING
8594,AKT,AMONG,BACKGROUND,CMS,LABEL,MOLECULAR,PI3K,RESULTS,STN,STNS,TFS,THESE,TMMN
3DMB,MRI,TRUS
PSA,SERUM,THERE
001,139,385,AMONG,BMI,CIS,CONCLUSION,DRE,LABEL,METHODS,OBJECTIVE,ORS,PSA,PSAD,RESULTS,THEN,TRUS
017,131,177,230,252,270,723,ATG5,BPH,CONCLUSION,GLEASON,LABEL,METHODS,OBJECTIVE,PCA,PCR,PIN,RESULTS,USING
001,002,169,2015,407,413,8364,8805,COMPARE,CONCLUSION,COPYRIGHT,COSTS,INC,IRELAND,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SETTING
001,005,115,169,180,2004,2008,2009,2014,2015,340,8201,8805,AGE,AMONG,BACKGROUND,CHINA,CHINESE,CIS,GLEASON,INC,LABEL,METHODS,NONE,OVERALL,PCA,PSA,RESULTS,UCA,WILEY
169,2015,8201,A2A,A2B,ADENOSINE,BACKGROUND,CONCLUSION,INC,LABEL,LNCAP,METHODS,PCR,RESULTS,TAQ,THESE,TOTAL,WESTERN,WILEY
009,169,177,178,183,2005,2010,2015,750,AFTER,ANTI,BACKGROUND,BETWEEN,COPYRIGHT,DEC,FUND,FUNDING,GRADE,IQR,LABEL,LTD,METHODS,N0M0,NETWORK,NOV,RESULTS,SPAIN,SPANISH,T1C,T3B
169,2015,BACKGROUND,BASED,CARLO,CONCLUSION,COPYRIGHT,D10,D90,FIVE,FMC,GROUP,IRELAND,LABEL,LTD,MATERIALS,MCCA,MCW,METHODS,MONTE,OBJECTIVE,PHYSICISTS,PURPOSE,RESULTS,TASK,TG186,TG43,V100
100,18F,AFTER,PET,PSA
000,100,180,195,1997,1998,2002,2006,2008,217,239,AMONG,CONTINENTS,INCIDENCE,OVERALL,RESULTS,THERE,THYROID,USING
152,AIMS,BACKGROUND,FINALLY,LABEL,LIFE,MEASURING,METHODS,OBJECTIVE,PTG,REGARDING,RESULTS,SPIRITUAL,SUBJECTIVE,THESE,YOUNGER
160,169,2015,8544,ADV,COPYRIGHT,EPITOPE,FZ33,INC,LACZ,TROP
111,169,2015,ABOUT,APA,CONCLUSION,CONSTRAST,COPYRIGHT,IEA,III,IPA,IRELAND,IVA,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PCA,PURPOSE,RESULTS,THERE
0001,0002,0023,0035,0042,0270,11152,169,2015,3P13,9876,COPYRIGHT,ERG,ETS,GLEASON,INC,SEC14L1,TMPRSS2,TMPSSR2
0001,137,1560,169,183,2010,2012,2014,2015,2353,292,324,358,400,611,770,779,781,784,AFTER,AMERICA,BACKGROUND,COMPANY,COPYRIGHT,CYP,FUNDING,HOWEVER,INC,IQR,JAN,JUNE,LABEL,LIMITED,LTD,METHODS,MILLENNIUM,NORTH,OCT,ORTERONEL,RESULTS,SERIOUS
169,2015,COPYRIGHT,INC,TOOLS
956,A375,BIOLOGICAL,CELLS,DMF,ELISA,IC50,LNCAP,PC3,THEIR,THREE
HGF,IC50,MET,SAR
166,169,2015,210,COPYRIGHT,EDUCATION,ERSPC,INC,INITIAL,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,ROTTERDAM,RRS,TREATMENT,UROLOGICAL
100,10878,665,AMONG,BACKGROUND,FOLLOWING,GLEASON,LABEL,METHODS,RESULTS,T3A
ADT,AMONG,CLAVIEN,CONCLUSION,DINDO,LABEL,LND,MEIER,METHODS,NEWLY,PALLIATIVE,PSA,RESULTS,SEVENTEEN,SLND,THREE
2006,2013,362,8804,8805,BACKGROUND,DESPITE,GLEASON,HOPKINS,LABEL,MATERIALS,MEAN,METHODS,MRI,PATIENT,PSA,RADICAL,RESULTS,T1C,TRUS,UPGRADING,UPSTAGING,VLR
1893,1915,2004,2007,555,AFTER,AMONG,BACKGROUND,EBRT,INVERSE,LABEL,MATERIALS,METHODS,OVERALL,PRUDENT,RESULTS,SEER
ADT,ANOTHER,BACKGROUND,CTCV3,IRB,LABEL,LHRH,MATERIALS,METHODS,NONE,RESULTS,SURGERY,TREATMENT
100,2012,8302,AVERAGE,BACKGROUND,COMPOSITE,DATA,ENGLISH,EPIC,INDEX,LABEL,MATERIALS,METHODS,PEER,POST,RESULTS,SCREENING,SURGERY
169,2015,ASCT2,AUTHORS,BRITAIN,E2F,GLUTAMINE,GREAT,IRELAND,JOHN,JOURNAL,LNCAP,LTD,PATHOLOGY,SOCIETY,SONS,TCA,USING,WILEY
1980,8226,FUNCTIONAL,GRPR,INCREASING,KEY,LABEL,MOST,MRI,OTHER,PET,PSA,PSMA,UNLABELLED
018,023,103,185,18F,8312,945,946,ANOTHER,CURRENTLY,FDG,FDHT,FES,ICRP,KETTERING,LOUIS,MBQ,PET,SEATTLE,SLOAN,SUV,UNIVERSITY,USING,WASHINGTON,YORK
ADT,CRPC,EVENTUALLY,FURTHER,GPCRS,KETTERING,MEIER,PCA,PTEN,SLOAN
CD44,GLEASON,PSA,SINCE,TNM
000,006,100,140,153,1977,2011,2015,2020,272,368,604,652,695,759,775,777,BACKGROUND,CZECH,DATA,LABEL,METHODS,REGARDING,RESULTS
INITIAL
0008,001,003,129,239,BACKGROUND,COHEN,CONCLUSION,FURTHER,GLEASON,LABEL,METHODS,MRI,RESULTS,START,STD,TAR,THESE
001,0110,169,199,1995,2005,2015,465,589,602,603,956,ADT,CONCLUSION,COUNCIL,GLEASON,GROUP,INTERGROUP,LABEL,MEDICAL,METHODS,NCIC,OBJECTIVE,OVERALL,PR07,PSA,PURPOSE,RESULTS,SOCIETY,T94
003,005,007,008,015,043,052,141,192,209,225,228,ARMS,BONFERRONI,DR4,GLEASON,HIGH,NORTH,PCA,SIMILARLY,VARIANT
169,1988,2010,2015,2268,239,307,377,522,AFRICAN,AMONG,BACKGROUND,CIS,CLINICIANS,DISTANT,END,INCREASING,LABEL,METHODS,ORS,RESULTS,SMRS,SOCIETY,SUICIDE,THERE
FINALLY
014,1007,3734,ENGLISH,FOCAL,HOWEVER,MEN
000,100,169,2008,2009,2015,BACKGROUND,BAYES,COMPONENT,DENMARK,EMPIRICAL,ENGLAND,LABEL,METHODS,POINT,PRESS,PUBLISHED,RATIO,RESULTS,SYSTEMATIC,UNIVERSITY,VARIATION,WARD
947,AKT,ILK,PDK1,PREVIOUSLY,PTEN,VE5
028,035,101,163,169,2008,2011,2015,215,8197,8201,898,AGE,AIM,BACKGROUND,CONCLUSION,COX,DATA,JANUARY,LABEL,LOG,MAIN,METHODS,NSS,NSSS,OBJECTIVE,OCTOBER,OUTCOME,RARP,REGRESSION,RESULTS,SCORE,SHIM,SOCIETY,SUBJECTIVE,TIME
0001,002,4519,595,8201,870,984,BACKGROUND,LABEL,MEN,METHODS,ONTARIO,RESULTS
AIRO,GIOVANI,GROUP,HIGHLIGHTS,MEMBERS,WORKING,YOUNG
169,2013,2015,CONTROL,DCCPS,DCP,INSTITUTE,NCI,POPULATION,PRESS,PREVENTION,PUBLISHED,THREE,UNIVERSITY,VALIDATION
160,8805,AREAS,BACKGROUND,COVERED,LABEL,MDV3100,METHODS,OPINION,PHASE,PREVAIL
160,169,2000,2012,2015,289,923,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,MEN,METHODS,OBJECTIVE,OPTIMAL,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
780,BABL,BACKGROUND,LABEL,LNCAP,MEAN,METHODS,NIRF,OATP1B3,RESULTS,RWPE,THERE
GIM
145,945,956,HELA,IC50,MECHANISM,NMR,TEXAS,THESE
AIMS,BACKGROUND,CCAU,CLEAR,FEW,LABEL,LITERATURE,METHODS,OBJECTIVE,RESULTS,THERE,UNASSIGNED,UROLOGISTS,VARIOUS
108,BILATERAL,LABEL,MATERIALS,METHODS,OBJECTIVE,OPEN,PURPOSE,RESULTS,SIXTY,VARIABLES
006,186,242,341,BASED,BCR,COX,EXOME,HUMANEXOME,INC,LABEL,LNI,MATERIALS,METHODS,OBJECTIVE,PCA,PURPOSE,RESULTS,SNPS,THESE
EVEN,SEVERAL,UROLOGISTS
HOWEVER
ENDOSCOPIC,PANCREATIC,PDAC,VARIOUS
169,2015,307,386,538,552,575,887,968,985,CALCULATOR,CONCLUSION,COPYRIGHT,INC,LABEL,LRS,METHODS,OBJECTIVE,OBJECTIVES,PREVENTION,RESULTS,RISK,SETTING,SNP,SNPS,TRIAL
001,008,047,3DCRT,796,ACUTE,CONCLUSION,CURRENT,INTESTINAL,LABEL,MATERIALS,METHODS,NRI,OBJECTIVE,OVERALL,PURPOSE,RESULTS,RTOG,TOMOSIB,WPRT
019,034,CONCLUSION,CRPC,GLEASON,LABEL,MATERIALS,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS,THERE
LN2,SEPARATOR,SMALLER,THESE,VAPOR
3886,ADT,BECAUSE,EASTERN,ECOG,END,GROUP,HOWEVER,NODE,OFF,RESULTS
145,169,2015,945,946,BACKGROUND,CD44,IGF1,INC,INSULIN,LABEL,LNCAP,METHODS,RESULTS,THESE,VCAM,WESTERN,WILEY
169,2015,3061,3067,3096,3102,449,455,8201,ARTIFICIAL,BACKGROUND,CCK8,DU145,DUAL,INC,IRS1,LABEL,METHODS,MIR200C,PC3,PCR,RESULTS,UTR,WILEY
160,169,2015,426,507,8201,8804,AES,AUTHORS,BACKGROUND,CONCLUSION,DATA,EAP,ECOG,FATIGUE,INC,LABEL,METHODS,RESULTS,SEIZURE,WILEY
169,2015,BACKGROUND,BLOOD,DATA,FINNISH,INC,LABEL,METHODS,PCA,PSA,RESULTS,RISK,USING,WILEY
000,0028,169,1800,1990,1993,2001,2011,2015,AGA,AIMS,BACKGROUND,COLORECTAL,COPYRIGHT,CRC,GERMANY,INC,INSTITUTE,LABEL,LUNG,METHODS,OBJECTIVE,OVARIAN,PUBLISHED,RESULTS,RISK,SCREENING,SIMILAR,TRIAL
169,2015,ARTOCARPUS,CG901,COPYRIGHT,DU145,FOSBERG,INDONESIA,JOHN,LTD,PARKINSON,PARP,SONS,STAT3,THESE,WILEY
169,1970S,2015,956,BOTH,CHIP,COBAS,COPYRIGHT,DDE,DDT,DESPITE,HOWEVER,INHIBITORS,IRELAND,LNCAP,LTD,PCR,PSA,PSMA,R1881,THESE,THUS,VCAP
BPH,CCR7,PC3,PCA,PCR,RWPE,SILENCING,THEN
169,2015,COPYRIGHT,INC
160,169,2015,223,ALPHARADIN,AUTHORS,COPYRIGHT,INC,PUBLISHED
169,16Q23,2015,BIOLOGY,DESPITE,SOCIETY,WWOX
001,169,2010,2011,2015,273,581,AOR,COPYRIGHT,EDUCATION,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,RESULTS,SEER,SIMILARLY,T2A,UROLOGICAL
169,2015,ATF4,AUTHORS,CONSISTENT,FINALLY,KNOCKDOWN,NADPH,PCA,PUBLISHED,ROS,THESE
169,2015,AFTER,CMI,COPYRIGHT,D95,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS,SBRT,SMALL,WITHOUT
169,2015,AMP,AUTHORS,COPYRIGHT,PDE4,PDE4S,PKA,PUBLISHED,UCR1
10Q,10Q23,AFFYMETRIX,CNV,FAS,PCA,PSA,PTEN,SNP
2010,2014,CONCLUSION,DATA,END,KNOWLEDGE,LABEL,LOCAL,MAJOR,MARCH,METHODS,OBJECTIVE,PFS,RESULTS,SBRT,SEPTEMBER,TOXICITIES
000,102MM,11TH,176,20MCG,2GR,800,8MG,956,99M,ADDITIONAL,ANOTHER,CRP,DUE,ESR,EXTENSIVE,FOUR,MDP,MRI,MRSA,SCJ,STIR,T10,WBC
001,007,458,AFTER,BACKGROUD,BCR,COX,LABEL,MEIER,METHODS,NONE,RESULTS,SNP,SNPS,UNLABELLED,WNT
169,2015,340,341,343,946,BIOLOGY,CUB,ECM,GFD,III,INC,MATRIPTASE,MOLECULAR,PDGF,SOCIETY,THROUGH
110,169,177,2015,302,BAY,CONCLUSION,DOSIMETRY,EXM,IMAGING,INC,LABEL,MBQ,MEAN,METHODS,MOLECULAR,NUCLEAR,PCA,PET,RESULTS,SOCIETY,TEN,THREE,UNLABELLED
169,177,2015,204,BEST,CHOLINE,CONCLUSION,FORTY,IMAGING,INC,LABEL,MBQ,METHODS,MODEL,MOLECULAR,NUCLEAR,PET,RESULTS,SOCIETY,SUV,TIME,UNLABELLED
18F,AMONG,BESIDES,FDG,PET
169,2015,263,465,BACKGROUND,INDEX,ISI,LABEL,METHODS,RESULTS,SIDE,SOCIETY
000,160,2014,230,UPON
EARLY,OCT,OPTICAL,SEVERAL
SINCE,THERE,TREATMENT
ADT,HOWEVER,IAD,POTENTIAL,PSA
DECADES,THESE
WHILE
CER,LUNG
PCA,THEIR
METASTATIC,SERUM,WHEREAS
FURTHER,SMALL,THERE
000,100,1299,291,3000,355,371,729,817,8364,QALY,USA
123,151,185,2006,2010,211,233,286,289,4364,440,8805,AIM,AVERAGE,CONCLUSION,COSTS,ICD,JANUARY,LABEL,METHODS,MOST,OBJECTIVE,PCA,RESULTS,THERE
68GA,99MTC,AHX,BRAIN,GLU,HBED,LYS,MDP,PET,PSMA
18F,FCH,OWING,PET
18F,EVEN,FDG,OWING,PET
000,233,BACKGROUND,LABEL,MOST
369,660,674,BPH,GLEASON,MMP,TIMP
BPH,CONCURRENT,GLEASON,TURP
ACTIVATION,HOWEVER,LKB1,MEANWHILE,PTCH,SHH,SMO,THESE
COMPONENT,EFSW,FIELD,FTIR,PCA,PRINCIPAL,WAVE
THEREFORE,URINE
AAA,ADDITIONAL,ANALYTICAL,AXB,CTV,D95,D98,DMAX,DMEAN,DMIN,IMRT,PTV,THERE
181,2000,2011,377,378,421,475,532,651,AMONG,BACKGROUND,COX,HOWEVER,LABEL,METHODS,MORTALITY,MOST,OVERALL,RESULTS,SOCIETY,THESE
169,2015,ACTIVATION,BIOLOGY,EMT,ERK,EZH2,HSP90,INC,MEK,MOLECULAR,REMARKABLY,SNAIL,SOCIETY,TWIST
169,184,185,1989,2010,2014,412,617,BACKGROUND,COPYRIGHT,DATA,FUNDING,HOWEVER,HRS,LABEL,LTD,METHODS,RESULTS,SWEDISH,UNIVERSITY,VASALOPPET
160,169,2015,COPYRIGHT,GATA2,IGF1R,IGF2,INC,INSR,THESE
160,169,2015,CELL,COPYRIGHT,GATA2,IGF1,IGF2,INC,VIDAL
0032,169,177,2015,BASED,COPYRIGHT,HOWEVER,IPSS,IRELAND,LTD,LUTS,PUBLISHED,QMAX,QOL,RUV,SCORE,SYMPTOM,TPV,ULTRASOUND
145,ANNEXIN,BAD,BASED,BAX,BCL,FINALLY,GLUCOSE,GRP78,GRP78KD,HOWEVER,MCL,MTT,THESE
102,139,153,292,GLEASON,NON,THESE
001,006,012,017,044,DIGE,MRM,PAP,THESE,THREE,THUS,URINARY,USING,WESTERN
001,006,013,169,2015,8804,ADT,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,COX,CRCP,CRPC,INSTITUTE,JOHN,LABEL,MANAGEMENT,MEIER,METHODS,OUTCOME,PSA,RESULTS,TTPP
169,2015,8804,8805,AIM,ANTICANCER,AUC,AUCS,BACKGROUND,CONCLUSION,COPYRIGHT,DCA,GLEASON,INSTITUTE,JOHN,LABEL,MATERIALS,METHODS,OBJECTIVE,PCA,PCA3,RESULTS,ROC,SARCOSINE,SEVERAL,SUCCESSFUL
002,169,188,1990,2009,2015,8805,CONCLUSION,COX,HOWEVER,JEFFERSON,LABEL,MAYO,METHODS,OBJECTIVE,PROGNOSTIC,PURPOSE,RESULTS,SOCIETY,THESE,UNIVERSITY
169,2014,2015,ACS,ASCO,CARE,GUIDELINES,LABEL,MEASURE,METHODS,OBJECTIVE,PANEL,PSA,PURPOSE,REFER,RESULTS,SOCIETY
231,264,954,BMMS,BONE,EXTENSIVE,FINALLY,MAPK,MDA,MOUSE,QUE,RANKL,RAW,THEREFORE
ADT,CRPC
DESPITE,OLDER
180,AMONG,APC,BACKGROUND,CPG,FIG,GSTP1,LABEL,METHODS,MSP,OBJECTIVE,OBJECTIVES,PCA,PCR,REF,RESULTS,TAB
252,BOTH,GLEASON,HISTOLOGIC,MEST,SIMILARLY,THESE
945,GLUTAMINE,METABOLIC,NCOA2,SRC,SREBP,TCA
117,118,1996,2007,2009,228,334,448,AFTER,BACKGROUND,BETWEEN,DATA,LABEL,MESORECTAL,METHODS,OBJECTIVE,POPULATION,RESULTS
169,2015,HOWEVER,PRESS,PUBLISHED,THUS,UNIVERSITY
169,2015,BACKGROUND,CHIP,CRC,HUR,KNOCKDOWN,LABEL,MEIER,METHODS,MYC,MYCLO,PRESS,PUBLISHED,RESULTS,RNAS,UNIVERSITY
169,1ST,2010,2013,2015,2ND,8201,ANY,BACKGROUND,CCP,CONCLUSION,INC,LABEL,METHODS,RESULTS,WILEY
169,2015,8201,AUTHORS,BACKGROUND,BALB,DEX,EPR,INC,LABEL,LIPOSOMAL,METHODS,RESULTS,WILEY
00E,10TH,169,2015,8201,8314,8315,AFFYMETRIX,ARRAY,AUTHORS,BACKGROUND,CD44,CD49F,CHIP,DATA,EPCAM,FACS,FETAL,FUNCTIONAL,INC,INGENUITY,LABEL,METHODS,PATHWAY,PCR,PLUS,RESULTS,STROMAL,SUITE,TIC,TOTAL,U133,VERSION,WILEY
169,2015,22RV1,945,946,ALTERED,BACKGROUND,BISULPHITE,CHANGES,CPG,CPGS,FFPE,FURTHER,HOWEVER,INC,ITGA2,LABEL,LNCAP,METHODS,PC3,PCR,RESULTS,TAKEN,WILEY
000,100,128,160,169,194,1996,2009,2015,482,510,767,860,923,AMONG,BACKGROUND,COPYRIGHT,ESRD,FACTORS,FOUNDATION,HISPANICS,HOWEVER,INC,LABEL,METHODS,PUBLISHED,RATES,RESULTS,RISK,SETTING,SIR,THESE
A11,A24,A26,A31,A33,CRPC,CTL,CTLS,HLA,IGG,KRM,MIED,TAA,TOTAL
008,103,157,169,192,2015,209,212,248,646,8805,AMONG,AUC,COPYRIGHT,EDUCATION,GLEASON,INC,LABEL,MATERIALS,MEAN,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SIMILAR,UROLOGICAL
GLI,PATCHED,SEVERAL,SMO
169,183,2015,956,CHINA,COPYRIGHT,DU145,DYSOSMA,FLACK,IC50,PC3,PUBLISHED,TUBULIN,UNIVERSITY
114,169,2015,592,862,COPYRIGHT,EDUCATION,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
1960S,1970S,1980S,1990S,BACKGROUND,CONCLUSION,DUE,LABEL,THEMATA,THUS,UNASSIGNED
2013,2014,212,237,253,269,280,375,80MM,ACCORDING,BACKGROUND,BRNO,CHK,CHO,CONCLUSION,FIRST,KEY,KOC,LABEL,MAY,MEAN,METHODS,NOV,OCTOBER,RESULTS,THERE,TME
MRI,PERINEURAL,PET,THEIR
0201,215,BDC,BDCA,CD1C,EACH,HLA,PHASE
30KB,ABOUT,CTCF,HOWEVER,LNCAP,MOST,RNAS,SAGE,SILENCING,THESE
169,2015,945,COPYRIGHT,EBP,LTD,MOLECULAR,WHILE
027,169,2015,CD44,COPYRIGHT,GLEASON,HOWEVER,INC,SMALL,SMCC
169,2015,COPYRIGHT,CURRENT,INC,PEIN,SIMILARLY,TNM,ULTIMATELY
0015,0MX,120,169,183,2007,2010,2015,410,820,BACKGROUND,BETWEEN,COPYRIGHT,DEC,DUTCH,EORTC,FUNDING,GRADE,HYPRO,LABEL,LTD,MARCH,METHODS,NON,PATIENT,PSA,RESULTS,RTOG,SOCIETY,T1B
11B6,169,177,2015,8243,BALB,CHX,CLI,CONCLUSION,DTPA,FINALLY,FIRST,FREE,IGG1,IMAGING,INC,LABEL,LNCAP,MBQ,METHODS,MOLECULAR,NMRI,NUCLEAR,RESULTS,SOCIETY,SPECT,THROUGH,UNLABELLED
169,2015,945,946,AKT,COPYRIGHT,DIETARY,ERE,ERK,FASL,ICI,INC,JNK,PS2,SERM,SERMS,TNF,TUNEL
BACKGROUND,CONCLUSION,CRPC,DOCETAXEL,GENERALLY,LABEL,MEAN,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS,TREATMENT
1990S,2014,480,AFRICAN,AMERICANS,BESIDES,GENERALLY,INCIDENCE,VARIOUS,WESTERN
D99,IMRT,LABEL,METHODS,OBJECTIVE,PTV,PTVS,PURPOSE,RESULTS,SPORT,STATION
FIVE,HEALTHCARE,IMRT,INITIAL,LABEL,MEDICAL,METHODS,NUCLEAR,OBJECTIVE,OPTIMIZED,PHILIPS,PURPOSE,RESULTS,SUN,SYSTEMS,UIMAT,VMAT
169,2015,AMONG,ASIA,AUTHORS,ELISA,LTD,NEU3,PTY,PUBLISHING,SCIENCE,WILEY
169,2012,2015,BASED,LUNG,OTHER,RISK,SOCIETY
001,5059,5104,ADA,ALT,AST,BACKGROUND,CRP,FRAP,HDL,HOWEVER,IMA,LABEL,LDL,METHODS,PSA,RESULTS,THUS
003,008,169,2015,AKT2,BACKGROUND,CYPD,GAMITRINIB,GBM,LABEL,MECHANISMS,METHODS,NOVEL,PI3K,PI3KI,PRESS,PUBLISHED,RESULTS,SER,SER31,SMALL,THR,UNIVERSITY
145,169,2015,22RV1,BACKGROUND,CONCLUSION,CRPC,FIRST,GAS5,INC,LABEL,LNCAP,METHODS,PI3K,RESULTS,SINCE,WILEY
001,028,059,068,155,467,616,812,835,894,939,HGPCA,HOWEVER,PCA
000,169,1975,2010,2015,2020,900,BACKGROUND,BETWEEN,END,LABEL,METHODS,OVERALL,PREDICTING,RESULTS,SINCE,SOCIETY
169,176,1986,2012,2015,625,798,8201,880,995,COX,EVER,MEN,RRS,UICC
LBD
169,2015,947,B16,CD4,CD8,COPYRIGHT,CPG,IFN,INC,ISCOMATRIX,OVA,PANC,TLR3,TLR9,TRAMP
129,169,2014,BNSRP,COPYRIGHT,HOWEVER,INDEX,PDE5,PUBLISHED,SEVERAL,TADALAFIL,THERE,TREATMENT
169,2015,C81,COPYRIGHT,CRPC,FINALLY,HIPPO,LNCAP,SOCIETY,YAP,YES
145,160,169,2015,ASIA,AUTHORS,FURTHER,LTD,PCA,PTY,PUBLISHING,SCIENCE,SENP1,SUMO,TAKEN,WILEY
001,100,169,2004,2010,2015,803,8804,AFTER,CAUCASIAN,COPYRIGHT,END,GLEASON,GREATER,INC,LABEL,METHODS,OBJECTIVE,PROGRAM,PURPOSE,RESULTS,T1C
1995,2001,2012,BASED,MEN,SERVICE
169,2015,BPH,COPYRIGHT,INC,INSIGHT,RECIPROCAL
ADDITIONAL,AFTER,BACKGROUND,CELLS,FINAL,LABEL,LUTS,PATIENT,PAZOPANIB,PEC,PSA,RESULTS,T1B,THERE,THEREFORE,THREE
2007,2014,CONCLUSION,CTV,GLEASON,IGRT,IMAGE,LABEL,MAXIMUM,MEAN,METHODS,OBJECTIVE,PCA,PSA,PTV,RESULTS,SCORE
168,2011,2013,BACKGROUND,CONCLUSION,DIAGNOSTIC,GLEASON,JUNE,LABEL,MATERIALS,METHODS,PCA,PSA,RESULTS,SPBX,T1C,TESLA
100,155,1ST,2ND,3RD,4TH,8804,8805,ASAP,GLEASON,MOST,PCA,SMALL,THESE
THESE,VITAL
2005,2014,ELECTRONIC,ENGLISH,EPBX,HOWEVER,JANUARY,LABEL,MEDLINE,METHODS,MRI,OBJECTIVE,PBX,PURPOSE,RESULTS,SATURATION,SINCE,SPBX
100,8482,AFTER,AIM,ASAP,AUC,BACKGROUND,GLAND,GRADE,HGPIN,HIGH,LABEL,MATERIALS,METHODS,NEOPLASIA,PCA,PCA3,PPV,PROSTATIC,RESULTS,ROC,SMALL,THESE
2008,2012,835,ASAP,CONCLUSION,GLEASON,JANUARY,LABEL,MATERIALS,METHODS,NEOPLASIA,OBJECTIVE,PIN,PROSTATIC,PSA,RESULTS,SMALL,THERE
0001,001,022,037,038,108,127,162,177,591,756,846,APPARENTLY,BACKGROUND,CAP,DRE,EVEN,LABEL,METHODS,PSA,RESULTS
100,BACKGROUND,BPH,CONCLUSION,FIRST,FOLEY,LABEL,LUTS,METHODS,ROBOTIC
169,183,2015,215,300,956,ACP,ALZHEIMER,ANTI,BESIDES,CL2,COPYRIGHT,H2O,IC50,IRELAND,LTD,MET,MIC,NO3,NONE,SEVERAL
001,003,008,169,2006,2009,2015,242,246,488,ASIAN,AUTHORS,BETWEEN,CENTERS,COPYRIGHT,GENERAL,GERIATRICS,HAWAI,JOURNAL,PACIFIC,PREVENTION,SELF,SOCIETY,TREATMENT
169,1995,2012,2015,435,8482,CAPSURE,COPYRIGHT,COX,DATA,EDUCATION,FACTORS,FURTHER,IMAGING,INC,LABEL,LAST,MANAGEMENT,MATERIALS,MEN,METHODS,OBJECTIVE,POISSON,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
124,2009,2010,2011,BACKGROUND,BELLINI,DIEU,EAST,HOTEL,LABEL,LEBANON,MATERIALS,METHODS,PATHOLOGY,RCC,RCCS,RESULTS,SAINT,UNIVERSITY
2006,2009,695,AMONG,BACKGROUND,IMAM,KERMANSHAH,LABEL,MATERIALS,MEDICAL,METHODS,RESULTS,REZA,SPSS,UNIVERSITY
169,2015,CTCS,GMBH,KGAA,VCH,WILEY
001,054,10540,169,178,1997,2010,2015,HCC,HIV,INC,INSURANCE,PWH,THERE,WILEY
0003,0009,169,175,2015,279,8201,BACKGROUND,E26,ERG,EXPRESSION,GLEASON,HENRI,KAZAL,LABEL,METHODS,PCA,POTENTIAL,PSA,RESULTS,SOCIETY,TFF3
0004,002,004,005,011,014,1007,169,2015,979,AKT,ARRYIPLEX,BACKGROUND,CHINESE,COPYRIGHT,EFEMP1AND,EGF,EGFR,FOUR,GBM,HAN,HOWEVER,LABEL,MASS,METHODS,NOTCH,RESULTS,SNPS
169,2015,COPYRIGHT,III,LTD,MDV3100,THERE
001,169,2010,2015,8804,BACKGROUND,BASED,END,HODGKIN,HOWEVER,LABEL,LARGE,METHODS,MOST,PRESS,PUBLISHED,RESULTS,SEPARATELY,SMALLER,UNIVERSITY,YOUNGER
159,168,177,2006,2014,BECAUSE,FIFTY,MAY,TYPE
169,1958,1960S,1985,1990,1990S,2005,2008,2010,2013,2015,8764,DECREASES,FUKUI,HOWEVER,JAPAN,JOINPOINT,PRESS,PUBLISHED,UNIVERSITY
169,2014,COPYRIGHT,CYDONIA,DYSURIA,IRANIAN,ITM,LTD,MALVACEAE,MOST,PORTULACA,THEREFORE
001,1115,169,2015,275,457,550,658,8805,ADVERSE,AFTER,BECAUSE,COPYRIGHT,CRT,IMRT,INC,LABEL,LYMAN,MATERIALS,METHODS,NTCP,OBJECTIVE,PARAMETERS,PATIENT,PURPOSE,RESULTS,WHETHER
1000,1992,2004,2009,2933,2DRT,3DRT,515,733,8804,DESPITE,END,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,POISSON,PUBLISHED,PURPOSE,RADIATION,RATES,RESULTS,THERE
169,2015,239,395,561,815,AUC,COPYRIGHT,EDUCATION,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PHI,PUBLISHED,PURPOSE,RESULTS,THESE,UROLOGICAL
169,178,187,2015,281,320,828,COPYRIGHT,DETECTION,EARLY,EDRN,EDUCATION,GLEASON,INC,INSTITUTE,LABEL,LESS,MATERIALS,METHODS,NCI,NETWORK,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SABOR,THESE,TREATMENT,UROLOGICAL,USING
169,2015,400,AUC,CALCULATOR,CLEVELAND,COPYRIGHT,DATA,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PCPT,PROTECT,PUBLISHED,PURPOSE,RESULTS,RISK,SABOR,TYROL,UROLOGICAL,USING
THERE
109,126,145,2000,2013,AKT,BETWEEN,BPH,CIP2A,HIGH,MYC,PCA,PCR,RWPE,SILENCING,WESTERN
946,AZA,CDK,DTCS,HNSCC,METASTASES,NANOG,NR2F1,RAR,SOX9
176,A549,AFTER,CASPASE,CELL,DU145,H1299,HSP90,LABEL,MATERIALS,MCF7,METHODS,MRC5,OBJECTIVE,PC3,PURPOSE,RESULTS,T98G,U87MG,VIABILITY
2013,8805,AMONG,BOARD,CHECK,FORCE,HOWEVER,MEDICAL,PHE,PHES,PREVENTIVE,SERVICE,SINCE,SWISS,TASK,THEREFORE
CPG,HER2,SHP,THESE
0001,0002,0014,056,100,169,2015,6687,ACRIN,CHANGES,COLLEGE,CONCLUSION,CRPC,DYNAMIC,IMAGING,INC,LABEL,MEN,METHODS,MOLECULAR,NETWORK,NUCLEAR,OTHER,PET,PFS,RADIOLOGY,RESULTS,SOCIETY,SRC,SUVMAXAVG,UNLABELLED
169,2015,BIOLOGY,HOWEVER,IAP,INC,MKN45,MOLECULAR,SOCIETY,THUS,TREATMENT,YM155
2002,2013,317,ALTOGETHER,BACKGROUND,CONCLUSION,HOWEVER,LABEL,METHODS,NEITHER,PSA,RESULTS,STILL
215,945,CHAIN,HCC,POLYMERASE,PTOV1,REAL
CLEARLY,MNK,MNK1,VNHM
169,2007,2012,2015,BASED,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,TESLA,UROLOGICAL
2015,CHOWDHURY,COMMENT,ONCOTARGET
185,8312,BRAIN,PET
DEVELOPING,ECM,HOWEVER,THEREFORE,USING
10877,10878,330,8764,954,AFFYMETRIX,BACKGROUND,CHRONIC,EARLY,EGR,EGR3,FOLD,IL6,IL8,LABEL,METHODS,POTENTIAL,RESULTS,SILENCING
001,002,077,080,169,2010,2011,2015,338,415,BLACK,COPYRIGHT,EDUCATION,FACILITIES,FEWER,HOWEVER,INC,IQR,LABEL,MATERIALS,METHODS,NCDB,OBJECTIVE,OPEN,PUBLISHED,PURPOSE,RESULTS,THERE,UROLOGICAL
549,AMONG,COMPOUNDS,ESPECIALLY,HELA,THP,URSOLIC
ACP,ATP,LOD,MPA,QDS,THEREFORE,USING
CELL,CELLS,DOCETAXEL,FOLLOWING,GTP,GTPASES,OVERALL,RAS,RHO,RHOA
COMPARISON,E26,ETS,ETV1,HOWEVER,MICE,NKX3,PCA,PIN,PTEN,WHILE,YET
169,2015,8201,ANOVA,BIOLOGY,BPH,ELISA,GLEM,HOWEVER,MMP3,MOLECULAR,RANKL,UNION
169,2015,239,8805,BACKGROUND,CSA,FK506,GLEASON,INC,LABEL,METHODS,NFAT,RESULTS,THUS,WILEY
169,2015,ANDROGENS,BACKGROUND,CELL,CHIP,FINALLY,HECT,HOWEVER,INC,LABEL,METHODS,PCA,PCR,RESULTS,SMAD,WESTERN,WHETHER,WILEY
946,BACKGROUND,DU145,LABEL,PC3,RESULTS,RHO,RHOB,THESE
100,116,205,549,87MG,956,COLO,H322,HCT,MCF,METHANOLIC,NCI,SPP,SRB,THP
145,956,A1CL3,A549,ALP,AMONG,ANTICANCER,CELL,CHLOROFORM,DRIED,FLAVONOID,IGR,MCF,OVI,PIPER,SGOT,SGPT,SRB,THP
0034,1000,285,4X10,789,8211,8X10,ADULT,AGING,G84E,GENOMES,IMPUTATION,MEIER,PERMANENTE,PROGRAM,PROJECT,RISK,WHITE
EARLY,PDE,THESE
CISR,CUMULATIVE,GERIATRIC,GERIATRICS,ILLNESS,OLDER,PCA,SCORE
FOCAL,HOWEVER,LEADING
2014,UNIVERSITY
001,1003,103,122,170,173,2007,2014,213,258,461,469,690,8201,8805,AMONG,BACKGROUND,GLEASON,IDENTIFIER,IMPORTANCE,INSTITUTE,LABEL,MAIN,METHODS,OBJECTIVE,PSA,RELEVANCE,RESULTS,RISK,SETTING,THERE,TRIAL
CTLA
AGS,ANTIGEN,AUTOLOGOUS,DCS,HOWEVER,MHC,TAAS,THESE
DESPITE,RESULTS,STRATEGIES
DESPITE,FURTHER,SOFT,STS,THERE
001,088,169,2015,8805,CONCLUSION,HRS,LABEL,METHODS,OBJECTIVE,PFS,PURPOSE,RESULTS,SIMILAR,SOCIETY
001,062,099,128,169,190,2015,400,653,700,739,760,8805,885,886,ADVERSE,AMERICA,BRIEF,CONCLUSION,FORM,INVENTORY,KEY,LABEL,METHODS,NORTH,OBJECTIVE,ORTERONEL,PAIN,PRIMARY,PSA,PSA50,PURPOSE,RESULTS,SHORT,SOCIETY,TAK
169,177,2014,BOTH,COPYRIGHT,DICE,DSC,FEM,MAD,MIND,MRI,THESE,TRE
002,032,116,169,2007,2014,2015,BECAUSE,COPYRIGHT,EDUCATION,GLEASON,INC,IQR,LABEL,MARCH,MATERIALS,MAY,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
001,169,2001,2011,2015,847,COPYRIGHT,COX,EDUCATION,GLEASON,INC,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THERE,THOSE,UROLOGICAL,USING
169,1998,2004,2015,598,AFFAIRS,AFTER,ANGELES,BEACH,COPYRIGHT,EACH,EDUCATION,INC,LABEL,LOS,MATERIALS,METHODS,OBJECTIVE,PCCI,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL,WEST
150,163,169,2015,219,AFTER,AMONG,COPYRIGHT,COX,EDUCATION,GLEASON,INC,IQR,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PATIENT,PUBLISHED,PURPOSE,RESULTS,UPGRADE,UROLOGICAL
169,2015,308,402,468,8804,AAS,AFRICAN,AMERICANS,AUC,AUCS,CALIFORNIA,CONCLUSION,COPYRIGHT,CURRENT,EPSTEIN,FRANCISCO,GLEASON,HOPKINS,HOWEVER,INC,JOHNS,KETTERING,LABEL,METHODS,MIAMI,NETWORK,OBJECTIVE,RESULTS,SAN,SLOAN,UNIVERSITY
001,004,169,185,2015,8804,CONCLUSION,COPYRIGHT,CRPC,INC,LABEL,LPRES,METHODS,OBJECTIVE,RESULTS,STAGE,THESE,URINARY
002,015,111,118,169,2006,2013,2015,603,CONCLUSION,COPYRIGHT,INC,JANUARY,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,RESULTS,SEPTEMBER,SEVENTEEN,THESE
001,1496,169,2000,2011,2015,AFRICAN,AMERICANS,CONCLUSION,COPYRIGHT,COX,EIGHT,HIV,III,INC,LABEL,METHODS,OBJECTIVE,PSA,RESULTS
001,150,160,169,2006,2010,2015,ADT,BETWEEN,COMPOSITE,CONCLUSION,COPYRIGHT,DISEASE,IMRT,INC,INDEX,LABEL,METHODS,OBJECTIVE,PCA,RESULTS,URINARY,UROLOGY
169,2015,AMONG,BLADDER,CARE,CONCLUSION,COPYRIGHT,ESTIMATED,FOUNDATION,GRADE,INC,INSTITUTE,LABEL,METHODS,NETWORK,OBJECTIVE,PEMS,RESULTS,SOCIETY,TESTICULAR,UROLOGY,WEB
001,100,160,169,1998,2010,2015,220,488,75TH,BETWEEN,COMPLEX,CONCLUSION,COPYRIGHT,DESPITE,INC,INCREASING,INPATIENT,LABEL,METHODS,NATIONWIDE,OBJECTIVE,RESULTS,THESE
169,2015,603,616,676,681,945,AREA,BETWEEN,CLINICIANS,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,PSA,RESULTS
169,2014,AQA,COPYRIGHT,DQD,E12,GLN,INC,NEOPLASIA,PI3K,PRESS,PUBLISHED,SER,THR,TQS
169,2015,ALTO,CBCT,CONCLUSION,COPYRIGHT,CROWN,IMAGE,LABEL,LAT,LTD,MATHWORKS,MEDICAL,METHODS,OBJECTIVE,ORGAN,PALO,PUBLISHED,PURPOSE,RESULTS,SYSTEMS,USA
2004,223,AFTER
001,069,117,154,2014,238,271,385,425,511,739,8202,953,AFTER,LIBRARY,MEDLINE,PSA,SCHOLAR,SECONDARY
005,100,110,169,171,1991,1999,2015,278,318,814,8201,AGDER,AUST,BACKGROUND,COX,GLEASON,HENCE,INC,LABEL,METHODS,PCSM,RESULTS,RSG,RSGS,WILEY
169,2015,22RV1,946,AKT,BACKGROUND,BRDU,CONCLUSION,FURTHER,HOWEVER,INC,KI67,LABEL,LAPC,LNCAP,METHODS,PCNA,PCR,PSA,PSMA,RESULTS,THERE,THESE,WILEY
HOWEVER,PCA,PET,PROSTATIC,PSMA,TOMOGRAPHY
169,2004,2015,AFTER,COPYRIGHT,EFFECTIVE,ELECTRODE,INC,PLASMID
169,17A,2015,231,945,946,956,AKR1C,COMPOUNDS,COPYRIGHT,HELA,HSD,IC50,LTD,MCF,MDA,PC3,SEVERAL,STRIKINGLY,SUPPORTING,THUS
169,2015,ATR,COPYRIGHT,DHT,INC,MRN,TOP1,USING
169,2015,947,BACKGROUND,CAV,CELL,CONCLUSION,DU145,INC,LABEL,LNCAP,METHODS,MTT,PC3,PCR,RESULTS,THERE,THESE,WILEY
106,114,118,170,183,185,2007,2013,214,230,240,267,314,428,534,APRS,ARP,BOTH,CONCLUSION,DATA,FBG,GENERAL,HAN,HOWEVER,HUI,JANUARY,LABEL,MEDICAL,METHODS,NINGXIA,OBJECTIVE,PSA,RESULTS,SEPTEMBER,UNIVERSITY
000,100,176,1999,2008,2015,217,259,471,713,ASR,ASRS,BACKGROUND,BLACK,BWIRR,CENTRAL,EAPC,EAPCS,EAST,END,INC,LABEL,METHODS,NPCR,PROGRAM,PUBLISHED,REGISTRIES,RESULTS,SEER,SOUTH,WESTERN,WHITE,WILEY
001,169,2014,2015,5KG,ADIPOSITY,ADULT,BACKGROUND,DOSE,HRT,LABEL,METHODS,PRESS,PUBLISHED,RESULTS,SEPTEMBER,UNIVERSITY,WHILE
169,2015,786,945,AUC,BACKGROUND,BECAUSE,HOWEVER,LABEL,METHODS,MOTIVATION,PRESS,PUBLISHED,RESULTS,THEREFORE,UNIVERSITY
001,006,023,043,10878,169,2015,261,6MGL,BACKGROUND,COPYRIGHT,COX,CRP,CSS,DFS,GLEASON,LABEL,LTD,MEIER,METHODS,PSA,RESULTS,ROC
160,169,176,2015,8805,947,BLADDER,COLLIMATOR,COPYRIGHT,DMIN,EACH,EUD,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,ROTATIONS,S78,SIMULATED,VMAT
169,2015,946,954,COPYRIGHT,EGF,EMT,HLA,LTD,NEXT,SNAIL,TAKEN,TGF,THESE,THUS
8805,CD11B,CTCS,CTX,DLS,FURTHER,LEN,LIN,MDSC,MDSCS,MTD,PSA,SIX
169,2015,COPYRIGHT,ERK1,IRELAND,LTD,NSCLC,PTP1B,THESE
BACKGROUND,BASED,DESPITE,HOWEVER,LABEL,OBJECTIVE,ORP,PURPOSE,RALP,REGARDING,RESULTS,ROBOT
000,1444,160,1604,169,1700,2015,542,570,8364,880,AUTHORS,BACKGROUND,CONCLUSION,COPYRIGHT,ICER,IMRT,IRELAND,LABEL,LIFE,LTD,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,QALY,QALYS,RESULTS,TREATMENT,YEARS
8482,ADP,AUSTRALIA,BRCA,CHINA,EWING,III,JAPAN,KOREA,SOUTH,USA
169,2015,BESIDES,CDK,CDK1,CELL,COPYRIGHT,HOWEVER,INC,KNOCKDOWN,MG132,MMP,MPM2,PLK,TAXANES,THESE,TUBULIN
8BR,AKT,AMP,BCRP,CHROMATIN,CRE,CREB,CRTC2,EGF,EGFR,EPIDERMAL,ERK,LNCAP,MAPK,PI3K,PUBLISHED,RAS,SILENCING
001,027,1000,116,177,339,552,555,613,733,770,794,8804,8805,954,ADC,ADCS,AUC,AUCS,CONCLUSION,DATA,DWI,ECE,FIFTY,GLEASON,HOWEVER,IMAGING,MATERIALS,METHODS,MRI,OBJECTIVE,RADS,REPORTING,RESULTS,ROC,STUDENT,THEN,THERE
001,100,130,177,192,5015,BRAZILIAN,GLEASON,IPSS,LABEL,MATERIALS,METHODS,MOST,OBJECTIVE,OBJECTIVES,PSA,RESULTS,THERE
169,181,2015,8482,954,A549,BACKGROUND,BASEL,CNS,CONCLUSION,EFFORTS,GI50,INSTITUTE,LABEL,METHODS,NCI,NSCL,PI3K,RESULTS,SCREENING,SRC,SRS06,STAT3,TRANSAM,WESTERN
130,169,2015,BPH,COPYRIGHT,EPIC,FACTORS,FINALLY,HEIDELBERG,HOWEVER,LTD,VITAMIN,WESTERN
125,169,2015,99M,AFTER,BECAUSE,CONCLUSION,IMAGING,INC,LABEL,LNCAP,METHODS,MIP1095,MIP1404,MOLECULAR,NUCLEAR,PMPA,PSMA,RESULTS,SINCE,SOCIETY,THESE,UNLABELLED
10878,130MMHG,169,2015,25KG,283,ADJUSTING,AMONG,BACKGROUND,BMI,CONTROL,COPYRIGHT,COX,GLEASON,LABEL,LTD,METHODS,RESULTS,SBP,VAT
0001,100,169,2015,381,442,8201,DATA,HHV,INC,LOW,POISSON,SERUM,THERE,WILEY
1955,2011,2096,474,EARLIER,LABEL,LIMA,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
160,169,2015,945,946,ASIA,AUTHORS,LTD,PTY,PUBLISHING,SCIENCE,WILEY

145,169,200,2015,ASIA,AUTHORS,BCL,GINKGETIN,LTD,PTY,PUBLISHING,SCIENCE,STAT3,THEREFORE,WILEY
107,225,267,341,DU145,EMT,FIRST,FURTHER,PLB,PLUMBAGIN,SILAC,THESE,WESTERN
169,2014,231,233,BIOLOGICAL,COPYRIGHT,CPMHS,CPMRC,FRAN,HSMPC,MCRPC,PUBLISHED,SAS,SOCI
160,169,2014,231,233,BRCA1,BRCA2,COPYRIGHT,FRAN,G84E,MENDELIAN,PUBLISHED,SAS,SOCI,THESE
001,160,8201,BACKGROUND,CDU,CONCLUSION,DOPPLER,FURTHER,LABEL,METHODS,PEARSON,POTENTIAL,RESULTS,ULTRASOUND
169,2015,COPYRIGHT,HIGH,RAMAN,SCIENCE,SERRS
274,459,CAUCASIANS,NQO1,OVERALL,PRO187SER
006,008,019,023,BLOOD,DYNAMIC,FDG,FOV,GIVEN,HISTOLOGY,LABEL,METHODS,MRI,OBJECTIVE,PET,PURPOSE,REGIONS,RESULTS,THREE
956,GLEASON,PET,T3B
ACUTE,AICAR,AKI,ALCAR,AMPK,OXIDATIVE,SIRT3,TREATMENT
219,228,ADVERSE,AMERICA,BACKGROUND,BMD,CONTEXT,FEWER,LABEL,MAIN,MEN,METHODS,NORTH,OBJECTIVE,OUTCOME,RESULTS,SETTING,THESE
1525,2009,2012,ACCORDING,AFTER,AIM,ASAP,DRE,HGPIN,IHC,LABEL,MATERIALS,METHODS,OBJECTIVE,PCA,RESULTS,TRUS
945,CRPC,STRUCTURAL,THESE
169,2015,A20,BAP1,CYLD,DUBS,UCHL1,USP22,USP7
100,1000,177,2000,500,8805,AREAS,CONCLUSION,CRS,DIFFUSION,DWI,DWIS,KNOWLEDGE,LABEL,METHODS,MRI,OBJECTIVE,PCA,RESULTS,THESE
2005,BACKGROUND,CONCLUSION,GLEASON,ISUP,LABEL,MATERIALS,METHODS,RESULTS,UPGRADING
197,2000,2012,8804,8805,ADT,BACKGROUND,COX,EIGHT,GLEASON,LABEL,MATERIALS,METHODS,NINE,PATHOLOGIC,RESULTS
000,0001,2008,2ND,5TH,900,BACKGROUND,IRANIAN,LABEL,METHODS,RESULTS,SMOKING
COMPETING,RNAS,THERE
23A,23B,JAK,LNCAP,MAPK,MICRORNAS,PC3,STAT,THESE
169,1964,2010,2015,FIVE,FURTHER,INCREASED,SIR,SIRS,SWEDISH,T2DM,UICC
THESE
KLF4,MICRORNAS,NANOG,OCT4,OCTAMER,POU,RNAS,SEVERAL,SOX2
102,104,145,163,223,282,3263,3722,4208,517,595,643,722,BACKGROUND,CONCLUSION,COSTS,KINGDOM,LABEL,METHODS,NHS,PREDICTORS,RESULTS,SERVICE,TRUST
2011,DIGITAL,JANUARY,MARCH,PSA,SINCE,T2CN0M0
FIVE,SMALL
113,1881,2000,2005,2008,2011,254,3713,8197,8804,BMJ,DATA,DETERMINE,GROUP,LABEL,LIMITED,METHODS,NON,OBJECTIVE,OBJECTIVES,PFOA,PUBLISHED,PUBLISHING,RESULTS,RHEUMATOID,RRS,THESE,ULCERATIVE
DATA,HT1,HT2,SEROTONIN,SERUM
0033,1000,1088,145,169,2015,238,302,354,365,387,435,540,542,546,741,773,BACKGROUND,COPRIMARY,COPYRIGHT,COU,EASTERN,FUNDING,IQR,JANSSEN,LABEL,LTD,METHODS,OVERALL,RESULTS,THESE
001,005,116,1603,169,1816,2008,2012,2015,202,251,282,2820,341,350,450,629,6424,652,653,8805,979,980,AUSTRALIA,AUTHORS,BJU,CONCLUSION,DATA,GLEASON,LABEL,MEN,METHODS,NCCN,NETWORK,OBJECTIVE,OBJECTIVES,OVERALL,PSA,RESULTS,THERE,VICTORIAN
ARF,CD24,MDM2,NPM,SV40,THESE,TP53
169,2015,ALKB,ANTICANCER,AUC,COPYRIGHT,DU145,HUHS015,INSTITUTE,JOHN,NEXT,PCA
0001,118,8805,954,967,CONCLUSION,DATA,DRE,IMAGING,LABEL,MANN,MATERIALS,METHODS,OBJECTIVE,PEARSON,PSA,PURPOSE,RADS,REPORTING,RESULTS,THERE,WHITNEY,YATES
100,1040,169,184,2014,8805,AFTER,CONCLUSION,GLEASON,HIPAA,LABEL,MATERIALS,METHODS,NPV,OBJECTIVE,PPV,PURPOSE,RESULTS,RSNA,SWE
263,360,4356,485,824,993,AFRICAN,ARAB,ASIAN,DANES,EAST,EASTERNERS,EUROPEANS,HRS,IRANIAN,LOW,NORTH,ORDINAL,PANCREATIC,SOUTHEAST,SWEDISH,TURKISH,TURKS
001,177,180,599,779,BPH,IPSS,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCORE,SYMPTOM,TARGETING,THERE,YANGPYEONG
0005,004,173,272,AMONG,DHT,GLEASON,HOWEVER,LABEL,MATERIALS,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS,SNPS,STEROID
ADDITIONAL,ADT,FAT
CURRENTLY,MRGB,MRI,PCA
169,177,2014,2015,ABOVE,BACKGROUND,FEBRURARY,INC,LABEL,METHODS,PET,PSA,PSMA,RESULTS,THEIR,THERE,WILEY
102,122,169,1987,2011,2015,287,595,ASAP,BACKGROUND,CHART,EPSTEIN,FIVE,GLEASON,INC,LABEL,MARCH,METHODS,PCA,RESULTS,TEN,USING,WHILE,WILEY
001,004,007,1000,169,2015,213,215,562,599,645,815,8201,AFTER,AUC,BACKGROUND,DENSITY,DRE,FR0348383,INC,LABEL,METHODS,PCA,PCA3,POST,PSA,RESULTS,ROC,WILEY
125B,152,169,200B,200C,2015,375,659,672,676,679,680,690,701,724,758,788,809,869,AMICO,AUC,BACKGROUND,DRE,INC,LABEL,METHODS,MRI,PCA,PCA3,PRIAS,PSA,RESULTS,SMALL,THESE,WHILE,WILEY
125B,126,151A,169,2015,221,222,486,8805,AKT,BACKGROUND,BPH,CHINA,INC,LABEL,METHODS,PCA,PCR,PI3K,RESULTS,WILEY
169,2015,348,559,AUTHORS,BJU,BONFERRONI,C61,CONCLUSION,CURRENT,ICD10,IRELAND,JOHN,LABEL,LTD,METHODS,OBJECTIVE,OVERALL,PREVALENCE,QUESTIONS,RESULTS,SONS,SYMPTOM,WHILE,WILEY
2014,MAY,PARTICULAR,RAF,RKIP,WHILE
000,2020,2030,255,416,620,GPS,POOR,UROLOGISTS
CRPC,MOST
AHT,CONCLUSION,ECT,LABEL,METHODS,MRI,OBJECTIVE,PSA,RESULTS
177,178,293,428,956,971,972,BMP6,BMPC,BPH,CONCLUSION,ELISA,FSTL,LABEL,METHODS,OBJECTIVE,RESULTS,THERE,USING
007,008,009,017,023,025,041,043,155,CHINESE,CONCLUSION,DNMT,DNMT1,GLEASON,HOWEVER,LABEL,MASSARRAY,METHODS,OBJECTIVE,PCA,RESULTS,USING
CRPC,H3K4ME3,JARID1B,K63,MEFS,PCA,PTEN,SKP2,TAKEN,TRAF6,TRP53
945,946,HGF,MMP,MSC,SMA,STROMAL,TGF,VEGF
0001,169,2015,2041,2093,4134,500,ANTIBIOTIC,CIPROALONE,CIPROCEFT,CONCLUSION,COPYRIGHT,EIGHT,INC,LABEL,METHODS,OBJECTIVE,PATIENT,RESULTS,SIRS
169,2015,754,COPYRIGHT,CROWN,DERIVED,DOSE,EFFECTS,INC,LABEL,LATE,LENT,MANAGEMENT,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RADAR,RESULTS,SEPARATION,SOMA,SUBJECTIVE,TISSUES,TROG,UNIVARIATE
001,004,007,169,1994,2010,2015,254,388,400,470,500,687,7974,COPYRIGHT,EBRT,FINAL,HDR,INC,LABEL,LDR,MATERIALS,MEIER,METHODS,OBJECTIVE,PATIENT,PROCARS,PROPENSITY,PURPOSE,RESULTS
0017,0343,250,293,375,ADRS,CAB,CTI,DSS,JAPIC,LTD,PFS,PSA,QOL
131,223,CD20,HODGKIN,III,STRONTIUM,THEREFORE,YTTRIUM,ZEVALIN
CTV,DVH,IGBT,MRI,PTV
1994,FOUR,GUNMA,HEAVY,INSTITUTE,ION,JAPAN,MEDICAL,NIRS,PRIMARY,SCIENCE,UNIVERSITY
IMRT
ARS,DESPITE,TARGETING
000,SEVERAL
169,2015,217,839,CONCLUSION,FIFTY,IMAGING,INC,LABEL,METHODS,MOLECULAR,MOST,NAF,NUCLEAR,OVERALL,PET,RESULTS,SOCIETY,UNLABELLED
169,2015,BPH,CHRONIC,COPYRIGHT,HOWEVER,INC,THEREFORE
100,169,2015,956,AKT,BOTH,COPYRIGHT,IRELAND,LNCAP,LTD,OBACUNONE,TREATMENT
ADT,GNRH
443,AVERAGE,BACKGROUND,BIAS,CAV1,CPRC,CRPC,CYTOSCAPE,DAVID,DEGS,EXPRESSION,FGFR3,LABEL,LNCAP,LYN,METHODS,MULTI,OMNIBUS,ORTHOTOPIC,PERL,RESULTS,RMA,SEVERAL,TFS,THEN,THESE,USUALLY
13C,181,945,946,BAX,BCL,COMMIPHORA,CYCLOARTAN,IC50,MTT,PLANT,THESE,TUNEL,WESTERN
118,IMR,LNCAP,PAP,PCR,PROSTATIC,RENEWED,SELEX,SYSTEMATIC
001,124,2015,945,946,CRPC,CYP17,GALETERONE,III,PHASE,TOK
936,ACA,BOX,FINALLY,RNAS,RNPS
169,2015,21KD,BCL6,BIOLOGY,CUL1,EXPRESSION,HIGH,INC,MOLECULAR,PCR,SINCE,SKP1,SOCIETY
100,160,553,8201,ASTRO,CONCLUSION,CRT,DFS,DISEASE,DOSE,IMRT,LABEL,LATE,LENT,MATERIALS,METHODS,OBJECTIVE,PHOENIX,PSA,PURPOSE,RESULTS,RFS,RTOG,SIB
100,169,2005,2015,675,ADT,AUSTRALIAN,BACKGROUND,COLLEGE,EBRT,EIGHT,FIVE,GRADE,HDR,IMRT,LABEL,LDR,METHODS,MFS,MRI,PCASS,PREVALENCE,RESULTS,ROYAL,ZEALAND
BACKGROUND,BETWEEN,CONCLUSION,CURRENTLY,DESPITE,DIAGNOSTIC,GERMANY,HIFU,HIGH,LABEL,OBJECTIVE,OBJECTIVES,PRIMARY,RESULTS,SALVAGE
231,H460,LNCAP,MCF,MDA,PCA,RAMAN
STEROID,THESE
128,483,AIM,BACKGROUND,CIS,ELISA,FISH,LABEL,METHODS,NMIBC,NMP22,NPVS,RESULTS,UROVYSION
0001,169,170,2015,274,AUTF,BACKGROUND,BUTF,HOPKINS,JOHNS,LABEL,METHODS,RESULTS,SOCIETY,UTF
64257,64CU,730,8209,BBN,GASTRIN,GRPR,PC3,PET
001,169,2007,2012,2015,4233,8805,CONCLUSION,COPYRIGHT,EPSTEIN,GLEASON,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,PREDICTIVE,PSA,RESULTS
1033,2000,365,401,962,AIMS,AMICO,ASSESSING,ATM,BMJ,ERG,GROUP,HISEQ,LABEL,LIMITED,MEK5,MEN1,METHODS,NCOR2,NGS,OBJECTIVE,PUBLISHED,PUBLISHING,RESULTS,SPOP,TMPRRS2,TP53,USING
ADIPOR1,AMPK,TAKEN,TSC2,VEGF
DESPITE,EARLY,HEPATOCYTE,III,PHASE
169,2015,248,8201,8805,AFTER,BACKGROUND,DTC,DTCS,DUE,GLEASON,INC,LABEL,M30,METHODS,PSA,RESULTS,WILEY
005,169,2015,22RV1,8764,8804,BACKGROUND,BOTH,CONCLUSION,CONVERSELY,CYP3A,DECREASED,DHT,IC40,IC60,INC,LABEL,LNCAP,METHODS,PSA,R1881,RESULTS,TMPRSS2,WILEY
169,2015,BACKGROUND,BARR,EARLY,EBV,EIGHT,EPSTEIN,FRESH,INC,LABEL,METHODS,NOG,NSG,PDX,PDXS,RESULTS,SIXTY,THERE,THEREFORE,WILEY
169,2015,BACKGROUND,BASED,CONCLUSION,DU145,E2F1,FINALLY,INC,LABEL,LNCAP,METHODS,RB1,RESULTS,USING,WESTERN,WILEY
169,2015,COPYRIGHT,EDUCATION,INC,LABEL,LYMPHATIC,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THREE,UROLOGICAL
169,2014,BRCA1,BRCA2,PARP
001,169,2004,2007,2011,2015,3001,744,827,BACKGROUND,COPYRIGHT,COSTS,LABEL,METHODS,NCCN,NETWORK,PROGRAM,RESULTS,SEER,TOXICITIES
0001,0004,006,169,2015,460,468,8201,CHEK2,I157T,IVS2,MUTATIONS,THESE,UICC
100,125,145,164,169,2000,2012,2015,638,700,AMICO,COPYRIGHT,FEW,INC,JANUARY,JULY,LABEL,MATERIALS,MEIER,METHODS,MOST,OBJECTIVE,OVERALL,PPB,PUBLISHED,PURPOSE,RESULTS,SEED,SOCIETY
119,125,BACKGROUND,BLOOD,CORE,GLEASON,LABEL,METHODS,MTT,NETWORK,PCA,PCT,PSA,RESULTS
001,023,150,169,177,193,2014,266,488,BACKGROUND,FREQUENCY,HOWEVER,JOHN,LABEL,LTD,MEAN,METHODS,PSCA,RESULTS,SONS,WILEY
12T,947,CELL,HOWEVER,LNCAP,LPB,NTSR1,SMALL,TAG
1514,169,2015,BACKGROUND,LABEL,METHODS,MIXED,OLDER,RESULTS,SIXTEEN,SOCIETY,THERE,THESE
169,2015,ACS,ACT,AFFORDABLE,CARE,EACH,INTERVIEW,NHIS,SOCIETY
007,009,013,015,020,043,BOTH,DIETARY,WESTERN,ZEALAND
169,2013,2014,343,APPRAISAL,AUTHORS,BACKGROUND,CONCLUSION,COPYRIGHT,DUTCH,ENGLISH,FACTORS,FURTHER,HOWEVER,IMPORTANT,LABEL,LTD,MATERIALS,METHODS,MIXED,OLDER,PUBLISHED,RESULTS,SYSTEMATIC,TEN,TOOL
946,AUSTRALIAN,EIGHT,LNCAP,NMR
104,105,181,183,211,8734,AUC,FE3,HDACI,LABEL,LAQ,LIPOSOMAL,METHODS,OBJECTIVE,PEGYLATED,PURPOSE,RESULTS,SAHA,SIMILARLY
160,181,BAX,BCL,CCK,CELL,FCM,FIRSTLY,FITC,KIT,NEXT,PEPEROMIA,THEN,THESE,TUNEL,WESTERN
169,2015,34B,946,COPYRIGHT,EMT,FOXO,HOWEVER,INC,TCF,UTRS
160,CONCLUSION,LABEL,MATERIALS,METHODS,MRGB,MRI,OBJECTIVE,PCA,PSA,PURPOSE,REPEATEDLY,RESULTS,TESLA
001,ADT,CSM,CSS,HIGH,OVERALL,PCA
021,109,8201,8805,BAX,HSP70,P27,PCA,PREVIOUSLY,STUDIES,THREE
009,027,169,2014,254,AIM,CME,COLLEGE,CONCLUSION,COPYRIGHT,DCE,DWI,LABEL,LTD,MATERIALS,METHODS,MRI,OBJECTIVE,OVERALL,PARAMETRIC,PUBLISHED,RESULTS,ROYAL,THERE
PET
100,105,151,177,8805,BMI,CONCLUSION,FIFTY,GLEASON,IIEF,LABEL,METHODS,NPT,OBJECTIVE,PABFV,PBI,PCA,PSA,RESULTS,THERE,TVSSLRP
156,CONCLUSION,HOWEVER,LABEL,METHODS,OBJECTIVE,PSA,RESULTS,SINCE
314,AKT,ARRAY,BRB,CONCLUSION,ECM,GEO,KEGG,LABEL,METHODS,MOTIFSCAN,OBJECTIVE,PI3K,PROTPARAM,RESULTS,SIGNALP,SPP1,TMHMM,TOLL,TOOLS,TOTALLY
AIDS,CHINA,GIVEN,HIV,HPV,HSV,JOINT,NATIONS,PROGRAM,RING,SHANG,WORLD
200,RNAS
169,2009,2011,2014,8804,ACUTE,ADVERSE,AIMS,COLLEGE,COMPOSITE,COPYRIGHT,DOSE,FURTHER,GLEASON,INDEX,INITIAL,INSTITUTE,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OVERALL,PSA,PUBLISHED,QUALITY,RESULTS,ROYAL,SIMILARLY
000,009,012,015,018,020,023,028,030,090,094,108,158,169,177,178,196,201,2015,224,262T,379,429,469,641,707,CAT,CAUCASIANS,COPYRIGHT,PCA,SEVERAL
169,2013,2014,2015,223,945,CRPC,DATA,DRUG,EXTRACTION,FOOD,FURTHER,LABEL,MAY,MEDICAL,MEDLINE,METHODS,OBJECTIVE,OCTOBER,PEER,PHASE,RESULTS,REVIEWS,SELECTION,SOC,SOURCES,SYNTHESIS
000,003,010,023,100,109,179,181,2003,2008,240,300,484,575,641,800,967,970,BFFS,CSS,DMFS,GLEASON,JANUARY,LABEL,MEIER,METHODS,OBJECTIVE,PERMANENT,PSA,RESULTS,T3A,THERE
946,DESPITE,FURTHER,LOW,PCA,WESTERN
125,956,AOAC,AVA,BBN2,BESIDES,BLOOD,BOTH,CURRENT,FA01010,FBZ,FDG,GBQ,GRP,IC50,INFLUENCE,LABELED,NH2,PC3,PET,QWAV,SAR,SFB,TLE,TYR
APOPTOSIS,ARRAYSCAN,CELL,CELLOMICS,FURTHER,MTT,PCR,VTI
223,945,CRPC,CYP17,DESPITE,III,PHASE
174,BRISTOL,CTLA,III,IPILIMUMAB,MYERS,PHASE,USA
GPS,ITALIAN,THEREFORE
1BBL,946,947,AIM,CD3,CD56,CIKS,CONCLUSION,DCS,FLOW,IFN,LABEL,METHODS,OBJECTIVE,RESULTS,TGF,THESE
177,1998,2010,2464,30MIN,3126,313,46GY,75CC,88CC,AVERAGE,DUE,EBRT,EIGHT,EVERY,FOUR,HOWEVER,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,POST,PUBLISHED,PURPOSE,R100,RESULTS,THEIR
001,169,2012,2015,8212,AQP1,BACKGROUND,CONCLUSION,COPYRIGHT,EDUCATION,FOUNDATION,IDENTIFIER,INC,KRUSKAL,LABEL,MAYO,MEDICAL,METHODS,OBJECTIVE,OCTOBER,PLIN2,PUBLISHED,RCC,RESULTS,THESE,TRIAL,URINE,WESTERN
0001,002,169,1995,2014,2015,251,557,AFTER,COPYRIGHT,COX,DUE,EDUCATION,FREEDOM,GLEASON,INC,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
108,135,169,1997,2005,2015,326,354,AJCC,BACKGROUND,COMMITTEE,CONCLUSION,COPYRIGHT,END,IIIB,INC,JOINT,LABEL,METHODS,PCSM,RESULTS,SEER,STAGE,STAGING,T3AN0M0,T3BN0M0,TANYNANYM1,USING
001,131,229,CHINESE,CONCLUSION,HAN,HARDY,IL1A,LABEL,METHODS,OBJECTIVE,PCA,PCR,RESULTS,RFLP,TTCA,UTR
177,2008,2013,321,336,341,361,378,399,423,457,500,771,916,942,ACCORDING,AMONG,CONCLUSION,FOUR,III,JANUARY,LABEL,METHODS,OBJECTIVE,OCTOBER,OPERATIVE,RESULTS,THERE,THREE,TOKUHASHI,VAS
100,ADC,DCE,HENCE,HSC,MRI,ROI,ROIS,SUPPORT,SVM,T2W
CONSENSUS,DICE,DSC,HOWEVER,INTER
2012,CHALLENGE,DETECTION,GRAND,IMAGE,MRI,OPTIMAL,OSD,PROMISE,SURFACE,THESE
ACCORDING,BASED,DCE,MRDI,MRI,PCA
DCE,MRI,SEVERAL
CURRENT,DIFFUSION,DWI,MRI
AAM,AUTOMATIC,SVM
100,109,187,200,280,295,350NM,550NM,956,EACH,HENCE,PARTIAL,THUS
1800S,PSA,SINCE,THERE
945,946,AKT,BISPHENOL,BPA,MAPK,PI3K,STAT3
2006,2011,2013,480,8201,FIVE,MOST,PATIENT,SIX,SURGERY
169,2014,2015,DATA,ENGLISH,LABEL,METHODS,OBJECTIVE,RESULTS,SELECTING,SOURCES,STUDIES,SYSTEMATIC
946,AKT,BTG3,CONSISTENT,E2F1,THUS
169,2015,946,BIOLOGY,DESPITE,DU145,IFN,INC,IRF3,LNCAP,MDA5,MOLECULAR,PC3,PCA,RIG,SOCIETY,SRC,STAT1,THEREFORE,TLR3,TOLL
169,2015,945,946,AFTER,AMONG,BIOLOGY,INC,MOLECULAR,OVERALL,PC3,PRCA,PTEN,RECIPIENT,RWPE,SOCIETY,TGF
169,2015,BACKGROUND,CITUP,CONTACT,INTRA,LABEL,METHODS,MOTIVATION,PRESS,PUBLISHED,RESULTS,UNIVERSITY,USING
100,169,2015,400,8805,ADTS,AFTER,BAT,CASTRATING,COPYRIGHT,CRPC,HOWEVER,PSA,RESISTANCE,SCIENCE,TARGETING
101,112,116,122,185,1977,2005,GLEASON,ISUP,LABEL,METHODS,OBJECTIVE,PATHOLOGY,RESULTS,UROLOGICAL,USING
100,160,945,956,MKN28,MKN45,NAFTOPIDIL,TNF
946,954,ACTIVATION,ATLAS,B100,FUDAN,FUSCC,INCREASED,LDL,LNCAP,OLR1,PCA,SERUM,STAT1,STAT3,TCGA,THEN,UNIVERSITY
2009,2012,APRIL,BACKGROUND,CONCLUSION,HIGH,LABEL,MALIGNANT,MARCH,METHODS,NIGERIA,PROSTATIC,RESULTS
0001,100,169,1998,2012,2015,416,8201,8804,8805,BETWEEN,GLEASON,NNS,NPV,PCA,PRIMARY,PSA,THEREFORE,UICC
948,956,APTAMER,BECAUSE,BLOOD,CTC,CTCS,LNCAP,SKBR3
2011,2013,419,CASE,CENTRAL,JANUARY,JUNE,NORTH,PROCESS,RAPID,USING
2005,2006,DISCUSSION,LABEL,MATERIALS,METHODS,OBJECTIVE,PFAA,PFAAS,PSA,PURPOSE,RESULTS,THESE,USING
001,033,100,104,247,627,COX,CRPC,MEIER,PCA,THERAPY,TIME
210,BASED,DMI,FEMS,IMRT,LABEL,METHODS,MLC,MUS,OBJECTIVE,PURPOSE,RESULTS,THESE,VALIDATION
120,176,2014,AFTER,KIM,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEPTEMBER,VMAT
DOSE,EGO,EVEN,IIP,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
100,120,BOTH,CBCT,CBCTS,GAMMA,GEOMETRIC,HOUNSFIELD,HOWEVER,IMRT,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,ROI,SIMILARLY,USING
177,DWI,HOWEVER,IMAGE,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS
169,2015,565,674,AFTER,AUA,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PROVIDERS,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
0005,1993,1995,2004,2013,36B4,922,935,BACKGROUND,CIS,CONCLUSION,GENOTYPING,GLEASON,LABEL,LTL,METHODS,OPENARRAY,ORS,PCR,RESULTS,SNP
1538,19DA,72H,ACT,AGALYCHNIS,AMERICA,AMPHIBIAN,CENTRAL,GLN,GLU,GLY,HPLC,LEU,LYS,MALDI,PHE,PRO,SOUTH,TOF,TPH,TRP,TYR
169,2015,BCL,COPYRIGHT,DFO,DPC,DU145,MIAPACA,PANC,SOCIETY,SRC,STAT3,THESE
001,120,130,190,656,742,827,945,ANALYZING,ATLAS,AUC,AZGP1,CA19,CEA,CHINESE,ELISA,FIRST,LEAVE,PCR,ROC,THEN,THESE,ZINC
010,029,115,160,169,189,2015,422,8804,8805,AUTHORS,BJU,BOTH,CONCLUSION,COX,GLEASON,HOWEVER,IIEF,INDEX,JOHN,LABEL,LTD,METHODS,OAD,OBJECTIVE,OBJECTIVES,PRN,PSA,PUBLISHED,RESULTS,SONS,THESE,TIME,WILEY
169,2015,AUTHORS,BACKGROUND,CAM5,CASTRATION,EMA,INC,LABEL,METHODS,PACP,PSA,RESULTS,SUCCESSFUL,TISSUES,TURP,UCRU,WILEY,XENOGRAFTS
169,2015,ALZHEIMER,ANTICANCER,BACKGROUND,BASED,CATALOGUE,CONCLUSION,CONSORTIUM,COPYRIGHT,CROHN,DELINASIOS,FIVE,GWA,GWAS,ICGC,INSTITUTE,INTEGRATOR,JOHN,LABEL,MATERIALS,METHODS,MUTATIONS,NCBI,ORF,ORFS,PANCREATIC,PHEGENI,PHENOME,RESULTS,RNAS,SOMATIC,STUDIES,THESE,WIDE
169,2015,8201,954,BACKGROUND,CGA,CRPC,DU145,ELISA,ERK,FINALLY,HOWEVER,INC,INSTEAD,LABEL,LAPC,LNCAP,METHODS,MMP,NED,PCR,PSA,RESULTS,TIMP,VCAP,WILEY
109,126,145,2000,2013,AKT,BETWEEN,BPH,CIP2A,HIGH,MYC,PCA,PCR,RWPE,SILENCING,WESTERN
169,2010,2015,464,COPYRIGHT,CRPC,CYP17A1,DEFINITIVE,GALETERONE,INC,ONCE,ORTERONEL,P450C17,PCA,PSA
169,2015,945,946,BACKGROUND,CELL,EGCG,ELISA,HOWEVER,INC,LABEL,LIVER,LNCAP,LXR,METHODS,PSA,RESULTS,TREATMENT,WILEY
169,1819,2014,312,620,AUTHORS,BACKGROUND,DUTCH,HPC,INC,JUNE,LABEL,METHODS,ORS,RESULTS,ROC,SEVENTY,SNPS,SPC,WILEY
169,2015,954,AGING,BACKGROUND,CONCLUSION,GPAT,HOWEVER,INC,LABEL,LNCAP,METHODS,MTT,RESULTS,RWPE,SERUM,THESE,WESTERN,WILEY
169,1995,2007,2009,2015,8805,ADT,CONCLUSION,LABEL,METHODS,OBJECTIVE,OLDER,PURPOSE,RCT,RESULTS,SEER,SOCIETY
120,156,169,177,2015,251,954,ACT,CONCLUSION,DATA,DCE,IMAGING,INSURANCE,LABEL,MATERIALS,METHODS,OBJECTIVE,PCA,PURPOSE,RADS,REGIONS,REPORTING,RESULTS,ROIS,RSNA,THREE
169,2015,FUNCTIONAL,GKIKA,HOWEVER,TCAF1,TCAF2,TCAFS,TRP,TRPM8
BACKGROUND,DISTORTION,EPE,FURTHER,LABEL,METHODS,MRI,PCA,RESULTS,RSI
2006,8482,EXPLORING,INSTITUTE,LABEL,METHODS,MOST,OBJECTIVE,PURPOSE,RESULTS,SCP,SCPS,SIXTEEN,SURVIVORS,THERE
945,946,AMONG,ANOTHER,LAP,MMP2,MMPS,OVERALL,PRCA,RII,SMAD3,SMADS,TGF
001,024,AIM,BACKGROUND,BCR,CLOSE,CONCLUSION,GLEASON,HIGH,LABEL,MATERIALS,METHODS,OBJECTIVE,PSA,PSM,PSMS,RESULTS
2013,2014,AFFILIATED,APRIL,AUC,CHINA,FURTHER,HOWEVER,JANUARY,PCR,PRISM,PSA,RELATIVITY,RESULTS,SERUM,SPSS,THIRD,UNIVERSITY
100,169,1MM,2015,956,CAV3,COPYRIGHT,HOWEVER,INHIBITION,LNCAP,NABU,SEVERAL,THESE
169,2015,BRITAIN,COPYRIGHT,FUNCTIONAL,G12V,GREAT,HOWEVER,IRELAND,JOHN,LTD,NR2E1,OVERCOMING,PTEN,PUBLISHED,RAS,SIRT1,SOCIETY,SONS,TLX,WILEY
001,162,1991,2013,239,328,ADT,AFTER,THUS
BACKGROUND,CONCLUSION,DOCKING,HIT,IRAN,LABEL,LYTHRACEAE,MATERIALS,METHODS,NPACT,OBJECTIVE,OBJECTIVES,RESULTS,STUDIES
140,280,BACKGROUND,FAISALABAD,LABEL,MATERIALS,METHODS,PAKISTANI,RESULTS,THEREFORE
001,003,177,1985,2012,264,290,606,ACCORDING,BACKGROUND,HODGKIN,IRAN,LABEL,MASHHAD,MATERIALS,METHODS,NON,OVERALL,RESULTS,SCREENING,THERE
1RNAI,AKT,BACKGROUND,BCL,BOTH,CASPASE,CKK,ENDOTHELIN,ERK1,LABEL,MATERIALS,METHODS,MMP,MMPS,PI3K,RESULTS,RNAI,TRANSWELL,WESTERN
145,169,183,2014,823,BGC,CHINA,COPYRIGHT,DMAP,EDC,HCL,MTT,NMR,PUBLISHED,SEVERAL,THEIR,TREATMENT,UNIVERSITY
181,1987,AS2O3,CELL,DEGS,DYNAMIC,FAT1,HIST1H2BD,KEGG,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,SYSTEMS,THESE
100,102,169,1C3,2014,440,945,946,AKR1C,ALDO,AMONG,BACCHARIN,BRAZILIAN,COPYRIGHT,CRPC,IC50,IRELAND,LOW,LTD,STUDIES
223,946
169,2014,AIM,COLLEGE,CONVERSELY,COPYRIGHT,LABEL,LTD,MATERIALS,METHODS,MRI,MSCC,OBJECTIVE,PUBLISHED,RESULTS,ROYAL,SIGNS,STAGING,THESE
0005,169,2014,8804,ACT,AIM,ARW,CCC,CCCS,COLLEGE,CONCLUSION,COPYRIGHT,DISTANCES,ERC,FIFTY,INSURANCE,INTER,LABEL,LTD,MATERIALS,METHODS,MRI,OBJECTIVE,PAC,PUBLISHED,RANK,RESULTS,ROYAL,SUM
169,2014,946,ACA,AHHHHHH,CBF5,COPYRIGHT,CSP,HADDOCK,LTD,NMR,RNP,RNPS,SHQ1,SSD,STRUCTURES
ANTIBODIES,EXPERIENCE,FURTHER,IGE,IGG
643,DU145,EXPRESSION,PCA,PSCS,TACSTD2,THESE,TSCS,USING
AMONG,CIP,CIZ1,THESE
10A,123,169,2014,231,A459,A549,AMONG,COPYRIGHT,COUMARINS,CYTOTOXIC,DOCETAXEL,ESTER,INC,MCF,MDA,MMP,MRC,PC3,RHODAMINE,THESE,TMRM
AKT,BAX,PI3K
BURKITT,PIM
AAL,ALEURIA,AMONG,BACKGROUND,CLINICALLY,GLEASON,LABEL,METHODS,PCA,PSA,RESULTS,ROC,SERUM,TIMP1
AMONG,ARRAY,BACKGROUND,BERBERINE,BMP7,EMT,LABEL,MEIER,METHODS,NODAL,PCR,RESULTS,SNAIL,THESE
000,001,169,2004,2013,2015,226,257,300,330,347,396,645,8804,967,ANOVA,CONCLUSION,CONTINUOUS,DATA,GLEASON,IMAGING,INC,LABEL,METHODS,MOLECULAR,NUCLEAR,PCA,PET,PSA,RESULTS,SOCIETY,STUDENT,UNLABELLED
169,2014,ACIDS,CHIP,FOXA1,GATA,H3K4ME2,NUCLEIC,PIAS1,PRESS,PUBLISHED,RNAI,SUMO,SUMO2,TAKEN,UNIVERSITY,VCAP
8243,956,ADDITIONAL,AKT,B2G2,BAX,BCL,CCM,CDC2,CDK,CDK2,CDKS,LNCAP,OVERALL,PC3,PCA,PI3K,SMAC,TARGETING
11TH,ALTAI,FEDERAL,SFD,THERE

ASSESSMENT,CURRENT,PSA,PSADT
ALSO,DISBALANCE,HODGKIN,OPG,RANK,RANKL
01105,CELL,EGFR,LNCAP,NSK,VEGF,WESTERN
0001,110,160,BOTH,BPH,GLEASON,HOWEVER,MST4,STE20,STK25
HIGH,LNM,STRATIFIED,TMPRSS4,TNM
001,169,2008,2011,2015,ANTICANCER,CICS,COPYRIGHT,COX,CSCS,HGF,INSTITUTE,JOHN,MET,OCTOBER,PSA
100,169,2012,2014,2015,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,DIAGNOSTIC,INSTITUTE,JANUARY,JOHN,JULY,LABEL,METHODS,MULTI,OBJECTIVE,PCA,RESULTS,SPBX,T1C,TESLA
169,2015,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,CRPC,CYP19,E10,ERE,GFP,HIGH,INSTITUTE,JOHN,LABEL,LNCAP,MATERIALS,MCF,METHODS,PCA,PCASC,PCR,RESULTS
169,2015,ADP,AMERICA,ANTICANCER,ASIA,BACKGROUND,BAX,BCL2,CONCLUSION,COPYRIGHT,DU145,INSTITUTE,JOHN,LABEL,LNCAP,MATERIALS,METHODS,NORTH,PARP,PC3,PETASIDES,PETASIN,RESULTS,T24,THESE,WESTERN
169,2015,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,DT08,HOWEVER,INSTITUTE,JOHN,LABEL,LNCAP,MATERIALS,METHODS,PSMA,RESULTS,VCAP,YPSMA
945,AKT,BAX,BCL,DU145,ERK,IKB,LNCAP,MEANWHILE,SHARPIN
169,2015,BIOLOGY,CONNEXINS,CX32,CXS,INC,MOLECULAR,SOCIETY
125,169,2015,4A4,916,BASAL,COPYRIGHT,INC,MOST,NP63,PCA,PCAS,TAP63
160,ABOUT,BACKGROUND,CASE,LABEL,METHODS,NUMB
AKT,CHD1,ETS,MOLECULAR,PI3K,PTEN,SPOP,TMPRSS2
THERE,WHILE
169,2014,COPYRIGHT,FOLFIRINOX,HOWEVER,PANCREATIC,PDAC,PRESENTLY,PUBLISHED,STRATEGIES
4GLCNAC,946,BPH,IGG,PSA,SPFS,THESE,WFA
000,160,169,2014,GMBH,KGAA,SEVERAL,VCH,WILEY
169,2014,373,520C,BPH,INC,MMP,MMP2,MMP9,MT1,U87GM,UTR,WILEY
013,113,169,2014,8OHDG,931,954,BACKGROUND,BAX,BCL,CONCLUSION,ELISA,GIVEN,INC,KI67,LABEL,METHODS,NUCLEAR,PSA,RESULTS,SECONDARY,TEA,THERE,TUNEL,WILEY
2014,2953,9241,BACKGROUND,BASED,BCR,CIS,CONCLUSION,HOWEVER,LABEL,LABORATORY,MAY,METHODS,RESULTS
100,124,5820,8201,BACKGROUND,GLEASON,LABEL,METHODS,PSA,RESULTS,ROC,THOSE
CONCLUSION,DCE,GLEASON,LABEL,LDA,MATERIALS,METHODS,MRI,OBJECTIVE,PCA,PRINCIPAL,PSA,RESULTS,RFE,SVM,T2W,USING
040,041,045,128,148,CHINESE,CHROMATIN,CLINICALLY,COX,ERG,ETS,ETV1,ETV4,ETV5,FLI1,FUNCTIONAL,FURTHER,GLEASON,MMP,MMPS,NOTABLY,OVERALL,PCA,SILENCING
169,2014,213,26GY,34GY,36GY,5GY,BACKGROUND,COPYRIGHT,HDRBT,IPSS,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PURPOSE,RESULTS,STRICTURE,TEN
169,2015,945,946,AKT,COPYRIGHT,HOWEVER,IGF1R,INC,PI3K,PTEN
008,042,100,2014,202,433,517,598,956,BACKGROUND,CIS,HIGH,HOWEVER,JANUARY,LABEL,LIBRARY,METHODS,OVERALL,RESULTS,STUDIES
INSTITUTE,INTENTION,LABEL,MAIN,METHODS,NURSING,OBJECTIVE,OBJECTIVES,PURPOSE,RESULTS,SETTING,VARIABLES
AUSTRALIA,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PEER,PERTH,PURPOSE,RESULTS,SETTING
169,2005,2011,2015,9011,992,AMONG,BASE,COPYRIGHT,DATA,FURTHER,INC,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
100,200,300,400,500,956,AGS,AKT,ANNEXIN,BAX,BCL2,CD44,ECM,FLUOS,OCT3,P53,PCNA,PCR,REAL
ATLAS,CREB,MYC,NOTABLY,TCGA,THESE,THUS,TTP,ZFP36
130,169,1998,2001,2003,2005,2015,539,AACE,AHA,ATP,COPYRIGHT,COUNSELING,EDUCATION,IDF,III,INC,LABEL,MATERIALS,METHODS,NCEP,NHLBI,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL,WAIST
1350,169,1995,2000,2004,2007,2008,2014,6561,AMONG,BACKGROUND,CONCLUSION,DIFFUSION,DOCETAXEL,EFFORTS,END,FDA,III,LABEL,MAY,METHODS,PRESS,PROGRAM,PUBLISHED,RESULTS,SEER,UNIVERSITY
169,2015,BIOLOGY,BOTH,HOWEVER,INC,LOX,MK591,MOLECULAR,MYC,SOCIETY,THESE
BACKGROUND,COLORECTAL,CONCLUSION,INITIATIVE,KEY,LABEL,LARGE,LUNG,OVARIAN,PREVENTION,RESULTS,SCREENING,TRIAL,USING,VITAMIN,WHILE,WOMEN
001,174,494,8201,8805,AMICO,ATM,BACKGROUND,BESIDES,ERCC1,ERCC2,GENOTYPIC,GLEASON,LABEL,LIG4,METHODS,OPENARRAY,PSA,RESULTS,SNP,SNPATOR,SNPS,SPANISH,TP53,XRCC1
001,AUSTRALIA,AUSTRALIAN,BACKGROUND,BMJ,COAST,COMMUNITY,GOLD,GROUP,LABEL,LIMITED,MAIN,METHODS,OBJECTIVE,OUTCOME,PSA,PUBLISHED,PUBLISHING,RESULTS,SETTING,TRIAL,ZEALAND
037,1306,149,346,418,AIM,CONCLUSION,ECM,LABEL,MATERIALS,METHODS,MMP,MMPS,OBJECTIVE,RESULTS,SIXTY,TIMP,TIMPS,TURKISH,WESTERN
125,130,163,169,175,180,2003,2009,2014,683,8805,BETWEEN,BFFS,COPYRIGHT,D90,D90S,GREATER,IMPLANT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PHOENIX,PURPOSE,RESULTS,ROC,THEREFORE
001,002,012,013,063,177,181,190,228,331,345,666,8804,8805,961,CONCLUSION,GLEASON,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PEARSON,PSA,RESULTS
100,225,239,CONCLUSION,LABEL,METHODS,MRI,OBJECTIVE,PCA,RESULTS,SIMULATED,THREE,TRUS
169,16Q23,2014,8201,BIOLOGY,DESPITE,SOCIETY,WWOX
102,169,2014,235,8201,BACKGROUND,EPIC,LABEL,METHODS,PATIENT,PROS,QOL,RESULTS,SOCIETY
169,2014,BECAUSE,COPYRIGHT,NIR
104,119,120,145,162,163,174,179,233,BAK,BAX,BCL,C42B,ESPECIALLY,FITC,IC50,MILL,PLEUROTUS,THEIR,THESE
200,239,400,700,ACUTE,ADVERSE,AES,BID,CRPC,CYCLE,DLT,DLTS,DOSE,FIFTEEN,GRADE,LABEL,METHODS,MOST,OBJECTIVE,ORTERONEL,PURPOSE,RESULTS,SERUM,TAK
116,145,169,174,180,2014,231,3T3,8243,A2780,ABCB1,ABCG2,COPYRIGHT,DARBY,HCT,HEPG2,IND,LOVO,LTD,MADIN,MCF,MDAMB,MDCK,NATURALLY,NIH,PC3,PXR,THESE
0001,160,169,177,2015,BASED,COPYRIGHT,DOSE,FIVE,FURTHER,HDR,HIGH,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SEVEN,SOCIETY,THERE,THESE,V100,V110,V120,V130,V150,V180,V200
009,100,110,2011,2013,239,250,308,343,AIM,AST,BMD,LABEL,LGNRH,MATERIALS,METHODS,OBJECTIVE,RESULTS,TOTAL,UNLABELLED
YET
2010,AIM,BPH,CAG,CONCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,PSA,RANDOMIZED,RESULTS
169,2014,945,946,BOTH,CONSISTENT,DHT,EGFP,FIRST,INC,LNCAP,MCF,MICROARRAY,PTHRP,R5020,THR,WILEY
BET,BRD4,CRPC,HOWEVER,JQ1,MEDICAL,THERE,UNIVERSITY,VCAP
224,234,5740,BACKGROUND,CONCLUSION,LABEL,METHODS,RESULTS,THERE
AFTER,ALSO,ANOVA,BACKGROUND,CHIP,DFA,EZH2,GLEASON,HIGH,LABEL,METHODS,OBVIOUSLY,PCA,PGR,PSA,RAR,RESULTS,RGMA,SRC3,THEREFORE,TUKEY
169,2014,AUTHORS,CHIP,FURTHER
2014,BMJ,GROUP,LDR,LTD,PUBLISHING
10877,10878,266,AGE,BACKGROUND,CCI,COMPETING,CONCLUSION,CONVERSELY,CSM,LABEL,MEN,METHODS,OCM,OUTCOME,OVERALL,PCA,RESULTS,TEN
223,AREAS,BACKGROUND,BOTH,COVERED,CRPC,LABEL,MDV3100,MECHANISMS,METHODS,OPINION,P17
169,2014,489,CONCLUSION,EXTENDING,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SOCIETY,THERE,TIME
169,2015,AFTER,ARTIFICIAL,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PATIENT,PUBLISHED,PURPOSE,RESULTS,SIX,TOTAL,UROLOGICAL
000,169,2014,254,BACKGROUND,CIS,COLORECTAL,COX,HOWEVER,INCIDENCE,INSTITUTE,LABEL,LUNG,METHODS,NBP,NBPS,OVARIAN,PLCO,RESULTS,SCREENING,SOCIETY,SQX,TRIAL,WOMEN
INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS
001,003,027,169,2015,224,APLN,COPYRIGHT,HOWEVER,INC,PCA,TAKEN
1015,CW2,H2052,HUHS,MKN45,NCI
HER2,HOWEVER,PERTUZUMAB
CTCS,ENGLAND,FURTHER,JOURNAL,PSA
BIOLOGY,ETS,GIVEN,HOWEVER,THEIR,UTILIZING,WYATT
1950S,A549,ANTICANCER,FITC,K562,MCF,MYC,SF5,THEREFORE
001,003,005,169,2014,659,BACKGROUND,CONCLUSION,CRP,LABEL,MEN,METHODS,MPC,RESULTS,SERUM
8804,946,AIM,BPH,CD117,CD133,CONCLUSION,CSCS,FZD,LABEL,METHODS,OBJECTIVE,RESULTS,WHILE,WNT,WNT7A
160,169,1996,2007,2014,2017,322,910,AUSTRALIA,AUSTRALIAN,AUTHORS,BACKGROUND,BASED,CENTRAL,COPYRIGHT,INCIDENCE,LABEL,LTD,METHODS,MODEL,NSW,PREVALENCE,PUBLISHED,RESULTS,SOUTH,THESE,VALIDATION,WALES
125,169,2014,945,AFTER,AUPD,CDS,COPYRIGHT,CUO,FIRSTLY,ITO,MEANWHILE,PEC,THEN,USING,ZNO,ZNTS
020,104,169,2015,274,BLIND,CONCLUSION,COPYRIGHT,INC,INTERFACE,LABEL,METHODS,MHZ,OBJECTIVE,PERIPHERAL,PREVALENCE,RESULTS,TRUS
169,2008,2010,2015,323,670,86E,8805,AMONG,AUC,CAUCASIAN,CONCLUSION,COPYRIGHT,GLEASON,INC,JANUARY,LABEL,METHODS,NET,OBJECTIVE,PCA,PERIPHERAL,PGS,PRIMARY,PSA,RESULTS,SEPTEMBER,THESE,TORONTO,UNIVERSITY
1201,160,169,2003,2006,2015,COMPOSITE,CONCLUSION,COPYRIGHT,EPIC,FORM,INC,INDEX,LABEL,METHODS,MID,MIDS,OBJECTIVE,RESULTS,SHORT,URINARY,USING
BACKGROUND,BECAUSE,CONCLUSION,ELISA,HENS,IGG,IGY,IGYS,LABEL,METHODS,PSA
169,2015,COPYRIGHT,INC,INCREASED,NAD,PARK2,PATHOLOGY,PROSTATIC,PUBLISHED,ROS,SIRT1,SOCIETY,SOD2,THUS
177,186,243,322,8804,99M,AIM,BACKGROUND,DEPT,GLEASON,JOHN,KRAK,LABEL,MDP,METHODS,NUCLEAR,OBJECTIVE,PAUL,PSA,RESULTS,THEN
036,041,045,046,060,169,2014,2185,AML,COPYRIGHT,FSHB,GIVEN,GNRH,GWAS,HOWEVER,INC,INHA,INHBB,LABEL,LHCGR,METHODS,OBJECTIVE,OVARIAN,RESULTS,SNPS,THERE,USING
169,1986,2000,2010,2015,5861,789,885,BACKGROUND,CALCIUM,COX,HIGH,LABEL,METHODS,NUTRITION,OBJECTIVE,PHOSPHORUS,RESULTS,SEVERAL,SOCIETY,THESE
138,169,1995,2009,2015,213,217,435,582,825,AMONG,ASIA,BACKGROUND,CIS,DIETARY,HOWEVER,HRS,LABEL,METHODS,NUTRITION,OBJECTIVE,RESULTS,SOCIETY,SOLUBLE,THESE,TOTAL
169,200,2013,2015,400,ANY,APRIL,BACKGROUND,CONTINUOUS,DAIRY,HIGH,INTAKES,LABEL,METHODS,NUTRITION,OBJECTIVE,PROJECT,RESULTS,RRS,SOCIETY,SUMMARY,TOTAL
169,194,1997,2002,2012,2014,561,623,8805,BACKGROUND,COX,DATA,FEW,HRS,LABEL,MET,METHODS,RESULTS
169,2014,CELL,CXCR4,DU145,GUANINE,PC3,RAC1,REX,REX1,THESE
169,2015,AKT,BIOLOGY,BOTH,CASTRATION,INC,MOLECULAR,PI3K,PTEN,ROLE,SOCIETY,USING
000,121,160,2013,8201,BACKGROUND,CBCT,FFF,LABEL,LINAC,METHODS,OBJECTIVE,PURPOSE,RESULTS
BACKGROUND,CONFRERES,COUPLES,DISTILLING,HOWEVER,LABEL,MEN,METHODS,OBJECTIVE,PCA,PCSGS,PURPOSE,RESULTS,THREE,WOMEN
BACKGROUND,CONCLUSION,CURRENT,HOWEVER,LABEL,LRP,METHODS,OBJECTIVE,OBJECTIVES,RALP,RESULTS,SINCE,THEREFORE
2D3,APART,BACKGROUND,CALCITRIOL,HOWEVER,KEY,LABEL,LANGERHANS,RAAS,T2DM,THESE,UNLABELLED,VITAMIN,WORDS
COX,MOST,SPSS,THERE
2006,2012,8202,AFTER,CYBERKNIFE,FORTY,FOUR,GRADE,MAY,PFS,PRIMARY,PSA,SBRT,THERE
2007,2008,394,AMONG,EHRS,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THESE,VETERAN,VHA
954,BCA3,EXON
146A,CHINESE,COX,GLEASON,HOWEVER,MEIER,PCR,PSA,RFLP,SEVENTY
8805,CLARITY,DEPARTMENT,EBRT,HENCE,IMAGE,MAXIMUM,NCCN
ABL,DU145,EXPRESSION,LACK,MLH1,MMR,PCA,PWR,RWPE,THESE,WESTERN
545,601,622,627,670,742,ACCORDING,AUC,HOWEVER,MALAT,PCA,PSA,ROC
100,174,2014,400,MAY,MEETING,SBRT,SCIENTIFIC,SOCIETY,SRS,USA
EARLY,RAMAN
CSPCA,MRI,PCA,PREBIOPSY,SEVERAL,TRUS
AUC,CADX,CHALLENGES,FURTHER,MRI,PCA
1500,2000,3000,8201,AVERAGE,BEST,CONCLUSION,INDEX,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,RESULTS,USING
MRI,STAGING
GIVEN,MRI
129,1996,2004,BETWEEN,CONCLUSION,HIF1A,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,WHILE
169,2015,FOUNDATION,INITIALLY,JOURNAL,SOCIETY,STICHTING
008,100,169,191,1995,2008,2010,2015,203,A1C,BECAUSE,COPYRIGHT,COX,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PRIMARY,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
1336,1539,1559,169,1845,2013,2014,2067,2373,2670,2712,2774,3060,808,8805,AUTHORS,BJU,CANCERS,CENTRAL,CONFERENCE,CONTROLLED,GRADE,GROUP,JOHN,LTD,MANAGER,MEDLINE,NON,PROSTATIC,PUBLISHED,SCIENCE,SONS,WEB,WILEY
ENTROPY,LIEBLER
169,1778,1998,2007,2014,8805,AAS,AFRICAN,AMERICANS,BACKGROUND,DATA,EMOTIONAL,END,FORM,FURTHER,HISPANICS,HOWEVER,HRQOL,LABEL,MEDICAL,METHODS,MIXED,NHWS,RESULTS,ROLE,SHORT,SOCIETY,STRATIFIED,TRUST
169,2014,5687,604,8201,COPYRIGHT,COX,INCIDENCE,INCREASED,OVERALL,RECIPIENTS,RESULTS,SIROLIMUS,SOCIETY,TRANSPLANT
100,110,CROSS,DESI,DESORPTION,LDA,PCA,RADICAL,RAPID,THESE
00016,013,141,30C,375,458,559,576,612,697,710,757,809,861,877,922,AUC,BPH,EXPRESSION,GLEASON,NONE,PSA,YAM
1990,2000,2010,ASR,BACKGROUND,BPSP,LABEL,MATERIALS,METHODS,MPSP,MUSLIMS,NHL,OBJECTIVE,OBJECTIVES,PBSP,PMSP,POPULATION,RESULTS
BPH,FURTHER,LABEL,LDL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PSA,RESULTS,VLDL,WHITNEY
006,180,2009,2013,ABO,BACKGROUND,JANUARY,LABEL,MATERIALS,METHODS,RESULTS,SPC,SPCS,TAIWANESE,THERE
156,191,207,347,946,ADPC,AFTER,AIPC,ANNOTATION,JAK,KEGG,LNCAP,MAPK,MAS,P450,P53,PPAR,STAT,TGF,THEN
000,100,2000,2010,HOWEVER,INCIDENCES,VIETNAM,WHILE
THERE,WORLDWIDE
946,HOWEVER,VARIOUS
162,ALLELIC,APA,BACKGROUND,FOK,HARDY,LABEL,MATERIALS,METHODS,PAKISTANI,PCA,PCR,RESULTS,RFLP,SIMILARLY,TAQ,VDR,VITAMIN
169,2015,BIOLOGY,INC,LIPIDOMIC,MOLECULAR,SOCIETY,WESTERN
015,575,ADAM7,ADT,BACKGROUND,BUB1B,CCNB1,CCNB2,CDK1,ERG,ETS,LABEL,METHODS,MSKCC,ONCOGENOME,PCA,PROJECT,PUBLICALLY,RESULTS,SEQ,TMPRSS2,TRUSS,TTK,USING
1197,1984,BACKGROUND,HODGKIN,HOWEVER,JANUARY,LABEL,METHODS,REPORTS,RESULTS,THESE
AREAS,BACKGROUND,CHECKPOINT,COLORECTAL,COVERED,CRC,CURRENT,GIVEN,LABEL,METHODS,OPINION,PDL1,SURGERY
223,DU145,HOWEVER,LNCAP,MICRORNAS,MIR,NOTABLY,PC3,PCA,SEPT6
2013,2014,BACKGROUND,BPH,EIA,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PSA,RESULTS,THESE,TOTAL,TUR
HENCE,HOPEFULLY,IGF,MEANWHILE,METS,PCA
1990S,CSC,CSCS,THEREFORE,THESE
2007,ACCORDING,MICRORNAS,RNAS
ETS,FOLLOWING,NGS,THOSE
HIGH,THEREFORE
DUE,HOWEVER,PSA,WIDESPREAD
HOWEVER,JAPAN,PSA,QOL,THEREFORE,UROLOGICAL,WESTERN
BASED,CBZ,CRPC,EZL,HOWEVER,JAPAN,THEREFORE,UNTIL
AKT,AMONG,CRPC,HGF,KINASES,MET,PCA,PI3K
2007,223,JAPAN,THEREFORE
BECAUSE,CRPC,CTLA,GVAX,IPILIMUMAB,PSMA,SIPULEUCEL,SURGERY,THOSE
CRPC,JAPAN,MANAGEMENT,TREATMENT
509,ARN,CRPC,EVEN,THESE
CRPC,DHT,JAPAN,THEREFORE
CRPC,DKK,OKAYAMA,PSA,REIC,TOKYO
HLA,PPV,SINCE
208,AE3,EP4,KUCAP,ONO,PGE2,TARGETING,THESE
EXTREME,PEDF,VAV3,VEGF
CRPC,HOWEVER,OXIDATIVE,ROS,THEREFORE
ASC,EVEN,HOWEVER,NOVEL
BECAUSE,CRPC,ODN,ODNS
IGF1,LDL,THESE
2014,239,ASCO,CRPC,HRPC,III,JAPAN
ADT,CRPC,REGARDING,THEREFORE
CRPC,CYP,ERG,FOXA,REGULATION,TMPRSS2
CASTRATION,CRPC,TAKEN
954,ECM,EMT,MET,RANKL,THOSE
177,956,BACKGROUND,BIOLOGICAL,CIOCALTEU,CONCLUSION,COR,DPPH,FOLIN,FRAP,HELA,HPLC,IC50,L23,LABEL,LPS,MCF,METHODS,MRC,OBJECTIVE,RESULTS,SRB,SUNG,SXH,TEAC,THUS,TOTAL,W264,YET,YOD
177,956,BACKGROUND,CIOCALTEU,CONCLUSION,CYTOTOXIC,DPPH,EC50,FOLIN,FRESH,GAE,IC50,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SRB,THAI,TOTAL
BORDERLINE,ERG,PIN,PTEN
215,8730,HOWEVER,LABORATORY,PCA3,PSA

HER2,HOWEVER
146,377,AIM,BACKGROUND,COMMANDER,DATA,FIFTY,LABEL,METHODS,OBJECTIVE,RESULTS,THOSE
169,2015,COPYRIGHT,INC,PUBLISHED,SOCIETY
8197,FET,HFO2,MOS2,PSA,TAKEN,THEN
8804,ACCORDING,BACKGROUND,BIAS,CIS,CONCLUSION,FIVE,HOWEVER,LABEL,MANAGER,METHODS,PFMT,QUALITY,RADICAL,RCTS,RESULTS,RISK,URINARY,VERSION
264,699,DAKAR,LABEL,MATERIALS,METHODS,RESULTS,UNLABELLED
169,174,2014,8482,AUTHORS,CD45,CELLSEARCH,CELLSIEVE,CTC,CTCS,DAPI,EPCAM,HOWEVER,INC,ISAC,PUBLISHED,TEST,THESE,USING,WILEY
145,8209,AQP,AQP3,AQPS,AQUAPORINS,ERK,ERK1,FINALLY,KNOCKDOWN,MMP,NOTABLY,THUS
7000,8212,SYAM,SYAMS,THESE
169,2014,8764,916,945,956,COPYRIGHT,DHEA,DHT,HOWEVER,IRELAND,LTD,P450C17,TAPS,THESE,TREATMENT
001,003,006,169,2014,CNR,CONCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,PDFS,PURPOSE,RESULTS,RSNA,SNR,WHOLE
062,109,119,122,136,139,142,164,301,309,336,445,536,557,633,694,774,880,BCR,LABEL,LOCATIONS,LRP,MATERIALS,MEIER,METHODS,OBJECTIVE,PSM,PURPOSE,RALRP,RESULTS,RPP,RRP,THERE
177,1990,2013,233,CENTRES,EARLY,EWING,HOWEVER,JUNE,LABEL,LUTTE,MATERIALS,METHODS,MOST,NATIONALE,OBJECTIVE,PRIMARY,PURPOSE,RESULTS
AMONG,FOCAL,T1A
MYC,NADPH,RNAS
169,2014,819,844,993,AMONG,CONCLUSION,GLEASON,LABEL,MAIN,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS,SOCIETY,THERE
1852,2003,2009,5362,BACKGROUND,END,LABEL,METHODS,MIRP,ORP,RESULTS,THERE
169,2014,BACKGROUND,BOTH,COPYRIGHT,HPV,ICAHN,INC,LABEL,LMICS,METHODS,MOUNT,OBJECTIVE,ORGANIZED,PUBLISHED,RESULTS,SCREENING,SINAI,VIA
000,100,169,2012,2014,20TH,ASIA,ASIAN,ASR,BACKGROUND,BAHRAIN,CANCERS,COPYRIGHT,COUNTRIES,DATA,HIGH,IARC,ICAHN,INC,IRAN,IRANIAN,LABEL,LACK,LEBANON,METHODS,MOUNT,NINE,OBJECTIVE,OBJECTIVES,OMAN,PUBLISHED,QATAR,RESULTS,SAUDI,SINAI,THEREFORE,THESE,TURKISH,WEST,WESTERN
BACKGROUND,BLADDER,CASE,LABEL,METHODS,THERE
DIGITAL,TOTAL
18TH,4TH,5TH,HPVG,JAPAN,MUCOSAL,PCI,SINCE
215,CASE,RIGHT
0055,135,2006,2008,65308,8804,8805,BASED,HOWEVER,NVB,UNIVARIATE
169,2014,218,BASED,CLEARLY,COPYRIGHT,D52,INC,KNOCKDOWN,PC3,THESE,TPD52
BACKGROUND,LABEL,METABOLOME,NMR,QUANTUM,RESULTS,SIMILAR
0001,001,012,450,BOTH,CAUCASIANS,CONCLUSION,CONTEXT,FORTY,LABEL,MATERIALS,METHODS,NIGERIA,OBJECTIVE,ODDS,PAIN,RESULTS,SEVENTY,STUDIES,THERE,TPBX
COLLEGE,PSA,RADIOLOGY,RATINGS
145,215,8310,AFTER,BAX,BCL,CONCLUSION,LABEL,MATERIALS,METHODS,MTT,OBJECTIVE,PSA,PURPOSE,RESULTS
2008,2012,DATA,GLEASON,LABEL,MARCH,METHODS,OBJECTIVE,PCA,PHOENIX,PSA,RESULTS,SCS,THREE
AMONG,EMT,HOWEVER,PCA
12A,12B,13A,13B,15A,169,17A,17B,2014,956,COPYRIGHT,DU145,IC50,MCF7,SAS
DENDRITIC,DESPITE,DRUG,FDA,FEDERAL
001,016,039,169,170,177,2014,326,967,AZD1208,BACKGROUND,CAP,CELL,CRPC,FINALLY,HOWEVER,HYPOXIA,IRRADIATED,LABEL,MANN,METHODS,MYC,PCS,PIM,PIM1,PRESS,PUBLISHED,RECURRENT,RESULTS,STUDENT,TEST,UNIVERSITY,WHITNEY
169,2014,73000,BACKGROUND,BASED,CONCLUSION,ERSPC,HOWEVER,LABEL,METHODS,PRESS,PSA,PUBLISHED,QALY,QALYS,RANDOMIZED,RESULTS,SCREENING,UNIVERSITY
001,1000,139,140,169,1988,2010,2014,226,267,4459,762,956,965,BACKGROUND,CAUTION,CONCLUSION,COX,CRUDE,FEW,LABEL,METHODS,PRESS,PUBLISHED,RESULTS,THERE,UNIVERSITY
169,2015,BIOLOGY,FINALLY,INC,MOLECULAR,PCA,PLK1,REDD,SOCIETY
100,169,2014,ACELLULAR,ALREADY,BACKGROUND,CAUTION,DTM,ECM,EMBRYOLOGY,HOWEVER,KNOWN,LABEL,MAIN,MATERIALS,METHODS,MTT,OBJECTIVE,PRESS,PUBLISHED,PXD001524,REASONS,RESULTS,RETENTION,ROLE,SDS,SETTING,SIZE,SOCIETY,SOLUBLE,SUMMARY,UNIVERSITY,WHAT,WIDER
100,169,2014,474,A2870,COPYRIGHT,FOLLOWING,HCC1806,JOHN,LNCAP,LND,LTD,SONS,WILEY
ELK,ELK1,ETS,JIP4,PCA,PKN1,PRK1,SPAG9
000,022,027,18F,8805,CONCLUSION,COX,CRPC,EARLY,FCH,FORTY,LABEL,METHODS,OBJECTIVE,PATIENT,PET,PFS,PSA,RESULTS,THESE,UNIVARIATE
BACKGROUND,CHALLENGES,HOWEVER,LABEL,METHODS,RESULTS
1906,1948,1949,1958,1971,246,250,782,850,CHAIR,GERMANY,MAX,PROF,THEREFORE,TUR,ULM,UNIVERSITY,UROLOGY
145,946,ADENOVIRAL,BASED,INFECTION,MET,PCA,WNT
001,006,2003,2010,242,456,8209,GLEASON,HOWEVER,NIN,NOB,NOB1,PCA,RFS,THESE
ATG3,CLU,COMBINING,LC3,LIR
0001,169,190,2014,256,445,676,AIM,ANTICANCER,ARD,BMI,CONCLUSION,COPYRIGHT,DATA,IMRT,INSTITUTE,JOHN,LABEL,METHODS,MVCT,OBJECTIVE,RESULTS,UNIVARIATE
001,169,2003,2010,2014,465,560,8805,AIM,ANTICANCER,BETWEEN,CONCLUSION,COPYRIGHT,FFBS,HOWEVER,INSTITUTE,JOHN,LABEL,METHODS,OBJECTIVE,RESULTS
0005,001,009,136,169,2014,246,252,AIM,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,HRAG,INSTITUTE,JOHN,LABEL,MATERIALS,METHODS,MUC1,OBJECTIVE,PLCE1,PSCA,RESULTS,SNPS,USING
169,188,2014,274,AIM,ANTICANCER,BPH,CONCLUSION,COPYRIGHT,DRE,INDEX,INSTITUTE,JOHN,LABEL,METHODS,OBJECTIVE,ODDS,PCA,PCA3,PHI,PIN,PSA,RATIO,RESULTS,THREE,UNIT
871,AUC,RNAS,RWR
195,PKP,PKP1,PKP3,PKPS,ROS,SRC,TYR
FIRST,SFRP4,WNT
100,33258,600,956,APOPTOSIS,ATP,CPT,FGC,GLYCOLYSIS,HEXOKINASE,HOECHST,HOWEVER,LNCAP,MMP,MTT,PC3,TREATMENT
160,380,HOMO,LAG1,LASS2,MCF,MMP,THEREFORE,TMSG1
1020,892,ARG,ARG399GLN,CAUCASIAN,GLN,META,MONGOLOID,XRCC1
113,130,239,352,AFFILIATED,AMONG,CHINA,COX,FIRST,GUANGDONG,GUANGZHOU,HOWEVER,SEN,SHANTOU,SUN,UNIVERSITY,YAT
BOTH,THEREFORE,WESTERN
125,169,2015,CELLS,CONCLUSION,IGG,IMAGING,INC,IR700,LABEL,METHODS,MOLECULAR,NIR,NUCLEAR,PC3,PSMA,RESULTS,SOCIETY,THEN,UNLABELLED
AMACR,CK5,HOWEVER,P504S,PIN,VARIOUS
001,003,008,127,169,1998,2010,2015,627,754,8804,BETWEEN,COPYRIGHT,DMFS,GLEASON,INC,LABEL,MATERIALS,METHODS,NETWORK,OBJECTIVE,PSA,PUBLISHED,PURPOSE,RESULTS,RFS,SOCIETY,THERE
169,2014,468,47D,495,562,568,956,CNS,COPYRIGHT,GI50,HOP,INSTITUTE,MDA,MOLT,MOTIVATED,RESULTS,SAS,SNB,USA
169,2014,COPYRIGHT,HDR,INC,THERE,WHILE
005,032,169,2014,343,BASED,COPYRIGHT,COX,INC,ISH,NEOPLASIA,PRESS,PUBLISHED,RNAS,SCHLAP1
001,006,007,025,048,169,2014,AZA,BORIS,CHD8,COPYRIGHT,CTCF,EPITHELIAL,GLEASON,HGPIN,INC,NEOPLASIA,PCA,PER,PRESS,PSA,PUBLISHED,TGCA,THEIR,TREATMENT
169,2014,293,330,945,ACCORDING,COPYRIGHT,DHT,FUNCTIONAL,FURTHER,HARDERIAN,HEK,HOWEVER,INC,PCR,REAL,THESE
169,196,1992,2012,2015,417,532,CAPRA,COPYRIGHT,INC,IQR,JANUARY,LABEL,MATERIALS,MEIER,METASTASIS,METHODS,OBJECTIVE,PREDICTION,PUBLISHED,PURPOSE,RESULTS
000,100,102,169,1990,2003,2010,2015,AREA,AVERAGE,COPYRIGHT,EDUCATION,FILES,FURTHER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PEARSON,PUBLISHED,PURPOSE,RESULTS,RUCCS,RURAL,SEER,STAT,STATISTICS,UROLOGICAL,UROLOGIST
001,034,036,141,146,169,2014,287,504,ASSOCIATES,COPYRIGHT,COX,LABEL,LTD,METHODS,OBJECTIVE,OCD,ORTHOTOPIC,PUBLISHED,PURPOSE,RESULTS,RISK,TOTAL
100,10A,143,145,15A,199A,205,221,223,452,CONCLUSION,EXTRACTION,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,RNU,THERE
2012,504,715,ANXIETY,EBRT,FORM,INVENTORY,ITEMS,JULY,LABEL,METHODS,OBJECTIVE,PCA,PPB,RESULTS,RRP,SHORT,STATE,TRAIT
001,2009,2012,759,8805,AUC,BACKGROUND,BETWEEN,DRE,GLEASON,HGPCA,LABEL,LGPCA,MATERIALS,METHODS,PCA,PSA,PVS,RESULTS,ROC,THERE
005,006,107,10NG,4950,55ML,8805,ASAP,CONCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,PBX,PSA,RESULTS,SEVENTY
131,169,177,2014,215,24HR,330,669,BBS,BBS7,BECAUSE,BMAX,COPYRIGHT,DOTA,GRPR,HIGH,INC,LABEL,LYS,METHODS,PRRT,RESULTS,TREATMENT,UNLABELLED
177,8201,BACKGROUND,CT1,CT2,CT3,CTS,IMPLANT,LABEL,METHODS,MRD,MRDS,RESULTS,THERE,THESE
KNOWLEDGE,THERE,THESE
CURRENT
160,169,2014,AUTHORS,BJU,BWU,JOHN,KING,LABEL,LTD,METHODS,MOST,OBJECTIVE,PADS,PUBLISHED,QOL,QUALITY,RANDOMISED,RESULTS,SONS,THERE,THREE,VALUE,WILEY
002,149,169,1991,2007,2014,354,8201,8804,ADT,AIM,BACKGROUND,COX,END,LABEL,MAIN,MEASURE,MEN,METHODS,OBJECTIVE,OUTCOME,OVERALL,PCSM,RESULTS,SOCIETY,TRT,USING
001,008,BECAUSE,CA125II,COLORECTAL,DATA,LUNG,MEAN,OVARIAN,PLCO,SCREENING,THESE,TRIAL
BACKGROUND,CONCLUSION,LABEL,RESULTS
175,2014,APA,FOLLOWING,LOD,LODS
CD2N2,CH2N2,DAG,MPIS,PC3,PTDINSP,TMS,USING
4001,BACKGROUND,CONVERSELY,COX,GLEASON,LABEL,METHODS,NRI,ONTARIO,PATHOLOGY,RESULTS
004,052,551,8804,BACKGROUND,BCR,BLACK,COX,ECE,GLEASON,LABEL,MEIER,METHODS,PSA,RESULTS,THERE
AKT,BACKGROUND,CASODEX,LABEL,METHODS,RESULTS,SORAFENIB,SUNITINIB,WHETHER
000,100,1977,2001,2011,258,475,681,802,BACKGROUND,CNCR,CONCLUSION,CZECH,DATA,LABEL,METHODS,POPULATION,RECORDS,RESULTS
ARGON,PROSTATIC
1000,AUTHORS,ERSPC,HOWEVER,PSA,RANDOMISED,SCREENING
CALCULATOR,CARCINOMA,COLLEGE,DUTCH,GENERAL,MAJOR,PSA,RISK,SOCIETY,UROLOGY,USING
169,2014,2015,306,415,423,583,8201,BACKGROUND,CIS,CONCLUSION,COX,END,FIRST,HRS,INC,LABEL,LIFESTYLE,METHODS,RESULTS,SEER,THEREFORE,VITAL,WASHINGTON,WILEY
001,003,169,1982,1988,2011,2012,2014,202,8804,900,ACCORDING,AMICO,BACKGROUND,BCR,COX,EQUAL,GLEASON,HOPKINS,JHH,JOHNS,LABEL,MEN,METHODS,NETWORK,NOS,PSA,RESULTS,SOCIETY,T2A,T2C,THESE,UROLOGICAL
100,169,2014,24H,2GY,956,COPYRIGHT,HENCE,HOWEVER,ZNFE2O4
000,GOLD,HDF,HOWEVER,NPS,PAH,PC3
7112,AFTER,ALSO,DEGS,DELS,FINALLY,GMEB2,LABEL,MATERIALS,METHODS,NEXT,OBJECTIVE,PTK6,RESULTS,STMN3,UCKL1,ZNF512B
004,152,165,169,2003,2005,2015,263,580,704,8364,BOTH,COMPOSITE,COPYRIGHT,EPIC,INC,INDEX,LABEL,MATERIALS,METHODS,OBJECTIVE,PROPENSITY,PURPOSE,RESULTS,SIDE,SIMILARLY,STUDIES,THESE,TOBIT
169,2015,891,CCN1,COPYRIGHT,DU145,EPA,ERK,FAK,FAS,FFA1,FFA4,FFAR,FURTHER,GPCR,GPCRS,GPR40,HOWEVER,INITIAL,KNOCKDOWN,LPA,OMEGA,SOCIETY,TUG
120,139,145,177,1ST,2007,2009,2010,2018,30TH,ASIA,BACKGROUND,BPH,CALABAR,CONCLUSION,DATA,EPI,HOWEVER,IMAGING,INFO,IUC,JULY,JUNE,LABEL,LOWER,METHODS,RESONANCE,RESULTS,SEVENTY,THERE,TOMOGRAPHY,UNIVERSITY,URINARY
ATLAS,MOLECULAR,PROTEIN
CONVERSELY,CRPC,GATA,GATA2
169,1997,2008,2015,382,953,AUSTRALIAN,HODGKIN,LABEL,METHODS,OBJECTIVE,READERS,RESULTS,SIRS,SMRS,TYPE
169,2014,956,CCK,COMPOUNDS,COPYRIGHT,DU145,IC50,LNCAP,LTD,PUBLISHED,RWPE,SAR
1253,1300,BACKGROUND,CHECK,EXECUTIVE,FORTY,HARYANA,INDIA,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,PSA,RESULTS,SERUM
001,161,714,CONTROLLED,CRPC,FOUR,HOWEVER,HRS,LABEL,MATERIALS,MEDLINE,METHODS,OBJECTIVE,PFS,PSA,RESULTS,TTP,ZIBOTENTAN
169,2014,932A,945,AMONG,CDP,CHKA,CHOK,CHOLINE,RSM
001,008,10877,1997,2012,304,375,8201,BACKGROUND,CONCLUSION,DEPENDING,GLEASON,LABEL,METHODS,OTHER,PSA,RESULTS
HOWEVER,METASTASES
162,BACKGROUND,COX,GLEASON,HOWEVER,LABEL,METHODS,MSP,PCR,PSA,RESULTS
ARF,E2F1,MDM2,PERIOSTIN,STRIKINGLY,THESE
183,1970S,1990S,2000S,AUTHORS,CURRENT,GEORG,RMS,STUTTGART,SURGERY,USING,YORK
AKT,ATP,BZATP,CLAUDIN,DOWN,EMT,ERK1,HOWEVER,MMP,P2X7,PI3K,SIMILAR,SNAIL,THESE
682,BAZ2A,CIMP,CPG,EPIGENETIC,EZH2,FINALLY,TIP5
0001,001,0025,105,122,8202,ANOVA,CD44,COMPARISON,DECREASED,GROUP,GSK,HTB41,INHIBITOR,KEULS,LABEL,METHODS,OBJECTIVE,PBS,PURPOSE,RESULTS,SCC,SGK,TEST
945,BOTH,DESPITE,HIGH,PKI,PRKAR2A,TAXOL
2014,ADT,BOTH,CONCLUSION,DESPITE,FURTHER,LOCAL,SALVAGE,SYNTHESIS,THERE
169,2005,2013,AUS,BACKGROUND,FIFTY,LABEL,MATERIALS,MEAN,MEN,METHODS,REGARDLESS,RESULTS,THEIR,UDS,VLPP
0001,120,177,2012,BACKGROUND,CONCLUSION,INCLUSION,IQR,JANUARY,LABEL,METHODS,PPI,RESULTS,RISK
230,349,362,AMICO,ASSESSMENT,BACKGROUND,CAPRA,EBRT,LABEL,MATERIALS,METHODS,PSA,PSAB,RESULTS,RISK,THERE,THESE,UNIVARIATE,UPON
ADDITIONAL,III,IIIA,IIIB,MUC1,NSCLC,PHASE,TAA
174,AFTER,AMONG
THOSE,TPD52
5T4,CURRENTLY,DESPITE,KRAS,MVA,THERE

NOVEL,THERE,VARIOUS
797,ACLY,ACTIVATION,ATP,BESIDES,EGF,EGFR,FASN,INCREASED,INHIBITION,MUTATIONAL,OPA1,PHB2
945,946,EMT,GSK,HIGH,JUN,MAPK,SER63,SER9,SMAD2,SMAD3,SMAD4,SMAD7,TGF,THUS,TRAF6
145,BOTH,DU145,EPN,FINALLY,LIPO,LIPOS,NPS,PC3,PEGYLATED,THESE,TIME,TLVM,ZOL,ZOLEDRONIC
AXL,BMS777607,CRK,IC50,KNOCKDOWN,LYN,MPCD84111,SRC,TAKEN,THEREBY
1037,1294,169,2014,946,COPYRIGHT,EGF,EGFR,ELK,INC,MAPK,MEK,RAS,SMAD3,TGF,U0126
169,2014,COPYRIGHT,FURTHER,GLS1,INC,MOST,TCA,THESE,TXNIP
169,2014,231,AMONG,CHAETOMIUM,COPYRIGHT,ETOAC,HOWEVER,HSP90,LNCAP,LTD,MDA,NMR,RRL,THYMELAEA
169,17A1,2014,945,COPYRIGHT,CYP17A1,ISSUE,LTD,P450,PUBLISHED,SPECIAL,STEROID
103,120,125,131,169,195,2015,COPYRIGHT,DEF,GBS,GNP,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE
ALPHA,BACKGROUND,BPH,BRDU,CELL,CPZ,DU145,ERK1,IP3,LABEL,LNCAP,METHODS,MTT,PC3,PCA,PCR,PKC,PLC,RESULTS,SIGNALLING,THERE,THESE,TRPV1,WS433
169,177,2015,826,876,917,CONCLUSION,COPYRIGHT,ICC,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SWE,THERE,YOUNG
001,003,012,025,169,2008,2013,2015,408,563,601,914,AFTER,ARIMA,COPYRIGHT,EDUCATION,GLEASON,INC,IQR,JUNE,LABEL,LOW,MATERIALS,METHODS,NETWORK,OBJECTIVE,OCTOBER,PUBLISHED,PURPOSE,RESULTS,TORONTO,UNIVERSITY,UROLOGICAL
169,2015,BIOLOGY,HOWEVER,INC,MOLECULAR,PC3,PICOMOLAR,SOCIETY,TRPM8,USING
169,2015,293,ALONG,BIOLOGY,HEK,INC,MOLECULAR,SOCIETY,THESE,TRPM8,USING
MATS,PCR,RNAS,SEQ,ULTRA
111,169,2014,47D,BBN,BOTH,COPYRIGHT,DOTA,DTPA,GLY5,GRPR,LNCAP,LTD,NLE,TYR
279,ANIMALS,BACKGROUND,CONCLUSION,E26,ERG,ETS,ETV1,EXPRESSION,GLYATL2,INHIBITION,LABEL,LNCAP,METHODS,MMP7,RESULTS,SCID,THEREFORE
169,177,2014,EZH2,FINALLY,PRESS,PUBLISHED,SFRP1,THESE,UNIVERSITY
0001,001,169,2014,3314,688,8804,8805,ACM,AFTER,CCI,CONVERSELY,COPYRIGHT,CSM,LABEL,LTD,METHODS,MVA,OBJECTIVE,PLND,PURPOSE,RESULTS,SEER,SIMILAR,SUBGROUPS,USING
BACKGROUND,BASED,CONCLUSION,CONSENSUS,DATA,DESPITE,GLEASON,LABEL,METHODS,PSA,RESULTS
8201,ACTIVATION,DHT,DYRK,R1881,RAC,RAS,SER10,TEN
1000,169,2014,COPYRIGHT,ELISA,GNPS,PSA
BACKGROUND,CURRENT,DESIRABLE,LABEL,OVERALL,RESULTS
169,2014,COPYRIGHT,INC,IRE1,NBR1,NIX,PERK,UPR
ALA119SER,ASN453SER,CAUCASIANS,LEU432VAL
169,2010,2013,2015,223,945,946,BONE,COPYRIGHT,DRUG,FOOD,INC,MAY,RACL2,SINCE,THESE
169,2015,BONE,COPYRIGHT,INC
169,178,2011,2012,2014,AIM,BACKGROUND,CNS,CONCLUSION,COPYRIGHT,DATA,DESPITE,IMPROVING,LABEL,LTD,METHODS,OBJECTIVE,OVERALL,PATIENT,RESULTS,THERE,THESE
MCL1,OCCURRENCE,PATIENT,PCA,PIAS1
BACKGROUND,CARLO,CONCLUSION,FURTHER,LABEL,LIFE,METHODS,MONTE,MOST,OBJECTIVE,OBJECTIVES,PCA,PREDICTED,RESULTS,SEVERAL,THEREFORE,TREATMENT,VALIDATION
001,085,169,2001,2007,2009,2014,327,389,8201,AMONG,CUMULATIVE,END,LABEL,METHODS,OBJECTIVE,RESULTS,THESE,USING,VALIDATED
4PG,BACKGROUND,CD24,CD44,CELL,CPT,CSC,CSCS,ENRICHMENT,HOWEVER,LABEL,LUC,MCF7,METHODS,MTT,NEUTRAL,NUCLEAR,OCT3,PARP,PC3,RED,RESULTS,THESE,TOPO
139,15Q26,37E,454,749,8201,89E,AFTER,AMONG,BLM,CHB,CHINESE,ERBB2IP,ERBB4,FRK,GEO,PAK7,RBL1,RPS6KA2,THEN
AVAILABLE,HOWEVER,JAK2,PRESENT,PRL,PRLR,STAT5,THUS
BOTH,DCE,LABEL,METHODS,MRI,OBJECTIVE,PROMISING,PURPOSE,RESULTS,THESE,THUS
LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIXTY,THREE,VALIDATION
176,2000,FURTHER,HIFU,HIGH,INSIGHTEC,LABEL,LNCAP,METHODS,MHZ,MRI,OBJECTIVE,PURPOSE,RESULTS,THERE
0941,169,2014,AKT,EGFR,GDC,HER2,HER3,HEREGULIN,HOWEVER,PI3K,RTKS,THESE,UICC
001,171,177,1999,2009,221,392,8201,ADDITIONAL,ADT,AMICO,BACKGROUND,BCR,COX,EBRT,HDR,JANUARY,LABEL,MEIER,METHODS,OVERALL,PCA,PHYSICIANS,RESULTS
PIVOTAL
2014,CANCERS,FRANCISCO,JANUARY,SAN,SOCIETY,SYMPOSIUM,USA
231,A549,BAD,BAK,BAX,BCL,FADU,GAS,HEP,LNCAP,MDA,OVERALL,RL95,SOE,TREATMENT
DARWINIAN,FINALLY,HOWEVER,THROUGH
ANOTHER,BECAUSE,PSMA,THESE
160,183,GEORG,STUTTGART,TEN,VALERIANA,YORK
848,8805,OPEN
956,ANNEXIN,DU145,FITC,FURTHER,GI50,MOLECULAR,MOST,STUDIES
000,169,183,1995,2005,2009,2015,279,AGAINST,AMERICA,ASIA,ATLANTA,AUSTRALIA,BACKGROUND,BELFAST,BERN,CENTERS,CONTINUOUS,CONTROL,COPYRIGHT,DEC,DISEASE,ECUADOR,ESTIMATES,FOCUS,FUNDING,INDIVIDUAL,INSTITUTE,IRELAND,JAPAN,KOREA,LABEL,LEXINGTON,LIVER,LTD,METHODS,NORTH,OPEN,PREVENTION,PUBLISHED,RESULTS,RICO,SOUTH,SWISS,TORONTO,UNIVERSITY,USA,WALES,WORLDWIDE
169,2014,946,COPYRIGHT,LTD,U251
169,2000,2014,497,AMERICA,AUSTRALIA,BACKGROUND,COMPARE,CONCLUSION,COPYRIGHT,DETERMINE,JANUARY,LABEL,LIBRARY,LTD,MEDLINE,METHODS,MOST,NORTH,OBJECTIVE,PSYCHINFO,RCTS,RESULTS,SCIENCE,STUDIES,THERE,WEB
231,CD1,CD2,CU1,LNCAP,MDA,UBIQUITIN,UPS
10877,169,2014,BACKGROUND,C30,CONCLUSION,COPYRIGHT,DIETARY,EFFECTS,FOOD,FREQUENCY,HRQOL,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PR25,PURPOSE,QLQ,RESULTS,SIDE,TREATMENT
169,2014,COPYRIGHT,GMBH
169,2B4,916,AMOT,CAD11,EXPRESSION,FASEB,FURTHER,HEK293T,HIPPO,LOSS,PC3,USING
BESIDES,HOWEVER,THEN
0001,0077,0216,0290,0419,123,15GY,169,2014,35GY,5FRACTIONS,5GY,CONCLUSION,COPYRIGHT,EBRT,HDR,IRELAND,LABEL,LTD,MATERIALS,MCIC,METHODS,OBJECTIVE,PATIENT,PURPOSE,QOL,RESULTS,SABR,THERE,URINARY
169,2014,ARB,ARBS,BASED,COPYRIGHT,DESPITE,FDA,HOWEVER,IRELAND,LTD,PUBLISHED
169,2014,COPYRIGHT,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PLANS,PURPOSE,RESULTS
001,169,2014,ADDITIONAL,BACKGROUND,BLACK,CONCLUSION,COPYRIGHT,DVD,FDR,FDRS,FIRST,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,PCA,PURPOSE,RESULTS,SEVENTY,THERE,THESE,WHITE
100,169,2008,2009,2012,2014,731,BACKGROUND,CONCLUSION,COPYRIGHT,DATA,DRUG,GLEASON,LABEL,LTD,MATERIALS,METHODS,NPCR,OVERALL,PATIENT,PCA,PRESCRIBED,RESULTS,SWEDISH,TIMELINESS
119,1364,353,402,431,593,624,958,990,99TC,AUC,DISC,DOR,EBSCO,KNOWLEDGE,LIBRARY,MDP,META,MRI,OVID,SROC,TCM,THEN,WEB
169,2014,AZDC,BOTH,CHIP,CLU,COPYRIGHT,CPG,DU145,LYS27,LYS9,PC3,PNT1A,SITE,START,TSA,TSS,WI38
169,2015,COPYRIGHT,EDUCATION,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
169,2015,516,549,550,551,558,648,654,658,661,698,707,708,AUC,AUCS,AUSTRALIA,COPYRIGHT,EDUCATION,EPSTEIN,FDA,GLEASON,INC,INDEX,LABEL,MATERIALS,METHODS,OBJECTIVE,PHI,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
169,2015,251,322,570,634,776,806,879,880,COPYRIGHT,DATA,EDUCATION,FURTHER,INACCURATE,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,QALYS,RESULTS,UROLOGICAL
169,1998,2009,2012,2015,779,CIS,COPYRIGHT,COX,DATA,EDUCATION,HRS,INC,INCREASED,KINGDOM,LABEL,MATERIALS,METHODS,OBJECTIVE,POST,PUBLISHED,PURPOSE,REPOSITORY,RESULTS,THESE,UROLOGICAL,USING
0001,100,169,1991,2013,2015,247,ANY,COPYRIGHT,COX,EACH,EDUCATION,FIRST,GLEASON,INC,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
169,2015,269,324,391,COPYRIGHT,EDUCATION,GLEASON,INC,IQR,LABEL,MATERIALS,MEN,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THESE,UROLOGICAL
001,010,016,169,190,2015,247,CLINICIANS,COPYRIGHT,COX,CRPC,EDUCATION,FURTHER,HOWEVER,INC,IQR,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,TREATMENT,UROLOGICAL
001,681,ACCORDING,AIM,IPSS,LABEL,LUTS,METHODS,OBJECTIVE,PSA,RESULTS,SERUM,THERE,TRUS
169,2014,COPYRIGHT,DETECTION,PEG,PSA
126,149,169,2014,946,AFTER,COPYRIGHT,DU145,FUNCTIONAL,GAL,INC,LNCAP,MICRORNAS,MTS,NANOG,OCT4,PC3,PCR,RNAS,SOX2,THESE
169,1992,1994,2014,601,744,775,7860,COPYRIGHT,DEPRESSION,DIFFERENT,FURTHER,HOWEVER,INSURANCE,KOREANS,MAJOR,REGARDING,SERVICE,THERE
100,160,169,200,2014,COPYRIGHT,HDAC,PUBLISHED,SAHA,SAS,VORINOSTAT
145,160,169,2014,956,A549,AKT,ALSO,AMONG,CELL,COPYRIGHT,FIVE,FURTHER,HELA,HEPG2,HOECHST,IC50,MCF,PKB,SAS
169,2014,945,COPYRIGHT,HIF,LNCAP,LTD,PC3,PGE,PGE2,THEREFORE,THESE
8201,956,DOCETAXEL,MBQ,METABOLITE,SEVEN,THESE
BACKGROUND,BCAS2,GST,HSP90,LABEL,LNCAP,METHODS,MTT,PCA,PROTEIN,RESULTS,THERE,THEREFORE,THUS
281,BACKGROUND,EXPRESSION,GLEASON,INDEX,KI67,LABEL,METHODS,RESULTS
001,0151,100TH,143,184,255,291,30TH,327,452,65TH,711,754,8805,963,BACKGROUND,COLORECTAL,CURRENTLY,CXR,EDITORS,FORCE,LABEL,LUNG,METHODS,NLST,NONE,OVARIAN,PLCO,PPV,PPVS,PREVENTIVE,RESULTS,RISKS,SCREENING,SMOKERS,SUMMARY,TASK,TRIAL
169,200NG,2014,3PG,963,AB1,AB2,COPYRIGHT,DNA1,DNA2,PSA,USING
169,2014,62FM,84NM,BASED,COPYRIGHT,EN2,FAM,FINALLY,THEN,VARIOUS
169,1ML,2014,COOH,COPYRIGHT,CTCS,EPCAM,IFA,LAPS,PBS,SEM,SPIKING,XPS
169,2014,AUTHORS,COPYRIGHT,LTD,MRI,PUBLISHED
169,177,2014,COPYRIGHT,DU145,LTD,MPA,PDMS,WM115,WM266
1686,947,ATM,CFS,COMPARING,FINALLY,H2AX,HOWEVER,TOP1
169,17TH,2014,946,ALDH,CD133,CD24,CD44,CD49F,COPYRIGHT,CSCS,CXCR4,EPCAM,ISSUE,LTD,NOTCH,SPECIAL,TGF,VITAMIN,WNT
169,2014,ADT,COPYRIGHT,CURRENTLY,IRELAND,LTD
BF3,BINDING,LNCAP,MR49F,PCA,PSA,THERE,THESE
111,177,20H,24H,255,321,6AHX,945,946,AHX,ALA,ARG,ASP,BACKGROUND,BFCA,CARE,DO3A,DOTA,ESI,GLN,GLU,GLY,GRPR,HPLC,IC50,INC,KNOWLEDGE,LABEL,LEU,METHODS,MICRO,NATURAL,NH2,PATIENT,PHE,PUBLISHED,RESULTS,RGD,RM2,SCID,STA,THESE,TRP,U87,VAL
169,2014,4955,632,657,669,705,ACCORDING,AUC,COPYRIGHT,NLR,PLR,PSA,PUBLISHED,ROC,SERUM,TEN,THERE
169,2014,945,946,99M,COPYRIGHT,CURRENTLY,EC145,EC20,FOLIC,LTD,PHASE,THEREFORE,VINCA
169,176,177,1HR,2014,24HR,48HR,BACKGROUND,BMAX,COPYRIGHT,DOTA,DSRED,ELISA,EPCAM,INC,LABEL,METHODS,PC3,RESULTS,SIMILAR
169,2015,8805,COPYRIGHT,FIFTY,GLEASON,HIGHEST,INC,MRI,PSA
169,2015,960,AFTER,AGREEMENT,CONCLUSION,COPYRIGHT,ERC,ICC,INC,LABEL,MATERIALS,METHODS,MRI,MRIS,OBJECTIVE,PURPOSE,RESULTS
169,2014,COPYRIGHT,FOUR,LTD,THEIR
126,169,177,2014,216,24HR,289,4HR,5HR,ALA,BMAX,COPYRIGHT,DOTA,GASTRIN,GLN,GLY,GRPR,INC,LEU,NH2,SO3H,STATINE,THESE,TRP,VAL
945,AFP,AFTER,ATP,BESIDES,BPE,BPES,ECL,ITO,NPS,PSA,SIO2,THUS,TPA
012,128,169,2014,ATLAS,BACKGROUND,BRAF,CONCLUSION,COPYRIGHT,FTC,FVPTC,HIGH,INC,LABEL,METHODS,NODAL,PTC,RESULTS,TCGA
169,2014,945,946,COPYRIGHT,EPR,ERP,TARGETING
CRPC,III
00013,0015,0024,0039,019,100,117,126,154,169,183,2014,AUC,BACKGROUND,BIOMEDICAL,CAMBRIDGE,CHARITY,COPYRIGHT,DAD,ENRICHMENT,FOUNDATION,FOX,FUND,FUNDING,GENOMIC,HUTCHISON,INSTITUTE,KETTERING,LABEL,LALONDE,LIMITED,LTD,METHODS,MOTORCYCLE,MSKCC,NIHR,ONTARIO,OPEN,PMH,PROGRAM,PUBLISHED,RADIATION,RESULTS,RIDE,SLOAN,SOCIETY,TERRY,TORONTO,UNIVERSITY,WHAMPOA
0001,1008,169,183,2014,463,545,AFFYMETRIX,AMENDMENTS,BACKGROUND,CHARITABLE,COPYRIGHT,DEFENSE,DEPARTMENT,DETECTION,DORIS,DUKE,EARLY,FOUNDATION,FUNDING,GLEASON,INSTITUTE,INSTITUTES,LABEL,LABORATORY,LTD,MEDICAL,METHODS,NETWORK,RESULTS,RNAS,SCHLAP1,THEREFORE,VALIDATION
169,2011,2014,3244,6191,936,ASIA,AUTHORS,DATA,FOBT,JAPAN,LTD,MEN,OSAKA,PSA,PTY,PUBLISHING,SCIENCE,USING,WILEY
169,2014,COPYRIGHT,FOURIER,FRDS,LTD
945,ATLAS,EMT,GYLTY1B,PCR,REDUCTIONS,SNAIL,ZEB1
8216,8217,COUP,DAX1,DISCOVERY,ERRS,LXRS,NRS,NUCLEAR,ONRS,RORS,TFS,ULTIMATELY
125,169,2003,2005,2015,COPYRIGHT,GRADE,INC,JAPAN,JULY,LDR,MOST,OUTCOME,PERMANENT,PUBLISHED,SCORE,SEED,SEVERAL,SOCIETY,SYMPTOM,URINARY
001,169,1991,2009,2014,5207,8805,ACCORDING,BACKGROUND,CCI,COPYRIGHT,END,INDEX,LABEL,LTD,METHODS,MORTALITY,RESULTS,SEER,T4A,UCUB
169,2014,AMICO,BACKGROUND,CONCLUSION,COPYRIGHT,LABEL,LOW,MEDLINE,METHODS,MRI,NOVEL,RESULTS,SAS
169,2014,946,CACO,CAV3,COPYRIGHT,FEDERATION,FINALLY,IKB,IKK,LARGE,MCF,MLL,PC3,PKC,PUBLISHED,RAPID,SOCIETIES,SW620,TARGETING
169,2014,945,946,ALLYL,ATE,BATE,BFRS,BROMINATED,COPYRIGHT,DPTE,HOWEVER,LAT,LTD,PSA,THESE,THREE,WESTERN
177,8320,8325,946,956,A549,BASED,EG5,HELA,HR22C16,MCF,ME180,MOLECULAR,MTT,THESE
169,1936,1995,2005,2009,2014,BACKGROUND,COPYRIGHT,LABEL,LTD,METHODS,ORS,OVERALL,PCA,RESULTS,THESE
169,2014,AKT,CICS,COPYRIGHT,EGFR,EGFR1,ERB,HER2,LTD,PI3K,PTEN
169,2014,2109A,22RV1,8764,ANTIBODIES,CONCLUSION,CWR22PC,IMAGING,INC,LABEL,METHODS,MOLECULAR,MSTP2109A,NUCLEAR,PC3,PCA,PET,RESULTS,SOCIETY,THESE,UNLABELLED
169,2014,611,ANTI,BRAIN,CONCLUSION,FACBC,FDG,IMAGING,INC,LABEL,METHODS,MOLECULAR,NUCLEAR,PET,RESULTS,SIXTEEN,SOCIETY,UNLABELLED
002,011,058,169,2015,526,8804,BCR,CAUCASIAN,CONVERSELY,COX,GENOTYPES,HOWEVER,HRS,MEIER,PCA,SNPS,SOCIETY,UGT1,UGT1A10,UGT2B,UGTS
103,169,2009,2013,2014,AIM,ASSESSMENT,BACKGROUND,BRITISH,CONCLUSION,CURRENTLY,DRE,EVALUATION,GENERAL,IRISH,JOURNAL,LABEL,MAY,METHODS,OBJECTIVE,OCTOBER,PATIENT,PSA,RAPID,RESULTS,SETTING,SEVENTY,TRUS
169,2014,CCR5,FVB,SFK,SRC
169,2013,2014,34S,COPYRIGHT,CRC,FURTHER,HCC,NPC,NSCLC,PCA,SCIENCE,THEREFORE,ULTIMATELY,WEB
160,169,2015,COMMENTARY,COPYRIGHT,INC,PATHOLOGY,PUBLISHED,SANTE,SIRT1,SOCIETY
181,BXPC,H1299,IC50,IND,INDANONES,INHIBITORY,MASS,MTT,NMR,RWPE
001,121,169,2015,AUC,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,RADS,RESULTS,UROLOGICAL,USING
100,169,1999,2014,2015,AGREE,AUA,COPYRIGHT,EDUCATION,ENGLISH,FOUR,HOWEVER,INC,IQR,LABEL,MATERIALS,METHODS,NICE,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
112,169,1994,1995,2009,2010,2015,526,985,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,MEN,METHODS,OBJECTIVE,OLDER,PCOS,PROLONGED,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL,USING
111,112,125,137,169,2015,230,COPYRIGHT,EDUCATION,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RADS,RESULTS,UROLOGICAL
119,150,169,2010,2012,2014,231,233,626,BETWEEN,CONCLUSION,COPYRIGHT,LABEL,MATERIALS,MAY,MEAN,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SAS,SEED,SFRO,SOCI,THERE
169,177,183,2011,2013,2014,231,233,BETWEEN,CBCT,CONCLUSION,COPYRIGHT,HENRI,IGRT,LABEL,MEAN,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SAS,SFRO,SOCI,STUDIES
169,2014,BRUCHOVSKY,COPYRIGHT,KUANG,LTD,NAGY,PORTZ,THUS
1A1,4EBP1,946,BPH1,CAFS,CAP,CCL5,CONSISTENT,INC,PDGFR,PIM,PIM1,PUBLISHED,WESTERN
169,2014,COPYRIGHT,CRPC,NEPC,PUBLISHED,SEVERAL
100,169,2014,COPYRIGHT,DOX,LNCAP,PSMA,THESE
169,2014,231,945,CD49F,COPYRIGHT,DU145,FAK,ILK,INC,INHIBITION,ITGA6,MDA,PC3B1,TAKEN
019,1966,1994,2013,2014,3245,AUC,CNKI,CONCLUSION,DOR,FINALLY,JANUARY,JULY,LABEL,MARCH,META,METHODS,OBJECTIVE,PCA3,RESULTS,SECTION,STATA,URINE
169,2015,AUTHORS,COPYRIGHT,HOWEVER,INC,INITIAL,PUBLISHED,THESE
169,2014,3LL,ALDH1A1,COPYRIGHT,CSC,CT26,ERK1,HIGH,ID1,ID1A,ID1B,INCREASED,IRELAND,LTD,NOTCH,OCT,PKH26,SCA,SOX,TERT,THROUGH,USING
169,2014,945,946,A549,AKT,COPYRIGHT,DRUG,FOOD,FURTHER,HGF,HOWEVER,IRELAND,LTD,MET,PC3,SAHA,SILENCING,THESE,XL184
005,100,122,169,2014,COPYRIGHT,GATA,GATA3,INC,INVUC,UCS,UPII,UROPLAKIN,UROPLAKINS
169,2014,311,B3LYP,COPYRIGHT,DFT,HELA,HMAT,HOMO,IC50,LUMO,MCF,MTT
2013,CONCLUSION,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,SIR,STUDIES
0NG,169,183,2014,2PG,COPYRIGHT,FCA,INC,LOW,MCM48,NH2,PSA,UNDER
169,2014,ACPS,AFM,AMP,AMPS,COPYRIGHT,HNP,STUDIES
169,178,185,2014,8309,8312,ACETYLATED,AKT,COPYRIGHT,FINALLY,FURTHER,HDAC,LYS,METASTASIS,MTA1,NURD,PTEN,TAKEN
0CM3,169,1CM3,2015,COPYRIGHT,D90,DVH,EGO,GRAPHICAL,GRO,HIPO,HOWEVER,IIP,INC,INVERSE,IPSA,LABEL,MATERIALS,METHODS,OBJECTIVE,PDR,PUBLISHED,PURPOSE,RESULTS,SOCIETY,TREATMENT,V100,V150
169,2014,BNI,CELL,COPYRIGHT,FAS,FOCAL,HGF,INC,INSTEAD,RAP1,SUBSEQUENT,THUS,TIRF
EARLY,FDA,HOWEVER,LICENSING,PET,PFS,PSA,SCREENING,SWISSMEDIC
1994,2008,279,387,902,948,COX,OPG,THERE
169,2014,954,COPYRIGHT,COX,EPAC,ERK,INC,LNCAP,PC3,PGE2,PI3,PI3K,PKA,RWPE,RWPE1,THUS,VASOACTIVE,VEGF,VIP
001,169,2014,AKT,COMBINING,COPYRIGHT,EMT,ERK1,FURTHER,HOWEVER,INC,MMP,MOST,PCA,STAT,VEGF
169,2015,307,388,4PN0,8805,AFTER,ARO,ART,COPYRIGHT,COX,FORTY,GLEASON,INC,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PSA,RESULTS,SRT
169,176,177,2015,267,CONTINUOUS,COPYRIGHT,DOF,INC,KIM,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE,VARIOUS
169,2014,AIMS,CONCLUSION,COPYRIGHT,CROWN,FIFTY,GRADE,HDPRT,LABEL,LOCAL,LTD,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,RESULTS,THERE
120,169,2014,BACKGROUND,BPH,CHINESE,CIS,COPYRIGHT,INC,LABEL,METHODS,ORS,PCA,PCA3,PCR,RESULTS,STR,TAAA
145,169,2014,COPYRIGHT,DDC,DOPA,GIVEN,MICRORNAS,MOTIVATED,OVERALL,PCR,PUBLISHED,RNAS,THUS,WESTERN
169,200,2014,956,AIMS,AKT,APOPTOTIC,BCL,C18,COPYRIGHT,DESPITE,ERK,FITC,INC,KEY,LABEL,MAIN,METHODS,MMP,MTT,OBJECTIVE,RESULTS,THESE,TUNEL,UNDERLYING,ZEA
10MG,169,177,2014,20MG,945,954,956,AIMS,COPYRIGHT,IC50,INC,KEY,LABEL,MAIN,METHODS,MRP,MRP3,MTX,OBJECTIVE,RES,RESULTS,TESTICULAR,THUS
164,169,174,1998,2011,2015,582,ASA,COPYRIGHT,COX,DEFINITIVE,ECOG,EDUCATION,GLEASON,HOWEVER,INC,LABEL,MATERIALS,MAY,METHODS,OBJECTIVE,PATIENT,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
169,2015,403,410,813,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,MUSIC,OBJECTIVE,PRACTICES,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
001,169,174,2015,COPYRIGHT,CURRENTLY,HOWEVER,INC,LABEL,MATERIALS,MEDLINE,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS
169,1995,2010,2015,213,255,798,837,COPYRIGHT,EDUCATION,EPSTEIN,GIVEN,GLEASON,INC,INITIAL,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
169,174,2015,945,COPYRIGHT,EDUCATION,HIF,HIF1,HIF2,HIFS,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THERE,THEREFORE,THUS,UROLOGICAL
120,169,181,2014,8201,AUC,COPYRIGHT,IRELAND,LTD,OCE,PCA
145,169,2014,947,948,APPPI,CAKI,COPYRIGHT,CYTOTOXIC,FURTHER,HOWEVER,IPP,IRELAND,LTD,U87MG,ZOL
169,1996,2013,2014,2015,223,303,APRIL,COPYRIGHT,CRPC,EDUCATION,GIVEN,GUIDELINE,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PRINCIPLES,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
169,2015,AUTHORS,BESIDES,FOUNDATION,IRF,JOHN,JOURNAL,LNCAP,LTD,MOLECULAR,NOTABLY,PC3,PCA,RWPE,SONS,THEREFORE,TLR3,TLRS,TOLL,WILEY
169,2014,BOTH,COPYRIGHT,EVALUATION,INC,SHEAR,THERE
169,2014,215,CONCLUSION,COPYRIGHT,GLEASON,HISTOLOGIC,INC,LABEL,MATERIALS,METHODS,MRI,NINE,OBJECTIVE,PSA,RESULTS,UROSTATION
100,124,169,177,1887,1909,2008,2010,2014,2015,702,716,726,8805,970,AREA,AUC,BXS,CAP,CONCLUSION,COPYRIGHT,HGPIN,INC,JULY,LABEL,MEAN,MEANS,METHODS,OBJECTIVE,PCA3,POST,PSA,RESULTS,TRUS
131,169,2014,262,CONCLUSION,COPYRIGHT,DEPENDING,DESPITE,INC,LABEL,METHODS,OBJECTIVE,OVERALL,PCA,RESULTS,SVI,SVS
0001,114,119,169,2001,2011,2014,6368,8804,8805,CONCLUSION,COPYRIGHT,GLEASON,INC,JULY,JUNE,LABEL,MATERIALS,MEN,METHODS,OBJECTIVE,PSA,RESULTS
169,2014,CLAVIEN,CONCLUSION,COPYRIGHT,FUNCTIONAL,GLEASON,HIFU,INC,KINGDOM,LABEL,METHODS,OBJECTIVE,RESULTS,THREE,WHOLE
023,028,115,117,118,169,175,176,2008,2012,2014,233,CLAVIEN,CONCLUSION,COPYRIGHT,FOUR,INC,LABEL,METHODS,MINIMUM,MINOR,OBJECTIVE,OCTOBER,OVERALL,RENAL,RESULTS,SERUM,SIMILARLY,VARIABLES
122,129,140,169,170,2014,230,CONCLUSION,COPYRIGHT,INC,LABEL,MEAN,METHODS,OBJECTIVE,RASP,RESULTS,SCORE,SYMPTOM,TEN
001,003,048,169,201,2014,408,431,839,8805,ASA,CONCLUSION,COPYRIGHT,CSPC,GLEASON,INC,LABEL,MEN,METHODS,NSAID,OBJECTIVE,RESULTS
001,003,023,2004,2009,274,CONCLUSION,END,HIGH,HOWEVER,IMRT,INC,LABEL,METHODS,OBJECTIVE,OVERALL,PUBLISHED,RESULTS
169,2003,2014,323,426,8805,AFFAIRS,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,POISSON,PSA,RESULTS,THESE
103,169,1995,2008,2013,2014,345,9568,ACUTE,CONCLUSION,COPYRIGHT,ESBL,FORTY,INC,LABEL,MARCH,MATERIALS,MAY,METHODS,OBJECTIVE,RESULTS,THESE,TRUS
169,2014,AFTER,CANONICAL,COPYRIGHT,DMA,HENCE,IPEM,LTD,MULTI,NTCP,PUBLISHED,RESULTS
169,1927,1999,2014,286,3056,843,ANGELES,CALIFORNIA,CAPSURE,COPYRIGHT,DESPITE,INC,INDEX,LABEL,LOS,METHODS,OBJECTIVE,PATIENT,RESULTS,UNIVERSITY
147,169,1995,1998,2003,2014,4285,COPYRIGHT,COX,DEPRESSION,END,INC,LABEL,METHODS,NINTH,OBJECTIVE,POISSON,RESULTS,THESE
001,009,041,160,169,2015,204,266,304,570,AUR,COLLEGE,COPYRIGHT,DATA,FORTY,HOWEVER,INC,LABEL,MATERIALS,METHODS,MOST,MRI,OBJECTIVE,OBJECTIVES,PSA,PUBLISHED,RADIOLOGY,RATIONALE,RESULTS
1176,169,1993,2004,2010,2014,247,316,563,929,945,946,947,AUC,BED,BEDS,BEST,BETWEEN,COPYRIGHT,DATA,INC,LABEL,LIKELIHOOD,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
100,169,177,2015,CALCULATED,CONCLUSION,COPYRIGHT,CTS,D99,DICE,DOSE,DRR,DRRS,DSC,DSCS,FULL,FURTHER,GAMMA,GENERATED,HOUNSFIELD,INC,LABEL,MAE,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIM
001,0017,0034,008,0102,1285,169,187,2006,2010,2015,217,ADVERSE,AUTHORS,COPYRIGHT,DVH,GR1,GR2,GR3,GR4,GR5,INC,LABEL,MATERIALS,MAY,METHODS,OBJECTIVE,POTENTIAL,PUBLISHED,PURPOSE,RESULTS,TECHNIQUES,THERE,TRANSIENT,UNIVARIATE,V75
1000,500,ACCORDING,BOTH,CALYPSO,CTS,CTV,D99,HOWEVER,INC,LABEL,MATERIALS,MEAN,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,REAL,RESULTS,SFUD,TEN
0001,169,2013,2014,250,954,AGREEMENT,CLEARER,CONCLUSION,COPYRIGHT,CTC,FORTY,GROUP,ICC,INC,INSTITUTE,JANUARY,JUNE,LABEL,LOW,MATERIALS,METHODS,NCI,OBJECTIVE,PURPOSE,RADIATION,RESULTS,RTOG,SEVENTY,THERAPY,USING,WEB
169,2014,786,ACHN,BAX,CASPASE,CDK4,COPYRIGHT,FUNCTIONAL,HOWEVER,INC,PUMA,ZFX
10878,169,2014,70GY,72GY,74GY,76GY,78GY,BACKGROUND,CONCLUSION,COPYRIGHT,DVC,IMRT,IMRTWHILE,IRELAND,LABEL,LRT,LTD,METHODS,R40,R50,R60,R65,R70,RESULTS,SIX,THERE
169,2014,COPYRIGHT,HOWEVER,LTD,MULTI,SWEDISH,USING
169,1996,2008,2014,2015,376,425,BACKGROUND,CASE,COPYRIGHT,DECREASES,DEPARTMENT,INC,JOURNAL,LABEL,METHODS,MULTILEVEL,OBJECTIVE,OHIO,PREVENTIVE,PUBLISHED,PURPOSE,RESULTS
100NM,169,16NM,2014,COPYRIGHT,EDAC,H2O2,LOD,NHS,PCA,SOX,SPES
169,2014,CLINICIANS,COLLEGE,COPYRIGHT,LTD,PUBLISHED,ROYAL,THESE,ULTIMATELY
001,003,169,2014,842,8804,8805,CONCLUSION,COPYRIGHT,FORTY,INC,INVENTORY,LABEL,MATERIALS,MEAN,MEN,METHODS,OBJECTIVE,PEARSON,RADIATION,RESULTS,SHIM
169,2015,ADVERSE,CONCLUSION,COPYRIGHT,EPSTEIN,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,RESULTS,THERE
169,201,2011,2012,2013,2015,212,AFRICAN,AFTER,AMICO,CONCLUSION,COPYRIGHT,FACTORS,FORCE,GLEASON,INC,JUNE,LABEL,MEN,METHODS,OBJECTIVE,PCA3,PREVENTIVE,PSA,RESULTS,TASK
0001,1258,1649,169,2004,2013,2015,750,7843,BCRFS,COMMITTEE,CONCLUSION,COPYRIGHT,COX,EPE,GLEASON,INC,JOINT,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,RESULTS
001,002,003,169,1994,2015,615,654,8804,982,AAS,ADJUSTING,AFRICAN,CAUCASIAN,CAUCASIANS,CONCLUSION,COPYRIGHT,EXAMINING,GLEASON,HOPKINS,INC,INCLUDING,JOHNS,LABEL,METHODS,NETWORK,OBJECTIVE,PSA,RESULTS,THEREFORE,VLR
169,2015,AFTER,CELL,CONCLUSION,COPYRIGHT,CRPC,D145,DU145,FINALLY,INC,KIT,LABEL,MATERIALS,METHODS,MMP,MMPS,OBJECTIVE,PC3,RESULTS,USING,WESTERN
002,130,133,169,171,174,183,2008,2011,2014,205,223,253,262,322,347,352,383,395,518,526,921,945,ASA,BACKGROUND,BAYER,COPYRIGHT,FEB,FUNDING,HEALTHCARE,JUNE,LABEL,LTD,METHODS,PRIMARY,RESULTS
169,1919,2014,849,ACADEMY,ALLERGY,ATOPY,BACKGROUND,CIS,CONCLUSION,COPYRIGHT,COX,HOWEVER,IGE,IMMUNOLOGY,INC,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,THERE
169,2014,AFTER,COPYRIGHT,INC,THESE
029,100,121,149,169,2006,2012,2014,3N0,COPYRIGHT,GLEASON,MARCH,NSM,PSM,PUBLISHED
001,117,197,2003,2005,379,475,6835,AFFAIRS,BACKGROUND,CHARITABLE,CONCLUSION,DEPARTMENT,DORIS,DUKE,FOUNDATION,FUNDING,GEOGRAPHIC,LABEL,LESS,LIMITATION,METHODS,MULTILEVEL,OBJECTIVE,OLDER,PER,PRIMARY,RESULTS,SETTING
945,DEPLETION,FINALLY,GLUT1,KI67,MAPK,MYC,PCA,PI3K,PTEN,SIMILARLY,WHILE
100,116,169,2014,539,549,8320,8325,956,CCRF,CELL,CEM,CNS,COLON,COPYRIGHT,GI50,H522,HCT,LTD,LUNG,MALME,NCI,NON,NSC,OVARIAN,OVCAR,RENAL,SMALL
169,2014,COPYRIGHT,EMT,FIRSTLY,HDAC,HDAC1,HDAC2,INC,MEANWHILE,OVERALL,PC3,SLUG,SW480,THEN,THESE,TSA
10Q,116,13Q,169,16Q,17P,18Q,2014,21Q,546,662,AUTHORS,CNA,CNAS,COPYRIGHT,ERG,INC,NKX3,PREDICTED,PTEN,PUBLISHED,TMPRSS2
006,061,169,2014,231,376,382,428,839,983,A453G,CIS,COPYRIGHT,G119T,HENCE,IRELAND,LTD,ORS,PUBLISHED,REGARDING,STATA,THERE
10Q11,1575,169,19Q13,1Q32,200,2014,215,554,754,COPYRIGHT,DNAS,GWAS,HOWEVER,KCPS,PCA,PREVENTION,PSA,SLC45A3,SNP,SNPS,THREE
ACMG,BASIC,BRCA1,BRCA2,BRIP1,HBOC,JAPAN,MLPA,PALB2,PCR,RISK,RRM,RRSO,THEREFORE
ALSO,COMMITTEE,JOINT,STATINS
AFTER,BPH,COMPARISON,CONCLUSION,EVALUATION,EXPRESSION,INCREASED,LABEL,MATERIALS,METHODS,OBJECTIVE,PCA,PCA3,PURPOSE,RESULTS
IGRT,IMRT,THESE
169,1B1,2014,945,946,956,AIM,BPH,CELL,COMT,COPYRIGHT,INC,KEY,LABEL,MAIN,MALIGNANT,METHODS,OBJECTIVE,P450,PCR,RESULTS,THESE,THUS
001,024,060,1634,169,1992,2013,2014,239,8804,890,993,AFRICAN,BCR,CONCLUSION,COPYRIGHT,GLEASON,INC,LABEL,MATERIALS,METHODS,NCCN,NETWORK,OBJECTIVE,PATHOLOGIC,RESULTS,STUDIES
0001,169,2014,304,510,8804,ASSESSMENT,CONCLUSION,COPYRIGHT,COX,INC,LABEL,MATERIALS,MEIER,METHODS,NADIA,OBJECTIVE,PCSM,PROSVUE,RESULTS,RISK,SALVAGE
001,0028,016,106,148,169,2014,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,NVB,OBJECTIVE,ORPP,ORRP,RARP,RESULTS,THESE
ADT,BRD4,CRPC,HOWEVER,MDV3100,PCA,SINCE,WHILE
966,ERSPC,SCHR,WHILE
169,2014,COPYRIGHT,DENOSUMAB,DRUGS,LTD,PUBLISHED,STILL
169,2015,ASC,BPH,COPYRIGHT,CURRENT,HOWEVER,INC,PATHOLOGY,PCA,PUBLISHED,SOCIETY
0001,002,107,2010,2014,408,8201,998,AMERICA,CIS,COLORECTAL,COX,GOVERNMENT,HRS,LUNG,OVARIAN,PUBLISHED,RCC,SCREENING,TRIAL
169,2014,309G,309GG,331,501,532,717,749,8201,830,AUTHORS,CONSISTENT,INC,MDM2,PUBLISHED,SNP285C,SNP285G,SNP309T,SNPS,UICC,WILEY
001,179,185,8202,8804,DU145,GLEASON,PC3,PCA,PET
8320,8325,956,AFTER,ANNEXIN,BALB,DU145,FITC,FOXO,LNCAP,MDM2,PC3,PLATYCODIN,RWPE,THESE,WESTERN
150,177,195,1SD,8201,BACKGROUND,IMRT,LABEL,METHODS,RESULTS,VMAT
176,8201,947,CONCLUSION,DOSES,KNOWN,LABEL,MEAN,METHODS,OAR,OBJECTIVE,PREVIOUSLY,PTV,PURPOSE,RESULTS,VMAT
174,2014,BOEHRINGER,COMMITTEE,INGELHEIM,IPF,MEDICINAL,MEDICINES,NINTEDANIB,OCTOBER,OFEV,PHASE
10TH,241,544,574,641,668,75TH,8201,8226,8804,900,ADC,ADCS,CONCLUSION,DATA,DIFFERENCE,GLEASON,HISTOGRAM,IVIM,KEY,LABEL,METHODS,MRI,OBJECTIVE,PCA,RESULTS,ROC,ROIS
160,169,2013,2014,204,ADDITIONAL,ASSESSMENT,AUTHORS,BJU,CENTRAL,CIS,CONTROLLED,EVALUATION,FINALLY,GHQOL,GRADE,GRADING,HOWEVER,JOHN,LTD,MEDLINE,MEN,OCTOBER,OVERALL,PAIRS,PUBLISHED,QOL,RANDOMISED,SMD,SMDS,SONS,THERE,WILEY
239,CRPC,CTLA,DCS,ENZ,ENZR,FURTHER,HOWEVER,OVERALL,THESE,THUS
FETAL,SINCE
BPH,LOD,LOQ,MRM,PCA,PSA,RIAS,SIL,SINCE
AFRICAN,AMERICANS,CARIBBEAN,FINALLY,GENOMIC,GWAS,HIV,HOWEVER,INCLUSION
CORTACTIN,CXCR4,DENBINOBIN,DENDROBIUM,PC3,RAC1,THESE,WHETHER
2011,HOT,INTO,PUTTING
2011,2012,BACKGROUND,CONCLUSION,CRC,INDIVIDUAL,JAN,LABEL,MAR,METHODS,RESULTS,THERE
2012,2014,ADVERSE,BACKGROUND,CUTANEOUS,EARLY,IDENTIFIER,IMPORTANCE,INSTITUTE,INSTITUTES,JUNE,LABEL,MAIN,MET,METHODS,OBJECTIVE,OCTOBER,REACTIONS,RELEVANCE,RESULTS,RET,SETTING,TRIAL
CBG,OFF,PSA,USING
ATP,CSK,METABOLIC,THESE,THUS
549,ALPL,BGLAP,IBSP,LNCAP,NOTCH,RUNX2,SP7,TAKEN
177,244,471,ATLAS,CONSORTIUM,CUP,METASTATIC,SEQ
3667,MYC,PCAT,RNAS
252,AKT,CREB1,ERK,HISTOLOGIC,HOMOZYGOUS,KLF5,MYC,PTEN,SP1,THESE
1000,169,2014,8805,CONFIRMED,EASTERN,GRADE,GROUP,HOWEVER,JAPAN,LABEL,MEN,METHODS,OBJECTIVE,PHASE,PRESS,PRIMARY,PUBLISHED,RESULTS,SECONDARY,TRIAL,UNASSIGNED,UNIVERSITY,WEEK
118,169,2014,AMONG,CONCLUSION,D10,GRADE,GROUP,LABEL,METHODS,OBJECTIVE,PRESS,PUBLISHED,RADIATION,RESULTS,THERAPY,TREATMENT,UNIVERSITY,V150
155,2013,BECAUSE,DIET,FOUR,LIBRARY,MEDLINE,RANDOMIZED
946,956,BECAUSE,FADU,IC50,MCF7,PC3,SAOS,THESE
145,945,ADP,ATF,ATF4,BIP,BORON,DIETARY,GRP78,LOW,MILD
ADVERSE,BACKGROUND,BPH,CHANGES,CLAVIEN,DESPITE,DISCUSSION,INSTITUTE,IPSS,LABEL,METHODS,PAE,SCORE,SYMPTOM,TRIAL,TUR,TURP
145,177,4551,99M,BALB,FURTHER,GGGC,HOWEVER,IGF,MCF,RENAL
ARTISTE,BACKGROUND,FFF,IMRT,LABEL,METHODS,PANTHER,PLANS,PROWESS,RESULTS,SCATTERED,SIEMENS,THERE,TREATMENT,VMAT,WHILE
212,HIGHEST,LABEL,METHODS,NEED,OBJECTIVE,PURPOSE,RESULTS,SUPPORTIVE,THEREFORE
169,181,2010,2012,2014,213,394,8201,8804,8805,ADVERSE,BACKGROUND,BLADDER,BOTH,COX,GRAY,IMRT,LABEL,MAXIMUM,METHODS,PBT,PCA,RBE,RESULTS,SOCIETY
0001,003,009,169,2014,202,25TH,75TH,8804,ADC,BLAND,CONCLUSION,DCE,FACTORS,GLEASON,LABEL,MATERIALS,MEAN,METHODS,OBJECTIVE,PURPOSE,RESULTS,RSNA,VADC,VDCE,VMAX,VOLUMES,VT2
238,AKT1,APPARENTLY,BACKGROUND,BESIDES,CODES,COX,DESPITE,EZH2,FOLLOWING,LABEL,METHODS,NONE,PSA,PSMA,RESULTS,THEIR,TREATMENT,UNIVARIATE
486,538,572,8201,ALCOHOL,BACKGROUND,HEAVY,HODGKIN,LABEL,METHODS,NON,RESULTS,RRS,THERE
945,946,BECAUSE,GAL4,LIGANDS,METHODS
080,AS1,BROWN,C20ORF166,HOWEVER,LABEL,MATERIALS,METHODS,OBJECTIVE,PCA3,PURPOSE,RESULTS,RP11,SEQ,THREE,THUS
AKT,ASIAN,CHINA,ERK1,MERR,MTT
0NG,117,183,207,4ML,559,BACKGROUND,CPC,CPCS,DRE,LABEL,MATERIALS,MEN,METHODS,P504S,PRIMARY,PSA,RESULTS
000,100,150,2008,2009,218,8804,AGE,BACKGROUND,DIGITAL,GLEASON,JULY,JUNE,LABEL,MATERIALS,METHODS,MOST,PSA,RESULTS,T1C,THERE
169,2014,946,BACKGROUND,DOWN,HOWEVER,INC,LABEL,MC3T3,METHODS,RESULTS,SEMA,SEMAPHORIN,WILEY
169,2014,8211,UROLOGICAL,VARIOUS
THERE,THEREFORE,THESE
ALSO,DISCOVERY,PCA
MOST,SIMILARLY,ULTIMATELY,WHILE
1097,1105,1106,1114,2010,BIOTECHNOL,BOCK,NAT,THESE

CPG,EPIGENETIC,WESTERN
169,1980,2013,2014,8201,AMONG,CLEARER,CODE,COPYRIGHT,DATA,FEW,JOHN,LABEL,LTD,MEDLINE,METHODS,OBJECTIVE,PURPOSE,RESULTS,SONS,WILEY
13C,LD50,NMR
1952,2003,2007,2011,246,BACKGROUND,LABEL,METHODS,RESULTS,SEGMENTED,SPAIN
177,8201,ACUTE,BPH,DYSURIA,FINALLY,NONE,OTHER,PCA,SIGNALMENT,TAKEN
CRPC,DESPITE,ERG,FINALLY,TAXANES
000,100,2001,2009,221,891,BARANJA,C60,C63,CANCERS,CROATIA,INSTITUTE,OBC,OVERALL,THESE
948,956,CUL1,HAX,HAX1,HCLS1,MCL,MYC,PRKCD,PROTEIN,SCF,SKP1
118,15A,19A,200B,BACKGROUND,DESPITE,FIVE,GO_BP,LABEL,LOCI,NFAT,PRCA,RESULTS,SCNA,SP1,TFS,TRAIT
2005,FINALLY,GLEASON,HOWEVER,PATHOLOGY,SEVERAL,SOCIETY,UROLOGICAL
010,016,029,066,156,168,169,172,1ST,2014,262,274,3RD,593,8201,BACKGROUND,CASES,CONCLUSION,DIET,FIBER,INC,LABEL,METHODS,PSA,RESULTS,WILEY
1008,169,2014,8805,90401,AGE,ATE,BACKGROUND,CALGB,COX,CYCLE,GROUP,LABEL,METHODS,RESULTS,SCANT,SOCIETY,VTE
001,003,005,169,2008,2012,2014,454,8201,8804,AFRICAN,BACKGROUND,CAUCASIAN,FIVE,GLEASON,INC,LABEL,LOW,METHODS,NEITHER,PSA,REMAINING,RESULTS,SEVENTY,T1C,T2A,THESE,WHILE,WILEY
0001,181,2003,2009,316,690,CONCLUSION,CONTINUED,END,INDIANS,LABEL,METHODS,OBJECTIVE,RESULTS,SEER,WHILE,WHITE
2008,2009,2012,2013,266,CNS,FUNDING,IMRT,LABEL,METHODS,OBJECTIVE,ONTARIO,PURPOSE,RESULTS,VALUE
1000,1102,169,2014,2092,990,BACKGROUND,CALCULATOR,CRC,END,FURTHER,INSTITUTE,LABEL,METHODS,PERMANENTE,PRESS,PUBLISHED,RESULTS,UNIVERSITY
1102,2014,990,BACKGROUND,CALCULATOR,END,HMO,INSTITUTE,LABEL,METHODS,NOMOGRAMS,OPERATING,PERMANENTE,PRESS,PUBLISHED,RESULTS,SEER,THESE,UNIVERSITY
2012,2014,BACKGROUND,BOTH,CONCLUSION,END,LABEL,METHODS,OBJECTIVE,PRESS,PROGRAM,PUBLISHED,RESULTS,SEER,UNIVERSITY,USING
169,2002,2008,2014,API,ASIAN,BACKGROUND,DISCUSSION,END,LABEL,LOUISIANA,METHODS,PACIFIC,PRESS,PUBLISHED,RESULTS,SEER,SES,SIMILARLY,UNIVERSITY
169,2000,2009,2010,2014,BACKGROUND,CONCLUSION,END,FIVE,INSTITUTE,JANUARY,LABEL,METHODS,PRESS,PROGRAM,PUBLISHED,RESULTS,SES,SLT,UNIVERSITY,USLT
125,147,160,200,457,600,BACKGROUND,CHIP,DESPITE,DSBS,FAIRE,LABEL,PROTEIN,RESULTS,SMS,STRUCTURAL,THESE

003,028,163,449B,672,8201,AMONG,BACKGROUND,CONCLUSION,HIGH,LABEL,MARKERS,METHODS,RESULTS,THERE
946,FURTHER,GRH2,MMPS,RH2,TAKEN,TGF
281,SIRS,STUDIES,SWEDISH
211,254,852,AFTERWARD,AUC,CONCLUSION,ECE,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,RESULTS,ROC,THUS,WHOLE
001,028,153,215,320,961,ADC,ADT,AFTER,CHANGES,CONCLUSION,DIFFUSION,DWI,FORTY,LABEL,MATERIALS,METHODS,OBJECTIVE,PSA,RESULTS,STUDENT
PROTONS
BECAUSE,PBT,THROUGH

FRESH,GRIN
128,2700,292,ACTIVATION,AUC,GEO,ONCOFINDER,PAS,PATHWAY,SIGNALING,THESE
945,AMONG,CHIP,FINALLY,HOWEVER,NEAT1,RNAS,USING
0001,00067,0017,139,154,5YRS,ATM,ATR,DDR,DESPITE,GLEASON,IGRT,NBN,PCA,PRKDC,PSA,RAD50,RADP,WALD
169,2013,2014,BACKGROUND,CONCLUSION,EMBRYOLOGY,ENGLISH,FULL,HOWEVER,LABEL,METHODS,OBESITY,PRESS,PUBLISHED,RELEVANTLY,RESULTS,SEVERAL,SOCIETY,UNIVERSITY
003,169,2010,2013,2015,8100,APRIL,COPYRIGHT,EACH,IMRT,INC,JULY,LABEL,MATERIALS,METHODS,OBJECTIVE,PTV,PUBLISHED,PURPOSE,RADIATION,RESULTS,SOCIETY,THERE,V33,V60,V65,V70,V75,V80,VMAT
169,2015,ALTO,CALYPSO,COPYRIGHT,INC,LABEL,MATERIALS,MEDICAL,METHODS,OBJECTIVE,PALO,PUBLISHED,PURPOSE,RADIATION,REGARDLESS,RESULTS,SOCIETY,SYSTEMS,THREE,UNILATERAL
169,2015,8805,AFTER,CBCT,CHANGES,COPYRIGHT,CROWN,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS
0001,114,127,165,169,2003,2010,2015,279,296,355,425,8804,8805,997,COPYRIGHT,GLEASON,INC,LABEL,LOW,MATERIALS,METHODS,OBJECTIVE,PSA,PUBLISHED,PURPOSE,RADIATION,RESULTS,SOCIETY
100,169,177,2014,946,ALA,CIS,CONCLUSION,DOTA,GASTRIN,GLN,GLY,GRPR,IMAGING,INC,INHIBITORY,JMV4168,JMV5132,LABEL,LEU,MBQ,METHODS,MOLECULAR,MPAA,NH2,NODA,NUCLEAR,PET,PHE,RESULTS,SMALL,SOCIETY,STA,THESE,TRP,UNLABELLED,VAL
112,259,3169,BACKGROUND,CONCLUSION,GERMANY,HAROW,INDICATION,LABEL,MATERIALS,MEDICAL,METASTASES,METHODS,OPERATION,RESULTS
2059,8201,ANXIETY,DEPRESSION,FEAR,FEMALES,FOP,GAD,HADS,HODGKIN,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCALE,THERE,WHILE
001,116,172,177,2008,2013,ASA,BACKGROUND,CONE,JANUARY,JULY,LABEL,LESS,METHODS,MLPL,RESULTS,SIX
169,2004,2010,2014,283,400,578,591,6TH,7TH,AJCC,BACKGROUND,COLLECTION,COMMITTEE,CSV2,DATA,END,GLEASON,IIA,IIB,JOINT,LABEL,METHODS,PROGRAM,RESULTS,SEER,SOCIETY,STAGE,T3A,VERSION
8201,956,ANNEXIN,CASTRATION,CRPC,HMGB,INSTEAD,LC3B,MET,RIPK1,RIPK3,SEVERAL,SIM,TREATMENT,WARBURG
126,172,228,8202,C57BL,CCL19,FIRST,GWAS,ITGAX,MICROARRAY,QTL,QTLS,TRAMP,TRAMPXNOD
169,200,2014,215,300,8776,BACKGROUND,BAX,BCL,BEST,BPH,CELL,CELLS,CONCLUSION,F344,IC50,LABEL,METHODS,MTT,RATS,RESULTS,REVERSE,SEMINAL
100,116,122,177,2011,2014,319,416,8201,901,ADT,AMONGST,CONCLUSION,DKFZ,GLEASON,GSC,HBED,HOWEVER,LABEL,METHODS,NPV,OBJECTIVE,PCA,PET,POTENTIAL,PPV,PSA,PSMA,PURPOSE,RESULTS,SINCE
0001,001,002,169,1997,2014,2799,8201,9202,9413,AFTER,BACKGROUND,DATA,GROUP,LABEL,METHODS,PSA,RADIATION,RADIOLOGY,RATES,RESULTS,RTOG,SOCIETY,THERAPY,THESE
5MM,948,949,CDME,LNCAP,PC3,PKC,PROTEIN,RWPE1,THESE,TREATMENT
APOPTOSIS,BACKGROUND,DD1,DIF,EXPRESSION,FAST2,FASTKD1,FASTKD2,LABEL,LNCAP,METHODS,NRIF3,NUCLEAR,RESULTS,S28A,TAMOXIFEN,TUNEL
AFRICAN,ALA,CAP,FURTHER,LNCAP,R1881,T877A
BACKGROUND,LABEL,OBJECTIVE,RATIONALE,RESULTS
169,2014,916,AGE,AUTHORS,BRITAIN,CD280,CLEC13E,CTLD2,ENDO180,EX2,GREAT,IRELAND,JOHN,JOURNAL,LTD,MLC2,MRC2,PATHOLOGY,PEC,PECS,SOCIETY,SONS,TEM9,THESE,WILEY
105,169,2014,443,635,8201,8805,AUTHORS,BACKGROUND,FIRST,INC,LABEL,METHODS,PUBLISHED,RESULTS,RRS,THIRD,WILEY
169,2014,2015,360,369,BACKGROUND,CRPC,EXOGENOUS,F10,HTRA2,INC,LABEL,METHODS,OMI,PC3,RESULTS,TPEN,WESTERN,WILEY
169,2015,946,BROMINE,GMBH,KGAA,NMR,VCH,WILEY
AREAS,CTV,GROUP,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,RADIATION,RESULTS,RTOG,TEN,THERAPY
FURTHER,THERE,THESE,WHILE
300,6480,7380,8804,BELOW,ESTIMATED,FORTY,IMRT,INCIDENTAL,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SERUM,THERE
0001,0005,100,113,179,1986,2010,575,8804,COX,FFBF,FFM,IQR,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PCSM,PCSS,PSA,PURPOSE,RESULTS,SRT,STEPHENSON,UNIVARIATE
180,2008,2012,IMRT,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE,THESE,THREE
001,035,039,059,063,160,168,171,177,2003,2010,396,411,431,463,935,956,BIVARIATE,COX,DISEASE,LABEL,MATERIALS,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS,SIXTY,SRT
8805,AFFAIRS,ASTRO,BOARD,DIRECTORS,DON,FOUNDATION,GOVERNMENT,LABEL,LITERATURE,MATERIALS,METHODS,OBJECTIVE,POTENTIAL,PURPOSE,QUALITY,RADIATION,RELATIONS,RESULTS,SOCIETY,THESE
AIM,CONCLUSION,J591,LABEL,MATERIALS,METHODS,MNP,MNPS,MRI,NOD,OBJECTIVE,PSMA,RESULTS,SCID
2012,2013,BACKGROUND,DATA,FURTHER,HOWEVER,IKT,LABEL,MAY,METHODS,RESULTS,SEPTEMBER
17Q12,940,AMONG,BACKGROUND,HER2,LABEL,MET,METHODS,MICRORNAS,MIEN1,MIGRATION,RESULTS,RNAS,THESE,UTR,WESTERN,WHILE
2010,2012,2013,2014,945,BELGIAN,BMJ,FGF23,GROUP,JANUARY,JUNE,LTD,MARCH,MID,PUBLISHING,TRP
BOTH,CONFIRMMDX,FINALLY,GENOMIC,LABEL,OBJECTIVE,PROMINENT,PURPOSE,RESULTS,SCORE,SUMMARY
ALONG,DRUG,EARLY,FOOD,FORCE,LABEL,OBJECTIVE,OTHER,PREVENTIVE,PURPOSE,RESULTS,SUMMARY,TASK,THESE,TMPRSS2,USING
ADDITIONAL,EPIGENETIC,LABEL,OBJECTIVE,OTHER,PCA,PURPOSE,RESULTS,SUMMARY,THERE
100,DESPITE,LABEL,OBJECTIVE,PSA,PURPOSE,RESULTS,SNPS,SUMMARY,THERE
EARLY,MOLECULAR,RISC,RNAI,SND1
007,008,083,306,425,469,658,713,740,891,955,GYEONGSANG,HOWEVER,LABEL,MATERIALS,MEDICAL,METHODS,OBJECTIVE,PREVENTIVE,PURPOSE,RESULTS,TRUS,UNIVERSITY
102,107,351,354,798,AFTERWARD,ASAP,GLEASON,HGPIN,LABEL,MATERIALS,METHODS,OBJECTIVE,PCA,PSA,PURPOSE,RESULTS,SIXTEEN
001,118,177,2000,2012,289,374,883,CANCERS,DAEGU,DRE,GLEASON,GYEONGBUK,LABEL,MATERIALS,MEAN,METHODS,NUMBERS,OBJECTIVE,PCA,PSA,PURPOSE,RESULTS
DUE,INDUCED
169,181,2014,AMONG,JULY,RRS,UICC
III,MEN,REGARDLESS

033,037,064,1995,2012,205,BACKGROUND,BCR,COX,DUAL,GLEASON,HOWEVER,JANUARY,LABEL,MARCH,MEIER,METHODS,PCA,RECIPIENTS,RESULTS,SEVEN,SEVENTY
0001,0005,0028,003,0143,120,BACKGROUND,GLEASON,LABEL,METHODS,NOTEWORTHY,PARTNER,PSA,PSF1,RESULTS,SLD5,TNM

001,169,196,2005,2006,2014,AFRICAN,AFTER,ASIAN,CONCLUSION,LABEL,METHODS,OBJECTIVE,PACIFIC,PPC,PURPOSE,RESULTS,SOCIETY
FURTHER
005,8804,AIM,CONCLUSION,EPB41L3,GLEASON,LABEL,METHODS,OBJECTIVE,PCA,PITX2,RESULTS,SPARC,TPM4,WNT5A
104,127,169,194,2009,2012,2014,208,234,ADT,AFTER,BASEL,CONCLUSION,COX,CRPC,FIFTY,LABEL,MAORI,METHODS,MIDLAND,NETWORK,OBJECTIVE,OVERALL,PACIFIC,RESULTS,THERE,ZEALAND
100,104,175,1982,1993,1995,2002,2007,2008,2009,239,386,526,AARP,ADVENTIST,AFRICAN,AMERICANS,AMONG,BLACK,BMI,COLORECTAL,COMMUNITY,COX,EAST,HRS,LUNG,NIH,OBESITY,OVARIAN,PREVENTION,SCREENING,TRIAL,WOMEN
429,452,595,714,726,786,798,8322,893,BPH,CGPCA,COMBINING,CONCLUSION,DCE,DWI,KAPPA,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,T2WI,WHILE
169,2014,EXPRESSION,GMBH,KGAA,OLFM4,OLM4,VCH,WILEY
ACANTHOSIS,ANTI,BACKGROUND,CASE,CAUCASIAN,CONCLUSION,CONCURRENT,LABEL,METHODS,UNDERLYING
169,2014,408,954,AMONG,ANTITUMOR,DU145,GSK3,LICL,LNCAP,PC3,RTA,SELECTIVE,THESE
169,2014,946,948,956,AKT,AZD8186,CELLS,GI50,INHIBITORS,LOSS,PI3K,PTEN,SCHEDULING,TBNC,TNBC
003,044,064,169,183,2014,AFRICAN,AIM,AMERICANS,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,HOWEVER,INSTITUTE,JOHN,LABEL,MEN,METHODS,OBJECTIVE,RESULTS,TANNING,VITAMIN,WASHINGTON
01105,956,AKT,ERK,LNCAP,MEK,NSK,PI3K,RAF,WESTERN
BACKGROUND,BMJ,BOARD,COX,ETHICAL,GROUP,HIGH,LABEL,LIMITED,METASTASIS,METHODS,PROCESS,PUBLISHED,PUBLISHING,QRESEARCH,REPORTING,SCIENTIFIC,STUDIES,UNIVERSITY,VGSC,VGSCS,VOLTAGE,YORK
036,1996,2002,8462,BACKGROUND,FEWER,HOWEVER,LABEL,METHODS,PCA,PREDICTION,RESULTS,SEER,SEVERAL
233,BCG,FDG,INCIDENTAL,PET
10MM,2MM,3MM,4MM,5MM,AMIDE,FWHM,LOWER,PET,PHANTOM,SUVMEAN,TNM
000,2005,2010,226,3127,578,859,885,DATA,FIVE,NEUCH,REGISTRIES,SHN,SWISS,THESE,VAUD
FDG,FINALLY,HOWEVER,PET
169,177,2014,8201,CANCEROUS,COPYRIGHT,GLEASON,HOWEVER,JOHN,LTD,MRE,SONS,WILEY
100,BACKGROUND,DISCUSSION,ESTIMATES,IDENTIFIER,LABEL,METHODS,THESE,TRIAL,USUAL
004,028,224,8201,HOWEVER,PCA,THEN
8209,BERBERINE,CHINESE,EGF,EGFR,FURTHER,HOWEVER,HUANGLIAN,LNCAP,WESTERN
169,2014,7TH,8TH,BACKGROUND,FIFTY,HOWEVER,LABEL,METHODS,RESULTS,SOCIETY
2013,2014,8202,HENCE,HOWEVER,LABEL,MARCH,OBJECTIVE,PSA,PURPOSE,RESULTS,SUMMARY
GENOMIC,LABEL,NEXT,OBJECTIVE,PCA,PURPOSE,RESULTS,STRUCTURAL,SUMMARY,THESE
5ARI,5ARIS,8202,945,ALCOHOL,LABEL,LUTS,MIRABEGRON,OBJECTIVE,PURPOSE,RESULTS,SEVERAL,SILODOSIN,SUMMARY,TADALAFIL
015,169,2009,2010,2012,2014,8201,BACKGROUND,CHOLINE,DIAGNOSTIC,DWI,EUDRACT,HOWEVER,INC,LABEL,MAY,METHODS,MRI,PATIENT,PCA,PLND,RESULTS,SUMMARY,THESE,UNIVERSITY,WILEY
169,2014,22RV1,AKT2,BACKGROUND,CONCLUSION,ERK1,HER2,INC,LABEL,LAPC,LHR,LNCAP,METHODS,MTS,PI3K,PKA,PSA,RESULTS,TREATED,TREATMENT,WILEY
169,2014,CENDR,CRGDKGPDC,NRP,RGD,RXXK,THESE
001,003,166,169,2014,273,484,BACKGROUND,BMCC1,CONCLUSION,COPS2,EXPRESSION,LABEL,LNCRNAS,METHODS,PCA3,PCR,RESULTS,RNAS,SOX11,TEAD1,URINARY,WDR48
AFTER,DIGITAL,GRP,IMAGING,NSE,PRO,PROSTATIC,PSA
945,956,AKT,FAK,LABEL,METHODS,OBJECTIVE,PPAR,REPORTS,RESULTS
169,2014,3306,947,AZ12253801,BO2,BRCA,BRCA1,BRCA2,CDK1,DSBS,FINALLY,GI50,GI80,H2AX,IGF,INHIBITION,PTEN,RAD51,SIMILAR,THESE,UICC
169,2014,945,946,CD44,NOTABLY,RNAI,SYK
160,223,239,DISEASE,DRUG,FOUR,HOWEVER
001,170,1995,1999,2000,2004,232,442,469,984,999,AFTER,AMERICA,BACKGROUND,CALI,CASES,EST,FIVE,FOLLOWING,LABEL,LATIN,METHODS,OBJECTIVE,RESIDENTS,RESULTS,SES,SITES,THERE
169,2009,2011,2014,859,CONCLUSION,GIVEN,INSTITUTE,JUNE,LABEL,METHODS,NPV,OBJECTIVE,PCA3,PPV,PSA,PURPOSE,RESULTS,SOCIETY,THESE
1106,16S,181,2618,946,A549,ATCC204508,ENDOPHYTIC,FDC83,GRAM,IC50,INDOLES,KOCURIA,LGMB259,NRRL,PC3,R5A,VINYL
115,146,224,AFTER,ATN,BACKGROUND,BRPC,COX,GLEASON,LABEL,METHODS,PSA,RESULTS
001,006,2013,BACKGROUND,CONCLUSION,GLEASON,HOWEVER,LABEL,METHODS,PCA,RESULTS,SUMMARY
177,2FSTC,497,947,952,AFRICAN,BMI,DESPITE,FSTC,SNPS
001,133,169,177,2009,2012,2014,321,674,8201,889,AIMS,AMONG,BACKGROUND,CAUCASIAN,COMPLIANCE,FURTHER,LABEL,MAIN,MEN,METHODS,OBJECTIVE,OUTCOME,RESULTS,SOCIETY
100,1000,169,181,2014,600,800,8201,ADC,AUC,COPYRIGHT,DWI,GAMMA,GLEASON,HOWEVER,JOHN,LTD,MRE,MULTI,SONS,WILEY
BETWEEN,HAEMATURIA
PCA,SMALL,SRPK1,SRSF1,VEGF,VEGF165
0264,100,104,1118,150,169,199,2014,255,AGES,ASSESSMENT,CASES,JAPAN,LABEL,METHODS,OBJECTIVE,PRESS,PRIMARY,PUBLISHED,RESULTS,RISK,SUBTYPING,UNIVERSITY
001,169,177,2014,2243,786,945,ANGPTL4,BAY,DECLINE,EGLN,FAZA,FDG,FLT,FOUR,FPP,H460,HIF1,LABEL,METHODS,MICE,OBJECTIVE,PC3,PET,PURPOSE,RESULTS,RGD
169,2014,CNA,CNAS,COPY,HOWEVER,MAPK,MET,PI3K,PTEN,THESE,TP53
169,2014,DU145,GLI,THESE,TIC
169,BPH,CONVERSELY,DU145,EGF,EGFR,EPIDERMAL,FASEB,GOLGI,IGF,NVP,THESE
177,217,532,AUC,CHINESE,PCA,PSA,ROC,USING
956,AFRICAN,AGNPS,CELL,FOURIER,GEAGNPS,GRACILARIA,PC3,VERO,ZNO
CRITICALLY,DESPITE,SIMILAR
AMONG,C18,CLA,CLNA,CONJUGATED,MOMORDICA,PUFA
ALSO,FURTHER,HIGH,HOWEVER,PARTICULAR,PUFA
169,2002,2004,2007,2008,2010,2014,AMONG,END,FIVE,GERMANY,HODGKIN,RESULTS,UICC
148A,169,19B,2014,AKT,ARC,CONCLUSION,GMBH,KGAA,LABEL,LAPC,LNCAP,METHODS,PI3K,RESULTS,SCOPE,STAT3,THEIR,VCH,WILEY
1926,1950,1965,1974,2013,746,AUTHORS,BACKGROUND,COLLECTION,CURRENTLY,DATA,ISSUE,LABEL,LIBRARY,MAIN,MEIER,METHODS,OBJECTIVE,OBJECTIVES,PRIMARY,QUALITY,REPORTING,RESULTS,SCIENCE,SELECTION,SURGERY,WEB,WHETHER
3T3,BRDU,CYTOTOXIC,HELA,NIH
BAX,BCL,HOWEVER,KNOCKDOWN,LEUCINE,PCA,TAKEN,THESE
AKT,ETS,FLI1,GAIN,PDEF,PI3K,SEQ,USING
160,8805,956,ACCORDING,MMP,MMP9,TAMS,TANS,TIMP,WHEREAS
BASED,CNS,FIRST,HID28
1184,169,1968,2014,215,6608,895,925,ASIAN,ATLAS,CAUCASIAN,HAPLOTYPE,HNF1B,PRESS,PUBLISHED,SNP,SNPS,THREE,TYPE,UNIVERSITY
159,169,2014,AMERICA,BACKGROUND,CHICAGO,CHINESE,CONCLUSION,ELDERLY,GREATER,HOWEVER,LABEL,METHODS,POPULATION,PRESS,PREVENTIVE,PUBLISHED,RESULTS,SOCIETY,UNIVERSITY
169,2014,A549,ABL,ACIDS,EGFR,EPIDAURUS,EZH2,FOXA1,GM12878,HELA,HEPG2,K562,LNCAP,MCF7,NUCLEIC,PRESS,PUBLISHED,UNIVERSITY,VCAP
AKT,ARCAP,CANCEROUS,CIP2A,HOWEVER,PCA,PP2A
26S,AUTOPHAGY,BORTEZOMIB,ERK,JNK,VELCADE
22RV1,CASTRATION,LNCAP,NOTABLY,PPD,RESURGENT
160,BEST,FIFTY,FOUR,GRADE,III,LABEL,METHODS,MTD,OBJECTIVE,PURPOSE,RESULTS,SIX,THERE
133,BACKGROUND,CONCLUSION,INTERVIEWS,LABEL,MEN,METHODS,MOST,PRODIET,PSA,RESULTS,SEMI,THESE
109,2012,2013,EVALUATION,FIFTY,GROSS,HOSPITALS,IBN,JUNE,LABEL,MARCH,METHODS,OBJECTIVE,PURPOSE,RESULTS,SINA,STRUCTURED
2003,2013,BACKGROUND,LABEL,METHODS,POST,PSA,RESULTS,SEVEN,THREE
103,177,4500,DEPARTMENT,FOUR,GLEASON,HIGH,PSA,THEREFORE
411,700,BACKGROUND,CAUCASIANS,GWAS,LABEL,MATERIALS,METHODS,PSCA,RESULTS,SMOKING
008,012,033,047,1RN,2014,511,LABEL,MATERIALS,MEDLINE,METHODS,OBJECTIVE,PCA,PURPOSE,RESULTS,STATA
078,106,127,132,18F,2009,2013,393,483,495,ADDITIONAL,DRE,FDG,GLEASON,HOWEVER,PET,PSA,SEPTEMBER,SERUM,THERE,TRUS
160,8201,894G,BPH,HOWEVER,PCA
008,1990,2008,254,479,AMONG,ANTIGEN,BACKGROUND,COX,GLEASON,LABEL,METHODS,PSA,RESULTS,TEN
NM23,USING
SINCE,TAKEN,THESE,USING
0001,AFFAIRS,BACKGROUND,COMPARE,COMPOSITE,FOUR,LABEL,METHODS,OBJECTIVE,RESULTS,WEAK
H2DCF,HCC,HEP3B,HOWEVER,LABEL,MET,METHODS,NH2,OBJECTIVE,PAR1,PAR4,PARS,PDGFR,PTP,PTP1B,PURPOSE,RESULTS,ROS,RTK,THERE,USING,WESTERN
AMONGST,PROSTATIC
1211,1995,DEV,FUKUI,INCREASING,JMJ,JUMONJI,KATOH,KONDO,PTMS,SEVERAL
177,65292,AFTER,BCL,CELL,CONCLUSION,HOWEVER,IGFBP,IP6,LABEL,LNCAP,MEANWHILE,METHODS,MTT,OBJECTIVE,PCR,RESULTS,WESTERN
1852,1912,1927,CONCLUSION,LABEL,METHODS,OBJECTIVE,PURPOSE,PURTSCHER,RESULTS,SINCE
106B,956,CDT1,GMNN,HOWEVER,MCM2,PTEN,THESE
110,2007,2011,AFTER,BOTH,CTP,MTT,MVD
946,FIFTEEN,NELUMBO,ROSA,THESE
197,AFTER,BALB,C34,CRM,GB5,GLOBO,HOWEVER,IGG,MCF,SSEA3,SSEA4
100,181,ALSO,BACKGROUND,CONCLUSION,DU145,FLOWERS,GI50,LABEL,METHODS,MTT,PYROGALLOL,RESULTS
160,169,2014,215,254,264,AFFYMETRIX,BACKGROUND,C2ORF43,FDR,ITGA6,LABEL,METHODS,MLPH,MSMB,MTL5,NEFM,PHYSICIANS,PSCA,RESULTS,SNP,THESE
2009,2011,438,511,BACKGROUND,CONCLUSION,DEPARTMENT,FUNDING,FURTHER,LABEL,MAY,METHODS,MOST,RESULTS,THREE,TRIAL,UROLOGY
8209,945,946,ANGPTL1,ANGPTL2,ANGPTL7,ANGPTLS,CELL,EMT,EXPRESSION,LNCAP,TARGETING
002,013,019,022,113,135,143,181,2002,2010,2014,421,521,CHI,COX,GLEASON,JANUARY,JUNE,LABEL,MARCH,METHODS,OBJECTIVE,PSA,RESULTS,STUDENT,THERAPY
916,BASED,DICE,DSC,EVALUATION,LABEL,MAD,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE,THREE
HIFU,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS
176,177,8201,GRE,LABEL,METHODS,NORMALIZED,OBJECTIVE,PURPOSE,RESULTS,T1W
177,AFTER,DICE,HDR,LABEL,METHODS,MRI,MRIS,OBJECTIVE,PURPOSE,RESULTS,THESE,TRE,TRUS
001,003,330,420,455,473,481,490,502,519,527,536,547,551,569,578,620,632,688,718,795,828,863,BOTH,LABEL,LINAC,METHODS,MISPORT,MLC,OBJECTIVE,PURPOSE,RESULTS,TEXTURE,THERE,THESE,VMAT
865,872,DICE,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THEN
350,KIM,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,TESTS,VMAT
8209,954,CLONOGENIC,NOTABLY,RELB
001,8805,ABCB1,BPH,ESR1,GSTP1,MOST,MSP,PCA,PCR,RARB,TEN,TSGS
003,045,BACKGROUND,BRCA1,CANDIDATE,CDC6,FANCG,FOLLOWING,INHIBITION,LABEL,LNCAP,MCM7,METHODS,ORC1,PARP,PCR,RAD51,RESULTS,THESE,USING,WHILE
001,026,1388,1702,697,794,892,ALP,AUC,HCC,HOWEVER,PLZF,ROC,TAKEN
141,22RV1,DSN,MCF
BOTH,DBP,DEHP,HOWEVER,KLK3,LNCAP,NED,PHTHALATE,TAKEN
095,169,2014,224,549,BACKGROUND,COMPONENT,DATA,EMOTIONAL,END,FORM,HODGKIN,HRQOL,ITEM,LABEL,MCS,METHODS,PCS,RAND,RESULTS,ROLE,SCALE,SHORT,SOCIETY,SUMMARY,SURVIVORS
169,2014,8201,8805,9142,BACKGROUND,BCS,CALIFORNIA,CARE,CENTERS,COMMITTEE,CONTROL,DISEASE,GEORGIA,HOWEVER,IIIA,JOINT,LABEL,LOUISIANA,METHODS,MINNESOTA,NETWORK,NORTH,POCBP,PREVENTION,PROGRAM,RADIATION,REGISTRIES,RESULTS,SIX,SOCIETY,WISCONSIN
069,106,110,169,2014,285,8804,913,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,INSTITUTE,JOHN,LABEL,METHODS,PSA,PSAV,PSAVS,RESULTS,THERE,UNIVARIATE
001,004,023,169,177,2014,227,AIM,ALP,ANTICANCER,CELLS,CELLSEARCH,CONCLUSION,COPYRIGHT,CTC,CTCS,INSTITUTE,JOHN,LABEL,METHODS,OBJECTIVE,RESULTS
169,2014,AIM,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,INSTITUTE,JOHN,KIT,LABEL,MATERIALS,METHODS,NCOR2,OBJECTIVE,REGARDING,RESULTS
169,2014,956,AIM,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,IGF,IGFBP,INSTITUTE,JOHN,LABEL,LNCAP,MATERIALS,METHODS,OBJECTIVE,PC3,RESULTS,WESTERN
169,17A1,2014,ANTICANCER,COPYRIGHT,CRPC,CYP17A1,HOWEVER,INSTITUTE,JOHN,P450,PERSISTENT
168,AFTER,EACH,PURPOSE,RETIREMENT,THEREFORE
000,169,2014,CROSSROADS,CTLA,IMMUNOLOGY,METASTATIC,PLUP
169,2014,EMT,LABEL,LUCAS,MET,SUMMARY,TMPRSS2
1582,FOCAL,MEDLINE,RADICAL,RECTO,SALVAGE,THEREFORE
FURTHER,OBESITY,SATURATED,THERE
945,946,BASED,INSTEAD,MEANWHILE,THERE
2013,RADIATION,SALVAGE,SOCIETY,UROLOGICAL
2012,ANTICANCER,FRAME,IAIN,PREVIOUSLY,SINCE,THERAPY,TRUST
HITEN,PATEL,PROF,PROFESSOR,ROBOTIC,SOCIETY,SURGERY,UROLOGY
160,HOWEVER,MOS2,PSA
169,193,2014,298,400,8805,ADP,AES,BRCA1,BRCA2,CONCLUSION,GRADE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESPONSES,RESULTS,SOCIETY
169,2013,2014,ASCO,ASTRO,AUA,GLEASON,LABEL,METHODS,OBJECTIVE,PHYSICIANS,PSA,PURPOSE,RADIATION,RESULTS,SOCIETY,THOSE,THUS,UROLOGICAL
AFRICAN,BACKGROUND,CASE,IIB,LABEL,METASTASES,METHODS,NORTH,SPLENIC
AREAS,BACKGROUND,COVERED,FDA,INNOVATIVE,LABEL,METHODS,OPINION,OTHER,SEVERAL,WHILE
AKT,DU145,HOWEVER,PC3,PKB,THESE
CTCS,GEDI,HOWEVER,LIMITED,LNCAP,VCAP
169,2014,COPYRIGHT,HOWEVER,JOHN,LTD,MEIER,SONS,THESE,WILEY
169,2014,AUTHORS,HOWEVER,JOHN,LTD,PUBLISHED,SIMULATION,SONS,STATISTICS,WILEY
200C,CCK8,DU145,HENCE,PCR,RESULTS,RWPE,ZEB1
160,2000,2008,ACCORDING,AMONG,BACKGROUND,CONCLUSION,GLEASON,HEMATURIA,IMAM,IRAN,LABEL,METHODS,MOST,REGARDING,RESULTS,SECONDARY,SPP,TCC,THEREFORE,TURP,URMIA
AKT,KEEPING,LNCAP,SOY,THESE
215,8201,8764,BLOOD
001,160,169,2014,264,674,8805,938,AFTER,ASSESSMENT,BACKGROUND,CDF,CONCLUSION,CUMULATIVE,DUE,FACT,FUNCTIONAL,LABEL,MEDICAL,METHODS,MMRM,PMM,PRESS,PUBLISHED,RESULTS,SOCIETY,THERAPY,TRIAL,UNIVERSITY
037,048,COMPLEX,CONCLUSION,DVC,FORTY,LABEL,LRP,MATERIALS,METHODS,NARROWING,OBJECTIVE,OPERATIVE,PURPOSE,RADICAL,RESULTS
169,CYP17A1,GIVEN,PRESS
AFTER,BACKGROUND,CASE,CLINICIAN,DAC,FORTY,LABEL,METHODS,POST,RESULTS,SDM,SEVENTY,USING
148,945,HIF,MHI,NEAR,NIR,OATP,OATPS,PCA,PET
177,947,CLONOGENIC,H2AX,HOWEVER,LNCAP,PNT1A,THERE,THESE,VMAT
22RV1,ADT,AKT,AKTI,AZD5363,BACKGROUND,CONCLUSION,CRPC,FOUR,HOWEVER,LABEL,LNCAP,LNCAP95,METHODS,PCA,PCR,PI3K,RESULTS,VCAP,WORTMANNIN
945,946,AKT,GSK3,LNCAP,MMP2,NKX3,PIA,PIN,S308,S473,THUS,TNF
382,937,BACKGROUND,LABEL,META,METHODS,PCA,RESULTS,SNPS,TLR,TLR4,TOLL,USING
110,128,150,924,HSP27,LABEL,LNCAP,METHODS,OBJECTIVE,OBVIOUSLY,PCR,PR1,QUERCETIN,RESULTS,RWPE,TSU
ALTOGETHER,CXCR4,DTX,LIM,LIMK1,PAK4,PCA
068,169,2014,ADP,CSMA,GLEASON,HIGH,HSPB,HSPBAP1,IHC,KI67,PCA,PSA,RNAI,TMPRSS2,UICC,VCAP
169,451,EVS,FASEB,HFOS,LABEL,MOB,MOBS,NMOB,NMOBS,PC3,PROTEOMIC
144,169,2014,8804,8805,AFTER,ERSPC,FINNISH,HOWEVER,MEN,NON,PCS,PSA,RANDOMIZED,SCREENING,UICC
169,2010,2012,2014,AIM,BACKGROUND,COMPOSITE,COUPLES,FAITH,INDEX,INDUCTION,INTERVIEWS,LABEL,MAIN,METHODS,NVIVO,OBJECTIVE,OUTCOME,RESULTS,SOCIETY
000,2012,215,AMONG,CONCLUSION,GRADE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SPAIN
169,1BB,2014,950,AACR,CAR,CD137,CD28,CD3,FINALLY,IMMUNOL,J591,P28BB,PSMA,RES,TAKEN,TARGETING
169,2014,ACADEMY,APPROACHES,BACKGROUND,CHECKPOINT,DISCUSSION,FOUNDATION,HOST,INC,JOLLA,JUNE,LABEL,MEETING,METHODS,PCF,RESULTS,SPONSORED,TARGETING,WILEY
007,017,198,240,8201,ADVERSE,CONCLUSION,INSTITUTE,ISR,ISRS,LABEL,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS,VERSION
100,10MBQ,169,2014,2015,215,348,357,359,8201,945,BACKGROUND,CONCLUSION,COS,DETECTING,DHT,FCH,FDG,GIVEN,IC50,IMAGING,INC,LABEL,METHODS,PET,PRESENTLY,RB390,RB448,RBA,RESULTS,SCID,STABILITY,T877A,WILEY
169,2014,8201,GIVEN,GLEASON,THESE,UROLOGICAL
001,010,011,020,025,169,181,2014,8201,BACKGROUND,BPH,FURTHER,GLEASON,INC,LABEL,METHODS,PCA,RESULTS,SERUM,UGM,VARIATIONS,WILEY
HOWEVER,OWING,STROMAL,STUMP
0002,0005,0084,0114,031,0373,CPF,DHT,EMT,GLI,LABEL,LNCAP,METHODS,NPF,OBJECTIVE,PCA,PCR,PSA,REAL,RESULTS,SHH,SONIC,WHILE
945,BACKGROUND,CONCLUSION,HER2,HIF,LABEL,RESULTS,THEREFORE,TNBC,TREATMENT,VEGF
169,600,AMONG,BACKGROUND,CONCLUSION,HIV,LABEL,METHODS,PRESS,PSA,RESULTS,SIMON
008,1139,1199,169,2014,761,AFRICAN,AMERICANS,AMONG,AUTHORS,CALIFORNIA,CASE,CONTROL,HISPANICS,HOWEVER,JOHN,LTD,PCA,SONS,WILEY
169,2014,AUTHORS,BASED,ILBC,JOHN,LTD,METASTASIS,OTHER,SONS,WILEY
1988,1997,2000,347,C30,EBRT,EFFECTS,EORTC,GOTHENBURG,HDRBT,HOWEVER,HRQOL,MEN,OCTOBER,PR25,PSA,QLQ
055,2011,CONCLUSION,ECL,LABEL,METHODS,OBJECTIVE,RESULTS,STK1,THERE
174,DATA,DOCETAXEL,LABEL,METHODS,NURSING,OBJECTIVE,OBJECTIVES,PURPOSE,RESULTS,REVIEWS,SOURCES,SYNTHESIS
ETS,METASTATIC,PTEN
AMC,AMSTERDAM,BACKGROUND,BMJ,BOARD,CURRENT,DATA,GROUP,IRE,LABEL,LIMITED,MEDICAL,METHODS,MRI,PRIOR,PUBLISHED,PUBLISHING,TRIAL
145,148,160,783,8209,946,DIFFERENT,LNCAP,MHI,NEAR,NIR,NIRF,OATP,OATP1,OATP1B1,OATP1B3,RWPE
181,8209,FOLLOWING,IC50,PC3,ROS,WESTERN
8201,CBCT,CENTRES,CONCLUSION,CTV,CTV2,DVH,DVHS,KNOWLEDGE,LABEL,METHODS,NTCP,OBJECTIVE,PLANS,PTV,PTV2,RESULTS,TCP,USING
DOCETAXEL
100,2008,2013,400,800,EXCLUDING,THEREFORE
223,ABIRATONE,THESE
10NM,50NM,B1R,B2R,BACKGROUND,CELL,CHAMBER,DU145,FURTHER,INCREASING,KKS,LABEL,METHODS,MTT,NEITHER,OBJECTIVE,OBJECTIVES,RESULTS,WHERE
000,169,2014,8805,BACKGROUND,CONCLUSION,ESTIMATES,GWAS,HOWEVER,LABEL,METHODS,PSA,RESULTS,RRS,SNP,SNPS,THUS
8209,99A,DU145,FOLLOWING
169,2014,464,ABI,CYP17A1,ENZ,FINALLY,HSD17B3,MR49C,MR49F,PCR,PSA,SIMILARLY,STAR,STEROID,THESE,WESTERN
169,2015,ANDROGENS,SOCIETY
145,160,8209,FCM,MTT,RPOI,RUDITAPES,VENERIDAE
8209,CELL,DECREASING,DU145,FLOW,MTT,THESE
145,18BP,947,ERK1,IFN,JAK1,JANUS,JNK,P38,PUFA,PUFAS,STAT1,THESE
160,4LYS,4SER,8LYS,BOTH,CRPC,CYTOTOXIC,DAU,DU145,GNRH,III,THESE,THUS
160,429,8209,IA8,IF11,MICRORNAS,MTT
DESPITE,FAS,INCREASED,RAMAN,SRS
532,AFTER,ANOVA,CONCLUSION,FURTHER,LABEL,METHODS,OBJECTIVE,PCA,PURPOSE,RESULTS,STUDENT,THESE
ASSESSMENT,BOTH,CHRONIC,EACH,EORTC,FACT,FUNCTIONAL,ILLNESS,LIFE,PR25,QLQ,QUALITY,THERAPY,TREATMENT
169,2014,946,ALSO,BIOLOGY,BLOT,CAKI,CELL,DAC,DNMT1,DNMTS,GSK3,HAUSP,MSP,PC3,PCR,SER9,SOCIETY,T24,UHRF1,WESTERN,WIF,WNT,WST
169,2015,NEPC,PROSTATIC,SMALL,SOCIETY,THUS,USA
003,021,169,2014,709,778,8201,957,DATA,IGF,IGFBP,INSULIN,UICC
001,100,169,177,2014,204,207,ASSESSMENT,AUC,BACKGROUND,BOTH,CHEMISTRY,GENOMIC,GLEASON,LABEL,METHODS,RESULTS,ROC,SOLID,USING
002,071,406,484,AMONG,AOR,BACKGROUND,BLACK,COMPARE,LABEL,METHODS,RESULTS,THERE
10878,177,414,8201,BACKGROUND,BPH,INCIDENCE,IPSS,LABEL,LUTS,METHODS,PRIMARY,PSA,QMAX,RESULTS,SCORE,SECONDARY,SIMILARLY,TPV
169,2014,BRITAIN,COPYRIGHT,CP1,GREAT,IRELAND,JOHN,LTD,MULTIPLEX,MYC,PUBLISHED,SOCIETY,SONS,TH17,WILEY
142,ACUTE,CONFORMAL,DETAILS
2009,480,8201,956,CAV1,CCAAT,CHOP,COA,EXPRESSION,FLU,GAPDH,GRP78,HMG,HMOX1,MCF,NDRG1,PAR4,REST,SGK1,TOOL,VARIANT
AUS,OPTIONS,PERSISTENT,PLACEMENT,RTS
043,1898,1930,2013,AFRICAN,ASIAN,AUTOPSY,CAUCASIAN,CAUCASIANS,DATA,EVALUATION,FIFTY,HOWEVER,LABEL,MATERIALS,METHODS,RESULTS,WHILE
10NG,1740,1751,2000,2013,8805,AGE,BACKGROUND,BCR,BMI,BOARD,ECE,FINALLY,GLEASON,HIGH,IDENTIFIED,IRB,JUNE,LABEL,MARCH,MATERIALS,METHODS,OPEN,PNI,PSA,PSM,PSMS,RATE,RESULTS,SVI,TNM,UNIVARIATE,VARIABLES
125,8804,ABOUT,ADDITIONAL,BACKGROUND,EIGHT,LABEL,MATERIALS,METHODS,OC125,RESULTS
225,BLI,DOSIMETRIC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,UNIFORMLY,VERNIER
AREAS,BACKGROUND,COVERED,DESPITE,III,LABEL,MET,METHODS,OPINION,PCA,PHASE,SEVERAL,SRC,TARGETS,THEREFORE,TKI,TKIS,UNTIL,VEGF,WESTERN
HEPG2,HIPERFECT,INTRA,PC3,SCID,THESE
OPG,RANK,RANKL,TNF
2PROPSA,INDEX,MOST,PCA3,PSA
ADT,CRPC,CTL,CURRENTLY,DESPITE,FAILURE,FUNCTIONAL,NAIP
479,AKT,AMG,COMBINING,GANR,HOWEVER,IGF,INHIBITION,PHOSPHO,REDUCTION,THESE,VCAP
945,946,GSK,TAKEN,THESE,WNT
078,145,898,BACKGROUND,CASE,FORTY,GLEASON,HOWEVER,JAPAN,LABEL,METHODS,MRI,PSA,SALVAGE,SIXTY,TEN
169,2014,945,COFILIN,FIRST,LIM,LIMK,LIMK1,LIMKI,THESE,TUBULIN
AUSTRALIA,BACKGROUND,CHRISTMAS,EAST,EASTERN,ENGLAND,HOWEVER,IRCO,LABEL,LATE,METHODS,NORTH,RESULTS,SYMPTOM,WESTERN
001,476,8201,ANXIETY,BACKGROUND,COMPOSITE,INDEX,INDIVIDUAL,INVENTORY,LABEL,LPC,MATERIALS,METHODS,OBJECTIVE,P3P,PATIENT,PROFILE,PURPOSE,RESULTS,SITE,STATE,THESE,TRAIT,TRIAL
000,250,500,595,649,8734,AUC,BASED,CAUCASIAN,CIS,CONCLUSION,JAPAN,LABEL,MEAN,METHODS,OBJECTIVE,PURPOSE,RESULTS
2CC,320,8804,8805,AIMS,ANOVA,BACKGROUND,BD2CC,BOTH,CONCLUSION,IMAGE,LABEL,METHODS,MOST,NONE,OBJECTIVE,RESULTS,V40,V50,V60,V65
ADT,AIMS,BACKGROUND,CONCLUSION,CSS,EBRT,GLEASON,HOWEVER,LABEL,METHODS,OBJECTIVE,PSA,RESULTS
137,2008,201,2012,233,434,872,AIMS,APRIL,BACKGROUND,CBCT,HERK,LABEL,METHODS,OBJECTIVE,RESULTS,VAN
002,045,100,174,2002,2007,211,385,ADDITIONAL,AIMS,BACKGROUND,GLEASON,JANUARY,LABEL,METHODS,OBJECTIVE,PSA,RESULTS,THERE,THESE
100,810,KING,THERE,UNIVERSITY
956,ANNEXIN,AURANOFIN,BCL,IC50,PC3,TREATMENT,VDAC
2AC,AKT,CLUSTERIN,HOWEVER,PC3,PP2AC,TAKEN,TRANSIENT
009,010,023,031,169,2014,230,361,8805,ASPIRIN,BACKGROUND,COLORECTAL,LABEL,LUNG,MEN,METHODS,OVARIAN,PLCO,RESULTS,SNPS,THESE,TRIAL
1404,1405,169,2014,99M,BECAUSE,BOTH,CONCLUSION,IMAGING,INC,LABEL,METHODS,MIP,MOLECULAR,NUCLEAR,PCA,PSMA,RESULTS,SOCIETY,SPECT,UNDER,UNLABELLED,WHOLE
145,945,954,AKT,BACKGROUND,CONCLUSION,DATA,DU145,DUE,ELISA,HIF,HPLC,INCREASING,LABEL,METHODS,MTS,NOBILETIN,PROTEIN,RESULTS,TAKEN,VEGF
500,600,ADT,FOLLOWING
916,INCREASED,NUCLEAR,PCA,THESE,THUS
205,BCL,CONVERSELY,E2F,E2F6,EZH2,SIRNA,THUS
TEN
006,0071,017,018,025,028,ECE,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,T2WI,VISTA
HOWEVER,PCA,SIMILARLY,T3A
1975,2003,COA,FFA,HODGKIN,HOWEVER,OBESITY,WHETHER,WHILE
0001,0004,017,1075,2003,2008,492,8201,BACKGROUND,FTA,GLEASON,HOWEVER,LABEL,METHODS,MORBIDITY,NFTA,PCA,POPULATION,PSM,RADICAL,RESULTS,URO
155,ANX,ANX7,FLOW,MICRO,MTT,RNAS
8201,8482,BACKGROUND,CASE,CONCLUSION,LABEL,METHODS,PSA,RESULTS,TREATMENT
001,133,134,160,189,2001,2011,543,549,738,8201,8805,EBRT,LABEL,MARCH,MATERIALS,METHODS,OBJECTIVE,OVERALL,PSA,PURPOSE,RESULTS
110,125,145,160,192,230,312,8201,8804,COMB,CONCLUSION,D90,DSS,GLEASON,LABEL,MATERIALS,METHODS,NONE,OBJECTIVE,OVERALL,PSA,PSI,PURPOSE,RESULTS
0001,0011,002,007,169,2014,784,8201,8805,COX,GLEASON,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,UROLOGICAL
105,153,156,2004,2008,893,ASR,ASR12,ASR13,BACKGROUND,DATA,INCIDENCES,IRAN,IRANIAN,IRAQ,KHUZESTAN,LABEL,MATERIALS,METHODS,RESULTS,SPSS
140,222,335,347,793,864,8805,8Q24,AFRICAN,ASIAN,BACKGROUND,BLOOD,CAUCASIAN,CHINA,CHINESE,GLEASON,LABEL,MATERIALS,META,METHODS,NORTH,ORADJ,PADJ,PCA,RESULTS,THESE
001,004,064,2014,841,8805,BACKGROUND,CRPC,LABEL,MARCH,MATERIALS,META,METHODS,ORR,PFS,PSA,RESULTS,SCIENCE,SIMILARLY,SOCIETY,STUDENT,VEGF,WEB
BIP,GLUCOSE,GRP78,HOWEVER,THUS
160,AMERICA,CRMP4,NORTH,NRP1,PET,SMALL,TAKEN
ADT,GIVEN,HOWEVER,PCA,VITAMIN,WESTERN
ERSPC,NOW,PLCO,PSA,RANDOMIZED,SCREENING
112,1991,301,378,538,583,BACKGROUND,BASE,CONCLUSION,LABEL,MEN,METHODS,RESULTS,SWEDISH
005,011,028,117,249,415,AMONG,GLEASON,IQR,LNGS,LNS,PATHOLOGIC,PGS,PLND
133,177,357,490,BPH,CONCLUSION,GLEASON,LABEL,METHODS,OBJECTIVE,OPSAD,PSA,PSAD,RESULTS,ROC
000,001,017,042,169,2014,239,8805,945,DHEA,III,LABEL,LOQ,METHODS,OBJECTIVE,PFS,PSA,PURPOSE,RESULTS,SAMPLES,SIXTEEN
002,003,009,018,048,169,17Q11,17Q12,17Q21,2014,215,272,2Q37,ALTOGETHER,AUTHORS,EFCAB13,FINLAND,G84E,HDAC4,INC,PRCA,PUBLISHED,SNPS,UICC,WILEY
2005,2013,309,939,JULY,OVARIAN,THERE
001,2000,2006,872,BACKGROUND,CLINICIANS,CONCLUSION,CVD,FINAL,INCREASED,INSURANCE,IRR,LABEL,METHODS,NHI,RESULTS,TAIWANESE
181,22RV1,945,946,955,A2780,A549,AURANOFIN,BASED,COMPLEXES,DTA,ESI,G361,HELA,HL5,HLN,HOS,IC50,LPS,MCF7,NMR,PPH3,THP,TNF
620,954,BPH,BPHS,CONSISTENT,ELISA,HOWEVER,OPG,PCA,PCR,RANK,RANKL,RWPE2,TRANSWELL
APART,EPIGENETIC,HOWEVER
945,CK2,PROTECTED,RNAI,TBG
145,231,8209,CELL,FACS,LIGHT,MCF7,MDA,PARP,THERE,WHILE,XTT
100,181,BRDU,FASUDIL,INHIBITION,MYPT,PCA,RHO,RHOA,ROCK,THESE,TUBE,WESTERN
215,AB1,AB2,BASED,DATA,H2O2,HRP,MBS,NRS,PDMS,PRIMARY,PSA,PSMA
089,106,435,8805,AFTER,AUSTRALIA,BACKGROUND,DESPITE,IPSS,LABEL,LUTS,METHODS,OBJECTIVE,ODDS,OUTCOME,OVERALL,RESULTS,SCORE,SETTING,SOUTH,SYMPTOM,UNASSIGNED,WALES
001,002,003,144,2007,2012,8804,8805,ACS,COLLEGE,HIGHEST,LABEL,METHODS,NSQIP,OBJECTIVE,OBJECTIVES,ORP,PBT,POD,PROJECT,QUALITY,RADICAL,RARP,RESULTS
199,263,737,ABT,BCL,DOCETAXEL,DTX,DU145,HOWEVER,LNCAP,PC3,THESE
208,946,ALTOGETHER,BMP,CRPC,DHT,KLK4,LNCAP,MDV3100,PCA,PSA,TGF,TMPRSS2
ATG7,AUTOPHAGY,FURTHER,MTOR,THESE
100,BONE,III,JACCARD,RESULTS
1956,679
BASED,MULTI,REGISTERED
118,169,1992,1993,1997,2009,2010,2014,301,427,441,8805,ASPIRIN,CONCLUSION,GLEASON,HOWEVER,JUNE,LABEL,METHODS,NUTRITION,OBJECTIVE,PCSM,PREVENTION,PURPOSE,RESULTS,SOCIETY
169,2015,COPYRIGHT,ERK,ETS,JUN,JUNB,JUND,MECHANISMS,RAS,SOCIETY,THUS
MTA,MTA1,PTEN
213,AMINOACIDS,BACKGROUND,CELL,CSC,CULTURE,ELISA,ISOTOPE,KNOCK,LABEL,METHODS,PCR,RESULTS,SILAC,SPARC,TRANSWELL
PPINS
145,169,176,2014,AUNP,AUNPS,BACKGROUND,BECAUSE,COPYRIGHT,GOLD,JOHN,LABEL,LTD,METHODS,RESULTS,RNAS,SONS,SUCCESSFUL,WILEY
8201,8804,8805,BACKGROUND,BASED,COX,DATA,GLEASON,LABEL,METHODS,OTHER,PSA,RESULTS,SCORE,SRT,TREATMENT
BOTH,DRE,PSA,THESE,UROLOGICAL
177,400MG,500MG,AIMS,BENIN,CONCLUSION,FEVER,INFECTIVE,LABEL,METHODS,OBJECTIVE,OBJECTIVES,POST,RESULTS,UNIVERSITY,URINE
2014,BMJ,ENGLISH,GROUP,HOWEVER,LCNEC,LIMITED,LTD,MOST,PUBLISHING,PURE
139,169,2015,AML,AMLS,CD34,EVI,EVI1,HEMATOLOGY,IKZF1,MECOM,MUTATIONS,MYCT1,PAWR,PREX2,RAS,RESULTS,SF3B1,SOCIETY,TP53,U2AF1,VIP
FIRST,METABOLOME,WEB
001,011,10878,1160,121,1268,189,199,2000,2009,635,809,8201,900,999,BACKGROUND,COX,DATA,GLEASON,LABEL,LVI,MEIER,METHODS,PSA,RESULTS,THESE
143,181,231,ASCIDIANS,IC50,MDA,RTCA,TCRP
2009,2012,ADJUSTMENT,AREA,BACKGROUND,CARE,CATALONIA,IRR,LABEL,MEDEA,METHODS,OBJECTIVE,POISSON,PRIMARY,RESULTS,SPAIN,SPANISH,THERE,THESE
EVALUATION,FOX,FOXA1,FOXP1,HOWEVER,TAKEN
169,2014,2015,292,302,APOPTOSIS,BACKGROUND,DECREASED,ENDOGENOUS,HOWEVER,INC,LABEL,LNCAP,LOSS,METHODS,MICE,PCA,PRIMARY,RAF,RESULTS,RKIP,THESE,TRAMP,WHILE,WILEY
169,176,2014,2015,332,335,AUTHORS,BACKGROUND,INC,IRE,JOULE,LABEL,METHODS,PUBLISHED,RESULTS,SIMULATION,WILEY
169,2014,2015,266,279,8201,ADDITIONAL,BACKGROUND,DHT,DOCETAXEL,DOWN,DU145,GAIN,GTP,GTPASES,HOWEVER,IFN,INC,INCREASED,LABEL,LNCAP,LOSS,META,METHODS,MMP13,MXA,MYXOVIRUS,PCA,RESULTS,STUDIES,THESE,TUBULIN,WILEY
169,2014,954,BACKGROUND,CD3,CD4,CD68,CD8,EXPRESSION,GDF,IHC,INC,LABEL,METHODS,PC3,RESULTS,WILEY
169,2014,ADC,ADCS,BACKGROUND,BLISS,CELLS,INC,LABEL,LARGELY,LNCAP,METHODS,PHASE,POTENTIAL,PSMA,RAPAMYCIN,RESULTS,SYNERGY,WILEY
2012,ABRF,ASN69,BECAUSE,GROUP,HOWEVER,PSA,PSAH,THERE,THREE
004,031,169,200,2000,2009,2014,252,452,ADT,AMI,AUTHORS,BJU,CHINESE,COX,EASTERN,ECOG,GROUP,JOHN,LABEL,LTD,MEIER,METHODS,OBJECTIVE,POTENTIAL,PUBLISHED,RESULTS,SONS,THERE,UPON,WILEY
954,ACTIVATION,AMONG,CHIR99021,CONSISTENT,CONVERSELY,EXPRESSION,FINALLY,GSK,GSK3,HOWEVER,IKK,RELB,THESE
169,2005,2014,ADT,AUSTRALIAN,AUTHORS,BJU,LABEL,METHODS,OBJECTIVE,RANGING,RESULTS,THERE
001,007,018,137,169,183,1998,2011,2014,8201,8804,8805,AFTER,ASAN,BACKGROUND,BCR,BETWEEN,CONCLUSION,COX,DES,GLEASON,HOWEVER,INC,INCREASING,LABEL,MEAN,MEDICAL,METHODS,NSM,PSA,PSM,RESULTS,RISK,WILEY
1354,169,1983,2003,2014,8201,BACKGROUND,GLEASON,INC,LABEL,METHODS,PSA,REGRESSION,RESULTS,UNI,WILEY
001,007,034,169,1991,2008,2014,362,478,8201,ADT,AMONGST,BACKGROUND,CASTRATION,CRPC,EBRT,GLEASON,INC,LABEL,METHODS,PSA,RESULTS,WILEY
001,138,169,2014,8201,8805,ANTIGEN,AUC,BACKGROUND,DIAGNOSTIC,EPSTEIN,GLEASON,HOWEVER,INC,INDEX,LABEL,METHODS,PCA,PHI,PREDICTIVE,RESULTS,WILEY
121,122,142,ANN,BONE,CONCLUSION,INDEX,LABEL,METHODS,OBJECTIVE,PATIENT,RESULTS,SCAN
0001,001,023,104,239,602,EUROQOL,FACT,GAMMA,HRQOL,LABEL,MEAN,METHODS,OBJECTIVE,OLS,PURPOSE,RESULTS,TOBIT,UNION,UTILITY
160,198,8201,EGFR,EGFR2,ERBB2,HER2,KRAS,MBC,MUTATIONS,NEU
148,169,197,2014,220,95E,95F,BIOLOGY,INC,KLK,KLK2,KLK3,KLKS,MOLECULAR,MOST,SOCIETY,TAKEN
007,013,2001,2003,2011,752,967,ASSESSMENT,BASED,CAB,CAP,CAPRA,CSS,GROUP,HOWEVER,JAPAN,LABEL,LHRH,MEIER,METHODS,OBJECTIVE,OVERALL,PADT,PURPOSE,RESULTS,RISK
A549,APOPTOSIS,BACKGROUND,BID,CELLS,CK2,HELA,LABEL,LNCAP,LOW,METHODS,MTT,NONE,PC3,RESULTS,TAT,THEREFORE,TRAIL,WESTERN
13TH,157,ATTRITION,FUNCTIONAL,HRQL,LABEL,METHODS,MISSING,OBJECTIVE,PURPOSE,RESULTS,SEM,T12,T13,T24
124,169,2014,3100,A11,LABEL,LAPC,MDV,METHODS,MICE,OBJECTIVE,PET,PSCA,PURPOSE,RESULTS
0001,0122,160,359,8201,ADDITIONAL,ART,BACKGROUND,CONCLUSION,LABEL,LND,LYMPHATIC,MEAN,METHODS,NODAL,PCA,PSA,RESULTS,WHETHER
BACKGROUND,CASE,CONCLUSION,GLEASON,LABEL,METHODS,PSA,THERE,UNASSIGNED,VIRTUAL
1993,2006,BACKGROUND,BESAG,BYM,GHR,HOWEVER,LABEL,METHODS,RESULTS,THUS,YORK
HORMONE,OTHER,PCA
DOX,FMOC,FTS,FTS2,PEG,PEG5K,PTX
035,053,250,500,AFTER,REGARDING,TRUS,USING,UTI
004,011,014,024,035,195,2007,2010,2012,250,8805,ANG,BMI,CASES,CHUNG,CORE,FEBRILE,GROWING,HOWEVER,JANUARY,LABEL,MATERIALS,METHODS,NOVEL,OBJECTIVE,PURPOSE,QUINOLONE,RESULTS,UNIVERSITY,UTI
CURRENTLY,DESPITE,KOREA,OPTIMAL
169,2014,956,BRAIN,CONCLUSION,HIGH,IMAGING,INC,LABEL,MBQ,METHODS,MOLECULAR,NUCLEAR,PARKINSON,PERIPHERAL,PET,RADIATION,RESULTS,SLOW,SOCIETY,UNLABELLED
154,169,2014,379,409,CONCLUSION,DIO3,DLK1,EMT,HOWEVER,LABEL,METHODS,MICRORNAS,OBJECTIVE,PURPOSE,RESULTS
2760,8300,956,EHD,HER2,LOD,PSA
0023,0028,0040,0043,0060,0064,0070,0130,0266,031,0332,0479,050,055,0860,100,1092,1177,1200,177,236,501,688,7200,7800,975,BPH,ELISA,EVALUATION,LABEL,METHODS,OBJECTIVE,PAI,PCA,PURPOSE,RESULTS,TRIS
121,2000,2012,239,4N0M0,8201,855,8804,8805,ADT,AMONG,BACKGROUND,COX,FURTHER,GLEASON,JAPAN,LABEL,METHODS,PSA,RESULTS,SECONDARY,THESE,ULTRA
160,ADC,GLEASON,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,ROC
FISH,FORTY,HOWEVER,SISH,THERE
AGGRESSIVE
2014,735,825,975,A1A1,A1A2,A2A2,AFRICAN,CIS,CYP17,HOWEVER,ODDS,ORS,OVERALL,PUBLISHED,RESULTS,SCIENCE,STRATIFIED,WEB
ELISA,PSA,RCA,THROUGH
169,2014,BACKGROUND,CONTACT,LABEL,METHODS,MOTIVATION,PRESS,PUBLISHED,REGULATION,RESULTS,UNIVERSITY
169,2014,AKT,AKT1,GLEASON,MASS,MYC
945,948,PSA,TREATMENT
58T,AIF,BAX,BCL,CHOP,DR5,OVERALL,PARP,ROS,TRAIL
CANONICAL,CAP,DCE,GNCCA,GROUP,MACHINE,MRI,SUPPORT,SVM,T2W,THESE
169,2014,441,455,BALTIMORE,CAPSURE,CUMULATIVE,END,HOPKINS,JOHNS,LABEL,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS,SEER,STRATEGIC,TIMES,UNIVERSITY
1000,169,2014,239,253,8805,GRADE,LABEL,MEN,METHODS,OBJECTIVE,PHASE,PRESS,PRIMARY,PUBLISHED,RESULTS,SECONDARY,TRIAL,UNASSIGNED,UNIVERSITY,WEEK
169,2014,CTR1,DSF,FDA,GIVEN,HOWEVER,PREVIOUSLY,SIMILARLY
169,2014,BECAUSE,BIOLOGY,CD33,FINALLY,INC,MAC,MOLECULAR,SIGLECS,SOCIETY,THESE
105,169,2014,270,BONE,CD19,CD33,CD34,CD45,DCC,DCCS,EPCAM,GYPC,HBA2,KLK3,KRT14,KRT18,KRT19,KRT5,KRT6A,KRT8,PSA,PTPRC,TARGETING,THESE,UICC,USING
2004,2012,229,780,963,AGE,BPS,CONCLUSION,DEC,LABEL,MAIN,MEIER,MEN,METHODS,OBJECTIVE,ONJ,RESULTS,SEP,SEQUENTIAL,TIME
GOLGI,HBP,METABOLIC,RTK,RTKS
DAPI,FISH,NUMERICAL
223,CPRC,CRPC,SINCE,SIPULEUCEL,STRATEGIES
001,054,066,112,160,1994,2011,207,236,505,556,593,598,610,774,8201,8805,966,AFTER,BACKGROUND,C00,C96,CANCERS,DETAILS,FEWER,ICD10,IRELAND,LABEL,METHODS,OVERALL,RESULTS,THESE
125,128,177,946,AFP,CEA,HCG,IDVT,PSA,SCC,SERUM,VTE
169,2014,HOWEVER,MRI,PSA,SEVERAL,SOON,WIDESPREAD
169,2014,FISH,LABEL,METHODS,OBJECTIVE,PCR,PURPOSE,RESULTS,SDC,SDCS,WESTERN
169,1998,2013,2014,BACKGROUND,COPYRIGHT,DECREASING,FORTY,INC,INFECTIONS,LABEL,METHODS,RESULTS
2013,BACKGROUND,EWING,GROUP,LABEL,LMS,MANAGEMENT,METHODS,RESULTS,RPS,TRANS,WORKING
0001,169,2014,8201,CONCLUSION,FURTHER,GLEASON,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,UROLOGICAL
THESE,VITAL
169,2014,945,AKT,AKT1,ATA,BOSWELLIA,CDK2,CDK4,COPYRIGHT,PRIOR,S6K1,SOCIETY,THESE
006,032,151,169,178,2014,279,798,946,952,AACR,BACKGROUND,BIOMARKERS,CAT,CONCLUSION,COX,EPIDEMIOL,FDR,GPX1,HRS,III,INCREASED,LABEL,METHODS,OXIDATIVE,PREV,RESULTS,SEVEN,SOD1,SOD2
024,100,106,119,169,2012,2013,2015,890,COPYRIGHT,EDUCATION,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OCTOBER,PUBLISHED,PURPOSE,RESULTS,SECONDARY,UROLOGICAL
2014,8197,946,BMJ,ESBL,FOLLOWING,GLEASON,GROUP,LTD,PUBLISHING
0001,164,169,179,189,200,2014,AURKB,BIRC5,CCNB2,CCNE2,EIGHT,EXPRESSION,FOXM1,KI67,LY6A,MKI67,NANOSTRING,NGFR,PXN,SYP,TEN,TRAMP
002,128167809,128393157,128498051,145,169,2014,215,8Q24,961,CAUCASIAN,CHR8,CHROMOSOME,COLORECTAL,CPG,FDR,LUNG,MYC,OVARIAN,POU5F1B,SCREENING,SNP,SNPS,THESE,TRIAL
177,231,8201,ANCT,CTGF,HMGN5,KNOCKDOWN,LC3,MDA,MMP,NEXT,PARP,PCNA,WESTERN
169,2014,8201,8805,BACKGROUND,CONCLUSION,FORTY,GLEASON,HIGH,LABEL,METHODS,RESULTS,SUSPICIOUS,USING
3AA,3BA,3CA,947,CISPLATIN,HILLMAN,K562,MTT,THESE,WHAT
MCTS,METABOLIC,OTTO,WARBURG
116,181,215,250,2YL,A375,A431,A549,AGILENT,C18,COLON,DAD,EPIDERMOID,FINALLY,H322,HCT,HPLC,IC50,MTT,NCI,PRANGOS
10878,8201,BACKGROUND,CRPC,CYP17A1,DURABLE,LABEL,METHODS,NINE,PSA,RESULTS,STUDIES,TREATMENT
013,100,157,310,370,470,945,AIM,AMACR,COA,IHC,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,THESE,TURP
AIM,AKT,ANOVA,CAM,CD31,CONCLUSION,ECS,FGF,FURTHER,INCREASED,LABEL,MATERIALS,METHODS,OBJECTIVE,PI3K,RESULTS,SARCOSINE,STUDENT,THERE,THESE,VEGF
0339,0515,1477,150,1511,1533,1593,3088,3201,3395,3666,4266,4829,5893,6047,9498,BOARD,BRAIN,CBCT,EVALUATION,HEAD,HENCE,IDV,IMAGING,LABEL,LATERAL,MATERIALS,METHODS,NECK,OBI,OBJECTIVE,OPI,PURPOSE,RESULTS,SIMILARLY,THERE
177,400,CONCLUSION,CRT,CTV,IMRT,LABEL,MATERIALS,MEAN,METHODS,OBJECTIVE,ORGAN,PTV,RESULTS
114K,169,2014,270K,31K,389K,400K,547K,85K,ACER,ACERS,BOTH,COPYRIGHT,COSTS,ICER,ICERS,NEITHER,NETWORK,NMB,NMBS,PREDNISONE,QALY,WTP
C75,FASN,HOWEVER,IC50,INHIBITION,STRUCTURE,THESE,TRICLOSAN,YET
946,KNOCKDOWN,MSC,MSCS,RUNX1,TARGETING,TGF,THESE
169,2014,BACKGROUND,COLON,CXR,DATA,END,LABEL,LUNG,METHODS,MPST,MPSTS,NLST,OVARIAN,PLCO,RESULTS,SCREENING,SEER,TRIAL
169,2014,8804,BACKGROUND,C3F,COPYRIGHT,ESI,LABEL,MALDI,METHODS,PCA,PSA,RESULTS,SAMPLES
2014,THERE
ATM,ATR,BRCA1,CDK12,CDKS,FANCI,PARP,THUS
001,045,2007,2012,645,8201,ACS,ASA,BACKGROUND,BPH,CLASS,COLLEGE,FURTHER,HOWEVER,LABEL,LVP,METHODS,NSQIP,OVERALL,PATIENT,PROGRAM,QUALITY,RESULTS,SOCIETY,TURP
10877,10878,113,190,1970S,2008,2011,AMONG,BACKGROUND,CAP,CRPC,GLEASON,LABEL,METHODS,OVERALL,RESULTS,SIXTY,WESTERN,YET
001,2003,2009,2010,292,347,610,8629,8981,AMONG,BACKGROUND,HOWEVER,LABEL,LOS,METHODS,MIRP,ORP,OVERALL,RESULTS,THEREFORE,USING
116,HCT,HOWEVER,PAS,POLYAMINES,SSAT,SW480,THEREFORE
001,169,2014,916,ADT,AFTER,CONCLUSION,CURE,CYP17,INTENSIVE,LABEL,LHRHA,METHODS,OBJECTIVE,PCA,PURPOSE,RESULTS,SOCIETY
8209,MMP,PCA,SPAG9,SPERM,TIMP,TMA,TNM,VEGF
8209,AKT,MTT,PAC,SEX,SOX2,WESTERN
196,260,266,456,8209,8805,945,967,ANDROGENS,CIS,GLEASON,HARDY,HOWEVER,ODDS,ORS,POLYMERASE,PUBLISHED,THEREFORE,V89L
107,175,1997,2011,322,643,8202,BIAGINI,BORIANI,JANUARY,KARNOFSKY,LABEL,LOG,LUNG,MEIER,METHODS,OBJECTIVE,RANK,RESULTS,SCORE,WALKING,WEINSTEIN
DESPITE,GROWING,MICRORNAS,PCA,RNAS,THEREFORE
946,CHINA,METHYLASE,RAR,SSS,THERE,THUS
169,2014,AMONG,DOSE,HOWEVER,INTENSITY,UROLOGICAL
000,006,011,020,031,035,158,169,177,2008,2011,2014,2015,225,232,278,499,8201,8805,886,945,AGAIN,ALP,BACKGROUND,CFS,COX,CRPC,EASTERN,ECOG,EPSTEIN,FURTHER,GLEASON,GROUP,HGB,HOWEVER,IDC,INC,LABEL,METHODS,PSA,RESULTS,TOTALLY,UNIVARIATE,WILEY
169,2014,8201,ALPHA,AMACR,BACKGROUND,COA,FFPE,HIGH,INC,LABEL,MEN,METHODS,PCA,PCR,RESULTS,SERUM,WILEY
169,2014,AIM,CAP,CONCLUSION,COPYRIGHT,FINALLY,HOWEVER,LABEL,LNCAP,LTD,METHODS,NED,OBJECTIVE,PCA,RESULTS,SGII,USING
169,177,186,2008,2012,2014,647,8201,887,BACKGROUND,BECAUSE,HOPKINS,INC,JHH,JOHNS,LABEL,MDC,MDCS,METHODS,MRI,NCCN,OVERALL,PCA,RESULTS,USING,WILEY
001,002,010,025,111,122,136,169,2014,233,374,8201,8805,AMONG,ANALYSING,AUTHORS,BJU,CHOLINE,CONCLUSION,DIFFERENT,DISEASE,GLEASON,LABEL,METHODS,OBJECTIVE,PET,PSA,PSADT,RESULTS,TRIGGER
169,2014,ADT,AR3,BACKGROUND,CELL,CONCLUSION,CRPC,DHT,DIM,EMT,INC,LABEL,METHODS,PCA,RESULTS,WILEY
001,100,169,181,2014,8201,954,ATHYMIC,BACKGROUND,BLOT,CAPSAICIN,CELL,DISCUSSION,GIVEN,INC,LABEL,LNCAP,METHODS,ONCE,PCA,RADIO,RESULTS,SENSITIZER,TRP,WESTERN,WILEY
001,003,108,125,169,2014,8201,AUTHORS,BACKGROUND,BCR,CD105,CD31,CD34,GLEASON,HOWEVER,INC,LABEL,METHODS,MVD,NHT,RESULTS,TSP,VEGF,WILEY
123,169,2014,BACKGROUND,BCL,DHR,DSB,DU145,EXPRESSION,FINALLY,FURTHER,GROUP,HIGH,HMGN,HMGN5,INC,LABEL,LOSS,METHODS,MNSOD,PARP,PC3,PCR,RESULTS,ROS,WESTERN,WILEY
GLEASON,IT1,LNCAP,PC3,RNAS,SPRY4,THERE
HOWEVER,PCA
135,198,257,340,700,CONCLUSION,LABEL,METHODS,OBJECTIVE,PSA,RESULTS,RLRP,THREE,URINARY,USING,VINCI
CONCLUSION,GLEASON,HOWEVER,LABEL,METHODS,OBJECTIVE,PSA,RESULTS
169,2002,2013,2014,COPYRIGHT,FOUR,HOWEVER,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,STUDIES
169,2014,COPYRIGHT,INC,INITIAL
169,2014,COPYRIGHT,INC,ORP,RARP
169,2014,COPYRIGHT,INC,RALP,ROBOTIC,RRP
169,2014,COPYRIGHT,INC,RARP,ROBOT,TECHNICAL
1284,169,2014,945,946,COPYRIGHT,DEPARTMENT,GLEASON,INC,PATHOLOGY,PUBLISHED
169,2014,500,800,956,BAPTA,CONVERSELY,COPYRIGHT,GF109203X,INHIBITION,PC3
169,2014,APP,AUTHORS,COPYRIGHT,DU145,INC,PCA,PUBLISHED,TARGETING
169,2014,ADDITIONAL,COPYRIGHT,LTD,MONITORING,NUTRITION,SEEKING,THROUGHOUT
169,2014,945,COPYRIGHT,COX2,FURTHER,LTD,PROSTATIC,PTGS2,TNF,VDR
169,2014,AUTHORS,COPYRIGHT,FACTORS,PUBLISHED,WHILE
058,123,141,169,2014,8805,CONCLUSION,COPYRIGHT,FLR,FUNCTIONAL,INC,KUTCHER,LABEL,LYMAN,MATERIALS,METHODS,OBJECTIVE,PCA,PURPOSE,RESULTS,TD50,V65GY
169,2014,843,BACKGROUND,COX,EDUCATION,EQUAL,GIVEN,HDL,HOWEVER,HRPER,LABEL,LDL,METHODS,PROGRAM,RESULTS,THESE,WESTERN
0001,001,014,100,103,125,130,154,169,174,2002,2013,2014,449,478,520,620,697,753,8805,927,ADVERSE,AUC,AUT,BLADDER,COPYRIGHT,COX,D20,D2CC,D90,EBRT,GRADE,INC,JANUARY,JULY,LABEL,LDR,LUT,MATERIALS,METHODS,OBJECTIVE,PALLADIUM,PURPOSE,RESULTS,ROC,STRUCTURES,THESE,V100,V150
169,2014,233,COPYRIGHT,EORTC,INC,LABEL,LIFE,MATERIALS,METHODS,NESTL,OBJECTIVE,PROCTITIS,PRT23,PURPOSE,QLQ,QUALITY,RESULTS,SYNBIOTICS,TREATMENT
169,2014,COPYRIGHT,DOSE,DOSIMETRIC,INC
00002,00004,00006,00008,00017,00030,169,2014,800,ADC,ADCS,BACKGROUND,CONCLUSION,COPYRIGHT,DIFFUSION,DWI,HEALTHY,IMRT,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PCA,PURPOSE,RESULTS,THESE
152,156,169,2015,308,ADT,COMPOSITE,COPYRIGHT,GLEASON,INC,INDEX,IRG,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,PLANNED,PSA,PUBLISHED,RESULTS,SOCIETY,T1C,T2C
125,138,155,169,195,2014,204,214,216A,217,218,26A,30B,4284,451A,802,COPYRIGHT,INGENUITY,IPA,IPMN,IRELAND,LTD,NGS,PATHWAY
100,146,169,2014,471,520,ACUTE,ADVERSE,DOSE,GRADE,IMAGE,JAPAN,MEAN,MUS,OAR,OARS,PRESS,PTV,PUBLISHED,RADIATION,SOCIETY,THESE,UNIVERSITY,VMAT,WPRT
0001,110,169,1990,2012,2013,270,290,8201,BACKGROUND,BECAUSE,BETWEEN,LABEL,METASTATIC,METHODS,RESULTS,SOCIETY,STUDIES
1996,2008,955,ALSO,BACKGROUND,BOTH,CONCLUSION,III,LABEL,METHODS,PHASE,RESULTS,THESE
169,176,17A1,2014,202,8764,945,A105L,ASN,BIOLOGY,CYP17A1,FIRST,INC,MOLECULAR,P450,SOCIETY,THIRD
151,169,2014,956,COPYRIGHT,DOCKING,EVALUATION,IC50,LNCAP,LTD,T877A,USING
ESL,KNOCK,MAP,PCA,RAS,SDF,THESE,USING
8314,8315,ADV,ADV_1,ADV_2,CD45,DTC,EPCAM,HOWEVER,NED,PCA
1000S,169,174,200S,2014,20HZ,215,235PG,23NG,24PG,250NM,488,60MIN,7MIN,916,ALEXA,ANNEXIN,BZATP,COPYRIGHT,CRYSTAL,FLUOR,INC,MVS,NTA,PC3,QCM,SAUERBREY,USING
004,048,116,169,1MONTHS,2014,378,4MONTHS,7MONTHS,COPYRIGHT,HOWEVER,INC,LABEL,MEIER,METHODS,OBJECTIVE,OVERALL,PSA,RESULTS,TREATMENT
AKT,ASTRAGALUS,BACKGROUND,CDK4,CONCLUSION,DU145,LABEL,MEANWHILE,METHODS,MTT,NEXT,PCR,RESULTS,THEREFORE
001,100,125,165,169,177,2015,BRITISH,COPYRIGHT,CTV,D90,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SOCIETY,V100
HIV,POC,POINT
100,AFTER
106,11C,665,8201,933,993,AUC,CONCLUSION,DUAL,LABEL,MATERIALS,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SUV
945,946,BALB,BECAUSE,CRPC,HIF,LNCAP,THESE
1165,825,BACKGROUND,C30,C61,DISCUSSION,EORTC,HRQL,HRQOL,ICD,KNOWLEDGE,LABEL,MATERIALS,METHODS,OTHER,PCA,PSM,QLQ,RESPONSES,RESULTS,TREATMENT
ADDITIONAL,AID,BACKGROUND,CHINESE,COCON,COMPETENCE,CONCLUSION,GERMANY,LABEL,METHODS,NETWORK,PSA,RESULTS,SOCIETY,UNASSIGNED
BASED,PCA,PUFA,PUFAS
103,CRCS,USING,VMY
AKT,CAMK2N1,CASODEX,CASTRATION,KNOCKDOWN,REDUCED,TAKEN
EFS,FYN,THEREFORE
001,002,005,1089,363,372,523,8201,NONE,RUSSIAN,SIX,TERT
145,EMT,FURTHER,GLEASON,PCA,PSA,THESE,THUS,ZEB2
145,231,435,549,946,ATCC,GRAM,HEPG2,HWE,MCF7,MDA,OVCAR,THEIR,THREE,WADSWORTH
002,169,2014,700,BACKGROUND,GLEASON,LABEL,METASTASIS,METHODS,NODE,PRESS,PUBLISHED,RESULTS,THOC1,THUS,TIME,UNIVERSITY
100,103,107,AIMS,ALSO,APOBEC3,BACKGROUND,LABEL,OBJECTIVE,RESULTS,THERE
000,100,2000,2006,2009,231,241,262,311,AAPC,AGE,AIMS,ASRW,ASRWS,AVERAGE,COLORECTAL,DATA,DCO,JOINPOINT,METHODS,OVERALL,RESULTS,SOFIA
BACKGROUND,CONCLUSION,FFPE,GLEASON,LABEL,METHODS,PCR,PREDICTING,RESULTS,SINCE,VGLL3
ADT,AKT,CRPC,MAPK,NCOA2,PCA,PI3K,PTEN,SRC,TAKEN,WHILE
0MG,2007,2011,666,CONCLUSION,DIET,DISEASE,FOUNDATION,GROUP,HOWEVER,JANUARY,LABEL,MDRD,METHODS,OBJECTIVE,RENAL,RESULTS,WORKING
BRCA,OTHER,THOSE
231,ALSO,BASED,FACULTY,MERAM,SEL,SOFT,UNIVERSITY
001,169,2014,521,616,8805,ADT,BIOMARKERS,CONCLUSION,COX,EBRT,FOUR,GLEASON,LABEL,LTADT,MDM2,METHODS,OBJECTIVE,PCSM,PURPOSE,RESULTS,RTOG,STADT
AMPK,LNCAP,PCA,PWR,R1881,SILIBININ,SREBP
954,KNOCKDOWN,L1CAM,MMP,THESE
169,2014,8201,AUTHORS,BJU,CONCLUSION,CRUZ,INC,LABEL,MATERIALS,MEDICAL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SANTA,USA
0001,0002,049,142,169,1ST,2014,292,301,3RD,ALPHA,ATBC,BACKGROUND,BETA,CLL,COLORECTAL,GREATER,HODGKIN,LABEL,LUNG,METHODS,NHL,OVARIAN,PLCO,PREVIOUSLY,RESULTS,SLL,THESE,TOCOPHEROL
0001,169,2014,2977,8805,AACR,ALPHA,ASIA,ATBC,BACKGROUND,BETA,BIOMARKERS,COLORECTAL,EPIDEMIOL,LABEL,LUNG,MATERIALS,METHODS,ORS,OVARIAN,OVERALL,PLCO,PREV,RESULTS,SWHS,TOCOPHEROL,WOMEN
65291,ABDOMINAL,BECAUSE,GLEASON,HEMOGLOBIN,HOWEVER,INJECTING,VITAMIN
AFTER,ANOTHER,HOWEVER,RADICAL
233,AFTER,BCG,CIS,FINAL
ACCORDING,HRPC,XTT
169,2014,COPYRIGHT,HOWEVER,IGF,IGFS,PROSTATIC,SOCIETY,USING
001,BACKGROUND,BOZOK,DATA,GLEASON,LABEL,MATERIALS,METHODS,PSA,RDW,RESULTS,TRUS,UNIVERSITY,UROLOGY
625,652,ASIAN,BACKGROUND,CASP8,CIS,D302H,DESPITE,EAST,HOWEVER,LABEL,MATERIALS,METHODS,NINE,NON,ODDS,ORS,PCA,RESULTS,THEREFORE
169,2014,945,BPH,CCNB1,CCND1,CHINESE,COPYRIGHT,HOWEVER,IIA,LTD,PCNA,RWPE,TAN,TANSHINONE,THESE,WPMY
169,2012,2013,2014,2380,643,8805,AMONG,BEST,CONCLUSION,COPYRIGHT,DATA,GLEASON,INC,LABEL,MARCH,MATERIALS,METHODS,OBJECTIVE,PSA,RESULTS,SEPTEMBER,STATEMENTS,SUCCESSFUL,SURGERY,UROLOGICAL
001,024,116,156,169,191,2014,946,AFTER,CONCLUSION,COPYRIGHT,EBL,FOUR,INC,LABEL,LPN,LPNS,MATERIALS,METHODS,OBJECTIVE,RESULTS,RISK,RPLPN,USING
169,170,2014,400,553,8805,AMICO,ASAP,CONCLUSION,COPYRIGHT,EPSTEIN,GLEASON,HGPIN,HOWEVER,INC,KETTERING,LABEL,METHODS,MSKCC,OBJECTIVE,RESULTS,SLOAN
APART,FURTHER,HOWEVER,HYDROXY,UNTIL
169,2014,FDA,FINALLY,HOWEVER,INC
169,2014,ACADEMY,BRITISH,CONFERENCE,COPYRIGHT,HOWEVER,JOURNAL,MEDICAL,PEDIATRICS,PREVENTING,THROUGH
123,169,2014,232,ADDITIONAL,CASTRATION,CRPC,EXPRESSION,FINALLY,GPER1,GPR30,HOWEVER,LNCAP,PCR,PCS,SOCIETY,USING
125,135,15NG,167,169,200,2001,2011,2014,231,233,239,60CM,ACUTE,ADVERSE,AMICO,BETWEEN,CONCLUSION,COPYRIGHT,DATA,EORTC,GLEASON,LABEL,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,RTOG,SAS,SFRO,SOCI,T2A
001,008,135,8201,8805,BOTH,CHINESE,COX,CRP,GLEASON,MEIER,THERE
111,177,BACKGROUND,DISCUSSION,DOTA,GASTRIN,GRP,GRPR,LABEL,METHODS,NEP,NMRI,RESULTS,SWISS
160,169,2014,231,233,COPYRIGHT,FINALLY,FIRST,IIA,III,MOL,SEVERAL,SFBBM,SOCI,THERE
ALTAS,AMONG,BICR,L31,LNCAP,MDM2,RPL31,THESE,THUS
001,104,120,160,169,2014,50B11,8805,964,BPH,COPYRIGHT,DU145,GLEASON,IHC,INC,LNCAP,NERVE,PATHOLOGY,PC12,PUBLISHED,RWPE,SOCIETY,THESE
145,169,2014,948,COPYRIGHT,INC,MCF,PANC,RICE
181,CD133,CD177,CELL,CSCS,ISOLATING,NANOG,OCT4,OVCA429,PROM1,SKOV3,SURVIVING,THEREFORE
200,2ND,945,946,956,AKT,ARP2,CAFS,EMT,FAK,GTPASES,MOLECULAR,PC3,PCA,PREVENTING,SILIBININ,SRC,TRANSWELL
492,AP4,FPN,INCREASING,INHIBITION,MYB,MZF,TARGETING,THESE,THUS
169,2014,BACKGROUND,BAX,BCL,CELL,DU145,ELLAGIC,HOWEVER,INC,KIP,LABEL,LNCAP,METHODS,PFJ,RESULTS,THREE,TRAP,WAF,WESTERN,WILEY
004,027,169,2014,406,8201,ABSENCE,AKT,BACKGROUND,CK19,CK5,CK8,COX,EXPRESSION,GLEASON,HOWEVER,INC,KI67,LABEL,MEIER,MET,METHODS,OVERALL,PI3K,PTEN,RESULTS,WILEY
251,330,AIM,BACKGROUND,CRM1,CTX,DU145,KPT,LABEL,METHODS,OBJECTIVE,PCA,PCB2,RESULTS,SELECTIVE,SELINEXOR,SIMILARLY,SINE,SINES,XPO1
111,169,2014,568,8201,8805,AMONG,BACKGROUND,CAT,COX,GLEASON,GPX1,GPX3,GPX4,HOWEVER,INC,LABEL,LESS,METHODS,OGG1,RESULTS,SEP15,SEPP1,SNPS,THESE,THUS,WILEY
169,2006,2008,2009,2010,2014,833,AUTHORS,CONCLUSION,COPYRIGHT,FIFTEEN,FORCE,GERIATRICS,JANUARY,JOURNAL,LABEL,MEN,METHODS,MIXED,OBJECTIVE,OBJECTIVES,PSA,RESULTS,SETTING,SOCIETY,TASK
ARSENIC,DATA,HOWEVER,INORGANIC,KOREA,SOUTH,THERE,WHILE
009,141,169,1992,2008,2014,310,8201,829,8804,BACKGROUND,BCR,CLINICIANS,COX,DESPITE,ESPECIALLY,GLEASON,INC,LABEL,MEIER,METHODS,PSA,RESULTS,TAKEN,WILEY
169,2002,2012,2014,BACKGROUND,COLD,CRYO,DATA,HOWEVER,INC,LABEL,LINE,METHODS,PCA,PHOENIX,RESULTS,SEVERAL,STUDIES,URINARY,WILEY
AFRICAN,AMERICANS,BECAUSE,CAUCASIAN,INC,PCA,PREVIOUSLY,PUBLISHED
102,165,2012,2013,432,BACKGROUND,CONCLUSION,DENMARK,DEPARTMENT,FOUR,FUNDING,JANUARY,LABEL,LUTS,METHODS,RESULTS,TRIAL,TUR,UROLOGY
155,160,169,2014,946,AS2,ASIA,AUTHORS,BRIEFLY,CURRENT,HENCE,HOWEVER,KNOCKDOWN,LNCAP,LTD,MIR,PTY,PUBLISHING,SCIENCE,SMAD,SMAD2,TGF,THROUGH,UTR,WILEY
BACKGROUND,CIS,FURTHER,HOWEVER,LABEL,METHODS,NSAID,ORS,RESULTS,THEREFORE
169,2014,COPYRIGHT,IC50,INC,NIR,THESE,UPON,VIS
169,2000,2010,2014,454,666,AMONG,BECAUSE,CALIFORNIA,CHART,COPYRIGHT,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,PERMANENTE,PURPOSE,RESULTS,THESE
418,BRCA2,MUTATIONS,RAD51,THREE
ALGEBRAIC,BM3D,CNR,CNRS,FOLLOWING,LABEL,METHODS,MVCT,OBJECTIVE,PURPOSE,RESULTS
1000,8805,CPCOP,CPOM,CTVSV,D98,DVHS,EACH,IMRT,LABEL,METHODS,NTCP,OBJECTIVE,PCA,PTV,PTVSV,PURPOSE,RESULTS,TCP,THESE
059,2012,238,287,500,6269,6277,952,966,ASSOCIATED,BASED,BIOL,CARLO,CTV,D90,DICOM,DIFFERENCE,DVHS,ENGER,FIVE,LABEL,MATERIALS,MED,METHODS,MONTE,OARS,OBJECTIVE,PHYS,PURPOSE,RESULTS,SEED,STUDENT,TG186,TG43
CARLO,DIC,DMC_LOG,DMC_TPS,DOSE,DTPS,LABEL,LINAC,MCLOGQA,METHODS,MLC,MONTE,OBJECTIVE,PURPOSE,RESULTS,WHILE
192,233,8804,AAPM,ADDITIONAL,CURIETH,ESTRO,EUROP,GEC,GROUP,HOWEVER,MOST,PHYSICISTS,SOCIETY,TASK,THESE
169,2014,240BP,CCAAT,COPYRIGHT,FOS,FURTHER,GIVEN,HOWEVER,LNCAP,PKC,PMA,PRMT5,PROTEIN
086,169,2015,309,313,640,AFTER,BLADDER,CONTINENCE,COPYRIGHT,DRY,EDUCATION,ENCRYPTED,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PADS,PUBLISHED,PURPOSE,RESULTS,SECONDARY,THERE,UROLOGICAL
169,2014,ERG,PRESS,PUBLISHED,THEREFORE,TMPRSS2,UNIVERSITY
082,1064,169,2014,2048,215,291,307,3944,3Q25,4098,4946,694,972,986,GWAS,PRESS,PUBLISHED,SNPS,STAGE,TGCT,THROUGH,UNIVERSITY
019,031,169,177,2014,AGGRESSIVE,AGING,BLOOD,CONCLUSION,COPYRIGHT,DEFICIENCY,HEART,INC,INSTITUTE,LABEL,LOH,LUNG,MATERIALS,METHODS,METS,OBJECTIVE,PCA,RESULTS,THERE,THESE
169,2014,945,COPYRIGHT,EARLY,LIFESTYLE,LTD,PSA,SEVERAL
150,169,174,181,2014,215,255,287,289,291,317,373,461,500,529,5500,8482,8594,945,ABSCIEX,ACQUITY,AUTHORS,C18,COPYRIGHT,DHT,FINALLY,HLB,KINETEX,OASIS,PROTONATED,PUBLISHED,QTRAP,UPLC,VALIDATION
AIMS,CLIC1,CONCLUSION,DU145,ERK,ERK1,LABEL,MAPK,MATERIALS,MEANWHILE,METHODS,MMP,MTT,RESULTS,THESE,TRANSWELL,UNLABELLED,USING
169,2014,COPYRIGHT,DEK,SCIENCE,SPOP
108,152,169,2014,210,AEZS,BLOOD,CONCLUSION,CRPC,CTC,CTCS,LABEL,LHRH,METHODS,MTD,OBJECTIVE,PSA,PURPOSE,RESULTS,THESE,THREE
MRI
169,2014,COPYRIGHT,CYTOTOXIC,FITC,LTD,MTT
1590,1618,169,2005,2009,2014,BACKGROUND,CIS,CONCLUSION,COPYRIGHT,LABEL,LTD,METHODS,ORS,PCA,PROTEUS,RESULTS,STIS
0001,008,169,2014,420,CONCLUSION,GIVEN,HOWEVER,LABEL,METHODS,OBJECTIVE,OVERALL,RESULTS,SELF
8201,AZD1152,FISH,HQPA,LNCAP,TAKEN,TREATMENT
085,2013,CONCLUSION,DESPITE,LABEL,LRP,METHODS,OBJECTIVE,OBJECTIVES,RALP,RESULTS,RRP
956,DOX,DUE,ENHANCING,HRPC,MTS,NDS,PC3,UTILIZING,VISIBLE
169,2014,45S,ACTIVATION,BMH,FINALLY,FURTHER,NCI60,POL,TESTING,THESE,VIABILITY
169,2014,AMONG,BASED,COPYRIGHT,EIGHT,GLEASON,INC,TEN
001,073,116,180,2001,2012,8201,8805,AUC,BACKGROUND,BCR,COX,GLEASON,HOWEVER,LABEL,METHODS,OVERALL,PREDICTIVE,PSA,PSM,RESULTS
956,ANIMALS,BACKGROUND,CASTRATION,CONCLUSION,CRPC,LABEL,LUC,MET,METHODS,MICE,NOD,NSG,RESULTS,SCID,TREATMENT,VCAP,VEGFR
169,2014,226,427,BIOLOGY,HSP27,INC,MOLECULAR,OGX,PREVIOUSLY,RESULTS,SOCIETY,TCTP,VALIDATION
145,22RV1,ATLAS,AZA,CPG,DAC,ENRICHMENT,EPIGENETIC,GLEASON,GS6,GSEA,PCA,SET,TCGA,THESE
126,216,945,946,BONE,CCN,CTGF,CYR61,DU145,FAK,NOV,OBCM,OSTEOBLAST,PC3,PCA,THUS,VCAM,WISP,WNT
036,110,117,2004,2012,540,994,ANALYZING,EG5,GLEASON,NOVEL,NUCLEAR,PCA,SAMPLES
FOLLOWING
2010,223,CRPC,FDA,HOWEVER,III,VARIOUS
DUE,MICRORNAS,PSA,THESE
AKT,CAP,NHEJ,PI103,PI3K,RAPAMYCIN
AHX,GLU,HBED,LYS,PET,PSMA
124,169,2011,2012,2014,954,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,GLEASON,INSTITUTE,JOHN,LABEL,MATERIALS,METHODS,RESULTS,THEREFORE
105,112,169,2014,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,INSTITUTE,JOHN,LABEL,METHODS,MRI,OBJECTIVE,RARP,RESULTS,WORKING
1819,1RA,2014,414,548,946,BACKGROUND,CCL,CCL11,CCL17,COLORECTAL,CRP,CURRENT,EOTAXIN,LABEL,LUNG,METHODS,ORS,OVARIAN,PLCO,PRESS,PUBLISHED,RESULTS,SCREENING,SMOKING,TARC,THESE,TRIAL,UNIVERSITY
169,2014,ADI,AKT,CRPC,CXCR4,EMT,FAK,SINCE,TPL2,UICC
003,169,19Q13,2014,600,827,8804,8805,GLEASON,KLK3,LABEL,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS,SNPS,THREE
169,2014,8201,AFTER,DUE,EPHB4,MFH,NVP,SEVERAL,SILENCING,SIZE,SOFT,STS,THEREFORE,UICC
001,144,169,2014,235,702,723,756,8201,866,ALTOGETHER,FINNISH,GLEASON,MEN,PSA,RISK,SCREENING,THERE,THEREFORE,TRIAL,UICC
169,2014,HOWEVER,OVERALL,SOMATIC,SPOP,SRC,USING
002,009,016,169,2014,270,8201,957,AKT1,COX,MIXED,PCA,PCSM,SNPS,THESE,UICC,VALIDATION,VARIANT,XRCC1
160,786,ADP,AIF,AKT,BAX,BCL,CCRCC,CLL,ERK1,FAS,FASL,HENCE,HL60,IAP1,III,JNK,JUN,MAP,MMP,PARP,PC3,PREVIOUSLY,RIBOFLAVIN,SCHMIDT,SRC,TNF,TNFR1,TRADD,TRAF,VEGFR
001,178,252,8804,967,ALSO,BACKGROUND,BDP,CONCLUSION,CONTROL,DEUTSCHER,DGP,GERMANY,GLEASON,LABEL,METHODS,PATHOLOGEN,PATHOLOGIE,PATHOLOGY,RESULTS,SOCIETY,UICC,UNION,WORLD
1000,CONCLUSION,DIFFUSION,DWI,LABEL,MDC,METHODS,MRI,OBJECTIVE,RESULTS,TESLA
946,956,IC50,LIGIA,MTT,NMR,PC3
BRIEFLY,CADMIUM,THUS
134,169,2014,322,CONCLUSION,CONTROL,DATA,IFS,LABEL,MATERIALS,MCNEMAR,METHODS,OBJECTIVE,PURPOSE,RATES,RESULTS,RSNA
1675,1907
173,2000,2010,209,DRUG,ENGLISH,FOOD,LABEL,MEDICINES,METHODS,OBJECTIVE,PATHOLOGIC,PURPOSE,QOL,RADIATION,RESULTS,SCC,SRE,SRES,TREATMENT
8211,ASCLEPIAS,C21,COMPOUNDS,DU145,ENZYMATIC,FIVE,MOLECULAR,NMR,THEIR
001,029,152,160,8201,ALTERED,EOC,HIGH,HOWEVER,IHC,MEIER,PCR,PTOV1,RESULTS
509,946,AREAS,ARN,BACKGROUND,COVERED,LABEL,METHODS,NON,NOVEL,OPINION
160,169,177,2008,2012,2014,966,ACADEMY,AGE,ANDROLOGY,BNR,CAVERNOUS,EFR,FEW,MEAN,PHYSICIANS,SOCIETY,UNR
169,2014,COMPOUNDS,COPYRIGHT,COSY,FIVE,HMBC,HSQC,LTD,NMR,ROESY,THEIR
0001,001,114,2000,2012,8201,8805,EPSTEIN,OHORI,SECTIONING
CF8,MK932,THEIR
2010,700,FINLAND,METASTATIC,POPULATION,PSA
012,436,566,782,808,AFTER,AGE,DRE,GLEASON,LABEL,METHODS,OBJECTIVE,PCA,PCAR,PSA,PSAD,RESULTS,THERE,TRUS
591,BELIEFS,CBE,HONG,KONG,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PSMI,RESULTS,SCREENING
ALPHA,ARIS,BPH,CURRENT,DATA,LABEL,OBJECTIVE,PURPOSE,RESULTS,SUMMARY,THEIR,THERE,THESE
CD8,CONSISTENT,CRPC,NKG2D,THESE,USING
160,169,183,2013,223,ADT,ALPHA,CABAZITXEL,CRPC,CYP17,GEORG,SIPULEUCEL,STUTTGART,THUS,WHILE,YORK
100,5000,670,945,API,BACKGROUND,BECKMAN,CONTEXT,LABEL,METHODS,OBJECTIVE,PSA,RESULTS,ROCHE,VALIDATION,WORLD
CHRONIC,LYMPHOMAS

181,ALKYLATION,BOTH,CONSISTENT,CRPC,CURRENT,CURRENTLY,HOWEVER,IC50,LBD,NTD
169,2014,HOWEVER,THESE,THUS,TYPE
946,BOTH,HIF,HYPOXIA,PDE5,TGF,TRAMP
169,2014,AKT,CRPC,ERK,IGF,IGF1,IGF1R,INSULIN,IRS,IRS1,LNCAP,NT157,PC3,THESE
169,2014,ASCS,NOVEL,OBESITY,PRESS,THESE
169,2014,AFTER,CASE,EFFECTS,HOWEVER,HRS,IRR,IRRS,POISSON,PSA,RISKS,SCREENING,SWEDISH,UICC
183,CVD,DENMARK,DESPITE,POTENTIAL,SEVEN
169,2014,ADT,BPH,CAP,CHIP,CPG,DNMT,EPIGENETIC,GLEASON,H3AC,H3K9ME3,HDAC,LNCAP,LUCIFERASE,MAQMA,MBD2,MECP2,NRF2,POL,RCAP,TAKEN,THREE,TMA,TRAMP,TSA
004,010,036,040,042,195,250,2518,8201,BONFERRONI,CCL2,CCR2,CHEMOKINES,GLEASON,HIGH,HOWEVER,NORTH,PCA,PCR,RFLP,SIMILARLY,V64I,VARIANT
169,2014,CELL,DU145,DUAL,GE11,INC,PEG,WILEY
1990S,EVEN,HOWEVER,SINCE,VINCI
169,2014,COPYRIGHT,ERG,ETS,FUSIONS,PRISM,PUBLISHED,SRM,STUDIES,THREE,TMPRSS2,VCAP
145,252,BURKITT,CAL,DAUDI,FRAW,HAH,HELIX,HIH,HLH,KLH,THEREFORE,THP
LNCAP,OBESITY,PACMETUT1,ROS,RWPE
001,119,129,150,165,2014,31TH,605,625,802,8202,974,ADT,BACKGROUND,CENTRAL,CIS,CVD,CVM,GNRH,LABEL,LIBRARY,MAY,MEDLINE,METHODS,PCA,RESULTS,THERE
956,CDK2,CDK4,DU145,INK4A,PC3,PROTEIN,WESTERN
100,169,2015,362,540,COPYRIGHT,DEFENSE,DETECTION,DOGS,EDUCATION,EXPLOSION,FURTHER,INC,ITALIAN,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL,VETERINARY
001,132,169,2015,322,381,703,COPYRIGHT,EDUCATION,INC,INITIALLY,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SHEAR,UROLOGICAL,USING
029,062,086,134,169,174,2015,610,742,AVERAGE,BASED,C30,COPYRIGHT,CS21,EDUCATION,EORTC,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,QLQ,RESULTS,UROLOGICAL,UTILITY
002,006,169,1993,1997,2014,8201,944,BMI,DATA,DENMARK,DIET,OBESE,STAGE,THERE,UICC
100,169,181,2012,2014,2B6,2C19,2C8,2C9,2D6,3A4,8201,AUC,COPYRIGHT,CYP,DDI,DDIS,DRAFT,FDA,IC50,JOHN,LTD,ORTERONEL,PBPK,SIMULATION,SONS,THEREFORE,THESE,WILEY
169,2014,COPYRIGHT,EZH2,FOXA1,HOWEVER,INC,INK4A,RAS,THESE
169,2014,ACTIVATION,ALTOGETHER,AUTHORS,COPYRIGHT,HOWEVER,INC,JAK2,PTEN,PUBLISHED,SASP,SHP2,STAT3
CELL,ERG,INHIBITION,TMPRSS2
001,015,023,038,048,083,169,2014,215,967,COPYRIGHT,DUCT,EACH,FINALLY,HGPIN,IDC,INC,INTRACLASS,SIX,SOLID,THERE
10MM,169,2014,5MM,643,716,COIN,CONFORMITY,COPYRIGHT,FOCAL,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIXTEEN,THERE,THESE,THREE
120,169,2014,215,A549,AAT,AATS,AMINO,BACKGROUND,COPYRIGHT,DU145,FAMP,INC,LABEL,MB468,MDA,METHODS,PET,RESULTS,SIMILAR,SKOV3,THESE,U87
0011,0025,0029,0301,0628,0772,120,169,2014,360,4648,8201,8805,BACKGROUND,CGA,CRPC,INC,LABEL,METHODS,PFS,PSA,RESULTS,UNV,WILEY
107,169,1A4,2014,2G7,3E6,4E6,7E11,BACKGROUND,CONCLUSION,D2B,DUE,ELISA,FINALLY,GCP,GCPII,INC,J415,J591,LABEL,METHODS,PSMA,RESULTS,SPR,USING,WESTERN,WILEY,YPSMA
169,2014,COPYRIGHT,LTD
100MG,10878,133MG,169,1WEEK,2014,2112,5422,89MG,BACKGROUND,COPYRIGHT,DOSES,HEAT,HER2,HSP90,LABEL,LTD,METHODS,MTDS,OVERALL,QOD,RESULTS,REVERSIBLE,SNX,THREE,USING
001,042,169,2014,304,384,729,739,8805,BACKGROUND,BMI,GLEASON,HOWEVER,LABEL,METHODS,OBESITY,OVERALL,PSA,RESULTS,STUDIES,THESE
100,169,2014,945,956,COPYRIGHT,DHT,LTD
100,120,1966,1982,1988,2014,APRIL,AUS,AUTHORS,BACKGROUND,BPH,CENTRAL,CIS,COLLECTION,CONTROLLED,DATA,GROUP,HOWEVER,JANUARY,LABEL,LUTS,MAIN,MARCH,MEDLINE,MEN,METHODS,MOST,OBJECTIVE,OBJECTIVES,RANDOMISED,RESULTS,SELECTION,THERE,TURP
169,1990,2013,2015,556,810,COPYRIGHT,COX,EDUCATION,FACTORS,FIVE,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THERE,UROLOGICAL
169,2014,947,954,COPYRIGHT,FASL,INC,JNK,PDTC,PEDF,PPAR
169,2014,22RV1,945,ASIA,CHOP,COPYRIGHT,INC,LNCAP,MANGOSTIN,NEXT,PCR,PRECS,SOUTHEAST,WESTERN
5819,8068,ASIAN,CAUCASIAN,CONCLUSION,K109R,LABEL,LEPR,METHODS,OBJECTIVE,ORS,OVERALL,PURPOSE,RESULTS,SNP,THESE
AFTER,ASODN,CONCLUSION,DIFFERENT,KDR,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
001,006,2N0,CONCLUSION,CRT,D50,EORTC,GLEASON,GRADE,LABEL,LATE,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS,RTOG,SIXTY,THERE,V70
125,169,2014,400,700,945,AFP,AGE,ARCHITECT,BACKGROUND,C28,CA125,CA15,CA153,CA19,CALIPER,CEA,CHEMISTRY,CLSI,HE4,HEALTHY,INITIATIVE,INTERVALS,LABEL,LABORATORY,METHODS,PEDIATRIC,PSA,REFERENCE,RESULTS,SCC
EGF,ERBB,ERBB1,FTS,NUCLEOLIN,PREVIOUSLY,RAS,SALIRASIB,THESE,U87
ALDH,DESPITE,PDTX,PRIMARY,STAT3,STATTIC,TICS
221,332,630,8804,AMONG,BETWEEN,CONCLUSION,GLEASON,LABEL,METHODS,OBJECTIVE,PCA,PURPOSE,RESULTS,TOTAL,TTV
169,2015,3183,COMPETING,CONCLUSION,COPYRIGHT,INC,LABEL,MATERIALS,MEN,METHODS,OBJECTIVE,OLDER,RESULTS
169,1994,2014,2015,CASE,COPYRIGHT,EDUCATION,FINALLY,HOWEVER,INC,LABEL,MATERIALS,METHODS,MOST,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,TOTAL,UROLOGICAL
1157,142,169,2014,934,AFTER,BONE,CONCLUSION,COPYRIGHT,COX,DUTCH,INC,KARNOFSKY,KPS,LABEL,MATERIALS,METASTASIS,METHODS,OBJECTIVE,PURPOSE,RESULTS,VAS,VRS
169,2014,COPYRIGHT,INC
169,2014,ARTICLE,AVAILABLE,COPYRIGHT,INC,ITEMS,META,OVERALL,PREFERRED,REPORTING,REVIEWS,SYSTEMATIC,WHETHER
8805,ACUTE,BACKGROUND,FREEDOM,GRADE,IGRT,IMRT,LABEL,METHODS,OUTCOME,OVERALL,RESULTS,SIB
100,125I,140,1X10,2009,2013,2014,AFTER,BONE,EBRT,HDR,LDR,MRI,PET,PSA
HETE,LOX,THEREFORE
2009,3RD,CONFERENCE,CONSENSUS,MRI,PSM,SOCIETY,STAGING
223,III,RANK
DUE,HOWEVER,HUNGARY,MEDLINE,OVERALL,PSA,RCT,RCTS
2011,2013,AFTER,AMONG,BASED,BEST,BETWEEN,FIVE,IMRT,LOCAL,MEDICAL,NONE,TEN,USA
HOWEVER,MINIMALLY,ROBOT,VINCI
BASIS,BEST,DISCOVERY,MEANWHILE
FOUR,GVAX,IPILIMUMAB,OTHER,USING
2004,2012,CHT,CRPC,ECOG,FIVE,JANUARY
2009,2013,215,2997,3375,363,451,659,666,FLAIR,GRE,III,INCIDENTAL,JUNE,LABEL,MATERIALS,METHODS,MRI,MRIS,OBJECTIVE,PURPOSE,RESULTS,STIR,THERE,TSE
009,591,AMONG,ANALYZING,LABEL,METHODS,OBJECTIVE,OVERALL,POPULATION,RESULTS,RRS,UPDB,UTAH
169,198,2000,2008,2014,361,AGE,ENGLAND,ENGLISH,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THERE,UROLOGICAL
169,2014,COPYRIGHT,ERK1,ISSUE,PNT2,RAF,SPECIAL,UNTIL
160,169,2014,ANEUPLOIDY,CONCLUSION,COPYRIGHT,DMR,H19,INC,INDIVIDUAL,ITGA6,KCNQ1OT,LABEL,MAIN,MEASURE,MEG3,METHODS,NONE,OBJECTIVE,OUTCOME,PATIENT,PEG,PEG3,PUBLISHED,RESULTS,SETTING,SOCIETY,SSCS,TESTICULAR,WHETHER
169,2014,250,500,ALCOHOL,BIOMEDICAL,BOARD,CDC,CHINA,CHINESE,CONCLUSION,COPYRIGHT,EDITORIAL,GREEN,LABEL,METHODS,OBJECTIVE,PCA,PUBLISHED,REGULAR,RESULTS
169,2014,233,242,7155,8891,CONCLUSION,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,UROLOGICAL
108,145,160,2000,2013,BETWEEN,BPH,CCL19,CCR7,PCA,PCR,RWPE,SILENCING
SENSITIVE
001,002,041,0625,196,330,3551,5667,BACKGROUND,DHT,GLEASON,LABEL,METHODS,RESULTS,THERE
146,169,2014,215,760,AFTER,BLOOMBERG,CONSORTIUM,HOPKINS,INSTITUTE,JOHNS,PRESS,PUBLISHED,RAD51,RAD51L1,SNP,SNPS,UNIVERSITY
001,169,2014,947,ADVERSE,BACKGROUND,CD3,CD4,CD8,DRUG,FOOD,FOXP3,IHC,LABEL,METHODS,PHASE,PRESS,PUBLISHED,RESULTS,SIPULEUCEL,UNIVERSITY
1237,169,2015,600,ABSTRACTS,COPYRIGHT,HIGH,INC,IRRITATIVE,LABEL,LITERATURE,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SOCIETY
10MG,148,169,175,2005,2011,2015,237,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PERI,PUBLISHED,PURPOSE,RESULTS,SOCIETY
686,ADJUSTMENT,BACKGROUND,CONCLUSION,GROUP,INSTITUTE,KARNOFSKY,KPS,LABEL,METHODS,OBJECTIVE,PURPOSE,RADIATION,RESULTS,SAQ,THERAPY,WHITE
MLH1,MSH2,MSH6,MSI,MUTATIONS
2008,2014,425,AFRICAN,ANN,ARBOR,BACKGROUND,BREAKFAST,COMMUNITY,CONTEXT,DESPITE,FELLOWSHIP,FIFTY,LABEL,MEN,METHODS,OBJECTIVE,RESULTS,UNIVERSITY,YPSILANTI
032,043,169,2015,COPYRIGHT,EDUCATION,GLEASON,INC,LABEL,MATERIALS,MEAN,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SURGERY,THESE,UROLOGICAL
660,745,ALTOGETHER,AURORAB,CKS1,ETS,FOXM1,LOSS,PCA,PLK,SAM,SPDEF,TOPO2ALPHA,TRANSGENIC,WHILE
169,2014,GIVEN,LNCAP,PCNA,PREVIOUSLY,THESE
169,2014,ADC,LIV,LIV1A,SGN,SLC39A6,THESE
946,954,BESIDES,CPG,CRE,PCR
169,2014,AKT,ASI,ASIS,CRPC,FINALLY,GIVEN,INHIBITION,NOTABLY,OVERALL,PI3K,PLK1,SREBP
111,169,177,2014,AFTER,BECAUSE,DOTA,HSG,IRDYE800CW,MBQ,MICROSPECT,NIRF,NUDE,PC3,RADICAL,SPECT,TF12,TROP
141,169,1993,2001,2014,221,8201,BACKGROUND,BASED,CASES,INC,LABEL,LOWER,METHODS,MICRORNAS,ORS,PCR,RESULTS,RNAS,SEVERAL,TOTAL,WILEY
119,169,2014,239,8201,BACKGROUND,CONCLUSION,CONVERSELY,DATA,ERG,GLEASON,HOWEVER,INC,KAPPA,LABEL,METHODS,RESULTS,TMPRSS2,WILEY
001,140,169,2014,435,653,680,744,8805,AUC,AUCS,AUTHORS,BJU,CDR,CDRS,HOWEVER,LABEL,METHODS,MOST,MRI,OBJECTIVE,OBJECTIVES,PSA,RESULTS,THREE,TRUS,USING
005,006,169,2014,513,532,8201,8Q24,ADDITIONAL,AFRICAN,BACKGROUND,BARBADIAN,BLACK,CARIBBEAN,EMPIRICAL,INC,JAMAICA,LABEL,META,METHODS,PCBP,POPULATION,PRCA,RESULTS,RS2124036,SEVERAL,SNP,SNPS,TEN,THESE,WILEY
001,009,013,033,286,430,448,726,858,LABEL,MATERIALS,METHODS,OBJECTIVE,PBX,PCA,PSA,PURPOSE,RESULTS
000,0815,0924,103,120,125,177,2001,2011,500,ADT,ALSO,DMFS,EBRT,GROUP,III,JANUARY,LABEL,LDR,MATERIALS,METHODS,OBJECTIVE,PALLADIUM,PURPOSE,RADIATION,RESULTS,THERAPY,THERE
023,196,208,BRAZILIAN,CHAIN,CLEMENTINO,CONCLUSION,FEDERAL,FILHO,FRAGA,GENOTYPES,GSTA1,GSTM1,GSTP1,GSTT1,HMK,INCA,INSTITUTE,JANEIRO,LABEL,MARIO,MATERIALS,METHODS,OBJECTIVE,PCA,PCR,POLYMERASE,RESULTS,RFLP,RIO,UFRJ,UNIVERSITY
182,2003,2012,BACKGROUND,BETWEEN,CONCLUSION,DISCUSSION,GLEASON,LABEL,MATERIALS,METHODS,PERINEURAL,PNI,RESULTS,SLIDE,THEIR
169,2014,COPYRIGHT,CRPC,DHEA,ESSENTIAL,HOWEVER,ISSUE,LTD,METASTATIC,PSA,SPECIAL
RNAS
MRI,PSA
169,2014,ADT,HOWEVER,PCA,READERS,RESULTS,THESE
167,ANXIETY,FCS,HOWEVER,IL1,IL1R2,LABEL,METHODS,NFKB2,OBJECTIVE,PURPOSE,RESULTS,THEREFORE,THESE,TNFA,USING,VARIATIONS
125,169,2014,703,8805,BACKGROUND,BMI,CCL13,CCL19,CCL2,COLORECTAL,CRP,CXCL5,CXCL6,ENA,FDR,GCP2,HOWEVER,LABEL,LUNG,MARKERS,MCP,METHODS,MIP,ORS,OVARIAN,RESULTS,SCREENING,SDF,TRIAL
169,2014,CONSISTENT,COPYRIGHT,GERIATRIC,INC,SIOG,SOCIETY,TREATMENT,VULNERABLE
115,177,COELIAC,CONCLUSION,HBED,LABEL,METHODS,OBJECTIVE,PET,PSMA,PURPOSE,RESULTS,SUV,SUVMEAN
602,DU145,HOWEVER,HPV,LNCAP,PC3,PNT2,STEAP,SUBSEQUENT
AKT,BACKGROUND,BIRC5,CONCLUSION,COX,INHIBITION,LABEL,LNCAP,PAK6,PI3K,PKC,PTEN,RESULTS,TAKEN,THESE,USING
BODP3,RELATED,SPECT
DUE,EARLY,TRUS
004,025,424,CLINICIANS,FACTORS,INFECTIOUS,NEITHER
001,130,2008,2011,2013,AFTER,ASSESSMENT,CALIFORNIA,CAPRA,COMPARING,COX,CPARA,DATA,FINALLY,FRANCISCO,MEIER,RISK,SAN,UNIVERSITY
ADM,HOWEVER,OSM,STAT,THESE
169,2014,500,CD8,DUAN,MHC,THESE
0001,0006,0045,0447,100,169,177,2014,2NG,3NG,43NG,AMICO,BACKGROUND,CONCLUSION,COPYRIGHT,DUE,GROUP,HOWEVER,IIEF5,LABEL,LEVEL,MATERIALS,METHODS,PSA,RALP,RATES,RESULTS,ROBOTIC,SAS,SEVENTY
001,002,107,169,1988,2010,2014,8804,CONCLUSION,COX,CSM,GLEASON,HOWEVER,LABEL,MEN,METHODS,OBJECTIVE,OVERALL,PLN,PLNS,PURPOSE,REGRESSION,RESULTS,SOCIETY,THESE
2006,2008,2010,2011,JANUARY,OWING
BACKGROUND,BCR,CTCS,FORTY,LABEL,LAPC3,LNCAP,MEN,METHODS,NON,PC3,PHC,PSA,RANDOMIZED,RESULTS,THERE
ATAP,BFL,RGD,SV129
100,630,8201,ARRHENIUS,CARLO,HEATING,LABEL,METHODS,MONTE,OBJECTIVE,OBJECTIVES,PARAMETRIC,RESULTS
COX2,DU145,ETV1,FURTHER,HOWEVER,JAK2,JANUS,OTHER,PC3,PTX,STAT3,ZERUMBONE
103,2007,2009,8211,8805,BACKGROUND,BETWEEN,BOTH,CONCLUSION,CRT,GROUP,IGRT,IMRT,LABEL,METHODS,RADIATION,RESULTS,THERAPY
DWI,MRI
ACCORDING,FDA,PCA,PCA3,PSA,RNAS,SINCE,THESE
001,024,050,10TH,169,2012,2013,2014,369,8594,ABI,CAB,CAST,DATA,HOWEVER,JULY,MINOR,PFS,PRIMARY,PSA,SIXTY,UICC
169,2015,8804,8805,BACKGROUND,CONCLUSION,COPYRIGHT,COX,CRPC,EACH,EARLY,GLEASON,IAD,INC,LABEL,MEN,METHODS,PSA,RESULTS,TIME
009,168,169,1999,2015,218,638,ADDITIONAL,AMONG,CALCULATOR,COPYRIGHT,EDUCATION,INC,LABEL,LIKELIHOOD,MATERIALS,METHODS,OBJECTIVE,PCPT,PUBLISHED,PURPOSE,RESULTS,RISK,SWEDISH,UROLOGICAL
001,169,2010,2011,2015,543,621,671,876,AMONG,BASE,COPYRIGHT,DATA,EDUCATION,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PRIMARY,PUBLISHED,PURPOSE,RESULTS,THEREFORE,UROLOGICAL,USING
169,2015,239,945,AFTER,CHOU,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,MTT,OBJECTIVE,PERSISTENT,PUBLISHED,PURPOSE,RESULTS,TALALAY,THESE,THUS,UROLOGICAL
1000,169,171,172,183,188,2010,2013,2014,2314,301,585,952,BACKGROUND,BETWEEN,COPYRIGHT,COU,FUNDING,IQR,JANSSEN,LABEL,LTD,METHODS,NOV,PSA,RESULTS,SEPT
100,169,2014,AIMS,BASED,CBCT,COMPARING,CONCLUSION,CONE,COPYRIGHT,CROWN,IGRT,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PART,PTV,PUBLISHED,RESULTS,SEVENTY
0001,0039,3261,CELLS,GLEASON,HBP,KNOCKDOWN,TAKEN,UAP1,UDP
145,8209,DUAL,DUSP6,FURTHER,LNCAP,TAKEN
108,169,2014,8NG,AMONG,CONCLUSION,COPYRIGHT,CTCAE,EBR,FOCUSED,GLEASON,HIFU,HIGH,INTENSITY,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PSA,RESULTS,SAS,ULTRASOUND,URINARY
108,169,177,2014,235,566,8805,CONCLUSION,COPYRIGHT,DCE,DWI,ESUR,GLEASON,IRELAND,LABEL,LESIONS,LTD,METHODS,MRI,NPV,OBJECTIVE,PCA,PSA,PSOVERALL,PSSUM,PURPOSE,RADS,RESULTS,T2WI,TRANSITION,USING
CARNS,FINALLY,LINEAGE,NKX3,ORGANOIDS
169,2007,2009,2014,5824,749,782,ADT,CONCLUSION,COPYRIGHT,COX,ELIXHAUSER,END,GIVEN,INC,LABEL,MATERIALS,MEN,METHODS,OBJECTIVE,OBJECTIVES,PARKINSON,RESULTS
001,013,033,169,201,2014,BACKGROUND,BONE,BSI,COPYRIGHT,DRUG,EXINIBONE,INC,LABEL,METHODS,RESULTS,TASQ
0001,0009,082,125,169,1998,2010,2014,2418,4015,AFTER,BRITISH,COPYRIGHT,COX,FURTHER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OLDER,PURPOSE,RADICAL,RESULTS,SIR,SIRS
169,2014,AMONG,COMPOUNDS,COPYRIGHT,IC50,NCI,SAS
001,034,1000,169,1961,2001,2003,2014,239,4999,500,5000,558,8805,999,COX,DATA,FIVE,GLEASON,GROUP,JAPAN,LABEL,MEIER,METHODS,OBJECTIVE,PRESS,PUBLISHED,RESULTS,SIMILAR,THERE,UNIVERSITY
169,2014,AMERICA,CY5,CYS,GLU,HOWEVER,IRDY800,NIR,NORTH,PSMA,RADICAL,SELECTIVE,THESE
100,125,160,169,2014,43U1,923,952,CARLO,COPYRIGHT,D10,D30,D90,LTD,MCNPX,MONTE,PUBLISHED,V100,V150
001,2014,215,2252,7619,8804,9P21,AS1,ASSET,BRC,ESCC,GWAS,IFNW1,PRC,PRESS,PUBLISHED,RCC,RS10511729,SNP,SNPS,TUSC1,UNIVERSITY
135,150,169,200,2014,2206,250,300,AKT,DUE,LABEL,METHODS,MRI,MTD,OBJECTIVE,PRP,PURPOSE,QOD,RESULTS,TREATMENT
169,2014,ALSO,ANN,BOTH,CD147,CD9,CONCLUSION,COPYRIGHT,HLA,LABEL,METHODS,OBJECTIVE,P4E6,RESULTS,ULTRA
169,916,COPYRIGHT,DETECTION,ERG,ERG72,ERG81,ETS,EXON,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PATHOLOGY,PCR,RESULTS,SOCIETY,TMPRSS2
169,200,2015,CONCLUSION,COPYRIGHT,FOCAL,INC,LABEL,LOCAL,MATERIALS,METHODS,MRI,NEWER,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,SOCIETY,TPMB,WHOLE
169,2008,2010,2014,946,CONCLUSION,COPYRIGHT,ESBL,FOUR,INC,LABEL,METHODS,OBJECTIVE,RESULTS,UROSEPSIS,UTI
377,440,8201,BACKGROUND,CBCT,CONCLUSION,IDEAL,LABEL,LOWER,METHODS,RESULTS,SINCE,XVI
224,452,AOX1,CCDC181,CURRENTLY,EPIGENETIC,GABRE,PITX2,SEVERAL,THUS,WESTERN
COMPOUNDS
A549,INFLUENCE,LNCAP,U251
IGFBP,KLK3,NIDOGEN,PSA
8804,AGR2,AGRWT,PCA,PCR,PSA,ROC,USING
CSCS,HENCE,RECURRENCE,TOP2A,TOP2AHIGH,USING
STROMAL
AFTER,AUA,DEPARTMENT,GUIDELINE,HOWEVER,KOREA,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,TRUS,UROLOGICAL,UROLOGY
169,2006,2011,2014,571,899,AMONG,BACKGROUND,COPYRIGHT,DATA,HODGKIN,INC,ISPOR,LABEL,METHODS,MOST,NETWORK,NHL,OBJECTIVE,PRIMARY,PUBLISHED,RESULTS,SOCIETY,VHA
0001,120,169,2014,BACKGROUND,BRITISH,CO2,COPD,FEV1,JOURNAL,LABEL,MEF50,METHODS,MIF50,PRESS,PUBLISHED,RESULTS,ROBOTIC,THEREFORE,UNIVERSITY
000,100,169,1998,2002,2003,2007,2008,2012,2014,AFRICAN,ASR,ASRS,CAPE,EASTERN,PBCR,PBCRS,REGISTERED,SAHARAN,THERE,UICC
169,2014,509,ADDITIONAL,ARN,HOWEVER,SOCIETY
169,1994,1995,1996,2002,2006,2009,2015,BACKGROUND,BETWEEN,COPYRIGHT,END,HOWEVER,INC,LABEL,MATERIALS,METHODS,PRIOR,PROCEDURES,RESULTS,THESE,USING
169,2014,ALONE,ALSO,RADIATION,SOCIETY
AREAS,BACKGROUND,BONES,COVERED,III,LABEL,MEDLINE,METHODS,OPINION,PCA,PHASE,PREVENTING
169,2014,548C,COPYRIGHT,CRPC,CRPCS,GLEASON,LABEL,MICROARRAY,MIR,PATIENT,PCA,PRINCIPAL,PUBLISHED,REANALYSES,RESULTS,SCS,SUMMARY,UNLABELLED,UROLOGY
BACKGROUND,COS,DU145,GSH,LABEL,LNCAP,METHODS,NPAA,NQM,OPH,PC3,PRODRUG,RESULTS,ROS,RWPE,SIMILAR
HOWEVER,MULTIMODAL,WHILE
160,294,762,APE1,ASP148GLU,HOWEVER
12V2,FORM,HRQL,INDEX,MEN,PCA,PCI,SHORT,UCLA
ACQUIRING,BACKGROUND,DESPITE,HOWEVER,LABEL,MBC,METHODS,RESULTS,THESE
1990S,2331,BACKGROUND,CONCLUSION,DRE,HOWEVER,LABEL,MALDI,MASS,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PCA,PSA,RESULTS,SEPHAROSE,THEREFORE,TOF,URINARY
128,185,192,197,200,204,267,389,400,427,533,8201,945,956,AFRICAN,BACKGROUND,ENDPOINTS,EYE,GROUP,HOWEVER,IDENTIFIER,IMPORTANCE,INDIVIDUAL,LABEL,MAIN,METHODS,OBJECTIVE,PREVENTION,RELEVANCE,RESULTS,RICO,SETTING,SIMILAR,SOUTHWEST,THERE,THESE,TRIAL,VITAMIN
DESPITE,LABEL,LIFESTYLE,LUTS,MEN,OBJECTIVE,PFMT,PURPOSE,RESULTS,SUMMARY,THERE
10Q23,169,2014,21Q22,8P21,COPYRIGHT,ERG,RESISTANT,SCIENCE
169,2014,COPYRIGHT,SCIENCE
001,012,014,016,169,170,2014,318,BACKGROUND,CONCLUSION,E6AP,LABEL,MEDICAL,METHODS,PML,PRESS,PSA,PUBLISHED,RESULTS,SOCIETY,UNIVERSITY
169,2014,945,ACTIVATION,AIMS,BACKGROUND,COPYRIGHT,HOWEVER,HSA,INC,LABEL,METHODS,MSC,MSCS,OBJECTIVE,PUBLISHED,RESULTS,SOCIETY,THERAPY,TNF,TRAIL,TSG
AKT,AMONG,EPHA3,GLEASON,HOWEVER,LNCAP,PCA,PRLZ,TAKEN
169,2014,GMBH,SEVERAL
1350,8197,APPROACHES,AUSTRALIA,AUSTRALIAN,BACKGROUND,BMJ,DIAGNOSTIC,GROUP,LABEL,LIMITED,METHODS,PUBLISHED,PUBLISHING,RESULTS,SECONDARY,TOTAL,TRIAL,UNIVERSITY,WESTERN,WHILE,ZEALAND
8201,AVERAGE,VARIATIONS
169,2014,8201,AATF,BIOLOGY,CELL,CHE,EPIGENOMIC,FEDERATION,HENCE,PAR,SINCE,SP1
169,1999,2000,2010,2012,2014,3282,8804,8805,AIMS,CONCLUSION,DATA,ENGLAND,GLEASON,JOHN,KINGDOM,LABEL,LTD,METHODS,OBJECTIVE,PROTECT,PSA,RESULTS,SONS,THERE,WHILE,WILEY
BASED,CELL,DRUG,FURTHER,HSP,HSP27,MAPK,PKD1
ANNEXIN,ATG5,ATG7,DAPI,FITC,LC3,LNCAP,NEMOPILEMA,THESE,TREATMENT,VDT
REGUCALCIN
8594,945,946,AMONGST,NMR,PC3,SCREENING
169,171NM,2014,72H,CACO3,COPYRIGHT,HOWEVER,IBUPROFEN,MSNS,THESE
A549,DU145,HELA,MCF
160,AMONG,LOIRE,PAPILLOMA
169,2014,CONSISTENT,CTBP2,HIGH,NCOR,NOTABLY,OVERALL,SNPS
0001,1557,169,2005,2014,BECAUSE,COPYRIGHT,GLEASON,GP5,INC,MOST,NBX,NBXS,PCA,PCAS
8226,946,BIOLOGICAL,INHIBITION,KEY,LABEL,MESSAGE,TGF,THEREFORE,THESE,TREGS,UNLABELLED
2000,2013,544,739,8804,8805,CITY,HOWEVER,IPSS,JAPAN,LUTS,PSA,SCORE,SYMPTOM,THERE,THESE
CERTAIN,HPV,HPV16,HPVS,IRAN,IRANIAN
APOPTOSIS,ARSENIC,PCR,PSA,RWPE,RWPE1,WHILE,YET
001,008,160,174,8201,ALTERED,BACKGROUND,CASES,CONCLUSION,COX,EBRT,EGFR,EZH2,KRUSKAL,LABEL,METHODS,MOST,MSMB,PADT,PCR,PSMA,PTEN,RESULTS,SIX,TRANSCRIPT
169,183,2014,362,370,713,753,754,827,858,945,EACH,INC,KUDER,LABEL,METHODS,OBJECTIVE,RESULTS,RICHARDSON,WILEY
103,1996,2012,239,248,ADT,ALSO,ASSESSMENT,CAPRA,CSS,HOWEVER,JAPAN,LABEL,METHODS,OBJECTIVE,PFS,PURPOSE,RESULTS,RISK,THEREFORE
160,8201,8226,8805,AUC,CCL,COMPUTERS,DATA,GLEASON,IMAGING,KEY,LABEL,METHODS,MRI,OBJECTIVE,OBJECTIVES,RADS,REPORTING,RESULTS,ROC,TPM

0001,0009,001,111,150,177,215,8201,CLINICALLY,HSG,LABEL,MBQ,METHODS,PC3,PRIT,RESULTS,RIT,TF12,TROP,TROP2,UNLABELLED
956,CHINESE,IC50,PC3,TEN
181,22RV1,361,8776,945,946,A2780,A549,ANTI,AURANOFIN,COMPLEXES,HELA,HLN,HOS,IC50,MCF7,NMR,PPH3,THP,TNF
176,177,8201,CIDISTANCE,CIS,CONCLUSION,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,RESULTS,SDS,THEN,VRI
100,169,2014,8805,CONCLUSION,CRPC,FEWER,LABEL,MET,METHODS,MOST,OBJECTIVE,OTHER,PURPOSE,RESULTS,SOCIETY,TAKEN,TREATMENT,XL184
070,138,169,2014,571,8212,8805,ADJUSTMENT,CIS,COLORECTAL,CONCLUSION,COX,GLEASON,HOWEVER,HRS,III,LABEL,LUNG,METHODS,OBJECTIVE,OTHER,OVARIAN,PLCO,PURPOSE,RESULTS,SCREENING,SOCIETY,THEREFORE,TRIAL
001,012,018,032,034,123,169,2014,CONCLUSION,COX,GLEASON,HRS,LABEL,MEDLINE,METHODS,NEPC,NEPCS,OBJECTIVE,ONCE,PCA,PURPOSE,RESULTS,SOCIETY,STUDIES,THERE,TREATMENT,TYPE
145,CNFS,CNTS,DEPENDING,EJ28,FOLLOWING,FORTY,THESE
105,2008,2010,BPFS,COX,GROUP,LABEL,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS,SRES,THERE,ZOLEDRONIC
006,1082C,10877,10878,2000,276C,49C,568,AFTER,AGE,BACKGROUND,BPH,CHRONIC,CIS,CLUE,CRP,HOWEVER,IL10,IL1B,IL6,IL8,INDEX,LABEL,LEP,LUTS,METHODS,NONE,ORS,PPARG,RESULTS,SCORE,SNPS,SYMPTOM,THUS,TLR4,TNF,UROLOGICAL
090,1015,1032,10878,418,844,BACKGROUND,CHINESE,CIS,GENOTYPES,GLEASON,HAN,LABEL,METHODS,ORS,RESULTS,SNPS,THESE
CRPC,THEREFORE
8209,946,CELLS,EGR,LNCAP,TGF,THUS
001,002,1072,1177,169,2014,8201,AMONG,BACKGROUND,BRCA,BRCA1,BRCA2,LABEL,METHODS,NETWORK,RESULTS,SIR,SIRS,SOCIETY
8804,ADT,BACKGROUND,BOTH,DISCUSSION,HOWEVER,LABEL,MDT,METASTASES,METHODS,MTD,PCA,PET,PSA,SBRT,TRIAL
169,178,1993,2010,2014,2895,844,AMONG,BACKGROUND,CENTRAL,KCCR,KOREA,LABEL,METHODS,RESULTS,SEER,SIRS,SOCIETY,STAT,THYROID
BOTH,FIRST,HOWEVER,PC3,RANK,RANKL,SIMILAR,THIRD,USING
001,177,967,CONCLUSION,EXCLUSION,GLEASON,HIPAA,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PCA,PURPOSE,RESULTS,THREE,TUKEY
005,025,101,149,169,2014,8201,ACCORDING,COX,ESCC,GASC1,KLF4,MDM2,MYC,NANOG,PPARG,ROC,SOX2,THEREFORE,UICC
169,2014,BASED,BONE,COPYRIGHT,THESE
101,111,112,124,169,2014,CD31,COPYRIGHT,ERG,ETS,FIFTY,GMBH,MVD,NONE,THERE,WESTERN
169,2014,COPYRIGHT,INC,LNCAP,NEOPLASIA,NOTA,PACE4,PET,PRESS,PUBLISHED
954,ADT,ARV,ARVS,CRPC,HOWEVER,LBD,PCA,THESE
185,2000,2006,2011,620,8315,AFTER,AGE,CHINA,HOWEVER,JAPAN,KOREA,MEAN,PSA,SERUM
CURRENT,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
169,2014,946,ACTIVATION,COPYRIGHT,ISSUE,LNCAP,MAP,MEDICAL,NDRG1,NHE1,PROTEOMICS,PSGR1,PYK2,SINCE,SPECIAL
001,009,169,2014,215,263,8201,8805,BLOOD,CELLSEARCH,COX,CTC,CTCS,III,JANSSEN,MEIER,NOTABLY,PSA,RECURSIVE,S0421,SAMPLES,SWOG,THEREFORE,UICC
0001,169,2015,639,A1C,COPYRIGHT,DATA,DCCT,EACH,EDIC,EDUCATION,INC,IQR,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,TOTAL,UROLOGICAL
ANTIGEN,ASSESSMENT,BACKGROUND,CONCLUSION,EIGHT,GPS,LABEL,LAP,LEICESTER,METHODS,ONCOLOGIST,PACKAGE,PSA,RADIATION,RESULTS,SIX,THEREFORE
PAR,THUS
103,107,126,190,230,307,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIX,THUS
169,2014,8322,956,APOPTOSIS,ASSESSING,BACKGROUND,COPYRIGHT,LABEL,METHODS,PBS,RESULTS,ROS,SPECIES
169,2014,946,ALZHEIMER,AMYLOID,APP,COPYRIGHT,DU145,EMT,INC,LNCAP,NOTABLY,SNAI2,THESE,VIM
001,008,031,038,046,115,160,169,177,189,2014,210,218,8805,ASSOCIATES,BMI,COPYRIGHT,GLEASON,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RALP,RESULTS,THERE
EVEN,HRQOL,LABEL,METHODS,OBJECTIVE,PERHAPS,PURPOSE,RESULTS
169,1990,2013,2014,AUTOMATED,BACKGROUND,CONCLUSION,COPYRIGHT,HIV,HPV,HSV2,LABEL,MEDLINE,METHODS,RESULTS,SAS
215,303,737,AFRICAN,GWAS,SNPS,THESE
001,2014,29321,BACKGROUND,CIS,COLORECTAL,CONCLUSION,COX,HRS,LABEL,LUNG,METHODS,OVARIAN,PLCO,PRESS,PUBLISHED,RESULTS,TVU,UNIVERSITY
169,2014,PATIENT,PRESS,PUBLISHED,UNIVERSITY,YET
0001,169,2004,2011,2014,8197,AMONG,COPYRIGHT,COX,CSM,END,LABEL,LOCAL,M1A,M1B,M1C,NLT,PATIENT,PUBLISHED,RESULTS,SUMMARY,THESE,UNLABELLED,UROLOGY
169,2014,COPYRIGHT,PC3,SAS,THESE
001,042,AQP5,AQPS,BACKGROUND,CD45,CEP8,CTCS,DAPI,FISH,HIGH,LABEL,LNCAP,METHODS,MTT,RESULTS,THESE,TNM
169,2012,2014,8805,ACUTE,ADVERSE,BED,COPYRIGHT,HOWEVER,IMRT,INC,INSTITUTE,LABEL,LYMPH,MATERIALS,METHODS,NODES,OBJECTIVE,OVERALL,PRIAMOS,PURPOSE,RADIATION,RESULTS,SEPTEMBER,URINARY,WITHOUT
AKT,DECREASED,PHLPP,UAF,USP12,WDR20
001,005,100,1000,133,300,500,8209,ACCORDING,ANNEXIN,CD133,CD44,CELL,CSCS,DEAD,DU145,THEREFORE
916,946,CK14,CK15,CK18,CK5,CK8,CONVERSELY,CPG,DESPITE,ERG,GSTP1,NKX3,NP63,OCT4,PTEN,THESE
737,ABT,BAD,BH3,BOTH,CD24,CD44,CONSISTENT,CONVERSELY,CSC,FACS
AKT,BACKGROUND,ERBB2,GLEASON,LABEL,PRINCIPAL,RESULTS,THERE
123,99M,BACKGROUND,CONCLUSION,CONTEXT,FCH,FDG,LABEL,METHODS,PET,RESULTS
MRI
009,165,169,177,2014,629,967,ANCTS,ANOVA,BPH,CHI,COPYRIGHT,FFPE,GMBH,IHC,MIBC,NMIBC,PCR,STUDENT,TCC,TCCS
123I,124I,125,125I,145,169,2014,8201,945,946,AUGER,BACKGROUND,DU145,INC,INITIALLY,LABEL,LNCAP,METHODS,RADIOIODO,RESULTS,RISAD,WILEY
110,137,169,1920,1929,1930,1939,1940,1949,1950,1959,316,455,8201,968,BACKGROUND,CARCINOMA,CONCLUSION,HEREDITARY,HOWEVER,III,LABEL,MATERIALS,METHODS,RESULTS
145,169,2014,945,BACKGROUND,EBR,HOWEVER,INC,LABEL,LNCAP,MDM2,PARP,PC3,RESULTS,ROS,SSAT,THEREFORE,THESE,WILEY
ARES,BCL,ETS,LNCAP,PSA,WALNUTS
146A,169,2014,BACKGROUND,EFFECTS,INC,LABEL,METHODS,PCR,RAC1,RESULTS,RTCA,UTR,WILEY
169,181,2014,8201,8805,BACKGROUND,DES,HOWEVER,INC,INK4A,JUN,LABEL,LAPC,METHODS,RESULTS,ROS,WILEY
160,AMONG,ARG,HPV,PCR,PRO,PSA,STDS
131,169,2014,367,AIMS,BFD,COLLEGE,COPYRIGHT,FOUR,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PHOENIX,PUBLISHED,RESULTS,ROYAL,USING
169,2014,8211,8764,ALIKE,BIOLOGY,CELL,COMMONS,DRUG,FOOD,HOWEVER,LICENSE,PACLITAXEL,SHARE,SOCIETY,TAXOL
160,240,360,956,BACKGROUND,BLOOD,CONCLUSION,DOSE,LABEL,METHODS,RESULTS,THREE
AREAS,BACKGROUND,COVERED,DESPITE,FDA,LABEL,METHODS,OPINION,THERE
169,2014,8201,AFTER,COPYRIGHT,ERC,JOHN,LINEWIDTH,LTD,MRSI,NINE,SONS,WILEY
169,2014,330,AFRICAN,BIOLOGY,BROADLY,EVOLUTION,KHOE,KHOESAN,L0D,L0D2C,L0D2C1A,L0D2C1B,L0D2C1C,MOLECULAR,NAMIBIA,PRESS,PROVIDING,PUBLISHED,SAN,SOCIETY,UNIVERSITY
100,169,2014,BODY,CONCLUSION,DEPARTMENT,FACULTY,HOWEVER,JAPAN,LABEL,METHODS,OBJECTIVE,RESULTS,SURGERY,TOTTORI,UNIVERSITY,UROLOGICAL,UROLOGY
032,129,169,2002,2010,2014,8805,APC,CRT,GRADE,IMRT,JAPAN,PRESS,PUBLISHED,RADIATION,SOCIETY,THREE,THUS,TIME,UNIVARIATE,UNIVERSITY,V10,V65
177,435,585,633,638,DOSE,HOWEVER,IMPT,IMRT,INTENSITY,LABEL,MATERIALS,METHODS,MFO,OBJECTIVE,PURPOSE,RESULTS,SFIB,SFO,SFUD,SIMILAR,SSPT,THERE
169,2014,GMBH,KGAA,MOST,NTD,VCH,WILEY
INCIDENTAL,IPC,LITERATURE,TUR
2012,ACCORDING,AFTER,DEFINITIVE,IPSS,QOL,SINCE,STRICTURES,TREATMENT,VUA,YAG
043,1000,129,2002,2011,868,8804,8805,AFTER,BACKGROUND,CLAVIEN,DINDO,FISCHER,IRB,LABEL,LITERATURE,MAJOR,METHODS,OBJECTIVE,OVERALL,PURPOSE,RARP,RESULTS,ROBOT,THERE
100,ALI,DESPITE,ECE,EMR,GLEASON,LABEL,METHODS,NATURAL,NLP,OBJECTIVE,PNI,POTENTIAL,RESULTS,SMS,SVI,TNM
001,160,169,2014,ASSESSMENT,AUTHORS,EPIGENETIC,EXPRESSION,FOUNDATION,JOHN,JOURNAL,LTD,MICROARRAY,MOLECULAR,MSP,NPT,PCA,PHENOTYPIC,SONS,WILEY
FAB,GHR,IGF,JAK2,JANUS,LNCAP,SHORT,SIMILARLY,SOL,STAT5
177,956,DIADEMA,ERK1,MYC,SNU,THESE,VIETNAMESE
001,003,006,022,043,169,2014,6649,BACKGROUND,CONCLUSION,FIVE,INDIVIDUAL,LABEL,METHODS,PRESS,PRINCIPAL,PUBLISHED,RESULTS,STEARIC,THERE,UNIVERSITY
000,100,102,104,177,2005,2009,4631,AGE,ASR,BACKGROUND,DATA,EXCEL,INCIDENCE,IRAN,LABEL,MEAN,METHODS,RESULTS,SPSS,YAZD
CSC,CSCS,DU145,HEPG2,K562,LSCS
426,8201,891,AIMS,CIS,DATA,HYPOTHESIS,LABEL,LIBRARY,METHODS,OBJECTIVE,OVERALL,RESULTS,RRS,THERE
100,169,2014,8764,BAX,CONCLUSION,DOX,HOWEVER,KEY,LABEL,METHODS,OBJECTIVE,RESULTS,ROYAL,SOCIETY,THERE
002,013,134,164,169,2000,2011,2014,8805,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OTHERWISE,RESULTS,UROLOGICAL
169,1972,2014,99M,BECAUSE,BONE,DRUG,FOOD,GROWING,NAF,PET,RSNA
013,040,1996,285,328,893,AFTER,BACKGROUND,FEW,LABEL,METABOLIC,METHODS,PROJECT,RESULTS,RISKS
3MM,947,DVH,IMRT,M3D,RTOG,TPS,VMAT
AAA,ALSO,AXB,CARLO,ECLIPSE,HOUNSFIELD,MONTE,TPS,ULTIMATELY,VMAT
ANY,BECAUSE,DOSE,IMRT,MLC,TPS
169,2010,2014,945,BCPT,CTLA,DESPITE,DRUG,EMA,FDA,FOOD,HLA,IDO,IFN,MEDICAL,NEXT,NSCLC,PHD,SOCIETY,THUS,TMZ
60012,CC13,DOSE,ECLIPSE,EDGE,FINALLY,IBA,MLC,NEXT,NUCLEAR,PTW,SBRT,SUN,THESE,USING,VERSION,VMAT
009,105,235,385,956,DEVIATIONS,GROUP,RMSE
100,3MGY,565,665,BEAM,CBCT,DLP,DLPCBCT,IMAGING,RESULTS,THESE
176,177,3DVH,ACPDP,BOTH,CVSP,DELIVERED,DOSE,DVH,MACHINE,OAR,OARS,PINNACLE3,PLANNED,PTV,SBRT,SRS,TPS,TREATMENT,VIE,VMAT
BIOLOGICAL,DVH,HOWEVER,IMRT,MASTERPLAN,OAR,OMP,PTV,QUALITY,THREE,TPS,VMAT
2012,52427,62225,APA1,BSM1,CDX2,FOK1,HODGKIN,HOWEVER,JUNE,TAQ1,VDR
FURTHER
DIFFERENT,HOWEVER,OVERALL
LIPID
169,174,2014,500,8201,ADVERSE,COPYRIGHT,JOHN,LTD,NEXRUTINE,SONS,THERE,TOXICITIES,WILEY
119,1995,2010,ADDITIONAL,BACKGROUND,CAP,LABEL,METHODS,RESULTS,SEER,SIMILARLY,SIR,SIRS,THERE
015,160,215,523,8201,8804,8805,AVERAGE,BACKGROUND,LABEL,METHODS,MRI,PSA,RESULTS
169,2014,CLINICALLY,HELA,IMR,NOTABLY,PPC1,RNAI,SER10,THROUGH
THERE,THESE,WHILE
003,004,009,011,023,046,169,2014,265,AIMS,BPFS,COPYRIGHT,COX,ERG,HENCE,LABEL,LOG,LTD,METHODS,OBJECTIVE,PCA,POZ,RESULTS,SPECKLE,SPOP,T2E,TMPRSS2
169,1761,1998,1ST,2009,2012,2014,31ST,6270,715,APRIL,BACKGROUND,CIS,CONCLUSION,COPYRIGHT,COX,HRS,KINGDOM,LABEL,LTD,METHODS,OBJECTIVE,OCTOBER,POST,RESULTS,SECONDARY,THERE,TIME
169,2014,8764,8805,CRT,EBRT,GRADE,HOWEVER,IMRT,JAPAN,LATE,PRESS,PSA,PUBLISHED,QOL,RADIATION,SOCIETY,THOSE,UNIVERSITY
121,169,2014,2015,500,817,827,AMIGO,IMAGE,OPERATING,SOCIETY
000,006,008,009,014,239,240,297,301,302,359,400,550,620,627,ABSORPTION,BACKGROUND,BASED,COU,III,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,STUDIES
189,650,9286,AUC,BCR,CANONICAL,CAP,FORTY,GLEASON,MEIER,MULTI,PEARSON
BPS,CURRENTLY,ZOLEDRONIC
AKT,AMINO,ANALYZING,ATRARIC,LNCAP,PCA,PP2,SRC,TAKEN,TREATMENT,USING
183,1998,2009,CONCLUSION,COX,DATA,GLEASON,IRELAND,LABEL,METHODS,OBJECTIVE,OLDER,PURPOSE,RESULTS
BRAF,E26,ERG,ETS,ETV1,ETV4,ETV5,FURTHER,HOWEVER,PCA,RAF1
BNC,BOTH,LABEL,MANAGEMENT,OBJECTIVE,OPEN,PURPOSE,RESULTS,SEVERAL,SUMMARY
2008,2011,AFTER,AREA,BETWEEN,CONCLUSION,DIAGNOSTIC,DICE,LABEL,MARCH,MATERIALS,METHODS,MOST,OBJECTIVE,PURPOSE,RESULTS,SEPTEMBER
150,169,174,2011,2013,2014,946,AFTER,AGING,ANTICANCER,BOD,BPH,CONCLUSION,COPYRIGHT,INSTITUTE,JANUARY,JOHN,LABEL,METHODS,OBJECTIVE,PCA,POD,RESULTS,RSH,TTG
169,2014,ANTICANCER,CBX,COPYRIGHT,COX,INSTITUTE,JOHN,LLW,MDA,PC3,PCA,STUDIES
002,0023,013,034,169,2014,946,COPYRIGHT,EMT,EPITHELIAL,FINALLY,INC,METFORMIN,NOTABLY,PCA,SOX4,TGF,VCAP
169,2014,BPH,COPYRIGHT,SAS,WOMEN
160,169,2014,CHD1,COPYRIGHT,ERG,FOXA1,INC,LOSS,SPOP,TMPRSS2,USING,WHOLE
169,2014,CK5,CK8,COPYRIGHT,INC,ORGANOIDS,THESE
000,001,100,10878,169,186,1998,2002,2009,2014,208,209,212,228,231,239,251,253,269,2776,395,406,40YEARS,436,441,446,467,468,474,481,488,508,698,700,737,741,742,786,9642,ASIAN,BACKGROUND,COPYRIGHT,COX,INSURANCE,LABEL,LTD,METFORMIN,METHODS,RESULTS,T2DM,TAIWANESE,WHETHER
001,035,145,177,188,416,653,731,854,8805,AMONG,BMI,CHI,CHINESE,CONCLUSION,GLEASON,HONG,KONG,LABEL,METHODS,OBESITY,OBJECTIVE,PARAMETERS,PSA,PURPOSE,RESULTS,TRUS
169,2014,22RV1,CASTRATION,COPYRIGHT,CRPC,DHEA,DHT,FORMATION,FURTHER,HOWEVER,LTD,MDV3100,THUS,UNDER
212,2278,AIPC,CSD,DU145,LIN28,MYC,PRIOR,TARGETSCAN,THEREFORE,THESE,THUS,ZNF
14YEARS,169,1994,2006,2014,243,332,350,874,985,BACKGROUND,COPYRIGHT,EBRT,HOWEVER,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
169,2014,8322,COPYRIGHT,DILUTED,IRELAND,LDR,LTD,PEG
0012,011,012,169,177,2014,600,ADC,CONV,COPYRIGHT,DISTORTION,DWI,FIFTY,INC,KRUSKAL,MRI,RANK,STUDENT,SUM,TEST
169,1985,2014,676,AFTER,CONCLUSION,COPYRIGHT,FIVE,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PERSONS,POPULATION,RESULTS,THERE
145,EXPRESSION,LNCAP,MTT,PCA,PCR,RWPE
021,125,169,2003,2008,2011,2013,2015,976,AUTOPSY,CONCLUSION,COPYRIGHT,DATA,INC,JAPAN,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SEPTEMBER,SOCIETY
169,2014,COPYRIGHT,CYP17,PUBLISHED,THESE

169,2014,76GY,8805,COPYRIGHT,FOCAL,IGRT,III,IMRT,INTENSITY,PUBLISHED,SAS,THESE
169,2014,COPYRIGHT,DESPITE,LTD,THUS,TODAY
169,2014,COPYRIGHT,FURTHER,IRELAND,LNCAP,LTD,METFORMIN,NKX3,PSA,PUBLISHED,SMILE,SRC,TAKEN
169,2014,223,CARE,CRPC,LABEL,METHODS,OBJECTIVE,ONTARIO,PALLIATIVE,PURPOSE,QOL,RESULTS,SIPULEUCEL,SOCIETY,THERE
ADHERENCE,ADT,BACKGROUND,DIET,DISCUSSION,IDEA,LABEL,METHODS,PILOT,TRIAL
001,160,326,8209,HCC,HEAT,HOWEVER,HSF1,KNOCKDOWN,S326,TAKEN,USING

1975,ALTOGETHER,INITIATING
034,AIM,BACKGROUND,CCL18,CD31,DU145,EXPRESSION,GLEASON,HOWEVER,KI67,LABEL,METHODS,OBJECTIVE,PCA,PCNA,PCR,RESULTS
L122R,MYOD1,RMS,TUR
000,169,1991,2001,2013,2015,655,873,COPYRIGHT,EDUCATION,GLEASON,GREATER,HIGH,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,RESULTS,SURGEON,THERE,UROLOGICAL
001,007,169,2004,2009,2015,499,AGE,COPYRIGHT,EDUCATION,HOWEVER,INC,LABEL,MATERIALS,MEN,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SEER,THERE,UROLOGICAL
0006,0035,110,169,2000,2010,2015,642,752,COPYRIGHT,COX,EDUCATION,FIVE,FURTHER,INC,IQR,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,PROPENSITY,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
173,BACKGROUND,CONCLUSION,FURTHER,HOWEVER,KEY,LABEL,MDT,MDTS,MEMBERS,METHODS,RESULTS,SPLITTING,THERE,UROLOGISTS
0125,169,2014,8201,ADC,AUSTRALIAN,AVERAGE,BACKGROUND,CENTRAL,COLLEGE,DCE,FURTHER,GLEASON,KEP,LABEL,METHODS,MRI,MTD,NCCN,NETWORK,PSA,RESULTS,ROYAL,ZEALAND
169,AUTHORS,EARLY,GMBH,HOWEVER,KGAA,LABEL,METHODS,NOTABLY,OBJECTIVE,PROTEOMICS,PSA,PUBLISHED,PURPOSE,RELEVANCE,RESULTS,VCH,WILEY
169,176,177,2013,532,8201,99M,AFTER,AUGER,AUNP,AUNPS,COPYRIGHT,CYS,DOTA,GLY,GRP,HIV,HYNIC,JOHN,LTD,LYS,PC3,SONS,TAT,WILEY,YAG
0001,169,2000,2007,2014,221,AGE,COPYRIGHT,END,FORTY,FURTHER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PALLIATIVE,POISSON,PURPOSE,RATES,RECEIPT,RESULTS,SEER
169,2014,945,CD56,COA,IMAGING,KIT,PRIMARY,UROLOGICAL,WORLD
SNP,SNPS,WESTERN
159,170,1966,1982,1989,1999,2014,268,379,428,430,515,525,577,619,695,6999,734,7578,870,922,943,ACCORDING,AUC,BASED,BPH,CNKI,CONCLUSION,DISC,DOR,LABEL,LIBRARY,META,METHODS,OBJECTIVE,PHI,RESULTS,SERUM,SROC,THERE,TOTALLY,VIP
001,208,213,262,547,787,AE3,CONCLUSION,EP4,LABEL,LUC,METHODS,OBJECTIVE,ONO,PC3,RESULTS,THEN
HIGH,THEREFORE
003,2004,2013,677,961,ALSO,ANALYSING,CRCP,CRPC,HOWEVER,PSA
169,201,2014,231,233,AFU,BETWEEN,COPYRIGHT,GLEASON,III,IMRT,LOCAL,PSA,PUBLISHED,SALVAGE,SAS,SEVERAL,SFRO,SOCI,THREE,TUMEURS,UROG
169,192,2008,2013,2014,231,233,6000,COPYRIGHT,PUBLISHED,SAS,SFRO,SINCE,SOCI
169,2014,231,233,COPYRIGHT,HOWEVER,MAJOR,MRI,PET,PUBLISHED,SAS,SFRO,SOCI,THUS
169,2014,COPYRIGHT,CURRENT,FOCAL,HOWEVER,SAS,VTP,WST11
169,2014,ABS_CAT,BACKGROUND,COPYRIGHT,GLOBALTEST,GLS,GSA,HOTELLING,LABEL,MED_CAT,METHODS,MMGSA,MRGSA,RESULTS,SET,TSAI
169,2014,COPYRIGHT,DUBS,EMT,HOWEVER,INC,NOTABLY,PC3,RWPE1,UBIQUITIN,UCH,YET
016,018,027,032,169,2015,215,ADT,COPYRIGHT,DISABILITY,INC,LABEL,MAIN,MAXIMAL,METHODS,OBJECTIVE,OBJECTIVES,OUTCOME,PCS,PUBLISHED,RANDOMIZED,RESULTS,RETENTION,SELF,SETTING
169,2014,ALSO,CK10,CK7,COPYRIGHT,MAC,NPH,P63,PAC,PSA,SAS,TCC
0005,003,105,1080,169,2014,540,6400,8805,ACUTE,BOTHELL,BVI,BVS,COPYRIGHT,INC,LABEL,MATERIALS,MAXIMUM,METHODS,OBJECTIVE,ORGAN,PUBLISHED,PURPOSE,QOL,RADIATION,RESULTS,SOCIETY,THERE,TPCT
014,017,019,024,025,031,037,173,177,CONCLUSION,GLEASON,LABEL,MATERIALS,METHODS,MRI,NOTH,OBJECTIVE,PCA,PFA,PURPOSE,RATIO,RESULTS,RRP,SEVENTY
173,177,CONCLUSION,DIODE,IPSS,LABEL,LUTS,MATERIALS,MEAN,METHODS,OBJECTIVE,PURPOSE,PVR,QMAX,RESULTS,SCORE,SYMPTOM,TURP,WHILE
181,1MG,956,CYP3A,EPR,HDAC4,IC50,IIA,P4503A4,THUS
576,906,C30,CONFIGURAL,EORTC,GIVEN,ITEM,LABEL,LIFE,METHODS,MULTI,OBJECTIVE,PURPOSE,QLQ,QUALITY,RESULTS
100,105,2009,2020,235,362,8201,AFTER,AUSTRIA,BACKGROUND,HOWEVER,LABEL,METHODS,PREDICTION,RESULTS,STATISTICS,THEREFORE,TYROL
180,297,8805,CONCLUSION,EASTERN,GLEASON,GRADE,GROUP,LABEL,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS,TREATMENT
006,1990,367,ASSESSMENT,BACKGROUND,BRITAIN,CCND2,CONCLUSION,COX,DPYS,GLEASON,GREAT,HSPB1,LABEL,METHODS,PSA,RESULTS,UNIVARIATE
169,2014,ADT,COPYRIGHT,INC,STUDIES
169,2014,AIMS,AMERICA,COLLEGE,CONCLUSION,COPYRIGHT,FIFTY,GROUP,III,IPSS,LABEL,LTD,MATERIALS,METHODS,MOST,NORTH,OBJECTIVE,PUBLISHED,RADIATION,RESULTS,ROYAL,SBRT,SYMPTOM,THERAPY
169,178,2014,8314,8322,AC1,AC10,ACS,ATP,CLASS,COPYRIGHT,III,ISSUE,MAMMALIAN,SPECIAL
169,2014,COPYRIGHT,EVEN,LARGE,MRI,PET,PSA,PUBLISHED,SAS,SBRT,SPECT,THESE,ULTIMATELY,WHILE
169,2014,231,233,COPYRIGHT,IGRT,IMRT,PUBLISHED,SAS,SFRO,SOCI
ABC,ATP,HOWEVER,MDR,THESE,TKIS,TKS
115,241,A549,CAP67,DESPITE,GALXM,GXM,MP84,MPS,PC3,THESE
169,2014,COPYRIGHT,DETECTION,EARLY,FDA,GUIDELINES,INDEX,NCCN,NETWORK,OVERALL,THESE
177,234,278,8201,BOTH,DU145,GMO,HOWEVER,PLGA,THEREFORE,THERMAL,TXR,WI26
169,2014,407,ADULT,CONCLUSION,COPYRIGHT,DIF,GENERIC,INC,LABEL,LIFE,METHODS,OBJECTIVE,PUBLISHED,QLACS,QUALITY,RASCH,RESULTS,SCORE,SURVIVORS
169,2014,CACO,CAEN,CCDC88A,CELLS,CLONOGENIC,CURRENTLY,FN1,GANIL,HOWEVER,JAPAN,MYH9,PC3,PRESS,PUBLISHED,RADIATION,RBE,ROCK1,SOCIETY,UNIVERSITY
001,004,117,160,2005,2009,214,516,8805,AMONG,BACKGROUND,BCR,JULY,LABEL,METHODS,PSA,PSM,PSMS,RESULTS
100,118,126,2013,2014,334,AFTER,BACKGROUND,GLEASON,IDENTIFIED,INITIAL,IQR,LABEL,LNS,METHODS,PLND,PSA,RESULTS,SLN,SLNS,SPIOS,USING
001,044,160,221,292,355,8201,892,DRE,GLEASON,LUTSS,MIRNA,PSA,TRUS
010,145,440,DOX,GROUP,IIA,IMMUNOBLOT,KNOCKDOWN,LNCAP,PCS,SPRL,THESE,THUS
001,169,2014,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,CRFS,INSTITUTE,JOHN,LABEL,LENS,METHODS,OBJECTIVE,RESULTS,VALIDATION
169,2014,AKT1,ANTICANCER,ANTISENSE,BCL,COPYRIGHT,INSTITUTE,JOHN,LNCAP,STAT3,THESE,TREATED
001,016,100,102,10MM,114,119,169,170,2014,211,5MM,8805,954,ACCORDING,AGREEMENT,APCA,CONCLUSION,COPYRIGHT,DATA,GLEASON,IMAGING,INC,LABEL,MAXIMUM,MCCL,METHODS,MRI,OBJECTIVE,PURPOSE,REPORTING,RESULTS,STEP,TRUS
001,102,109,121,1985,2013,535,COX,CRIBRIFORM,FORTY,GLEASON,JULY,MARCH,PSA
106B,128,252,375,CHO,DRUG,EACH,GUO,HOWEVER,LARYNGEAL,LAST,LIANG,LUNG,NON,PROJECT,RNAS,THEIR,THEREFORE,THESE,THUS,WANG
000,001,017,024,039,240,352,421,650,794,8805,BACKGROUND,IPSS,LABEL,METHODS,RESULTS,SCORE,SYMPTOM
169,2014,ADT,AMONG,BRAF,CDH1,CDK19,CHD1,CPSF6,CRPC,KDM3A,KDM4A,KLK2,KLK3,LABEL,MEN,NCOR1,NOTABLY,PCR,RASA1,RASGRP3,RNAS,SETD5,SETD7,SND1,TP53BP1,UNLABELLED,USING
169,2014,IMAGING,INC,MOLECULAR,NUCLEAR,RECEPTORS,SELECTIVE,SOCIETY
236,HSP75,HSP90,KARNOFSKY,KPS,THESE,TRAP1,WORLD
008,031,057,105,127,169,2014,377,512,525,563,713,753,8805,970,D9901,III,SIPULEUCEL
105,CHINESE,ELK4,FOUR,PCR,RNAS,SLC45A3,THESE,USP9Y
001,867,8804,956,BACKGROUND,CONCLUSION,DATA,DCE,LABEL,MANN,METHODS,MRI,OBJECTIVE,PCS,RCC,RCCS,RESULTS,SIMILARLY,SUMMARY,WHITNEY
BMX,BTK,CTN06,DTX,DUAL,EGFR,ETK,KNOCKDOWN,PC3,RAF,SRC,TEC,TREATMENT,VEGFR,WHILE
EFFECTIVE,EXPRESSION,OVARIAN,PSP94,SIGNALING,THUS
25D,945,CELL,CONNEXIN32,CX32,FINALLY,GAP,LNCAP,THESE,VITAMIN
169,2014,956,ABBS,ACADEMY,BIOLOGICAL,BIOLOGY,CDK,CELL,CHINESE,EDITORIAL,INSTITUTE,INSTITUTES,MTT,PRESS,PUBLISHED,T24,UNIVERSITY
10NM,231,956,BACKGROUND,FC101,FURTHER,HACAT,HUC,IC50,LABEL,MCF,MDA,PC3,RESULTS,SCC,UC14,VEGF
0006,001,1958,3467,390,8Q24,AMERICA,NORTH,SNP,SNPS
100,116,169,2000,2010,2014,APRIL,ASPIRIN,EXCLUSION,GROUP,INCLUSION,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,UROLOGICAL
001,151,160,227,8804,BACKGROUND,BPH,CONCLUSION,GLEASON,HPIN,INCREMENT,LABEL,METHODS,PCA,PLAC1,PSA,RESULTS
000,112,116,126,137,169,2008,2012,2014,236,8201,ACCORDING,AMICO,AUD,AUSTRALIAN,BACKGROUND,COLLEGE,CONCLUSION,CTAP,DESPITE,JANUARY,LABEL,METHODS,NONE,RESULTS,RISK,ROYAL,THERE,WBBS,ZEALAND
093,BASED,CHOLINE,CONCLUSION,GTV,LABEL,MEAN,METHODS,OBJECTIVE,PARTIAL,PET,PURPOSE,RESULTS,SUVMEAN,TVP
EFFECTIVE,LABEL,METHODS,OBJECTIVE,PPB,PURPOSE,Q2D,Q2DVA,RESULTS,THESE,USING,WHILE
FINALLY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEED,SOCIETY,THREE,TRUS,V100
176,177,8776,AVERAGE,BASED,CBCT,D95,DIR,DVF,DVFS,FIFTY,LABEL,MAXIMUM,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS,SVS,TEN
101,BOTH,CTV,D95,D99,DMLC,EVALUATION,LABEL,LINAC,METHODS,MLC,OBJECTIVE,PTV,PURPOSE,RESULTS,THESE,V65,WITHOUT
223,945,AREAS,BACKGROUND,BONE,COVERED,INITIAL,LABEL,METHODS,OPINION,PROSTATIC,UNTIL
006,009,068,100,415,AGR2,BILIARY,HOWEVER,MEIER,THUS,WHILE
109,BACKGROUND,CURRENT,FACS,HIR7,LABEL,PSMA,RESULTS,SEVEN
169,2014,BONE,COPYRIGHT,FGF,FGFR,FGFR1,FGFRS,PCA,SCIENCE,THESE
169,2014,COPYRIGHT,INC,PUBLISHED,SOCIETY
FFPE,IMAGING,IMS,MALDI,OTHER
001,002,004,006,AMONG,BACKGROUND,DETECTION,FOUNDATION,LABEL,METHODS,PSA,RESULTS,SIMILARLY,THESE
BLM,DU145,DYE,THESE,WHILE
946,BPH,BPHS,CONVERSION,GLEASON,HIGHEST,HSD,HSDS,MOST,PSA,SAMPLES,TLC,USING
169,2000S,2014,DESPITE,DIFFUSION,DWI,FOLLOWING,MRI,PHYSICS,RSI,USING
1181,169,2012,2013,2014,2126,2483,7202,APRIL,ASIA,AUTHORS,DIAGNOSIS,EVEN,HOWEVER,LTD,MARCH,PROCEDURE,PTY,PUBLISHING,SCIENCE,WILEY
169,2014,239,ADT,CAP,CRPC,ENDOCRINE,HOWEVER,JAPAN,RELATED,SOCIETY,ZOL
570,726,844,952,BACKGROUND,BIOGRID,CHIP,CYTOSCAPE,LABEL,METHODS,PPI,PROTEIN,RESULTS,SEQ,SMT3,SUMO2,THERE,UBA52,YWHAQ
BME,WALES
FLNA,RAC1,UPON

109,150,177,252,8201,ADT,BOLOGNA,CHANGES,CHOLINE,CONCLUSION,DISTANT,FURTHER,GLEASON,LABEL,METHODS,OBJECTIVE,PET,PSA,PURPOSE,RESULTS,TNM
160,BEAMNRC,CARLO,DOSXYZNRC,EPID,FRAME,IMRT,MLC,MONTE,SYNERGY,THREE
007,400,BACKGROUND,CONCLUSION,DKK,HIGH,HOWEVER,LABEL,METHODS,RESULTS,WNT
016,035,037,1000,1500,169,2000,2014,ADC,AIM,COLLEGE,CONCLUSION,COPYRIGHT,DWI,FORTY,LABEL,LTD,MATERIALS,METHODS,MRI,OBJECTIVE,PUBLISHED,RESULTS,ROYAL,SNR
2012,CRPC,DESIGNING,FDA,HCC,HEPATOCYTE,MEDULLARY,MET,MTC,RCC,SCLC,THYROID,VEGF,XL184
169,2014,BAX,BCL2,BID,CHINESE,COPYRIGHT,DU145,FAS,FLIPL,INC,INHIBITION,JNK1,JUN,MMP,NH2,PC3,PWR,ROS,SER70,SMAC,STEPHANIA
177,8201,945,956,AAG,COMPOUNDS,DHT,EXPRESSION,GFP,GIVEN,HIV,IC50S,LIBRARY,LOPAC,LXXLL,NRS,PPI,PPIB,PPIS,REV,RFP,SMALL,TIF2
BACKGROUND,HOWEVER,LABEL,LRIG,LRIG1,LRIG2,LRIG3,METHODS,OPTIMAL,RESULTS,SEVERAL
169,2005,2012,2015,COPYRIGHT,COX,EDUCATION,INC,JUNE,LABEL,MATERIALS,MEIER,METHODS,MOST,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SALVAGE,SIX,UROLOGICAL
COLLEGE,LABEL,METHODS,NUMERICAL,OBJECTIVE,PURPOSE,RADIOLOGY,RESULTS
1976,2009,2013,4362,AMONG,ANDROLOGY,COLLEGE,INCREASED,LABORATORY,NHS,SPERM,THESE,TRUNCATING,TRUST
BASED,BAYES,CART,HOWEVER,NIM
125,AFTER,AMS,ART,GIVEN,GLEASON,IMAGING,PATHOLOGIC
2008,2012,BETWEEN,CASES,COLOSTOMY,SIX,THERE,WALLACE
169,2014,COPYRIGHT,DCE,DYNAMIC,HOWEVER,LTD,MRI,THEREFORE
100,10878,150,AMONG,BACKGROUND,CAB,CONCLUSION,CRPC,ITT,LABEL,METHODS,PARTIAL,PSA,RESULTS,SECONDARY,SIXTY
100,177,ADVERSE,AFTER,AMICO,BACKGROUND,FOCAL,FURTHER,IQR,IRE,LABEL,METHODS,MPMRI,MRI,NCI,NINE,OVERALL,PSA,RESULTS
169,2014,BACKGROUND,BECAUSE,CONCLUSION,GUIDELINES,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE
169,2014,COPYRIGHT,GIVEN,HOWEVER,MEDLINE,PROGNOSTIC,PSA,PUBLISHED,SAS
001,003,169,195,1ST,2014,8805,945,BACKGROUND,CASES,COLORECTAL,GLEASON,III,INDIVIDUAL,LABEL,LUNG,METHODS,OR4TH,ORS,OVARIAN,RESULTS,RISK,SCREENING,TRIAL
100,169,2014,956,BACKGROUND,CHINA,COPYRIGHT,CUMULATIVE,IRELAND,KOREA,LABEL,LTD,MATERIALS,METHODS,RELEVANCE,RESULTS,SCE,SCHISANDRA
169,177,2014,774,967,ANCTS,ANOVA,BLADDER,BPH,CEP55,CHI,COPYRIGHT,FFPE,GMBH,IHC,MIBC,NMIBC,PCR,STUDENT,TCC,TCCS,UNTIL
169,2014,47D,AROMATASE,COPYRIGHT,HOWEVER,LTD,PSA,THESE,VARIANT
150,169,2015,AFTER,BACKGROUND,CONCLUSION,COPYRIGHT,FIFTEEN,GADD45A,GRADE,INC,LABEL,METASTATIC,METHODS,RESULTS,SIX
0001,003,100,1821,2014,4801,8201,8805,CIS,EBL,FURTHER,LABEL,LIBRARY,LOS,MARCH,MATERIALS,MEDLINE,METHODS,OBJECTIVE,OPERATING,ORS,OUTCOME,PSM,PSMS,RARP,RESULTS,SCHOLAR,THERE,WMD,WMDS
001,17Q12,2012,535,726,946,AFRICAN,AFTER,AMERICANS,CAUCASIANS,CIS,HNF1,ORA,ORAA,ORAG,ORS,POR
ALTERATION,BAK,BAX,BCL,BID,PCR,THERE,THOSE,TOMM,TOMS,VDAC,VDAC1,VDAC2,VDAC3,VDACS
001,285,BPH,COX,FIVE,III,LABEL,LOG,METHODS,OBJECTIVE,PCA,RESULTS
CONSISTENT,FASN,FATTY,INHIBITION
169,2014,AUTHORS,COPYRIGHT,INC,MMP,MT1,PUBLISHED,TKS4,TKS5
APOPTOSIS,PROGRAMMED,TRAIL
169,2014,582,AILNCAP,BACKGROUND,EFNB2,FUNCTIONAL,INC,LABEL,LNCAP,METHODS,MICRORNAS,MIR,PCR,RESULTS,UTR,WILEY
169,2014,916,936,COMPOUNDS,COPYRIGHT,FURTHER,LTD,ROS,SEM,STOBBEL
001,002,100,124,169,1RECTUM,2009,2012,2014,231,233,46GY,8482,CONCLUSION,COPYRIGHT,CTV,D100,D1URETHRA,D90,DHI,LABEL,MAY,METHODS,NUCLETRON,OBJECTIVE,PLATO,PUBLISHED,PURPOSE,RESULTS,SAS,SFRO,SOCI,STOCKHOLM,V100,V150,V200
169,2014,A549,COPYRIGHT,DU145,HELA,LTD,MCF,PUBLISHED,UGI
169,2012,2013,2014,362,457,636,800,8201,AMONG,AUC,BACKGROUND,BECKMAN,CHINA,CHINESE,COULTER,CURVE,DCA,DXI,GLEASON,HOWEVER,INC,LABEL,METHODS,PCA,PHI,PSA,RESULTS,SCORE,SERUM,SIMILAR,WILEY
181,401,BASED,CD45,CTC,CTCS,GFP,HOWEVER,OBP,SEVEN,THEREFORE,WBCS
145,160,8209,DMAG,EGFR,HER2,HOWEVER,HSP90,LNCAP,PC3,PCA,RTK,TREATMENT,TREATMENTS
0001,013,073,089,107,169,2014,239,8201,8805,AFTER,AMONG,BACKGROUND,COX,CROSS,INC,LABEL,METHODS,PFS,PSA,RESULTS,THESE,TTPP,WILEY
001,169,2014,8201,BACKGROUND,BIOMARKERS,CHD1,ERG,FISH,INC,LABEL,METHODS,OVERALL,RESULTS,THESE,TMPRSS2,USING,WILD,WILEY
169,2014,239,8201,8805,967,BACKGROUND,CONCLUSION,INC,LABEL,METHODS,NOTABLY,PFS,PRIOR,PSA,QUESTIONS,RESULTS,THESE,TREATMENT,WILEY
ANNEXIN,BCL,CAP,DATA,HOWEVER,LNCAP,PARP,TREATMENT
169,2014,8201,BACKGROUND,CHIP,CHROMATIN,INC,LABEL,LNCAP,METHODS,NANOG,NANOGP8,RESULTS,THUS,WILEY
169,2014,APART,COPYRIGHT,GMBH,H2O2
169,2014,ABCG2,BACKGROUND,INC,KLF4,LABEL,METHODS,OCT4,PCA,PCR,RECURRENT,RESULTS,SOX2,STUDIES,WILEY
114,169,185,2014,299,8201,AFRICAN,BACKGROUND,CARIBBEANS,CAUCASIAN,CAUCASIANS,CLC,CRPC,ERG,INC,LABEL,METHODS,PCA,PIN,RESULTS,TMPRSS2,WILEY
000,100,106,110,1986,1990,1996,2006,2010,8201,AGE,ALGERIA,APC,APCS,ARAB,ASR,BACKGROUND,BETWEEN,INCIDENCE,INSTITUTE,LABEL,METHODS,RESULTS,SETIF,STATISTICS
169,1990S,2014,CARE,COPYRIGHT,HOWEVER,PCBE,PUBLISHED,SAS
169,2014,231,233,COPYRIGHT,EACH,LOCAL,MRI,PET,PUBLISHED,RADICAL,SALVAGE,SAS,SFRO,SOCI
0001,001,002,005,015,016,017,019,026,027,028,030,031,033,034,037,169,2014,240,AUGMENTED,BCR,BFS,COPYRIGHT,EXPRESSION,GLEASON,INC,NRF,OHDG,SAMPLES,THESE
125,160,166,169,172,2014,COIN,COPYRIGHT,D90,LABEL,LTD,MEANS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,REGARDING,RESULTS,V100,V150,V200,V90
160,DR5,HOWEVER,PCA,PIN,PSA,YANG,YIN,YY1
145,ADC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RCM,RESULTS,RIBE,USING
106,10878,120,126,169,2002,2012,2014,271,347,353,377,ADT,BRFS,CONCLUSION,COPYRIGHT,CSS,EBRT,HDR,HDRB,IRELAND,JULY,LABEL,LATE,LTD,MATERIALS,METHODS,MOST,OBJECTIVE,OVERALL,PSA,PURPOSE,RESULTS,T2C,THESE
169,2014,946,ADP,EMT,FUNCTIONAL,IMPAIRING,PARP,POLY,PRESS,PUBLISHED,SMADS,TGF,TRAMP,UNIVERSITY,ZEB
001,169,2014,COPYRIGHT,EDX,ELISA,FOURIER,FTIR,H2O2,ICP,KLK3,LOD,PSA,PTNP,TEM,UNDER
967,993,AUC,BOUTROS,SEQCONTROL,THESE,USING
160,HOWEVER,METASTATIC,NCCN,NETWORK,USING
00001,822,8805,CDRT,CONCLUSION,CRT,GRADE,HDRT,HOWEVER,INDEX,LABEL,LIBRARY,MANAGER,MEDLINE,METHODS,OBJECTIVE,OVID,PCSS,PURPOSE,RESULTS,SCIENCE,SIX,STATA,THUS,WEB
ALK,CONSISTENT,CRIZOTINIB,IGF,IRS,SIMILAR,TKI
2000S,ANNEXIN,CD31,CD56,DESPITE,ORAI1,PCA,S100A11,SOCE,THUS,TRANSIENT,TRPC1,TRPV6,XENOGRAFTS
169,185,2014,A549,CCL,COPYRIGHT,DU145,HELA,HTB,LTD,MCF7
001,008,237,409,625,8201,ANALOGOUS,CAIX,EXPRESSION,FASN,FIFTY,FURTHER,PCR,VEGF
HOWEVER,THUS
169,2014,COPYRIGHT,CTC,CTCS,INC,THUS,USING
UROLOGISTS
2009,2012,208,234,259,579,8805,ADVERSE,BACKGROUND,BMI,BODY,CHI,CONCLUSION,CPT,CURRENT,FINAL,LABEL,M22,MATERIALS,METHODS,RALP,REASONS,RESULTS,ROBOTIC
100,ADVANCE,AUR,DESPITE,FINALLY,FURTHER,MRI,WHILE
00001,100,2008,2011,ADVANCE,AMS,BACKGROUND,CIC,LABEL,MATERIALS,METHODS,PPD,PPI,RESULTS,SIXTEEN,TOV,WHILE
9FY,CAP,ELISA,ERG,FURTHER,INCREASING,L57,MAB,P23,P27,P30,Q53,QQDW,R50,THESE,TMPRSS2,W56
121,18F,2014,444,47925,AIM,FDG,LABEL,METHODS,OBJECTIVE,OVERALL,PERIPHERIC,PET,PIU,PIUS,RESULTS,SIX,SUV,THERE,THEREFORE
ALTERED,HOWEVER,III,LOX,MMP,NOTICEABLY,VEGF
ALSO,EMT,FAK,HOWEVER,HT1B,HT1D,MMP,PACA,PANCREATIC,SNAIL,SRC,THUS,ZEB1
005,013,163,1985,2009,2014,303,8804,8805,BASEL,GLEASON,LABEL,METHODS,OBJECTIVE,PSM,RESULTS
002,005,007,548,945,946,BACKGROUND,BIOMARKERS,COLORECTAL,LABEL,LUNG,METHODS,OVARIAN,PRESENTLY,RESULTS,THESE
0079,0198,141,CAST,CELL,CONCLUSION,GLEASON,ITGA5,KNOCKDOWN,LABEL,LNCAP,METHODS,OBJECTIVE,OPHN1,PC3,PCA,RESULTS,THESE
CELL,DU145,KNOCKDOWN,NIN,NOB1
12Q21,169,18P11,2014,20Q12,7Q31,BRAF,COPYRIGHT,GENOMIC,GMBH,PROTEIN,PTPRM,PTPRQ,PTPRT,PTPS,THEIR,THESE,THUS
100,169,2014,COPYRIGHT,GLEASON,INC,LABEL,MEAN,METHODS,MTT,OBJECTIVE,OBJECTIVES,PSA,RESULTS
169,2014,264,330,350,540,657,AFTER,CAUCASIAN,CISD1,CLIC5,COPYRIGHT,CYP26B1,FIRST,GWAS,GWASS,HOWEVER,LEU,MET,OVERALL,PCA,PSA,SER,SNPS,TBX1,THIRD,THR
2008,2010,2011,2014,439,8197,AFTER,BMJ,GROUP,LTD,MARCH,MRI,OCTOBER,PSA,PUBLISHING,RETROGRADE
DESPITE,MALIGNANT,METFORMIN,THEREFORE
169,2002,2007,2014,AFTER,AUTHORS,BETWEEN,BJU,BPFS,COX,CSS,FURTHER,GLEASON,JOHN,LABEL,LTD,MEIER,METHODS,OBJECTIVE,PSA,PUBLISHED,RESULTS,SONS,STAGE,T3A,T3B,THERE,WILEY
169,2014,IMAGING,INC,MOLECULAR,NUCLEAR,SOCIETY
169,2005,2011,2014,AVERAGE,CONCLUSION,COPYRIGHT,EIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,RESULTS,TYPES
147,169,177,2014,205,352,472,8804,8805,AMONG,CONCLUSION,COPYRIGHT,HOLEP,INC,LABEL,METHODS,NPI,OBJECTIVE,RESULTS
001,002,005,029,114,169,2014,206,744,AMICO,ASSESSMENT,CAPRA,CONCLUSION,COPYRIGHT,COX,EACH,INC,LABEL,METHODS,OBJECTIVE,PHOENIX,RESULTS,RISK
027,169,1982,2012,2014,ADULT,COMMITTEE,CONCLUSION,COPYRIGHT,COX,CSS,DIAGNOSIS,INC,JOINT,LABEL,MATERIALS,METHODS,MOST,OBJECTIVE,OVERALL,RESULTS,SURGERY,UNIVARIATE
169,2014,BECAUSE,CLINICALLY,DAB2,DRUGS,DUAL,DVL,DVL3,EGFR,ERK,ERKS,GRB2,IGF,IGFI,IGFIR,MEK,RAS,SHC,SOS,WNT
169,1990,2012,2014,239,286,4453,4734,AUC,AUTHORS,BJU,CONCLUSION,GODOY,JOHN,LABEL,LNI,LNS,LTD,LUTS,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,SONS,THESE,WILEY
8201,8482,ABAS,ANY,CONCLUSION,CRAWLEY,DICE,DSC,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,OUTLINING,RESULTS,THERE
169,2014,945,954,AKT,COPYRIGHT,LNCAP,MMP,PI3K,THEREFORE,THESE,TIANEPTINE,TNF,TSS,USING
1000,1500,169,2000,2014,800,ACTA,ADC,BACKGROUND,CONCLUSION,DIFFUSION,DWI,FIVE,FORTY,FOUNDATION,HOWEVER,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,TESLA,THEREFORE,WHEREAS
AMONG,CONCLUSION,FIRST,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,USING
0002,155,AGA,AUSTRALIAN,BACKGROUND,CELL,FACS,IGG,IGM,LABEL,METHODS,MONOCLONAL,RESULTS
BASED,CHANGES,ULTRASOUND
223,AMONG,CRPC,DISEASE,III,LABEL,OBJECTIVE,OSTEOCLAST,PHASE,PURPOSE,RESULTS,SUMMARY,THESE
169,2014,22RV1,954,C42,CELL,CONVERSELY,LABEL,LAPC4,LNCAP,LOSS,METHODS,OBJECTIVE,PLK3,PSA,PURPOSE,RESULTS
001,017,118,169,1710,2004,2007,2014,548,7371,9081,AFTER,AHR,BACKGROUND,BETWEEN,COPYRIGHT,DISCUSSION,DRE,GLEASON,INCREASING,LABEL,LTD,METHODS,PCSM,PSA,RESULTS,T1C
1136,177,2012,8201,BACKGROUND,DATA,GHANA,JANUARY,KORLE,LABEL,RESULTS,SAHARAN,SUB,THEIR
169,1996,2004,2014,AMONG,BACKGROUND,BRAZILIAN,DISCUSSION,HODGKIN,INC,LABEL,METHODS,MOR,MORS,RESULTS,WILEY
169,2014,466,806,GLEASON,INC,NOS3,ORAB,ORCC,PCA,SEVERAL,THESE,TNM,WILEY
001,002,2011,570,679,8805,CYSTECTOMY,DATA,INDEX,LABEL,MATERIALS,METHODS,OBJECTIVE,PROMETRICS,PURPOSE,RADICAL,RESULTS,SOCIETY,THERE
100,1643,169,183,1999,2001,2009,2014,2016,228,2417,247,2664,2896,337,429,444,538,545,553,7414,8566,956,966,ASSESSMENT,BACKGROUND,BETWEEN,CONSENTING,CONTROLLED,COPYRIGHT,FUNDING,GLEASON,INSTITUTE,JAN,LABEL,LANE,LTD,METHODS,OCT,OPEN,PROGRAMME,PROTECT,PSA,PUBLISHED,RANDOMISED,RESULTS,T1C,TECHNOLOGY,TREATMENT,TRIAL
2008,2012,400,BACKGROUND,DISCUSSION,DUE,EVALUATION,JANUARY,JUNE,LABEL,MATERIALS,METHODS,OPEN,RESULTS,RPE
BYSH,CONCLUSION,FURTHER,HOWEVER,HRPC,LABEL,LIVER,METHODS,MOST,OBJECTIVE,PSA,RESULTS,TEN
136,143,177,236,383,400,800,956,BACKGROUND,CELL,CELLS,ELISA,HUVEC,IC50,LABEL,METHODS,MTT,RESULTS,TDT,THEREFORE,TUNEL,UMBILICAL,VEIN
ALTOGETHER,AUD8,AUD9,BACKGROUND,CONCLUSION,DU145,III,LABEL,PC3,RESULTS
116,181,183,295,435,FIVE,H358M,HCT,IC50,MDAMB,NCI,OVCAR,PBMC,PC3
001,177,215,8201,ADC,BASED,CONCLUSION,DWI,IMRT,KNOWLEDGE,LABEL,METHODS,MRI,OBJECTIVE,PCS,RESULTS,ROC
947,FLOW,PPAR,THESE
1000,169,2014,ATLAS,AUC,BACKGROUND,CALLING,CONSORTIUM,LABEL,METHODS,MOTIVATION,PRESS,PUBLISHED,RESULTS,ROC,TCGA,UNIVERSITY,USING,VARIANT,VCF
HODGKIN,INTERVIEWS,LABEL,METHODS,OBJECTIVE,PROVIDERS,PURPOSE,RESULTS,STRATEGIES,THERE
BPNN,FNN,NETWORK,PSO
HEALTHCARE,HOWEVER,ITERATIVE,VISIONARY,VITA
100
005,682,954,AMONG,BACKGROUND,BECAUSE,FINALLY,HALF,HOWEVER,LABEL,METHODS,MUSIC,OBJECTIVE,OUTCOME,OVERALL,PATIENT,PSA,PUBLISHED,RESULTS,SETTING,SUMMARY,SURGERY,THERE,UROLOGICAL
000,169,2014,252,946,AMH,BECKMAN,COLORECTAL,COULTER,CURRENT,DESPITE,DIFFERENT,ELISA,GEN,LUNG,MEANWHILE,ORQ4,ORS,OVARIAN,PLCO,PSA,SCREENING,TGF,THUS,TRIAL
8211
AMONG,BACKGROUND,CASE,CONCLUSION,DESPITE,GIVEN,HODGKIN,LABEL,METHODS,THERE
168,AFTER,CALIFORNIA,FCS,GMM,IL1R2,KNOWLEDGE,LABEL,MAIN,METHODS,NFKB2,NURSING,OBJECTIVE,OBJECTIVES,PURPOSE,QOL,RESULTS,SETTING,SNPS,VARIABLES
CALIFORNIA,DATA,FATHERS,HOPEFUL,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OPEN,PCA,PURPOSE,RESULTS,SETTING,SONS,THEREFORE
DOX,FREE,H9C2,LABEL,METHODS,OBJECTIVE,PAESE,PURPOSE,RESULTS,ROS,SSL,TREATMENT
009,100,172,1995,2011,ANY,BCR,COX,FIFTY,LABEL,LOG,MANN,MEIER,METHODS,MRI,OBJECTIVE,PSA,PURPOSE,RANK,RESULTS,SIXTY,UNIVARIATE,WHITNEY
141,520,670,RNAS
169,2014,COPYRIGHT,FINALLY,GST,HOWEVER,INC,LNCAP,MEIS1,NCOR,PSA,R1881,SMRT,TAKEN
169,2008,2011,2015,544,547,AMONG,COPYRIGHT,DATA,EDUCATION,FACTORS,GLEASON,INC,LABEL,LYMPH,MATERIALS,METHODS,OBJECTIVE,OPEN,PUBLISHED,PURPOSE,RESULTS,SECONDARY,UROLOGICAL
PSA,RESULTS,THERE
121,126,8201,BACKGROUND,BIG,CELLS,CONCLUSION,CONVERSION,ECE1,ENDOTHELIN,ET1,LABEL,METHODS,MICRO,RESULTS,SOST,TMOB
008,149,945,CIS,COLORECTAL,CONCLUSION,CRP,INC,INCREASED,LABEL,LIMITED,LUNG,METHODS,OBJECTIVE,ODDS,ORS,OVARIAN,PRE,PRO,PUBLISHED,RESULTS,SCREENING,THESE,TNF,TRIAL
AFTER,AH2,DBCO,IDEPT,PCA,PEG4,PSMA,TG97,THEREFORE
145,177,956,BALB,HISTOLOGY,IGF1R,INSULIN,LNCAP,MCF,NOTA,PET,PROMINENT
100,169,2014,8201,CELL,GFP,METATARSAL,PC3,SCC4,SCID,UICC
169,2014,COPYRIGHT,KNOWLEDGE,LTD,SEVERAL
169,2014,COPYRIGHT,JOHN,LTD,OATPS,SLC,SONS,THEREFORE,VARIOUS,WILEY
127,145,150,169,2006,2009,2014,AMONG,ASIA,BASED,CBM,CCTS,CHINA,CHINESE,CNKI,COMMISSION,DATA,HELICAL,HTAS,LABEL,LIBRARY,LTD,METHODS,OBJECTIVE,OBJECTIVES,PTY,PUBLISHING,RESULTS,SICHUAN,UNIVERSITY,VIP,WANFANG,WEST,WILEY
1RA,CD11B,CXC,CXCR2,IL1RA,PTEN,STRIKINGLY,TAKEN,TARGETING,WHETHER
169,2014,476,8201,ADJUSTING,CIS,COLORECTAL,DBP,LUNG,NEITHER,ORS,OVARIAN,SCREENING,TRIAL,UICC
0001,001,005,1148,1987,2009,333,400,415,427,8804,8805,AMICO,BACKGROUND,COX,GLEASON,HOWEVER,IQR,LABEL,MEIER,METHODS,NHT,RESULTS
001,002,213,BACKGROUND,COX,CRPC,GLEASON,HIGH,LABEL,MEIER,METHODS,PCA,PSA,RESULTS,THEREFORE,YWHAZ
000,100,169,2000,2004,2008,2010,2014,AGE,APC,AUTHORS,BACKGROUND,BRAIN,CENTRAL,CNST,HODGKIN,INC,LABEL,METHODS,RESULTS,SOCIETY,STATISTICS,TIME,WILEY
169,2003,2013,2014,ADT,ASIA,CAP,FURTHER,HOWEVER,LOCAL,LTD,MOST,PTY,PUBLISHING,THERE,WILEY
169,2014,945,CASTRATION,COPYRIGHT,CRPC,CURRENT,FGF,FGF23,FGFR,FGFR1,FGFRI,LTD,TIO,WHILE
120,169,2014,BIOLOGICAL,COMPARE,COPYRIGHT,LTD,SAR
BACKGROUND,ETS,FINALLY,GENOMIC,LABEL,REMARKABLY,RESULTS,TEN
103,169,2014,8201,8804,ADT,AFTER,BACKGROUND,COX,LABEL,MEIER,METHODS,PFS,RESULTS,SOCIETY,WHETHER
100,1472,169,2014,8201,ACUTE,AUSTRALIAN,COLLEGE,CYBERKNIFE,DOSE,LATE,ROYAL,SBRT,TEN,THERE,THREE,ZEALAND
100,169,2014,270,8805,948,952,CBCT,COM,COMAP,COPYRIGHT,D95,DOSE,INC,LAM,MEDICAL,PUBLISHED,V100,WEAK
239,BEER,CONTINUED,CRPC,ENGLAND,JOURNAL
169,2014,258,286,ADT,BACKGROUND,CRPC,EXPRESSION,FDA,INC,LABEL,METHODS,PCR,RESULTS,SERUM,THEREFORE,THESE,WILEY
0001,001,150,177,215,297,380,8201,ADC,ARTEFACTS,DISTORTION,DWI,EPI,FOV,FURTHER,ICCS,KEY,LABEL,METHODS,MRI,OBJECTIVE,OBJECTIVES,PTX,RESULTS
169,17TH,2014,DUE,INC,PECHLIN,VON,WILEY
001,169,183,2014,300,AMERICA,ASIA,CARIBBEAN,EAST,GIVEN,HPT,JOHN,LABEL,LATIN,LTD,MEMBERS,METHODS,NINE,OBJECTIVE,OCEANIA,RESULTS,SONS,THERE,THESE,WEB,WILEY
2007,2010,257,960,BACKGROUND,GPS,JANUARY,LABEL,LARGE,MEN,METHODS,MIDLAND,NETWORK,PSA,RESULTS,SCREENING,THERE,ZEALAND
895,ALZHEIMER,AUC,BASED,THEN
169,2014,BASED,COPYRIGHT,LTD,THERE
001,169,1992,2005,2014,389,856,8805,BLACK,CONCLUSION,COPYRIGHT,END,INC,LABEL,MEN,METHODS,MHI,OBJECTIVE,OLDER,RESULTS
AKT,DESPITE,FUNCTIONAL,PCA,PTEN,RNAS
141,2006,2010,275,642,ASIA,AUSTRALIA,AUSTRALIAN,FOBT,MOST,OVERALL,POISSON,PSA,SELF,SOUTH,WALES
KLK,KLK2,KLK3,KLK4,LNCAP,USING
006,018,030,034,050,378,COX,FINALLY,GLEASON,KLK2,KLK4,MEIER,PCA,PSA,REGARDING,THEREAFTER,TOTAL
378,422A,AKT3,FINALLY,GLEASON,GRB2,KLK14,KLK15,KLK2,KLK3,KLK4,MICRORNAS
ACCORDING,ASN,GOLGI,KLK,KLK3,KLKS,MOST,NOVEL,POTENTIAL,PSA,REMARKABLY,SEQUONS,SER,THESE,THR,XAA
KLK,KLK3,KLKS,PAR,PSA
231,947,COMPARISON,DEA,HNO,HSP70,IL24,INC,IPA,MDA,NOS2,PUBLISHED,THESE
144,169,2014,BGS,COPYRIGHT,EVEN,FORTY,GLEASON,INC,MOST,MVPC,OVERALL
FIFTH,FIRST,GERIATRIC,JAPAN,MOST,SIXTH,THIRD
100,125,169,2014,COPYRIGHT,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PRE,PURPOSE,REGARDLESS,RESULTS,SOCIETY,USING,V100,V150
125,169,1998,2009,2011,2014,2709,8804,8805,ACTUARIAL,CONCLUSION,COPYRIGHT,COX,CROWN,D90,GROUP,INC,IPSS,LABEL,MATERIALS,MEIER,METHODS,NETWORK,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,RADIATION,RESULTS,RTOG,SCORE,SYMPTOM,THERAPY,TIME
169,200,2014,4CM,CARLO,COPYRIGHT,EACH,LTD,MONTE
ALONG,BACKGROUND,CONCLUSION,FUNCTIONAL,LABEL,RESULTS,SEARCHING,THUS,USING
028,169,2007,2014,2015,COPYRIGHT,CORES,EDUCATION,GLEASON,HOWEVER,INC,IQR,LABEL,MARCH,MATERIALS,MEN,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
169,174,2015,AFTER,COPYRIGHT,EDUCATION,FINALLY,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,REAL,RESULTS,THEN,UROLOGICAL,VINCI
0001,015,111,169,2010,2013,2015,685,821,839,AUC,COPYRIGHT,EDUCATION,GLEASON,INC,JANUARY,JULY,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,ROC,UROLOGICAL
169,2009,2013,2015,COPYRIGHT,EDUCATION,INC,IQR,LABEL,MATERIALS,METHODS,OBJECTIVE,PRIMARY,PUBLISHED,PURPOSE,RESULTS,SINCE,THREE,UROLOGICAL
0116,2006,2009,45GY,CTCAE,DAILY,FUFA,GRADE,INT,LATE,MAGIC,MAYO,MEANWHILE,MEIER
003,006,007,169,2014,268,8805,945,946,947,BACKGROUND,CLUE,CYTOKINES,GLEASON,IFN,IL1,IL10,IL12P70,IL6,IL8,LABEL,MEN,METHODS,ORS,OTHER,RESULTS,TH1,THUS,TNF,WHETHER
1993,2001,2014,562,905,ALCOHOL,BLOOMBERG,COLORECTAL,COX,GOVERNMENT,HOPKINS,JOHNS,LUNG,OVARIAN,PRESS,PUBLISHED,SCREENING,TRIAL,UNIVERSITY,WHETHER
169,2014,AKT,COPYRIGHT,EGF,EGFR,EMT,EPIDERMAL,EPITHELIAL,ERK,ERK1,INC,PI3K,QUERCETIN,SLUG,SNAIL,THUS,TWIST,WESTERN
2002,2012,AAA,BACKGROUND,CAS,DISCUSSION,ENGLISH,FORCE,LABEL,METHODS,OVERALL,PREVENTIVE,RESULTS,SIXTY,SYSTEMATIC,TASK
001,13C,169,17OHP,2014,2AT6,6MONTHS,945,COPYRIGHT,CRPC,CYP17A1,INC,OHP,PC3,PROG
169,1985,2005,2014,818,902,BACKGROUND,CRS,CRSS,DATA,FIVE,HODGKIN,ITALIAN,LABEL,MEDICAL,METHODS,OVERALL,PERSONS,PRESS,PUBLISHED,RESULTS,SOCIETY,THEREFORE,UNIVERSITY
169,2014,947,AKT,CHK1,CONSISTENT,COPYRIGHT,DESPITE,DU145,ETOPOSIDE,H2AX,INC,PCSC,PCSCS
169,2014,COPYRIGHT,INC,THERE
145,169,2014,3Q13,8Q24,CD96,CHROMOSOME,CXORF36,E2F1,FURTHER,GSDMC,HOWEVER,LNCAP,MYC,OTHER,PRESS,PUBLISHED,PVT1,RRP12,SMIN3,TCF3,UNIVERSITY,USP14,WNT
169,2014,AMP,BOTH,HOWEVER,LABEL,MAPK,NVP,PDE4D,SHH,THESE,UNLABELLED
169,181,2014,8320,8325,BACKGROUND,CONCLUSION,COPYRIGHT,COR,DIOSCOREA,HELA,HEPG2,IC50,IRELAND,L23,LABEL,LTD,MATERIALS,MCF,METHODS,MRC,PC3,RELEVANCE,RESULTS,SRB,THAI,THUS,TTM
169,2014,945,956,BIOACTIVE,COPYRIGHT,DUE,IC50,LNCAP,LTD,PSEE
00714,169,170,2014,319,BONFERRONI,CONCLUSION,DESPITE,EQUATIONS,ESTIMATING,FEV1,FOLLOWING,FURTHER,FVC,GEN,HEART,LABEL,MEAN,METHODS,OBJECTIVE,PRE,PURPOSE,RESULTS,THEREFORE,VO2
MAXIMUM,SUB,WMAXC
CURRENTLY,HENCE,HOWEVER,PCA,THEREFORE,ULTIMATELY
100,1000,300,700,967,975,979,981,989,990,993,994,ADC,BLAND,CONCLUSION,CVS,DWI,FORTY,ICC,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,STUDENT
10TH,2010,2012,25TH,ADC,APRIL,BETWEEN,CONCLUSION,DWI,ECE,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,ROIS,WHOLE
ANDROGENS,ATP,CONTINUED,HOWEVER,PCA
002,035,040,054,169,2005,2011,2014,308,831,8804,8805,AMONG,BACKGROUND,BMI,BOTH,GLEASON,LABEL,METHODS,PPAT,RESULTS,THESE,VFA
116,169,2014,77301,HCT,LNCAP,MDM2,PUMA,REMARKABLY,RS4,SAR405838,SJSA
169,2014,AEG,MTDH,PC3,PET,THROUGH
945,946,HIGH,PDGF,PDGFR
000,BASED,BRCA,PRCA,SNPS
000,100,1996,1997,2002,2006,2007,AIM,AUSTRALIA,AUSTRALIAN,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,SIMILAR,SUMMARISED,UNTIL,WORLD,ZEALAND,ZEALANDERS
000,100,183,350,441,8202,8482,GEORG,GERMANY,MRI,RFA,SEVERAL,STAR,STUTTGART,YORK
0001,007,008,BACKGROUND,CPG,CRPC,GSTP1,III,LABEL,METHODS,PCR,PCS,PHASE,PSA,RESULTS
ADT,INCREASING,LABEL,MOST,OBJECTIVE,PURPOSE,RESULTS,SUMMARY
001,102,120,123,169,2014,AMONG,ANGELES,CALIFORNIA,FORM,INDEX,ITEM,LABEL,LOS,METHODS,OBJECTIVE,OBJECTIVES,RESPONDERS,RESULTS,SCORE,SHORT,SYMPTOM,UNIVERSITY,UROLOGICAL
153,177,219,317,CONCLUSION,DOSIMETRIC,FOUR,GIVEN,INITIAL,LABEL,LIVER,METHODS,MIRD,OBJECTIVE,OPTIMAL,PET,PURPOSE,RESULTS,TEN,WHOLE
HORMONE,HOWEVER
115,3GAL,3GALNAC,3GALT,3GLCNAC,4FUCT,4GLCNAC,945,946,A78,GAL,HER2,HIGH,III,IIIGLYCANS,OVERALL,SIA,TACA,THESE,TYPE
DPS,MLC,VMAT,VOLUMETRIC
062,160,174,238,284,450,518,690,798,8201,908,ADVERSE,AFTER,BACKGROUND,CYBERKNIFE,LABEL,METHODS,PSA,RESULTS,THERE,USING,V36GY
001,002,169,1995,2009,2014,7616,8804,8805,COMPETING,EARLY,END,GLEASON,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,UROLOGICAL
169,2014,215,ANNEXIN,CELL,HEPG2,HL60,JOHN,MTT,PC3,SONS,WILEY
1999,2001,2002,2006,2008,264,665,929,ANESTHESIA,BACKGROUND,BCR,COX,GLEASON,KETTERING,LABEL,METHODS,PSA,RESULTS,SLOAN,THESE
BESIDES,DIAGNOSIS,THEIR
0009,002,004,006,009,107,2003,2006,7164,726,ACTIGRAPH,AFTER,BOTH,CONCLUSION,DATA,LABEL,METHODS,MVPA,NUTRITION,OBJECTIVE,PSA,PURPOSE,RESULTS,SOBEL,WBC
223,BASED,CRPC,THESE
008,18F,BACKGROUND,BLINDED,CONCLUSION,CRPC,FCH,IMAGING,LABEL,METHODS,MONITORING,MRI,PET,PSA,RESULTS,SERUM,SEVERAL,TIS
169,2014,ANNEXIN,ANXA2,BMSC,FINALLY,HSC,HSCS,LABEL,SCID,SDF,THUS,UNLABELLED
169,2014,AIM,COPYRIGHT,COX,EP1,INC,INCREASES,KEY,LABEL,MAIN,METHODS,OBJECTIVE,PGE2,RESULTS
1041,1627,828,945,946,947,954,ATP,BESIDES,CHS,HEPATITIS,HODGKIN,IKK,IMD,NEMO,THROUGH
160,223,BASED,CTLA,CURRENT,CURRENTLY,SEVERAL
2012,2014,690,BASEL,CONCLUSION,LABEL,LIBRARY,METHODS,OBJECTIVE,RESULTS,SIR,THERE
169,2014,22RV1,945,954,ABCG2,AKT,BASEL,CONCLUSION,DU145,DUE,KNOCKDOWN,LABEL,LUCIFERASE,METHODS,OBJECTIVE,PI3K,PTEN,RESULTS,TREATMENT
001,002,017,028,043,169,2014,240,554,8804,8805,929,937,941,AMONG,BMI,BOTH,CONCLUSION,CURRENT,GLEASON,LABEL,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS,WHETHER
169,2014,GPS2,INC,MLL4,UDS,WILEY
001,013,683,DUE,ECM,ELISA,EMMPRIN,PERIPHERAL,PSA,SERUM
AKT,CPP,NM23,PRUNE,USING
160K,169,2014,CHIP,CRPC,GEL,HOWEVER,PCA,PCR,PSA,UICC,USING
1136,169,194,2002,2006,2014,8201,8804,8805,AUTHORS,BCR,BJU,CONCLUSION,COX,DATA,EPE,GLEASON,JOHN,LABEL,LOG,LTD,MEIER,METHODS,OBJECTIVE,PATHOLOGY,PUBLISHED,RESULTS,SOCIETY,SONS,UROLOGICAL,WILEY
8201,931,963,CONCLUSION,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,RESULTS,SDS
007,033,089,108,129,169,2014,281,8201,ANXIETY,CES,COPYRIGHT,DCS,DECISIONAL,DEPRESSION,DUTCH,INVENTORY,JOHN,LABEL,LTD,MAX,METHODS,NINE,NTR1718,OBJECTIVE,OVERALL,QOL,REGISTERED,RESULTS,SCALE,SONS,STAI,STATE,STUDIES,THESE,TRAIT,WILEY
125,ASIAN,BONE,COUNTRIES,HOWEVER,METASTATIC,PAGET,RADIOLOGIC,WESTERN
945,946,ASGM1,CELL,COMPLEX,GM1,GSLS,ST3GAL3,STS,THESE
8220,BACKGROUND,CELLS,CHO,D609,ETN,GF109203X,GPETN,IONOMYCIN,LABEL,LNCAP,MALIGNANCY,METHODS,P4E6,PC3,PCA,PHORBOL,PKC,PLD,PLD1,PLD2,PNT1A,RESULTS,RKIP,RO31,TPA
134,759,GREEK,PATIENT,SIMILAR,T1DM,T2DM,THEREFORE
8201,AFTER,ASSESSMENT,CONCLUSION,EOS,FDG,FTP,HOWEVER,HPLC,LABEL,MBQ,METHODS,OBJECTIVE,PET,RADIO,RESULTS,TLC
GBM,LDH,MYELOID,NATURAL,NKG2D
139,169,173,1998,2010,2014,221,344,483,CELL,CONCLUSION,CSI,FIVE,GERM,GROUP,LABEL,LATE,METHODS,MOST,OBJECTIVE,OVERALL,PURPOSE,RELAPSE,RESULTS,SOCIETY,THESE,THREE
1657,1663,169,2002,2014,AUTHORS,CNS,COPYRIGHT,INC,PUBLISHED
169,2014
PSA
AGO2,ALTOGETHER,ARGONAUTE2,CCK,DICER,DU145,FIRST,GLEASON,IHC,LNCAP,NEXT,PCA
BECAUSE,CRPC,ENZ
0001,002,160,AMONG,APOPTOSIS,ATLAS,GBM,GSCS,IDH1,PAR,SAC,SELECTIVE
BETWEEN,DESPITE,LABEL,METHODS,MOST,OBJECTIVE,ONCE,PURPOSE,RESULTS,SIX,SURVIVORS
160,1P21,BACKGROUND,DR1,EVI5,FISH,FOUR,FURTHER,HOWEVER,LABEL,METHODS,PCR,RESULTS,RPL5,TMED5
120,2004,2012,AMONG,BJF,CONCLUSION,DESPITE,IRB,LABEL,LOS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,VUAR
001,100,102,12TH,177,2007,2012,3RD,455,8482,8804,8805,ACMI,BACKGROUND,BIPOLAR,BPE,CLAVIEN,DINDO,EVALUATED,EXCLUSION,GYRUS,HOWEVER,IIEF,INCLUSION,INDEX,IPSS,KINETIC,LABEL,MEAN,METHODS,OBJECTIVE,OPERATION,PFR,PURPOSE,PVR,QOL,RESULTS,SCORE,SYMPTOM,TURP,USA
10877,120,157,1994,1995,3533,684,961,ADT,AMONG,BACKGROUND,HALF,LABEL,MEN,METHODS,RESULTS
NOTCH,NUMB,VARIOUS
AUTOPHAGY,HOWEVER,NOTABLY
956,CLA,CYTOTOXIC,MTT,OLA,PC3,TAX
M13,WHILE
0001,012,033,036,107,1157,125,128,133,2007,2011,2012,276,342,4772,523,5725,8201,8805,966,991,ADHERENCE,AMONG,CONCLUSION,COX,CPRC,CRPC,CSS,JUNE,LABEL,LETS,MAY,METHODS,MPR,NORTH,OBJECTIVE,OBJECTIVES,PVD,RESULTS,THOSE
000,2400,8764,PCR,THEREFORE,THESE,VARIOUS
2000,2010,404,8201,8805,DATA,IMPORTANCE,INTERVIEW,LABEL,MAIN,METHODS,NHIS,OBJECTIVE,RATES,RELEVANCE,RESULTS,ROUTINE,SETTING,THERE,THESE,USING
001,003,010,106,200,DIFFERENT,LABEL,MATERIALS,METHODS,OBJECTIVE,PSA,PURPOSE,REGRESSION,RESULTS,TOTAL
0001,001,169,2014,300,945,946,ALPHA,AMACR,AMONG,ATBC,AUTHORS,BETA,COA,JOHN,LTD,PREVENTION,PRISTANIC,SONS,THERE,TOCOPHEROL,WILEY
169,200,201,2014,8201,8805,BACKGROUND,BONE,INC,KINGDOM,LABEL,METHODS,MOST,ODDS,ONJ,PCA,RESULTS,WILEY
1586,169,2014,897,AF5,BACKGROUND,CHIP,CHROMATIN,CONCLUSION,CTD,GLI,GLI2,GST,INC,LABEL,LNCAP,METHODS,MUTATIONS,PCA,PREVIOUSLY,RESULTS,THESE,WILEY,WXXLF
169,2014,945,AMP,AMPK,ATG,ATG5,ATG7,BAICALEIN,FEBS,GFP,LC3,LC3B,LC3WT,RLUC,RNAS,THESE,ULK1,UNC,VPS34
AKT,BRCA1,CHK1,DDR,MYC,P53,PARP,THESE
169,2015,22RV1,ARFL,ARV,CHROMATIN,COPYRIGHT,EDUCATION,INC,INTEGRATED,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SPLICED,UROLOGICAL
169,2014,22RV1,CONSISTENT,FEBS,PAX2,THESE
169,2014,ASIA,AUSTRALIAN,LTD,POTASSIUM,POTENTIAL,PSA,PTY,PUBLISHING,QUESTIONS,WILEY
CRPC,CURRENTLY,CYP17,HOWEVER,JAPAN,RHAGONISTS,WHILE
CRPC,JAPAN
0001,CSF,III
2013,CYP17A1,DATA,III,JAPAN,JULY,QOL,WELFARE
160MG,199,2012,2013,2014,239,717,ANOTHER,COMMITTEE,CRPC,DATA,DRUG,FOOD,IDMC,III,JAPAN,MAR,MAY,MEDICINES,MEDIVATION,MONITORING,PREVAIL,PSA,QOL,SRE,TTPP,WELFARE
CRPC,JAPAN,WESTERN,Y2014
000,CONCLUSION,GENERALLY,GLEASON,LABEL,METHODS,OBJECTIVE,PSA,RESULTS,T3ANXM0,THEIR,THERE,THREE
100,110,150,2011,2013,230,242,750,8805,956,CONCLUSION,GLEASON,JUNE,LABEL,METHODS,OBJECTIVE,PSA,RESULTS,SEPTEMBER
2005,2014,228,235,865,8804,AMONG,CONCLUSION,GLEASON,IPCA,IPCAS,JANUARY,LABEL,MARCH,METHODS,MOST,OBJECTIVE,PCA,RCP,RESULTS,TURP
169,2014,FINALLY,INC,REPORTS,RNAS,WILEY
012,021,024,1071,169,183,2003,2007,2014,215,267,268,8200,8805,956,AUG,AUSTRALIA,BACKGROUND,BETWEEN,CALVARY,CARE,COPYRIGHT,COUNCIL,CUMULATIVE,FUND,FUNDING,GLEASON,INSTITUTE,IQR,ITAS,LABEL,LTD,MATER,MEDICAL,METHODS,NEITHER,NEWCASTLE,OCT,POST,PSA,RADIATION,RESULTS,SHR,SOCIETY,STANDARDS,STAS,T2A,T2B,UNIVERSITY,ZEALAND
0001,0002,0075,169,2011,2014,233,914,956,ALBERTA,BLACK,CALGARY,CONCLUSION,COPYRIGHT,FORTY,INC,JANUARY,LABEL,LABORATORY,METHODS,OBJECTIVE,OBJECTIVES,POISSON,PSA,PUBLISHED,RESULTS,SOCIETY,THERE,VISIBLE
145,AKT,HOWEVER,MMP,MMPS,PI3K,RCM,RUBUS,TIMPS
169,2014,ATRA,COPYRIGHT,TAM,TAMS,THESE
001,007,142,169,2014,383,440,8201,8805,965,AMONG,AUTHORS,BJU,BMI,CONCLUSION,GLEASON,INDEX,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PHI,PROMETHEUS,PSA,RESULTS
PCA,PDE5I
0001,001,0015,1656,619,715,754,755,8805,ANN,AUC,BCR,GLEASON,HOWEVER,LRP,PSA,ROC,SCORE
0001,169,2014,8804,COPYRIGHT,FURTHER,GLEASON,HH1,HISTONE,INC,INCREASED,SIMILARLY,SIXTY
142,169,2014,654,946,AKT,EGF,EMT,GSK3,HSP27,INCREASED,METASTASIS,MMPS,PCA,SLUG,THESE,UICC
004,100,1246,1290,169,2014,215,375,8805,BACKGROUND,CANDIDATE,COPYRIGHT,COX,CRPC,LABEL,MEIER,METHODS,OBJECTIVE,OUTCOME,PATIENT,PUBLISHED,RESULTS,RNAS,SETTING,SUMMARY,UROLOGY
169,2014,ALA,ALSO,AMPK,BOTH,COPYRIGHT,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OE19,OE33,RESULTS
100,ANNA1,INTRAVITAL
HOWEVER,MOST,PLND,RARP,ROBOTIC
070,665,8201,8804,8805,933,BASEL,BCR,COX,CURRENTLY,GLEASON,IQR,MTD,PCA,PSA,PSMS
0001,00035,0088,166,169,183,2014,3790,8804,955,BACKGROUND,BHASKARAN,BMI,COPYRIGHT,COUNCIL,COX,EACH,FUNDING,HIGH,INSTITUTE,LABEL,LTD,MEDICAL,METHODS,OPEN,PUBLISHED,RESULTS,TRUST
152,160,439,821,BLADDER,CONCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEVENTY,TIME,TREATMENT
2009,2011,2013,ACS,ASIA,ASIAN,CONSENSUS,NCCN,NETWORK,STATEMENT
947,ACC,AMP,AMPK,BACKGROUND,COA,CONCLUSION,CSCS,GAMMA,LABEL,METHODS,PCA,PSP,RESULTS,SER
169,2014,BOTH,COPYRIGHT,DISULFIRAM,DSF,HELA,IC50,PEVA
169,2014,916,ATG7,BIP,COPYRIGHT,ERK,GRP78,HOWEVER,INC,LC3B,MEK,RAF,UNDER,UPON,V600E,WHILE
169,2014,COPYRIGHT,FAK,HIF,INC,PCA,PTX,ROS,S13,SRC,VEGF
100,145,160,169,2014,231,293,956,AKT,COPYRIGHT,HEK,IC50,MCF,MDA,SAS,THREE,WHILE
169,2014,COPYRIGHT,GLEASON,INC,THESE
0001,084,169,2015,961,ASSESSMENT,BACKGROUND,CONCLUSION,COPYRIGHT,FDG,INC,KINETIC,LABEL,MATERIALS,METHODS,NAF,PET,RESULTS,SUV,SUVS
169,2014,BRONJ,COPYRIGHT,CURRENTLY,LTD,ORAL,PUBLISHED,THUS
015,033,039,169,172,2014,215,AURKA,COPYRIGHT,GLEASON,INC,MOST,NED,THEREFORE
169,2004,2005,2014,2677,AMONG,COPYRIGHT,END,INC,ISPOR,LABEL,LARGE,METHODS,NETWORK,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,SOCIETY,VARIATION
000,160,169,2014,8804,ART,ASSESSMENT,CAPRA,COPYRIGHT,INC,ISPOR,LABEL,METHODS,NADIA,OBJECTIVE,OBJECTIVES,PROSVUE,PUBLISHED,QALY,QALYS,RESULTS,RISK,SOCIETY
000,0001,1201,125,169,2014,818,COLORECTAL,CONCLUSION,CONTROLLED,COPYRIGHT,INC,INSTITUTE,LABEL,LUNG,MENOPAUSAL,METHODS,NCI,OBJECTIVE,OVARIAN,PLCO,RANDOMIZED,RESULTS,SCREENING,THERE,TRIAL,WOMEN
169,2014,947,ANNEXIN,BOTH,BRCA,BRCA1,DSB,DSBS,FLOW,H2AX,HDAC,HDACI,HOWEVER,LABEL,PARP,PARPI,RAD51,SAHA,SILENCING,SIMILARLY,THESE,UNLABELLED
BASED,CHROMATIN,COS,EGFP,FOX,FOXA1,K267,K389,LNCAP,POST,PSA,SUMO,TAKEN
001,125,126,1313,169,2003,2009,2015,BETWEEN,COPYRIGHT,COX,FORTY,GLEASON,GRADE,INC,JAPAN,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SIDE,SOCIETY,T1C
BROADER,CURRENT,HOWEVER,MRI,PCA,PSA
169,2014,945,954,IKK,IL8,LABEL,NAD,NADPH,NOTABLY,NQO1,THESE,TRAMP,UNASSIGNED,UNLABELLED
048,169,1997,2006,2014,2168,256,2653,5077,ADT,AFTER,AHR,AUTHORS,BJU,CHF,CONCLUSION,CSM,FINE,GRAY,HOWEVER,JOHN,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,SONS,WILEY
BPH,COLLAGEOUS,ECM,LNCAP,PEC
1236C,150MG,169,2014,2677G,3435C,34G,421C,ABCB1,ABCG2,AFTER,BACKGROUND,BCRP,COPYRIGHT,DRUG,HOWEVER,LABEL,METHODS,RESULTS
106A,106B,139,18A,18B,195,19A,20B,E2F1,EIGHT,H19,HIPK3,HOWEVER,LINC00152,MRES,PAK7,PTEN,RB1,RNAS,RP4,RUNX1,TARBASE,THEN,THESE,VEGFA
946,A549,AKT,BOTH,EGF,EGFR,EMT,GSK,HOWEVER,PI3K,PKC,SNAIL,TAKEN
100,252,BACKGROUND,CA25,CAM,CASE,CAUCASIAN,CD10,CD117,CK20,CK7,CLEAR,GLEASON,HMB,III,LABEL,METHODS,OTHER,PAX,PLAP,PSA,RCC
169,1996,2000,2010,2011,2014,257,529,8805,AUTHORS,BJU,CAUSE,COLLECTION,CONCLUSION,COX,DESPITE,LABEL,MAY,MEIER,METHODS,MORTALITY,OBJECTIVE,RESULTS,ZEALAND
169,177,2000,2001,2007,2011,2014,214,259,ABORIGINAL,AGE,AUTHORS,BJU,CONCLUSION,COX,JOHN,LABEL,LTD,METHODS,NSW,OBJECTIVE,RESULTS,SONS,SOUTH,THERE,WALES,WILEY
160,169,2014,263,395,461,684,8201,AUTHORS,BJU,CONCLUSION,FOUR,HOWEVER,III,JOHN,LABEL,LTD,METHODS,NORTH,OBJECTIVE,PHASE,RESULTS,SONS,WILEY
946,AKT,EGF,EPIDERMAL,MMP,PGG,PI3K,THEREFORE
169,2014,945,946,956,CAP,COPYRIGHT,DIM,DIMA,ERS,HOWEVER,INC,LNCAP
145,169,2014,BALB,BCL,CONCLUSION,COPYRIGHT,CRPC,ESCIN,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,WESTERN
169,2014,DECREASING,PCM,PSA,PSAT,SCREENING,UICC,USING,WHILE
001,127,151,169,2014,299,445,5227,633,BACKGROUND,COLORECTAL,CONCLUSION,COPYRIGHT,CXR,IRELAND,LABEL,LTD,LUNG,METHODS,OVARIAN,POTENTIAL,RESULTS,SCREENING,TRIAL,TRUE
001,117,INITIAL,PCR,T24,TCC,UCA1,URINE,UROTHELIAL
BMI1,EMT,MCF,MTT,RHOC,TAKEN,THERAPY,WESTERN,YET
2011,2014,233,AIM,BACKGROUND,BCG,COMMITTEE,GROUP,HYALURONIC,IPSS,LABEL,MEAN,METHODS,NMIBC,POST,RESULTS,SCALE,SCORE,SYMPTOM,THESE,THREE,TOR,TRIAL,VAS,VERGATA
PSA
ASS1,ATG5,AUTOPHAGY,BECLIN1,FURTHER,HOWEVER,NUP98,ROS,THUS
169,2014,HGF,LABEL,LOSS,MET,THROUGH,TMPRSS2,UNLABELLED
BACKGROUND,BASED,CALCIUM,CCBS,CONCLUSION,DISCUSSION,LABEL
169,2014,946,AKT,CPT1,CPT1A,HOWEVER,KNOCKDOWN,LNCAP,THESE,VCAP,WESTERN
169,2014,LNCAP,MCL,PACLITAXEL,PC3,PTTG1,THESE
169,172,175,2014,250,2B3,2B4,308,350,473,485,491,500,872,945,956,AKT,AMPK,COA,COAR,CRPC,DOCETAXEL,HMG,NCR,SER,STUDIES,THR
005,100,181,945,ACUTE,AKT,ATF4,CFU,CHOP,CRPC,CUR,DESPITE,DTX,HOWEVER,IHC,NFR,PI3K,PREC,RWPE,TARGETING,THEREFORE,TRIB3,TUNEL
16M,AIPC,AMONG,BECAUSE,BIOLOGICAL,CPRC,CRPC,DESPITE,VCAP
CPT11,CURRENT,HOWEVER,SUICIDE
100,8201,CONCLUSION,EARLY,FCH,LABEL,MATERIALS,METHODS,OBJECTIVE,OTHER,PET,PSA,PURPOSE,RESULTS
001,002,100,135,144,177,195,8804,8805,CONCLUSION,LABEL,METHODS,OBJECTIVE,PCA,PSA,RESULTS,ROC,TRTE
118,157,169,177,181,193,200,204,226,239,251,264,289,318,336,367,398,409,436,520,550,566,728,754,758,931,945,946,979,BHP,BPH,CON,GAL,HOWEVER,PCA,PNA,RLU,THESE,UEA,ULEX
BNCT,BNCTS,CONCLUSION,EMA,LABEL,METHODS,MRI,OBJECTIVE,ONCE,PAIN,PURPOSE,RESULTS,S100,THERE
AKT,BIOMARKERS,FURTHER,PI3K,SIGNALLING,THEREFORE
173,272,GLEASON,SNPS
956,CCK,COMPOUNDS,DU145,HOWEVER,IC50,LNCAP,RWPE,SAR
ALSO,BPH,CD4,CD8,FLOW,FURTHER,PCA,TIM
CD117,DESPITE,MAST,MCS
005,028,2006,2013,3345,973,AMONG,BACKGROUND,BONE,CONCLUSION,JANUARY,LABEL,MATERIALS,METHODS,RESULTS
BAK,BAX,BCL,DU145,FURTHER,HOWEVER,MAPK,NOR1,PC3,SILENCING,THUS
2D3,BOTH,COX,DESPITE,PGDH
ALSO,C2C12,PC3
1000,169,2013,2014,239,250,500,8805,ASIA,AUTHORS,CRPC,JULY,LTD,PERSISTENT,PTY,PUBLISHING,SCIENCE,WILEY
177,COLON,IHC,LYNCH,MAYO,MLH1,MMR,MSH2,MSH6,MSI,ONTARIO,UNDER
003,160,169,2007,2014,564,ABOVE,BELOW,CLINICALLY,CONVERSELY,COPYRIGHT,EDUCATION,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THESE,THUS,UNIVARIATE,UROLOGICAL
169,2014,COPYRIGHT,FEDERATION,HUVEC,INTEGRATED,MYND,NOTABLY,PUBLISHED,SOCIETIES,USING,ZINC
1079,169,2014,954,BAX,BCL,COPYRIGHT,FINALLY,FIRSTLY,GNT,INC,LNCAP,PC3,PCA,SUMMARY
169,2014,CELL,CNPY2,COPYRIGHT,DROSOPHILA,INC,MEP1A,MRGBP,THESE,USING
323,9617,ASIAN,CIS,ODDS,ORS,PSCA,SEVERAL
MUC1,THESE,YMB
001,002,169,2002,597,AFTER,BACKGROUND,CHINA,CONCLUSION,COX,DIFFERENT,INSURANCE,LABEL,METHODS,PRESS,RESULTS
138,945,AKT,EMMPRIN,EMT,ERK,HOWEVER,LINN,MMP,MMPS,PI3K,RECK,RESULTS,SOLANUM,TAKEN,THESE,TIMP
169,2014,CONCLUSION,COPYRIGHT,JOHN,LABEL,LTD,MEN,METHODS,OBJECTIVE,RESULTS,SONS,WILEY
169,195,2010,2011,2014,251,863,AMACR,BESIDES,COPYRIGHT,FOAMY,GLEASON,INC,JANUARY,PERIPHERAL,TRUS
2014,BASEL,BONE,DECISIONS,LIMITED
1950S,1973,1979,1985,2008,647,690,ADDITIONAL,BACKGROUND,BASE,CAMP,CAUSE,CIS,CONCLUSION,CORPS,CUMULATIVE,HRS,LABEL,LEJEUNE,METHODS,MORTALITY,NORTH,PARKINSON,PCE,PENDLETON,RESULTS
100,174,8202,AIM,BACKGROUND,CERVARIXTM,CONCLUSION,CURRENTLY,CZECH,GENERALLY,HPV,LABEL,LARGE,OBJECTIVE,OVERALL,PERSISTENT,SILGARD,THERE,WHILE
001,1264,169,2014,AMICO,CONCLUSION,CURRENT,EXCELLENCE,INSTITUTE,JAPAN,LABEL,LOW,MEDICAL,MEIER,METHODS,NETWORK,OBJECTIVE,RESULTS,SOCIETY,STRATEGIC,UROLOGICAL,USING
C81,CHIP,CHROMATIN,DNMT1,DU145,ENRICHMENT,EZH2,HOWEVER,ID4,INCREASED,INHIBITOR,KNOCKDOWN,LNCAP,PRC2
23B,27B,DU145,EXPRESSION,GAIN,GOLM1,MEIER,PC3,PCA
124,CAM,CHICK,CTBP1,EXPRESSION,EZH2,MIR,MMP1,P4HA,P4HA1,P4HAS,USING
169,2014,316,658,CASES,COLORECTAL,GBV,HODGKIN,LUNG,NHL,OVARIAN,PLCO,SCREENING,TRIAL
ACCOUNTING,BACKGROUND,CONCLUSION,DETECTION,ENRICHMENT,ERG,ESC,GLEASON,GSEA,LABEL,METHODS,MYC,PCA,RESULTS,SET
103,AUDIO,BACKGROUND,CONTROLLED,CONVERSELY,CURRENT,LABEL,METHODS,PROTECT,RCT,RCTS,RECRUITERS,RESULTS,TREATMENT,TRIAL,WITHOUT
1161,1220,148,169,2014,240,2624,BACKGROUND,BRITISH,ESBL,GROUP,KLEBSIELLA,LABEL,METHODS,PRESS,PUBLISHED,RESULTS,SOCIETY,TRUBP,UNIVERSITY
169,2010,2014,COPYRIGHT,DATA,JAPAN,LTD,RISK
169,2014,CONFORMITY,COPYRIGHT,EACH,HOWEVER,IMRT,INC,MEDICAL,MOST,MUS,OVERALL,PUBLISHED
107,11C,160,8201,ADVERSE,ART,BACKGROUND,C30,CONCLUSION,EORTC,HOWEVER,LABEL,LEADING,LND,MEAN,METHODS,OVERALL,PCA,PR25,QLQ,RESULTS,VERSION
001,169,2015,221,416,675,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,MEN,METHODS,OBJECTIVE,POISSON,PUBLISHED,PURPOSE,RESISTANCE,RESULTS,STUDENT,UROLOGICAL
003,007,010,026,032,037,046,169,2014,535,8201,BACKGROUND,CD20,CD3,CD4,CD8,INC,LABEL,METHODS,RESULTS,WILEY
169,2014,8805,BACKGROUND,CYP17,INC,LABEL,METHODS,PSA,RESULTS,SEVEN,WILEY
0005,169,2014,382,8201,8804,BACKGROUND,BRCA2,FIVE,HIGH,INC,LABEL,METHODS,PRCA,PSA,RESULTS,VUS,WHILE,WILEY
000,169,174,2013,2014,270,2745,650,ARCH,BOZEC,CELLSEARCH,CTC,CTCS,EUR,HEAD,HNSCC,METASTATIC,THEREFORE,UICC,VALIDATED
1501,169,2014,947,BACKGROUND,CD25,CD8,CTLA,DISCUSSION,DR2B,DRB1,HLA,IFN,INC,LABEL,METHODS,MOUSE,PSA,PSA65,RESULTS,TRAMP,TRANSGENIC,WILEY
8220,AGC,ATP,PRK,PRK1,PROTEIN,RHO
169,2014,22RV1,AKT,ANNEXIN,BACKGROUND,BCL,BLUE,CELL,CELLS,COMBINING,DOWN,DU145,FOUR,INC,LABEL,LNCAP,METHODS,PC3,PI3K,PROPIDIUM,PTEN,RESULTS,SILENCING,WESTERN,WILEY
169,176,2014,BACKGROUND,BPH,CD3,FRESH,HOWEVER,INC,LABEL,METHODS,RESULTS,VARIOUS,WESTERN,WILEY
1154A,169,2014,400,8805,ABI,BACKGROUND,DOCETAXEL,ELISA,FORTY,GRADE,LABEL,METHODS,PCR,PFS,PRISM,REAL,RESULTS,SDS,SNP,SOCIETY,VEGF
169,2014,ALTOGETHER,AUTHORS,BACKGROUND,EVS,INC,LABEL,LNCAP,METHODS,MLH1,PCA,PCR,PTEN,RC92A,RESULTS,RNAS,TP53,WILEY
052,169,2014,856,ALA295THR,ARG283GLN,ARG441TER,BACKGROUND,BLM,CYP3A43,FORTY,FOUR,FURTHER,GLN123ARG,HOWEVER,INC,KIF2B,LABEL,METHODS,OVERALL,PARP2,PCA,RESULTS,SIX,SNVS,WILEY
169,2014,8201,946,BACKGROUND,DU145,FINALLY,HIGH,HOWEVER,HUS1,INC,ITGB1,LABEL,METHODS,MOUSE,MRAD9,PARP,PC3,PREVIOUSLY,RAD1,RAD9,RESULTS,THESE,WILEY
2004,2009,2012,8201,8805,BETWEEN,COX,GRADE,IGRT,IMRT,LABEL,MATERIALS,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS
945,COLORECTAL,CRC,HOWEVER,MAPK,RESISTANCE,STUDIES
FOUR,INITIAL,INSULIN,INSULINOMA
001PM,169,2014,500,COPYRIGHT,ELISA,HOWEVER,PCR,PLA,PROXIMITY,THUS
10NG,156,177,2000,2011,263,431,4702,875,945,BACKGROUND,DRE,ELISA,INDIA,JANUARY,JUNE,LABEL,LUTS,METHODS,OBJECTIVE,OBJECTIVES,PSA,RESULTS,ROC,TRUS
001,280,555,8201,BACKGROUND,BASED,CONCLUSION,EXON,LABEL,RESULTS
ARR2,ARRESTIN2,CRPC,EXPRESSION,FK506,PCA,THESE
1000,169,183,1929,2010,2014,490,6107,7408,781,AFTER,BACKGROUND,CONTROLLED,COPYRIGHT,CURRENT,DESPITE,EACH,ERSPC,FUNDING,LABEL,LTD,METHODS,PSA,RANDOMISED,RESULTS,SCREENING
169,1973,1980S,1990,1990S,1995,1998,2000S,2005,2009,2014,BACKGROUND,BOTH,CONCLUSION,COPYRIGHT,INC,INCIDENCE,LABEL,LUNG,METHODS,RESULTS,SEER
169,2014,425,APS,BACKGROUND,COPYRIGHT,CPS,CYBERKNIFE,IRELAND,LABEL,LTD,MATERIALS,METHODS,MULTIPLAN,OBJECTIVE,OVH,PTV,PURPOSE,RESULTS,ROBOTIC,SBRT
169,2003,2010,2014,6018,COPYRIGHT,FISH,FOOD,FREQUENCY,LTD,NUTRITION,PSA,PUFA,PUFAS,SERUM
2000,AFTER,CCK,CONCLUSION,FITC,FLOW,LABEL,METHODS,OBJECTIVE,PCR,RESULTS,THEN,TRANSWELL,WESTERN
001,055,169,2004,2010,2015,338,412,522,COPYRIGHT,COX,EDUCATION,END,FIVE,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,RESULTS,SEER,SIMILAR,UROLOGICAL
169,2014,COPYRIGHT,HIGH,LTD,MEN,POST,SIXTY
169,2014,239,COPYRIGHT,LTD
169,2014,947,AAS,COPYRIGHT,IFN,IRELAND,JAK2,LTD,STAT3,THESE
POLYMERASE,PTRF
EFFECTIVE,OWING
100,101,169,2015,272,CARCINOMA,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PROSTATIC,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
001,169,2004,2010,2015,237,257,465,591,COPYRIGHT,EDUCATION,GLEASON,INC,LABEL,MATERIALS,METHODS,NCDB,OBJECTIVE,PCA,PUBLISHED,PURPOSE,RESULTS,SEER,THESE,UROLOGICAL
128,195,221,8201,8804,8805,BACKGROUND,BKV,CHLAMYDIA,GLEASON,HPV,HSV,LABEL,METHODS,MYCOPLASMA,OVERALL,PCR,RESULTS,TURP,UREAPLASMA,XMRV
160,CONCLUSION,FOUR,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,REAL,RESULTS
002,012,023,174,231,945,946,ASSAY,BACKGROUND,CDK11,DFS,EXPRESSION,HOWEVER,LABEL,MDA,MEIER,METASTASIS,METHODS,PCR,RESULTS,SER,THESE,THR,TRANSWELL,WESTERN
000,140,2012,AMERICANS,APRIL,BACKGROUND,DISCUSSION,EUROPEANS,FURTHER,LABEL,MEDLINE,METHODS,RESULTS,T2DM
10878,CRPC,DOCETAXEL,HOWEVER,IC50,IHC,PC3,PCA,PSA,TR4
BACKGROUND,BECAUSE,DISCUSSION,EFFORTS,LABEL,RESULTS,THEREFORE
AFTER,BACKGROUND,BRISTOL,CANCERS,CHI,CONCLUSION,EFFORTS,INDIA,KASHMIR,LABEL,MATERIALS,METHODS,PACKAGE,PEARSON,PRESENT,RESULTS,UNIVERSITY
0001,0004,0018,0079,101,160,169,174,183,2014,248,259,275,399,625,652,800,8804,8805,BACKGROUND,BPI,BRIEF,COPYRIGHT,ECOG,FORM,FUNDING,HRQOL,INVENTORY,LABEL,LTD,MEAN,MEDIVATION,METHODS,OVERALL,PAIN,RESULTS,SECONDARY,SHORT
2006,BACKGROUND,CASE,CAUCASIAN,LABEL,METHODS,PAP,PSA
169,2014,946,BMSC,CHRONIC,FINALLY,INC,PCA,TAKEN,USING,WILEY
002,006,108,169,2015,8804,ADT,BACKGROUND,COPYRIGHT,COX,EVEN,GLEASON,GROUP,HOWEVER,INC,LABEL,METHODS,OCCURRENCE,PSA,RADIATION,RESULTS,SIXTY,THERAPY
349,436,AUSTRALIAN,BACKGROUND,BOTH,CONCLUSION,FINNISH,JOB,LABEL,METHODS,RESULTS,USING
001,006,011,012,063,200,2408,939,GLEASON,HGPCA,HIGH,HSC,NSC,PCA
1996,2012,BACKGROUND,DUKE,LABEL,MAIN,MASON,METHODS,OBJECTIVE,OUTCOME,RESULTS,SETTING,THERE,UNIVERSITY,YORK
100,177,188,2005,2014,BETWEEN,CONCLUSION,EVAR,FURTHER,IBD,III,ILIAC,JANUARY,LABEL,METHODS,NONE,OBJECTIVE,PURPOSE,RESULTS
1998,2010,2012,4187,BACKGROUND,BRCA2,LABEL,MEN,METHODS,PSA,RESULTS,THESE
2013,AIDS,BARR,CALIFORNIA,EPSTEIN,FRANCISCO,HIV,HODGKIN,IAS,MARCH,MITSUYASU,MORTALITY,SAN,USA
001,002,200,2005,2013,343,592,8201,GLEASON,INVENTORY,LABEL,MEN,METHODS,OBJECTIVE,PSA,RESULTS,SERUM,SHIM,T1C,T2A,THERE,TTH
113,181,303,BACKGROUND,CPCS,FREE,LABEL,METHODS,P504S,PRIMARY,PSA,RESULTS
0001,001,0134,017,021,028,044,086,129,182,317,351,396,524,734,8201,860,887,BACKGROUND,EVALUATION,LABEL,METHODS,RALP,RESULTS,ROBOTIC,UNIVERSITY
2001,2004,202,608,8201,897,ADJUSTMENT,AFFAIRS,AOR,BLACK,CRT,III,IMRT,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,WHITE
001,304,8201,AUC,AUCS,COMBINING,CONCLUSION,DCE,DIAGNOSTIC,DWI,GLEASON,KEY,LABEL,METHODS,MRI,OBJECTIVE,OBJECTIVES,PCA,PREDICTIVE,RESULTS,TESLA
001,017,2005,2011,375,8805,BODY,DATA,HOWEVER,ICI,IIEF,INCLUSION,INDEX,RARP,UNIVARIATE
AFTER,BECAUSE,MRI
080,1000,169,2014,725,8805,956,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,TAIWANESE,UROLOGICAL
0001,003,169,1992,2006,2014,COX,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PREZEON,PTEN,RESULTS,UROLOGICAL
239,946,CASTRATION,CRPC,MET,NANOG,PCA,PTEN,RTK,SOX9,SRY,TRP53
1138,120,1300,163,169,177,200,2000,2008,2014,214,299,600,AMICO,APRIL,AUTHORS,BJU,GLEASON,LABEL,LRP,METHODS,OBJECTIVE,OBJECTIVES,PLND,RESULTS,THERE,WHILE
169,2010,2014,8291,8764,AMICO,CONCLUSION,EACH,GROUP,HIGH,JAPAN,LABEL,METHODS,OBJECTIVE,PRESS,PUBLISHED,RESULTS,T1C,UNIVERSITY
2000,446,BACKGROUND,CARE,ECOG,IMSS,LABEL,METHODS,OBJECTIVE,RESULTS,UNIT
CONDUCTION,PSA
AMERICANS,BACKGROUND,CURRENT,EDUCATION,INC,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,ROUTINE,STUDIES
652G,652T,CASE,EMSA,GATA,PCA,PCR,SEVERAL,SNPS,XRCC4
001,004,1509,169,2012,2013,2014,416,8805,AMONG,BASED,BECAUSE,CONCLUSION,COPYRIGHT,GLEASON,GUIDELINES,INC,JUNE,LABEL,MARCH,MATERIALS,METHODS,NETWORK,OBJECTIVE,PSA,RESULTS,SURGERY,UROLOGICAL,UROLOGY,USING
169,2014,HOWEVER,PCA,SOCIETY
169,2014,ACTIVATED,ALCAM,DOTA,PRESS,PUBLISHED,UNIVERSITY
CAG,SEVERAL
0196,221,242,257,726,8202,834,8804,AFTER,AMONG,BACKGROUND,CONCLUSION,EPSTEIN,FDR,GLEASON,HUMANEXOME,ILLUMINAM,INC,LABEL,METHODS,PCA,PGU,PSA,RESULTS,SNP,SNPS,T2A
010,015,24RGD,916,AD5,E1A,EVALUATION,IMPROVING,ONYX,ORCA,RGD
945,954,CDT1,CRLS,HOWEVER,MLN4924,ORC1,RING,TAKEN,WEE1
123,BDSF,ECOG,GRADE,LABEL,METHODS,OBJECTIVE,PCA,PURPOSE,RESULTS
167,BACKGROUND,CNVS,COLORECTAL,COPY,EAGLE,FINALLY,FUNCTIONAL,LABEL,LUNG,OVARIAN,PLCO,PRINCIPAL,RESULTS,SCREENING,SNP,TRIAL
BACKGROUND,CONSENSUS,CONTEXT,FORCE,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PREVENTIVE,RESULTS,SYSTEMATIC,TASK,THESE,VITAL
H2O2,LNCAP,THESE
145,ATOMISTIC,COMPLEXES,CONCLUSION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SSTS,SYBR,TONPS
2009,2013,EARLY,JULY,LABEL,METHODS,NINE,OBJECTIVE,PSA,RESULTS,SOCIETY,T1C,T2C,THERE,TURP
169,2014,945,ARS,BUD31,COPYRIGHT,FEDERATION,FUNCTIONAL,FXX,LBD,PHAGE,PUBLISHED,SOCIETIES,STRUCTURAL,TREATMENT,TYR
169,2014,210,CAF,COPYRIGHT,EMT,FEDERATION,HYPOXIC,PUBLISHED,SOCIETIES
169,2013,323,428,751,8805,AFTER,ASIAN,BMI,CASES,COPYRIGHT,GLEASON,LABEL,LTD,METHODS,OBESITY,OBJECTIVE,OBJECTIVES,OVERALL,PSA,PUBLISHED,RESULTS,THESE
0001,100,1000,101,111,112,114,116,169,177,181,2013,8805,ASIAN,BACKGROUND,BMI,COPYRIGHT,HBA1C,LABEL,METHODS,OBESITY,OBJECTIVE,PSA,RESULTS,TREATMENT,WAIST
BACKGROUND,BPH,EXPRESSION,LABEL,METHODS,PCA,RESULTS,SOX,SOX2,SRY
10877,10878,BACKGROUND,IMAGING,LABEL,METHODS,OWING,PPC,RESULTS,SEVENTY,TEN,THERE
169,2009,2014,8201,AUSTRALIAN,BACKGROUND,COLLEGE,CONCLUSION,GEELONG,LABEL,LOWER,METHODS,RESULTS,ROYAL,RURS,SOUTH,TIME,WESTERN,WHETHER,ZEALAND
0018,0260,0315,0354,0362,0461,152,BACKGROUND,BCR,COX,GLEASON,HOWEVER,LABEL,MEIER,METHODS,MSP,PCR,PSA,RESULTS,THEN
ABOUT,ADT,BLADDER,CRPC,DEPENDING,LABEL,LHRH,OBJECTIVE,PCA,PSA,PURPOSE,RESULTS,SUMMARY,THERE,TUR
PET
946,IGF,TGF
169,2014,945,AMONG,COPYRIGHT,ERE,GREB1,HOWEVER,INC,NAKAI,ROSMARINIC
169,2014,3DVH,3MM,ALSO,COPYRIGHT,DOSE,DVH,DYK,FURTHER,INC,MEDICAL,NUCLEAR,OAR,PDP,PEARSON,PTV,PUBLISHED,SUN,TPS,VAN,VMAT
169,2014,946,AKT,BACKGROUND,BASIC,BOTH,COPYRIGHT,ECTOPIC,EMT,EPITHELIAL,GENERAL,GSK,HOWEVER,LABEL,METHODS,PCR,PI3K,RESULTS,SNAIL,WESTERN,WOUND
169,2014,ASIA,AUTHORS,ERG,LNCAP,LTD,PTY,PUBLISHING,SCIENCE,SYNTHETIC,TARGETING,TMPRSS2,WILEY
169,2014,236,COPYRIGHT,CSC,DEPENDING,LTD,MAPK,MOST,PI3K,PTEN
116,169,2014,205,549,956,COLO,COPYRIGHT,HCT,IC50,LTD,MTT
1981,947,ATM,BMI1,CHK2,CONSISTENT,CONVERSELY,DDR,DU145,ECTOPIC,ETOP,H2AX,KRMK,MCF7,NBS1,NLS,S15,T68,TAKEN
169,2014,ALZHEIMER,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,SCHOLAR,SCIENCE,SOCIETY,UPLC,WEB
001,169,2014,256,473,801,AFRICAN,ASSESSMENT,CAPRA,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,NETWORK,OBJECTIVE,PCA,POST,PRESENTING,PURPOSE,RESULTS,RISK
001,003,1535,169,2014,3040,765,770,BACKGROUND,CASTRATION,COPYRIGHT,INC,INSTITUTE,LABEL,MEN,METHODS,PSA,REPLACING,RESULTS,THERE
0001,134,169,1991,2007,2014,640,883,977,COPYRIGHT,EACH,END,HOWEVER,ICD,INC,INITIAL,LABEL,LESS,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEER,USING
169,1993,1995,2006,2010,2014,283,792,952,AARP,COLORECTAL,COPYRIGHT,COX,DIET,INC,INSTITUTES,LUNG,NIH,OVARIAN,PLCO,SCREENING,SIMILAR,TRIAL,WOMEN
102,2011,2013,AIM,BACKGROUND,BETWEEN,LABEL,LATE,METHODS,NOVALIS,OAR,OBJECTIVE,RESULTS
034,169,2015,BACKGROUND,CONCLUSION,COPYRIGHT,INC,LABEL,MET,METHODS,PHASE,PROGRAM,RCC,RESULTS,SIX
169,2014,3DCRT,4CGY,5CGY,6CGY,7CGY,8CGY,COPYRIGHT,IMRT,INC,INSTEAD,LARGE,MEDICAL,OAR,OARS,PLDR,PTV,PUBLISHED,THESE,TREATMENT,V18,V30,V40,V45
005,124,169,2014,277,366,AGE,BACKGROUND,BED,CONCLUSION,COPYRIGHT,COX,GLEASON,IIEF,IRELAND,LABEL,LTD,MATERIALS,MEIER,METHODS,OBJECTIVE,PURPOSE,RESULTS
0001,0002,0046,0068,0303,0389,151,BACKGROUND,BCR,BPH,FRESH,GLEASON,LABEL,METHODS,MSP,PCR,PSA,RESULTS,SCORE
BEAMNRC,CARLO,CASE,DATA,DOSXYZNRC,III,IMRT,LABEL,MERT,METHODS,MEV,MLC,MONTE,OBJECTIVE,PET,PTV,PURPOSE,RESULTS,SIEMENS,THESE,THREE,TPS
176,177,180,500,AFTER,EXTRACTED,HOWEVER,LABEL,METHODS,OBJECTIVE,OTPS,OVERALL,PURPOSE,RESULTS,RIS,SDI
177,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,USING
COMPOSITE,DVH,LABEL,METHODS,OBJECTIVE,OTHERWISE,PURPOSE,RESULTS,THESE,VOXELWISE
138,2009,2010,ALA,APRIL,BACKGROUND,DRE,GLEASON,HOWEVER,LABEL,METHODS,PAST,PCA,PDD,PPD,PPIX,PSA,RESULTS,URINE
169,2014,945,946,C2GNT,FINALLY,GCNT1,GCNT3,GLEASON,GM130,GOLGI,GORASP1,GRASP65,IIA,LABEL,MYH9,PDIA3,PLK3,RAB6A,ST3GAL1,UNLABELLED
169,2014,BIOLOGY,DBD,EVENTUALLY,FINALLY,INC,LBD,MOLECULAR,PCA,SOCIETY,TREATMENT
169,2014,682,695,8805,BACKGROUND,DATA,GLEASON,LABEL,METHODS,POLYTOMOUS,PREVENTION,PSA,RESULTS,THERE,THESE,TRIAL,VITAMIN
169,2014,AFRICAN,OHD,PCPT,PREVENTION,TRIAL,VITAMIN
107,112,169,1995,2008,2014,357,508,611,CONCLUSION,CONTINENCE,COPYRIGHT,LABEL,LTD,METHODS,OBJECTIVE,PDE,POTENCY,RESULTS,RRP,SCP,SEPTEMBER
035,155,2014,670,CNKI,FAS,MAY,ODDS,OVERALL,STUDIES,THEREFORE,WANFANG
5637,BCL,BID,BIU,BLADDER,CELL,E1A,FAS,FITC,MTT,PSCAE,UPII,UROPLAKIN
160,169,2014,CARLO,COPYRIGHT,D10,D2CC,D90,DOSE,FOCAL,HEMI,INC,LABEL,MATERIALS,MEAN,METHODS,MONTE,MRI,OBJECTIVE,PTV,PUBLISHED,PURPOSE,RESULTS,SOCIETY,SYSTEMATIC,V100
100,160,169,1990,2013,2014,COMMENTARY,COPYRIGHT,DATA,GRADE,HDR,INC,LABEL,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SOCIETY
160,169,177,2013,2014,BRAGG,COPYRIGHT,HOWEVER,LABEL,LTD,MATERIALS,MED,METHODS,OAR,OBJECTIVE,PHYS,PUBLISHED,PURPOSE,RESULTS,SOBP
CD14,FURTHER,HLA,INCREASED,MDSC,MYELOID,TREG,TREGS
169,18F,2009,2011,2014,8805,ADVERSE,COPYRIGHT,DATA,HIGH,INC,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SEPTEMBER,TREATMENT
CELLS,CNV,CTC,CTCS,HIGH,HOWEVER,MYC,OVERALL,REMARKABLY,WHILE
22RV1,MB49,PAE,PAES,PLASMONIC,TAKEN
169,2014,947,COPYRIGHT,ERMAS,INC,PPAR,RESULTS,THESE,TZD,TZDS,WARBURG
169,2014,244,BECAUSE,COPYRIGHT,L1S,SCIENCE
169,2014,AUSTRALIAN,BACKGROUND,BESIDES,COLLEGE,III,LABEL,LEVEL,METHODS,RADAR,RESULTS,ROYAL,TROG,USING,VARIATIONS,ZEALAND
10878,125,169,2001,2009,2014,500,BFS,COPYRIGHT,D90,HORMONE,IRELAND,LABEL,LTD,MATERIALS,MEN,METHODS,MOST,OBJECTIVE,PSA,PURPOSE,RESTAGING,RESULTS,STI,WELLINGTON,ZEALAND
087,104,105,122,147,163,188,1982,2000,2009,209,236,271,305,320,445,641,888,904,982,984,AGE,APC,ASIRC,ASIRW,CHINA,CHINESE,CONTROL,LABEL,LUNG,METHODS,OBJECTIVE,OVERALL,PREVENTION,PROVINCIAL,RESULTS,SEGI
2013,CHENNAI,CONCLUSION,INDIA,LABEL,METHODS,OBJECTIVE,PREVALENCE,RESULTS
001,034,ACC,EBP1,ERBB3,HCC,HOWEVER,KI67,L02,OSCC,SERUM,UNIVARIATE,WESTERN
005,100,169,2011,2014,2015,8804,ACHIEVA,BACKGROUND,CONCLUSION,COPYRIGHT,DIAGNOSTIC,GLEASON,INC,JUNE,LABEL,MARCH,METHODS,PCA,PHILIPS,PSA,RESULTS,SPBX,T1C,TESLA
169,2014,AUSTRALIAN,AUTHORS,COLLEGE,HORMONE,JOURNAL,PHYSICIANS,ROYAL,ZEALAND
946,EMT,NOTCH,NSCLC,TGF,WESTERN,ZEB
239,III,PREVAIL,PSA
169,2014,BACKGROUND,CONCLUSION,CRC,DATA,EIGHT,EXTENSIVE,FURTHER,LABEL,METHODS,OBJECTIVE,PRESS,PUBLISHED,RESULTS,UNIVERSITY
169,2014,946,A2B,ADORA2B,ADP,AMP,ATP,CD44,CD73,GIVEN,ITGB1,LABEL,NT5E,THESE,TREATMENT,UNLABELLED
169,2014,APPL1,CURRENT,LABEL,MICROARRAY,TFR2,TFRC,THERE,THESE,UNLABELLED
ATLAS,BACKGROUND,EPIGENOME,H3K9ME3,HER2,LABEL,METHODS,PRC2,RESULTS,SERVICE,SUZ12,WORKBENCH
2003,AMONG,AREAS,BACKGROUND,COVERED,HBA1C,INJECTABLE,LABEL,MEDLINE,METHODS,OPINION,RCTS,SIMILAR
1995,2009,CHINESE,CONCLUSION,HONG,KONG,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
169,2014,650,8201,8805,BACKGROUND,COPYRIGHT,DISEASE,HOWEVER,JOHN,LABEL,LTD,METHODS,OBJECTIVE,PURPOSE,RESULTS,SONS,THEREFORE,WILEY
AMONG,BACKGROUND,DIFFERENT,EGFR,EPIDERMAL,ESR1,HPC,LABEL,METHODS,MYC,PPIN,RESULTS,SP1
0001,108,169,174,1999,2012,2015,500,918,COPYRIGHT,COX,EDUCATION,GLEASON,INC,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PHOENIX,PRIMARY,PUBLISHED,PURPOSE,RESULTS,RISK,SB200,SB500,SECONDARY,SONABLATE,T1C,UROLOGICAL
108,150,169,186,2013,2015,294,COPYRIGHT,EDUCATION,GLEASON,HOWEVER,INC,LABEL,MATERIALS,MCNEMAR,METHODS,OBJECTIVE,OVERALL,PREDICTORS,PUBLISHED,PURPOSE,RADS,RESULTS,SYSTEMATIC,UROLOGICAL
154,8805,ERG,GLEASON,PCA3,PHI,PSA,TMPRSS2,UNIVARIATE
169,2010,2013,2014,COPYRIGHT,GERIATRIC,LTD,SIOG,SOCIETY
169,2014,COPYRIGHT,LOG,SAS
150NM,169,2014,AFM,BACKGROUND,CD44,CDDP,CONCLUSION,COPYRIGHT,CSC,CSCS,DSC,FTIR,LABEL,METHODS,MTS,PDI,RESULTS,SEM,SPHERICAL
169,2014,AKT,COPYRIGHT,EOC,HIPPO,HOSE,HOWEVER,HYPOXIA,HYPOXIC,INC,LATS1,PDZ,S127,S69,SKOV3,TAZ,YAP,YES
ALDH1L1,BAK,BAX,BCL,BH3,BID,JNK,JNK1,JNK2,JNKS,JUN,T59,T59D,THR59
599,AFRICAN,EXTENSIVE,GENUINE,GLY,PAR,PCA,SCID,SER,SILENCING,THERE,THESE
181,8482,8805,BACKGROUND,CONCLUSION,DU145,HOWEVER,LABEL,METHODS,MIGRATORY,PC3,PNT,PNT2,RESULTS,WST
125,145,8804,ACUTE,ADVERSE,AIMS,BACKGROUND,GRADE,LABEL,METHODS,OBJECTIVE,RESULTS,TOXICITIES,USING
2009,2011,ADT,AIMS,APRIL,BACKGROUND,CASTRATION,CGA,CONCLUSION,JANUARY,LABEL,LHRH,METHODS,OBJECTIVE,PSA,RESULTS,SEVERAL,THERAPY,TIME,TOTAL
223,946,THESE
035,118,160,170,946,954,BOTH,COX,HIGH,IFN,THERE
225,803,BACKGROUND,BELEM,BRAZILIAN,HIV,HTLV,LABEL,METHODS,PAR,PCR,RESULTS,STATE,THERE,XENOTROPIC,XMRV,XRMV
004,005,026,040,100,169,2014,205,AIM,ANTICANCER,CAB,CONCLUSION,COPYRIGHT,GLEASON,INSTITUTE,JOHN,LABEL,METHODS,NTX,OBJECTIVE,PSA,RESULTS,ZOL
001,100,169,2014,5X4,8805,AIM,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,INSTITUTE,JOHN,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,RESULTS,SIX,WBI
169,2001,2009,2014,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,CRPC,DATA,IMRT,INSTITUTE,JOHN,LABEL,METHODS,OBJECTIVE,PSA,RESULTS,SEPTEMBER,SIB
169,2003,2010,2014,203,560,ADT,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,DOSE,INSTITUTE,JOHN,LABEL,MEIER,METHODS,OBJECTIVE,RESULTS,THERE
169,2014,956,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,DEX,INSTITUTE,JOHN,LABEL,LOWER,MATERIALS,METHODS,PC3,RESULTS,RWPE
169,2014,5336,8764,AACR,CONSISTENT,METADHERIN,MTDH,RES,TRAMP
007,164,1998,2004,291,8201,873,BACKGROUND,GLEASON,LABEL,MATERIALS,METHODS,PHOENIX,PPB,PSA,RESULTS,RRP,THREE,USING
HOWEVER,THEREFORE
169,2014,946,AKT,BALB,BIOMEDICAL,BOARD,CDC,CHINA,CONCLUSION,COPYRIGHT,EDITORIAL,ELISA,HOWEVER,HVJ,IFN,JAK,JAPAN,JNK,LABEL,MAPK,MAPKS,METHODS,MOI,MTT,NEXT,OBJECTIVE,PARP,PC3,PUBLISHED,RESULTS,STAT
BACKGROUND,DESPITE,LABEL,MEN,METHODS,RECEIVING,RESULTS
169,2014,COPYRIGHT,HOWEVER,INC,MOSBY,MRI,SCREENING
001,002,008,009,011,014,022,023,210,542,8211,8360,CAUCASIAN,DESPITE,GLN,GLU,GLU185GLN,NBS1,OVERALL
145,956,ALGAL,CHLORELLA,EVEN,FLOW,INCREASED,THEREFORE
PREVAIL
159,160,1994,2002,946,956,MAX
169,2014,COPYRIGHT,GIVEN,HOWEVER,INC,MEN,PCA,TST
169,2014,8804,AFTER,AUTHORS,BACKGROUND,COPYRIGHT,DISCUSSION,EARLY,EPIC,FACT,FOCAL,GLEASON,IDEAL,IIEF,INC,INCLUSION,IPSS,IRE,LABEL,MAX,METHODS,MRI,NEAT,PSA,PUBLISHED,TREATMENT,UCLA
945,AKT,BACKGROUND,COCL2,FURTHER,HIF,INHIBITION,LABEL,MALIGNANT,METHODS,PC3,RESULTS,SURGERY
8197,ARYL,GRP78,HCC,LIVER,TGF,VEGF
2011B,945,AKT,FURTHER,HOWEVER,ISA,KINOMESCAN,PC3,PI3K,PIP5K,PNT1A,THUS
HOWEVER,PCA,PROVIDING,THEREFORE,TREATMENT
169,2014,BECAUSE,ELDERLY,SOCIETY,THEREFORE,THESE
APOPTOSIS,ASOS,BIRC6,CRPC,IAP,INHIBITOR,NFKB,TREATMENT,XIAP
145,264,AGP,APOPTOSIS,BAX,BCL,BID,CDK,CDK1,CDK4,CONCLUSION,DU145,FITC,FLOW,FMK,HOWEVER,IETD,INSTITUTE,LABEL,LNCAP,METHODS,MTT,NCI,OBJECTIVE,PURPOSE,RAW,RESULTS,SIMILAR,SRJ23,TAKEN
0001,177,188,295,590,8201,ALSO,CONCLUSION,EDTMP,III,KARNOFSKY,KPS,LABEL,MBQ,METHODS,NONSERIOUS,OBJECTIVE,PAIN,PURPOSE,RESULTS,THERE,VAS
169,2014,260,AGE,ANXIETY,ASSESSMENT,AUTHORS,BJU,DEPRESSION,FUNCTIONAL,HRQL,INVENTORY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OUTCOME,OVERALL,PEARSON,RESULTS,SCALE,STATE,THERAPY,TRAIT
160,CRPC,ERK,EXTENSIVE,MEK,PI3K,RAF,RAS,THERE,TREATMENT
107,120,169,2014,AUSTRALIAN,AUTHORS,BJU,HIGH,LABEL,MDM,MDMS,METHODS,OBJECTIVE,OBJECTIVES,PRIMARY,RESULTS
150,200,DESPITE,HOWEVER,PSA,TST
160,8209,945,AFTER,AMPK,BAD,DU145,FLOW,INHIBITION,RNAI,TRANSWELL,UBIQUITIN,UPS,USING
178,8314,AREAS,BACKGROUND,COVERED,INCREASED,LABEL,METHODS,OPINION,TRP,TRPM7
8209,CARCINOMA,EMT,GLI1,HOWEVER,LNCAP,LPS,PCA,THESE
HAFP
2PROPSA,2PSA,BESIDES,INDEX,PSA
195,956,A2780,A549,ESI,G361,HELA,HOS,IC50,LNCAP,MCF7,NMR
169,2015,BLADDER,COPYRIGHT,EDUCATION,HOWEVER,INC,INDEX,INVENTORY,LABEL,MATERIALS,MEN,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SECONDARY,THERE,URINARY,UROLOGICAL
169,179,2015,314,833,COPYRIGHT,COX,DATA,EDUCATION,INC,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PLCO,PUBLISHED,PURPOSE,RESULTS,SCREENING,THOSE,UNIVARIATE,UROLOGICAL,WHITE
128,169,1700,2014,8805,BACKGROUND,BECAUSE,CAB,CONCLUSION,COPYRIGHT,DRUG,FOOD,GLEASON,INC,LABEL,METHODS,PSA,RESULTS
169,2014,AUTHORS,COPYRIGHT,DESPITE,EPIGENOME,INC,PUBLISHED
000,100,120,169,2013,2014,2025,710,BACKGROUND,CONTINUED,CONTINUING,LABEL,METHODS,PSA,RESULTS,SOCIETY
HORMONE,MPA,OPG,RANK,RANKL,THESE
BONE
169,2014,COPYRIGHT,H3K4ME3,H3K9ME1,INC,JMJC,NSCLC,PHF8,TSSS
130,169,2014,AFM,BACKGROUND,BOTH,CRPCA,CSPCA,CTC,CTCS,INC,LABEL,METHODS,PEAKFORCE,QNM,RESULTS,WILEY
169,2014,ADENOVIRAL,ASSAY,BACKGROUND,CTC,CTCS,E1A,HOWEVER,INC,LABEL,LUCIFERASE,METHODS,MLUC,PBN,PCA,PSE,RESULTS,THEREFORE,VIRAL,WILEY
10878,135A,135A2,8201,AFTER,GLEASON,LNCAP,PCA,PCR,R1881,ROCK1,ROCK2,THEREFORE,THROUGH,USING
409,DIO3,DLK1,RAS,RNAS,STRIKINGLY,THEREFORE,THUS
3758309,AKT,FURTHER,LYN,MAPK,MEK,PAK2,PC3,YAP1
169,2014,945,BRITAIN,COPYRIGHT,GREAT,HIF,HOWEVER,IRELAND,JOHN,LTD,PUBLISHED,RACK1,SOCIETY,SONS,THESE,TRPM8,WILEY
160,177,2005,2009,904,962,BACKGROUND,CONCLUSION,GREATER,INTERVIEWS,LABEL,MEN,METHODS,ORS,PCA,RESULTS,SIMILAR,THESE
AGENT,OVERALL,TCDD,VIETNAM,WAR
201,227,587,8201,ARG194TRP,CAUCASIANS,HENCE,OVERALL,XRCC1
169,2014,BACKGROUND,COMPLIANCE,COPYRIGHT,IMRT,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PRE,PURPOSE,RESULTS,WHILE
150MG,169,2014,COPYRIGHT,DIETARY,IIB,INC,LC3,PIPER,ROS
001,003,004,007,100,169,2001,2012,2014,459,AIDS,BACKGROUND,CCI,CD4,CONCLUSION,EXCLUDING,FEWER,HIV,LABEL,METHODS,NETWORK,RADICAL,RESULTS,UNDER
001,002,015,169,2013,2015,718,APRIL,COPYRIGHT,EDUCATION,INC,JUNE,LABEL,MATERIALS,METHODS,OBJECTIVE,POST,PUBLISHED,PURPOSE,RESULTS,RISK,UROLOGICAL
001,509,700,ARN,CASTRATION,CYP17,DHT,FINALLY,GALETERONE,HOWEVER,III,NEWLY,ORTERONEL,PERSISTENT,RESISTANT,TAK,THERE,TOK
008,015,169,177,2014,265,963,AIM,COLLEGE,CONCLUSION,COPYRIGHT,LABEL,LTD,MEAN,METHODS,MRI,OBJECTIVE,PUBLISHED,RESULTS,ROYAL,TEN,THERE,THESE
125,144,169,2005,2007,2014,8805,AUM,DU90,DUD90,DUP90,GRADE,JANUARY,JAPAN,NONE,PRESS,PUBLISHED,RADIATION,SOCIETY,UNIVARIATE,UNIVERSITY,URINARY
169,2014,DICER,GIVEN,SOCIETY,UTRS
150,174,8201,CARE,HEM,LABEL,MEDICAL,METHODS,OBJECTIVE,PARK,PATIENT,RESULTS,RVF
DBD,FDA,FURTHER,PCA,SITE,THROUGH
HOWEVER,PRACTICAL,TURP
582,993,AAS,AFRICAN,AMERICANS,ANOTHER,CAS,CAUCASIAN,GRM1,PCA,PCR,PRO,SER,SNP,SNPS,THESE,UTR,UTRS
116,169,2014,205,431,923,936,956,A549,COLO,COPYRIGHT,H322,HCT,IC50,MTT,NCI,SAS,SKIN,T47D
169,2014,956,BESIDES,CONCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,POCC,PURPOSE,REGIONS,RESULTS,RSNA
8201,BTC,COIL,CONCLUSION,HIR,KNOWLEDGE,LABEL,METHODS,MRI,OBJECTIVE,RESULTS
100,150,169,2014,PCA,PCSGS,RESULTS
2012,AMONG,BACKGROUND,BASED,CARE,CASE,CDSR,CONCLUSION,DARE,ECONLIT,EXCELLENCE,HTA,INSTITUTE,JULY,LABEL,LYS,MEDLINE,METHODS,NICE,OBJECTIVE,OBJECTIVES,OTHER,QALYS,REFERENCE,RESULTS,SIMILARLY,STUDIES,USA
169,2014,COPYRIGHT,IMAGING,LTD,MSC,RESONANCE,SINCE,THESE,TRAMP
22RV1,8209,A10,B10,C10,COMPOUNDS,CWR,DHT,E10,F10,LNCAP,SEVERAL
1989,2008,233,8073,BACKGROUND,BESAG,CASE,CONCLUSION,LABEL,METHODS,MOLLI,RESULTS,SPAIN,YORK
169,2014,699,AFTER,BACKGROUND,LABEL,MEN,METHODS,PSA,PSAV,RESULTS,USING
169,2014,221,8201,8804,8805,AUTHORS,BJU,CCL,CONCLUSION,GLEASON,GROUP,HOWEVER,JOHN,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,OCD,PUBLISHED,RESULTS,SONS,UNIVARIATE,WILEY
100,1101,117,150,160,169,197,1985,2013,2014,436,449,8804,AUTHORS,BJU,CONCLUSION,DISEASE,DISTANT,DSS,GLEASON,JOHN,JULY,LABEL,LTD,MARCH,MEIER,METHODS,MFS,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,SONS,WILEY
145,AKT,ALSO,BACKGROUND,CONCLUSION,CRPC,DOCETAXEL,ERK,HOWEVER,LABEL,MATERIALS,METHODS,PI3K,RESULTS,THEREFORE
404,669,AUC,BETWEEN,BPH,CAP,DOR,FIFTY,HOWEVER,META,MICRORNAS,NLR,PLR,RESULTS,SEN,SPE,THEREFORE
947,AGILITY,COMPLIANCE,CONCLUSION,DHVS,DMEAN,DOSE,FURTHER,IMRT,LABEL,METHODS,MLC,MLCI2,OAR,OARS,OBJECTIVE,PTV,PTVS,PURPOSE,RESULTS,STOCKHOLM,USING,VMAT
008,011,160,177,8201,CONCLUSION,FAB,FDG,HSG,IMMUNOPET,LABEL,METHODS,OBJECTIVE,PC3,PROCEDURES,PURPOSE,RESULTS,TF12,TROP
169,2014,AIMS,CENTRAL,COLLEGE,CONCLUSION,COPYRIGHT,ENGLISH,HORMONE,LABEL,LIBRARY,LTD,MATERIALS,MEDLINE,METHODS,OBJECTIVE,OPTIMAL,PREMEDLINE,PUBLISHED,RESULTS,ROYAL,SCI,SCIENCE,SSCI,WEB
001,005,031,045,047,8201,CDX2,CEA,CK20,CK7,DAC,EGFR,ERG,GLEASON,HMWCK,PAX,PSA,PSAP,PSMA,PTEN,WHILE
169,2013,2014,288,4852,5141,ABSTRACTS,CONCLUSION,COPYRIGHT,CRD,DARE,DESPITE,ECONLIT,EED,HTA,IRELAND,JUNE,LABEL,LTD,MEDLINE,METHODS,MRI,NHS,OBJECTIVE,PET,PRE,PSA,RESULTS,RISK,SIX,TRUS
001,169,2005,2013,2014,8804,8805,AMONG,CONCLUSION,COPYRIGHT,GLEASON,INC,LABEL,METHODS,OBJECTIVE,RATES,RESULTS,T1C,THESE
0001,169,2011,2014,228,509,8201,8805,AIM,ART,BACKGROUND,DESPITE,HOWEVER,JUNE,LABEL,MAIN,MEN,METHODS,OBJECTIVE,OUTCOME,PDE5I,PRIOR,RESULTS,SOCIETY,THERE,UNTREATED,WHILE
169,2014,8201,946,ADJUSTMENT,ADT,AIMS,APC,ASSESSMENT,BACKGROUND,COMPOSITE,DEPRESSION,FACTORS,FUNCTIONAL,GENERAL,GREATER,INDEX,LABEL,MAIN,MEN,METHODS,OBJECTIVE,OUTCOME,PEARSON,QOL,RESULTS,SCALE,SOCIETY,STUDIES,THERAPY
169,2014,COPYRIGHT,ETS,LTD,MATH,POZ,SPECKLE,SPOP,TRAF
DISEASE,HOWEVER,IDR,IDRS,SLIM,SLIMS,THEREFORE
FINALLY,HIGH,PATHWAY,THESE,THROUGH
169,2014,AFTER,BIOLOGY,DPP4,HOWEVER,INC,MOLECULAR,SOCIETY
100,147,196,EARLY,NSRRP,PDE5,POTENCY
0001,174,2008,2011,269,6854,8805,ALPHA,ASSOCIATED,BACKGROUND,CTCAE,CYBERKNIFE,EPIC,GEORGETOWN,GRADE,HOWEVER,IPSS,JULY,LABEL,LATE,METHODS,OVS,PATIENT,PRIOR,RESULTS,SBRT,TRANSIENT,TREATMENT,TURP,UNIVERSITY
AD5,DETECTION,FOLLOWING,GLEASON,ID1,PSA,SEAP,THESE
AUGMENTED,MMP9,PC3,SMAD3,TAKEN
160C,2014,APRIL,CHINESE,CIS,CNKI,HOWEVER,KNOWLEDGE,LIBRARY,ORS,SCIENCE,WEB
002,008,011,018,024,061,087,101,105,110,113,169,2014,230,AAM,AFRICAN,CAM,CAUCASIAN,ERG,FISH,FURTHER,GLEASON,LABEL,METHODS,OBJECTIVE,PTEN,PURPOSE,RESULTS,SPOP
169,2014,240,536,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,UROLOGICAL,USA
169,2014,ADT,ENDOCRINE,SOCIETY
RNAS
PRL,PRLR
2005,2012,954,BETWEEN,CONCLUSION,GLEASON,INTERRATER,JANUARY,JUNE,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PREBIOPSY,PSA,RESULTS
FINALLY,HOF,PREDICTIVE
100,8201,BECAUSE,DETECTORS,HOWEVER
169,2014,AFRICAN,AGE,AGER,GLYCATION,RAGE
594,AFTER,AMONG,CIS,FURTHER,GSTP1,ORS,PCA,RARB,WANFANG
169,1995,2010,2014,258,415,AMONG,CIS,COX,DRUG,EHR,EHRS,HRS,LABEL,MAYO,MEDICAL,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,THESE,UNIVERSITY,USING,VANDERBILT
169,2014,COPYRIGHT,DEGARELIX,GNRH,JOHN,LTD,PEPTIDE,SOCIETY,SONS,WILEY
169,2014,BACKGROUND,CD3,CD4,CD8,HOWEVER,INC,LABEL,METHODS,PSCA,RESULTS,SIMILAR,THERE,WILEY
169,2014,BACKGROUND,INC,LABEL,METHODS,OVERALL,PSCA,PSMA,RESULTS,SIMILAR,TMS,WILEY
146A,148A,169,2014,34A,598,AUTHORS,BACKGROUND,BCL,DOCETAXEL,FOLLOWING,INC,LABEL,METHODS,RESULTS,SNCA,USING,WILEY
100,169,2014,231,8201,8764,BACKGROUND,CAFS,CONCLUSION,ERGETGP,FAP,FURTHER,INC,LABEL,LCMS,LNCAP,MCF,MDA,METHODS,MICROMOLAR,RESULTS,THESE,WILEY
1286,160,169,2014,438,684,8804,AUTHORS,BJU,GLEASON,INCREASING,JOHN,LABEL,LTD,MEN,METHODS,NCCN,NETWORK,OBJECTIVE,PSA,PUBLISHED,RESULTS,SONS,T1C,WILEY
169,2014,257,502,BACKGROUND,INC,LABEL,METHODS,PFS,PRIOR,PSA,PSA30,PSA50,RESULTS,THERE,THEREFORE,TREATMENT,WILEY
169,177,2014,8764,BACKGROUND,DIETARY,GPX3,INC,KCAL,LABEL,METHODS,PIN,RESULTS,SIX,TRAMP,WESTERN,WILEY
169,2014,916,946,ALTERED,BMP,FURTHER,HTY,NOTABLY,PC3,RUNX2,SMAD,SMADS,TGF,THUS,UICC
776,790,946,947,AE36,AE37,DTH,IFN,TGF,THESE,USING
AIMS,CONCLUSION,FIVE,LABEL,METHODS,OBJECTIVE,PHASE,RESULTS
655,ASSESSMENT,ENCOUNTER,GAQ,HOWEVER,IIEF,INDEX,NERVE,PCA,PDE5,PROFILE,SEP,TEAES,THEREFORE,USING
100,169,2014,8202,956,BALB,CASTRATION,PC3,SOCIETY,WHETHER,ZOL
ARGON
169,2014,COPYRIGHT,FINALLY,PUBLISHED,SAS
145,2GY,AAS,DU145,FOLLOWING,FURTHER,HOWEVER,MEGA,PLGA,THUS
160,BORTEZOMIB,E3S,PC3,UBIQUITIN,WWP1
169,2014,COPYRIGHT,DIETS,LTD,WHEREAS
169,2014,AKT,AMD,AMN,AMONG,COPYRIGHT,DME,FURTHER,HENCE,IRELAND,LNCAP,LTD,METASTATIC,PCA,PHE,PI3K
169,2014,ADC,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,MATERIALS,METHODS,MRI,NPV,OBJECTIVE,PSA,RESULTS,SMALL,TRUS
CURRENT,CURRENTLY,EVEN,PCA,PSA
4TH,ACCORDING,GIVEN,GROSS,LABEL,METHODS,OBJECTIVE,RESULTS,THREE
145,169,2014,486,687,956,AIM,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,DELINASIOS,INSTITUTE,JOHN,LABEL,MATERIALS,METHODS,NCI,OBJECTIVE,PROGRAM,RESULTS,USPTO
AMONG,BOTH,CRPC,DRUG,FDA,RESISTANCE,SEVERAL
001,061,406,572,8201,BACKGROUND,DOCETAXEL,LABEL,PNP,RESULTS,UPON
009,169,2014,220,AHS,BACKGROUND,EIGENSOFT,FARMING,IBD,INBREEDING,IOWA,LABEL,METHODS,NORTH,PLINK,RESULTS,SNPS,THESE,WHITE
169,2014,231,945,954,COPYRIGHT,GOD,MDA,MOST,RANK,RANKL,SAS,THUNDER,THUS,TRIPTOLIDE,U266,VINE
115,131,166,169,2006,2010,2014,BETWEEN,CARE,COPYRIGHT,D90,FINALLY,INC,MEDICAL,PUBLISHED,V100,V150
1980,2010,559,718,8202,BACKGROUND,CONCLUSION,INCREASED,LABEL,METHODS,PCA,RESULTS,SIR,SIRS,SITE,THERE
169,2004,2013,2014,750,ADT,AUSTRALIA,AUTHORS,BJU,CONCLUSION,COUNCIL,EVEN,GROUP,LABEL,METHODS,OBJECTIVE,RADIATION,RESULTS,SOCIETY,TOAD,TRANS,UROLOGICAL,USANZ,ZEALAND
BACKGROUND,BRCA1,BRCA2,DISCUSSION,FINALLY,HOWEVER,LABEL,METHODS,MOST,MRI,PRIOR,PSA,TRIAL
BACKGROUND,CRPC,CYP17A1,DOC,FRET,FURTHER,LABEL,LAPC4,LNCAP,METHODS,PHASE,RESULTS
001,103,1272,1998,2013,CONCLUSION,EACH,GLEASON,HOLEP,LABEL,MEN,METHODS,OBJECTIVE,OLDER,PSA,RESULTS,SEVENTY
140,160,169,2014,COPYRIGHT,COX,DHH,EDUCATION,GLI1,GLI2,GLI3,IHH,INC,KI67,LABEL,LIMITED,MATERIALS,METHODS,OBJECTIVE,PTCH1,PUBLISHED,PURPOSE,RESULTS,SHH,SMO,UROLOGICAL
III,IPILIMUMAB,JUNE,KWON,PERHAPS,WHILE
169,2014,COPYRIGHT,INNOVATIVE,LTD,SEVERAL
169,2014,AUTHORS,BJU,HOWEVER,JOHN,LTD,PATIENT,PUBLISHED,SONS,THERE,WILEY
001,007,025,1000,115,154,1596,1649,169,2000,2011,2014,2163,500,8201,AUTHORS,BAUS,BJU,BRITISH,CONCLUSION,CONTINUOUS,EBL,JANUARY,LABEL,LRP,MANN,METHODS,MOST,OBJECTIVE,ORP,OVERALL,PEARSON,PSM,RALP,RESULTS,RPS,THERE,UNIVARIATE,UROLOGICAL,WHITNEY
169,2014,APMIS,JOHN,LTD,PUBLISHED,SONS,WILEY

169,2014,AUTHORS,BJU,CONCLUSION,GROUP,IRLA,LABEL,METHODS,OBJECTIVE,PNB,PPB,PSA,RESULTS,THERE,TRUS,VAS
001,177,2012,2014,BETWEEN,CLAVIEN,CONCLUSION,DINDO,FATTY,III,LABEL,MAY,MEAN,METHODS,OBJECTIVE,PURPOSE,QOL,QUALITY,RALP,RALPS,RESULTS,THERE
2007,2013,2014,2344,4688,791,8201,8805,893,AGREEMENT,CONCLUSION,DETECTION,EVEN,GLEASON,GOVERNMENT,LABEL,METHODS,MRI,OBJECTIVE,PER,PSA,PUBLISHED,RESULTS,USA
17P13,LOH,LOSS,LOW,REN
018,188,2011,268,JANUARY,JUNE,LABEL,MATERIALS,METHODS,OBJECTIVE,OTHER,PSA,PURPOSE,RESULTS,THEREFORE,TRUS
115,1990,2014,FURTHER,INDEX,JANUARY,PCA,PHI,PSA,THESE,THUS
001,100,141,169,182,2014,215,8201,874,8805,BACKGROUND,CONCLUSION,CS7,GS6,INC,LABEL,METHODS,MRI,NPV,RESULTS,SEVENTY,UPGRADING,WILEY
169,2014,CONCLUSION,GMBH,KGAA,LABEL,METHODS,NETWORK,OVERALL,RESULTS,SCOPE,SFN,SP1,VCH,WILEY
169,2014,COPYRIGHT,HODGKIN,JOHN,LTD,SONS,TYPE,WHEREAS,WILEY
169,17Q21,2014,215,678,8201,853,8Q24,AFRICAN,ASIAN,FURTHER,UICC
0001,160,169,186,2014,AUROC,AUTHORS,BIOMARKERS,C1M,COPD,ECM,ELM,IMF,IPF,JOHN,LTD,MMP,SONS,VICM,WILEY
169,2014,8197,GMBH,KGAA,MTSB,VCH,WILEY
169,2014,8201,916,968,CELLS,CK2,FURTHER,INC,RESULTS,TBB,TBCA,THUS,UTILIZING,WILEY
169,2014,ACTIVATION,BACKGROUND,CONCLUSION,CRPC,DHT,DU145,ENDOGENOUS,INC,LABEL,LNCAP,METHODS,PC3,PCR,RESULTS,RU486,SIMILARLY,STAT5,USING,WESTERN,WILEY
001,107,120,136,169,2014,8201,BACKGROUND,EXPRESSION,HGPIN,INC,LABEL,METHODS,MOUSE,PCA,PI3K,PIA,RESULTS,THESE,WILEY
150,169,2014,8764,945,946,AFTER,ALA,ASP,BASED,COPYRIGHT,DGEA,DOTA,GDVO4,GLU,GLY,LTD,MRI,NSS,PAA,PET
100,169,2014,BACKGROUND,BLOOD,CRPC,CTCS,ERG,INC,KLK3,LABEL,METHODS,PBMC,PCA3,RESULTS,TMPRSS2,WILEY
169,201,2012,2014,231,COPYRIGHT,ESUR,PUBLISHED,SAS
AKT,CD117,CSC,PI3K,RAS,SIMILARLY,ZEB1
169,2014,ANNEXIN,APOPTOSIS,ATG5,AUTOPHAGY,BACKGROUND,CAP,CELL,HNK,HOWEVER,INC,LABEL,LC3,LNCAP,METHODS,MITOSOX,MYC,PEG,RESULTS,ROS,WILEY
100,110,169,2014,300,8201,BACKGROUND,CRPC,ERG,FISH,HOWEVER,IHC,INC,LABEL,METHODS,PSA,RESULTS,THESE,THUS,TMA,WILEY
169,2014,COPYRIGHT,IRELAND,LTD,LUNG,WNT
169,2014,945,946,BRITAIN,CAFS,COPYRIGHT,CXCR4,GREAT,IRELAND,JOHN,LTD,MAST,NPFS,PCA,PUBLISHED,SOCIETY,SONS,THERE,WILEY
169,2014,AIM,BACKGROUND,BRCA,BRCA1,LABEL,METHODS,OBJECTIVE,RESULTS,SOCIETY,TRANS
169,2000,2001,2004,2009,2014,AMONG,BACKGROUND,END,LABEL,METHODS,RESULTS,SEER,SOCIETY,SUBSTANCE
008,169,2005,2006,2013,2014,233,BPR,CONFERENCE,CONSENSUS,COPYRIGHT,COX,DEPARTMENT,EDUCATION,GLEASON,GMBH,HOWEVER,PATHOLOGY,PSA,SOCIETY,THERE,UROLOGICAL
066,1000,111,169,2009,2013,2014,250,500,BACKGROUND,COPYRIGHT,CYP17,DATA,LABEL,LOW,LTD,MARCH,METHODS,OBJECTIVE,OUTCOME,PSA,RESULTS,THERE,THESE
032,049,169,1991,2007,2014,8804,8805,AMONG,BACKGROUND,END,GLEASON,LABEL,LIFE,MEN,METHODS,OVERALL,RESULTS,SOCIETY
006,014,169,194,2005,2009,2014,249,349,741,967,AFTER,AMICO,COX,DESPITE,DUKE,LABEL,MEAN,MEDICAL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,UNIVERSITY,UROLOGICAL
103,124,169,177,201,2012,2013,2014,8201,8804,8805,AUTHORS,BJU,CONCLUSION,GLEASON,JULY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,RADS,RESULTS,TESLA,TPSB,TPSBS
001,002,003,012,013,023,028,045,047,048,056,097,108,135,136,159,170,2014,203,204,228,261,269,278,281,338,346,356,414,447,474,562,566,661,768,786C,789,892,APRIL,CHINA,CNKI,EBSCO,G894T,INCREASED,KNOWLEDGE,OVERALL,SCHOLAR,THEREFORE
001,016,021,100,BACKGROUND,IRAN,LABEL,MATERIALS,METHODS,PCA,REGRESSION,RESULTS
027,072,123,154,169,2014,224,370,372,418,433,435,518,524,8201,907,960,990,GENOMIC,LABEL,MET160VAL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THERE,TMPRSS2,UROLOGICAL
25D,945,RNAS,THEREFORE,VDRES,VITAMIN
169,2014,468,CHRONIC,COEXISTING,JOHN,LTD,MPN,NORWEGIAN,PUBLISHED,QUALITY,SEVERAL,SONS,SPR,SPRS,SWEDISH,WILEY
100,108,ADC,AMONG,BPH,FURTHER,GLEASON,HIGHEST,IRB,LABEL,MAPPING,MATERIALS,METHODS,MRI,NPV,OBJECTIVE,PPV,PURPOSE,RESULTS
CARCINOMA,METASTATIC,OTHER
036,154,1993,2011,897,COLORECTAL,CONSENT,COVARIATES,INC,LABEL,LUNG,METHODS,NON,OBJECTIVE,ORS,OVARIAN,PLCO,PUBLISHED,RESULTS,SCREENING,TRIAL,USING
147,2008,2011,8805,EIGHT,LNS,LYMPH,MAY,WHILE
MUCP,RARP,SEVERAL,THESE,URINARY,URODYNAMIC
036,043,1036,179,215,8315,917,CHINESE,ELISA,HAN,PCA
169,2014,BOTH,COPYRIGHT,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SOCIETY
000,169,2014,COPYRIGHT,CURRENT,EARLY,FOCAL,INC
546,FINALLY,THESE,UTRS
0325901,AZD6244,CCLE,CELL,ERK,FINALLY,HDAC,HOWEVER,IRINOTECAN,LINE,MAP,MDR,MEK,NOTABLY,PIONEERING,STAT,TOP1,TOPOTECAN,USING
275,BASED,BLP,CROSS,FINALLY,HDAC,HDAC1,INTEGRATED,LIBRARY,LINCS,MCF7,NETWORK,PC3,SIGNATURES
11C,120,2007,2011,250,CTAC,GLEASON,LABEL,METHODS,OBJECTIVE,PET,PSA,PSAV,PURPOSE,RESULTS
0001,160,2011,544,COX,HOWEVER,LABEL,MCNEMAR,MEIER,METHODS,MSCC,OBJECTIVE,PURPOSE,RESULTS,REVISED,TOKUHASHI
001,004,136,169,2007,2012,2014,339,8804,APRIL,CHART,COPYRIGHT,GOC,HOSPICE,INC,INPATIENT,JULY,LABEL,MATERIALS,METHODS,MOST,OBJECTIVE,ONCOLOLOGY,PURPOSE,RADIATION,RATES,RECORDS,RESULTS,SOCIETY,THESE
001,169,2007,2011,2014,8601,898,BCCA,BRITISH,COPYRIGHT,DESPITE,FURTHER,INC,KINGDOM,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SFRT,THERE
0001,032,139,169,2014,8804,AMONG,AUTHORS,CONCLUSION,COPYRIGHT,COX,GENOMIC,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PSA,PUBLISHED,PURPOSE,RESULTS,STEPHENSON,STRATIFIED
1000,169,2014,261,8805,AUC,COPYRIGHT,DVH,INC,KUTCHER,LABEL,LKB,LYMAN,MATERIALS,METHODS,NTCP,OBJECTIVE,PARAMETERS,PREDICTIVE,PURPOSE,RESULTS
0001,100,1287,169,2014,215,2969,AUCS,BECKMAN,COPYRIGHT,COULTER,CURRENTLY,DATA,INC,META,PCA,PHI,PSA
0003,0004,0005,001,003,177,CONFIDENCE,FIVE,FOLLOWING,GLEASON,HIPAA,INDEX,IRB,LABEL,MATERIALS,METHODS,OBJECTIVE,PCA,PURPOSE,REFERENCE,RESULTS
169,2014,COPYRIGHT,DIGITAL,FINALLY,INC
047,100,103,1929,1998,2009,849,BACKGROUND,CAPTURE,CAUSE,CONCLUSION,DRUG,LABEL,MEN,METHODS,NPCR,PATIENT,PRESCRIBED,RESULTS,SWEDISH,TEN
160,B3LYP,CL3,DACH,FTIR,IC50,III,LANL2DZ,MTT,NMR,PC3,SGC7901,THEIR,VIS
002,003,007,009,021,022,055,8201,8226,DCE,KEY,LABEL,LVA,LVD,LVP,METHODS,MRI,MVA,MVD,MVP,OBJECTIVE,OBJECTIVES,PARAMETERS,PERIPHERAL,RESULTS
CPG,DESPITE,LUNASIN,ROS,RWPE,USING
160,BACKGROUND,CONVERSELY,GLEASON,KEY,LABEL,METHODS,RESULTS,TNM,USING
1992,AMACR,P504S
ADPC,ADT,AIPC,EARLY,EGR1,FURTHER,HOWEVER,ID1,LNCAP,PC3,PCR,WESTERN
000,132,169,2014,ACIDS,CELL,FACS,FISH,FOLLOWING,NUCLEIC,PACS,PCR,PRESS,PUBLISHED,UNIVERSITY
JAPAN,RARP,THESE
169,2014,HOWEVER,MEDLINE,METFORMIN
0257,1541,169,2014,7786,DHT,FINALLY,HOWEVER,LABEL,MCR,RNAS,TAKEN,UNLABELLED
APC,CTLA,DCS,FDA,HOWEVER,MHC,PLGA,TAA,THUS
100,139,169,2014,406,852,GLEASON,LABEL,METHODS,OBJECTIVE,PRESS,PUBLISHED,RESULTS,THESE,UNIVERSITY
100,200,ANNEXIN,CONCLUSION,INJECTION,LABEL,METHODS,MTT,OBJECTIVE,P53,RESULTS,THEN
103,130,233,252,255,422,667,677,CONCLUSION,GLEASON,GS3,ISUP,LABEL,METHODS,OBJECTIVE,PATHOLOGY,RESULTS,SOCIETY,UROLOGICAL
124,AFTER,CONCLUSION,LABEL,LUCIFERASE,METHODS,MTT,OBJECTIVE,PC3,PCR,PKM2,RESULTS,RWPE,UTR,WESTERN
GLEASON,NEXT,THESE
946,AMACR,CK5,E12,ERG,GATA3,GLEASON,HMWCK,IHC,ISUP,NKX3,P501S,PAP,PATHOLOGY,PCA,PSA,SOCIETY,UROLOGICAL
169,2014,590,BACKGROUND,EOS,FINAL,LABEL,METHODS,MONITORING,PCPT,PREVENTION,RESULTS,TRIAL
131,169,2014,205,946,AKT,BCL,CELL,COPYRIGHT,CUR,FURTHER,LTD,MCL,MTS,NPS,PARP,PCR,PLGA,PSMA,STAT3,THUS,WESTERN
174,BOTH,CELLSEARCH,CONCLUSION,CTC,CTCS,FIVE,FOUR,GLEASON,LABEL,METHODS,NEWER,OBJECTIVE,OTHER,PSA,PURPOSE,RESULTS,SAMPLES
0001,10877,128,225,8201,8804,AFTER,BACKGROUND,BIOMARKERS,HOWEVER,KNOWLEDGE,LABEL,METHODS,NADIA,ODDS,PROSVUE,PSA,RESULTS,SELECTING
001,003,011,012,107,131,1998,2011,287,ADT,AFTER,AGE,BACKGROUND,CONCLUSION,COX,LABEL,LOCAL,MEIER,MEN,METHODS,RESULTS,SMALL,TREATMENTS,UPON,USING
233,BACKGROUND,BOTH,FINALLY,LABEL,RESULTS
231,900,HOWEVER,HSPA2,K16,K29,K51,K73,PC3,SENP,SENPS,SENTRIN,SI2,SILAC,SUMO,USING,USP39
005,169,2010,2013,2014,8805,ARTEMIS,COPYRIGHT,EIGEN,FURTHER,GLEASON,GRASS,INC,JANUARY,LABEL,MARCH,MATERIALS,METHODS,MONITORING,MRI,OBJECTIVE,OBJECTIVES,RESULTS,T1C
169,2008,2010,2014,AIMS,BOWEL,COLLEGE,COMPOSITE,CONCLUSION,COPYRIGHT,EBRT,EFFECTS,EPIC,HDR,HIGH,INDEX,JULY,LABEL,LATE,LENT,LTD,MANAGEMENT,MARCH,MATERIALS,METHODS,OBJECTIVE,PATIENT,PUBLISHED,RESULTS,ROYAL,SCORE,SOMA,SUBJECTIVE,SYMPTOM,THERE,TISSUES
263,ABT,ADP,BAK,BAX,BCL,BH3,CRPC,DU145,LENTIVIRUS,MCL,MLN2238,NOXA,PARP,PC3,POLY,PROTEIN
2001,2011,219,434,556,932,CONCLUSION,HOWEVER,IATROGENIC,LABEL,LOS,METHODS,MIS,OBJECTIVE,OPEN,RESULTS,USING
169,2014,CELL,COPYRIGHT,INC
169,2014,CELL,COPYRIGHT,INC,ORAI1
BF3,LNCAP,SEVERAL
1993,2013,EVEN,OTHER,SEVEN,SIXTEEN,THREE
ARTICLE,FOUR,IHC,ISUP,MEMBERS,PATHOLOGY,SOCIETY,SPECIAL,UROLOGICAL
104,168,CNA,FEW,GLEASON,PREVIOUSLY,PRIMARY
169,2014,BMP,COLD,EPIGENETIC,FN1,HOWEVER,IDH1,LABORATORY,MASSIVELY,PRESS,PUBLISHED
169,2014,CXCR4,ECS,G12D,PCA,PRESS,PTEN,PUBLISHED,UNIVERSITY,USA
1800,1900,200,2005,2009,5000,517,6200,900,BETWEEN,CAP,EFFORTS,END,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PATIENT,RESULTS,THERE,TREATMENT,USING
110,180,1992,2009,717,ADT,AMONG,END,IMPORTANCE,LABEL,MAIN,METHODS,OBJECTIVE,PRIMARY,PROGRAM,RELEVANCE,RESULTS,SEER,SETTING
001,004,005,068,2006,2009,2145,8201,AFTER,CASE,END,IMPORTANCE,LABEL,MAIN,MASTERFILE,MEDICAL,METHODS,MIXED,OBJECTIVE,PATIENT,PHYSICIAN,RATES,RELEVANCE,RESULTS,SETTING,TREATED
013,019,033,063,8201,APE1,ASP148GLU,CAUCASIANS,CIS,META,ODDS,ORS,OVERALL,WANFANG
10GY,114,169,192,2001,2009,2014,2NG,45NG,50GY,COPYRIGHT,FOUR,HDR,HDRB,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PSA,PUBLISHED,PURPOSE,RESULTS,SOCIETY,THERE
1000,2010,BACKGROUND,CENTERS,CONCLUSION,CONTROL,DISEASE,ESTIMATES,FUNDING,HARMS,INSTITUTE,LABEL,LIMITATION,METHODS,OBJECTIVE,PREVENTION,PRIMARY,RESULTS,SCREENING,SETTING
CEUS,DUE
WHETHER
OPERATIVE,PERFORMED,RADICAL
100,169,174,2014,494,6TH,CALYPSO,CBCT,CONCLUSION,COPYRIGHT,ERB,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PURPOSE,REAL,RESULTS,TOTAL
001,002,008,106,114,8201,ABOUT,CLINICIANS,CRC,DATA,LABEL,METHODS,OBJECTIVE,PURPOSE,QOL,RESULTS,SURVIVORS
2002,2003,2013,BACKGROUND,COST,CRT,DUE,EACH,IMRT,LABEL,METHODS,OBJECTIVE,PBT,QALY,QALYS,RESULTS,SBRT,STUDIES,THERE
001,106,2005,2011,485,558,966,AIM,CONCLUSION,FIFTEEN,IDENTIFIED,LABEL,METHODS,OBJECTIVE,RESULTS
FURTHER,HOWEVER,HSP27,JNK,MAPK,MITOGEN,MMP,ORTHOTOPIC,PCA,THESE
001,160,169,177,2014,8805,AUR,COPYRIGHT,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RATIONALE,RESULTS
0001,160,169,2014,215,AUR,COPYRIGHT,ETHICAL,EVALUATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RATIONALE,RESULTS
169,2014,947,948,COPYRIGHT,INC,PPAR,THESE
115,169,2014,8805,ANTITUMOUR,BACKGROUND,BRITISH,CONFIRMED,COPYRIGHT,HOWEVER,LABEL,METHODS,OBJECTIVE,OUTCOME,PATIENT,PSA,PUBLISHED,RESULTS,SETTING,SUMMARY,THESE,UNIVARIATE,UROLOGY
169,2014,COPYRIGHT,PUBLISHED,RANDOMIZED,SCREENING,UROLOGY
109,118,169,2014,215,227,956,AES,BACKGROUND,CONCLUSION,COPYRIGHT,GRADE,HDR,IPSS,IRELAND,LABEL,LTD,MEIER,METHODS,PHOENIX,PSA,RESULTS,RTOG,SCORE,SYMPTOM,THESE
169,200C,2014,COPYRIGHT,E2F3,EZH2,PCA,RESULTS,TARGETING,UTR,WESTERN
160,231,26S,BAX,C15H11O2N2,C15H11O3N2,C15H9O4N2,C17H13O3N2,C19H14O3N3,LNCAP,MDA,STUDIES,UPS
MIXED
PRIMARY,PROGNOSIS
AFTER,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,RRP,THESE
001,002,174,179,180,196,6TH,8805,ALSO,GROUP,LABEL,LOC,LRP,MATERIALS,METHODS,OBJECTIVE,OVERALL,RESULTS,UVA
108,118,137,2007,2008,2012,211,8804,8805,AMICO,CHI,CONCLUSION,DATA,GLEASON,HIGH,KLOTZ,LABEL,MANN,MATERIALS,METHODS,MISSTAGING,NCSS,OBJECTIVE,PASS,PSA,RANDOMIZED,RESULTS,RRP,SOLOWAY,T2A,USA,UTAH,WHITNEY
005,169,2014,806,ADDITIONAL,ADHERENCE,AICR,BACKGROUND,FUND,GREATER,HIGH,INSTITUTE,LABEL,MEETING,METHODS,PROTECT,PSA,RESULTS,THERE,WCRF,WORLD
112,169,1998,2009,2012,2014,258,8805,935,938,AFTER,APRIL,BACKGROUND,CONCLUSION,GIVEN,KINGDOM,LABEL,METHODS,OCTOBER,OVERALL,RESULTS
117,155,162,232,241,24H,357,387,403,483,500,752,AKI,AMONG,AVERAGE,BECAUSE,MEAN
0001,0036,0082,112,134,719,749,816,AUC,BACKGROUND,LABEL,LDH,METHODS,PSA,RESULTS,USING
010,169,177,2014,AUNPS,BPH,COPYRIGHT,FREE,PCA,PSA,PUBLISHED,SPR
160,169,2014,822,COPYRIGHT,CURRENTLY,EPIGENETIC,GLEASON,HISTONE,INC,KDM5,KDM5C,KDMS,MOST,PATHOLOGY,PUBLISHED,SOCIETY
169,2014,COPYRIGHT,PUBLISHED
169,2014,COPYRIGHT,CTC,CTCS,DTC,DTCS,FURTHER,IRELAND,LTD,PCA,THEIR,THESE
100,169,CK20,CK7,COPYRIGHT,ERG,GATA3,IHC,LABEL,METHODS,NKX3,NOVEL,OBJECTIVE,OBJECTIVES,PATHOLOGY,PCA,PSA,RESULTS,S100P,SOCIETY,UCA
026,031,034,041,042,045,046,084,099,233,470,528,582,642,673,678,791,797,854,BACKGROUND,CONCLUSION,GLEASON,LABEL,LCFD,METHODS,RESULTS
270,375,600,CONCLUSION,FORTY,IPSS,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,QOL,RESULTS,SCORE,SIX,SYMPTOM,THERE
100,1084,1165,2010,2012,2047,APRIL,COHEN,CONCLUSION,KAPPA,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,THEIR,TRUS
137,195,2003,2010,332,AMONG,BETWEEN,CONCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,PSA,PSAD,PURPOSE,RESULTS,THERE,TRUS
135A,BAX,CONVERSELY,DR5,DU145,OVERALL,PARP,PCR,ROS,TANSHINONE,TRAIL,TUNEL
102,106,AD5,CMV,E1A,KU7,LUC,TAKEN
001,004,CUMULATIVE,INC,LABEL,MATERIALS,METHODS,MMC,OBJECTIVE,PDFF,PUBLISHED,PURPOSE,RANK,RESULTS,T10,THESE,WBC
OPTIMAL,PROGNOSTIC,SOCIETY
ATM,CDT,CYTOLETHAL,DAB2,DOC,DSB,PCA,THESE
CANCEROUS,CIP2A,INHIBITOR,MYC,PP2A
169,2014,956,COPYRIGHT,DU145,GLN,GNRH,IC50,INC,LABEL,LNCAP,SKOV,UNASSIGNED,UNLABELLED
468,BAX,BCL,CASPASE,JNK,JUN,MAPK,MDA,SLC39A9,THESE,TREATMENT,ZIP9
169,2014,293T,CADMIUM,COPYRIGHT,IRELAND,LNCAP,LTD,PSA,RNAI,SENP1,SUMO,SUMOYLATED
169,2014,BACKGROUND,BOTH,EMBRYOLOGY,LABEL,MEDLINE,METHODS,PRESS,PSCS,PUBLISHED,RESULTS,SOCIETY,THERE,UNIVERSITY
000,100,169,2014,239,8805,956,AFTER,CONCLUSION,DLT,EIGHT,HIGH,LABEL,METHODS,OBJECTIVE,PRIMARY,PSA,PURPOSE,RESULTS
0005,169,2014,744,ANDROGENS,BACKGROUND,BECAUSE,CAG,CONCLUSION,LABEL,MEN,METHODS,PSA,RESULTS,SERUM,SNP,USING
0001,005,169,2014,960,BOTH,COPYRIGHT,D1CC,FORTY,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PTV,PUBLISHED,PURPOSE,RADIATION,RESULTS,SOCIETY,V50,V80,V90,VMAT
940,BACKGROUND,CB1,CP55,EGF,EGFR,EGR,HOWEVER,INHIBITION,LABEL,MGL,RESULTS
057,139,161,162,169,2011,2013,2014,250,289,592,604,6MONTHS,BACKGROUND,BONE,COPYRIGHT,IQR,IRELAND,LABEL,LTD,MARCH,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEPTEMBER,TRIAL
0001,001,100,169,2014,220,320,ASIAN,BPH,CAUCASIAN,COCHRAN,COPYRIGHT,HISTOLOGIC,JAPAN,LABEL,MEN,PATIENT,PUBLISHED,RESULTS,SUMMARY,TOKYO,UNLABELLED,UROLOGY
22RV1,8201,AKT,CD133,DU145,ERK,ERK1,LNCAP,MEK,NANOG,NOTABLY,NOTCH,OCT,PI3K,SNAIL,SOX2,THESE,WHILE
001,002,169,177,2014,AFTER,BOTH,BT474,CELL,CONCLUSION,DU145,EMT6,FDG,FPIA,IMAGING,INC,LABEL,METHODS,MOLECULAR,NUCLEAR,PET,PIVALIC,REGARDING,RESULTS,SOCIETY,U87,UNLABELLED
1013,BACKGROUND,BONE,BSI,CONCLUSION,COX,HOWEVER,INDEX,LABEL,METHODS,RESULTS,SCAN,SCAPULA,SPINE
BACKGROUND,CONSISTENT,DESPITE,LABEL,MOST,POLYMERASE,REPENRICH,REPETITIVE,RESULTS,THESE
104,2014,AFTER,BASEL,FOUR,GLEASON,MEN,RRP
001,013,177,2007,2010,264,775,CHINESE,DOPPLER,DVT,HOWEVER,LABEL,METHODS,OBJECTIVE,RALP,RESULTS,SEPTEMBER
062,169,2003,2006,2014,320,647,739,942,CONCLUSION,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,ODDS,ORS,PCA,RESULTS,SELF
001,162,8201,BACKGROUND,CONCLUSION,ECLIPSE,HOWEVER,IMRT,LABEL,METHODS,MUS,OARS,PLANS,RESULTS,THESE,TPS,VMAT
615,8201,BACKGROUND,DIFFERING,FINNISH,LABEL,METHODS,NSAID,RESULTS,SCREENING,TRIAL
183,404,4710,8805,BACKGROUND,BPH,COLORECTAL,LABEL,LUNG,LUTS,MEN,METHODS,OVARIAN,POISSON,RESULTS,SCREENING
ALSO,ALZHEIMER,FINALLY,FULLY,HOWEVER,MRI,PET,POTENTIAL,PROMISING,SINCE,WHILE
2007,2013,8201,822,JUNE,LABEL,MARCH,METHODS,MRI,OBJECTIVE,OBJECTIVES,PCA,RESULTS,SVI,SVS,TESLA
108,117,136,244,8805,ADT,AFTER,BCR,BPFS,COX,CPFS,CSS,GLEASON,LABEL,MATHERIALS,METHODS,OBJECTIVE,PCA,PSA,PSMS,PURPOSE,RADICAL,RESULTS,SCORE,T3N0,UNASSIGNED
118,127,129,1999,2009,GLEASON,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PCA,PSA,RESULTS,THOSE
001,005,022,100,1250,161,1991,2008,228,8805,BACKGROUND,BCR,CHI,CONCLUSION,COX,GLEASON,HOWEVER,JUNE,LABEL,MARCH,MATERIALS,MEIER,METHODS,PSA,PSMS,REGARDING,RESULTS,RRP,TIME,UNIVARIATE
0001,0011,006,0424,0438,195,261,8202,ABOUT,EXPRESSION,GLEASON,IHC,OMNIBUS,PSA,SSTR,SSTR2,THEREFORE,WHILE
169,2014,BRACHYURY,LABEL,METHODS,MICROARRAY,OBJECTIVE,PIN,PURPOSE,RESULTS,SUCCESSFUL
169,2014,COPYRIGHT,EBR,HOWEVER,THEREFORE
169,2014,627,660,AMONG,AR3,COPYRIGHT,CRPC,FOXA1,HOWEVER,INSTEAD,LBD,LNCAP,LTD,NTD,PCA
001,002,049,138,2010,2012,867,CONTINENCE,COX,ENDOPELVIC,GLEASON,JUNE,LABEL,MEIER,METHODS,OBJECTIVE,OCTOBER,PROGNOSTIC,RALP,RESULTS,URINARY
1373,169,1997,2007,2011,2014,2669,356,400,500,641,771,8805,BACKGROUND,BEGINNING,CONCLUSION,JUNE,LABEL,METHODS,NEITHER,NUTRITION,OBJECTIVE,PHYSICIANS,RESULTS,SOCIETY,THERE
001,031,694,ERG,IHC,MEIER,PCA,PCR,PSA,RECURRENT,THREE,TMA,TMAS,TMPRSS2
BIOLOGICAL,ERG,ETS,ETV1,PTEN
APC,ARGON,BACKGROUND,BEAM,D1CC,D2CC,DATA,EBRT,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,V40,V60,V70
136,200,8211,8804,CONCLUSION,DRE,DWI,EACH,GLEASON,LABEL,MATERIALS,MCNEMAR,METHODS,MRI,MRS,OBJECTIVE,PSA,PURPOSE,RESULTS,TRUS
169,2014,ADDITIONAL,COMMITTEE,FIVE,FOUR,GROUP,INSTITUTE,LIFE,MANAGEMENT,NCI,PRESS,PUBLISHED,QUALITY,RELATED,SYMPTOM,THESE,UNIVERSITY,WORKING
945,AKT,AMPK,H9C2,HORMONE,HOWEVER,HRMPC,LKB1,SER2448,TAKEN,TSC1,TSC2,WESTERN
169,2014,8727,BACKGROUND,BODY,COMPOSITE,COPYRIGHT,D1CC,EPIC,INDEX,INITIAL,IQR,IRELAND,LABEL,LTD,MCIC,METHODS,OBJECTIVE,PATIENT,PURPOSE,QOL,RESULTS,SABR,UNIVARIATE,URINARY,V20,V31,V35
223,945,946,AROMATASE,BOTH,ELISA,ESTROGENS,GBM,III,PCR
0001,0006,031,113,145,185,187,198,2006,2010,233,258,405,422,435,688,708,716,728,747,8805,944,9TH,BACKGROUND,CONCLUSION,COSTS,ICD,JANUARY,LABEL,MEN,METHODS,OBJECTIVE,OVERALL,PCA,PREMIER,RESULTS,SINCE,THERE
160,177,8201,8804,ADT,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,SEMI
2012,2013A,8764,ALSO,CTV,DOSE,EUD,LABEL,MATERIALS,MCMAHON,METHODS,OBJECTIVE,PURPOSE,RESULTS,SMALL,TCP
174,2009,2013,CELGENE,DRUG,EMA,FOOD,OCTOBER,USA
RESISTANCE,STRATEGIES
181,200,22R,400,945,947,956,957,BAD,BAX,BCL2,FURTHER,HOWEVER,MSA,NRF2,OVERALL,PCA,PREVENTION,PSA,STUDIES,THUS,TRIAL,VITAMIN
132,152,367B,410,AFRICAN,CAUCASIAN,DNMT1,ECTOPIC,EVALUATION,LNCAP,MDA,PCA,SEQUENCING,THERE,UTR
LABEL,MOLECULAR,MRI,OBJECTIVE,PCA,PET,PURPOSE,RESULTS,SEVERAL,SUMMARY,THESE
203,ACTIVATION,API5,BIRC2,EGFR,EREG,TGFA,TKI,TKIS
AKT,CAMK2N1,CONVERSELY,ERBB2,ERK,HOWEVER,IGF,MEK,PI3K,REDUCED,VEGF
2000,2011,3595,4770,BACKGROUND,LABEL,METHODS,RESULTS
BPH,EN2,GLEASON,PCA
215,DAMPS,DU145,ELISA,LNCAP,PC3,PCR,RADIATION,TOTAL
ACTIVATION,AMP,AMPK,CONVERSELY,INSTEAD,METABOLIC,MODULATION,STRIKINGLY
4GALNACT3,4GALNACT4,4GALNACTS,4GLCNAC,8594,946,LDN,THEREFORE
001,169,2004,2007,2014,275,8804,894,CONCLUSION,CONVERSELY,DEPRESSED,END,LABEL,MEN,METHODS,OBJECTIVE,PURPOSE,RESULTS,SOCIETY
023,1986,2010,321,405,811,ADDITIONAL,AMONG,CIS,CONCLUSION,COX,GLEASON,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,RISK,VASECTOMY
169,2014,FDA,III,PREVAIL
169,2014,COPYRIGHT,EGFR,EMT,HMLE,METASTATIC,POST,SOCIETY

169,2014,COPYRIGHT,INC,MYC,THUS
CEA,CRC,ECGS,ESTIMATING,HEART,HOWEVER,HRV,HRVS,PSA,RATE,THESE
2009,2010,2011,233,BCG,FEB,MAY,SEP,SKIN,THEREFORE,TREATMENT
AFTER,BCG,CIS,III,PET
FAS,GRP78,PAR
107,114,143,148,153,201,8804,8805,ADVERSE,AES,BACKGROUND,BASED,CSFS,EASTERN,FEBRILE,GRADE,GROUP,IQR,LABEL,METHODS,MOST,Q3W,RESULTS,SPANISH,THERE
AIM,HIGH,THUS,TRP,TRPV,TRPV2
ANTITUMOUR
132,ADAM,EGF,EGFR,GHRH,HER2,JMR,PC3,PKA,SRC,TIME
1277,1740,177,2000,2002,345,8201,8805,AUA,BACKGROUND,BMI,BPH,CIS,FORM,INDEX,KNOWLEDGE,LABEL,LIFESTYLE,LUTS,MEN,METHODS,ODDS,ORS,RESULTS,SEVERAL,SHORT,SYMPTOM,UROLOGICAL
18F,FCH,PET
FDG,LABEL,LUNG,METHODS,MRI,OBJECTIVE,PET,PURPOSE,RESULTS,SEVEN
945,946,DOSE,PSA
0001,0003,0999,103,169,2015,7019,BACKGROUND,CONCLUSION,COPYRIGHT,CRPC,INC,ITALY,LABEL,METHODS,PFS,PSA,RESULTS,ROMAGNA
023,024,035,169,1998,2010,2015,247,AMONG,BACKGROUND,COPYRIGHT,COX,INC,LABEL,LMWH,METHODS,RESULTS,THESE,UNIVARIATE
160,169,2014,AKT,ATP,COA,COPYRIGHT,HISTONE,INC,KRAS
10878,144,169,2014,ADVERSE,C30,CONCLUSION,COPYRIGHT,CTCAE,DOSE,EARLY,EORTC,FOCAL,GRADE,I125,IRELAND,LABEL,LTD,MATERIALS,METHODS,MRI,OBJECTIVE,PCA,PHOENIX,PR25,PSA,PURPOSE,QOL,QUALITY,RESULTS,TREATMENT,WHOLE
147,169,2014,COPYRIGHT,FINALLY,IRELAND,LTD,LUCAP,SPOP
AREAS,BACKGROUND,COVERED,EXOGENOUS,GREB1,LABEL,METHODS,OPINION,STEROID
169,2014,COPYRIGHT,INC,OCN
177,8321,8322,8804,BACKGROUND,BONE,CARLO,DOSE,EACH,HOUNSFIELD,LABEL,METHODS,MONTE,MRI,RESULTS
001,003,017,032,169,2004,2011,2012,2014,967,AJCC,BACKGROUND,COMMITTEE,CONCLUSION,CONSISTENT,COPYRIGHT,EIGHT,ENGLISH,HAITIAN,INC,INCREASED,JOINT,LABEL,MARCH,METHODS,MORTALITY,OCTOBER,PATIENT,PEARSON,RESULTS,THERE
001,2014,572,8201,ADT,APRIL,BFR,CFRT,FURTHER,HFRT,HOWEVER,LIBRARY,STUDIES
169,2014,231,945,946,COPYRIGHT,ERE,ERS,FURTHER,INC,MCF,MDA
99M,BONE,BSI,FIRST,INDEX,MDP,SCAN,THERE,THESE,WHOLE
2008,2012,8805,AES,CRPC,DOCETAXEL,HOWEVER,LABEL,LOW,METHODS,NON,OBJECTIVE,PRE,PURPOSE,RESULTS
BASED,HOX,HOXA,HOXA9,HOXB,HOXC,HOXD
0001,0003,0079,100,8211,AIMS,EXPRESSION,FURTHER,HER2,IDC,ILC,ILCS,LABEL,METHODS,NKX3,NUCLEAR,OBJECTIVE,RESULTS
2008,2012,282,8211,AIMS,APF,APRIL,BETWEEN,LABEL,METHODS,OBJECTIVE,RALP,RESULTS,SEPTEMBER,THESE
145,160,169,2014,231,COPYRIGHT,DU145,GASTRIC,HGC,MCF,MCF7,MDAMB,MNK,SAS,SEVERAL,SIX,THESE,VILLSMEIER
169,2014,215,239,AREA,BACKGROUND,COX,FOUR,LABEL,LIVER,MARSDEN,METHODS,NLR,RESULTS,ROYAL,SOCIETY,THREE,ULN
001,1044,127,1370,169,2004,2006,2008,2014,326,880,COPYRIGHT,MPCC,NETWORK,OVERALL,PATIENT,TEXAS,TRIAL,UNIVERSITY
CRPC,THESE
AFRICAN,F102S,FURTHER,G111E,HOWEVER,I106I,PCA,POZ,SPOP,Y87C
103,IIEF,INDEX,RPS
157,2010,2013,276,ALBERTA,CALGARY,CLS,DRES,JANUARY,LABORATORY,MARCH,PSA,SERUM,THUS
169,2014,946,AICAR,AKT,AMPK,EMT,FOXO3,IKK,MDM2,OSU,OVERALL,PHENOTYPIC,THESE
169,2014,DIFFERENT
CONVERSELY,LOCALIZED,TREATMENT
169,2014,2ND,500,956,AFTER,AMACR,COA,COPYRIGHT,EGBS,ELAA,FINALLY,PCR,SELEX
108,145,AEZS,AUTOPHAGY,CRPC,DOX,GFP,LHRH,LHRHR,LYS,MANAGEMENT,NUDE,ROS
169,177,2014,785,BACKGROUND,BASEL,CAUCASIAN,CONCLUSION,HOWEVER,LABEL,LUNG,METHODS,RESULTS
160,ECM,NCK,SH3,SRC,TKS5
001,002,003,006,007,014,029,030,034,035,8201,AST,BACKGROUND,BMD,BPAQ,DISEASE,LABEL,METHODS,PAST,RESULTS,UNLABELLED
160,169,2014,BESIDES,COPYRIGHT,COST,CURRENT,INC,PUBLISHED,ROBOTIC,SOCIETY,VINCI
DIAGNOSIS,MEN,MOST,PERCEIVED,POMS,RAPID,SELF,THESE
028,030,038,042,045,058,8201,ACUTE,COMPOSITE,CONCLUSION,CRANBERRY,EPIC,FORTY,INDEX,LABEL,MEN,METHODS,OBJECTIVE,OVERALL,PACS,PURPOSE,RESULTS
CLEVELAND,ENHANCING,HOWEVER,LABEL,METHODS,OBJECTIVE,OHIO,PURPOSE,RESULTS,SURVIVORS,UNIVERSITY
109,1629,169,2014,BASED,COPYRIGHT,FURTHER,HOWEVER,IES,INC,STROMAL,THESE
169,2014,BOLUS,COPYRIGHT,THEREFORE,YM155
252,KI16425,KLF4,LPA,TAKEN
ESUR,MRI,RADS,TESLA,TRUS
169,1903,2014,786,ACIDS,BCL,INXS,NUCLEIC,PRESS,PUBLISHED,SAM68,SIMILARLY,THESE,THREE,UNIVERSITY
HOWEVER,PAR,PRKC,SPRY,USING,WT1
200C,205,ALTERED,BACKGROUND,EMT,EPCAM,EPITHELIAL,EXPRESSION,LABEL,MET,METHODS,OPPOSITELY,RESULTS,THUS
0001,00056,0094,012,021,046,169,2014,BACKGROUND,COPYRIGHT,ELISA,FIFTY,GLEASON,III,LABEL,MEN,METHODS,MOST,NTX,PCA,PSA,RESULTS,SERUM,THESE
001,244,787,CONVERSELY,HODGKIN,MCC,MCCS,QUEENSLAND,SIR,SIRS,THESE
0001,177,8201,8289,956,ACCORDING,BACKGROUND,CONCLUSION,FACBC,HOWEVER,LABEL,METHODS,MRI,PDT,PET,PROCEDURE,PSA,RESULTS,THERE
169,2014,945,946,COPYRIGHT,HER2,IMPORTANCE,LABEL,OBJECTIVE,PI3K,PTEN,SINCE,SOCIETY,UNLABELLED,WHETHER,Y315F
ARBS,DU145,GOVERNMENT,INHIBITION,PC3,VEGF,WHEREAS
169,2014,CHOP,CUL3,DDIT3,HOWEVER,INC,POZ,RBX1,SER,SPOP,STRIKINGLY,THR,WILEY
004,005,2003,2005,2006,2007,2008,2009,325,401,8201,HEALTHCARE,IMPORTANCE,INDICATORS,INPATIENT,JANUARY,LABEL,MAIN,METHODS,MIRP,NATIONWIDE,OBJECTIVE,PATIENT,PSI,PSIS,QUALITY,RAPID,RELEVANCE,RESULTS,SETTING,VINCI
ABCG2,ACCORDING,CD133,CD44,CK18,CK5,CSCS,MOLECULAR,MOST,PCA,PSA
181,207,8201,COBALAMIN,DCC,HCY,IC50,METHIONINE,METS,MTHF,THESE,THF
183,323,334,629,8201,A392G,CAUCASIANS,MET235THR,OVERALL,PREVIOUSLY,THUS
145,169,2014,900,AMG,AUTHORS,HISTONE,JOHN,LNCAP,LTD,PC3,PCA,PLK1,SONS,WHILE,WILEY
NMR
2010,2013,223,AMONG,ASSESSMENT,BACKGROUND,BPI,BRIEF,DIMENSIONS,DRUG,EMA,EUROQOL,FDA,FIVE,FOOD,FORM,FUNCTIONAL,HRQOL,INTENSITY,INVENTORY,LABEL,MEDICINES,METASTATIC,METHODS,NINE,PAIN,PRESENT,PRO,PRODUCT,REPORTS,RESULTS,SHORT,SUMMARIES,THERAPY
1066,177,203,215,LABEL,METHODS,OBJECTIVE,PURPOSE,REGIONS,RESULTS,ROC,SVM,ULTRASOUND
8201,8764,8805,FINALLY,GIVEN,HOWEVER,LABEL,METHODS,MRI,NEXT,OBJECTIVE,OPTIMIZED,PURPOSE,RESULTS,RMS,RMSE,THEREFORE,THESE,TRUS
2012,AAM,APPEARANCE,ASM,AUTOMATIC,DDD,DICE,FIRST,HOWEVER,LABEL,METHODS,MODEL,OBJECTIVE,PURPOSE,RATIO,RESULTS,SHAPE,THESE,THIRD
ANCOR,DICE,DSC,ELASTIC,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,THESE,WHILE
174,2620,2MM,500,800,BATCH,CARLO,CPU,DOSXYZNRC,DUE,GAMMA,GPU,GPUS,INTEL,K20,K40,LABEL,M2090,METHODS,MONTE,OBJECTIVE,PATIENT,PSF,PSFS,PTV,PURPOSE,RESULTS,USING
ALSO,ART,GSI,HENCE,HOWEVER,IMRT,LABEL,METHODS,OBJECTIVE,OPTIMIZING,PURPOSE,RESULTS,TPS,TRP
100,169,179,1998,2012,2014,650,AUTHORS,BJU,COX,LABEL,MEIER,METHODS,NEITHER,OBJECTIVE,RADICAL,RESULTS,SATURATION
169,2014,675,946,CURRENTLY,DUAL,FEBS,H19,M12,P69,PC3,RNAS,TAKEN,TGFBI,UTR
1000,169,2014,265,8201,AUTHORS,BJU,ITALIAN,LABEL,METHODS,NPP,OBJECTIVE,RESULTS
180,GLEASON,PCR,PROTEIN,PTK7,THEN,WESTERN
169,2014,239,945,ACSL,APP,AUC,CANCEROUS,CRP,CSS,EXPRESSION,FIVE,FOX,GLEASON,HER2,KLF4,LABEL,METHODS,MYC,OBJECTIVE,OCT,OCT1,PSA,PURPOSE,RESULTS,SOX2,TRIM
169,2014,239,AKT,CASTRATION,DESPITE,OVERALL,PI3K,PRESS,PTEN,PUBLISHED,THEREFORE,THESE,UNIVERSITY
001,140,169,2014,COPYRIGHT,DOSIMETRIC,HOWEVER,IBCL,INC,LABEL,MATERIALS,MEAN,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEED
169,1971,2011,2014,CHLAMYDIA,COPYRIGHT,DESPITE,DUE,LTD,MEN,MYCOPLASMA,NEISSERIA,SIMPLEX,SRR,STI,STIS,TREPONEMA,UREAPLASMA,VIRUS
BACKGROUND,BRCA1,BRCA2,CASE,CHEK2,GENERATION,ITALIAN,LABEL,METHODS,MLPA,NEXT,SEQUENCING
8G4,ECFC,EL2,HOWEVER,MSC,PC3,THEREFORE,THESE
116,169,181,2014,224,294,BACKGROUND,C30,CARE,CLINICIANS,CONCLUSION,COPYRIGHT,CORE,EXIT,FORM,LABEL,LIFE,METHODS,NEEDS,PATIENT,PRO,PROS,QLQ,QUALITY,RESULTS,SCNS,SF34,SHORT,SOCIETY,SUPPORTIVE,THESE,TREATMENT
169,2014,239,COPYRIGHT,PUBLISHED,THERE,THROUGH,UROLOGY
169,2014,946,ADT,AKT,COPYRIGHT,ERK,HOWEVER,IRELAND,JNK,LTD,PI3K,RHOA,SMAD,TGF,THUS
0283,0294,119,8201,967,BACKGROUND,CONCLUSION,LABEL,METHODS,RESULTS,UROLOGISTS
ACTIVATION,AKT,CAMK2N1,CAP,COMPARISON,FINALLY,FOXO,FOXO1,FOXO3,FOXO4,INCREASED,KNOCKDOWN,LNCAP,PGC,PI3K,PIP,PLA2G16,RUNX2
1997,2012,AVERAGE,BACKGROUND,DATA,FEMALES,HOWEVER,LABEL,LUNG,METHODS,RESULTS,STATISTICS,YLL
7082,946,947,954,BAY,ERK,FLIPL,IFN,JNK,LNCAP,PI3,REDUCED,UO126
045,087,169,1996,2010,2014,648,AMONG,CD4,CONCLUSION,DLBCL,HIV,HODGKIN,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SOCIETY,TEXAS
169,2010,2012,2014,ACUTE,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,GRADE,IMRT,INSTITUTE,JOHN,LABEL,MAY,METHODS,OBJECTIVE,RESULTS,SEPTEMBER,SIB
169,174,2014,ANTICANCER,COPYRIGHT,CTC,CTCS,FIFTY,GLEASON,INSTITUTE,JOHN
169,2014,946,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,DUE,HEAT,HSPB1,HSPS,INSTITUTE,JOHN,LABEL,MATERIALS,METHODS,PCA,RESULTS,TGFB1
169,182,2014,956,ACCORDING,AKT,ANTICANCER,COPYRIGHT,CRPC,FLOW,IC50,INSTITUTE,JOHN,NVP,PI3K,TKI
169,2014,AIM,ANTICANCER,BACKGROUND,CD9,CONCLUSION,COPYRIGHT,INSTITUTE,JOHN,LABEL,LNCAP,MATERIALS,METHODS,OBJECTIVE,PSMA,RESULTS,SINCE
169,2014,954,AIM,ANTICANCER,APOPTOSIS,BACKGROUND,BCL2,CONCLUSION,COPYRIGHT,INSTITUTE,IVIS,JOHN,LABEL,LIPITOR,MATERIALS,METHODS,NUCLEAR,OBJECTIVE,ORTHOTOPIC,RESULTS,SCID,VCAP
100,118,120,137,169,194,2014,420,480,CONCLUSION,CONVERSELY,COPYRIGHT,GLEASON,INC,LABEL,MATERIALS,MCCL,METHODS,MRI,OBJECTIVE,OVERALL,RESULTS,TPM,TRUS
100,1C3,8201,946,AFTER,ALDO,ASP9521,BACKGROUND,HENCE,HSD5,IC50,LABEL,LNCAP,METHODS,PSA,RESULTS
173,954,BTG2,CISPLATIN,GGAAAGGAA,GGAAAGTCC,GGGCACC,LNCAP,PSA
169,2014,ACIDS,CHIP,EBP,FITTINGLY,FOXA1,K386R,K520R,NUCLEIC,PRESS,PUBLISHED,TAKEN,UNIVERSITY
100,155,169,2014,228,303,374,529,ARIC,CONCLUSION,COPYRIGHT,INC,LABEL,MATERIALS,MEAN,METHODS,MODEL,OBJECTIVE,PREDICTORS,RESULTS,RISK,SELF,TARGETING
169,2014,CHITINASE,EVALUATION,LNCAP,PCA,TREATMENT,YKL40
AFM,HOWEVER,THESE
169,177,2014,956,BOTH,DRUG,IC50S,MCF7,OBJECTIVE
038,061,174,284,458,539,829,DRE,HOLEP,HOLMIUM,HOWEVER,LABEL,METHODS,OBJECTIVE,PRIOR,PSA,PURPOSE,RESULTS,TRUS,USING
203,CONVERSELY,HOWEVER,LASP1,LIM,LNCAP,PCA,PCR,PSA,SEVERAL,SH3,SUBSEQUENT,THESE
BCL2,HEPATOCYTE,HGFL,HOWEVER,RON,STAT3,THESE,TRAMP,WHILE
133,884,945,AIM,ANTITUMOR,BALB,CONCLUSION,DIM,LABEL,LNCAP,MATERIALS,METHODS,OBJECTIVE,RESULTS
000,023,169,1996,2004,2013,2015,350,COPYRIGHT,EAU,EDUCATION,INC,LABEL,MATERIALS,MAXIMUM,MEAN,METHODS,NUMBERS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
169,177,187,2015,234,843,945,COPYRIGHT,EDUCATION,FIVE,HIF,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SEMINAL,SERUM,UROLOGICAL
001,018,019,043,149,160,169,2014,253,8804,ASSESSMENT,COPYRIGHT,EDUCATION,GLEASON,GSTP1,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RARB,RESULTS,THESE,UROLOGICAL
169,2014,COPYRIGHT,GLEASON,JOHN,LTD,SONS,WILEY
169,2014,BACKGROUND,INT,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SYSTEMATIC
001,2007,2010,203,8201,ACA,ACT,AFFORDABLE,AMERICANS,AMONG,AOR,BACKGROUND,CARE,COX,END,FINE,GRAY,INSURED,LABEL,METHODS,PCSM,PROGRAM,RESULTS,UNINSURED
8211
MEN,SNPS
8TH,AFTER,DENTASCAN,EXTENSION,METASTATIC
169,2014,AMERICA,AUTHORS,BIOLOGY,CRPC,INC,IUBMB,LIFE,MOLECULAR,PCA,RNAS,UNION,UTR,WILEY
1336,1539,1559,1845,2013,2067,2073,2373,2670,2712,2774,3060,480,546,808,AUTHORS,BACKGROUND,CANCERS,CENTRAL,COLLECTION,CONFERENCE,CONTROLLED,CURRENTLY,DATA,FURTHER,GRADE,GROUP,HOWEVER,LABEL,MAIN,MANAGER,MEDLINE,METHODS,NON,OBJECTIVE,OBJECTIVES,PREDEFINED,PROSTATIC,RESULTS,SCIENCE,SELECTION,THEN,WEB
001,002,134,174,AU1,BACKGROUND,BC17,BC21,CONTEXT,III,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,STUDIES,UROPLAKIN
102,118,169,2014,215,220,748,762,775,802,815,8730,8804,956,ACCESS2,AUC,AUCS,COPYRIGHT,INCLUDING,PCA,PSA,SERUM
002,1067,2011,521,AUC,BACKGROUND,BOTH,DRE,JANUARY,LABEL,MATERIALS,METHODS,MODEL,PRE,PSA,PSAF,RESULTS,ROC,THESE,TRUS
2003,2012,524,AFRICAN,AMICO,BACKGROUND,CAUCASIAN,CAUCASIANS,CONCLUSION,CONVERSELY,DHMC,GLAND,JANUARY,LABEL,MATERIALS,MEDICAL,METHODS,MOST,REFERRALS,RESULTS,WHOLE
001,012,123,154,164,2769,BACKGROUND,CHI,CLOSE,CONTROL,EXACT,GLEASON,LABEL,MATERIALS,METHODS,OUTCOME,PSA,RESULTS,THESE
008,011,115,699,8804,BACKGROUND,BCR,COX,GLEASON,HOWEVER,LABEL,MATERIALS,MEIER,METHODS,PSA,PSM,RARP,RESULTS
0006,124,132,187,2005,2011,BACKGROUND,LABEL,LOCAL,MATERIALS,METHODS,MRI,PSA,RESULTS,TRUS
BECAUSE,HISTOLOGY,HOWEVER,PET,THEREFORE
169,2014,AMONG,COPYRIGHT,GDEPT,MSC,MSCS,P450,SAS
006,010,040,053,061,177,183,400,632,902,HOWEVER,IMMEDIATE,INCREASES,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,TESTING
177,1991,1996,486,AFTER,BACKGROUND,JANUARY,LABEL,METHODS,RESULTS,SINCE,THERE
CBCT,HERK,PTV,TIME,VMAT
435,47D,562,CNS,HCT,INSTITUTE,MAXIMUM,MDA,NCI
3262,CD57,COX,GLEASON,HOWEVER,LABEL,LOSS,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,PCA,PSA,RESULTS,THERE
110,160,169,2014,8805,ADT,AUTHORS,IMRT,JOHN,LTD,SIB,SONS,THERE,WILEY
0003,128,169,2014,8201,COMPOSITE,CONCLUSION,INDEX,LABEL,METHODS,NERVE,OBJECTIVE,OBJECTIVES,RESULTS,THERE,THEREFORE,URINARY,UROLOGICAL
160,169,174,2014,327,440,457,839,8805,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,RESULTS,TRUS
169,2014,613,ADT,AMERICA,ASSESSMENT,BMD,CONCLUSION,COPYRIGHT,FRAX,INC,LABEL,METHODS,OBJECTIVE,RESULTS,RISK,TOOL,WORLD
0001,031,032,053,169,1756,2000,2010,2014,CONCLUSION,COPYRIGHT,COX,GLEASON,INC,INDICES,LABEL,METHODS,OBJECTIVE,RESULTS,THERE
001,169,2000,2010,2014,845,8804,CONCLUSION,COPYRIGHT,EPSTEIN,GLEASON,INC,JULY,JUNE,LABEL,METHODS,OBJECTIVE,PNI,RESULTS,VALIDATION
018,021,169,2014,247,250,254,341,ALPP,CONCLUSION,COPYRIGHT,FILLING,H2O,INC,LABEL,MCC,METHODS,MUCP,NERVE,OBJECTIVE,RARP,RESULTS,ULR
1951,1966,BETWEEN,THESE,WHILE,YORK
133B,169,2014,203,221,361,463,950,AUC,BPH,DEPARTMENT,FOUR,FURTHER,MIRNA,PCA,PCR,PSA,PSS,ROC,SINCE,SPSS,STUDENT,UICC,UROLOGY
169,2014,AFTER,FORCE,PREVENTIVE,PRUDENT,SOCIETY,TASK
169,2014,2ND,ASCO,CONCLUSION,COPYRIGHT,ESMO,FIRST,GOAL,HOWEVER,III,LABEL,LHRH,LITERATURE,MATERIALS,METHODS,OBJECTIVE,OTHER,PROMISING,PSA,RESULTS,SAS,STUDIES
169,2014,8804,968,COPYRIGHT,ECE,GLEASON,LABEL,LEVEL,METHODS,OBJECTIVE,OHORI,PSA,RESULTS,SAS,STEUBER
169,2011,2014,BACKGROUND,BPH,COPYRIGHT,DATA,HBP,LABEL,LEVEL,MEN,METHODS,PCA,PSA,RESULTS,SAS,SNIIRAM
0001,169,2014,518,ASSESSMENT,BOWEL,COLORECTAL,COMPOSITE,CONCLUSION,COPYRIGHT,FORM,FUNCTIONAL,INC,INDEX,LABEL,LUNG,MATERIALS,MEDICAL,METHODS,OBJECTIVE,OVARIAN,PEARSON,PUBLISHED,QOL,RESULTS,SCREENING,SHORT,THERAPY,THESE,TREATMENT,TRIAL,WHITE
001,128,160,169,189,2004,2010,2014,490,8805,AAS,AFRICAN,AFTER,AMERICANS,AOR,CONCLUSION,COPYRIGHT,END,FACTORS,GLEASON,INC,LABEL,METHODS,OBJECTIVE,PCA,RESULTS,T2B,THERE
133,133A,133B,206,HDAC4,HOWEVER,RNAS,SFR,WHILE
169,2014,CCL2,CCR2,CHROMATIN,FINALLY,GLEASON,LUCIFERASE,MECHANISM,PCA,TESTICULAR,TR4,UICC
001,169,2014,724,ASIA,AUTHORS,CBP,CSC,FOLLOWING,ICG,LTD,PRI,PTY,PUBLISHING,SCIENCE,SSC,THROUGHOUT,WILEY
169,2014,CSF,HOWEVER,UICC
001,004,123,169,2014,8201,COMPARISON,CONCLUSION,LABEL,METHODS,OBJECTIVE,PAIN,RESULTS,UROLOGICAL
215,368,633,741,AMERICA,EBRT,HOWEVER,NORTH,PCOMBINED,SPANISH,TANC1,THERE,THESE
169,1CM,2014,5MM,COPYRIGHT,FOUR,INC,USING
000,0004,004,105,169,2007,2010,2014,BACKGROUND,BLACK,CONCLUSION,LABEL,METHODS,PSA,RESULTS,THERE,THESE
169,1992,2013,2014,BACKGROUND,CAP,COPYRIGHT,ENGLISH,HOWEVER,INC,LABEL,MEDLINE,METHODS,PAPERCHASE,PSA,PSAV,RESULTS
1000,110,124,1400,169,1800,200,201,2011,2013,2014,400,600,APRIL,BACKGROUND,COPYRIGHT,CPY17,EASTERN,ENDO,FUNDING,GROUP,INC,LABEL,LTD,MARCH,MEN,METHODS,NONE,ODM,ORION,PSA,RESULTS,THESE,USA
169,2014,BAX,BCL,BID,COPYRIGHT,CORDYCEPIN,CORDYCEPS,FAS,LC3,LNCAP,SEVERAL,THESE,VAD
125,169,2014,985,COPYRIGHT,CRET,FAM,FREE,HOWEVER,PSA,TMPG,USING
160,169,2014,BI2S3,COPYRIGHT,HIFU,LTD,MEANWHILE,PLGA,THUS
947,CANDIDATE,CYTOTOXIC,EFFICIENT,ELISPOT,EWING,EWS,IFN,PRAME,STRATEGIES,TCR,XAGE1
0001,160,169,177,2015,AFFAIRS,BACKGROUND,CHRONIC,CONCLUSION,COPYRIGHT,CRP,CURRENT,ENDOSCOPIC,ENDOSCOPY,FLORIDA,FURTHER,HEALTHCARE,IQR,LABEL,MAIN,METHODS,OBJECTIVE,OUTCOME,RESULTS,RFA,RTD,SECONDARY,SETTING,SOCIETY,TREATMENT
169,2014,956,AUSTRALIAN,COMPOUNDS,COPYRIGHT,DFT,HYRTIOS,IC50,LNCAP,LTD,MASS,MEOH,NMR,STRUCTURAL
26A,ALTOGETHER,MICRORNAS,NEXT,RNAS,THEN,WESTERN,WNT5A
160,177,200,235,566,8201,8226,8804,8805,AUC,CONCLUSION,DATA,DCE,DWI,ESUR,GLEASON,HISTOLOGY,IMAGING,KEY,LABEL,METHODS,MRI,OBJECTIVE,PCA,PSA,PURPOSE,RADIOLOGY,RADS,REGARDING,REPORTING,RESULTS,SOCIETY,T2WI,UROGENITAL
177,BACKGROUND,CONCLUSION,FRAMELESS,LABEL,METHODS,PROCEDURE,RESULTS,TAMIS,TME
0001,0003,002,004,109,169,177,2014,8202,ADDITIONAL,CAP,DESPITE,GLEASON,KLLN,MEN,NONE,PSA,RFS,SOCIETY
001,005,033,169,177,2014,AFTER,BACKGROUND,BLS,COPYRIGHT,DFS,FGS,GREEN,HALF,INC,LABEL,MATERIALS,METHODS,RESULTS,SIX,ZOL
945,954,HIF,HYPOXIA,LNCAP,MDM2,MST,P300,SIMILARLY,STAT3,VEGF
169,2014,AUTHORS,COPYRIGHT,DCE,IMAGING,MRI,PUBLISHED,RESONANCE,TOFTS,TYPICALLY
032,057,096,125,152,160,25E,312,AKT,CRPC,ERG,GLEASON,HOWEVER,PCA,PCSM,PI3K,SWEDISH,TURP,WNT
5703,630,EGFR,EMBRYONIC,GAK,GLEASON,SER,TAKEN,THR,U2OS
002,100,1207,2000,2064,8764,AFTER,BACKGROUND,COX,GNRH,INCIDENCE,INDEX,INSURANCE,LABEL,METHODS,RESULTS
169,177,2014,386,416,422,946,955,956,COPYRIGHT,CYP17A1,DOCKING,IC50,INC,INHIBITORY,THESE
183,H3K9ME3,JMJD2,JUMONJI,K36,KDM4,KDM4A,KDM4B,KDM4D,KDM4S
008,021,177,745,ADT,AMG,BACKGROUND,CONCLUSION,CONTEXT,FOUR,LABEL,LBM,METHODS,MYOSTATIN,OBJECTIVE,RATES,RESULTS
CONSISTENT,EGFR,FURTHER,GTPASES,HEPG2,HOWEVER,ICMT,INHIBITORS,MEFS,PC3,RAS,TREATMENT
ADT,DIFFERENT,GLEASON,III,PHASE,PSA,SEVERAL
4827,947,ADP,BOTH,CLONOGENIC,DSBS,H2AX,H2O2,NIRAPARIB,PARP,RAD51,SSBS,TAKEN,THESE
AUTOCRINE,CAP,CCL2,CCR2,CXCL8,CXCR1,CXCR2,CXCR4,PC3,PTEN,THP,WPMY
446,COX1,COX2,DU145,FYN,INITIAL,TYR,WHILE
169,2014,946,954,CONSISTENT,FN14,IKK,TNF,TNFRSF12A
GIST,GISTS
169,2014,COPYRIGHT,INC
124,945,DU145,EMT,HOWEVER,SLUG,TGF,THUS
169,2014,215,BASEL,SNP,THERE
169,2014,COPYRIGHT,THREE
2004,CLU,CRPC,DRUG,FINALLY,GDF,HOWEVER,HSPS,MIC
126,7901,CRK,HOWEVER,MIR,PLK2,SGC,SOX2
APC,HCPS,HEALTHCARE,INTERVIEWS,LABEL,METHODS,OBJECTIVE,OBJECTIVES,ONTARIO,PURPOSE,RESULTS,SETTING,SUPPORTIVE
CANTRIL,CONTROL,DUKE,ILLNESS,LABEL,MAIN,MEN,METHODS,MONITORING,MOOD,NURSING,OBJECTIVE,OBJECTIVES,PROFILE,PSA,PURPOSE,RESULTS,SCALE,SELF,SETTING,THREE,UNIVERSITY,UROLOGY,VARIABLES
ENGLISH,PRIMARY,THERE
EBRT,PDE5I,TADALAFIL
CRPC,HOWEVER,LARGE,POZ,SPOP
1924,ANOTHER,DIET,OTTO,REMARKABLY,THUS,WARBURG
100,2009,2013,CONTINENCE,FOLLOWING,FORTY,GROUP,MRI,OCTOBER,PATIENT,PCA,PSM,PSMS,RARP
006,008,009,2003,2011,222,AFRICAN,ANALYZING,CAUCASIAN,CAUCASIANS,COX,HOWEVER,LABEL,MEIER,METHODS,MOST,OBJECTIVE,PURPOSE,RESULTS,THERE,UNIVARIATE,YORK
169,2014,COPYRIGHT,CRPC,EGFR,EXPRESSION,FUNCTIONAL,HIGH,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PC3,PCA,PRL1,RESULTS,WESTERN
MICRORNAS,TFS
169,2000,2007,2014,5771,885,AGE,COMMUNITY,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,OVERALL,PAF,PUBLISHED,RESULTS,STATISTICS,THOUSANDS,WHERE
231,AZA,BECAUSE,GPAT,GPAT2,MDA,OVERALL,USING
133B,145,AFTER,DATA,FIRST,PCA,PCR,PEARSON,STUDENT,THEREFORE,TOTAL
231,293,33258,474,956,CAUCASIAN,CHINESE,CHO,HEK,HOECHST,IC50,MDA,MTS,OVERALL
1995,2013,JANUARY,LIBRARY,MEDLINE,MRI,PCA,PUBLISHED
PALPATION,SINCE
BILATERAL,EMERGENCY,PLEURAL,SHORTLY
141,901,GLEASON,HGPIN,HOWEVER,IDC,REGULAR
ENDOGENOUS,LENTIVIRUS,NATURAL,PC3,PROTEIN,RNAI,RNAS,UTR
002,008,026,177,241,292,570,862,AGE,AIM,CONCLUSION,DEPARTMENT,FOUR,LABEL,MEAN,MEDICAL,METHODS,OBJECTIVE,POMERANIAN,RESULTS,UNIVERSITY
1039,169,2014,FGF,FGF2,FGFR,FGFR1,FGFS,FISH,HNSCC,LABEL,MALIGNANT,MPM,MPMS,NONE,PREVIOUSLY,RNAI,THESE,TKI,UNLABELLED
169,2007,2013,2014,AUSTRALIAN,BACKGROUND,CAPITAL,COLLEGE,CONCLUSION,FOUR,LABEL,MARCH,METHODS,NCS,NINE,OCTOBER,RESULTS,ROYAL,SERVICE,SEVEN,ZEALAND
2008,2010,204,8201,ACCURAY,AVERAGE,BETWEEN,COMPOSITE,CYBERKNIFE,EPIC,GEORGETOWN,GRAY,INDEX,LABEL,LESS,METHODS,OBJECTIVE,OCTOBER,PURPOSE,RESULTS,SBRT,THREE,UNIVERSITY,URINARY
169,2014,ALTOGETHER,COPYRIGHT,DENDRIMERS,DICER,FURTHER,INC,LABEL,RNAI,RNAS,SIMILAR,SMALL,UNASSIGNED,UNLABELLED
169,2014,300,700,8804,8805,945,ADVERSE,LABEL,MEIER,METHODS,MOST,OBJECTIVE,ORTERONEL,PSA,PURPOSE,RESULTS,SECONDARY,TAK
PSA
169,2014,574,AUSTRALIA,BACKGROUND,DRUG,EASTERN,FDA,FOOD,HOWEVER,KINGDOM,LABEL,METHODS,MOST,PATIENT,PCA,RESULTS,SEVENTEEN,SIX,SOCIETY,THERE,THESE
150MG,945,BCL,DOCETAXEL,INCREASED,LHRH,METASTATIC
107,169,1991,2003,2014,700,922,APPLIED,BACKGROUND,COX,EQUIPMENT,FOLLOWING,FURTHER,HRS,INC,LABEL,METHODS,NATURAL,OPERATORS,RESULTS,TRANSPORT,WBV,WILEY
FOCAL,SHORT
169,2014,HCC,INC,PHC,PRIMARY,WILEY
100,169,197,2011,2013,2014,236,262,8201,964,AFTER,ASAP,BETWEEN,CONCLUSION,DRE,HGPIN,IMPRINT,INC,LABEL,MALIGNANT,MAY,METHODS,OBJECTIVE,OVERALL,PSA,RESULTS,SAMPLES,SEVEN,THESE,TRUS,UPON,WILEY
001,2005,2010,210,255,449,486,548,561,584,613,766,BETWEEN,CONCLUSION,DATA,GLEASON,LABEL,LATE,LRP,METHODS,OBJECTIVE,PSA,RALP,RESULTS,SIRIRAJ
001,015,100,130,169,2014,8201,CLAVIEN,DINDO,LABEL,LYMPHOCELE,METHODS,MINIMALLY,OBJECTIVE,OBJECTIVES,RESULTS,UROLOGICAL
169,2014,8201,AVASCULAR,CONVERSELY,FURTHER,HOWEVER,THESE,UROLOGICAL
169,2014,409,CONCLUSION,EMT,GLEASON,LABEL,METHODS,OBJECTIVE,ORTHOTOPIC,PURPOSE,RESULTS
0043,160,169,1992,2005,2014,2205,CONCLUSION,COPYRIGHT,COX,INC,LABEL,LEE,METHODS,OBJECTIVE,OVERALL,PRACTICAL,RESULTS,WALD
001,0CM,106CM,169,176,191,2014,3CM,49CM,5CM,6CM,9CM,COLLECTED,COPYRIGHT,INC,LABEL,MATERIALS,MEAN,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SOCIETY
169,1999,2007,2014,635,AFRICAN,AMONG,BACKGROUND,COMMITTEE,FACTORS,III,JOINT,LABEL,METHODS,POISSON,RESULTS,SOCIETY,USA
169,2014,BIOLOGY,INC,MOLECULAR,QUERCETIN,SOCIETY
169,2014,693,8201,BACKGROUND,COMPOSITE,EPIC,FORM,HOWEVER,INDEX,INSTRUMENT,LABEL,METHODS,RESULTS,SERIOUS,SHORT,SOCIETY
231,945,946,DU145,HEPG2,HT29,HUH7,MCF,MCP,MDA,MIP,PSO,TAKEN,TNF,VEGF
ANTIGEN,DHT,LNCAP,MTS,PSA
169,2014,ENDOCRINE,GRP78,OVERALL,RNAI,SUPPORTING,THEREFORE,TRIB,TRIB1
007,070,169,2014,334,339,532,676,769,8201,8805,BACKGROUND,CONCLUSION,DRE,EXTREME,GLEASON,INC,LABEL,METHODS,PCA,PSA,RESULTS,THREE,TRUS,WILEY
0008,007,169,2014,8201,BACKGROUND,CFTR,GLEASON,GOLDENGATE,GSTM2,HTR1B,INC,LABEL,METHODS,PANEL,PENK,RESULTS,WILEY
0002,001,005,169,2001,2004,2009,2014,211,533,746,945,947,GLEASON,INCIDENCE,JUNE,MEN,PREVENTION,TRIAL,VITAMIN
006,014,056,064,079,169,1991,1996,2009,2014,246,558,8201,855,BACKGROUND,COX,DIET,HOWEVER,INC,LABEL,MALM,METHODS,PCA,RESULTS,T2D,VARIATION,WILEY
946,AJS,HEME,PCA,ROS,THESE
115,BPH,ERG,ETS,FISH,PCA,PCAS,PCR,PIN,THESE,TMPRSS2
THESE
CD44,CSC,CSCS,DU145,EPI,IM7,LNCAP,PCI,PDT,RIP,ROS
002,006,309,AMONG,ARD,BACKGROUND,CHANGES,EBRT,ENDOSCOPIC,LABEL,METHODS,RECTOSCOPY,RESULTS,SCORE,VRS
101,118,169,194,2008,2012,2015,219,233,343,444,BLADDER,COPYRIGHT,EDUCATION,INC,LABEL,MALIGNANT,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RECURRENCE,RESULTS,THREE,UROLOGICAL
171,COPD,DENMARK,DISEASE
169,2014,DNAPK,ETS,EWING,HDAC1,PARP1,THESE
169,2014,ACUTE,AMICO,COPYRIGHT,DATA,HOWEVER,III,LATE,MOST,PUBLISHED,SAS,URINARY
125,160,169,2014,COPYRIGHT,DIL,HDR,INC,LABEL,MATERIALS,MEAN,METHODS,MRI,OBJECTIVE,PHASE,PUBLISHED,PURPOSE,RESULTS,SOCIETY,TREATMENT,V100
033,160,169,174,2000,2008,2014,8805,ASSESSMENT,BCR,CONCLUSION,COPYRIGHT,COX,DNVR,HOWEVER,INC,INCREASED,LABEL,METHODS,OBJECTIVE,RECORDS,RESULTS,RISK,THERE
000,169,200,2003,2005,2007,2010,2014,369,399,400,489,8200,8805,9000,AUTHORS,BJU,CONCLUSION,HIGH,LABEL,METHODS,OBJECTIVE,RARP,RESULTS,RPS,THERE,USA
169,2014,AUTHORS,BASED,BJU,ITEMS,JANUARY,LITERATURE,META,PREFERRED,PSA,REPORTING,REVIEWS,SYSTEMATIC
TARGETING
169,181,1990,2011,2014,326,COPYRIGHT,INC,INCIDENCE,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PSA,RATES,RESULTS,SIR,THERE
169,2010,2014,CYBERKNIFE,D5CM,HDR,HOWEVER,JAPAN,PRESS,PTV,PTVS,PUBLISHED,RADIATION,SBRT,SOCIETY,THEN,THESE,UNIVERSITY,V40,WHILE
143,183,223,600,ART,BACKGROUND,CBCT,CBCTS,CONCLUSION,DAILY,LABEL,METHODS,PTV,RESULTS,SMALL,UNLABELLED
BACKGROUND,CONCLUSION,DART,DIR,DMIN,DVH,DVHS,DYNAMIC,FINALLY,INITIALLY,LABEL,METHODS,NTCP,RADIATION,RESULTS,THERAPY
240,241,8805,BACKGROUND,CONCLUSION,GLEASON,GRADE,GROUP,IRELAND,LABEL,METHODS,NODE,PSA,RESOLUTION,RESULTS
038,089,170,579,616,737,755,819,985,BACKGROUND,BOTH,COX,D9901,DISEASE,FOUR,HOWEVER,III,LABEL,MEIER,METHODS,PAIN,RESULTS,SIPULEUCEL,TDRP,TFOA,TREATMENT
PSA,SEVERAL,THEREFORE
CURRENTLY,DESPITE,PATIENT,RADICAL,RPE,THEIR
263,FIVE,GLEASON,HOPKINS,JOHNS,MARSDEN,REGARDLESS,RMH,ROYAL
15F,160,169,2014,549,956,COPYRIGHT,IC50,SAS,WHEREAS
169,181,2014,2B4,8201,8764,AMD3100,BONE,CAP,CXCR4,MINERAL,NW1,PC3,SOCIETY,VYBRANT,WHEREAS
BPH,CURRENTLY,HRPC,MORBIDITY,PCA,PROSTATIC,SELEX
8201,ALONG,APATONE,DAMAGED,DU145,MOST,ROS,SHAM,THESE,VK3
047,100,177,AE105,BOTH,DOTA,ELISA,FINALLY,IC50,LUC2,PET
131,177,C12,DU145,DUE,HPMA,INCREASED,PG1,PG2,SPECT
000,139,169,1987,1988,1997,2010,2014,600,BACKGROUND,CALIFORNIA,FARM,FARMERS,INC,LABEL,METHODS,NHW,PCIR,RESULTS,STAGE,THESE,UFW,WILEY,WORKERS
946,ATG4,ELISA,FOLLOWING,FURTHER,INHIBITION,LC3I,LC3II,TREATMENT
007,124,168,169,172,2014,30KG,565,8805,BACKGROUND,BMI,COPYRIGHT,COX,FURTHER,GLEASON,HOWEVER,LABEL,MEIER,MEN,METHODS,OBESITY,OBJECTIVE,OUTCOME,PATHOLOGIC,PATIENT,PCA,PUBLISHED,RESULTS,SETTING,SUMMARY,UROLOGY
112,168,169,191,2014,213,240MG,392,80MG,8804,ADVERSE,BACKGROUND,COPYRIGHT,EACH,GLEASON,GUIDELINES,IAD,INDUCTION,LABEL,METHODS,OBJECTIVE,OFF,OUTCOME,PATIENT,PSA,PUBLISHED,QOL,RESULTS,SECONDARY,SETTING,SUMMARY,TIME,TREATMENT,TRIAL
13A12,169,174,176,1NG,2014,5C5,8804,ANNEXIN,ANTI,ANXA3,BOTH,COPYRIGHT,DRE,INC,INTERASSAY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PCA,PUBLISHED,RESULTS,SOCIETY,TGC44,THESE,UNTIL,VIDAS
169,2014,COPYRIGHT,GCPII,GLUTAMATE,HOWEVER,LOW,LTD,PSMA,SAR,STRUCTURE
A9G,CELL,HOWEVER,PSMA,TREATMENT
160,169,2014,COPYRIGHT,INC,ORAI,ORAI1,ORAI3,THESE,THUS
001,026,045,1998,2009,200GY,429,50CC,967,CONCLUSION,COX,D90,INC,LABEL,MANN,MATERIALS,METHODS,OBJECTIVE,PATIENT,PEARSON,PSI,PUBLISHED,PURPOSE,RESULTS,V200,WHITNEY
169,2014,947,AUTHORS,COPYRIGHT,DZNEP,EZH2,IFN,INC,JAK,MYC,PI3K,PUBLISHED,STAT1,THUS
169,1932,1958,1969,2010,2014,965,AIM,COPYRIGHT,GENERATION,JANUARY,LABEL,LTD,METHODS,MULTI,OBJECTIVE,RESULTS,SIR,SWEDISH
169,177,185,2014,8201,AUSTRALIAN,BACKGROUND,BLAND,CBCT,CBCTS,CLINICALLY,COLLEGE,COMPARISON,FMS,INTER,LABEL,LOA,LOAMEAN,METHODS,RESULTS,ROYAL,RTS,SIX,ZEALAND
169,1776,2014,224,3654,COPYRIGHT,HIGH,INC,P450,PIM,PUBLISHED,SGI
160,169,180,2014,231,453,COPYRIGHT,FLOW,HELA,MCF,MDA,MTT,SAS,SIX
169,2014,ADT,COPYRIGHT,CRPC,CSC,EMT,IRELAND,LTD,NED
160,169,2014,COPYRIGHT,CSC,CSCS,HOWEVER,LTD,THEREFORE
169,1979,2014,2320,4299,8805,AFTER,AGE,AUTHORS,BECAUSE,BJU,GLEASON,LABEL,METHODS,NORTH,OBJECTIVE,PSA,RESULTS,SNP,SNPS,T2C,UNASSIGNED
0132,169,2014,859,AUC,BACKGROUND,BPH,CONCLUSION,COPYRIGHT,DCA,ELISA,FURTHER,LABEL,METHODS,PCA,PSA,PSP94,RESULTS,SERUM,UTILITY
169,2014,CLDN3,CLDN4,COPYRIGHT,CPE,IRELAND,LTD,MOST,PSA
549,BLK,CNS,CURRENTLY,DISCOVERY,DU145,HBCC,HDF,HEAT,HELA,HPCC,HSP70,IHC,LNCAP,MCF7,NG108,PC3,SHOCK,TDF,THESE,USING,WESTERN
0006,108,109,160,177,213,217,8201,CONCLUSION,CURRENTLY,EVALUATION,FECH,FUROSEMIDE,LABEL,MAXIMUM,METHODS,OBJECTIVE,OVERALL,PATIENT,PCA,PET,PURPOSE,RESULTS,SUV,THEREFORE
A10,MTT,PCR,RNAI,THESE
169,2008,2013,2014,8805,AMONG,LABEL,METHODS,OBJECTIVE,ONCOLOGIC,PRESS,PUBLISHED,RESULTS,UNIVARIATE,UNIVERSITY,WESTERN
005,169,177,2014,492,8201,8482,ACTA,BACKGROUND,CONCLUSION,DESPITE,FNAB,FOUNDATION,LABEL,METHODS,MYLAB,OBJECTIVE,PURPOSE,RESULTS,SCC,SINCE,SUBPLEURAL,TUS,TWICE,UNDER
169,2004,2006,2010,308,416,569,BACKGROUND,BASED,CARE,CONCLUSION,DATA,END,ESTIMATES,GIVEN,LABEL,METHODS,NPCR,NSFG,PHYSICIANS,POC,PRESS,PROGRAM,QUALITY,REGISTRIES,RESULTS,THESE
8776,ADC,AVERAGE,CONCLUSION,DIFFUSION,DWI,GLEASON,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,THERE
10878,169,2014,262,343,372,AUC,BACKGROUND,COPYRIGHT,CTV,EMLASSO,IRELAND,LABEL,LTD,MATERIALS,METHODS,MODEL,OBJECTIVE,PCA,PREDICTOR,PURPOSE,RESULTS,VARIABLES
169,2014,BPH,CRP,PENTRAXIN,PSA,PTX3,ROC
169,2014,COPYRIGHT,SAS
BPE,PSA
027,101,117,177,315,4208,8202,AUSTRALIA,CONCLUSION,CONTEXT,EVERY,FOLLOWING,FURTHER,LABEL,LOWER,MAIN,METHODS,OBJECTIVE,OUTCOME,PERTH,RESULTS,SETTING,SHR,WESTERN
169,2014,509,945,ANDROGENS,ARN,CASTRATION,COPYRIGHT,CRPC,CYP17A1,HSD17B6,INC,MDV3100,PATHOLOGY,PCA,PSA,PUBLISHED,SERUM,SOCIETY,TAKEN,VCAP
100,200,597,AAS,AFRICAN,AMERICANS,CAS,CAUCASIAN,DNAS,DUE,E213,GLEASON,GLY,HOWEVER,PCA,SER,SILENCING,SNP,SOMATIC,THESE
916,MYC,NP63,PSA,SKP,THESE,TRANSGENIC
267,534,ACK1,CAP,SFK,SRC,THERE
ANDROGENS,CRPC,FOX,FOXA1,FOXO1,FOXO3,INCREASING,PCA,PTEN,THEREFORE
11OH,945,ADT,AED,CRPC,DHEA,DHT,DOC,GIVEN,HOWEVER,PCA,SRD5A,WHILE
ADT,CAP
000,ADT,CRPC,DOCETAXEL,EMT,HOWEVER,HUGGINS,INITIALLY,RESISTANCE,SINCE
ADT,ARES,BOTH,CAP,CURRENT
129,169,1988,2012,2014,240,ALTOGETHER,BACKGROUND,DATA,JANUARY,LABEL,MAYO,METHODS,NEURO,PCNSL,PRESS,PRIMARY,PUBLISHED,RESULTS,SMS,SOCIETY,TEN,THEREFORE,UNIVERSITY
III,SBRT
169,2014,BONE,COPYRIGHT,LTD,MMP,MT1,RAC1
001,003,005,169,BACKGROUND,COX,HOWEVER,LABEL,METHODS,PCR,PTOV1,RESULTS,UNIVARIATE
001,169,2014,223,270,8201,8805,AUTHORS,BJU,DOCETAXEL,HOWEVER,LABEL,METHODS,OBJECTIVE,PFI,POTENTIAL,PSA,RESULTS,THERE
000,14284,200,2004,2008,20202,486,AIMS,BACKGROUND,BLADDER,BRAIN,CANCERS,CONTEXT,EASTERN,ESOPHAGUS,GALL,HEAD,LABEL,LUNG,METHODS,OBJECTIVE,ORGAN,OROPHARYNX,OVARY,RAJASTHAN,RESULTS,THERE,USED,WESTERN
129,169,198,1996,2004,2014,BETWEEN,COPYRIGHT,GLEASON,INC,INCREASED,LABEL,MATERIALS,METHODS,OBJECTIVE,P21,PAK6,PSMB4,PURPOSE,RESULTS
001,142,160,2005,2010,2013,382,8805,AUA,CAP,END,GLEASON,GUIDELINES,LABEL,MEN,METHODS,NODAL,OBJECTIVE,OCTOBER,PSA,PURPOSE,RESULTS,SCREENING,THOSE,UNSCREENED,UROLOGICAL,YOUNG
169,2014,945,BERBERINE,COPYRIGHT,CSA,CYP,INC,INHIBITION,LNCAP,MMP,NAC,P53,PFT,ROS,SFA
1420,1765,1777,1783,1857,1898,233,252,ALSO,ANTOINE,CAS,CHANGES,CHOLERA,FECAL,LAVOISIER,PETTERS,SALMONELLA,VIL,WILHELM
ADT,BACKGROUND,CONVEYING,CQP,CROP,DESPITE,EBRT,HIFU,HOWEVER,LABEL,METHODS,OVERALL,PROCESS,RCT,RESULTS,RRPC,SALVAGE,SPC
1523,2405,303,310,315,3928,8201,COMMERCIAL,CONCLUSION,COX,FACTORS,INCLUSION,LABEL,MAIN,METHODS,OBJECTIVE,OUTCOME,RESULTS
160,169,1MG,2003,2006,2015,300MG,420,ACADEMY,BACKGROUND,CONCLUSION,CONTEXT,COPS,COPYRIGHT,GIVEN,HOSPICE,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PALLIATIVE,PUBLISHED,REMARKABLY,RESULTS,STUDIES,USING
169,186,2014,BACKGROUND,BUMELIA,COPYRIGHT,CYRTOMIUM,CYTOTOXIC,FRACTIONS,IRELAND,LABEL,LNCAP,LTD,METHODS,RELEVANCE,RESULTS,TRICHILIA
169,2014,ERG,MOLECULAR
100,169,2014,8322,BLOOD,JOHN,LTD,PUBLISHED,SONS,THESE,THUS,WILEY
169,2014,HOWEVER,JOHN,LTD,PUBLISHED,SONS,WILEY
001,137,169,2014,ADT,ALSO,CON,FIFTY,HRMAX,JOHN,LBM,LTD,MEAN,PCA,PUBLISHED,SECONDARY,SONS,WILEY
169,2014,946,COPYRIGHT,FINALLY,HOWEVER,INC,RII,SMAD2,TGF,THESE,WDR77
AMPK,BACKGROUND,CAV,CHAIN,CHOP,GAPDH,LABEL,MATERIALS,MCF,METFORMIN,METHODS,PAR,PCR,POLYMERASE,REAL,RESULTS,SGK,TIME,TYPE,UPR
169,2014,AMONG,AUSTRALIAN,PRESS,PUBLISHED,THREE,TWIN,UNIVERSITY,USA,WHILE
4F2,8201,945,ANDROGENS,ANTI,ASCT2,DHT,DU145,EXPRESSION,FACBC,LABEL,LAT3,LNCAP,METHODS,OBJECTIVE,PROCEDURES,PURPOSE,RESULTS,SNAT5
BRAIN,CTV,DEVICES,INCREASES,JAPAN,MEDICAL,MRI,PMDA,TAKEN
169,181,2014,FMS,GMBH,IC50,KGAA,TGI,VCH,WILEY
160,169,2014,COPYRIGHT,FINALLY,LNCAP,LTD,M12,SYNTHETIC,THESE
611,614,947,CSE,H2S,LNCAP,PSA,THESE,TMPRSS2
A549,BCL,DU145,FAK,FOCAL,FOCUSSING,FOS,MAPK,POD,THESE
100,169,181,200,2014,8201,ANNEXIN,BIOLOGY,CELL,FEDERATION,FITC,LNCAP,PROTEIN,ROS,THUS
1000,160,8805,AIM,CONCLUSION,CRPC,LABEL,METHODS,NHA,NHAS,OBJECTIVE,PSA,RESULTS,UNIVARIATE
0001,169,174,177,2011,2014,252,351,967,BACKGROUND,BASEL,GLEASON,JANUARY,LABEL,LUCERNE,MATERIALS,METHODS,POISSON,RARP,RESULTS,SINCE,VINCI
BACKGROUND,CONCLUSION,CURRENTLY,FOCAL,GERMANY,HEMI,HOWEVER,LABEL,METHODS,MRI,PCA,RESULTS
AMP,AMPK,CAPSAICIN,STATS
114,22737,8202,BACKGROUND,CENTRAL,CONCLUSION,CURRENT,DECREASED,LABEL,MEDLINE,METHODS,NEWCASTLE,OBJECTIVE,OBJECTIVES,RESULTS,SCIENCE,WEB
160,169,183,8202,948,CCC,GEORG,STUTTGART,YORK
945,CHINESE,FOUR,PCA,ROS,SCHIFFN,STEPH
ANTI,BLOOD,CLSM,DCT,NPS,PDLLA,POLY
169,2014,24H,C646,CBP,COPYRIGHT,GCPII,GLUTAMATE,HDAC,INC,M344,MG132,REAL,SIMILARLY,TAKEN,TREATMENT,U87MG,VPA
169,2014,HOWEVER,MALIGNANT,METASTASIS,PRESS,PUBLISHED,UNIVERSITY,WHILE
169,2014,946,BCL2,COPYRIGHT,CRPC,CXCR4,DOC,FINALLY,FURTHER,GMBH,IGF,IL6,PC3,PROTEOMICS,ROS,SOD2,STAT3
127,169,200,2014,285,945,956,COMPLIANCE,GSH,OHDG,OVERALL,PGF2,PRIMARY,PSA,RESULTS,SECONDARY,SEMET,THESE
25S,8320,8325,945,946,956,A549,COMPOUNDS,ETOAC,GBM,NMR,NSCLC,THEIR,U373
0043132,215,BCR,BPH,COX,HAAO,HIGH,HOXD3,LABEL,METHODS,OBJECTIVE,PCA,PCR,PITX2,PURPOSE,RESULTS,TDRD1,UNI
286,8209,ECM,NH2,PROGNOSCAN,SNPS,SPARC
169,2014,633,946,CRPC,EXPRESSION,LOC,MED12,MET,PCA,SMAD3,SOCIETY,TGF,THEREFORE,WNT
001,007,10521,169,2007,2010,2014,2105,365,BACKGROUND,LABEL,METHODS,NAVIGATION,PATIENT,PRESS,PROGRAM,PUBLISHED,RESULTS,THERE,THESE,UNIVERSITY
628,8805,ANTIGEN,BACKGROUND,CONFIDENCE,FRAILTY,INTERVALS,IRISH,LABEL,LIKELIHOOD,MEN,METHODS,ODDS,PSA,RESULTS,THESE,TILDA
0001,378,405,430,441,470,524,954,AREAS,CONCLUSION,DATA,GLEASON,IMAGING,LABEL,MATERIALS,METHODS,MLS,OBJECTIVE,PURPOSE,REPORTING,RESULTS,THEN
227,854,899,AMACR,APC,AUCS,BACKGROUND,BPH,DGKZ,HES5,HOXC6,LABEL,METHODS,MICROARRAY,PCA,PCA3,RARB,RESULTS,TACC2
001,120,BACKGROUND,CONCLUSION,FFF,FLATTENING,LABEL,METHODS,RESULTS,STD,VMAT
169,2014,COPYRIGHT,H4K20,HISTONE,INC,PSA,SET8,THEREFORE
169,2014,COPYRIGHT,EPH,INC,LOSS,MEMBERS,PICK1,THESE,THUS
3584,AFTER,AMONG,BACKGROUND,BCC,COX,HAMPSHIRE,LABEL,METHODS,NMSC,OBJECTIVE,PURPOSE,RESULTS,SCC,SEVERAL,SKIN
100,13A,14A,169,2014,COPYRIGHT,FINALLY,HCT,J774,MCF,SAS
CAP,CELL,DESPITE,DU145,ERBB2,LNCAP,MYC,PC3,RAS
8Q24,THERE
159,160,8804,8805,CIS,DVHS,GRADE,KUTCHER,LKB,LYMAN,VOLUMES
ANALOGIES,PARTICULAR
034,200,2004,2011,792,821,867,AFTER,ANTIGEN,BCR,CALCULATOR,COX,FINALLY,GLEASON,JULY,JUNE,KOREA,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PCA,PSA,RESULTS,SNUH,T3A,THESE
125,169,174,2000,2012,2014,ASA,CLAVIEN,CLOT,COPYRIGHT,CYSTECTOMY,EDUCATION,III,INC,IQR,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SOCIETY,UROLOGICAL
001,049,060,111,134,157,160,169,2004,2010,2014,287,360,376,398,418,509,670,692,720,913,916,AFTER,CLAVIEN,COPYRIGHT,DESPITE,EDUCATION,INC,INPATIENT,LABEL,MATERIALS,METHODS,NATIONWIDE,OBJECTIVE,OPEN,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL,YEARS
139,150,174,177,2005,2010,2013,220,234,397,8201,8805,AMERICA,BACKGROUND,BPH,CLAVIEN,CYBERTM,DATA,FORTY,III,IPSS,LABEL,MATERIALS,METHODS,NINE,NORTH,OCTOBER,PVR,QMAX,QOL,RESULTS,SCORE,SIX,SYMPTOM,THERE,THULIUM,THUVP
148,169,172,177,2014,605,625,677,ADT,AUC,CONCLUSION,GLEASON,IMAGING,INC,LABEL,METHODS,MOLECULAR,NUCLEAR,PCA,PET,PSA,PSADT,RESULTS,SEVENTEEN,SOCIETY,UNLABELLED
169,2014,68936,BACKGROUND,BECAUSE,COMPARING,DATA,HODGKIN,HOWEVER,LABEL,MEDLINE,METHODS,PRESS,PROLONGED,PUBLISHED,RESULTS,RRS,SCISEARCH,SEDENTARY,UNIVERSITY
103,600,AFTERWARD,CONCLUSION,HISTOLOGIC,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,RESULTS,THERE,USING
169,2002,2013,BACKGROUND,CASTRATION,CONCLUSION,CRPC,INC,LABEL,METHODS,MOST,PUBLISHED,RESULTS
0304,100,2006,2013,343,363,417,865,AIMS,FAHAD,GLEASON,JANUARY,KING,LABEL,MADINAH,MATERIALS,METHODS,MOST,OBJECTIVE,PROSTATIC,PSA,RESULTS,SAUDI,SEVENTY,THERE
1100,1200,169,2014,400,800,8201,ADC,AUSTRALIAN,BACKGROUND,COLLEGE,CONCLUSION,DWI,GLEASON,KEP,LABEL,METHODS,MRI,PER,PERFUSION,RESULTS,ROYAL,THERE,WEAK,ZEALAND
169,1940S,2014,231,233,COPYRIGHT,PUBLISHED,SAS,SNFMI,SOCI
005,125,199,507,BACKGROUND,BALB,DOWN,DU145,ELISA,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,SERUM,SIX,SONOVUE,SPECIMENS,TREATMENT,ULTRASOUND,WESTERN
061,2008,2011,2012,651,8805,FURTHER,LABEL,METHODS,MOST,OBJECTIVE,PLND,PURPOSE,RALP,RESULTS,ROUTINE,THEREAFTER
169,2014,946,A549,COPYRIGHT,DEPLETION,INC,NEDD4,PUBLISHED,TGF,THESE
231,CARS,COMBINING,INCREASING,LNCAP,MDA,METHODS,MPA,PC3,PRINCIPAL,R1881,RAMAN,T47D,USING
169,2014,AKT,COPYRIGHT,LTD,NOTCH,PI3K,PTEN
0534,169,2014,CIS,COPYRIGHT,CTV,D100,D95,D99,EACH,GROUP,INC,MEDICAL,PRO,PTV,PUBLISHED,RADIATION,RESULTS,RTOG,THERAPY,VMAT
0001,001,1121,169,2014,531,720,ASP312ASN,COPYRIGHT,HAPLOTYPE,NER,PUBLISHED,SNP,SNPS,XPA,XPD,XPG
100,169,2014,954,956,AKT,ANNEXIN,COPYRIGHT,ELISA,FITC,GMBH,GREEK,JNK,MIC,MTT,S473,S536
DOCKING,GLUCOSE,GLUT,GLUT1,GLUT4,GLUTS,LNCAP,RESULTS,THUS,WESTERN,XYLE
169,174,2010,2014,403,634,COPYRIGHT,EDUCATION,GLEASON,INC,LABEL,MATERIALS,METHODS,NCCN,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SEER,UROLOGICAL
145,169,2014,946,CREB1,JUN,KLF5,MYC,RELA,SP1,TGF,THESE,UICC
169,2014,CNAS,COPYRIGHT,GENOMIC,IMPORTANT,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
169,2014,AMACR,BRITAIN,COPYRIGHT,ERG,FURTHER,GREAT,IRELAND,JOHN,LTD,PUBLISHED,SOCIETY,SONS,TMPRSS2,TP53,WILEY
169,2014,COOH,CRPC,FINALLY,INC,PCA,THESE
GLEASON,PCA,RNAS,TRPM2
028,137,169,2000,2013,2014,2053,549,8201,95TH,GUIDELINES,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THESE,UROLOGICAL
169,2014,COPYRIGHT,INC,MRI
010,029,041,059,163,169,2014,2171,6426,724,AUTHORS,AVAILABLE,BJU,CONCLUSION,GLEASON,LABEL,MEN,METHODS,METS,OBJECTIVE,PSA,REDUCTION,RESULTS,WHILE
132,340,945,D131G,INDUCTION,PAR,TAKEN,TNF
018,031,040,169,2006,2012,2014,8201,ACCORDING,ADVERSE,EACH,JUNE,KETTERING,MAY,SLOAN,UROLOGICAL
169,174,2009,2012,2013,8201,8805,ABLATHERM,AFTER,AUTHORS,BCR,BETWEEN,BJU,CONCLUSION,CONTINENCE,DISEASE,EORTC,HSH,ICS,IIEF,IMAGING,INCLUSION,INDEX,INTEGRATED,IPSS,LABEL,METHODS,OBJECTIVE,PHOENIX,PSA,QLC,QLQ,RESULTS,SOCIETY,TREATMENT
169,2014,8243,946,CHEV,COPYRIGHT,ESI,GUTTIFERAE,HYPERICUM,LTD,NMR,THEIR
160,169,2014,AFTER,AGREEMENT,CONCLUSION,COPYRIGHT,FORCE,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,OVERALL,PCA,PREVENTIVE,RESULTS,TASK
1300,1349,160,169,1991,2008,2014,656,705,8804,8805,CONCLUSION,COPYRIGHT,GLEASON,INC,LABEL,MEN,METHODS,OBJECTIVE,PCA,PCAS,RESULTS,THERE
0001,0034,011,165,347,547,8805,APV,BMFS,CONCLUSION,CRPC,DISEASE,INC,LABEL,MATERIALS,METHODS,MULTI,OBJECTIVE,OBJECTIVES,PSA,PSADT,PUBLISHED,RAPID,RESULTS,THESE
1000,169,2014,3DCRT,AUSTRALIAN,BACKGROUND,COPYRIGHT,COSTS,IMRT,INTENSITY,IRELAND,LABEL,LTD,METHODS,QALYS,RESULTS
AIM,CHALLENGES,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,ZEALAND,ZEALANDERS
160,169,2014,COPYRIGHT,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SOCIETY,TRUS
001,002,003,006,012,019,020,031,032,047,170,1995,2005,535,AFTER,BACKGROUND,BFFS,CFFS,GLEASON,LABEL,MEIER,METHODS,NORWEGIAN,PCD,PCDFS,PNI,PSA,PSM,RESULTS,SCORE,STAGE
0001,003,010,169,2006,2011,2014,CAUTION,CONCLUSION,COPYRIGHT,GRADE,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SBRT,THRESHOLD
001,034,036,047,64257,AN3CA,BACKGROUND,ELISA,KNOCKDOWN,LABEL,LOSS,METHODS,MMP2,MTT,PCR,RESULTS,THEREFORE,TRANSWELL,WESTERN
169,2014,ANN,ANNS,COPYRIGHT,DARBY,MADIN,MDCK
169,2014,3057,AACR,AKT,BRAF,CLIN,EGF,FAST,HOWEVER,LIPID,PI3K,PTEN,RES,YET
169,AMONG,FURTHER,MTA,MTAP,PRESS,SIXTY
BASED,CHEM,CHIP,JUMONJI,KDM4C,SD70
AMONG,ARRAY,BACKGROUND,BASED,ESPECIALLY,LABEL,METHODS,OPN,OPNA,OPNB,OPNC,OVCAR,OVERALL,PATHWAY,PCR,RESULTS,VEGFA
169,2014,400,AMONG,BACKGROUND,CONCLUSION,COPYRIGHT,DLT,HOWEVER,LABEL,LTD,METHODS,MOST,QUESTIONS,REANALYSIS,RESULTS,THEREFORE
ACTIVATION,BACKGROUND,BCL,BIM,EBP,GAMITRINIB,HSP90,JUN,LABEL,METHODS,MTT,RESULTS
160,169,177,192,2014,CARLO,CATHETERS,COPYRIGHT,DOSE,HOWEVER,INC,LABEL,MATERIALS,METHODS,MONTE,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SOCIETY,STAINLESS
2009,460,734,ADVERSE,AMONG,BACKGROUND,LABEL,METHODS,PCA,RESULTS,SNIIRAM,THESE
000,071,102,104,105,193,2013,232,373,3RD,416,428,624,770,BACKGROUND,CARLO,CONFIDENCE,DRUG,LABEL,LHRHA,MEN,METHODS,MONTE,PCA,RESULTS
AFTER,DRUGS,EMERGENCE,STEROID
BACKGROUND,DIRICHLET,ESTIMATING,LABEL,METHODS,RESULTS,STUDENT
001,002,005,22RV1,945,954,BAX,BCL,CFLAR,HIF1,HOWEVER,IC50,KRAS,MT1A,MT2A,MTT,PI3K,PNT1A,THEREFORE,ZINC,ZIP1,ZNT
145,946,CD133,CD44,CSC,CSCC,CSCS,HIGH,ITG,MICROARRAY,MMP1,MMP14,MMP16,TGF,THBS1,THESE,TIMP1,VCAN
ALZHEIMER,KALLIKREIN,KLK,KLK1,KLK15,KLK3,KLKS,PARTICULAR,PSA
231,946,BRK,CD31,COMPOUNDS,FAK,GFP,HPCD,MDA,MET,NOVEL,PMH,PMHS,RAC1,SAR,SETH,THUS,WESTERN
GNRH,HOWEVER,PC3,ROS,SN09,THESE,TRP
25D,945,ARTIFICIAL,BECAUSE,CYP24A1,ETS,LNCAP,NEXT,P450,PCA,PCAS,THUS,TMPRSS2,VCAP,VDR
8209,A549,AXL,H460,MER,NSCLC,RTK,TAKEN,TAM,THESE,TYRO,UPON,XIAP
001,1366,717,967,BACKGROUND,LABEL,METHODS,MOST,OBJECTIVE,OVERALL,PEARSON,RADIATION,RELEVANCE,RESULTS
169,CASE,COPYRIGHT,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PATHOLOGY,PSA,RESULTS,SOCIETY
085,160,169,2014,231,280,325,930,AMONG,CALIFORNIA,CONCLUSION,COPYRIGHT,FRANCISCO,INC,LABEL,METHODS,MODIFYING,NCCN,NETWORK,OBJECTIVE,PCA,PRIAS,PSAD,RESULTS,SAN,THEREFORE,UCSF,UNIVERSITY,USING
147,169,2014,221,291,BACKGROUND,CAG,ERG,LABEL,MEN,METHODS,ORS,RESULTS,THESE,TMPRSS2
169,2014,7082,8201,945,954,AFTER,BACKGROUND,BAY,CONCLUSION,DECREASES,FLOW,HOWEVER,LABEL,METHODS,MTS,NUCLEAR,PCA,RESULTS,SHANK,SHARPIN,SOCIETY,TRANSWELL
169,2014,ABC,ATP,BACKGROUND,DU145,EXPRESSION,INC,LABEL,LNCAP,METHODS,MTT,PACLITAXEL,PCA,PCR,RESULTS,SHH,SONIC,WILEY
169,2014,3100,945,COPYRIGHT,CRPC,DHEA,ESSENTIAL,FDA,GNRH,ISSUE,LTD,MDV,SPECIAL,WHILE
169,2014,AMONG,BOTH,COPYRIGHT,GATA3,INC,INTENSITY,NUCLEAR
169,177,2013,CONCLUSION,GLEASON,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,WILEY
115,119,169,177,2014,8805,COPYRIGHT,GLEASON,PUBLISHED,THERE
001,051,1500,169,177,2013,ADC,BPH,CONCLUSION,DIFFUSION,DKI,DWI,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,ROC,WILEY
169,2014,A10,COPYRIGHT,EPH,HOWEVER,INC,SCREENING,THEREFORE,THUS
169,177,190,2013,720,CONCLUSION,HISTOLOGY,INC,LABEL,MATERIALS,METASTASIS,METHODS,MRI,OBJECTIVE,PURPOSE,REGIONS,RESULTS,WILEY
169,2014,COPYRIGHT,PUBLISHED,ROBOTIC,VINCI
100,169,2013,215,239,ADC,BAYES,CONCLUSION,EACH,EIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,T2WI,WILEY
8201,CONTINENCE,FORTY,LABEL,MATERIALS,MEN,METHODS,OBJECTIVE,PERMANENT,PURPOSE,RARP,RESULTS,THESE
000,140,169,1968,1991,1992,2001,2007,2014,31ST,CANCERS,FIRST,INDIANS,NATIONS,ONTARIANS,ONTARIO,UICC
185,8315,BOTH,HOWEVER,LNCAP,MDA,PCA
1367,160,169,1990,2010,2014,2270,267,378,777,BACKGROUND,COLORECTAL,COPYRIGHT,LABEL,LTD,METHODS,RCC,RCCS,RESULTS,RISKS,SIR,SIRS,SWEDISH
004,052,100,109,112,126,169,2002,2012,2014,319,AIM,AMICO,ANTICANCER,CONCLUSION,COPYRIGHT,FIVE,HDR,INDEX,INSTITUTE,ISBT,JOHN,LABEL,METHODS,NCCN,NETWORK,OBJECTIVE,PRIX,RESULTS,RISK,SEATTLE
169,2014,AKT,ANTICANCER,CACO2,COPYRIGHT,FINALLY,FOCUSSING,INSTITUTE,JOHN,MTT,POD,PROTEIN,THESE,TREATMENT
007,015,016,022,026,109,154,169,2014,209,234,437,545,ANTICANCER,BPH,COPYRIGHT,EXPRESSION,GLEASON,INSTITUTE,JOHN,KNOCKDOWN,LNCAP,MEIER,PCA,PPM1D,PROTEIN
169,2014,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,GSH,GSSG,H2O2,INSTITUTE,JOHN,LABEL,MATERIALS,METHODS,OHDG,RESULTS,SINCE,SOD3
169,2014,AFTER,ANTICANCER,COPYRIGHT,CRPC,INSTITUTE,JOHN
PCA,PSA,UPLC
945,ESIPT,THESE
CRPC,HOWEVER,ID4,LNCAP,NKX3,PCA,WESTERN
AMACR,CK903,GATA,NAS,PIN,SIXTY
BOTH,DOSE,METHODS,ROC
159,160,BACKGROUND,CONCLUSION,HOPKINS,JOHNS,LABEL,MEN,METHODS,OBJECTIVE,RESULTS,USING
100,2ND,3RD,8804,ADT,ADVERSE,CONCLUSION,III,LABEL,METHODS,NON,OBJECTIVE,PCA,PFS,PSA,PURPOSE,RESULTS,SBRT,SECONDARY,TEN
000,169,2014,500,EPIC,FRUIT,NUTRITION,SOCIETY,THERE
BASED,CONCLUSION,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,THEREFORE
169,2014,COPYRIGHT,ECM,GMBH,KGAA,LACK,METASTASIS,SIMILAR,VCH,WILEY
0097,1086,1302,215,283,303,413,8197,8804,ASIAN,AUC,BACKGROUND,BMJ,CHINESE,GROUP,GWAS,HOWEVER,KLK3,LABEL,LIMITED,METHODS,PCA,PSA,PUBLISHED,PUBLISHING,RESULTS,RS16856139,SLC45A3
945,946,ARNT,CHIP,GST,HIF1,HOWEVER,LOCALIZED,MCF7,NOTABLY,THESE,TRIP230,USING
2014,COPYRIGHT,PROUS,SCIENCE,STOCKHOLM,UROLOGY
1999,2371,AMONG,APPROACHES,BACKGROUND,DELAY,HOWEVER,LABEL,METHODS,OVERALL,RESULTS,URINARY
LEUPROLIDE,OFUJI
053,1166,1964,1999,2005,458,798,BACKGROUND,COX,JANUARY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRIOR,RESULTS
0001,130,169,2004,2011,2013,2014,681,8201,BACKGROUND,BASE,DATA,LABEL,METHODS,OLDER,RADIATION,RESULTS,SOCIETY,UROLOGICAL,USING
027,164,383,CAMBRIDGE,COMPARING,CONCLUSION,EVEN,FISCHER,GLEASON,HEIDELBERG,KRUSKAL,LABEL,LOW,MDA,METHODS,MRI,MTTP,OBJECTIVE,PATIENT,PURPOSE,RESULTS,STP,THERE,TRUS
113,169,175,2014,592,676,703,751,754,769,812,8201,834,869,8805,AGE,BACKGROUND,CAP,DRE,LABEL,MEN,METHODS,MRI,PREVENTION,PSA,RESULTS,SOCIETY,TESLA,THREE,TRIAL
AFTER,BECAUSE,CPT,HOWEVER,XELOX
144,207,5MG,EACH,JAPAN,TAP
2012,FORCE,INSTITUTE,JAPAN,PREVENTIVE,PSA,TASK,USA
246,ERSPC,HOWEVER,JAPAN,PSA,QOL,RANDOMIZED,SCREENING,THEREFORE,UROLOGICAL
6TH,JAPAN,THERE
169,2014,COLD,CPG,FINALLY,LABORATORY,NDR,NDRS,NOME,PRESS,PUBLISHED,REMARKABLY,TFS
169,2014,BASED,SOCIETY,THESE,WHILE
111,150,160,169,2014,CONCLUSION,COPYRIGHT,GLEASON,INC,LABEL,METHODS,OBJECTIVE,PCA,REDUCTION,RESULTS
NHS
ADEQUATELY,BACKGROUND,BARRETT,CHRONIC,CRP,HALO,LABEL,METHODS,RESULTS,RFA,ULTRA
99M,BLOOD,DB4,DEMOBESIN,GRPR,LABEL,METHODS,OBJECTIVE,PROCEDURES,PURPOSE,RESULTS,SPECT
169,2014,COPYRIGHT,LTD,THROUGH
001,169,1988,2009,2014,205,551,8804,8805,ADVANCING,COMPETING,CONVERSELY,COPYRIGHT,CSM,END,GLEASON,HOWEVER,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OVERALL,PCA,RESULTS,SEER
100,2004,2012,228,CDX2,CGA,FIFTEEN,GASTRIC,GCDFP15,HMB45,LABEL,LYMPH,METASTASES,METASTATIC,METHODS,MOLECULAR,MPNST,OBJECTIVE,OVARIAN,P504S,PANCREATIC,PAX8,PSA,RESULTS,SEVEN,SYN,TTF,WT1
132,145,169,2014,945,946,947,CHK1,CHK2,COPYRIGHT,DACA,H2AX,HDAC,HDAC1,HDAC6,HRMPC,INC,RPA32,ULTIMATELY,VORINOSTAT,WJ35435
169,2014,296,COPYRIGHT,HOWEVER,PIN1,PUBLISHED,UTR
169,2014,215,COLLIMATOR,DELTA,DMLC,DYNAMIC,IMRT,INTENSITY,JAPAN,MODULATED,MULTILEAF,PRESS,PUBLISHED,RADIATION,SOCIETY,TDIS,THERAPY,UNIVERSITY
169,2014,ACIDS,EXPRESSION,LIGHT,MT1,NUCLEIC,ORF1,PRESS,PUBLISHED,UNIVERSITY
0002,169,2014,215,510,8805,BACKGROUND,FDG,FIVE,HOWEVER,INC,INCLUSION,LABEL,METHODS,NEPC,PCA,PET,RESULTS,STRATIFIED,WILEY
169,2014,946,AKT,BACKGROUND,DISCUSSION,DKK1,FOXP3,INC,LABEL,LENTIVIRAL,METHODS,MYC,NUCLEAR,PGF,PGFS,PREC,PRECS,RESULTS,TCF,WILEY,WNT
001,010,023,138,156,8805,BCR,FIRST,GLEASON,PSA,REGARDING,USING
1B1,881,890,937,942,996,997,ARTICLE,ASIAN,BACKGROUND,BEGG,CAUCASIAN,CYTOCHROME,HOWEVER,L432V,LABEL,METHODS,ODDS,P450,RESULTS,STATA,THEREFORE,UNASSIGNED,VIRTUAL
169,2014,8594,940,AT1,AUTHORS,BACKGROUND,CB1,CP55,DATA,DOWN,ERBB2,FAAH,FURTHER,INC,LABEL,RESULTS,THUS,WILEY
124,169,2014,AUTHORS,BACKGROUND,BPH,CLINICALLY,DU145,INC,LABEL,METHODS,MIR,PACE,PACE4,PCA,PCR,RESULTS,UTR,WILEY
954,AKT,BACKGROUND,CONCLUSION,HIGH,LABEL,METHODS,MID1,PCA,PCR,PI3K,PP2A,PROMOTION,RESULTS,THUS,WESTERN
100,125,149,160,169,185,2014,43U1,AAPM,CARLO,COPYRIGHT,D10,D90,DVH,FORMULA,GROUP,HOWEVER,INC,ISA,LABEL,MATERIALS,METHODS,MONTE,OBJECTIVE,PERIPHERAL,PUBLISHED,PURPOSE,RESULTS,SOCIETY,TASK,V100
1194,1201,177,1994,1998,6069,6073,9150,9156,BACKGROUND,BARR,BLS,BURKITT,CONCLUSION,EBNA1,EBV,EPSTEIN,JID,LABEL,METHODS,MUTU,MUTUI,PCR,PLAC1,REAL,RESULTS,RNAS,THUS
157,167,169,1999,2012,2014,225,551,708,8201,GLEASON,JANUARY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OPERATIVE,RESULTS,ROBOT,SEPTEMBER,THERE,THUS,UROLOGICAL
169,2014,COPYRIGHT,CYTOSCAPE,GSEA,HOWEVER,LTD,PROTEOMICS,THERE
0267,CENTROSOME,FLAG,ILK,INHIBITION,LIVE,QLT,RB1,THESE,Y79
945,AIM,CONCLUSION,DU145,GIVEN,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,THESE,TNF
169,2014,AIM,CAP,CONCLUSION,COPYRIGHT,DU145,EXPRESSION,LABEL,LNCAP,LTD,METHODS,OBJECTIVE,OREXINS,OX1R,OX2R,OXA,RESULTS
169,192,2014,ARF,COPYRIGHT,EMT,FEDERATION,MECHANISMS,PTEN,PUBLISHED,SLUG,SOCIETIES,THESE,TRP53
169,2014,231,233,COPYRIGHT,PUBLISHED,SALVAGE,SAS,SFRO,SOCI
12A,145,169,2014,945,946,AMONGST,COMPOUNDS,COPYRIGHT,INC,LNCAP,WHILE
005,160,169,2014,232,ANALYZING,AUSTRALIAN,AUTHORS,AZGP1,BECAUSE,DIAGNOSTIC,EXPRESSION,GLEASON,IHC,JOHN,LTD,MEN,MRR,MRRS,MUC1,NKX3,POISSON,PTEN,SONS,USING,WILEY
104,169,2014,AGE,ASIAN,BACKGROUND,CAP,ERG,ETS,FILIPINOS,GENERAL,GLEASON,INC,LABEL,MAB,MEN,METHODS,OVERALL,PGH,PHILIPPINE,RESULTS,TMPRSS2,TRUSP,TURP,UNIVERSITY,WESTERN,WILEY
AIS,ANDROGENS,CRPC,DBD,EARLY,HOWEVER,LBD,SEVERAL
100,2011,508,784,842,AGE,CAB,CASTRATION,CONCLUSION,CRPC,LABEL,METHODS,OBJECTIVE,ORAL,PSA,RESULTS,TIME
145,CELL,CONCLUSION,ERS,GPR30,IC50,LABEL,METHODS,OBJECTIVE,PCR,RESULTS
CXCL8,HMGB1,INCREASED,SDS
BINDING,CXCL8,CXCR2,GTP,HOWEVER,KNOWLEDGE
2005,2014,ACCORDING,ELECTRONIC,ENGLISH,EPBX,HOWEVER,JANUARY,LABEL,MEDLINE,METHODS,MRI,OBJECTIVE,PBX,PSA,PURPOSE,RESULTS,SPBX
AGE,BACKGROUND,COLORECTAL,CRC,KATHMANDU,LABEL,LEFT,MAXIMUM,METHODS,NEPAL,RESULTS
145,169,2014,BCAA,BCAT,COPYRIGHT,INC,KIC,LEU,MRS,THESE,TRAMP,USING
169,2014,BECAUSE,COPYRIGHT,FATTY,FINALLY,GLEASON,INC,LNCAP,PATHOLOGY,PUBLISHED,SOCIETY
000,100,169,1970S,1980,2000,2005,2009,2014,AMERICA,BACKGROUND,BETWEEN,COSTA,CUBA,HOWEVER,LABEL,LATIN,MEDICAL,METHODS,PRESS,PUBLISHED,RESULTS,RICA,SOCIETY,TOBACCO,UNIVERSITY,USA,VENEZUELA,WORLD
169,1999,2012,2013,2014,BLOOMBERG,CAUCASIANS,GSTT1,HOPKINS,HOWEVER,JOHNS,LIBRARY,MARCH,PRESS,PUBLISHED,UNIVERSITY
149,169,2014,ATLAS,EXPRESSION,LARGE,PRESS,PUBLISHED,TCGA,UNIVERSITY
ACUTE,END,EPIC,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SBRT,URINARY,VMAT
169,2014,945,FUT8,GLEASON,LNCAP,PC3,PCA,PRESS,PUBLISHED,THREE,UNIVERSITY,USING
1970,1972,1973,2008,254,350,823,ADDITIONAL,COX,FEW,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SERUM,SUA,VLAGTWEDDE
120,169,2014,8805,AAWS,AUTHORS,BJU,FURTHER,LABEL,METHODS,MOST,NONE,OBJECTIVE,PATIENT,POST,PSA,RESULTS
169,2014,AKT,CAO,CHINESE,COPYRIGHT,DTT,DU145,ERK,ERK1,FURTHER,HOWEVER,JNK,JUN,MAPK,METASTASIS,MMP,ROS
169,2014,946,GSK3,INC,LRP6,WILEY,WNT
098,169,199,2004,2009,2014,303,368,IRR,KNOWLEDGE,MEN,POISSON,PSA,THESE,UICC
169,177,2014,956,ABC294640,ACADEMY,BACKGROUND,COPYRIGHT,ENDOGENOUS,INSTITUTE,INTRINSIC,LABEL,LNCAP,METHODS,PARTNER,PUBLISHED,RESULTS,SPHK,SPHK2,URBAN
1125,169,1995,2014,202,AUTHORS,BJU,FURTHER,HOPKINS,JHH,JOHNS,LABEL,METHODS,OBJECTIVE,PRIAS,PSA,PSADT,RESULTS,SINCE,THERE
10A,169,2014,COPYRIGHT,CPT,DOX,DU145,GENERALLY,HCT,HELA,MCF,MOST,PIPERAZINE,SAS,SEVERAL,T47D,TAKEN
000,0014,003,156,169,2014,334,425,454,465,991,AFRICAN,AMERICANS,HAWAIIANS,HOWEVER,IGF1,LATINOS,MAF,ROCHE,SNP,SNPS,THREE
1000,122,2008,2012,ASSURANCE,BACKGROUND,DIFFERENT,GERMANY,GLEASON,GROUP,IQUO,LABEL,MATERIALS,MAY,METHODS,NEWER,OBJECTIVE,OBJECTIVES,ODM,PSA,QUALITY,RESULTS,RISK,URO,WORK
2013,ANGLO,BACKGROUND,CURRENTLY,ENGLISH,EVALUATION,LABEL,MATERIALS,METHODS,RESULTS,SAXON,THEREFORE,THESE
017,019,026,169,2006,2011,2014,8805,BACKGROUND,CONCLUSION,GMBH,JANUARY,LABEL,MAY,METHODS,POTENTIAL,RESULTS
107,109,169,2005,2014,670,746,791,954,ACCORDING,AUTHORS,BJU,CONCLUSION,GLEASON,HOWEVER,KAPPA,LABEL,METHODS,OBJECTIVE,PATHOLOGY,RESULTS,SOCIETY,THREE,TREATMENT,UNWEIGHTED,UROLOGICAL
169,2014,ACTIVATION,BACKGROUND,BRITISH,CLOFOCTOL,CONCLUSION,DRUG,FINDING,HOPKINS,JOHNS,KEY,LABEL,LIBRARY,METHODS,OBJECTIVE,PURPOSE,RESULTS,SOCIETY
128,169,2014,BMI,CSC,NANOG,USING
001,007,009,164,169,2014,221,AIMS,BACKGROUND,ECE,HISTORY,IIEF,INDEX,LABEL,MAIN,MEAN,METHODS,NVB,OBJECTIVE,OHORI,OPTIMAL,OUTCOME,PDE5I,RESULTS,RRP,SIXTY,SNG,SOCIETY,THERE
0001,177,2003,2009,235,273,307,856,C30,CLAVIEN,DINDO,EORTC,IIEF,LABEL,METHODS,OBJECTIVE,PURPOSE,QLQ,QUALITY,RADICAL,RESULTS,WHILE
BRCA2,CELL,ECM,HOWEVER,INDUCTION,PCD,ROS,TAKEN,TREATMENT,USING
AFTER,BACKGROUND,CASE,CONCLUSION,EGIST,LABEL,METHODS,PRIMARY
34BETAE12,CD44,CHRONIC,CONCLUSION,ERG,LABEL,LUMINAL,MET,METHODS,OBJECTIVE,RESULTS
COA,OTHER,PCA,USING,WHILE
128,169,183,2012,2013,8805,ACCORDING,AMONG,BACKGROUND,CEUS,CONCLUSION,DRE,EAU,ESPECIALLY,GEORG,GLEASON,JANUARY,LABEL,LOW,METHODS,MRI,PCA,PRIOR,PSA,RADS,REAL,RESULTS,STUTTGART,TESLA,TRUS,UROLOGY,YORK
150,AFTER,AFTERWARDS,GLEASON,POST,SCORE,THEN,THEREFORE,THROUGH,USING,WEB
AUSTRALIAN,IC50,NFF,PC3,PIPESTELA,STRUCTURE,THEIR,THESE
115,180,A139,BACKGROUND,CONTENT,DCR,DIGITAL,DISSECTION,LABEL,LOCAL,MAIN,METHODS,NEXT,OBJECTIVE,OUTCOME,RESULTS,SETTING,THERE,VIDEO
BNC,BNCS,DESPITE,LABEL,OBJECTIVE,PURPOSE,RESULTS,SUMMARY,THERE
010,100,132,173,2010,2011,323,BOO,BOTH,BPH,CONCLUSION,FIFTY,GUDP,HOLEP,IPSS,LABEL,LUTS,METHODS,OBJECTIVE,PAIN,RESULTS,SCORE,SYMPTOM,VAS
22RV1,CCT,EMT,PC3,PCA
032,154,169,2014,8805,AUTHORS,BJU,CIS,COX,FREE,LABEL,MEIER,MEN,METHODS,OBJECTIVE,ODDS,ORS,PCA,RESULTS,STUDENT,TOTAL
616,620,NONE,SNPS,SPANISH,TAKEN
169,2008,2012,2014,283,AMONG,BACKGROUND,BCR,FURTHER,GLEASON,INC,LABEL,METHODS,METS,OBJECTIVE,PSA,RESULTS,THEIR,WILEY
169,2014,264,484,805,820,COX,LABEL,META,METHODS,OBJECTIVE,READERS,RESULTS
ACCORDING,ETS,MMP,PC3,PDEF
AWARENESS,BACKGROUND,DISCUSSION,INCORRECT,LABEL,OBJECTIVE
CASTRATION,CLINICALLY,CRPC,THESE
CHOLINE,MRS
124,160,177,231,549,956,ACCORDING,HELA,HOWEVER,IC50,MCF,MDA,MRC,MTT
414,CONCLUSION,DESMOGLEIN,DSG1,DSG2,DSG3,DSG4,DSGS,FURTHER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE
000,169,2014,215,285,376,AFTER,BPC3,CONSORTIUM,FINALLY,INSTITUTE,ORS,PRESS,PUBLISHED,SNPS,TNM,UNIVERSITY
169,2014,CIOCALTEU,COPYRIGHT,FOLIN,JOHN,LTD,SONS,TOTAL,WILEY
ALSO,ARES,DESPITE,PCA,UTR
001,002,010,156,160,229,385,635,658,COX,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,UCB
169,2014,BAYES,COPYRIGHT,JOHN,LTD,SONS,WILEY
102,A549,ANP,B16,BALB,C57BL,ECTOPIC,LINE,NH2,NP73,NPR,THESE
169,2014,946,AMERICA,ASIA,AUTHORS,BJU,CONCLUSION,DATA,EAST,ERTAPENEM,LABEL,METHODS,OBJECTIVE,RESULTS,RISK,SIX,SOUTH
169,2014,ANXIETY,AUSTRALIAN,AUTHORS,BJU,CONCLUSION,HRQL,IIEF,INDEX,IPSS,LABEL,MAX,METHODS,MOST,OBJECTIVE,RESULTS,SCALE,SCORE,SYMPTOM,THERE,THREE,UAS
169,2014,AUTHORS,BJU,GASTRIN,GRP
169,2014,AUTHORS,BJU,INSERTION,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SPACERS
169,177,2013,2014,258,470,8201,8804,ANZUP,ART,AUSTRALIA,AUSTRALIAN,AUTHORS,BJU,CONCLUSION,COUNCIL,EARLY,GROUP,III,INSTITUTE,LABEL,LOCAL,MEDICAL,METHODS,OBJECTIVE,OBJECTIVES,OCTOBER,PSA,RADIATION,RAVES,RESULTS,SALVAGE,SMS,SOCIETY,SRT,SURGERY,TRANS,TRIAL,TROG,UROGENITAL,UROLOGICAL,USANZ,ZEALAND
0001,003,10TH,169,2014,254,278,447,676,8201,90TH,BACKGROUND,BONFERRONI,COLORECTAL,LABEL,LUNG,METHODS,OVARIAN,OVERALL,RESULTS,SCREENING,SERUM,SOCIETY,TRIAL,USING
169,2005,2013,2014,8201,JAPAN,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SLEEP,UROLOGICAL
CTCS,CURRENT,ECS,HOWEVER,INITIAL,METASTASIS,THEREFORE
0052,011,016,0441,045,117,135,169,2014,228,450,676,777,811,866,882,COX,NKX3,PREVENTION,SIMILARLY,TRIAL,VITAMIN
001,021,026,100,103,2004,2011,8201,8804,8805,ACUTE,EACH,ENI,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PURPOSE,RESULTS,V70
169,2014,208,725,8804,AUC,BACKGROUND,COPYRIGHT,GLEASON,GLS,INC,INDEX,LABEL,MATERIALS,METHODS,PCA,PSA,RESULTS
330,LIP,RESULTS,SEVERAL
19A,345,519C,ALSO,BOTH,CAPRA,GLEASON,HOWEVER,PSA,SERUM
120,169,2014,240,4846,954,CIS,COHEN,CONCLUSION,IMAGE,LABEL,MATERIALS,METASTASES,METHODS,OBJECTIVE,PURPOSE,RESULTS,RSNA,SHORT,WRITTEN
150,2009,2013,3965,9257,9433,9681,APRIL,BACKGROUND,CONCLUSION,DESPITE,LABEL,LRP,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEPTEMBER,THERE,TREATMENT
361,8764,CTCS,EFFECTIVE,EPCAM,MCF,MDA,PAMAM,PCA,PSA,THESE
221,222,AFTER,CELLS,LNCAP,MIR,SIRT1,STUDIES,THEIR,THERE,THESE
945,946,BSA,CAM,CAMS,ECFP,FUNCTIONAL,LNCAP,PCA,PNI,SCN2B,VOLTAGE,VSSC
BACKGROUND,BAX,BP1,DCA,HT29,INCREASED,LABEL,LC3B,MCT1,METHODS,NAD,NADH,PC3,REDUCED,RESULTS,ROS
177,AFTER,ANOTHER,INSTITUTE,NCI,PHYSICS,RIGID,RPC,SOLID,SR4,SUBSTITUTE,THUS,TLD,TLDS,TPS
CGE,DOSE,ECLIPSE,EUD,EUDS,PTV,TPS,USPT,VMAT,XIO
1995,2000,2005,2009,219,518,555,609,BETWEEN,COX,HOWEVER,LABEL,METHODS,OBJECTIVE,PALATINATE,RESULTS,RHINELAND
3000,EPHA2,GNR,GNRS,GOLD,LBL,OVERALL,TARGETING,YSA
013,032,100,169,2014,215,8805,AFRICAN,AMERICANS,BIOMARKER,EVALUATION,EVALUATORS,GENOMIC,METASTATIC,OVERALL,PPV,UNDER
169,2014,COPYRIGHT,EVENT,IES,JOHN,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,REVISED,SCALE,SONS,WILEY
APOPTOSIS,AREAS,BACKGROUND,COVERED,LABEL,METHODS,OPINION,PAR
169,2014,ASIA,AUTHORS,LTD,NOTABLY,PTY,PUBLISHING,SCIENCE,SEVEN,SEVENTY,THESE,WILEY
169,2014,AUTHORS,HERV,HERVS,HOWEVER,INC,PUBLISHED,UICC,WHETHER,WILEY
169,2014,2024,AMERICANS,BASE,DATA,END,INSTITUTE,JANUARY,RESULTS,SEER,SOCIETY,THERE
169,2008,2012,2014,8805,ACUTE,ADVERSE,BETWEEN,COPYRIGHT,DOSE,HOWEVER,INC,LABEL,LOCAL,MATERIALS,MAYO,METHODS,MOST,OBJECTIVE,PUBLISHED,PURPOSE,RADIATION,RESULTS,SBRT,SOCIETY,THERE
0001,169,2014,448,COPYRIGHT,COX,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PCSD,PSA,PUBLISHED,PURPOSE,RADIATION,RESULTS,SOCIETY,SRT,THESE,TNPSA,UNIVARIATE
AREAS,BACKGROUND,COVERED,CYP17A1,HOWEVER,LABEL,METHODS,OPINION,THERE
000,003,BACKGROUND,BLOOD,CONCLUSION,LABEL,METHODS,PSA,RESULTS,THREE
001,11C,215,785,8201,8226,832,ADC,AUC,BOTH,CONCLUSION,DWI,KEY,LABEL,MEAN,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,ROC,SUV,SUVS
DASL,FGFR1,HPT,HRPT2,IHC,MAPK,MUTATIONS,PCR,RNAS,SIXTEEN,TOTAL,WELCH
2014,EMT,INC,PUBLISHED
169,1999,2009,2014,672,BACKGROUND,COX,DATA,GROUP,INC,JULY,LABEL,MEIER,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SARCOMA,SSG,WILEY
169,2014,COPYRIGHT,INC
0001,002,015,169,2014,8201,AIMS,BACKGROUND,GAY,GMPCA,HOWEVER,HRQOL,INDEX,LABEL,MAIN,METHODS,OBJECTIVE,OUTCOME,PCA,RESULTS,SOCIETY,WHERE
916,BACKGROUND,BIOLOGICAL,BLOT,CONCLUSION,CRPC,DUE,EXPRESSION,FIDAS,LABEL,LBD,METHODS,NUCLEAR,PCR,Q640X,REPRESSION,RESULTS,RSV,SUCCESSFUL,WESTERN
058,1238,1600,1996,2010,2878,289,3681,448,456,5ARI,5ARIS,803,945,AFTER,BECAUSE,COX,EXPOSURES,GLEASON,IMPORTANCE,INCREASED,LABEL,MAIN,METHODS,OBJECTIVE,REDUCTASE,RELEVANCE,RESULTS,SETTING,THERE,WHILE
946,ANDROGENS,CAS,ELK1,EVI1,FILTERING,GAPDH,GATA2,MECOM,MYBL1,MYBL2,NFKB,NFKB1,NFKB2,NFY,REL,RELA,RELB,TBP7,THESE
2013,APRIL,BACKGROUND,BOTH,DATA,DISCUSSION,GIVEN,IDENTIFIER,LABEL,MAY,MEN,METHODS,SIXTY,SPECIALIST,THESE,TRIAL
AFTER,BACKGROUND,CASE,FOUR,HOWEVER,LABEL,METHODS,ROUTINE,SUBSEQUENT,THEREAFTER,THEREFORE
145,945,BACKGROUND,BERBERINE,CELL,HIF,LABEL,LNCAP,METHODS,RESULTS,UNASSIGNED,VEGF,VIRTUAL,WESTERN
BACKGROUND,DATA,FOCUS,HOWEVER,INTERVIEWS,LABEL,MEN,METHODS,PROVISION,PSA,RESULTS,THERE
BASED,BIOLOGICAL,EAR,EFFECTS,ERR,HCC,IMRT,LABEL,LAR,METHODS,OBJECTIVE,OED,OEDS,PURPOSE,RADIATION,RESULTS,TOMO,TREATMENTS,VII,VMAT
ADP,ARTD,ARTD8,ARTD9,BACKGROUND,BAL,BAL1,BBAP,DLBCL,DTX,DTX3L,DU145,EFFECTS,HPE,IL4,IRF1,LABEL,LNCAP,METHODS,PARP9,PC3,PCA,PCR,RESULTS,RWPE1,STAT1,STAT3,STAT6,WESTERN
160,480,BACKGROUND,CAFS,CAIX,LABEL,MCT1,MCT4,METHODS,PCA,RESULTS,REVERSE,THESE,TISSUES,WARBURG
1040,170,2006,2013,8804,8805,BACKGROUND,FAVORABLE,GLEASON,LABEL,LARGE,LESS,METHODS,MRI,PATHOLOGIC,PCA,PSAD,RESULTS
156,216,280,878,ADT,BACKGROUND,LABEL,METHODS,PCA,PROPENSITY,RESULTS,THEREFORE
048,180,2004,2008,327,570,8201,8805,994,BACKGROUND,BCR,BED,COX,GY2,JULY,LABEL,LDR,METHODS,PHOENIX,PSA,RESULTS,SEPTEMBER
BACKGROUND,CASE,CDX,CK20,CK7,CONCLUSION,LABEL,METHODS,MUCIN,PATHOLOGY,PSA,PSAP,THESE,THUS,TURBT,TURP
001,128,177,ADC,ADCS,AUC,BACKGROUND,BOTH,GLEASON,LABEL,METHODS,MRI,PCA,RESULTS
001,8201,947,AIPC,BACKGROUND,GCOM1,HOWEVER,LABEL,LTR,METHODS,MEX3D,PCA,PCR,PTRF,RESULTS,RNAI,RVS,TRPM4,TYPICALLY
1CM,2003,215,ACCORDING,BACKGROUND,CASE,CAUCASIAN,CLINICIANS,GLEASON,LABEL,METHODS,MOST,SIX,SKIN,SMALL,THERE
146A,433,444,954,AZA,BACKGROUND,BSP,CDR,COBRA,CONCLUSION,CPG,DNMTS,IRS,LABEL,LINE,LNCAP,MEANWHILE,METHODS,MIR,MTS,NOTABLY,PC3,PCR,RESULTS,THEREFORE
946,BACKGROUND,DU145,EPCAM,ITGB4,LABEL,LN4,METASTASIS,METHODS,MICROARRAY,PLAU,RESULTS,SIRNA,THESE,UK122,USING
0005,001,120,2003,2006,8201,8805,ADT,AFTER,BACKGROUND,BETWEEN,COX,CTCAE,FIVE,HDR,INSTITUTE,LABEL,LATE,MEIER,METHODS,PHOENIX,PREDICTORS,RESULTS,V120
004,012,013,049,145,1993,2007,227,8201,8805,945,946,ACUTE,ADT,ADVERSE,AFTER,BED,BETWEEN,COX,CTCV3,EVEN,FFBF,HDR,LABEL,LATE,LDR,MATERIALS,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS,UNIVARIATE
384,945,AKT,BACKGROUND,BASED,CONCLUSION,EGF,ELISA,ERK,ERK1,GIVEN,GSK3,IGF1,IL6,JNK,LABEL,LNCAP,MDA,METHODS,MTT,NORMALIZED,PC3,PCA,PI3K,RESULTS,RPS6,TNF
001,127,8805,AGE,BACKGROUND,BMI,GLEASON,LABEL,MEDICAL,METHODS,MHZ,MRI,NONE,PBX,PSA,RESULTS,SUSPICIOUS,TRUS
ACI,AUSTRALIA,AUSTRALIAN,BACKGROUND,CLINICIANS,DISCUSSION,INNOVATION,LABEL,METHODS,NETWORK,NSW,OUTCOME,PHASE,PROCESS,SEMI,SOUTH,THERE,TRIAL,UROLOGY,WALES,ZEALAND
100,110,8201,AES,BACKGROUND,CTV,D95,IMRT,LABEL,MARGINS,METHODS,PTV,RESULTS,THREE,V70
GLEASON,HIGH,PCSCS,PKM2,WHILE
BACKGROUND,CDK1,CDK2,DUAL,LABEL,MDL,NED,RESULTS,RNAI,TAKEN
000,100,2010,2012,AGE,AMONG,BACKGROUND,CONCLUSION,DATA,EPI,EXCEL,GHANA,HISTOLOGY,HOUSING,INFO,KOMFO,LABEL,LABORATORY,LIVER,LUNG,METHODS,MICROSOFT,OVARY,PATHOLOGY,POPULATION,RATE,REGISTRIES,RESULTS,SOUTH,STOMACH,VERSION
160,AFM,AKR1B10,ALDH3A1,BACKGROUND,BESIDES,CLDN2,DU145,HCT,INCIDENCES,LABEL,METASTASIS,METHODS,PCR,RESULTS,ROS,SEQUENCING,SW480,TNS4
SINCE,THESE
ADT,FOLLOWING,REMARKABLY,THESE
018,160MG,8805,ARV7,BACKGROUND,BENEFIT,CYP17,E26,ERG,FOLLOWING,KI67,LABEL,LIMITED,MAXIMAL,MET,METHODS,OBJECTIVE,OUTCOME,P450,PATIENT,PERSISTENT,PSA,PUBLISHED,RESULTS,SETTING,SRC,SUMMARY,TRIAL
945,946,B16,CYTOKINES,KNOCKDOWN,LAL,LEWIS,LYSOSOMAL,MDSCS,MYELOID,THEREFORE
ATM,BECAUSE,CHK2,DU145,FINALLY,LOX,LYSYL,MRE11,PC3,THESE
001,1982,1992,1996,1997,2001,2002,2007,686,DESPITE,JANUARY,LABEL,MAIN,METHODS,OBJECTIVE,OBJECTIVES,OUTCOME,OVERALL,RER,RESULTS,SETTING,SOUTH,THERE,URBAN,WALES
CURRENT,WHILE
177,2006,2013,ACCORDING,MEAN,MRI,PSA,TESLA,THESE
001,160,1717,532,540,626,BACKGROUND,FATIGUE,LABEL,MEDIVATION,METHODS,PREVAIL,PSA,RESULTS
004,031,139,177,181,220,2906,293,8201,8805,BMI,RAHE
AFRO,BRCA2,CARIBBEAN,GLEASON,OTHER,PSA,WESTERN
1087,10878,169,1999,2013,2014,2084,936,AFTER,ASSESSMENT,BACKGROUND,CONCLUSION,COPYRIGHT,CTCAEV3,DLT,DLTS,DOSE,EARLY,EORTC,FIFTEEN,GROUP,LABEL,LTD,METHODS,MTAS,RDI,RESULTS,TARGETT,TREATMENT
169,2014,AUTHORS,BACKGROUND,COPYRIGHT,FDE,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PET,PUBLISHED,PURPOSE,RESULTS
048,10CC,125,169,2014,7MM,9MM,BACKGROUND,COMPOSITE,CONCLUSION,COPYRIGHT,EBRT,FURTHER,GRADE,INC,INDEX,LABEL,MATERIALS,METHODS,PUBLISHED,QOL,RESULTS,SALVAGE,SOCIETY,SPACING,THERE
169,2014,BONE,COPYRIGHT,ENDOCRINE,LTD
169,2014,ALVA,DU145,ERK,GLP,KI67,LNCAP,MAPK,P504S,PC3,READERS,THESE
125,2014,8197,956,BMJ,GROUP,IMMEDIATE,LDR,LTD,PUBLISHING
2622,480,803,956,C2WU,CCNE2,HEPG2,IC50,MAX,MGC,PANC,PC3,PCR,WERI
001,006,139,2001,2009,245,254,499,8805,887,ADDITIONAL,AFFAIRS,BLACK,CONCLUSION,GLEASON,LABEL,MEDICAL,METHODS,OBJECTIVE,POPULATION,PSA,PURPOSE,RESULTS,RRR
169,174,8482,AGENDIA,ALSO,COLOPRINT,COLORECTAL,CRC,CTC,CTCS,CYTO,EMT,EPCAM,NGS,ONCO,TNM,TODAY
244,494,BIO,CLC,DATA,EXOME,FFPE,HOWEVER,LIBRARIES,NGS,PEARSON,SEQ,WORKBENCH
ALTOGETHER,BIOMARKERS,DUE,MOLECULAR,RNAS,SNPS,SPECIAL

169,2014,AMONG,COPYRIGHT,LACK,THESE
3DPCM,BACKGROUND,CONTEXT,GLEASON,GROUP,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RADIATION,RESULTS,SEVENTEEN,THERAPY
003,007,017,024,177,400,8804,8805,947,EPID,IVD,LABEL,METHODS,OBJECTIVE,PMMA,PURPOSE,RESULTS,VMAT
8805,916,BASED,BEV,CTV,IMRT,INTENSITY,LABEL,METHODS,MUS,OBJECTIVE,PURPOSE,RESULTS,TCP
ART,DVH,DVHS,GPU,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
187,2000,2010,3N0M0,606,BASED,COX,LABEL,MEDICAL,METHODS,OBJECTIVE,RESULTS,TOKYO,UNIVERSITY
115,141,229,234,242,8211,8722,8805,946,DESPITE,GLEASON,KOREANS,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,TESLA
022,027,132,COX,ELISA,GLEASON,HIGH,PAI,PCA,PCR
PSA,THEREFORE
3BETA,8BETA,ADIOL,AMONG,DPN,VE2
ADC,CECT,CHOLINE,CONCLUSION,DRS,EBRT,IMAGING,LABEL,METHODS,MRI,NPV,OBJECTIVE,PET,PURPOSE,REGARDING,RESULTS,SUV
2012,213,AIM,ASR,BEIDA,CONCLUSION,EASTERN,LABEL,LIBYA,METHODS,NORTH,OBJECTIVE,POTENTIAL,RESULTS
100,169,2014,215,8764,BACKGROUND,BECAUSE,BPR,CHROMOSOME,LABEL,METHODS,MOTIVATION,NGS,PRESS,PUBLISHED,RESULTS,SLIDESORT,UNIVERSITY
000,169,190,2000,2008,2014,420,538,809,875,AFTER,CKD,COPYRIGHT,ESRD,NEPHROLOGY,SOCIETY
001,004,005,009,012,148,CRPC,GLEASON,HIGH,MEIER,PCA,THESE
ARES,FKHD,FOXA1,TAKEN
013,2006,2007,257,293,FALL,RESULTS,THERE
169,2000,2010,2014,8804,ADT,CONCLUSION,COPYRIGHT,CRPC,GREATER,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,PSA,RESULTS,SERUM,SWEDISH
000,BCR,CGA,CGAS,FORMULA,GLEASON
945,DOWN,HIF,HIF1A,LNCAP,TAKEN
169,2014,ARS,CRPC,CYP17A1,EFFECTS,FINALLY,FURTHER,GALETERONE,LABEL,LNCAP,METHODS,OBJECTIVE,PC3,PURPOSE,RESULTS,SIMILAR,T878A,VP16
ADRENERGIC,CLINICALLY
186,240,273,AUR,BPH,CONCLUSION,LABEL,METHODS,MFR,OBJECTIVE,PCA,PSAD,RESULTS,THERE,TOTALLY
CONCLUSION,LABEL,METHODS,OBJECTIVE,QUANTITIES,RESULTS,UNDER
13C,COSY,HMBC,HSQC,NMR,PANCRATIUM,THEIR
169,2014,ADT,CROSS,FAT,SOCIETY,UNTIL
169,2014,SOCIETY,STROMAL
100,225,BACKGROUND,CONCLUSION,CYSTECTOMY,CYSTOSCOPY,DIGITAL,GIANT,HOWEVER,LABEL,LOBE,LOBES,METHODS,OBJECTIVE,PATIENT,RESULTS,THERE,TREATMENT,URINARY,URINE,UROGRAPHY
169,1990S,2014,COPYRIGHT,DENDRITIC,HOWEVER,LTD,SINCE
2008,2012,ARGENTINA,MULTILEVEL,SPATIAL,TOBACCO
169,2014,FINALLY,NUTRITION,PCA,SOCIETY,THEREFORE
188,198,8482,AUC,EACH,HAMBURG,LABEL,MARTINI,METHODS,NPV,OBJECTIVE,OVERALL,PPV,PURPOSE,RESULTS
169,2014,946,COPYRIGHT,CTLA,CYTOTOXIC,OVERALL,SCIENCE,TCR,THESE,WHEREAS
160,160A,347,54T,ASIAN,CDH1,GAGA,HOWEVER,RESULTS,UTR
001,102,CAB,CUMULATIVE,ENGLISH,INCLUDING,PSA,REGARDING
015,017,027,042,2005,2012,CRPC,FOUR,MAY,WBC
BACKGROUND,CENTRAL,ICER,KOREA,KRW,LABEL,MATERIALS,METHODS,NCSP,OFF,PROGRAM,PSA,RESULTS,SCREENING,SEVERAL,THEREFORE,TIME,TRADE,UNDER
2001,2013,490,BACKGROUND,CRP,CSS,FURTHER,JAN,LABEL,LIBRARY,MATERIALS,MEDLINE,METHODS,RCC,RESULTS,RFS,SEP,STUDIES
2013,260C,660,8201,943,CD14,CHINESE,CNKI,FULL,HOWEVER,ODDS,OVERALL,STATA,WANFANG
91R,BECAUSE,CCR9,IGG2B,MOLT,RAG2
169,2014,8201,BRITAIN,COPYRIGHT,ERG,GREAT,IRELAND,ITH,JOHN,LTD,PCA,PCAS,PUBLISHED,SOCIETY,SONS,TAKEN,TMPRSS2,WILEY
2007,CONCLUSION,FUND,INSTITUTE,LABEL,MAIN,OBJECTIVE,PRIMARY,RESULTS,SUGGESTED,WORLD
CCNE1,CDH1,CXCL2,DU145,EXPRESSION,IL8,LNCAP,P16,PC3,PCR,PNT2,THESE
GROUP,SUBGROUPS
169,2014,954,ARS,CONCURRENT,DRUGS,EGCG,HENCE,HINGE,HSP90
1930,1969,3355,BACKGROUND,BMI,BODY,CASES,COPENHAGEN,COX,ESTIMATES,HOWEVER,LABEL,METHODS,OVERALL,RECORDS,RESULTS,THESE
DESPITE,EFFORTS,THESE
114,198,221,271,302,929,AMONG,BACKGROUND,CAP,CARE,CLUSTER,CONTROL,ENGLAND,LABEL,METHODS,PSA,RESULTS,SCREENING,SEVEN,THERE,WALES
100,169,2005,2012,2014,8805,CONCLUSION,COPYRIGHT,COX,CRFS,DAB2,DMFS,DOC,EZH2,FFBF,FIFTY,GLEASON,INC,LABEL,LOG,LOSS,MATERIALS,METHODS,OBJECTIVE,PROTEIN,PURPOSE,REDUCTION,RESULTS,STRATIFIED,T3A
AIM,BACKGROUND,CAND1,FURTHER,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,SEQ,SEQUENCING,THESE
PCA,RADICAL,SEVERAL

128,132,160,169,177,2014,239,AFTER,COMBINING,COPYRIGHT,EDUCATION,GLEASON,HOWEVER,INC,IQR,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,TESLA,UROLOGICAL
HOWEVER,THEREFORE,ZINC
169,2014,AKT,LABEL,LOSS,PARP,PI3K,PTEN,TP53,TRP53,UNLABELLED
100,235,8201,8776,BRESSON,HOWEVER,T2W
8201,8226,945,CLINICALLY,CONCLUSION,KEY,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,OBJECTIVES,RESULTS,SEVENTEEN,T2W,TESLA,THREE,VISIBILITY
8226,8991,ASSESSMENT,AUC,DATA,DIAGNOSTIC,DWI,GENERAL,KEY,LABEL,METHODS,MRI,OBJECTIVE,OBJECTIVES,PATIENT,PCA,QUALITY,RESULTS,SROC,STUDIES,THERE
BPH,OVERALL
103,150,2009,2013,AFTER,CTV,HOWEVER,LABEL,METHODS,MRI,NCCN,OBJECTIVE,PURPOSE,RADIATION,RESULTS
110,169,2014,510,8201,8805,CAUCASIAN,EVEN,GLEASON,HORMONE,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,UROLOGICAL,USING
945,AKT,DESPITE,EMT,FOXO1,HIF1,KNOCKDOWN,MAOA,PCA,ROS,THESE,VEGF
169,2014,945,956,COPYRIGHT,DU145,HYPOXIA,INDONESIAN,INDUCIBLE,LTD
AIM,HENCE,HOWEVER
001,100,8805,ACUTE,AIM,CFRT,FIFTY,GRADE,HFRT,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,TOTAL
104,BPH,DEPLETION,EAST,GPX,HOWEVER,NIGERIA,PCA,ROS,SOD,SOUTH
AKT,ANNEXIN,ANXA7,HOWEVER,INGENUITY,LNCAP,PATHWAY,PCD,PTEN,SGK1,THUS,USING
17P12,1P36,1Q24,1Q42,20Q13,ACCORDING,BRCA1,BRCA2,CAPB,CYP17,HOWEVER,HPC,HPC1,HPC2,HPC20,HPCX,MLH1,NBS1,PCAP,THERE,THROUGH,XQ27
169,2014,CONCLUSION,COPYRIGHT,ENRICHMENT,HLA,ID4,INC,ITGA6,LABEL,MACS,MAIN,MEASURE,METHODS,OBJECTIVE,OUTCOME,PATIENT,PUBLISHED,RESULTS,SETTING,SOCIETY,SSCS,UCHL1
2014,236,457,6623,7118,8201,AUCS,BIOMEDICAL,CBM,CHINESE,CNKI,DISC,DLR,FANG,HOWEVER,KNOWLEDGE,MAY,META,OVERALL,PCA,PCA3,PLR,SIXTEEN,STATA,URINE,VIP,WAN
169,177,1NM,2014,263,57MV,BIO,COPYRIGHT,DSC,DU145,FTIR,HOWEVER,SILIBININ,SURFACE,TEM,VARIOUS
001,8201,8226,ADC,CONCLUSION,CTP,CTPI,DWI,KEY,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PERFUSION,RESULTS,T2WI,THERE,TUMOURS
169,2014,COPYRIGHT,LTD
001,169,1988,1997,1998,2007,2014,474,713,8201,978,AFRICAN,AFTER,AMERICANS,BACKGROUND,END,FINE,GRAY,LABEL,METHODS,RACE,RESULTS,SOCIETY,THESE
005,168,2010,2012,2014,BASEL,EVALUATING,LABEL,METHODS,MRI,OBJECTIVE,PSM,PSMS,PURPOSE,RARP,RESULTS,SEPTEMBER
169,2014,AFTER,COPYRIGHT,ECE,GLEASON,INC,LABEL,MATERIALS,METHODS,NPV,OBJECTIVE,OBJECTIVES,OVERALL,PPV,RESULTS
169,2014,AMP,JOHN,LTD,METFORMIN,PUBLISHED,SONS,THESE,WILEY
169,2014,231,B16,COPYRIGHT,F10,FURTHER,HOWEVER,INC,MDA,NEOPLASIA,ORAL,PC3M,PRESS,PUBLISHED,THESE
169,2014,254,5468,5826,6664,8804,8805,942,AFRICAN,ANTONIO,BIOMARKERS,CONCLUSION,COPYRIGHT,DATA,DETECTION,EARLY,GLEASON,GROUP,INC,LABEL,METHODS,NETWORK,OBJECTIVE,PERCENT,PREVENTION,PSA,RESULTS,RISK,SAN,TRIAL
001,169,1992,2005,2014,2277,8805,BIVARIATE,CONCLUSION,COPYRIGHT,END,EXCEPTIONS,INC,LABEL,LPN,LRN,METHODS,OBJECTIVE,OPN,RESULTS,SIMILARLY,THESE,USING
126,169,2006,2009,2014,390,944,AIM,ALSO,AMONG,BACKGROUND,CONCLUSION,DESPITE,LABEL,MAIN,MEN,METHODS,OBJECTIVE,OUTCOME,RESULTS,SOCIETY,USING
131,139,169,2014,531,626,AMONG,COX,EPIC,NUTRITION,THERE,UICC
169,2014,INC,STEROID
001,169,2004,2010,2014,644,674,795,879,8805,AFRICAN,AMONG,CAP,CONCLUSION,COPYRIGHT,END,GLEASON,INC,LABEL,METHODS,OBJECTIVE,PCSM,PROGRAM,PSA,PURPOSE,RESULTS
003,032,034,045,169,2004,2009,2014,209,258,315,7523,792,8804,AFRICAN,AFTER,AHR,AMONG,BACKGROUND,BOTH,CAP,CONCLUSION,COPYRIGHT,END,FINE,FURTHER,GLEASON,GRAY,INC,LABEL,MEN,METHODS,PCSM,RESULTS,SEER,T2A
169,181,2014,215,250,C18,CONFERENCE,COPYRIGHT,FIVE,JOHN,LTD,NILUTAMIDE,Q1A,SONS,WILEY
005,047,169,1999,2011,2014,253,321,CONCLUSION,COPYRIGHT,GLEASON,GRADE,LABEL,LEVEL,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,PUBLISHED,RESULTS,SAS,SIXTY,THREE
120,120DAYS,169,2000,2011,2013,816,8804,BETWEEN,CONCERNING,COPYRIGHT,DATES,INSTITUTE,LABEL,LEVEL,LYON,METHODS,OBJECTIVE,RESULTS,SAS,STATISTICS,STUDIES,THEREFORE
169,2014,ASL,BACKGROUND,BOLD,CONCLUSION,COPYRIGHT,DIFFUSION,DWI,IMAGING,LABEL,MATERIALS,METHODS,MRI,PET,RESULTS,SAS,THEREFORE
001,0042,0064,4EBP1,500,8201,ACC,AMPK,BACKGROUND,DATA,FORTY,KI67,LABEL,MEN,METFORMIN,METHODS,PRE,PSA,RESULTS,SCORE,THERE,TREATMENT
PADT
169,17G,2014,945,ADT,AFTER,COPYRIGHT,DHEA,DHT,DIOL,ESSENTIAL,FINALLY,LTD,THESE,UDP,UGT,UGT2B15,UGT2B17
001,020,031,169,177,180,2012,2014,8201,ASIA,BACKGROUND,CONCLUSION,ENDOSCOPIC,FORCE,JANUARY,JAPAN,LABEL,LOC,LTD,METHODS,OCTOBER,PTY,PUBLISHING,RESULTS,SOCIETY,SURGERY,TASK,UBS,USING,VUA,WILEY
464,BPH,DFS70,ELISA,MDM2,NPM1,PCA,PSA,RALA,TAA,TAAS,WESTERN
169,2014,PCA,SOCIETY,THESE
169,2014,PELP1,PROLINE,SOCIETY,SRS
2HF,8209,AKT,BAX,BCL,CRPC,DU145,HOWEVER,MCL,OVERALL,PCA,STAT3,THUS
008,157,193,417,8201,ADT,KNOWLEDGE,LABEL,LIBRARY,MEDLINE,METHODS,OBJECTIVE,PRIOR,PURPOSE,RESULTS,SCIENCE,THESE,WEB
128,945,DEPLETION,HIF,HOWEVER,LUCIFERASE,PCA,PCR,PKM2,RPS6KB1,SNAIL,USING
002,004,005,006,008,016,177,2014,462,478,665,703,707,8201,826,847,CAUCASIANS,CNKI,ESR1,ESR2,HOWEVER,SCHOLAR,THESE,WANFANG
145,BLUE,FLAVONOIDS,MTT
0001,136,160,169,1993,2008,2014,566,AFTER,COPYRIGHT,EDUCATION,GLEASON,INC,JANUARY,LABEL,MATERIALS,METHODS,NCCN,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SEVEN,UROLOGICAL
160,2005,2008,2012,222,CONSUMERS,FORCE,NEWS,PREVENTIVE,PSA,TASK
169,2014,COPYRIGHT,COX,EPCAM,INC,NON
169,2014,945,ALA,BASED,COPYRIGHT,DHA,EPA,LINOLENIC,LTD
100,169,2014,226,5MG,COPYRIGHT,EBL,LOD,LSPR,PBS,POC,PSA,RIU,THESE
223,ADVANTAGE,EIGHT,EVALUATION,EVITA,HTAS,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SLE
001,003,004,036,042,2000,2013,8201,833,BACKGROUND,CIS,JANUARY,LABEL,MATERIALS,METHODS,RCTS,RESULTS,RRS,SUMMARY
0012,005,100,169,2014,AUNPS,BASED,COPYRIGHT,EPADS,GOX,MNO2,PSA,PWE,TMB
001,008,012,017,2002,2008,ALP,AMONG,CRPC,GLEASON,LABEL,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS
160,200,LABEL,MEAN,METHODS,NIRF,OBJECTIVE,PURPOSE,RESULTS,SVN
13C,169,2014,COPYRIGHT,DTG,ESR,FOUR,H3L,H874Y,MOLECULAR,NMR,TGA,VIS
740,99M,ANN,AREAS,ARTIFICIAL,AUC,BSI,HOWEVER,LABEL,MBQ,METHODS,OBJECTIVE,OBJECTIVES,PIXON,RESULTS,WHOLE
EXPRESSION,MLC,THESE,VEGF,VEGFR
100,169,176,1NM,200NM,2014,40PG,956,AFTER,COPYRIGHT,ESI
182,780,945,946,ARS,BRDU,CELL,DBP,ERS,ICI,LNCAP,MTT,PCR,TGF,THESE
135,2014,294,947,AFRICAN,COMBINING,EXAMINING,HERV,MEN,PBMC,PCR,PRESS,PSA,PUBLISHED,UNIVERSITY
001,007,177,236,668,8NG,ABOUT,DRE,GROUP,PSA,TRUS
145,CAHPV,FOUR,HEPATOCYTE,HGF,HOWEVER,PZHPV,RWPE,STEM,THESE,TIGHT,TJS,WPE
ATP6AP2,ATPASES,CL1,DSRED,EXPRESS,LNCAP,PCR,PEDF,PIGMENT,PROTEIN,THESE
BOTH,CLINICIANS,III,LARGE,SUPPLEMENT,VITAMIN
DEVELOPING,FIRST,GROUP,NOW,PCWG2,THIRD,WORKING
ADDITIONAL,ASSAY,CELLSEARCH,CTC,CTCS,DRUG,FDA,FOOD,III,VERIDEX
223,ALPHARADIN,BONE,CRPC,IIA,III
223,AFTER,III,PHASE,THERE
169,194,1973,2002,2004,2014,BACKGROUND,BLADDER,CIS,CONCLUSION,COPYRIGHT,COX,GLI1,HAMPSHIRE,INC,JANUARY,JULY,LABEL,METHODS,ORS,PATHOLOGY,RESULTS,SIMILARLY,SOCIETY,STATE,TNM,UROLOGICAL,WORLD
AMP,AMPK,MCF,OLEANOLIC,TARGETING
017,370,371,427NG,725,8805,AUA,BMI,BPH,FURTHER,LABEL,LUTS,MATERIALS,MEDICAL,METHODS,OBESITY,OBJECTIVE,PAULO,PURPOSE,RESULTS,SAO,SHBG,UNIVERSITY,UROLOGICAL,VARIABLES
1002,2005,2010,227,AUC,BRIER,GLEASON,LABEL,LOESS,MATERIALS,METHODS,NOMOGRAMS,OBJECTIVE,OCD,PAULO,PPBC,PSA,RESULTS,ROC,SVI,UNIVERSITY,USP,VARIABLES
10NG,167,8804,CONCLUSION,FIFTY,GLEASON,LABEL,MATERIALS,METHODS,OBJECTIVE,OTHER,PSA,RESULTS,RPS,T1C,T2A,THEREFORE
236,CONCLUSION,GLEASON,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,THREE
2000,2009,483,CONCLUSION,LABEL,MARCH,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PSA,RECURRENCE,RESULTS,THERE
169,2014,COPYRIGHT,EVEN,INC,OLDER,STUDIES
AGA,CAG,GGN,PFS
341,945,DESPITE,IKB,LNCAP,LOW,NFKB,PC3,THEREFORE,TSA,VELCADE,WESTERN,WST
169,2014,8201,BACKGROUND,ELISA,GCNT1,INC,LABEL,LEWIS,METHODS,MUC1,PAP,PCR,PROTEIN,PSA,RESULTS,WILEY
169,2014,BACKGROUND,BPH,CAP,COMPLEX,DETECTION,EARLY,FURTHER,HGPIN,INC,LABEL,LGPIN,METHODS,PIN,PSA,RESULTS,TELOMERASE,WILEY
946,CHINA,MENELLA,NOESY,SEA,SOUTH
145,169,2014,BACKGROUND,BAD,BAX,CONCLUSION,COPYRIGHT,FLOW,IHC,INC,LABEL,METHODS,PCR,PUMA,REDUCTION,RESULTS,THEN,WESTERN
169,2014,COPYRIGHT,DOCETAXEL,LTD,NOVEL,SEVERAL
169,2014,847,ALPHA,ATBC,BETA,COLORECTAL,FINLAND,LEUKOCYTE,LUNG,ORS,OVARIAN,PLCO,PREVENTION,SCREENING,SWHS,TOCOPHEROL,TRIAL,WOMEN
169,2014,CDR,CRPC,IAD,PSA,THUS
169,2014,COPYRIGHT,CRPC,DESPITE,DOCETAXEL,DTX,PC3,THESE
169,19TH,2014,CONFERENCE,COPYRIGHT,NCCN,NETWORK
169,19TH,2014,CARROLL,CONFERENCE,COPYRIGHT,DETECTION,EARLY,FEW,GUIDELINES,NCCN,NETWORK,PETER,PSA,VICKERS
100,145,945,BACKGROUND,CASY,CELLS,CHANGES,CURRENT,E2F1,HIF,HIF1,HIF2,LABEL,LNCAP,METHODS,PCR,RESULTS,RNAI,RNAS,SCR,SRF,STAT3,TARGETING,THREE
ACUTE,ADVERSE,AIMS,BACKGROUND,BLADDER,CTCAE,DOSE,IPSS,LABEL,METHODS,OABSS,OBJECTIVE,OVERACTIVE,RESULTS,SCORE,SYMPTOM,V20
169,2014,COPYRIGHT,INC,MRI,XGP
042,8805,AUC,GLEASON,PCA,PHI,PSA
8230,III,PHASE
0164,030,160,164,169,177,2014,956,COMPOUNDS,COPYRIGHT,FINALLY,HEPG2,IC50,MCF,NMR,SAS,THREE
169,2014,COPYRIGHT,ULTRASOUND
000,0001,017,018,116,119,177,181,2014,235,431,665,705,881,BACKGROUND,BASEL,BLOOD,FURTHER,LABEL,MATERIALS,METHODS,RADICAL,RESULTS,RRP,TEA
169,2014,AIMS,ATRA,BACKGROUND,BASEL,CDK,CDK5,CELL,DU145,LABEL,METHODS,OBJECTIVE,RESULTS
AZA,CLASSIC,DDS,DECITABINE,DU145,EMHV,EMHVS,EPIGENETIC,ERYTHRO,LNCAP,MAGNETO,THESE,VIROSOMES
066,074,177,215,284,315,517,867,914,ADC,BPH,CONCLUSION,DWI,LABEL,METHODS,MOST,MRI,OBJECTIVE,PCA,RESULTS,T1WI,T2WI,THEIR
CONCLUSION,DETECTION,LABEL,METHODS,OBJECTIVE,PCR,RESULTS,SERA,SERUM,USING
044,120,125,142,164,195,2011,2012,210,230,245,264,400,402,550,BLADDER,BNP,CONCLUSION,JANUARY,LABEL,LRP,METHODS,OBJECTIVE,RESULTS,THERE
AKT,GAC,PI3K,THEREFORE
007,088,BPH,GLEASON,HOWEVER,PCA,PIN,PSA,SERUM
120,1A1,BPH,COMPARING,CYTOCHROME,GIVEN,GLEASON,P450,PCA,PCR,REGARDING
169,2014,740,AA3G,GRPR,LABEL,LNCAP,METHODS,OBJECTIVE,PAI,PC3,PURPOSE,RESULTS
036,169,2014,947,ELISPOT,IFN,LABEL,METHODS,OBJECTIVE,PAP,PSA,PURPOSE,REPETITIVE,RESULTS,SIX,SIXTEEN,TH1
0033,0156,0325,116,131,169,2014,286,309,453,643,644,683,704,749,8805,961,980,ADC,ADCMEAN,AREAS,AUC,AUCS,BOTH,CONCLUSION,GLEASON,HOWEVER,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,UNIVARIATE,VOLUMEADC
822,ALZHEIMER,RNAS,ROC,RWRLNCD
945,CHALLENGES,DIETARY,HOWEVER,PUFA,THEREFORE,THESE
002,150,250,8201,8805,AES,NINTEDANIB,PSA
100,181,8201,8243,ANNEXIN,BHQ,BIFONAZOLE,CONVERSELY,GF109203X,INHIBITION,PC3
160,169,2014,956,A549,AMONG,AMPICILLIN,COPYRIGHT,DU145,HOWEVER,HT29,NMR,SAS,SKOV3
293,945,AFTER,ANNEXIN,CD40,CD80,CD83,CD86,E1A,LNCAP,NOVEL,PC3M,PPT
FIRST,NOTABLY,PI3K,RAC1,THESE,THROUGH,USING,WAVE2
ANIMALS,FLOW,LABEL,LPCU,METHODS,OBJECTIVE,PURPOSE,RESULTS,ROS,THERE,TOXICOLOGY
145,428,APC,APCS,POPC,STUDIES
001,1000S,169,177,2014,300,4NG,600,ADC,ALTOGETHER,CONCLUSION,COPYRIGHT,DKI,FULL,GLEASON,INC,KAX,KMEAN,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PSA,PURPOSE,RESULTS,ROI,THERE
177,2002,2007,CASODEX,COMPOSITE,IMRT,INDEX,QOL,TOTAL,ZOLADEX
1873,BACKGROUND,INSTITUTE,LABEL,LOGISTICAL,METHODS,NAVIGATION,PATIENT,PROGRAM,RESULTS,SCALE
169,2007,2014,AICR,FUND,INSTITUTE,NUTRITION,SOCIETY,THERE,WCRF,WORLD
CPG,CURRENTLY,EARLY,FDA,PSA,THUS,TLR9
DTC,ERK
129,135,176,188,5500,8211,945,AFRICAN,AMERICANS,BACKGROUND,C18,CAP,CAUCASIAN,CONCLUSION,DHEA,DHT,FINALLY,HPLC,LABEL,LNCAP,LUNA,METHODS,QTRAP,RESULTS,SAMPLES,SCIEX,UNLABELLED
008,013,031,035,2011,2012,BACKGROUND,CHI,GLEASON,H3PH,HOXD3,LABEL,MAY,METHODS,MOLECULAR,OCTOBER,PCR,PMR,RESULTS
169,2014,ADP,ATR,AZD7762,BRCA1,CHK1,COPYRIGHT,DDR,MICROARRAY,MYB,PARP,PCA,RAD3,SCIENCE
ACCORDING,EPIGENETIC,MEANWHILE
145,DAB2,HOWEVER,NOTABLY,PC3,THESE
001,006,169,2007,2010,2014,277,AFRICAN,AOR,CAP,COPYRIGHT,END,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PROGRAM,RESULTS,THERE
169,2014,AMERICANS,BACKGROUND,BLADDER,COPYRIGHT,HOWEVER,INC,KINCAID,LABEL,METHODS,PATHOLOGY,PNBX,REPORTS,RESULTS
114,16063,MICRORNAS,RNAS,RRSM,THESE
SEVERAL,SHORT,THESE
BESIDES,LNCAP,PCA,PSA
139,2008,2011,404,945,BPH,CONCLUSION,HOWEVER,KLF4,LABEL,METHODS,MYC,NANOG,OBJECTIVE,OCT4A,PCA,PCR,RESULTS,SOX2
180,ADVERSE,HOWEVER,IMRT,LABEL,LADT,MEN,METHODS,RAD,RESULTS,UNLABELLED
2012,2013,AGAINST,AUA,FORCE,HOWEVER,OPTIMIZING,PREVENTIVE,PSA,TASK,UROLOGICAL,WHILE
947,AKT,DSBS,EGFR,H2AX,PI3K,PKCS,THROUGH
177,246,AT1,HOWEVER,R3327
001,169,2014,264,286,8201,BACKGROUND,CONCLUSION,CRP,FOUR,INC,LABEL,MEAN,METHODS,NONE,PHYSICIANS,RESULTS,SNP,SNPS,WILEY
160,8482,CONVERSELY,CRPC,FOXA1,IHC,KDM5B,LNCAP,NOVEL
000,029,169,2003,2006,2014,446,454,CONCLUSION,COPYRIGHT,COSTS,FEE,FFS,HMO,HMOS,HODGKIN,IMAGING,LABEL,MATERIALS,METHODS,MRI,NETWORK,NHL,OBJECTIVE,PET,PURPOSE,RATES,RESULTS,SOCIETY,THERE
152,509,ARN,BASED,CRPC,CYP17,GNRH,MOST
001,003,006,008,1058,296,599,653,8804,8805,BOTH,CONCLUSION,GLEASON,LABEL,MATERIALS,METHODS,OBJECTIVE,PRIOR,RESULTS,ROI,ROIS,SEVEN,SHEAR,SWE
AKT,BCL,BECAUSE,CD74,ERK,HUMIF,INFECTIONS,MIF,SERA,TVMIF
169,2014,823,CONTROL,CTBP1,ENRICHMENT,GSEA,HENCE,HFD,HIGH,LABEL,METABOLIC,METHODS,MICE,NAD,NADH,OBJECTIVE,PC3,PURPOSE,RESULTS,SET
169,1992,2010,2014,441,504,8201,BACKGROUND,CONVERSELY,END,LABEL,MEN,METHODS,PROGRAM,RESULTS,SEER,SIR,SIRBLADDER,SIRRECTAL,SOCIETY,THERE
169,2014,241,243,CIRUJANOS,COPYRIGHT,ESPA,IMAGING,INDICATION,PUBLISHED,RESONANCE,TEAM
160,8209,947,AKT,CXCR4,HOWEVER,OVERALL,PCA,PI3K,PPAR,RSG,THEREFORE
160,945,946,D50,FORMULA,LEM,SEVERAL,TCP,THEIR,TPS
00016,0045,0058,0069,023,025,155,169,2006,2012,2014,436,901,ACL,ACLS,CASES,COPYRIGHT,GLEASON,HGPIN,IDC,INC,USING
2B4,BAL,CONCLUSION,EIGHT,FLOW,LABEL,LASS2,LYMPH,METHODS,MMP,MTT,NUCLEAR,OBJECTIVE,RESULTS,SILENCING,TMSG1
022,029,118,ERG,GLEASON,LABEL,METHODS,OBJECTIVE,PROSTATIC,RESULTS
360,CDK5,DRUG,HOPKINS,JOHNS,LIBRARY,MTS,PC3,SCREENING,VALIDATION
BASED,DONOR
HOWEVER,PRIMARILY,THEREFORE
0402,044,075,215,529,611,685,756,762,8201,893,ADC,AUC,CONCLUSION,GLEASON,LABEL,METHODS,MRI,OBJECTIVE,PARAMETRIC,PET,PETMR,PURPOSE,RESULTS,ROC,SUV,WHILE
HEAVY,LABEL,OBJECTIVE,PURPOSE,RESULTS,SUMMARY,URINARY
HOWEVER,IATROGENIC,LABEL,MOST,OBJECTIVE,PURPOSE,RESULTS,RUF,RUFS,SUMMARY
001,002,125,160,168,1990,2009,251,8805,BACKGROUND,COMPETING,CSM,CUMULATIVE,GLEASON,HIGH,INITIAL,LABEL,METHODS,NETWORK,PROPENSITY,PSA,RESULTS,T3A,THERE,THEREAFTER
001,002,003,008,154,703,8201,8804,8805,BACKGROUND,BCR,BMI,COX,DATA,GLEASON,GREATER,ITV,LABEL,METHODS,PCA,PSA,RESULTS
AUC,DOR,MRI,PET,PUBLISHED,SIXTEEN,SPECT,SROC,SUMMARY
DEVELOPING,DISEASE,GENERAL,HRQOL,QUALITY,SEVERAL
0001,1523,169,2001,2003,2007,2014,255,863,866,ACT,ADT,AFTER,COPYRIGHT,END,INC,LABEL,MASTERFILE,MATERIALS,MEDICAL,METHODS,NON,OBJECTIVE,OBJECTIVES,OVERALL,PHYSICIAN,RESULTS
169,2014,2020,2030,HOWEVER,LUNG
100,169,2014,9990,9999,AAS,C18,COPYRIGHT,LOQ,LOQS,RSDS,SPE,TURBOFLOW
001,169,2007,2008,2014,AIM,ASSESSMENT,AUC,BACKGROUND,CONCLUSION,CONVERGENT,DATA,EHS,GAQ,HOWEVER,IIEF,INDEX,JANUARY,LABEL,MAIN,METHODS,NPS,NUMERIC,OBJECTIVE,OUTCOME,PAIN,RESULTS,ROC,SCALE,SCORE,SOCIETY
1941,HOWEVER,HUGGINS
HOWEVER
MRI,PSA,THEREFORE
3NEO,3R2IIIB,EXPRESSION,FGFR2,FGFR2IIIB,FIBROBLAST,INDUCED,MTT,THESE,VIABILITY,XIAP
108,169,2014,BOTH,CAF,CAFS,COPYRIGHT,FEDERATION,FURTHER,GSEA,MOST,NCF,NCFS,PUBLISHED,SOCIETIES,THESE,WNT
BACKGROUND,BPH,CPG,EXTRACTED,GENOMIC,GLEASON,GSTP1,LABEL,METHODS,PCA,PCR,PSA,RESULTS,ROC,WESTERN
223,HEMATURIA
EARLY,MOLECULAR,SEVERAL,THEREFORE,URINE
014,021,040,053,337,419,717,763,794,8201,913,C609T,CAUCASIANS,FURTHER,HOWEVER,LIBRARY,NQO1,PUBLISHED,STATA,THUS
169,2014,AKT,AKT1,AKT2,BAX,DEPLETION,LABEL,LOSS,PI3K,PTEN,THESE,UNLABELLED
001,004,014,017,042,160,629,870,941,LABEL,MEDLINE,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,TERMS,USA
PSA
109,2003,2008,8201,ADT,BACKGROUND,BETWEEN,CONCLUSION,CTV,EVEN,GRADE,HDR,ISBT,JULY,JUNE,LABEL,MAXIMAL,METHODS,NCCN,NETWORK,OBJECTIVE,OSAKA,PTV,PURPOSE,RESULTS,RISK
THESE
169,2014,8804,COMBINING,COPYRIGHT,FFF,FORTY,IMRT,INC,LABEL,MATERIALS,MEN,METHODS,OBJECTIVE,PURPOSE,QOL,RESULTS,SECONDARY,THERE
169,2014,ARRB1,AUTHORS,HIF1A,HYPOXIA,PUBLISHED,SDHA
169,2014,FOLLOWING,HOWEVER,PRESS,PUBLISHED,SIX,THERE,THUS,UNIVERSITY
169,2014,464,70807,BACKGROUND,CALGB,CONCLUSION,COPYRIGHT,DIET,HOWEVER,III,INC,LABEL,MEAL,MEN,METHODS,PSA,SECONDARY
182,250,765,780,946,BOTH,HMGA1,ICI,THESE
THEREFORE
ADT,CRPC,HOWEVER
112,169,175,2011,2012,2014,464,530,639,AIM,ASIA,CAT,FEW,JULY,LABEL,LTD,METHODS,OBJECTIVE,PTY,PUBLISHING,RESULTS,THERE,WILEY,WOMEN
100,AFRICAN
169,2014,AKT,CELL,COPYRIGHT,INC,KIT,LABEL,LNCAP,MATERIALS,METHODS,OBJECTIVE,PARP,PC3,RESULTS,WESTERN
168,169,177,1G12,2014,COPYRIGHT,DFO,GPC3,HCC,HCCS,HEP3B,HEPG2,IMAGING,LTD,PC3,PET,THUS
949,BLACK,CARLO,FINALLY,FORMULA,MONTE
169,2014,945,AIM,BACKGROUND,DESPITE,DHT,LABEL,LITERATURE,LOSS,MAIN,MEDICAL,METHODS,OBJECTIVE,OUTCOME,RESULTS,SOCIETY,THREE
169,2014,COPYRIGHT,LTD,PCA3,PCAT1,PUBLISHED,RNAS,SEVERAL
00037,116,169,183,2008,2011,2014,202,223,233,307,614,921,945,BACKGROUND,BAYER,BETWEEN,BONE,COPYRIGHT,FEB,FUNDING,HEALTHCARE,JUNE,LABEL,LTD,METHODS,RESULTS,TIME
169,2014,COPYRIGHT,PUBLISHED,UROLOGY
001,003,005,167,169,198,1997,2011,2014,288,395,441,732,ASSESSMENT,BACKGROUND,COPYRIGHT,COX,FURTHER,GENOMIC,GLEASON,GPS,LABEL,METHODS,OBJECTIVE,OUTCOME,PATIENT,PCA,PUBLISHED,RESULTS,RISK,SCORE,SETTING,SUMMARY,UNASSIGNED,UROLOGY
169,185,2014,A549,CCL,COPYRIGHT,DU145,EACH,HELA,HTB,LTD,LUNG,MBC,MCF7,PROMISING,SHARPLESS
169,2014,COPYRIGHT,CTBP,CTBP2,GLEASON,HOWEVER,HSPC111,MYC,PC3,PSA,TAKEN

002,006,008,1644,176,204,6740,929,935,938,940,941,943,975,978,980,BACKGROUND,COLORECTAL,CONFIDENCE,DATA,LABEL,METHODS,RATIO,RESULTS,THESE
0001,169,2014,368,889,ACHR,CLUSTERING,CRMP5,IGG,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIGNATURE,SOX1
169,2014,AMONG,BACKGROUND,CONCLUSION,COPYRIGHT,CTV,INTRA,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PLANS,PURPOSE,RESULTS,SCANNED
169,176,177,1CM,2014,377,COPYRIGHT,INC,MEDICAL,POTENTIAL,PUBLISHED,USING,VARIATIONS
169,174,2014,945,AUTHORS,COPYRIGHT,HSPG2,MMP,OTHER,PCA,PUBLISHED,TRANSWELL,WHILE
001,006,009,041,124,129,795,8201,946,AJCC,AMACR,COA,COMMITTEE,DMFS,DSS,ENDOGENOUS,GIVEN,HONE1,III,JOINT,LRFS,NPC,NPCS,PCR,THOSE,THROUGH,TW01,WESTERN
9027,APFO,BMJ,CIS,COX,GROUP,HRS,INDEX,INDUSTRIAL,LABEL,LIMITED,METHODS,MINNESOTA,MORTALITY,OBJECTIVE,PUBLISHED,PUBLISHING,RESULTS,SIMILARLY,WISCONSIN
ASAP,LOH,OTHER,PIN,PSA,TRT
107,2005,256,8804,G7MINIGP4,GLEASON,GP4,GS6,GS7,GS7MINIGP4,HOWEVER,ISUP,PATHOLOGY,SOCIETY,TEN,UROLOGICAL
005,169,2014,8201,ANTIBODIES,CSF,ELISA,GVAX,HASHIMOTO,NOTABLY,TGABS,UICC,USING
169,2014,213,215,3758,3KB,5966,BONFERRONI,CONSORTIUM,GWAS,POPULATION,PRESS,PUBLISHED,SNP,SNPS,TET2,UNIVERSITY,USING
0031,053,101,169,183,2009,2012,2014,393,396,399,400,799,BACKGROUND,BRISTOL,COPYRIGHT,EASTERN,FEB,FOUR,FUNDING,GROUP,HOWEVER,IPILIMUMAB,LABEL,LTD,MAY,METHODS,MYERS,NON,RESULTS
169,2014,50MG,511,AKT,BENC,COPYRIGHT,DU145,IRELAND,LTD,NOTABLY,PARP,PC3,PI3K,PTEN,THESE,USING
169,185,2014,BACKGROUND,CASES,COPYRIGHT,GLEASON,GMBH,HOWEVER,LABEL,MATERIALS,METHODS,RESULTS,THERE
169,2014,COPYRIGHT,JOHN,LABEL,LPC,LTD,MEN,METHODS,OBJECTIVE,RADICAL,REGULARLY,RESULTS,SONS,TREATMENT,WILEY
PCA,PSA,THUS
017,033,250,BCR,FIVE,GLEASON,GROUP,NVB,PSM,RALP,THERE
PCA,PI3K,THESE
2000,2011,COMMERCIAL,HOPKINS,JANUARY,JHH,JOHNS,MARCH,MARKETSCAN,PDE5,POPULATION,REUTERS,THOMSON
169,2014,ACT,AFFORDABLE,CARE,COPYRIGHT,INC,PATIENT,PCA,PHYSICIANS,PROTECTION,UNIVERSAL
947,HHD,HLA,HSPC,HSPCS,IL2R,NOD,NSG,USING
ADT,DEPRESSION,EORTC,LABEL,LOM,METHODS,OBJECTIVE,OBJECTIVES,PCA,QLQ,RADAR,RESULTS,SCORE,SYMPTOM,TROG,URINARY,UROLOGICAL
169,2014,BECAUSE,CRPC,DRUGS,OPTIMAL,SOCIETY,USA
169,2014,946,APC,AXIN1,BIOLOGISTS,CK1,COMPANY,DU145,EMT,FRAT1,GSK3,HOWEVER,HT29,LTD,NDRG1,PAK4,PUBLISHED,SER33,TGF,THR41,WNT
169,2014,ACPP,INC,PROSTATIC,SOCIETY,THUS
169,2014,BIOLOGY,CDT1,FINALLY,INC,MOLECULAR,SOCIETY
231,234,8321,8322,8323,8326,8331,AMONG,B02,DEBIO0719,EGF,ELISA,HOWEVER,KI16425,LPA,LPA1,MCF,MDA,PC3,QPCR,THEREFORE
0001,001,005,2906,724,802,8201,887,967,ATP,BMI,HDL,III,LABEL,METHODS,NCEP,OBJECTIVE,RESULTS,SIX
GLEASON,THREE
1283,2005,2009,3612,8201,AFTER,AMONG,CAH,CAHS,EXPOSURES,HOWEVER,IMPORTANCE,INPATIENT,LABEL,MAIN,METHODS,NATIONWIDE,OBJECTIVE,RELEVANCE,RESULTS,SETTING,THERE,THESE
169,2014,BRITAIN,COPYRIGHT,DEPLETION,GREAT,IRELAND,JOHN,LTD,PCR,PIN,PUBLISHED,SKA1,SOCIETY,SONS,TAKEN,THESE,WILEY
1013,105,169,2014,247,269,659,668,727,777,782,793,796,869,8764,880,921,BIOLOGY,CHIP,EMSA,INC,MOLECULAR,PKC,PRKCE,RNAI,SER,SOCIETY,SP1,STAT1
169,2014,25D3,392,451,946,ADT,CRPC,CYP24A1,ECTOPIC,HIC,LABEL,LNCAP,SIMILARLY,TGF,THEREFORE,UNLABELLED,VDR,WPMY
169,1979,1982,2014,945,CAB,DHEA,GNRH,MOST,SOCIETY,SOON
329,AFTER,ANXIETY,C30,DEPRESSION,EORTC,FATIGUE,HOWEVER,INVENTORY,LABEL,METHODS,OBJECTIVE,PURPOSE,QLQ,RADICAL,RESULTS,SCALE
001,169,1996,2012,2014,2424,518,8776,8804,8805,APART,AUTHORS,BJU,CONCLUSION,GLEASON,INCIDENCES,JANUARY,JUNE,LABEL,METASTASIS,METHODS,MOST,NODE,OBJECTIVE,OVERALL,RCP,RESULTS,TNM
PCA,PSA,RISK,THUS,WESTERN
001,010,1000,177,1998,2000,2001,2008,8408,HRS,LABEL,METHODS,METS,OBJECTIVE,OBJECTIVES,RESULTS,SIRS,THEREFORE
001,004,007,009,169,2008,2012,2014,262,8805,AMICO,AUTHORS,BJU,CONCLUSION,LABEL,MAY,MELBOURNE,METHODS,NEITHER,OBJECTIVE,OLDER,PSA,RARP,RESULTS,ROCCO,SEPTEMBER,THERE
017,1062,1182,169,2009,2013,2014,230,234,584,633,696,784,8201,8805,HOWEVER,LABEL,MARCH,METHODS,OBESITY,OBJECTIVE,OBJECTIVES,RESULTS,SEPTEMBER,THERE,UROLOGICAL
001,169,2014,207,209,269,8201,AUSTRALIAN,AUTHORS,BJU,CLAVIEN,CONCLUSION,DESPITE,FELLOWSHIP,LABEL,LRP,METHODS,OBJECTIVE,OPERATIVE,OVERALL,PSMS,RESULTS,THERE
2000,AMERICANS,ARAB,CALIFORNIA,DETROIT,END,HISPANICS,HOWEVER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,POPULATION,PROGRAM,RESULTS,SEER
10TH,169,2014,25TH,50TH,75TH,909,90TH,BACKGROUND,COPYRIGHT,CRPC,ESTIMATES,LABEL,LTD,MEIER,METHODS,RESULTS
169,2014,8201,AFTER,THERE,UROLOGICAL
2004,2009,563,BACKGROUND,CHF,INSTITUTE,LABEL,MEN,METHODS,MOST,OBJECTIVE,RESULTS,SEER,TREATMENT
140,169,1991,2007,2014,553,8805,AMONG,BACKGROUND,END,LABEL,MEN,METHODS,PROPENSITY,RESULTS,SOCIETY
ADT,DESPITE,ECOG,EVEN,HENG,PSA
DEPENDING,METASTASES,RESECTION,THERE,UROLOGICAL
001,169,2014,232,CONCLUSION,COPYRIGHT,EACH,INC,LABEL,METHODS,OBJECTIVE,OVERALL,PCA,RESULTS
160,169,2014,2162,789,796,831,862,869,876,882,885,ASSESSMENT,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,RESULTS
1344,195,CAG,CONCLUSION,ETS,INC,LABEL,METHODS,OBJECTIVE,PREVENTION,PUBLISHED,RESULTS,THERE,TMPRSS2,TRIAL
001,003,2424,313,530,5887,704,AMONG,BACKGROUND,CONSORTIUM,COX,HRHIGHEST,HRS,IGF,IGF1,IGF2,INSTITUTE,LABEL,METHODS,PCA,RESULTS,SNP,SNPS,SSTR2
169,2014,969,EPA,GLEASON,HOWEVER,RBC,THESE,THUS
916,946,BACKGROUND,BINDING,BOTH,CONCLUSION,CONSISTENT,ECTOPIC,HNRNPA2B1,LABEL,METHODS,NUCLEAR,PCA,RESULTS,RGG,RNAI,UTR
587,BACKGROUND,CETUXIMAB,DIFFERENT,EGFR,HNSCC,LABEL,METHODS,PI3K,PKI,RESULTS,TREATMENT
169,2014,CENPF,COPYRIGHT,CROSS,FOXM1,INC,THUS
120,145,183,197,24H2O,335,894,A549,CUTLM,FTIR,LNCAP,N2O2,RAMAN,SEVERAL
2ND,9TH,BLADDER,CYSTECTOMY,HOWEVER
125,OVERALL,PERMANENT
ANTIGEN,DIFFERENT,PSA,THEN,THERE
526,AUSTRALIA,AUSTRALIAN,LABEL,METHODS,OBJECTIVE,PERTH,PURPOSE,RESULTS,WESTERN
0001,169,2013,967,ACCORDING,ANOVA,BPX,CONCLUSION,COPYRIGHT,GLEASON,LABEL,MEANS,METHODS,OBJECTIVE,PCA,PSA,PUBLISHED,PURPOSE,RESULTS,SAS,TURP
169,2013,941,CONCLUSION,COPYRIGHT,EVEN,IHT,LABEL,LEVEL,METHODS,OBJECTIVE,PROOF,PSA,RESULTS,SAS,UROLOGY
169,2012,2013,AMICO,ANTIGEN,CONCLUSION,COPYRIGHT,HOWEVER,LABEL,LITERATURE,METHODS,MRI,OBJECTIVE,PSA,PSM,QUALITY,RESULTS,SALVAGE,SAS
046,141,1505,169,2000,2012,2013,8805,ADJUVANTS,AFRO,CARIBBEAN,CONCLUSION,COPYRIGHT,GLEASON,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PSA,PSAD,RESULTS,ROC,SAS
000,100,124,145,160,169,188,1966,2000,2009,2010,2014,206,3125,3646,6771,ASR,AUTHORS,DESPITE,JOHN,LTD,NCR,POPULATION,RATES,SIMILARLY,SONS,STATE,SUDAN,WILEY,WORLD
CTC,CTCS
FAVOURABLE,GLEASON,LOW,PSA,SCORE
223,ADT,ANOTHER,BMD,DESPITE,FINALLY,SRES
8805,AMONG,CURRENT,HOWEVER,MOST,RADICAL
169,2014,ASP,EDMAN,FULL,GLN,ILE,JOHN,LITORIA,LYS,MET,PHE,PHT,PRO,SONS,TPHS,TRP,TYR,WILEY
169,2014,BELGIUM,COMPLETED,COPYRIGHT,EORTC,HRQOL,III,ITALY,KINGDOM,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,TIME,TREATMENT
001,101,158,158G,3845,3845G,ADENINE,ALSO,BACKGROUND,CAG,GLEASON,GUANINE,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRE,PSA,RESULTS,SNPS,WIDE
BACKGROUND,CONCLUSION,DATA,ENGLAND,HOWEVER,LABEL,METHODS,NHS,PSA,RESULTS,THERE
001,361,387,AARAU,AFTS,CHISM,CONCLUSION,CONVERSELY,DEPARTMENT,HAROW,KSA,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RADIATION,RESULTS,UROLOGY
000,001,008,100,102,1195,131,182,1996,2000,2007,424,799,BACKGROUND,CALIFORNIA,DECREASED,HIV,JANUARY,KPNC,LABEL,METHODS,PERMANENTE,POISSON,PSA,RESULTS
100,169,2014,8721,8805,CBCT,IMRT,JAPAN,PRESS,PTV,PUBLISHED,RADIATION,SET,SOCIETY,THESE,UNIVERSITY,WHILE
177,8804,8805,AMONG,GLEASON,PERINEURAL,PSA
AREAS,BACKGROUND,COVERED,CRPC,FDA,HOWEVER,LABEL,METHODS,OPINION,PCA
29A,29S,947,DU145,LAMC1,LUCIFERASE,PC3,PCA,SILENCING
177,1958,400,611,ACHIEVA,ANNEXIN,ION,LNCAP,MHZ,MIRB,MRI,NMR,PHILIPS,PSMA,RHODAMINE
INTERPLAY
169,2014,BACKGROUND,ENOLASE,EXPRESSION,HAUSP,HOWEVER,INC,LABEL,LNCAP,METHODS,NED,NSE,PARACRINE,RE1,REST,RESULTS,THESE,VP16,WILEY
0001,169,2014,380,435,570,653,781,814,8805,AFTER,CONCLUSION,DATA,FOM,IMAGING,INC,LABEL,METHODS,MOLECULAR,NAF,NUCLEAR,ONCOLOGIC,OVERALL,PET,POM,RESULTS,SOCIETY,UNLABELLED
0001,100,8201,BACKGROUND,CHRONIC,CPPS,GROUP,INDEX,LABEL,METHODS,NIH,OVERALL,RESULTS,SYMPTOM
161,1998,2002,2006,322,5156,8201,AMONG,BACKGROUND,CAPSURE,INGENIX,LABEL,METHODS,MRI,RESULTS,SINCE,STRATEGIC,THERE,THESE
146,2013,232,336,6122,7114,781,782,8201,CAUCASIAN,CIS,CONNECT,CURRENT,DIETARY,FOUR,FURTHER,HIGH,MEDLINE,OCTOBER,ORS,REMOVAL,THERE,THESE
169,2010,2014,8201,8805,ACTA,AUC,BACKGROUND,CONCLUSION,DATA,DCE,DWI,ESUR,FOUNDATION,IMAGING,INTER,IRB,LABEL,METHODS,NPV,OBJECTIVE,OBSERVERS,PPV,PSA,PURPOSE,RADIOLOGY,RADS,REPORTING,RESULTS,ROC,SOCIETY,T2W,THREE,UROGENITAL
160,169,2014,6982,ACADEMY,BACKGROUND,CONCLUSION,CONTEXT,COPYRIGHT,COX,END,HOSPICE,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PALLIATIVE,PUBLISHED,RANDOMIZED,RESULTS
001,044,2008,2010,AMICO,BETWEEN,DESPITE,DIEGO,FUNCTIONAL,GLEASON,GROUP,HEALTHCARE,INSTRUCTOR,INVENTORY,KRUSKAL,LABEL,MANN,MEN,METHODS,OBJECTIVE,OCTOBER,PATIENT,PEARSON,PHASE,PROCTORED,PURPOSE,RALP,RALPS,RESULTS,RISK,SAN,WHITNEY
8804,CURRENT,EARLY,FIRSTLY,USA
THESE
ADT,HOWEVER,THUS

000,200,2000,2010,2013,2014,2050,214,220,494,700,ALZHEIMER,AMERICANS,AVERAGE,BETWEEN,TODAY,TOTAL
CD117,CD34,DOG,EGIST,GIST,IMAGING
169,2014,3607,BECAUSE,EXPRESSION,GENOMIC,HOWEVER,LYN,SRC
017,028,2005,2011,288,592,634,880,8805,AMICO,ASIAN,BCR,BMI,COX,GLEASON,JULY,LABEL,METHODS,OBESE,OBJECTIVE,PCA,PSA,PURPOSE,RESULTS,THESE
ADP,BESIDES,CDDP,CISPLATIN,CUSN2,FURTHER,HEPG2,LD50,MCF,MTT,PARP,TRP
THERE,THESE
2009,2012,8804,CONCLUSION,GLEASON,LABEL,METHODS,MRI,NINE,OBJECTIVE,OVERALL,PCA,PSA,PURPOSE,RESULTS,T2A,VARIATION
003,281,395,NAT2,OVERALL,SMOKERS
000,001,003,169,2014,8201,AFRICAN,BACKGROUND,DECISIONAL,DECREASED,FEW,FURTHER,LABEL,MEAN,METHODS,PERCEIVED,POOR,RESULTS,SCALE,SOCIETY
169,2014,AUTHORS,COLLEGE,HOWEVER,JOURNAL,PHYSICIANS,POPULATION,PSA,ROYAL
169,2014,COPYRIGHT,MODEL,THESE
160,169,2014,218,ASIA,AUTHORS,DU145,LASP1,LIM,LTD,LUCIFERASE,PC3,PCA,PTY,PUBLISHING,SCIENCE,SH3,WILEY
003,006,042,046,048,749,8Q24,AIMS,AMONG,BEIJING,CHINA,CHINESE,CONCLUSION,EUROPEANS,GWAS,HAN,HRM,LABEL,METHODS,OBJECTIVE,ORDOMINANT,PCA,RESULTS,SIX,TIANJIN
100,ALTOGETHER,CHINESE,EASTERN,ERG,ETV1,ETV4,FISH,GLEASON,NEITHER,PSA,THERE,TMPRSS2,TNM,WHILE
103,128,149,151,209,4NG,AMONG,DRE,EIGHT,LABEL,LUTS,MATERIALS,METHODS,OBJECTIVE,PCA,PSA,PURPOSE,RESULTS,TRUS
144,169,2014,COLLEGE,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RADIOLOGY,RESULTS
145,169,176,2014,AMONG,COPYRIGHT,DNASE,HEPG2,INC,MCF,PUMPKIN,RNASE,SECONDARY,THESE
1130,138,169,176,2014,314,3PSA,8A6,945,BACKGROUND,COPYRIGHT,HYB4,INC,LABEL,MAGPLEX,METHODS,MFI,PCA,PSA,RESULTS,SERUM
169,2014,AUGER,CARLO,CELL,COPYRIGHT,LTD,MB231,MCF7,MCNPX,MDA,MONTE,PC3
169,2014,CALCIUM,CLINICALLY,COPYRIGHT,HOWEVER,INC
1042,177,AFTER,AIDS,BACKGROUND,CONCLUSION,GIVEN,HAART,HIV,LABEL,METHODS,NADM,NON,RESULTS,THERE,VIRUS
169,2014,AFTER,AMONG,BASED,CHOLINE,COPYRIGHT,EVEN,FDG,IRELAND,LTD,PET,PSA
0001,111,160,169,2014,239,649,891,AMICO,COLD,COPYRIGHT,EDUCATION,GLEASON,HRS,INC,LABEL,MATERIALS,MEIER,METHODS,MINIMUM,NADIR,OBJECTIVE,PHOENIX,PHREG,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL,VARIABLES
160,169,2006,2011,2014,321,COPYRIGHT,EDUCATION,INC,LABEL,METHODS,OBJECTIVE,PRIMARY,PUBLISHED,PURPOSE,RESULTS,RISK,SWEDISH,UROLOGICAL
EGF,EGFR,EGFRS,HOWEVER,NUCLEAR,OSCC,REGARDING,SCCS,THEREFORE
9346,ADT,CERTAIN,GLEASON,GROUP,HOWEVER,III,INSTITUTE,NCIC,PSA,SOUTHWEST,SWOG
CLINICALLY,HOWEVER,MYC,NEPC,ONGOING,PI3K,THESE
GUIDELINES,NCCN,PANEL
BPH,DU145,LNCAP,PC3,PCA,THESE,THUS,ZEB2,ZINC
001,CHEMICALLY,HOWEVER,HRPC,PC3,THEREFORE
054,169,2014,680,AMONG,BACKGROUND,LABEL,METHODS,RESULTS,TWIN
169,2014,BONE,COMPLEX,COPYRIGHT,LTD
169,2014,BACKGROUND,CONCLUSION,DU145,ERK,HEPACAM,HOWEVER,INC,LABEL,LNCAP,MAPK,MEANWHILE,METHODS,PC3,PCR,RESULTS,RWPE,THEN,THEREFORE,WESTERN,WILEY,WST
AMIDA,AUTOMATED,DATA,DYNAMIC,GLANDULAR,IMAGE,RAC,THESE
134,1997,2002,2007,214,376,450,639,BMI,BODY,CIS,COX,DATA,HRS,LABEL,METHODS,OBESE,OBJECTIVE,PURPOSE,RESULTS
169,183,BOTH,BPH,CAP,EXPRESSION,GEORG,HSD17B2,HSD17B3,STUTTGART,THESE,YORK
CASP3,CASP8,CCAAT,CEBPD,CLINICALLY,E2F1,EZH2,INCREASES,PRCA,SUZ12
001,177,BOTH,CL1,CRPC,CTX,CXCR1,DTX,IL8,IL8RA,INVERSELY,LNCAP,METASTASES,NEXT,NT3,PC3,PEDF,SIMILARLY,THERE,USING
TMA,TMAS
000,115,116,146,190,2002,2013,220,224,250,GLEASON,HOWEVER,JANUARY,JUNE,LABEL,METHODS,OBJECTIVE,RESULTS
CTCS,DIFFERENT
CAP,HOWEVER,LABEL,OBJECTIVE,PURPOSE,RESULTS,SUMMARY,VARIOUS
LABEL,OBJECTIVE,PURPOSE,RESULTS,RISK,SALVAGE,STRICTURE,SUMMARY
100,1000,102,114,1200,1400,1600,169,177,2014,402,407,422,424,548,595,604,605,666,671,698,713,ASL,COPYRIGHT,DCE,FORTY,JOHN,LTD,MRI,PERFUSION,SONS,THESE,WILEY
APART,BOTH,DU145,IGF1R,INSR,INSRA,INSRB,LNCAP,PC3,PCA,RWPE
GIVEN,KLK,KLK2,KLK3,KLKS,PSA
153,177,8804,CONCLUSION,GLEASON,INDEX,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,SLOW,SMALL,THESE
169,2014,COPYRIGHT,IDLE,IDLES,LTD,SCREENING,THEREFORE
001,002,1995,2008,2010,253,8805,AJCC,COMMITTEE,CONCLUSION,COX,CSS,DATA,FIVE,GFR,GIVEN,JOINT,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,RFS,RNU,UTUC
404,880,936,ABOUT,AMONG,CONCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,PCA,PSA,PURPOSE,RESULTS,UROLOGISTS
001,009,012,041,169,2000,2010,2014,2041,3227,8201,8805,AMICO,GLEASON,HIGH,LABEL,METHODS,OBJECTIVE,RESULTS,SMALL,THERE,UROLOGICAL

BACKGROUND,BASED,DESPITE,DUE,HOWEVER,LABEL,OBJECTIVE,OBJECTIVES,RESULTS,TUR,TURP
246,AFTER,HODGKIN,INCREASED,LABEL,LIMITED,METHODS,OBJECTIVE,RESULTS
002,005,009,012,169,2014,8805,BACKGROUND,CONCLUSION,COPYRIGHT,CRPC,FCH,INC,LABEL,METHODS,PET,RESULTS,ROI,ROIS,SUV,THESE,VOI
001,031,049,074,075,1120,169,2014,289,584,703,715,784,BACKGROUND,CONCLUSION,COPYRIGHT,COX,ECOG,HIGH,III,INC,LABEL,LDH,MEIER,METHODS,NLR,PSA,RESULTS,SUN,THESE
017,100,109,149,169,186,200,2013,215,232,239,298,313,322,805,8201,824,8804,8805,ADT,AGE,AUTHORS,BJU,CONCLUSION,ERG,GLEASON,III,LABEL,METHODS,OBJECTIVE,OTHER,PCA3,PHASE,PSA,RESULTS,THESE,TMPRSS2,TRIPTOCARE,URINARY
100,133,169,183,205,305,BACKGROUND,CONCLUSION,GEORG,LABEL,METHODS,PCA,RESULTS,STUTTGART,THEREAFTER,YORK
001,009,177,180,BOTH,GLEASON,MMP,PAR,PCA,THEN,THESE
231,946,AKT,BMP9,BONE,ERK1,HER2,HOWEVER,MDA,PD98059,PI3K,RESULTS,TGF,THESE,THUS
1100,1350,1600,1870,2200,2500,400,650,950,CCD,DUE,LIGHT,NIR,OPTICAL
100,125B,160,34A,AGO2,ARGONAUTE,DU145,EMT,HOWEVER,KLF4,MYC,NOTABLY,OCT4,TAKEN
803,CONVERSELY,EZH2,H3K27,KI67,MGC,TET1
8217,BMI,FURTHER,GLEASON,HOWEVER,PSA,PSMS,SCORE,TURP
142,164,166,169,2014,330,354,CSS,CYP19,CYP19A1,DU145,EACH,HAPLOTYPE,PC3,SNP,SNPS,THESE,UICC
0001,146,8201,DATA,DCS,DECISIONAL,LABEL,METHODS,OBJECTIVE,OVERALL,PHYSICIANS,RESULTS,SCALE,TREATMENT
122,169,2014,587,697,804,956,AUC,AUCS,BACKGROUND,COPYRIGHT,GLEASON,LABEL,METHODS,PCA,PCA3,PCR,PSA,RESULTS,ROC
169,2014,8804,AUTHORS,BOWEL,CTC,DOSIMETRIC,EPIC,FFG2,GRADE,IGRT,IMRT,JOHN,LTD,PATIENT,QOL,SONS,THREE,V40,V65,V70,WILEY
008,166,169,2014,8805,967,CONCLUSION,COPYRIGHT,ENDOSCOPY,INC,LABEL,MATERIALS,METHODS,NABUREN,OBJECTIVE,PURPOSE,RESULTS,THERE
DIGITAL
231,AMPK,CA2,CALCIUM,FUNCTIONAL,HMEC,MCU,MDA,MICU1,THESE
169,2014,7858,AFTER,BACKGROUND,COPYRIGHT,DATA,END,HRS,LABEL,LTD,METHODS,PRCA,RESULTS,SEER,SIMILAR,THESE
112,169,2000,2006,2014,205,8201,AUTHORS,BJU,BXT,CONCLUSION,DATA,IPSS,LABEL,LDR,LUKE,METHODS,OBJECTIVE,PVR,QMAX,QOL,RESULTS,SCORE,SELECTION,SYMPTOM,TURP
169,2014,557,558,561,588,689,753,8805,AUC,BACKGROUND,CONCLUSION,ELISA,FUC,FUT8,GLEASON,GSS,HPT,INC,LABEL,METHODS,PCR,PSA,PSAD,RESULTS,SERUM,WESTERN,WILEY
0001,169,1973,1994,1995,1998,2005,2014,AAM,AFRICAN,AGE,BACKGROUND,CONCLUSION,EAM,END,LABEL,METHODS,PSA,RESULTS,SEER,THERE,UROLOGICAL
001,1000,2000,215,602,645,8202,8804,8805,961,ADC,GLEASON,LABEL,LCS,MATERIALS,MEAN,METHODS,MRI,OBJECTIVE,RESULTS,TNR
120,1400,159,161,169,177,180,1975,200,2000,2008,2013,2014,302,330,446,8201,8805,APRIL,AUTHORS,BJU,CONCLUSION,GLEASON,HRPC,LABEL,LRP,METHODS,NVB,NVBS,OBJECTIVE,PSA,PSM,RESULTS
169,2014,22RV1,BACKGROUND,BUB1,CDC20,CELL,CENP,COX,EP1,EP2,EP3,EP4,FLOW,HOWEVER,INC,KNOCKDOWN,LABEL,LNCAP,METHODS,MTT,NDC80,PC3,PCR,PGE2,PLK1,RESULTS,SC51322,TREATMENT,WILEY,ZWINT
169,2013,2014,585,8201,850,8805,AUTHORS,BJU,CEE,CENTRAL,CONCLUSION,EASTERN,EAU,GLEASON,GROUP,HIGH,LABEL,MATERIALS,METHODS,OBJECTIVE,PARTY,PCA,PRE,PSA,RESULTS,SEPTEMBER,THERE,THESE,UROLOGISTS,UROLOGY,WESTERN,WORKING,YOUNG
169,2014,BASEL,BONE,SRES
169,2014,AFTER,AUTHORS,BJU,CONCLUSION,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,OBJECTIVES,PSA,RESULTS,TRUS
945,DU145,HIF,HIF1,HOWEVER,HYPOXIA,LNCAP,PC3
246,CHIP,FOX,FOXA1,LNCAP,NFI,NFIA,NFIB,NFIC,NFIX,THESE,VALIDATION
036,1950,215,228,AFRICAN,AMONG,CASE,IORS,JAZF1,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
16GAS,656,661,8202,8805,CONCLUSION,DEL,GLYCINE,GNMT,HAPLOTYPES,HOWEVER,HPFS,INS,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,STRP1,TAIWANESE
DEFINITIVE,DOSE,HYALURONIC
113,AIM,BLOOD,CONCLUSION,LABEL,LOWER,LYMPHOCYTE,METHODS,OBJECTIVE,RESULTS,WHOLE
700,CYP17A1,EARLY,ELM,HOWEVER,III,ORTERONEL,PC5,PHASE,TAK,TREATMENT
169,2014,ALONGSIDE,BRCA2,HOWEVER,INHIBITION,LOSS,OVERALL,PCA,UICC
100,177,609,8758,AIPC,CONCLUSION,FINALLY,LABEL,LNCAP,MATERIALS,METHODS,OBJECTIVE,PCR,RESULTS,SONOVUE,UNDER,USING,WESTERN
FINALLY,RESISTANCE
CELL,HEAT,HSP27,INCREASED,MMP,MORTALITY,PCA,THESE
2004,2005,2010,8202,8805,960,AMONG,BASED,GLEASON,GS6,ISUP,LYMPH,OLDER,PSA,REVISED,SEER
MOLECULAR,PRE
169,2014,215,2672,AIMS,CONCLUSION,DESPITE,EIGHT,JOHN,LABEL,LTD,METHODS,MOST,OBJECTIVE,PSA,RATIONALE,RESULTS,SONS,TREATMENT,WILEY
10A,10B,122,PATHOLOGY,PSA,THERE
ASSESSMENT,CTC,DETECTION,INDIVIDUAL,PROGNOSIS
100,BEAMNRC,CARLO,CTV,DOSXYZNRC,ECLIPSE,IMRT,MEDICAL,MONTE,OARS,PTV,SYSTEMS,TPS
000,169,1966,2014,BACKGROUND,INC,LABEL,METHODS,RESULTS,USING,UTAH,WILEY
169,17Q21,2009,2014,202,BACKGROUND,BRIC,BROAD,BTB,CUL3,ERG,HOPKINS,INC,JOHNS,LABEL,METHODS,N296I,POZ,PROJECT,RESULTS,SPECKLE,SPOP,TAKEN,TRAMTRACK,UNIVERSITY,UTRS,WILEY
EGF,EPIDERMAL,ERK1,KINASES,LNCAP,NPM1,NUDE,REGULATED,YET
007,022,071,118,121,CONCLUSION,ERG,GLEASON,HOWEVER,LABEL,MATERIALS,METHODS,NOTABLY,OBJECTIVE,PCA,PSA,PURPOSE,RESULTS,THERE
1976,2013,278,CASE,CONCERNING,ENGLISH,FEW,INCLUSION,LABEL,MEDLINE,MESH,METHODS,NATURAL,NEPC,NEPCS,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,SERUM,TERMS
113,189,AFTER,AUGMENTED,COA,HIBCH,PCR,PSA,SERA,USING
001,033,139,1616,169,16Q21,2014,215,2397,2952,4013,8201,946,998,ASIA,BACKGROUND,COLORECTAL,CSNK2A2,HEART,INC,LABEL,LUNG,METHODS,NEXT,OVARIAN,RESULTS,SCREENING,SIKHS,SOUTH,TRIAL,TWIN,UKCVD
169,2013,2014,AMPK,CSC,CSCS,FOLLOWING,FOXM1,JUN,MECHANISM,MELK
8201,ACS,AIMS,COX,HEENT,HOWEVER,INSURANCE,LABEL,MATERIALS,METHODS,NHI,OBJECTIVE,RESULTS
118,169,2014,COPYRIGHT,LQB,LTD,MYC,PACLITAXEL,THESE
145,169,2014,960,COMPOUNDS,COPYRIGHT,EXPRESSION,LTD,MATRIPTASE,THESE
169,2014,945,COPYRIGHT,DAG,HOWEVER,LTD,PKC,RAS,THESE,THUS
169,2009,2011,2013,BACKGROUND,BRASILEIRA,CO2,COPYRIGHT,EDITORA,JANUARY,LABEL,LTDA,MAIN,METHODS,OBJECTIVE,OBJECTIVES,PET,PUBLISHED,RESULTS,ROBOTIC,SIXTEEN,SOCIEDADE,THERE
001,003,115,169,2014,270,8804,8805,AFTER,COPYRIGHT,GLEASON,INC,LABEL,LOG,LOG10,MATERIALS,METHODS,NGF,OBJECTIVE,OBJECTIVES,PATHOLOGIC,PATIENT,PCA,PERINEURAL,RESULTS,TOTAL,URINARY
GIVEN,PFOA,PFOS,TAKEN
169,2014,946,956,A549,COPYRIGHT,DU145,FURTHER,HELA,MCF7,MTT,SAS
2B4,946,CDK5,EXPRESSING,HOWEVER,MM2,PC3,PCA,S425,S425A,S425D,USING
169,2014,CHIP,COPYRIGHT,FINALLY,H3K4,H3K4ME3,HOWEVER,INC,MLL,MLL1,PKN1,SET1,UPON,USING,WDR5
2000,2013,250,8201,BASED,CRPC,CTCS,CYP,III,PFS,PSA
ADIPOR1,ADIPOR2,ELISA,MTT,OBESITY,PCR
169,2014,AFTER,BACKGROUND,CD133,CONCLUSION,COPYRIGHT,CSPCS,FINALLY,LABEL,METHODS,OVARIAN,OVTC,PA1,PUBLISHED,RESULTS
160,169,2014,COPYRIGHT,EDUCATION,FINAL,GLEASON,INC,LABEL,MATERIALS,MEAN,METHODS,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,RESULTS,UCLA,UROLOGICAL,USING
169,2014,COPYRIGHT,HOWEVER,PUBLISHED,SAS
169,2014,COPYRIGHT,LTD,PEARSON,PUBLISHED,QUALITY,THI
0002,0006,0007,0008,001,002,003,014,169,2014,BACKGROUND,COPYRIGHT,CTV,D50,D95,D98,DOSE,EACH,EUD,IMRT,LABEL,LTD,MATERIALS,METHODS,OAR,PLAN,PTV,PUBLISHED,RESULTS,TEN
169,2014,COPYRIGHT,INC,TRUS
2009,2703,2710,CLIN,MEYER,RES,THESE,WESTERN
BONE,LABEL,OBJECTIVE,PURPOSE,RESULTS,SIMILAR,SUMMARY,THERE,THESE
169,2014,COPYRIGHT,INC,PUBLISHED,SOCIETY
2006,2007,ACMI,APRIL,CLINICALLY,CONCLUSION,DEDICATED,GYRUS,KETTERING,LABEL,METHODS,OBJECTIVE,RESULTS,SLOAN,THERE,ULTIMATELY
169,2014,COPYRIGHT,ESPECIALLY,FIRSTLY,HCC,INC,KNOCKDOWN,THEREFORE,WWP1
215,945,946,AD48,AD5,ADENOVIRUS,PCA,RFC,RIIFC,SEVEN,THUS
2013,744,962,APRIL,AUC,BACKGROUND,CNKI,CONCLUSION,LABEL,MEDLINE,METHODS,NCBI,PCA,PCA3,PSA,RESULTS,SCIENCE,SROC,WEB
105,107,169,2005,2007,2011,2012,2014,BOWEL,COMPOSITE,CONCLUSION,FORM,INDEX,ITEMS,JANUARY,JULY,JUNE,LABEL,MEDICAL,METHODS,OBJECTIVE,OCTOBER,OUTCOME,PRESS,PUBLISHED,RESULTS,SCORE,SHORT,SYMPTOM,UNIVERSITY,URINARY
123,136,147,153,180,239,AIMS,BACKGROUND,DXA,LABEL,METHODS,OBJECTIVE,OSTEOPENIA,PRIMARY,QUALIFIED,RESULTS
100,145,205,549,620,AMONG,CNS,COLO,FURTHER,H23,HELA,HEP,HOLARRHENA,HOWEVER,IMR,MCF,NCI,NIH,OVCAR,SIHA,SRB
APAO,FAD,LNCAP,MC3T3,NAC,ROS
169,2014,204,248,APART,BACKGROUND,HRS,LABEL,METHODS,NMSC,RESULTS
480,BOTH,COMPOSITE,EPIC,INDEX,LABEL,METHODS,OBJECTIVE,PATIENT,RESULTS,SCALE,SPANISH,UTILITY
156,169,2014,AUSTRALIA,CONCLUSION,COPYRIGHT,GAD,HOWEVER,JOHN,LABEL,LTD,MDD,METHODS,OBJECTIVE,PCA,RESULTS,SELF,SONS,THESE,WILEY
160,177,8201,CBDIV17,CBIDV17,CMC,CONCLUSION,HNMR,HOOC,IHC,LABEL,LHRH,LNCAP,METHODS,OBJECTIVE,PEG,PSA,PURPOSE,RESULTS,THERE,THESE
169,2014,BRCA,HER2,KRAS,UICC
0001,0002,0005,0012,152,169,2014,3P13,5Q21,6Q15,761,8201,BACKGROUND,ERG,ESO,GLEASON,INC,LABEL,METHODS,PSA,PTEN,RESULTS,THERE,WILEY
003,006,008,169,2014,667,8804,8805,AACR,AFRICAN,AMONG,CHICAGO,GLEASON,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SERUM,THERE
169,2014,2241,AACR,CLIN,PSA,RES,VITAMIN
140,169,2014,BACKGROUND,GLEASON,HPIN,INC,LABEL,LNCAP,METHODS,PCNA,PCR,RESULTS,RNAI,TUNEL,WILEY
200,API,BACKGROUND,BIOGRID,CYTOSCAPE,GUIDE,HELP,JAVA,LABEL,LINUX,MODULEROLE,NON,PAJEK,PPI,RAPIDLY,UNLABELLED,USER,USERS,WINDOWS
100,8201,ACTIVATION,ASSESSMENT,BACKGROUND,BAP,BTM,CEDIRANIB,CRPC,CTX,DOCETAXEL,FACT,FUNCTIONAL,GROUP,INTENSITY,LABEL,METHODS,MOST,PAIN,PATIENT,PCWG2,PFS,PHASE,PPI,PRESENT,PRIMARY,RESULTS,SRC,THERAPY,VEGFR,WORKING
PIN,PSA,PSMA
001,169,2010,2013,2014,297,300,APRIL,COPYRIGHT,GLEASON,INC,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SIR,TECHNICAL
100,169,2014,AACR,BONE,NOTABLY,RANKL
160,8209,947,AKT,PPAR,RSG,THESE,VEGF
160,169,2014,8805,BACKGROUND,CONCLUSION,COPYRIGHT,DOCETAXEL,III,INC,LABEL,METHODS,PSA,RESULTS,SUBSEQUENT
001,004,100,169,2001,2008,2014,354,8804,8805,AFTER,ART,BACKGROUND,CONCLUSION,COPYRIGHT,COX,ESTIMATES,GLEASON,INC,LABEL,MEN,METHODS,MTD,PSA,RESULTS,SEPTEMBER,T1C
7721,B23,FOS,GST,HMBA,MYC,NPM,P53,SMMC,THESE
169,2014,946,COPYRIGHT,DDR2,DISCOIDIN,KNOCKDOWN,MOLECULAR,PTHRP,RTK,RUNX2,TGF
169,2014,COPYRIGHT,INC
169,2014,ADULT,BACKGROUND,BASED,CONCLUSION,COPYRIGHT,GRAPHICAL,HRQOL,INC,INCLUSION,LABEL,METHODS,MOSBY,PRIMARY,PROVIDERS,RAPID,RESULTS,SCALE,SUBJECTIVE,YET
FLIP,HECT,INHIBITION,ITCH,JUN,JUNB,NOTCH,PREVIOUSLY,THESE,USING
0001,160,169,2014,215,945,AKT,FOXN1NU,HIF,JOHN,KI67,LNCAP,LTD,MELATONIN,NRF2,PUBLISHED,SONS,THESE,WILEY
000,169,200,2014,8201,BACKGROUND,CVD,DARLING,ENRICHMENT,FDR,GWA,GWAS,HDL,HNF1B,HOWEVER,LABEL,LDL,METHODS,PCA,PRESS,PUBLISHED,RESULTS,SNPS,T2D,THESE,UNIVERSITY
177,946,ARRAY,BCS1L,CONCLUSION,DAYS,EBRT,FATIGUE,FIS1,FURTHER,INC,LABEL,METHODS,MIXED,OBJECTIVE,OBJECTIVES,PATIENT,PCR,PUBLISHED,RESULTS,RT2
1184,169,1998,2006,2011,2014,3531,BACKGROUND,BETA,COPYRIGHT,LABEL,LTD,METHODS,ODDS,POST,PUBLISHED,RESULTS,SIMILAR,STATISTICS,THERE
001,081,1684,2010,2012,3760,LABEL,LOS,MATERIALS,METHODS,MIS,NON,OBJECTIVE,OPEN,OPERATIVE,PROGRAM,QUALITY,RESULTS,USING
1993,2001,504,AFTER,BACKGROUND,CIS,COLORECTAL,COX,HRS,LABEL,LUNG,METHODS,OVARIAN,PLCO,RESULTS,SCREENING,TRIAL,USING
120,8962,ABO,DISEASE,EMR,EMRS,IKZF1,SIMILARITY,SIMILARLY,VARIMED
6012,946,AIM,CONCLUSION,COOH,DIFFERENT,FOUR,FURTHER,LABEL,LNCAP,METHODS,NH2,OBJECTIVE,PCR,RESULTS,SCID
EN2,ENGRAILED,HEK293T,HOWEVER,IHC,MAB2600,RESULTS,TAKEN,THEN
169,2014,ACP,CONCLUSION,COPYRIGHT,GLEASON,INC,LABEL,MAXWELL,METHODS,MRI,NETWORK,OBJECTIVE,RESULTS,THERE
1217,164,169,1850,2014,215,355,516,633,862,BACKGROUND,COPYRIGHT,GWAS,HOWEVER,IRELAND,LABEL,LEND,LTD,MATERIALS,METHODS,OBJECTIVE,PARE,PUBLISHED,PURPOSE,RESULTS,SNP,SNPS,STRONGEST
400,CAIX,GENERALLY,PET
169,2014,508,773,841,BIOLOGY,COPYRIGHT,FEDERATION,INC,LIBRARY,MEDLINE,PUBLISHED,RTE,ULTRASOUND,WORLD
177,178,185,8309,BASED,DSA,EVERY,LABEL,METHODS,NRS,OBJECTIVE,RESULTS,TPS,UNDER
169,2014,ADPC,ARR2,BIKDD,CRPC,GAL4,HOWEVER,R1881,THEREFORE,UNDER,VISA,VP16,WPRE
116,184,BNSRP,OVERALL,PDE5,THESE
004,169,2014,AMICO,AUTHORS,BJU,BRCA2,CONCLUSION,CSS,GENOTYPING,JOHN,LABEL,LTD,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SONS,WILEY
001,107,110,118,122,130,145,169,193,2014,276,303,530,ART,AUTHORS,BJU,JOHN,KNOWLEDGE,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,PATIENT,PSMS,RESULTS,RPS,SONS,THESE,TREATMENT,WILEY,WITHOUT
174,BOT,BOTH,DESPITE,DOSE,HT1,HT2,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,RSS,RSS2,RSS5,WBHA
100,153,154,1CC,535,651,956,CARLO,GBQ,HDR,LABEL,METHODS,MONTE,OBJECTIVE,PURPOSE,RESULTS,RSBT,TREATMENT
029,103,177,538,ADDITIONAL,BLOCKED,CARLO,ICRP,LABEL,LAR,METHODS,MONTE,OBJECTIVE,PARA,PURPOSE,RESULTS,TESTICULAR
125,BOYER,DOSE,FOURIER,ISODOSE,LABEL,METHODS,MOK,OBJECTIVE,PURPOSE,RESULTS
RAMAN
AFTERWARD,ARB,DIAE,FIBEROPTIC,ICU
225,AIM,BACKGROUND,CONCLUSION,ELISA,FURTHER,HIGH,HIV,HOWEVER,LABEL,METHODS,NTM1,OBJECTIVE,RESULTS,RO60,SEQUENCES,SERA,WATER
050,1000,128,250,285,300,768,801,8201,8211,838,8764,8Q24,AFRICAN,AFTER,AMERICANS,BACKGROUND,BASED,BECAUSE,CLL,GHANA,GWAS,HOPKINS,JOHNS,LABEL,METHODS,MYC,PROJECT,RESULTS,SNPS,UNIVERSITY,USING
116,149,177,APTT,BPH,CRP,HCT,HGB,INR,LOX,PAI,PLT,PSA,RBC,TGB,WBC
181,AFTER,GIVEN,IC50,KING,LAAO,THESE,TUNEL
1RN,511,AMERICA,CDH1,FURTHER,GASTRIC,LATIN,OTHER,PSCA
169,2014,FINALLY,FIRST,MEDICAL,PRESS,PUBLISHED,SOCIETY,THERE,THROUGH,UNIVERSITY
169,2014,447,ADDRESSING,AUSTRALIA,CONCLUSION,COPYRIGHT,GEOGRAPHIC,JOHN,LABEL,LTD,MEN,METHODS,OBJECTIVE,RESULTS,SONS,THESE,WILEY
138,199,2184,973,CONCLUSION,LABEL,METASTATIC,METHODS,OBJECTIVE,RESULTS
ABCC1,CHIP,CHROMATIN,FINALLY,ICN1,INHIBITION,LNCAP,PC3,PCR,PCSCS,PROTEIN,SHRNA
1992,2012,410,8805,ADT,CSS,GLEASON,HAKULINEN,HOWEVER,MEANWHILE,PFS,THEIR
169,2014,636,AMERICANS,ARAB,CHI,CIS,INTERVIEW,NATIONS,NHIS,ORS,PSA,THERE,WHITE
169,2014,40S,50S,60S,DESPITE,HOWEVER,MASCULINE,STRUCTURED,THESE
169,2014,CRPC,E2F1,FINALLY,JNK,LNCAP,MDV3100,PHORBOL,PKC,PMA,SOCIETY,TAKEN,THEREFORE
169,2014,946,BMP,CAF,ECTOPIC,FURTHER,GDF15,MIC,NOTABLY,TGF
169,2014,COPYRIGHT,GMBH,PUBLISHED
020,10878,169,2014,BACKGROUND,CONCLUSION,COPYRIGHT,CTV,CTVRTOG,EACH,FCH,IMRT,IRELAND,LABEL,LTD,MATERIALS,METHODS,PET,RESULTS,RTOG,TOMOGRAPHY
169,177,2014,246,584,AMONG,BACKGROUND,CONCLUSION,COPYRIGHT,DOTA,FMOC,GRPR,IC50,INC,LABEL,METHODS,PEG,PEG12,PEG2,PEG4,PEG6,RESULTS,THERE
169,2005,2007,2014,3379,AMONG,COPYRIGHT,ELDERLY,END,GREATER,INC,LABEL,METHODS,OBJECTIVE,PCA,POISSON,RESULTS,SEER,SNF,THERE
169,2014,C35,COPYRIGHT,HPLC,LTD,PUBLISHED,THEIR,THESE
100,126,21OHD,230,250,254,345,664,764,945,BACKGROUND,CHRONIC,CONCLUSION,CONTEXT,CYP17A1,LABEL,MAIN,MEAN,MEASURE,METHODS,OBJECTIVE,OUTCOME,RESULTS,SECONDARY,SERUM,SETTING
946,BACKGROUND,CONCLUSION,DRUGS,EGFR,ERK1,HOWEVER,INHIBITION,LABEL,METHODS,PCR,PDGFR,PI3K,RESULTS,TNBC,WESTERN
177,8764,CH3,CYS,ENGINEERED,IMAGING,KDS,PET,PSMA
145,169,2014,AKT,AUTHORS,BOTH,FOUNDATION,HDAC,HDAC1,IGF,IGFR,INVERSELY,JOHN,JOURNAL,LTD,MOLECULAR,RAPAMYCIN,SONS,STILL,VPA,WILEY
013,023,033,037,039,044,286,288,574,859,8Q21,8Q24,907,ACCORDING,BACKGROUND,BEIJING,BLOOD,CHINA,CHINESE,JING,LABEL,METHODS,RESULTS,SIX,SNPS,TAC,THREE,TIANJIN
160,CONVERSELY,MRI,THESE,ULTIMATELY,WHILE
002,DUE,MOST,SIEMENS
104,169,2013,349,8805,AACR,BECAUSE,III,PSA,TH1
215,5893,6213,III,KALLIKREIN,KLK2,KLK3,KLK3E,MED1,PSA,RNAI,RNAS
177,AIM,ASSESSMENT,BACKGROUND,CAPRA,CCP,COMBINING,CONCLUSION,EIGHT,GLEASON,INITIAL,LABEL,MEAN,METHODS,MRI,NINE,OBJECTIVE,PSA,RESULTS,RISK,THUS,TRUS
122,2002,2011,400,AIM,BACKGROUND,BETWEEN,BOLOGNA,CONCLUSION,LABEL,LRP,MARCH,METHODS,OBJECTIVE,RESULTS,UNIVERSITY,UROLOGICAL,YEARS
169,2013,2AG4,AACR,MDSC,MDSCS,TAM,TAMS,THESE
001,169,2014,8201,ERG,FISH,INC,PSCC,SIXTY,SMALL,TMPRSS2,WILEY
8201,ARTISTE,BACKGROUND,DEPENDING,DOSIMETRIC,IMRT,LABEL,METHODS,PANTHER,PATIENT,PROWESS,RESULTS,SIEMENS,TREATMENT
945,BOTH
001,104,144,2013,2014,226,8804,BASEL,JANUARY,LABEL,METHODS,OBJECTIVE,PCA,PSA,RESULTS
945,946,BAX,BCL,CRH,CRHR,CRHR1,CRHR2,CRHRS,IL1,PERIPHERAL,PREVIOUSLY,SILENCING,UCN2,UROCORTIN
BACKGROUND,CLINICALLY,DESPITE,DRUG,FOOD,LABEL,MATERIALS,MEDLINE,METHODS,RESULTS
223,BACKGROUND,DOCETAXEL,FINALLY,III,LABEL,MATERIALS,MEDLINE,METHODS,RAPID,RESULTS
ADT,BACKGROUND,BONE,CONCLUSION,CTIBL,LABEL,MATERIALS,MEDLINE,METHODS,RESULTS,SRES
BACKGROUND,CRPC,DOCETAXEL,DRUG,EIGHT,FDA,FOOD,FRONT,GIVEN,LABEL,MATERIALS,METHODS,RESULTS
223,BACKGROUND,BONE,CONCLUSION,CRPC,CYP,FURTHER,III,LABEL,METHODS,RESULTS,THERE
2010,2012,223,258,ABSTRACTS,ASCO,BACKGROUND,CONCLUSION,DRUG,FOOD,LABEL,MATERIALS,MDV3100,MEDLINE,METHODS,ONGOING,PSA,RESULTS,SINCE,SOCIETY
BACKGROUND,CRPC,III,LABEL,MATERIALS,METHODS,RESULTS,WHILE
BACKGROUND,DRUG,FDA,FOOD,GVAX,III,LABEL,MATERIALS,MECHANISMS,METHODS,OTHER,PSA,RESULTS,WHILE
99M,BACKGROUND,BONE,CONCLUSION,CRPC,DUE,LABEL,MATERIALS,MEDLINE,METHODS,MRI,OSSEOUS,RESULTS
BACKGROUND,BASED,CASTRATION,CRPC,HOWEVER,LABEL,MATERIALS,METHODS,PSA,RESULTS,SHMS,THERE
ADT,BACKGROUND,CADT,CENTRAL,CONTROLLED,HOWEVER,HRQOL,IADT,III,LABEL,MATERIALS,MEDLINE,METHODS,PUBLISHED,RCTS,RESULTS
2003,2005,ADT,BACKGROUND,CAD,DRUG,DUE,FDA,FOOD,LABEL,LHRH,LITERATURE,MATERIALS,METHODS,RESULTS
ADT,BACKGROUND,DATA,FSH,LABEL,LHRH,MATERIALS,METHODS,NEWER,NORTH,RESULTS,THERE
1992,2013,ADT,BACKGROUND,CRPC,DESPITE,FURTHER,LABEL,MATERIALS,METHODS,OLDER,RESULTS,THEREFORE
2010,223,239,BACKGROUND,BONE,CRPC,JOURNAL,KEY,LABEL,MATERIALS,METHODS,NEWER,PET,RESULTS,UROLOGY,WHILE
MEDICAL,PCRY
115,182,1990,2010,234,BACKGROUND,BOTH,INTRA,LABEL,MATERIALS,METHODS,NPV,PPV,RESULTS,TUR,UNIVERSITY
0010,0234,0278,140,2010,2012,226,402,8805,AUA,BACKGROUND,CONCLUSION,DRE,GLEASON,GSS,LABEL,MATERIALS,METHODS,OVERALL,PSA,RESULTS,THERE,UROLOGICAL
1ST,2014,2ND,ALBERTSEN,ALLEN,ANGER,ANN,ANTHONY,BELLA,BURNETT,CHAIR,DRS,GOMELLA,GORMLEY,HOLE,HOPKINS,JACKSON,JHS,JIM,KIM,LEONARD,MARSHAL,MICHAEL,MOREY,OLIVIER,PANEL,PETER,PRESIDENT,PROGRAM,RALPH,STOLLER,USA,WYOMING
151,945,DOSE,ELISA,ENO1,ETP,ETPS,FINALLY,GI50,HIF,LDHA,PCR,SEVERAL,THEREFORE,THESE,VEGF,VEGFA
169,2014,464,945,COPYRIGHT,CYP17,CYP17A1,LTD,MES,PHASE,USING
169,2014,AIM,BACKGROUND,CONCLUSION,CROSS,DOES,DUE,FTOM,GUIDELINES,HOWEVER,LABEL,MAIN,METHODS,MTOF,OBJECTIVE,OLDER,OUTCOME,RESULTS,RISKS,SOCIETY
006,008,023,099,137,174,1998,2005,221,271,332,362,408,517,757,813,861,889,BACKGROUND,COX,CRPC,GLEASON,GROUP,LABEL,LOWER,METHODS,NADIR,NARA,PADT,PRIMARY,PSA,RESULTS,URO
12TH,1ST,6TH,BACKGROUND,BECAUSE,CONCLUSION,CONTEXT,DISCUSSION,EXPRESSION,FORTY,HLA,IGG,LABEL,METHODS,MST,PHASE,PPV,RESULTS
0001,2009,2010,524,663,765,AIM,DATA,LABEL,METHODS,OBJECTIVE,RESULTS
112,125,165,176,634,AMACR,ANDR,AVERAGE,BCL2,HIFU,LOCAL,MINIMUM,PCNA,RECURRENCE

169,2014,DESPITE,EARLY,HIGH,LOCATED,REALIZING,THESE
169,2014,8804,AMONG,ATLAS,FGF2,FGF9,FGFR,FGFR1,GCN,IC50,KRAS,LABEL,LUNG,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCC,SCCS,TCGA,TKI,TKIS
169,2014,239,945,CHANGES,CONSISTENT,DHEA,FRESHLY,HRPC,LABEL,METHODS,OBJECTIVE,PURPOSE,REDUCTION,RESULTS
169,2014,2536,FINALLY,GLEASON,INHIBITION,LABEL,METHODS,MYC,NOTABLY,OBJECTIVE,PIM1,PLK1,PURPOSE,RESULTS,RNAI,XENOGRAFT
INTENSITY
169,2014,945,ADT,ANDROGENS,CAP,CYP17A1,DHT,EARLY,PSA,SOCIETY,SRD5A,THERE
8201,946,ASP9521,BACKGROUND,GIVEN,HOWEVER,HSD5,LABEL,METHODS,RESULTS
0001,268,380,468,8804,BACKGROUND,GLEASON,GROUP,HOWEVER,LABEL,METHODS,MICHINOKU,PCA,PSA,PSAD,RESULTS,UROLOGICAL
282,289,744,8201,8805,DIAGNOSTIC,END,FACTORS,HRQOL,INTERVIEW,LABEL,LUNG,MDD,METHODS,MHOS,OBJECTIVE,POR,PROGRAM,PURPOSE,RESULTS,RISK,SEER,SURVIVORS,UNASSIGNED
165,182,347,MRI,RESULTS,THEREFORE
181,6273,946,9845,AKT,CALCULATED,CSD,EGF,EMT,EPITHELIAL,FISETIN,PCA,PLASMON,RESONANCE,SILENCING,SURFACE
002,8804,BMI,DRE,HEALTHCARE,LABEL,LESS,MAIN,METHODS,OBJECTIVE,PSA,RESULTS,SCREENING,THOSE
ADT,AREAS,BMD,COMPARISON,HOWEVER,SEVERAL
162,2011,CONCLUSION,LABEL,METHODS,OBJECTIVE,OBJECTIVES,ONTARIO,RESULTS
AIPC,BRIEFLY,DATA,PSA,THERE,TOTAL
169,2014,946,COPYRIGHT,FERMENTED,FPP,WHAT
169,2014,AKT,ALTOGETHER,CONSISTENT,COPYRIGHT,ERK,PUBLISHED,TRPM7,WHEREAS
IRELAND,LTD,PUBLISHED
001,002,003,028,033,040,152,160,169,1982,2012,2014,356,8804,ACTUARIAL,BETWEEN,COPYRIGHT,COVARIATES,COX,EDUCATION,GLEASON,HOWEVER,INC,LABEL,MATERIALS,METHODS,NOTABLY,OBESE,OBESITY,OBJECTIVE,PREDICTORS,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
160,169,174,2013,2014,AMONG,COPYRIGHT,DATA,EDUCATION,IMAGING,INC,LABEL,MATERIALS,MEDLINE,METHODS,OBJECTIVE,OCTOBER,OPTIMAL,PUBLISHED,PURPOSE,RADS,REPORTING,RESULTS,TECHNIQUES,UROLOGICAL
001,160,169,2014,452,8804,946,AFTER,AIM1,APC,CCND2,COPYRIGHT,EDUCATION,GPX3,GREATER,GSTP1,INC,LABEL,MATERIALS,MCAM,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RAR,RECURRENCE,RECURRENT,RESULTS,SSBP2,STAGING,TIMP3,UROLOGICAL
045,160,169,174,1992,2011,2014,ADG,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,ONTARIO,PUBLISHED,PURPOSE,RADICAL,RESULTS,UROLOGICAL
169,2014,224,COPYRIGHT,FEDERATION,PCA,PUBLISHED,SILENCING,SOCIETIES,TPD52
169,2014,BIOLOGICAL,COPYRIGHT,COX5,DB1,DJ1,ESI,FTL,GDP,HSP27,LABEL,MTPN,PROTEOMICS,PSME1,REMARKABLY,RHO,SH3BGRL,SOD1,THERE,TNBC,UBE2N,UNASSIGNED,UNLABELLED
000,169,2014,579,640,954,961,AKT,ALSO,COPYRIGHT,FHKR,GSK,HOWEVER,INC,INCREASED,MYC,PERINEURAL,PTEN,SRC1,THESE,TIF2
169,2014,945,946,AKT,AMONG,COPYRIGHT,COUMESTROL,GSK,HIF,LTD,OVERALL,PUBLISHED,ROS,SKI,SPHK1,THUS
169,177,2014,BACKGROUND,BECAUSE,COPYRIGHT,DPP4,ERK,FURTHER,GFP,INC,LABEL,LNCAP,MATERIALS,METHODS,MLK,PCR,PD98059,PSA,RESULTS,TRANSCRIPT,TREATMENT,WESTERN
169,2014,BECAUSE,BONE,CAP,COPYRIGHT,FEDERATION,MC3T3,PUBLISHED,RUNX2,S1P,S1P1,S1P2,S1P3,SOCIETIES,SPHK1,SPNS2,STRATEGIES
001,169,172,173,2003,2007,2009,2014,214,215,268,269,405,647,7534,8805,957,966,AFTER,CONCLUSION,COPYRIGHT,END,INC,INCREASING,LABEL,MATERIALS,METHODS,OBJECTIVE,QUARTILES,RESULTS
169,2014,AMONG,ASAP,COPYRIGHT,IHC,INC,MEANWHILE,THERE
0001,001,0015,019,035,169,173,2014,BAF250A,BARR,CASES,COPYRIGHT,EPSTEIN,HER2,INC,LOSS,OVERALL,THESE,TORONTO,VANCOUVER
169,2014,BONE,COPYRIGHT,HOPEFULLY,LTD,SEVERAL
0275,106,169,2014,640,945,954,961,AIB,ANTI,COPYRIGHT,COX,DATA,DAX,GSK,INC,INCREASED,MYC,NERVE,P27N,PCA,PGP,PIM,PROTEIN,PTEN,SKP,SRC,SRF
114,169,2014,226,COPYRIGHT,E318K,INC,MITF,V320I
1164,1655,169,1994,1995,2014,3533,491,BACKGROUND,COPYRIGHT,FUNCTIONAL,HOWEVER,INC,INSTITUTE,LABEL,METHODS,PCOS,RESULTS,SIMILARLY
015,048,169,2003,2011,2014,280,359,ASIAN,BACKGROUND,BESIDES,BETWEEN,BODY,CLAVIEN,CONCLUSION,COPYRIGHT,DINDO,HOWEVER,III,JANUARY,LABEL,METHODS,MINIMALLY,PUBLISHED,RADICAL,RALP,RESULTS,THERE,WESTERN
169,2014,653,956,963,COPYRIGHT,H2O2,HRP,NPS,PCA,TMB,UNDER
001,0415,0828,169,2014,ACT,CARE,COMPOSITE,DIEGO,ENGLISH,EPIC,FORTY,GROUP,INC,INDEX,INSTITUTE,INSURANCE,LABEL,MATERIALS,METHODS,MISSING,OBJECTIVE,OPTIMAL,PUBLISHED,PURPOSE,QOL,RADIATION,RESULTS,RTOG,SAN,THERAPY,VISIONTREE,VTOC
RESULTS
169,2014,CHANGED,COPYRIGHT,JOHN,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,SIX,SONS,SUPPORTING,WILEY
100,169,181,2014,300,COPYRIGHT,JOHN,LTD,MRE,MRI,RESULTS,SONS,WILEY
111,168,169,177,2014,COPYRIGHT,D2B,FAB,IGG,JOHN,LNCAP,LTD,MAXIMUM,PC3,PSMA,SONS,WILEY
150,170,200,8201,8805,888,ABT,ADP,AES,BIOMARKER,GRADE,PARP,PSA,TMZ,VELIPARIB
143,145,146A,199A,946,SEVERAL,SMAD,TGF
945,A138,AARRR,ASP,ATP,D199,DFG,E106,HENCE,HOWEVER,K88,MARK,MARK4,PAR,SER,THESE,THR,WNT
0000,0001,0010,0011,0021,1071,128,169,2014,8295,8804,AFTER,FEC,GLEASON,HENCE,LABEL,METHODS,MRI,OBJECTIVE,PET,PURPOSE,RESULTS
BRD4,H2O2,HDAC6,HMOX1,JQ1,KEAP1,KNOCK,NRF2,ROS,SEQ,SESN3,SP1,WITHOUT
AKT,ALTOGETHER,FURTHER,MLCK,STIM1
ALDH,ALDH1A1,ALDH3A1,ALDH7A1,BACKGROUND,DU145,LABEL,METHODS,PCSCS,PIN,RESULTS,WHEREAS,XENOGRAFT
0001,123,189,ERG,PTEN,TMPRSS2
BACKGROUND,CONCLUSION,CSC,CSCS,HOWEVER,LABEL,MATERIALS,METHODS,PSMA,RESULTS
181,533,5MM,683,CONCLUSION,DAILY,HOWEVER,LABEL,LEVEL,MATERIALS,METHODS,MVCT,NAL,OBJECTIVE,OFFLINE,PTV,PURPOSE,RESULTS,USING
169,2014,ING4,MYC,PTEN,THUS
448,BACKGROUND,CONTINUOUS,DEPOT,GNRH,HEALTHY,KISSPEPTIN,LABEL,METHODS,OBJECTIVE,RESULTS,TAK
SLCO1B1,SLCO1B3,SLCO2B1,SLCOS,SNPS,THEREFORE
174,EVEN,III,PHASE
956,IC50,LAT,LAT1,LAT3,LEUCINE,LNCAP,QUEENSLAND,USING,XENOPUS
145,33258,BAX,BCL,HOECHST,MTT,RASD1,WESTERN
572,639,BACKGROUND,CIS,EQUOL,LABEL,MATERIALS,METHODS,NATTS,ORS,RESULTS,SERUM,SLACKIA
BACKGROUND,LABEL,MATERIALS,METHODS,RESULTS,THESE,TRACE
177,8805,AGE,ALSO,DRE,GLEASON,HBA1C,HISTOLOGIC,LABEL,MATERIALS,MEAN,METHODS,OBJECTIVE,PCA,PSA,PURPOSE,RESULTS
8764,956,CONVENIENT,HOWEVER,ICTS,MUA,PSA,QDS,UNDER
000,100,2009,2010,2012,2013,228,425,449,488,492,515,994,998,ADDITIONAL,ADHERENCE,ANALYTICS,BACKGROUND,DATASET,JUNE,LABEL,MARCH,MARKETSCAN,MEAN,METHODS,MPR,OBJECTIVE,POPULATION,RESULTS,SIMILAR,SOLUTIONS,THESE
3BETA,APOPTOSIS,BAX,BCL,CASPASE,CONCLUSION,HOECHST,LABEL,METHODS,MYRRH,OBJECTIVE,PC3,RESULTS,THESE,TREATMENT,WESTERN
001,002,004,012,034,036,057,116,1233,221,222,8804,CRPC,GLEASON,LNCAP,MICRORNAS,PC3,RNAS,THESE
176,2008,2010,500,CONCLUSION,HOWEVER,LABEL,MAGNESIUM,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE,THEREFORE
2011,464,945,ACTH,CRPC,CYP17,HOWEVER,III,INHIBITION,P450,REGULATORY
CRPC
DRUG,FDA,FOOD
ADT,IADT
ADT,AKT,CASTRATION,CRPC,PCA,PCAS,PI3K,THUS
000,100,138,169,1988,2009,2014,250,323,500,581,600,742,BACKGROUND,FIGURES,GERMANY,ITALY,LABEL,MEDICAL,METHODS,NOTABLE,PANCREATIC,POPULATION,PRESS,PROJECTED,PUBLISHED,RESULTS,SOCIETY,SPAIN,UNION,UNIVERSITY,WORLD
BET,BRD4,CRPC,DESPITE,ERG,JQ1,MDV3100,MEN,TAKEN,TMPRSS2
002,024,047,282,AFTER,CONCLUSION,COX,DCE,DWI,GLEASON,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PSA,RESULTS,T2WI,UNIVARIATE
041,117,215,ADC,AMICO,CONCLUSION,GLEASON,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PSA,RESULTS,ROC,THEIR,TRUS
1973,1980S,1981,1985,1993,2001,2005,AGE,BACKGROUND,CLAYTON,CONCLUSION,DATA,FURTHER,HOWEVER,LABEL,MARTINIQUE,METHODS,RESULTS,SCHIFFLERS,WORLD
BACKGROUND,CONCLUSION,EORTC,FIFTY,GRADE,IMRT,LABEL,LATE,METHODS,PEG,RADIATION,RECTOSCOPY,RESULTS,RTOG,SCALE,SEVENTY,THERE,VRS

2013,8201,CURRENTLY,LIBRARY,MEDLINE,MRI,PCA,PET,PSA,PUBLISHED
0449,174,2012,2013,BCC,DRUG,EMA,FDA,FOOD,GDC,JANUARY,JULY,MEDICINES,SMO,VISMODEGIB
0052,COOH,HODGKIN,MOST,NOTABLE,NPI,PROTEOSOME
2012,FDA,FLT3,HEREDITARY,III,KIT,MEN,MET,MTC,NSCLC,RET,THEREFORE,VEGFR
2013,411,792,CAUCASIAN,GLU298ASP,LIBRARY,NOS3,SEPTEMBER,STATA,SUMMARY
FINALLY,SHORTLY,TRANSIENT,TRP,TRPM8
157,1999,2001,2002,2003,2004,2005,2006,2008,2011,2012,2013,378,681,ACG,AFRICAN,AKEY,APPARENTLY,AUG,C197,CAT,CAT1,ECAC2,FIXEMER,HAHN,M418,M721,PENG,R197,STAJICH,T721,TROST,TRP,TRPV5,TRPV6,V418,VOETS,WISSENBACH
160,174,240,8804,DEGARELIX,GONAX,III,INJECTION,JAPAN,PSA,THUS
COMPOUNDS,TOUCH
100,BACKGROUND,GNRH,HOWEVER,LABEL,REGULATORY,UNASSIGNED
001,169,2000,2007,2009,2014,488,AMONG,CONCLUSION,COPYRIGHT,COSTS,END,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEER,SOCIETY,STUDIES,TEXAS,THOSE
8804,8805,940,980,AFTER,AIM,BONE,CONCLUSION,DAILY,ENDORECTAL,IGRT,IMRT,LABEL,METHODS,MVCT,OBJECTIVE,PTV,RESULTS,SIB
001,062,2007,22092,26089,29233,8202,ADDITIONAL,BACKGROUND,CEC,CECS,CEP,CEPS,CHEMONAIVE,CONCLUSION,CRPC,EUDRACT,HOWEVER,LABEL,METHODS,MTD,PFS,PSA,REGISTERY,RESULTS,SUNITINIB,THESE,TRIAL,UNASSIGNED
AHR,BACKGROUND,BASAL,DISTANT,DU145,HRPC,LABEL,LNCAP,METHODS,PC3,PC3M,PCR,RESULTS,SEVERAL
169,2014,GRK,GRK5,INHIBITION,MASS,T66,TAKEN
169,2014,367,468,542,BIOLOGY,CYS,DU145,HOWEVER,INC,MASS,MOLECULAR,SEPHAROSE,SOCIETY,STAT3
108,242,BMI,CHINESE,KLK2,KLK3,LABEL,METHODS,MGB,OBJECTIVE,PCA,PROBE,RESULTS,SNPS,TECHNOLOGY,UNASSIGNED,UNIVARIATE,VDR,VIRTUAL,WHILE
100,158,678,786,890,CONCLUSION,LABEL,METHODS,MRI,MTD,OBJECTIVE,PEARSON,RESULTS,THREE,TVP
1999,2009,ANS,AREA,CHSDA,IHS,INCIDENCE,INDIANS,LABEL,METHODS,NATIVES,OBJECTIVE,OBJECTIVES,RESULTS,SERVICE,WHITE
AFRICAN,CONFERENCE
215,HEPG2,LIVER
0020,0036,0252,0483,1023,1029,169,180,2014,4885,7665,8073,8201,AIM,BACKGROUND,CER,CONCLUSION,DCE,FIVE,LABEL,LIFE,MAIN,METHODS,MRI,OBJECTIVE,OUTCOME,PATIENT,QUALITY,RANK,RESULTS,SOCIETY,SUM,THESE
MEN,NURSE


10Q11,146,169,17Q24,19Q13,2014,437,804,854,8805,8Q24,BACKGROUND,GWAS,LABEL,METHODS,PROTECT,PSA,RESULTS,SNPS,THESE
169,2014,HIGH,PC3,RAD51,RESISTANCE,SNF2,SWI2,TREATMENT
169,2014,945,ACIDS,CRPC,ERG,ETS,ETV1,EXPRESSION,GABP,NUCLEIC,PRESS,PUBLISHED,UNIVERSITY
169,2014,BACKGROUND,CERTAIN,COPYRIGHT,GMO,JOHN,LABEL,LTD,M21,METHODS,MVL5,RESULTS,SONS,WILEY
169,2014,BIOLOGY,FK506,HOWEVER,HSP,HSP70,HSP90,INC,MOLECULAR,SGTA,SMALL,SOCIETY,STEROID,TAKEN
107,169,2010,2014,267B1,2GAL,4GLCNAC,6GAL,732,737,8594,945,946,ACAD,BIOLOGY,CARROLL,F77,FUC,FUT1,GCNT,GCNT1,GCNT2,GCNT3,INC,LAL,LLERA,MOLECULAR,MOYA,NATL,PCR,PROC,RWPE1,SCI,SOCIETY,THESE,WANG,ZHANG
169,2014,BIOLOGY,F77,INC,MOLECULAR,MONOCLONAL,PC3,SOCIETY
1946,1967,2013,26TH,DESPITE,LABEL,METHODS,OBJECTIVE,PARTNER,PURPOSE,RESULTS,SEPTEMBER,STUDIES,SURVIVORS
169,2014,946,AFRICAN,AMERICANS,C2C3,CAP,CAUCASIAN,CAUCASIANS,DOCK1,EMPLOYING,EPIGENETIC,HIGH,HOWEVER,RAC,RAC1,ROBO1,SH2,SH3,UICC,USING,WHILE
SIGNALING,WORK
001,116,1252,181,2129,397,415,437,6640,945,CONIFER,GREEK,HAEC,HONEY,MCF,ORAC,TNF,VCAM
995,CTC,CTCS,FIFTY,POWER
001,002,967,ANY,CONCLUSION,CORD,IMPAIRMENT,LABEL,MEASURE,METHODS,MSCC,OBJECTIVE,RESULTS,SCALE,TOKUHASHI
8804,COMPOSITE,CONSENSUS,GLEASON,GROUP,PSA,RCT,THESE
169,2014,47D,CACO,CD34,COPYRIGHT,EAC,EHRLICH,GSH,HELA,HEP,HEPG2,IRELAND,LTD,MCF,PC3,PCNA,SUNITINIB,SWISS,TAKEN,THESE
169,2014,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,MVCT,NMAR,OBJECTIVE,PURPOSE,RESULTS,THESE
003,131,160,169,2000,2011,2014,8776,8804,AUTHORS,BJU,CONCLUSION,FURTHER,GLEASON,JANUARY,JOHN,LABEL,LTD,METHODS,OBJECTIVE,PSA,PUBLISHED,RESULTS,SONS,THERE,THEREFORE,THOSE,WILEY
169,2010,2014,233,ASIA,LTD,PRIOR,PTY,PUBLISHING,TODAY,WILEY
1109,154,177,1903,794,8805,AIMS,BACKGROUND,BMI,LABEL,METHODS,NUTRITION,OBJECTIVE,ORAL,OVERALL,RESULTS
100,ANGELES,ATTRIBUTE,CALIFORNIA,COMPOSITE,CURRENT,EACH,EIGHT,EMPRO,EPIC,EVALUATING,INDEX,INSTRUMENT,LABEL,LIFE,LOS,METHODS,OBJECTIVE,PATIENT,PCI,PURPOSE,QOL,QUALITY,RESULTS,SCALE,THESE,UCLA,UNIVERSITY,UTILITY
946,CXCR4,GLEASON,HIGH,LABEL,LOW,METHODS,OBJECTIVE,PCR,REAL,RESULTS,SDF
169,191,2014,209,AACR,BACKGROUND,CHRONIC,CONCLUSION,GLEASON,LABEL,MEN,METHODS,PREVENTION,PSA,RESULTS,THESE,TRIAL
000,100,200,642,8805,GLEASON,HIGH,HOWEVER,LABEL,METHODS,OBJECTIVE,PCA,PCASS,PSA,PURPOSE,REGARDLESS,RESULTS,THERE
169,2014,BECAUSE,HORSE,PSA,THEREFORE,THUS
1008,1232,169,2014,252,390,AVERAGE,BACKGROUND,COMPARISON,CONCLUSION,COPYRIGHT,DATA,DISCUSSION,GRID,INC,LABEL,MATERIALS,MEDICAL,METHODS,MODEL,OBJECTIVES,ODM,OVERALL,RESULTS,SEVERAL,SYSTEMATIC,THERE,THESE,UROLOGY
169,2014,AML,AMLS,BOTH,COPYRIGHT,DESPITE,DNR,EME,LIPOSOMES,MOLECULES,MTX,NANO,PEGYLATED,USING
169,2014,COPYRIGHT,DESPITE,PACP,PCA,PI3K,PIP,PTEN,PTP,TSG,TSGS
160,169,2014,350,ACTB,APC,CONFIRMING,COPYRIGHT,DUE,EDUCATION,GSTP1,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
125,BACKGROUND,CEA,CEACAM1,COLORECTAL,CYFRA,HOWEVER,LABEL,LUNG,METHODS,MOST,NSE,OPG,OPN,OVARIAN,PLCO,PRL,RESULTS,SCREENING,SEVERAL,SIXTY,TRIAL
835,925,AUC,BPH,CCL,CSF,FAS,HOWEVER,IGFBP,PCA,ROC,SERUM,TNFRSF6
169,2014,AGR3,COPYRIGHT,DESPITE,HCC,ICC,INC,ROC,SINCE,THUS
169,2014,231,945,946,CHIP,CHROMATIN,COPYRIGHT,EXPRESSION,HIC,HIC1,MCF,MDA,PC3,PRM1,PRM3,THROUGH,TXA,TXA2,URRS,WILMS,WT1
037,154,160,166,169,2014,272,307,352,ACCRA,AFRICAN,COPYRIGHT,EDUCATION,FURTHER,GHANA,INC,LABEL,MATERIALS,MEN,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL,WEST
002,160,169,2014,258,902,AFTER,BODY,COPYRIGHT,EDUCATION,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PREVENTION,PUBLISHED,PURPOSE,RESULTS,TRIAL,UROLOGICAL,VITAMIN
102,169,2014,956,COPYRIGHT,IMR,INC,LTR,LTRS,STUDIES
169,201,2014,231,COPYRIGHT,PUBLISHED,SAS,THERE
169,2014,285,5000,AFRICAN,AIMS,COLLEGE,COPYRIGHT,EIGHT,FIFTEEN,LABEL,LOCALLY,LTD,LUNG,MATERIALS,METHODS,MOST,OBJECTIVE,PUBLISHED,RESULTS,ROYAL
169,2014,450,750,CONCLUSION,COPYRIGHT,DATA,ELSSS,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS
001,002,1336,169,2003,2009,2014,237,742,979,AMICO,AMONG,BCR,CONCLUSION,COPYRIGHT,EXCLUSION,GLEASON,INC,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,ORP,PATHOLOGIC,RALP,RESULTS,THERE
169,2014,606,AVERAGE,BACKGROUND,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,SNPS,SPANISH,STAT,TOTAL,USING
001,100,10ML,12MM,169,177,200,2009,2013,2014,2MM,4MM,5ML,8482,APRIL,BACKGROUND,BETWEEN,BMI,COPYRIGHT,GEL,HALF,HDR,IRELAND,JULY,LABEL,LTD,MANSFIELD,MATERIALS,METHODS,OBJECTIVE,PEG,PURPOSE,RESULTS,SEALANT,THERE,TRUS
169,2014,231,233,COPYRIGHT,PUBLISHED,SAS,SFRO,SOCI,V70
115,169,1999,2009,2014,539,8805,BCR,CONCLUSION,COPYRIGHT,COX,DIAGNOSIS,EVER,GLEASON,INC,LABEL,MEN,METHODS,OBJECTIVE,PROJECT,RESULTS,RRP,UNIVERSITY
169,2014,BECAUSE,COPYRIGHT,HIGH,HOWEVER,IAC,PSA,RSD
169,2000,2009,2014,4201,BACKGROUND,COPYRIGHT,DISCHARGE,DISCUSSION,HOWEVER,LABEL,LTD,METHODS,RESULTS
169,2014,3E6,AIM,BPH,CD34,COPYRIGHT,GLEASON,LABEL,METHODS,MONOCLONAL,OBJECTIVE,PR8,PSA,PSMA,PUBLISHED,RESULTS,SAS,SERUM
8201,ACUTE,AFTER,AIM,AVERAGE,EORTC,HELICAL,LABEL,METHODS,MOST,OBJECTIVE,PSA,RESULTS,RTOG
8201,8226,8322,GLEASON,INTER,KEY,LABEL,METHODS,MRI,OBJECTIVE,OBJECTIVES,PRE,RESULTS,TARGETING,THERE,TRUS,TTP
001,008,023,026,168,2003,2011,239,8805,ACTUARIAL,BETWEEN,CSS,EFFECTIVE,JANUARY,LABEL,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS,SRT
208,AE3,EP4,LNCAP,ONO,PC3,THEIR
104,946,DACH1,DACHSHUND,ED2,KYSE150,KYSE510,LOSS,NETWORK,PCR,RETINAL,RNAS,TGF
135,169,2014,253,496,BCL,FISH,HNSCC,OVERALL,PRESS,PUBLISHED,SCC,SINCE,SOX2,TARGETING,UNIVERSITY
123,181,ACCORDING,HOWEVER,NRS,THEREFORE,THESE
181,AGA,DISSECTING,LBD,LNCAP,MINOXIDIL,THESE
ANNEXIN,JNK,MAPKS,PARP1,THUS,TREATMENT
002,169,1997,2012,2014,392,COPYRIGHT,COX,EDUCATION,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PREDICTORS,PUBLISHED,PURPOSE,RESULTS,TRANSITION,UROLOGICAL
945,954,BACKGROUND,CHIP,E2F1,HELA,HOWEVER,ICAM,LABEL,METHODS,RESULTS
001,133,797,8805,ARC,ARMSTRONG,BACKGROUND,CASTRATION,CRPC,CTR,DTX,LABEL,MEDICAL,METHODS,MOST,NETWORK,PSA,RESULTS,SEVENTY,TRIAL,UMIN,UNIVERSITY
ADT,AFTER,CSCS,DIFFERENT,EMT,HOWEVER,MDR,TAXANES,UTR
2000,2004,393,BACKGROUND,CHANGES,END,HEAD,INSTITUTE,LABEL,METHODS,RESULTS,SIR,THERE,WEST
AFTER
001,291,945,BACKGROUND,BPH,COX,GLEASON,GNAS1,HOWEVER,LABEL,METHODS,PCA,PCAS,PSA,RESULTS,T393C
1430,169,2014,220,BIOLOGY,INC,MOLECULAR,PCA,SOCIETY,SWATH
0002,0024,0047,0459,0919,1000,120,2092,360,8202,8805,CGA,CRPC,DECLINE,PFS,PSA,UNV
169,2014,BACKGROUND,CRPC,HOWEVER,INC,LABEL,LNCAP,METHODS,PCR,PREVIOUSLY,RESULTS,RSK,RSK1,TAKEN,WESTERN,WILEY
001,004,005,169,2014,320,526,8201,AFTER,ASIAN,BCR,CAUCASIAN,CDON,COX,MEIER,RESULTS,SNPS,UICC
169,2014,AKT,DU145,FABP4,FATTY,PARP,PI3K,SEVERAL,THESE,THUS,UICC
001,003,160,CIS,COX,DWI,GLEASON,HARRELL,HIPPA,IRB,LABEL,METHODS,MRI,MRSI,OBJECTIVE,PURPOSE,RESULTS,SIXTY,THERE,THESE
169,2014,DDR2,DDRS,DESPITE,DISCOIDIN,H1299,JM2,RTKS,TAKEN,THUS,UICC
169,2014,945,ACTIVATION,BCS,CYP17,ESR1,MOST,SOCIETY
0020,0377,DU145,GLEASON,HOWEVER,MTT,SPAG9,SPERM,THERE
120,169,2014,CRPC,DESPITE,FDA,LABEL,LIBRARY,METHODS,OBJECTIVE,PRESTWICK,PSA,PURPOSE,RESULTS
093,169,2014,215,312,398,412,502,BACKGROUND,BONFERRONI,COLORECTAL,DIETARY,GIVEN,ICCS,INTRACLASS,LABEL,LARGE,LUNG,METHODS,NUTRITION,OBJECTIVE,OBJECTIVES,OTHER,OVARIAN,PEARSON,PLCO,RESULTS,SCREENING,SOCIETY,TRIAL,USUAL
11P15,215,8Q24,NOVEL,TAKEN,THERE
160,169,2014,BACKGROUND,COPYRIGHT,EASTERN,FIVE,GROUP,LABEL,LTD,MEN,METHODS,NINE,PSA,RESULTS,THESE
AKT,ANTITUMOR,BACKGROUND,BALB,BAX,BCL,CONVERSELY,ERK,JNK,K562,LABEL,MCL,METHODS,MSCS,NH2,PARP,PI3K,RESULTS,THESE,THUS,TUNEL,WESTERN,WHARTON
169,2014,945,ANIMALS,CD49F,ITGA6,J8H,LAMININ,MEIER,SCID,THESE
00001,0001,100,8201,CONTINENCE,COX,EACH,LABEL,MEN,METHODS,MULP,OBJECTIVE,PCA,PRAS,PSA,PURPOSE,RALP,RESULTS,USING
2001,2005,2006,2010,8202,BACKGROUND,CONCLUSION,CZECH,LABEL,METHODS,RESULTS,USING
945,946,BOTH,DEPLETION,DHT,LNCAP,PI3K,SER,SGK3,THR
237,460,ADAM,BRAZILIAN,CONCLUSION,HOWEVER,LABEL,METHODS,MMAS,OBJECTIVE,PORTO,RESULTS
169,2014,ALTOGETHER,AUTHORS,HOWEVER,JOURNAL,OCT4A,PATHOLOGY,SOX2,THESE,UTF1

129,1996,2012,343,ACCORDING,APRIL,BASED,BETWEEN,C49,CONCLUSION,DRE,LABEL,METHODS,OBJECTIVE,PCA,PSA,PSAD,RESULTS,THERE,TRUS
114,144,CONCLUSION,LABEL,MAB,METHODS,OBJECTIVE,PCA,PSA,RESULTS,UNIVARIATE
BAX,BCL,CASPASE,CONCLUSION,GFP,HOWEVER,INHIBITION,LABEL,METHODS,OBJECTIVE,PCR,RESULTS,STIM,STIM1,WESTERN
ANNEXIN,BORTEZOMIB,CCK,CONCLUSION,DU145,LABEL,LNCAP,METHODS,OBJECTIVE,PCA,RESULTS
33258,CONCLUSION,HOECHST,IC50,LABEL,LNCAP,METHODS,MTT,OBJECTIVE,PCA3,PCR,RESULTS
008,009,024,026,052,056,065,072,076,081,087,146,163,215,256,293A,498,502,589,CONCLUSION,LABEL,LACZ,METHODS,MTT,OBJECTIVE,PCR,PTEN,PTIEN,RESULTS,TR2A,WESTERN
150,2000,DOPE,LF2K,PC3,SLN,SLNS,SOLID,THERE,THESE
DESPITE,HOWEVER,STUDIES
ABOVE,ACCORDING,BACKGROUND,BCR,CONCLUSION,ECE,LABEL,MEIER,METHODS,PATIENT,RESULTS
063,121,169,2000,2004,2006,2007,2008,2014,8805,AMONG,CONCLUSION,COPYRIGHT,COX,ESA,ESAS,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEER,SIMILARLY,SINCE,SOCIETY
CRPC,E2F,E2F1,HES6,MYC,PLK1
169,198,2014,224,281,293,452,8764,AACR,AUC,AVAILABLE,CONCLUSION,COX,DIAGNOSTIC,DU145,FINALLY,FUNCTIONAL,GABRE,GSEA,LABEL,MEIER,METHODS,METHYLIGHT,OBJECTIVE,PC3,PURPOSE,RESULTS,ROC
104,105,130,164,169,186,2014,215,361,474,514,8201,946,BACKGROUND,CHALLENGE,COPYRIGHT,JOHN,LABEL,LTD,MEMBERS,METHODS,PTG,RESILIENCE,RESULTS,SONS,WILEY
169,1998,2002,2003,2004,2009,2010,2014,547,719,789,941,AFTER,BACKGROUND,BASE,DATA,EXCLUDING,LABEL,METHODS,NCDB,NETWORK,RESULTS,SOCIETY
145,786,8209,A498,FOLLOWING,MMP,MTT,RCC,THESE
169,2014,AKT,BACKGROUND,CELL,DU145,INC,KLF,KLF9,KLFS,KRUPPEL,LABEL,LNCAP,METHODS,PC3,PCA,PCR,RESULTS,TET,THESE,WESTERN,WILEY
169,2000,2013,2014,BACKGROUND,BASED,DISCUSSION,HES6,HEY1,HOWEVER,INC,INCREASED,JAGGED2,LABEL,METHODS,NOTCH,RESULTS,WILEY
169,2014,ANTIBODIES,BIOLOGY,CDRH3,CDRL1,INC,MOLECULAR,SOCIETY,THESE
169,2014,ETS,ETV1,EWING,MEMBERS,THESE
160,64257,APOPTOSIS,CELL,HSC70,HSP70,HSP72,HSP90,KIT,PARP,PCR,RWPE,THESE,UTMD,VCAP
160,8209,BUPLEURUM,DU145,FLOW,FURTHER,HOWEVER,SSD,THEREFORE,TREATMENT
APART,BACKGROUND,HDRT,HFRT,LABEL,LADT,LDRT,METHODS,PSA,RESULTS,SADT
100,1000,270,518,8201,BACKGROUND,CHOU,CLINICALLY,CRPC,GEMOX,LABEL,METHODS,NCT,PSA,RESULTS,TALALAY,THERE
169,176,2014,ALBUMIN,APOA,BIOLOGY,GIVEN,INC,METHIONINE,MOLECULAR,SAMPLES,SOCIETY
CELLSEARCH,CTCS,FDA,HER2,OTHER,THEIR
10YEARS,147,169,17YEARS,1997,2006,2009,2010,2014,50NG,ADT,AIM,BASE,CASTRATION,CONCLUSION,COPYRIGHT,DATA,ESTIMATED,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PSA,RESULTS,TOTALLY
169,2014,COPYRIGHT,CTEN,HOWEVER,LTD,PTB,SH2,TNS4
RARP
AKT,HOWEVER,PI3K,PTEN
169,2014,8201,AFRICAN,CHINESE,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,UROLOGICAL
THERE,TREATMENT
120,COLLOIDAL,DU145,EPR,MDR,THESE
300,CELL,DLS,FINALLY,NPS,OVERALL,PLGA,POLY,SEM,SILYMARIN,SNPS,TGA,VERO,XRD
100,181,462,700,780,ARNEBIA,CALF,DPPH,GAE,LPO,TPC
008,015,100,3GALNAC,945,946,EARLY,III,QUADRAMET,STUDIES,THESE
001,2008,2009,439,476,8804,915,CONCLUSION,FINALLY,GIVEN,HOWEVER,LABEL,METHODS,OBJECTIVE,OCTOBER,ORP,OVERALL,PURPOSE,RARP,RESULTS,SEER
8805,IVIM,LABEL,METHODS,MRI,OBJECTIVE,PCA,RESULTS
GLEASON,MRI
001,039,046,2014,205,216,223,275,64257,8804,AUC,BASEL,GLEASON,INDEX,LABEL,METHODS,OBJECTIVE,PCA,PHI,PHID,PSA,PSAD,RESULTS,UNIVARIATE
008,010,016,037,092,1494,165,169,181,2014,203,250,436,504,731,823,AACR,AFRICAN,AMONG,BACKGROUND,BIOMARKERS,BOTH,COX,DATA,EPIDEMIOL,GLEASON,HRS,LABEL,METHODS,PREV,PREVENTION,RESULTS,THERE,TRIAL,VITAMIN
HETE,HPCA,HPETE,LOX2,MYC,NHP,PC3,PCA,PIN,RWPE,TRANSGENIC
CNAS,EOC,MOST,PATHWAY
001,003,015,022,2005,2011,2943,4950,7893,8201,ACS,BACKGROUND,COLLEGE,COMPARISON,DESPITE,LABEL,LARGE,METHODS,NSQIP,OPERATIVE,PGY,PROGRAM,PVP,QUALITY,REGRESSION,RESULTS,RISK,THERE,TURP,USING
100,160,174,177,200,DOSIMETRY,LABORATORY,OARTRAC,PSD,SOLID,TEXAS,THESE,UNIVERSITY,WATER
150,160,177,215,8764,CARLO,MEV,MONTE,PGS,SINCE,USING
0001,2014,215,754,BASEL,IMAGING,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,T1WI,T2WI

CELLSEARCH,CTCS,INC,K562,PUBLISHED,SEVENTY,TOLL,TREATMENT,USING
169,2014,COPYRIGHT,PUBLISHED,THESE,UROLOGY
169,1999,2007,2014,325,3386,COMMITTEE,COPYRIGHT,COX,GLEASON,III,INC,JOINT,LABEL,METHODS,NUTRITION,OBJECTIVE,OBS,OXIDATIVE,PREVENTION,PURPOSE,RESULTS
001,004,008,046,117,140,160,213,245,8201,8805,BMI,CONCLUSION,DATA,DOSE,FAT,I125,LABEL,MATERIALS,METHODS,NONE,OBJECTIVE,PURPOSE,R100,R150,RESULTS
169,2014,COPYRIGHT,GCPII,LTD,THESE,UREA
CCR5,CHEMOKINE,LTD,PREVIOUSLY,PUBLISHED
016,018,122,126,160,169,2000,2011,2014,800,AMS,AUS,AUTHORS,BETWEEN,BJU,CONCLUSION,EARLY,EROSION,FINALLY,HOWEVER,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS
1022,105,2000,2009,2010,BACKGROUND,CHINA,CHINESE,COX,EARLY,INDEX,JIADING,KARNOFSKY,LABEL,METHODS,PUTUO,RECORDS,RESULTS,SCALE,STAGING
1103,169,174,185,2005,2010,2014,210,348,3D14PBX,463,503,8201,8805,AGE,AUTHORS,BETWEEN,BJU,DRE,GLEASON,LABEL,METHODS,OBJECTIVE,PSA,RECURSIVE,RESULTS
001,1132,169,183,1992,2012,2014,608,8201,8804,8805,AMICO,AUTHORS,BCR,BJU,GLEASON,LABEL,MEN,METHODS,OBJECTIVE,PCA,PIH,PII,PSA,PSAD,RESULTS,T2A,THESE
001,130,918,AFTER,BACKGROUND,BLOOD,BMI,CONTEXT,DECREASED,EPO,ESTRADIOL,FRACTURES,HOWEVER,LABEL,MAIN,MEN,METHODS,MROS,OBJECTIVE,OUTCOME,RESULTS,SETTING
100,10Z,11Z,160,200,946,A549,CCL4,RED,SEA,TME,U373
145,954,CRGDK,GSH,NPS,NRP
APLASIA,FGF,FGF10,FGFR2,THESE
CURRENT,FOUR,LABEL,MEAN,MEDLINE,METHODS,OBJECTIVE,RESULTS,THERAPY
0146,0507,ABOVE,CGA,CONCLUSION,CRPC,CSS,DATA,FORTY,HOWEVER,LABEL,METHODS,NED,OBJECTIVE,PSA,RESULTS,SERUM
126,12669,12676,2004,2008,2009,442,4428,4433,453,500,ANKER,BESIDES,CHEM,LABEL,LETT,LSPR,MATER,NANO,NAT,SOC,SPR
NPS,THERE
200,ALBUMIN,CNFS,CNTS,INHIBITION
109,169,2012,2014,490,789,8764,APRIL,INTENSITY,JAPAN,LABEL,METHODS,OBJECTIVE,PRESS,PUBLISHED,RESULTS,UNIVERSITY
126,169,177,2014,BBN,COPYRIGHT,DYNAMIC,FDG,GRPR,IC50,JOHN,LTD,NOTA,PARTITION,PET,SONS,WILEY
169,2014,ATLAS,COAD,FURTHER,HELA,INC,OVERALL,PRAD,SKCM,TCGA,THROUGH,WILEY
169,2014,ACTIVATED,BACKGROUND,ERK,HOWEVER,INC,LABEL,METHODS,NATURAL,RAF,RESULTS,RSK,TAKEN,TAXANES,TAXUS,WESTERN,WILEY
116,956,A549,ANNEXIN,ASPC,CAM,CELL,H2DCFDA,HCT,IC50,MTT,R24,ROS
112,119,124,161,1980,2012,300,372,381,675,8804,BACKGROUND,CONCLUSION,GLEASON,LABEL,METHODS,OPEN,PATIENT,RESULTS,THERE,TOM,TRIAL
169,2014,946,BACKGROUND,BOTH,CAS,CRK,EMT,GLEASON,IHC,INC,KNOCKDOWN,LABEL,LNCAP,METHODS,NEDD9,PCA,PSA,RESULTS,TGF,VCAP,WHILE,WILEY
160,BACKGROUND,BOTH,CONCLUSION,GIVEN,HOWEVER,INTERVIEW,LABEL,MEN,METHODS,NINE,NVIVO,OBJECTIVE,PARTNER,PURPOSE,RESULTS,SIX,TEN
0002,126,160,347,9371A,ASN3124ILE,BRCA1,BRCA2,GERMANY,HGVS,SOUTH,VUS,WEST
945,946,948,ADP,APC,CATENIN,ECTOPIC,HIF,LEF,MUTATIONS,MYC,THEREFORE,WNT
2013,230,AMONG,HOWEVER,INCRNAS,RNAS,THROUGH,THUS,YANG
169,2008,2011,2014,228,402,AFTER,COPYRIGHT,INSURANCE,KBV,LTD,MORAN,PAP,PHYSICIANS,SPATIAL,STATUTORY
160,169,2014,956,COPYRIGHT,GI50,OVERALL,SAS,THESE
169,2014,COPYRIGHT,EAF2,ELL,FINALLY,FURTHER,GFP,INC,LIN,LNCAP,RAS,RBBP,RBBP4,RNAI,WHILE
169,2014,COPYRIGHT,ERG,ETS,FDA,HOWEVER,INDEX,OTHER,PCA,PCA3,PSA,PUBLISHED,THERE,TMPRSS2
100,BASED,EBRT,EPCAM,GRPR,PSMA,THEREFORE,VEGF
169,2014,BECAUSE,THEREFORE,THESE
169,2014,CHO,COPYRIGHT,ECD_FGFR1A,ECD_FGFR1B,ECD_FGFR2A,ECD_FGFR2B,ECD_FGFR3A,ECD_FGFR3B,ECD_FGFR4A,ECD_FGFR4B,FGFR,FGFRS,FIBROBLAST,INC,WESTERN
160,169,2005,2009,2014,735,844,ADVERSE,COPYRIGHT,EDUCATION,ELLISON,EPIC,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PCI,PREDICTORS,PUBLISHED,PURPOSE,RESULTS,UCLA,UROLOGICAL
169,2014,CCNA2,COPYRIGHT,DU145,HIPPO,INC,LNCAP,THESE,YAP1
169,1776,1999,2000,2007,2009,2014,609DAYS,7062,COPYRIGHT,END,HRS,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PCA,PSMS,RESULTS,SCC,SRE,SRES,USING
169,1995,1999,2000,2001,2004,2005,2007,2008,2009,2014,21ST,64328,BACKGROUND,COPYRIGHT,DCI,ECR,ESTONIA,HODGKIN,LABEL,LTD,METHODS,RESULTS,RSR,RSRS
1506,169,2011,2012,2014,APRIL,ASSESSMENT,COMPLIANCE,CONCLUSION,COPYRIGHT,GENERAL,INC,JANUARY,LABEL,METHODS,MODEL,OBJECTIVE,OCTOBER,PHYSICIANS,RESULTS,RISK,SCORE,SELF
169,2014,260,358,946,COPYRIGHT,COX,GLEASON,LABEL,LOW,LTD,METHODS,OBJECTIVE,PDGFR,PURPOSE,RESULTS
1110,169,2014,215,8804,956,ARCHITECT,COPYRIGHT,CVI,FOLLOWING,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OPTIONS,PASSING,PSA,PUBLISHED,RESULTS,ROCHE,SOCIETY,THESE,WORLD
169,2014,8804,8805,CLAVIEN,CONCLUSION,COPYRIGHT,FIFTY,GLEASON,INC,LABEL,MEAN,METHODS,OBJECTIVE,PATHOLOGIC,RESULTS,THERE
169,2014,956,A877,AFTER,COPYRIGHT,IC50,LNCAP,LTD,Q738,T877A,USING
160,169,2014,COPYRIGHT,CYBERKNIFE,GROUP,LABEL,LTD,METHODS,MONITOR,MUS,OBJECTIVE,PTV,PUBLISHED,PURPOSE,RESULTS,SBRT
124,145,149,169,2004,2012,2014,237,8804,AFTER,CONCLUSION,COPYRIGHT,DATA,GIVEN,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PBX,PSA,RESULTS
00002,0003,0005,001,118,169,2014,ADT,AGE,BMI,CONCLUSION,COPYRIGHT,DESPITE,INC,INCREASING,LABEL,MEN,METHODS,OBJECTIVE,OUTCOME,RESULTS,THREE
119,169,2014,ANXIETY,C30,CLOSE,COPYRIGHT,DEPRESSION,DISCUSSION,EMOTIONAL,INC,LABEL,LIFE,LOWER,METHODS,OBJECTIVE,PHYSICIAN,QUALITY,RESULTS,REVISED,SCALE,THESE,TREATMENT,TRUST,WAKE
115,1317,169,2005,2013,2014,8201,8804,AUTHORS,BJU,CONCLUSION,GLEASON,HOWEVER,KETTERING,LABEL,METHODS,OBJECTIVE,RESULTS,SEVERAL,SLOAN,WHILE
169,2006,2011,2014,755,8805,BASE,COPYRIGHT,DATA,EBRT,INC,LABEL,MATERIALS,METHODS,NCCN,NETWORK,OBJECTIVE,OVERALL,PURPOSE,RESULTS,USING
169,2014,COPYRIGHT,GLEASON,INC,LOGICAL,SEVERAL
169,2014,COPYRIGHT,INC,PCA3,PSA,REPEATING,VARIOUS
169,2014,COPYRIGHT,INC,MRI
169,2014,COPYRIGHT,HEMATURIA,INC
169,2014,COPYRIGHT,INC,THERE
169,2014,COPYRIGHT,INC,THERE
INC,PUBLISHED
FORCE,INC,PREVENTIVE,PSA,PUBLISHED,TASK,WHEREAS
169,1970,2008,2014,2050,BECAUSE,COPYRIGHT,INC
169,2014,COPYRIGHT,ENTHUSIASM,INC
169,2014,COPYRIGHT,FORCE,INC,PREVENTIVE,PSA,TASK
006,015,10878,125,169,2014,BACKGROUND,COLLECTION,CONCLUSION,COPYRIGHT,DEPENDING,LABEL,LTD,MEIER,METHODS,OVERALL,PFS,PSA,PUBLISHED,RESULTS,THESE
24H,AFTER,CLSM,COLO205,CONJUGATE,FACS,FITC,LN18,LNCAP,PC3,U373
1AND,945,CK2,CONSISTENT,COP9,CSN4,CSN5,HOWEVER
177,2012,2013,BACKGROUND,BETWEEN,COLOR,CONCLUSION,DOPPLER,DRUG,EARLY,FOOD,INSTITUTES,LABEL,METHODS,RESULTS,SEPTEMBER,THYROID,TKI
169,2014,487,8201,COMPOSITE,INDEX,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,URINARY,UROLOGICAL
150,250,500,800,A431,COPOLYMER,DRUG,DTA,EPIDERMOID,F68,FTIR,GLYCOLIDE,HELA,L929,LACTIDE,NMR,PC3,PENTABLOCK,PEO,PLGA,POLY,PPO,PPPC,SOLVENT,VESICULAR
000,0001,0042,169,181,2014,8201,8805,ADJUSTING,AFRICAN,AMERICANS,AUTHORS,BACKGROUND,BLACK,CONCLUSION,GLEASON,HOWEVER,INC,LABEL,METHODS,PCA,PSA,RESULTS,SAPCS,SOUTH,USING,WHITE,WILEY
169,2014,902,AIM,COX,INSURANCE,LABEL,METHODS,NHI,OBJECTIVE,PHYSICIANS,PRESS,PUBLISHED,RESULTS,UNIVERSITY
177,1999,2013,504,CHINESE,JANUARY,LABEL,MARCH,METHODS,MOST,OBJECTIVE,OBJECTIVES,RCP,RESULTS,SPARING,THERE,WHOLE
AIM,BAX,CRPC,DU145,GNRH,MAPK,PC3,THESE
ATG12,ATG5,AUTOPHAGY,BCL,LC3,MAP1S,UNDER
143,2007,2011,415,848,AMICO,BACKGROUND,COMPARISON,DETECTION,ENGLISH,GLEASON,JULY,LABEL,METHODS,NONE,OCTOBER,PSA,RESULTS,TOOLS
1002,10878,2010,8201,ADVERSE,BACKGROUND,BEGINNING,CIRT,FORTY,GYE,LABEL,MAY,METHODS,PHOENIX,RESULTS,T1B,T3BN0M0
0024,0025,0162,101,8201,BACKGROUND,BIOMARKERS,CI95,CONCLUSION,HIGH,III,INCLUSION,LABEL,LOW,METHODS,PSA,RESULTS,SHT,TLS

8805,ERG,G84E,GLEASON,HISTOLOGIC,MOLECULAR,PSA,THESE
1980,2013,BCG,CIS,CLOSE,COMPARING,INCIDENCE,JANUARY,MEDLINE,OPEN,PAPILLARY,PSA,RCC,REPORTS,RISK,TCC,UPPER,UUT
2002,FINALLY,HOWEVER,PARTICULAR,RARP,ROBOTIC
169,2014,231,AKT,CELL,COPYRIGHT,COUMARINS,EC50,HOWEVER,LNCAP,LTD,MCF,MDA,MTT,NMR,PARP,REDUCED,THESE,U937
169,2014,956,A549,AMONG,COPYRIGHT,FLOW,FURTHER,HOECHST,IC50,LTD,OVERALL
954,AKT,CAM,CCN3,FAK,FINALLY,HOWEVER,NOV,PCA,PCACM,TAMS,VEGF
169,177,2014,COPYRIGHT,DICE,DSC,EFFICIENT,GPUS,T2W
100,1268,169,199,2000,2009,2014,228,317,333,8804,8805,AFTER,AMICO,DATA,FIVE,GLEASON,LABEL,METHODS,OBJECTIVE,PRESS,PUBLISHED,RESULTS,UNIVERSITY
001,002,003,134,169,2014,356,666,AOR,BACKGROUND,COMBOGS,CONCLUSION,COPYRIGHT,DIFFERING,GSS,INC,LABEL,METHODS,PCSM,RESULTS,THEREFORE,WHETHER
160,2011,420,8364,883,BACKGROUND,CARLO,CONCLUSION,GROUP,HOWEVER,LABEL,METHODS,MONTE,QALYS,RESULTS,THERE,TREEAGE,UTILITY
14035,169,1991,2009,2014,270,351,38581,762,9654,9919,AIMS,AUSTRALIA,CENTRES,COLLEGE,COPYRIGHT,FRIESLAND,LABEL,LEEUWARDEN,LIVERPOOL,LTD,MACARTHUR,MATERIALS,METHODS,OBJECTIVE,OVERALL,PUBLISHED,QUEENSLAND,RBWH,RESULTS,RIF,ROYAL,SOUTH,THERAPY,WALES,WOMEN
169,2014,COPYRIGHT,INC,LNCAP,MLV,XENOTROPIC,XMRV
145,177,181,185,8310,8312,8323,945,946,FDG,FEC,NOTA,PCA,PET,RGD,RGDFV,THEREFORE,THESE
946,AKT,CAP,CRPC,CSC,CSCS,NOTCH,PI3K,THERE,THEREFORE,WNT
001,002,177,ADT,AFTER,CONCLUSION,GROUP,LABEL,MATERIALS,METHODS,OBJECTIVE,PCA,PURPOSE,RESULTS,SERUM,THEREAFTER
169,2013,2014,20TH,FOUNDATION,INC,OCTOBER,PCA,PCF,RETREAT,RNAS,SCIENTIFIC,WILEY
HIGH,HMGB1
111IN,124I,125I,160,177,CORRECT,HIGH,LNCAP,MAXIMUM,PC3,PET,PSMA
8202,AOA,ASP,DAU,GLP,GLY,GNRH,III,LYS,NH2,PRO,TRP
104,169,2014,215,407,ABHD9,ADHB9,AVERAGE,BACKGROUND,CPG,CPGS,END,HOXD3,LABEL,METHODS,RECURRENCE,RESULTS,SEER,THESE
169,1994,2001,2010,2014,283,544,8805,COLORECTAL,IGE,IMMUNOCAP,LUNG,ODDS,ORS,OTHER,OVARIAN,OVERALL,PLCO,SCREENING,THERE,TRIAL,USING
BASED,GLEASON,IMAGING,MRI,SUBSEQUENT
169,2014,239,ADT,ANDROGENS,COPYRIGHT,CRPC,CYP17A1,DHEA,ESSENTIAL,HOWEVER,ISSUE,LTD,PCA,PSA,SPECIAL,TAD,THEN,TOTAL
276,295,956,BACKGROUND,BRITISH,CASE,CONCLUSION,LABEL,METHODS,WHITE
ANOVA,BACKGROUND,DDW,LABEL,MATERIALS,METHODS,MTT,PACLITAXEL,RESULTS,TREATMENT
102,105,109,112,128,156,177,27TH,ABOUT,AIM,BACKGROUND,COLON,LABEL,MATERIALS,METHODS,NEPHROLOGY,OBJECTIVE,PSA,RESULTS,THERE,TODAY
AMONG,BACKGROUND,BOTH,CIS,HEALTHY,IRAN,IRANIAN,LABEL,MATERIALS,METHODS,ORS,PRIOR,RESULTS,WESTERN
DIFFERENT,THERE,VARIOUS
001,004,009,180,8201,BACKGROUND,CONCLUSION,COX,GLEASON,HIGH,LABEL,MEIER,METHODS,RABEX,REAL,RESULTS,WHILE
DESPITE,SCARAMANGA
125B,130B,155,169,2013,ASCS,GTPASES,MSCS,PRESS,RAB1A,RAB1B,RAS
002,040,123,160,303,397,623,8805,DATA,FPCA,GAD,HOWEVER,HPCA,PCA,PERCEIVED,PHQ,QSC,R10,SIMILARLY,SPCA
169,2014,946,AIM,BACKGROUND,CLONOGENIC,CRM1,DSB,DSBS,GSK,HOWEVER,INC,KU70,LABEL,METHODS,P529,PKCS,RAD51,RESULTS,SIX,TORC1,TORC2,TTP,UPON,WILEY
10001,333,BONE,MEDICAL,PUBLISHERS,SEVENTH,SEVERAL,SPECT,USA,YORK
10001,333,BONE,MEDICAL,OSSEOUS,PATIENT,PET,PUBLISHERS,SEVENTH,USA,YORK
231,CRYSTAL,HEPG,IC50,LNCAP,MDA,NMR,THREE
167,1731,174,203,283,773,BRAZILIAN,CROSS,LABEL,METHODS,OBJECTIVE,RESULTS,SCROTAL,SETTING,TINEA
1980,2010,DATA,MORTALITY,NORTHEAST,PRAIS,WINSTEN
EZH2,PC3,PCA,PEI,SMALL,TAKEN,TARGETING
001,169,2014,5064,AACR,CLIN,EXPRESSION,LABEL,MEMBRANOUS,METHODS,NSCLC,OBJECTIVE,PURPOSE,RCC,RES,RESULTS,THESE
200,200B,20A,8764,ARRAY,BACKGROUND,COX,CRPC,DOCETAXEL,HOWEVER,LABEL,MANN,METHODS,NON,PSA,RESULTS,WHITNEY
0001,0008,001,003,007,BACKGROUND,BRFS,DESPITE,DOSE,DU145,GLEASON,HIGH,HYPOXIA,LABEL,LDH5,LDHA,METHODS,MIB1,PC3,PSA,RESULTS,SILENCING
153,2004,2010,223,AMONGST,HOWEVER,III,THESE
010,030,039,2002,2013,211,FUDAN,GSCC,LDH,MOST,PFS,PRIMARY,SCC,SERUM,UNIVERSITY
DEFECTS,HSPS,PCA
2013,APRIL,ASAP,AUCS,HGPIN,HOWEVER,MEDLINE,ORS,PCA,PCA3,PSA,SCIENCE,THEREFORE,USING,WEB
169,2014,8482,ANALYTICS,WEB,YOUTUBE
100,106,140,169,2014,BTG2,FDPS,GLEASON,MXI1,OVERALL,PI3K,SIRT1,SIXTEEN,VALIDATION
169,2014,BECAUSE,CD34,COPYRIGHT,DATA,INC,PATHOLOGY,PUBLISHED,SOCIETY
MRI,SUSPICIOUS
169,2013,2014,COPYRIGHT,FREE,INC
001,169,2014,349,354,363,8805,964,AFRICAN,AUTHORS,BJU,CAUCASIAN,LABEL,METHODS,OBJECTIVE,OVERALL,PCA,PSA,RESULTS,SNP,SNPS,THERE,THESE
169,2013,273,AUC,AUTHORS,BJU,CHUN,LABEL,MATERIALS,METHODS,NAKANISHI,OBJECTIVE,RESULTS,STEYERBERG
000,169,177,2014,8201,AIMS,BACKGROUND,BMI,CONCLUSION,FINALLY,HBA1C,HDL,LABEL,LATE,LDL,LOH,MAIN,MEN,METHODS,METS,OBJECTIVE,OUTCOME,PARAMETERS,RESTORING,RESULTS,SOCIETY
169,2006,2011,2013,337,8201,ACTUARIAL,ADT,AUTHORS,BETWEEN,BJU,BOTH,C30,CONCLUSION,DEPARTMENT,IGRT,IIEF,INDEX,IPSS,JANUARY,LABEL,LIFE,METHODS,MISSING,OBJECTIVE,PR25,QLQ,QUALITY,RESULTS,SCORE,SCP,SYMPTOM,TREATMENT
001,112,121,162,169,2014,241,499,8804,AUTHORS,BJU,CONCLUSION,FGB,FORTY,GLEASON,LABEL,LENGTHS,METHODS,MRI,OBJECTIVE,PCA,PSA,RESULTS,SIX,SIXTY,TRUS
169,2014,AIRE,FURTHER,HOWEVER,JOHN,LTD,PUBLISHED,SONS,TREGS,WILEY
103,1063,107,110,146,169,1994,2004,2014,373,519,599,762,AMONG,COPYRIGHT,MONITORING,RECIPIENTS,SCIENTIFIC,SOCIETY,SRTR,THERE,TRANSPLANT
100,22RV1,945,AKT,AMACR,BACKGROUND,BPH,COA,LABEL,LNCAP,MATERIALS,METHODS,METHYLACYL,PC3,PCA,RESULTS,TFIP
001,002,025,169,1996,2005,2014,204,338,8804,8805,ALASKAN,ANS,BACKGROUND,DISEASE,EFFORTS,END,FEWER,INDIANS,LABEL,METHODS,NATIONALLY,NATIVES,NONRECEIPT,RATES,RESULTS,SOCIETY,TREATMENT
CBCT,DBNRR,LCNRR,NRR
178,9993,DVH,DYNALOG,ECLIPSE,EPID,IMRT,MILLENNIUM,MLC
176,177,4DVH,4PT,ANATOMY,DELTA,DOSE,ECLIPSE,GAFCHROMIC,GAI,ISOCENTER,PTV,SCANDIDOS,TPS,VMAT
177,BOTH,COMPASS,D10,D20,D80,D90,D95,DVH,JTSA,MATRIXX,MLCS,OAR,VMAT
DICOM,DVH,MLC,TREATMENT,USING,VMAT
DAO,GFO,IMRT,MART,MLC,PLANUNC
176,177,313,438,546,8804,8805,933,CBCT,OVERALL,PTV,ROTATIONAL,VMAT
169,2014,945,CAF,HIF1,INDUCTION,NOS1,NRF2,SIGNALS
100,144,177,BLOOD,CONCLUSION,CTP,FURTHER,GLEASON,LABEL,METHODS,MTT,MVD,OBJECTIVE,OBJECTIVES,RESULTS
177,CCMFM,DICE,GPU,T2W,TRUS
215,284,ADC,CHANGES,DWI,MANN,MRF,MRI,RESPONDING,SEMI,WBDWI,WHITNEY
FAVORABLE,FOCAL,GLEASON,LABEL,LOW,OBJECTIVE,PURPOSE,RADICAL,RESULTS,SUMMARY
BIOMARKERS,ERG,INDEX,LABEL,OBJECTIVE,PCA3,PSA,PURPOSE,RESULTS,SUCCESSFUL,SUMMARY,TMPRSS2
ADDITIONAL,DIFFERENT,FOCAL,HIFU,HIGH,LABEL,OBJECTIVE,PURPOSE,RESULTS,SUMMARY
ARIS,DRUG,FOOD,HOWEVER,LABEL,OBJECTIVE,PCA,PURPOSE,RESULTS,SUMMARY,THESE,THREE
001,112,2003,2010,2012,240,417,482,704,768,786,811,AGE,AUC,CALCULATOR,ERSPC,JUNE,LABEL,MAY,METHODS,OBJECTIVE,OBJECTIVES,PCPT,PREVENTION,RANDOMIZED,RESULTS,RISK,SCREENING,SEOUL,SNUPC,TRIAL,UNIVERSITY,WESTERN
BIOMARKERS,MOLECULAR,POTENTIAL,SEMINAL,STRATEGIES,THESE
BACKGROUND,BRAIN,CONCLUSION,CXORF66,LABEL,MATERIALS,METHODS,ORF,ORFS,RESULTS,SGPX
160,169,2014,CNT,COPYRIGHT,FITC,LTD,PEI,PSCA
001,100,169,2014,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,MRI,NETWORK,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SOCIETY,THESE
145,169,2014,223,CD24,CD44,CD49F,COPYRIGHT,HES1,HES5,HEY2,INC,KNOCKDOWN,LFNG,LOSS,LUNATIC,NEOPLASIA,NKX3,NOTCH,PRESS,TAKEN
169,177,2014,AUR,COPYRIGHT,CORRECTION,DISTORTION,DWI,FORTY,GEOMETRIC,IMAGE,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,OBJECTIVES,PHANTOM,PUBLISHED,RATIONALE,RESULTS,STRATEGIES,THERE
000,ADVENTIST,AFRICAN,AHS,BACKGROUND,BLACK,LABEL,LESSONS,METHODS,PROMOTIONS,RESULTS
001,063,082,163,8804,AMONG,ART,ASTRO,AUA,BACKGROUND,BCR,COX,LABEL,METHODS,PSA,RADIATION,RESULTS,SOCIETY,SRT,THEREFORE,THESE,UROLOGICAL
160,BACKGROUND,CCND1,HMMR,HOXC6,IGF1,LABEL,METHODS,MKI67,PCA,PREDICTIVE,PROGNOSTIC,RESULTS,SIAH2,SMAD4
BACKGROUND,DISCUSSION,LABEL,METASTATIC,METHODS,RESULTS
HOWEVER,PCA,PSA,SEVERAL,THERE
169,177,192,198,2014,212,945,A375,AMP,BRAF,COPYRIGHT,JOHN,LTD,MCF,MEK,METABOLIC,MRS,PC3,SONS,U0126,WILEY
000,002,004,041,042,048,052,160,514,8201,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SURVIVORS,WHILE,WOMEN
145,EPCAM,LNCAP,PROTEIN,PSA,SHORT
100,2010,2012,AGE,AIMS,BACKGROUND,ECE,GLEASON,LABEL,METHODS,MRI,OBJECTIVE,PCA,RESULTS,SVI
8805,BACKGROUND,LABEL,MEAN,METHODS,PSA,RESULTS,THESE,TREATMENT
CONCLUSION,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PITUITARY,PURPOSE,RESULTS,WHILE
CALCITRIOL,VITAMIN
231,945,DEGENERATE,LXXLL,MCF,MDA,SRC,SRC1LXXLL,THEREFORE,THESE,TP10
222,8202,AUC,EXPRESSION,HOWEVER,LABEL,MATERIALS,METHODS,OBJECTIVE,PCR,PURPOSE,RESULTS,USING,VALIDATION
2013,CARCINOID,FOUNDATION,JULY,LARGE,MIXED,SMALL,USUAL
113,129,945,AMACR,COA,ERG,MOST,SIXTY
169,2014,CALCIUM,COPYRIGHT,DU145,HOWEVER,INC,LNCAP,LOSS,NUMB,PTEN,THESE,TRPV6
169,185,1990,2011,2014,2532,515,840,BLADDER,CONCLUSION,COPYRIGHT,CYSTOSCOPY,DETECTION,INC,LABEL,LOW,MATERIALS,METHODS,MOST,OBJECTIVE,RESULTS
110,169,2014,AUTHORS,COPYRIGHT,III,LTD,PUBLISHED,ULTIMATELY
0002,130,169,2005,2014,246,BACKGROUND,CIS,CONCLUSION,COPYRIGHT,COX,CROWN,GLEASON,HRS,IDC,ISUP,LABEL,LTD,MEIER,METHODS,PATHOLOGY,PUBLISHED,RESULTS,SOCIETY,UROLOGICAL
169,2014,302,5283,853,947,AUR,AUTOMATIC,BETWEEN,COPYRIGHT,FORTY,HOWEVER,INC,INTRA,LABEL,LUNG,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RATIONALE,RESULTS,TODAY
169,2001,2013,2014,698,AUR,COPYRIGHT,DIFFUSION,DOR,DWI,FURTHER,INC,JANUARY,LABEL,LIBRARY,MATERIALS,METHODS,MRI,MRSI,OBJECTIVE,OBJECTIVES,OCTOBER,PSA,PUBLISHED,RATIONALE,RESULTS,SUMMARY,T2WI
169,2010,2014,954,ACT,ADC,AUR,CENTRAL,COPYRIGHT,INC,INSURANCE,LABEL,MATERIALS,METHODS,MRI,NEXT,OBJECTIVE,OBJECTIVES,PUBLISHED,RATIONALE,RESULTS
100,169,183,2014,7784,953,AUR,COPYRIGHT,HOWEVER,INC,KVCT,LABEL,MATERIALS,MAXIMUM,METHODS,MVCT,OBJECTIVE,OBJECTIVES,PUBLISHED,RATIONALE,RESULTS,SIMAX,THEN,USING
169,2014,AMERICA,COLLEGE,COPYRIGHT,GWAS,INDIVIDUAL,LTD,NORTH,PUBLISHED,REQUITE,ROYAL,SIMILAR,THESE,ULTIMATELY
954,ADP,CDK,CDK4,CDK6,D52,E2F1,FINALLY,FURTHER,G2M,LNCAP,MOZ,MYST1,N1A,NOTABLY,PC3,PCA,SAS2,TAKEN,TIP60,TPD52,YBF2
947,CLEAR,NR2C2,TESTICULAR,TR4
CHALLENGES,PCA,PSA,SEVERAL
BECAUSE,PCA,SNP,SNPS,WHILE
111,168,169,177,2014,956,BALB,BOTH,CONCLUSION,D2B,DTPA,DUAL,IMAGING,INC,IRDYE800CW,ITC,LABEL,LNCAP,MBQ,METHODS,MOLECULAR,NIRF,NUCLEAR,PC3,PSMA,RESULTS,SOCIETY,SPECT,THESE,UNLABELLED
169,2014,99M,BINDING,COPYRIGHT,ELISA,FACS,JOHN,LNCAP,LTD,NANOBODIES,PC3,PSMA,PSMA6,SONS,SPECT,WILEY
169,191,2014,BACKGROUND,CONCLUSION,COPYRIGHT,DEPRESSION,DEPRESSIVE,DIFFERENT,GMDS,GOTLAND,HOWEVER,JOHN,LABEL,LTD,MAJOR,MDD,METHODS,PATIENT,PHQ9,RESULTS,SCALE,SONS,THEREFORE,WILEY
169,2014,AKT,EMT,EUPAFOLIN,INC,MAPK,OVERALL,PI3,PROTEIN,PTEN,PULL,RAS,WILEY
169,2014,BASED,GIVEN,GMBH,HENCE,III,KGAA,MRI,NOPO,PET,PSMA,RGD,THESE,THUS,TRAP,VCH,WILEY
169,2014,945,946,954,HSPG2,INC,SMAD3,STUDIES,TGF,THESE,TNF,TREATMENT,WILEY
169,2014,CFSE,CYTOMETRY,EDU,MONITORING,SOCIETY
HOWEVER,MOLECULAR,SELECTION,THERE
ESPECIALLY,HOWEVER,MRI,PET,PSMA,SINCE
2012,317,392,600,BETWEEN,DESPITE,IQ1,IQ2,IQ3,IQ4,IQ5,IQ6,KNOWLEDGE,LABEL,MATERIALS,MAY,METHODS,OBJECTIVE,PCA,PRIMARY,PSA,RESULTS,SIX,THUS,UNTIL,WHILE
169,183,GEORG,MRI,RADS,STUTTGART,YORK
946,ASF1A,ATR,CRL1,FINALLY,THEREFORE,TRCP
AML,CAR,CD33,ECAR,ECARS,EMAB,PCA,PRIOR,PSCA,TAG
038,068,177,780,844,FIRST,LPQ,SVM
8805,956,PINE,PINUS,PLANT,SCOTS,THESE,TRAIL,WESTERN
ARCAP,BAX,CAMALEXIN,CELL,EPITHELIAL,LNCAP,LYSOSOMES,MTS,PARP,PCA,ROS,SPECIES,THEREFORE
156,178,5000,945,ACUTE,BALB,EB719,INTESTINAL,LD50,NLD
CSC,CSCS
001,005,009,013,017,030,032,040,041,160,169,174,2014,669,898,CAUSE,COPYRIGHT,COX,EDUCATION,HORMONE,INC,LABEL,MATERIALS,MEIER,METHODS,NCCN,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,TREATMENTS,UROLOGICAL
HELLEBORUS
AMONG,ARES,COMPELLING,CONTROL,CONVERSELY,HUR,SEVERAL,TTP
000,GPI,HGF,MATRIPTASE,MCOTI,MDCK,MOMORDICA,THESE,USING
0001,001,005,007,015,148,160,177,8201,8804,CHANGES,DXA,HBBS,LABEL,MCNEMAR,MEN,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE
169,2005,2006,2014,490,BACKGROUND,CALIFORNIA,CARE,CONCLUSION,COPYRIGHT,LABEL,METHODS,MOST,PCP,PCPS,POST,RESULTS,SEER,SOCIETY,SURVIVORS
C3D,C4D,C57BL,CTLA,IPILIMUMAB,NOTABLY,PITUITARY,SJL
4EBP1,AKT,FURTHER,HOWEVER,MOST,PARP,PI3K,S6K,THEREFORE
0001,006,100,177,215,661,852,935,ADC,ADCM,DIFFUSION,DWI,ICC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PSA,RESULTS
0001,150,204,354,723,732,8805,AUC,AUCS,BACKGROUND,GLEASON,LABEL,METHODS,PCA,RESULTS,SIMILARLY,USING
10TH,15TH,177,183,729,ADT,APART,BRUCE,LABEL,MAXIMAL,METHODS,O2MAX,OBJECTIVE,PURPOSE,RESULTS,SIXTY,UNLABELLED
0115,AFRICAN,CAP,CAUCASIAN,CELL,CPG,NEDD4,PCR,REDUCED,THUS
8482,IMAT,STEP,VMAT
8320,8325,956,AKT,BAX,BCL,CAP,CASPASE,DU145,KHC,PI3K,THEREFORE,TUNEL
117,41BB,CAR,CARS,CD28,CD3ZETA,COMPARING,DESPITE,HA1,PSCA,WHILE
144,41BBL,947,AFTER,CD152,CD274,CD275,CD70,CHANGES,CONVERSELY,CTL,CTLA,DU145,EBRT,ELISPOT,EPITHELIAL,FINALLY,ICOSL,IFN,LAST,LNCAP,OX40L,PC3,PCA,THESE
007,0172,100,109,ADVERSE,AIM,CONCLUSION,CTCAE,EARLY,GROUP,HDR,ISBT,LABEL,LATE,MATERIALS,METHODS,OBJECTIVE,OSAKA,RADIATION,RESULTS,RTOG,THERAPY
029,124,AIM,CAB,CONCLUSION,FIVE,GNRH,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS
001,AIM,BACKGROUND,CELL,CONCLUSION,HOWEVER,LABEL,MATERIALS,METHODS,OBJECTIVE,PNT2,RESULTS,ROSMARINIC
954,BACKGROUND,CONCLUSION,HEPG2,IIA,III,LABEL,MATERIALS,METHODS,RESULTS,SILIBININ,SP1
956,AIM,ANTI,BACKGROUND,CELL,CONCLUSION,DTS,HEN,IC50,LABEL,MATERIALS,METHODS,OBJECTIVE,PETIVERIA,RESULTS,RSK1,WEED,WST
123,231,A549,BACKGROUND,COMPOUNDS,CONCLUSION,EFFECTS,LABEL,MATERIALS,MDA,METHODS,PC3,RESULTS,THESE
174,EPIDERMAL,HER2,HOWEVER,III,PERJETA,PERTUZUMAB
169,2014,FOLLOWING
169,2014,AUTHORS,CSF,GIVEN,JOHN,LTD,RAPID,SIMILARLY,SONS,WILEY
138,169,2014,723,DATA,NERVOUS,OVERALL,SIR,SIRS,SWEDISH,UICC
025,2013,911,ACE,ALU,CIS,CNKI,CQVIP,JULY,MANAGER,ORS,OVERALL,STATA,WANFANG
001,134,8805,AKT,EGFR,EXPRESSION,FDR,HOWEVER,KNOCKDOWN,LINC00963,LNCAP,MTT,PCA,PCR,RNAS,WHOLE
8211,945,946,PHG
2012,440,495,503,AAWS,BACKGROUND,DATA,EWS,GERMANY,LABEL,MEAN,METHODS,NONE,OHLMANN,PSA,RESULTS,UROL,WORLD
121,2009,2012,2013,221,8201,ADJUSTMENT,AMONG,BACKGROUND,IDENTIFIER,IMPORTANCE,INDEX,LABEL,LOCKE,MAIN,MARCH,MARITAL,METHODS,OBJECTIVE,OBJECTIVES,PRIMARY,RELEVANCE,RESULTS,SECONDARY,SETTING,STRATIFIED,TADALAFIL,TEST,THESE,TRIAL
HOWEVER,LABEL,LOW,METHODS,NIAS,OBJECTIVE,PURPOSE,RESULTS,S100,USING,VIP
169,2014,945,954,BAX,BCL2,CCL5,DESPITE,DU145,HMVP2,LNCAP,OVERALL,PC3,SHO,SHOGAOL,STAT3,TNF
BACKGROUND,DCE,DYNAMIC,LABEL,METHODS,MRI,NONE,OBJECTIVE,PURPOSE,RESULTS,TOFTS
001,007,2001,2011,AFTER,BACKGROUND,BIS,COX,FURTHER,JANUARY,LABEL,MBD,METHODS,RESULTS
001,153,2009,2011,216,EVEN,GLEASON,IMC,JUNE,LABEL,LRP,MEAN,METHODS,OBJECTIVE,OBJECTIVES,PSA,RALRP,RESULTS,THERE
169,2014,488,956,ACLY,ACYL,ALEXA,ANNEXIN,ATP,CASPASE,COPYRIGHT,CUB,FLUOR,HOWEVER,IC50,IRELAND,LNCAP,LTD,PARP,PREC,STRIKINGLY,SUB,THUS,USING
0001,004,006,106,169,2014,265,274,425,BCL,BPH,COPYRIGHT,GLEASON,GMBH,HGPIN,REGARDING
001,002,115,169,2002,2005,2013,8201,AUSTRALIAN,BACKGROUND,COLLEGE,LABEL,METHODS,MRI,RESULTS,ROYAL,SEMINAL,SEPTEMBER,ZEALAND
132,140,145,CRPC,EGFR,FINALLY,HOWEVER,PC3,RAL,SEVERAL,SMA
001,176,177,184,204,3752,8814,CAPSAICIN,CONCLUSION,FLUO,HILL,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE,TRPV1
145,169,2014,BAX,BPH1,DU145,FURTHER,PARP,RWPE,THESE
0003,169,1983,2004,2014,427,879,AKT,ERG,GLEASON,LABEL,METHODS,OBJECTIVE,PHYSICIANS,PROTEIN,PTEN,PURPOSE,RESULTS,SEVENTY,THERE,TMPRSS2
1966,2013,APRIL,CIS,ELECTRONIC,JANUARY,LABEL,LIBRARY,METHODS,OBJECTIVE,PURPOSE,RCTS,REGULAR,RESULTS,RRS,SEVERAL,THEREFORE
001,002,003,004,006,2009,2012,8201,BACKGROUND,CCA,DCA,GLEASON,KEY,LABEL,MATERIALS,METHODS,MRI,PROSTATIC,RESULTS,SIR,THERE
CONCLUSION,LABEL,MRI,OBJECTIVE
100,195,203,99M,CONCLUSION,DETECTION,FINALLY,HISTOLOGIC,LABEL,LYMPH,MBQ,METHODS,RESULTS,SLN,UNILATERAL,UNLABELLED
118,4668,BACKGROUND,CAD,HRS,IAD,LABEL,METHODS,MOST,RESULTS,THERE
8201,BACKGROUND,BOTH,EXCLUSION,FORTY,INSTEAD,LABEL,METHODS,MIDSTREAM,PBS,PCA,RESULTS,URINE
FOCUSED,HIFU,HIGH,INTENSITY,LOW,MALIGNANT,MULTIMODAL,THUS,TREATMENT,ULTRASOUND
100,169,1980S,3978,AH01,HYGIENE,SOCIETY
CSC,CSCS,HLA,HLAI,HOWEVER
169,2014,945,954,HOWEVER,MYC,THEREFORE,USING
015,026,035,044,053,085,127,171,215,288,289,2P21,313,327,485,602,700,BACKGROUND,CHINESE,CONCLUSION,EUROPEANS,HRM,LABEL,METHODS,PCA,RESULTS,SNP,THADA
2005,2012,BACKGROUND,CAUCASIANS,CHINA,CHINESE,CONCLUSION,DISEASE,EIGHT,EMPD,JANUARY,LABEL,MARCH,MEDICAL,METHODS,MMS,MOHS,OBJECTIVE,PAGET,RESULTS,THREE
110,115,125,140,169,2014,5CC,945,946,AUTHORS,COPYRIGHT,D50,DIL,DILS,DMAX,FOUR,INC,KUTCHER,LABEL,LYMAN,MARSDEN,MATERIALS,METHODS,NTCP,OBJECTIVE,POISSON,PTV,PUBLISHED,PURPOSE,RESULTS,SABR,TCP,TEN
169,2014,ALTO,BOARD,CBCT,CBCTS,COPYRIGHT,DIR,HOUNSFIELD,INC,LABEL,MATERIALS,METHODS,MLT,OBJECTIVE,PALO,PCT,PURPOSE,RESULTS,STUDENT
001,042,169,2014,301,AUC,COPYRIGHT,COU,PUBLISHED,THESE,UROLOGY
0803,169,2014,AIMS,COLLEGE,CONCLUSION,COPYRIGHT,FIFTEEN,GROUP,HOWEVER,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,RADIATION,RAVES,RESULTS,ROYAL,SCREENING,TRANS,TROG
001,006,009,1422,169,2014,BOTH,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SPECIALTY
BACKGROUND,BEIGE,CHIP,CONVERSELY,DROSOPHILA,ENDOGENOUS,EXCEL,EXOGENOUS,HACAT,HES1,HEY1,HIGH,KNOCKDOWN,LABEL,METHODS,NOTCH,PCR,PROTEIN,PTOV1,RESULTS,SCID,UNDER,WESTERN
001,169,1990,2013,2014,232,523,6470,8201,AMICO,AUC,AUTHORS,BCR,BJU,GLEASON,LABEL,MEIER,METHODS,OBJECTIVE,OVERALL,PCA,PSA,RESULTS,ROC,T2B
169,2014,211,247,AUTHORS,BJU,CONCLUSION,LABEL,MEN,METHODS,OBJECTIVE,PATIENT,RESULTS,TEXAS,THERE,UROLOGY
054,100,144,155,169,1992,2012,2014,300,8804,8805,AUTHORS,BJU,CONCLUSION,DISEASE,GLEASON,LABEL,METHODS,OBJECTIVE,PSA,PSAD,RESULTS
AUTOPSY,BECAUSE,GLEASON,THERE,WHETHER
000,100,110,183,1900,1966,1980,2004,2011,2013,4765,698,743,ASSESSMENT,AUTHORS,BACKGROUND,CANCERLIT,CCMED,CENTRAL,COLLECTION,CONTROLLED,DATA,DENNERT,HOWEVER,ISSUE,LABEL,MAIN,MEDLINE,METHODS,NEWCASTLE,NPCT,OBJECTIVE,OBJECTIVES,OVID,PREVENTION,QUALITY,RCT,RCTS,RESULTS,REVIEWS,SCALE,SELECTION,SYSTEMATIC,THESE,TRIAL,VITAMIN,WHAT
150,300,335,956,99M,CONCLUSION,LABEL,METHODS,NODAL,OBJECTIVE,PURPOSE,RESULTS,SLN,SLNS,USING,WITHOUT
054,102,108,176,2008,2009,236,AIM,CENTERS,FIFTY,IGRT,IMRT,LABEL,METHODS,OBJECTIVE,RESULTS,SIXTY,SPAIN,VIRTUAL
001,025,038,074,114,1973,2004,2007,2008,745,CNS,HET,LABEL,METHODS,NCI,OBJECTIVE,PURPOSE,RADIATION,RESULTS,RISK,SIR,SIRS
169,2014,213,2971,526,AACR,ACCORDING,CLIN,COMT,CONCLUSION,CYP3A43,HSD17B2,LABEL,METHODS,NQO1,NQO2,OBJECTIVE,PURPOSE,REMARKABLY,RES,RESULTS,SNP,SNPS,SULT2A1,SULT2B1
000,1162,1646,1756,1921,1981,1995,2295,246,767,8805,AMONG,CONTINUING,GENERAL,GOTHENBURG,INCIDENCE,LABEL,MAIN,MALM,METHODS,OBJECTIVE,OUTCOME,POPULATION,PREVENTIVE,PROJECT,PSA,RESULTS,SCREENING,SETTING
001,109,1961,2009,2010,327,714,8202,958,ASRS,DENMARK,FURTHER,ICELAND,INCREASED,LAOS,MEN,MRR,MRRS,POISSON,WOMEN
105,BACKGROUND,BPE,DESPITE,FURTHER,HOWEVER,LABEL,LUTS,METHODS,PSA,RESULTS,UROLOGISTS,WEST
169,2014,474,549,945,946,956,CC50,CHO,COPYRIGHT,CSCS,DU145,GAEL,GAELS,GAL,GLC,JIMT,NH2,PC3,SAS,TAKEN
0201,947,ANTIGEN,CD4,CD8,CODON,HLA,KASEKIFYV,PBL,PERIPHERAL,SSX2,TCR,TCRS
ALTOGETHER,DEPLETING,ETS,LNCAP,NLR,NWD1,PCA,PDEF,PROTEOMIC,SRY
946,GTPASES,RAC,RHO,RHOA,SIMILARLY,THESE,WHILE
CDH11,COX,THESE
27R,CD11C,CD4,CD8,COX,DU145,FGFR,FLT,FRAGILE,PC3,PCA,PTGS1,THESE,TIMP,TIMP3
043,050,169,2004,2009,2010,2014,BASED,COPYRIGHT,COX,EDUCATION,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SEER,THUS,UROLOGICAL
109,115,136,169,174,1992,2000,2001,2009,2014,300,AMONG,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS
153,169,177,2014,277,99M,AIMS,BACKGROUND,COPYRIGHT,DEPARTMENT,EDTMP,IMSS,INC,ININ,INSTITUTE,INSTITUTO,LABEL,MBQ,MDP,MEAN,METHODS,MEXICAN,NUCLEAR,NUCLEARES,OBJECTIVE,PAIN,PUBLISHED,RESULTS,VAS,VRS
169,2014,945,946,954,CCL2,COPYRIGHT,FINALLY,HOWEVER,IKB,IL1,IL6,IRELAND,LPS,LTD,MAR,MARCHANTIN,PBMCS,PCA,SINCE,STAT3,TNF
169,2012,2014,BACKGROUND,CONCLUSION,COPYRIGHT,COX,GLEASON,HOWEVER,INC,JANUARY,LABEL,MEAN,MEN,METHODS,OVERALL,RESULTS,THERE,THESE,VITD
169,2014,COPYRIGHT,HOWEVER,INC,THEREFORE
169,2014,946,ADIPOSE,ADSC,ADSCS,CONSISTENT,COPYRIGHT,HOWEVER,INC,LNCAP,MSCS,NHDFS,PC3,PCA,SINCE,TGF
045,100,169,176,2014,8805,BOTH,CONCLUSION,CONTINENCE,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,RESULTS,USING
100,117,169,2014,410,8804,AAS,AFRICAN,AMONG,CANCERS,CAUCASIAN,CAUCASIANS,CONCLUSION,COPYRIGHT,EPSTEIN,FIVE,GLEASON,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,PSA,RESULTS,SIX,T1C
169,2014,491,581,AFTER,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,MUSIC,OBJECTIVE,RESULTS,SURGERY,TNM,UROLOGICAL
001,008,048,169,2002,2012,2014,480,561,AMICO,APRIL,CONCLUSION,COPYRIGHT,EPSTEIN,INC,LABEL,MARCH,MATERIALS,MEN,METHODS,OBJECTIVE,PCA,RESULTS,SPBX,THESE
0001,111,113,148,159,169,2014,307,388,AFTER,ARO,ART,BACKGROUND,COPYRIGHT,COX,HOWEVER,ITT2,LABEL,LOCAL,METHODS,NEITHER,OBJECTIVE,OUTCOME,PATIENT,PCA,PFS,PUBLISHED,RESULTS,SETTING,SUMMARY,THREE,UROLOGY
000,169,2014,350,COPYRIGHT,HODGKIN,IRELAND,LTD,MOST,PUBLISHED,RISK,SOCIETY,SPM,THESE
102,169,1988,2008,2013,626,8804,8805,CONCLUSION,GROUP,INC,LABEL,LATE,MATERIALS,METHODS,NETWORK,OBJECTIVE,PUBLISHED,RADIATION,RESULTS,THERAPY,UNIVARIATE,USING
123,153,169,2013,3DCRT,BACKGROUND,CHANGES,CLINICALLY,IMRT,INC,LABEL,METHODS,PBT,PUBLISHED,QOL,RESULTS
0001,001,1005,169,183,198,2013,232,233,311,502,503,945,956,BACKGROUND,CHARITABLE,COMIT,EORTC,FUNDING,INC,LABEL,LATE,LIGUE,METHODS,NATIONALE,PUBLISHED,RESULTS,TREATMENT,TRUST
001,554,852,ADT,CAD,IAD,LABEL,METHODS,OBJECTIVE,PSA,RESULTS
005,956,A549,CALOTROPIS,CISPLATIN,EGYPT,IC50,NMR,THEIR,U373
2205,AGE,ASA,BACKGROUND,COMPETING,CONCLUSION,COX,GLEASON,LABEL,MEIER,METHODS,RESULTS,SEVENTY,SOCIETY
8805,ASPIRIN,BACKGROUND,CIS,GENERALLY,LABEL,METHODS,NSAID,PCA,RESULTS,THEREFORE
169,176,2014,8804,CONCLUSION,INC,KNOWLEDGE,LABEL,METHODS,MRSI,NOE,NUCLEAR,OBJECTIVE,OVERHAUSER,PURPOSE,REMARKABLY,RESULTS,WILEY
169,2014,BACKGROUND,CONCLUSION,COPYRIGHT,DOCTORS,INTERVIEW,JOHN,LABEL,LTD,MEN,METHODS,NAVIGATED,NAVIGATION,OBJECTIVE,RESULTS,SIX,SONS,WILEY
1966,2013,221,ELECTRONIC,FURTHER,HOWEVER,JANUARY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PCA,RESULTS
946,BPH,EMT,FOXM1,HOWEVER,METFORMIN,PCA,SLUG,TGF,THESE
CONCLUSION,DAB4,DEFECTIVE,EARLY,EL4,LABEL,METHODS,PANC,UNLABELLED
0001,0005,0068,0072,0173,0223,0371,0458,169,2014,215,225,543,688,CONCLUSION,COX,CRPC,IMAGING,INC,LABEL,MATV,MEIER,METASTATIC,METHODS,MOLECULAR,NET,NUCLEAR,PEARSON,PET,RESULTS,SOCIETY,SURVIVORS,SUV,TLA,UNLABELLED
0001,246,AGE,AMONG,ASIAN,ASSESSMENT,CAPRA,GROUP,JAPAN,LABEL,MEN,METHODS,OBJECTIVE,OBJECTIVES,PADT,PEARSON,PFS,PRIMARY,RESULTS,RISK,THERE,USA
034,2001,2011,295,BOTH,HOWEVER,HPV,JULY,KOREANS,LABEL,MARCH,METHODS,OBJECTIVE,OBJECTIVES,P16,RESULTS
223,BOTH,DESPITE,FRONT,III,NONE,POST,SIX
945,946,BLOOD,ERK1,FURTHER,GAL,HOWEVER,SRC,THOMSEN,WESTERN
ABOUT,METASTATIC
001,1759,1980,1998,1999,2002,2003,3001,8805,ACTUARIAL,AIMS,AMICO,BACKGROUND,DATA,HOWEVER,ITALIAN,LABEL,METHODS,OBJECTIVE,RESULTS
AIMS,BACKGROUND,BLADDER,LABEL,METHODS,OBJECTIVE,RESULTS,THERE
169,2014,945,AMACR,COA,COPYRIGHT,HENCE,INC,METHYLACYL,SPN,SPNS,THEREFORE
BACKGROUND,HBA1C,LABEL,METHODS,RESULTS,THESE
ADT,AIS,HORMONE,HOWEVER,RANK
946,DESPITE,FOUR,LNCAP,MASS,ORAL,OVERALL,PC3,SENL,TREATMENT
169,2014,8805,BACKGROUND,CASTRATION,CONCLUSION,COPYRIGHT,CRPC,INC,LABEL,METHODS,METRONOMIC,NONE,PSA,RESULTS,SIX
946,947,954,AFTER,AZD3514,BACKGROUND,BCTI,COHEN,CONTENT,CTC,ELISA,HOWEVER,IHC,ISR,KAPPA,LABEL,METHODS,POM,RESULTS,THESE
169,2000,2012,2013,CONCLUSION,COPYRIGHT,FUR,LABEL,MASON,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SAS,SEVENTEEN,YORK
102,1447,169,177,1ST,2004,2010,2013,31ST,660,812,AIM,CONCLUSION,COPYRIGHT,DAKAR,DEPARTMENT,DRE,GENERAL,GLEASON,GRAND,JANUARY,LABEL,MAY,METHODS,OBJECTIVE,RESULTS,SAS,THERE,UNLABELLED,UROLOGY,YOFF
169,2009,2013,BONE,CONCLUSION,COPYRIGHT,I125,JANUARY,LABEL,LOCAL,METHODS,MRI,OBJECTIVE,OBJECTIVES,PATHOLOGY,PSA,RESULTS,SALVAGE,SAS,SINCE,TURP
140,2012,BACKGROUND,CONFERENCE,CONTINUING,EDUCATION,LABEL,MEDICAL,METHODS,PCA,PCSGS,POOR,PPS,RESULTS,WHILE
128,143,169,2014,8805,ADC,AGREEMENT,AMONG,AUTHORS,BJU,BLAND,CONCLUSION,DCE,DWI,GLEASON,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,RESULTS,T2WI,THESE
462,AMONG,CORRECT,LABEL,METHODS,NONE,OBJECTIVE,PURPOSE,RESULTS
019,239,300,8201,8805,ARM,CONCLUSION,EGFR,FURTHER,LABEL,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS,TIME,TREATMENT,VEGF,VEGFR
DETECTION
8805,CTC,CTCS,PSA,THUS
HOWEVER,MOLECULAR
MEN1,PSIP1,PULMONARY,RB1,SNF,SWI,THESE,TP53
FOCAL,FURTHER,IMAGE,LABEL,MRI,OBJECTIVE,PURPOSE,RESULTS,STUDIES,SUMMARY
CURRENT,HOWEVER,LABEL,MRI,OBJECTIVE,PSA,PURPOSE,RESULTS,SEVERAL,SUMMARY
2014,457,8805,9032,AFTER,AULA,BACKGROUND,COPYRIGHT,EDICIONES,LABEL,MATERIALS,METHODS,OBJECTIVE,PSA,PUBLISHED,RESULTS
1990,1995,1999,2005,2009,BACKGROUND,BETWEEN,CONCLUSION,DESPITE,FIVE,FOLLOWING,HODGKIN,IMPROVING,LABEL,LITHUANIA,LITHUANIAN,METHODS,RAPID,RESULTS,WESTERN

169,2014,26S,564,945,AUTHORS,COCL2,HIF,HYPOXIA,JOHN,LO1,LTD,PRO,SONS,WILEY
0001,122,169,2014,8201,8805,945,946,ADT,BACKGROUND,CHEMOKINES,CONCLUSION,COX,CRPC,ECOG,INC,LABEL,MCP,METHODS,PSA,RESULTS,THERE,TNF,WILEY
169,2014,AFTER,BACKGROUND,CD44,CELL,GLEASON,GS7,HAS1,HAS2,HAS3,HMMR,HYAL1,HYAL4,HYALURONAN,LABEL,METHODS,PCA,RESULTS,SOCIETY,SPAM1
169,2013,GMBH,HOWEVER,KGAA,POTENTIAL,THERE,VCH,WILEY
000,008,2013,370,945,947,BACKGROUND,BLOOD,CIS,LABEL,METHODS,NINE,OCTOBER,RESULTS,RRS
036,049,169,177,2004,2011,2014,4N0M0,8804,8805,945,946,AIMS,BETWEEN,COLLEGE,COPYRIGHT,GLEASON,GROUP,IMRT,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,RADIATION,RESULTS,ROACH,ROYAL,THERAPY,WPRT
140,169,1999,2002,2014,398,AFRICAN,COPYRIGHT,GIVEN,LABEL,LATINOS,LTD,MEN,METHODS,MEXICAN,OBJECTIVE,PSA,PURPOSE,RESULTS
126,142,169,2012,2013,2014,223,BACKGROUND,COPYRIGHT,JANUARY,JULY,LABEL,MEN,METHODS,MRGB,MRI,NPVS,OBJECTIVE,OUTCOME,PATIENT,PCA,PUBLISHED,RESULTS,SECONDARY,SETTING,SUMMARY,UROLOGY
14C,160,956,BACKGROUND,CASTRATION,CONCLUSION,CRPC,DOSE,ELISA,HMGCR,HOWEVER,LABEL,LNCAP,METHODS,PSA,RESULTS
004,013,026,047,085,093,137,145,238C,238G,308C,308G,477,531,757,8201,945,967,BACKGROUND,BIOMEDICAL,CBM,CHINA,CHINESE,CNKI,KNOWLEDGE,LABEL,LIBRARY,LITERATURE,METHODS,RESULTS,THERE,TNF,UNASSIGNED,VIRTUAL
AKT,BAX,BCL,CHINA,RWPE1,THESE,TRIFOLIUM,WESTERN
BBC,LYNCH,NURSE,SILK
160,169,195,2014,309,ACADEMY,AGA,BACKGROUND,BOTH,BPH,CAP,DATA,LABEL,METHODS,NORWOOD,OBJECTIVE,OVERALL,PCR,PSA,RESULTS,RFLP,SNP,THERE,VII
169,2002,2008,2013,ADDITIONAL,AFFAIRS,BACKGROUND,CENTRAL,COX,EPIGENETIC,LABEL,METHODS,RESULTS,SAS,SOCIETY,VPA
0038,CONCLUSION,GLEASON,LABEL,LNS,LYMPH,MATERIALS,METHODS,OBJECTIVE,PLND,PSA,PURPOSE,RESULTS
BACKGROUND,CELL,DECREASED,ELISA,HOWEVER,LABEL,METHODS,PCR,REAL,RECIPROCAL,RESULTS,SDF,USING
2OXO,945,954,CELASTROL,CHINESE,ELISA,HOOK,IKK,IMMUNOBLOT,KNOCKDOWN,PMA,RESULTS,TNF
156,314,ELISA,FURTHER,LABEL,METHODS,NEITHER,OBJECTIVE,ODDS,ORS,PSA,PURPOSE,RESULTS,THUS
450K,8202,AZA,BACKGROUND,BLOT,CONCLUSION,DSC3,EMT,EPIGENETIC,FINALLY,FUNCTIONAL,LABEL,MEIER,METHODS,MICROARRAY,NGS,PCA,PCR,RESULTS,TAKEN,UCSC,WESTERN,WHILE
103,170,1992,2010,COX,END,III,INSTITUTE,LABEL,METHODS,OBJECTIVE,RATIO,RESULTS,SECONDARY,WHILE
954,BONE,RANK,SEVERAL,SRES
232,730,763,767,945,946,947,ABTS,ALTOGETHER,ANTI,BURKINA,DPPH,EOS,ESSENTIAL,EUCALYPTUS,FASO,LNCAP,MAJOR,MTT
005,3100,792,AMP,AMPK,ARSI,ATG,AUTOPHAGY,CAP,CMI,CRPC,ENZA,MACRO,MDV,USING
AKT,DLG5,KNOCKDOWN,SER1416,SMALL,TAKEN
EGFR,ERBB3,HER3,NEDD4,SHORT,TAKEN,USING
CONSENSUS,MELBOURNE
CURRENTLY
BASED,HISTOLOGY,PET
169,2014,293,294,556,ALSO,COPYRIGHT,CRPC,DHT,GFP,HOWEVER,HSP90,LBD,LTD,NTD,SINCE,THESE
002,023,100,166,169,2009,2012,2014,ADVERSE,CHI,COPYRIGHT,COX,INC,LABEL,MANN,MATERIALS,METHODS,OBJECTIVE,PHOENIX,PREEMPTIVE,PROACTIVE,PRW,PURPOSE,RECURRENT,RESULTS,SEPTEMBER,TGC,WHITNEY
03CC,169,2014,CARLO,COPYRIGHT,HOWEVER,INC,LABEL,MATERIALS,METHODS,MONTE,OBJECTIVE,PURPOSE,RESULTS,V100,VMAT
169,176,180,2014,360,548,COPYRIGHT,CTV,CYBERKNIFE,FIXED,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PLANNED,PURPOSE,RESULTS,V100
016,101,102,169,2014,6GY,8805,CIMRT,COPYRIGHT,DOSE,GROUP,HIMRT,IMRT,INC,LABEL,LATE,MATERIALS,MEN,METHODS,MINIMIZING,OBJECTIVE,R64,RADIATION,RESULTS,THERAPY,THERE
001,169,1995,2005,2014,2991,4N1M0,796,8805,AMONG,COPYRIGHT,COX,EBRT,END,INC,LABEL,LOCAL,MATERIALS,MEIER,METHODS,NLT,OBJECTIVE,PCSS,PSA,PURPOSE,RESULTS
014,022,048,169,177,198,2014,214,8804,8805,CD4,CD8,COPYRIGHT,COX,FINALLY,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PERIPHERAL,PURPOSE,RESULTS,V65
169,200,2011,2012,2014,2042,5357,AFTER,AUTHORS,BETWEEN,BJU,DESPITE,FEWER,FORCE,JOHN,LABEL,LTD,MATERIALS,MAY,METHODS,OBJECTIVE,OCTOBER,PREVENTIVE,PSA,PUBLISHED,RESULTS,SONS,TASK,THERE,TWITTER,USING,WILEY
169,2014,329,ADJUSTMENT,ANXIETY,CHRONIC,DEPRESSION,HOWEVER,ILLNESS,JOHN,LTD,PERCEIVED,PERSISTENT,SCALE,SONS,THESE,WILEY
002,019,125,126,160,169,2014,240,ADVERSE,CONCLUSION,COPYRIGHT,DEGARELIX,III,INC,LABEL,METHODS,OBJECTIVE,RESULTS
2013,COMMITTEE,DIEGO,DRUG,DRUGS,FDA,FOOD,INC,INVITED,MAY,ONCOLOGIC,PRODUCT,PUBLISHED,SAN,SUMMARY,UROLOGICAL
001,076,1172,169,175,1992,2008,2014,580,592,648,651,8201,876,BETWEEN,COMPETING,GLEASON,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,ROBOT,UROLOGICAL
CAP,FINALLY,GNRH,GSG,HORMONE,NMR,RELEASING
001,160,169,183,1998,2002,2014,COX,DISCUSSION,HRS,INSURANCE,JANUARY,JOHN,KNOWN,LABEL,LHID,LTD,METHODS,NHI,OBJECTIVE,PRIOR,RESULTS,SONS,TZD,TZDS,USING,WHAT,WILEY
169,1991,2005,2014,379,758,AABB,ALLOGENEIC,BACKGROUND,EACH,GLEASON,LABEL,METHODS,PRIMARY,RESULTS,STRATIFIED
AREAS,BACKGROUND,COVERED,LABEL,METHODS,OPINION,RNAI
001,2008,2011,609,8805,AFTER,BACKGROUND,BNSRP,IIEF,INDEX,JANUARY,JUNE,LABEL,METHODS,ORP,PCA,RARP,RESULTS,SIMILARLY,URINARY
001,456,828,900,ADC,ADCS,CONCLUSION,DWI,ECE,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,SEVENTY
3A4,AREAS,BACKGROUND,COVERED,CYP,CYPS,DIAGNOSTIC,GRANTED,INHIBITORS,LABEL,METHODS,OPINION
145R,954,CD44,DOCETAXEL,EMT,EXPRESSION,INCREASED,MOLECULAR,RELA,REVERSION,VIM,ZEB1
200,2003,2004,2006,2008,2010,2013,400,500,6400,7000,8364,900,AIM,BACKGROUND,DESPITE,FIFTEEN,JANUARY,LABEL,MEDLINE,METHODS,OBJECTIVE,OCTOBER,RESULTS,USA
001,2002,2007,2011,AGE,C00,C96,DISEASE,LABEL,METHODS,NON,OBJECTIVE,PURPOSE,RESULTS,TREND
0487,0492,BPH,CONCLUSION,DFS,GLEASON,HAI,HEPATOCYTE,IHC,LABEL,METHODS,N0M0,OBJECTIVE,PCA,PCR,PURPOSE,RESULTS
145,ADAR,APC,AXIN,BTRC,CD133,CD44,CONCLUSION,CSCS,FRAT1,FZD,FZD1,HOWEVER,LABEL,METHODS,OBJECTIVE,PCR,PPARD,PURPOSE,RESULTS,WNT,WNT1
ECM,KLK,KLK1,KLK15,KLK2,KLKS,PSA
CRPC,THESE
954,ATP,DATA,G6PD,GLUT1,LNCAP,ME1,PKM2,PPP,PPPS,TARGETING,THESE
ERG,ETS,ETV1,FINALLY,MOST,TMPRSS2,TMRPSS2
001,002,012,028,029,140,177,418,674,760,DATA,ELISA,GLEASON,HOWEVER,LABEL,METHODS,OBJECTIVE,PCA,PCR,PURPOSE,RESULTS,THEN,THESE,THUS,WESTERN
558,8805,AUCS,CHINESE,PSA,ROC,SIMILARLY,WESTERN
001,048,207,297,364,373,546,792,945,BLOOD,BPH,FIFTY,FURTHER,GLEASON,OMENTIN,PCA,PSA,THERE,THEREFORE
184,1997,2007,637,8211,836,898,ASH,CONCLUSION,CURRENT,DEPENDENT,INSURANCE,LABEL,METHODS,OBJECTIVE,PART,PURPOSE,RECEIPT,RESULTS,SCM,SCMS
001,101,169,201,2014,223,3514,509,ARN,AZD,CTLA,DESPITE,EPI,FINALLY,GVAX,MEDICAL,MET,NOVEL,ODM,PRESS,PROMISING,PUBLISHED,SARDS,SOCIETY,SRC,TOK,UNIVERSITY
176,177,CELLS,CMV,CMVP,FITC,GFP,HSP70,HSPP,PC3,POST,RFP,THESE,THREE
145,E2F,PEGYLATED,PEP,TREATMENT
136,147,148,192,214,460,691,947,CONCLUSION,DEGRO,DUE,EVALUATION,HOWEVER,IMRT,LABEL,MAJOR,METHODS,OBJECTIVE,OVERALL,PURPOSE,QUIRO,RESULTS,THEREFORE
175,BACKGROUND,EVENTUALLY,HBD,HSC,INDUCTION,LABEL,METHODS,MMP,OSCC,OVERALL,RESULTS,RHOA,RHOC,ROC,SCC,UM1
003,008,032,039,2005,2008,ACS,ASPIRIN,FFBF,GLEASON,HIGH,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
1198,231,CONVERSELY,DU145,ENMD,JAK1,MDA,MKC,MTI,MTIS,PC3,PEBP,PREVIOUSLY,RAF,RKIP,SRC,STAT3
8764,ARRAY,AT2R,BAG3,BMP6,BMP7,BNIPI,DU145,GADD45A,HRK,IL6,IL8,INCREASED,MAPK,NEXT,PCR,TAKEN,TNFSF10,TP53BP2,TRAIL
HEPIN,HPN,THESE,WHILE
169,2014,AKT2,BIO1,CONCURRENT,COPYRIGHT,DCP,EEA1,H2O2,HOWEVER,INC,LPA,LPAR1,NADPH,PROTEIN,PTP1B,RHO1,THESE
160,169,2014,382,590,956,CEM,COPYRIGHT,HELA,IC50,L1210,MOLT4,NOVEL,SAS,SEVERAL,THESE
169,2014,CELL,COPYRIGHT,DISULFIRAM,HOWEVER,INC,INHIBITION,MTT,NON,NSCLC,PCR,REAL
169,2014,COPYRIGHT,ECM,INC,PERIOSTIN
125,160,169,2014,217,296,8805,946,ATM,COPYRIGHT,CROWN,ERCC2,GENOMIC,GRADE,GSTA1,GSTP1,HOWEVER,INC,LABEL,LIG4,MATERIALS,METHODS,MSH6,NONE,NOS,OBJECTIVE,PUBLISHED,PURPOSE,RAD51,RESULTS,SCORE,SNPS,SOD2,SYMPTOM,TGF,TP53,XRCC1,XRCC3
013,083,105,169,2013,609,8805,ADT,CONCLUSION,COX,INC,LABEL,MATERIALS,METHODS,NETWORK,OBJECTIVE,PSA,PUBLISHED,PURPOSE,RESULTS
169,2014,954,ALSO,BASED,COPYRIGHT,HOWEVER,LTD,RELA,TG2,THESE
145,169,2014,COPYRIGHT,GFLG,HOWEVER,LTD,VPA
2011,2012,BACKGROUND,LABEL,RESULTS,WHOLE
1590,1618,169,2005,2009,2014,233,8805,AUTHORS,BJU,BLACK,CIS,CONCLUSION,FURTHER,JOHN,LABEL,LTD,METHODS,MONTR,OBJECTIVE,OBJECTIVES,ORS,PROTEUS,RESULTS,SONS,WILEY
APO2,APO2L,ATG7,BACKGROUND,BECN1,CASPASE,DU145,GFP,INHIBITION,LABEL,LAMP2,LC3,LNCAP,METHODS,PC3,PCA,RESULTS,THUS,TMAS,TRAIL
169,2014,279,556,735,AFTER,CONCLUSION,COPYRIGHT,GLEASON,HOPKINS,INC,JOHNS,LABEL,MATERIALS,MEN,METHODS,OBJECTIVE,PNI,RESULTS
BACKGROUND,CELASTROL,CONCLUSION,CONTEXT,DISCUSSION,DRUG,FORMATION,LABEL,LIPOSOMAL,MATERIALS,METHODS,OBJECTIVE,PEGYLATED,RESULTS
107,121,169,183,2014,353,ANTI,BRITISH,CARCINOMA,CELL,ELISA,EN2,ENGRAILED,ESO,ESOPHAGEAL,IGG,IMMUNOLOGY,SOCIETY,SUN,WHILE,YORK
CURRENTLY,DETAILS,SBRT,SEVEN
AKT,BASED,DU145,LC3,NVP,PC3,PI3K,PTEN
026,168,170,173,192,198,200,215,226,8804,959,967,AIMS,BACKGROUND,GLEASON,LABEL,METHODS,OBJECTIVE,PCA,PSA,RESULTS,SPSS,THERE,UROLOGISTS
001,010,028,100,113,119,174,849,855,8805,ACCORDING,AREA,BACKGROUND,BCR,COX,GLEASON,LABEL,METHODS,NONE,PSA,RESULTS
004,046,047,100,105,107,109,129,177,192,8201,BACKGROUND,BMI,CONCLUSION,FURTHER,LABEL,MEAN,METHODS,MINIMUM,OPERATIVE,RESULTS,ROBOTIC,THERE
180,BACKGROUND,BCR,BPH,COX,GLEASON,HIGH,HOWEVER,LABEL,LAPTM4B,MEIER,METHODS,PCA,PSA,RESULTS
CRR9,GWAS,NUCLEOTIDE,ROC,SNP,SNPS,STUDIES,TERT,THROUGH,WIDE
BMI,CELLS,CSCS,LABEL,OBJECTIVE,OCT4,PURPOSE,RESULTS,SEVERAL,SOX2,SUMMARY,THESE
100,APC,HOXD3,METHYLIGHT,PCA,TGFB2,THESE
ADP,DT40,DU145,HENCE,NAD,PARP,SF295
169,2014,COPYRIGHT,LTD,MCL1,TCTP
0001,169,2004,2006,2014,2698,444,537,BACKGROUND,COPYRIGHT,HOWEVER,LABEL,LTD,METHODS,NSCLC,RESULTS,SCLC
001,169,2014,8201,952,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,UROLOGICAL
003,028,048,116,125,169,2007,2012,2014,8201,8805,APRIL,BETWEEN,CONCLUSION,LABEL,MARCH,METHODS,OBJECTIVE,REGRESSION,RESULTS,UROLOGICAL
E1A,GIANT,HOWEVER,ONCOLYTIC,PPT,THESE,WESTERN
ALSO,CLINICALLY,EPIGENETIC,REVERSIBLE
CURRENTLY,PCA,T1C
1125
1ST,400,ANOTHER,SAFOCID
2014,254,255,BIOMARKERS,COLORECTAL,LUNG,MOST,ODDS,OVARIAN,PRESS,PUBLISHED,SELF,UNIVERSITY
169,2014,CHANGES,HOWEVER,NKX3,OVERALL,RUNX,RUNX2,SNAI2,SNAIL,THESE
169,2014,AACR,AP1,CD24,CHIPSEQ,JMD2C,JUMONJI,KDM4C,PAWR,PYMT,REDUCED,SRC,THROUGH
641,8201,946,ATTENDANCE,BACKGROUND,DIET,DIETARY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SESSION,TELEPHONE
169,2014,8201,956,ASSAY,BACKGROUND,BINDING,DCFH,GAUSSIA,INC,INHIBITOR,JUND,LABEL,LBD,LUCIFERASE,METHODS,PCA,PLA,PREVIOUSLY,PROXIMITY,RESULTS,ROS,SPERMIDINE,SSAT,WILEY
131,169,193,1998,2011,2014,206,527,611,8804,8805,ADT,AFTER,BACKGROUND,BCR,FAVORABLE,GLEASON,HOWEVER,LABEL,METHODS,OVERALL,PSA,RESULTS,SOCIETY
169,2014,2G7,8201,ANOTHER,BACKGROUND,CONCLUSION,GCPII,GLUTAMATE,INC,LABEL,METHODS,NAAG,PGCP,RESULTS,USING,WILEY
160,169,174,2014,231,233,ARC,ARTPELVIS,CONCLUSION,COPYRIGHT,DATA,IMRT,LABEL,METHODS,OBJECTIVE,PLAN,PUBLISHED,PURPOSE,RAPID,REGARDING,RESULTS,SAS,SFRO,SOCI
181,22RV1,8201,954,AFTER,COMPOUNDS,CWR,FIG,FOUR,SCID
0001,0017,0035,0151,1088,169,2009,2010,2014,302,5MG,8805,945,ADVERSE,APRIL,BACKGROUND,BRIEN,CIS,COPYRIGHT,COU,COX,EASTERN,FLEMING,GROUP,HRS,JUNE,LABEL,LAN,MEIER,METHODS,OBJECTIVE,OUTCOME,PATIENT,PUBLISHED,RESULTS,SETTING,SUMMARY,TREATMENT,TRIAL,UROLOGY,WHILE
003,152,173,2000,2011,298,391,HOPKINS,IPP,IPPS,JANUARY,JOHNS,MEAN,SEVEN,THERE
BACKGROUND,LABEL,RESULTS,SCLC,SHH,VALIDATION
231,950,BACKGROUND,CONCLUSION,DGK,GTPASES,KNOCKDOWN,LABEL,MDA,METHODS,PAK,PAK1,RAC1,RESULTS,RHO,RHOA,SIMILARLY,SW480,SW620,THERE,THESE,TRANSWELL,UNRAVELING
450,750,8201,CONCLUSION,DOSE,IGRT,IMRT,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,PTV,RESULTS,THERE,V100,V95,V99
HOWEVER,MRI,THEREFORE
006,1032,114,160,169,183,1994,2010,2014,AMONG,CALCULATED,DHT,ELDERLY,FURTHER,ISCHAEMIC,JOHN,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,SHBG,SONS,TOTAL,WILEY
069,130,1955,2008,620,9608,BACKGROUND,CMM,FACTORS,FURTHER,LABEL,METHODS,NORWEGIAN,RATES,RESULTS,SCC,SIR,SKIN
ADDITIONAL,AFRICAN,AMONG,BACKGROUND,CONCLUSION,HRQOL,LABEL,MEN,METHODS,OBJECTIVE,OVERALL,PCA,RESULTS,ROUTINE
TEN
169,2014,494,ARTIFICIAL,BACKGROUND,CXCR4,DU145,HOWEVER,INC,LABEL,LNCAP,MATERIALS,METHODS,MIR,MTT,RESULTS,RWPE,SDF,TUNEL,UTR,WILEY
1994,2007,2008,439,DENMARK,INDIVIDUAL,LABEL,METHODS,OBJECTIVE,OCTOBER,PURPOSE,RESULTS,SEPTEMBER,STRATIFIED
2010,2013,ANOTHER,APRIL,AVAILABLE,BASED,COLORECTAL,CONTROLLED,ERSPC,HARMS,HEART,IMPORTANCE,JANUARY,LABEL,LUNG,MEDLINE,METHODS,OBJECTIVE,OTHER,OVARIAN,PLCO,PSA,RANDOMIZED,RELEVANCE,RESULTS,SCORING,SCREENING
001,169,2014,ACE,ADULT,COPYRIGHT,DISEASE,EVALUATION,INDEX,LABEL,MATERIALS,METHODS,OBJECTIVE,PATIENT,PURPOSE,RESULTS,SOCIETY,STRATIFIED
184,240,LABEL,METHODS,OBJECTIVE,RESULTS,WHILE
2001,2007,497,DATA,FIRST,FLORIDA
CURRENTLY,EVEN,SIX
009,144,165,189,2014,BASEL,CONCLUSION,DUE,LABEL,MANN,METHODS,NOMINAL,OBJECTIVE,ODDS,PURPOSE,RESULTS,WALD,WHITNEY
0001,002,020,022,037,042,044,049,BACKGROUND,BAX,BEL7402,CHILD,HCC,HEPG2,HUH,IRT,LABEL,MEIER,METHODS,MMP,OBJECTIVE,PROGNOSTIC,PUGH,PURPOSE,RESULTS,UNIVARIATE,ZINC,ZIP4,ZRT
115,2014,AFTER,BACKGROUND,BASEL,LABEL,METHODS,PSA,RESULTS,SHORTER
177,231,8764,945,956,GELATIN,HOWEVER,IC50,MCF,MDA,NOS,NOSCAPINE
169,2014,916,936,BASEL,CASPASE,CELL,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,TED
945,946,954,AKT,BACKGROUND,EMERGENCE,EMT,GSK3,LABEL,METHODS,PCA,PP2A,PREVIOUSLY,RESULTS
34A,CRC,EMT,IL6R,MEMBERS,REPRESSION,SNAIL,STAT3
169,2014,EQUALLY,PPI,PPIS,PROTEIN,VARIOUS
AKT,BACKGROUND,ERK,ETS,LABEL,OFTEN,PI3K,PTEN,RAF,RAS,RESULTS
172,2000,2013,4675,8243,ADT,CAD,DATA,ENGLISH,IAD,LABEL,MATERIALS,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SEVEN,TEN,THUS
001,255,278,533,8243,ADDITIONAL,DATA,GLEASON,HOWEVER,LABEL,MATERIALS,METHODS,MOST,NONE,OBJECTIVE,OBJECTIVES,OVERALL,PCA,PSA,RESULTS,USING
111,160,169,2014,954,COPYRIGHT,DIFFUSION,EDUCATION,FINAL,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PCA,PRIMARY,PUBLISHED,PURPOSE,RESULTS,SECONDARY,TESLA,THREE,UROLOGICAL
160,169,2014,COPYRIGHT,EDUCATION,GIVEN,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SCREENING,UROLOGICAL,USING
160,169,2006,2009,2014,COPYRIGHT,EDUCATION,GLEASON,INC,INVENTORY,IQR,LABEL,LOW,MATERIALS,MEN,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
945,946,BACKGROUND,CTC,DISCUSSION,DUE,IDENTIFIER,III,IPI,LABEL,METHODS,NCI,PFS,PRIMARY,PSA,QOL,RADIATION,SECONDARY,TRIAL
240,AUSTRALIAN,BACKGROUND,CARE,DESPITE,DISCUSSION,LABEL,METHODS,THERE,THEREFORE,TRIAL,USUAL,ZEALAND
110,145,946,956,LNCAP,MAJOR,SOY,THREE
ICT2588,MMP,PRODRUG,VDA,VDAS,WILLEBRAND
001,019,024,025,031,184,BACKGROUND,BMI,CONCLUSION,CRP,LABEL,METHODS,MRI,PEARSON,RESULTS,RRP,SSPS
120,177,BACKGROUND,COL1,COL3,EPITHELIA,HOWEVER,III,IMAGE,LABEL,METHODS,PLUS,PONCEAU,PRO,RESULTS,THERE,TRTE
100,2006,2011,315,410,BACKGROUND,FOLLOWING,GLEASON,LABEL,LOW,MATERIALS,METHODS,NCCN,PCA,PSA,RESULTS,VARIOUS
001,161,2005,2010,2013,APRIL,BACKGROUND,CONCLUSION,HOWEVER,JANUARY,LABEL,MARCH,MEIER,METHODS,RESULTS,SEVERAL
CTC,CTCS,FDA,SINCE
169,2014,ANOTHER,DESPITE,PCA,SOCIETY
001,104,111,145,177,179,191,208,536,CONCLUSION,CUCL2,LABEL,LENTI,METHODS,OVERALL,PET,RESULTS,SCR,UNLABELLED,WESTERN
169,2014,8201,AUTHORS,DCA,FOLLOWING,JOHN,LACTATE,LDH,LN3,LNCAP,LTD,METABOLITE,NMR,SONS,WILEY
112,113,160,194,371,560,8201,910,BACKGROUND,BRT,CONCLUSION,ESCHWEILER,HDR,LABEL,LDR,MAIN,METHODS,OFFENBACH,RADIATION,RESULTS,ROOM,SOCIETY,WORKING
170,1995,2008,2010,CONCLUSION,COX,GIVEN,LABEL,MEN,METHODS,OBJECTIVE,OVERALL,PADT,PRIMARY,PURPOSE,RESULTS
AFTER,BCG
0003,1000,301,347,546,8201,BACKGROUND,COU,HOWEVER,LABEL,LLOQ,METHODS,PSA,REDUCTION,RESULTS,SERUM
0220,130,2005,2007,5F3,BACKGROUND,COX,DISIALOSYL,DSGB5,FURTHER,HOWEVER,JANUARY,LABEL,MEIER,METHODS,PSA,RCC,RESULTS,THESE
FOUR,LABEL,MEN,OBJECTIVE,PCA,PREDICTIVE,PURPOSE,QOL,RESULTS,SUMMARY
FOCAL,III,LABEL,MRI,OBJECTIVE,PURPOSE,RESULTS,SUMMARY,THERE,THESE
FOCAL,LABEL,MRI,OBJECTIVE,PURPOSE,RESULTS,STATE,SUMMARY,THERE,ULTRASOUND
EARLY,FOCAL,LABEL,OBJECTIVE,PARTIAL,PCA,PURPOSE,RESULTS,SUMMARY
169,2014,878,945,AACR,ACID,AML,APL,ATRA,CONVERSELY,LABEL,LINC00478,MOL,PML,RAR,RARES,RES,RESPONSIVE,THEREFORE,THESE,UNLABELLED
169,2014,20DB,CARLO,COPYRIGHT,DCE,HOWEVER,INC,MONTE,MRI
117,162,169,2014,236,718,ASSESSMENT,COPYRIGHT,EUROQOL,FACT,FOUR,FUNCTIONAL,HRQOL,INC,ISPOR,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,SOCIETY,THERAPY
027,103,702,8805,ADDITIONAL,BACKGROUND,CIS,CONCLUSION,FORTY,HOWEVER,LABEL,METHODS,OURRESULTS,RESULTS,RRS
001,048,177,215,485,556,99M,ADC,BACKGROUND,BONE,CRPC,E26,ERG,LABEL,MANN,MDP,METHODS,NOD,RESULTS,SCID,VCAP,WHITNEY
8201,8462,8804,BPH,CAP,E211,GENOTYPING,PCR,RFLP
145,AFTER,CELLIGENCE,HIPC,PCR,WESTERN
THESE,USING
DOWN,FOXO1,INHIBITION,LNCAP,PC3,PCR
102,120,124,177,956,ALA,ARG,ASN,ASP,ATBBN,BBN,GBQ,GLN,GLY,GRPR,HOWEVER,IC50,LEU,NOTA,PARTITION,PET,PHE,THERE,TRP,VAL,VARIOUS
231,300,BACKGROUND,CONCLUSION,HIGH,LABEL,MATERIALS,MDA,METHODS,RESULTS,SIXTEEN,THESE,WHILE
ABCB1,CASP3,CASP9,DTX,DU145,INDUCTION,MTT,OCT,PCA,PCR,THERE,THESE,THUS,VEGFA
169,17NM,2014,20NM,5CL,BN52021,COPYRIGHT,DMSO,FTIR,IC50,INC,MCF,NMR,PAF,PC3,T98G,UPON,WEB2170
169,2014,22RV1,945,946,CELL,CONVERSELY,COPYRIGHT,HOWEVER,RESULTS,RHOA,TRAMP
169,2014,945,946,956,COPYRIGHT,FOUR,IC50,INC,LNCAP,OXIME
125,169,2014,3000,34BETAE12,COA,COPYRIGHT,GATA,GATA3,P501S,PUBLISHED,SVS,UROLOGY
169,199A,2014,COPYRIGHT,GLEASON,INC,PATHOLOGY,PCA,PUBLISHED,REVEALING,SOCIETY,SURGERY,THEREFORE
169,2014,2MM,CBCT,CONCLUSION,COPYRIGHT,EVEN,GROUP,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PROBE,PURPOSE,RESULTS,THEREFORE
10878,169,2014,3MM,4MM,5MM,6MM,9CM,BACKGROUND,CONCLUSION,COPYRIGHT,CSA,FFBF,IGRT,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS
10878,116,131,169,2014,247,2GY,56CC,5CC,5GY,7GY,AUC,BACKGROUND,BEST,CONV,COPYRIGHT,DATA,DSH,DSHC,DSHW,DUE01,DVH,DVHC,DVHW,HYPO,IPSS,IRELAND,LABEL,LTD,MATERIALS,METHODS,MVA,OBJECTIVE,PURPOSE,RESULTS,SCORE,SIMILAR
001,017,072,121,169,2007,2012,2014,212,249,262,373,382,AMICO,COPYRIGHT,EDUCATION,GLEASON,INC,JUNE,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SEPTEMBER,TESLA,UROLOGICAL
1523,169,2014,ASSESSMENT,COPYRIGHT,DESPITE,IMRT,INC,MEDICAL,PUBLISHED,VMAT
047,117,169,177,2014,ACCEPTABLE,COPYRIGHT,DOSIMETRIC,IMRT,INC,MCO,MEDICAL,MINIMIZING,NAVIGATED,NUCLETRON,PUBLISHED,RAYSEARCH,RAYSTATION,STEP
169,2014,309,ARD,COPYRIGHT,IRELAND,ITEMS,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,ROC,THERE
103,124,127,134,139,140,146,169,170,177,198,2014,218,AFTER,CONCLUSION,COPYRIGHT,DTI,FIFTY,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
100,169,198,2014,239,AFTER,AMONG,CONCLUSION,COPYRIGHT,FDG,INC,LABEL,METHODS,OBJECTIVE,RESULTS
169,2013,ALA,BACKGROUND,CONCLUSION,COPYRIGHT,HVJ,JAPAN,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PDT,PORPHYRUS,PPIX,PUBLISHED,RESULTS
067,119,126,169,1999,2000,2014,257,782,ADT,BRITISH,COPYRIGHT,DATA,EXCLUSION,FIVE,INC,LABEL,LST,MATERIALS,METHODS,OBJECTIVE,PHOENIX,RADIATION,RESULTS
001,169,2006,2008,2014,654,8804,8805,COPYRIGHT,END,GLEASON,INC,LABEL,METHODS,OBJECTIVE,OVERALL,PCSS,PURPOSE,RESULTS,SEER
143,169,2003,2014,8805,COPYRIGHT,EIGHT,GLEASON,GMBH,NSI,PGI,PSA
138,169,2014,BACKGROUND,CCL20,CHRONIC,CONCLUSION,COPYRIGHT,GMBH,LABEL,MANT,METHODS,PANCREATIC,PCA,RESULTS
160,169,2014,CFS,COPYRIGHT,HERVS,INC,XENOTROPIC,XMRV
169,2014,946,AUTHORS,FOUNDATION,JOHN,JOURNAL,LTD,MOLECULAR,PPP1,PROTEIN,SONS,TGF,WILEY
169,2010,2014,AUTHORS,BJU,MEN,SINCE
2013,ASCO,BACKGROUND,CANCERS,CONCLUSION,DUE,ENGLISH,EPSCC,ESPCC,HIGH,HOWEVER,LABEL,METHODS,OCTOBER,PCI,RESULTS,SCC,SCCS,SCLC,SCOPE,SMALL,SOCIETY,THEREFORE
946,FAK,MOST,THESE
181,DU145,HOWEVER,IC50,OCH3,PC3,U251
AFRICAN,AMERICA,CAUCASIAN,LIMITED
1990S,450,CYP,DATA,DME,GST,HENCE,HOWEVER,LEBANON,NAT,PHASE,THERE
167,17Q12,17Q24,CHILEAN,CONCLUSION,HOWEVER,IBM,LABEL,METHODS,OBJECTIVE,PCA,PCR,PSA,PURPOSE,RESULTS,SNPS,SPSS
946,INCREASED,PC3,PTTG1,SHRNA,SINCE,SMAD3,TAKEN,TGF,WHEREAS
ADP,COMBINING,CPT,E2F1,PARK,PC3,RAD51,SN38,THESE
HER2,HOWEVER,MMTV,RUNX2,USING
001,005,105,8804,BPH,CHANGES,HNRNP,LNCAP,PCA,PSA,THESE
CGP,HOWEVER,INDUCTION,LNCAP,M30,MFN1,MYC,PCR,THEREFORE,THESE,TREATMENT
169,2014,AFTER,CGA,COPYRIGHT,DNR,LOD,MUC1,NIR,QDS
001,169,2014,500,CNT,COPYRIGHT,ECL,PSA,ZNO
954,AIPC,ALDH1,APOPTOSIS,CSC,CSCS,CXCR4,DU145,FACS,JAGGED1,NANOG,NOTCH,NOVEL,PC3,SOX,THESE,TRAIL
3805,ECOG,LABEL,OBJECTIVE,PURPOSE,RESULTS,SIPULEUCEL,SUMMARY
AMENDMENT,BECKMAN,CLIA,COULTER,DRUG,FDA,FOOD,GEN,INC,INDEX,LABEL,LABORATORY,OBJECTIVE,PCA,PCA3,PROBE,PURPOSE,RESULTS,SEVERAL,SUMMARY,THESE
7553,8202,838,BONE,CONSISTENT,LABEL,OBJECTIVE,PREVALENCE,PURPOSE,RESULTS,SRE,SRES,SUMMARY,THERE,TRIAL
177,180,AFTER,DAYS,FORTY,FREE,PSA,THEREFORE
001,1486,2007,853,8804,BETWEEN,CHINA,CHINESE,DRE,FUDAN,FURTHER,HUASHAN,PCA,PSA,TRUS,UNIVERSITY
GRS,HOWEVER
HIGGINS,OVERALL,SRR,THERE
8804,CARLO,CHINESE,DOSE,FOUR,MONTE,OAR,OARS,RBM,RED,YBM
169,2014,BEST,CMT,CONFORMAL,EBRT,ENDORECTAL,GERIATRIC,INTENSITY,LEVEL,MEDICAL,MGMT,NSCLC,PATIENT,PRESS,PUBLISHED,SBRT,SHORT,SHORTER,SIOG,SOCIETY,UNIVERSITY,WHERE
946,BASED,COPY,ETS,EZH2,GIVEN,LABEL,OBJECTIVE,PAKT,PCAT,PTEN,PURPOSE,RESULTS,SUMMARY,TGF,TMPRSS2,TP53
FOCAL,LABEL,MRI,OBJECTIVE,POST,PURPOSE,RESULTS,SUMMARY
GROWING,LABEL,OBJECTIVE,PURPOSE,RESULTS,SUMMARY
CANDIDATES,GLEASON,HOWEVER,LABEL,MRI,OBJECTIVE,ORIGINALLY,PURPOSE,RESULTS,SINCE,SUMMARY,TODAY
BECAUSE,FLA,FOCAL,LABEL,MRI,OBJECTIVE,PURPOSE,RESULTS,SUMMARY
LABEL,MRI,OBJECTIVE,PURPOSE,RESULTS,SUMMARY
215,8201,CARLO,CONVERSELY,LABEL,MATERIALS,METHODS,MONTE,OAR,OBJECTIVE,PHILIPS,PTV,PURPOSE,RESULTS,THERE,TPSS,VMAT,XVMC
CHANGES
023,135,141,161,169,184,1940,2000,2002,2014,276,278,583,7483,782,861,8764,9423,BACKGROUND,CONCLUSION,INSURANCE,JANUARY,LABEL,MALIGNANCY,MATERIALS,METHODS,PHYSICIANS,PRESS,PUBLISHED,RESULTS,SPM,SPMS,UNIVERSITY
11Q23,12P24,259,483,542,945,ANOTHER,APOA5,BUD13,CIS,ORS,SNP,SNPS,VITAMIN
112,132,181,A375,AVPI,CHO,DU145,FOUR,IAP,IC50,INHIBITOR,LEU,M14,MIMICKING,OVERALL,SMAC,TOP
169,2014,947,FIRST,HOWEVER,NR1C3,NR2C2,NRS,PCA,PEROXISOME,PPAR,SOCIETY,THESE,THIRD,TR4,TZD,TZDS
177,8201,99M,BINDING,BT474,ERBB,HER3,IMAGING,ISOLINK,LABEL,MCF7,MEMBRANOUS,METHODS,OBJECTIVE,PURPOSE,RESULTS
ALSO,BACKGROUND,CHIP,DELTA,EZH2,JAK,LABEL,METHODS,PRL,PRLR,PRLRS,PROLACTIN,RESULTS,STAT,WESTERN
116,344,ADDITIONAL,AFTER,AIP,COX,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,RISK
160,MREIT,RES,SINCE,WITHOUT
169,2014,FESEM,NPS,PLA,PLGA,TPGS
169,2014,ART,CONCORD,COPYRIGHT,CTS,HEALTHCARE,IGRT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OPT,PROWESS,PUBLISHED,PURPOSE,RADIATION,REALART,RESULTS,SIEMENS,SOCIETY,THREE,VARIOUS
100,169,2011,2012,2014,ALTO,COPYRIGHT,DMAX,DOSE,ECLIPSE,INC,LABEL,MATERIALS,MEDICAL,METHODS,OBJECTIVE,PALO,PLANS,PTV,PUBLISHED,PURPOSE,RADIATION,RESULTS,SIXTY,SOCIETY,STUDIES,SYSTEMS,THERE,VMAT
100,169,2014,ALTO,COPYRIGHT,CROWN,DOSE,HOWEVER,INC,LABEL,MATERIALS,MEDICAL,METHODS,OBJECTIVE,PALO,PUBLISHED,PURPOSE,RESULTS,SYSTEMS,TEN
0321,122,200,8804,8805,ADVERSE,COIN,DOSIMETRY,DVH,GROUP,HDR,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PTV,PUBLISHED,PURPOSE,RADIATION,RESULTS,THERAPY,THERE,V100PTV,V80BLADDER,V80RECTUM
ADDITIONAL,AREAS,BACKGROUND,COVERED,FDA,LABEL,METHODS,OPINION,SIPULEUCEL,THESE
025,169,200,2014,211,22RV1,8201,BACKGROUND,CHINESE,CLINICALLY,CONNECTIVE,CTGF,EGFR,EMT,EPITHELIAL,ERG,ERK,ETS,HOWEVER,INC,KAZAL,KNOCKDOWN,LABEL,MAPK,MEK,METHODS,PCA,PCAS,PCR,REAL,RESULTS,RWPE,THESE,WESTERN,WILEY
HOWEVER,ZINC
1435,1449,2006,2008,2011,565,577,6508,6528,BEUKEMA,BRUN,FOWLPOX,FPV,PAP,REV,THESE,VACCINE
DENDRITIC,HOWEVER,PHASE
176,201,DNS,EPE,GLEASON,HOWEVER,INSTEAD,NON,PCA
NANOSIZED
AAG,ATRASENTAN,CONCLUSION,DOCETAXEL,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
DU145,EGFR,ERK,ERK1,MEK1,MEK6,MERT,PCA
DESPITE,KNOWLEDGE,MMC,NMIBC,STRATEGIES
160,174,8764,8804,CALYPSO,CYBERKNIFE,INITIAL,RMSE,TRANS
009,027,046,2012,2013,ACUTE,APRIL,BACKGROUND,BETWEEN,BOWEL,CONCLUSION,FAMOTIDINE,GRADE,III,LABEL,METHODS,OBJECTIVE,ORAL,PURPOSE,RESULTS,RTOG
ADT,EGFR,HER2,HER3,HRPCA,NOS,PCA,SEQUENCING,SGCS,TP53
AES,ASSESSMENT,BNSRP,EIGHT,ENCOUNTER,GAQ,HOWEVER,IIEF,INDEX,PDE5,PROFILE,RADICAL,RCTS,SEP
2013,3120,418,GLEASON,HGPIN,HOPKINS,JANUARY,JOHNS,JUNE,PATHOLOGY,PCA,PERINEURAL,PNI,SERVICE
100,AB1,AB2,DNA1,DNA2,REPA,THEREFORE
CASTRATION,CRPC,CSCS,EMT,NOTABLY,REVERSE,THESE
648,ALTERED,AMONG,BACKGROUND,FURTHER,HOWEVER,LABEL,METHODS,MICRORNAS,PCA,PCR,RESULTS,RNAS,THESE,USING
160,ARCAP,BACKGROUND,DHE,DISMUTASE,EMT,LABEL,LNCAP,METHODS,MIGRATION,MITOSOX,MSKE,MTS,MUSCADINE,RESULTS,ROS,SNAIL,SOD,SPECIES,STAT,SUPEROXIDE,THEREFORE
008,120,FIVE,LUNG,NON,PRIMARY
AFTER,BLI,NMIBC
139,171,1998,2011,255,716,759,803,AMONG,HOWEVER,JANUARY,MARCH,PATIENT,PCA,PSA,ROC,THEREFORE
1999,DIFFUSION,HOWEVER,MRI,WHILE
CPRC,CRPC,FDA,HOWEVER,SEVERAL
169,2014,AGING,CONCLUSION,FTOM,LABEL,METHODS,MTOF,OBJECTIVE,PRE,RESULTS,SOCIETY,STUDIES,WHY
001,009,023,2008,2011,335,645,670,8805,BECAUSE,CONCLUSION,EACH,IMRT,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SBRT,STUDIES
8805,CELLSEARCH,CONCLUSION,COX,CTC,CTCS,IDI,III,LABEL,METHODS,OBJECTIVE,PSA,PURPOSE,REGRESSION,RESULTS,ROC,S0421,THESE
169,2014,239,945,946,CAF,CAFS,CCM,INC,PC3,PCA,PRSCS,SILIBININ,SMA,TGF,WILEY
0001,0008,0095,169,177,2014,8201,8805,916,ARG,BACKGROUND,CPD,G129R,IHC,INC,LABEL,MEAN,METHODS,PRL,PRLR,QPCR,RESULTS,SEM,TMA,TMAS,WILEY
169,2014,8201,BACKGROUND,CONCLUSION,CYS,GLU,INC,LABEL,METHODS,PC3,PIP,PLACEMENT,PREVAILING,PSMA,RESULTS,SMALL,THROUGH,USING,WILEY
169,2014,946,AKT,BACKGROUND,CAP,CD44,CELL,DU145,EMT,EXPRESSION,INC,KNOCK,LABEL,LNCAP,METHODS,PCR,PI3K,RESULTS,WESTERN,WILEY,WNT
MOLECULAR
22RV1,BECAUSE,CELL,CORT,CRPC,CWR,DESPITE,DUSP,DUSP1,FLAG,GSK650394,INCREASED,LAPC4,MAP,MDV3100,MKP1,NR3C1,PSA,R1881,SGK1,SGKI,THEREFORE
169,1960S,1991,1992,2000,2002,2004,2010,2013,AIDS,HIV,HODGKIN,INCIDENCE,KAMPALA,NHL,OTHER,THERE,UICC
169,2014,BRITAIN,COPYRIGHT,GREAT,HUNTINGTON,IRELAND,JOHN,JOURNAL,LTD,PATHOLOGY,PUBLISHED,SOCIETY,SONS,VELASCO,WILEY,YESTE,ZDHHC
174,MAPISAL,PREDICTIVE,RADIATION,RRD
101,108,109,129,132,138,163,169,183,200,2013,ALB,CA19,CARLO,CRP,CTRL,CTRLS,EARLY,MONTE,PDAC,SAMPLES,SERA,UICC
001,036,101,124,169,2014,BPH,BPHS,HOWEVER,IGF2,IMP3,PCS,SERUM,THEREFORE,UICC
229,238,384,CCNH,CHINA,CHINESE,CSB,GENOTYPING,MASSARRAY,NER,XPC,XPG
AFTER,BONE,DENOSUMAB,DUAL,GROUP
10TH,161,241,4276,554,8201,BACKGROUND,DATE,EVENTUALLY,LABEL,MAIN,METHODS,OVERALL,PSA,RESULTS
0008,014,115,199,967,BACKGROUND,CIS,FSG,GLEASON,LABEL,METHODS,POLYPHENOL,PSA,RESULTS,THERE
1989,2007,3619,8201,AFTER,ASSESSMENT,BACKGROUND,BCR,CAPRA,CAPSURE,FIVE,LABEL,METHODS,PPV,PSA,RESULTS,RISK,STRATEGIC,THESE,THREE
LABEL,MRI,OBJECTIVE,PURPOSE,RESULTS,SUMMARY,THERE,THESE
LABEL,OBJECTIVE,PURPOSE,RESULTS,SUMMARY
001,169,2014,945,946,954,CCL2,CCL5,CD14,CHLAMYDIA,COPYRIGHT,ICAM,LTD,MYD88,PCR,SEVERAL,TLR,TLR2,TLR4,TNF,TOLL,VEGF
169,2014,COPYRIGHT,GLEASON,GMBH,HOWEVER,PROSTATIC,THERE,THESE
169,2002,2007,2014,4772,BACKGROUND,COPYRIGHT,COX,LABEL,LTD,MEIER,METHODS,OVERALL,REGARDING,RESULTS
169,2014,COPYRIGHT,LTD,PCA
001,028,100,125,160,169,2014,COPYRIGHT,D90,DOSE,EMULATING,HELP,HIGH,INC,LABEL,LOW,MATERIALS,METHODS,OBJECTIVE,PLACING,PUBLISHED,PURPOSE,RATE,RESULTS,SOCIETY,THERE,V100
169,2004,2014,COPYRIGHT,EVEN,HOWEVER,IRELAND,LTD
000,148,169,1975,1980,2005,2009,2010,2012,2014,233,355,AFTER,BACKGROUND,CONCLUSION,COPYRIGHT,INCIDENCE,LABEL,METHODS,MORTALITY,RESULTS,SAS
02GY,03GY,04GY,12GY,15GY,160,169,2014,57GY,5GY,62GY,63GY,89GY,AFTER,COPYRIGHT,CTV,CTV1,CTV2,D90,DOSE,INC,IPS,LABEL,MATERIALS,METHODS,OARS,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,SOCIETY,V200
739,AP1,BACKGROUND,BASED,EPITHELIAL,INDUCED,LABEL,MET,MYC,NFKB1,OVOL,OVOLS,REFLECTING,RESULTS,STAT1,STAT3,TFS,THESE,TRANSITION
169,1997,2012,2014,BMI,CONCLUSION,COPYRIGHT,DISCUSSION,JANUARY,JULY,LABEL,METHODS,OBJECTIVE,RESULTS,SAS
CANCERS,CUTANEOUS
001,002,1559,169,2005,2013,2014,8805,ACCORDING,AUTHORS,BCR,BJU,COX,GLEASON,LABEL,METHODS,NCCN,NETWORK,OBJECTIVE,PCA,RESULTS
111,169,2013,245,AUTHORS,BJU,BOTH,EPWORTH,HEALTHCARE,HOWEVER,LABEL,MACCALLUM,MELBOURNE,METHODS,OBJECTIVE,PETER,RESULTS,TRUS
100,169,190,2014,8804,ANGELES,CALIFORNIA,CONTINENCE,INDEX,LABEL,LOS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,UNIVERSITY,URINE,UROLOGICAL
001,140,169,1995,2009,2014,239,474,8201,8805,ADT,AFTER,AMI,AUTHORS,BJU,CAD,COMPETING,END,GNRH,LABEL,METHODS,OBJECTIVE,OVERALL,RESULTS,SCD,SEER,USA
169,2014,581,AUTHORS,BJU,CONSOLE,DATA,GLEASON,LABEL,MATERIALS,METHODS,OBJECTIVE,PROPENSITY,RALP,RESULTS,RETZIUS,THERE
120,1998,2003,2006,2007,2011,228,BETWEEN,GLEASON,LABEL,LOW,METHODS,NPCR,OBJECTIVE,PSA,RESULTS,T1C,USING
000,100,120,240,308,308A,5537,8059,AIM,ALSO,BESIDES,CALPHAP,CROATIA,EASTERN,GLEASON,INSTRUMENT,PCR,PHD,ROCHE,SNP,SNPS,THERE,THESE,TNF,V50
2012,2013,CONDITIONS,FEDERAL,ICD,LIST,PROGRAM,RELATED,SEPTEMBER,THROUGH,TRADE,WORLD,WTC
169,2014,945,946,BECAUSE,BIOLOGISTS,COMPANY,FAK,LTD,PTK2,PUBLISHED,THESE
1210,1577,1990,1999,2000,2009,2471373,4528134,878,985,BACKGROUND,INCIDENCE,LABEL,METHODS,PSA,RATE,RESULTS,THERE
133B,133BM,169,178,2014,AACR,CCK,COX,LABEL,LNCAP,METHODS,OBJECTIVE,PCR,RESULTS,WESTERN
169,2008,2013,2014,HOWEVER,INC,WILEY
174,223,8482,ALPHARADIN,CRPC,III,THUS
945,HIF,HOWEVER,HYPOXIA,MMP,PC3,SNAIL,TNF
169,181,2014,8201,BACKGROUND,CYP17A1,DHEA,ESPECIALLY,H295R,HOWEVER,INC,INHIBITION,LABEL,METHODS,PIC,RESULTS,RSV,RSVDA,RSVTA,RSVTM,SECRETION,STEROID,SULT1E1,TREATMENT,WILEY
1ST,2ND,344,392,3RD,4TH,736,8201,BOTH,COMPARISON,GENOTYPING,GPX1,GSTP1,MNSOD,PCA,PCR,PSA,RUSSIAN,SNP,SNPS
145,169,2014,8201,BACKGROUND,BOTH,CH2,CH3,CONCLUSION,DOTA,F11,IGG3,INC,LABEL,METHODS,MONOCLONAL,OTHER,PET,PSMA,RESULTS,SINCE,WILEY
2003,BRCA2,EMSY
001,029,169,2014,945,AACR,ADDITIONAL,ATTITUDES,BACKGROUND,BANKS,BIOBANKING,CONTENT,ENGLISH,INTENTION,ITEMS,KNOWLEDGE,LABEL,METHODS,RESULTS,SPANISH
001,015,100,200,BLACK,CONCLUSION,HIGH,HRQOL,LABEL,MEAN,METHODS,OBJECTIVE,OVERALL,PATIENT,PURPOSE,RESULTS,SCALE,THESE,UTILITY,WHITE
0001,100,110,398,407,805,8805,COX,GLEASON,LABEL,LRP,MATERIALS,MEAN,METHODS,OBJECTIVE,OVERALL,PCA,PSA,PURPOSE,RARP,RESULTS,RFS,RRP,THERE
FURTHER,TEPHROSIA
169,2014,221,947,AACR,IFN,IRF2,JAK,SOCS3,STAT,STAT1,STAT3
169,2014,231,47D,946,956,ACTIVATION,AMP,AMPK,COPYRIGHT,DU145,FINALLY,INC,LRP6,MDA,WNT
10A,10D,10H,10K,12A,160,169,2014,205,549,945,946,COLO,COPYRIGHT,HRMS,IC50,MTT,NMR,PANC,SAS
169,2014,954,COPYRIGHT,FEDERATION,PUBLISHED,RAS,RASSF,SOCIETIES
100,169,2014,27632,956,COPYRIGHT,EMD638683,FEDERATION,GSK650349,NHE,NHE1,PI3K,PUBLISHED,RHO,ROCK,SGK1,SOCIETIES,TAC,THUS
150NM,169,176,2014,24H,500,8764,956,COPYRIGHT,FINALLY,FURTHER,MNPS,PAC,PC3,R11
0001,0086,022,038,215,8201,ASSESSING,CRPC,ERG,FUNCTIONAL,GLEASON,KETTERING,MSKCC,PCA,PTEN,RESULTS,SLOAN,SWEDISH
169,2014,AKT,ALTERED,COPYRIGHT,DEPLETION,ENABLED,INC,PI3K,PTEN,RAMAN,THESE
169,2014,AKT,COPYRIGHT,INC,PI3K,PTEN,YUE
8212,ALTOGETHER,ATPASES,THEREFORE,THESE
BOTH,ID1,INHIBITOR,PC3,SIMILAR
000,001,100,2003,2009,ASR,BACKGROUND,BLADDER,EDUCATION,IRAN,LABEL,MATERIALS,MEDICAL,METHODS,RESULTS,UROLOGICAL
2013,283,301,302,343,940,ASSESSMENT,BACKGROUND,BASED,CONCLUTIOS,COU,DATA,EVALUATION,GRADE,GRADING,HRS,JULY,LABEL,LIBRARY,LITERATURE,METHODS,PSA,QUALITY,RCT,RCTS,RESULTS,RPFS,SCIENCE,STATA,SUMMARY,TEN,THEREFORE,TTPP,WEB
APOPTOSIS,CELL,CRPC,HSC70,HSP70,HSP72,HSP90,PCA,RWPE,THESE,UTMD,VCAP,WESTERN
0001,0002,0123,0168,945,APAI,BACKGROUND,BPH,BSMI,CYP17,FOKI,LABEL,MATERIALS,METHODS,PCR,RESULTS,SNPS,TAQ,VDR

177,215,945,956,BCH,BNCT,CONCLUSION,HIGH,HPLC,ICP,LABEL,MATERIALS,METHODS,MTS,OBJECTIVE,PURPOSE,RESULTS
13527,1825,19191,1977,1988,1992,2001,2002,2011,2020,2153,32718,4178,AFIP,ARMED,COMPARISON,CONCLUSION,DEPARTMENT,INSTITUTE,LABEL,METHODS,OBJECTIVE,PATHOLOGY,RAWALPINDI,RESULTS,SPSS,TUMOURS
0001,117,459,AMICO,BOTH,EIGHT,FIFTY,FIRST,FOUR,GLEASON,LABEL,LYMPH,METHODS,OBJECTIVE,RESULTS,THEN
0076,0121,169,2014,8201,GLEASON,INC,JAG1,JAGGED1,LNCAP,PC3,PSA,SPRY1,THESE,WILEY
127,169,197,1995,2001,2014,206,8201,AFTER,AST,BACKGROUND,FINE,GLEASON,GRAY,LABEL,METHODS,PCSM,RESULTS,SOCIETY,THERE
177,187,383,8201,ABZ4,BBN,GGG,GSG,IC50,IR800,LABEL,METHODS,NH2,NIRF,OBJECTIVE,PROCEDURES,PURPOSE,RESULTS,T47D
174,223,BECAUSE,CRPC,DRUG,EMA,FDA,FOOD,MEDICINES
145,8209,CCL11,CCR,CCR3,CCR5,CHEMOKINES,ELISA,EOTAXIN,ERK,ERK1,KNOCKDOWN,MEK,MMP,PCR,THUS,U0126
0001,001,015,8804,8805,BACKGROUND,CONCLUSION,CONVERSELY,DRE,DSM,ESI,FURTHER,LABEL,METHODS,PCA,PSA,RESULTS,STUDIES,THEREFORE,USING
001,002,2012,2014,392,600,BASED,BASEL,BETWEEN,GERMANY,GPS,ISS,LABEL,MAY,METHODS,MLRA,OBJECTIVE,OBJECTIVES,PCA,PSA,RESULTS
169,184,2007,2012,2014,425,921,CHARLOTTE,COPYRIGHT,EDUCATION,EFFORTS,INC,LABEL,MATERIALS,METHODS,NORTH,OBJECTIVE,PREMIER,PUBLISHED,PURPOSE,RESULTS,SURGERY,UROLOGICAL
018,024,027,033,043,045,049,160,169,172,174,2014,279,COPYRIGHT,DAILY,EDUCATION,IIEF,INC,LABEL,MATERIALS,MEDICATION,METHODS,OBJECTIVE,PSS,PUBLISHED,PURPOSE,RAND,RESULTS,UROLOGICAL
160,169,2014,233,COPYRIGHT,EARLY,EDUCATION,INC,IQR,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL,USING
001,006,2014,466,8805,BASEL,CONTROLLED,IPSS,LABEL,MATERIALS,MEDLINE,METHODS,OBJECTIVE,PCA,RCTS,RESULTS,SCORE,SMD,SYMPTOM,THREE
169,2004,2009,2014,5556,7878,ADT,BACKGROUND,COPYRIGHT,END,LABEL,METHODS,OBJECTIVE,ORP,OUTCOME,PATIENT,PROPENSITY,PUBLISHED,RARP,RESULTS,ROBOT,SETTING,SUMMARY,UROLOGY
001,169,177,2014,325,729,828,8805,956,ADC,CONCLUSION,COPYRIGHT,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PCA,PEARSON,PURPOSE,RESULTS,THERE
001,122,2001,2008,280,647,679,836,979,BACKGROUND,BCR,LABEL,METHODS,ONCOLOGIC,POTENCY,PSA,QUALITY,RESULTS,THERE
0001,006,169,1994,2012,2014,2061,258,5124,680,7443,752,AABB,BACKGROUND,BETWEEN,BRFS,CONCLUSION,COX,CSS,LABEL,MEIER,METHODS,NOTABLY,PCSS,POTENTIAL,RESULTS
001,177,8201,AREAS,CONCLUSION,DIL,DILS,DVHS,IMRT,INTENSITY,KNOWLEDGE,LABEL,METHODS,MRI,NTCP,NTCPS,OBJECTIVE,RESULTS,TCP
947,AKT,BASED,CD8,ERK1,IFN,NAIVE,PBMC,RADIATION,TCR,TH1,THESE,WHEREAS
190,214,946,AKT,P2X4,PHLPP,PTEN,TGF
0001,003,169,2014,368,725,736,EGGER,HIGH,INCLUSION,JANUARY,LITERATURE,MANAGER,MEDLINE,RRS,UICC
187,220,365,AFTER,CHOLINE,CONCLUSION,CT0,CT1,DOSES,GRADE,GROUP,HIGH,HTT,LABEL,LNS,METHODS,OBJECTIVE,PCA,PET,PSA,PSA0,PSA1,PURPOSE,RADIATION,RESULTS,RTOG,SIB,THERAPY
009,036,047,052,587,BACKGROUND,LABEL,METABOLIC,METHODS,RESULTS
169,2014,AACR,HOWEVER
002,005,ALLOCATION,BACKGROUND,CENTRAL,CONCLUSION,CONTROLLED,FAES,HOWEVER,INCREASED,LABEL,MEDLINE,METHODS,RESULTS
806,8322,945,CLU,COCL,HIF,HOWEVER,HRE,HRES,LNCAP,PC3M,PCR,PRO,USING
013,113,183,215,441,6P21,BACKGROUND,BIOVU,CLL,CONCLUSION,DLBCL,GWAS,HODGKIN,INITIATIVE,LABEL,LSP1,METHODS,MSH5,MSMB,NHL,OBJECTIVE,PAGE,POPULATION,RESULTS,RISK,SLL,SNPS,TERT,TET2,WOMEN
22RV1,BRDU,CHOP,DIET,GADD153,LNCAP,MTT,TAKEN,THESE,UNION,USING,WESTERN
004,113,ASSIGNING,AUC,DCE,DWI,HOWEVER,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,RADS,RESULTS,T2WI
001,131,178,293,8201,8805,AFTER,BACKGROUND,CAB,CTC3,KATTANS,LABEL,LAPC,LYMPH,METHODS,MRI,NCHT,PATHOLOGIC,POST,PRIMARY,PSA,RESULTS,SECONDARY,WHILE
101,200,502,506,EMT,EPITHELIAL,FURTHER,MET,MIRNA,SET8
AIM,CELL,G2M,LABEL,METHODS,MSC,MTT,OBJECTIVE,RESULTS
FOCAL,MEDICAL,PATHOLOGY,RADIATION,RADIOLOGY,SYMPOSIUM,TREATMENT,UROLOGY
AMP,BACKGROUND,COX1,HIF,LABEL,MCT1,MCT4,MCTS,METHODS,PCA,RESULTS,ROLE,THEREFORE,TPE
001,1989,1999,200,2012,247,347,348,695,BACKGROUND,BETWEEN,GROUP,HOWEVER,LABEL,METHODS,RADICAL,RESULTS,SECONDARY,SOCIETY,SPCG,SWEDISH
133,169,199,2014,253,8201,8482,AUSTRALIAN,BACKGROUND,BVI3000,BVI9400,CBCT,COLLEGE,DATA,LABEL,METHODS,RESULTS,ROYAL,TREATMENT,ZEALAND
169,2014,370,8201,BACKGROUND,BRITISH,EPH,EPHA2,EVEN,KEY,LABEL,METHODS,OBJECTIVE,PC3,PURPOSE,RESULTS,SOCIETY,TRP
RELEASE,THESE
114,2011,221,268,ANTIGEN,ATHS,BACKGROUND,HOWEVER,LABEL,METHODS,MOST,OBJECTIVE,OCTOBER,PSA,RESULTS,THESE
100,AIM,ANTI,CONCLUSION,FOXA1,HER2,LABEL,MATERIALS,METHODS,MOST,OBJECTIVE,PGR,PSA,RESULTS,THEREFORE
005,126,1ST,2008,2012,213,2ND,BACKGROUND,HOWEVER,JANUARY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RATE,REMISSION,RESULTS,SEPTEMBER
ACS,ACT,ACUTE,CAD,CARDIAC,CONCLUSION,GENSINI,GRACE,INFARCTION,LABEL,MACES,MATERIALS,METHODS,MYOCARDIAL,NSTE,OBJECTIVE,PSA,PURPOSE,RESULTS,SERUM,SIXTY,STEMI,THERE,TIMI,WHILE
001,177,190,COMPOSITE,CONCLUSION,EPIC,HOLMIUM,INDEX,IPSS,LABEL,LSUS,MATERIALS,MAXIMUM,METHODS,NONE,OBJECTIVE,PURPOSE,QMAX,QOL,RESULTS,SCORE,SYMPTOM
HOWEVER,INFECTIOUS,PATHOGENIC
ACTIVATING,CHINESE,DELETIONS,EGFR,GLEASON,IHC,KRAS,L858R,MUTATIONS,PCA,THERE,TKIS
177,18F,215,ADC,ADCMEAN,ADCS,CONCLUSION,DIFFUSION,FIFTY,FURTHER,LABEL,METHODS,MRI,OBJECTIVE,PET,RESULTS,SUVMEAN,SUVS,THERE
ASIA,ASIAN,CONVERSELY,PSA,WESTERN,WESTERNERS
145,BACKGROUND,BMEC,BONE,CAP,FUNCTIONS,GFP,INHIBITION,LABEL,METHODS,PC3,PUFA,RESULTS,RHO,RHOA,RHOC,ROCK1,ROCK2,SELECTIVE,SIM,TEM
012,100,181,22RV1,8202,BPA,DOSE,LNCAP,NPREC,PSA,RWPE,THESE
001,8810,ART,DESPITE,EACH,NAF,NEITHER,PET,SIXTEEN,SKELETONS,TEN,THREE,TRT
117,150,168,177,191,ATLAS,DESPITE,DICE,HAUSDORFF,PET,SIXTEEN,SKELETONS,THEREFORE
116,FINALLY,RESULTS,THEN
NSE,THEREFORE,TURP
COMPOSITE,EPIC,INDEX,JAPAN,QOL,SWITCHING
177,227,5146,705,946,BMJ,BRITISH,GROUP,HOWEVER,IFN,LABEL,LIMITED,METHODS,OBJECTIVE,PUBLISHED,PUBLISHING,RESULTS,STATISTICS,THERE,USING,VITAL
001,005,0815,127,169,1989,2000,2014,268,333,8805,ADT,AFTER,BACKGROUND,COMBOGS,CONCLUSION,COPYRIGHT,GPC,INC,INCREASING,JULY,LABEL,MEN,METHODS,PCSM,RESULTS,RTOG,WHETHER
0000001,068,081,169,2003,2007,2014,474,615,639,AFRICAN,AMERICANS,CAUCASIAN,COPYRIGHT,HGPC,JANUARY,LABEL,METHODS,OBJECTIVE,PSA,PSAV,RECORDS,REPRINT,RESULTS,STUDENT
100,160,169,176,2011,2013,500,5895,8805,946,AMP,COPYRIGHT,ESBL,GROUP,INFECTION,INFECTIOUS,JANUARY,JRGU,LTD,NOTABLY,PUBLISHED,SIMILARLY,SOCIETY,TRACT,URINARY
019,169,2014,859,COPYRIGHT,EDUCATION,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PLCO,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
DIGITAL,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,VARIOUS,YOUNG
1000,176,2100,215,8201,8764,ARRAY,DISCOVERY,ERUS,FOCUSED,INSIGHTEC,ISATA,LABEL,LTD,METHODS,MHZ,NUMERICAL,OBJECTIVE,PRFS,PURPOSE,RESULTS,TMAX,TREATABLE
100,120,140,165,241,274,947,BASED,CTDIVOL,IMRT,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
100,177,ABAS,ART,CTS,CTV,DICE,DSC,DSCS,IGRT,IMRT,LABEL,LARGE,METHODS,OAR,OARS,OBJECTIVE,PTV,PURPOSE,RESULTS,SIEMENS,THREE,V100,V45GY,V60GY
003,2008,2010,AUC,AUCS,CAD,CONCLUSION,DIAGNOSTIC,LABEL,MATERIALS,MEAN,METHODS,OBJECTIVE,PURPOSE,RESULTS,ROC,SEPTEMBER,SEVEN
2006,EBP,INSTITUTE
CNB,ECM
LAM,PIVOTAL,THESE,TSC
8764,ERG,THUS,TMPRSS2,TREATMENT,USP9X,VCAP
169,2014,ADT,CURRENT,SOCIETY
114,194,GLEASON,GRAND,JOURNAL,LABORATORY,PSA
299,470,645,680,AFTER,CONCLUSION,EARLY,III,LABEL,MEN,METHODS,OBJECTIVE,OVERALL,PRIMARY,PURPOSE,RATES,RESULTS,SRE,SRES,ZOLEDRONIC
266,661,CHRONIC,FAT,NETWORK,PERINEURAL,REPORTING,TOTAL,WHILE
169,2013,916,HSC70,MYC,TPX2,UICC,VCAP
148,169,2013,737,FDRS,PAF,PAFS,SDRS,SIRS,SWEDISH,UICC
DESPITE,LATINAS,THEIR
165,239,8201,BACKGROUND,DRE,GLEASON,LABEL,METHODS,PSA,RESULTS,TPTPB,TRUS
129,475,670,AGE,BACKGROUND,BED,CONCLUSION,COX,FFBR,LABEL,MEIER,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,VARIABLES
169,2014,COPYRIGHT,DU145,GPNMB,HOWEVER,INC,MMP,NON,PC3,PCA
1780,1978,2008,6976,8764,BMI,CIS,COX,FOLLOWING,HOWEVER,HRS,LITHUANIAN,SMOKING,UADT
292,300,786,794,A172,CTL,EF292,EF786,HLA,HNSCC,HODGKIN,IGG,KNOCKDOWN,MCF7,NHL,PBMCS,PC14,PCI6,TAAS,THESE
CHINESE
00001,002,007,169,2014,967,BACKGROUND,BETWEEN,CENTRAL,CONCLUSION,CONTROLLED,COPYRIGHT,EGGER,FIXED,INC,LABEL,MATERIALS,MEDLINE,METHODS,OVERALL,PCSM,RADICAL,RESULTS,SCIENCE,SEVENTEEN,SURGERY,WEB
497,CRP,CSS,DATA,HOWEVER,PCA,PFS,RELATED,SEVERAL
ADP,BRCA,ETS,PARP,PARP1,PTEN
CXCR2,IL8,MOST,P53,PCAS,PSA,SCNC,THERE
METASTASIS,METASTATIC,VARIOUS
DCE,DWI,MRI,TRUS,WORLD
001,1036,169,2014,238,511,549,557,704,8804,AUC,AUTHORS,BECKMAN,BJU,CONCLUSION,COULTER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PCA,PHI,PRO,PROMETHEUS,PSA,RESULTS
001,169,2014,561,8805,AUTHORS,BJU,CRPC,INDIVIDUAL,LABEL,METHODS,OBJECTIVE,PFS,RESULTS
169,2014,697,ABOUT,AFTER,AUTHORS,BJU,DISEASE,EBRT,HRQL,ICED,INDEX,LABEL,METHODS,OBJECTIVE,REGRESSION,RESULTS
001,004,1146,169,2014,384,AFTER,AUTHORS,BCR,BJU,CONCLUSION,COX,EQUAL,GIVEN,LABEL,METHODS,OBJECTIVE,POST,RESULTS,WHETHER
CAP,CONTROL,CURRENT,GLEASON,THESE,TNM,UNION,WESTERN
STUDIES
169,2013,8211,ABL1,BCR,BRITAIN,COPYRIGHT,DRUG,FGFR,FGFR1,FGFR2,FGFR3,GREAT,IRELAND,JOHN,LTD,PUBLISHED,SOCIETY,SONS,WILEY
GASTRIC,HOWEVER
954,BACKGROUND,LABEL,METHODS,NUCLEAR,PAL,RESULTS,THESE
1000,500,AMONG,HIGH,IMS,MALDI,OCT,OPLS,PAS,PES,PIS,THESE
1784,2188,246,3840,400,457,ECM,EXOME,LNCAP,MLCK,THESE
945,946,AGR,CASPASE,FAILURE,LOSS,PC3,PROTEIN,THESE,TRAIL
DU145,HOWEVER,THESE
0003,0009,0022,0086,0178,0467,0823,181,215,8202,CALCITRIOL,HOWEVER,MWF,OVERALL,THEREFORE,TRAMP
0001,0208,228,7P15,8202,8Q24,947,FINNISH,POISSON,PRCA,SIMILAR,THESE
034,2010,2012,287,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS,TPUS
945,BTG2,CPT,DOX,GGAGTCC,GGCAGAGCCC,GGGAAAGTCC,IMMUNOBLOT,LNCAP,PSA,TRANSIENT
181,DEPENDING,NEURITE,RGD,SCLC,SCLCS,SMALL
002,005,020,022,664,702,8202,CHINESE,IGF,IGFBP,INSULIN,NINE,PCA,SNPS
ALZHEIMER,CANCERS,CENTRAL,CNS,COLORECTAL,LUNG,NERVOUS,P53,PARKINSON,PIN1,THERE,THESE,WNT
001,044,108,125,143,158,210,251,270,426,8805,ASSESSMENT,BACKGROUND,FOUR,GLEASON,JAPAN,LABEL,METHODS,RESULTS,RISK
169,2014,BCL,CDK2,CURRENT,INC,RU486,WILEY
AFTER,CASE,LABEL,MATERIALS,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS
169,2014,272,8805,AACR,BACKGROUND,GLEASON,LABEL,METHODS,NEITHER,NUTRITION,OBESITY,PREVENTION,RESULTS,THESE
BACKGROUND,BMI,BPH,DFRS,FINALLY,INDEX,KEY,LABEL,LOAD,RDA,RESULTS,WHR,WHTR
123,2013,455,461,8805,909,CIS,GLEASON,HOWEVER,JUNE,LABEL,METHODS,OBJECTIVE,ORS,PURPOSE,RESULTS,SYSTEMATIC
181,AKT,APOPTOSIS,BAX,BCL,DIAMIDINO,DU145,JUN,PI3K
134,2013,351,397,884,945,BIOLOGY,CAUCASIANS,CBM,CHINA,CIS,CNKI,HOWEVER,IVS1,ORS,PVUII,RESULTS,XBAI
001,0039,012,015,DU145,HBXAP,HOWEVER,PSA,RSF,THERE
003,007,008,015,031,100,165,190,254,518,8209,967,CRS,DBS,DIFFUSION,DWI,FORTY,GBS,GLEASON,GSS,HGG,HGG3,HGG4,HGG5,HGGS,MCNEMAR,MRI,MRS,PCA,TRUS
169,2014,ATM,MECHANISM,PCA,PRESS,PUBLISHED,RWPE1,TESTICULAR,TR4,UNIVERSITY,USING
2AX,8201,CHK1,DU145,GLIONITRIN,RAD3,SER1778,TAKEN
0008,103,125B,222,CAP,CPG,MICROARRAY,PCR,PREDICTION,PSA,THESE
169,2014,COPYRIGHT,DPV,OVERALL,PPY,PSA,SEM
130,226L,AMD3100,ANOIKIS,CD24,CD44,CXCR4,FACS,HOWEVER,MCF7,MFE,SDF,SKBR3,T47D
169,2014,CDC6,COPYRIGHT,E2F,FOXM1,INDIRECTLY,PCA,THESE,THROUGH,USING
169,2014,BIP,COPYRIGHT,GLUCOSE,GRP78,HCC,HCCS,HEPG2,INC,PCR,SORAFENIB,WESTERN
116,169,18B,2014,969,COPYRIGHT,EARLY,H460,HCT,PC3,SAS,THESE
001,134,1344,169,2005,2014,8804,8805,ACCORDING,BACKGROUND,CONCLUSION,COPYRIGHT,GLEASON,INC,ISUP,LABEL,MATERIALS,METHODS,PATHOLOGY,PSA,RESULTS,SOCIETY,UROLOGICAL,USING
INC,LNCAP,NAP,PUBLISHED,SET,THESE,TSPY,VARIOUS
169,2014,806,8482,CAPSURE,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PCI,PROVIDERS,PUBLISHED,PURPOSE,RESULTS,SECONDARY,UCLA,URINARY,UROLOGICAL,WHILE,YOUNGER
0001,0008,0065,015,169,2012,2013,2014,793,COPYRIGHT,EDUCATION,INC,JUNE,LABEL,MARCH,MATERIALS,MEN,METHODS,MUSIC,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THERE,THESE,UROLOGICAL,WHILE
100,169,174,2014,AUC,CHEMPRO,COPYRIGHT,EDUCATION,INC,LABEL,LEAVE,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL,USING
001,101,123,160,169,1995,2003,2014,294,627,683,850,AFTER,ASIAN,CLPC,CONCLUSION,COPYRIGHT,COX,EDUCATION,END,FOUNDATION,HISPANICS,INC,JANUARY,LABEL,MAYO,MEDICAL,METHODS,OBJECTIVE,OVERALL,PUBLISHED,RESULTS,THESE,TREATMENT
169,2014,ADC,ASSESSMENT,COLLEGE,COPYRIGHT,DIFFUSION,DWI,LTD,MRI,PREDICTION,PUBLISHED,RCC,ROYAL
0003,118,169,170,183,190,1998,2001,2011,2014,221,236,391,421,422,843,862,AUG,BACKGROUND,BASED,BETWEEN,COPYRIGHT,COUNCIL,DEARNALEY,DEC,FUNDING,IQR,JAN,LABEL,LTD,MEDICAL,METHODS,NEITHER,OPEN,OVERALL,PUBLISHED,RESULTS,RT01,T1B,T3A,THESE,TREATMENT
169,2014,8Q24,COPYRIGHT,INC,OCT4,POU5F1B,PUBLISHED,SEVERAL,SOCIETY
COLOR,DOPPLER,INC,PUBLISHED
169,177,2014,946,BAX,BCL,CD31,COPYRIGHT,GMBH,PAS,PCA,TAKEN
0001,0005,0011,0040,0139,0162,0295,160,169,193,2014,ADL,CLINICIANS,CONCLUSION,COPYRIGHT,IADL,INC,LABEL,MEDICAL,METHODS,OBJECTIVE,PANEL,QOL,RESULTS,USING
001,008,061,088,100,160,169,1992,2009,2014,341,440,543,CONCLUSION,COPYRIGHT,END,HOWEVER,INC,LABEL,MEN,METHODS,OBJECTIVE,PROPENSITY,RESULTS,SCT,SRP,THERE
160,169,2012,2013,2014,BACKGROUND,CONCLUSION,COPYRIGHT,FIFTY,FORM,FURTHER,ICIQ,INC,JUNE,LABEL,METHODS,PEARSON,POSTERIOR,RARP,ROCCO,SCORE,SHORT,SUPPORT,SYMPTOM,TECHNICAL
005,017,160,169,2014,CONCLUSION,COPYRIGHT,CORE,GLEASON,INC,LABEL,METHODS,OBJECTIVE,RESULTS,THOSE
100,160,169,2014,8805,CONCLUSION,COPYRIGHT,DUTCH,FINDING,GLEASON,INC,LABEL,LINKAGE,MEN,METHODS,MRI,OBJECTIVE,PCA3,PCS,RESULTS,T1C
169,2014,COPYRIGHT,GIVEN,HIGH,INC,PSA
038,160,169,2009,2014,8805,CONCLUSION,COPYRIGHT,HOWEVER,INC,LABEL,LUTS,METHODS,OBJECTIVE,RESULTS,SCORE
001,169,2014,8201,AUSTRALIAN,BACKGROUND,COLLEGE,CONCLUSION,D95,GRADE,LABEL,METHODS,MRI,POST,RESULTS,ROYAL,SECONDARY,TEN,TREATMENT,V30,V40,V65,V70,V75,V80,ZEALAND
169,2013,AIMS,BACKGROUND,FOCUS,JOHN,LABEL,LTD,MEN,METHODS,OBJECTIVE,OBJECTIVES,PREDICTORS,RELEVANCE,RESULTS,SONS,THERE,UNIVARIATE,WILEY,WIVES
0001,0014,014,108,135,184,2009,2012,232,8804,8805,CONCLUSION,CONTINENCE,ESI,IIEF,INDEX,LABEL,METHODS,OBJECTIVE,PSA,RARP,RESULTS,SCP,SELF,USING
CONFORMAL,IMRT
ALSO,BACKGROUND,BESIDES,CONCLUSION,FIG,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OUTPATIENT,PCA,PSA,PTH,REF,RESULTS,SERUM,TAB,UROLOGY,YET
145,2009,5MM,ACUTE,AFTER,BACKGROUND,BPH,CONCLUSION,CONSISTED,JANUARY,LABEL,LAGOS,LUTH,METHODS,NIGERIA,NIGERIANS,OBJECTIVE,RESULTS,THERE,WHOLE
ANOTHER,CROHN,DESPITE,HOWEVER,RESULTS
AFRICAN,BACKGROUND,CASE,CONCLUSION,CUTANEOUS,ENGLISH,LABEL,MANAGEMENT,NIGERIA
THUS
349,CTS,DSC,IGRT,ILSM,IMAGE,VALIDATED
LABEL,METHODS,RESULTS,ROC,UNLABELLED
HAAR,HOWEVER,IMAGE,ISA
DUE,KPCA,LAPLACIAN,NLDR,PCA,PSA,VINK
GPUS,T2W
CURRENT
SEVERAL,TRUS
8308,8310,8322,8324,ALA,AR06,CONCLUSION,GLEASON,GLN,GLY,GRPR,LABEL,LEUNH,METHODS,PEG,PET,PHE,RESULTS,STA,T1C,T2B,TE2A,THREE,TRP,UNLABELLED,VAL
100,169,2014,COPYRIGHT,FIVE,GATA,GATA3,INC,WILEY
110,169,176,2014,BACKGROUND,BLOOD,HOWEVER,INC,INDEX,LABEL,MEAN,METHODS,PRO,PSA,RESULTS,THUS,WHOLE,WILEY
024,510,997,AFTER,CONCLUSION,FDG,FOM,LABEL,MEN,METHODS,NAF,NOPR,ONCOLOGIC,PET,POM,REFERRING,RESULTS,UNDER,UNLABELLED
095,107,116,125,366,661,CONCLUSION,HIGH,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SURVIVORS,UNASSIGNED
102,174,LABEL,MAIN,MEDICAL,METHODS,MOS,MOST,NURSING,OBJECTIVE,OBJECTIVES,OPEN,PROGRAM,PURPOSE,RESULTS,SETTING,SURVIVORS,VARIABLES
1095,124,131,300,BACKGROUND,BASED,CONCLUSION,DOSIMETRY,EACH,EXM,GBQ,HIGH,LABEL,MBQ,METHODS,MIP,PCA,PET,PSA,PSMA,RESULTS,SINCE,SIXTEEN,VOLUMES
AZD1480,ERK1,HOWEVER,JAK,JAK1,METASTATIC,MOST,STAT3
206,8201,880,ASP,EUROPEANS,GLU,GLU298ASP,NOS3
001,007,10924,1986,2011,2183,2936,5119,5805,BACKGROUND,CLEVELAND,COMPETING,EBRT,LABEL,MDS,METHODS,OVERALL,RESULTS
169,2014,BACKGROUND,COLORECTAL,FINAL,FIVE,HOWEVER,IMPUTATION,INITIALLY,LABEL,LCS,LUNG,METHODS,NLST,OVARIAN,PLCO,RESULTS,SCREENING,SOCIETY,TRIAL
151,AFTER,BACKGROUND,BPFS,CONCLUSION,COX,GLEASON,HOWEVER,LABEL,METHODS,OBJECTIVE,OVERALL,PARAMETERS,PCSS,PSA,PSADT,PURPOSE,RESULTS,SRT,UNIVARIATE
001,011,023,029,1276,177,8201,8805,C30,DATA,GLEASON,GNRH,HRQOL,PR25,QLQ,TREATMENT
00001,945,BESIDES,HIF,P582S,STUDIES,THERE
103,108,141,164,305,BASED,CCP,CLINICIANS,CONCLUSION,CONVERSELY,LABEL,METHODS,OBJECTIVE,OVERALL,PHYSICIANS,POST,PRE,RESULTS,TEST,THERE,TREATMENT
BACKGROUND,DOG,DOGS,HOWEVER,LABEL,METHODS,OVERALL,RESULTS,STAGE,TEST,TESTS,THREE
2004,223,CRPC,DRUG,FOOD,III,SELECTION,TEN,TODAY
118,169,2014,218,ADT,AKT,DU145,HOWEVER,JAGGED1,LABEL,LAPC4,LNCAP,NOTCH,PC3,THESE,THROUGH,UNLABELLED
1996,2010,515,533,982,AMONG,COMPETING,CUMULATIVE,LABEL,MAIN,METHODS,OBJECTIVE,OUTCOME,RESULTS,SETTING,SEVERAL,YOUNGER
109,153,406,ANN,CAD,CONCLUSION,HOWEVER,LABEL,MATERIALS,METHODS,NPV,OBJECTIVE,PPV,PPVS,RESULTS,ROC,THERE
22RV1,CAO,CHINESE,HOWEVER,LNCAP,PSA

8805,ACCORDING,DCE,DWI,FUNCTIONAL,GLEASON,MRI,MRS,RADS
BASED,PSA,THESE,WHOLE
ANCTS,CCK,ERK,FIRST,HOWEVER,IHC,LOX,LYSYL,MAPK,MMP,MMPS,NEXT,PI3K,SIMILARLY
15R,945,ANIMALS,CD8,INHIBITION,TRAMP,TUBO
150,AFTER,AUSTRALIA,BACKGROUND,COMPLETION,EDUCATION,FACTORS,GPS,HOWEVER,LABEL,MEN,METHODS,OBJECTIVE,PHASE,RESULTS,THERE,THESE
AFTER,AKT,AKT1,BACKGROUND,BESIDES,CCK,FLOW,HOWEVER,LABEL,LNCAP,METHODS,PI3K,PSMA,RESULTS,TAKEN,THEN,TRANSWELL,WESTERN
174,APART,AREAS,BACKGROUND,CAP,COVERED,III,KLK,KLK3,KLKS,LABEL,METHODS,NOVEL,OPINION,PHASE,SYNTHETIC,TARGETING
011,025,036,1C3,377,396,8201,AKR,ALDO,BACKGROUND,BPH,CONCLUSION,CRPC,GLEASON,LABEL,LNCAP,LOW,METHODS,PCA,PIN,PSA,RESULTS,SIXTY,UNASSIGNED,VIRTUAL
169,2014,AIMS,BASED,BPH,CAJAL,JOHN,LABEL,LTD,METHODS,OBJECTIVE,PCA,RESULTS,SONS,WILEY
001,104,169,1751,1999,2013,2014,2375,417,492,842,AUTHORS,BJU,CONCLUSION,GLEASON,GROUP,HOWEVER,JOHN,LABEL,LRP,LRPS,LTD,METASTASIS,METHODS,NERVE,NODE,OBJECTIVE,PSM,PUBLISHED,RESULTS,SONS,THERE,TNM,WILEY
AFM,AUNP,BINDING,RFBP,RIBOFLAVIN
ADIPOSE,BACKGROUND,CONSISTENT,EXPLANT,GLEASON,HOWEVER,LABEL,METHODS,OBESITY,PCA,PPA,RESULTS,SQA,THEREFORE,THESE,TISSUES
0001,004,035,1080,2003,2008,546,8805,BACKGROUND,CONCLUSION,GLEASON,LABEL,MEN,METHODS,RCT,REFERRALS,RESULTS,YEAR
000,100,2005,ASR,BACKGROUND,CANCERS,CASABLANCA,CONCLUSION,FEW,HODGKIN,LABEL,METHODS,MOROCCO,RESULTS,STAGE,THESE,TUMOURS
231,453,ARV,ARVS,ATT,CE3,CE9,EXPRESSION,FOUR,GTT,HEPG2,ILE,LNCAP,MCF,MDA,RNAS,SEQUENCING,T47D,VAL,VCAP,ZR75
0001,007,100,177,2007,2010,385,BETWEEN,CONCLUSION,EASTERN,FACTORS,GROUP,LABEL,MAIN,METHODS,OBJECTIVE,PLANNED,PURPOSE,RESULTS,THEREFORE
1C2,1C4,AKR1C,AML,BACKGROUND,HOWEVER,LABEL,MDDT,METHODS,MPA,NCI,RESULTS,SCREENS
001,002,003,169,2014,2235,494,8805,BACKGROUND,BOTH,COPYRIGHT,CSPC,GLEASON,HGPC,HOWEVER,LABEL,METABOLIC,METHODS,METS,OBJECTIVE,ODDS,OUTCOME,PATIENT,PCA,PUBLISHED,RESULTS,SETTING,SUMMARY,TESTS,THERE,TORONTO,UROLOGY
10Q23,8P21,8Q24,BACKGROUND,BPH,CEP10,CEP7,CEP8,FISH,IDENTIFIER,LABEL,LOCUS,LPL,LSI,METHODS,MYC,PTEN,RESULTS
113,ANOTHER,BACKGROUND,FOLLOWING,GLEASON,HOWEVER,IRAN,IRANIAN,LABEL,MATERIALS,MEIER,METHODS,PATHOLOGY,RESULTS,SCORING,SEVERAL,THERE,THEREFORE,UNIVERSITY,YAZD
946,CATENIN,CRUDE,FLOW,HOWEVER,IRANIAN,LAMIACEAE,SW480,T47D,THESE
2006,AAR,AMONG,BACKGROUND,BANGALORE,CHENNAI,DELHI,INDIA,LABEL,SIMILARLY
2000,2012,BACKGROUND,LABEL,MATERIALS,METHODS,PAHS,PCBS,RESULTS,THESE
ADIPOSITY,THERE
0001,100,125,2003,2011,2013,31ST,8804,956,AIM,CHICAGO,DEPARTMENT,EPI,EXCEL,INC,INFO,KATHMANDU,LABEL,MATERIALS,METHODS,NEPAL,OBJECTIVE,OCTOBER,PACKAGE,PCA,PSA,RESULTS,SPSS,USA,VERSION,WINDOWS
000,ACCORDING,CARE,ESSENTIAL,EXCELLENCE,HOWEVER,INSTITUTE,NICE
785,LNCAP,NIR
000,163,3633,4310,8201,AWMSG,CONCLUSION,CS21,CS21A,DEGARELIX,III,ITT,LABEL,LHRH,METHODS,OBJECTIVE,PAS,PHASE,PSA,QALY,RESULTS,SERVICE,TREATMENT
008,012,085,169,2014,554,AACR,ATP,FINALLY,HSP,LABEL,NSCLC,PARP,THESE,TMRM,TNF,TRAP1,UNLABELLED
ABL,BCR,BTK,HOWEVER,PROTEIN,SELECTIVE
ADDITIONAL,SHH,SONIC,TESTICULAR,THESE
1999,2000,2002,2009,268,362,567,974,COX,FEW
DCE,DWI,FINALLY,GIVEN,MRI,PSA,T2WI
001,061,139,187,189,18F,2009,2012,325,456,8201,ADT,ALSO,CONCLUSION,LABEL,MANN,MATERIALS,METHODS,OBJECTIVE,PET,PSA,PURPOSE,RESULTS,SIMILARLY,WHITNEY
169,183,8201,AGAIN,BACKGROUND,BASED,GEORG,GERMANY,HOWEVER,INSTEAD,LABEL,METHODS,NATIONWIDE,POMERANIA,RESULTS,STUTTGART,USING,WESTERN,YORK
001,1366,BACKGROUND,EACH,GIVEN,GLEASON,LABEL,METHODS,PEARSON,PSA,QOL,RADIATION,RESULTS
18F,PET
FDG,PET
HONEY,THESE,THUS
001,005,25TH,778,BACKGROUND,COX,CRPC,III,INCREASING,LABEL,MARKERS,METHODS,PRIOR,RESULTS,S0421,SERA,SERUM,SWOG,WALD
169,2014,COPYRIGHT,F876L,FL425,FL442,IRELAND,LNCAP,LTD,NOTABLY,THESE,VCAP
169,2013,AFTER,AIMS,BACKGROUND,BCH,COPYRIGHT,HGPIN,LABEL,METHODS,OBJECTIVE,OTHER,PRODUCTION,PSA,RESULTS
169,2014,22RV1,916,956,BOTH,CASTRATION,COPYRIGHT,CRPC,DHEA,DHT,LNCAP,LTD,OVERALL,PCA,POM,PSA,PTEN,UPLC,WESTERN
169,2014,22RV1,3000,453,4541,945,COPYRIGHT,DHT,DU145,HENCE,HOWEVER,LNCAP,LTD,MDA,PC3,PCA,SARM,SARMS,THEREFORE,THESE
BACKGROUND,GIVEN,LABEL,METHODS,RESULTS
145,946,954,ALSO,BACKGROUND,CD44,CXCR4,EGR,EMT,IHC,LABEL,METHODS,MTT,NA22,NB14,PC3,PCA,RANKL,RESULTS,RUNX2,RWPE,SHEC,SMALL,SNAI1,SRC,WESTERN,WPE1
ASSOCIATED,BACKGROUND,LABEL,METHODS,MHC,MMP11,RESULTS,THESE
BACKGROUND,CONCLUSION,DESPITE,DEVELOPING,KNOWN,LABEL,RESULTS,THESE,THREE
1154,1828,205,BACKGROUND,CREB1,GWAS,HOWEVER,IGF,LABEL,LOCI,PCA,RESULTS,SNP,SNPS,SP1,TRAIT,UCSC


100,8TH,DESPITE,MELAN,MFH,PSA,UPS
1998,2002,2008,2009,2011,NMIBC,NON,PROSTATIC,PSA,RENAL,TLCNOMO,TURBT
2004,2012,241,643,AMONG,AREA,CDDP,CRPC,DTX,EIGHT,HAMAMATSU,JANUARY,JULY,LABEL,MATERIALS,METHODS,MOST,OBJECTIVE,OBJECTIVES,PSA,RESULTS,SALVAGE,SIX,TRANSITORY,UNIVERSITY
200,AMERICA,APOPTAG,BALL,CARIBBEAN,JAMAICA,LABEL,METHODS,MOSS,OBJECTIVE,RESULTS,SOUTH,THERE,TILLANDSIA
720,AFRICAN,ASIAN,BACKGROUND,CAUCASIAN,CHD1,CONCLUSION,ERG,HOWEVER,HRM,LABEL,METHODS,OBJECTIVE,OVERALL,POZ,PROTEIN,PTEN,RECURRENT,RESULTS,SETTING,SPECKLE,SPOP,SPOPMUT,THERE,TYPE
007,008,111,1739,3117,40TH,489,60TH,8805,BACKGROUND,CIS,COX,GLEASON,HRS,LABEL,MEN,METHODS,PCA,PREVENTION,RESULTS,THERE,TOENAIL,TRIAL,VITAMIN
005,1048,817,COX,GPX1,III,LOWER,PCA,SEPP1,THREE,TOENAIL
CAP,FINALLY,FURTHER,NUCLEAR
00001,AVAILABLE,BEGG,CELLSEARCH,CTCS,DFS,DTCS,FORREST,HRS
0494,138,2008,2012,586,8201,DIFFICULTY
BAX,BCL,DU145,HDAC1,IAP1,IAP2,KU70,THESE,TREATMENT,XIAP
001,003,004,099,162,464,746,916,COX,LABEL,MEIER,METHODS,NMIUC,OBJECTIVE,PCR,PRIMARY,PURPOSE,RESULTS
BACKGROUND,DISCUSSION,GERMANY,IGEL,LABEL,METHODS,PSA,QUESTIONS,RESULTS,THERE,UNASSIGNED
321,594,EVEN,THERE
ALONG,APART,PSA,USA,WESTERN
169,2014,CRPC,FLOW,FURTHER,GPX2,NEXT,PC3,PCAI1,PRESS,PUBLISHED,ROS,SILENCING,THERE,THESE,UNIVERSITY
AMP,AMPK,CRPC,DESPITE,DEVELOPING,ZADRA
001,064,142,2001,2007,483,8804,8805,AFTER,BACKGROUND,COMPETING,CONVERSELY,CSM,EIGHT,END,IMRT,LABEL,METHODS,NNT,NNTS,OVERALL,PCA,RESULTS,SEER
100,178,179,185,200,223,8315,8322,956,CRPC,DOSE,MBQ,RACL,RADIATION,REMOVAL,SUBSEQUENT,TEN
PET
18F,FEC,HOWEVER,PET,USING
169,2014,COPYRIGHT,FURTHER,HOWEVER,INC,THROUGH
WHOLE
145,169,2014,231,COPYRIGHT,INC,L929,MDA,NMR,PDCL,PF6,PPH3
169,2014,BPH,COPYRIGHT,INC,PCA,PUBLISHED,SOCIETY
15GY,169,1WEEK,2014,25GY,30GY,3145,42GY,5969,6GY,8764,945,946,BACKGROUND,COPYRIGHT,HOWEVER,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE,TREATMENTS
169,1711,1989,2007,2014,74GY,AFRICAN,BETWEEN,COPYRIGHT,COX,GLEASON,IRELAND,LABEL,LTD,MATERIALS,MEN,METHODS,OBJECTIVE,PCSM,PSA,RESULTS,THERE
169,177,1CM,2014,377,BACKGROUND,BEAM,BLADDER,CBCT,CONE,COPYRIGHT,CTV,IMRT,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS,THESE,VARIATIONS
169,1CM,2014,267,3MM,490,4MM,BMI,BODY,CONCLUSION,COPYRIGHT,DAILY,IGRT,IRELAND,LABEL,LEVEL,LTD,METHODS,OBJECTIVE,PCA,PTV,PURPOSE,RCS,RESULTS,THESE,WITHOUT
015,100,125,144GY,169,2014,281,384,AMONG,BACKGROUND,CONCLUSION,COPYRIGHT,CTCAE,IPSS,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PURPOSE,QUADRELLA,RESULTS,URINARY
169,188,2014,BONE,COPYRIGHT,GMP,HEDP,RHENIUM
169,2014,AIF,AIFS,COMPARING,COMPARISON,COPYRIGHT,DCE,DYNAMIC,FIRST,IMAGING,INC,INTRA,MRI,MULTI,PCA,RESONANCE,ROI,THESE
001,1500,160,169,1998,2003,2010,2013,250,279,500,BETWEEN,CONCLUSION,COPYRIGHT,HOWEVER,LABEL,LRP,METHODS,OBJECTIVE,OPERATIVE,ORP,PSA,PUBLISHED,RESULTS,SAS,T1C,THERE
169,1995,2012,2013,224,AFRO,CARIBBEAN,CASES,CONCLUSION,COPYRIGHT,GUADELOUPE,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PITRE,RESULTS,SAS
169,2013,ACUTE,ARU,COPYRIGHT,PUBLISHED,SAS,SEVERAL
169,2013,AUTHORS,COPYRIGHT,DIAGNOSTIC,SAS
124,169,1CM,2013,8805,ADC,COPYRIGHT,DCE,DWI,EACH,ECE,ESTIMATION,FIVE,LABEL,METHODS,MRI,NPV,OBJECTIVE,PPV,RESULTS,SAS,T2W,THREE,VPN
220,269,789,CHINESE,CHUN,GLEASON
0001,001,100,114,125,160,169,177,2014,AVERAGE,COPYRIGHT,D90,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SOCIETY,V100
160,EBRT,FIRST,FURTHER,PRESUMABLY
124,4T1,AIM,CONCLUSION,F11,HER2,JAA,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,THESE,THOMSEN
2012,FDA,III,OVERALL,PHASE
154,163,1842,2014,ACTA,BIOCHIM,BIOPHYS,FRET,HIPK1,JNK1,JUN,PAGE4,REGARDLESS,T51,THESE
2006,2012,2014,243,AMERICA,ARGENTINA,AULA,BACKGROUND,BEVERAGES,COMPONENTS,CONCLUSION,CONE,COPYRIGHT,CRC,EDICIONES,FEEDING,FOUR,LABEL,LATIN,METHODS,OBJECTIVE,PATTERN,PRINCIPAL,PRUDENT,PUBLISHED,RESULTS,RURAL,SOUTH,STARCHY,SWEET,TYPICAL

945,954,CCCTC,CTCF,DECREASED,GENOMIC,H19,HDAC1,ICR,IGF2,INSULIN,LOI,LOSS
083,100,160,177,341,345,8201,956,BEHNKEN,BOX,CONCLUSION,EQUAL,HEME,IC50,LABEL,METHODS,NPS,OBJECTIVE,OXIDATION,PC3,PLGA,PURPOSE,RESULTS,ROS,ZNPP
FINALLY,MRI,THEREFORE
100,160,169,183,222,8202,9658,CONCLUSION,ECE,ENDORECTAL,GEORG,KEY,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PCA,PURPOSE,RESULTS,STUTTGART,SVI,YORK
AFRICAN,AMERICANS,OLDER,PRCA,THERE,YOUNGER
177,8201,8805,BACKGROUND,CONCLUSION,EBRT,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE
0001,160,174,177,2010,277,550,8201,ALTO,BOTH,CONCLUSION,D30,D50,D60,DOSE,DVHS,HOWEVER,LABEL,MATERIALS,MEDICAL,METHODS,MUS,OAR,OARS,OBJECTIVE,PALO,PTV,PURPOSE,REGARDING,RESULTS,SMALL,SYSTEMS,TREATMENT,USA,VMAT
175,2014,AKT,BASEL,EXPRESSION,HGPIN,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS
BPH,IHC,PCA,PCR,SILENCING
169,2014,AACR,ARV7,CRPC,LUCAP23,LUCAP86,TAXANES
BOARD,CARLO,CBCT,CONE,CTDI,GPU,HIGH,IGRT,IMAGING,MEAN,MONTE,OBI,RADIATION
00164,191,AGILENT,ANNOVAR,BACKGROUND,BWA,GATK,LABEL,LOF,METHODS,PRCA,RESULTS,THESE,TOOLKIT
169,2014,COPYRIGHT,CRPC,DCA,DPA,GCDC,PCA,THESE,THREE
000,001,041,043,054,177,195,540,ASIAN,BACKGROUND,COX,LABEL,METHODS,PRIOR,RESULTS,THERE,TOTAL,TPE,UNASSIGNED,VIRTUAL
BACKGROUND,CBP,CHINESE,ERK1,EXPRESSION,KNOCKDOWN,LABEL,METHODS,RESULTS,ZYFLAMEND
945,963,ACCOUNT,III,INITIAL,IRIDIUM,NAD,OCTAHEDRAL,THEIR,THESE
001,015,032,167,771,ADC,AUC,CONCLUSION,DWI,ECE,FURTHER,GLEASON,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,UNIVARIATE
8805,AFTER,CONCLUSION,DETECTION,DWI,GLEASON,HOWEVER,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,RTE,VOLUMETRIC
001,215,664,723,753,818,915,916,989,ADC,BPH,CONCLUSION,DTI,LABEL,MATERIALS,MCNEMAR,METHODS,OBJECTIVE,RESULTS,ROC
001,1000,1500,200,2000,ADC,AUC,CONCLUSION,DWI,GLEASON,HOWEVER,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,RESULTS,ROIS
177,CONCLUSION,DWI,EBRT,HOWEVER,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,RESULTS
240,BACKGROUND,CASE,CAUCASIAN,FOLLOWING,GLEASON,HEM,LABEL,METHODS,T1C,THERE
AFTER,BACKGROUND,BASED,COMPARISON,ESR1,ESR2,KEGG,LABEL,MICROARRAY,MICRORNAS,ORT,RESULTS
13C,205,A431,A549,ALPINIA,COLO,COMPOUNDS,DCM,H460,MEOH,NCI,NMR,SHARPLESS
031,077,16ALPHA,3BETA,BOTH,ESI,GI50,ICH,LYSIMACHIA,NMR,UPLC
DESPITE,OVERALL,ROBOTIC
169,183,GEORG,GIVEN,HEAD,HNC,QOL,STUTTGART,THERE,YORK
823,945,946,BAX,BCL,BGC,CPS,DU145,HEMSL,JNK,LYSIMACHIA,P38,PC3,RESULTS,THEREFORE
ANTI,BACKGROUND,DFS,EGFR,GIVEN,HER2,LABEL,METHODS,RESULTS,SDC,SDCS,SINCE,WHILE
001,1994,2007,233,3313,COX,MAX,MIN,SUPPL,VITAMINES
001,104,113,2005,2008,217,361,65308,65309,AMICO,BMI,COLLEGE,GLEASON,KHR,MAY,PSA,PSM,RARP,SEPTEMBER,THERE,UNIVERSITY
206,640,FINALLY,KRAS
AE37,BRAFV600E,PRE,PREDICTIVE
CHINESE,DIF,EORTC,HRQOL,LABEL,MCID,METHODS,OBJECTIVE,PR25,QLQ,RASCH,RESULTS
BISPHENOL,BPA,MASS,PND,PND35,TAGS,TMT
169,2014,3966,533,AUTHORS,BJU,GLEASON,JOHN,LABEL,LTD,METHODS,OBJECTIVE,ORGAN,PBX,PUBLISHED,RESULTS,SONS,WILEY,XML
1000,2012,2013,2014,233,BACKGROUND,DESPITE,DISCUSSION,LABEL,METHODS,TAKEN,WESTERN
001,152,169,2014,8201,8804,8805,AUTHORS,BJU,GLEASON,LABEL,METHODS,MRI,OBJECTIVE,OBJECTIVES,PCA,PSA,RESULTS,TRUS,UROSTATION,V10
123,169,2014,8805,AFTER,AUTHORS,BCR,BECAUSE,BJU,CHT,GLEASON,HOWEVER,JOHN,LABEL,LTD,METHODS,OBJECTIVE,PSA,PUBLISHED,RESULTS,SONS,WILEY
001,168,169,1998,2005,2011,2014,8201,AFTER,AMONG,AUTHORS,BJU,GLEASON,GRADING,ISUP,LABEL,METHODS,NPCR,OBJECTIVE,OBJECTIVES,PATHOLOGY,PSA,RESULTS,SOCIETY,THERE,UROLOGICAL
783,CTC,CTCS,EPCAM,EVEN,ISOLATION,LIVE,NIR,PBMCS,PERIPHERAL,STAINED
ATLAS,CONSISTENT,GABA,GAD1,GLUL,PNEC,THESE,USING
AMPK,ATG5,CGA,FURTHER,INCREASING,INHIBITION,KNOCKDOWN,LC3,LNCAP,MOST,NED,PCA,REST,SIMILAR,THESE,TREATMENT
139,174,FFPE,NGS,PCR,PLUS,SHORT,SNP,SNPS,STR,STRS
177,181,8202,AMONG,BCL,EXCESSIVE,FURTHER,IC50,LCMS,LNCAP,MMP,NAUCLEA,NMR,OVERALL,ROS,RWPE,SUBDITINE,WESTERN
17Q21,215,3195,440,469,700,8202,ADDITIONAL,G84E,GWAS,HOXB,PRACTICAL,PRCA,SNPS
CAMLS,CTC,CTCS,TAMS,THESE,USING
032,169,2005,2014,944,AACR,BACKGROUND,HOWEVER,III,LABEL,METHODS,OVERALL,PATIENT,PET,PREDICTORS,RESULTS,ROUTINE,SEEKING,THESE,YET
169,2013,BRITAIN,CD133,CD44,COPYRIGHT,FINALLY,GREAT,HOLOCLONES,INCREASING,IRELAND,JOHN,LTD,NADPH,NOX,OGT2115,PC3,PUBLISHED,RNAI,SOCIETY,SONS,TAKEN,THESE,TICS,TRAMP,WILEY
169,2014,ANDROGENIC,COPYRIGHT,DHT,LTD,PGD,THEREFORE
105,2010,2012,5714,ADT,BLOOD,CONCLUSION,DXA,FIFTY,FURTHER,GLEASON,HALF,JANUARY,LABEL,MARCH,METHODS,NONE,OBJECTIVE,RESULTS,SMOKING,THERE,TREATMENT
167,252,294,384,549,THP
102,169,199,2014,204,239,945,946,AACR,ARM,ARMS,CONCLUSION,IGF,IGG2,LABEL,METHODS,OBJECTIVE,PFS,PSA,PURPOSE,RESULTS
004,1205,1387,169,2014,370,401,ACO1,CIS,COLORECTAL,DIETARY,HEME,HOWEVER,IRON,LUNG,ORQ4,OVARIAN,PRESS,PUBLISHED,SCREENING,SEVERAL,SNPS,TRIAL,UNIVERSITY
169,2014,24A1,27B1,2D3,945,CYP24A1,CYP27B1,HPV,INC,P450,THESE,THUS,VDR,WILEY
169,2014,GMBH,KGAA,KLK,KLKS,RAPIDLY,SUBSTRATES,VCH,WILEY
ADT,AURKA,BOTH,DESPITE,ERG,HOWEVER,MYCN,PSA,PURE,SCC,SCCS
EXCESSIVE,ILLICIT,USA
10TH,2014,232,684,CAUCASIANS,CNKI,JANUARY,REVMAN4,STATA10,WANFANG,XRCC7
3P25,487,945,CA2,DAG,GPCR,HRH1,IL3,IP3,MYB,PKC,PLC,PROGNOSCAN,SNPS
169,2014,COPYRIGHT,CROWN,LTD,MICRO,PC3,PUBLISHED
100,1083,169,2010,2014,406,473,4814,623,AGREEMENT,BEST,CAPI,COPYRIGHT,DISCUSSION,ESPECIALLY,HEINZ,ICD,LABEL,LTD,METHODS,NIXDORF,OBJECTIVE,RESULTS,VERSION
10TH,119,177,265,ADC,AUC,CONCLUSION,GLEASON,HIPAA,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,ROI,ROIS
DO3A,DOTA,NOTA,OXO,PC3,PCTA,PET,PIP,PSMA,TE2A
169,2014,EPS,INC,MGS,THERE,WILEY
RALP,RLESS,THEREFORE
001,008,009,022,025,031,041,121,177,1992,2005,308,336,540,656,681,775,857,8805,907,CCI,CONCLUSION,COX,DATA,FIVE,GLEASON,INDEX,IQR,LABEL,MATERIALS,METHODS,NON,OBJECTIVE,PCA,PCASS,PRE,PSA,PURPOSE,RESULTS,TEN
AES,ASIAN,CONCLUSION,HOWEVER,LABEL,MATERIALS,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS,THERE
006,146,169,2014,8201,ACTIVITIES,AMONG,ASSESSMENT,BARTHEL,BATTERY,BRODY,CONCLUSION,COPYRIGHT,DAILY,DATA,FRONTAL,FUNCTIONAL,GENERAL,INDEX,JOHN,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,SONS,THERAPY,THESE,WILEY
169,191,2014,COPYRIGHT,DEPRESSION,EQUATIONS,IBI,ILLNESS,INDEX,INDICES,INDIVIDUAL,JOHN,LABEL,LTD,METHODS,OBJECTIVE,PATIENT,PHQ9,RESPONSES,RESULTS,SONS,THESE,WILEY
001,012,014,027,136,160,952,966,975,BRIEF,BSI,CATS,INVENTORY,LABEL,METHODS,OBJECTIVE,PATIENT,PURPOSE,RESULTS,ROC,SECONDARY,SYMPTOM,USING
8201,EDUCATING,POST,PRIOR,PROVIDING,SUGGESTED
082,2009,259,609,816,BEHAVIORAL,BMI,HOWEVER,LABEL,METHODS,OBJECTIVE,ONGOING,PURPOSE,RESULTS,RISK,SHORT,SURVIVORS
LEVEL,MANAGEMENT,MEN,PIVOT,PSA,RESULTS,TRIAL
AKT,BIOMARKERS,ERG,RESULTS,TMPRSS2
CCP,GLEASON,PSA,RESULTS,THESE
DESPITE,INSTITUTE,PSA
FAVORABLE,GLEASON,IIA,IIB,THESE
BPH,EARLY,SIMILARLY
EVEN,FLAVONOIDS,MIGRATION,PRIMARY,THERE,THEREFORE,THESE
210,ASPIRIN,DATA,HOWEVER,INFERENCE,THUS
945,EFFECTIVE,LOE,SERMS
ANOTHER,HOWEVER
2006,2013,BASED,COLORECTAL,ERSPC,LUNG,OVARIAN,PLCO,RANDOMIZED,RCTS,SCREENING
COLON,DETAILS,ERSPC,HOWEVER,LUNG,OVARY,PLCO,PSA,RANDOMIZED,SCREENING,USA
000,1990S,COLORECTAL,DRE,LUNG,OVARIAN,PLCO,PSA,SCREENING,THUS,TRIAL
1993,1998,ANTIGEN,ERSPC,GLEASON,PCA,PSA,RANDOMIZED,SCREENING
000,150,1990S,EPIC,IGF,MOST,NUTRITION,THERE
BOTH,DIFFERENT,HOWEVER,PCA,THEREFORE
EARLY,GWAS,SINCE,THEIR,THESE
AMACR,DESPITE,FASN,HOWEVER,HPN,IGF,INSULIN,MYC,PSA,WHILE
169,2014,COPYRIGHT,H1299,H522,INC,NCI,PARP,RV1
10A,145,231,390,A549,AMONG,HELA,IC50,MCF,MDA,PUBLISHED,SAS,TAKEN
1989,1991,20TH,792,80TH,956,AFTER,ARIZONA,BACKGROUND,CADMIUM,HEART,HRS,INDIANS,LABEL,LOW,METHODS,NORTH,OBJECTIVE,RESULTS,SOUTH
169,2014,945,947,ASTRAGALUS,ATF,COPYRIGHT,COSCINIUM,EGR,INC,LAMIACEAE,NAG,NATURAL,NSAID,PLANT,PPAR,SEVERAL,SP1
169,2014,946,COPYRIGHT,CROWN,INC,LNCAP,MICROARRAY,PCA,PUBLISHED,R1881,TAKEN,TEB,TEBS
169,2014,22RV1,600,8321,8322,8323,945,946,COPYRIGHT,HCPT,MCF,PUBLISHED,RGDFK
169,2014,8322,8331,945,COPYRIGHT,LABEL,NAD,NRF2,PC3,SILENCING,TOCOPHERYL,UNASSIGNED,UNLABELLED,WHILE
024,169,193,2014,8NMOL,AUC,COPYRIGHT,INC,INDEX,KRUSKAL,LABEL,MANN,METHODS,OBJECTIVE,PCA,PHI,PSA,PUBLISHED,RESULTS,ROC,SOCIETY,TOTAL,WHITNEY
169,2014,945,956,COPYRIGHT,IC50,L929,LAPACHONE,LTD,PBMC,V79
169,2014,945,946,AIMS,COLLEGE,CONCLUSION,COPYRIGHT,CURRENT,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,RESULTS,ROYAL
169,2014,CDC42,FINALLY,GROUP,GTPASES,INC,PAK,PAK1,PAK4,PAKS,RAC,RHO
169,2014,COPYRIGHT,ERASMUS,FULLY,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS,TPS,V95,VMAT,VMATMAN
169,2014,COPYRIGHT,LTD
2014,COPYRIGHT,PATIENT,QOL,QUALITY,SLACK,THEREFORE
1285,169,1986,2011,2012,2013,237,7010,7013,7285,7288,7559,7562,AUC,AUTHORS,BJU,HUMS,INSTITUTO,IVO,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OCD,ONCOLOG,RESULTS,ROC,THEIR,VALENCIANO,VICKERS
001,002,169,1998,2010,2013,238,8804,AUTHORS,BJU,COX,LABEL,MEIER,MEN,METHODS,NLR,OBJECTIVE,RECORDS,RESULTS,THESE
001,009,103,125,169,177,2013,8201,AUSTRALIAN,AUTHORS,BACKGROUND,COLLEGE,IMAGING,JOURNAL,LABEL,MEDICAL,METHODS,OPERATIVE,POST,RADIATION,RESULTS,ROYAL,ZEALAND
169,2010,2011,2013,8201,AUSTRALIA,AUSTRALIAN,AUTHORS,BACKGROUND,COLLEGE,CONCLUSION,EQD2,GROUP,HDR,IMAGING,JOURNAL,LABEL,MEDICAL,METHODS,RADIATION,RESULTS,ROYAL,THERE,TOTAL,WESTERN,ZEALAND
HOWEVER,LEIOMYOMAS,MRI
BACKGROUND,COULD,CTC,DESPITE,DOES,FOLLOWING,HOWEVER,LABEL,LNCAP,MAXIMAL,METHODS,NBD,PBMC,RESULTS,RWPE1,THESE
948,ANOVA,BACKGROUND,CSC,CSCS,INHIBITION,LABEL,METHODS,NOVEL,PKC,RAS,RESULTS,SMALL,STUDENT,THESE
ASIAN,CONCLUSION,ESTIMATES,FURTHER,HOWEVER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,STRATIFIED,TEA
493,BACKGROUND,BC28,CONCLUSION,CONTEXT,LABEL,METHODS,MMP40,OBJECTIVE,OBJECTIVES,RESULTS,RPP40
160,169,183,1980,2006,2013,6815,901,FINLAND,HODGKIN,JOHN,LTD,NHL,POISSON,RRS,SONS,WILEY
000,001,1423,173,2000,2012,ANTITUMOR,BACKGROUND,BONE,EASTERN,GROUP,JANUARY,LABEL,METHODS,PATIENT,RESULTS,SOLID
AIM,III,LABEL,METHODS,MEXICAN,NUTRITION,OBJECTIVE,RESULTS,SDPPSU6,UDPSI,UNDER,WTPFEX6
AFRO,EMRO,EURO,LDR,MDR,PAHO,SEARO,SMCB,WPRO
242,476,484,541,730,763,BPH,CONCLUSION,CX26,CX32,CX43,CXS,LABEL,METHODS,OBJECTIVE,PCA,PSA,RESULTS,SABC
2009,2011,397,BMI,CONCLUSION,FANGCHENG,GUANGXI,INCREASED,LABEL,METHODS,OBJECTIVE,PSA,RESULTS,SEPTEMBER,THERE
TMPRSS2
169,2014,AACR,CONCLUSION,HPA,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SELE,SELP
BOTH,DIAGNOSTIC
100,CYSTECTOMY,IMRT,RADIATION
8217,8232,8233,BODY,IGRT,IMAGE,IMRT,INTENSITY,RADIATION,SBRT,THERAPY,TREATMENT
AFTER,C30,CHINESE,CONTROL,CORE,IIA,LABORATORY,LIFE,PSA,PSS,QLQ,ROUTINE
002,118,2009,2013,8804,CONCLUSION,CRPC,LABEL,MATERIALS,METHODS,NLR,OBJECTIVE,PFS,PSA,PURPOSE,RESULTS
169,170,1996,2006,2008,2014,365,481,669,751,AACR,AARP,BETWEEN,BMI,COX,DIET,HRS,NIH,SEDENTARY,SIMILAR,THERE
001,007,075,68366,ENGLISH,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIR,SIRS,SLE,STATA,SUMMARY
TAXANES
3215,6E3,8804,EXPRESSION,HOWEVER,NANOG,OCT4,SALL4,WILMS
1058,1588,193,1998,2011,232,298,BCR,HRS,PCA
CAP1,CHEK1,DOCETAXEL,HOWEVER,IGR,INHIBITION,KNOCKDOWN,LZTS1,NSC663284,PLK1
169,2014,3KINASE,AKT,COPYRIGHT,CXCR4,DU145,HOWEVER,INC,MMPS,PI3K,PTEN,TAKEN
169,1908,2014,AMONG,BACKGROUND,COMPOSITE,CONCLUSION,COPYRIGHT,FIFTY,GLEASON,INC,INDEX,LABEL,LARGE,METHODS,NORWEGIAN,PCA,PROS,RAD,RESULTS,SPAIN,SPANISH,USING
169,2014,CAS,COPYRIGHT,EACH,IAS,LTD,PSA,THUS
169,2014,A549,BSA,DOX,FINALLY,JOHN,MTT,NPS,SONS,WILEY
1997,2009,967,BACKGROUND,EDI,INDEX,LABEL,METHODS,PAF,POISSON,POPULATION,RESULTS
AKT,ANNEXIN,BASED,BCL,BMI1,CSC,ERK,GLIOMAS,GRP,HNGC,KNOCK,MUSASHI,PAR,PARP,SECRETORY,SOX2,TAM,UCN
049,186,1998,215,2305,2543,3079,3509,7031,BPC3,CONSORTIUM,DESPITE,GWAS,INSTITUTE,NONE,SNPS
945,BAG,CONVERSELY,FXXLF,HOWEVER,LBD,LXXLL,SEVERAL,THESE,UPON
0001,152,169,2014,BOTH,DESPITE,IHC,NUCLEAR,PSA,THESE,TP53,UICC
169,2003,2007,2014,BACKGROUND,FEW,GREATER,HIGH,HRR,HSA,HSAS,LABEL,METHODS,REPORTING,RESULTS,SOCIETY,STATE,TURP,WASHINGTON
120,1491,1498,169,2005,2010,2014,8201,8805,BACKGROUND,DATA,INTERVIEW,LABEL,MEN,METHODS,MOST,PSA,RESULTS,SCREENING,SOCIETY,SURVEYS,TWICE
1300,169,2014,AMERICA,AMONG,BACKGROUND,BART,BRCA1,BRCA2,CARIBBEAN,DATA,FACTORS,LABEL,LARGE,LATIN,METHODS,RESULTS,SEVERAL,SOCIETY,TEST
133,169,1995,2011,2014,8201,8805,BACKGROUND,CONCLUSION,COX,INC,LABEL,MEIER,METHODS,OBJECTIVE,OVERALL,PSA,PSM,RESULTS,RISK,WILEY
AGE,HOWEVER,PPI
KINASES,KNOWLEDGE,SFK,SFKS,SRC,THESE
112,181,182,8805,969,AIM,BACKGROUND,GI50,IC50,LABEL,LC50,MCF,METHODS,MTS,NEITHER,OBJECTIVE,PBMC,PERIPHERAL,PMS,RESULTS,THEIR,THESE,TREATMENT
163,451,736,958,983,ASSESSMENT,CAPRA,COX,DISEASE,GROUP,JAPAN,LABEL,MEIER,METHODS,NADIR,OBJECTIVE,PADT,PFS,PSA,PURPOSE,RESULTS,RISK,TTN,UNIVARIATE
100,110,169,177,2014,21EX,280,357,365,469,8764,963,ARC,CDR,IMRT,JAPAN,MUS,PHILIPS,PRESS,PUBLISHED,RADIATION,RTPS,SMART,SOCIETY,THUS,UNIVERSITY,VMAT,VOLUMETRIC
AMPLE,CTC,CTCS,EVERY,THESE
007,039,1997,2009,467,7153,ACUTE,ANZDATA,AUSTRALIAN,BACKGROUND,CONCLUSION,COX,LABEL,METHODS,RECIPIENTS,RESULTS,THERE,TRANSPLANT,USING,ZEALAND
NOVEL
125,145,169,192,2014,8805,BLADDER,BOTH,CONCLUSION,COPYRIGHT,DESPITE,EBRT,HDR,IMIT,IMPT,INC,ISOE,LABEL,LDR,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RBE,RESULTS,TEN,VMAT
169,2014,211,ACTUARIAL,ADVERSE,CGE,COMPOSITE,COPYRIGHT,CTCAE,FIVE,FURTHER,INC,INDEX,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SYMPTOM,THERE,TOXICITIES
CELLSEARCH,CTCS,FDA,KRAS,STUDIES,THUS,WHETHER
106,184,1998,2006,2011,291,339,435,511,762,814,8201,849,ACEI,ACEIS,ARB,ARBS,BACKGROUND,HOWEVER,LABEL,METHODS,OVERALL,POPULATION,RESULTS,STATISTICS,THERE,THESE
GANT,HAACK,MEIER,SANT,SMALL,SYNTHESIS,THEREFORE,THESE,VILS
0001,007,023,112,2004,2007,248,690,8804,8805,AMICO,BETWEEN,BPFS,COX,EIGHT,GLEASON,LABEL,MEIER,METHODS,OBJECTIVE,OVERALL,RESULTS
485,709,767,BASED,BEGG,BPH,CAG,CONCLUSION,EGGER,LABEL,METHODS,OBJECTIVE,PCA,RESULTS,SHORTER,THERE
160,34BETAE12,BCCP,CONCLUSION,LABEL,METHODS,OBJECTIVE,P504S,P63,PSA,RESULTS
029,034,288,297,BPH,CONCLUSION,GLEASON,LABEL,LC3A,OBJECTIVE,PCA,PSA
AKT,CURRENTLY,DASATINIB,FYN,GSK,INHIBITION,PC3,SRC,TREATMENT,Y216GSK,YES
001,LOC728606,METASTATIC,PCA,PES,RNAS,THESE
001,019,1052,1686,169,1995,2004,2007,2014,634,AFTER,AUTHORS,CHI,COX,CRT,END,FIRST,IMRT,INTENSITY,JOHN,LTD,PROPENSITY,RESULTS,SEER,SONS,WILEY
100,169,177,2014,233,8201,AUTHORS,BACK,CRAM,CRLB,DATA,HOWEVER,JOHN,LTD,METABOLITE,MRSI,NMR,OUTER,QUEST,RAO,REST,SONS,TES,WILEY
000,2013,804,BECAUSE,BEGG,CHINESE,CIS,CONCLUSION,EGGER,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCIENCE,THERE,WEB
0008,003,004,009,1994,1MMOL,2007,233,514,557,APOA1,BIOMARKERS,COX,HDL,HOWEVER,MIN,SUPPL,VITAMINES
204,562,580,956,DISCOVERY,DU145,FINALLY,FORTY,INHIBITORS,MV4,PIM,SPECS,THEIR,THESE,THREE
110,111,122,160,169,2014,209,238,278,393,498,681,CHOLINE,COPYRIGHT,DIAGNOSTIC,EDUCATION,IMAGING,INC,LABEL,LYMPH,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SALVAGE,UROLOGICAL
169,174,2011,2014,795,ACT,AFFORDABLE,ASA,CARE,COPYRIGHT,EDUCATION,GIVEN,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OUTPATIENT,PATIENT,PROGRAM,PROTECTION,PUBLISHED,PURPOSE,QUALITY,READMITTED,RESULTS,RISK,UROLOGICAL,USING
0001,0002,001,003,026,043,125,169,174,182,187,189,2014,273,711,ANOTHER,ARRAY,AUC,COPYRIGHT,EDUCATION,ERG,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PCA3,PUBLISHED,PURPOSE,RESULTS,RNAS,TMPRSS2,TOTAL,UROLOGICAL
001,169,192,2004,2007,2014,347,AFTER,COPYRIGHT,EDUCATION,END,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SEER,UROLOGICAL,USING
001,169,170,2014,936,AUC,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PCA3,PHI,PUBLISHED,PURPOSE,RESULTS,ROC,UROLOGICAL
001,169,2007,2013,2014,226,260,396,COPYRIGHT,EDUCATION,GLEASON,HOWEVER,INC,JUNE,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THEREFORE,UROLOGICAL
160,169,2000,2011,2014,786,945,947,ACHN,CAKI,CHIBA,COCL2,COPYRIGHT,CXCR3,EDUCATION,FINALLY,HIF,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RENAL,RESULTS,RHOA,UNIVERSITY,UROLOGICAL
169,192,2014,457,574,COPYRIGHT,COX,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PCPT,PREVENTION,PUBLISHED,PURPOSE,RESULTS,THESE,THUS,TRIAL,UROLOGICAL,WHETHER
001,002,038,100,150,165,166,169,2014,626,810,913,954,AGGREGATE,AUC,CHI,COPYRIGHT,DATA,EDUCATION,FOUR,IMAGING,INC,LABEL,MATERIALS,MEN,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RADICAL,RADS,REPORTING,RESULTS,TESLA,UROLOGICAL

174,294,414,711,ADVERSE,AIM,BAP,CONCLUSION,LABEL,MATERIALS,METHODS,NTX,OBJECTIVE,OPG,RESULTS,SERUM,TAIWANESE,THERE,TRACP5B
CLINICALLY,HEAT,HSP90,HSPS
158,946,954,BACKGROUND,BMP,CAP,CONSISTENT,CRPC,FURTHER,HOWEVER,LABEL,METHODS,RESULTS,SMAD5,THESE,WNT5A
BACKGROUND,DISRUPTION,FRET,LABEL,METHODS,PART1,PC3,PDE,PDE4,PDES,RESULTS,VCAP,WESTERN
BACKGROUND,CELECOXIB,COX,COXS,CREB,EP2,HOWEVER,LABEL,LNCAP,METHODS,NON,PC3,PCR,RESULTS,WESTERN
BLOOD,LESS,PSA
138,154,162,26E,50E,COMPARING,ERG,FISH,MOST,NDRG1,SLC45A3,THESE,TMPRSS2
150,2012,2014,AHEAD,APRIL,AUSTRALIA,AUSTRALIAN,BACKGROUND,CBT,DISCUSSION,FEB,IDENTIFIER,LABEL,METHODS,RCT,ROAD,THERE,TRIAL,ZEALAND
BASED,INHIBITORS,QSAR,SAR,SERCA,SIXTEEN
101,107,138,186,224,26A,26B,374A,410,551,660,AMACR,BACKGROUND,BLOT,BPH,EZH2,LABEL,METHODS,MIR,PCA,PCR,PSGR,PSMA,RESULTS,THEN,TRPM8,USING,WESTERN
001,126,2006,2011,2439,4794,ACS,ALSO,BACKGROUND,BPH,CAUCASIAN,CAUCASIANS,COLLEGE,LABEL,LEP,LVP,MEN,METHODS,NSQIP,OBJECTIVE,OVERALL,PROGRAM,PURPOSE,QUALITY,RELYING,RESULTS,TURP
8776,946,956,IC50
176,300,8776,FURTHER,HOWEVER,IC50,OVERALL,THESE,ULTIMATELY
308,945,AKT,FIRST,PDK,PDK1,PIP3,RNAI,SILENCING,STUDIES,THR
022,038,173,176,178,190,224,8202,CHINESE,EGFR,ERG,ETS,FISH,GLEASON,HER2,NOTABLY,OVERALL,PCA,PCAS,PSA,PTEN,TUR,USING
161,8805,GLEASON,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,USING
ABOUT,BONE,HOWEVER
169,2014,945,946,AKT,AUTHORS,HIF,JOHN,LTD,MSEA,PTEN,REDD1,SONS,WILEY
001,169,2009,2010,2014,297,AUDIT,AUTHORS,CARE,DIAGNOSIS,ENGLISH,INC,IQR,PRIMARY,PUBLISHED,ROUTINELY,THESE,UICC,USING,WILEY
001,165,2012,400,8201,ABOUT,BOTH,CONCLUSION,FEDERATION,GENERALLY,HRQOL,LABEL,MAY,METHODS,OBJECTIVE,PCA,PURPOSE,RESULTS,SWEDISH,THOSE,VAS
177,2011,2013,ADVERSE,CAUTIONARY,CONTROL,CTCAE,ELECTRONIC,EPR,LABEL,MAY,METHODS,OBJECTIVE,OSCIR,PATIENT,RESULTS,SUNNYBROOK,SYMPTOM,TIME,USING
125,145,2000,2008,BACKGROUND,BCR,CONCURRENT,COX,ERG,FISH,IHC,LABEL,METHODS,PTEN,RESULTS
294,451,ACIDS,AUFA,CIS,FATTY,FIBER,ITALIAN,LABEL,METHODS,OBJECTIVE,ORS,PURPOSE,RESULTS,VEGETABLE,VUFA
002,004,005,0074,010,015,239,CD4EM,CD8,CTLA,NEG,PERIPHERAL,PHASE,PSA,THERE,THESE,TIM,TREGS
AMERICA,ETHANOL,MYRTACEAE,NFKB1,SOUTH,UPLC
169,2014,AACR,PAI
169,2013,COPYRIGHT,INC,MAPS,ORGANIZING,SELF
2001,2012,308,BACKGROUND,DRE,LABEL,METHODS,OVERALL,PCA,RESULTS,RIGHT
DMR,DMRS,EPIGENETIC,EXPRESSION,EZH2,H19,HOXC6,IGF2,IGN,LIT1,MEG3,NDN,PCR,PPP1R9A,THEREFORE,ZAC1
036,169,2014,215,461,8805,BACKGROUND,CONCLUSION,COPYRIGHT,COX,GLEASON,LABEL,METHODS,RESULTS,SEVENTY,T2C
169,2004,2010,2014,845,ASIAN,CALIFORNIA,CHINESE,COPYRIGHT,EDUCATION,GLEASON,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,ORS,PUBLISHED,PURPOSE,RESULTS,THESE,UROLOGICAL,USING,VIETNAMESE
169,2014,COPYRIGHT,INC
001,006,100,113,169,1994,2014,ALSO,COPYRIGHT,EDUCATION,EPSTEIN,GLEASON,HOWEVER,INC,LABEL,MATERIALS,MEN,METHODS,MRI,OBJECTIVE,PUBLISHED,PURPOSE,REPORTING,RESULTS,STANDARDS,START,STUDIES,TARGETS,UPON,UROLOGICAL
057,169,1982,2010,2013,2014,305,4974,8805,AMONG,BACKGROUND,CIS,COPYRIGHT,COX,HOWEVER,INC,JOURNAL,LABEL,METHODS,OBJECTIVE,PREVENTION,PREVENTIVE,PUBLISHED,PURPOSE,RESULTS,RRS,SHORT,STUDIES,THERE,THESE,WORK
126,2007,2011,228,239,ACCURAY,AUA,BACKGROUND,BETWEEN,BOWEL,COMPOSITE,CYBERKNIFE,EPIC,HOWEVER,INDEX,JULY,LABEL,LARGE,METHODS,QUALITY,RESULTS,SBRT,SCORE,SYMPTOM,TRANSIENT,TREATMENT,URINARY,UROLOGICAL
E2C,EMT,HOWEVER,MTT,TRANSWELL,UBE2C,UBIQUITIN
162,197,577,BACKGROUND,END,ESTIMATES,LABEL,METHODS,PSA,PSAS,RESULTS,SWEDISH
1071,132,169,177,2003,2007,2013,215,222,239,AUTHORS,BETWEEN,BJU,BMD,CONCLUSION,LABEL,METHODS,OBJECTIVE,OSTEOPENIA,RESULTS,SUBSIDIARY,THEIR,TREATMENT,ZDA
121,8805,AIMS,ANOTHER,AUROC,B2M,BPH,CONCLUSION,ERG,GAPDH,GLEASON,HSPD1,LABEL,OBJECTIVE,PATIENT,PCA,PCA3,PSA,RESULTS,TMPRSS2,UAP1
145,945,ANAA,BACKGROUND,BLUE,COS,DU145,ESTERASES,FAST,LABEL,LNCAP,METHODS,OPH,PAGE,PC3,RESULTS,RWPE,THESE,WESTERN
371,ANDROLOGY,PREDICTORS,PRESENT,SELF,TRADITIONS,UNIT
169,2004,2014,439,8805,ACE,ADULT,AUTHORS,CARE,CONCLUSION,COPYRIGHT,CROSS,EVALUATION,GERIATRICS,GUIDELINE,III,INDEX,JOURNAL,LABEL,METHODS,NPCR,OBJECTIVE,OBJECTIVES,OLDER,PROGRAM,RESULTS,SETTING,SOCIETY
100,ACETATE,AERVA,ALCF,ALEAF,CHLOROFORM,ETHYL,SRB,THERE
AMONG,HER2,MOLECULAR,MRI,MRSI,NEWER,PET,RADIATION,USING
500,600,ANTIGEN,BACKGROUND,CONCLUSION,DISEASE,KARNOFSKY,LABEL,LIFE,METHODS,PRIMARY,RESULTS,REVIA,TEN,THESE,THIOCTACID
100,155,2000,2012,8804,8805,AIM,CONCLUSION,CSS,GLEASON,JULY,LABEL,METHODS,OBJECTIVE,PSA,RADICAL,RESULTS,RRP
AIM,CONCLUSION,EXPRESSION,FGF,FGF9,LABEL,LNCAP,MATERIALS,METHODS,OBJECTIVE,RESULTS,TISSUES,VEGF
133,141,170,26A,AFTER,AIM,BACKGROUND,CENTRES,CONCLUSION,GLEASON,HOWEVER,INCREASED,LABEL,METHODS,OBJECTIVE,PCA,PCR,PRE,RESULTS,RNU1,SCORE,SERUM,SNORD43
0001,0099,152,169,2014,3P13,5Q21,6Q15,ERG,GLEASON,HIGH,KPNA2,NBS1,PTEN,TMPRSS2,UICC
HIV,HOWEVER,NOW,WHILE
DNAS,ELECTRO,RNAS,VEGF
045,1015,1044,169,2014,8201,953,CAUCASIAN,CHINESE,EASTERN,INC,PCA,PKC,PRKCI,SNPS,WILEY
1961,2005,422,DATA,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SIR,THERE
169,2014,ADC,COPYRIGHT,CURRENT,DIFFUSION,FUNCTIONAL,INC,MRI,RARER,SUCCESSFUL,THESE,WILEY
001,169,2011,2012,2014,3072,3691,8804,8805,AFTER,BACKGROUND,DATA,EPIC,INDEX,LABEL,METHODS,RADIATION,RESULTS,SOCIETY,SURGERY,UNADJUSTED
160,AAZTA,III,MRI
CARLO,CONCLUSION,IMRT,LABEL,MATERIALS,METHODS,MLCS,MONTE,MUS,OAR,OARS,OBJECTIVE,PURPOSE,RESULTS,VMAT
100,215,8201,956,ECLIPSE,ENDOGENOUS,PLUS,RRHD
379,CAP,DATA,GLEASON,LABEL,MEAN,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,RRP,SEER
LABORATORY,POTENTIAL,RAMAN,THERE
003,006,132,174,445,GLEASON,INCLUDING,LABEL,METHODS,OBJECTIVE,OVERALL,PSA,PURPOSE,RESULTS
8197,CIA,ECAS,ELISA,H2O2,INTRA,METHODS,PSA,RESULTS
169,2014,946,AACR,CFL,COFILIN,CONVERSELY,FURTHER,LIMK,NOTABLY,SER3,TGF
004,2007,2013,336,751,855,8804,AGE,CONCLUSION,FORTY,GLEASON,INCLUSION,JUNE,LABEL,MARCH,MATERIALS,METHODS,MRI,OBJECTIVE,PSA,PURPOSE,RESULTS,TEN,TRUS
205,400,945,AZGP,BCR,ERG,GLEASON,LOW,THESE
123,169,176,2014,215,283,582,AFFAIRS,COPYRIGHT,EDUCATION,HEALTHCARE,HOWEVER,INC,LABEL,MARTINI,MATERIALS,MEDICAL,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THESE,UROLOGICAL
122,150,169,2000,2002,2009,2011,2014,317,BASE,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL,USING
169,2014,COPYRIGHT,MOST,PIPER,SAS
140,169,2014,6NM,80NM,916,945,ABI,COPYRIGHT,CYP17A1,INHIBITION,LTD,P450C17
160,169,2014,AUTHORS,COPYRIGHT,INC,PUBLISHED,SER,SPOP,THR
169,2014,260,CHILEAN,COPYRIGHT,COX,GSTM1,GSTM1NULL,GSTT1,GSTT1NULL,INC,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PROGNOSTIC,RESULTS,THUS
18H,6AHX,949,AHX,AVA,BBN,CUCL2,DUPA,ESI,GASTRIN,GRPR,HPLC,INC,LABEL,LNCAP,METHODS,NH2,NOTA,PET,PSMA,PUBLISHED,RESULTS,SCID,UNLABELLED,WHOLE
1100,125,1574,169,170,1730,1805,1995,2006,2014,487,AIMS,COLLEGE,COPYRIGHT,LABEL,LIMITED,LTD,MATERIALS,METHODS,MORTALITY,OBJECTIVE,OVERALL,PUBLISHED,RESULTS,ROYAL,SERVICE,SIR,SPC,YORKSHIRE
8805,DVH,EPIC,IRELAND,LABEL,LOW,LTD,MEAN,METHODS,OBJECTIVE,PATIENT,PUBLISHED,PURPOSE,QOL,QUANTEC,RESULTS,SEGMENTAL,V25,V40,V50,V60,V70,V80
169,177,2010,2012,2014,CAG,COLLEGE,COMPARING,COPYRIGHT,DEPARTMENT,FEB,HAN,LABEL,MEDICAL,METHODS,OBJECTIVE,PCR,PUBLISHED,RESULTS,SIXTY,SURGERY,THERE,URINARY
0002,169,2013,839,ACCORDING,AEU,CONTROLLED,COPYRIGHT,DATA,HOWEVER,LABEL,MEDLINE,METHODS,OBJECTIVE,PSA,PUBLISHED,RESULTS,SEVEN
116,1365,169,177,1977,2010,2014,236,BECAUSE,BLADDER,COPYRIGHT,DATA,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PCA,RCC,RESULTS,SIXTEEN,TCC,TCCS,THERE,TREATMENTS
001,151,168,171,435,872,BACKGROUND,BASED,FEW,FUNCTIONAL,HOWEVER,ICIQ,LABEL,LRP,METHODS,OVERALL,RESULTS,RRP,SURGEON
103,125,126,131,144,160,198,4RS,945,946,BED,DIFFERENT,HELA,HOWEVER,INCLUSION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,USING
004,DDSH,DISH,DSH,EACH,GRADE,IMRT,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SPATIAL
EFFORTS,EXCESSIVE,FINALLY,IMRT,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THEN,THERE,VMAT
177,AFTER,CBCT,CBCTS,CONCURRENT,D95,IMRT,LABEL,MAP,METHODS,NINE,OBJECTIVE,PLNS,PURPOSE,RESULTS,SIX
2013,CALYPSO,DOSE,LABEL,METHODS,MLC,OBJECTIVE,PURPOSE,RESULTS,V60,VMAT
169,189,2014,236,425,BACKGROUND,JOHN,LTD,PCA,RESILIENCE,RESULTS,SONS,THESE,WILEY
169,2014,ADDITIONAL,AIM,BACKGROUND,CONVERSELY,EACH,INVENTORY,LABEL,MAIN,MEAN,MEN,METHODS,OBJECTIVE,OUTCOME,RESULTS,SOCIETY,VED
001,004,027,029,042,043,363,AMSTERDAM,AVL,C30,CORE,EORTC,FORM,ICIQ,IIEF,INDEX,LABEL,LIFE,MAIN,METHODS,NCI,OBJECTIVE,PR25,QLQ,QOL,QUALITY,RARP,RESULTS,SHORT,TREATMENT
1214,2011,2012,2500,400,AIM,GLEASON,JANUARY,LABEL,MEAN,METHODS,OBJECTIVE,PSA,RADICAL,RESULTS
EPITHELIAL,INDIVIDUAL,LAYER,LUMEN,RATIO
BCR,CAP,CELL,CORE,ENTROPY,FIRSTLY,RANDOMIZED,THIRDLY,TMA
DSC,MAD,MAXD,MIND,TRE,TRUS
INCREASED,MET,RAB7,TAKEN
946,BASED,ERG,EXPRESSION,GLEASON,KI67,NOVEL,PDGFR,TMPRSS2
000,163,2006,274,CONCLUSION,HOWEVER,LABEL,METHODS,PSA,RESULTS,SINCE,THUS,UNASSIGNED
100,1000,174,300,8482,ADAM9,DU145,HSP70,ITIH4,L1CAM,LDH,LYSATES,MET,MFG,NOTCH,RAC1,ROR1,SEVERAL,SOMAMER,THESE,WESTERN
002,225,354,CONCLUSION,DYNAMIC,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THEN
BPH,PCA,THESE,YOUNG
163,197,2011,230,ALK,DATA,EML4,ERG,ESRRA,III,PCR,SALZMAN,TMPRSS2
169,2014,215,8201,8804,8805,ACTA,ADC,AUC,BACKGROUND,CCC,CONCLUSION,FOUNDATION,GLEASON,LABEL,METHODS,MRI,OBJECTIVE,PCA,PURPOSE,RESULTING,RESULTS,TRUS,USING
945,HIF,HOWEVER,HYPOXIA,MAMMALIAN,MRV,MRVINFECTS,PAS,PCA,RACK1,THESE,VIRUS
8805,CELL,LABEL,METHODS,NRF2,OBJECTIVE,PURPOSE,RESULTS,THERE,THESE
1260B,AFTER,BACKGROUND,GENISTEIN,INITIALLY,LABEL,METHODS,MIR,RESULTS,SMAD4,TCF,UTR,WESTERN
2156,421,835,843,AUSTRALIA,BACKGROUND,BRITISH,FIVE,HOUSEHOLD,LABEL,METHODS,MIDLIFE,MODEL,PANEL,RESULTS,RETIREMENT,SIBLING,THESE,WISCONSIN
181,233,ACC,BELGIAN,CAEN,FN1,GRAND,IONS,NUCLEAR,PC3,SEVERAL
3716,GEM,HOWEVER,KSI,KU19,MYC,THESE
AKT,AML,CD24,CD44,CHEK1,ERG,ETS,EZH2,ITGB3,ITGB5,NILOTINIB,PKC,SUZ12,TMPRSS2,WNT
18F,2008,2012,236,FDG,FOUR,INCIDENTAL,JAPAN,PET,PSA,UNIVERSITY
125,8805,AIMS,GROUP,LABEL,LATE,MATERIALS,METHODS,NCCN,OBJECTIVE,PSA,RADIATION,RESULTS,THERAPY,THREE
120,2013,AIMS,AIRO,BACKGROUND,GIOVANI,HIGHLIGHTS,ITALIAN,ITALY,LABEL,MAY,METHODS,OBJECTIVE,RADIATION,RESULTS,YOUNG
2006,2013,CK903,GATA3,GLEASON,HIGH,NKX3,PSA,PSMA,THREE
945,946,954,ALK5,CLAUDIN,DISRUPTION,EMT,PAR,PROLONGED,SMAD,SMAD2,SMAD4,SNAIL,TGF
145,169,2014,2_FI2,946,CX43,FUNCTIONAL,HIGH,INCOMPLETE,LYLU,MAT,PRESS,PUBLISHED,SNAIL,THESE,UNIVERSITY
169,2014,223,COPYRIGHT,DATA,IRELAND,LTD,SIPULEUCEL
HMBA,LNCAP,LTD,PUBLISHED,SEVERAL
DPC,HIPPOPHAE,MDA,PCO,PHIP,SBT,THESE
000,0003,100,119,200,500,C57BL,POLYPHENON,THEREFORE,TRAMP
183,2013,ATTENTION,GEORG,STUTTGART,WHAT,YORK
169,2000,2014,FND,FNDS,GMBH,HIGH,HOWEVER,HPHT,KGAA,NDS,PEG,VCH,WILEY
8764,946,969,CELL,MOUSE
002,017,019,020,048,169,2014,215,260,26S,343,637,646,8201,ADDITIONAL,ALAD,BACKGROUND,BLACK,FURTHER,GLEASON,INC,INORGANIC,IOR,LABEL,LEAD,METHODS,RESULTS,USING,WILEY
THERE
BAY,EQUAL,FLORIDA,INSTITUTE,LEE,MEDICALLY,MOFFITT,SOUTH,TAMPA,UNIVERSITY
183,ADT,AMONG,BACKGROUND,BMD,CONCLUSION,FLEX,LABEL,METHODS,PCS,POWIR,PREVENT,RESISTANCE,RESULTS,RETENTION,THERE
18F,ACCORDING,CLINICALLY,CUP,FDG,IMAGING,ISSUE,LABEL,METHODICAL,METHODS,MODALITIES,MRI,OBJECTIVE,PET,PRACTICAL,RESULTS,SUBSEQUENT,WHOLE
595,8805,ADDITIONAL,GLEASON,LABEL,METHODS,OBJECTIVE,PCA,PCA3,PCA3D,PSA,PSAD,PURPOSE,RESULTS,SERUM,SIMILAR,USING
DESPITE,DETECTION,FFPE,MOST
1468,1471,169,2013,2939,413,531,712,COPYRIGHT,FIVE,IRELAND,IRR,LTD,THERE
26A,CHIP,CPG,EZH2,H3K4ME3,HIPPO,HOWEVER,MST1,MYC,PCR,REDUCTION,RNAI,THESE
000,002,007,035,095,141,2006,2013,413,419,618,750,8805,BMI,GLEASON,JANUARY,LABEL,MARCH,METHODS,MRI,OBJECTIVE,PSA,RESULTS,STUDENT,T3A,T3B
017,2002,2004,3153,9017,BACKGROUND,CARE,CONTROL,DISEASE,EBRT,GLEASON,IMRT,INTENSITY,LABEL,MEDICAL,METHODS,NCCN,NON,PREVENTION,PSA,RESULTS,THOSE,UNIVARIATE
100,169,200,2014,223,946,DDR,GIVEN,JOHN,LNCRNAS,LTD,MODULATION,PREVIOUSLY,PUBLISHED,RNAS,SONS,THESE,UVB,VDR,VDRE,VDRES,VDS,VITAMIN,WHILE,WILEY,WNT
001,002,2008,2009,512,706,806,BACKGROUND,DESPITE,END,FOLLOWING,LABEL,METHODS,ORP,OVERALL,PCA,PROPENSITY,RARP,RESULTS,SEER,THESE
BACKGROUND,CONCLUSION,DU145,HOX,HXR9,LABEL,LNCAP,METHODS,PBX,PC3,PCR,RESULTS,TARGETING
268,631,8211,963,CASE,HENCE,OVERALL
200,A549,BIP,CAR,CONCLUSION,DKK,EGFR,GRP78,JNK,JUN,LABEL,MATERIALS,METHODS,MOI,NSCLC,OBJECTIVE,OBJECTIVES,OUMS,REIC,RESULTS,THESE,TKI
145,174,945,DOXAZOSIN,ECM,IGFBP,ILK,LOSS,TSP
ABOLITION,APA,ECE,ENDOTHELIN,UTR,UTRS
727,8805,CHIP,FOXA,GWAS,H3K27,JAZF1,LNCAP,NKX3,RS4907792,SNP,SNPS
169,2014,945,BOTH,METABOLIC,MYC,PCA,SOCIETY,THESE
AMP,AMPK,CRPC,FINALLY,HOWEVER,MDV3100,PCA,PCAS
160,169,183,8202,CONCLUSION,GEORG,IRB,LABEL,MATERIALS,METHODS,MRGB,MRI,OBJECTIVE,OBJECTIVES,PCA,RESULTS,STUTTGART,YORK
181,183,8201,ANDROGENS,FIRST,GEORG,IC50,LNCAP,STUTTGART,THESE,THIRD,YORK
146,169,2000,2010,2013,303,390,6275,8201,839,BACKGROUND,CAPSURE,GLEASON,LABEL,METHODS,PATIENT,PEARSON,PRIMARY,RESULTS,SALVAGE,SOCIETY,STRATEGIC,THERE,TYPE
956,BAX,BCL,DIOSCIN,FLOW,LNCAP,THESE,WESTERN
174,177,2000,2600,DTX,HRPC,LNCAP,PCL,PEG,PMS,PSA,TWEEN
000,100,2001,2006,388,493,CONCLUSION,HOWEVER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
001,011,115,2000,2010,386,388,3DCRT,503,8201,BACKGROUND,CONCLUSION,IGRT,IMAGE,IMRT,LABEL,METHODS,PCA,PTV,RESULTS
007,1006,169,2013,327,335,8805,AMONG,BOTH,COPYRIGHT,DPQ1W,DPQ3W,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PSA,RESULTS,TAX,THERE
001,008,016,025,169,2013,967,976,AFTER,CLASS,CONTROL,COPYRIGHT,FIRST,INC,INCENTIVE,LABEL,MAIL,MATERIALS,METHODS,MOST,OBJECTIVE,OBJECTIVES,RESULTS
169,2013,CURRENTLY,DRUG,ERG,FOOD,INC,INITIALLY,PCA,PROMISING,PSA,TMPRSS2,WHILE,YET
147,182,285,309,ANGELES,BACKGROUND,CIS,LABEL,LOS,METHODS,ORS,RESULTS,RISK,THERE
178,8314,8644,956,BAPTA,BAYK,BHQ,CA2,FURA,INHIBITION,PC3
DENDRIMERS,G4ARG,PAMAM,SUCCESSFUL,TEA
169,2010,2014,312,ACD,AUSDIAB,AUSTRALIA,AUSTRALIAN,AUTHORS,COHEN,LABEL,LIFESTYLE,METHODS,OBESITY,OBJECTIVE,RESULTS,SELF,SIMILARLY,YEARS
169,2000,2007,2014,482,AFFAIRS,AUSTRALIA,AUSTRALIAN,CONCLUSION,DEPARTMENT,DVA,FEMALES,GOVERNMENT,LABEL,METHODS,NSW,OBJECTIVE,RESULTS,RISK,SIR,SIRS,SMR,SMRS,SOUTH,THESE,WALES
GNRH
CRPC,PRCA
223,CASTRATION,CRPC,OTHER,THESE
CRPC,FURTHER,PRCA,THESE,WHILE
REGULATION,THROUGHOUT,VGSC,VGSCS
CURRENT,FATOSTATIN,FURTHER,LNCAP,PARP,PSA,SREBP
169,2014,BACKGROUND,CONVERSELY,COPYRIGHT,COUPLES,FINALLY,HOWEVER,JOHN,LABEL,LTD,METHODS,QOL,RESULTS,SONS,THESE,WILEY
001,300,BACKGROUND,BCRFS,GLEASON,LABEL,METHODS,NOB1,RESULTS,THESE,WESTERN
301,374,407,8201,824,990,ARG,ARG194TRP,CAUCASIANS,CHINA,CNKI,KNOWLEDGE,NINE,ODDS,OVERALL,TRP,XRCC1
177,181,8201,AKT,ERK,FURTHER,IC50,MAPK,MEOH,PI3K,SNU,USING,VIETNAMESE
HOWEVER,PIN,STRIKINGLY,TAKEN
173,272,BACKGROUND,BPH,CYP24A1,FIVE,GLEASON,HOWEVER,LABEL,METHODS,NCBI,PSA,RESULTS,SNPS,THEREFORE,VITAMIN
946,ACID,EZH2,GLEASON,RAR,THUS,USUALLY
111,169,2014,APL,CD8,COPYRIGHT,HENCE,HLA,HOWEVER,LTD,PLASMID,SSX2,TH1,THESE,USDA
145,231,956,DU145,EPE,IC50,MDA,MMP,PNT1A,THERE
169,2014,AACR,CBP,CIP1,CONVERSELY,DESPITE,EZH2,K27,KIP1,PTEN
BASED,III,MDV3100,OTHER,PREVAIL
169,2014,361,ADPC,BCL,CASTRATION,COPYRIGHT,CRPC,INC,PCA,STAT6,THEREFORE
169,2014,CLU,CLUSTERIN,COPYRIGHT,CRPC,HOWEVER,IGF,INVERSELY,IRELAND,LTD,PTEN,STAT3
169,2013,2014,787,BACKGROUND,CONTEXT,COPYRIGHT,CURRENT,GLEASON,IMAGING,ITEMS,JULY,LABEL,META,METHODS,MRI,OBJECTIVE,PATIENT,PCA,PREFERRED,PUBLISHED,REPORTING,RESULTS,REVIEWS,SEVERAL,STUDIES,SUMMARY,SYNTHESIS,SYSTEMATIC,THESE,UROLOGY
002,003,008,119,169,2007,2013,2014,239,8805,BACKGROUND,COPYRIGHT,CROSS,CRPC,LABEL,MAY,MEN,METHODS,OBJECTIVE,OUTCOME,PATIENT,PFS,PSA,PUBLISHED,RESULTS,SETTING,SUMMARY,TAXANES,UROLOGY
169,2014,COPYRIGHT,DALY,HOWEVER,LTD
BACKGROUND,CONCLUSION,D35,D99,LABEL,MAR,METHODS,MVCT,PTV,RESULTS,TREATMENT
001,00279,0203,0341,945,BACKGROUND,ERK,EXPRESSION,GEO,HIF,HOWEVER,LABEL,METHODS,MICROARRAY,MSC,NRF2,PCR,RAF,RAS,RESULTS,TCGA,THEREFORE,VEGFA
159,CEM,CHRONIC,DLBCL,PBSCT,RELAPSE
223,AREAS,BACKGROUND,COVERED,FIRST,HOWEVER,III,LABEL,METHODS,OPINION,PHASE,TARGETING,THERE
431,956,HYGROCINS,IC50,LZ35,MDA,NMR,PC3,SIX
1120,250,2992,8805,AIMS,BIBF,BIBW,COMBI40,COMBI70,CONCLUSION,ERBB,LABEL,METHODS,NINTEDANIB,OBJECTIVE,PSA,RESULTS
CLINICALLY,CROATIA,GLEASON,LOCALLY,METASTATIC,PSA,TNM,TREATMENT
1044,107,184,8211,8805,CONCLUSION,GLEASON,HOWEVER,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,ROC,STATISTIC,TESLA,THREE,TRUS
283,665,BRCA,BRCA1,BRCA2,COX
1225,1228,134,168,169,188,2014,223,30D,376,544,8201,939,940,FUNCTIONAL,HOWEVER,INGENUITY,IPA,MIR,NORMFINDER,PATHWAY,RNU6B,SEVEN,UICC
102,2000,2013,242,8805,AMONG,DRE,GLEASON,JULY,LABEL,METHODS,NONE,OBJECTIVE,PSA,PURPOSE,RCP,RESULTS
009,017,039,2013,371,8201,854,ARG,CAUCASIAN,CAUCASIANS,CHINA,CIS,CNKI,FIXED,GALBRAITH,GLEASON,HARDY,HOWEVER,KNOWLEDGE,LIBRARY,META,OCTOBER,PCA,PRO,SYSTEMATIC,THEREFORE
246,8201,ACADEMY,HOWEVER,IDM,NETWORK,PCS,PHYSICIAN,PHYSICIANS
169,2014,ATR,COPYRIGHT,GMBH,KGAA,NATURALLY,THERE,VCH,WILEY
113,116,177,AES,CAUCASIAN,CRPC,CYCLE,DLT,DOSE,LABEL,METHODS,MILD,MTD,OBJECTIVE,PURPOSE,RESULTS,SEVENTEEN
106,192,3800,387,674,ARHGEF3,C8ORF38,CORRECTING,ERG,EXCLUSION,G089,MOST,MPP5,OVERALL,PCA,PCR,RWPE,TMPRSS2,USING
BONJ,ORAL,SURGERY,TREATMENT,UNIVERSITY
DRE,FISH,GLEASON,INTER,MYC,PSA,PTEN
947,CD31,H2AX,ISEL,KI67,PHD2,RESULTS,SEVERAL,TUNEL,VEGF,VIII
169,180,2014,231,453,8320,8325,956,COPYRIGHT,FLOW,HELA,MASS,MCF,MDA,MOST,MTT,NMR,SAS,SIX,THEIR
000,600,BONE,LOCAL
169,2014,954,CAF,CAFS,CAV,COPYRIGHT,HIF1,HOWEVER,LTD,MCT4,ROS,THESE
100,169,2014,2D3,945,956,COPYRIGHT,FORMATION,HEPATIC,IC50,LTD,NADPH,RESULTS,RG1,RH2,SIMILAR
0003,1360,169,2014,8804,AUC,BACKGROUND,COPYRIGHT,COX,GLEASON,HIGH,LABEL,METHODS,OBJECTIVE,OUTCOME,OVERALL,PCA,PCSS,PSA,PUBLISHED,RESULTS,RETROPUBIC,SETTING,UROLOGY
001,169,1993,1995,1998,2012,2014,451,892,AFTER,BETWEEN,CONCLUSION,COPYRIGHT,COX,EDUCATION,FOUNDATION,GIVEN,GLEASON,INC,JANUARY,LABEL,MAYO,MEDICAL,METHODS,MIB,OBJECTIVE,PREDICTIVE,PUBLISHED,RESULTS
1664,169,2000,2009,2014,3760,416,8805,BACKGROUND,COPYRIGHT,END,FOLLOWING,HBT,HBTS,LABEL,LOS,METHODS,MIBC,OBJECTIVE,OUTCOME,OVERALL,PATIENT,PUBLISHED,RELYING,RESULTS,SETTING,SUMMARY,THESE,UROLOGY
007,108,1430,169,2014,4296,465,890,CONCLUSION,COPYRIGHT,DISEASE,IMPORTANT,INC,LABEL,METHODS,OBJECTIVE,RESULTS
169,2014,BECAUSE,COPYRIGHT,DFU,DFUS,LTD,NEXT,TYPE
10MM,169,2014,477,4MM,BECAUSE,CBCT,CBCTS,CONCLUSION,COPYRIGHT,CROWN,CTV,CTVS,FIFTY,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PTV,PTV10,PTV5,PUBLISHED,PURPOSE,RESULTS
169,2014,220,290,AUTHORS,COPYRIGHT,IMRT,IRELAND,LTD,PCA,PUBLISHED,SPC,THERE
10MG,145,169,180,2014,4000,421,746,BACKGROUND,CONCLUSION,COPYRIGHT,CSF,CUP,CUPS,EAP,EAPS,LABEL,LTD,METHODS,RESULTS
102,169,1990,2002,2003,2009,2014,AFTER,CAMEY,CONCLUSION,COPYRIGHT,EARLY,EIUA,ICP,INC,LABEL,METHODS,OBJECTIVE,RESULTS,SEVEN,SIXTY,SSC
106,10MM,112,113,118,169,2000,2012,2014,BACKGROUND,COPYRIGHT,IRELAND,JANUARY,LABEL,LTD,MEDICAL,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,SAMSUNG,THERE
169,2013,946,BASAL,COPYRIGHT,E12,GMBH,TRIM,TRIPARTITE
169,2005,2010,2013,BACKGROUND,CCAFU,CONCLUSION,COPYRIGHT,GLEASON,GUIDELINES,INDIVIDUAL,ISP,LABEL,MEDLINE,METHODS,PSA,RESULTS,RMN,SAS,SIDE
169,1980,2005,2008,2009,2012,2013,317,416,549,781,792,841,CANCERS,CONCLUSION,COPYRIGHT,FRANCIM,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRESENT,RESULTS,SAS,TESTICULAR,THERE
169,2010,2011,2013,CONCLUSION,COPYRIGHT,HOWEVER,IPSS,JANUARY,LABEL,METHODS,OBJECTIVE,PRIMARY,PURPOSE,QMAX,RESULTS,SAS,SCORE,SECONDARY,SEPTEMBER,SIXTY,SYMPTOM,TURIS,TURP
00001,0001,0004,001,169,2000,2006,2010,2013,303,APRIL,BMI,CLAVIEN,CONCLUSION,COPYRIGHT,GLEASON,HOWEVER,JUNE,LABEL,LRP,METHODS,OBJECTIVE,PSA,RADICAL,RESULTS,SAS,THERE
169,2007,2009,2013,50MG,AVS,BACKGROUND,BETWEEN,CONCLUSION,COPYRIGHT,LABEL,MARRAKESH,METHODS,RESULTS,SAS,THERE
169,2008,2012,2013,AMICO,CONCLUSION,COPYRIGHT,DIFFUSION,JUNE,LABEL,METHODS,MRI,NPV,OBJECTIVE,PPV,PSA,PUBLISHED,RESULTS,SAS,TNM
169,2013,ANG,AT1,AT1R,BACKGROUND,CONCLUSION,COPYRIGHT,LABEL,METHODS,RAS,RESULTS,SAS,SEVERAL,VEGF
160,169,2014,CHRONIC,COPYRIGHT,CXCL1,FEDERATION,FINALLY,PUBLISHED,SOCIETIES,TAKEN,USING,UTR
239,945,AMPK,BACKGROUND,COIP,HOWEVER,INHIBITION,LABEL,METFORMIN,METHODS,MID1,PCR,PP2A,RESULTS,THESE,WESTERN
116,169,2014,549,956,AMONG,COPYRIGHT,HCT,HUISGEN,IC50,LTD,MCF,MICHAEL,T98G
169,178,185,2013,8308,8310,8311,8312,8313,945,CAIX,DFO,EVALUATION,FDG,HBED,INC,J591,OTHER,PET,RENAL,THERE
1000,169,1994,2007,2013,311,AMONG,BACKGROUND,BASED,COX,FALL,LABEL,METHODS,PERIPHERAL,RESULTS,SEER
001,108,113,169,2013,518,8804,ACTIVITIES,ADL,ADLS,ASSESSMENT,BACKGROUND,CGA,CONCLUSION,CROSS,CUMULATIVE,DAILY,DEPRESSION,GERIATRIC,GERIATRICS,ILLNESS,LABEL,MATERIALS,METHODS,MINI,OBJECTIVE,PARIS,PREVALENCE,REFERENCE,RESULTS,SCALE,SETTING,STATE,THESE,TIMED
005,1997,2012,BACKGROUND,CALIFORNIA,CONCLUSION,EBRT,FRANCISCO,HOWEVER,LABEL,MATERIALS,METHODS,PHOENIX,PSA,PSAS,RESULTS,SAN,SBRT,SIMILARLY,UNIVERSITY
162,169,199,2014,2481,428,531,731,791,BACKGROUND,BRCA,BRCA1,BRCA2,COPYRIGHT,LABEL,MEN,METHODS,OBJECTIVE,OUTCOME,PATIENT,PCA,PCAS,PPV,PSA,RESULTS,SETTING,SUMMARY,TARGETING,THESE,UROLOGY
1040,1341,16913,1989,2000,20005,2005,2009,2015,2019,20359,25910,2791,2908,46269,5870,8083,AGE,AMONG,BACKGROUND,CHANGES,FEDERAL,HODGKIN,LABEL,METHODS,RESULTS
169,2014,688,696,ACADEMY,BACKGROUND,BADO,CONCLUSION,LABEL,METHODS,RESULTS
2009,2012,450,8804,CONCLUSION,FINALLY,GLEASON,HOLEP,LABEL,LUTS,MEAN,METHODS,OBJECTIVE,PCA,PSA,RESULTS,THERE,THOSE
8320,8325,956,BUFALIN,COMPOUNDS,THEIR
100,CANCERS,CIS,CONCLUSION,DETECTION,DIAGNOSTIC,GLEASON,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
2004,2005,277,491,718,762,AFTER,BACKGROUND,FACILITIES,FDG,HOWEVER,JAPAN,LABEL,METHODS,OSAKA,PET,PREFECTURE,RESULTS,SCREENING,WHOLE
001,1522,169,2014,BOTH,CARE,COPYRIGHT,JOHN,LABEL,LTD,MARITAL,METHODS,NEITHER,OBJECTIVE,RESULTS,SEDM,SONS,SURVIVORS,WHILE,WILEY
10001,1960S,1970S,333,ADDITIONAL,CURRENTLY,FURTHER,HOWEVER,LUNG,MEDICAL,NLST,PUBLISHERS,RANDOMIZED,SCREENING,SEVENTH,TRAIL,USA,WHAT,YORK
0001,0002,0004,0012,0013,0019,0038,0112,0238,104,169,2014,206,8201,BACKGROUND,CSS,EPE,FORTY,GLEASON,IDC,INC,LABEL,METHODS,PFS,PSA,RESULTS,SVI,WILEY
954,956,BONE,CHINESE,ERK,MOLECULAR,RANKL,THUS
954,AIM,AMONG,AP4,BBX,CONSORTIUM,FOXO4,GATA,GENOMES,GEO,HODGKIN,KYOTO,MBNL1,MFAP2,MYELOMA,RKIP,SNAIL,SP1,TPD52,USING,YY1
AKT,CSC,CSCS,H1975,HIGH,LUNG,NSCLC,OVERALL,REGULATION,SOX2,SRY
596,600,8201,8804,8805,BACKGROUND,BOTH,CONCLUSION,CRPCA,HNPCA,LABEL,METHODS,RESULTS,SMALL,THEIR,TMA,TMAS
001,146,147,APPLIED,BCR,BMI,FURTHER,GLEASON,GSC,KOREA,MEIER,NAFLD
123,BNCT,CLOSO,IC50,LNCAP,PMPA,PSMA,THERE
HOWEVER,ORBITAL
2006,2007,2011,2012,2014,256,770,837,847,858,875,AUC,BASEL,BULGARIAN,DESPITE,KETTERING,LNI,MSKCC,PCA,PREDICTED,SLOAN
169,1ST,2013,5TH,ACCORDING,BASEL,HUNGARY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,ROMAN
ATP,AUGMENTED,CTL,HMGB1,RADIATION,THESE
169,2014,COPYRIGHT,EVEN,HOWEVER,INC,KEGG,THEREFORE
169,2014,AACR,PTEN,SER81,TAKEN,THESE
160,169,2014,BECAUSE,COMPASS,COPYRIGHT,DICOM,DVH,INSTEAD,LTD,OAR,PEARSON,PLAN,PUBLISHED,WEAK
169,1993,1996,2014,AIM,BACKGROUND,BECAUSE,CONCLUSION,COPYRIGHT,LABEL,LTD,METHODS,NONE,OBJECTIVE,PUBLISHED,RESULTS,SURGERY
169,177,2014,2MM,3MM,CONTROL,COPYRIGHT,EACH,GAMMA,INC,LINAC,MEDICAL,MELBOURNE,MONITOR,NUCLEAR,OVERALL,PATIENT,POINT,PUBLISHED,SBRT,SNC,SUN,UNIT,VMAT
125,169,177,2014,24H,518,6AHX,8805,945,946,AHX,ALA,ARG,ASP,BACKGROUND,BBN,COPYRIGHT,ECHISTATIN,ESI,GLN,GLU,GLY,GRPR,HPLC,INC,LABEL,LEU,METHODS,MICRO,NH2,NO2A,NOTA,PHE,RESULTS,RGD,RM2,STA,TRP,TYR,U87,VAL
001,028,031,102,111,169,2014,369C,590C,606T,AMONG,APMIS,CLDN1,CLDN7,FFPE,FURTHER,JOHN,LTD,PUBLISHED,SNP,SNPS,SONS,THESE,TIGHT,TNM,WILEY
ANNEXIN,ANX,ANXS,AREAS,BACKGROUND,CCC,COVERED,LABEL,METHODS,OPINION
177,956,ANNEXIN,CELL,CELLS,DEEP,DRUG,GIVEN,PC3,RAMOS,RED
0614,1541,169,17Q21,2014,485,7786,AACR,ATG6,ATLAS,BECLIN1,BECN1,BRCA1,LABEL,LARGE,MCR,MOL,RES,TCGA,UNLABELLED
001,004,8805,ADVERSE,AES,BACKGROUND,FIVE,III,LABEL,METHODS,PSA,RESULTS,STATISTICS
945,954,ABROGATING,AP4,FOXA2,HIF1,LNCAP,MAX,MET,MYC,NANOG,OCT3,PCA,RANK,RANKL,RUNX2,SITE,SLUG,SOX2,SOX9,TFS,THESE,ZEB1,ZEB2
169,1995,2008,2010,2014,427,BACKGROUND,BLOCK,CALIFORNIA,COX,DESPITE,HISPANICS,LABEL,METHODS,RESULTS,SOCIETY,STAGE
PSMA
0001,001,101,628,8201,AFRICAN,CANDIDATE,CAUCASIAN,PCA,PCR,USA
2010,CTLA,CURRENT,III,SINCE,WHILE
000,152,160,218,281,380,BIOMARKERS,CLDN3,COA,FLNC,GLEASON,KLK3,NONE,PCA3,PSA,SPECIAL,THOSE
AMONG,CTIBL,EVEN,LABEL,METHODS,MOST,OBJECTIVE,PHYSICIANS,PURPOSE,RESULTS,THERE,YET
153,172,222,DATA,HOWEVER,JADAD,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIX
001,003,006,013,027,030,128,155,2000,2006,BACKGROUND,COX,GLEASON,IMMEDIATE,LABEL,MEIER,METHODS,NONE,RADICAL,RESULTS
2036,ADT,BACKGROUND,CASE,CONCLUSION,CUP,DIGITAL,LABEL,METHODS,PSA,TEN
001,019,0197,0214,0246,0260,0301,0343,0377,151,579,AMICO,BACKGROUND,CD20,HOWEVER,IHC,LABEL,METHODS,PCA,RESULTS,TILS
0001,10TH,116,131,2013,25TH,692,704,723,758,961,ADC,ADCS,CLINICALLY,CONCLUSION,FORTY,GLEASON,HIPAA,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,RSNA
001,009,021,025,026,051,078,082,092,109,2013,2680,3007,3147,3656,867,8804,881,946,CONCLUSION,COX,FDG,FDHT,LABEL,MATERIALS,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,RSNA
001,177,2013,20MIN,BPH,CONCLUSION,FACBC,HIPAA,LABEL,MATERIALS,MEAN,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,RSNA,SUVS,THUS,WHOLE
DEF,DU145,IRON,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RADIATION,RESULTS
001,004,010,017,221,8202,942,BACKGROUND,CIS,FURTHER,HCC,HRS,LABEL,METHODS,RESULTS,RFS,SCIENCE,WEB
104,EVEN,NANOG,NEITHER,OCT3,PACLITAXEL,SCG10,USING
178,8202,8314,8323,945,E2F1,FLOW,TRANSIENT
ALTOGETHER,KNOCK,MMP,RUNX3,STRIKINGLY,TIMP,TMA,TNM,VEGF
031,061,119,1989,2006,437,BRAF,MUTATIONS,V600
011,048,2000,427,8202,ASSOCIATED,BACKGROUND,BRITISH,COMPLEX,CONCLUSION,END,GENERAL,GPRD,LABEL,METHODS,OVERALL,PRS,RESULTS,SHIPMAN,THESE,WORLD
169,2014,ANTIGEN,GMBH,KGAA,LABEL,MOS,VCH,WILEY
1995,2007,AFTER,CANCERS,IRELAND,OTHER,RISKS,VARIATIONS
176,8805,AIM,BACKGROUND,DATA,GLEASON,HIGH,LABEL,MATERIALS,MEIER,METHODS,PSA,RADICAL,RESULTS
115,2009,2010,D90,EBRT,HOWEVER,LABEL,LOCAL,MAY,METASTATIC,METHODS,OBJECTIVE,PCA,PSA,PURPOSE,RESULTS,RRP,SOCIETY
11C,18F,PET,PSA
2014,AMERICA,CD4,CD8,DIGITAL,FEW,GOVERNMENT,HOWEVER,IHC,PBMC,PBMCS,PSA,PUBLISHED,THERE,THESE,TILS,TREG,TREGS
HOWEVER,SOAKING,SOY,SYSTEMATIC
RFX6,SNP
169,2014,AACR,BRCA2,DSB,HOWEVER,IMPAIRMENT,PARP1,PCAT,THESE,UTR
145,1522B,8201,AGO,CATCHESIDE,CLINICALLY,CONCLUSION,H460,KNOWLEDGE,LABEL,LEA,METHODS,OBJECTIVE,RESULTS,SINCE,THERE,THESE
956,9908,BACKGROUND,CD34,CTCE,CXCR4,HENCE,LABEL,METHODS,RESULTS,THESE
001,169,2014,276,331,360,945,AUTHORS,BJU,BPH,CONCLUSION,DRE,DRUG,FOOD,FURTHER,ITALIAN,LABEL,METHODS,OBJECTIVE,PCA3,PIN,PSA,RESULTS,THERE,THREE
520,AIM,DISCUSSION,DMSO,III,LABEL,LAF3,MATERIALS,METHODS,OBJECTIVE,PC3,PLGA,PPIX,RESULTS,UPON
001,009,015,169,2013,461,536,603,AXIAL,BIOT,BOTH,CONCLUSION,INTERRATER,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,RSNA,SNR,SPAC,STUDENT,THERE
043,2001,2010,215,250,299,ASSESSING,BACKGROUND,BASED,CONCLUSION,COX,FRANKEL,HARRELL,KARNOFSKY,LABEL,MEDICAL,MEIER,METHODS,PREDICTIVE,RESULTS,SBM
GTPASES,RHO,RNAI,SEVERAL
BONE,BRONJ,DATA,INTER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THUS
001,003,010,036,100,2009,2010,AFFAIRS,AGENT,BACKGROUND,FIFTY,FURTHER,HIGH,HOWEVER,JANUARY,LABEL,LEVEL,METHODS,RESULTS,RISK,WASHINGTON
0001,102,8211,946,AKT,CD74,ECTOPIC,EGF,ERBB2,ERBB3,III,LABEL,NRG1,PI3K,THUS,UNLABELLED
0001,114,117,AIM,BACKGROUND,ERG,ETS,KI67,LABEL,METHODS,PCS,PSA,REMARKABLY,RESULTS,THESE,TMA,TMPRSS2
0001,1987,2009,687,803,822,BACKGROUND,COX,DATA,GLEASON,GPSM,INCREASING,IQR,LABEL,MAYO,MEANWHILE,MEIER,METHODS,PATIENT,PSA,RESULTS
BMD,CURIOUSLY,DENOSUMAB,LABEL,OBJECTIVE,OTHER,PURPOSE,REGARDLESS,RESULTS,SUMMARY
169,174,2014,CONCLUSION,COPYRIGHT,ERG,EXPRESSION,HBP,INC,LABEL,METHODS,OBJECTIVE,PCA,PCA3,RESULTS,SIMILAR,TMPRSS2
001,006,115,169,2014,8804,8805,CLINICIANS,CONCLUSION,COPYRIGHT,EPSTEIN,GLEASON,INC,LABEL,METHODS,MRI,NPV,OBJECTIVE,PPV,RESULTS
160,169,2014,ASSESSMENT,CD44,CD44S,CD44V10,COPYRIGHT,EXPRESSION,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,UNIVARIATE
COLLECTED,FIRST,MAP,MAXIMUM,NMF,NON,PNMF,THIRD
001,004,008,015,019,022,026,028,042,045,169,2014,8201,8804,ADT,AUTHORS,BJU,COMMENCING,CONCLUSION,CONCURRENT,LABEL,METHODS,OBJECTIVE,OTHER,RESULTS,SIXTY,THERE
001,1382,169,1995,2009,2014,8804,AUTHORS,BJU,COMPETING,CONVERSELY,CSM,END,GLEASON,LABEL,METHODS,NNT,NNTS,OBJECTIVE,OVERALL,PCA,RESULTS,T3A,T3B
185,BEAS,LUNG,NMR,PACLITAXEL,PTX,SLNS,THESE,THUS
169,2014,AIMS,DAC,JOHN,LABEL,LTD,METHODS,OBJECTIVE,PAPILLARY,PIN,RESULTS,SONS,WILEY
EACH,FINALLY,HOWEVER,TARGETING,USA
181,AEA,BACKGROUND,CACO2,CYP17,FAAH,FATTY,HEPG2,IC50,LABEL,PRINCIPAL,RESULTS
ADT,CONVERSELY,CRPC,DESPITE,DHT,LNCAP,NRF1,NRF2,PCA,PCR,PSA,SUBSEQUENT,THEREFORE,TMPRSS2
BOTH,DIM,EPIGENETIC,HOWEVER,LNCAP,OVERALL,PC3,PREC,RESULTS,SFN
ARP2,BASED,CHINESE,CHO,LNCAP,NEOPLASTIC,THEREFORE,WHILE,XENOPUS
141,145,173,EMT,INCREASED,PTHRP,SNAIL,THUS
1968,CCP,FEW,LUAD,NEXT
153,155,8230,EUCLIDEAN,PFS,PFSS,PHASE
004,027,039,144,177,2008,2012,299,336,383,498,701,8202,877,988,AGE,EFFICIENT,HOLEP,HOLMIUM,JULY,LABEL,MARCH,MATERIALS,METHODS,OBJECTIVE,RESULTS,USING
1564,AIMS,EPCAM,EPEX,EPICD,LABEL,MEMBRANOUS,METHODS,MOC,OBJECTIVE,REGULATED,RESULTS,TMA
169,2014,607,AACR,ANNEXIN,ANXA1,CAF,CD49F,FURTHER,LABEL,MOL,NPF,PTEN,RES,SCA,THESE,UNLABELLED
169,1983,2011,2014,945,ADT,AUTHORS,BOTH,CRPC,DIGOXIN,EXPRESSION,GLEASON,HIF,HIF1,JOHN,LTD,PSA,SONS,WILEY
BASED,CURCUMA,DOCKING,EGF,FURTHER,GST,PDGFA,PRESENT,VARIOUS
169,2014,20A,ABL,ABL2,ASO,DU145,GLEASON,INC,KNOCKDOWN,WILEY
169,2014,217,946,BAX,COLON,EMT,INC,PROTEIN,WILEY,WNT,WNT5A
SVM
169,177,2014,8201,AHX,BACKGROUND,BZH3,CELL,FMOC,GLU,GRPR,HBED,IC50,INC,LABEL,LYS,METHODS,PET,PSMA,RESULTS,SINCE,WILEY
169,2014,ANOTHER,BACKGROUND,INC,METHODS,MSMB,PSP94,RESULTS,SNP,VARIANT,WILEY
CAP,CPG,GSTP1,THESE
THEIR,THUS
COMBINING,DUE,HOWEVER,NANO,NPS,PC3,PEG,PEG2K,PEGYLATION,THESE
009,1986,2010,49898,967,AMONG,BACKGROUND,BECAUSE,CIS,COMPARING,COX,DIETARY,HRS,JANUARY,LABEL,METHODS,RESULTS
ENDOGENOUS,LABEL,OBJECTIVE,PAR,SAC
11A,12B,13A,14B,169,2014,956,COPYRIGHT,IC50,INC,MCF,STRUCTURAL
169,2014,BONE,COPYRIGHT,IRELAND,LTD,WNT
169,2013,COPYRIGHT,DEVELOPED,LTD,PCA
111,169,2014,BACKGROUND,CONCLUSION,COPYRIGHT,DOTA,DU145,HPMA,IMAGING,INC,LABEL,LOCALIZED,METHODS,RADIOLABEL,RAFT,RESULTS,SPECT
169,2014,231,233,COPYRIGHT,HOWEVER,INTENSITY,PUBLISHED,SAS,SFRO,SOCI
169,2014,AFTER,COPYRIGHT,DU145,HUHS015,LTD,PCA
046,169,2012,2013,817,APRIL,BASED,BEGG,CONCLUSION,COPYRIGHT,EGGER,EXTRACTION,LABEL,LTD,METHODS,MOOSE,OBJECTIVE,PUBLISHED,RESULTS,ROYAL,RRS,SIR,SIRS,SMR,SMRS,SOCIETY,TCDD
169,2013,COPYRIGHT,GERIATRIC,LTD,NURSING,SIOG,SOCIETY
169,2013,COPYRIGHT,CRPC,LTD,THESE
169,1995,2005,DATA,END,LABEL,MEN,METHODS,OBJECTIVE,OBJECTIVES,PRINCIPAL,RESULTS,SETTING,SOURCES,TRUST,UROLOGIST
III,OXIDATIVE,SKBQ,SKQ1,SKQT1,THUS,UNDER
8201,CELL,DU145,OXIDATIVE,SEM,SHAM,TEM,THESE,VK3
177,ADDITIONAL,BACKGROUND,BFE,CARLO,CHAIN,FFE,HAUSDORFF,LABEL,MAD,MBFE,MCMC,METHODS,MONTE,RESULTS
419,BACKGROUND,CAD,CENTRAL,CONCLUSION,CONFIDENCE,CSS,DATA,IAD,INTERVALS,LABEL,MEDLINE,METHODS,OVERALL,QOL,RATIO,RESULTS,RISK,SEVERAL,TTP,USA,WESTERN
000,100,2002,2009,801,ASR,ASRS,BACKGROUND,BASED,CHICAGO,DATA,ICD,IRAN,KHUZESTAN,LABEL,MATERIALS,METHODS,RESULTS,SPSS,THERE
1200,215,BACKGROUND,CONCLUSION,DVH,DVHS,EBRT,GIVEN,HDR,LABEL,METHODS,OAR,OARS,RESULTS
1244,1995,2011,ANALYZING,CHINA,CNKI,DEC,EBSCOHOST,EVENTUALLY,JAN,LIBRARY,MEDLINE,MYSQL,OVID,PHP,WILEY
DHA
169,2014,BACKGROUND,BPH,COPYRIGHT,EMG,EUS,INC,LABEL,METHODS,MOTOR,MUP,PCA,RESULTS,SIXTY,THERE,WILEY
160,1984,2013,CRPC,DATA,DRUG,ENGLISH,EXTRACTION,FOOD,LABEL,MDV3100,METHODS,OBJECTIVE,PSA,RESULTS,SELECTION,SOURCES,SYNTHESIS
001,8805,ASC,ASCS,BMI,CD31,CD34,CD45
003,007,108,2013,245,8804,8805,BACKGROUND,LABEL,MARCH,MARSDEN,METHODS,NHS,NLR,POTENTIAL,PSA,RESULTS,ROYAL
10TH,BASED,HISTOLOGIC,PET
013,2013,229,577,ALS,ALZHEIMER,BACKGROUND,CNS,CONCLUSION,DOWN,HUNTINGTON,INCREASED,ISI,KNOWLEDGE,LABEL,MARCH,MEDLINE,METHODS,PARKINSON,RESULTS,SCZ,SOURCES,THERE,WEB
CK2,D123,D131,FINALLY,HOWEVER,PAR,S124,S231,THUS
ARI,BPH,DHT,PCA
BODY,SEX,SIMILARLY,T2DM
169,2014,202A,602,880,ASIAN,BASEL,CIS,FURTHER,HENCE,HOWEVER,IGFBP,LABEL,METHODS,OBJECTIVE,ORS,PCA,RESULTS,THESE
001,002,100,119,169,2014,6H2,925,AUTHORS,CONTROLLED,COPYRIGHT,FLEX,HOWEVER,IHC,INC,PATTERN,PTEN,PUBLISHED
2007,2010,25UM,5ARI,5ARIS,ARS,BPH,CELLS,ELISA,FIVE,GROUP,LABEL,LNCAP,MARCH,MATERIALS,METHODS,MTT,OBJECTIVE,OBJECTIVES,PSA,RESULTS,THESE,TURP,WESTERN
106,125,1320,156,172,249,8805,AMONG,ANALYZING,EPE,GLEASON,LABEL,MATERIALS,METHODS,OBJECTIVE,PCA,PSA,PSMS,PURPOSE,RADICAL,RESULTS,SCORE,SVI
000,003,009,011,014,015,016,027,037,051,052,074,078,092,095,098,120,137,193,2006,2012,258,384,391,519,584,740,ACCORDING,AGE,BETWEEN,BINDING,BMI,DRE,HORMONE,LABEL,MATERIALS,METHODS,OBJECTIVE,PCA,PSA,PURPOSE,RESULTS,SERUM,SEX,SHBG
400,COX,GLEASON,LABEL,MATERIALS,MEIER,METHODS,MOST,OBJECTIVE,PSA,PURPOSE,RESULTS,TIME,YOUNG
002,007,024,034,100,2005,2008,2009,2011,BACKGROUND,CONTINENCE,IPSS,LABEL,LRP,METHODS,OBJECTIVE,PVR,QMAX,RESULTS,SCORE,SEVERAL,SYMPTOM,THREE,URINARY
169,2014,CLINICALLY,COUPLED,DISTANT,EHRS,FEW,JOHN,LTD,MOST,PUBLISHED,REVIEWING,SONS,WILEY
7974,ASTRO,BFFS,COX,GLEASON,GUROC,MEIER,NCCN,PROCARS,RADIATION,RISK,SOCIETY
000,001,169,2014,471,753,8201,8805,AMONG,BACKGROUND,BCR,EARLY,GLEASON,INC,LABEL,MEN,METHODS,NCCN,NETWORK,PCA,RESULTS,THEREFORE,THESE,WILEY
169,1999,2013,2B4,HOMO,HOWEVER,INC,LAG1,LASS2,MMP,PCA,SILENCING,THESE,THUS,TMSG,TMSG1,WILEY
002,041,053,064,073,154,1B1,238,432,504,783,8201,853,942,981,BEGG,EGGER,HOWEVER,LEU,LEU432VAL,P450,VAL
160,200,COMMITTEE,CONSORTIUM,GEM,INSTITUTES,LADY,MOUSE,MYC,PCA,PTEN,TODAY,TRAMP,WHICH
160,223,CRPC,SINCE,STRATEGIES


009,016,023,034,30C,EXPRESSION,GLEASON,HOWEVER,MEIER,MIR,PCA,PCR
946,ATLAS,ERBB,MAPK,MICRORNAS,NGS,PC3,RNAS,TCGA,TGF,THEREFORE,WNT
160,169,183,8202,GEORG,MRI,RADS,STUTTGART,YORK
001,002,270,AMU,BPW,EUS,FOV,FUNCTIONAL,LABEL,METHODS,MRI,MUL,OBJECTIVE,PURPOSE,RESULTS
169,183,2014,20S,4DMSO,CL3,CLO4,COPYRIGHT,CRL2221,H2O,III,INC,NO3,PUBLISHED,RESULTS,SPECIES
169,2014,AKT,ATP,EHBP1,EMPLOYING,MEVALONATE,P2X7,PRESS,PTEN,PUBLISHED,REX1,STATINS,THESE,UNIVERSITY
003,FURTHER,HGPIN,HOWEVER,PROSTATIC,PSA,SINCE
HOWEVER,LABEL,MRI,OBJECTIVE,PURPOSE,RESULTS,SUMMARY
2012,215,526,ASSESSMENT,CENTRAL,CONCLUSION,CONTROLLED,DCE,DIAGNOSTIC,DWI,LABEL,MATERIALS,MEDLINE,METHODS,MRI,NPVS,OBJECTIVE,QUALITY,RESULTS,SEVEN,STUDIES
177,AIM,CONCLUSION,DOTATOC,LABEL,MEAN,METHODS,NET,OBJECTIVE,PET,RESULTS,SIXTY
174,8201,BASED,FIVE,GEOGRAPHIC,TILEPRO,TRUS,VINCI
169,2014,AACR,CRPC,CYP17A1,HOWEVER,LABEL,MECHANISMS,METHODS,OBJECTIVE,PURPOSE,RESULTS,VCAP
AKT,BASIC,ERBB3,JAK,JANUS,MAPK,MEK,RTKS,STAT,THUS,TKI
177,AFTER,HOWEVER,IMAT,MEAN,PTVS,RCF,RCFS,RPGD,SEVERAL
001,050,90401,CALGB,CONCLUSION,DATA,EASTERN,GROUP,III,LABEL,METHODS,OBJECTIVE,PROGNOSTIC,PURPOSE,RESULTS
047,127,415,490,8805,COLORECTAL,EARLIER,HRS,LUNG,OLDER,OVARIAN,SCREENING,TRIAL,USING
CARLO,HIGH,MONTE,MRI
313B,313H,EFFECTIVE,GATA2,INGENUITY,LNCAP,LTL,REGULATOR,SIX
169,2014,COPYRIGHT,DU145,LTD,MDM2,P53,PCA,PMP53,THESE,ZINC
BACKGROUND,CTV,FORTY,HERK,LABEL,METHODS,PTV,RESULTS,SEVEN,TVE
143,2014,215,8201,AUC,DRE,GOVERNMENT,LABEL,MEN,METHODS,MRI,OBJECTIVE,OBJECTIVES,PATIENT,PSA,PSAD,PUBLISHED,RESULTS,SPL,USA
001,169,199,2009,2012,2014,413,492,8201,954,AUTHORS,BJU,CONCLUSION,HTS,HTV,HTVS,JULY,LABEL,METHODS,MRI,MRTS,MRTV,MRTVS,OBJECTIVE,RESULTS,T2W,TVS,WHOLE
100,169,2014,729,756,781,AVERAGE,BIOMEDICAL,CIS,COPYRIGHT,EACH,ICT,INTER,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,QUESTIONS,RESULTS,TOOL
126,2000,BCL,BPH,EASTERN,ECOG,GLEASON,GROUP,LABEL,LNCAP,METHODS,MMP,MTT,OBJECTIVE,PCA,PSA,RESULTS,TNM,TRANSWELL,WESTERN
100,169,177,2013,949,956,COPYRIGHT,DOX,ECM,LNCAP,LRP,LTD,MDR,MRP1,NPS,OVERALL,PCA,PCL,PEG,SEPARATELY,THREE
485,512,BACKGROUND,CPG,CPGS,CURRENTLY,HOWEVER,LABEL,RESULTS,SNPS
001,140,169,1997,2010,2013,260,400,470,870,AUTHORS,BETWEEN,BJU,DMFS,IMRT,LABEL,LATE,METHODS,MOST,OBJECTIVE,PSA,RESULTS,RFS,WHILE
AKT,CHK2,H2AX,KI67,LNCAP,MSEA,P21CIP1,P53,PANC,RESULTS,SCID,SER15,THESE
100,169,2014,HOWEVER,TILE,UROLOGICAL
DCG,MICROARRAY,REGULATORY,TFS,THESE
140,164,174G,AFRICAN,AMERICANS,CAUCASIAN,CAUCASIANS,PCR,PGA,SERUM,SINCE
0001,001,177,8807,CONCLUSION,LABEL,MATERIALS,METHODS,MTV,OBJECTIVE,PET,PIN,PURPOSE,RESULTS
00001,113,2351,BACKGROUND,BESIDES,CONTROLLED,FIXED,LABEL,MEDLINE,METHODS,PSA,RCTS,RESPECTIVE,RESULTS,TRT,UROLOGISTS

AKT,CAP,CSCS,EMT,LOCAL,PI3K,PTEN,RADIATION
946,AKT,AMONG,CELL,DU145,GSK3,HOWEVER,IMMUNOBLOT,STAT3
001,003,005,015,039,061,846,967,HCC,LABEL,LITERATURE,METHODS,OBJECTIVE,PITUITARY,PURPOSE,RESULTS
LABEL,LDN,LND,LYMPH,OBJECTIVE,PURPOSE,RESULTS,ROUTINE,SUMMARY,THERE
001,005,006,008,017,122,504,8805,CONVERSELY,COX,LABEL,MEAN,MEIER,METHODS,NONE,NSM,OBJECTIVE,PSM,PURPOSE,RESULTS
169,2014,COPYRIGHT,ERG,ETS,ETV1,INC,LAST,PTEN,TMPRSS2
000,169,2014,COPYRIGHT,DATA,EARLY,ERG,ETS,INC,PCA,PCAS,REMARKABLE,SRS,TMPRSS2,WHEREAS
074,155,169,2014,211,215,272,CONSORTIUM,COPYRIGHT,INC,PRACTICAL,SNPS,THESE
169,2014,COPYRIGHT,CRPC,CRPCS,INC,NCOR1,NOTABLY,SIAH2
0001,10000,169,2014,400,40000,BACKGROUND,CONTEXT,COPYRIGHT,GLEASON,HOWEVER,INC,KI67,LABEL,MAIN,METHODS,OBJECTIVE,ORAL,OUTCOME,PCA,PSA,PTH,RESULTS,SETTING,THESE,TORONTO,VITAMIN
001,002,052,1348,169,1998,2001,2014,243,2658,413,897,AMONG,BETWEEN,EBRT,INC,LABEL,LEVEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,RADIATION,RESULTS,SMS,THERAPY,TYPE,UNLABELLED,USING,WHAT
001,1121,169,2004,2007,2014,8201,8804,969,ADD,AFTER,AHR,BOTH,CONCLUSION,DOES,END,FINE,GLEASON,GRAY,INC,KNOWN,LABEL,MEN,METHODS,OBJECTIVE,PCSM,PENDING,PIVOT,PSA,PUBLISHED,RESULTS,SUBJECT,T1C,TRIAL,UNLABELLED,WHAT,WHETHER
160,169,2006,2010,2014,660,BACKGROUND,C30,CONCLUSION,COPYRIGHT,CORE,DESPITE,EORTC,HRQOL,INC,LABEL,LIFE,MARCH,METHODS,QLQ,QUALITY,RESULTS,TREATMENT
001,100,160,169,2013,COPYRIGHT,EARLY,LTD,MAXILLO,PUBLISHED,SURGERY,TIME
AKT,BRD4,GEM,JQ1,LIVE,MYC,PTEN,TAKEN,USING
160,169,2013,226,COPYRIGHT,CRPC,EACH,ETOPOSIDE,GRADE,PSA,PUBLISHED,SIXTEEN,TREATMENT
169,2014,231,BACKGROUND,COPYRIGHT,GNP,GNPS,GOLD,HOWEVER,IRELAND,LABEL,LTD,MATERIALS,MDA,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE
169,2014,4MM,5MM,8805,COPYRIGHT,DEFORMABLE,ENDORECTAL,EXPANDING,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
169,2014,ACCORDING,BACKGROUND,COPYRIGHT,FOCAL,GLEASON,INCLUSION,LABEL,METHODS,OBJECTIVE,OUTCOME,PATIENT,PCA,RESULTS,SETTING,SUMMARY,T1C,T2A,UROLOGY
001,1181,149,169,1992,2007,2014,354,8201,AIM,BACKGROUND,END,FOLLOWING,HOWEVER,LABEL,LATE,MAIN,MEN,METHODS,OBJECTIVE,OUTCOME,RESULTS,SOCIETY,THESE,USING
169,2014,300,588,AFTER,BRITISH,COST,LYG,PLAUSIBLE,PSA,QALYS,RANDOMIZED,SCREENING,UICC
768,AMONG,CHINESE,HOWEVER,IDENTIFIED,MALAY,MALAYSIAN,SNPS,THERE
160,BACKGROUND,CONCLUSION,LABEL,METHODS,RESULTS,THUS
1072,119,169,177,2014,284,8201,927,BACKGROUND,CLINICALLY,INC,IRE,LABEL,LESIONS,METHODS,NUMERICAL,PROSTATES,RESULTS,THESE,WILEY
A172,DAOY,GBM,GFP,PCR,TGIFX,U87,U87MG,UPON
CCR2,CCR2B,ERK,PBLS,PBMC,PC3,PSMP,TAKEN,THP
CCR7,CD20,RITUXIMAB
946,ACTIVATION,SMAD,TGF
HOWEVER,KNOCKDOWN,LNCAP,PCA
ATP,BACKGROUND,LABEL,METHODS,OBJECTIVE,RESULTS,SIX,UCP2,WESTERN
DDM,DIR,DIRS,DVFS,ICE,PEARSON,THEREFORE
169,2014,COPYRIGHT,FOLLOWING,HIC,IRELAND,LTD,PUBLISHED,TGFB1I1,THERE,THESE
0001,169,183,2002,2009,2014,465,8200,BACKGROUND,CHAIR,COPYRIGHT,FUNDING,HOWEVER,LABEL,LTD,METHODS,OLDER,ONTARIO,RESULTS,STUDIES,THESE
169,2014,BASED,BLOCK,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,MEAN,MEN,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
001,129,169,2008,2011,2014,260,261,353,AFTER,AMICO,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,ROBOTIC,UROLOGICAL
037,169,2014,956,ACETATE,BACKGROUND,CELL,COPYRIGHT,DMEM,DU145,EAGLE,FDG,FFA,INC,LABEL,LNCAP,MBQ,METHODS,PC3,PCA,RESULTS,THEN
000,100,135,160,169,177,2011,2012,2014,335,4028,4282,720,8280,CONCLUSION,COPYRIGHT,CURRENTLY,EACH,GLEASON,HOWEVER,INC,LABEL,MATERIALS,METHODS,NEWS,OBJECTIVE,RESULTS,SEVENTY,SURGEON,THERE,WIDE,WORLD
2013,AUTOPSY,BACKGROUND,BECAUSE,CAREFUL,CENTRAL,CONTEXT,CONTROLLED,ELECTRONIC,FACTORS,JULY,LABEL,METHODS,OBJECTIVE,PATIENT,PCA,PUBLISHED,RESULTS,SCREENING,SUMMARY,SYNTHESIS
100,169,2014,AUR,COPYRIGHT,DOT,HCM,INC,PRIOR,PUBLISHED,TRUS
0001,002,110,169,2013,BACKGROUND,CELL,COPYRIGHT,EBUS,EXCLUSIVE,LABEL,METHODS,PUBLISHED,RESULTS,SEPAR,TBNA
169,2013,36V2,583,BACKGROUND,COPYRIGHT,LABEL,LIFE,METHODS,NOTTINGHAM,OVERALL,PROFILE,PUBLISHED,QUALITY,RESULTS,SPAIN,SPANISH,SURVIVORS
169,2013,4534,BACKGROUND,BONFERRONI,CONCLUSION,COPYRIGHT,COX,FURTHER,HASHIMOTO,HOWEVER,INSURANCE,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SEVERAL,SOCIETY,TAIWANESE
100CM,125,169,1MSV,2014,30CM,COPYRIGHT,INC,JAPAN,LABEL,MATERIALS,MEDICAL,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RADIATION,RESULTS,SOCIETY,TOKYO
001,160,169,2003,2014,284,327,AFFAIRS,AGE,AMONG,BASED,COMBINING,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,PSA,RAISING,RESULTS
169,2014,946,ASIA,AUTHORS,CALU3,EXPRESSION,H23,KNOCKDOWN,LTD,NCI,NOD,PTY,PUBLISHING,RERF,SB208,SCID,SCIENCE,SMAD,SMAD2,TGF,THESE,WILEY
786,ADR,ANTICANCER,EHRLICH,ERS,H460,K562,MCF7,MODULATORS,NCI,OVCAR,PSIDIUM,RECEPTORS,RES,SELECTIVE,SERMS,SOLID,UACC
BACKGROUND,HOWEVER,KNOCK,LABEL,METHODS,MV3,PC3M,RESULTS,STRIKINGLY,THEREFORE,VICE
947,950,BACKGROUND,CAR,CD28,CD3,IFN,LABEL,LOG,MEIER,METHODS,PSCA,RESULTS,STUDENT
AMPK,CRE,CREB,CRTC2,IGF,LNCAP,METFORMIN,SIMILARLY,SRC,THESE
10726,7532,BOTH,BPC3,CONSORTIUM,G10398A,GIVEN,GPX,LEU198LEU,MNSOD,ND3,OVERALL,PRO198LEU,ROS
145,169,177,2014,220,8764,956,BIASING,COPYRIGHT,GI50,GMBH,KGAA,MCF,VCH,WHEREAS,WILEY
169,2013,8804,8805,BACKGROUND,BIRTHPLACE,END,HISPANICS,LABEL,MEIER,METHODS,RESULTS,SEER,SOCIETY
150,2177,515,983,AMONG,BACKGROUND,EASTERN,GROUP,INVENTORY,LABEL,METHODS,RATINGS,REGRESSION,RESULTS,SYMPTOM
160,8804,8805,ADP,AIMS,BACKGROUND,BOTH,BPH,CHINESE,CONCLUSION,GLEASON,HOWEVER,LABEL,METHODS,OBJECTIVE,PAR,PARP,PCA,PSA,RESULTS,TPSA
169,2014,946,BACKGROUND,CLINICALLY,CONCLUSION,EMT,ERG,H3K4ME3,HOWEVER,INC,LABEL,METHODS,PCA,PCR,REAL,RESULTS,SILENCING,SOX4,TGF,TSA,WESTERN,WILEY
164,169,194,2001,2008,2014,8201,BACKGROUND,CRP,INC,LABEL,MARKERS,METHODS,NEUTROPHIL,NLR,NUTRITION,PLR,PSA,RESULTS,SERUM,WILEY
169,2014,222,BACKGROUND,HETE,HETES,INC,LABEL,MEIER,METHODS,PCA,PSA,RESULTS,UHPLC,WILEY
003,004,006,009,1498C,160,1612G,2489C,2578C,496,634G,8201,936C,ATTGC,ATTGT,BACKGROUND,CCCCC,CCCGC,CONCLUSION,GENOTYPES,HAPLOTYPE,HAPLOVIEW,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SNPS,VEGF
145,169,2014,22RV1,8201,8804,BACKGROUND,CAHPV10,HPV,INC,LABEL,LIMP,LNCAP,METHODS,PCR,PNT1A,PNT2,RESULTS,RWPE,THERE,WESTERN,WHILE,WILEY
169,2014,945,BACKGROUND,CONVERSELY,EGF,EMT,EPIDERMAL,FURTHER,HIF,HOWEVER,HYPOXIA,INC,LABEL,MAPK,METHODS,NAC,PCR,RESULTS,ROS,SILENCING,STAT3,WILEY
032,169,2014,337,569,8805,906,ALTOGETHER,ANNOTATION,APPLIED,BACKGROUND,BIOSYSTEMS,DISCOVERY,HOWEVER,INC,INTEGRATED,LABEL,METHODS,NS1,PCR,RESULTS,SOLID,TLR4,WHILE,WHOLE,WILEY
947,H2AX,IL18,IMRT,INTENSITY,NINE,ORC4,PCR,RAD17,SMC2,SMC6,TLR3,USING
067,131,160,169,2000,2007,2009,264,308,472,496,501,537,649,653,662,684,696,730,761,793,837,868,928,933,AFRICAN,BACKGROUND,CONCLUSION,END,HEALTHCARE,INDEX,LABEL,METASTATIC,METHODS,OBJECTIVE,PRICE,RESULTS,SEER,SRE,SRES,THERE
AKT,DU145,LOSS,OST,OST3P,PC3,PTEN,TUSC3
001,100,105,118,123,125,127,12M,177,BOOI,LABEL,LUTS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SILODOSIN,URINARY
012,8805,ANTI,DOSE,FIFTY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,VEGF
1940S,2004,2010,CHARLES,CRPC,HOWEVER,HUGGINS,III,PHASE,THESE,UNTIL
954,DENOSUMAB,MEN
DRUG,FOOD,III,PSA,WHILE
DOT1L,PCAT8,RNAS,YANG
142,160,BOARD,FIVE,OVERALL,PSDS
188,1998,1999,2009,2012,CONCLUSION,END,JUNE,LABEL,LYNCH,METHODS,OBJECTIVE,OHIO,PURPOSE,RESULTS,STATE,UNIVERSITY
169,2011,2012,2014,2017,CASCADE,CENTERS,COMMUNITY,CONTROL,COPYRIGHT,DISEASE,INC,LYNCH,MOSBY,NVIVO,PREVENTION,SIXTY,UNIVERSITY
946,BECAUSE,GRK3,RNAI,TAKEN
AKT,BACKGROUND,LABEL,METHODS,RESULTS,USING
169,16MOL,2014,24H,5MOL,63MOL,BINDING,COPYRIGHT,CRPPR,FINALLY,FVB,LIPOSOMES,LPP,NRP,PPC,PRIOR,RXXR,TAKEN,THESE,USING
0064,0079,100,115,761,812,898,909,927,952,AMONG,CONCLUSION,DOCUMENTED,LABEL,METHODS,PATIENT,PET,RESULTS,UNLABELLED
169,2014,947,ATM,COPYRIGHT,CPT,DDR,DSB,E2F,H2AX,H2O2,LNCAP,LTD,NKX3,OVERALL,RAD50,S139,S1981,THEREFORE,THUS
105,10MG,169,2014,24H,250NG,26NM,293,3485NGH,50MG,50NM,532,5NM,946,AUC,C17,COPYRIGHT,HEK,HOWEVER,HSD17B3,HSD3,IC50,LTD,NADPH,SINCE,TREATMENT
001,002,007,169,2014,3DCRT,BEAM,COPYRIGHT,IMRT,INC,MEDICAL,MLC,MLCS,MODULATOR,OAR,OARS,PUBLISHED,V50,V60,V65,V70
169,2014,COPYRIGHT,PUBLISHED,SUCCESSFUL
169,2014,ADT,AUTHORS,BJU,FURTHER,HOWEVER,HRQL,IADT,III
916,946,947,ACTIVATED,ARES,CHROMATIN,CPD,GAS,LUCIFERASE,MCF,PRL,R1881,STAT5,T47D
177,1999,2003,8201,8805,975,AFFAIRS,CENTERS,GERD,HIV,IHD,LABEL,METHODS,OBJECTIVE,RESULTS

CONCLUSION,LABEL,METHODS,OBJECTIVE,PSA,PSAP,RESULTS
124,912,BONE,CONCLUSION,LABEL,METHODS,OBJECTIVE,PSA,RESULTS
22RV1,BOTH,CONCLUSION,DU145,LABEL,METHODS,OBJECTIVE,PC3,PC3M,PCR,RESULTS,RWPE,UNC5B,WESTERN
22RV1,AFTER,AKT,CONCLUSION,FLOW,LABEL,METHODS,MTT,OBJECTIVE,RESULTS,TORC2,WESTERN
10G,169,2014,HOWEVER,ISOLATING,MIX,PRESS,PUBLISHED,THESE,UNIVERSITY
134,138,143,155,181C,181D,205,34C,373,AKT,BCL,BCL2,CASE,CSC,ERK,INORGANIC,KRAS,MICRORNAS,NRAS,PI3K,PTEN,RAN,RAS,REDUCED,RRAS,RWPE,THUS,VEGF,WPE
003,ELISA,FASN,FATTY,INCREASED,THESE
MRI
KNOWLEDGE,MRI,MRL,NODAL
MRI,MULTI,PSA
107,177,359,711,800,8201,8805,BACKGROUND,LABEL,MESCC,METHODS,OLDER,RESULTS,SEER,THOSE
8201,CIS,HOWEVER,LABEL,METHODS,OBJECTIVE,OVERALL,RESULTS,SIR,SIRS,SLE
127,169,1995,2009,2014,2701,AIMS,FORTY,GLEASON,JOHN,LABEL,LTD,METHODS,OBJECTIVE,PSA,PSM,RESULTS,SONS,WHILE,WILEY
2008,2009,300,400,9TH,BACKGROUND,BECAUSE,CONCLUSION,DISEASE,INPATIENT,LABEL,LOS,METHODS,NATIONWIDE,OBJECTIVE,PURPOSE,RARP,RESULTS
169,177,183,1994,2014,2143,BMI,BUSSELTON,CVD,DHT,FURTHER,JOHN,LABEL,LOWER,LTD,MEAN,MEN,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SERUM,SHBG,SONS,TOTAL,WILEY
DRAWING,THESE
2011,2012,437,696,BETWEEN,CONCLUSION,GLEASON,LABEL,LRP,MAXIMAL,METHODS,NONE,OBJECTIVE,OCTOBER,PATIENT,PSA,RESULTS
AFTER,BOTH,BPE,BSA,CK5,CK8,DMEM,EGF,EXPRESSION,F12,HOWEVER,LIF,LNCAP,NOD,PPRCC,PRCSC,PRIMARY,SCF,SCID,SFE,THUS
215,ADHERENCE,AFTER,BL21,DE3,ELISA,FOLLOWING,LNCAP,M13,PC3,PSMA,VHH
PCA,USA,WHILE
169,2014,AACR,LYNCH,MMR
169,2014,945,ADAPTATION,BRITAIN,COPYRIGHT,ERR,FRET,GREAT,HIF,IRELAND,JOHN,LTD,OESTROGEN,PUBLISHED,SOCIETY,SONS,THESE,WARBURG,WILEY
449,8209,ADP,AKT,BAX,BCL,ERK,FOXO1,HOWEVER,LNCAP,MHY,PC3,PD98059,PREVIOUSLY,PTEN,TAKEN,THEREFORE
100,101,160,8209,CD9,DEVELOPING,EARLY,LNCAP,MVB,PSMA,THEREFORE,TSG,USING
160,8209,BPH,CONVERSELY,EMT,GLEASON,LNCAP,PC3,RESULTS,SEMI,SEVERAL,SNAIL,TMA,TMAS
010,039,1377G,160,171,175,404,585,607,670A,8201,844C,844T,844TT,878,8805,956,AFTER,BACKGROUND,EORTC,FAS,FASL,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,RTOG,THESE,UNIVARIATE
8201,CBCT,CONCLUSION,HOUNSFIELD,LABEL,MATERIALS,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS,THEREFORE
169,2014,FINALLY,GREATER,HOWEVER,SOCIETY,THUS
105,160,BACKGROUND,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
169,2014,ADIPOSE,AIMS,ASC,ASCS,BACKGROUND,CCM,COPYRIGHT,DU145,EPITECT,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,PC3,PEDF,PUBLISHED,RAS,RESULTS,SOCIETY,THERAPY,THESE
165,169,2013,220,385,ADT,AMGEN,ASTRA,AVENTIS,BACKGROUND,COPYRIGHT,DATA,FUNDING,III,INSTITUTE,KAPPA,LABEL,LTD,METHODS,PHRC,PHYSICIANS,RESULTS
100,200,250,946,956,AKT,BPA,CONTINUOUS,ERK,FURTHER,SIMILAR
160MG,2007,2008,427,AFTER,AMONG,CAB,CENTRAL,DISTANT,M1B,NODAL,PCA,PSA,RADICAL,T1C,TREATMENT
FINALLY,FOXA1,GATA2,MED1,THESE
177,3DVH,916,947,D95,DHR,DMAX,DMEAN,DSR,DVH,GPRS,IMRT,NUCLEAR,OAR,OARS,PDP,PTV,PTVS,ROI,ROIS,SUN
1991,2012,COMPARISON,PROTECTION,SCREENING,STATE,SUMY,THEREFORE
125A,956,AKT1,DU145,EGF,ERK1,LNCAP,WHETHER
0001,AFTER,BACKGROUND,CASTRATION,CHANGES,CONFERRING,LABEL,LHRH,METHODS,PSA,RESULTS,THUS
8805,ACTUARIAL,ACUTE,ADVERSE,BACKGROUND,III,LABEL,LATE,MEIER,METHODS,PRIMARY,RESULTS,SECONDARY
011,048,164,169,177,184,2006,2011,2014,286,8201,ASIA,BACKGROUND,CONCLUSION,ENDOSCOPIC,FORCE,JAPAN,LABEL,LTD,METHODS,NEXT,NHT,PTY,PUBLISHING,RESULTS,SOCIETY,SURGERY,TASK,WILEY
001,180,967,BACKGROUND,BCR,BPH,COX,GLEASON,LABEL,MEIER,METHODS,NUCB2,PCA,PSA,RESULTS,THEREFORE,THROUGH
945,946,956,AMONG,CACO,COSY,DUNAL,HMBC,HRMS,IC50,MCF,MTT,NMR,NOW,WRL
2009,2011,AFTER,BACKGROUND,IMRT,LABEL,METHODS,OVERALL,PSA,RESULTS,WHILE
231,549,956,ACCORDING,DYSIDEA,HELA,IC50,MCF,MDA,MRC
VON
0023,0032,026,169,171,17Q12,2014,261,BPH,INC,META,PCA,PCR,RFLP,SERBIAN,SNP,SNPS,WILEY
ADULT,ANTIGEN,IMAGING,PROSTATIC
COMMENTARY,ERM,HIGH,INCREASING,MEMBERS,SIMILARLY,THUS
145,2006,2010,331,954,BLADDER,BNP,BOTH,CONCLUSION,CONTINENCE,ECT,JULY,LABEL,MAY,METHODS,MRI,OBJECTIVE,RESULTS,SOCIETY,T2C,THERE,TLB,URINARY
015,019,126,8201,HOWEVER,NSCLC,PCR,RAF,REAL,RKIP,TNM
781,8805,AMONG,ASAP,AUC,BIOPLEX,BMI,CSF,FIFTY,FURTHER,HGF,MAIN,PDGF,PECAM,PIN,PSA,ROC,VEGF
FORCE,GLEASON,HOWEVER,PCA,PSA,RADICAL,T1C,T2A,TASK,THUS
000,118,1998,2009,ADULT,ENGLAND,ENGLISH,EPISODE,HODGKIN,INCIDENCE,JANUARY,KINGDOM,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,STATISTICS,STRATEGIES,THERE
1975,1985,1989,2000,2004,2005,BETWEEN,CONCLUSION,CVD,END,FALLING,LABEL,MEASURING,METHODS,OBJECTIVE,OTHER,PURPOSE,PYLL,RESULTS
1P36,CHD5,HOWEVER,NURD,THUS,TSG
012,022,110,136,ARTIFACTS,EVEN,MRI,TESLA
001,002,008,011,137,214,301,380,ADT,AMONG,BACKGROUND,BCR,EQUAL,LABEL,METHODS,PSA,PSADT,PSAV,REGRESSION,RESULTS,THEREFORE
001,003,0044,021,0291,038,1E8,2B4,967,AFTER,BACKGROUND,BPH,COX,DU145,EXPRESSION,GLEASON,KNOCKDOWN,LABEL,LNCAP,MEIER,METHODS,PC3M,PCA,PCR,PEARSON,PSA,RAS,RASGRP3,RESULTS,THERE,THESE
13C,2013,MRI,PET,THESE
169,2013,223,COPYRIGHT,CROWN,CRPC,DESPITE,INITIAL,LTD,PUBLISHED,THERE,WESTERN
100,169,2014,239,300,400,600,700,8805,956,AACR,DECREASES,FIFTY,LABEL,LYASE,METHODS,OBJECTIVE,ORTERONEL,PSA,PURPOSE,RESULTS,TAK
100,169,2013,8MIN,ALGORITHMS,BOTH,COPYRIGHT,ESPECIALLY,EVALUATION,IMAGE,IMORPHICS,MICCAI2012,MRI,OVERALL,PROMISE12
177,BACKGROUND,CONCLUSION,FEZ,GENERAL,GPS,LABEL,METHODS,MONITORING,MOROCCO,PREFECTURE,QUESTIONS,RESULTS
BACKGROUND,CHROMATIN,DEFECTS,ERG,GENOMATIX,LABEL,METHODS,NKX3,PCR,QRT,REAL,RESULTS,THESE,TIME,TMPRSS2
123,169,2014,ADT,AUSTRALIAN,BACKGROUND,BEPREPARED,COLLEGE,CONCLUSION,HENCE,LABEL,METHODS,P1NP,P1NPS,RADAR,RESULTS,ROYAL,THERE,ZEALAND
169,2014,8804,946,956,COLLEGE,COPYRIGHT,LABEL,MEDICAL,METHODS,OBJECTIVE,PSA,PUBLISHED,RESULTS,SABC,TGF,TWIST
169,2014,AMONG,CALCIUM,COLLEGE,COPYRIGHT,DU145,FOUNDATION,LABEL,LNCAP,MEDICAL,METHODS,MMP,MMP9,OBJECTIVE,OCCURRENCE,PC3,PCR,PREC,PUBLISHED,QPCR,REAL,RESULTS,SABLE,TPRC6,TRANSWELL,TRPC6,WESTERN
945,BOTH,CK2,CONCLUSION,LABEL,LNCAP,LUC,METHODS,OBJECTIVE,PCR,PSA,R1881,RESULTS
144,289,CONCLUSION,GLEASON,LABEL,MAB,METHODS,OBJECTIVE,PCA,PSA,RESULTS,THEIR,UNIVARIATE
160,169,2013,956,COPYRIGHT,HOWEVER,LOW,LTD,ROUTINE
100,ENDORECTAL,HOWEVER,MRI,SINCE
CHUV
946,AUF1,CSF,ERBB2,FUNCTIONAL,HUR,KSRP,MYC,NCOA3,PIN1,PTH,RAF,RAS,RNAI,SEVERAL,SLBP,TGF,THUS
015,2013,384,631,APRIL,BORDERLINE,CENTRAL,DESPITE,EGGER,HOWEVER,THEREFORE,WEB,WHILE
174,CELLSEARCH,CTC,CTCS,THESE
946,947,FINALLY,LNCAP,NSG,OLFACTORY,ORS,PCR,PI3,PSGR,THUS,USING
169,2014,946,ADAMTS3,CRT,ERP57,GP96,HEC,HSP27,HSPA9,INC,JAR,LOSS,MALDI,NANO,PDI,RL95,TAPASIN,TOF,WILEY
AAA,AT2,HSF,LUCIFER
013,2006,2009,8201,A549,HIGH,HOWEVER,IMMUNOBLOT,KI67,MEIER,NSCLC,RING,RING1,TNM
FURTHER,ORN,RCC,WHEREAS,WHILE
009,010,8201,945,CAUCASIANS,CIS,FURTHER,HOWEVER,ORS,PCA,PVUII,RESULTS
231,CAMELID,CORTACTIN,HENCE,MDA,MMP,NOTABLY,SH3,USING,WIP
HOWEVER,MSC
IGF,WHILE
000,DESPITE,USA

CRITERION,LNCAP,MDA,PC3,PCA,THESE,UTILIZING
169,2014,491,503,946,AACR,CK1,DVL2,GLEASON,HEF1,KIF3A,LABEL,MMP9,MOL,OTHER,RES,THESE,UNLABELLED,WNT
954,AKIP1,AP2,ESCC,HENCE,HOWEVER,SP1,VEGF
169,2014,946,948,AKT,APART,COPYRIGHT,FGR,FYN,GSK3,HOWEVER,LYN,SRC,TAKEN,TYR,Y1073,Y1112,Y1176
169,2013,BOTH,COPYRIGHT,ERSPC,PCA,PSA,PUBLISHED,RANDOMIZED,SCREENING,UROLOGY
1000,1460,169,2010,2011,2012,2013,8804,8805,BACKGROUND,COPYRIGHT,CRPC,ESMO,FORTY,LABEL,METHODS,OBJECTIVE,OUTCOME,PATIENT,PCA,PFS,PSA,PUBLISHED,RESULTS,SETTING,SIMON,SUMMARY,SWISS,THERE,TREATMENT,TRIAL,UNASSIGNED,UROLOGY
121,169,177,2013,418,78GY,7CM,BOOLEAN,CBCT,CBCTS,DVH,MEDICAL,OVERALL,PRV,PUBLISHED
102,169,2013,BACKGROUND,COPYRIGHT,ENDOSCOPIC,FOBT,HOWEVER,IGRT,IMRT,IRELAND,LABEL,LTD,MATERIALS,METHODS,PRD,RESULTS,ROUTINE
169,2013,BACKGROUND,COPYRIGHT,HOWEVER,IRELAND,LABEL,LNCAP,LTD,METHODS,NAD,NAMPT,PC3,RESULTS
001,122,169,1777,2013,2985,BACKGROUND,COPYRIGHT,DESPITE,EAU,FINALLY,LABEL,LNI,METHODS,OBJECTIVE,OUTCOME,PATIENT,PLND,PUBLISHED,RARP,RESULTS,SETTING,SEVERAL,SUMMARY,THEREFORE,THESE,UROLOGY
169,2013,COPYRIGHT,PSA,PUBLISHED,UROLOGY
169,2013,25MG,427,ADP,AKT,BACKGROUND,COPYRIGHT,CRPC,HEAT,HSP,HSP27,HSP90,HSPS,INDUCIBLE,KRUSKAL,LABEL,LNCAP,MEIER,METHODS,OBJECTIVE,OGX,OUTCOME,OVERALL,PATIENT,RESULTS,SETTING,SUMMARY,THESE,UROLOGY
169,2013,239,8805,ANTITUMOR,BACKGROUND,CHANGES,COPYRIGHT,CRPC,EVALUATION,LABEL,METHODS,OBJECTIVE,OUTCOME,PATIENT,PSA,PUBLISHED,RADIOLOGIC,RESULTS,SETTING,SOLID,SUMMARY,THESE,UROLOGY
001,169,2010,2013,484,946,AFRICAN,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PCA,PUBLISHED,RACE,RESULTS,SES,UNIVARIATE
169,2013,BACKGROUND,COMPARISON,CONCLUSION,CURRENT,FLA,HIFU,HOWEVER,INC,LABEL,MATERIALS,METHODS,PCA,PDT,PROSTATIC,PUBLISHED,RESULTS,SEVERAL,THERE
001,169,2008,2009,2013,3357,5804,8804,BACKGROUND,COPYRIGHT,EFFORTS,END,LABEL,LTD,METHODS,ORP,OVERALL,PCA,PLND,RARP,RELYING,RESULTS,SEER,STRATIFIED,UNI
002,160,169,2014,215,COPYRIGHT,CT1,CT2,CTS,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PLANA,PLANB,PUBLISHED,PURPOSE,RESULTS,SBRT,THERE,V90
137,160,169,2014,945,946,ALGEBRA,CARLO,COPYRIGHT,EQUIVALENT,GROUP,INC,LABEL,LARGE,MATERIALS,METHODS,MONTE,OBJECTIVE,PHYSICISTS,PURPOSE,RESULTS,TASK
001,003,005,006,009,160,169,2004,2008,2014,268,8805,AFTER,COPYRIGHT,COX,DOSE,INC,IPSS,JUNE,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PURPOSE,REDUCTION,RESULTS,SCORE,SEVENTY,SYMPTOM,UNIVARIATE,V90
001,169,2004,2007,2014,8804,AMONG,COPYRIGHT,END,GUIDELINE,INC,LABEL,MATERIALS,METHODS,NETWORK,OBJECTIVE,PURPOSE,RESULTS,SEER,THERE
169,2013,8776,AMONG,COPYRIGHT,CURRENT,HOWEVER,IRELAND,LTD,SIX,SUNITINIB
169,2014,293T,AUNP,BAX,BCL,CIT,COPYRIGHT,EGFP,FCM,GFP,HELA,LTD,MDR1,PAH,PEI,PROPIDIUM,WESTERN
024,1053,169,2013,487,AMONG,BACKGROUND,C2ORF43,COPYRIGHT,COX,EIGHT,JAZF1,KLK3,LABEL,LMTK2,METHODS,MSMB,OBJECTIVE,OUTCOME,PATIENT,PCA,PCSM,RESULTS,RS11672691,SCREENING,SETTING,SNP,SNPS,STUDIES,SUMMARY,UROLOGY
1178,1570,169,177,2004,2012,2013,204,220,224,246,253,265,AFTER,BACKGROUND,BLOOD,COPYRIGHT,DVP,LABEL,METHODS,NEUROSAFE,OBJECTIVE,OUTCOME,PATIENT,PROCEDURE,PSM,PSMS,PUBLISHED,RESULTS,SETTING,SUMMARY,THERE,UROLOGY,VINCI
169,2013,227,ADVERSE,C30,CONCLUSION,COPYRIGHT,EORTC,HRQOL,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PREVENTION,PURPOSE,QLQ,QUALITY,RESULTS,TREATMENT,URINARY
169,2014,COPYRIGHT,INC
169,176,2014,945,946,AMC,APLAN,CONCLUSION,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,T10,T50,T90
0001,169,2014,947,BOTH,COPYRIGHT,DSB,DSBS,H2AX,INC,INDUCTION,LABEL,MATERIALS,METHODS,OBJECTIVE,PATIENT,PURPOSE,RAD51,RESULTS
1104,238,761,853,ACCORDING,AGE,BACKGROUND,CHINESE,DRE,GLEASON,LABEL,METHODS,PSA,RESULTS,TRUS,WESTERN
215,BACKGROUND,CTV,EXTREME,HYPO,III,LABEL,METHODS,MRI,MRIS,PTV,RESULTS,THERE
000,060,119,120,1976,2010,2012,260,338,361,399,518,536,553,635,699,754,807,813,880,8805,881,979,AMONG,CONFIDENCE,DATA,DISCUSSION,EAR,EARS,FIRST,HODGKIN,HOWEVER,IACR,IARC,ICD,INCIDENCE,INCREASED,ISLANDS,ITALIAN,LABEL,LIFESTYLE,METHODS,MPS,NON,NORTH,OBJECTIVE,OBJECTIVES,OVERALL,RATIO,RESULTS,RISK,SIR,SIRS,SOUTH,WOMEN
174,ALPHARADIN,METASTRON,QUADRAMET
1000,5000,947,EACH,EWING,INJECTION,NSG,OVERALL,RAG2,TUMOURS
0001,002,009,010,037,195,2004,2007,967,CONCLUSION,GLEASON,HOWEVER,JULY,LABEL,METHODS,PCA,PET,RESULTS,SEVERAL,UNLABELLED
169,2014,ACT,AFFORDABLE,CARE,CME,CNE,EACH,INC,INTERVIEW,PATIENT,PROTECTION,SOCIETY
APAI,ASIAN,BAMI,BSMI,CAUCASIAN,FINALLY,FOKI,HOWEVER,MEANWHILE,TAQI,THEREFORE,VDR
169,2014,6Q25,AUTHORS,BRITAIN,CORRECTED,FINALLY,GENOMIC,GREAT,IRELAND,JOHN,JOURNAL,LTD,PATHOLOGY,SNP,SOCIETY,SONS,THUS,WILEY,ZDHHC14
SEVERAL,SNPS,THUS,WESTERN
2010,ADEQUATELY,CVD,DHT,HOWEVER,META,RCTS,STUDIES,THERE
001,177,184,707,MRI,THESE
945,ANDROGENS,HOWEVER,KNOWING,WHETHER
100,ERG,MEAN,TMPRSS2
169,2013,APOPTOSIS,COPYRIGHT,E2F,E2F1,HOWEVER,LNCAP,P53,PCR,TFDP3
169,1RA,2013,946,COPYRIGHT,INCUBATION,LEUPROLIDE,LNCAP,PBMC,SAS,WHILE
ALTOGETHER,CCL2,CCR2,MTT,PCA,PCR,TRANSWELL,TUNEL,WESTERN
169,2014,454,ERG,GLEASON,RPS,TMPRSS2
169,2013,223,5MG,CMCTS,COPYRIGHT,DERIVED,FAK,FGFR3,FIBROBLAST,FOCAL,INTESTINAL,IRELAND,KIT,KITR,LCK,LTD,LYMPHOCYTE,LYN,MASITINIB,MCS,STROMAL,YES
231,946,AGILENT,BACKGROUND,CELL,CHANGES,DAVID,ELISA,FADU,FAK,GENESPRING,H522,IL1,LABEL,MAPK,MAPKK,MCF7,MDA,METHODS,MSCS,NCI,PCR,PD98059,RESULTS,TGF,THUS
48H,ATP,DOC,DU145,HOWEVER,HSP70,LABEL,METHODS,MTT,OBJECTIVE,PC3,RESULTS,THEN,WESTERN
145,250,8482,ABCG2,ALDEFLUOR,ALDH,ALDH1A1,ATP,BACKGROUND,CELLS,CWR,HIGH,INHIBITION,LABEL,LOW,METHODS,PSA,RESULTS,RWPE
BACKGROUND,CONCLUSION,D98,DATA,DVH,HOWEVER,LABEL,METHODS,MRI,PTV,RESULTS
007,169,2014,3006,8804,8807,GROUP,JAPAN,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THEIR,THESE,UROLOGICAL,YOUNG
110,114,160,177,ASSESSMENT,BUFFERING,COMPOSITE,COUPLES,DAS,EPIC,EXPERIENCE,INDEX,INTERVIEWS,MEAN,MEN,PBS,POTENTIAL,PROTECTIVE,SCALE,THESE
AIDS,CMV,HOWEVER,SEVERAL
001,945,BACKGROUND,CONCLUSION,LABEL,METHODS,NON,RESULTS,STEROID,TSH
2C9,CTLL,IGG1,MOUSE,PBMCS,PSMA,THESE,USING
2013,BPS,CONCLUSION,FINALLY,LABEL,MATERIALS,MEDLINE,METHODS,RESULTS,UNLABELLED
169,2013,ACK1,AUTHORS,CAP,CASTRATION,CWR22,CWR22PC,JOHN,KXO1,LTD,RECURRENCE,SONS,SRC,TAKEN,WILEY
169,1997,2006,2013,ALSO,AUTHORS,GERMANY,HODGKIN,JOHN,LTD,SONS,SPC,SPCS,SWEDISH,WILEY
160,169,2013,AUTHORS,BPH,DU145,GLCE,GLEASON,HSPG,JOHN,LNCAP,LTD,PC3,PCR,PEARSON,PNT2,PSA,SONS,TNM,WILEY
169,2013,946,956,AUTHORS,FRIZZLE,JOHN,LRP5,LTD,MEMBERS,PCA,SONS,THESE,WHILE,WILEY
001,002,055,2008,2011,327,8804,954,AGREEMENT,AIMS,BASED,DATA,GLEASON,INTER,LABEL,METHODS,OBJECTIVE,PATHOLOGY,RESULTS,SOCIETY,UROLOGICAL
169,2014,COPYRIGHT,REPRINT,VITAMIN
0001,004,052,169,2013,226,253,AUTHORS,CRPC,DYN2,DYNAMIN,GLEASON,INHIBITION,JOHN,LTD,PCA,SONS,TURP,WILEY
AKT,HGF,IGF,MET,PI3K,SRC,TREATMENTS
25OHD,AMERICA,MOST,NORTH,RTC,RTCS,SINCE,THUS,UVB
160,AG490,IGF,JAK2,MSM,RECURRENCE,STAT3,THEREFORE,THESE,VEGF
ADDITIONAL,CRPC,CTLA,III,LABEL,OPINION,PAP,PSA,SEVERAL,SIPULEUCEL,STATEMENT,THESE,UNASSIGNED,WHEREAS
169,2014,ERA,ERB,MOST,SOCIETY
125,2003,2009,206,8805,ADT,BACKGROUND,BETWEEN,BFFS,EBRT,GLEASON,HIGH,LABEL,METHODS,PHOENIX,RESULTS,STAGE,THERE
2011,2013,8201,ABDOMINAL,AFTER,BAKER,FACES,LABEL,METHODS,MSE,NONE,OBJECTIVE,PURPOSE,RARP,RESULTS,THERE,WHILE,WONG
143,2011,2013,219,8805,BACKGROUND,BOTH,CONTINENCE,GLEASON,LABEL,MAY,METHODS,RESULTS,ROBOTIC
188,2009,CONCLUSION,LABEL,METHODS,NCCN,NETWORK,OBJECTIVE,PURPOSE,RESULTS,SPECIALIST
BACKGROUND,CHANCES,END,GLEASON,LABEL,METHODS,PSA,RESULTS
945,946,956,ADP,ALSO,BACKGROUND,BAX,BCL,CAM,DU145,GSK3,IC50,LABEL,LNCAP,MCL,METHODS,PARP,RESULTS,THESE,URSOLIC,WNT,WNT3A,WNT5
100,108,1118,115,1385,159,1973,2007,212,247,254,267,405,506,879,BACKGROUND,COX,END,FOUR,LABEL,MEIER,METHODS,PRISM,RESULTS,SEER,STAT,THERE
129,130,945,946,947,DBZ,ICD,NOTCH,PRESENILIN,PS1,TACE,TGF,THESE,TNF,TRAF6
160,ALSO,BAX,BCL,CASPASE,HOWEVER,KANK,KANK1,THUS
0025,0116,1000,19620,2004,3933,8364,8805,BPH,COX,IRS,ITALIAN,LABEL,MEN,METHODS,OBJECTIVE,OBJECTIVES,PCA,PROPENSITY,RESULTS
173,LABEL,MALIZIA,MATERIALS,METHODS,OBJECTIVE,RESULTS
100,AIM,BPH,CTCS,HEALTHY,IVD,LABEL,MATERIALS,METHODS,OBJECTIVE,PCA,PSA,PSMA,RESULTS,ROUTINELY
160,CPT,CPTS,ERLOTINIB,MCF7,THEIR,THEREFORE,THESE,TKIS,WHILE
MET,RANK,RANKL,THESE,VEGF
H2A,NONCODING,PTMS,RNAS
ADIPOCYTES,AGE,CCL2,COX,INCREASED,SPECIAL
BONE,RECURRENT
002,003,230,252,468,504,8805,CASE,CIS,COLORECTAL,HIGH,LUNG,ODDS,ORS,OVARIAN,PCR,RCC,RESULTS,SCREENING,THESE,TRIAL
001,002,006,008,028,2007,2012,BACKGROUND,FIFTY,HRPCA,ICI,LABEL,MARCH,MCT,MEAN,METHODS,MOT,OBJECTIVE,OBJECTIVES,OCTOBER,PDR,PERCENTAGE,QOL,RESULTS
169,174,2013,956,CASODEX,COPYRIGHT,CRPC,DRP,IRELAND,LNCAP,LTD,RBIC,THESE
121,122,123,124,125,134,135,138,169,1B7,2013,APC,CD4,COPYRIGHT,DRB1,EBV,ESO,LTD,MINIMAL,PBMCS,TCR,USING
8902,BACKGROUND,CAM,DU145,EACH,GIVEN,H460,HCC1143,HCC1937,LABEL,METHODS,MISTLETOE,NCI,RESULTS,VAE
001,131,177,190,2009,2012,BLOOD,CATEGORIC,LABEL,MEAN,METHODS,OBJECTIVE,OCTOBER,PURPOSE,RESULTS,STUDENT
100,106,200,396,BIOLOGICAL,DESPITE,EXPRESSION,HOWEVER,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RB1,RESULTS,TP53,USING
143,2011,2013,8805,APRIL,AUC,BECAUSE,CONCLUSION,ESUR,GLEASON,LABEL,METHODS,MRI,OBJECTIVE,OCTOBER,PURPOSE,RADS,REGARDING,RESULTS,TESLA
MIA,PACA
METASTASIS,TNF,TRAIL
22RV1,602,606,690,ADT,BECAUSE,CRPC,GHRH,LNCAP,MIA,SV1,VCAP
121,169,2013,206,ADT,BACKGROUND,CONCLUSION,COX,DISTANT,INC,LABEL,MDT,METHODS,PCA,PCSS,PSA,RESULTS,WILEY
PUFAS,THERE
0162,9346,ADT,AFTER,CONTINUOUS,HOWEVER,INT,JPR7,KEY,LABEL,LHRH,MEDICAL,NOVEL,OPINION,STATEMENT,SWOG,UNASSIGNED
001,189,1986,2001,641,BACKGROUND,COX,ESC,LABEL,MEIER,METHODS,PCA,RESULTS,SWEDISH,UNIVARIATE,VGLL3
2011,2013,250,CYP17,JANUARY,PSA
000,300,350,500,750,FINALLY,HAI,INITIALLY,RFA,THEREFORE,THREE
OTHER,SIMILARLY,TREATMENT
125,33258,7901,8201,956,997,A549,ABOUT,AFTER,APOPTOSIS,BACKGROUND,CASPASE,CONCLUSION,CONTEXT,DIELS,DISCUSSION,HOECHST,IC50,LABEL,MATERIALS,MCF,METHODS,MTT,OBJECTIVE,PANC,PREVIOUSLY,PROTEIN,RESULTS,SGC,WESTERN
2005,AKT,PHLPP,PI3K,PIP3,PLECKSTRIN,PRECISE,PTEN
945,GLA,LNCAP,MTX,NAALADASE,PAMAM,PC3,PSMA,SIMILAR
1990,2000,2010,2012,CASE,CHINA,CUBA,FINALLY,ITALY,JULY,LABEL,MAY,METHODS,OBJECTIVE,ORS,RESULTS,SELECTION,SYNTHESIS
198,1A1,ADDITIONAL,ASIAN,BACKGROUND,CAUCASIANS,CIS,CYP1,CYTOCHROME,FURTHER,ILE462VAL,LABEL,METHODS,MSPI,ODDS,OVERALL,P450,RESULTS
HDAC,HOWEVER,MICRORNAS,RAS,RESULTS,SHANNON,SMAD4,THESE,USING
33342,FIRST,HOECHST,HOWEVER,SMA,THEREFORE
200
100,169,216,233,248,8764,AFTER,ALIX,AMT,BACKGROUND,CANDIDATE,CURRENT,ENO1,FASN,FTMS,LABEL,LTQ,MASS,MATERIALS,METHODS,PCA,PDCD6IP,PROTEOMIC,PSA,RESULTS,RWPE,THEREFORE,TIME,VALIDATION,VCAP,WESTERN,XPO1
AFRICAN,HOWEVER,LINDL,SEVERAL,WEST
112,169,2013,AUTOPHAGY,BACKGROUND,BPH,CHINA,CITY,GREATER,GUANGZHOU,LABEL,METHODS,PCA,PTEN,RESULTS,SOCIETY
CHANGES,HOWEVER,PCA,THESE
223,5P15,680,8201,CAUCASIANS,EAST,HOWEVER,TERT,USING
FILAMIN,FLNA,GLEASON,MMP,PSA,WESTERN
109,181,8201,AMID,COMPOUNDS,IC50,IVA,IVB,IVD,LC50,MOST,NCI,SORAFENIB,TGI
EFFORTS,SUCCESSFUL,TARGETS
160,AFTER,AMONG,CRPC,DRUG,FOOD,III
160,927,ASIA,BASED,BCR,BMI,DIFFERENT,MEDLINE,OBESITY,PCA,THERE,USA
6Q22,FINALLY,HOWEVER,RFX6,SNP,SNPS
ALK1,CK7,CRIBRIFORM,EGFR,KRAS,LUNG,MOLECULAR,ROS1,TTF1
120,177,252,8201,946,956,CONCLUSION,DYNAMIC,FAVORABLE,FSH,FSH1,FSHR,GBQ,HEART,IC50,LABEL,MAL,METHODS,MOLECULAR,NOTA,OBJECTIVE,PC3,PET,PROCEDURES,PURPOSE,RESULTS
193,1995,2009,332,400,461,8805,AMONG,INITIATION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SRE,SRES,USING
169,2013,COPYRIGHT,DESPITE,EMT,OVERALL,PCA
005,641,8805,BASIC,EXTREMITY,HLPA,LABEL,LLPA,LOWER,METHODS,METS,MVPA,OBJECTIVE,PURPOSE,RESULTS,UNLABELLED,WHILE
169,2013,549,BECAUSE,COPYRIGHT,DPPH,GPX,MCF,RWPE,SAS
169,2014,945,946,AZA,BPH,COPYRIGHT,CPG,DUCAP,FINALLY,HEX,HEXA,LNCAP,PC3,RESULTS,SAS
169,2013,AKT,BIOLOGY,COPYRIGHT,DECORIN,EGFR,IGF,IGF1R,MET,NOTABLY,PUBLISHED,SOCIETY,THUS,USING,WHETHER
RECURRENT,THEREFORE
ADC,ADCS,PSMA
BRCA,BRCA1,BRCA2,PCA,THEREFORE
169,2014,ABDOMINAL,COLLEGE,COPYRIGHT,INC,LABEL,METHODS,MOST,MRI,NINE,OBJECTIVE,PUBLISHED,PURPOSE,RADIOLOGY,RESULTS,SOCIETY,TEXAS,THERE
169,2013,COPYRIGHT,DMM,GOX,LOD,PSA,UNDER
169,2013,COPYRIGHT,HOWEVER,STAT3,STATS,THERE
1241,14Q31,169,2013,AFFYMETRIX,COPYRIGHT,FEDERATION,FINALLY,HCC,HOWEVER,NOTABLY,PCR,PUBLISHED,SNP,SOCIETIES,THESE
169,2013,313H,COPYRIGHT,FEDERATION,LTL,NOD,OMN54,PHASE,PSA,PTEN,SCID,SOCIETIES,TRIAL
001,002,006,035,160,169,2014,8805,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,QOL,RESULTS,TEN,THEN
001,160,169,2011,2012,2014,APRIL,BLADDER,BOTH,COMPOSITE,CONCLUSION,COPYRIGHT,FIFTY,FORM,INC,INDEX,LABEL,METHODS,OBJECTIVE,RARP,RESULTS,SCORE,SHORT,SYMPTOM
125,169,174,177,2013,600,CATPHAN,CBCT,CONCLUSION,COPYRIGHT,CTDI,FOV,HEAD,IMAGE,LABEL,LUNG,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SAS,XVI
169,177,2013,956,COMPOUNDS,COPYRIGHT,IC50,LTD,NSAID,PC3,PCA
A549,ANNEXIN,APOPTOSIS,ATF4,BACKGROUND,BLOT,CELL,CFLAR,CONCLUSION,DDIT3,DR5,EIF2A,ERN1,FITC,FLIP,HOWEVER,HSPA5,KNOCKDOWN,LABEL,LUNG,MCL1,METHODS,MTT,NOXA,NSCLC,PTL,RESULTS,SILENCING,SRB,TNFRSF10B,WESTERN
100,135,150,200,2206,250,8201,8805,AKT,AUC,BACKGROUND,CONCLUSION,DLTS,INHIBITION,LABEL,MAD,METHODS,MTD,NSCLC,PRS,Q3W,QOD,RESULTS,SIX

CARLO,FLA,HOWEVER,LABEL,METHODS,MONTE,OBJECTIVE,PURPOSE,RESULTS,USING
176,360,8804,CARLO,HOUNSFIELD,HUS,IMRT,LABEL,METHODS,MONTE,MRI,OBJECTIVE,PURPOSE,RESULTS,RTP,VMAT,VOXEL
100,1113,ADT,BACKGROUND,CASODEX,CDX,CRPC,LABEL,MICRORNAS,RESULTS,RNAS,THERAPIES,THESE,VALIDATION
169,2014,ALI,APART,BLACKWELL,GMBH,PCA,PCAS,TDS,THEREFORE,THUS,TONGKAT,TRT
125B,146A,221,222,MICRORNAS
LNCRNAS,RNAS
001,032,143,AIPC,CAD,CONCLUSION,CRPC,IAD,LABEL,LHRH,MAB,MEIER,METHODS,OBJECTIVE,PSA,RESULTS
198,204,CONCLUSION,LABEL,LMO2,LNCAP,METHODS,OBJECTIVE,RESULTS,THESE,TRUNCATED
016,488,CTC,CTCS,HOWEVER,J591,LEWIS,PCA,PSMA,SEVERAL
181,ARI,ARIS,BACKGROUND,CELL,DU145,FDA,LABEL,LNCAP,MATERIALS,METHODS,MMP2,MMP9,PC3,RESULTS,RWPE,TIMP
0001,500,ANTIBODIES,BTF3,HINT1,NDRG1,ODC1,OPERATING,PROTEIN
018,020,022,248,FIGO,HOWEVER,NORWEGIAN,OSLO,OTHER,OVCAR,PFS,SEX,SHBG,SKOV,UNIVERSITY,WESTERN
001,017,018,019,026,069,167,2005,2007,284,8804,8805,BETWEEN,EPE,GLEASON,JAPAN,PSA,RATES,SVI
169,2014,945,946,AACR,ANOTHER,GIVEN,HOWEVER,INCREASED,MMP2,MMP9,OVERALL,PTHRP,TGF
169,2014,946,AACR,ALCAM,BOTH,KI67,PC3,PREVENTION,TGF,THROUGH
002,009,028,038,039,8201,AMONG,HOWEVER,INCREASED,METAL,SMOKERS,THESE
UROLOGISTS
ARS,EXPRESSION,NOVEL,THERE
132,1998,2009,2012,605,792,920,APRIL,CIS,COX,DATA,KINGDOM,LABEL,METHODS,OBJECTIVE,OCTOBER,PURPOSE,REPOSITORY,RESULTS,STATISTICS,TYPE
160,169,1998,2012,2014,BOTH,COPYRIGHT,EDUCATION,ERECTIONS,FOUR,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PADUA,PUBLISHED,PURPOSE,RESULTS,SURVIVORS,THEREFORE,UROLOGICAL
2005,2007,456,504,507,538,569,574,590,598,620,621,650,651,665,679,690,705,708,715,BACKGROUND,BASED,CONCLUSION,END,ICD,LABEL,METHODS,PCA,PPV,RESULTS,SEER
017,025,047,169,194,AMACR,BACKGROUND,COA,E277K,FURTHER,GGCGG,KOREANS,LABEL,MATERIALS,METHODS,RESULTS,SNPS
169,2013,8805,BACKGROUND,DOC,EASTERN,ENZ,GROUP,IQR,LABEL,METHODS,PSA,RESULTS,SIXTY,SOCIETY
1243,169,2013,204,ASSESSMENT,AUTHORS,BACKGROUND,COMPOSITE,DATA,EPIC,HOWEVER,IMRT,INC,INDEX,INDIVIDUAL,LABEL,METHODS,PROSTQA,QOL,QUALITY,RESULTS,SOCIETY,THERE,THESE,TREATMENT,WILEY
169,2013,224,BOTH,HOWEVER,PCA,PSA,TRIB1,UICC
001,2006,2010,8201,BACKGROUND,BODY,COMPOSITE,EPIC,FURTHER,GRADE,INDEX,LABEL,METHODS,NCCN,OVERALL,PSA,QUALITY,RESULTS,RTOG,SBRT,THERAPY
1989,2008,232,313,AFTER,CLL,CLLS,EPM,FURTHER,HOWEVER,INTENSIVE,OVERALL,SIR,SPM
0001,0084,152,169,2013,BACKGROUND,CONCLUSION,COPYRIGHT,E26,ERG,GLEASON,HIGH,LABEL,LTD,METHODS,PSA,PTEN,RBM3,RESULTS,THERE
20Q13,CAR,HIGH,HPC20,LABEL,THESE,UNLABELLED
246,DUE
150,2003,2007,ASIAN,BETWEEN,GRADE,LABEL,MARCH,MEIER,METHODS,OBJECTIVE,RESULTS,SALVAGE,T1C,THERE,THREE
000,100,177,190,1950,426,497,5250,550,575,576,862,910,BACKGROUND,BEST,CASE,COLORECTAL,CONCLUSION,DATA,END,FUNDING,GENERATOR,HARMS,HISTORY,HORIZON,INSTITUTE,LABEL,LUNG,METHODS,OBJECTIVE,OUTCOME,OVARIAN,POPULATION,PRIMARY,RESULTS,SCENARIOS,SCREENING,SMOKING,SOURCES,TIME,TRIAL,UNASSIGNED
100,1000,1080,116,1350,145,160,172,181,231,2OS,4510,500,549,786,872,A2058,CA2,CELL,DOTC,ECM,FADU,FBS,HCC,HCT,HELA,HEP,MCF,MDA,MIA,MMP,PMA,RAJI
001,004,140,1635,181,351,522,ACUTE,ASSESSMENT,BCG,LABEL,LOW,METHODS,OBJECTIVE,PURPOSE,RESULTS,URINARY,UROTHELIAL
BELLA,D2R,DISEASE,FURTHER,LABEL,MATERIALS,METHODS,OBJECTIVE,PAC,PARTIAL,RESULTS,STAGE,TAKEN
169,2014,ACUTE,ADT,BACKGROUND,CONCLUSION,COPYRIGHT,DLT,DLTS,GNRHA,HRPC,IMRT,INC,LABEL,MEN,METHODS,MTD,RESULTS
177,181,DUE,KLAKLAK,LABEL,LARGE,METHODS,OBJECTIVE,PBS,RESULTS,TMTP1,TUNEL,WHITE
169,2014,HOWEVER,INC,REGULATION
169,2000,2013,2392,2423,323,8364,8805,BACKGROUND,COPYRIGHT,DESPITE,LABEL,METHODS,MRGB,MRI,OBJECTIVE,OUTCOME,PATIENT,PCA,PUBLISHED,QALY,QALYS,QOL,QUALITY,RESULTS,SETTING,SUMMARY,THRESHOLD,TOTAL,UROLOGY
ATP,GBSA,IC50,PRK1,PROTEIN,RELATED,SINCE
100,163,BACKGROUND,BETA,HOWEVER,IRAN,IRANIAN,LABEL,MATERIALS,METHODS,PCR,RESULTS,XMRV
0001,021,159,177,2004,2012,502,50S,657,ACCORDING,AFRICAN,ALSO,AMERICA,AMERICANS,BACKGROUND,BMI,BMIS,CAUCASIANS,GLEASON,KOREA,KOREANS,LABEL,MATERIALS,METHODS,PSA,PSAS,RESULTS,THESE
231,916,945,946,947,BASED,MCF,MDA,PGJ2,PPAR
005,011,042,049,288,289,577,8Q24,BLOOD,CHINA,CHINESE,EIGHT,HAPLOTYPE,PCA,SNPS,THREE
947,DCM,DSK,HEPG2,KK6,LNCAP,MEOH,METHANOLIC,MTP,MTT,NAN,PAYAO,PIGMENTED,PRE,PRES,PYO,ROS
0019,040,057,090,0MG,1271,177,2010,286,351,479,871,945,BACKGROUND,CONTINUOUS,DICLOFENAC,FOLEY,GLEASON,HOWEVER,JANUARY,LABEL,LRP,MATERIALS,METHODS,PSA,RESULTS,THERE,THUS,WHILE
100,CANCERS,FAS,FASL,HOWEVER,PCA,RSV,THEREFORE,XRT
178,2007,2012,ABOUT,CONCLUSION,DOPPLER,DVT,LABEL,MARCH,METHODS,NIGERIA,OBJECTIVE,PROSTATIC,RESULTS,THERE,VTE
945,946,LNCAP,PACLITAXEL,PHB,PROHIBITIN,THESE
007,119,130,177,292,2AM,5AM,8202,BMI,COLORECTAL,LUNG,MELATONIN,OVARIAN,PEARSON,PLCO,SCREENING,SERUM,TRIAL
120,14627,174,17438,196,8202,BACKGROUND,CAUCASIANS,EAST,FURTHER,HOWEVER,LABEL,PRINCIPLE,RESULTS,SNPS,SOUTH,TLR2,TLR4,TLRS,TOLL
100,1000,169,200,2014,DUE,GMBH,KGAA,LOD,LODS,SARCOSINE,VCH,WILEY
169,2013,22RV1,BACKGROUND,CAV,CELL,DU145,INC,LABEL,LNCAP,METHODS,PC3,PCA,PROTEIN,RESULTS,RWPE1,THESE,WILEY
039,100,169,177,2013,8201,99M,AJCC,AUC,BACKGROUND,BVC,ESUR,INC,LABEL,METHODS,MRI,N0M0,PCA,RESULTS,ROC,TNM,TXR,WHOLE,WILEY
001,140,149,169,2013,289,8201,8805,CGA,CSS,GLEASON,INC,LABEL,LOCAL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,TEN,WILEY
006,169,2013,713,8201,BACKGROUND,DUE,ETS,INC,LABEL,METHODS,RESULTS,SAM,SPDEF,SPEF,WILEY
954,AKT,CSC,CSCS,GROWING,HENCE,PCA,SEVERAL,THEREFORE
169,2013,481,8201,8804,8805,945,BACKGROUND,CD117,CD133,EXPRESSION,EZH2,GLEASON,INC,LABEL,METHODS,OCT3,PSA,RESULTS,STEM,VARIOUS,WILEY
169,2013,CSC,CSCS,EMT,ESC,INSIGHT,NANOG,UICC
177,8201,BHP,BILLERICA,ELISA,HOWEVER,MDA,MILLIPORE,ROS,THESE,USA
169,2013,718,946,CRPC,DHT,FISH,IHC,LOC,MED15,MET,PCA,SMAD3,TAKEN,TGF,UICC
169,177,2013,22RV1,945,CAF,CHROMATIN,DISSECTION,MMP3,MMP9,PCA,PRESS,PUBLISHED,THBS2,UNIVERSITY
169,2013,BACKGROUND,COPYRIGHT,DIET,HOT,HOWEVER,IGF,IRELAND,LABEL,LTD,MAP,METHODS,NCBI,OBJECTIVE,OCTOBER,P450,PI3,RESULTS,ROS,THERE
002,005,100,169,1980,2000,2014,AFTER,COPYRIGHT,EDUCATION,GLEASON,INC,LABEL,MATERIALS,MEN,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SIMILAR,UROLOGICAL
001,009,130,169,2004,2012,2014,359,COPYRIGHT,EDUCATION,HIGH,INC,JUNE,KINGDOM,LABEL,MATERIALS,METHODS,METICULOUS,OBJECTIVE,OCTOBER,PUBLISHED,PURPOSE,REDO,RESULTS,UROLOGICAL,VALIDATED
ASIAN,CELL,HOWEVER,LTD,PCA,PUBLISHED,SOY,THERE,THESE
197,1995,2010,BACKGROUND,CONCLUSION,DATA,DEBAKEY,DESPITE,INC,LABEL,MEDICAL,MEIER,METHODS,MICHAEL,NOTABLE,PUBLISHED,RESULTS,SMNS,THEREFORE
160,169,195GY,2014,7MM,CHANGES,COPYRIGHT,FOLEY,INC,LABEL,MATERIALS,MAXIMUM,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SOCIETY,SPATIAL,TRUS
160,169,192,1AND,2014,3200,6840,8100,8640,CAUSE,COPYRIGHT,EBRT,FORTY,GRADE,HDR,INC,LABEL,LATE,METHODS,OBJECTIVE,PHASE,PUBLISHED,PURPOSE,RESULTS,SALVAGE,SOCIETY,THREE
315,522,837,AFRICAN,BACKGROUND,BLACK,DESPITE,LABEL,METHODS,PILOT,PSA,RESULTS,SAPCS,SOUTH,WHILE
169,2013,BACKGROUND,CONTEXT,COPYRIGHT,ENGLISH,GENOMIC,INCREASED,LABEL,LNCRNAS,MEDICAL,METHODS,OBJECTIVE,PATIENT,PUBLISHED,RESULTS,RNAS,SUBJECT,SUMMARY,SYNTHESIS,UROLOGY
0001,0007,001,004,018,160,8201,BACKGROUND,CRPC,EVALUATION,FURTHER,HLA,HOWEVER,IGG,LABEL,METHODS,PEPTIDE,PPV,PSA,PSADT,RESULTS,SEVERAL,SOLID,TRIAL,WORLD
160,169,175,2008,2010,2011,2013,291,493,679,ADJUSTING,IMPAIRMENT,JOHN,LABEL,LTD,METHODS,MUI,OAB,OBJECTIVE,OUTCOME,QUESTIONS,RESULTS,SONS,THESE,URGE,UUI,WILEY,WORK
1405,169,2013,653,CUMULATIVE,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,UROLOGICAL
125,169,2003,2010,2013,616,BETWEEN,JAPAN,JIKEI,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OPTIMAL,RESULTS,SALVAGE,THESE,TOKYO,UNIVERSITY,UROLOGICAL
169,2013,AIM,ASIA,ASPC1,BACKGROUND,BXPC3,DKK,FOUNDATION,HEPATOLOGY,JOURNAL,KLM1,LABEL,LTD,METHODS,OBJECTIVE,PANC1,PTY,PUBLISHING,REIC,RESULTS,SUIT,T3M4,WILEY
114,160,1679,169,1999,2004,2013,DAN,DYSURIA,FINLAND,HOWEVER,JOHN,LABEL,LTD,LUTS,MATERIALS,MEN,METHODS,OBJECTIVE,PSS,RESULTS,SEVENTY,SONS,TAMPERE,THESE,WILEY
SMOKING,TOBACCO
1980,CUSHING,EXTENSIVE
001,169,2010,2012,2015,ASIAN,CONCLUSION,HCV,HEPATITIS,HIV,IBHPC,LABEL,METHODS,OBJECTIVE,OCTOBER,RESULTS,TEST,THERE,VIRUS,WHITE
000,100,AMONG
PRESENTED
ALSO,CONTINENT
111,148,150,2001,2005,2006,2010,2011,2013,242,868,AVERAGE,BACKGROUND,BILATERAL,BLADDER,CELL,CLEVELAND,CONCLUSION,DENMARK,LABEL,METHODS,NEPHRON,NOVI,NSS,PROF,RADICAL,RCC,RENAL,RESULTS,SAD,SURGERY,THERE,UROLOGY,USA,VHL
2010,2014,21ST,ADVANCE,ARGUS,ASSESSMENT,BACKGROUND,CONCLUSION,LABEL,OBJECTIVE,PAD,PRPUI,RESULTS,SUI,UNASSIGNED
169,2014,INC,RNAS
2014,AULA,BACKGROUND,CONCLUSION,COPYRIGHT,COUNTRIES,DIET,EDICIONES,FURTHER,HOWEVER,LABEL,METHODS,OBJECTIVE,OLIVE,PUBLISHED,RESULTS,SCIENCE,THERE,WEB
BOTH,FFPE,PCA
954,ADDITIONAL,ATG5,BASED,CONSISTENT,IFN,INHIBITION,INTRINSIC,ISGS,PC3,RELA,VESICULAR,VSV
115,BACKGROUND,COMPOSITE,EPIC,FORM,INDEX,LABEL,LRP,MEDICAL,METHODS,MIE,QOL,RESULTS,SHORT,THERE
169,2013,205,COMPELLING,COPYRIGHT,INC,LAMP3,OVERALL,THESE
239,264,946,954,BACKGROUND,ERK1,HOWEVER,INHIBITION,LABEL,MCSF,METHODS,NFAT,OPG,RANKL,RAW,RESULTS,SOLUBLE,TGF
CONCLUSION,LABEL,MRI,OBJECTIVE,ULTIMATELY
CONCLUSION,LABEL,MRI,OBJECTIVE,STRATEGIES
00001,0006,914,ADDITIONAL,BCR,EPLND,HOWEVER,LABEL,LIBRARY,LNS,METHODS,OBJECTIVE,OPERATING,PCA,PLND,PURPOSE,REGARDLESS,RESULTS,WMD
8804,FIFTEEN,FORTY,FOUR,GLEASON,IPSS,IQR,LRP,MOST,NBD,QMAX,QOL,QUALITY,RRP,SCORE,SYMPTOM,VAS
1414,1416,2013,3204,337,434,506,916,ADDITIONAL,ADT,ALSO,AUTHORS,BACKGROUND,CENTRAL,CIS,COLLECTION,CONTROLLED,DATA,FINALLY,GHQOL,GRADE,HIGH,HOWEVER,INDIVIDUAL,LABEL,MAIN,MEDLINE,MEN,METHODS,OBJECTIVE,OBJECTIVES,OCTOBER,OVERALL,PAIRS,QOL,RANDOMISED,RESULTS,SELECTION,SMD,SMDS
300,LABEL,METHODS,MILD,MOST,MRI,OBJECTIVE,OBJECTIVES,PET,RESULTS,SIX,THREE,WHOLE
169,2014,COLLEGE,COPYRIGHT,HDR,HIGH,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RADIOLOGY,RESULTS,THREE
ADDRESSING,ADT,BODY,CHANGES,LABEL,MAIN,METHODS,NURSING,OBJECTIVE,OBJECTIVES,PURPOSE,RESULTS,SETTING,URBAN,VARIABLES
AFRICAN,BECAUSE,FORCE,III,PREVENTIVE,PSA,TASK,YET
100,956,ADENOSINE,AMPK,ATP,DU145,HENCE,MMP,MNSOD,NCTD,PCNA,PEG,ROS,SOD
22RV1,BRDU,FLOW,LNCAP,MANGOSTEEN,MFE,MTT,NEXT,PRECS,WESTERN
BASED,PREDICTING,THUS,TSP
BPH,IGM,PCA,PSA
ADULT,CHRONIC,CP9,CREER,K14,PREVIOUSLY,PTEN
106,761,CONCLUSION,INADEQUATE,LABEL,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS
CDR1,LNCAP,PCA,PCR,PNT1A,THESE,XQ26
147,CUFFLINKS,DEGS,FUNCTIONAL,GENOMES,IPA,KEGG,KYOTO,NCBI,REGULATORY,SRA
001,150,160,181,22RV1,ABTS,BAX,BCL,CELL,FRAP,MTT,PCR,PNT1A,THESE
0012,0021,0475,946,BACKGROUND,COX,FINALLY,HOWEVER,LABEL,LNCAP,MEIER,METHODS,OGT,OVERALL,RESULTS,THESE
BACKGROUND,BRCA2,LABEL,METHODS,PCA,RESULTS
024,030,177,2009,2010,BACKGROUND,BLADDER,DATA,IIEF,INDEX,IPSS,LABEL,LTME,METHODS,PROSTATIC,RESULTS,RTME,SCORE,SYMPTOM,URINARY
169,2013,3MONTHS,AN1,CONCLUSION,COPYRIGHT,CURIE,IPSS,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PSA,QOL,RESULTS,SAS,SCORE,SYMPTOM,THERE,THREE,URINARY
169,2013,COPYRIGHT,DRE,EIGHT,FFOCT,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PSA,RESULTS,SAS,SIX,SIXTEEN
169,2013,8230,BLADDER,COPYRIGHT,FUROSEMIDE,PET,PSA,SAS,TEP,THERE
COMPARING,TMAX
DYSMORPHIC,HOWEVER,UROLOGICAL
001,003,2000,2010,874,8804,897,BCR,BOTH,LABEL,METHODS,OBJECTIVE,POST,PSA,PSMS,PURPOSE,RESULTS,T3A
KNOWLEDGE,PSA,QUITE
1985,1999,2006,BACKGROUND,CASE,CAUCASIAN,CONCLUSION,CONVERSELY,HOWEVER,LABEL,LOWER,METHODS,NSGCT,PROSTATIC,RPLND,TCGTS,TGCT,TGCTS
007,022,036,057,2011,2012,AIMS,APRIL,COX,MAY,METHODS,RESULTS,UNIVERSITY
QALY,USING
169,2013,AACR,BALB,CDH2,CONVERSELY,ERBB2,FASN,FATTY,HNSCC,MMP,OTSCC,SCC,THESE,VEGFA165B,ZSGREEN
169,2013,COPYRIGHT,CTC,CTCS,DETECTION,EMT,GENOMIC,INC,SIMILARLY
169,2013,215,365,833,8730,883,BACKGROUND,CAUCASIAN,COPYRIGHT,DCA,FINALLY,INDEX,LABEL,METHODS,OBJECTIVE,OUTCOME,PATIENT,PCA,PHI,PUBLISHED,RESULTS,SETTING,SUMMARY,THESE,TOTAL,UROLOGY
135,169,193,2005,2014,261,308,328,341,359,8804,8805,BACKGROUND,CONCLUSION,COPYRIGHT,INC,ISUP,KAPPA,LABEL,MATERIALS,METHODS,PATHOLOGY,RESULTS,SOCIETY,UPGRADING,UROLOGICAL
169,2014,COPYRIGHT,INC,OPEN,POSTERIOR,SIMILARLY,TREATMENT,UROLUME
169,2013,956,COPYRIGHT,EVALUATION,GI50,LTD
169,2013,DVH,IMRT,MCO,MEDICAL,PUBLISHED,RAYSEARCH,RAYSTATION,STOCKHOLM,VMAT,WEIGHTS
116,117,122,160,169,1986,1992,2014,945,946,ACCORDING,CONFORMAL,COPYRIGHT,DOSE,EBRT,FIRST,HDR,INC,KIEL,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PHOENIX,PUBLISHED,PURPOSE,RADIOLOGY,RESULTS,SOCIETY,THESE
169,2006,2010,2014,285,COPYRIGHT,INC,INPATIENT,LABEL,LOCAL,LTD,LTDS,MATERIALS,METHODS,MOST,NATIONWIDE,NINTH,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,SIMILAR
164,169,2013,CELL,CITY,CONCLUSION,COX,EXPRESSION,GLEASON,HOPE,INC,LABEL,MATERIALS,MEDICAL,MEIER,METHODS,OBJECTIVE,PCA,PUBLISHED,PURPOSE,RAF,RAS,RESULTS,RRM2,UNIVERSITY
A549,HPGD,IC50,LNCAP,LTD,NAD,PGDH,PGE2,PUBLISHED,SAR,TOP
169,2012,241,COPYRIGHT,CPG,ESPA,FIVE,MLH1,MSH2,PCR,PORTUGUESA,PUBLISHED,SOCIEDADE,TNM
145,169,2014,CAP,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,PCA,RESULTS,THEREFORE,USING
0005,155,160,169,177,2014,374,CONCLUSION,COPYRIGHT,FORTY,FOUR,INC,LABEL,MEAN,METHODS,OBJECTIVE,RESULTS
BACKGROUND,BAX,BCL,BESIDES,BIP,CELL,CHOP,FLOW,J82,LABEL,METHODS,PEE,RESULTS,T24,TAIWANESE,UBUC
520,APPRAISAL,BACKGROUND,BRITISH,CASP,FIVE,FURTHER,HODGKIN,LABEL,METHODS,MINIMISING,NHS,NONE,PROGRAMME,RESULTS,SEVEN,SIX,THERE,ZEALAND
150,184,CRPC,DESPITE,METABOLIC,OCM,PSA,THESE,UDP,UGT
BACKGROUND,DIRECTIONS,HOWEVER,LABEL,QSOX1,RESULTS,SEVERAL
ANOTHER,BACKGROUND,CONCLUSION,CTC,CTV,LABEL,METHODS,MRI,OBJECTIVE,PEAK,PSA,PURPOSE,RESULTS,URINARY
ALA,CONCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,PDD,RALP,RESULTS,TILEPRO,VINCI
GSTP,GSTP1,THESE,TRIS
2010,544,CENTRAL,ELIZABETH,JANUARY,PERFORMING,QECH,QUEEN,THERE,WITHOUT
001,8202,945,946,BACKGROUND,CAHPV,CLAUDIN,CONCLUSION,CURRENTLY,DU145,HOWEVER,LABEL,LNCAP,METHODS,OBJECTIVE,PNT2,RESULTS,THESE
169,2013,HOWEVER,INC,WILEY
169,2013,CONCLUSION,INC,LABEL,METHODS,MRSI,OBJECTIVE,PURPOSE,RESULTS,THEREFORE,WILEY
086,2010,252,447,578,AOK,BACKGROUND,DETMOLD,DISCUSSION,DISEASE,LABEL,MANAGEMENT,METHODS,PROGRAM,RESULTS,SIR,T2D,THUS
300,CAB,CRPC,EMP,GLEASON,LABEL,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS,UFT
1131,2001,2006,ASPIRIN,BACKGROUND,CIS,CONSISTENT,GENERAL,HRS,III,IRISH,LABEL,MEDICAL,MEN,METHODS,RESULTS,THESE
000,100,ACTRN,AUSTRALIAN,BACKGROUND,BEP,BLEOMYCIN,CONCLUSION,LABEL,METHODS,MOST,PRIMARY,RESULTS,ZEALAND
8230,CHANGES,CTCS,EFFORTS,GIVEN,STRATEGIES,VALIDATION
ERBB2,HIPPO,HOWEVER,ILK,INHIBITION,LATS1,MST1,MYPT1,PDZ,PP1,TAZ,TEAD,YAP,YES
169,2013,AACR,FURTHER,PROLONGED,XENOGRAFTS
169,2013,COPYRIGHT,ISET,MALDI,PSA
001,181,2007,2011,2012,2013,584,592,623,8805,BACKGROUND,BASEL,BETWEEN,EUR,GLEASON,LABEL,MATERIALS,METHODS,PCA,PSA,RESULTS,UROL
1995,2011,300,8805,BACKGROUND,BRFS,COX,DENMARK,FURTHER,LABEL,MEIER,METHODS,PCA,PHD,PRESENTLY,PSA,PSM,RESULTS,RPS,SINCE,THEREFORE
2003,2006,2012,AMICO,BACKGROUND,CASES,CENTRAL,CONCLUSION,DENMARK,FOUNDATION,FOUR,FUNDING,LABEL,METHODS,PHOENIX,PSA,RECURRENT,RESULTS,SOCIETY,STRATIFIED,THERE,THREE,TRIAL,UNIVERSITY
169,2013,3700,AIMS,BACKGROUND,CONCLUSION,DATA,EDUCATION,HOWEVER,JOHN,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,RELEVANCE,RESULTS,SONS,VARIOUS,WILEY
000,0012,007,018,142,158,161,307,60YS,66YS,77YS,817,BACKGROUND,BLINDED,COMBINING,HEREDITARY,HHT,IQR,LABEL,LIFE,METHODS,OVERALL,RESULTS,THESE
169,2014,AVM,BRAGG,JAMES,LINDA,LOMA,MEDICAL,TREATMENT,UNIVERSITY,WHILE
100,169,2014,8201,DDA,DELIVERED,DOSE,DVHS,FITCHBURG,LYMAN,MVCT,NTCP,PHILIPS,PINNACLE3,RADIADYNE,RADIATION,SINCE,SYSTEMS,USA
BECAUSE,CRPC,DBD,HER2,NRS,PYRVINIUM,USING

107
ECT,FDG,HOWEVER,MRI,PET,REGARDING,SPECT
AKT,DATA,EZH2,IGF,INHIBITION,KI67,LABEL,LUCAP23,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS
001,019,026,042,3P21,639,CPG,GLEASON,HENCE,HOWEVER,OVERALL,PCA,PSA,RAS,RASSF1A
209,233,8201,LABEL,OVERALL,THERE,UNASSIGNED,UNLABELLED,VEGF
CONCLUSION,DATA,HBED,HOWEVER,LABEL,METHODS,MRI,OBJECTIVE,PCA,PET,PSMA,PURPOSE,RESULTS,SUVMEAN,SUVS
003,008,010,023,047,049,118,134,2002,2003,ACCORDING,BETWEEN,LABEL,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS
185,HOWEVER,RFS,TAKEN
169,2013,22RV1,8220,AACR,LABEL,LNCAP,METHODS,OBJECTIVE,PKC,PURPOSE,RESULTS,RO31,SIMILARLY,TAKEN
106,169,2013,643,AACR,AKT,ERC,ERG,FORTY,HOWEVER,IHC,INDIVIDUAL,LABEL,MEIER,METHODS,OBJECTIVE,PTEN,PURPOSE,RESULTS,USING
946,DU145,FURTHER,HGF,HT29,PAK6
145,181,268,ATTEMPTING,H460,HCT,IC50,MCF,N13,SGF,SIF
PCA
178,1998,2004,ANSELIN,ARABIAN,EASTERN,GWR,HODGKIN,MORAN,NHL,OLS,POPULATION,SAUDI,THESE
034,038,045,047,121,123,2005,2008,8804,AHT,AMICO,AMONG,BETWEEN,CRT,EBRT,FURTHER,HDR,MAY,NHT,PSA
169,1993,2006,2013,374,390,8804,8805,BCR,COPYRIGHT,COVARIATES,COX,EARLY,GIVEN,GLEASON,HIGH,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PCA,PSA,PURPOSE,RESULTS,UNI
1005,141,169,177,2013,ABDOMINAL,CBCT,COPYRIGHT,DESPITE,EVERY,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SBRT,TUKEY
000,100,2012,3047,8364,8764,961,ANY,BACKGROUND,COSTS,EXCEL,HOWEVER,III,LABEL,METHODS,PCA,RESULTS,SPAIN,SPANISH,STAGE,THESE,USING
DLEU,DNLE,LEU,MULTI,NLE,PACE4
CONCLUSION,FURTHER,LABEL,OBJECTIVE,PURPOSE,THERE
0001,2004,2010,300,312,3739,8201,BACKGROUND,CHARLOTTE,INC,INPATIENT,LABEL,MATERIALS,METHODS,ORP,PREMIER,RARP,RESULTS
001,003,006,126,128,177,8201,BCR,CONCLUSION,COX,HOWEVER,LABEL,MEIER,METHODS,OBJECTIVE,PCA,PCR,PSA,RESULTS,THESE,UNASSIGNED,VIRTUAL
000,100,185,1992,1997,1998,2003,265,455,INCIDENCE,JANUARY,KOREA,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SIR,SIRS,VIETNAM,WAR
100,150,8804,CAP,CCNB1,DLG7,GLEASON,HENCE,HMMR,HURP,HYPOXIA,OVERALL,PSA,SINCE
104,145,811,AKT,AKT1,BCL,EGFR,ERK,HOWEVER,LNCAP,MDM2,MYC,P53,PACLITAXEL,PI3K,PSA,S166,S473,S807,SKP2,SRC
632,ALSO,DEGS,FORMULA,FORWARD,HOWEVER,KMGS,KMSFS,SELECTION,SEQUENTIAL,SUPPORT,SVM
1622,183,215,807,815,8202,ALA,ALPHA,BACKGROUND,BLOOD,DHA,EPA,IDENTIFIER,LABEL,MEAN,METHODS,OMEGA,PSA,RESULTS,THEREFORE,TRIAL,UNASSIGNED,URL
001,8201,8805,945,946,CONCERNING,D50,DVHS,EORTC,HOWEVER,LABEL,MATERIALS,METHODS,NIEMIERKO,OBJECTIVE,PURPOSE,RESULTS,RTOG,V60
169,2013,BACKGROUND,CRPC,DESPITE,DUAL,INC,K847,K847R,LABEL,METHODS,NVP,PCA,PI3K,PSA,RESULTS,SKP2,TARGETING,WESTERN,WILEY
PCR,THESE,WHILE
160,169,2013,239,945,946,AKT,ANNEXIN,CAF,CD63,CD81,EXO,HSP70,HSP90,HYPOXIC,IL6,ILK1,INC,LNCAP,PC3,PCA,PRSC,SMA,TGF,THESE,TNF1,WILEY
001,004,043,112,119,231,BACKGROUND,CONCLUSION,COX,CSS,DMFS,EBRT,GLEASON,LABEL,LOCAL,LPFS,MEIER,METHODS,PCA,RESULTS,T3B
123,140,CHOLINE,CONCLUSION,EBRT,GLEASON,LABEL,MATERIALS,METHODS,OBJECTIVE,PET,PSA,PURPOSE,RESULTS,SUV
008,047,091,1642,169,2013,AFTER,BACKGROUND,BRITISH,DATA,GLEASON,JOURNAL,LABEL,MEDICAL,MEIER,METHODS,PRESS,PUBLISHED,RESULTS,UNIVERSITY
1024,4096,945,946,DETECTION,ELISA,HOWEVER,OVERALL,PSA,TNF
169,2013,472,8804,8805,BACKGROUND,BCR,COPYRIGHT,COX,EARLY,GLEASON,HARRELL,LABEL,MEAN,METHODS,OBJECTIVE,OUTCOME,OVERALL,PATIENT,PSA,PUBLISHED,REGRESSION,RESULTS,SALVAGE,SETTING,SUMMARY,THESE,UNASSIGNED,UNI,UROLOGY,USING
0026,169,2012,2013,2014,AUA,COPYRIGHT,EDUCATION,INC,INFECTION,JUNE,LABEL,MARCH,MATERIALS,METHODS,MUSIC,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,TRAINED,UROLOGICAL,USING,WHILE
10Q26,169,19Q13,2014,321,8Q24,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OTHER,PSA,PUBLISHED,PURPOSE,RESULTS,THEREFORE,UNIVARIATE,UROLOGICAL
169,2013,AUSTRALIAN,COLLEGE,RESPONSES,ROYAL,ZEALAND
169,2013,AMONG,BRITISH,HOWEVER,SOCIETY,TRP,TRPA1,TRPC,TRPM,TRPV
BRB,NECTARS,TEXTURE,THUS
121,ATP,BACKGROUND,BPH,CONCLUSION,CONVERSELY,DAC,H3AC,H3K4ME2,H3K4ME3,H4AC,HGPIN,HOWEVER,LABEL,MDR1,MULTIDRUG,NPT,NPTS,PCA,PCR,RESULTS,TSA
AFRICAN,BACKGROUND,CASE,CONCLUSION,EAST,LABEL,METHODS,PSA
HOWEVER,PCA,PSA,SEXTANT
946,CLINICALLY,FAS,HFD,LFD,LNCAP,MIC1,PCA
1980,2013,AMONG,CONCLUSION,JANUARY,JUNE,LABEL,LIBRARY,MEDLINE,METHODS,OBJECTIVE,ONGOING,PURPOSE,RESULTS,TEN
2003,2011,2675,39351,3RD,5152,CANCERS,CHILDHOOD,CONCLUSION,DEC,EDITION,GENERAL,HACETTEPE,HIGH,HOSPITALS,ICCC,JAN,LABEL,MEDICAL,METHODS,MOST,OBJECTIVE,PEDIATRICS,PURPOSE,RADIATION,RESULTS,SURGERY,UNIVERSITY,UROLOGY
023,127,242,709,823,838,905,990,995,APAI,BSMI,CAUCASIAN,CAUCASIANS,CONCLUSION,CONVERSELY,FIXED,FOKI,FURTHER,GLEASON,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,STRATIFIED,TAQI,THEREFORE,VDR,VITAMIN
0001,003,182,1994,2004,CONCLUSION,FACULTY,GLEASON,LABEL,MEDICAL,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS,UROLOGY
0025,128,2003,2008,8804,ADT,BETWEEN,CONCLUSION,LABEL,MARCH,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS
CRPC,CURRENT,FDA,SEVERAL
153,223,945,946,BONE,DRUG,EDTMP,FOOD,METASTATIC,THESE,TREATMENT
177,2012,314,CBCT,CONCLUSION,IMRT,JUNE,KOREA,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THOSE,UNIVERSITY
164,AUSTRALIA,CONCLUSION,DEPRESSION,DSM,HDRB,LABEL,LDRB,MDD,METHODS,OBJECTIVE,PCA,QUEENSLAND,RESULTS,SCALE,SELF,THERE,THESE,TREATMENT,ZUNG
096,2013,206,8973,BEGG,EGGER,EXCLUSION,HOWEVER,JUNE,TEN
145,174,956,ADP,AUTOPHAGY,BH3,CELL,CHOP,ERS,GADD153,IC50,INCREASING,PC3,PCA,PNT1A,POLYPHENON,PUMA,THEREAFTER,UPR
169,1975,1992,2001,2005,2010,2013,ACS,AMONG,BACKGROUND,CDC,CENTERS,CENTRAL,CONTROL,DATA,DISEASE,END,ESTIMATES,INSTITUTE,LABEL,METHODS,NCI,NORTH,OVERALL,PREVENTION,REGISTRIES,RESULTS,SEER,SOCIETY,THROUGH
169,2013,3MM,BOTH,CONFORMITY,DOSIMETRIC,HOWEVER,IMRT,INTENSITY,MASTERPLAN,MEDICAL,MUS,OARS,PRECISE,PUBLISHED,SIB,VMAT
160,169,2008,2009,2012,2014,498,CASE,COPYRIGHT,EDUCATION,FORCE,FURTHER,HOSPITALS,INC,JANUARY,LABEL,MARCH,MATERIALS,MEDICAL,METHODS,MOST,OBJECTIVE,OHIO,PREVENTIVE,PUBLISHED,PURPOSE,RESULTS,SIMILAR,TASK,UNIVERSITY,UROLOGICAL
004,101,169,196,2014,ADT,AMICO,BACKGROUND,CONCLUSION,COPYRIGHT,HOWEVER,INC,LABEL,MEIER,METHODS,RESULTS,TIME,TTBR
169,2013,COPYRIGHT,DHH,FURTHER,HHS,IHH,IRELAND,LNCAP,LTD,POST,SHH,SONIC,THESE
0001,014,2008,2012,453,585,APRIL,DAN,HOWEVER,IIEF,INDEX,LABEL,MAY,METHODS,OBJECTIVE,OVERALL,PATIENT,POTENCY,PSS,RALP,RESULTS,RRP,SCORE,SYMPTOM,THERE
001,1044,1176,132,178,185,1998,2011,8201,8309,ADT,BACKGROUND,BED,BIOLOGICAL,COX,FAILURE,FOLLOWING,GLEASON,IOP,JULY,JUNE,LABEL,MEN,METHODS,PHOENIX,PSA,RESULTS,T1C,T2B
ANATOMICAL,CONCLUSION,LABEL,METHODS,OBJECTIVE,PAX,RESULTS,SPECIMENS,THESE
450,492,942,CBM,CHINESE,CONCLUSION,ELRP,FULL,JOURNAL,LABEL,LIBRARY,MEDLINE,META,METHODS,NINE,OBJECTIVE,RESULTS,SMD,TLRP,WANFANG
AMONG,ANOTHER,BPH,CONCLUSION,DIAGNOSTIC,GLEASON,IPSS,LABEL,LUTS,METHODS,OBJECTIVE,PCA,PSA,RESULTS,SYMPTOM,THEREFORE,TURP
1999,2010,2013,APC,CENTRAL,JANUARY,JOINTPOINT,LABEL,METHODS,OBJECTIVE,PROGRAM,PURPOSE,PYLL,RATE,REGRESSION,RESULTS,ROMEDER,SUMMARY,TIME,VERSION,WHAT
AZA,CROHN,IBD,TNF
2000,ATP,FINALLY,FTS,JNK1,MAPK,MITOGEN,PCA,USING
AKT,FURTHER,HOWEVER,PCA,PI3K,PLZF,PTEN,TAKEN,THESE
BAD,BASED,MCL,PI3K,PKA,S112,THESE
100,114,197,CAP,GLEASON,OVERALL,PATHOLOGIC,PSA,PSAD,TUR,TURP,VARIABLES
169,2014,C18,C19,CHINESE,COPYRIGHT,EARLIER,GMBH,HOOK,KGAA,SKOV,TRIPTOLIDE,VCH,WILEY
169,2014,COPYRIGHT,EC50,GMBH,KGAA,MCF,NOSCAPINE,PANC,PAPAVER,PC3,VCH,WILEY
156,2001,2012,8804,AMONG,CONCLUSION,FIVE,FORTY,GLEASON,HOWEVER,LABEL,MATERIALS,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS,T1A,T1B,THERE,THESE
169,2014,AFTER,COPYRIGHT,GMBH,HACAT,KGAA,LNCAP,SHG,VCH,WILEY
169,2013,946,954,BACKGROUND,CCL2,CXCL8,ELISA,ERK,HOWEVER,INC,INCUBATION,LABEL,MAP,MAPK,METHODS,PCR,RESULTS,ROS,RWPE,T016,THP,WESTERN,WILEY
023,043,140,162,169,2012,2013,8201,BACKGROUND,COX,CYP,ECOG,GLEASON,HOWEVER,INC,KEIZMAN,LABEL,METHODS,ONCOLOGIST,PFS,PSA,RECORDS,RESULTS,WILEY
169,2013,ANNEXIN,APOPTOSIS,BACKGROUND,HDCA,HNK,HOWEVER,INC,LABEL,LNCAP,METHODS,NUCLEAR,PSA,R1881,RESULTS,REVERSE,TRAMP,WILEY
169,2013,945,954,BACKGROUND,CAFS,ELISA,ERK,FINALLY,HSP90,INC,LABEL,MEK,METHODS,MMP,PRSFS,RESULTS,STAT3,TME,WILEY
EMP,EMP1,GLEASON,PSA,VEGFC,WESTERN
114,128,169,174,2013,230,244,299,313,947,C57BL,CD4,CD8,DR1,FDA,GMBH,HHDII,IFN,IMMUNOBODY,KGAA,PAP,PROSTATIC,TREATMENT,VCH,WILEY
133,169,2013,321,563,686,8201,8764,881,945,946,ALPHA,BETA,BODY,FINNISH,NEITHER,PREVENTION,TOCOPHEROL,UICC
169,2013,302,947,ATHYMIC,BIOMARKERS,DIOC7,EF5,H2AX,KI67,MCF,UICC
001,002,009,011,026,BOTH,GLEASON,MYL9,PCA,PSA,THEN,WESTERN
ATP,FACTORS,HOWEVER,IGF,INHIBITORS,INSULIN,IRA,OTHER,THESE
0005,001,003,006,160,2006,2010,BETWEEN,BOWEL,COMPOSITE,CONCLUSION,EPIC,FORM,HOWEVER,HRQOL,IMRT,INDEX,ITEM,LABEL,MCS,MEDICAL,METHODS,OBJECTIVE,PCA,PCS,PURPOSE,RESULTS,SHORT,THESE,URINARY
174,177,190,225,307,BACKGROUND,FOLEY,IMA,IPSS,LABEL,LCA,METHODS,RESULTS,SCORE,SYMPTOM,VINCI
BACKGROUND,CONCLUSION,FORMULA,HIFU,HIGH,LABEL,MATERIALS,METHODS,MRI,OPTICAL,RESULTS
AMONG,LABEL,METHODS,OBJECTIVE,OVERALL,PCS,PCSS,PREDICTOR,PURPOSE,RESULTS,SYMPTOM,THESE
200,8804,ASSESSING,AUC,AUC3,BASED,DOCETAXEL,EVALUABLE,FATIGUE,HOWEVER,INVENTORY,LABEL,MDASI,METHODS,MODAFINIL,MSADI,OBJECTIVE,OVERALL,PURPOSE,RESULTS,SYMPTOM,THERE,TP1,TP2
AIM,BACKGROUND,ESCC,LABEL,MATERIALS,METHODS,MTT,OBJECTIVE,PCR,PLNCRNA,RESULTS,RNAS
000,100,120,177,240,300,500,956,99M,B12,CONCLUSION,DYNAMIC,LABEL,MBQ,METHODS,PAMA,PREDOSING,RENAL,RESULTS,SIX,SPECT,TARGETING,TEN,UNLABELLED
107,177,215,225,945,956,A10,CONCLUSION,HUVEC,J591,LABEL,LNCAP,MAT,MATLU,METHODS,PEGYLATED,PSMA,RESULTS,THESE,UNLABELLED
119,122,2008,2012,8804,BACKGROUND,BETWEEN,CONCLUSION,GLEASON,JANUARY,LABEL,MEAN,METHODS,PSA,RESULTS,TPTPB,TRUS
231,ALTOGETHER,MCF,MDA,NAV1,RHOA,VGSCS,VOLTAGE
143,145,148A,15A,200B,200C,20A,375,AKT,LABEL,MICRORNAS,MIR,PCR,THESE,UNLABELLED
127,191,2012,AIM,BACKGROUND,CHARING,CONCLUSION,CROSS,DESPITE,DETAILS,LABEL,MALIGNANT,MATERIALS,METHODS,NICE,OBJECTIVE,ONGOING,RESULTS,TREATMENT,WEST
CONCLUSION,GLEASON,LABEL,MAIN,MESSAGE,METHODS,OBJECTIVE,PSA,QUALITY,RESULTS,TREATMENT
CUS,NPS,PSA,THROUGHOUT
2012,648,AMED,BACKGROUND,CENTRAL,CONCLUSION,CONTROLLED,DESPITE,EXPECTING,HOWEVER,LABEL,MEDLINE,METHODS,PEDRO,RCTS,RESULTS,SMD
AAC,AFRICAN,AFRO,AIM,AMONG,CARIBBEAN,CAUCASIAN,FURTHER,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,THERE,UNLABELLED
8805,GLEASON,LABEL,MATERIALS,METHODS,MRSI,OBJECTIVE,OBJECTIVES,PHOSPHORUS,RESULTS,SIGNALS
CHELATABLE,TPP,ZP1
223,GUIDELINES,III,NCCN,PANEL
181,231,474,946,CC50,DU145,HEXADECYL,JIMT,MDA,PC3
012,014,BLOOD,CEC,CECS,CEP,CEPS,CONCLUSION,LABEL,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,T28,T56,T84,TEN,THESE,ZOL
ACHN,F136,FINGUIMOD,HELA,MOLECULAR,THESE
2013,BASEL,FACBC,PET,SALVAGE
0001,0004,0005,001,002,006,2013,220,8804,8805,956,AGE,BACKGROUND,BASEL,CONCLUSION,GLEASON,HIGH,LABEL,MATERIALS,METHODS,MLRA,OBJECTIVE,PSA,RESULTS,SLRA
170,177,2013,222,2ND,474,4TH,BASEL,CONCLUSION,LABEL,METHODS,OBJECTIVE,PCA,RESULTS
160,EPID,IMRT,MLC,MLCS,THREE,VMAT
169,2013,COMPOUNDS,COPYRIGHT,NCI,PALLADIUM,SAS,THESE
013,100MG,10MG,169,2013,385,BOTH,COPYRIGHT,GNRH,GONADAL,TAK,TWICE
005,169,2014,AGREEMENT,COPYRIGHT,EDUCATION,FINALLY,GLEASON,HISTOLOGY,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESIDUALS,RESULTS,TESLA,UROLOGICAL
105,153,169,2012,2013,2014,COPYRIGHT,EDUCATION,GIVEN,III,INC,INSTITUTES,LABEL,LESIONS,MATERIALS,MEAN,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,TESLA,UROLOGICAL
005,169,2014,204,AFTER,ASSESSMENT,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PROVIDING,PUBLISHED,PURPOSE,QUALITY,RESULTS,SCALE,SERVICE,SOURCES,THERAPY,UROLOGICAL,VARIOUS
001,013,169,2014,AMONG,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,MEAN,METHODS,OBJECTIVE,OUTCOME,PUBLISHED,PURPOSE,RESULTS,SUCCESSFUL,UROLOGICAL
169,2013,COPYRIGHT,DIH,GPCRS,INC,MEANWHILE,PI3K,PLC,ROS,S1P,S1P1,S1P5,THUS,XBP
001,073,169,2014,341,599,679,682,697,702,AUC,COPYRIGHT,EDUCATION,GLEASON,INC,LABEL,MATERIALS,MEAN,METHODS,OBJECTIVE,OVERALL,PCA3,PUBLISHED,PURPOSE,RECORDS,RESULTS,ROC,THESE,UROLOGICAL,USING
0001,0008,001,003,091,169,1980,2006,2014,COPYRIGHT,COX,EDUCATION,FIVE,INC,LABEL,LATE,MATERIALS,MEIER,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL,YOUNGER
0001,001,102,135,153,168,169,2013,239,8805,AIM,AUC,COLLEGE,CONCLUSION,COPYRIGHT,GLEASON,LABEL,LTD,MATERIALS,METHODS,MRI,OBJECTIVE,PSA,PUBLISHED,RESULTS,ROC,ROYAL,SSS,USING
106,169,2013,231,233,AMONG,CONCLUSION,COPYRIGHT,FIFTY,LABEL,MATERIALS,METHODS,MOST,OBJECTIVE,PUBLISHED,PURPOSE,RESIDENTS,RESULTS,SAS,SEVENTY,SFJRO,SFRO,SOCI
169,2006,2012,2014,3117,COPYRIGHT,HOWEVER,INC,JANUARY,METASTATIC
120,169,2013,AFTER,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PCA,PUBLISHED,RECEIVING,RESULTS,THERE
0107,0127,169,1991,1992,1993,1995,1996,2001,2002,2004,2005,2006,2013,831,969,COMPETING,DEPARTMENT,DRESDEN,EAST,GERMANY,HAMBURG,INC,LABEL,MARTINI,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RATES,RESULTS,TECHNOLOGY,THREE,UNIVERSITY,UROLOGY,WALD
001,1305,169,2013,371,471,795,8805,BMI,GLEASON,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERWEIGHT,PUBLISHED,RESULTS
169,2000,2005,2013,758,BCR,COX,GLEASON,INC,LABEL,METHODS,OBJECTIVE,PSA,PUBLISHED,RESULTS,RPE,UNIVERSITY
169,2013,INC,PUBLISHED
169,2013,434,946,AFTER,CLC,CRC,CTBP2,GLEASON,HNF1,INC,LABEL,MATERIALS,METHODS,MSMB,OBJECTIVE,OBJECTIVES,PCA,PIN,PROTEIN,PUBLISHED,RESULTS,THESE
169,2013,3DVH,BASED,CLS,CONFIDENCE,DQA,DVH,IMRT,MEDICAL,OARS,PTV,PUBLISHED
169,2013,COPYRIGHT,OUTCOME,PUBLISHED,UROLOGY
169,176,177,2013,466,6MM,BACKGROUND,BONE,CBCT,CBCTS,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PBM,PTV,PURPOSE,RESULTS
169,176,1FA,1PA,2013,210,360,6MM,8MM,AGILITY,ARC,AUTHORS,BACKGROUND,COPYRIGHT,CTV,IGRT,INCLUDING,IRELAND,LABEL,LTD,MATERIALS,METHODS,MLC,MODULATED,OAR,OBJECTIVE,PTV,PUBLISHED,PURPOSE,RESULTS,SABR,SEVEN,THERAPY,USING,VMAT,VOLUMETRIC
0102,015,016,169,2013,515,8805,COPYRIGHT,IRELAND,LABEL,LINC,LTD,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,V40,V75
169,2014,215,AFTER,AMONG,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
0001,100,1434,169,1998,2008,2014,2223,585,8764,8804,8805,BETWEEN,COPYRIGHT,DFS,EIGHT,FAILURE,INC,LABEL,LDR,MATERIALS,MEIER,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS
169,177,2007,2010,2014,BACKGROUND,CHO,CONCLUSION,COPYRIGHT,INC,INCLUSION,JULY,LABEL,METHODS,PET,RESULTS,TREATMENT
112,118,122,126,132,2008,2011,244,BACKGROUND,DELAYED,DVC,ESTIMATED,LABEL,MATERIALS,METHODS,OPERATIVE,RALP,RESULTS,THERE,UNIVERSITY
037,2011,ARS,BACKGROUND,ENGLAND,LABEL,MATERIALS,METHODS,MID,QUESTIONS,RESULTS,UROLOGICAL
017,125,350,445,607,714,8804,8805,926,BACKGROUND,FACTORS,GLEASON,IQR,LABEL,MATERIALS,METHODS,PSA,RESULTS
001,003,270,BACKGROUND,DEPENDING,DISCERN,LABEL,MATERIALS,METHODS,PCWS,RESULTS
2006,2009,367,BACKGROUND,DEPARTMENT,EDS,EMERGENCY,INCREASING,JANUARY,LABEL,MATERIALS,METHODS,NATIONWIDE,NEDS,NORTHEAST,RESULTS
8217,BACKGROUND,BCSCS,BOTH,CELL,GENISTEIN,GLI1,LABEL,MCF,METHODS,PATHWAY,PCR,RESULTS,SIGNALING,THESE
169,2013,INC,PUBLISHED,QOL,SURVIVORS,THEREFORE
160,8201,BACKGROUND,CONCLUSION,I131,IGG,LABEL,LNCAP,METHODS,PSCA,RESULTS
BACKGROUND,BAX,CBP,CONVERSELY,DU145,ECTOPIC,GAIN,HLH,ID4,K373,LABEL,LNCAP,METHODS,P223L,P300,PUMA,RESULTS,TAKEN,V274F
160,ADT,ADVERSE,AFTER,BACKGROUND,CLUB,COPENHAGEN,DISCUSSION,LABEL,METHODS,SECONDARY,TRIAL,UNIVERSITY,USING
160,ADT,ADVERSE,BACKGROUND,BOTH,EARLY,EVALUATION,FFBF,IMRT,LABEL,METHODS,PROGRAM,RESULTS,SEVENTEEN,THERAPY,TREATMENT,VERSION
160,169,2013,AIM,BRITAIN,COLORECTAL,CONCLUSION,DISEASE,GREAT,IRELAND,LABEL,METHODS,OBJECTIVE,RESULTS,THERE,VINCI
169,2013,502,940,AIMS,FEW,JOHN,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,SONS,WILEY
151,160,169,173,177,1975,2006,2013,2306,303,AMSTERDAM,BLACKWELL,GMBH,HOWEVER,MEAN,MEDICAL,MTOF,PCA,PSA
EGCG,GREEN,GTPS
0200,181,BACKGROUND,CONCLUSION,ESI,FDA,HPLC,LABEL,LLE,ORAL,RESULTS
1076,2005,2010,227,374,475,AMICO,BASED,CLAVIEN,FEW,HIGH,LABEL,METHODS,OBJECTIVE,OSLO,RALP,RESULTS,ROBOT,UNIVERSITY
169,2013,BASED,BIOMETRIC,SOCIETY,THESE
808,918,AIM,ANXIETY,BACKGROUND,C30,CONCLUSION,FORTY,HOWEVER,IIEF,IPSS,LABEL,LRP,METHODS,MINIMALLY,OBJECTIVE,PR25,PREVALENCE,QLQ,QOL,RESULTS,THERE
946,AKT,ALSO,CONVERSELY,DU145,ELISA,EMT,MMP,OVERALL,PCR,PI3K,SNAIL,TGF,TWIST
100,2007,2008,604,AFRICAN,BACKGROUND,CARE,CONCLUSION,DATA,LABEL,METHODS,MOST,PCP,PCPS,PHYSICIANS,PRACTICES,PRIMARY,PSA,REGARDING,RESULTS,SCREENING
169,2013,8201,BBN,COPYRIGHT,GRPR,JOHN,LTD,NLE,SONS,THESE,WILEY
169,2013,700,760,888,994,998,ALEXA,CD45,CELLSEARCH,CTC,CTCS,CYTOMETRY,DRUG,EMT,EPCAM,EXCELLENT,FLUOR,FOOD,HOWEVER,SOCIETY,SPIKE,TAKEN
120,177,240,956,AFTER,BESIDES,DU145,GSTP1,LABEL,METHODS,OBJECTIVE,PCR,PURPOSE,RESULTS,SIMILARLY,THREE,WESTERN
0001,006,007,012,019,036,044,1562,BACKGROUND,FIVE,III,LABEL,METHODS,MMP,PCR,RESULTS
2009,2012,AIMS,BACKGROUND,BETWEEN,IGRT,IMRT,LABEL,LOW,MARCH,METHODS,OBJECTIVE,PRIOR,RESULTS
100,150,200,250,550,CONCLUSION,EERPE,EXCLUDING,LABEL,LRP,METHODS,OBJECTIVE,PSM,PURPOSE,RESULTS
ADR,CPLA,DOX,MCF7,NCS,PC3,PGP,THESE
169,2013,CDK1,COPYRIGHT,DESPITE,E2F1,IHC,IRELAND,LNCAP,LTD,PCA,PIN,S780,S795,THUS
ASSESSMENT,BACKGROUND,CARE,CEA,CGS,COST,COUNCIL,DATA,DES,ESTIMATES,EXCELLENCE,FUNDING,FURTHER,HOWEVER,INSTITUTE,LABEL,LIBRARY,MEDICAL,METHODS,NICE,NIHR,OBJECTIVE,OBJECTIVES,PROGRAMME,RESULTS,SOURCES,TECHNOLOGY,THERE,VOL,WHERE
AMONG,H3K4,H3K9,JMJC,JMJD2,KDM,KDM1,KDM4,LNCAP,LSD1,MEPR
005,CURRENTLY,DXR,FIRST,RPA,RPARPAR,TPP
SUPPORTED
2007,JUSTINE,NHS,NOW,SIX
001,2004,2006,2007,2009,4752,BACKGROUND,HOWEVER,JAPAN,LABEL,MEDICAL,METHODS,NARA,PADT,RESULTS,UNIVERSITY
169,2013,ACCORDING,ASIA,CHINA,CHINESE,CONCLUSION,DESPITE,LABEL,LTD,MEN,METHODS,MOST,OBJECTIVE,OBJECTIVES,PTY,PUBLISHING,RESULTS,SICHUAN,THESE,UNIVERSITY,WEST,WILEY
044,133,160,566,ADHERENCE,ADULT,AMONG,COX,DIET,DIETARY,FOOD,HOWEVER,LCHP,MEN,RELATIONS,RISK,SCORE,THERE,UPPSALA
100,125I,169,2014,8201,FIVE,PAIN,SEVEN
027,100,124,150,274,782,793,800,806,844,887,953,966,ADC,AUC,CHO,CIT,CONCLUSION,DWI,LABEL,METHODS,MRS,OBJECTIVE,OOP,RESULTS,ROC,ROI
104,106,142,143,ACCORDING,BPH,CONCLUSION,HOWEVER,LABEL,METHODS,MILD,OBJECTIVE,PCA,RESULTS,THERE
BACKGROUND,DISCUSSION,EFFECTIVE,FOCUS,GPS,LABEL,MEN,METHODS,RESULTS
DESPITE,MCS
0002,003,006,0072,032,071,16250,16273,227,784,ATM,GROUP,MDM2,PCR,RADIATION,RTOG,THERAPY,THESE,TP53
177,370,740,AIM,CONCLUSION,DATA,HERK,IGRT,IMRT,INTRA,LABEL,METHODS,MVCT,OBJECTIVE,PTV,RESULTS
164,216,346,AIM,BACKGROUND,CONCLUSION,COX,DESPITE,INSTEAD,LABEL,MATERIALS,MEDICAL,METHODS,OBJECTIVE,RESULTS,UNIVARIATE
270,AIM,AMH,BASED,CONCLUSION,IGA,IVU,LABEL,LOW,METHODS,NEWLY,OBJECTIVE,RESULTS,THREE,UUT
117,2007,2009,ADVERSE,AIM,CONCLUSION,CTV,IMRT,JULY,JUNE,LABEL,LATE,METHODS,MVCT,OBJECTIVE,PTV,RESULTS,THEREFORE
0102,765C,765GC,765GG,AIM,AMONG,BLADDER,CONCLUSION,COX,HOWEVER,LABEL,MATERIALS,METHODS,OBJECTIVE,PCR,RESULTS,RFLP,SIX
0047,31G,57G,991C,BACKGROUND,CENTRAL,CONCLUSION,DSBS,HOWEVER,KU70,LABEL,MATERIALS,MEANWHILE,METHODS,NON,RESULTS,XRCC6
231,954,ADP,AIM,ASIA,BACKGROUND,CONCLUSION,DU145,ELISA,LABEL,MATERIALS,MDA,METHODS,OBJECTIVE,PARP1,PIPER,RESULTS,ROS,SOUTHEAST
023,024,027,100,8804,APC,BACKGROUND,CONCLUSION,CPG,GLEASON,GSTP1,HIGH,LABEL,METHODS,PCA,PCR,PSA,PTGS2,RAR,RARBETA,RESULTS,SCORE,TIG1
BACKGROUND,CONCLUSION,EXPRESSION,HPRT1,LABEL,MATERIALS,METHODS,PCR,REAL,RESULTS,TATA,TEN,TPB
150,169,2013,AACR,IHC,LABEL,LOSS,METHODS,OBJECTIVE,PTEN,PURPOSE,RB1,RESULTS,SMALL,THUS,TP53
0133,051,054X,066X,094,171,174,208,2144,469,8482,973,977,ARCHITECT,BACKGROUND,CVS,FREND,INC,KOREA,LABEL,LINEARITY,LOD,METHODS,NANOENTEK,PLUS,PSA,RESULTS,SEOUL,TOTAL
001,012,169,2013,3931,6238,892,900,ACUTE,BACKGROUND,LABEL,METHODS,PCA,REDUCTION,RESULTS,SOCIETY
176,1820,1825,2008,2010,319,330,AFTER,CD41,CD44,CO2,LEF1,MF12,MOL,PC3,RES,ZHANG
109,2008,2012,301,8201,BPH,CALIFORNIA,DIEGO,LEVEL,LOS,OPEN,OSP,RASP,ROBOTIC,SAN,THESE,UCSD,UNIVERSITY
001,097,168,289,584,591,725,762,873,890,914,AES,AFTER,CONCLUSION,LABEL,MEN,METHODS,OBJECTIVE,OVERALL,PFS,PURPOSE,RESULTS
001,8804,945,CONCLUSION,DHT,LABEL,METHODS,OBJECTIVE,PCA,PURPOSE,RESULTS,TMPRSS2,ZBD,ZBDK
2000,2010,792,ASSESSMENT,BACKGROUND,CROSS,LABEL,MEDICAL,METHODS,PANEL,PLANS,PREVENTIVE,PRIOR,RESULTS
GLEASON,TRUS
946,BRCA1,CHK1,CIP1,E2F1,H2AX,INDUCTION,INK4A,KIP1,KU70,LABEL,LOW,METHODS,OBJECTIVE,PCA,PURPOSE,RESULTS,RICCARDIN
000,169,2004,2007,2012,2014,300,AMICO,BONE,COPYRIGHT,COSTS,END,GLEASON,HOWEVER,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,OVERALL,PSA,PURPOSE,RESULTS,SEER,THERE
11C,169,2011,2013,223,75MG,ADT,COPYRIGHT,CRPC,EAU,ENDORECTAL,LABEL,LHRH,METHODS,OBJECTIVE,PATIENT,PCA,PET,PSA,PUBLISHED,RELAPSE,RESULTS,SRP,SRT,SUMMARY,SYNTHESIS,THERAPY,THESE,TREATMENT,UROLOGY,ZOLEDRONIC
120,169,2013,CONCLUSION,DOD,DRE,ENGLISH,LABEL,MEDLINE,METHODS,OBJECTIVE,PSA,RESULTS,SUSPECT,THERE
001,002,020,025,038,042,100,169,1995,2007,2013,419,544,963,ART,BRE,CONCLUSION,EARLY,END,HOWEVER,INC,INITIATING,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PCSM,PUBLISHED,RESULTS,UTILIZING
169,2014,GENOMIC,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,WHILE
1019,169,1993,2013,20TH,CONSENSUS,DESPITE,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PSMA,PUBLISHED,RESULTS,SEVERAL,SINCE,SIXTY
2010,2011,215,320,BACKGROUND,DESPITE,JUNE,LABEL,METHODS,PSA,QUESTIONS,RESULTS,RISKS,SIXTY,THESE
002,294,8201,CCP,FIFTEEN,LABEL,METHODS,OBJECTIVE,PHYSICIANS,REAL,RESULTS,T3B,UROLOGISTS
LAPC,PSCA
100,160,180,2003,2007,233,BACKGROUND,CONCLUSION,GLEASON,IMRT,INTENSITY,JUNE,LABEL,METHODS,PSA,RESULTS,SEVENTY,SIB,TREATMENT
2003,2007,233,BACKROUND,CONCLUSION,FORTY,GRADE,IMRT,INTENSITY,JUNE,LABEL,LATE,LENT,METHODS,PRESCRIBED,RESULTS,RTOG,UNASSIGNED
117,DICE,DSC,INTER,LABEL,METHODS,NEXT,OBJECTIVE,PURPOSE,RESULTS,SLICE
BASED,HENCE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIMILARLY,TREATMENT,TYPICALLY
176,946,CARLO,COMPARING,FINALLY,HOWEVER,LABEL,METHODS,MONTE,OBJECTIVE,PCC,PEARSON,PET,PURPOSE,REGARDING,RESULTS,ROTATIONAL,SETUP,THUS
1386,8482,8725,ART,DDT,DOSE,GPS,IMRT,LABEL,LOW,METHODS,OBJECTIVE,PERFORMING,PURPOSE,RESULTS
100,2500,AFTER,BECAUSE,CENTROIDAL,CVT,D90,EIGHT,FINALLY,GROUP,HDR,HOWEVER,IPSA,LABEL,METHODS,OBJECTIVE,PLANS,PURPOSE,RADIATION,RESULTS,THERAPY,TREATMENT,ULTIMATELY,V100,VORONOI
001,947,BEV,DMLC,DOSE,LABEL,METHODS,MLC,OBJECTIVE,PEARSON,PURPOSE,RESULTS,TIME,VMAT
177,CTS,CTV,D99,DAILY,DSC,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEVEN,THESE
001,100,DECREASED,DMLC,HDMLC,IMAT,INTENSITY,LABEL,METHODS,MILLENNIUM,MLC,OBJECTIVE,PURPOSE,RESULTS
BEAM,FACTORS,HOWEVER,LABEL,LEM,LOCAL,METHODS,MODEL,OBJECTIVE,PURPOSE,RBE,RESULTS,SPECIAL,THUS
DVH,FIVE,HOWEVER,LABEL,METHODS,MLC,OBJECTIVE,PTV,PURPOSE,RESULTS,THERE,TOLERANCES,VMAT
100,2CC,CBCT,DVH,HOWEVER,LABEL,METHODS,OAR,OBJECTIVE,OPTIONS,PATIENT,PURPOSE,RESULTS,RTOG,SELECTING,SIMULATED,V50,V70GY,V76GY
200,255,BEAM,CARLO,EACH,FAN,LABEL,MCNPX,METHODS,MEV,MONTE,OBJECTIVE,OVERALL,PURPOSE,RESULTS,SEVERAL,TREATMENT
8201,CARLO,CONCLUSION,DOSE,IMRT,KNOWLEDGE,LABEL,LOWER,METHODS,MONTE,MRI,MUS,OARS,OBJECTIVE,PTV,PTV78,PTV86,RESULTS,SIB,V30,V50,V60,V80,VMAT
169,2013,BACKGROUND,CELLS,DISCUSSION,HOWEVER,INC,LABEL,METHODS,NANOG,NANOGP8,RESULTS,THEREFORE,WILEY
169,2002,2005,2013,380,546,8805,942,AMONG,CONCLUSION,DATA,DIGOXIN,GIVEN,INC,KING,LABEL,METHODS,OBJECTIVE,PCA,PSA,PURPOSE,RESULTS,THESE,WASHINGTON,WILEY
ACHIEVING,DU145,HDV,MTT,PACE4,SOFA,XTT
160,293,C30,CONCLUSION,DATA,EORTC,GERMANY,HOWEVER,LABEL,METHODS,OBJECTIVE,PROCASP,PURPOSE,QLQ,QOL,RESULTS,SEXUALITY
26S,946,948,CKI,CURRENTLY,METASTASIS,MTSS1,NOTABLY,S322A,SCF,THEREFORE,TRCP,TRCP1
001,028,049,150,2008,2012,509,8201,COLLEGE,CONCLUSION,GLTEQ,GODIN,HRQOL,IIEF,INDEX,IPSS,JUNE,LABEL,LEISURE,MEN,METHODS,OBJECTIVE,PATIENT,PRIOR,PURPOSE,QUALITY,RADICAL,RESULTS,SCALE,SCORE,SURVIVORS,SYMPTOM,TIME,UTILITY
8Q21,900,D52,PCR,STRONGEST,THESE,TPD52
ADAM,HER2,USING
BURGEONING,HOWEVER,HSPC111,MYC,PC3,RHO,RHOA,ROCK,ROCK1,THEREFORE
0002,177,BACKGROUND,BIMS,COLOGNE,CONCLUSION,EXTENSIBLE,FINALLY,FIRST,HOWEVER,LABEL,MATERIALS,METHODS,RESULTS,TEN,THEREFORE,XML
200B,BMI,CD44,MOLONEY,OCT4,P16,PCA,RNAS,THESE
044,160,176,2008,2013,346,8201,ADVERSE,BETWEEN,CONCLUSION,CTCAE,GRADE,HDR,IHT,LABEL,MARCH,MEIER,METHODS,OBJECTIVE,PHOENIX,PSA,PURPOSE,RESULTS,SEPTEMBER
A125,AFTER,ASA,BACKGROUND,BELGIUM,CONCLUSION,CONTENT,DCR,DIGITAL,DOUGLAS,LABEL,MAIN,METHODS,OBJECTIVE,OUTCOME,RESULTS,SETTING,THERE,TRANSANAL,VIDEO
945,AFTER,EMT,FACS,HIF,PCA,STEM,STRATEGIES,THESE
0001,1119,215,299,391,580,676,778,AFTER,ALPHA,ATBC,BETA,CIS,COLORECTAL,FINNISH,LINE1,LUNG,ORS,OVARIAN,PLCO,PREVENTION,SCREENING,THESE,TOCOPHEROL,TRIAL
169,2014,2015,CA125,COLORECTAL,COPYRIGHT,DATA,INC,KINGDOM,LUNG,OVARIAN,PLCO,PUBLISHED,RISK,ROC,SCREENING,TRIAL,UKCTOCS
145,169,2014,8482,CHK1,CHK2,COPYRIGHT,EDUCATION,FURTHER,HORMONE,HOWEVER,INC,JNK,JUN,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SEVERAL,UROLOGICAL
059,160,169,2014,534,COPYRIGHT,EACH,EDUCATION,GLEASON,HOPKINS,HOWEVER,INC,JOHNS,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
BACKGROUND,CONCLUSION,CRPC,LABEL,MEDICAL,METHODS,UROLOGY
169,1995,2000,2004,2005,2008,2013,BACKGROUND,COPYRIGHT,CZECH,HOWEVER,LABEL,LTD,METHODS,RESULTS
169,2013,AEU,ALTERATION,CONCLUSION,CONTEXT,COPYRIGHT,DETERMINE,EVIDENCES,HLA,LABEL,OBJECTIVE,PUBLISHED,SYNTHESIS,THERE,THOSE,UNASSIGNED
100,169,2013,406,8804,BACKGROUND,COPYRIGHT,FMD,IIEF,INDEX,LABEL,PROS,PUBLISHED,SECONDARY,THERE,TRIAL,UNLABELLED,UROLOGY,VO2PEAK
169,2013,COPYRIGHT,IRELAND,LTD
002,005,169,1999,2012,2014,AMICO,CONCLUSION,COPYRIGHT,GLEASON,INC,LABEL,MEN,METHODS,OBJECTIVE,PSA,PUBLISHED,RESULTS,SIXTY
160,169,2014,267,BECKMAN,BPH,CHPI,COMPARING,CONCLUSION,COPYRIGHT,COULTER,INC,INDEX,LABEL,METHODS,OBJECTIVE,PCA,PHI,PSA,RESULTS
013,015,1761,2727,CONCLUSION,CRYO,INC,LABEL,METHODS,NADT,OBJECTIVE,PHOENIX,PUBLISHED,RESULTS,THESE
0005,169,2014,2500,3600,412,999,CLEVELAND,CONCLUSION,COPYRIGHT,EBRT,FOLLOWING,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,PVP,RESULTS,SIXTY,TURP
169,2013,ACUTE,COPYRIGHT,INC,THESE
169,2012,233,241,243,400,COPYRIGHT,ESPA,PUBLICADO,WILMS
169,2013,BACKGROUND,CONCLUSION,COPYRIGHT,CYP17A1,DHEA,INHIBITION,LABEL,MEDLINE,METHODS,REGARDLESS,RESULTS,SAS,SIMILARLY,STROMAL
169,2004,2013,BACKGROUND,CONCLUSION,COPYRIGHT,CRPC,DOCETAXEL,ERG,GLEASON,LABEL,METHODS,NORTH,PROMISING,PSA,RESULTS,SAS,SEVERAL,THUS,WHILE
169,174,2013,509,BACKGROUND,CONCLUSION,COPYRIGHT,CRPC,CYP17,ENGLISH,FINALLY,HENCE,LABEL,MATERIALS,MEDLINE,METHODS,RESULTS,SAS
169,2013,AMONG,BACKGROUND,CONCLUSION,COPYRIGHT,III,LABEL,MEDLINE,METHODS,PCRC,PSA,RESULTS,SAS
169,2013,BACKGROUND,CONCLUSION,COPYRIGHT,CYP17A1,HOWEVER,LABEL,METHODS,RESULTS,SAS
169,2012,2013,239,ALTERNATE,BACKGROUND,CASTRATION,CONCLUSION,COPYRIGHT,CRPC,DESPITE,ENGLISH,LABEL,MAJOR,MEDLINE,METHODS,RESULTS,SAS,SEPTEMBER,STERO
107,169,1999,2000,2000S,2001,2002,2005,2007,2008,2014,BACKGROUND,CARIPLO,COMMISSION,COMPAGNIA,COPYRIGHT,FOUNDATION,FUNDING,FURTHER,HODGKIN,IRELAND,ITALIAN,LABEL,LTD,MAJOR,METHODS,PAOLO,RESULTS,SAN,UNIFORM,VARIATIONS
169,2014,GIVEN,INC,RADIATION
001,003,024,039,1213,169,2013,344,408,446,498,8201,8805,AMONG,ASIAN,AUTHORS,BJU,BMI,DRE,GLEASON,LABEL,METHODS,OBESE,OBESITY,OBJECTIVE,PSA,RESULTS
140,2001,2008,8201,8805,ACTUARIAL,APRIL,BACKGROUND,CLINICALLY,CONCLUSION,CTCAE,DISTANT,FIVE,HIGH,IMRT,LABEL,LATE,METHODS,NCI,PSA,PTV,RESULTS,SEPTEMBER,STAGE,TOXICITIES
156,169,2013,2042,332,8201,AUSTRALIAN,COLLEGE,CONCLUSION,GAS,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,ROYAL,ZEALAND
163,169,18F,2009,2012,2013,239,363,526,8201,99M,AUTHORS,BJU,FCH,GLEASON,LABEL,MARCH,MAY,MDP,METHODS,MRI,NAF,OBJECTIVE,PET,PSA,RESULTS,SCANS,THEIR,WBS
169,175,179,2013,8805,AUTHORS,BCR,BJU,CLAVIEN,GRADE,III,LABEL,MEIER,METHODS,OBJECTIVE,PFS,POTENCY,PSA,RARP,RESULTS,SALVAGE
169,2003,2011,2013,8805,JOHN,KARNOFSKY,KPS,LABEL,LTD,MATERIALS,METHODS,MOST,NONE,OBJECTIVE,OBJECTIVES,OSLO,PUBLISHED,RESULTS,SONS,UNIVERSITY,WILEY
111,125,159,177,181,ALA,ALF,BBN,EXPRESSION,GBQ,GLN,GLY,GRPR,HIGH,IC50,LESS,LEU,NH2,NOTA,PEG2,PET,PHE,RM26,STA,STABILITY,TRP,TYR,VAL
0001,001,0025,0128,0431,169,2013,251,8201,8804,8805,ACAT1,AMERICA,BACKGROUND,DISCUSSION,ERG,GLEASON,GS7,HOWEVER,INC,LABEL,METHODS,NORTH,PREVIOUSLY,PSA,RESULTS,TAKEN,USING,WHILE,WILEY
043,160,2002,2011,278,CONVERSELY,LABEL,MATERIALS,MAY,METHODS,OBJECTIVE,OCTOBER,RESULTS
2013,8804,BACKGROUND,DUE,JULY,LABEL,METHODS,MOST,PCA,PET,PSA,PSADT,RESULTS
000,013,030,039,103,105,191,197,202A,224,300,332,376,413,441,719,744,776,809,831,832,834,844,849,862,882,893,902,958,959,962,968,ASIAN,CA19,HOWEVER,IGF1,IGFBP,INSULIN
160,649,AFRICAN,G84E,PRAP,PREVALENCE,WHILE
001,160,184,1998,2006,531,ADJUSTMENT,AFTER,ASPIRIN,CONCLUSION,LABEL,METHODS,OBJECTIVE,ORS,POST,PURPOSE,RESULTS,THERE
005,163,264,7SNP,AVERAGE,BRCA1,COLORECTAL,CONSORTIUM,END,GAIL,LUNG,MAMMOGRAM,MRI,NUTRITION,OVARIAN,PREVENTION,QALY,RESULTS,RISK,SCREENING,THESE,TRIAL
169,2013,AMP,AMPK,BACKGROUND,COPYRIGHT,CSCS,EGF,EGFR,EPCAM,EPITHELIAL,HOWEVER,INC,LABEL,LAT1,METHODS,RESULTS
10NM,169,2013,AKT,AKT1,BOTH,COPYRIGHT,GSK3,LTD
000,ITALY
PSCA
169,2013,600,8201,831,ASIA,ENDOSCOPIC,FORCE,JAPAN,LTD,PTY,PUBLISHING,SOCIETY,SURGERY,T4BN0M0,TASK,TOTAL,TPE,WILEY
183,CHD,CVD,ESTIMATES,FFQ,HOWEVER,META,PUFA,SFA
120,147,174,174G,ALSO,BPH,CAP,CROATIA,EASTERN,FURTHER,SNP,SNPS
169,2013,AG490,CHIP,DOWN,ELISA,EXPRESSION,HOWEVER,IL6,INC,LABEL,METHODS,MYC,OBJECTIVE,PCR,PSA,PURPOSE,RESULTS,STAT3,WESTERN,WILEY
056,272,593,8201,CASE,CAUCASIANS,HENCE,INDIANS,OVERALL
100,125,CARLO,DEF,DEFS,DOSE,FE2O3,HOWEVER,MAXIMUM,MCNPX,MONTE,PROSTASEED,WHILE
001,002,2011,2012,8201,BACKGROUND,FIVE,JAMES,LABEL,METHODS,OBJECTIVES,QUESTIONS,RESULTS,ROCHESTER,SCP,SCPS,SURVIVORS,TSS,UNIVERSITY
169,2013,8201,COPYRIGHT,JOHN,LTD,NUMERICAL,REQUIRING,SONS,WILEY
117,125,2001,2010,8201,BLADDER,CONCLUSION,DUE,INDEX,JUNE,LABEL,METHODS,OBJECTIVE,OCTOBER,PURPOSE,RESULTS,SCORE,SYMPTOM,TME,WJD
001,505,795,873,961,965,975,BPH,COMPARING,COMPARISON,ICC,LABEL,METHODS,OBJECTIVE,PSAD,PURPOSE,RESULTS,SVM,THREE
215,946,BOTH,CAT,FGFR1,GLEASON,JOCK1,PRO,TGF,THEREFORE,UBI,USING,WNT
001,169,2013,AACR,EPI,HSP90,PARP,THESE
169,2013,ASIA,AUSTRALIAN,AUTHORS,COLLEGE,HOWEVER,IMAGING,JOURNAL,LTD,MEDICAL,PTY,PUBLISHING,RADIATION,RESPONSES,ROYAL,WILEY,ZEALAND
HOWEVER,METASTATIC,USING
178,8314,BACKGROUND,BIACORE,LABEL,MEIER,METHODS,RESULTS,SEC61,SEC62,TARGETING,TFP,THEREFORE,TREATMENT,USING
115,161,8201,APO10,BACKGROUND,BIOMARKERS,BOTH,EDIM,EXPRESSION,FURTHER,LABEL,METHODS,OSCC,RESULTS,TKTL1,WARBURG
0001,100,160,169,2013,AJCC,APMIS,CD31,DCIS,FURTHER,HER2,HOWEVER,JOHN,LTD,PSMA,PUBLISHED,SONS,WILEY
FINALLY,KLF,MYC,NANOG,OCT,RNAS,SOX
AMONG,ERS,HOWEVER,THUS
231,239,FINALLY,HCC1954,MCF,MDA,OTHER,TREATMENT,USING,ZEBRAFISH
1995,2013,BIOLOGICAL,DUE,FIFTY,LABEL,MATERIALS,METHODS,PCA,RESULTS,SIMILARLY,SUPPORTED,UNLABELLED
BACKGROUND,ELASTIC,LABEL,MICRORNAS,RESULTS,RNAS,USING
BACKGROUND,FUZZY,HOWEVER,LABEL,RESULTS
NAD,NADH
146B,152,19A,19B,26A,30C,AFTER,ANNOTATION,FUNCTIONAL,SET,SIMILARITY,STUDENT,THEN,THEREFORE,THESE
001,1117,169,1990,1998,1999,2000,2011,2013,215,244,658,8128,8201,8804,BACKGROUND,CAPSURE,EBRT,LABEL,MEN,METHODS,RESULTS,SOCIETY,STRATEGIC,T3CN0M0
169,2013,CURRENT,GMBH,KGAA,SPANISH,THEREFORE,THESE,VCH,WILEY
179,2013,2278,424,BACKGROUND,CASE,CIS,HCC,HOWEVER,JULY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,RRS,SCIENCE,THEREFORE,WEB
1144,150,159,192,194,2008,2012,212,2614,2681,284,2900,669,693,8202,8804,8805,AGED,EPE,GLEASON,ISUP,PATHOLOGY,PSA,SEMINAL,SOCIETY,SPECIMENS,THESE,TUMOURS,UROLOGICAL
1996,2000,2003,2010,8202,ADC,ADCS,AIDS,APC,APCS,BASED,CONCLUSION,FALLING,HIV,HODGKIN,LABEL,MATCH,METHODS,NADC,NADCS,NHL,OBJECTIVE,POISSON,POPULATION,RESULTS,SIRS
2012,8203,AFFYMETRIX,HERV,HERVS,LTRS,PCA3,PSA,RNAS,THUS
118,177,180,2011,2012,ACCORDING,BETWEEN,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,THERE,VAS
000,002,169,177,2013,264,2818,ADT,AMONG,BACKGROUND,BED,CONCLUSION,COPYRIGHT,CSS,EARLY,EBRT,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PCSM,PSA,PURPOSE,RESULTS
169,2013,215,699,741,756,946,COPYRIGHT,DSC,FTIR,LTD,NMR,PXRD,ROESY,TEL,THESE
169,2013,AIM,BRITAIN,COLORECTAL,CONCLUSION,DISEASE,GREAT,GROUP,IRELAND,LABEL,METHODS,MOST,OBJECTIVE,RADIATION,RESULTS,SEVEN,SIX,SPE,SPES,THERAPY,TREATMENT
001,042,2001,2009,3071,BETWEEN,CONCLUSION,GPS,LABEL,MAIN,METHODS,OBJECTIVE,OUTCOME,PRIMARY,RESULTS,SETTING
169,2013,AUTHORS,BJU,MRI,PCA,TRUS
001,101,169,2013,221,873,964,AUTHORS,BJU,COX,GROUP,III,KENDALL,LABEL,METHODS,OBJECTIVE,PCWG,REMOVAL,RESULTS,SUB,WORKING
OVERALL,SEVERAL,THESE
014,143,410,461,590,CLINICIANS,CONCLUSION,ERG,G300104,GLEASON,GTX,HGPIN,HIGH,III,LABEL,METHODS,OBJECTIVE,PCA,PSA,PURPOSE,RESULTS
110,956,DU145,ROS,STUDIES
FLNA,LNCAP,THEREFORE
012,2010,2012,AUC,BETWEEN,CONCLUSION,DWI,IMAGING,JUNE,LABEL,LNS,MAY,METHODS,NEITHER,OBJECTIVE,OVERALL,PATIENT,PCA,PET,PURPOSE,RESULTS
946,AR3,AR3TG,CK5,CK8,IGF1,TGF
CUDI
8209,CULTURING,LNCAP,SCID,TREATMENT
2013,376,BASEL,DEPICTION,GLEASON,IIA,IIB,III,LABEL,METHODS,OBJECTIVE,OHORI,PCA,RESULTS,SVI,THERE,TYPE,WHEELER
300,8201,956,AFTER,FEW,FURTHER,OPTIMIZED,PCA,TSC,TSCS
177,2001,2007,223,365,8804,AIAN,AIANS,ALASKAN,AMONG,BACKGROUND,BECAUSE,CALIFORNIA,CARE,COMPARING,CONCLUSION,IHSCS,INDIANS,LABEL,METHODS,NATIVES,REGISTRIES,RESULTS,SERVICE,STATE,USING,WASHINGTON
228,239,8805,AMONG,BACKGROUND,BMI,CONCLUSION,GLEASON,HMW,LABEL,LMW,METHODS,RESULTS,TOTAL
0001,0008,0150,1528,155,1989,2011,8201,BACKGROUND,DESPITE,FEWER,GLEASON,LABEL,MEIER,METHODS,PSA,RESULTS,SPECIMENS,THERE,TOTAL
CURRENTLY,EVALUATING,GWAS,HOWEVER,WORLDWIDE
169,2004,2010,2013,8805,BACKGROUND,BASEL,FIVE,GLEASON,LABEL,LRP,METHODS,PERITONEAL,PSA,RESULTS,SIX,THREE
100,169,2013,8804,946,956,BACKGROUND,BASEL,CA2,ERYPTOSIS,FLUO3,HALLMARKS,LABEL,METHODS,RESULTS,SIDE
169,2013,8321,945,947,COPYRIGHT,CRPC,EGF,EGFR,GABA,GEFITINIB,HOWEVER,INCLUSION,IRELAND,LNCAP,LTD,PCA,SIMILARLY,SPATIAL,SRC,THESE,USING
001,100,103,169,2014,CHRONIC,COPYRIGHT,CRPC,FIVE,GRADE,INC,INCLUDING,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SIXTY,SOCIETY,TOTAL
160,169,2014,384,8805,ACTUARIAL,ADVERSE,COPYRIGHT,EVEN,GLEASON,GRADE,HDR,IMRT,INC,LABEL,LOW,MATERIALS,MEIER,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RATES,RESULTS,SOCIETY,THERE
001,169,2003,2011,2013,359,COPYRIGHT,CRPC,JUNE,METASTATIC,PUBLISHED,UROLOGY
0B1,945,946,COUP,ERB,FUNCTIONAL,GCNF,NOR1,NR0B2,NR1D1,NR2C1,NR2C2,NR2E1,NR2E3,NR2F1,NR2F2,NR2F6,NR4A1,NR4A2,NR4A3,NR6A1,NUR77,NURR1,PNR,RESULTS,REV,TFI,TFII,THESE,THUS
4GY,A549,AREG,BMP4,EREG,ERK,GATA3,ID2,IGF2,PC3,PCR,THROUGH
218,AIM,CONCLUSION,III,ITALIAN,LABEL,METHODS,OBJECTIVE,PHASE,RESULTS,THESE
1200,169,2013,600,956,AFTER,CONCLUSION,COPYRIGHT,CROWN,HETE,HOWEVER,INC,LABEL,LNCAP,LOX,MEIER,METHODS,OBJECTIVE,PUBLISHED,RESULTS,TEN,TRAMP,WESTERN
1995,2009,ANOTHER,COA,FURTHER,HMG,RAC,RAS,REGARDING,RHO,STATINS,THUS
PARKINSON
262,AMONG,INCIDENCE,KNOWLEDGE,VIRGINIANS,WEST
AKT,AURKA,DU145,EIF2,HDAC1,HISTONE,HOWEVER,INGENUITY,IPA,KAT2B,KAT5,KAT6B,PATHWAY,PCA,PDEF,PI3K,RNAI,SUBSEQUENT,THEN,THEREFORE
BET,MYC,POLII,SMALL
CCNG2,CDK2,GLEASON,MTT,PCR,PSA,REVERSE,WESTERN
169,2013,945,946,GMBH,HOWEVER,KGAA,LODS,RSD,SARCOSINE,VCH,WILEY
122,143,145,HOWEVER,LUCIFERASE,MRES,TRAIL
028,945,CASTRATION,CRPC,DHT,FOXA1,HIGH,LNCAP,PTEN,WNT
ABCB1,APPARENTLY,ATP,BACKGROUND,CONCLUSION,DRUG,FITC,LABEL,MATERIALS,MDR,METHODS,MTT,PC3,RESULTS,TAP
001,002,BCR,FIFTY,LABEL,MEIER,METHODS,OBJECTIVE,PCA,PCR,PLN,PLNS,PSA,PSMA,RESULTS,UNDER,WITHOUT
2B4,673,811,ALTOGETHER,BMD,CASTRATION,CRPC,LNCAP,MC3T3,OSTEOBLAST,OSTEOGENIC,THERE
001,119,1243,1982,2005,AMONG,BACKGROUND,BMI,BODY,CIS,COX,DATA,ERG,LABEL,METHODS,PHYSICIANS,RESULTS,THESE,TMPRSS2
ASSESSMENT,FIVE,FUNCTIONAL,GENERAL,LABEL,METHODS,MSAS,OBJECTIVE,OVERALL,PURPOSE,QOL,QUALITY,RESULTS,SCALE,SURVEYS,SYMPTOM,THERAPY,WHILE
114,145,185,2000,2010,244,245,438,465,591,709,720,945,CONCLUSION,DESPITE,DVT,FOLLOWING,ICD,LABEL,MEN,METHODS,OBJECTIVE,ORP,PURPOSE,RALP,RESULTS,VTE
169,2013,2014,8482,COPYRIGHT,DISCUSSION,IMAGING,INC,LABEL,MAPPING,MEN,METHODS,MRI,OBJECTIVE,PHS,PICTURE,RESONANCE,THOSE,TPM
120H,169,2013,24H,AMONG,ARSENIC,COPYRIGHT,FURTHER,H2A,HOWEVER,THESE,USING
169,184,2013,390,COPYRIGHT,CYBERKNIFE,GMBH,HOWEVER,LABEL,LATE,MATERIALS,METHODS,OBJECTIVE,OFTEN,PTV,PUBLISHED,PURPOSE,RESULTS,TPS
169,2000,2011,2013,393,4918,7697,9778,AUSTRALIA,BACKGROUND,CLASSIC,COPYRIGHT,CRUDE,GLEASON,JANUARY,LABEL,LOWER,METHODS,OBJECTIVE,OCTOBER,OPEN,OUTCOME,PATIENT,PCA,PSM,PSMS,PUBLISHED,RESULTS,SETTING,SUMMARY,UNASSIGNED,UROLOGY
001,129,169,2004,2010,2013,245,7811,8185,8805,AJCC,BACKGROUND,COMMITTEE,COPYRIGHT,CSM,DEFINITIVE,DSS,END,FACTORS,FEW,JOINT,LABEL,LOCAL,M1A,MEIER,MEN,METHODS,NSR,OBJECTIVE,OUTCOME,PATIENT,PCA,PUBLISHED,RESULTS,SEER,SETTING,SIMILAR,SUMMARY,THEREFORE,THESE,UNDERGOING,UROLOGY
169,2013,231,ATP,COPYRIGHT,FURTHER,HOWEVER,III,LTD,MDA,PC3
169,2013,531,6MONTHS,ALSO,CFA,CONCLUSION,DIF,GIVEN,ILLNESS,IPQ,ITEM,LABEL,METHODS,OBJECTIVE,PERCEPTION,RASCH,RESULTS
100,169,2013,AFTER,BACKGROUND,COPYRIGHT,FERRP,FIFTY,ICG,LABEL,LYMPHATIC,METHODS,OBJECTIVE,OUTCOME,PARAMETERS,PILOT,PRIOR,PROCEDURE,PUBLISHED,RESULTS,RETZIUS,SETTING,TEN
169,2004,2010,2012,2013,COPYRIGHT,CRPC,DATA,DRUG,EAST,FIVE,FOOD,IRELAND,LTD
0001,104,194,645,DRE,GLEASON,HEALTHY,HOWEVER,PCA,PSA,QOL,THERE,THESE,TURKISH
174,384,AIM,CCNH,CSB,LABEL,MASSARRAY,METHODS,NER,OBJECTIVE,RESULTS,XPA,XPC,XPD,XPG
ADRB2,CDH1,EZH2,PCA,TRIPTOLIDE
169,2013,206,215,CDK2,CDK4,EXPRESSION,JOHN,LTD,MIR,PUBLISHED,SONS,THESE,UTR,WESTERN,WILEY
ADDITIONAL,AREAS,BACKGROUND,BMD,COVERED,DENOSUMAB,LABEL,METHODS,OPINION
001,002,160,181,608,726,8201,ARMBAND,BACKGROUND,FORM,ICIQ,LABEL,METHODS,NOR,PRIMARY,PRO3,RESULTS,SENSEWEAR,SHORT,THERE,URINARY
141,5TH,BOTH,ELISA,KLKS,PCR,PSA,THESE
001,002,034,0381,150,GLEASON,HPV,MEIER,PCA
FUNCTIONAL,HMG,SOX,SOX7,SRY,THUS
AKT,GIVEN,PI3K
145,181,HECK,IC50,MCF,THREE
378,468,680,908,AIMS,ASHAMAS,BENIN,CITY,CONCLUSION,DIAGNOSTIC,FOUNDATION,HIGH,HOWEVER,LABEL,MATERIALS,METHODS,NIGERIA,NODULAR,NPH,OBJECTIVE,OBJECTIVES,PROSTATIC,RESULTS,SIX,SOUTH
2014,ABDOMINAL,AFTER,BASEL,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,VAS
128,282,295,319,329,398,8201,954,AC1,AGREEMENT,FINALLY,GPS,GWET,IQR,KAPPA,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,RTTS
108,1511,1552,169,182,200,2006,2012,2013,300,3000,600,609,686,700,800,861ST,866,866TH,AUSTRALIAN,BACKGROUND,COMPOSITE,COPYRIGHT,EARLY,INDEX,LABEL,METHODS,OBJECTIVE,ORP,ORPS,OUTCOME,PSM,PUBLISHED,QOL,RARP,RARPS,RESULTS,SETTING,UROLOGY
169,2013,946,COPYRIGHT,DIANA,LTD,MAPK,PRODUCTION,TARGETSCAN,TGF,THEREFORE,THESE,WNT
110,116,120,169,177,1994,2013,2014,4N0,COPYRIGHT,EDUCATION,INC,IQR,LABEL,MATERIALS,MEAN,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
169,2005,2012,2014,214,AAM,AFRICAN,BETWEEN,CONCLUSION,COPYRIGHT,DISEASE,FAILURE,GLEASON,INC,LABEL,METHODS,OBJECTIVE,RESULTS
120,160,177,224,596,8201,BACKGROUND,ECGS,IPSS,LABEL,METHODS,PVP,QMAX,RESULTS,RUV,SCORING,SYMPTOM,THERE
125,168,1ST,ANOTHER,CSF,LABEL,METHODS,MRI,NEITHER,NONE,OBJECTIVE,RESULTS,SDH,SDHS,THEIR
ACCORDING,BAX,BCL,HEPG2,HOECHST,HOWEVER,PLANT
2013,MEDLINE,MOLECULAR,PCA,THERE
004,021,023,052,169,2013,AIMS,DATA,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,PVS,RESULTS,SELF,SMALL,WILEY
8209,945,954,AKT,BCL,CONSISTENT,COX,DAPI,DIAMIDINO,DU145,FLOW,HOWEVER,MTT,RURTHER,TUNEL,WESTERN,XIAP
177,181,730,8209,AKT,CELLS,CHINESE,DU145,ERK,ERK1,JNK,JUN,MAPK,PC3,PI3K,THUS
169,2013,8201,BACKGROUND,CRITICALLY,FURTHER,HOPKINS,HOWEVER,HPC,INC,JOHNS,LABEL,MEN,METHODS,PCR,RESULTS,TELOMERES,WILEY
BELOW,DIAGNOSIS,PNE,RADIATION
CNF1,CNFY,GTPASES,LNCAP,RHO,RHOA,ROCK
143,145,DU145,GOLGI,GOLM1,LOSS,PC3,PCA,SILENCING
CELLS,CTC,CTCS,DIFFERENT
169,2013,ALA,BACKGROUND,CONCLUSION,COPYRIGHT,INHIBITION,LABEL,METHODS,NOC,PDT,PPIX,RESULTS
169,2013,AACR,MET,TREATMENT
043,1996,2009,AMONG,BACKGROUND,CONCLUSION,ENGLAND,EPISODE,FIVE,LABEL,METHODS,RESULTS,STATISTICS,THERE,USING
BIOACTIVE,BMP,BOTH,CDX2,EPIGENETIC,THREE,TREGS
1230,1471,1481,1482,1507,177,2005,954,BACKGROUND,CONTEXT,GLEASON,ISUP,LABEL,METHODS,OBJECTIVE,PATHOLOGY,REDUCTION,RESULTS,SOCIETY,UROLOGICAL
ANTIBODIES
169,2013,AUTHORS,BRAF,CELL,CRAF,JOHN,L505H,LTD,MAPK,PIGMENT,PLX4032,PLX8394,PUBLISHED,SONS,V600K,WILEY
169,176,2013,377,8201,AUSTRALIAN,BACKGROUND,COLLEGE,LABEL,METHODS,MOST,RESULTS,ROYAL,THERE,ZEALAND
053,1966,2007,2013,205,523,BACKGROUND,CENTRAL,CIS,FIXED,FURTHER,HOWEVER,INSULIN,JANUARY,LABEL,LIBRARY,METHODS,PCA,RESULTS,THERE,THUS
CTB,GLUCOSE,GRP78,PAR
AKT,LENTIVIRAL,MYC,THESE
946,BMP,EMT,ENDOGENOUS,GOOSECOID,PTEN,SMAD4,SNAIL,TGF,TWIST,WNT
2013,BASEL,PCA,PNSS
945,EARLY,NEXT,OTHER
130,188,1998,2007,2013,8805,AGE,BACKGROUND,BASEL,ECE,GLEASON,JANUARY,LABEL,MATERIALS,METHODS,PATHOLOGIC,PSA,PSAD,RESULTS,ROC
160,FINALLY,HELA,HUVEC,LIVE,PVA
ENDOCRINE,THEREFORE
CAM,DECREASED,GLEASON,IGF,PCA,PROTEIN,SOCS2,SUPPRESSOR
160,2002,2008,8201,8804,BETWEEN,DOSE,EVALUATION,FOUR,GLEASON,LABEL,MATERIALS,METHODS,OBJECTIVE,PSA,PSRM,PURPOSE,RESULTS,SRT,WHILE
DU145,HCA,HIGH,HTS,JAVA,PC3,PCA,SCREENING,THREE,THROUGHPUT,TOWARDS,UTILISING
146A,149,196A2,27A,499,CRUDE,FINALLY,FURTHER,HOWEVER,MICRORNAS,SCCHN,SNPS
0006,0011,0023,0031,125,169,2013,8805,AACR,CCL16,CD11B,CD14,CD33,CD68,CHEMR23,CKLF,CMKLR,CMTM3,GLEASON,III,ILK,LABEL,LEC,LIGHT,METHODS,OBJECTIVE,PCR,PURPOSE,RESULTS,THESE,TNFSF14
169,17G,2013,945,946,AACR,FURTHER,LABEL,METHODS,OBJECTIVE,PURPOSE,REMARKABLY,RESULTS,SIMILARLY,SRD5A,V89L
2004,2010,223,HOWEVER,SELECTION
223,CRPC,UNION,UNTIL,USA

464,945,946,BESIDES,C17,CRPC,CYP,CYP11B1,CYP17,HOWEVER,UNDER
2013,BACKGROUND,EIGHT,GLEASON,JULY,LABEL,MATERIALS,MEDLINE,METHODS,PCA,RESULTS,STUDIES,TNM
160,169,2008,2012,2014,CLINICALLY,CONCLUSION,COPYRIGHT,EACH,INC,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS,THESE
169,1996,1997,2010,2013,212,384,400,480,7915,8805,CONCLUSION,COPYRIGHT,DENMARK,FIVE,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,ODDS,ORA,ORS,OVERALL,PCA,PURPOSE,RESULTS,RISK,THEREFORE
169,1990,2009,2013,619,638,AGE,AIM,ASR,ASRS,AUSSIEDLER,COPYRIGHT,DATA,DISCUSSION,GERMANY,HOWEVER,LABEL,LTD,LUNG,METHODS,OBJECTIVE,RESULTS,SIR,SIRS,STOMACH,UNION
169,2013,COPYRIGHT,LOCAL,MOST,SAS
169,177,2006,2011,2013,APRIL,BACKGROUND,COPYRIGHT,DISCUSSION,FIFTY,FINALLY,JUNE,LABEL,LITERATURE,METHODS,MRI,NPV,PPV,PSA,PUBLISHED,RESULTS,SAS
169,2013,456,BACKGROUND,CONCLUSION,COPYRIGHT,FIFTY,LABEL,METHODS,OISE,PSA,RESULTS,SAS
001,2014,946,APA,AUSTRALIAN,HOWEVER,LABEL,MEN,METHODS,OBJECTIVE,PSA,RESULTS,STAGE,UNAFFECTED
006,047,055,101,169,2013,234,244,345,8201,8804,ASSESSMENT,AUTHORS,BJU,CALIFORNIA,CAPRA,CONCLUSION,COX,EBRT,FRANCISCO,GLEASON,LABEL,LDR,METHODS,OBJECTIVE,PHOENIX,PSA,RESULTS,RISK,SAN,THERE,UNIVERSITY
ADDITIONAL,AREAS,BACKGROUND,COVERED,CRPC,FDA,LABEL,METHODS,OPINION,PHYSICIANS
INCREASED,MYC,PIM1,SEVERAL,THUS
183,PC3,PT1
169,2013,INC,POSITIVITY,PSA,PSMA,THEREFORE,WILEY
169,2013,AT6,BACKGROUND,CONCLUSION,EAF2,ELL,INC,LABEL,LNCAP,METHODS,PC3,PIRIN,RESULTS,THROUGH,U19,WILEY
001,107,8201,AXON,PCA,PCAS,ROBO1,ROBO2,SEVERAL,TSG
22RV1,8201,954,ARRAY,BPH,DU145,LIMITED,LNCAP,METHODS,OBESITY,PCR,PREC,QPCR,SIMILAR,WESTERN,ZFP91
CC50,CTZ,KTZ,RUTHENIUM
0001,189,279,8804,8805,ALP,BACKGROUND,CONCLUSION,CRP,CRPC,DTX,LABEL,METHODS,PROGNOSTIC,PSA,RESULTS
BECAUSE,THESE
18Q21,946,GLEASON,HOWEVER,MEIER,PSA,SMAD,SMAD4
174,945,C17,CRPC,CYP,CYP17,GIVEN,III,P450,UNION
ATP,BOTH,CHANGES,P2X1,PURINERGIC,THERE
160,ADC,HOUNSFIELD,HOWEVER,INCREASING,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,OVERALL,RESULTS,SIXTEEN
001,002,006,030,036,ADT,FAILURE,GLEASON,LABEL,METHODS,OBJECTIVE,PRE,PSA,PSAV,PURPOSE,RESULTS,RISK,SRT
0083,039,148,8482,8804,AFTER,AMICO,LABEL,METHODS,OBJECTIVE,OVERALL,PCA,PURPOSE,RESULTS,TVHS,TVP
001,033,132,171,174,177,251,389,472,527,820,AMICO,COX,DISEASE,FIFTY,HIFU,LABEL,METHODS,OBJECTIVE,PHOENIX,PSA,PURPOSE,RESULTS,SONABLATE,STUTTGART
001,007,015,303,BACKGROUND,FOUR,KLK2,KLK3,KRUSKAL,LABEL,LEUKOCYTE,LOW,METHODS,NINE,PSA,RESULTS,SNP,SNPS,THREE
059,079,1730,215,265,786,810,DCE,DWI,LABEL,METHODS,OBJECTIVE,PCA,PURPOSE,RESULTS,THERE
BLINDED,LABEL,METHODS,MRI,NINE,OBJECTIVE,RESULTS
169,2013,COPYRIGHT,FURTHER,NDRG1
169,2013,APS,CYS,CYS32,CYS35,CYS62,CYS69,FURTHER,GLEASON,INC,KNOWLEDGE,LYSATES,MNSOD,PCA,PRX3,PRXS,REDOX,RESULTS,SO3,THESE,TRX1,WESTERN
001,169,2013,734,AIM,BACKGROUND,COPYRIGHT,LABEL,METHODS,NPV,PCA,PCA3,RESULTS,UROLOGISTS
100,10MIN,169,16TH,176,2013,2D3,3A4,8764,945,956,COPYRIGHT,CYP17A1,D3IN,FORMATION,IC50,ISSUE,LTD,NADPH,P450,PUBLISHED,SIMILAR,SPECIAL,VITAMIN
169,2013,COPYRIGHT,SAFFRON,TAKEN,TH1,TH2
0001,001,002,169,2014,2536,502,582,AFTER,BMD,BMI,CONCLUSION,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS
046,104,160,169,2014,210,8804,972,CONCLUSION,COPYRIGHT,GLEASON,INC,LABEL,METHODS,OBJECTIVE,PCA,RESULTS
160,169,177,192,2009,2013,2014,3800,4500,5040,8805,950,ADVERSE,BETWEEN,COPYRIGHT,FIVE,GRADE,HDR,IMRT,INC,LABEL,MATERIALS,MAY,METHODS,MRI,OBJECTIVE,OCTOBER,PUBLISHED,PURPOSE,RESULTS,THERE,TOXICITIES
160,169,2013,231,233,COPYRIGHT,HOWEVER,PUBLISHED,SAS,SFRO,SOCI,THESE
169,2013,AFTER,BMI,COPYRIGHT,DT2,METS,SAS,SHBG
169,2013,BRCA2,COPYRIGHT,FEDERATION,GEMMS,KNUDSON,PUBLISHED,SOCIETIES,THESE,THUS,TP53
0CC,160,169,2014,COPYRIGHT,D90,DELIVERED,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PTV,PUBLISHED,PURPOSE,RESULTS,SOCIETY,V150
233,342,AFRICAN,AFTER,BACKGROUND,BMI,CAUCASIAN,FIFTEEN,GLEASON,LABEL,METHODS,NOVEL,REGRESSION,RESULTS,SNP,SNPS,THESE,UGT2B,UGT2B15,UGT2B17
169,2013,AIM,BACKGROUND,DAYTIME,LABEL,MAIN,MEANWHILE,MEASURE,MEDLINE,METHODS,NERVE,OAI,OAP,OBJECTIVE,OUTCOME,RESULTS,SOCIETY,SPARING,THESE,TURP,UISS,WEB
181A,3CELL,APOPTOSIS,BACKGROUND,BCL,BUFALIN,CASPASE,CHINA,HOWEVER,LABEL,METHODS,PCR,RESULTS,THUS,WESTERN
169,2013,COPYRIGHT,INC,MICRORNAS,MODULATING,RNAS,THESE,VARIATIONS
005,131,140,2009,2011,405,AGE,CONCLUSION,JULY,LABEL,MATERIALS,MEAN,METHODS,OBJECTIVE,PAIN,RESULTS,SCORE,THESE,VAS
CASE,DIFFERENT,HYPOTHESIS,LABEL,MAIN,MALIGNANCY,RESULTS,SIMILAR
2010,AMONG,FURTHER,JANUARY,LABEL,MARCH,MATERIALS,METHODS,OBJECTIVE,PCA,PCR,PGC,PSMA,PURPOSE,RESULTS,TRUS
140,152,153,2000,2010,445,8805,AMONG,CONCLUSION,GLEASON,HRCAP,IRB,JANUARY,LABEL,LRP,MARCH,MATERIALS,METHODS,OBJECTIVE,PSA,PSM,RALP,RESULTS,RRP,T3A
ELISA,EN2,EXTENSIVE
CEC,CECS,CURRENTLY,GIVEN,HOWEVER,PCA,SIMILARLY,WHILE
HOWEVER,NUCLEIC,PSA
ERG,TMPRSS2
COMBINING,IDEALLY,PBX,PCA,PSA
0006,0012,0060,AIM,CONCLUSION,ELISA,LABEL,MANN,MEAN,METHODS,OBJECTIVE,OPN,PCA,PSA,RESULTS,RETRIEVAL,SERUM,TOOL,URINARY,WHITNEY
2012,2013,LABEL,MATERIALS,MCMAHON,METHODS,OBJECTIVE,POISSON,PURPOSE,RESULTS,SCENARIOS,TCP,UNDER
HOWEVER,IPSS,LABEL,LND,METHODS,OBJECTIVE,OBJECTIVES,PANP,RESULTS,SCORE,SYMPTOM,URINARY,URINE
AD4BP,BCAPT10,BPH,CRPC,FINALLY,NOTABLY,NR5A1,SF1,THEREFORE,THESE
169,2013,COPYRIGHT,DWI,INC,MRI,TREATMENT,WILEY
001,015,035,155,169,191,2013,403,770,781,8201,AFTER,ALLELIC,AREAS,AUC,BACKGROUND,IDI,INC,INTEGRATED,LABEL,METHODS,MGRS,NET,NRI,PCA,PREDICTIVE,PSA,RESULTS,ROC,SNPS,THREE,WILEY
AKT,DU145,LABEL,METHODS,OBJECTIVE,PC3,PURPOSE,RESULTS,SAMD4,SMAD4,VPA,WESTERN
169,2013,CASR,FINALLY,GPCR,GPR39,HOWEVER,HSY,INC,MAP,MAPK,PC3,PI3,PI3K,SILENCING,WILEY,ZINC,ZNR
ACTA2,CDH2,DU145,ERBB2,FAS,GLCE,HOWEVER,IFNA1,IFNB1,IGF1,IL6,IL8,ITGA1,ITGB3,LNCAP,MMP1,MMP2,MMP9,PC3,PDGFB,PNT2,TAGLN,TEK,TNF
177,2006,2825,BRAZILIANS,FORA,JUIZ,MINAS,POISSON,PSA
1000,177,400,689,8804,956,9754,ADDITIONAL,AU400,AU640,BACKGROUND,BECKMAN,COULTER,DOCETAXEL,DRUG,DTX,FOOD,INSTITUTE,LABEL,LABORATORY,LINEARITY,METHODS,RESULTS,STANDARDS,TESTING
666,8201,AMONG,CARE,CHA,FOCUS,HEALTHCARE,LABEL,METHODS,MODEL,OBJECTIVE,PURPOSE,RESULTS,SURVIVORS
169,2013,246,ANTIGEN,BSA,COPYRIGHT,CTA,DISRUPTING,HOWEVER,JUN,PAGE4,PCA
1270,AMONG,BACKGROUND,INC,LABEL,METHODS,MORTALITY,PUBLISHED,RACE,REPORTS,RESULTS,STUDIES
160,169,1989,1999,2003,2014,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
160,169,2013,COPYRIGHT,DUE,MEDICAL,PUBLISHED,SAS
169,2013,956,A431,A549,COPYRIGHT,FURTHER,H322,IC50,MIAPACA,NCI,PARP,SAS,SIMILARLY,T47D,T98G,THESE
0104,0523,125,1374,169,172,2012,2013,8805,AMONG,ARTEMIS,BACKGROUND,COPYRIGHT,GLEASON,INCREASING,JUNE,LABEL,MARCH,MCNEMAR,METHODS,MRI,NAV,OBJECTIVE,OUTCOME,PUBLISHED,RESULTS,SETTING,TARGETS,UROLOGY
945,AKT,ATP,BACKGROUND,CD31,CONCLUSION,DISCOVERY,ERK,FAK,HOWEVER,HUVEC,LABEL,LNCAP,METHODS,MOLECULAR,RESULTS,SRC,VEGF,WESTERN
0001,0005,152,412,5Q21,6Q15,8201,BACKGROUND,ERG,GLEASON,LABEL,METHODS,MTC02,PSA,PTEN,RESULTS,TMA
BAFF,IGG4,MASSIVE,SERUM,THESE
CONCLUSION,LABEL,MRI,OBJECTIVE
ANTI,CA125,CEA,CK7,FDG,MRI,PET,PRIMALY,PSA,SERUM
2007,2010,ACUTE,AMICO,CONCLUSION,CTCAE,IMRT,JULY,LABEL,METHODS,NCI,OBJECTIVE,PSA,RESULTS
002,294,ABC,AKT,DCRP,HOWEVER,MDR,MDR1,MRP1,PI3K,PROCESSING,THESE,THUS
DU145,FOXO1,LNCAP,THEREFORE,UTR
028,160,1772,1772C,1790,1790G,4884,7522,8154,945,9847,BACKGROUND,CAUCASIANS,HIF,LABEL,ODDS,PRINCIPAL,RESULTS
AG490,ARTEMISIA,BCL,CHINESE,CONSISTENT,DU145,JAK2,MYC,PCR,SCOPARONE,SH2,SOCS3,SRC,STAT3,TRANSIENT,WESTERN
CRPC,DOC,DOCETAXEL,GIVEN,JNK,KLK,LNB4,LNCAP,PAC,PSA,THERE
129P2,C57BL,EAF2,ELL,FVB,MICE,OLA,PIN,POL,STROMAL,THESE
1973,2013,AFTER,CURRENT,DATA,DRUG,EXTRACTION,FDA,FOOD,HOWEVER,INTRANASAL,JANUARY,LABEL,MEDICINES,MEDLINE,METHODS,MOST,OBJECTIVE,OVID,RESULTS,SCT,SELECTION,SEPTEMBER,SOURCES,SYNTHESIS
169,176,2013,225,245,CONCLUSION,FOLLOWING,IMAGE,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,SNR,T2WI,TESLA,WILEY
00001,003,159,169,2010,2012,2013,211,ANOTHER,BACKGROUND,CONCLUSION,GLEASON,INC,JAPAN,LABEL,METHODS,PSA,RESULTS,THREE,WILEY
100,110,158,169,185,956,AE1,AE3
231,947,CACO,HOWEVER,IIA,ITAM,MCF,MDA,PC3M,PLATELETS,RIIA,SUPPORTING,SYK,TCIPS
001,169,1988,1992,1993,1997,1998,2004,2009,2013,336,8201,8805,BACKGROUND,CALIFORNIA,COX,HOWEVER,LABEL,MEIER,MEN,METHODS,OVERALL,PSA,RESULTS,SOCIETY,THERE,THESE
ASIA,CDK1,CONTINUED,CRPC,EAST,MURRAYA,SER
100,127,131,258,366,422,463,8805,BACKGROUND,CONTINUOUS,CPA,EORTC,LABEL,LHRH,METHODS,PRIMARY,PSA,QLQ,QOL,RESULTS,SYMPTOM,THERE
LABEL,OBJECTIVE,PCA,PURPOSE,RESULTS,ROBOTIC,SUMMARY
4MM,BASED,CBCT,DIR,DMP,DVF,FEM,FOURIER,PATIENT,REGIONS,SINUSOIDAL
ACCORDING,HOWEVER,IMRT,MOST,SEVERAL
169,2013,JOHN,LTD,PUBLISHED,SONS,THESE,WILEY
001,002,003,005,008,019,169,2013,283,290,397,641,763,8197,8201,839,8804,8805,DESPITE,GLEASON,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PERCENT,RESULTS,T3A,T3B,T4N0,UROLOGICAL
001,0021,004,006,008,010,045,100,169,174,2003,2010,2013,219,260,361,604,8201,BETWEEN,GLEASON,GY2,JAPAN,JIKEI,LABEL,LOW,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,TOKYO,UNIVERSITY,UROLOGICAL
CRPC,DES
160,FISCHER,FORTY,HOWEVER,LABEL,MANN,METHODS,OBJECTIVE,PSA,RESULTS,WHITNEY
103,916,CONCLUSION,LABEL,METHODS,OBJECTIVE,PET,PET1,PET2,PSA,PSADT,RESULTS,ROC,TOTAL
000,001,046,100,1046,341,410,4110,4172,438,8805,95TH,BACKGROUND,CAP,CONCLUSION,DRE,FORTY,GLEASON,LABEL,LAGOS,METHODS,NIGERIA,PSA,RESULTS,THOSE,TRBP,TRPB
001,034,039,111,134,136,169,2013,AACR,BIOMARKER,BIOTECH,FORTY,LABEL,LDH,METHODS,OBJECTIVE,PFS,PURPOSE,RESULTS,TIME,TOXICITIES,VEGF
001,026,047,169,2013,8804,956,BPH,GMBH,HOWEVER,KGAA,PCA,PSA,THEREFORE,THESE,THROUGH,VCH,WILEY
1302,131,548J,AIM,CNVS,DOMINANCE,EXPRESSION,GEO,LABEL,MATERIALS,MENDELIAN,METHODS,OBJECTIVE,OMNIBUS,PENNCNV,RESULTS,SNP,WHOLE
177,BACKGROUND,BETWEEN,BOTH,DRE,GROUP,LABEL,LEVATORES,METHODS,OWING,PAIN,PSA,RESULTS,TRUS,VAS,VSA
169,183,AIM,BOTH,CARDIOLOGY,CONCLUSION,GEORG,LABEL,METHODS,OBJECTIVE,RESULTS,SOCIETY,STUTTGART,WHILE,WORK,YORK
001,005,009,012,018,023,040,067,8201,DTCA,SPILLOVER,USING
ACHIEVING,AFRICAN,AMERICA,ASIAN,CURRENT,HOWEVER,IRISH,NORTH,SOCIO,SOUTH,THESE
CAMBRIDGE,THESE,UNIVERSITY
160,2008,2011,229,2X10,APRIL,BACKGROUND,CONCLUSION,CTC,EBRT,LABEL,MARCH,METHODS,RESULTS,SIX,THREE,UNIVERSITY
0001,038,169,2013,8804,CHEMOKINES,COPYRIGHT,CXCL1,FURTHER,GLEASON,GMBH,HOWEVER,INCREASED,STUDIES,UTILIZING
026,100,130,8764,956,AGR2,ELISA,LARGE,LOQ,PRISM,PSA,SRM
223,945,954,FCS,HOOGSTEEN,HOWEVER,IFN,IRF3,PC3,PPRHS,REGARDING,RNAS,THESE,TNF,USAGE
1RA,526,592,BACKGROUND,BCA,CCL17,CCL22,COLORECTAL,CONTROL,COX,CRP,CXCL5,CXCL9,DESPITE,ENA,LABEL,LUMINEX,LUNG,MDC,METHODS,MIG,ORS,OVARIAN,RESULTS,SAA,SCREENING,SERUM,TARC,TGF,TRIAL
488,AMONG,CONCLUSION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,RPP,RRP
121,122,169,2014,8805,AIMS,CONTINENCE,FLOOR,INC,IPSS,KHQ,KING,LABEL,LARP,MATERIALS,METHODS,OBJECTIVE,PFMT,QOL,RESULTS,SCORE,SUI,SYMPTOM,THERE,VALIDATED,WILEY
169,1985,2007,2013,APPROACHES,BACKGROUND,CRPC,DEPENDENT,DISCUSSION,INC,INSTITUTE,LABEL,MEETING,METASTATIC,METHODS,NECK,ORGAN,PATHWAY,PERSISTENT,RESULTS,SYSTEMS,THESE,WILEY
005,029,151,169,2013,824,BACKGROUND,CASTRATION,CONCLUSION,CRPC,HOWEVER,INC,LABEL,METHODS,PCA,RESULTS,SRF,THESE,TURPS,WILEY
ALK,EGFR,ETS,EVALUATION,MAPK1,RET,SRC,WHETHER
001,005,007,014,016,019,023,025,030,049,118,126,167,187,198,203,209,320,361,492,501,566,714,778,779,911,946,BACKGROUND,CORE,ILLNESS,LABEL,LIFE,METHODS,PERCEPTION,QUALITY,RESULTS,SCALE,THEREFORE,TREATMENT
038,177,956,BPE,CONCLUSION,ELISA,HOWEVER,LABEL,METHODS,ONFFN,RESULTS,TCC,UNLABELLED,URINE
2011,8805,CRPC,DES,DISEASE,DURABLE,FORTY,FOUR,HOWEVER,JULY,MEIER,PATIENT,PCWG2,PSA,SIXTY,TDP,THERE
129,2007,2010,239,AIM,CONCLUSION,DIAGNOSTIC,LABEL,METHODS,OBJECTIVE,PRIMARY,PROSTATIC,RESULTS,TUR
169,2013,945,A2780,AIMS,ARES,BACKGROUND,BASEL,CLOFIBRATE,CONCLUSION,DU145,LABEL,METHODS,NRF2,OBJECTIVE,PPAR,PPRES,RESULTS
FINALLY,GPS,HOWEVER,PRIMARY,SEVERAL
110,169,2013,664,956,ASTRO,BCF,CONCLUSION,COPYRIGHT,HOWEVER,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PCD,PHOENIX,PRIMARY,PSA,PURPOSE,RADIOLOGY,RESULTS,SECONDARY,SOCIETY,T1B,T4N0
154,169,2013,755,838,8805,ASSESSMENT,BPI,BRIEF,CASTRATION,COPYRIGHT,CRPC,FACT,FUNCTIONAL,INVENTORY,LY2181308,PAIN,PFS,PSA,PUBLISHED,SECONDARY,THERAPY,UROLOGY
1331,169,1999,2004,2014,CONCLUSION,COPYRIGHT,FINLAND,INC,INCIDENCE,LABEL,LUTS,MEN,METHODS,OBJECTIVE,OVERALL,PIRKANMAA,PROSTATIC,REMISSION,RESULTS,SCORE,SYMPTOM
160,169,2014,291,8805,AMONG,BPH,CONCLUSION,COPYRIGHT,FOUR,INC,IPSS,LABEL,LUTS,MATERIALS,METHODS,OBJECTIVE,OVERALL,RESULTS,SCORE,SYMPTOM
169,2013,ADT,GROUP,MPS,PCA,SEVEN,TEG,THESE,WHILE,WHOLE
169,186,2007,201,2011,2013,GLEASON,ORS,PFAAS,PFDA,PFHXS,PFNA,PFOA,PFOS,PSA
005,012,034,160,169,200,2013,447,8805,945,AFTER,AIMS,BPH,COX,HOWEVER,IPSS,JOHN,LABEL,LTD,LUTS,MATERIALS,METHODS,OBJECTIVE,PSA,PVR,QMAX,RESULTS,SCORE,SONS,SYMPTOM,TREATMENT,WILEY
2014,ADT,APA,DATA,DEPRESSION,DESPITE,DUE,INCLUSION,LABEL,LIBRARY,MEDLINE,METHODS,OBJECTIVE,OVID,PCA,QOL,RESULTS,REVIEWS,SYSTEMATIC

2600,8300,HILIC,HOWEVER,METAL,MOAC,PC3,THESE,TIO2,TRIS
002,003,004,008,015,021,038,046,562,8805,AJCC,BACKGROUND,CONCLUSION,COX,CTEN,LABEL,MEIER,METHODS,RESULTS,USING
424,503,SRC,THESE
AKT,GRP78,HOWEVER,KDEL,PI3K,PIP3,THUS
145,176,956,AMONG,CIP,HOWEVER,HSP,HSP70,HSPS,KNOCKDOWN,LNCAP,MYC,PFT,QUERCETIN,THESE,WAF1
FINANCIAL,IRELAND,OSWS,THESE
239,8202,BACKGROUND,CRPC,CYP11A1,CYP17A1,HSD17B6,INDUCED,INTRA,LABEL,NON,PCR,PRINCIPAL,RESULTS,SUB,TRANSCRIPT,UNTREATED
100,123,154,163,169,2012,2013,351,437,BASED,CONCLUSION,COU,FURTHER,LABEL,METHODS,OBJECTIVE,RESULTS,USD
169,2013,BOARD,BOTH,CONCLUSION,COPYRIGHT,DUAL,DWI,INC,LABEL,LESIONS,MATERIALS,MEAN,METHODS,MRI,MRIS,OBJECTIVE,PPVS,PURPOSE,RESULTS,T2W,TESLA,WHILE,WILEY
169,2013,BACKGROUND,COPYRIGHT,GETTING,GROWING,JOHN,LABEL,LTD,MEN,METHODS,RATIONALES,RESULTS,SLOWING,SONS,WILEY
005,19S,946,HOWEVER,KRT18,NKX3,SIMILARLY,TBLR1,TRANSDUCIN
169,2014,8201,956,BCL,GMBH,KGAA,PC3,TEN,VCH,WILEY
169,2013,949,968,ANN,AUC,AUTOMATIC,BOARD,CONCLUSION,HIPAA,INC,LABEL,MATERIALS,METHODS,MRI,MRSI,OBJECTIVE,PURPOSE,RESULTS,ROC,THESE,WILEY
002,025,033,035,8201,ADT,CA9,EGFR,HRPC,PDGFR,PS6K,VEGF
2013,AFRICAN,CONDUCTING,LAGOS,NIGERIA,PRE,STATE,UNIVERSITY
CPMV,PEG,USING,VIRAL,VNPS
169,2013,663,CASTRATION,CRPC,GLEASON,INC,LNCAP,TNM,WILEY
169,2013,945,946,ADT,BACKGROUND,CRPC,CYP3A,CYP3A43,DATA,DHEA,HSD17B2,INC,INHIBITION,LABEL,LAPC,LNCAP,MASS,METHODS,PCR,QRT,REAL,RESULTS,THESE,TIME,UGT2B15,VDR,WILEY
BECAUSE,BTC,CRPC,HCO,LUCAP,MC3T3,PAP,PCA,THESE
AGR2,AMP,CREB,EXPRESSION,GRADE,IHC,NAALAD1,PSMA,SPON2,USING
231,946,CONVERSELY,DU145,FURTHER,HHEX,MDA,PC3,PRH
ARSB,C4S,EGF,EGFR,THESE
2003,2011,2062,741,BCS,BODY,CRC,CRCS,INVARIANCE,LABEL,METHODS,NOVA,NSCR,OBJECTIVE,OVERALL,PATH,PBC,PCS,PURPOSE,RESULTS,STRUCTURAL,THESE,TPB,TREATMENT
945,946,947,BETA,DDT,GAMMA,GAS,GST,GSTM1,GSTT1,HCH,OCP,OCPS,PCR,THESE,UBC,URINARY
007,172,249,2578,BACKGROUND,LABEL,METHODS,MEXICAN,OBJECTIVE,ODDS,PCA,RATIO,RESULTS,VEGF
001,098,111,160,177,314,467,787,AUC,AUCS,BACKGROUND,IGM,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OTHER,PCA,PSA,RESULTS
176,748,CURRENT,ICP
0005,001,101,127,158,1998,2013,2348,280,3167,381,404,609,661,938,967,CHOLINE,HEAD,PET,PSA,SEPTEMBER,THESE
945,CA2,CRAC,DHT,DU145,FIRST,HOWEVER,LNCAP,ORAI1,ORAI3,PSA,SOCE,THIRD,THREE
946,947,BONE,FABP4,HMOX,INCIDENCE,PPAR
APART,INDICATOR
169,2013,ADP,AKT,COPYRIGHT,CRPC,EGF,EGFR,FOXO1,INC,PARP1,PC3
000,001,094,100,169,1739,182,2001,2008,2013,215,ASIR,ASIRS,BACKGROUND,CIR,CIRS,CONCLUSION,COPYRIGHT,FURTHER,IRR,JANUARY,JIZAN,KING,LABEL,METHODS,PACKAGE,POISSON,PUBLISHED,RESULTS,SAUDI,SCR,SPECIALIST,SPSS,THERE,YEARS
169,2013,COPYRIGHT,FURTHER,INC,WHILE
169,2013,4000,COPYRIGHT,HIV,HOWEVER,RETINOIDS,THERE
169,2013,COPYRIGHT,E2F1,INC,THEREFORE,THESE
169,2014,ARTEMIS,COPYRIGHT,CURRENTLY,EIGEN,GEOSCAN,HITACHI,INC,MRI,PHILIPS,RVS,UROSTATION
169,2014,COPYRIGHT,ETS,INC,LABEL,LESIONS,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PI3K,RESULTS,SPOP,THESE
169,2006,2011,2014,AFTER,CONCLUSION,COPYRIGHT,INC,LABEL,MANN,METHODS,OBJECTIVE,PCWG2,PSA,RESULTS,STEIN,VALIDATION,WHITNEY
169,2014,BACKGROUND,BPH,COPYRIGHT,GLEASON,INC,LABEL,MATERIALS,METHODS,PIN,REGARDING,RESULTS,SEVERAL,SIX,THEREFORE
169,2014,401,COPYRIGHT,FURTHER,INC,INCIDENCE,INSURANCE,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,SCI
103,169,2013,300,COPYRIGHT,DOSE,DOSES,EDS,EFFECTIVE,EQUIVALENT,EXM1,FIFTY,HTS,ICRP,LABEL,LTD,MBQ,METHODS,OBJECTIVE,PET,PUBLISHED,PURPOSE,RESULTS,ROI
169,2014,8805,919,BACKGROUND,CONCLUSION,COPYRIGHT,CRPC,ENDPOINTS,GLEASON,GRADE,INC,LABEL,METHODS,PSA,RESULTS,SERIOUS
1252,1339,160,169,2004,2005,2014,207,3486,8804,895,AMONG,CONCLUSION,COPYRIGHT,COX,INC,LABEL,LESS,MEIER,METHODS,NORWEGIAN,OBJECTIVE,RESULTS
169,2013,COPYRIGHT,HOWEVER,IMAGE,INC
169,176,2013,8201,8482,APPLIED,AUTHORS,BJU,ICE,LABEL,MARGARITA,MEDICAL,METHODS,OBJECTIVE,RARP,RESULTS,SANTA,USA
2007,509,572,601,603,622,647,AUC,BACKGROUND,CONSORTIUM,ECE,HOWEVER,IRISH,LABEL,METHODS,PREDICTION,RESULTS,SENS,SPEC,T1C,T2A,THERE
001,4303,8804,BACKGROUND,CONCLUSION,CPG,FDR,LABEL,META,METHODS,MICROARRAY,POL,RCC,RESULTS,RNAS,SAMPLES
169,2013,212,BASED,BIOLOGY,BOTH,HYBRIDOMAS,ICC,IHC,INC,MICE,MOLECULAR,NONE,PLAC1,REACTIVITY,UNION,WESTERN
2659,AGE,AIM,CONCLUSION,DIVERSE,HEALTHCARE,HTE,INCLUSION,LABEL,MEDLINE,METHODS,OBJECTIVE,QUALITY,RESULTS,S4PC,ULTIMATELY
GIVEN,HOWEVER,MOST
3691,BACKGROUND,CONCLUSION,HALF,LABEL,METHODS,RADIATION,RESULTS,RISK,SURGERY,USA,WHILE
RARP,USA
ACHIEVA,HEALTHCARE,HOWEVER,MRI,PHILIPS,SINCE
AFTER,BIC,CPA,LNCAP,PCA,PHOSPHATE,PSA,THESE,WESTERN
280B,945,FURTHER,KNOCK,MDM2,THUS,ZINC,ZNF

956,BACKGROUND,CONCLUSION,HISTOLOGIC,IC50,LABEL,METHODS,MTT,NLC,RESULTS,TUNEL
RFS,VOI,VOIS
177,8201,980,BALB,BOTH,CY3,FITC,LNCAP,MOUSE,NAYF4,NIR
200,MOST,PORTUGUESE,PSA,THERE
176,AICC,CHINESE,CRITERION,MOST,RELATIVELY,SEVERAL,THESE
DEPARTMENT,HSP
100,169,2013,BOOST,COPYRIGHT,EBRT,FREEDOM,GROUP,HDR,LATE,LDR,LTD,RADIATION,STUDIES,THERAPY,WHILE
LABEL,OBJECTIVE,ONGOING,PURPOSE,RESULTS,SUMMARY
169,2013,AIMS,BAX,BID,COPYRIGHT,DR5,HOWEVER,INC,KEY,LABEL,MAIN,METHODS,NBIF,OBJECTIVE,RESULTS,TAKEN,TRAIL
101,198,1ST,BACKGROUND,COLORECTAL,HEALTHY,LABEL,LTD,LUNG,MATERIALS,METHODS,OVARIAN,PCR,PLCO,PUBLISHED,RESULTS,RTEL1,RTL,SCREENING,TERT,THERE,THEREFORE,TRIAL
115,165,169,2013,215,8804,AES,BACKGROUND,CONCLUSION,COPYRIGHT,EARLY,GRADE,HDR,HOWEVER,IPSS,IRELAND,LABEL,LTD,METHODS,RESULTS,RTOG,SCORE,SYMPTOM,WEEK
10877,10878,169,2001,2013,7974,AUC,BACKGROUND,BFFS,COPYRIGHT,GLEASON,GUROC,INDEX,IRELAND,LABEL,LTD,METHODS,NET,PROCARS,PSA,RADIATION,RECURSIVE,RESULTS,RPA,T1T2A,T2B
0006,001,100,139,145,167,169,16GY,177,2013,36GY,BACKGROUND,COPYRIGHT,D90,IRELAND,LABEL,LTD,MEAN,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,SEVENTY,THERE,V100,VCF,VOLUMETRIC
159,232,ACCOUNTING,BACKGROUND,CONCLUSION,EQUALLY,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,QUANTEC,RESULTS,SIX
169,2013,COPYRIGHT,INC,KPC1,LOSS,PIRH2,SKP2
PRIMARY,RCC
GRADE,IHC,III,MOST,NOTABLY,RMP,THERE,TMA,URI
0002,117,132,145,AMONG,BACKGROUND,ERK1,HOWEVER,JNK,LABEL,MAPK,METHODS,NOB1,PATHWAY,PCA,RESULTS,SIGNALING,THESE,WESTERN
008,043,068,1000,118,129,146,174,2003,2007,336,490,574,579,585,594,601,947,BACKGROUND,END,HIGH,IMRT,LABEL,MARKETS,METHODS,OBJECTIVE,RESULTS
001,2009,274,630,GUIDELINES,NCCN
003,034,2006,2010,8805,GLEASON,HOWEVER,MEAN,PATHOLOGY,RPS,SOCIETY,UPON,UROLOGICAL
ALK,ANTIBODIES,DOG1,ERG,ETS,GIST,HMG,LACK,LANGERHANS,MUC4,OCT3,PAX8,SALL4,SCHWANN,SOX10,SOX11,SRY,SV40,TREPENOMA
169,2013,954,AKT,BRADYKININ,COPYRIGHT,INC,TAKEN,VEGF
821,BACKGROUND,COMMONS,CURRENT,CURRENTLY,LABEL,LICENSE,RESULTS
ADP,BRCA,BRCA1,MUT,PARPI,POLY,SEVERAL
III,KEY,PHASE,THERE
000,104,132,283,536,ACCOUNTING,QALY,SIPULEUCEL,THRESHOLD
096,100,105,169,2013,8201,8482,8805,AUTHORS,BELGIUM,BJU,LABEL,LESIONS,MEDICAL,METHODS,OBJECTIVE,OBJECTIVES,PEARSON,PHS,RESULTS,THESE,TRUS,TTB,TTBS

024,034,037,169,1Q25,2013,8Q24,ALSO,ARG462GLN,ASP541GLU,AUTHORS,CHILEAN,FOUNDATION,JOHN,JOURNAL,LTD,MINITAB,MOLECULAR,PCA,PCR,PSA,REGARDING,SONS,THERE,WILEY
FOXO,HEM,HEME,HOWEVER,NUCLEAR,PC3,PC3HO,PCA,PMOS,SCID,THESE,USING
0001,001,002,104,GLEASON,LABEL,MAJOR,METHODS,OBJECTIVE,OVERALL,PURPOSE,RADIATION,RESPONDENT,RESULTS,SINCE,THERE,UROLOGISTS
CHINESE,CONSORTIUM,DEALING,EGFR,ERBB2,ERK,GENEVAR,HOWEVER,PCA,PROJECT,PTK2,RAF1,RTK,SNPS
001,174,430,530,786,947,975,AUC,BACKGROUND,BOTH,CD16,CD3,CD56,IFN,LABEL,METHODS,NATURAL,NKA,PBMCS,PCA,PROMOCA,REDUCTION,RESULTS,THEN,THESE
4723,ABELSON,ABL,ABL1,ABL2,ALSO,CPG,EXPRESSION,FURTHER,HOWEVER,LOW
946,BACKGROUND,CATHEPSIN,LABEL,LAMP,MYCOPLASMA,NLRP3,PRINCIPAL,RESULTS,ROS
100,178,192,2003,2008,8805,ADT,AFTER,DATA,EBRT,GRADE,GROUP,HDR,NCCN,NETWORK,RADIATION,THERAPY,VHR
001,002,003,006,206,AIM,CONCLUSION,GLEASON,LABEL,METHODS,NDRG2,NDRG3,OBJECTIVE,PCA,RESULTS,RFS
22RV1,BACKGROUND,CONCLUSION,HSPB1,LABEL,MATERIALS,METHODS,NOTABLY,PCA,RESULTS,SHORTENED
0090,0188,218,580,AIM,C521A,CAV1,CONCLUSION,G14713A,G21985A,G32124A,LABEL,MATERIALS,METHODS,OBJECTIVE,PCR,RESULTS,RFLP,T28608A,T29107A,TAIWANESE,UPPER,WESTERN
945,CERTAIN,CRPC,FDA,RESULTS,THESE
0004,016,246,817,BACKGROUND,DIET,FURTHER,LABEL,MALM,METABOLITE,METHODS,ORS,RESULTS,SWEDISH,WHOLE
1INTEGRIN,945,946,AFTER,BACKGROUND,CD133,CFE,FINALLY,HDAC,LABEL,METHODS,PRIMARY,RESULTS,SCS,STEM
224,253,EACH,GLEASON,ROLL,THESE
100,2009,2012,8805,CSR,CSRS,DATA,GGP,GLEASON,IMAGING,LABEL,MATERIALS,METHODS,MRGB,MRI,OBJECTIVE,OBJECTIVES,RADS,REPORTING,RESULTS,RISK
945,946,CD151,CLUSTERING,HOWEVER,PKC
DUTCH,HODGKIN,THESE
ALSO,BACKGROUND,BECAUSE,HIGH,LABEL,LOW,PEGYLATED,PEGYLATION,RESULTS
AMONG,ASIA,BESIDES,DIETARY,EAST,SINCE,SOUTH,VARIOUS
1985,2000,2005,2007,DATA,FUKUI,HOWEVER,JAPAN,LABEL,METHODS,OBJECTIVE,RESULTS,SEVEN,THREE
8764,AAV,AAV6,ADDITIONAL,CBA,CD11C,CTLS,DCS,DENDRITIC,EGFP,LNCAP,MODCS,S663V,SV40,T492V,TAKEN
169,2013,BACKGROUND,BASEL,CLUSTERIN,CONCLUSION,LABEL,METHODS,PCR,REAL,RESULTS,SIMILAR,WESTERN
169,2014,BASEL,COPYRIGHT,WHILE
FDG,MALIGNANT,PET,SERUM
DIFFUSE,HDP,MYOCARDIAL
154,2008,2009,212,635,BACKGROUND,BONE,CONCLUSION,GLEASON,LABEL,METHODS,MRI,OBJECTIVE,OUTCOME,PCA,PSA,RESULTS,SETTING,THEIR,THESE
ACCORDING,DESPITE,DOCETAXEL,PATIENT,UNTIL
169,172,2013,945,BASEL,C30,EORTC,KNOWN,LABEL,METHODS,MULTITRAIT,OBJECTIVE,PR25,QLQ,QOL,RESULTS,TREATMENT
169,2013,COPYRIGHT,LTD,PEGYLATED,THESE
169,2010,2013,COPYRIGHT,CROWN,OCTOBER,PUBLISHED
169,2013,302,ACTIVATION,COPYRIGHT,HENCE,PUBLISHED,RB1,TERT,TP53,UROLOGY
169,2013,8201,8805,AMERICA,AUTHORS,BJU,CONSENSUS,LABEL,METHODS,MRI,NORTH,OBJECTIVE,RESULTS,STATE,STRUCTURED,UROLOGICAL
COMPARISON,NEXT,NPS
ANY,BACKGROUND,COMPARISON,DATA,FEW,INCREASED,INSULIN,LABEL,LIBRARY,META,METHODS,NON,OBJECTIVE,OUTCOME,PICOS,POPULATION,RESULTS,SCIENCE,SOURCES,SYSTEMATIC,USERS,WEB
169,2013,945,954,AUTHORS,BJU,CD4,CRPC,EXPANSION,IKK,PCA
BURNS,EDUCATING,HIGH,KUCC,MCDONNELL,PREVENTION,PROGRAM,RISK,UNIVERSITY,UROLOGY
ACTIVITIES,ADVOCATES,AUDIO,BECAUSE,FINALLY,GIVEN,INCLUDING,INSTITUTE,LABEL,METHODS,OBJECTIVE,PURPOSE,RELATED,RESULTS,SEMI,SURVIVORS
1985,2004,2005,499,BACKGROUND,CLINICIANS,CONCLUSION,CONTEXT,EVALUATING,INDEX,LABEL,LINKING,MAIN,METHODS,OBJECTIVE,OUTCOME,PERSISTENT,PSA,RESULTS,SETTING,SURVIVORS,YET
169,2013,ADT,AFTER,BMD,COLLEGE,DENOSUMAB,INCREASES,PMO,THEREFORE,TIME
CAR,CARS,HOWEVER
BONE
CIP1,HOWEVER,PC3,RNAI,SCIN,THESE
1SEC,231,297,8209,945,946,ARG,ASN,ASP,CD13,GLY,MAGNEVIST,MDA,MRI,NGR,RGD
223RA,945,MEDICAL,PARTICLES
169,2013,BACKGROUND,BECAUSE,CHEMISTRY,CONTENT,LABEL,LARGE,SEVERAL,SUMMARY
169,2013,COPYRIGHT,INC,PARAMETERS
169,2013,231,945,946,AHCC,AIMS,COPYRIGHT,DISRUPTION,EAJ,H2O2,HRAS,INC,INDUCTION,KEY,LABEL,MAIN,MDA,METHODS,NAC,OBJECTIVE,PMA,PREVIOUSLY,RESULTS,ROS,SEVERAL,TEM,TREATMENT
169,2013,AFTER,COLO205,COPYRIGHT,DOTA,EXPRESSION,PC3,U2OS,U373
169,2013,916,956,COPYRIGHT,IC50,IRELAND,LNCAP,LTD,MOLECULAR,PC3
169,2013,215,ACTA,CDTE,CMC,COPYRIGHT,INC,LTD,MATERIALIA,PUBLISHED,QDS
169,2014,ANALYTICAL,BIOMARKER,CELL,COPYRIGHT,DIGITAL,EDUCATION,ERG,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PCA3,PUBLISHED,PURPOSE,RESULTS,ROC,STUDENT,THUS,TMPRSS2,URINARY,URINE,UROLOGICAL
169,2013,AUNP,CVS,DLS,EDX,ELISA,HRTEM,INTRA,LOD,PASS,PEI,PSA,PSAA,PUBLISHED,SEM,SPR,THEREAFTER,UNDER,UPON
145,169,2013,23120,23206,23244,23704,23926,BIM,COPYRIGHT,ERK1,IRELAND,LNCAP,LTD,PCA,SS1R,SS2R,SS3R,SS4R,SS5R,SSRS,SST,THESE
169,201,2013,231,COPYRIGHT,DCE,DWI,HOWEVER,MRI,PUBLISHED,SAS
100,1522,169,183,186,2008,2011,2013,760,762,8805,914,956,APRIL,BACKGROUND,BETWEEN,BRISTOL,COPYRIGHT,DASATINIB,DATA,EASTERN,FUNDING,GROUP,IQR,LABEL,LTD,METHODS,MYERS,OCT,RESULTS,SRC
169,1998,2007,2013,BACKGROUND,BYM,CLASSIC,CONCLUSION,COPYRIGHT,DATA,DIC,FOUR,ISERE,LABEL,MAPPING,METHODS,MORAN,POISSON,RESULTS,SAS,SIRS
0001,001,169,1998,2009,2014,2937,500,8804,8805,ACUTE,AUR,BOTH,BRITISH,COPYRIGHT,CROWN,GROUP,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,RADIATION,RESULTS,RTOG,THERAPY
169,177,2014,288,947,COPYRIGHT,EPID,IMRT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE,TRANSIT
071,169,2004,2012,2013,ALSO,BACKGROUND,BIAS,CONTEXT,COPYRIGHT,INCLUDING,JANUARY,LABEL,LIFE,MARCH,METHODS,OBJECTIVE,PATIENT,PCA,PRO,PUBLISHED,QUALITY,RCTS,RESULTS,RISK,SIXTY,SOCIETY,STUDIES,SUMMARY,SYNTHESIS
002,1686,169,2005,2012,2013,2328,239,642,ACTIVITIES,ADT,AMONG,BACKGROUND,COPYRIGHT,DATA,DICTIONARY,EASTERN,EVENT,GNRH,GROUP,LABEL,MEDICAL,MEIER,MEN,METHODS,OBJECTIVE,OUTCOME,PUBLISHED,REGULATORY,RESULTS,SETTING,SINCE,TREATMENT
001,100MG,169,2013,8805,CONCLUSION,COPYRIGHT,CRPC,INC,LABEL,MET,METHODS,OBJECTIVE,PFS,PRIMARY,PURPOSE,RESULTS,SERUM,SEVENTY,THOSE,XL184
001,003,1535,169,2013,3040,765,770,BACKGROUND,CASTRATION,COPYRIGHT,INC,LABEL,MEN,METHODS,PSA,REPLACING,RESULTS,THERE
001,1000,1088,169,2013,5MG,BACKGROUND,COPYRIGHT,GRADE,INC,LABEL,METHODS,RESULTS
169,192,193,2004,2008,2013,ADT,AFTER,BACKGROUND,BELGIUM,BETWEEN,COPYRIGHT,DEC,DOCETAXEL,EARLY,FOUR,GLASS,INC,IQR,KARNOFSKY,LABEL,METHODS,OCT,RESULTS
169,2013,ATM,CEC,CECS,COPYRIGHT,DPS,FURTHER,GADD45A,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SHORTLY
001,003,016,1999,2010,207,993,AMICO,ANTIGEN,BACKGROUND,BDFS,CSS,GLEASON,IMRT,JANUARY,LABEL,MARCH,METHODS,MOC,OVERALL,PCA,PSA,RESULTS,THERE,TREATMENT
169,2011,2013,8805,ADT,BACKGROUND,CONTEXT,COPYRIGHT,CURRENT,DIAGNOSIS,EAU,KNOWLEDGE,LABEL,METHODS,NERVE,OBJECTIVE,PATIENT,PCA,PSA,PUBLISHED,RADIATION,RADICAL,RESULTS,SCREENING,SUMMARY,SYNTHESIS,SYSTEMATIC,THESE,TREATMENT,UROLOGY
000,001,048,144,169,2006,2010,2013,220,239,291,377,8804,BACKGROUND,COPYRIGHT,FOCAL,GLEASON,LABEL,METHODS,OBJECTIVE,OUTCOME,PCA,PUBLISHED,RESULTS,SETTING,TTPM,UROLOGY
160,228,252,ADAPTATION,BACKGROUND,BASED,BEAM,BEV,BOOST,CONCLUSION,CTV,DMPO,EYE,IMITATION,IMRT,INTEGRATED,LABEL,METHODS,MLC,MONITOR,PTV,RESULTS,SOIS,STEP,UKW,UNITS,UNIVERSIT,VIEW
0001,001,129,169,2013,AIM,BACKGROUND,CONCLUSION,COPYRIGHT,DESPITE,HOWEVER,LABEL,MATERIALS,METHODS,OBJECTIVE,PRODUCTION,RESULTS,THERE
001,1047,113,158,169,2003,2007,2013,8804,928,AEU,CONCLUSION,COPYRIGHT,ERG,FDR,FORTY,HOXC6,LABEL,MAY,METHODS,OBJECTIVE,PCA,PCA3,PCR,PDK4,PPM,PUBLISHED,RESULTS,TEN,TMPRSS2
1119,1405,157,160,191,2009,2010,3477,348,ADELPHI,BACKGROUND,BONE,CRPC,DATA,DISEASE,DSP,GERMANY,ITALY,LABEL,LHRH,MAY,METHODS,MOST,OVERALL,PROGRAMME,REAL,RESULTS,SPAIN,WHILE,WORLD
AREAS,BACKGROUND,COVERED,DUE,LABEL,METHODS,OPINION,WHILE
169,2013,AUTHORS,BJU,MELBOURNE,VARIOUS,WORLD
LUCAP,MET,PCA,USING
110,208,BACKGROUND,CURRENT,FFL,FFLS,FURTHER,LABEL,PRINCIPAL,RESULTS,STAT3,TFS,THEREFORE
C33A,HERV,PCR,PRIMERS,RNAS,SPLICED,THERE,THESE
177,947,ADP,COMET,DU145,ERG,ETS,EWING,H2AX,NEUTRAL,PARP1,PC3,SEM,THEREFORE,THESE,USING
2LUC,BAD,BCL,BT549,J591,LNCAP,MCL,PC3,PE38QQR,PI3K,PSMA,RESULTS,THESE,ZSTK474
2000,2009,518,8805,BACKGROUND,CONSISTENT,ECONOMISTS,EMPIRICAL,HBM,INSURANCE,LABEL,MEDICAL,METHODS,MODEL,PANEL,PREVENTIVE,RESULTS,SURVEYS
169,2013,AACR,SUCCESSFUL,THESE
014,028,134,8201,967,COX2,GLEASON,PEARSON,PSA
223,MET
001,CAD,CHOLINE,CONCLUSION,KIMOD,LABEL,MATERIALS,METHODS,NAD,OBJECTIVE,OBJECTIVES,PEARSON,PET,PSA,RESULTS,SUV60,TEN,THERE,TMR60
AFTER,FIVE
888,EPS,LNCAP,MICRORNAS,PC3,RBL1,RNAS,SMAD4,THESE
8201,8211,BOWEL,DCR,FOUR,NON,OAR,OARS,RESULTS,V50,V60,VMAT
100,CRPC,RESULTS
169,2013,BACKGROUND,COPYRIGHT,LABEL,LTD,METHODS,RESULTS,SINCE,TIME,TREATMENT
EZH2,HDMS,HMTS,HOWEVER,KDM4B,KDM5A,KDM6A,KMT2A,MLL1,PCA,PRMT6,REMARKABLY,SMYD3,SUV39H2
001,002,004,031,081,094,155,169,173,177,178,2013,208,245,459,779,800,803,850,8804,906,936,ADC,AUR,BPH,CONCLUSION,COPYRIGHT,FORTY,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PCA,PEARSON,PUBLISHED,RATIONALE,RESULTS
051,169,1998,2006,2013,613,8201,892,994,A1C,AIMS,BMI,CHD,CLEVELAND,COMPARISON,COX,GFR,HDL,JOHN,LABEL,LDL,LTD,METHODS,OBJECTIVE,ORAL,RESULTS,SONS,WILEY
293T,ALONG,FE3O4,H2O2,HEK,HOWEVER,NPS,PARTICULAR,ROS
ARG,ASN,CYS,FINALLY,GLY,ILE,LEU,PHE
160,169,200,2013,215,AIMS,BACKGROUND,CALIPER,COPYRIGHT,DU145,GFP,HOWEVER,INC,IRES,IVIS,LABEL,LIFE,METHODS,MIXED,MSCS,OBJECTIVE,PC3,PUBLISHED,RESULTS,SOCIETY,SV40,TAKEN,THERAPY
493,941,CIS,HOWEVER,ORS,PCA,STATA
INCREASING,MYC,NOTABLY,TAKEN,USP22
8201,BACKGROUND,FDG,IMAGING,LABEL,METASTATIC,PCA,PET,PSA,RESULTS,ROUTINE
DATA,FOLLOWING,FRIENDS,LABEL,MEN,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
128,445,8226,DATA,ESUR,IMAGING,KEY,LABEL,MANN,METHODS,MRI,OBJECTIVE,OBJECTIVES,PCA,RADIOLOGY,RADS,REPORTING,RESULTS,ROC,ROIS,SOCIETY,SUSPICIOUS,TRUS,UROGENITAL,WHITNEY
109,150,2005,8805,ACUTE,CONCLUSION,CONFORMAL,CTCAE,FAVORABLE,FFBF,IGRT,IMRT,INTENSITY,LABEL,METHODS,OBJECTIVE,PHOENIX,PURPOSE,RESULTS,SIB,SINCE,TREATMENT
264,BACKGROUND,COMPOSITE,EPIC,HALF,HRQOL,INDEX,LABEL,MEDICAL,METHODS,PCA,RESULTS,URINARY
100,141,200
945,DSPE,FDA,HOWEVER,PEG,TNF,TRAIL
0001,001,007,011,028,046,946,BESIDES,CAP,ERG,FISH,GLEASON,THERE,TMPRSS2,TOP2B
100,BASED,EBRT,FFBF,GROUP,HDR,LDR
ERSPC,FORCE,PCA3,PREVENTIVE,PSA,RESULTS,SCIENTIFIC,SCREENING,TASK
157,160,177,1819,2007,8805,BIOBANK,GLEASON,HOSPITALS,INTEGRITY,PROCURE,PSA,RIN,T3A,T3B,THESE,UNIVERSITY
AZT,CX43,GJIC,GJICS,PANNEXIN1,PANX1,TAKEN,TMPK
AKT,CRPC,DOCETAXEL,DU145,FAK,HOWEVER,PC3,THESE,TKI,TKIS,TREATMENT,USING,Y397,Y576
2000,2006,CONCLUSION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,VALUE,VOI
0451,110,2494,945,946,EXPRESSION,PCR
141,200,200C,424,DU145,ECTOPIC,EMT,EPCAM,LN1,LN4,MET,USING
003,004,177,601,617,623,8201,8226,961,CHOL,FDG,GLEASON,KEY,LABEL,METHODS,MRI,OBJECTIVE,OBJECTIVES,PET,RESULTS,TESTS,THESE,TRUS
AIR,EASTERN,GOF,GWR,HIGH,HOWEVER,NO2,OVERALL,SAUDI,THESE
011,1958,2010,248,8805,931,AMONG,FDRS,SIRS,SWEDISH,USING
009,2000,2007,520,540,BACKGROUND,COX,END,HEREDITARY,HHT,LABEL,MEIER,METHODS,RESULTS,THERE
19A,205,220,221,222,23B,374B,8804,8805,BACKGROUND,CHINESE,LABEL,PCR,RESULTS
8243,954,AP1,B2G2,BOTH,GSE,ISOLATING,PARP,PCA,STAT3
BMBU,BMCHF,BMET,BMHX,HOLOPTELEA,PLANT,ROXB,THESE
0019,2013,223,945,BAYER,BC1,BSOC,CRPC,DRUG,FDA,FOOD,HEALTHCARE,INC,MAY,SSE
169,2013,INC,WILEY,WNT
146,2003,2008,2012,ASCO,ASTRO,CNS,FIRST,MEDLINE,NEXT,QOL,THERE
CTC,CTCS,EARLY,FDA,GIVEN,HOWEVER,MEETING,NOVEL
571,945,ABL,ANNEXIN,BOTH,CELLS,DEVDASE,EARLY,EGR,LNCAP,MTT,STI,TNF
005,006,181,194,1990,2009,239,247,COX,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,T1G3,TUR,VARIATIONS
109,110,705,BMI,CONCLUSION,CONCORD,LABEL,MEN,METHODS,OBJECTIVE,PROJECT,PSA,PURPOSE,RESULTS,SERA,THERE
002,1982,1986,1998,2010,372,539,603,995,BIENNIALLY,CONCLUSION,DIAGNOSIS,HPFS,LABEL,METHODS,NMSC,OBJECTIVE,PCA,PHS,PHYSICIANS,PURPOSE,RESULTS,STEROID,THESE
1998,2009,2012,499,772,791,APRIL,CIS,CONCLUSION,COX,HOWEVER,HRS,KINGDOM,LABEL,METHODS,OBJECTIVE,OCTOBER,OVERALL,PURPOSE,RESULTS,THESE,TIME
001,753,8201,8805,AMONG,BACKGROUND,CURRENT,GLEASON,HOPKINS,JOHNS,LABEL,MEN,METHODS,NCCN,NETWORK,PCA,PSA,RESULTS,THESE,VHR
024,0773,2013,3984,4033,CANCER1,COMPLETED,ENOBOSARM,GTX,III,LABEL,LGD,MAY,OBJECTIVE,PHASE,PREVENTION,PURPOSE,RESULTS,SARM,SARMS,SUMMARY,WASTING
005,946,947,948,BOTH,BPH,FABP,GLEASON,PPAR,PPARS,STUDENT,THUS,WHILE
0001,0004,3106,AFTER,BACKGROUND,CLINICIANS,CONCLUSION,DESPITE,E2Z02,EASTERN,ECOG,GROUP,LABEL,METHODS,QOL,RESULTS,SOAPP,SYMPTOM,THESE,UNIVARIATE
169,2013,916,946,AKR1,AKR1C,ALTERED,C17,C20,COPYRIGHT,GABAA,INC,MUTATIONS,NADPH,NMDA,THESE
136,2011,500,945,ADT,IRONICALLY,PSA
LARGE,OTHER,PCPT,PREVENTION,REDUCTION,THEIR,TRIAL,VITAMIN
169,2013,COPYRIGHT,INC,NOVEL,OPTIMIZING,SRES
169,2013,223,945,COPYRIGHT,CROWN,CRPC,CYP,INC,MEN,PUBLISHED,STRATEGIES,THESE
169,2013,COPYRIGHT,DESPITE,HSPC,INC,TARGETING
169,2013,COPYRIGHT,INC
INC,MOST,PUBLISHED
169,2013,COPYRIGHT,IMAGING,INC
169,2013,COPYRIGHT,CROWN,DOSE,HOWEVER,INC,PUBLISHED,THESE
169,2013,COPYRIGHT,INC,SURGERY
169,2013,COPYRIGHT,INC,LESS,PSA
2006,2012,615,BACKGROUND,EAU,HOWEVER,LABEL,LNI,LNS,MATERIALS,METHODS,PLND,RARP,RESULTS,SIMILARLY,UROLOGY
160,2009,2012,APRIL,CONCLUSION,CONTINENCE,LABEL,MARCH,METHODS,OBJECTIVE,RARP,RESULTS,RRP,SIRS,WHITE
946,ALZHEIMER,CROHN,EXCESSIVE,HOWEVER,III,LACK,NSCLC,ORGAN,TGF,THERE,THUS
945,AMP,AMPK,ATP,PGC,TAKEN,USING
10877,22RV1,8201,947,AZ12253801,DSB,DSBS,DU145,FINALLY,H2AX,IGF,INHIBITION,IRRADIATED,LN3,LNCAP,MUTATED,NHEJ,PC3,SF50,THESE
200C,CHIP,EMT,ERG,ETS,MOST,PCA,SEQ,THEREFORE,THROUGH,TMPRSS2,ZEB1
ERCC1,PCK3145,PROSTATIC,PSP94
169,2013,264,8217,BMP,DTR,INC,LNCAP,METHODS,PREVIOUSLY,RAW,RESULTS,SMAD1,THP,TRAMP,WILEY
ALANINE,EXTENSIVE,PROTEIN,PTD,TAKEN,THESE
10P14,160,29E,360,458,474,543F8,5Q31,66E,6Q21,8805,95E,AFRICAN,AGE,ASIAN,CONSORTIUM,FURTHER,GATA3,GHANA,GLEASON,GWAS,HUMANOMNI,QUAD,RP11,SNP,SNPS,WEST,XQ28
AFRICAN,AMERICANS,DATA,PHASE,WHILE
000NM,12MIN,169,2013,ACCAD,ACPUT,ACSPD,ACSPM,C18,CAD,COPYRIGHT,DAP,DEUTERIUM,DIACCAD,DIACPUT,DIACSPD,DIACSPM,DILUTED,ESI,HFBA,HOWEVER,IONIZATION,POLYAMINES,SPD,SPM
100,169,2013,946,ALA,BBN,CHA,COOH,COPYRIGHT,DMPTACN,EXPLOITING,GLU,GRPR,NLE,NMRI,PET,SAS,SMALL
169,2013,ATG4B,C74A,COPYRIGHT,DEVELOPING,HOWEVER,INC,THUS
068,169,174,2014,AMONG,ASSESSMENT,CAPRA,CAPSURE,COPYRIGHT,EDUCATION,EMOTIONAL,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,QUALITY,RESULTS,RISK,STRATEGIC,SUBSCALES,TREATMENT,UROLOGICAL,WHILE
169,2014,300,688,800,AGE,CONDITIONS,COPYRIGHT,DATA,EDUCATION,HOWEVER,INC,KRIMPEN,LABEL,MATERIALS,MEN,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
169,2013,COPYRIGHT,LTD
169,2013,COPYRIGHT,HOWEVER,LTD,MRI,NCSE,NON,THESE
169,182,2013,780,945,946,ADIOL,BECAUSE,COPYRIGHT,DU145,ICI,LTD,NOTABLY,PC3,PCS,THESE
147,169,2002,2007,2014,4MM,750,8804,8805,BCR,CIPC,COPYRIGHT,FINALLY,GLEASON,INC,JANUARY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRIAS,RESULTS,T1C
169,2013,COMPLEX,COPYRIGHT,EZH1,EZH2,H3K27,LTD,REPRESSIVE,THESE,ZESTE
007,104,10NG,125,169,2003,2009,2013,663,9MONTHS,ASTRO,BETWEEN,BFFS,CONCLUSION,COPYRIGHT,COX,CSS,D90,EARLY,GLEASON,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PHOENIX,PSA,PURPOSE,RADIOLOGY,RESULTS,SOCIETY,THERE
169,2013,3MM,4MM,5MM,BACKGROUND,COPYRIGHT,CTS,CTV,D99,DVH,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS,TREATMENT
012,1107,1110,1138,1353,169,1705,1797,1986,1987,1988,2006,2007,2008,2013,2259,240,242,245,267,2736,295,577,773,7827,904,AUSTRALIA,BACKGROUND,COPYRIGHT,HODGKIN,LABEL,LTD,METHODS,OTHER,RESULTS,THERE
169,2013,AMBA,CONCLUSION,CONVERSELY,DO3A,DOTA,DTPA,ESI,GALLIUM,HPLC,LABEL,METHODS,NO2A,NOTA,RESULTS,UHPLC,UNLABELLED
036,114,169,185,2013,BPH,COPYRIGHT,GLEASON,GMBH,GRADE,HGPIN,HIGH,IRANIAN,NEOPLASIAS,PCA,PROSTATIC,PSCA,THEN
001,002,003,013,055,169,1987,1997,1998,2008,2014,229,BCR,BETWEEN,CALIFORNIA,COPYRIGHT,COX,GLEASON,INC,LABEL,LOG,MATERIALS,MEIER,METHODS,OBJECTIVE,OBJECTIVES,PATHOLOGIC,PSA,PUBLISHED,RESULTS,UNIVERSITY
169,2013,223,AIM,ANSM,CONCLUSION,COPYRIGHT,LABEL,LIBRARY,MEDLINE,METHODS,OBJECTIVE,RESULTS,SAS,UROLOGIST
169,2013,AIM,ANSM,CONCLUSION,COPYRIGHT,LABEL,LHRH,LIBRARY,MEDLINE,METHODS,OBJECTIVE,RESULTS,SAS
169,2013,3PUFA,969,CVD,DHA,DRUG,EPA,FOOD,GIVEN,GRAS,LTD,PUBLISHED,WHILE
169,176,2013,360,COPYRIGHT,FFF,IMRT,IRELAND,LABEL,LTD,MATERIALS,METHODS,MUS,OAR,OBJECTIVE,POFS,PURPOSE,RESULTS,VMAT
169,2006,2013,BACKGROUND,BLOOD,CONCLUSION,COPYRIGHT,GSI,HEAVY,HEIDELBERG,HELMHOLTZ,IMRT,ION,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PURPOSE,RESULTS,UNIVERSITY
144,162,169,2005,2010,2013,243,270,8320,8321,8323,8325,945,946,BED,COPYRIGHT,FURTHER,GRADE,HDR,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS,THREE
169,2013,COPYRIGHT,DISCUSSION,DOPPLER,INC
169,2013,COPYRIGHT,INC,UROLOGISTS
169,2013,CAREFUL,COPYRIGHT,GRAYSCALE,INC
153,186,188,223,PHOSPHORUS,RHENIUM,STRONTIUM
DESPITE,DIET,DIETARY,EVALUATION,HISTORY,INSTITUTE,NCI,PROGRAM,SERUM,THERAPY
169,2013,3RD,8201,AUTHORS,BJU,LABEL,MATERIALS,METHODS,MRSI,OBJECTIVE,PSA,RESULTS,THREE
169,2013,AUTHORS,BJU,CONCLUSION,FEW,LABEL,METHODS,MTX,OBJECTIVE,PAIN,PALLIATIVE,RESULTS
169,2013,AUTHORS,BJU,CONSENSUS,DISCUSSION,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,RESULTS
100,160,2008,2011,216,239,ACCURAY,ADT,AVERAGE,BACKGROUND,BETWEEN,COMPOSITE,CYBERKNIFE,EPIC,GEORGETOWN,GIVEN,HOWEVER,INDEX,INVENTORY,LABEL,MARCH,MEDICATION,MEN,METHODS,OVERALL,POST,POTENCY,PRIOR,PSA,RESULTS,SBRT,SHIM,UNIVERSITY
945,BACKGROUND,CONCLUSION,ESL,ESLS,FOLLOWING,FT3,FT6,FT7,FTS,INHIBITION,LABEL,MASS,METHODS,PCA,RESULTS
001,044,459,5A2,8201,8804,AKT,BACKGROUND,BOTH,CONCLUSION,COX,CUTANEOUS,EUKARYOTIC,FACS,FURTHER,LABEL,METHODS,MMP,PCR,PI3K,PMS,RESULTS,STRIKINGLY
2010,2012,339,585,664,768,786,HOWEVER,HYBRITECH,IPP,IRPPS,JUNE,OCTOBER,PCA,PSA,PSAD,ROC,TPV,TRUS,TZV,USING
114,15D,C30,DEPARTMENT,EORTC,FATIGUE,HRQOL,LABEL,METHODS,OBJECTIVE,PURPOSE,QLQ,RESULTS,UNIVERSITY,UTILITY,VAS
2000,2005,2009,COMMUNITY,END,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SES
001,160,ALA,ANOVA,COLON,DGLA,FATTY,GLA,LABEL,METHODS,OBJECTIVE,PUFAS,PURPOSE,RESULTS,SDA,SNK,THESE
002,003,015,023,034,042,140,168,169,2013,240,262,269,404,421,424,453,464,576,596,684,750,762,768,769,820,829,834,835,837,843,852,855,863,874,898,904,908,912,915,916,955,958,994,ACCORDING,CAUCASIANS,CHINESE,CONSORTIUM,COPYRIGHT,CROWN,ERK,HOWEVER,IGF1,PCA,RTK,SNP,VEGF
169,1990S,2013,BOTH,COMBINING,CTCS,ERG,HOWEVER,PCA,PCA3,PSA,SINCE,TMPRSS2
169,2013,AACR,CSC,CSCS,HOWEVER,STAT3
169,2013,945,946,956,CD133,CD44,CELL,COA,COPYRIGHT,FAK,FURTHER,H1152,HMG,INC,MYPT1,RHO,ROCK,ROCK1,THESE,WESTERN
169,2003,2010,2014,8805,AFFAIRS,BACKGROUND,CD4,CONCLUSION,COPYRIGHT,DEPARTMENT,DOSE,HIV,INC,LABEL,MATERIALS,MEIER,METHODS,MOST,RESULTS,THERE,YORK
169,2013,ASIA,ASIAN,BANGKOK,COPYRIGHT,LTD,PACIFIC
169,2013,BULKING,COPYRIGHT,SAS
169,174,2013,BLADDER,CIS,COPYRIGHT,DUE,MIBC,MUSCULARIS,NMIBC,PROPRIA,SAS,THUS,TURBT
136,8804,AUSTRALIA,AUSTRALIAN,DRE,GENERAL,GPS,PCA
0MG,5MG,BACKGROUND,CAT,CYTOTOXIC,DTNB,DU145,GPX,GSR,LABEL,MATERIALS,MDA,METHODS,MTT,PC3,PCR,PROTEIN,RESULTS,SOD,TBARS
275,506,588,DEGS,EXPRESSION,GSE3824,ITGA2,ITGAV,ITGB1,ITGB3,ITGB6,LABEL,LIMMA,MATERIALS,METHODS,MIR,OBJECTIVE,OMNIBUS,PURPOSE,RESULTS,SP1,USF1
17000,177,2006,2011,358,478,8804,99M,BACKGROUND,BONE,CIPTO,GLEASON,LABEL,MATERIALS,METHODS,PSA,RESULTS,THERE
ENGLISH
197
122,CONCLUSION,CRP,FSH,GLU,GROUP,HCY,HDL,III,LABEL,LDL,METHODS,OBJECTIVE,PRL,RESULTS,SEX,THERE
001,BACKGROUND,CELL,DEPLETION,HOWEVER,LABEL,MANN,METHODS,RESULTS,SMYD3,SP1,STUDENT,WESTERN,WHITNEY
003,175,397,CONTROL,JAPAN,LABEL,METHODS,OBJECTIVE,RESULTS,SEVENTEEN,SEVENTY,SMALL,THERE
ROC
169,1ST,2013,2ND,947,BACKGROUND,CAR,CARS,CD28,IFN,IGCD28TCR,IGTCR,IL2,INC,LABEL,METHODS,PSMA,RESULTS,WILEY
169,184,2013,557,619,BACKGROUND,GLEASON,INC,LABEL,LNCAP,METHODS,REMARKABLY,RESULTS,SRC,TKS5,WILEY
ADT,PCA,WHILE
145,CD151,LNCAP,LVD,MVD,THESE
240,AFRICAN,AGE,AMERICANS,CONTINUED,NONE,PATIENT,THERE
375,AZA,DNMT,DNMTS,PCA,TAKEN
205,HRPCA,OVERALL,PCA,THESE
110,1128,149,166,177,188,2163,228,239,476,987,CHO,CIT,CONCLUSION,LABEL,LCMODEL,MEAN,METABOLITE,METHODS,MRS,OBJECTIVE,PURPOSE,RELAXATION,RESULTS,SPECTRA
ADC,COMBINING,CONCLUSION,DCE,DWI,LABEL,MATERIALS,METHODS,OBJECTIVE,PPV,PPVS,PURPOSE,RESULTS,SIXTY,T1W,T2W
2003,2009,2012,AFTER,APRIL,AUXILIARY
BOTH,CURRENT,LARGE
100,160,2010,2011,2012,APRIL,BACKGROUND,LABEL,METHODS,MISC,OCTOBER,PCA,PERI,PSA,RARP,RESULTS,SEQUENTIAL
160,8764,AFTER,ANOTHER,BONE,CBCT,DEFORMABLE,DICE,DIR,FURTHER,HOWEVER,JAC,ORGAN,REDUNDANT,SEMINAL,THREE
0002,0008,001,002,8201,BACKGROUND,CHIP,DNASE,ESR1,FIMO,GENOMIC,HOWEVER,LABEL,METHODS,PARKINSON,RESULTS,THERE
125,185,252,945,AFP,AUC,CEA,HCG,INCREASED,NSE,PSAFREE,ROC
PSA
100,2001,2009,418,757,8805,AMONG,CALIFORNIA,COX,LABEL,METHODS,NPH,OBJECTIVE,PERMANENTE,RESULTS
150,8805,ANXIETY,ASSESSMENT,BRIEF,BSI,CHRONIC,CTCAEV4,FACIT,FATIGUE,FORTY,FUNCTIONAL,ILLNESS,INDEX,INVENTORY,LABEL,METHODS,OBJECTIVE,PRIMARY,PURPOSE,RESULTS,STRETCHING,SURVIVORS,SYMPTOM,THERAPY
003,040,048,112,169,2013,8805,946,ADT,BLOOD,BMD,DATA,DEXA,FITNESS,LABEL,MEN,MET,METHODS,NURSE,OBJECTIVE,PURPOSE,REGRESSION,SOURCES
129,149,1996,2012,299,575,8805,931,AFTER,AMONG,GLEASON,JANUARY,JUNE,LABEL,METHODS,MOST,OBJECTIVE,PCA,PCAS,PURPOSE,RCP,RESULTS
169,2013,BACKGROUND,COPYRIGHT,EARLY,FEM,JOHN,LABEL,LTD,MATERIALS,METHODS,PPV,RESULTS,SONS,THESE,WILEY
001,125,2003,2006,382,665,BACKGROUND,BETWEEN,LABEL,METHODS,MOUNT,MSEFS,NONE,PATIENT,POTENCY,RESULTS,SCORE,SINAI,UNIVARIATE
169,2013,AACR,BLT1,CCP,ELISA,FURTHER,HETE,IGF,KI67,LFFO,LTB4,PCR,SERUM,WESTERN
001,160,CBCT,CUFF,D95,DICE,DOI,ERB,ERBS,FLEXI,HOWEVER,PTV,SBRT,SEVENTY,T1CN0M0
100,169,2014,COPYRIGHT,FURTHER,INC,MEANWHILE,TODAY
142,169,2014,400,8805,9584,BACKGROUND,CONCLUSION,COPYRIGHT,CRPC,DOSE,EVALUATION,GLEASON,GRADE,INC,LABEL,METHODS,PSA,RESULTS,SECONDARY,SOLID,SORAFENIB,TEN,TTP
038,043,169,177,2013,COPYRIGHT,DISEASE,GMBH
4176,AFTER,ALT,AST,BACKGROUND,CONCLUSION,CRPC,DLT,DLTS,EZN,FIBONACCI,LABEL,METHODS,PHASE,RESULTS
0001,002,011,018,023,161,BACKGROUND,COHEN,COMPONENT,COMPOSITE,CONCLUSION,DENMARK,EPIC,INDEX,INTENSION,LABEL,METHODS,PCA,PRIMARY,QOL,RESULTS,SCALE,SHORT,SUMMARY
041,043,143,224,471,ALPHA,BACKGROUND,BETA,CONCLUSION,COX,JAPAN,LABEL,METHODS,RESULTS,VEGETABLE
169,2013,215,BACKGROUND,COPYRIGHT,D10,D25,IMRT,LABEL,LTD,MAXD,METHODS,MRI,PTV1,PTV2,PUBLISHED,RESULTS,SBRT,SIMILAR,THEREBY
2005,734,7759,BACKGROUND,CENTRAL,EFFORTS,EXCLUDING,LABEL,MEASURING,METHODS,NORTH,OBJECTIVE,RESULTS,USING,WORKFORCE
016,019,032,139,141,143,169,1MM,2013,20MG,5MG,675,704,8804,8805,916,BACKGROUND,COPYRIGHT,DFW,EDT,ENCOUNTER,FOUR,GLEASON,IIEF,INDEX,LABEL,MCID,METHODS,NSRP,OBJECTIVE,OUTCOME,PDE5,PROFILE,PUBLISHED,RANDOMISED,RESULTS,SECONDARY,SEP,SETTING,TADALAFIL,TREATMENT,TRIAL,UNASSISTED
174,292,8201,DOPPLER,DSW,EDV,LABEL,METHODS,NVB,OBJECTIVE,OBJECTIVES,OVERALL,PSA,PSV,RESULTS,THERE,THESE
8201,ABOUT,AIM,ALSO,DECREMENT,GLEASON,LABEL,METHODS,OBJECTIVE,PCA,PSA,PURPOSE,RESULTS,SURFACTANT,THERE,TNM,WESTERN
2009,2011,618,BACKGROUND,CONTEXT,DIAGNOSES,ECPBS,GLEASON,GUIDELINES,IHC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
100,150,200,945,956,ALA,DHA,EPA,GLA,HENCE,PCA,PUFAS,RWPE,THESE,TNF
300,BIOLOGICAL,BMA,CELL,DLS,FLU,LNCAP,MNCS,PHEA,TEM
1006,169,1968,2001,2011,2013,AMONG,BETWEEN,CALIFORNIA,CURRENTLY,FRANCISCO,GLEASON,HOPKINS,JANUARY,JOHNS,KETTERING,KOREA,LABEL,MEDICAL,METHODS,MIAMI,OBJECTIVE,OBJECTIVES,RESULTS,SAMSUNG,SAN,SEOUL,SLOAN,TORONTO,UNIVERSITY,UROLOGICAL
946,CELL,DU145,ELISA,FINALLY,IETD,IMMUNOBLOT,LC3II,MTT,PC3,SCREENING
THERE
181,GENISTEIN,H874Y,HOWEVER,LAPC,LNCAP,PCA,SIMILAR,T877A,THESE,THR877ALA,THUS,W741C
0001,001,205,214,221,99B,AFRICAN,CAUCASIAN,FFPE,MICRORNAS,MIR,PCA,PCR,ROC,WHILE
169,2013,AACR,DATA,LABEL,METHODS,MTC,OBJECTIVE,PURPOSE,RESULTS,SRE,SRES,STUDIES,ZOLEDRONIC
000,169,2013,AUC,CROHN,EMPIRICAL,GWAS,GWASS,HOWEVER,INC,PHASE,SNP,SNPS,WILEY
113,EASTERN,ERG,EUROPEANS,GLEASON,MOLECULAR,PROSTATIC,WESTERN
169,2013,8764,BACKGROUND,CD31,CXC,CXCL3,CXCL5,CXCL6,CXCL8,DISCUSSION,INC,LABEL,METHODS,PC3,RESULTS,WILEY
14Q32,154,299,376A,376C,377,381,485,487B,495,654,FINALLY,FZD4,GLEASON,PCA,PREC,PSA
169,2013,500,598,780,BACKGROUND,BECAUSE,CURRENT,INC,KALLIKREIN,LABEL,LITERATURE,META,METHODS,PANEL,RESULTS,WILEY
2009,2013,203,BECAUSE,CINPT,DAVINCI,GLEASON,JANUARY,LABEL,METHODS,MONTSOURIS,NVB,OBJECTIVE,PSM,PURPOSE,RESULTS,SEPTEMBER
ADT,ATRIGEL,GLEASON,LABEL,METHODS,OBJECTIVE,OVERALL,PCA,PRIMARY,PSA,PURPOSE,RESULTS,SECONDARY,T2A
001,008,109,110,169,180,2006,2010,2013,260,270,275,290,521,8201,BACKGROUND,DIAGNOSTIC,JANUARY,LABEL,MARCH,METHODS,NAVIGATION,NAVIGATORS,PATIENT,PROGRAM,RESULTS,SOCIETY,THERE
001,003,010,031,169,2005,2010,2013,8521,AMBULATORY,BACKGROUND,CARE,CURRENT,DATA,FACTORS,FORCE,GUIDELINES,LABEL,MEDICAL,METHODS,PREVALENCE,PREVENTIVE,RESULTS,SOCIETY,TASK,WHITE
CRPC,DOCETAXEL,III,WHILE
169,2013,390,800,CAM,CD45,CELLSEARCH,CTCS,EMT,ICC,PSMA,UICC,VITATEX,WHOLE
160,2000,2011,277,320,8804,8805,AMONG,CONCLUSION,LABEL,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS
SCHLAP1,SNF,SNF5,SWI
001,173,208,381,8804,8805,ALREADY,BACKGROUND,BECKMAN,COULTER,GLEASON,GS6,GS8,GSS,INCLUSION,LABEL,METHODS,NOC,PCA,PCAS,RESULTS,SCORE,THUS
1953,946,LNCAP,THESE
001,2005,2011,2278,669,8391,ACS,BACKGROUND,COLLEGE,COMPARISON,DATA,HOWEVER,LABEL,LRP,LRPS,METHODS,NSQIP,OPERATIVE,ORP,ORPS,OVERALL,PGY,PROGRAM,QUALITY,RESULTS,TRAINEE,USING
169,2013,ASPECTS,AUSTRALIA,AUTHORS,BACKGROUND,BJU,FURTHER,GLEASON,IMAGE,LABEL,MRI,PSA,SCREENING,SELECTION,TECHNICAL,TESLA,THERE,TREATMENT,UNASSIGNED,USANZ
1ST,329,3RD,6TH,HOWEVER,ICIQ,IIQ,LABEL,METHODS,OBJECTIVE,PURPOSE,REGARDING,RESULTS,SIMILAR,THERE,WITHOUT
CURRENT,ERG,GUIDELINES,PCA,POTENTIAL,PRO,PSA,THERE,THESE,TMPRSS2
611,AKT,ATM,DACI,ERK,FURTHER,H2AX,HDAC,HDACI,HDACS,INCREASED,OVERALL,PAN,PC3,PCA,PI3K,THESE
946,CHROMATIN,GLEASON,MDV3100,REST,TRCP
10Q11,11Q13,160,17Q12,17Q24,283,2P15,368,506,560,6Q25,7P15,8804,8Q24,946,CONSORTIUM,FBAT,GENIE,GWAS,HOWEVER,ICPCG,SNPS,XP11
120,597,776,ADVERSE,BONE,DENOSUMAB,ENDPOINTS,GRADE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SRE,SRES
000,200,EXPRESSION,PCA,PCR,PITX2,THESE,WNT,WNT5A
001,100,102,108,1152,125,148,154,234,305,329,344,361,414,419,442,490,541,597,624,631,636,798,BACKGROUND,LABEL,METHODS,MOST,OBJECTIVE,OLDER,OUTCOME,PATIENT,PROMS,PROS,REMINDERS,RESULTS,ROUTINE,SURVIVORS
ADDITIONAL,HEALTHCARE,KNOWLEDGE,LABEL,LYMPHEDEMA,MAIN,METHODS,NURSING,OBJECTIVE,OBJECTIVES,PURPOSE,QOL,RESULTS,SETTING,SPOUSES,SUPPORTING,TELEPHONE,VARIABLES
141,169,177,2013,5FU,8804,8805,CIS,COPYRIGHT,DOSE,HT3,IMRT,INC,KUTCHER,LABEL,LSS,LYMAN,MATERIALS,METHODS,MMC,OBJECTIVE,PBM,PURPOSE,RESULTS,TD50,TREATMENT
BACKGROUND,CONCLUSION,CORE,FAK,LABEL,METHODS,RESULTS,TGASE
947,BIS,CD2SU,CD2UR,DIAMIDE,FINALLY,OVERALL
ANTIGEN,CHAIN,DOCETAXEL,DTX,DUPA,FOLLOWING,GFLG,HPMA,PSMA,RAFT,REVERSIBLE,SHORT
8201,BACKGROUND,DOSE,DOSIMETRIC,FOUR,HELICAL,LABEL,METHODS,MODULATION,OAR,PTVS,RESULTS,TEN
CON,EVANS,FITC,LECTINS,TISSUES
MALIGNANT,THEIR
171,187,BONE,CALCIUM,DENOSUMAB,HOWEVER,III,NON,OBJECTIVE,SRE,SRES,THERE,TREATMENT
177,2011,2012,207,248,530,945,AFTER,AIMS,BESIDES,CONCLUSION,DATA,FEDERATION,INSTITUTE,LABEL,MEASURING,METHODS,OBJECTIVE,RESULTS,THESE,THOSE,UNLABELLED,WAITING
10B,253J,946,BASED,FM4,MCF7,PC3,WNT,WNT11,WNTS
185,8312
1990,2015,FINALLY,INCIDENCE,ITALIAN,ITALY,MORTALITY
1970,1990S,2012,2015,AIMS,BACKGROUND,CONCLUSION,ITALIAN,LABEL,METHODS,OBJECTIVE,RESULTS,THERE,THESE
000,100,106,140,167,180,1970,1992,201,2012,2015,205,295,300,493,512,AIMS,BACKGROUND,CONCLUSION,ESTIMATES,LABEL,METHODS,OBJECTIVE,RESULTS,SASSARI
000,100,1970,2012,2015,500,ACCORDING,AIMS,BACKGROUND,CONCLUSION,ESTIMATES,ITALIAN,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS
1970,1985,2000S,2002,2003,2005,2010,2015,AIMS,BACKGROUND,BASILICATA,CATANZARO,CONCLUSION,ITALY,LABEL,METHODS,OBJECTIVE,RESULTS,THESE
1970,2015,AIMS,BACKGROUND,CONCLUSION,ITALIAN,LABEL,METHODS,OBJECTIVE,PREVALENCE,RESULTS,SINCE
000,100,1996,2012,2015,629,675,969,AIMS,BACKGROUND,CONCLUSION,ITALIAN,LABEL,METHODS,OBJECTIVE,PREVALENCE,RESULTS,SALERNO
1970,200,2000S,2012,2015,300,341,394,698,ABRUZZO,AIMS,BACKGROUND,CONCLUSION,INCIDENCE,ITALY,LABEL,METHODS,OBJECTIVE,PREVALENCE,RESULTS
000,100,1970,1980S,1983,2012,2015,239,315,529,617,759,934,AIMS,BACKGROUND,CONCLUSION,INCIDENCE,ITALIAN,LABEL,LAZIO,METHODS,OBJECTIVE,PREVALENCE,RESULTS,SINCE,THESE
098,191,1970,1980S,1985,2002,2003,2012,2015,215,224,228,269,539,563,844,AGE,AIMS,BACKGROUND,COLORECTAL,CONCLUSION,ITALIAN,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS
000,2010S,2012,615,729,900,970,AGING,AIMS,BACKGROUND,CONCLUSION,ESTIMATED,EVALUATION,FAVORABLE,ITALIAN,ITALY,LABEL,METHODS,MODEL,OBJECTIVE,PUBLISHED,RESULTS
000,082,092,188,1970,1985,2012,2015,ACCORDING,AIMS,BACKGROUND,CONCLUSION,ITALIAN,LABEL,METHODS,OBJECTIVE,PREVALENCE,RESULTS,THESE,TUSCANY
000,100,1970,1980S,1988,2000,2001,2005,2010,2015,400,700,AFTER,AIMS,AMONG,BACKGROUND,CONCLUSION,ITALY,LABEL,METHODS,MORTALITY,OBJECTIVE,RESULTS,ROMAGNA
000,100,130,1970,1995,2015,700,800,AIMS,BACKGROUND,CONCLUSION,INSTITUTE,ITALIAN,ITALY,LABEL,METHODS,OBJECTIVE,RESULTS,STATISTICS,THESE,VENEZIA
000,1970,1987,2007,2012,2015,390,677,729,760,AIMS,BACKGROUND,CONCLUSION,ITALIAN,LABEL,METHODS,OBJECTIVE,PREVALENCE,RESULTS
100,1970,1986,2000S,2002,2006,2012,2015,ADIGE,AIMS,ALTO,BACKGROUND,BOLZANO,INCIDENCE,ISTAT,ITALIAN,LABEL,LIFESTYLE,METHODS,MORTALITY,OBJECTIVE,RESULTS
118,1970,1988,2012,2015,208,400,500,839,AIMS,BACKGROUND,CONCLUSION,GENOA,ITALIAN,LABEL,LIGURIA,METHODS,MORTALITY,OBJECTIVE,RESULTS
000,116,1970,1976,200,2012,2015,500,700,900,AIMS,BACKGROUND,CONCLUSION,HOWEVER,INCIDENCE,ITALIAN,LABEL,METHODS,MORTALITY,OBJECTIVE,PREVALENCE,PUBLISHED,RESULTS
000,1990S,2012,2015,300,700,900,AIMS,AOSTA,BACKGROUND,COLORECTAL,INCIDENCE,ITALIAN,LABEL,METHODS,MONITORING,MORTALITY,OBJECTIVE,PREVALENCE,PUBLISHED,RESULTS,TURIN
153,BACKGROUND,BESIDES,BONE,CONCLUSION,EDTMP,LABEL,MATERIALS,MBQ,MEIER,METHODS,OBJECTIVE,PRIOR,RESULTS
231,ACTIN,INCREASED,MDA,RHO,RHOA,ROCK,TREATMENT
BPS,FINALLY,III,KRAS,MAPK,PCA,ZOL
AMP,ATP,FINALLY,MYC,NADPH,NCI60,SOG,TAKEN
3RR,AKT,CAP,CHK1,CHK2,CSC,CSCS,DU145RR,EMT,LNCAPRR,PCR,PI3K
APART,CRP,LABEL,OBJECTIVE,OVERALL,PURPOSE,RESULTS,STUDIES,SUMMARY,THERE
0001,169,2013,8804,956,AREA,ATROPHY,FOCI,GLEASON,HGPIN,THESE,WHETHER
100,AREAS,BACKGROUND,COVERED,CRPC,DRUG,FDA,FOOD,HOWEVER,III,LABEL,METHODS,OPINION,OWING,PHASE,SEVERAL,WESTERN
000,0019,0026,0112,0133,0176,2011,BACKGROUND,FDA,III,LABEL,METHODS,OBJECTIVE,PLAN,PMPM,PREVALENCE,RESULTS,TREATMENT
0001,0006,0017,0046,174,2005,2013,3000,323,4000,8201,8804,8805,BACKGROUND,GREENLIGHT,LABEL,METHODS,PSA,RESULTS,SERUM
CERTAIN,HOWEVER,TMA
0001,001,005,114,8201,885,BACKGROUND,HOWEVER,LABEL,MEDLINE,METHODS,RCTS,RESULTS,URO,WHILE
100,CLU,CUSTIRSEN,DPC,ESTIMATED,LOWERED,MEN,MPC,PHASE,PSA,SUBJECT,THESE
398,922,BASED,COX,DOCETAXEL,EGFR,EGRF,MMP,PCA,THESE,VEGF
133,169,1995,2011,2013,649,8201,8805,BACKGROUND,BETWEEN,CONCLUSION,COX,INC,LABEL,MEIER,METHODS,OBJECTIVE,PCA,PSA,PSM,PSMS,RESULTS,RISK,SEVERAL,WILEY
169,2013,945,946,AMACR,BACKGROUND,CD44,CONCLUSION,DU145,ERG,INC,LABEL,METHODS,PC3,PCA,PSA,RESULTS,THESE,TIC,TICS,TMPRSS2,WILEY,ZEBRAFISH
326,586,912,946,AFTER,CAV1,CCND2,DEGS,EXPRESSION,GEO,MAPK,OMNIBUS,PPI,PROTEIN,REFERENCE,RXRA,SHC1,SRF,TGF,TGFB2,TGFB3,THEN,THEREFORE,THESE
1975,2010,ACCORDING,CONNECTING,CURRENT,SEER,STATISTICS
184,BPH,DU145,FCM,GLEASON,PC3,QKI,THESE,TNM,TUNEL,USING
BECAUSE,CANCERS,CURRENT,FDG,FDOPA,NAF,PET,WHILE
EPH,EPHA2,PC3,STRUCTURE,THESE
FDG,PET,PRIMARY,SERUM
PET
CRPC,RESULTS,USING,WHILE
001,2005,2010,AMONG,BACKGROUND,IMRT,LABEL,METHODS,NETWORK,RADIATION,RESULTS,SOCIETY,UROLOGISTS,USING
001,350,BASED,IC50,INDICATIVE,MODEL,OWING,P53
185,8312,PET,PRIMARY,THERE,ULTRASOUND
169,2013,954,BACKGROUND,ELISA,EXPRESSION,ICAM,INC,LABEL,LUCIFERASE,METHODS,MMP,RESULTS,WESTERN,WILEY
169,2013,3032,3123,BACKGROUND,EFFECTS,KEY,LABEL,METHODS,PREDICTORS,RESULTS,SOCIETY
169,2013,AKT,IKKI,IKKS,INCREASING,MOST,P450,TBK1,THEREFORE,TREATMENT,UICC,VEGF
169,2013,8201,8811,945,BACKGROUND,CAP,CHO,CONCLUSION,CURRENTLY,CWR22,DHT,INC,LABEL,METHODS,PROTEIN,REDUCED,RESULTS,WILEY
005,115,169,178,185,2013,8308,8309,8804,946,BACKGROUND,E12,GRP,HOWEVER,INC,LABEL,METHODS,MIB,PIN,RESULTS,ROD,THERE,TYR,WILEY
ARE2,ARES,E2F1,EMSA,PC3,TAKEN,TTP,UTR
037,1000,2011,263,267,923,931,AIMS,CONCLUSION,GPS,LABEL,METHODS,OBJECTIVE,PSA,RESULTS,THERE,ZEALAND
BDNF,BMI1,COMP,CSF2,DRS,GLI2,KIT,LABEL,LIF,LNCAP,METHODS,NINE,OBJECTIVE,OCT4,PCR,PURPOSE,RESULTS,RNAS,THESE,USING,VEGFA
0001,169,2011,2012,2013,239,302,542,546,AACR,APRIL,BIOTECH,BRIEN,COU,DRUG,FLEMING,FOOD,FULL,INC,JANSSEN
277,346,8805,ANAL,CHANGES,EBRT,LABEL,LOW,MEDLINE,METHODS,MUCOSAL,OBJECTIVE,PURPOSE,RECTOSCOPY,RESULTS,SCORE,THREE
BESIDES,EVS,HOWEVER,OTHER
0201,ALGORITHMS,ALSO,BECAUSE,CTLS,DETECTION,ERG,ETS,FINALLY,FIVE,HIGH,HLA,IDEAL,PCA,TMPRSS2
100,AZA,BOTH,COLORECTAL,CRC,DACH1,LEF,LOSS,MYC,SILENCING,TCF,THESE,WNT
169,195,1990,2013,268,8805,CAP,CONCLUSION,CONVERSELY,COPYRIGHT,GLEASON,INC,LABEL,MEN,METHODS,OBJECTIVE,OLMSTED,PSA,RESULTS,SINCE
105,116,1635,169,177,2013,431,549,946,956,9962,9999,ARTEMISIA,BASED,COLON,COPYRIGHT,CRL,DAD,DECNE,EXCELLENT,FINALLY,HCT,HPLC,IC50,LEUKAEMIA,LUNG,MTT,THP
169,2013,945,AROMATASE,BASED,COMPOUNDS,COPYRIGHT,CYP17A1,LTD,PC3,VIRTUAL
001,006,128,169,2013,9559,AUTHORS,BJU,FURTHER,G84E,GLEASON,HOPKINS,JOHN,LABEL,METHODS,OBJECTIVE,RESULTS,UNIVERSITY
1000,2001,2013,6442,BACKGROUND,BOTH,CLAVIEN,DINDO,DONAT,EACH,JANUARY,JUNE,LABEL,METHODS,OBJECTIVE,PROGRAM,PURPOSE,QUALITY,RESULTS,THREE
100,8201,CONCLUSION,HOLEP,III,LABEL,LUTS,MEDIANS,METHODS,OBJECTIVE,PCA,QOL,RESULTS,SCORE,SYMPTOM,TREATMENT
0001,CONCLUSION,DICE,ESTIMATES,LABEL,MATERIALS,MEAN,METHODS,MRI,OBJECTIVE,PEARSON,PSA,RESULTS
00001,0002,0007,961,CENTRAL,CONCLUSION,GLEASON,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PEARSON,PSA,PSAD,RESULTS,THESE
000,177,200,2012,AFTER,DICE,DSC,PCG,SIMILARITY,THEREFORE
2548,270,6569,7504,8405,9581,ATG,BACKGROUND,CBM,DESPITE,FURTHER,LABEL,LEP,LEPR,MEDLINE,METHODS,OVERALL,Q223R,RESULTS,SCIENCE,SNP,THEREFORE,WEB
CHANGES,HIV,IC50,KLK2,KLK3,MICHAELIS,PAGE,PROTEASES,PSA,SDS
060,134,160,197,2005,2007,262,290,ADT,BACKGROUND,DXA,FEWER,FURTHER,LABEL,MEN,METHODS,PART,RESULTS,TEXAS,THOSE,VARIATION
123,756,820,8201,CAUCASIANS,EAST,MEANWHILE,OVERALL,PSCA,SINCE
RNAS
177,2000,2011,637,671,714,717,733,ASIAN,BECAUSE,CAUCASIAN,JANUARY,LABEL,MEDICAL,METHODS,OBJECTIVE,OVERALL,RESULTS,SIMILARLY,STEPHENSON,TOKYO,UNIVERSITY,USING
100,CD56,CK20,CK7,FORTY,PSA,THESE,THREE
2008,BONE,IOF,TREATMENT,USA
145,22RV1,954,ARS,CRPC,CURRENT,F876L,H874Y,HOWEVER,SC245,SC97,T877A,W741C
011,036,121,123,151,160,185,1992,2005,336,795,8805,CCI,CSM,CUMULATIVE,DATA,GLEASON,HOWEVER,LABEL,METHODS,OBJECTIVE,OCM,PSA,PURPOSE,RESULTS,THERE,VARIABLES
CTC,CTCS,HOWEVER
CTV,D1CC,D95,DOSIMETRIC,EMT,FIVE,OAR,OARS,PDF,PTV
100,2040,460,823,AMONG,BOND,GATA3,GCDFP,L50,LEICA
003,006,165,241,GLEASON,THESE
001,003,BACKGROUND,BCR,CAPRA,COX,DUE,GLEASON,LABEL,METHODS,PSA,PSADT,RESULTS,ROC,STEPHENSON,TIME,WHILE
100,CRPC,THESE
200,CRPC,LEADING
CONSISTENT,FINALLY,PC3,RADIATION,S1P,SGPP1,USING
001,016,020,090,144,147,471,ANXIETY,CONCLUSION,DEPRESSION,EFFECTS,LABEL,MEN,METHODS,MOST,OBJECTIVE,OVERALL,PURPOSE,RESULTS,SCALE,TESTING,TREATMENT
169,2013,945,CD98,IDO1,INC,LAT1,MICROARRAY,MITOVES,TICS,TRP
132,916,COMPARISON,FINALLY,KINETIC,T325A,T325D,THESE,UDP,UGDH
169,2013,AKT,BXPC,CDDP,CISPLATIN,COPYRIGHT,ECTOPIC,EMT,HOWEVER,INHIBITION,IRELAND,LTD,PAR,PI3K,THEREFORE,TREATMENT
169,2013,AMONG,COPYRIGHT,LTD,NMR,SEMI,SINULARIA,STRUCTURES
111,169,174,2014,ANTI,COPYRIGHT,EDUCATION,FACBC,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,REFERENCE,RESULTS,UROLOGICAL
001,169,2001,2007,2014,614,661,ADHERENCE,AREAS,CONSORTIUM,COPYRIGHT,DESPITE,EDUCATION,END,FORUM,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PHYSICIAN,PUBLISHED,PURPOSE,QUALITY,RESULTS,SEER,SERVICE,UROLOGICAL
110,169,2013,233,BACKGROUND,BCG,COPYRIGHT,COX,LABEL,MAIN,METHODS,NMIBC,OBJECTIVE,OUTCOME,PATTERN,PREDICTORS,PRIMARY,PUBLISHED,RESULTS,SECONDARY,SETTING,TIS,UUT,VARIOUS
956,AKT,ALSO,ASIAN,COMPOUNDS,EAST,ERK1,IC50,MAPK,NMR,SNU,THESE,TREATMENT
CAF,CAFS,ERK1,HOWEVER,TIMP,TREATMENT
2013,ASSESSMENT,DIAGNOSTIC,ERG,HOWEVER,JULY,OVERALL,PCR,QUALITY,STUDIES,TMPRSS2,WEB
112,117,GLEASON,LABEL,MATERIALS,METHODS,NONE,OBJECTIVE,PER,PET,PURPOSE,RESULTS
001,108,152,2004,2009,524,AUR,CONCLUSION,IPSS,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS,SCORE,SIXTEEN,SYMPTOM,T1C,T3B
0001,946,BOTH,CAF,DNMT1,GSTP1,H3K9ME3,HOMOLOGOUS,LNCAP,PCR,RESTORING,SEVENTY,STROMAL,TAKEN,TGBR2,TGF
0001,160,169,199,2012,2013,399,6067,800,8805,AACR,CLIN,DRUG,FDA,FOOD,INC,MEDIVATION,OVERALL,RES
0106,169,1996,2012,2013,504,AACR,CLINICALLY,CONCLUSION,HYPOXIA,IGRT,IHC,LABEL,MEIER,METFORMIN,METHODS,OBJECTIVE,PET,PURPOSE,RADIATION,RESULTS,THREE
946,COLLEGE,DUKE,JULY,MEDICAL,MOUNT,SCIENCE,SINAI,THESE,UNIVERSITY
169,2013,8320,8321,8325,947,956,COPYRIGHT,LNCAP,PM49,PPAR,SAS,THESE
169,2013,231,946,DUE,HB1,IFN,MCF,MDA,PCR,SCF,VEGF
160,CBCT,CTV,EIGHT,IMRT,NTCP,PTV,SIM,TCP
001,004,035,169,1987,2010,2014,271,472,BLOOD,COPYRIGHT,EDUCATION,GLEASON,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THESE,UROLOGICAL,WHILE
169,2013,BLOOD,COPYRIGHT,HOWEVER,RIA,STEROID
169,2014,COPYRIGHT,HENCE,HPV,HPVS,INC,INFECTION,LABEL,MATERIALS,METHODS,MOST,OBJECTIVE,OBJECTIVES,RESULTS
169,2013,9821,ALP,CLEIA,COPYRIGHT,MMP,MMPS,PSA,RESULTS
169,2013,CHANGES,COPYRIGHT,CRPC,EACH,LTD,POST,RNAS,TAKEN
001,1118,113,168,169,170,177,185,194,2005,2011,2013,BODY,CASES,CONCLUSION,CONCURRENT,COPYRIGHT,ESTIMATED,INC,JULY,LABEL,MEAN,METHODS,OBJECTIVE,RARP,RARPS,RESULTS,THERE
001,160,169,1990,1996,2000,2007,2014,AFRICAN,CONCLUSION,COPYRIGHT,DATA,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PSA,RESULTS,SERUM,THESE
0001,024,169,177,2013,450,ASSESSMENT,BOTH,COMPOSITE,CONCLUSION,CONSORTIUM,COPYRIGHT,HRQOL,INC,INDEX,LABEL,METHODS,NADT,OBJECTIVE,QUALITY,RESULTS,TREATMENT
103,125,131,160,169,2014,CARLO,COPYRIGHT,DOSIMETRIC,HOWEVER,INC,LABEL,MATERIALS,METHODS,MONTE,MRI,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SOCIETY,VOLUMETRIC
169,2013,215,226,8805,ARGON,BOTH,CLINICALLY,COMPOSITE,CONCLUSION,COPYRIGHT,CUMULATIVE,GROUP,INC,INDEX,LABEL,MATERIALS,MEIER,MEN,METHODS,OBJECTIVE,PSPT,PURPOSE,QOL,RADIATION,RESULTS,SSPT,THERAPY,THERE
0001,100,125,155,169,2000,2004,2008,2013,419,574,AUTOMATED,CONCLUSION,COPYRIGHT,D90,DOSIMETRIC,FIRST,GLEASON,GRADE,INC,LABEL,MATERIALS,METHODS,NUCLETRON,OBJECTIVE,PPB,PURPOSE,RESULTS,UNIVARIATE,V100
019,049,169,2013,AIM,APC,ARGON,BRITAIN,COLORECTAL,CONCLUSION,CONTROL,CRP,DISEASE,FOLLOWING,GREAT,IRELAND,LABEL,METHODS,OBJECTIVE,RESULTS,SIXTY
ADC,DWI,GLEASON,LABEL,METHODS,MRI,OBJECTIVE,OBJECTIVES,RESULTS
8482,ARRAY,BASED,DEFENSE,LNCAP,OXIDATIVE,PCR,PNT1A,SELOL,UNDER
248,488,507,ANOTHER,BACKGROUND,DATA,EASTERN,GROUP,III,LABEL,METHODS,RESULTS,SEVERAL,SPARC
169,177,2013,8201,CONCLUSION,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,MOLDING,OBJECTIVE,PERCENT,PURPOSE,RESULTS,TEN,WILEY
10R,CCL16,CD4,CD8,CPG,INTRA
1996,2007,218,693,8805,COX,GLEASON,LABEL,MEAN,METHODS,OBJECTIVE,OBJECTIVES,PSA,RESULTS,SCORE
0001,051,132,163,177,1989,2009,210,598,AMICO,BPFS,EACH,GLEASON,GROUP,LABEL,METHODS,MRI,OBJECTIVE,OBJECTIVES,PSA,PT3B,RESULTS,UNIVARIATE
HOWEVER,RADICAL,THERE
ANTI,ASC,FACBC,FDG,LABEL,MET,METHODS,MLLB2,OBJECTIVE,PET,PROCEDURES,PURPOSE,RESULTS,USING
AFTER,ANTI,BACKGROUND,CASE,CLINICIANS,CONCLUSION,LABEL,METHODS,PSA
104,2008,2013,547,634,654,768,781,APRIL,ASIAN,INDEX,LABEL,METHODS,OBJECTIVE,PCA,PSA,PURPOSE,RESULTS
8201,ACCORDING,ALP,BMD,BONE,CLINICIANS,GLEASON,PLAIN
11C,169,18F,2014,BACKGROUND,CONCLUSION,COPYRIGHT,FACBC,FURTHER,INC,LABEL,METHODS,PCA,PET,PSA,RESULTS,TBR
169,2000,2010,2013,3080,425,438,513,CONCLUSION,COPYRIGHT,INC,INCREASED,INSURANCE,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS,SIR,SIRS
0001,169,2014,COPYRIGHT,EDUCATION,EIGHT,GLEASON,INC,J591,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SPECIMENS,TESLA,UROLOGICAL
169,2013,COPYRIGHT,INC
106,106B,169,2013,30D,8805,AUTHORS,CLINICALLY,EMPLOYING,GLEASON,INC,LNCAP,NED,PC3,PCA,PCR,PUBLISHED,REST
101,2005,2011,259,8805,CUMULATIVE,FIRST,GRADE,IMRT,INCIDENCES,THEN
HAFFNER,JCI,PROGNOSIS,THEIR
DESPITE,PTEN,SIMILAR
100,169,2013,AGE,BONE,COPYRIGHT,GMBH,HOWEVER,SRC,THERE
CTC,CTCS,INC,PUBLISHED,THERE
435,BASED,BOTH,CNS,DUE,FURTHER,GHR,GHRS,III,INC,INSTITUTE,MDA,MEL,NCI60,PRL,PRLR,PUBLISHED,STAT5,STRIKINGLY,UACC,WHILE
169,2013,COPYRIGHT,LTD,OVERALL,SSRIS,TCAS,THEREFORE,THUS
169,2013,ADT,DATA,JOHN,LTD,SONS,THESE,WHILE,WILEY
1200,1951,CITY,CURRENTLY,YORK
019,169,2000,2011,2013,620,8201,JAPAN,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,UROLOGICAL
100,945,946,ACUTE,ADT,BACKGROUND,BORTOLO,CYBERKNIFE,FOUR,GRADE,IRB,ITALY,LABEL,LATE,METHODS,PSA,RADIATION,RESULTS,RISK,ROBOTIC,SAN,SBRT,VICENZA
ETS,III,PCA3,PCR,PSA,TMPRSS2
169,2013,COPYRIGHT,JOHN,LTD,REUSE,SOMETIMES,SONS,WILEY
0001,0003,003,122,169,2013,8201,8805,ADT,BACKGROUND,CONCLUSION,COX,CRPC,DATA,ECOG,IGF,IGFBP,INC,INSULIN,LABEL,METHODS,PSA,RESULTS,THERE,WILEY
169,1998,2010,2013,826,8805,BACKGROUND,CONVERSELY,INC,INPATIENT,LABEL,METHODS,MOST,NATIONWIDE,OVERALL,PCA,RESULTS,THERE,THESE,WILEY
131,177,CD34,FINALLY,FURTHER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIMILAR,USING,WHOLE
169,1989,2008,2010,2013,672,AUTHORS,BJU,LABEL,METHODS,OBJECTIVE,PCA,RESULTS
169,2013,AUS,AUTHORS,BJU,CONTINENCE,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,THERE
102,126,169,183,184,2008,2009,2013,8364,BACKGROUND,COPYRIGHT,LABEL,LTD,LUNG,LUXEMBOURG,METHODS,RESULTS,THESE,UNION
1987,1993,2000,2007,2010,5315,649,964,CRC,FINLAND,FINNISH,IBD,INSURANCE,METHODS,OBJECTIVE,OVERALL,RESULTS,SIR
1040,AAG,AKT,BIM,ERK,HRCP,HSP90,PCA,PTEN,SLUG,USING
LAPC4,LNCAP,PAK6
BACKGROUND,BOTH,CASODEX,CONCLUSION,EGF,EGFR,LABEL,METHODS,MMP,PRESENT,RESULTS,SRC,THEREFORE
945,946,CD4,DYNAMIC,EXOGENOUS,IGF,INTEGRINS,PRCA
00001,135,226,241,385,8202,ALPHA,AMACR,BACKGROUND,CAUCASIANS,COA,EXPRESSION,IHC,LABEL,METHODS,PCA,PCR,RESULTS,THEN,THERE
033,036,268,351,AFRICAN,AMERICANS,ASIAN,ASSESSMENT,FUNCTIONAL,GENERAL,LABEL,LACK,METHODS,OBJECTIVE,PURPOSE,QUALITY,RESULTS,THERE,TREATMENT,TRIAL
169,1983,2004,2013,4VS,902,AACR,BACKGROUND,COX,ERG,GLEASON,HIGH,HRQUARTILE,HRS,LABEL,METHODS,PARTIAL,PSA,PSMA,RESULTS
215,CD82,COX,HOWEVER,KAI1,RHO,TAKEN
CAP,CURRENT,LABEL,METFORMIN,MYC,PCA,PIN,REDUCED,RWPE,SUMMARY,UNLABELLED
169,2013,231,8201,AFRICAN,CENTERS,CONTROL,COPYRIGHT,DISEASE,HIGH,HOWEVER,JOHN,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,RRR,SONS,WILEY
001,031,2011,2012,235,250,CONCLUSION,CONVERSELY,INCLUSION,JANUARY,LABEL,MEAN,METHODS,MRI,OBJECTIVE,PATIENT,PCA,PSA,PURPOSE,RESULTS,THERE,TRUS
0001,0002,001,044,168,2005,2010,2012,295,BACKGROUND,BETWEEN,GLEASON,LABEL,MATERIALS,MAY,MEN,METHODS,OVERALL,RESULTS,SEPTEMBER,THOSE,TRUS
169,2013,AMP,AMPK,HOWEVER,INC,WILEY
ALSO,ANY,FSH,SERTOLI,THERE
018,022,169,2014,451,AMONG,BACKGROUND,CONCLUSION,COPYRIGHT,FIFTY,FURTHER,ID1,INC,LABEL,METHODS,MOLECULAR,RESULTS,SEVENTY
10X,1200,250,CHUM,HOPITAL,INTUITIVE,LUC,RADICAL,RARP,RARPS,ROBOTIC,SUNNYVALE,UNIVERSITY,USA,VINCI
0001,100,125I,145,2002,2006,ASTRO,BACKGROUND,D100,D90,GLEASON,LABEL,MATERIALS,MAY,MEIER,METHODS,PATIENT,PHOENIX,PREPLANNED,PSA,RESULTS
00003,006,114,BACKGROUND,INCLUSION,LABEL,LDB,MATERIALS,METHODS,RESULTS,TAB,WITHOUT
0MM,169,176,1MM,2013,2MM,3MM,4MM,5MM,8MM,931,963,BACKGROUND,COPYRIGHT,INCLUSION,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS
056,096,126,140,195,200,2000,2010,208,229,249,625,884,BACKGROUND,BMI,JANUARY,LABEL,METHODS,NINTH,REGARDLESS,RESULTS,THERE
2011,428,500,BOTH,PSA,SINCE
174,533,8201,ACCURAY,CONCLUSION,DATA,IMAGE,INSTITUTES,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,RESULTS,SCAN,SUNNYVALE,THERE
1024,169,2013,297,400,473,8804,AUTHORS,BJU,DRS,FOUR,GLEASON,LABEL,METHODS,OBJECTIVE,OVERALL,PCA,REAL,RESULTS,RTE,TRUS
001,002,006,007,010,012,015,102,1218,123,153,169,1987,2008,2012,2013,2175,2182,2219,2385,317,387,534,592,ADT,AUSTRALIA,AUTHORS,BJU,DATA,IRR,LABEL,METHODS,OBJECTIVE,PATIENT,PSM,PSMS,RESULTS,RPS,THESE
100,137,150,169,200,2010,2011,2013,2061,400,700,750,ASPIRIN,AUTHORS,BETWEEN,BJU,CLAVIEN,III,LABEL,MAJOR,METHODS,OBJECTIVE,RARP,RARPS,RESULTS,RPS
169,174,2010,2013,AFTER,AUTHORS,BJU,CARE,CONCLUSION,DATA,FERTI,HOWEVER,IIEF,INDEX,JOHN,JULY,LABEL,LTD,MARCH,METHODS,OBJECTIVE,PVS,RESULTS,SONS,THERE,WILEY
8805,HSP90,INHIBITING,NOVOBIOCIN,PRESTWICK,UTILIZING
100,945,BISPECIFIC,CD3,DUPA,EC50,FAB
CHIP,CONVERSELY,EPIGENETIC,FINALLY,H2A,H2AFZ,HISTONE,INDUCED,INHIBITION,REMARKABLY,SIRT1,THUS,TSS
001,015,021,024,026,044,1121,1450,169,2013,217,335,509,549,AFTER,AMONG,BACKGROUND,BCR,COX,CRPC,CURRENT,EQUAL,LABEL,MEIER,METHODS,RESULTS,SIMILAR,SOCIETY
169,2013,7417,8201,BACKGROUND,C30,CORE,COX,EORTC,HRQOL,LABEL,LIFE,METHODS,QLQ,QUALITY,RESULTS,SOCIETY,TREATMENT,WORLD
160,169,177,2011,2012,2013,8805,ACADEMY,ANDROLOGY,DESPITE,EJD,JULY,KNOWLEDGE,MAY,MSHQ,OVERALL,SOCIETY
174,III,MDV3100
956,BAP,CRPC,GLEASON,HOWEVER,LABEL,METHODS,OBJECTIVE,PLT,PSA,RESULTS,SCORE,STRONTIUM,USING
1154G,2578C,285,879,FINALLY,HOWEVER,META,THERE,THEREFORE,VEGF
1485,181,2008,213,255,271,983,CONCLUSION,DEGRO,IMRT,JULY,LABEL,METHODS,OBJECTIVE,OCTOBER,PERSONNEL,PURPOSE,QUIRO,RADIATION,RESULTS,SOCIETY,TIMES,TOTAL
137,258,8201,8805,BACKGROUND,GLEASON,LABEL,METHODS,MPMRI,PSA,RESULTS,SECONDARY,TPM
000,006,040,061,248,676,BACKGROUND,DUAN,INDEX,LABEL,METHODS,PATIENT,PCI,RESULTS,RMSE,SCALE,UTILITIES,UTILITY
AKT,BBN,BCA,CASODEX,EGF,EGFR,EPIDERMAL,MAPK,PI3K
001,007,2001,2011,314,327,357,438,BACKGROUND,LABEL,METHODS,PRIMARY,PSA,RATES,REASONS,RESULTS,SECONDARY,TAX,TRIAL
APOPTOSIS,BXPC,CELL,CELLS,CONTINUOUS,HPAC,METHIONINE,THESE
169,2014,320,8805,BACKGROUND,CONCLUSION,COPYRIGHT,DATA,EASTERN,ECOG,GROUP,INC,INVENTORY,LABEL,MDASI,METHODS,QOL,RESULTS,SOAPP,SYMPTOM
169,2014,ADT,BACKGROUND,CONCLUSION,COPYRIGHT,COX,DPD,FAILURE,INC,LABEL,MARKERS,METHODS,PSA,RESULTS,SERUM,SRE,SRES
010,012,018,100,1006,125,130,169,2000,2014,833,990,ADT,COPYRIGHT,D90,DATA,DFS,GLEASON,HOWEVER,INC,LABEL,LDR,MATERIALS,METHODS,MOST,NETWORK,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SOCIETY,UNIVARIATE,V100
177,25411,AAA,ALGORITHM,ANALYTICAL,ARIZONA,AXB,CARE,CONCLUSION,DOSE,ECLIPSE,FINALLY,LABEL,MATERIALS,MEAN,METHODS,OARS,OBJECTIVE,PLANS,PTV,PURPOSE,RESULTS,V100
169,2013,24H,AKT,AMPK,APOPTOSIS,ATG,ATG12,ATG5,ATG7,AUTOPHAGY,AYURVEDIC,BAF,CHX,COPYRIGHT,CSCS,HOWEVER,IRELAND,LC3,LTD,PI3K,RNAI,ROTT,ROTTLERIN,WESTERN
1994,2006,874,CONCLUSION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,UNIVERSITY,USING
169,2013,AR3,BLACKWELL,EXPRESSION,FSH,GMBH,OVERALL
HDR,HIGH,HOWEVER,LDR,LOW,STUDIES
917,CELL,EMT,EPITHELIAL,ESRP1,MET,OVOL,OVOL1,OVOL2,PROTEIN,REGULATORY,SEVERAL,TFS,USING,ZEB1
169,2013,AACR
DU145,ECS,LNCAP,PC3,PTRF
005,169,2013,CONCLUSION,COPYRIGHT,INC,LABEL,MATERIALS,MEAN,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,WEAK,WILEY
169,2013,627,8201,BXS,COPYRIGHT,EMPIRICAL,ESTIMATION,GLEASON,HOPKINS,HOWEVER,JOHN,JOHNS,LTD,SONS,UNIVERSITY,WHETHER,WILEY
169,2013,ACCORDING,APOPTOSIS,GMBH,KGAA,MCF7,MTT,PC3,SKNMC,THESE,VCH,WILEY
169,2013,BACKGROUND,BORIS,CTCF,DETECTION,GLEASON,INC,INCREASED,LABEL,METHODS,RESULTS,WILEY
001,006,007,026,030,222,8805,AIM,CONCLUSION,DRE,GLEASON,ITALIAN,LABEL,METHODS,OBJECTIVE,PCA3,PSA,RESULTS,SCORE
100,AIM,CONCLUSION,HFRT,HRPC,LABEL,METHODS,NINE,OBJECTIVE,PHASE,RESULTS
177,2007,2012,2AGU,3DCRT,3DRCT,ACUTE,AFTER,AIMS,BETWEEN,CONCLUSION,FORTY,GRADE,GROUP,HYPO,LABEL,METHODS,OBJECTIVE,RADIATION,RESULTS,THERAPY,TREATMENT,V70GY,V95,VMAT
241,8552,8804,AIM,CONCLUSION,DRE,LABEL,MATERIALS,METHODS,OBJECTIVE,PICOGREEN,PSA,RESULTS,SERUM
001,023,215,8805,AGE,AIM,BACKGROUND,CONCLUSION,LABEL,METHODS,MSCC,OBJECTIVE,RESULTS,SIX
BACKGROUND,CD133,CONCLUSION,CSC,CSCS,LABEL,LNCAP,LOW,MATERIALS,METHODS,RESULTS,ROS,THEREFORE
239,BACKGROUND,CONCLUSION,DU145,LABEL,LNCAP,MATERIALS,METHODS,PREVENTION,RESULTS
100,956,BACKGROUND,CELL,CONCLUSION,CONJUGATED,DU145,LABEL,LNCAP,MATERIALS,METHODS,MTT,PC3,PCR,PNT2,RESULTS,VCAP
500,CONCLUSION,DU145,E2F1,ECTOPIC,ID1,ID2,ID3,ID4,INHIBITOR,LABEL,MATERIALS,METHODS,RESULTS,UNLABELLED,WESTERN
OPTIONS
169,2013,BACKGROUND,BMSC,BONE,DU145,HOWEVER,INC,LABEL,LAMP1,LC3B,MDA,METHODS,PC3,PCA,QPCR,RESULTS,SMALL,VCAP,WESTERN,WILEY
ADT,ALBERTA,BACKGROUND,BRITISH,CONCLUSION,HOWEVER,LABEL,METHODS,ONTARIO,PHYSICIANS,PROVINCES,RESULTS,THERE
169,2006,2009,2013,447,652,BACKGROUND,DOWNSTREAM,HRR,HRRS,IRR,LABEL,METHODS,PSA,RESULTS,SOCIETY
150,2007,2011,303,352,374,398,412,CONCLUSION,DATA,EVALUATION,IPSS,LABEL,LUT,LUTS,MARCH,METHODS,NIGERIA,OBJECTIVE,PSA,PVR,RESULTS,SCORE,SEVENTY,SYMPTOM,THERE,TRUS,WHILE
BIP,CREB3L4,DNAJC12,HSC70,HSP70,LNCAP,THESE
169,2008,2011,2013,862,8804,8805,BACKGROUND,BRIGHAM,COX,DANA,EASTERN,GROUP,JULY,JUNE,LABEL,LES,METHODS,PREDICTING,RESULTS,SOCIETY,WOMEN
169,2013,HOWEVER,INC,NMRI,NOD,SCID,THEIR,WILEY
169,2013,BACKGROUND,CIS,LABEL,METHODS,RESULTS,SOCIETY,UPPER,WALKING
DPD,DU145,EVENTUALLY,PCR,TAKEN,THEN,THUS,WST
169,183,BARTH,BRAF,CTLA4,GEORG,IPILIMUMAB,PARTIAL,REGRESSION,STUTTGART,THEREFORE,YORK
ARA70,CRPC,FURTHER,HISTOLOGIC,HOWEVER,KLK2,LNCAP,PCA,RESULTS
196,697,827,893,BECAUSE,CHINESE,DATA,DRE,PSA,PSAD,SEVERAL,TRUS
CHALLENGES,CURRENTLY,HOWEVER,MOST
ADTH,LNCAP,SEVERAL,THROUGH,UDP,UGT,UGT2B,UGT2B15,UGT2B17
HOWEVER,WARBURG
169,2013,AACR,C601,HSP90,THESE,UBIQUITOUS
ABL,ATF,ATF2,CCAAT,CONCLUSION,KR28,LABEL,MAPK,METHODS,NUGC,OBJECTIVE,PCR,PURPOSE,RESULTS,RHOB,ROS,SRB,WESTERN
103E,HAI,KNOCKDOWN,PCA,THESE
1031,1294,1463,1465,198,1991,2009,230,3034,326,454,505,656,767,851,927,BACKGROUND,CIS,COOKING,DAILY,FRIED,ITALY,LABEL,METHODS,ODDS,ORS,RESULTS,RISK,THESE,WESTERN
169,2013,BACKGROUND,BOTH,CONCLUSION,DCFDA,DHR,DU145,EMSA,EXPRESSION,FURTHER,GENERAL,GSH,GSSG,KNOCK,KNOCKDOWN,LABEL,MATERIALS,METHODS,NRF2,PC3,PCR,RESULTS,ROS,THEIR
169,2013,ANNEXIN,ANXA5
000,072,100,169,1996,2004,2009,2014,236,276,407,425,459,498,6282,768,843,910,912,948,981,989,BACKGROUND,CONCLUSION,COPYRIGHT,COX,INC,INCIDENCE,INSURANCE,JANUARY,LABEL,METHODS,RESULTS,TAIWANESE,THERE,WHETHER
169,2013,327,COPYRIGHT,COX,MEN,PUBLISHED,TAX,THESE,THUS
169,173,2013,272,GLEASON,HOWEVER,LOW,PSA,SNPS,VDR
169,177,2007,2010,2013,8230,BVZ,COX,DATA,HOWEVER,ONJ,OTHER
169,1988,2008,2013,BACKGROUND,COPYRIGHT,DATA,DECREASES,DISCUSSION,INCIDENCE,INCREASING,INDIVIDUAL,LABEL,LTD,METHODS,RESULTS,THUS
169,194,2013,864,COMPOSITE,CONCLUSION,COPYRIGHT,DATA,EPIC,INC,INDEX,LABEL,MATERIALS,METHODS,OBJECTIVE,PATIENT,PURPOSE,QOL,RESULTS,SBRT
169,2013,COPYRIGHT,IMRT,INC,INCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,THESE
169,2013,241,CHOLINE,COPYRIGHT,ESPA,HOWEVER,PET,THEREFORE,ULTRASOUND
0001,108,169,180,2013,6MM,AFTER,CONCLUSION,COPYRIGHT,EBRT,IRELAND,LABEL,LTD,MATERIALS,METHODS,MRI,MRIS,OBJECTIVE,PCA,PURPOSE,RESULTS,SIS
169,2014,COPYRIGHT,LTD,SEVERAL,TREATMENT
001,007,038,100,169,2013,ADT,ASSESSMENT,BACKGROUND,CLINICALLY,COPYRIGHT,DISEASE,DURABILITY,FACT,FATIGUE,FUNCTIONAL,FURTHER,LABEL,METHODS,OBJECTIVE,OUTCOME,PUBLISHED,QOL,RESULTS,SETTING,THERAPY,TRIAL
001,002,169,1980,2006,201,2013,8805,AMONG,AUTHORS,BJU,CONCURRENT,COX,LABEL,MEIER,METHODS,OBJECTIVE,RESULTS
169,2002,2006,2013,8201,8804,8805,904,AUTHORS,BCR,BJU,CONCLUSION,COX,LABEL,METHODS,OBJECTIVE,PSA,PSM,PSMS,RARP,RESULTS,SMS
075,160,169,176,180,183,2013,8805,ADT,AGE,BACKGROUND,CON,INDICES,ISO,JOHN,LABEL,LTD,MEN,METHODS,MHS,NINE,NUCLEAR,PCA,PEAK,PHYSIOLOGY,PSA,PUBLISHED,RESULTS,RTLM,SOCIETY,SONS,TBLM,THESE,TOTAL,WBS,WILEY
0045,076,169,2013,296,8025,AIMS,BACKGROUND,CONCLUSION,LABEL,MAIN,METHODS,OBJECTIVE,OUTCOME,RESULTS,SOCIETY
001,169,2013,8201,ADT,AGING,AUSTRALIAN,BACKGROUND,CHANGES,COLLEGE,CSA,HOUNSFIELD,LABEL,METHODS,PRE,RESULTS,ROYAL,THERE,THEREFORE,ZEALAND
001,169,2013,8201,859,ADT,AUSTRALIAN,BACKGROUND,COLLEGE,EIGHT,FACE,HOME,LABEL,METHODS,PROGRAMME,RESULTS,ROYAL,SUPPORT,ZEALAND
001,028,032,160,169,177,2013,AMONG,B2M,CRBN,FORTY,IHC,IMID,IMIDS,ISS,JOHN,LTD,PUBLISHED,SONS,WILEY
169,2013,ERK1,KI67,LNCAP,MEK,NADPH,OHDG,POSITIVITY,REDUCTION,THERE,THESE,TRAP
169,2013,213,ASSESSMENT,FUNCTIONAL,FURTHER,GENERAL,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,THERAPY,UROLOGICAL
001,169,176,2013,215,SUCCESSFUL,UROLOGICAL
109,169,2013,AIMS,JOHN,LABEL,LTD,METASTATIC,METHODS,OBJECTIVE,RESULTS,SONS,SUBMISSION,WILEY
102,160,169,177,2013,252,ACADEMY,ANDROLOGY,DATA,MRI,MRIS,SOCIETY,TYPICAL
2000,2011,2012,335,454,9679,COLORECTAL,FORCE,INSTITUTE,INSTITUTES,LUNG,OVARIAN,PLCO,PREVENTIVE,SCREENING,TASK,TRIAL
169,2013,760,946,BACKGROUND,DRE,FOLLOWING,INC,LABEL,MALDI,METHODS,MSMB,PCA,PRE,PSA,RESULTS,THESE,WILEY
169,190,196,2013,330,BACKGROUND,CAP,DESPITE,ERG,ERP,ERPS,INC,LABEL,META,METHODS,MONOAMINE,RESULTS,TMPRSS2,VCAP,WILEY
141,169,2013,221,26A,26B,BACKGROUND,ERG,INC,LABEL,METHODS,NETWORK,PCBN,PCR,QUALITY,RALP,RESULTS,RIN,RRP,TMPRSS2,WILEY
169,2013,945,BACKGROUND,BONE,CD45,FUNCTIONAL,HEALTHY,INC,LABEL,MET,METHODS,PSA,RESULTS,THESE,WILEY
001,002,031,134,169,177,2013,280,546,8201,BACKGROUND,INC,LABEL,METHODS,RESULTS,URINE,VOIDING,WILEY
169,2013,BRITAIN,CASTRATION,COPYRIGHT,CRPC,DATA,EFFECTS,FFPE,FISH,GREAT,IRELAND,JOHN,LTD,NGS,PC3,PCA,PTK2,PUBLISHED,SCNA,SCNAS,SOCIETY,SONS,WILEY,YWHAZ
198,BOTH,DATA,SNP,SNPS,THESE
960,EACH,EPIGENETIC,ERG1,ETS,GSTP1,MYC,PIA,PIN,RARE,SUBSEQUENT,TMPRSS2
100,1897,300,SINCE
169,2013,2801,3106,8805,BACKGROUND,EASTERN,FATIGUE,GROUP,LABEL,METHODS,RESULTS,SOCIETY,USING
946,947,AFTER,MEROPENEM,PSA,SUSPECTING,THEN
12TH,2011,20TH,61ST,ADDITIONAL,MAY
021,027,036,038,2000,2010,342,65308,65309,8805,GLEASON
AUA,FORCE,HOWEVER,INTERIM,ONGOING,SOCIETY,STUDIES,TASK,UROLOGICAL
BESIDES,BORTEZOMIB,CIP1,ELASTIN,ELP,FDA,USING,WAF1
169,2013,BOTH,COPYRIGHT,CPG,HOWEVER,INC,MOTIF,PATHOLOGY,PUBLISHED,SOCIETY,SP1
160,ANALYTICAL,PHI,PSA,PSAL,PSAT,ROC
169,2013,945,AKT,ERK,EXCESSIVE,HIF,KNOCKDOWN,NADPH,NOX1,PUBLISHED,ROS,THESE,VEGF
10MIN,169,2013,COPYRIGHT,INC,LPA,LPA1,LPA3,NADPH,NOX,OVERALL,PKC,PLC,ROS,USING,VEGF
002,006,019,028,029,050,100,169,2010,2011,2013,400,ACTRN,AUSTRALIA,BACKGROUND,BETWEEN,COPYRIGHT,GROUP,LABEL,METHODS,OBJECTIVE,OUTCOME,PCA,PUBLISHED,RADAR,RADIATION,RANDOMISED,RESULTS,SECONDARY,SETTING,SUPERVISED,TRANS,TRIAL,ZEALAND
100,111,169,170,2013,215,8804,8805,AFTER,APC,ARGON,COPYRIGHT,EACH,EFFECTS,INC,LABEL,LATE,MANAGEMENT,MATERIALS,METHODS,OBJECTIVE,PURPOSE,REDUCTIONS,RESULTS,SUBJECTIVE,THERE,TISSUES
0001,001,005,0126,034,039,099,169,2013,257,491,748,763,8805,ACUTE,COPYRIGHT,CRT,GROUP,IMRT,INC,INTENSITY,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RADIATION,RESULTS,THERAPY,THERE,TREATMENT,UNIVARIATE,V70
115,169,2013,366,ADT,AUTHORS,BJU,COLD,CRYO,EBRT,LABEL,LINE,METHODS,OBJECTIVE,PHOENIX,RESULTS
169,2013,AUTHORS,BJU,GLEASON,METASTASIS,NODE,PSA,TMN
001,004,005,078,1065,122,169,2005,2011,2013,383,8201,AUTHORS,BCI,BCIS,BCR,BGTI,BGTIS,BJU,JANUARY,LABEL,MEIER,METHODS,NSS,OBJECTIVE,PSM,PSMS,RESULTS,THERE
169,2013,320,8805,AUTHORS,BJU,COX,KRUSKAL,LABEL,MEIER,METHODS,OBJECTIVE,PATIENT,PREDICTORS,PRIAS,RECURRENCE,RESULTS,RFS,THERE,THESE
169,2013,240,AUTHORS,BJU,FLEMISH,LABEL,METHODS,OBJECTIVE,PREDICTIVE,RESULTS,TOTAL
169,2013,AFTER,AUTHORS,BJU,BT1,BT2,CONCLUSION,LABEL,METHODS,OBJECTIVE,PROS,RESULTS,THEREFORE
TWITTER,USING
CAMI,MEDICAL,TOOLKIT
184,8764,EACH,EGF,EPCAM,EPITHELIAL,FET,PSA,SILICON,SINW,SINWS,VDBP
103,CBCT,CTV,DICE,EACH,LOCAL
AUC,HGNC,OMIM,RANKBOOST,ROC,SEVERAL
FINALLY
PET,RMS,SPECT,THUS
ACCORDING,AFTER,DCE,DIAGNOSIS,FITTING,HOWEVER,MRI,NONE,TCCS,TOFTS
EVALUATION,SOLUBLE,WST
BOTH,DNASE,ETS,GATA,GATA2,SNP,THESE,TMPRSS2
8805,CAVERNOUS,CHOROIDAL,HOWEVER,IMAGING,MELANIN,NEOPLASMS,ORBITAL
169,2013,BRITAIN,COPYRIGHT,CRPC,ETS,GREAT,IRELAND,JOHN,LTD,PCA,PCAS,PUBLISHED,SOCIETY,SONS,SPOP,TUMOURS,WILEY
0001,0232,0245,0262,0337,169,2013,753,8201,8805,AUC,BACKGROUND,FAS,GLEASON,INC,INCREASED,LABEL,METHODS,RESULTS,UPGRADING,WILEY
001,005,015,135,169,1984,2011,2013,8805,APART,BACKGROUND,BEP,CUMULATED,GCC,GERM,LABEL,METHODS,OCTOBER,RESULTS,SOCIETY,TREATMENT
000,100,10TH,2000,2010,243,APVP,BAJA,CALIFORNIA,CITY,DURANGO,GEOGRAPHY,INSTITUTE,LABEL,METHODS,NAYARIT,NUEVO,OBJECTIVE,RATES,RAW,RECORDS,RESULTS,SINALOA,STATISTICS,SUR,YPLL
169,2013,GMBH,P27,PTEN,UPS,VARIOUS
000,1000,2002,2005,2011,8805,BACKGROUND,CARE,GENERAL,LABEL,MEN,METHODS,MOST,NETWORK,OBJECTIVE,PRIMARY,PSA,RESULTS,RRS
100,181,8202,BACKGROUND,BESIDES,CASE,CONCLUSION,FOUR,GLEASON,HOWEVER,LABEL,METHODS,PSA,TAPENTADOL,THERE
169,2013,CASTRATION,IDIOPATHIC,OBESITY,UROLOGICAL
006,151,165,169,2013,8804,AUTHORS,BJU,GLEASON,IQR,LABEL,MEN,METHODS,OBJECTIVE,PNI,PSA,RESULTS,RISK,T2A
169,2013,3000,8776,COPYRIGHT,GMBH,INTENSE,KGAA,SIMILAR,SNA,SNAS,VCH,WILEY
CHECKPOINT,CHEK2,FOUR,I157T,IVS2,LOW,MEDICAL,MUTATIONS,STUDIES
000,150,8805,AES,ALC,CONCLUSION,CRPC,EVALUATION,METHODS,OVERALL,PBO,PERIPHERAL,RESULTS,SAG,SOLID,STUDIES
2005,2013,BOTH,III,LARGE,MEDICAL,MEDLINE,METHODS,MPDL3280A,NON,NSCLC,RESULTS,SOCIETY,START,VALIDATING
029,100,125,130,145,173,175,305,D90,DATA,GRADE,V100
002,006,145,169,2013,8201,946,BACKGROUND,GLO,GLO1,INC,LABEL,LNCAP,MCF,METHODS,RESULTS,WILEY
169,2013,BACKGROUND,BMS,BPH,CAFS,CELL,EXPRESSION,FGF5,INC,INCREASED,LABEL,METHODS,NPFS,PCA,PCR,PRIMARY,PROSTATIC,RESULTS,SMO,THESE,WILEY
001,FURTHER,ICE,NRS
145,215,ANTI,BACKGROUND,BALB,BASED,CCRT,CD34,CONCLUSION,CONCURRENT,LABEL,METHODS,RESULTS,THESE,TREATMENT,TUNEL
001,002,005,008,031,113,169,1995,2010,2013,480,BACKGROUND,CENTRAL,CONCLUSION,LABEL,LASER,METHODS,MOR,RESULTS,SOCIETY
177,307,8804,929,994,ACE,BOTH,COHEN,CONCLUSION,FCH,LABEL,LYMPH,MBQ,METHODS,OBJECTIVE,OVERALL,PET,PSA,PURPOSE,RESULTS
132,2D3,945,BOTH,NINE,NRS,RWPE,THESE
160,AFTER,AMONG,BOTH,DU145,HOWEVER,LNCAP,THEIR,THESE
0005,100,2006,2050,8201,ADDITIONAL,CME,DELIVERED,EDUCATION,HODGKIN,INSTITUTE,IOM,KNOWLEDGE,PROGRAM,USA,WEBMD
BACKGROUND,CELLS,CONCLUSION,DU145,EPITHELIAL,EVS,GLEASON,IDS,INGENUITY,ISOLATION,LABEL,MASS,PATHWAY,PREC,PRECS,RESULTS,WESTERN
169,1972,1999,2007,2013,39852,AUSTRALIA,BACKGROUND,CCR,CENTRAL,COPYRIGHT,COX,DATA,HOWEVER,LABEL,LTD,METHODS,NSW,RESULTS,SOUTH,SUMMARY,WALES
169,2013,946,BP2,COPYRIGHT,CR6,CRIF1,IRELAND,LTD,STAT3
005,100,177,320,956,ANALYTICAL,ASSAY,BACKGROUND,FPE,GENOMIC,GPS,LABEL,PCR,RESULTS,SCORE
169,2005,2013,266,AIMS,AMONG,ANY,CLARITY,CONCLUSION,GLEASON,ISUP,JOHN,KEY,LABEL,LTD,NETWORK,OBJECTIVE,PATHOLOGY,RESULTS,SOCIETY,SONS,UROLOGICAL,WILEY
AGE,AGING,BECAUSE,THERAPIES
RNAS
CRPC,HOWEVER,LBD,PCA,TALEN,THESE,THUS
D5HS,EPT2,ROS,STAT3
001,8805,ADJUSTING,CONCLUSION,DATA,III,LABEL,METHODS,OBJECTIVE,PSA,PTE,PURPOSE,RESULTS,SURROGACY,THUS
2002,2006,303,745,ADT,BCDF,BETWEEN,CIMRT,CONCLUSION,HIGH,HIMRT,IMRT,JUNE,LABEL,MAY,MEN,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE
FINALLY,ROBOT
384,8209,DECREASED,HELA,MTT,SNP,SNPS,THESE,TRANSWELL,U2OS,WESTERN
201,509,700,ARN,ODM,TAK
0001,156,371,AFTER,BACKGROUND,BCR,COX,CRPC,EQUAL,LABEL,METFORMIN,METHODS,RESULTS,TIME,UNADJUSTED,WHILE
1991,2008,BACKGROUND,CAUTION,KI67,LABEL,LHRH,METHODS,PCA,RESULTS,THERE
200,205,8805,BACKGROUND,BRPC,FREQUENCY,GLEASON,HOPKINS,JHH,JOHNS,LABEL,METHODS,PLACEBO,PSA,PSADT,PSAS,RCT,RCTS,RESULTS,THESE
0001,8209,BPH,CDR,CW22R,DU145,FURTHER,HOWEVER,IHC,LNCAP,PC3,PCA,PCR,PRAC,PSA,THUS
169,2013,6138,945,AACR,AMR,CLIN,CLR,CRAF,DU145,ERK,GLEASON,HISTOLOGIC,LABEL,LNCAP,MEK,METHODS,OBJECTIVE,PC3,PURPOSE,RAMP2,RAMP3,RES,RESULTS
1793,945,AKT,FINALLY,FIRSTLY,HIF,HOWEVER,HYPOXIC,PI3K,TAKEN,THESE,VEGF
CURRENT,HOWEVER,MANAGEMENT
2384,A2058,AMONG,CONSISTENT,JAK,JANUS,MCL,MLS,MYC,PARP,SRC,STAT,STAT3,TAKEN,UPON
29A,8209,CONSIDERED,DU145,HOWEVER,LNCAP,LUCIFERASE,PC3,TARGETSCAN,TLR,TNF,TNFR,TOLL,TRAF,TRAF4,UTR
000,300,BONE,TREATMENT,ZOLEDRONIC
ADP,BOTH,LC3,LNCAP,LTD,NAC,PARP,PROPIDIUM,ROS,THEREFORE,VAD
108,169,183,2013,215,8320,8321,8329,8804,956,ADT,BACKGROUND,COPYRIGHT,COX,EBRT,FFBR,HDR,IRELAND,LABEL,LTD,MEIER,METHODS,PSA,RESULTS,UNIVARIATE
BIPARTITE,DBD,NLS,THR877ALA
004,041,111,169,2014,45CM,5GY,80GY,8804,8805,ADVERSE,AES,COPYRIGHT,COX,EARLY,IMRT,INC,MEDICAL,MOST,PUBLISHED,STAGE,T1C,T3A
120,169,1999,2013,500,BACKGROUND,CONCLUSION,COPYRIGHT,CRPC,EVALUATION,FORTY,GIVEN,GROUP,INC,LABEL,MEN,METHODS,OVERALL,PEMOX,PSA,RESULTS,SECONDARY,SIX,SOLID,WORKING
100,124,169,2013,670,8805,AEU,ANALYZE,BOTH,COPYRIGHT,GLEASON,LABEL,METHODS,OBJECTIVE,PCA3,PSA,PUBLISHED,RESULTS,THERE
0001,0019,0022,1000,155,169,1995,2013,331,398,478,503,506,5MG,797,853,859,863,8804,8805,BACKGROUND,COPYRIGHT,COX,ELDERLY,GRADE,INCIDENCES,LABEL,METASTATIC,METHODS,OBJECTIVE,OUTCOME,PRIMARY,PSA,PUBLISHED,RESULTS,SECONDARY,SETTING,TREATMENT,TRIAL,TTPP
178,8201,8805,AUC,BACKGROUND,CONCLUSION,DLTS,EIGHT,GRADE,INCREASES,LABEL,METHODS,MONITORING,MTD,PRIMARY,RESULTS,THERE,TRIAL
945,946,BEIGE,CELLS,DESPITE,ERBB,HNSCC,HOWEVER,SCID
231,956,CD11B,CDK,CIP1,HL60,HL60R,IC50,K562,LNCAP,MDA,NBT,PIN,SEVERAL,WAF1
DOCETAXEL,HOWEVER,OWING
000,254,726,8202,AFTER,CHINESE,DEPRESSION,GDS,GERIATRIC,HONG,KONG,LUTS,SCALE,SYMPTOM
19B,23B,26A,92A,AKT,BACKGROUND,HOWEVER,LABEL,PI3K,PRINCIPAL,PTEN,RESULTS,THESE,UNDER,UTR
1986,1990,2009,AGE,ASR,BACKGROUND,GHIS,HBV,HEPATITIS,HIV,HODGKIN,HOWEVER,HPV,INCIDENCE,LABEL,METHODS,NCR,NHL,PBCR,RATES,RESULTS,SAHARAN,SIMILARLY
001,110,8202,AMONG,CRPC,ERG,ESPECIALLY,FISH,INTRA,MET,OVERALL,PTEN,TMPRSS2
AKT,CRM1,MECHANISMS,NLS,PI3K,PTEN,THESE
210,296,HOWEVER
169,2013,6101,954,AACR,BACKGROUND,BECAUSE,CELLS,CLIN,CONCLUSION,DATA,GST,LABEL,METHODS,MONOCLONAL,RES,RESULTS,S4F,SEMAPHORIN,THESE,TRANSWELL
169,2013,AACR,ACE,CONCLUSION,LABEL,LUCAP,MET,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE,USING,VEGF
EVEN,LOCALLY,SIMILAR,THERE
BPH,GREENLIGHT,LABEL,METHODS,OBJECTIVE,PURPOSE,PVBT,PVP,RESULTS,SIXTY
18F,INCIDENTAL,PET
945,954,LNCAP,PC3,PCA,RELA,TAKEN,ZNT,ZNT4
001,AFRICAN,CAP,WHILE
112,2007,2009,315,8805,ABOUT,CASES,CONCLUSION,EPE,GLEASON,LABEL,METHODS,OBJECTIVE,PROSTATES,PSM,PSMS,PURPOSE,RARP,RESULTS
176,197,1997,2004,2005,2011,8804,COX,GLEASON,LABEL,MEIER,METHODS,MGS,OBJECTIVE,PATHOLOGY,PURPOSE,RESULTS,SGS,SOCIETY,T1C,TIME,UROLOGICAL
1970,2012,367,COLORECTAL,LABEL,METHODS,OBJECTIVE,OTHER,PURPOSE,RESULTS,SIR
000,100,1485,169,2013,2604,3001,3337,BACKGROUND,BELARUS,BLM,BLOOM,BRCA2,HOWEVER,LABEL,METHODS,MUTATIONS,NBS1,Q548X,RESULTS,UKRAINE
101,153,169,2004,2005,2014,AFTER,CAPSURE,COPYRIGHT,COX,DIET,EDUCATION,FOOD,FREQUENCY,INC,LABEL,LIFESTYLE,LIMITED,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,T2C,UROLOGICAL
0295,169,181,2013,215,231,33RD,500,8320,8325,A375,A549,ASTERACEAE,BACKGROUND,BENTH,BODY,CONCLUSION,FURTHER,HL60,IRELAND,LABEL,LTD,MATERIALS,MCF,MDA,METHODS,MIA,PACA,RELEVANCE,RESULTS,UPON,VGDE,WST
CCR5,CURRENTLY,HIV,PUBLISHED,RESULTS,SAS,THEREFORE,THUS
0687,100ML,169,2006,2011,2013,221,COPYRIGHT,CZECH,JUNE,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,OLOMOUC,PSA,RESULTS,SEVERAL,UNIVERSITY,UROLOGY
102,169,2013,COMPLETELY,COMPOSITE,CONCLUSION,COPYRIGHT,INC,INDEX,LABEL,MEN,METHODS,MIXED,OBJECTIVE,RESULTS,URINARY
100,169,2013,2MM,3MM,4MM,915,CARLO,COPYRIGHT,GATE,INITIALLY,IRELAND,LABEL,LTD,METHODS,MONTE,OBJECTIVE,PURPOSE,RESULTS,THROUGH,VMAT
1107,169,1988,2010,2013,8804,ACCORDING,BACKGROUND,BASED,COPYRIGHT,COX,CSM,GLEASON,HOWEVER,LABEL,LNI,METHODS,OBJECTIVE,OUTCOME,PCA,PSA,PUBLISHED,RESULTS,SETTING,THESE,TNM
1982,1987,1992,1997,2002,421,BACKGROUND,EARLIER,FURTHER,LABEL,METHODS,OULU,RESULTS,TNM,UNIVERSITY
1966,1970,2013,AIM,APRIL,CNKI,CONCLUSION,DATA,LABEL,LIBRARY,META,METHODS,OBJECTIVE,ODDS,PAT,PCA,RESULTS,SCIENCE,SIMILAR,THESE,XPC
BACKGROUND,DEPENDING,DIRECTIONS,LABEL,RADIATION,RESULTS,THUS
160,308,455,456,8201,911,AUS,AUSTRALIA,AUSTRALIAN,BACHELORS,BACKGROUND,LABEL,MEN,METHODS,PATIENT,PSA,RESULTS,THERE,TRIAL,UNLABELLED
ADT,COLORECTAL,ERSPC,LUNG,MAJOR,OVARIAN,PLCO,PSA,RANDOMIZED,SCREENING,THESE
COX,HOWEVER,MEIER,NUCB2,PCA,THUS
167,2000,956,ADVIA,ARCHITECT,CENTAUR,ELECSYS,FURTHER,G1200,HYBRITECH,LUMIPULSE,PASSING,PSA,WORLD
1982,2006,CASE,CHRONIC,CNS,DATA,HODGKIN,ICD,INCREASED,LABEL,METHODS,MORTALITY,OBJECTIVE,PCR,PURPOSE,RESULTS,SMR,SMRS,SNC,SOUTH
APOPTOSIS,CONCLUSION,DU145,KNOCKDOWN,LABEL,METHODS,OBJECTIVE,PAI,PURPOSE,RESULTS,SFN,SIMILAR,TRANSWELL,WESTERN
NEWLY,PCA,SCID,SCLC
EACH,EIGHT,IMAGE,LABEL,MATERIALS,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,TIME,TOF
115,124,1993,2001,2009,386,COLORECTAL,COX,DIETARY,FURTHER,HOWEVER,LUNG,OVARIAN,SCREENING,THESE,TRIAL
956,960,ABCC1,ABCC2,GST,III,INORGANIC,MMA,ODD,PRIOR,SOD,THUS,VARIOUS
1227,CAFS,EVS,LARGE,RWPE
000,169,200,2013,COPYRIGHT
ANN,ARBOR,BECAUSE,ECOG,GLEASON,KARNOFSKY,ONKOPEDIA,TNM,WIKIPEDIA
CHIP,JUN,PCA,RADIATION,THESE
1490,169,1772,2013,736,754,ADT,AGE,COPYRIGHT,HIF1A,LTD,MOLECULAR,PCA,PCR,REAL,TIME,UNIVARIATE
AFTER,ATLASES,BACKGROUND,DICE,EACH,EVEN,FINALLY,LABEL,METHODS,RESULTS,SEMI,SIMILARITY,TEN
2003,2011,455,APRIL,BACKGROUND,GLEASON,JUNE,LABEL,METHODS,MRI,NINE,PCA,PSA,RESULTS,SERUM,TRUS,TURP
003,110,113,146,215,372,541,564,741,837,BLOCKED,CARLO,HIP,LABEL,METHODS,MONTE,OBJECTIVE,ORGAN,PURPOSE,RESULTS
AFTER,ASPC,BACKGROUND,DESPITE,DIL,DU145,FIJI,FURTHER,HOWEVER,HT29,INDIVIDUAL,JAK1,LABEL,LNCAP,METHODS,RESULTS,SW620,T47D,USING,WASF3
000,100,124,133,149,169,2013,259,392,40TH,542,746,759,AACR,ABC,AGE,BACKGROUND,COLORECTAL,CONCLUSION,COX,EFFECTIVE,HGBC,LABEL,LUNG,METHODS,NOMOGRAMS,OVARIAN,PLCO,RESULTS,USING
024,125,169,1930S,1969,2013,211,372,636,987,AACR,ADJUSTMENT,ADULT,BACKGROUND,BIRTH,COPENHAGEN,COX,CSHRR,HOWEVER,HRS,LABEL,METHODS,RECORDS,RESULTS,THERE
2007,AFTER,AICR,CHILE,FOOD,FUND,INSTITUTE,NUTRITION,PREVENTION,THESE,WCRF,WORLD
037,177,2010,2012,ACCORDING,BACKGROUND,GROUP,IFS,JULY,JUNE,LABEL,MEAN,METHODS,PCA,PRE,RALRP,RESULTS,THEREFORE,TRUS
946,ALDH,AR79,CD133,DUE,GSK3,HOWEVER,KI67,LABEL,SIMILARLY,THESE,UNLABELLED,WNT
ACCURAY,ALTO,BACKGROUND,BOTH,D20,D50,DELIVERING,LABEL,MATERIALS,MEDICAL,METHODS,MULTIPLAN,PALO,RESULTS,SBRT,SUNNYVALE
ASIAN,GNRHA
100,ATP,BOTH,IKK,M659G,PKD,PKD1,PKD3,PP1,SAR
APO2L,BACKGROUND,DCR1,DCR2,DR4,DR5,JAK,JAK2,LABEL,MCL,MCL1,MONOCLONAL,PREVIOUSLY,PRINCIPAL,RESULTS,SOLUBLE,STAT3,TRA,TRAIL,TUNEL
293T,916,CHROMATIN,EXPRESSION,FURTHER,GBM,GLI,GLI1,GLI2,GLI3,GLI3R,THESE
33258,ANXA1,BACKGROUND,BAK,BAX,BCL,CELL,CONCLUSION,DU145,ERK,ERK1,EXPRESSION,FURTHER,HOECHST,LABEL,METHODS,NAB,PC3,PCR,RESULTS
037,APC,BACKGROUND,BCR,CHINESE,CNKI,CONCLUSION,CPG,ENGLISH,FURTHER,GST,GSTM1,GSTP1,GSTS,LABEL,LANGUAGES,MATERIALS,MEDLINE,METHODS,RARBETA,RESULTS
8804,8805,AFRICAN,BPH,CAUCASIAN,GLEASON,REDUCTION
000,2006,2010,205,300,518,ADT,BACKGROUND,CONCLUSION,CUMULATIVE,HIP,LABEL,METHODS,PCA,RESULTS,RISK,SMRS
120,945,946,ALDH,CASTRATION,CD133,CD44,CELLS,CIC,CK5,ERG,HORMONE,INITIATING,PRCA,PSA,RESISTANT,SCID,SSEA4,STAGE,TERT,TMPRSS2
100,1214,181,BACKGROUND,CD133,CD44,CMC2,CSC,CSCS,FOUR,LABEL,NOD,PCR,PPT2,PRINCIPAL,RESULTS,SBT,SCID
COPY,FIVE,NUCLEIC,SNP,SUFFICIENT,WHILE
001,AGREEMENT,BLAND,BOTH,CONCLUSION,FIFTY,LABEL,METHODS,MRI,OBJECTIVE,PEARSON,PET,PURPOSE,RESULTS,SUVMEAN,VOI
002,005,007,023,030,041,049,085,1465C,196,197,199,202,261,300,357,625,648,667,776,815,835,CHINESE,LABEL,MDR1,THESE,UNASSIGNED,UNLABELLED
ACTIVATED,AKT,CONVERSELY,FOXO3,GFP,NSC126188,RHOB,S253,TAKEN,THESE
119,1990,1993,1994,1996,1999,2009,203,233,506,697,DEPRESSION,DEPRESSIVE,ELECTRICIT,GAZ,GAZEL,HOWEVER,JANUARY,OVERALL,SCALE,STUDIES
946,AIF,ELLAGIC,FINALLY,HUR,LNCAP,ROS,SIRT1,TGF
MOLECULAR,PET
BALB,PCA
COLLEGE,PATIENT,SOCIETY
169,2013,BOTH,COPYRIGHT,INC,KLK3,LCC,LNCAP,PCR,SNP
169,2013,AMONG,ANTI,HPLC,KLK3,LNCAP,MMTV,PCR
0042,0085,019,0348,114,166,169,177,2013,326,3P14,AACR,BACKGROUND,CRPC,CRPCS,ERG,EZH2,FISH,LABEL,LOSS,METHODS,PTEN,RESULTS,TP53
002,012,023,044,087,089,094,111,2012,312,341,434,458,488,530,551,573,610,656,668,865,918,964,CHECKLIST,GUIDELINES,HOWEVER,JUNE,LABEL,LIBRARY,LOS,MATERIALS,METHODS,NETWORK,OBJECTIVE,OPERATING,RARP,REFERENCES,RESULTS,THERE
001,130,160,200,2005,2012,285,BACKGROUND,BPH,FPSA,KAYSERI,LABEL,MATERIALS,METHODS,OUTPATIENT,PSA,RESULTS,THERE,TPSA,UROLOGY,WBC,WBCS
037,8805,967,AFTER,AIM,IMRT,LABEL,METHODS,OBJECTIVE,RATES,RESULTS,SIXTY
1993,2008,207,326,450,SEOUL
100,137,947,967,ANOVA,EACH,FISH,KRUSKAL,MANN,PERIPHERAL,THUS,WHITNEY
489,AFTER,ALSO,PSA,THESE
169,191,2013,22Q11,292,483,6112,AACR,CLIN,ELISA,GAG,HERV,HERVS,III,LABEL,METHODS,OBJECTIVE,PATIENT,PURPOSE,RES,RESULTS,SERUM,WHILE
120,215,ASSESSMENT,CONCLUSION,FEW,FUNCTIONAL,HFSSS,HOT,LABEL,METHODS,MOST,NEITHER,OBJECTIVE,PURPOSE,QOL,RESULTS,SOY,THERAPY
CYP24A1,HIGH,LOCAL,REMARKABLY,RNAI
0001,0002,0010,0058,1000,102,301,352,398,775,797,8201,843,ADVERSE,BACKGROUND,COU,CYP17,HRS,LABEL,METHODS,ORR,ORRS,PSA,RESULTS,TREATMENT
0001,0002,0007,0518,109,8201,ARM,BACKGROUND,BMD,LABEL,LHRH,METHODS,QOL,RESULTS,RTOG,SECONDARY,VITAMIN
169,2013,945,954,COPYRIGHT,DU145,DUAL,DUSP1,FEDERATION,JNK,MAPK,OVERALL,PUBLISHED,SOCIETIES,THESE,THUS,TNF
8202,EXPRESSION,FURTHER,IGF1,IGF2,INSULIN,THERE
169,2013,8764,CASPASE,CELLS,COPYRIGHT,GMP,IRELAND,JNK,LTD,MAPK,NOS,NOS2,PDT,THUS
160,169,2014,574,CBCT,COPYRIGHT,FOLLOWING,HDR,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SOCIETY,STUDIES,TREATMENT,TRUS
169,171,2013,808,CONCLUSION,COPYRIGHT,EVALUATING,FOUR,INC,LABEL,METHODS,OBJECTIVE,PCA3,RESULTS,SINCE
169,177,2013,956,CAFFEIC,CAPE,COPYRIGHT,DHT,HOWEVER,IC50,LNCAP,LTD,PSA,SEVERAL
145,CDC2,CELL,CHK1,CHK2,THESE,THR68,TYR15,WEE
000,100,200,EAST,THERE
018,117,2005,2011,8804,BILATERAL,CONCLUSION,GLEASON,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS,SAME,T1C
146,FINALLY,RESULTS
AFRICAN,COUNCIL,EVALUATING,INSTITUTE,MOST,SUGGESTED
100,2008,2012,BACKGROUND,CONCLUSION,JANUARY,JUNE,LABEL,METHODS,MRI,OVERALL,PSA,REASONS,REGARDING,RESULTS
2007,2013,AMONG,CURRENTLY,DESPITE,HOWEVER,LABEL,MEDLINE,METHODS,MRI,OBJECTIVE,PCA,PURPOSE,REAL,RESULTS,TRUS
005,008,019,153,232,247,265,312,8201,8211,99M,ACCORDING,CONCLUSION,EANM,EDTMP,LABEL,LBM,MDP,METHODS,MOST,OBJECTIVE,PATIENT,PLT,PURPOSE,RESULTS,ROC,USING,WBC

946,ETV1,GLEASON,LNCAP,THERE,THESE
22RV1,945,946,ADIOL,AKT,DPN,GLEASON,KNOCKDOWN,LNCAP,PC3,PUMA,VE2
LINC00913,SCHLAP1,SNF,SWI,THESE
169,177,201,2014,8804,AUC,COMPOSITE,COPYRIGHT,EDUCATION,EPIC,INC,INDEX,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
169,2013,4EBP1,AKT,CAP,CD326,CELL,CHEMO,COPYRIGHT,DU145,EPCAM,EXPRESSION,LNCAP,LTD,PCR,PI3K,S6K,WESTERN
169,2013,ASIC1,BDNF,CANCEROUS,CIBP,COPYRIGHT,FINALLY,IRELAND,KNOWLEDGE,LTD,NGF,PART,TRPV1
0001,003,005,0490,1088,109,169,183,2009,2010,2013,542,546,APRIL,ASSESSMENT,BACKGROUND,BETWEEN,BPI,BRIEF,COPYRIGHT,FACT,FORM,FUNCTIONAL,HRQOL,INVENTORY,IQR,JUNE,LABEL,LTD,METHODS,PAIN,RESULTS,SHORT,THERAPY,THESE
001,10172,1456,160,169,2014,229,ACUTE,AMONG,BACKGROUND,COPYRIGHT,INC,INSTITUTES,ISP,ISPS,LABEL,METHODS,NORSTROKE,NORWEGIAN,ORG,PUBLISHED,RESULTS,SCALE,TREATMENT,TRIAL
0001,169,2004,2008,2013,3355,3967,4019,4241,ACEI,ARB,ARBS,BACKGROUND,BBS,CCB,CCBS,COPYRIGHT,COX,DPIN,DRUG,HOWEVER,LABEL,LTD,METHODS,NETWORK,OBJECTIVE,OBJECTIVES,PROGRAM,PROVINCIAL,PUBLISHED,RESULTS,TDS,THERE
160,169,2013,BOWEL,CONCLUSION,COPYRIGHT,INC,INCREASING,LABEL,MEAN,METHODS,OBJECTIVE,RESULTS,SEVERAL,SIXTY,TREATMENT
160,169,179,2003,2012,2013,516,8805,ATYP,ATYPS,BECAUSE,CONCLUSION,COPYRIGHT,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS
100,169,177,2013,231,CONCLUSION,COPYRIGHT,DICE,DIR,DSC,HOUNSFIELD,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIX,UNDER
1100,169,2009,2012,2013,330,346,655,CIED,CIEDS,COPYRIGHT,FIVE,INC,JULY,LABEL,MARCH,MATERIALS,MAXIMUM,METHODS,OBJECTIVE,PBT,PURPOSE,RESULTS,SIX
169,2013,AFTER,BACKGROUND,CONCLUSION,COPYRIGHT,DISCUSSION,DRUG,EVADING,FDA,FOOD,LABEL,LTD,METHODS,MODULATION,RESULTS,WHAT
10878,169,2013,70YEARS,85YEARS,AMONG,BACKGROUND,CONCLUSION,CONFIRMED,COPYRIGHT,CROWN,CRPC,CYP17,LABEL,LTD,METHODS,OVERALL,PSA,PUBLISHED,RESULTS
163,169,2013,256,280,954,AMONG,ERG,FURTHER,GLEASON,TMPRSS2
175,2009,2012,208,253,365,650,8201,AFTER,APRIL,ASA,AVERAGE,BACKGROUND,BOARD,DATA,INDEX,INDICATION,LABEL,LONGEST,METHODS,MORBIDITY,OBJECTIVE,OCTOBER,PURPOSE,RADICAL,RARC,RESULTS,SEVEN,SOCIETY
161,2005,2013,223,277,946,BOOK,CHEM,CLIN,COST,CRPC,CURR,EDUC,HRPC,III,KARAMOUZIS,MED,NONHORMONE,NOVEL,ONCOL,PAPATSORIS,PHASE,REGARDING,SOC,SRES
001,2002,2011,768,ANOVA,BACKGROUND,BLACK,GLEASON,JULY,LABEL,METHODS,POST,PSA,RARP,RESULTS,WBC,WHITE
AFRICAN
169,BACKGROUND,LABEL,MATERIALS,METHODS,MOST,RESULTS,SPANISH,WEB
8201,BACKGROUND,CXCR7,HS5,LABEL,METHODS,PC3,PCA,RESULTS,RWPE,UTILISING
150,945,946,CAP,EXPRESSION,HOWEVER,PRY,SIMILARLY
FOUR,FUND,HODGKIN,REPORTS,VARIOUS,WCRF,WORLD
1431,565,GLEASON,PCA,PSA,RAS,RASSF1A,STRATIFIED,THEREFORE,THESE
PARACRINE
200NM,22R,957,ADP,BAX,BCL,CHIT,EGCG,HOWEVER,PCA,THROUGH,TREATMENT
169,2013,AACR,CD11B,GR1,MMP,PTHRP,SRC,TAKEN,VEGF,Y418
100,2006,2007,2008,2010,222,532,649,745,767,984,AIMS,BACKGROUND,EIGHT,INTER,IRELAND,LABEL,METHODS,OBJECTIVE,PSA,RESULTS,THERE,THESE
114,116,132,177,237,263,374,CONCLUSION,HOWEVER,LABEL,MBQ,METHODS,OBJECTIVE,PCS,PET,PSA,PSMA,PURPOSE,RESULTS,THEREFORE
136,138,ERG,OVERALL,PCA3,TMPRSS2
CD68,HOWEVER,TAM,TAMS,THERE,TYPE
ASSAY,BACKGROUND,BASED,CONTEXTUAL,DRUG,EARLY,EGAPP,EVALUATION,FOOD,GEN,GENOMIC,GROUP,LABEL,PCA3,PREVENTION,PROBE,RATIONALE,RESULTS,SUMMARY,UTILITY,WORKING
34B,916,936,CDDP,DOXO,GSH,MYC,ROS,THROUGH,USP2A
00001,0007,044,2000,2005,2006,2010,AGE,ANGLIAN,BACKGROUND,CONCLUSION,INCREASED,IRS,KINGDOM,LABEL,METHODS,NETWORK,NICE,PSA,RESULTS,RISK
159,169,2007,2011,2014,205,500,AMONG,COPYRIGHT,EDUCATION,GLEASON,INC,LABEL,MATERIALS,METHODS,NPCR,OBJECTIVE,PREDICTORS,PUBLISHED,PURPOSE,RESULTS,SWEDISH,T1C,UROLOGICAL
169,177,2007,2013,2014,AFTER,AMONG,APRIL,COPYRIGHT,EDUCATION,HEMOSTATIC,HOWEVER,INC,LABEL,MATERIALS,MAY,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL,USING
169,2013,21EX,ACCURAY,AIMS,BOTH,COLLEGE,COPYRIGHT,CYBERKNIFE,ECLIPSE,GIVEN,HOWEVER,III,LABEL,LTD,MATERIALS,METHODS,OAR,OARS,OBJECTIVE,PACE,PTV,PUBLISHED,RESULTS,ROYAL,SBRT,THERE,VSI
169,2013,COPYRIGHT,FINALLY,GATA,HOOGSTEEN,INC,PC3,PPRH,PPRHS,SP1,THESE
169,2013,AKT1,C842KSAKDR,COPYRIGHT,CX5R,D847E,FURTHER,INC,K843M,K846M,LIPID,PTEN,PTP,REDUCED,TAKEN,USING
COLLEGE,PATIENT,SOCIETY
13Q,13Q14,162,169,2013,COPYRIGHT,GLEASON,HOWEVER,INC,OLFM4,PATHOLOGY,PUBLISHED,SOCIETY
003,005,008,012,047,064,143,179,2011,213,2425,283,293,343,416,457,505,5782,859,8805,898,983,ABSTRACTS,ASSESSMENT,BACKGROUND,BETWEEN,CENTRAL,CITATIONS,CONCLUSION,CONFERENCE,CONTROLLED,CURRENT,DARE,DATA,EACH,EED,EFFECTS,EVALUATION,FULL,FUNDING,GLEASON,HTA,INDEX,INDEXED,INSTITUTE,JUNE,LABEL,MEDLINE,METHODS,MRI,NETWORK,NHS,NIHR,NON,OBJECTIVE,OBJECTIVES,OTHER,OVERALL,PORTFOLIO,PROCESS,PROGRAMME,RCTS,RESULTS,REVIEWS,SCC,SCIENCE,SERVICE,SEVENTEEN,SEVERAL,SOURCES,SYSTEMATIC,TECHNOLOGY,THERE,TYPES,UKCRN,WEB
ALP,BACKGROUND,BSP,CASTRATION,CRPC,DKK1,ET1,FINALLY,LABEL,METHODS,MOST,OPG,OPN,PC3,PC3C,RESISTANT,RESULTS,RUNX2,SCID,THUS,TRAP
ADDITIONAL,BACKGROUND,CIS,CONCLUSION,DIET,HOWEVER,LABEL,MEDLINE,METHODS,OVERALL,RESULTS,RRS,WESTERN
947,ATM,ATR,BRCA1,CHK1,CHK2,COMET,CONSISTENT,H2AX,KU70,NHEJ,RICCARDIN,THUS,TIME,TOPO
231,BONE,DEFICIENT,DKK,HOMOLOG,MDA,SCID,THESE,TREATMENT
001,008,1268,2000,2009,398,8805,ABOUT,DATA,LABEL,METHODS,OBJECTIVE,PATIENT,RADICAL,RESULTS,T3B
CAREFUL,SCORE,SUNITINIB,SYMPTOM,WEEK
001,003,004,107,160,BACKGROUND,BONE,HOWEVER,LABEL,METHODS,RESULTS,SPINE
0001,028,956,AKT,BIM,DISRUPTION,FOXO,KIP1,LNCAP,PI3K,THESE,TRAMP
THEIR,THEN
908,946,BPH,FID,LUTS,POWDERS,SAMPLES,SAW
945,DEPLETION,HIF
285,291,CONCLUSION,COX,FOUR,LABEL,LINDA,LOMA,MEDICAL,MEIER,MIBC,NCCN,PATHOLOGY,PCV,PPBC,RESULTS,UNIVERSITY,UNLABELLED
GI50,HOWEVER,LC50,TGI,THEIR
4BIS,FINALLY,GNR,GNRS,GOLD
2011,8805,954,AFRICAN,AMERICANS,CAUCASIAN,CHINESE,FFPE,GLEASON,LNCAP,MET,NEUROPILIN,NRP,PLOS,RANK,RANKL,THESE,VEGF
COMMITTEE,ERG,GLEASON,JOINT,KLK2,KLK3,TMPRSS2
150,2012,648,ADHERENCE,AMED,ATTRITION,AUTHORS,BACKGROUND,CENTRAL,COLLECTION,CONTROLLED,DATA,DESPITE,HENCE,HOWEVER,ISSUE,LABEL,LIBRARY,MAIN,MEDLINE,METHODS,NONE,OBJECTIVE,OBJECTIVES,PEDRO,PSYCLIT,RCTS,RESULTS,SELECTION,SMD,THESE,WHAT,WHICH
017,035,039,196,2003,2007,APRIL,BETWEEN,CONCLUSION,DFS,FACTORS,GLEASON,LABEL,LATE,LHRH,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS,THERE,TREATMENT
0001,402,513,5418,622,672,679,763,785,8255,839,870,AUC,BPH,CONCLUSION,LABEL,METHODS,METHYLIGHT,OBJECTIVE,PCR,PSA,PURPOSE,RESULTS,SEARCHING,YAM
1001,BACKGROUND,CONCLUSION,CRITICALLY,IMPERATIVE,LABEL,METHODS,RESULTS,UNMET
102,28A,400,8209,BL21,DE3,ELISA,HIS6,PAGE,SDS,TAG,THESE,WESTERN
8209,ALSO,BMSC,BMSCS,BONE,DU145,LNCAP,PC3,PCA,SILENCING,WNT5A
136,1971,1975,2008,217,219,615,787,8804,8805,A1C,ABSENCE,BACKGROUND,EARLIER,FRAMINGHAM,HEART,HRS,IFG,INCREASED,LABEL,LIFESTYLE,METHODS,OBESITY,OFFSPRING,RESULTS,SASV9,SERUM
169,1RA,1RI,1RII,2013,945,946,COPYRIGHT,COX,EXPRESSION,GLEASON,ILRI,INCREASED,IRAK,LTD,MEIER,PSA,REDUCED,REMARKABLY,TNF,TNFRI,TRAF2,TRAF6
169,2013,215,AD5,BIOLOGY,CMV,COPYRIGHT,FEDERATION,IMPROVING,INC,LUC,MBS,MOIS,PUBLISHED,ULTRASOUND,WORLD
169,2013,BMI,CONCLUSION,COPYRIGHT,ESTIMATED,HIGH,INC,LABEL,LRP,LRPS,METHODS,OBJECTIVE,POTENTIAL,PPFA,RESULTS,RETZIUS,VFA
169,2013,BACKGROUND,BASED,CONCLUSION,COPYRIGHT,FRANCIM,LABEL,LTD,METHODS,NET,RESULTS
169,2013,AACR,CSC,CSCS,HENCE,MYC,NOTABLY,RNAI,SEVERAL,TREATMENT
135,613,751,761,BACKGROUND,GEO,H19,LABEL,METHODS,RESULTS,RNAS,ROC,TNM,TOTAL
160,177,BPH,DATA,PSA,PSMA,RESULTS
123,125,CARBOXY,CYS,GLU,IGLCE,LNCAP,PMPA,PSMA,RESULTS,THESE
AIDS,CURRENTLY,HIV,NOTABLY,PROTEASES,THEREFORE,THESE
001,2004,2008,260,734,889,898,CONCLUSION,COX,END,EVEN,HODGKIN,LABEL,MARRIED,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE
2000,2011,287,377,664,774,863,ACTUARIAL,BCR,COX,GLEASON,LABEL,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS
044,069,079,1ST,250,265,277,2ND,3RD,500,517,641,688,689,730,750,BCRFS,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PSM,RARP,RARPS,RESULTS,RRP,RRPS
1999,496,509,ASSOC,FINE,GRAY,IPCW,SINCE,STAT
100,160,FEW,LABEL,MEN,METHODS,OBJECTIVE,PCA,PSA,RESULTS,SIX,TPB
013,065,256,477,58102,AFRICAN,AMERICANS,AMONG,ASSAY,ASSESSMENT,BACKGROUND,CAUCASIANS,COX,GENOTYPING,LABEL,MEN,METHODS,PRAP,PROGRAM,PSA,RAF1,RESULTS,RISK,SNP
1813,2001,2009,741,BACKGROUND,COX,HRS,JANUARY,LABEL,METHODS,RESULTS,STATINS
FURTHER,MRI,OTHER,REPORTING,STANDARDS,START
FACTORS,HOWEVER,MRI,TRUS,USED
001,8322,BACKGROUND,BPH,CONCLUSION,CRP,GLEASON,IIA,LABEL,LNCAP,MATERIALS,METHODS,PCA,PSA,RESULTS,SAA,SERUM,THESE
184,AIMS,BACKGROUND,CONCLUSION,LABEL,MATERIALS,METHODS,MOST,NINE,OBJECTIVE,PSA,RALP,RESULTS,SMALLER,TCC,TRUS,TURP,UROLOGISTS,WIDESPREAD
1990,2011,AFRICAN,ANTIGEN,ASIAN,BACKGROUND,GLEASON,HOWEVER,LABEL,MATERIALS,METHODS,PSA,RESULTS,SOUTH,STAGE,WHEREAS
169,2013,CARE,COPYRIGHT,CROWN,DETECTION,OHDG,POC,POINT,PUBLISHED,SINW
125,145,169,2013,297,306,ABA,BRAD,CAMV35S,COPYRIGHT,GFP,GUS,MIRABILIS,MSCP,MUAS,MUAS35SCP,NICOTIANA,PETUNIA,PROTEIN,TATA,UAS
025,037,169,1995,2012,2014,275,668,6818,6960,7423,AUC,COPYRIGHT,COX,EDUCATION,GLEASON,HOWEVER,INC,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PRIMARY,PUBLISHED,PURPOSE,RESULTS,ROC,T1C,TREATMENT,UROLOGICAL
169,185,2013,A549,CCL,COPYRIGHT,DU145,HELA,HTB,LTD,LUNG,MCF7
0001,001,002,005,024,10878,125,169,175GY,2013,225,3MONTHS,42CM,5CC,5CM,BACKGROUND,COPYRIGHT,ENDPOINTS,IPSS,IRELAND,LABEL,LTD,LUTS,MATERIALS,METHODS,OBJECTIVE,POST,PRE,PURPOSE,RESULTS,SCORE,SYMPTOM,VPR
001,10877,10878,1100,135,169,2003,2013,25GY,2NG,ADT,AUTHORS,CONCLUSION,COPYRIGHT,CYBERKNIFE,IRELAND,LABEL,LTD,MATERIALS,MEIER,METHODS,OBJECTIVE,PSA,PUBLISHED,PURPOSE,RESULTS,SBRT
109,215,BACKGROUND,CONCLUSION,CONVERSION,LABEL,METHODS,PHAGE,RESULTS,SCREENING,SUCCESSFUL
094,283,287,340,376,400,471,472,477,497,519,542,608,677,8805,AGREEMENT,CCC,CONCLUSION,DATA,FIFTY,IMAGING,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,RADS,REPORTING,RESULTS,THREE
006,025,072,1000,1500,183,2000,357,383,500,569,617,655,691,714,734,743,8804,ADC,ADVERSE,AUC,CONCLUSION,FIFTY,GLEASON,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PARAMETRIC,RESULTS,STUDENT,T2A
610,645,800,ALSO,BASED,GSH,NAOH,NIRL
BOTH,CD4,DATA,DNAS,HOWEVER,LNCAP,PCR,RAJI,THUS,XMRV
945,954,HOWEVER,LNCAP,STZ,TNF,TYPE
001,422,8201,AFRICAN,BURKINA,FASO,MEN,PCA,SIX,SIXTY
ADRB2,AKT,BAD,CONCLUSION,CREB,ELISA,ERK,LABEL,METHODS,OBJECTIVE,PEARSON,PKA,PURPOSE,RESULTS,S112BAD,S473,T202,THESE,WESTERN,Y204ERK
181,2003,2011,8804,CSS,DMFS,EBRT,FIVE,FORTY,GLEASON,JULY,JUNE,LABEL,METHODS,OBJECTIVE,PADT,PHOENIX,PSA,PURPOSE,RESULTS,TEN
169,2013,945,947,AACR,CURRENT,STUDIES,THEIR,THEREFORE,THESE
26A,NOTABLY,THESE,ZCCHC11
000,149,AMONG,HODGKIN,INFECTIONS,POISSON,USA
DOTA,MRI
CHIP,HENCE,MDM2,NEDD4,UAF,USP12,WDR20
022,163,2007,2010,257,272,290,4817,5820,6268,7685,777,8364,870,877,8887,957,ABOUT,AIM,BACKGROUND,CALLS,GPS,LABEL,MEN,METHODS,MIDLAND,MOST,NETWORK,PCA,PSA,RESULTS,SCREENING,ZEALAND
132,169,2013,7082,946,954,AKT,BAY,COPYRIGHT,EST,HSD,IGF,IRELAND,LTD,NBD,NEMO,PCR,PI3,STS,TAKEN,WESTERN
108,137,169,2014,8805,COLLEGE,COPYRIGHT,FIFTY,GLEASON,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PSA,PURPOSE,RESULTS,TRUS,UCL,UNIVERSITY
002,014,021,064,169,2000,2011,2014,310,372,398,508,540,698,8805,BCR,COPYRIGHT,GLEASON,INC,IQR,LABEL,LNS,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS
0001,001,169,2013,257,4509,AUASS,CONCLUSION,COPYRIGHT,DATA,INC,LABEL,METHODS,OBJECTIVE,OBTAINING,PREVENTION,PSA,RESULTS,SIX,TRIAL,UROLOGICAL
169,2013,AUTHORS,COPYRIGHT,INC,INCREASING,PUBLISHED,SILAC,USING
169,2013,ADT,COPYRIGHT,LTD
001,169,2013,215,COPYRIGHT,FORTY,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,PVCR,RADIATION,RESULTS
169,2013,946,ADT,BACKGROUND,COPYRIGHT,CRPC,FUNCTIONAL,LABEL,LNCAP,METHODS,OBJECTIVE,OUTCOME,PCA,PCR,PROOF,PUBLISHED,RESULTS,RNAS,SETTING,UROLOGY,WNT
007,024,059,12Q,15Q,191,219,2P24,317,392,441,536,632,8805,AMONG,ANTONIO,BIOMARKERS,CAUCASIAN,CAUCASIANS,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PCA,PUBLISHED,RESULTS,RISK,SAN,SOUTH,TEXAS
169,2014,945,CACNA1D,CONSISTENT,COPYRIGHT,ERG,INC,TAKEN,THESE,TMPRSS2,WIDESPREAD
090,169,1988,2008,2014,8804,8805,COMMITTEE,COMPETING,COPYRIGHT,CROWN,CSM,FUHRMAN,HOWEVER,III,INC,INCREASING,JOINT,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,OCM,POISSON,PUBLISHED,RCC,RESULTS,SIMILARLY
001,005,025,169,2013,ADRB2,ADT,ASIC3,BACKGROUND,CFS,COMPARING,COPYRIGHT,CXCR4,DBI,GABA,HSPA2,LABEL,LTA,LTD,METHODS,NR3C1,P2RX7,P2RY1,PCF,PCR,PURINERGIC,RESULTS,SOD2,THESE,TLR4,TNF,VIPR2
169,2013,AUTHORS,BJU,CHIP,CURRENT,E2F,FURTHER,HRPC,MDV3100,MYC,PERSISTENT,STAT
002,118,169,177,2013,8201,AUTHORS,BJU,EFD,INDEX,LABEL,MEN,METHODS,OBJECTIVE,OBJECTIVES,PDE5I,PEARSON,RESULTS,SFPL
169,2009,2012,2013,8804,ARDEN,AUTHORS,BJU,CLAVIEN,FOCAL,GALIL,GLEASON,HEMI,HILLS,IIEF,INC,INCLUSION,INDEX,JANUARY,LABEL,MARCH,MEDICAL,METHODS,OBJECTIVE,OBJECTIVES,PCA,PRECISE,PSA,RESULTS,SCORE,SYMPTOM,T1C,T2A,THERE,URINARY,USA
001,169,1992,2009,2011,2013,268,443,8805,AFTER,AMICO,AMONG,AUTHORS,BCR,BJU,CONCLUSION,COX,FAVOURABLE,GLEASON,IIEF,INDEX,LABEL,MEN,METHODS,OBJECTIVE,RESULTS,URINARY
001,002,003,005,169,2007,2012,2013,227,AUTHORS,BETWEEN,BJU,C30,JANUARY,LABEL,METHODS,NONE,OBJECTIVE,ONB,QOL,RESULTS,TREATMENT
001,160,177,194,317,AFTER,BMI,SERUM,USING
153,169,174,2007,2011,2013,307,634,8201,AUTHORS,BETWEEN,BJU,GLEASON,JANUARY,LABEL,METHODS,OBJECTIVE,PER,PROCEDURES,PSA,RESULTS,THERE,TPSB,TRB
BACKGROUND,BOTH,CAMP,DESPITE,EPS,LABEL,RESULTS,SH3,THESE,WHEREAS
1000,120,169,2013,345,3706,4861,661,AMONG,BJU,BLACK,CANCERS,COLORECTAL,CONCLUSION,GOVERNMENT,LABEL,LUNG,METHODS,MORTALITY,OBJECTIVE,OVARIAN,PLCO,PUBLISHED,RATES,RESULTS,SCREENING,USA
169,2013,2071,221,2291,258,8805,AUTHORS,BJU,CIS,CONCLUSION,DEFINITIVE,GLEASON,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PSA,PSADT,RESULTS,THERE
003,009,028,169,2013,8201,8805,ACCORDING,AUTHORS,BJU,BOO,BPE,CRPC,EXCLUSION,INCLUSION,IPSS,LABEL,LUTS,METHODS,OBJECTIVE,PSA,RESULTS,SCORE,SYMPTOM,URODYNAMIC
001,018,116,169,2001,2010,2013,470,4803,5152,8201,8804,8805,ACTUARIAL,AUTHORS,BCR,BCRFS,BJU,COX,CSS,GLEASON,LABEL,MEIER,METHODS,MFS,OBJECTIVE,PSA,RARP,RESULTS,THERE
003,016,169,2013,211,280,484,663,8201,8804,AUTHORS,BCR,BJU,CONSIDERED,COX,ENE,IQR,LABEL,LNS,METHODS,OBJECTIVE,OVERALL,RESULTS
003,169,2009,2011,2013,299,8201,8805,AUTHORS,BJU,CAIA,LABEL,MAY,METHODS,OBJECTIVE,RADICAL,RESULTS,SEPTEMBER
169,184,1993,2007,2008,2011,2013,AUTHORS,BJU,CONCLUSION,HOWEVER,HRQL,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SUCCESS,TECHNIQUE,THERE
127,169,2011,2012,2013,AUTHORS,BJU,GLEASON,HITACHI,JUNE,LABEL,METHODS,OBJECTIVE,PREIRUS,RESULTS,RTE,SIMILARLY,THREE
169,2013,AMED,AUTHORS,BJU,CUMULATIVE,INDEX,LABEL,LIBRARY,LITERATURE,MEDLINE,META,METHODS,MOST,NURSING,OBJECTIVE,PCA,PSA,RCTS,RESULTS,SHBG,SIX,STUDIES
169,2013,AUTHORS,BJU,PERFORMING,TRUS
001,1354,169,200,2013,367,ADT,AUTHORS,BJU,BPH,CRPC,DATA,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,RHAMM,THERE
169,173,2013,272,AUTHORS,BJU,CONCLUSION,FGF23,FIVE,LABEL,METHODS,OBJECTIVE,ODDS,RESULTS,SNPS,THREE
001,AUC,BACKGROUND,EORTC,LABEL,METHODS,MODEL,NTCP,PURPOSE,RESULTS,RTOG,SEVERAL,THEIR,V65
001,169,1992,2011,2013,595,8804,AFTER,AUTHORS,BCR,BJU,COX,GLEASON,HGTV,HOWEVER,LABEL,MEIER,METHODS,OBJECTIVE,RESULTS,THEREFORE
207,COMPOSITE,EPIC,HRQOL,INDEX,LABEL,METHODS,OBJECTIVE,RESULTS,THUS,URINARY
169,2013,AUTHORS,BJU,CRPC,EMT,ERK1,JAK,JANUS,MAPK,PI3,SERUM,STAT,VIA
001,136,142,169,2005,2011,2013,263,298,8201,8804,AUTHORS,BJU,CONCLUSION,GLEASON,IMAGING,JUNE,LABEL,METHODS,MRI,OBJECTIVE,PRIAS,PSA,PSAD,RESULTS,T1C
033,1000,1038,125,169,2002,2007,2013,8804,ASTRO,AUTHORS,BJU,FURTHER,GLEASON,LABEL,LDR,METHODS,OBJECTIVE,PHOENIX,PSA,RESULTS,T2B
001,002,1366,169,2011,2012,2013,8805,APRIL,AUTHORS,BJU,CONCLUSION,FORCE,HOWEVER,LABEL,MASTERFILE,MEDICAL,METHODS,OBJECTIVE,OVERALL,PHYSICIAN,PREVENTIVE,PSA,RESULTS,TASK,USA,WHILE
001,004,032,169,195,197,2003,2007,2008,2009,2013,247,315,3458,6993,8201,AUTHORS,BJU,END,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OPERATIVE,POPULATION,RARP,RESULTS,RPS,RRP,SEER,USA
002,018,107,169,2013,ADDITIONAL,AUSTRALIA,AUTHORS,BJU,FORM,ICIQ,JOHN,LABEL,LTD,METHODS,OBJECTIVE,PFMT,RESULTS,SELF,SHORT,SONS,THERE,URINARY,WESTERN,WILEY
169,1998,2011,2013,411BN,APRIL,AUTHORS,BIOLOGICAL,BJU,COMPOUNDS,CRPC,CURRENTLY,DRUG,FOOD,GIVEN,III,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PHASE,RESULTS
160,BAX,BCL,FLOW,MTT,PCR,THESE,USING,WESTERN
000,031,100,1101,128,146,167,169,174,2001,2008,2013,4629,AGE,AUSTRALIA,AUSTRALIAN,AUTHORS,BJU,CONCLUSION,DESPITE,GLEASON,INSTITUTE,LABEL,METHODS,OBJECTIVE,OVERALL,PCA,PCAS,PSA,RESULTS,SCREENING,THERE,TRUS,VICTORIAN,WELFARE
0187,098,155,235,4F2HC,571,962,987,ASCT1,ASCT2,BACKGROUND,BCH,CDC20,CDK1,CONCLUSION,E2F,FINALLY,INHIBITION,LABEL,LAT,LAT1,LAT3,LATS,MANN,METHODS,RESULTS,UBE2C,WHITNEY
215,ADV,DESPITE,EACH,FIRST,MONTERREY,NINE,PSA,THERE
CIP1,DIETARY,EXOGENOUS,HOWEVER,LNCAP,PIAS1,SBE1,SBE3,SMAD,SMAD2,SMAD4,WAF1
205,22RV1,691,945,BACKGROUND,CONCLUSION,CWR22,DLKP,DLKPA,DU145,EL102,HIF1,LABEL,MDR1,METHODS,MULTIDRUG,PARP,RESULTS,TAXANES,TUBULIN
947,FGF
001,2013,223,945,DRUG,FDA,FOOD,FURTHER,III,MAY,RACL2
0001,0028,103,186,ART,CUMULATIVE,FFBF,FFMF,LABEL,MEIER,METHODS,OBJECTIVE,OBJECTIVES,PROPENSITY,RESULTS,SRT,TEN,THESE
005,169,183,2003,2007,2013,BACKGROUND,BAHNA,COPYRIGHT,DEFENSE,DEJORIA,DEPARTMENT,FOUNDATION,FUNDING,GREENBAUM,IQR,LABEL,LTD,MEN,METHODS,NCI,NIH,RESNICK,RESULTS,SAFEWAY
001,035,169,2014,412,906,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
001,169,193,2004,2009,2014,763,911,920,929,BETWEEN,COPYRIGHT,EBRT,END,INC,LABEL,MATERIALS,METHODS,NETWORK,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SEER,SOCIETY,USING
CMP,EGFR,PSMA,SPR,SURFACE
AREAS,BACKGROUND,COVERED,EVEN,LABEL,METHODS,OPINION,THEIR
ENGLISH,THERE,WHETHER
174,177,AMERICA,CONCLUSION,EBT2,GAFCHROMIC,HITACHI,HOUSTON,ISP,KNOWLEDGE,LABEL,LTD,METHODS,OBJECTIVE,PHYSICS,PTCH,RESULTS,RPC,TARRYTOWN,TEXAS,THERAPY,TPS,UNIVERSITY,WAYNE
118,499,ADULT,BMI,BODY,CIS,HOWEVER,LABEL,METHODS,OBJECTIVE,ORS,OVERWEIGHT,PURPOSE,RESULTS,USING
001,007,389,BCR,BCRFS,CONCLUSION,COX,FIFTY,GLEASON,JAPAN,LABEL,MATERIALS,METHODS,OBJECTIVE,PREDICTORS,PSA,PURPOSE,RARP,RESULTS
145,916,936,BAK,CHK1,CHK2,HISTONE,HRPCS,MCL,RPA32
169,2013,AACR,ANTITUMOR,GRP78,HUMANIZED,LABEL,MAPK,METHODS,OBJECTIVE,PI3K,PTEN,PURPOSE,RESULTS
BPH,CAVITATION,FOLLOWING,HENCE,THEREFORE,UPON
10MG,60MG,PSA
BPH,DUE,LUTS,PSA,TDS,TRT
AGING,CURRENTLY,NIH,THERE,THESE
DRE,PSA,REFERENCES,TRT
110,DEFICIENCY
PSA,SINCE
145,H2O,INITIAL,LNCAP,METAL,MN8FE4O12,MRI,NMR,THESE,VBA
945,946,954,AKT,CULTURING,ECM,FAK,MMP,MMPS,PI3K,PKB,STUDIES
448,683,AMINO,ARG,GNRH,PYA,TAK,TRP,TYR
280,FINALLY,SEVERAL
118,1373,8804,8805,APOA4,ESI,FPA,PARTICULAR,STUDIES,THESE,WHEREAS
056,2013,682,841,945,C111A,CHINA,CNKI,DATA,FURTHER,HIF,HOWEVER,JULY,KNOWLEDGE,OVERALL,THEREFORE
1998,2012,BACKGROUND,BIO,CALIFORNIA,FINALLY,LABEL,MASON,METHODS,OVERALL,RESULTS,ROME,RUF,SEVERAL,UCBM,UNIVERSITY,USC,YORK
BASED,DESPITE,INTERVIEWS,MODEL,MOTIVATION,PRCA,PRISM,RELATIONAL,TEN
2006,2008,BACKGROUND,CONCLUSION,EAST,ENGLAND,EPS,LABEL,METHODS,RESULTS
001,160,1613,169,2014,AFRICAN,AFTER,ASIAN,BMI,BODY,CONCLUSION,COPYRIGHT,INC,IPSS,LABEL,METHODS,OBJECTIVE,PVS,RESULTS,SCORE,SYMPTOM,THERE,USAGE
0001,001,169,2013,504,531,8805,BOTH,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,NMP22,OBJECTIVE,RESULTS
103,125,131,1437,160,169,2014,3094,4547,8805,COPYRIGHT,D90,EXCELLENT,FURTHER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SOCIETY,V100
169,2011,2013,AUTHORS,BACKGROUND,COPYRIGHT,DESPITE,IRELAND,LABEL,LTD,MEDLINE,METHODS,NINE,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,QOL,RESULTS,STUDIES,SYSTEMATIC,THERE
003,104,169,177,2013,916,CBCT,COPYRIGHT,COV,CTV,D95,ERB,ERBS,EUD,IGRT,IMRT,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,TEN,WHILE
CELLS,OVERALL,PC3,RELEASE,ROS,SECM,WHILE
LNCAP,MDV3100,SAR,STRUCTURE,THEREFORE
001,103,108,140,2000,2010,229,3267,337,8201,8805,910,BCR,CONCLUSION,COX,HOWEVER,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PSA,PSM,PSMS,RARP,RESULTS,ROBOT,UNIVERSITY
004,006,028,042,120,2006,2010,432,660,8804,8805,BMFS,CONCLUSION,CRPC,DENOSUMAB,ENROLLMENT,JULY,LABEL,METHODS,OBJECTIVE,PSA,PSADT,PURPOSE,RANK,RESULTS
160,FINALLY,TFF3,TREFOIL
BINDING,CURRENTLY,PCR,PSA,THEREFORE
PRIMARY,PSAP
008,029,178,280,ACCORDING,CHANGES,ESTIMATED,HOWEVER,LABEL,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS
945,ANTITUMOR,BACKGROUND,BIP,CCAAT,CDK,CELL,CELLS,CHOP,EXPRESSION,GADD153,GRP78,IIA,LABEL,LNCAP,METHODS,RADIX,RATE,RESULTS,SALVIAE,TAN,TANSHINONE,THESE
106,188,2010,2012,8805,BETWEEN,CONCLUSION,CURRENTLY,DESPITE,FURTHER,GERMANY,LABEL,MAY,METHODS,MUSE,OBJECTIVE,OCTOBER,PDE5,RESULTS,VCD
BMP,CAF,CAFS,PTEN,SEVERAL
100,116,160,169,2014,CBCT,COPYRIGHT,D10,HDR,INC,LABEL,LARGE,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SOCIETY,TRUS,V100
169,2013,AKT,AML,COPYRIGHT,I3C,INC,OSU,PARP,ROS,THP
169,2013,DOTAU,ELECTRONIC,KNL,KNLS,NUCLEOSIDE
169,2013,92A,BOTH,CD133,CSCS,CURRENT,CYP,DTX,HOWEVER,HPMA,RAFT,SEVERAL,THUS
0001,8805,BACKGROUND,CDS,CONCLUSION,DCE,DWI,FALSE,GLEASON,LABEL,MANN,METHODS,MRI,MVD,MVDS,RESULTS,TRUE,WHITNEY
001,176,FINALLY,GAL3,LIGHT,MONOCLONAL,RLU,THERE,THESE,UNIT
001,138,22RV1,CPG,DU145,EPH,EPHA1,GLEASON,INCREASED,LNCAP,LOSS,PC3,PCR
112,22RV1,AKT,AZA1,BAD,CDC42,DAILY,GTPASES,PAK,RAC,RAC1,RHO,RHOA,THESE
BAD,BCL2,MCL,MYELOID,PI3K,PTEN,THESE,YET,ZSTK474
000,480,ATLAS,BESIDES,CHG,CPG,DMRS,FASTDMA,TCGA
571,580,588,A111E,CHAIN,FINALLY,GLYOXALASE,PCA,POLYMERASE
300,946,ADAPTOR,BCH,BCL2,BMCC1,BNIP,C9ORF65,COMPLEX,CONSISTENT,E1B,GST,GTP,INSTEAD,PCA3,PRUNE,RAB,RELATED
149,190,ALDH,EGCG,GIVEN,HDLEC,IBC,REDUCTION,STEM,SUM,THUS,VEGF
100,2002,464,BASED,COLLECTION,ENGLISH,ICS,LABEL,METHODS,NLP,OBJECTIVE,OBJECTIVES,RESULTS,SENTIMENT,TOTAL,UNMET,WEB
169,179,2013,682,8805,ASAP,AUC,BACKGROUND,FPSA2,GLEASON,HGPCA,HOWEVER,INC,LABEL,MEANWHILE,METHODS,PCA,PSA,PSA2,PSAD2,PSADT,PSAK,PSAV,RESULTS,ROC,TPV,UNIVARIATE,WILEY
117,169,2013,573,8805,945,947,AMONG,BACKGROUND,COX,GLEASON,HOWEVER,INC,LABEL,METHODS,RESULTS,SEC14L2,SNPS,SOD,SOD1,SOD2,SOD3,THUS,TTPA,WILEY
0001,100,169,2013,5AZA,AZA,BACKGROUND,CONVERSELY,CRPC,DNMT1,E2F1,EVALUATION,GLEASON,HOWEVER,INC,LABEL,METHODS,PCA,RESULTS,THESE,TMA,TMAS,TRAMP,TREATMENT,WILEY
000,169,200,2013,480,945,BACKGROUND,CONCLUSION,CPG,FUNCTIONAL,INC,LABEL,LCM,METHODS,RESULTS,WILEY,XENOGRAFTS
169,182,2013,780,946,BACKGROUND,HOWEVER,ICI,INC,LABEL,METHODS,PCA,PCR,RESULTS,USING,WILEY
001,169,175,2013,8201,8804,8805,922,ABOUT,AFRICAN,AMONG,BACKGROUND,CHINESE,CONCLUSION,CONSORTIUM,GLEASON,GWAS,INC,LABEL,METHODS,ORS,PCA,RESULTS,SEVERAL,SNPS,THESE,WILEY
001,015,2013,415,430,ADHERENCE,BACKGROUND,CONCLUSION,DATA,ENDOCRINE,III,LABEL,METHODS,PHASE,RESULTS,THEIR,THESE,WHEREAS
002,169,2013,548,726,735,834,8805,AUC,DRE,PSA,SEVERAL,SNP,SNPS,UICC
169,2013,CURRENT,DHT,HOWEVER,INC,INHIBITION,PCA,WILEY
145,169,2013,BACKGROUND,CONCLUSION,DESPITE,DU145,INC,LABEL,LNCAP,METHODS,P21,PC3,PMCA,RESULTS,SERCA,THESE,THREE,WILEY
0004,0011,11P13,169,2013,509,8201,8Q24,AFRICAN,AIM,AMERICANS,BACKGROUND,CAP,FEW,INC,LABEL,LOUISIANA,MALD,METHODS,NORTH,PCAP,PROJECT,RESULTS,SNP,THESE,WILEY
169,2013,215,667,ADDITIONAL,AUC,BACKGROUND,CHINA,CONCLUSION,HUASHAN,INC,LABEL,METHODS,PCA,RESULTS,SNP,SNPS,UNDER,WILEY
169,2013,232,239,8805,BACKGROUND,BASED,CIS,INC,LABEL,METHODS,MSMB,ORS,PCA,PSP94,RESULTS,SIMILAR,STIS,THESE,WILEY
946,HOWEVER,SMAD2,TARGETING,TGF,UTR
DISRUPTION,THERE,THESE,TRAIL
2009,2011,248,BETWEEN,CLAVIEN,GLEASON,LABEL,LESS,LRP,METHODS,OBJECTIVE,OCTOBER,PATHOLOGY,PSA,PURPOSE,RESULTS,T3A,THERE
160,CDX2,FIFTY,IHC,ISLET,NET,NETS,PAP,PAX8,SINCE,THERE
046,145,8776,ADVANTAGES,COMPARE,DPC4,MDR,MECHANISM,NCI,OVERALL,SCID,SMAD4
BACKGROUND,CURRENTLY,LABEL,MATERIALS,METHODS,MORALES,MRI,OBJECTIVE,OBJECTIVES,RESULTS,SVBS,SVI,T3B,THESE
001,002,007,413,485,734,8805,BMI,CHINESE,ECE,FURTHER,GLEASON,HOWEVER,MRI,PATIENT,PCA,PEARSON,SAT,SVI,VAT
197,1997,2012,205,ALP,COX,GLEASON,MEIER,PCA,THESE
160,1987,1996,2006,603,657,AFTER,APOC1,ARIC,CIS,COX,CRP,GRS,HNF1A,HRS,LABEL,LEPR,METHODS,OBJECTIVE,PURPOSE,RESULTS,RISK,SNPS
177,ALGORITHM,FIVE,HERA,INTENSITY,SEQUENTIAL,VOLUMES
CYBERKNIFE,EIV,SBRT,THERE,TODAY,TREATMENT,V75
PHASE,RMVS,RPM,THUS
169,2013,ACTIVATION,CONVERSELY,DU145,EGF,EGFR,FINALLY,PCSC,PCSCS,SOX2
956,A549,AFTER,CELL,DCM,ETOH,JACARANDA,K562,MCF,PC3
169,2014,947,ATM,COPYRIGHT,EDUCATION,FEW,H2AX,INC,INDUCTION,LABEL,MATERIALS,METHODS,NOTABLY,OBJECTIVE,PUBLISHED,PURPOSE,RAG2,REGARDLESS,RESULTS,UROLOGICAL
169,1996,2011,2013,465,8804,BACKGROUND,CALIFORNIA,COPYRIGHT,DISEASE,FRANCISCO,GLEASON,LABEL,MEN,METHODS,OBJECTIVE,OUTCOME,PCA,PSA,PUBLISHED,RESULTS,SAN,SETTING,UNIVERSITY
001,169,1987,2005,2013,521,8804,ANALYZE,BACKGROUND,COPYRIGHT,CSM,FINE,GRAY,HOWEVER,LABEL,METHODS,OBJECTIVE,OUTCOME,PSM,PSMS,PUBLISHED,RESULTS,SETTING,UROLOGY
169,2013,ALSO,COPYRIGHT,IRELAND,LTD
169,2013,99M,ALA,ARG,ASN,CONH2,COPYRIGHT,DYNAMIC,ESI,GLN,GLY,GRP,H2O,LEU,LTD,MBN,MET,PC3,SPPS,TECHNETIUM,TRP,VAL
169,2014,COPYRIGHT,FINALLY,INC,MICRO,RNAS
001,100,169,177,2013,ATA,COMPOSITE,COPYRIGHT,HBOT,INC,INDEX,LABEL,MATERIALS,MEAN,METHODS,OBJECTIVE,PURPOSE,RESULTS,SYMPTOM
001,1344,169,2013,945,ADT,BIOLOGICAL,COPYRIGHT,CWR22,FOUR,HIF1,HK2,INC,LABEL,MATERIALS,METHODS,MOST,OBJECTIVE,PCR,PURPOSE,RESULTS,SIX
0001,007,169,2013,215,AKT,BP1,CONCLUSION,COPYRIGHT,ERG,EXPRESSION,INC,LABEL,METHODS,OBJECTIVE,PTEN,RESULTS
002,004,140,143,169,177,2013,AFTER,AREA,CONCLUSION,COPYRIGHT,GROUP,HOWEVER,IRELAND,LABEL,LTD,MATERIALS,METHODS,MRGB,OBJECTIVE,PURPOSE,RESULTS,THEREFORE
001,143,169,177,196,2000,2006,2013,ACCORDING,AMICO,BACKGROUND,CONCEPTION,CONCLUSION,COPYRIGHT,LABEL,MARSEILLES,OBJECTIVE,OBJECTIVES,RESULTS,SAS,SBR,THERE,UROLOGY
169,2008,2013,CARE,COPYRIGHT,LONGWOODS,ONTARIO,PUBLISHING,SINCE
169,2012,233,241,243,COPYRIGHT,ESPA,PUBLICADO,QUATERNARY,THROUGH
169,2013,AFTER,CLUSTERING,ICP,INNER,LTD,PREDICTION
177,189,2009,AVERAGE,BACKGROUND,BENEFIT,CALYPSO,CBCT,D1CC,D99,DMEAN,DOSIMETRIC,DUKE,DVH,HERK,HOWEVER,IGRT,IMRT,INITIAL,IRB,LABEL,LARGEST,MATERIALS,MEDICAL,METHODS,MRI,OAR,OARS,OBI,OBJECTIVE,PER,PRECISE,PRIOR,PTV,PURPOSE,RESULTS,RIGID,SBRT,T2C,UNIVERSITY,V50,VAN
169,2013,946,AKT,CCL20,CXCL1,FURTHER,GSK3B,IGF1,INSULIN,JOHN,LTD,MEF,MELATONIN,OBESITY,PC3,PUBLISHED,SONS,WILEY
169,2013,2595,2705,325,865,AUTHORS,BACKGROUND,BRITISH,DIETARY,DIETETICS,JOHN,JOURNAL,LABEL,LTD,METHODS,NUTRITION,NUTS,RESULTS,SONS,THREE,WALNUTS,WILEY
169,2013,HCC,HNSCC,HOWEVER,THEREFORE
0399,100,139,147,169,2013,GLEASON,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,T1C,T2A,T2C,THERE,UROLOGICAL
916,946,CHIP,EZH2,H3K27,JAK,MTS,PRL,PRLR,PROLACTIN,STAT,WESTERN
8230,AREAS,BACKGROUND,COMPELLING,COVERED,EVEN,LABEL,MDM2,MDM2P,MECHANISMS,MELATONIN,METHODS,OPINION,SIRT1
008,048,109,131,171,177,8805,BACKGROUND,BOOST,FURTHER,GRADE,LABEL,METHODS,RESULTS,RTOG,SRT
0001,2012,8201,8805,AUC,INCLUSION,JANUARY,LABEL,METHODS,OBJECTIVE,PCA,PHS,POSTERIOR,PURPOSE,RESULTS,SEPTEMBER
11C,PET
945,946,AKT,BECAUSE,CDKS,ERS,KIP1,PI3K,PTEN,SKP2,WAF1
IGF,JANUS,LABEL,PCA,SOCS2,SRC,STAT5,SUMMARY,UNLABELLED
029,204,206,218,415,8Q24,BMI,CHINA,HOWEVER,ODDS,TAIXING,THESE,UADT
946,CRE,GHR,IGF,JANUS,LNCAP,PTP,SHP,STAT5
141,169,2006,2013,AUTHORITY,BASEL,COPYRIGHT,COW,DESPITE,DIRECTIVE,EARLY,FOOD,GOAT,MILK,THERE,UNMODIFIED
001,169,174,200,2013,300,8201,8805,ADVERSE,AES,AUTHORS,BJU,EIGHT,LABEL,LDI,MEN,METHODS,MOST,MRI,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,SOLUBLE,THERE,VTP
THESE
HSC,PC3,PCA,RAPAMYCIN,TAKEN,TANK,TBK1
169,2013,AACR,DNAPKCS,FINALLY,LABEL,SUBSEQUENT,THESE,UNLABELLED
169,2013,AACR,CHIP,FINALLY,LABEL,NEXT,UNLABELLED,USING
169,189,2013,463,740,8201,8805,ANXIETY,AUC,AUCS,AUTHORS,BACKGROUND,BRIEF,BSI,COMPARISON,DEPRESSION,EVENT,HADS,HOWEVER,IES,INVENTORY,JOHN,LABEL,LTD,METHODS,RESULTS,REVISED,SCALE,SONS,SYMPTOM,WILEY
FGFR1,GLEASON,PMP22,USING,VALIDATION
WORLDWIDE
120,167,8201,DESPITE,G84E,HOWEVER,MEN,PCA,THEN
113,133,160,CRP,ECGS,HOWEVER,HRV,NSCLC,PSA,THEREFORE
024,2010,2012,215,239,8805,DATA,DOCETAXEL,PSA,THERE,TTN
001,174,956,ACE,BACKGROUND,CELL,LABEL,METHODS,PACLITAXEL,PC3,RESULTS
205,CNS,ESTIMATES,HODGKIN,LABEL,MEDLINE,METHODS,ORS,RESULTS
ART,BACKGROUND,IGRT,LABEL,METHODS,TECHNIQUES
8201,BACKGROUND,BPH,DUE,LABEL,METHODS,PCA,PSA,RESULTS,THEREFORE
1148,169,2013,DC1,OTHER,RECURRENCE,RSNA
110,160,176,981,AFTER,DERENZO,DETECTION,FOV,GATE,OPENPET,PET,SEVERAL,THREE
946,ARD,CHRM1,INHIBITION,PCA,PNS,SCIENCE,SNS
DU145,INHIBITOR,LNCAP,MYC,PP2A
COHEN,MYC,PP2A,PROFESSOR,SET,SIR
593,603,833,971,BACKGROUND,COCHRAN,COMPARING,CONCLUSION,CONTROLLED,CURRENT,LABEL,METHODS,RESULTS,TRIAL
169,198,2013,ADJP,AIMS,BCR,BPH,GLEASON,JOHN,LABEL,LTD,METHODS,OBJECTIVE,PCA,RESULTS,SONS,THESE,WILEY
AREAS,BACKGROUND,COVERED,LABEL,METHODS,OPG,OPINION,RANK,RANKL
ANTI,AREAS,BACKGROUND,COVERED,FURTHER,LABEL,METHODS,MOST,OPINION
216,259,945,950,ACETYLATED,ERK,HDAC6,HDACI,HISTONE,LNCAP,PCA,PP1,RAF
180,2045,ANTIGEN,CELL,EUROPEANS,PSCA,SNP,SNPS,STEM,VENEZUELA
177,427,8482,AFTER,AIM,BACKGROUND,BODY,CONCLUSION,DESPITE,LABEL,MARGINS,METHODS,NOVALIS,OBJECTIVE,RESULTS,SDS,SNAP,SYSTEMATIC
0137,0215,169,2003,BACKGROUND,BRONJ,CONCLUSION,FURTHER,HOWEVER,LABEL,MARX,METHODS,NINE,RESULTS,SEPARATION,SINCE
019,021,239,8805,AIM,CAB,CONCLUSION,CRPC,GLEASON,HORMONE,LABEL,METHODS,OBJECTIVE,PFS,RESULTS,SRES,THERE,ZOLEDRONIC
AFFAIRS,BACKGROUND,CONCLUSION,LABEL,MATERIALS,MEDICAL,METASTATIC,METHODS,NODAL,PCA,PSA,RESULTS,THESE,USING
169,177,2013,CONCLUSION,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,MRI,MRIS,MUL,MUL1,MUL2,MUL3,OBJECTIVE,PRM,PRM2,PRM3,PURPOSE,RESULTS,WILEY
001,002,006,008,044,215,8805,ADC,ANALYZING,GLEASON,HIGH,LABEL,LOW,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,THERE
BPH,HORMONE,PRCA,SEX
215,586,8804,CIS,GWAS,IRX4,SNPS
100,273,3714,ADENOVIRUS,BACKGROUND,CAR,CONCLUSION,COXSACKIE,EXPRESSION,HOWEVER,LABEL,METHODS,RESULTS,TMA
BACKGROUND,ERG,LABEL,METHODS,RESULTS,SCC,SMALL,WHILE
169,2013,CONCLUSION,COPYRIGHT,CROWN,IRELAND,LABEL,LTD,METHODS,MOST,OBJECTIVE,PUBLISHED,RESULTS,ROM,STUDIES
1413,947,BACKGROUND,CBCT,CBCTS,CONCLUSION,CTS,EPID,HOUNSFIELD,IMRT,LABEL,METHODS,PDI,PDIS,RESULTS
CELLSEARCH,CTCS,FDA,METASTATIC,TAKEN,VACV
946,CARM1,GIVEN,HOWEVER,THEREFORE,TREATMENT
169,2013,509,AACR,ARN,F876L
006,112,169,2013,8201,ANOVA,BACKGROUND,FAMOTIDINE,FURTHER,INC,LABEL,MAGNITUDE,METHODS,RESULTS,WILEY
2012,BMD,ENDOCRINE,SECONDARY,SOCIETY
135,169,1982,1990,1991,2000,2001,2011,2013,505,BACKGROUND,GLEASON,HOPKINS,INC,JOHNS,LABEL,MEIER,METHODS,N1PC,PREDICTORS,PSA,RESULTS,WHILE,WILEY
0001,015,954,ERC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,QUALITY,RESULTS,SNR
2013,310,376
AKT,FEOJ,HENCE,LNCAP,MMP,MMPS,OROSTACHYS,PI3K,TAKEN,TER,TIGHT,TIMPS,TJS
HOWEVER,IDC,THEREFORE
001,106,177,200,8201,AMONG,AUR,BACKGROUND,BPO,FOLLOWING,LABEL,METHODS,PFR,PVRV,RESULTS,TWOC
001,50TH,58102,8201,AGENT,BACKGROUND,BCR,GLEASON,HOWEVER,LABEL,METHODS,NEITHER,RESULTS,TEQ
1980S,1990S,EBRT,FINALLY,HDR,IGRT,IMRT,SBRT
HOWEVER,MHC,MICB,NKG2D,TRAMP
169,174,2013,20YEARS,DOXIL,INCREASED,MAIN,PNM,PNMS,SINCE
169,1995,2012,2014,625,AJCC,COMMITTEE,COPYRIGHT,CURRENT,EDUCATION,FUHRMAN,HOWEVER,INC,IQR,JOINT,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SMOKING,TREATMENT,UROLOGICAL
041,169,2011,2012,2014,403,591,COPYRIGHT,EDUCATION,FIVE,HOWEVER,INC,JANUARY,LABEL,MATERIALS,MEN,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
2008,2011,8805,AFTER,BACKGROUND,FURTHER,GLEASON,IBD,LABEL,METHODS,PSA,RESULTS,THERE
169,2013,2GY,3GY,45GY,4N1M0,65GY,72GY,80GY,945,946,ACTUARIAL,BACKGROUND,CONCLUSION,COPYRIGHT,CTC,IMAT,IRELAND,LABEL,LENT,LTD,MEIER,METHODS,OBJECTIVE,PCA,PURPOSE,RESULTS,RILIT,RTOG,SOMA,THREE
041,100,10877,169,2013,239,54GY,75GY,ACUTE,AFTER,COPYRIGHT,END,FORTY,INCIDENCE,IRELAND,LABEL,LATE,LTD,MATERIALS,MEAN,METHODS,OBJECTIVE,PBRT,PURPOSE,RESULTS,WPRT
ACID,COMPARISON,EXCLUSION,NUCLEIC,REMOVAL,SELECTIVE,SNARE,THUS
177,8320,8325,956,BACKGROUND,CONCLUSION,DORSTENIA,LABEL,METHODS,MTT,RESULTS,ROS,WEST
145,8320,8325,956,DOPPLER,OXI8006,OXI8007,SAR,SCID
945,946,947,LNCAP,POLYAMIDE,WHILE
169,2013,COPYRIGHT,CYTOTOXIC,FEW,HENCE,SAS,SIRT1
160,169,2013,674,BOTH,CONVERSELY,COPYRIGHT,HOWEVER,INC,OVERALL,PATHOLOGY,PUBLISHED,SOCIETY,SOX7
169,2013,315,788,ATR,COPYRIGHT,EIF2AK1,GLYR1,HOWEVER,IRELAND,LNCAP,LTD,PSA,USING
169,177,2013,AIMS,COG,DESPITE,FACT,KEY,LABEL,MAIN,METHODS,OBJECTIVE,RESULTS
169,2000,2009,2014,342,COPYRIGHT,EDUCATION,IIEF,INC,INDEX,IQR,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL,WHILE
169,2013,A549,AKT,CK2,COPYRIGHT,LTD,MAPK,MMP,PI3K
169,2013,AUTHORS,COPYRIGHT,HOWEVER,IRELAND,LTD,LUNG,MICROARRAY,NSCLC,PUBLISHED,SQCC,WHILE
169,2013,BECAUSE,CBCT,COPYRIGHT,HOWEVER,IGRT,PUBLISHED,SAS
169,2013,BACKGROUND,CONTEXT,COPYRIGHT,CURRENT,DECADES,LABEL,MEDLINE,METHODS,OBJECTIVE,PCA,PUBLISHED,RESULTS,SYNTHESIS,THESE,UROLOGY
1A1,CYTOSOLIC,SNPS,SULT,SULT1A1,SULTS
169,2013,252,AKT,BAX,BCL,CD10,CD41,CD44,CD61,CONCLUSION,DAMI,ERK,FUNCTIONAL,JOHN,LABEL,LTD,MATERIALS,MAY,METHODS,MTT,OBJECTIVE,OBJECTIVES,PCR,REAL,RESULTS,SONS,STAT,TAKEN,THESE,WILEY
480,FATIGUE,FEMALES,PAIN,PREDICTORS
103,106,8805,AMACR,BACKGROUND,FINALLY,FIRST,GLEASON,IMAGE,LABEL,METHODS,PROCRUSTES,RESULTS,SIFT,THREE,TIME,TRF
ELASTICITY,FINALLY,FORCE,IMAGING,MODULATED,RADIATION,SMURF,SPATIALLY,SUPERSONIC,ULTRASOUND,WAVES
CRPC
017,145,265,775,CONCLUSION,COX,GLEASON,HDAC1,HDAC2,HDACS,LABEL,METHODS,OBJECTIVE,PSA,RESULTS,UNIVARIATE
150,258,ACCORDING,CONCLUSION,LABEL,METHODS,MUNICIPAL,OBJECTIVE,QINGDAO,RESULTS
CRPC,HOWEVER,MDV3100,PCA,UPON,WESTERN
109,169,1968,2006,2013,897,ADDITIONAL,AREVA,BACKGROUND,BASED,BCNS,CONCLUSION,COX,HRS,INC,LABEL,METHODS,MORTALITY,NUCLEAR,RESULTS,WILEY
107,140,2000,2008,2010,2197,239,5603,642,9874,AGE,AMONG,ASIAN,CANCERS,COX,FURTHER,ICD,INCREASED,INSURANCE,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS,USING
3E6,AIMS,BACKGROUND,BPH,CD34,GLEASON,LABEL,METHODS,MONOCLONAL,OBJECTIVE,PR8,PSA,PSMA,RESULTS
108,169,2006,2011,2013,500,BASEL,BCR,COPYRIGHT,JULY,LABEL,METHODS,MINOR,OBJECTIVE,RARP,REGARDING,RESULTS,SRARP
2013,2360,237,239,8201,ALSO,ANY,BACKGROUND,CONCLUSION,CRPC,DESPITE,GLEASON,LABEL,MAIN,MAJOR,METHODS,OTHER,PRIMARY,PSA,QOL,RESULTS,SECONDARY
000,100,169,2013,8230,ALTERED,COPYRIGHT,CURRENT,DUE,ENT,JAPAN,MOST,PUBLISHED,SAS,UNTIL
169,2013,2348,8804,8805,BACKGROUND,BASED,BCR,COPYRIGHT,LABEL,METHODS,OBJECTIVE,OUTCOME,PSA,PSAS,PUBLISHED,RADICAL,RESULTS,SETTING,UROLOGY,USING
120,169,1836,2013,AFTER,ANGELES,ASSESSING,BACKGROUND,CALIFORNIA,COPYRIGHT,GLEASON,INDEX,LABEL,LOS,MEN,METHODS,OBJECTIVE,OUTCOME,OVERALL,PUBLISHED,RESULTS,SETTING,THERE,UNIVERSITY
AXIAL,BACKGROUND,CONCLUSION,CTV,LABEL,METHODS,RESULTS,THEREFORE
049,124,8805,945,946,ADT,ARM,BACKGROUND,BOTH,CRD,EPIC,GRADE,IMRT,LABEL,METHODS,QOL,RESULTS,THERE
17ALPHA,945,C21,CYP17,MOST
177,232,BECAUSE,EVALUATION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THREE,TRE,TRES
8764,EPID,IMRT,LABEL,METHODS,MLC,OBJECTIVE,PURPOSE,RESULTS,SIMULATED
ARGON,CDTE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,USING
182,AUTOMATIC,BASED,FINALLY,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THEN
169,2008,2011,2013,326,541,8201,883,ASIAN,AUTHORS,BJU,GLEASON,JANUARY,LABEL,LNI,LNS,METHODS,OBJECTIVE,PLND,PSA,RESULTS
004,016,110,169,2013,AUTHORS,BJU,CONCLUSION,ERG,GLEASON,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PCA,PROTEIN,RESULTS,SVD
177,181,CELL,COA,DU145,HMG,IC50,RAS
001,003,1151,169,2013,229,392,431,597,672,677,753,8201,8805,BACKGROUND,COPYRIGHT,GLEASON,LABEL,METHODS,RESULTS,SOCIETY,VALIDATED
PC3,RESULTS
PLGF,THESE,VEGF
169,2013,AACR,EZH2,HHV,HOWEVER,MECHANISMS,MSMB,STRIKINGLY,TAKEN
102,560,CAB,CRPC,EMP,PSA,THUS
COX2,IMR,LNCAP,NAD,NQO1,NRF2,PGE2,PI3K,THESE,ULVA
1999,2011,BACKGROUND,COMPLIANCE,DATA,GROWING,LABEL,METHODS,NORWEGIAN,PEARSON,PRIMARY,PSA,RESULTS,SOGN,THERE
120HD,2100,215,BACKGROUND,BOTH,CARLO,CONCLUSION,DICOM,GHZ,IAEA,INTEL,LABEL,METHODS,MILLENIUM,MLC,MONTE,PRIMO,RESULTS,XEON
769,786,ADDITIONAL,BACKGROUND,CAKI,EPO,EPOR,ERK1,HOWEVER,JAK2,LABEL,METHODS,RCC,RESULTS,RPTEC,TMA,USING
1349,2666,DENMARK,EMPLOYMENT,FINLAND,ICELAND,LABEL,METHODS,OBJECTIVE,ODDS,RESULTS,TESTICULAR,VALID
001,2004,2011,240,AMICO,BETWEEN,CDS,CLAVIEN,DINDO,GLEASON,LABEL,LRP,MEAN,METHODS,OBJECTIVE,RESULTS,THERE
AMONG,DIVERSE,DU145,HAT,HDAC,HDACI,HISTONE,LEADS,LNCAP,THESE
ALSO,OTHER,THESE,THUS
160,215,420,CARLO,CCE,CLOUD,COMPUTE,EC2,ELASTIC,IMRT,MONTE,STX,THREE,TVR,UNITS,VMAT
954,ID1,IHC,JNK,JUN,KNOCKDOWN,MAPK,PCR,PTPRK
120,240,300,480,509,8805,945,ARN,CONCLUSION,CRPC,DOSE,FDHT,LABEL,METHODS,OBJECTIVE,PRIMARY,PURPOSE,REDUCTION,RESULTS
0001,0002,001,002,004,007,101,114,8804,CONCLUSION,ESTIMATES,HARRELL,KARNOFSKY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
BASE,BECAUSE,BENCHMARK,COMPARISON,DATA,NCDB,REPORTS,STUDIES,TREATMENT
000,100,AFRICAN,ASHANTI,FEMALES,GHANA,KATH,KOMFO,SAHARAN,STEPS,THESE,USING,WEST
CRPC,THESE,VARIOUS
121,239,8202,8805,AFTER,BMI,FIFTY,LABEL,METHODS,OBJECTIVE,PSA,RESULTS,THESE
169,2013,954,COPYRIGHT,DAD,HT29,INFUSIONS,JOHN,LTD,PC3,TOTAL,WORT
1000,169,2013,AAWD,CONCLUSION,COPYRIGHT,CRPC,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,REGARDLESS,RESULTS,THREE
000,1107,115,169,171,2009,2013,240,2950,498,541,5669,6224,6448,692,736,8174,8979,9157,941,AFTER,AMONG,ANY,APRIL,BIOBANK,COMMUNITY,CONCLUSION,COPYRIGHT,EACH,EDUCATION,ENGAGEMENT,FIFTY,FOUNDATION,INC,LABEL,MAYO,MEDICAL,METHODS,MINNESOTA,OBJECTIVE,OLMSTED,PUBLISHED,RESULTS,ROCHESTER,SEVENTY
140,145,BACKGROUND,CONCLUSION,FUNDING,GLEASON,III,LABEL,METHODS,OBJECTIVE,PLND,PSA,RESULTS,SIX,THERE,TRIAL
000,001,008,149,232,239,300,8804,8805,AMONG,BACKGROUND,CLAVIEN,CONCLUSION,DAVINCI,DINDO,FINAL,FUNDING,IIIB,LABEL,METHODS,OVERALL,RESULTS,ROBOT,TRIAL
AKT,BACKGROUND,CONVERSELY,DNMT,DNMT1,DNMTS,LABEL,MG132,PCR,PI3K,RASSF1A,RESULTS,TAKEN,THEREFORE,USING
11C,2005,2011,2013,ADT,ASTRO,BETWEEN,CTCAE,EBRT,GLEASON,HIFU,JULY,PET,PHOENIX,PSA,SALVAGE,SEVEN,VMAT
177,500,570,750,CD31,MICE,MODULATION,PC3,SCID,THERE,TREATMENTS,TUMOURS,XENOGRAFT
EACH,SET
169,2013,UROLOGICAL
HENCE,KLK,PCA,PCA3,PCR,PSA
1373,1992,2012,262,2675,4391,559,682,728,BACKGROUND,CONCLUSION,EVEN,GLEASON,LABEL,METHODS,PSA,RESULTS,UNTIL
1400,169,2009,2013,BOTH,COPYRIGHT,DRE,JOHN,LTD,MRI,NEWER,PSA,RANDOMIZED,SCREENING,SONS,TRUS,WILEY
174,2002,2011,8805,BMET,BMETS,BONE,COMMERCIAL,CUMULATIVE,IVB,IVBS,KEY,LABEL,MARKETSCAN,METHODS,OBJECTIVE,PURPOSE,RESULTS,USA
169,2013,946,BACKGROUND,CPG,EPIGENETIC,FOCAL,GSTP1,HISTONE,IGF2,INC,INCREASING,INSULIN,LABEL,LOI,LOSS,METHODS,RAR,RASSF1A,RESULTS,SEVERAL,THESE,WILEY
169,2013,BACKGROUND,BAX,CONCLUSION,GENISTEIN,HOWEVER,INC,JEVTANA,LABEL,METHODS,PC3,PCA,RESULTS,WILEY
FSH,GNRH,LHRH,PCA
1044,107,160,169,183,184,8805,CONCLUSION,GEORG,GLEASON,HOWEVER,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,ROC,STATISTIC,STUTTGART,TESLA,THREE,TRUS,YORK
177,2000,2011,2275,58106,6842,778,ACTUARIAL,BACKGROUND,BCR,LABEL,METHODS,OVERALL,RESULTS,UNI
0001,0003,0006,001,0016,163,267,58106,8201,BACKGROUND,BXGS,GLEASON,INCLUSION,INCREASING,LABEL,METHODS,PCA,PNI,PSA,RESULTS,THUS
LOW,OVERALL,SINCE,TREATMENT,TTH
169,2013,231,ANIMALS,BOTH,COPYRIGHT,MDA,PAIN,PUBLISHED,THESE
CAREFUL,HOWEVER,OMEGA,PUFAS,ROS,THESE
013,015,046,049,100,150,169,2013,649G,690C,714G,764A,786T,894G,AUTHORS,BPH,GENOTYPING,GWAS,JOURNAL,NOS,NOS3,PATHOLOGY,PCA,PSA,RFLP,SNPS,THERE
GLYCINE,GNMT
2009,2012,BETWEEN,DEFINITIVE,LABEL,METHODS,OBJECTIVE,OCTOBER,RESULTS
8226,8315,8322,BECAUSE,CHICAGO,CUZN,FINALLY,LAKE,PCB,PCB11,PCBS,RESULTS,ROS,RWPE
119,138,169,172,2013,8805,AGE,BACKGROUND,CONCLUSION,FIFTY,FURTHER,INC,LABEL,METHODS,MMT,MMT84,MMT95,OVERALL,PROCEDURE,RESULTS,RMS,SIOP,WILEY
946,A549,AXIN1,CONCLUSION,LABEL,METHODS,OBJECTIVE,PC3,PCR,RESULTS,SMAD3,TGF,WESTERN
100,169,2013,251,779,8201,961,AUC,BACKGROUND,CONCLUSION,EIS,INC,LABEL,METHODS,MHZ,RESULTS,ROC,SIMILARLY,WILEY
169,2013,BACKGROUND,CRPC,CYP17A1,DESPITE,FKBP5,HOWEVER,INC,LABEL,LNCAP,METHODS,PSA,RESULTS,THESE,TMPRSS2,VCAP,WILEY
628,CALIFORNIA,DATA,DOING,INCLUDING,MEN,SYMPTOM,TECHNIQUE,WHILE
001,122,177,8201,8226,ADC,DIFFUSION,GLEASON,HOWEVER,KEY,LABEL,METHODS,MRI,NEITHER,OBJECTIVE,OBJECTIVES,PROSTATIC,REDUCED,RESULTS,SCORE
001,010,014,031,8805,CBCT,CONCLUSION,CSA,KNOWLEDGE,LABEL,MEAN,METHODS,OBJECTIVE,RESULTS
174,8482,ALTO,CONCLUSION,ECLIPSE,IMRT,KNOWLEDGE,LABEL,MEDICAL,METHODS,MUS,OAR,OARS,OBJECTIVE,PALO,PTV,RESULTS,SYSTEMS,TREATMENT
169,1C3,200,2013,AACR,CASTRATION,CELLS,CHROMATIN,CRPC,GLEASON,LABEL,LNCAP,METHODS,NOVEL,OBJECTIVE,PURPOSE,RESULTS,VCAP
13R,945,ADV,CEA,EGFR,EPCAM,FZ33,IGG,OVERALL,PAP2A,PSMA,THEREFORE,USING,Z33
AMONG,CD44,INCLUSION,PCA,SAM68,SEVERAL,SND1,STRIKINGLY,THUS
946,AKT,AKT1,HGPIN,HOWEVER,MUTATIONS,PTEN,TGF
498,DAUN,DOX,DOXOL,EACH,H460,H9C2,HCT,HEPG2,LC50,MCF,MTT,NCI,OVCAR,OVERALL,PANC,THEREFORE,WESTERN
144,192,2000,2011,244,65308,GLEASON,JANUARY,PSA,THESE
NANOLITER,PCR
1080,10A,10F,169,2013,945,946,947,COMPOUNDS,COPYRIGHT,CRPC,DU145,FINALLY,H2AX,LNCAP,PC3,SAS,STRUCTURE
601,8804,8805,CHUN,DIAGNOSTIC,HGPCA,PCA,PCA3,PCPT,PREVENTION,TRIAL,WHILE
169,1B1,2013,COPYRIGHT,HODGKIN,LTD,N3ADE,N7GUA,OHE1,P450,PAH,THEREFORE,THESE
169,2013,350,386,BENCHMARK,CEN10,COPYRIGHT,ERG,ERG3P,ERG5P,HOWEVER,INC,MOLECULAR,PATHOLOGY,PTEN,PUBLISHED,SOCIETY,THERE,THESE,ULTRA
031,169,185,200,2013,947,954,ADDITIONAL,CAUCASIAN,COPYRIGHT,HOWEVER,IGG2,INC,NONE,PUBLISHED,RIIA,RIIIA,SOCIETY
145,169,2013,956,COPYRIGHT,EACH,FOUR,H460,IC50,LTD,MOST,NCI,OXI8006
169,2013,ACCORDING,COPYRIGHT,PUBLISHED,SAS
169,2013,ATG,ATG12,ATG5,ATG7,AUTOPHAGY,BACKGROUND,COPYRIGHT,LABEL,LC3B,METHODS,PDT,PHA,RESULTS,ROS,WESTERN
154,169,2013,308,445,900,AFTER,COLORECTAL,COPYRIGHT,DIAGNOSTIC,IRELAND,LTD,LUNG,METHODS,OVARIAN,PLCO,SCREENING,TRIAL
169,2013,916,ASSESSMENT,COPYRIGHT,GRAPE,GSES,H2O2,HBV,HEPG2,LTD,PC3
169,2013,ADT,COPYRIGHT,FURTHER,HOWEVER,LTD,PCA,TARGETING,THESE
169,2013,COPYRIGHT,FINALLY,IRELAND,LTD
0008,003,169,2013,ADC,AIM,COLLEGE,CONCLUSION,COPYRIGHT,DATA,DCE,DICE,EVALUATION,INCLUDING,LABEL,LTD,METHODS,MRI,OBJECTIVE,PUBLISHED,RESULTS,ROYAL
111,169,177,2013,8482,COPYRIGHT,CZT,FURTHER,HYBRIDYNE,IMAGING,IMMEDIATE,INC,IRELAND,LABEL,LTD,METHODS,MOLECULAR,MRI,OBJECTIVE,PATHOLOGY,PROXISCAN,PURPOSE,RESULTS,SPECT,THERE,TRGI,TRUS
169,2013,367T,946,COPYRIGHT,CRPC,DHT,FOLLOWING,HOWEVER,HSD1,INC,N367T,WHEREAS
169,192,2013,231,233,COPYRIGHT,EVEN,HOWEVER,PUBLISHED,REGARDING,SAS,SFRO,SOCI
169,1998,2013,COPYRIGHT,DATA,FURTHER,INC,INSTITUTE,MEDLINE,NUTRITION,PHYSICIAN,QUERIES,THERE
110,160,169,2001,2008,2012,2013,240,376,4655,538,581,AMONG,CONCLUSION,COPYRIGHT,HOWEVER,INC,LABEL,MEDICAL,METHODS,OBJECTIVE,RESULTS,TRUS,UNIVERSITY
001,169,2013,3062,357,531,726,BACKGROUND,CONCLUSION,COPYRIGHT,HOWEVER,LABEL,LTD,METHODS,NOTABLY,RESULTS
FLUOZIN
DERIVED,DESPITE,PCA,THEIR
161,CAP,CYP1B,NQO2,P450,THESE
2009,48H,956,AIM,BAD,BAX,BCL2,BCLXL,CONCLUSION,GLIDE,HESPERETIN,IC50,LABEL,METHODS,MTT,OBJECTIVE,RESULTS
100,HELA,THREE
2013,BECAUSE,CHINESE,CNKI,KNOWLEDGE,LABEL,MAY,METHODS,OBJECTIVE,RESULTS,SCIENCE,WEB
300,ABOUT,SCIENTIFIC
945,CURRENT,THESE
057,110,153,189,AMONG,ENRICHMENT,MASS,NPY,PSA,QUEST,QUICK,ROC,SMALL,TARGETS,THUS
11C,169,18F,2013,IMAGING,UROLOGICAL,WESTERN
000,002,2006,2010,ADC,ADCS,AIR,CONCLUSION,DIFFUSION,GLEASON,III,KRUSKAL,LABEL,MANN,MARCH,METHODS,OBJECTIVE,REGIONS,RESULTS,ROIS,THERE,WHITNEY
MRI,RADIOLOGY,SOCIETY,UROGENITAL
177,8805,954,AKT,BP65,ERK,EXPRESSION,GLEASON,LABEL,LOSS,MEK,METHODS,OBJECTIVE,PSA,PSMA,PURPOSE,RAF,RESULTS,RKIP,S473,T308
CAP,DSB,IC20,LNCAP,MTT,NHEJ,RADIATION,RWPE,THESE
945,HOWEVER,INDUCTION,INHIBITION,MCF,T47D,THERE,VEGF
954,DOCETAXEL,DTX,DU145,EXPRESSION,FE3O4,LNCAP,MGNPS,THESE
0001,100,108,322,430,8804,GLEASON,GROUP,LABEL,METHODS,OBJECTIVE,PCA,PURPOSE,RESULTS,THERE,UNG,UNS,UPG
1998,2002,CONCLUSION,DEPRESSIVE,DISTANT,INSTITUTE,LABEL,METHODS,MHOS,OBJECTIVE,PURPOSE,RESULTS
LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THUS,WESTERN
8805,COX,DYSURIA,HEMATURIA,LABEL,LATE,LENT,METHODS,NINE,NOMOGRAMS,OBJECTIVE,RESULTS,SOMA,UNIVARIATE,URINARY
BACKGROUND,CCH,CD8,CONCLUSION,CRPC,DCS,DELAYED,DTH,ELISPOT,EXPANSION,HOWEVER,LABEL,METHODS,PCCL,PSA,RESULTS,SIX,TREATMENT
169,2013,AACR,CRPC,CURRENTLY,FINALLY,HOWEVER,LABEL,METASTATIC,UNLABELLED
003,160,1982,1995,476,8805,BLOOD,FASN,FIVE,GLEASON,MUFA,MUFAS,PHYSICIANS,SFA,SFAS
135,ACSM,ADT,AHA,AMBULATORY,COLLEGE,CROSS,HEART,HIGH,INSIGHT,KNOWLEDGE,LABEL,MAIN,METHODS,NURSING,OBJECTIVE,OBJECTIVES,PURPOSE,RESULTS,SETTING,VARIABLES
8804,8805,AIM,BACKGROUND,CHRONIC,CONCLUSION,COPD,FEV1,LABEL,MATERIALS,METHODS,OBJECTIVE,PSA,RESULTS,THERE
169,2013,COPYRIGHT,END,INC,LABEL,LEAD,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEER
013,021,169,2013,247,405,AIM,BACKGROUND,FDR,GBC,GRS2978974,HOWEVER,LABEL,LINKAGE,METHODS,NORTH,OBJECTIVE,PCORR,PSCA,RESULTS,SNPS,SPSS,THEREFORE,THESE,TRS2294008
113,121,134,148,200,209,306,354,731,BACKGROUND,COMMITTEE,ENDPOINTS,FINAL,GROUP,HOWEVER,INITIAL,LABEL,METHODS,OBJECTIVE,PIVOT,PURPOSE,RESULTS,SPCG,THERE,THREE,TRIAL,USING
483,503,HOWEVER,LABEL,MATERIALS,METHODS,NVBS,OBJECTIVE,OVERALL,PDE,POTENCY,PURPOSE,RARP,RESULTS,SHIM
001,008,100,2002,2009,241,8201,8805,AMICO,AMONG,ASIAN,BCR,BETWEEN,GLEASON,LABEL,LRP,MEN,METHODS,OBJECTIVE,PSM,PURPOSE,RADICAL,RESULTS,T2C
100,169,177,2013,BACKGROUND,CONCLUSION,COPYRIGHT,GMHS,INC,LABEL,MEAN,METHODS,SIX,TECHNICAL
018,022,035,169,199,1992,2003,2013,223,300,CONCLUSION,COPYRIGHT,EPLND,HOPKINS,INC,JOHNS,LABEL,LNS,LPLND,MEN,METHODS,OBJECTIVE,RESULTS
169,2013,BACKGROUND,BEAUCHAMP,CHILDRESS,ELSI,FACULTY,LABEL,METHODS,PRESS,PUBLISHED,RESULTS,ULTIMATELY,UNIVERSITY
945,A549,CRUCIALLY,EGF,EGFR,ERK1,EXPRESSION,H460,HOWEVER,INHIBITION,NAV,NAV1,NSCLC,THUS,TTX,VARIOUS
954,BLT2,NADPH,NOX,PWR,RNAI,ROS,TAKEN
ENDOCRINE,FURTHER,HOWEVER,PSA,RADICAL
HDL,HIGH,LOW
181,8201,AKT,BXPC,COMPOUNDS,ERK,FIGS,H1299,IC50,INHIBITORY,MTT,PFBR2,PFBR3,PFBR4
IFN,IRF3,OVS,PC3,TPL,TRIPTOLIDE,TSA,VSV
031,095,954,KI67,OHDG,POM,POMX,PRIMARY,PSA,SEVENTY,THERE,UROLITHIN,WONDERFUL
1128,127,CONCLUSION,EACH,GLEASON,GROUP,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PREDICTIVE,PSA,RESULTS,SEMINAL
001,1996,2007,204,627,8804,EXCEL,GLEASON,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PSA,RESULTS,ROC,RPAS,UNIVARIATE
1980,2013,INITIALLY,JANUARY,LABEL,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,ONCOLOGIC,RESULTS
002,003,006,0270,046,049,124,138,174,5120,526,580,585,612,620,740,853,883,967,980,BASED,BEIJING,BMI,CHI,CHINESE,DENDROGRAM,GLEASON,LABEL,LMTK2,METHODS,MTK2,OBJECTIVE,PCA,PSA,RESULTS,TET2,THERE
2000,2010,EIGHT,FIVE,JANUARY,LABEL,MARCH,METHODS,OBJECTIVE,RESULTS,STUDIES
297,BACKGROUND,LABEL,MEDULLARY,METHODS,MTC,PATIENT,THEREFORE
ADT,ADVERSE,BACKGROUND,CASTRATION,CRPC,EFFECTIVE,FINALLY,FOLLOWING,GLEASON,HIGH,HOWEVER,HRPCA,LABEL,METHODS,RESULTS,TSGS
2013,3402,3411,AKT,CEN,ELEVATION,EVALUATION,FOLLOWING,HOWEVER,KRAFT,MAHAJAN,PI3K,PIM,RES,WANG
947,BACKGROUND,CONCLUSION,DMLC,LABEL,METHODS,ORGAN,RESULTS,SCANDIDOS,TRILOGY,VMAT
108,ADT,AEZS,AREAS,BACKGROUND,COVERED,DEGARELIX,DESPITE,LABEL,LHRH,METHODS,OPINION,PCA
BOTH,CONCLUSION,EXPRESSION,FINALLY,FUNCTIONAL,ITGA5,LABEL,METHODS,OBJECTIVE,OMNIBUS,RDX,RESULTS,RETRIEVAL,THEN,TOOL
176,177,191,231,HOWEVER,LNCAP,MDA,SPHL,THEREFORE,URSOLIC
ALS,ALZHEIMER,GLUTAMATE,INHIBITION,NDD,NDDS,PARKINSON
001,AIM,ALSO,BPH,CONCLUSION,EDUCATION,HOWEVER,IRANI,KAYSERI,LABEL,LABORATORY,METHODS,MPV,OBJECTIVE,PSA,RESULTS,TABLE
ADP,AMPA,GLYCINE,GLYPHOSATE
169,2013,4T1,947,A2A,AACR,AMP,ANTI,CD4,CD73,CD8,CTLA,FOXP3,IFN,LABEL,MC38,MCA,METHODS,MONOCLONAL,OBJECTIVE,OVA,PURPOSE,RESULTS,TAKEN
169,2013,805,AACR,BACKGROUND,GLEASON,IGF,LABEL,LOSS,LOW,METHODS,PHYSICIANS,PI3K,PROTEIN,PSA,PTEN,RESULTS
169,2013,AUTHORS,CCL2,CCR2,EMBO,EMT,HOWEVER,INCREASED,JOHN,LTD,MOLECULAR,PCA,PUBLISHED,SONS,STAT3,WILEY
0001,169,196,2013,481,719,ADDITIONAL,AFTER,BONFERRONI,CHRONIC,CIS,NADPH,NAPDH,NCF4,PLCO,SCREENING,SNPS,TRIAL,UICC,WHILE
172,2011,346,8805,BEGG,CAG,CAUCASIANS,EGGER,HISPANICS,NCBI,OCTOBER,STATA
CAS,IAS
169,2013,AACR,EMT,F191G,FINALLY,HOXA9,LABEL,STRUCTURE,TARGETING,THEREFORE,THESE,TWIST,UNLABELLED
ACCORDING,ALSO,DU145,EMT,ERK,FAK,FINALLY,FURTHER,HOWEVER,JNK,LOSS,MMP,P53,SRC
100,169,2013,8320,8325,956,AMONG,CHANGES,COPYRIGHT,ETOAC,GARCINA,HEX,HOESCHT,MMP,MTT,ROS,THERE,TREATMENT
138,140,169,2013,278,LABEL,MEN,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,UROLOGICAL
AIM,CONCLUSION,CRPC,CYC,DOCETAXEL,FINALLY,LABEL,MATERIALS,METHODS,METRONOMIC,MICE,OBJECTIVE,PC3,RESULTS,THESE
0042,1200,BASED,CRPC,III,MEN,PHASE
163,1972,2000,2005,300,ASSISTANT,BRITISH,CAMBRIDGE,FOUNDATION,GALUKANDE,JOURNAL,KIRBY,MEDAL,MEDICAL,MEN,NATASHA,PETER,ROGER,UNIVERSITY,UROLOGICAL,UROLOGY
100,120,135,168,169,170,200,2006,2012,2013,250,406,575,8201,956,AMICO,AUTHORS,BCR,BJU,COX,EERPE,GLEASON,IQR,JANUARY,LABEL,METHODS,OBJECTIVE,OVERALL,PSA,PSM,PSMS,RESULTS
001,002,006,009,030,043,048,064,411,541,584,599,771,898,946,AFTER,BNP,DIL,LABEL,METHODS,OBJECTIVE,PSM,PURPOSE,RARP,RESULTS,SIMILAR,THERE
2011,945,C17,CYP17,FDA,III,ONGOING,P450
BLADDER,DESPITE,USA
0001,0048,0077,027,105,143,176,177,204,AUC,BISULPHITE,BNIP3,COBRA,CPG,D191V,EXPRESSION,GCPII,GLUTAMATE,GSTP1,H475Y,MDA,PCR,PSMA,R190W,RASSF1A,ROC,SOD
1978,2002,2010,515,810,CIS,CROHN,DENMARK,HODGKIN,IBD,JUTLAND,LABEL,METHODS,NORTH,OBJECTIVE,OBJECTIVES,POPULATION,RESULTS,SIR,SIRS
174,ARRAY,CAUCASIAN,CD31,ECS,FURTHER,LDL,NDECS,PCR,TDEC,TDECS,WILLEBRAND
169,2013,70GY,COPYRIGHT,CTV,D95,ESTIMATION,FIVE,IMRT,INC,LABEL,LEVEL,MATERIALS,METHODS,NTCP,NTCPS,OBJECTIVE,PURPOSE,RESULTS,TRUTH,USING,V70GY
169,2013,HOWEVER,JNK,PREVIOUSLY,SP1,SP3,THESE,TMPRSS4
1051,1993,2008,BACKGROUND,CIS,COX,DENMARK,DIAGNOSTIC,DIET,LABEL,MEN,METHODS,ORS,PSA,RESULTS
001,010,011,144,676,8804,C30,CONCLUSION,CORE,EORTC,FORM,ICIQ,IIEF,INDEX,LABEL,LIFE,MATERIALS,METHODS,OBJECTIVE,OVERALL,PURPOSE,QLQ,QOL,QUALITY,RALP,RESULTS,SHORT,TREATMENT
8201,941,MECHANICAL,ROC
2014,828,ANXIETY,APA,C30,CLUSTER,CROSS,DEPRESSION,EORTC,FATIGUE,INDEX,INVENTORY,LABEL,LIFE,LOW,METHODS,NIGHT,OBJECTIVE,QUALITY,RESULTS,SCALE
ADT,CURRENT,PCA,THERE
THUS
174,2013,223,945,ALPHARADIN,COPYRIGHT,CRPC,III,PROUS,SCIENCE
945,FCF,GTP,HIF,MAMMALIAN,RAPID,SEPTINS
0001,007,148,BACKGROUND,BCR,COX,GENERAL,GLEASON,INCREASED,LABEL,MEIER,METHODS,PSA,RESULTS,RRP
ADT,BACKGROUND,BRAIN,GIVEN,HIGH,LABEL,MAPPING,METHODS,MRI,PARAMETRIC,RESULTS,VBM
BASED,COPII,COQ10,EGFP,GOLGI,L02,PARKINSON,RPWS,SCD,SINCE,SITE,T24,USING
ALU,AML,BACKGROUND,EXPRESSED,LABEL,MEASURING,NSCL,RESULTS,THESE
8482,CCN4,LUC,PC3,TRAMP,WISP1
001,8202,BACKGROUND,CIS,FURTHER,GSTM1,GSTP1,HOWEVER,ILE,ILE105VAL,LABEL,ORS,PRINCIPAL,RESULTS,VAL
BONE,CONVERSELY,HOWEVER,LNCAP,MSC,MSCS,PC3,TAKEN,THESE,UTR
CD105,CD73,CD90,CHRONIC,MSCS,THESE
000,200,2006,585,838,EVEN,LABEL,METHODS,OBJECTIVE,ONTARIO,OOP,OVERALL,PURPOSE,RADICAL,RESULTS,SURVIVORS,TIME
160,874,895,CONCLUSION,DISABLING,LABEL,MEN,METHODS,OBJECTIVE,PURPOSE,QOL,RESULTS,SURVIVORS
000,003,004,005,020,021,037,041,045,048,049,081,091,141,165,184,339,717,741,8201,946,CAUCASIANS,OVERALL,TGF
011,020,053,086,111,194,368,411,459,480,8201,876,891,962,BEGG,CHINA,DATABASES,EGGER,GPX,GPX1,KNOWLEDGE,ODDS,ORS,PCA
001,046,120,160,297,386,578,597,620,8201,901,DENOSUMAB,III,LABEL,METHODS,OBJECTIVE,PAIN,PURPOSE,RESULTS
CRPCA,ONCE,PSA,SEVERAL
AIM,BACKGROUND,BMI,LABEL,OBJECTIVE,OVERWEIGHT,RCC,RESULTS,VEGF
176,AUSTRALIA,BACKGROUND,CONCLUSION,EASTERN,LABEL,METHODS,OBJECTIVE,PURPOSE,QUEENSLAND,REGRESSION,RER,RESULTS,SOUTH,SUV,UVB,WALES
0001,004,015,017,043,207,242,246,295,415,AEG,APC,ASTROCYTE,BACKGROUND,BASIC,CONCLUSION,COX,GLEASON,HOWEVER,IHC,LABEL,MATERIALS,METHODS,MMP,PASW,RESULTS
ETS,PSA,THEREFORE,TMPRSS2
211,236,308,353,BONE,FURTHER,LABEL,METHODS,MULTISTEP,OBJECTIVE,PURPOSE,RESULTS,SPECT,UPSTAGING,WBS
001,005,042,139,GLEASON
BACA,CELL,EARLY,HOWEVER,WHILE
33342,7A1,ALTOGETHER,ELK1,HOECHST,IGF1R,MTT,PCR,REAL,REDUCED,TARGETSCAN,UTR,WESTERN
205,ERK1,FAK,FUNCTIONAL,PCA,PCR,PSA,REAL,SRC,THROUGH,WESTERN
C2H2,H3K4ME3,H3K9ME3,STUDIES,ZNF,ZNFS
EXPRESSION,IGF2,IMPRINTED,INSULIN,PCR,PIE
169,2013,2620,3225,3230,3582,ASP312ASN,CIS,HOWEVER,LYS751GLN,ODDS,ORS,XPD
169,2013,231,233,COPYRIGHT,IGRT,IMRT,PUBLISHED,SAS,SFRO,SIMILARLY,SOCI,STUDIES,THESE
10MM,169,2013,231,233,5MM,8MM,COPYRIGHT,CTV,GTV,IGRT,MRI,PTV,PUBLISHED,SAS,SFRO,SOCI
0001,1195,169,2013,ALSO,ASSESSMENT,BACKGROUND,COPYRIGHT,FACT,FUNCTIONAL,HRQOL,III,LABEL,LTD,METHODS,RESULTS,SIMILAR,THERAPY
169,1994,2013,728,8482,ADJUSTMENT,BIAS,COPYRIGHT,EXTENDING,LTD,SATSCAN,SIMILARLY,THESE
1055,169,2013,BNO,BRDU,CIMICIFUGA,CONSISTENT,COPYRIGHT,ENT,ENT1,ENT2,GMBH,SIMILAR,THESE
169,2013,954,COPYRIGHT,CRT,DIFFERENT,DVH,III,IMRT,INC,LABEL,MAJOR,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,TREATMENT,VMAT
1476,169,2013,325,CLINICALLY,COPYRIGHT,ECOLOGICAL,LABEL,LOWER,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PCSM,RESULTS,SERUM,THERE
169,2013,8804,AMONG,BACKGROUND,BASED,BRFS,CONTEXT,COPYRIGHT,DEPENDING,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PSA,RESULTS,SIMILARLY,SYNTHESIS,TEN,UROLOGY,WHETHER
169,2013,945,946,COPYRIGHT,LARGE,PUBLISHED,SAS,WHILE,WITHOUT
1078,1087,157,160,169,2013,8805,BCR,CONCLUSION,COPYRIGHT,INC,LABEL,MEN,METHODS,OBJECTIVE,PATIENT,PSA,RARP,RESULTS,SRT,STEPHENSON,THREE
GGTT,GTG,GTT,JNK,TAG
177,ALSO,CONCLUSION,DCE,FORTY,GLEASON,KEP,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,RESULTS,THERE,TOFTS
087,BLAND,COMPARISON,CONCLUSION,EVALUATION,LABEL,MATERIALS,METHODS,OBJECTIVE,PACS,PERCENTAGE,RESULTS,SOLID
001,2011,BACKGROUND,CAPE,CDL,CONCLUSION,DESPITE,FEW,FURTHER,GAUTENG,HIV,LABEL,MEAN,METHODS,NATIONWIDE,OBJECTIVE,PROVINCES,RESULTS,SCREENING,SOUTH,THERE,WESTERN
CHLAMYDIA,PCA3,PSA
169,2013,AACR,FOUR,RSK,RSKS
183,COMPOUNDS,GEORG,NMR,PANCRATIUM,STUTTGART,YORK
169,2013,239,500,AACR,ALDEFLUOR,ALDH,ALDH1A1,BPH,EPCAM,EXPRESSION,FACS,GLEASON,HIGH,HOWEVER,LABEL,METHODS,MOST,NOTABLY,OBJECTIVE,PCR,PIN,PURPOSE,RESULTS,TROP2
358,CONGENITAL,HOWEVER,NSCL,THERE
ATP,BACKGROUND,CLAUDIN,CONCLUSION,EMT,FURTHER,HOWEVER,KNOCKDOWN,LABEL,METHODS,P2Y,P2Y2,RESULTS,RNAI,SNAIL,THEREBY
8209,GPR,GPR54,KISS,KISSPEPTIN,METASTASIS,THESE
169,1970,2013,20TH,COPYRIGHT,HOWEVER,NSD,PUBLISHED,SAS,WHILE
169,2013,CBCT,COPYRIGHT,DEFORMABLE,DICE,DSC,GERMANY,GMBH,NORMALIZED,PUBLISHED,THESE,THREE
125,169,177,2013,BACKGROUND,BBN,CONCLUSION,GRP,HPLC,IC50,LABEL,METHODS,NMRI,PC3,PET,RESULTS,SFB,THREE,TYR
100NM,169,2013,ABBOTT8,COPYRIGHT,CPC,FURTHER,HUVEC,IAP,LLP3,LLP9,LTD,PC3,SEVERAL,THUS
145,150,956,COOH,LNCAP,MTT,NPS,PCA,PCL,PEG,PLGA,RSV
AIM,BACKGROUND,BELGIUM,CARE,CONCLUSION,GIVEN,LABEL,MANN,MEMBERS,METHODS,OBJECTIVE,QUALITY,RESULTS,THERE,THESE,WHITNEY
946,ACTRIIA,ALK2,DOWNSTREAM,FURTHER,IIA,III,MORTALITY,PCA,SMAD1,TGF
947,ATPASES,NHES
BCL2,ETK,HUVEC,MYC,SRC
169,2013,AACR,AKT,AZD5363,CRPC,HOWEVER,LNCAP,NKX3,PSA,THEREFORE,THESE
215,HOLEP,HOLMIUM,LEIOMYOMA
169,2013,945,946,AACR,RCC,SLUG,STS
0001,2011,2012,239,945,CRPC,III,INHIBITION,P450,SEPTEMBER,THESE,UNION
946,AKT,E2F,ERK1,GSK,HOWEVER,MAPK,PI3K,THESE,UNDARIA,WAF,WNT
000,0001,012,100,2005,2009,300,HOSPITALS,INPATIENT,LABEL,LOCAL,METHODS,OBJECTIVE,RESULTS,ROBOTIC,STATE,THERE
120,125I,177,89ZR,946,IMAGING,NIR,THESE
APART,CTV,DAILY,DVF,DVFS,LABEL,METHODS,PCA,RESULTS,THERE,UNLABELLED
CBCT,CTDI,HOWEVER,IGRT,IMAGE,OBI,OTHER,PTV,ROTATIONAL,RTPS,THESE,TLD
INHIBITION,VEGF
001,168,2006,COMPLETED,FLORIDA,KNOWLEDGE,PCPS,SEVEN,SEVENTY,SIXTY
169,2013,8201,956,ADP,AKT,BAD,BAX,BCL,BCL2,CELL,COPYRIGHT,FADDR,FAS,IGF,IGF1,IGF1R,JOHN,LTD,NIMBOLIDE,PARP,PI3K,SONS,WILEY,XIAP
527,CATABOLIC,DU145,EBR,GENERALLY,HOWEVER,INDUCTION,INITIALLY,LNCAP,MDL,ODC,PAO,PARP,PNT1A,POLYAMINE,POLYAMINES,SMO,SSAT
600,8201,HOWEVER,PREFERE,PSA
1995,2009,8804,9486,A1C,BMI,COX,DISEASE,INSULIN,JANUARY,METFORMIN,THERE,TYPE
0007,169,1986,2010,2013,4538,6220,867,BACKGROUND,BETWEEN,COPYRIGHT,COX,DIET,GREATER,HOWEVER,JANUARY,LABEL,MED,METHODS,OBJECTIVE,OUTCOME,PCA,PUBLISHED,RESULTS,SETTING,UROLOGY
LESS,POPULATION,PSA,RESULTS
CARE,COUNTRIES,FIVE,SYSTEMS,TOTAL
160,177,183,2H2O,956,CO2H,DAPI,IC50,LNCAP,MCF,SKBR3
120,169,1991,2009,2010,2012,2013,710,800,8201,AIHW,AIMS,ASIA,AUSTRALIA,AUSTRALIAN,CONCLUSION,INDIGENOUS,INSTITUTE,LABEL,LTD,LUNG,METHODS,OBJECTIVE,PTY,PUBLISHING,REGISTRIES,RESULTS,WELFARE,WILEY
129,2008,2009,ACCORDING,BACKGROUND,CHECK,CONCLUSION,GLEASON,JULY,LABEL,METHODS,OBJECTIVE,PROSTATIC,PSA,RESULTS,ROC,THAI,THERE,TRUS
BLUE,CLINICALLY,DU145,ELISA,GLUCOSE,IGFS,LNCAP,PC3,PCA,PROTEIN,WESTERN
169,1986,2008,2013,656,896,FFQ,FFQS,FRAP,MAJOR,TAC,TOTAL,UICC,USING
1941,HUGGINS,III,NOVEL,THEIR
8322,945,946,954,DCF,ELISA,JAK,ME45,MEK,PI3K,TFA,THERE,TNF
003,8201,8211,EIGHT,HIGH,LIVER,MEIER

145,3T3,956,AMONG,BALB,EC50,FRIEDEL,MCF7,T24
006,177,CAUCASIAN,EBRT,ELISA,IFI27,PERIPHERAL
169,2013,APAF,BAK,BCL,CHANG,COPYRIGHT,DECREASED,EXPRESSION,HEP,HOWEVER,LTD,OVERALL,PRDX,SKHEP,TUNEL
250,500,58102,8201,BACKGROUND,CHANGES,COHORTS,DISULFIRAM,DOSE,GIVEN,LABEL,METHODS,PBMC,PCA,PSA,RESULTS,SECONDARY,THREE
003,1244,133,1817,2000,2006,2009,2011,206,58102,8201,AFTER,BACKGROUND,BMI,CASES,FLORIDA,GLEASON,LABEL,MAYO,METHODS,OBESE,PCA,PSA,RESULTS,ROCHESTER
105,152,754,8805,BASED,CANDIDATE,ERBB3,EXPRESSION,LABEL,METHODS,MICRORNAS,OBJECTIVE,PCA,PREDICTED,PURPOSE,RESULTS
169,2013,COPYRIGHT,HOWEVER,LTD,MCF
180,BACKGROUND,BCR,COX,GLEASON,HOWEVER,LABEL,MEIER,METHODS,NUCB2,PCA,PSA,RESULTS
169,2013,CSF,IGGS,THESE
0001,001,169,2010,2013,223,301,6MONTHS,7MONTHS,9MONTHS,AUTHORS,COPYRIGHT,COU,HOWEVER,III,LTD,PHASE,PUBLISHED,WITHOUT
160,BECAUSE,BILATERAL,CALYPSO,CTV,D99,IMPT,INC,INTENSITY,LABEL,MATERIALS,METHODS,OBJECTIVE,PBS,PUBLISHED,PURPOSE,RESULTS,SFUD
217,5003,BACKGROUND,CELSIUS,CLUJ,DUE,LABEL,METHODS,MUNICIPAL,RESULTS
169,2004,2013,223,ABSTRACTS,BACKGROUND,CONTEXT,COPYRIGHT,LABEL,METHODS,OBJECTIVE,OTHER,PUBLISHED,RESULTS,SYNTHESIS,UNTIL,UROLOGY
169,2013,BACKGROUND,BASED,CONTEXT,COPYRIGHT,FURTHER,IDEAL,ITEMS,LABEL,META,METHODS,MOLECULAR,OBJECTIVE,PREFERRED,PUBLISHED,REPORTING,RESULTS,REUTERS,REVIEWS,SCIENCE,SYNTHESIS,SYSTEMATIC,THOMSON,UROLOGY,WEB
002,007,036,047,120,169,1788,2000,2012,2013,8805,ANGELES,BACKGROUND,BETWEEN,CALIFORNIA,COPYRIGHT,GLEASON,INDEX,LABEL,LIMITATION,LOS,MEN,METHODS,OBJECTIVE,OCTOBER,OUTCOME,PCI,PUBLISHED,REGRESSION,RESULTS,SEPTEMBER,SETTING,THESE,UCLA,UFS,UNASSIGNED,UNIVERSITY,URINARY,UROLOGY
009,1006,169,2000,2002,2004,2013,327,674,8804,8805,BACKGROUND,COPYRIGHT,COX,GLEASON,LABEL,METHODS,OBJECTIVE,OUTCOME,PUBLISHED,RESULTS,SETTING,SINCE,TAX,UROLOGY,USING
BACKGROUND,BLADDER,CASE,CONCLUSION,FOLEY,LABEL,METHODS,RALP,THUS,TUR
389,946,CONCLUSION,DCGS,LABEL,METHODS,MICROARRAY,OBJECTIVE,RESULTS,SAM,TGF,THESE
BACKGROUND,GAMMA,IMRT,LABEL,MATERIALS,METHODS,RESULTS,VMAT
001,100,130,945,BACKGROUND,C30,EFFECTS,EORTC,FURTHER,GISEQ,LABEL,METHODS,PR25,QLQ,RESULTS,SIDE
0001,1995,2005,2011,6489,AFTER,AMICO,BACKGROUND,CHANGES,CONCLUSION,DENMARK,GLEASON,HOWEVER,LABEL,METHODS,PCA,PSA,RESULTS,RPS,TESTS
1950,DU145,HOWEVER,LITERATURE
169,2013,AUTHORS,DRAWING,FOUNDATION,ILLNESS,JOHN,LTD,RESULTS,SOCIOLOGY,SONS,WESTERN,WILEY
NGS
IMRT,LABEL,MATERIALS,METHODS,OBJECTIVE,PLATO,PURPOSE,RESULTS
223,AMERICA,CRPC,NORTH,THESE,THUS,USUALLY
EACH,GIVEN,MEDLINE,PROGNOSTIC,TOOLS,USING
001,007,123,AMONG,DISCOVERY,GLEASON,NGEP,TAKEN
2007,2010,AIM,BACKGROUND,CONCLUSION,DATA,FIVE,FURTHER,IRELAND,LABEL,LINCOLN,METHODS,NCR,OBJECTIVE,REGISTRIES,RESULTS
0219,1075553,22RV1,BAY,CONCLUSION,FAST,LABEL,LNCAP,MBQ,METHODS,NON,OBJECTIVE,PET,PSMA,PURPOSE,RESULTS
231,AFTER,ANIMALS,MDA,PLAIN
013,024,753,866,8805,CRPC,DTX,FORTY,PSA,QOL,SIXTY,THERE,WHETHER
063,105,146,160,172,193,2009,276,571,8201,LABEL,METHODS,OBJECTIVE,PILOT,PURPOSE,RESULTS,SELECTION,THERAPY,TIME,USA
145,169,2013,COPYRIGHT,INHIBITION,IRELAND,LTD,NEITHER,PNT2,PROMINENT,THESE
10775,10797,169,2013,4965,6284,6657,AUC,BILIVERDIN,BIOLOGICAL,BLVRB,BVR,HPLC,IHC,IMAGING,LABEL,MALDI,PCA,PUBLISHED,ROC,TOF,UNASSIGNED,UNLABELLED
001,120,169,2014,788,AUASS,COPYRIGHT,EDUCATION,GLEASON,INC,LABEL,MATERIALS,MEN,METHODS,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,RADICAL,RESULTS,UROLOGICAL
169,2014,2AT6,AKT,ALSO,COPYRIGHT,EDUCATION,EFFECTIVE,INC,INCREASED,LABEL,MATERIALS,METHODS,NVP,OBJECTIVE,PI3K,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL,WST
169,2013,AIMS,COLLEGE,CONCLUSION,COPYRIGHT,DMAX,DMEAN,DOSE,FIFTEEN,IMRT,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PTV,PTVS,PUBLISHED,RESULTS,ROYAL,SEQUENTIAL,V20,V30,V40
001,008,135,169,2013,3929,510,COPYRIGHT,INC,MEAN,PROSTATIC,PSG,PSGS,RETENTION,RPS
169,2013,COPYRIGHT,KNOWLEDGE,PCA,SAS
038,169,2013,752,ANALYTICAL,BACKGROUND,BIOMARKERS,CELLSEARCH,COPYRIGHT,CPE,CTC,FOXA1,GRHL2,KLK2,KLK3,LABEL,METHODS,OBJECTIVE,OUTCOME,PAXGENE,PCA,PCR,PUBLISHED,RESULTS,SETTING,TRANSCRIPT,UROLOGY
169,2013,833,BACKGROUND,COPYRIGHT,CORRECTION,ERSPC,LABEL,LARGE,METHODS,OBJECTIVE,OUTCOME,PCA,PSA,PUBLISHED,RANDOMIZED,RESULTS,ROTTERDAM,RRS,SCREENING,SETTING,TRIAL,UROLOGY
169,1993,2011,2013,8805,BACKGROUND,COPYRIGHT,GLEASON,LABEL,LIMITED,METHODS,MOST,OBJECTIVE,OUTCOME,OVERALL,PATHOLOGIC,PUBLISHED,REASONS,RESULTS,SETTING
015,1006,160,169,177,1998,2003,2014,8764,COPYRIGHT,DATA,DFS,HOWEVER,INC,LABEL,LDR,MATERIALS,MEIER,METHODS,OBJECTIVE,PHOENIX,PSA,PUBLISHED,PURPOSE,RESULTS,SOCIETY,THESE,THREE
169,2013,COPYRIGHT,DESPITE,EBRT,IRELAND,LTD,RADICAL,THERE,TREATMENT
169,2013,241,COPYRIGHT,DUE,ESPA,FDG,HOWEVER,LABEL,METHODS,OBJECTIVE,PET,REAL,RESULTS
169,2012,2013,BACKGROUND,CONTEXT,COPYRIGHT,FORCE,HOWEVER,INC,JOURNAL,LABEL,METHODS,PREVENTIVE,PSA,PUBLISHED,RESULTS,SYNTHESIS,TASK
016,019,024,683,736,746,759,874,875,875G,875GG,891,916,946,ADT,CRPC,GLEASON,PCR,SMAD7,TGF
FOXO1,HOWEVER,PCR,TAKEN,UTR
178,8314,916,936,COMPLEX,CSA,DU145,LNCAP,NADH,PREC
276,543,640,658,814,8202,856,871,CIS,HOWEVER,LABEL,METHODS,OBJECTIVE,ORS,PUBLISHED,RESULTS
185,342,BOTH,COA,FASN,HMGCR,INTRINSIC,SREBP,THESE
105,CDK6,DU145,PC3
BACKGROUND,HDMP,LABEL,PRINCIPAL,RESULTS,THEREFORE
001,2001,2011,283,8804,BACKGROUND,CASE,CONCLUSION,DFS,FINALLY,FUNCTIONAL,IPSS,LABEL,METHODS,ONCOLOGIC,PREDICTIVE,PSA,RESULTS,RRPC,SCT,WHILE
ACTIVATION,EGFR,ERLOTINIB,HRR,IGF1R,IRS1,NHEJ,RAD51,REDUCED,THESE
BPC3,COUNTER,FIRST,GWAS,HOWEVER,NCI,NEXT,OTHER,SNP,SNPS,YET
001,237,8201,ASSOCIATED,BACKGROUND,ILC,LABEL,NUCLEAR,PROTEIN,RESULTS,SINCE,TEAD,YAP,YES
CEA,HOWEVER,PANCREATIC
100,DMSO,IRE,METHODS
152,177,AGREEMENT,CBCT,COHEN,FURTHER,IGRT,IMRT,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,RTT,RTTS
CURRENTLY,FACBC,ISSUE,LABEL,METHODICAL,METHODS,MRI,OBJECTIVE,PET,PRACTICAL,PSMA,RESULTS
946,BACKGROUND,CONCLUSION,CRPC,DHT,ELISA,FINALLY,LABEL,LNCAP,METHODS,MTS,PAF,PCR,RESULTS,WNT
160,174,8804,GLEASON,LOW,MILD,SOLUBLE,VTP,WST11
ACCORDING,AFTER,CONCLUSION,LABEL,LNCAP,METHODS,MTT,OBJECTIVE,PCR,RESULTS,RNA1,THEREAFTER,TRANSWELL,WESTERN
0001,0026,0296,152,169,2013,3P13,5Q21,6Q15,7628,CD147,DECREASED,DESPITE,ERG,GLEASON,PSA,PTEN,REDUCED,RESULTS,THERE,TMPRSS2
0002,00185,008,169,2007,2011,2013,223,945,ASSESSMENT,COPYRIGHT,DENOSUMAB,EXCLUSION,INC,ISPOR,LABEL,LAST,METHODS,MPC,OBJECTIVE,PROS,PUBLISHED,RESULTS,SIMILAR,SOCIETY
111,151,160,190,2006,2010,245,490,8201,8805,AFRICAN,AMONG,BACKGROUND,CONCLUSION,GLEASON,LABEL,METHODS,RESULTS
GLEASON,PRIMARY,THESE
BACKGROUND,BOTH,CASE,CONCLUSION,LABEL,METHODS,TAMOXIFEN
177,AIM,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS
1982,1993,2000,2004,2005,207,8805,GLEASON,HOWEVER,ISUP,PHYSICIANS,PSA
140,1981,2010,450,8804,8805,ADT,BACKGROUND,BRPC,COX,LABEL,METHODS,MFS,RESULTS
000,179,185,230,IMAGING,THESE
CRPC
BINDING,DOT1L,PCAT8,PHD,RNAS
004,011,018,022,040,213,239,308,650,791,CRPC,HNPC,THESE
139,141,1995,2007,BACKGROUND,BRAIN,CONCLUSION,DISEASE,EPSCC,IRELAND,LABEL,MANAGEMENT,METHODS,PATIENT,PCI,RESULTS
AFTER,MVAC,PATHOLOGY
108,146,2002,2008,2N0M0,3N0M0,65308,8805,HOWEVER,JUNE,MARCH,NHT,PSA,T1C,THUS
169,2013,8201,945,GLEASON,HOLMIUM,SERUM,UROLOGICAL
CAM,CONCLUSIVE,INITIAL,SPES,VITAMIN,ZYFLAMEND
001,1412,2003,2011,2496,2538,286,333,880,9423,9457,989,AMONG,BACKGROUND,GLEASON,HIGH,INDEX,INSTITUTE,LABEL,METHODS,OCTOBER,PCPT,PREVENTION,RESULTS,TEN,TRIAL
095,1526,2003,2008,241,BACKGROUND,CART,CAUTION,CONVERSELY,DATA,GLEASON,HOWEVER,LABEL,MCL,METHODS,MPC,OBJECTIVE,OBJECTIVES,REGRESSION,RESULTS,TREE,UNIVARIATE,WHILE
001,147,8805,ANALGESICS,BPI,BRIEF,CONCLUSION,CONSORTIUM,FOUR,INVENTORY,LABEL,MATERIALS,METHODS,OBJECTIVE,PAIN,PREVALENCE,PRO,PURPOSE,RESULTS,THESE
233,CONCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,OPTIMAL,PURPOSE,QIS,RCC,RESULTS,THESE
001,2000,2007,2009,610,AMONG,BLACK,CONCLUSION,END,FORTY,INEQUALITY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,USING
2005,2010,BACKGROUND,LABEL,MEN,METHODS,NUTRITION,PSA,RESULTS,SHIFTWORK,USING
AFTER,CAH,ENDOCRINE,INADEQUATE
143,160,2010,377,902,CONCLUSION,INPATIENT,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SPANISH,SRE,SRES,UNIT
00001,108,169,2005,2007,2013,228,3501,457,487,546,8804,AFTER,BACKGROUND,BETWEEN,CHT,COPYRIGHT,HIGH,LABEL,METHODS,PFS,PSA,RESULTS,SEPTEMBER,SOCIETY,TAX
000,245,8805,ANGELES,CALIFORNIA,COGNITIVE,CONCLUSION,EXACT,FORM,INDEX,INTRACLASS,LABEL,LOS,MEDICAL,METHODS,MOS,OBJECTIVE,PCI,PURPOSE,RESULTS,SEVENTY,SHORT,STRATEGIC,UCLA,UNIVERSITY,WEB,WHITE
ADT,DESPITE,EGFR,III,OTHER,PDGFR,VEGFR

100,174,2012,241,386,AVERAGE,BACKGROUND,CALCULATED,ESPECIALLY,HOWEVER,IMRT,LABEL,METHODS,MRI,RESULTS,V70,WITHOUT
0001,0033,8201,DATA,GENOMIC,IDC,ILC,THBS4,THERE
GATEWAY,INSTITUTE,NROR,RADIATION,SOCIETY
ADMS,AIDS,ANAL,HIV,LABEL,LDCT,LIVER,LUNG,MSM,OBJECTIVE,PLWHA,PURPOSE,RESULTS,SCREENING,SUMMARY,TRIAL
2013,BACKGROUND,BASEL,FURTHER,HOWEVER,LABEL,MARCH,METHODS,OBESITY,PCA,RESULTS,THERE,THEREFORE
169,2013,AACR,AZD1480,CRPC,CWR22PC,FINALLY,JAK2,LABEL,METHODS,OBJECTIVE,PATIENT,PURPOSE,RESULTS
178,8311,CDK5,GLEASON,S727A,SER,STAT3
0001,0002,0005,0073,152,169,2013,8786,8805,COPYRIGHT,ERG,FEDERATION,FURTHER,GLEASON,HIGH,INCREASED,PSA,PTEN,PUBLISHED,SOCIETIES,THESE

946,AFTER,BACKGROUND,BCC,CASE,E12,HOWEVER,KI67,LABEL,METHODS,TURP
183,1994,2011,378,632,AGE,CONCLUSION,DATA,GLEASON,JANUARY,LABEL,MAY,METHODS,OBJECTIVE,PSA,RESULTS,UNIVERSITY,UPGRADE
BMI,HOWEVER,MRI,ROBOTIC,STAGE,THEREFORE,TME
0037,13Q14,8202,ADP,ALTOGETHER,ARL11,DELETIONS,MDR,PCA,REGULATION,T442C
003,007,016,100,1004,1051,8202,ABNORMALLY,BACKGROUND,BMI,CHINESE,CVC,EASTERN,LABEL,PCA,PRINCIPAL,RESULTS,SNPS,THESE
ANDROGENS,LUC,LUCIFERASE
954,B16,DU145,EF24,EXPRESSION,JAK,KI67,PDCD4,PTEN,STAT,TAKEN
E2F,E2F3,ERG,ETS,EWING,EWSR1,FLI1,SUPPORTED,THUS,TMPRSS2,WHILE
124,169,177,2013,8776,8804,8805,CHO,COPYRIGHT,GLEASON,GPC,JOHN,LTD,MRSI,ROC,SONS,THERE,TRUS,WILEY
169,2013,945,954,AKT,BOTH,CCL21,CCR7,INC,JAK1,JAK2,KNOCK,MSCS,PC3,PI3K,STAT3,TRANSWELL,VEGF,VEGFR,WILEY
169,2013,5MIN,956,ACID,ASSESSING,BECAUSE,LMP,TAMOXIFEN,TOREMIFENE,TREATMENT
10H,169,2013,3033,AACR,LNCAP,MDV3100,NOTABLY,THESE,THUS,VPC,YET
002,005,006,177,199,22RV1,268,300,383,742,956,CONCLUSION,LABEL,MEANWHILE,METHODS,OBJECTIVE,RESULTS,THERE,TUNEL
945,946,AE1,AE3,AMACR,CAREFUL,CD10,CEA,CK20,CK7,COA,CONCLUSION,E12,EACH,LABEL,METHODS,MME,OBJECTIVE,P504S,P63,PAX2,PAX8,PSA,RESULTS
001,005,031,074,170,1990,2011,283,58102,8201,999,ADT,AFRICAN,BACKGROUND,HIGH,LABEL,METHODS,PSA,RESULTS
169,2013,8320,8321,CELL,CIP1,COPYRIGHT,DU145,KIP1,LC3,LC3B,LINN,LNCAP,LTD,NOTABLY,PIPER,TAKEN
EVALUATION,MEMBERS,POLYMERASE,PTRF
169,2013,946,EMT,FINALLY,III,IIIC,MZ7,SMAD,SMAD2,SMAD3,SMAD7,TGF,V717M,WWP2
160,215,BOARD,IMAT,IMRT,KIM,NAVOTEK,PCXMC,SBRT,TREATMENT
2008,2009,2011,510,8805,BACKGROUND,BOARD,ENDOSCOPIC,ENDOSCOPY,EPIC,FIFTY,GEORGETOWN,GRADE,IMRT,IRB,LABEL,MEAN,METHODS,QOL,RECTOSCOPY,RESULTS,SBRT,SCORE,THERE,TRIAL,VRS
100,169,2013,765,778,830,8805,AUTHORS,BJU,COMPOSITE,EPIC,IIEF,INDEX,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PDE5,PPPR,RESULTS,VALIDATED
001,005,039,169,2005,2009,2013,314,8805,AUTHORS,BJU,CONCLUSION,COX,GLEASON,JANUARY,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,UNIVARIATE
001,087,169,1988,2005,2013,499,8805,AMONG,AUTHORS,BJU,CONCLUSION,CONVERSELY,COX,END,LABEL,METHODS,OBJECTIVE,PCA,RESULTS,SIMILAR,STRATIFIED,USING
169,2001,2006,2013,391,5732,AUTHORS,BJU,CIS,DIGOXIN,FURTHER,HRS,IRISH,LABEL,METHODS,OBJECTIVE,PCSM,RESULTS,THESE
169,2013,8201,ACETATE,AUTHORS,BJU,DUE,IMAGING,ISI,PET,PSA,SCHOLAR,SCIENCE,STUDIES
169,2010,2012,2013,8201,AIM,ASIA,GUM,JANUARY,LABEL,LTD,METHODS,OBJECTIVE,PATIENT,PTY,PUBLISHING,RESULTS,WILEY
169,2013,8197,AUTHORS,BJU,DROSPHILA,EN1,EN2,ENGRAILED,HOX,HOX13,PCA,STUDIES,URINARY
10Q,10Q11,10Q26,12Q24,169,174,17Q12,19Q13,2013,5P15,707,AFRICAN,APPLIED,ASSESSMENT,AUTHORS,BIOSYSTEMS,BJU,BRCA,CAUCASIAN,CITY,GENOTYPING,LABEL,METHODS,OBJECTIVE,PRAP,PROGRAM,PSA,RESULTS,RISK,RS10788160,SNP,USA
1177,169,2013,8201,AUTHORS,BJU,DATA,DCE,DWI,EVERY,HOWEVER,IMAGING,LABEL,METHODS,MRI,MRS,NPV,NPVS,OBJECTIVE,OBJECTIVES,PPV,PPVS,PSA,REPORTING,RESULTS,ROC,T2W,THERE,THESE
BOTH,BPH,PCA,ULTIMATELY
029,1966,2012,248,25307,312,365,389,410,561,595,742,836,847,871,AIMS,APRIL,DATA,HYPOTHESIS,JANUARY,LABEL,MEDLINE,METFORMIN,METHODS,OBJECTIVE,RANDOMIZED,RESULTS,THERE
CDC42,CRIB,GTP,GTPASES,P21,PAK1,PC3,RAC,RHO,S79,S79A,THUS
182,ATO,BCL2,LC3,LNCAP,PC3,STUDIES,THESE
215,34A,60K,BOTH,DU145,FUNCTIONAL,GENISTEIN,KNOCKDOWN,LABEL,LUCIFERASE,METHODS,MICROARRAY,OBJECTIVE,PC3,PCA,RESULTS,RNAS,SUREPRINT,THESE
CD44,CD90,DHT,GLEASON,HOWEVER,LNCAP,NANOG,OCT3,SHBG
AGGRESSIVE,FURTHER,PSA,PTEN,THESE
174,601,ANDALUSIA,ATM,BACKGROUND,BECAUSE,CATALONIA,CONCLUSION,COUNTRY,ERCC1,ERCC2,LABEL,LIG4,METHODS,NON,OBJECTIVE,OPENARRAY,OUTCOME,P53,PRINCIPAL,RESULTS,SETTING,SNP,SNPATOR,SNPMATRIX,SNPS,SPANISH,THESE,XRCC1,XSNPMATRIX
FIRST,PTEN,USING,WHILE
141,200A,200C,210,365,375,8764,945,HIF,MICRORNAS,PSA,RNAS
181,AFTER,GDHSPFT,PSMA,SHFSVGS,THESE,WHILE
AARP,AUCS,BACKGROUND,BMI,COLORECTAL,DIET,EDITORS,INSTITUTES,LABEL,LUNG,METHODS,MHT,NIH,OVARIAN,PLCO,RESULTS,SCREENING,SUMMARY,THESE,TRIAL,USING,WHILE
169,2013,7548,AACR,ALA,BAY86,CONCLUSION,DOTA,GLN,GLY,LABEL,LEU,METHODS,NH2,OBJECTIVE,PCA,PET,PHE,PURPOSE,RESULTS,STA,TRP,VAL
171,215,338,8Q24,967,BONFERRONI,CCFR,COLON,COLORECTAL,GECCO,LABEL,METHODS,OBJECTIVE,PAGE,POPULATION,RESULTS,SEVERAL,SNP,SNPS
169,2013,778,BACKGROUND,FORCE,GIVEN,GREATER,HOWEVER,INC,LABEL,METHODS,PCA,PSA,RESULTS,ROC,TASK,WILEY
160,CNS,CROSS,FUNCTIONAL,MRI,THESE
949,APO,APOE,APOE2,FURTHER,HIGH
160,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SFQ
505,916,BMS,CDC42,EX2,INHIBITION,LIM,LIMK,LIMK1,LIMK2,LIMKS,MSC,MSCS,NF2,PAK,PAKS,RAC,SCHWANN,SCS,SER3,SIMILARLY
22RV1,945,CAVIN,HOWEVER,LNCAP,PTRF,TAKEN,UTILIZING
946,947,AE37,BOOSTED,ELISPOT,IDO,IFN,LOCAL,LTB,LTI,REGULATORY,TGF,TREG,TREGS
178,2009,2010,8805,INSTITUTES,METS,OBESITY,THESE,THUS
001,100,125,158,2000,2011,285,305,560,8805,AMICO,AUC,BEST,BETWEEN,HALF,LABEL,MEIER,METHODS,OBJECTIVE,OBJECTIVES,PSA,RESULTS
169,2013,241,ABOUT,BCR,CHOLINE,COPYRIGHT,CURRENT,ESPA,FACBC,GLEASON,IMAGING,LOW,MRI,NUCLEAR,PCA,PET,PROSTATIC,PSA,RESONANCE,TIME,TODAY,TRUS
005,006,160,169,1691,2013,389,ARTESUNATE,CONCLUSION,COPYRIGHT,HOWEVER,INC,LABEL,METASTASIS,METHODS,MOLECULAR,MOSBY,OBJECTIVE,OVCA,RESULTS,TGF,USING,WNT
169,2013,215,BMP,CURRENTLY,GLEASON,INC,SLUG,SNAIL,TWIST,USING
169,2013,916,945,946,BPH,COPYRIGHT,DHT,LNCAP,RIS,SAS,STEROIDAL,THEREFORE
169,2013,FK506,FKBP,FKBPS,HSP90,THESE,TPR
001,169,2013,BLOOD,BOTH,COPYRIGHT,FPSA,LABEL,LTD,METHODS,OBJECTIVE,PSA,RESULTS,TOTAL,TPSA
143,145,169,2013,DDX6,DEAD,HOWEVER,MIR,MKN45,RCK,THESE,THP
11TH,169,2012,2013,COPYRIGHT,ELECTRONIC,FEW,IRELAND,JANUARY,LTD,MOST
169,2013,ALSO,COPYRIGHT,FINALLY,INSULIN,ROS
169,2013,APRIL,BACKGROUND,CONTEXT,COPYRIGHT,LABEL,LEVEL,MEDLINE,METHODS,OBJECTIVE,PARTICULAR,PATHOLOGY,PSMS,PUBLISHED,RALRP,RESULTS,REVIEWS,SCIENCE,SOCIETY,STUDIES,SYNTHESIS,SYSTEMATIC,TECHNICAL,UROLOGICAL,UROLOGY,WEB
0001,0085,169,2013,269,30891,492,493,769,985,ADT,AFTER,BACKGROUND,BASED,COPYRIGHT,EORTC,HOWEVER,LABEL,METHODS,OBJECTIVE,OUTCOME,PCA,PSA,PUBLISHED,RESULTS,SETTING,TIME,TREATMENT,UROLOGY
160,169,177,2013,521,956,BIOLOGY,COPYRIGHT,FEDERATION,INC,NBS,PUBLISHED,SONOVUE,THEREFORE,ULTRASOUND,WORLD
001,169,2013,227,C30,CONCLUSION,COPYRIGHT,EORTC,IRELAND,LABEL,LTD,METHODS,MIXED,OBJECTIVE,PURPOSE,QLQ,QOL,RESULTS
016,105,1176,169,2013,AIMS,GLEASON,IDC,JOHN,LABEL,LTD,METHODS,NINE,OBJECTIVE,PBX,PCA,RESULTS,SEMINAL,SONS,THREE,WILEY
ADT,LHRH
001,1889,197,2196,307,ASSESSMENT,BACKGROUND,CONCLUSION,CORE,GLEASON,LABEL,MATERIALS,MEAN,METHODS,PSA,RESULTS,SECONDARY,WHEREAS
COUPLES
DATA,PROVIDING
1999,2004,COX,HODGKIN,HRS,MEIER,NHL,WHILE
169,2013,8197,8208,945,AMACR,COA,COPYRIGHT,GMBH,KGAA,VCH,WILEY
169,183,CONTROLLED,DESPITE,GEORG,MAP,STUTTGART,TRANEXAMIC,YORK
169,183,GEORG,HOWEVER,LRP,RADICAL,RALP,RRP,STUTTGART,YORK
150,169,1990,1993,2010,2013,218,248,300,635,8805,913,ALCOHOL,JAPAN,JPHC,SMOKING,UICC
MSS31,THESE
001,153,160,514,791,8201,967,AFTER,COMPASSION,CONVERGENT,DPES,EMOTIONAL,FIVE,FURTHER,HOWEVER,INVENTORY,LABEL,METHODS,MEYER,OBJECTIVE,OLKIN,PTG,PTGI,PURPOSE,RESULTS,SCALE
136,2012,8805,945,946,ACUTE,AFTER,CONCLUSION,CTV,GLEASON,INITIAL,IPSS,LABEL,MAY,METHODS,MVCT,NCCN,OBJECTIVE,PSA,PTV,PURPOSE,RESULTS,SBRT,SINCE,TOTAL
ADT,ASC,CASODEX,CCL2,CCR2,DESPITE,MDV3100,MECHANISM,PCA,PIAS3,STAT3,THESE,THP1,TRAMP,USING
20S,945,946,AKT,ATG5,CHOP,FURTHER,HOWEVER,LC3B,MAR,PCA,PROTEASOME,TIME
113,114,239,8805,BACKGROUND,CASTRATION,CONCLUSION,CRPC,DES,LABEL,METHODS,POST,PRE,PSA,RESULTS,TIME
169,2013,ANOTHER,BACKGROUND,COPYRIGHT,DATA,DISCUSSION,ENGLISH,EXPERTS,FINALLY,FIRST,KLIBANSKI,LABEL,LITERATURE,MONITORING,ORAL,PROLACTIN,PUBLISHED,RESULTS,SAS,SOMETIMES
169,2013,AML,BOTH,KEY,LABEL,METHODS,MINIMAL,OBJECTIVE,P123,POST,RESULTS,ROYAL,SOCIETY,USING
169,2013,8ADT,956,AMONG,ASP,BOC,FEBS,LEU,LNCAP,SERCA
001,CURRENTLY,LABEL,METHODS,MHZ,OBJECTIVE,PURPOSE,RESULTS,THESE,ULTRASOUND
200,215,350,528,8764,BREGMAN,GPU,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SPLIT
3DCRT,780C,ALSO,CARLO,ECLIPSE,GAFCHROMIC,IMRT,LABEL,METHODS,MIMIC,MONTE,OBJECTIVE,PURPOSE,RESULTS,THESE
HDR,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
MICRORNAS
125,125I,CONCLUSION,IHT,IPSS,LABEL,METHODS,OBJECTIVE,PSA,QMAX,RESULTS,SCORE
AFTER,ANNEXIN,AS2,CONCLUSION,INHIBITION,LABEL,METHODS,MTT,OBJECTIVE,P38,RESULTS,WESTERN
169,177,2013,AACR,J591,PSMA
149,2007,2009,2011,271,AIMS,BACKGROUND,CLINICS,CONVERSELY,DATA,GLEASON,HOWEVER,JAMES,LABEL,METHODS,OBJECTIVE,PCA,PRIOR,PSA,RAPC,RAPCS,RAPID,RESULTS,SEVEN,THESE,USING
169,2013,CTC,CTCS,DEP,GMBH,HELE,J591,KGAA,LNCAP,SHAW,VCH,WILEY
CAFS,FGF10,FGF7,HGF,HOWEVER,IGF1,MTT,PC3,PCA,SDF1,TARGETING,TGFB2,THESE
1950,2007,30846,30891,BACKGROUND,EORTC,GROUP,LABEL,LAPC,MATERIALS,MEDLINE,METHODS,SAKK,SOURCES,SYSTEMATIC,TREATMENT,UROLOGICAL
001,002,144,166,169,172,177,191,2013,221,449,473,621,707,CONCLUSION,HISTOLOGIC,LABEL,MATERIALS,MEAN,METHODS,OBJECTIVE,PURPOSE,RESULTS,RSNA,THREE,VARIABLES
AIM,BACKGROUND,BOTH,GROUP,HIGH,HYLAK,LABEL,MATERIALS,METHODS,OBJECTIVE,RADIATION,RESULTS
2004,2012,CSCS,DATA,EMT,ENGLISH,ESPECIALLY,LABEL,METHODS,MICRORNAS,OBJECTIVE,RESULTS,SELECTION,SOURCES
100,169,2013,AUTHORS,BJU,CONCLUSION,CT1,LABEL,METHODS,OBJECTIVE,PST,RARP,RESULTS,STEP
169,2013,300,AUA,BJU,FURTHER,OTHER,PSA,UROLOGICAL
BACKGROUND,FACTORS,FEW,HISTORY,HRQOL,LABEL,MCS,METHODS,MHOS,PCS,RESULTS,SEER
ADC,BACKGROUND,CDI,HENCE,LABEL,METHODS,RESULTS,ROC,THESE
205,954,AIMS,CAF,CAFS,CONCLUSION,EMT,HIF,INNOVATION,LABEL,METHODS,OBJECTIVE,OVERALL,PCA,RESULTS
GNRH,THESE
001,002,007,015,017,026,036,110,ALSO,BACKGROUND,BPH,CONCLUSION,HOWEVER,LABEL,METHODS,RESULTS,SNAIL
026,215,400,AUC,AUCS,BACKGROUND,FEULGEN,GLEASON,HGPIN,LABEL,METHODS,NUCLEAR,PCA,PHASE,RESULTS
169,2013,945,BACKGROUND,CAP,DU145,EMSA,GDI,GDP,HOWEVER,INC,INHIBITOR,LABEL,LNCAP,METHODS,PCR,RESULTS,RHO,TREATMENT,WESTERN,WILEY
145,CELL,COX,DISSECTION,GLUCOSE,GRP78,HOWEVER,SILENCING
34C,BACKGROUND,CONCLUSION,LABEL,MET,METHODS,PC3,PCA,RESULTS,THESE,UTR
145,916,968,BAX,BCL,HOWEVER,LNCAP,NAC,PC3,ROS,THESE,THUS
000,008,252,389,414,487,500,800,AMONG,FURTHER,PSA,RESULTS,SERUM,SEVERAL
468,AZA,CDK,EPIGENETIC,ETS,HDAC,INHIBITION,MDA,MTT,NOTABLY,OTHER,PDEF,USING
160,AKT,DOSE,GRADE,LABEL,METHODS,OBJECTIVE,PI3K,PURPOSE,RESULTS,THREE
100,160,ALSO,DOX,DU145,LABEL,METHODS,OBJECTIVE,PEI,PURPOSE,RESULTS,TPP
002,004,026,043,ATG5,AVERAGE,BECAUSE,INCIDENCE,PDC,PIN,SFN,THERE,WDC
169,2001,2010,2013,BASEL,CONCLUSION,GLEASON,LABEL,MATERIALS,METHODS,MOST,OBJECTIVE,RESULTS,THEREFORE,THESE,TURP,WHOLE
169,2013,945,946,COPYRIGHT,CXCR4,CXCR7,DU145,ECM,LNCAP,LTD,MMP,PC3,PCA,SDF,TAKEN
AMPK,FAK,HSP90,METABOLIC,THESE,TRAP,ULK1,UNC,USING
GENOMIC,PROJECT,TAKEN,YET
BASED,CURRENTLY,GIVEN
500,AMONG,ANN,ANNS,ARTIFICIAL,NEOPLASIA,REALIZING,THERE
169,2013,COMPOUNDS,COPYRIGHT,IC50,LTD,MCF7,PC3
001,1024,169,2013,954,ACM,ACTIVATED,ADT,CCL17,COPYRIGHT,COX,FOUR,LSAMP,LTD,MEIER,MON1B,MYCN,NUCLEAR,PCSM,PSMD7,SNPS
0001,002,169,1996,2009,2013,660,8805,COPYRIGHT,COX,GLEASON,INC,LABEL,MATERIALS,MEN,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS
169,2013,945,AKT,ALPHA,APOPTOSIS,BAD,BCL,CONSISTENT,COPYRIGHT,GMBH,PI3K,RESULTS,RWPE,THESE
169,2013,AACR,BCL,DEFECTIVE,DU145,HELA,HSP70,LYSOSOMAL,MCF7,NOTABLY,REMARKABLY,SU11652,WEHI
169,2013,COPYRIGHT,GLEASON,GLTSCR2,IRELAND,LTD,TAKEN
026,169,2000,2010,2013,APRIL,BACKGROUND,BASEL,COPYRIGHT,GROUP,HBO,LABEL,MARCH,MATERIALS,METHODS,OVERALL,PSA,RADIATION,RESULTS,RTOG,THERAPY
C81,CPRC,CRPC,CURRENT,LNCAP,RESISTANT,SXR,TERE1,THESE,THUS,VITAMIN
001,015,169,1998,2011,2013,272,351,868,BASEL,CONCLUSION,COPYRIGHT,COX,HGPIN,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PSA,RESULTS,RFS
AUSTRALIA,CATS,EPIC,FOLLOWING,HADS,LABEL,LESS,MELBOURNE,METHODS,OBJECTIVE,RESULTS,SCNS,SF34R,WHILE
1067,169,2013,234,BIC,FOLLOWING,HOWEVER,INTENSIVE,JOHN,LTD,LYMPHOMAS,MARSEILLE,PARIS,PWH,SONS,THERE,THREE,THUS,VIII,WILEY
149,160,169,177,2006,2007,2013,ACCEPTANCE,AIM,BACKGROUND,BETWEEN,BRIEF,CONCLUSION,COPE,FEWER,INTERVIEWS,IRELAND,JOHN,LABEL,LTD,MEN,METHODS,OBJECTIVE,RESULTS,SEPTEMBER,SONS,WILEY
114,293,AOX1,CONCLUSION,COX,DENMARK,DIAGNOSTIC,FINLAND,GAS6,GERMANY,KLF8,LABEL,METHODS,MICROARRAY,MOB3B,OBJECTIVE,PURPOSE,RESULTS
291,343,837,CONCLUSION,COX,CRUDE,CUMULATIVE,DATA,HRS,INCREASED,IQR,LABEL,METHODS,OBJECTIVE,ONTARIO,PURPOSE,RESULTS,THERE
169,2013,215,AACR,AKT,CXCR4,ERG,ETS,IKK,LABEL,PREVIOUSLY,THESE,TMPRSS2,UNLABELLED,USING,VCAP
118,126,169,2013,AACR,BACKGROUND,CGH,COX,ERG,GLEASON,IGRT,IHC,LABEL,METHODS,PSA,RESULTS,TMA,TMPRSS2
001,021,125I,2007,244,8804,8805,ACUTE,APRIL,ASIAN,BCR,CONCLUSION,COX,D90,DESPITE,GLEASON,LABEL,LDR,MATERIALS,METHODS,OBJECTIVE,PCA,PHOENIX,PSA,PURPOSE,RESULTS,T2C
001,1035,116,2001,2011,724,890,AMONG,CONCLUSION,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,PCA,PSA,PSAD,PURPOSE,RESULTS
CRE,ETS,ETV4,FUNCTIONAL,KRAS,NOTABLY,PI3,PTEN,RAS,THESE,USING
945,946,PA28,PSME1,THESE,WHEREAS
010,011,059,111,123,136,179,2013,233,258,455,566,717,747,795,8201,JULY,LIBRARY,MEDLINE,STATA,SUMMARY,THR241MET,XRCC3
DESPITE,HENCE,HOWEVER,PCA,PCIBP,THESE,THUS
2003,FURTHER,MRI,QUALITY,SINCE,THEREFORE
0001,22RV1,CCL7,CDH6,DU145,EIGHT,EXPRESSION,ITGB3,LNCAP,MDM2,MMP2,MMP3,MTSS1,PCA,PCR,PSMA,THERE,THESE
1940S,ANOTHER,CHD1,CRPC,ETS,FOXA1,MLL2,NINE,PATHOLOGY,SIX
177,8764,BACKGROUND,DUE,FIVE,GLEASON,LABEL,METHODS,RESULTS,SAFE,THESE
024,033,103,140,175,2010,2011,283,543,946,BACKGROUND,EPIC,FEW,LABEL,METHODS,RARP,RESULTS
001,005,009,017,023,052,230,241,946,BACKGROUND,CHINESE,COX,EMT,FURTHER,GLEASON,HER2,IHC,KI67,LABEL,MEIER,METHODS,MTT,NOTABLY,PCA,PCAS,PCR,REAL,RESULTS,SOX4,TGF,THREE,TURP,USING,VCAP
169,2013,945,STEROID,T877A,THUS
169,2013,INC,SIX,STEAP,THESE,USING
169,2013,2993,BACKGROUND,COPYRIGHT,LABEL,LNS,METHODS,MRI,OBJECTIVE,OUTCOME,PER,PLND,PUBLISHED,RESULTS,SETTING,TESLA,TIME,UROLOGY,USPIO
160,APO,APOA1,APOE,ASSESSMENT,BACKGROUND,CHRONIC,CONCLUSION,CONTEXT,EBRT,FATIGUE,FUNCTIONAL,ILLNESS,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,THERAPY,THESE,TTR,WESTERN
169,2013,COPYRIGHT,ONCE,PAIN,PUBLISHED,SIMILAR,THESE
162,169,2013,336,CONCLUSION,COPYRIGHT,DRE,FALSE,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,PSA,RESULTS,SIXTY,SONOVUE,THERE,TRUS
169,2013,BASED,COPYRIGHT,FEDERATION,LABEL,METASTASIS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SOCIETIES,SPARCL1
125,2001,2012,222,BACKGROUND,CONCLUSION,DOSIMETRY,FIVE,FUNCTIONAL,LABEL,MARCH,MATERIALS,METHODS,MRI,NONE,PSA,RESULTS,RIS
1471,2490,COMMENTARY,GIVEN
160,729,ARRAY,BACKGROUND,FFF,GAFCHROMIC,HOWEVER,IMRT,LABEL,METHODS,PANTHER,PHILIPS,PROWESS,PTW,RESULTS,RTP,SIEMENS,TPS,VMAT
THERE,VESICLE,ZINC,ZN2BDPA
001,066,177,180,2003,2004,2005,2007,2008,216,280,31Y,496,75Y,8201,AMICO,BACKGROUND,CHI,CONCLUSION,DATA,DEPENDENT,GLEASON,GRADING,HOWEVER,LABEL,MANN,METHODS,PSA,RADIATION,RESULTS,THESE,TIME,WHITNEY
100,169,174,2013,APPLIED,BIOLOGISTS,BIOLOGY,BOTH,HOWEVER,JOHN,LTD,MOST,NANOBODIES,PSA,SOCIETY,SONS,THEREFORE,TSP,VHH,VHH7,VHHS,WILEY
169,2013,946,AACR,ERG,ETS,IWP,LEF1,MOST,OVERALL,STUDIES,TCF,TMPRSS2,WNT
1253,1257,169,2014,ACC,BACKGROUND,CONCLUSION,COPYRIGHT,DESPITE,FGFR1,FISH,HEAD,HPV,INC,LABEL,METHODS,NECK,NONE,RESULTS,SCC,SCCS,SNUC,SNUCS,WILEY
1005,1050,129,169,2013,277,342,366,635,728,8805,90401,ASI,ASIS,BACKGROUND,CALGB,COPYRIGHT,GROUP,LABEL,METHODS,ORR,PFS,POISSON,PSA,RESULTS,SOCIETY,THERE
105,2008,368,AFFAIRS,AMERICA,AREA,BACKGROUND,CENTRAL,COMMUTING,GOVERNMENT,LABEL,METHODS,PATIENT,RESULTS,RURAL,URBAN
145,945,IFN,IL6,INTERFERON,IRF9,LNCAP,MDA,PC3,PCA,PCR,SILTUXIMAB,STAT1,THREE
169,2004,2007,2013,356,5531,708,8201,AFTER,BACKGROUND,BLACK,COPYRIGHT,END,GEOGRAPHIC,GEORGIA,LABEL,MASTERFILE,MEDICAL,METHODS,OVERALL,PHYSICIAN,RESULTS,ROS,SEER,SOCIETY,WHICH
001,005,015,046,160,8201,CK5,CK7,DONOR,HOWEVER,TTF
169,1A5,2013,2C7,343,348,AACR,BOTH,CDH11,EC3,HOWEVER,LABEL,MC3T3,PC3,THESE,UNLABELLED
901,AFTER,BLACK,INCLUSION
2008,2010,239,249,APRIL,BACKGROUND,CONCLUSION,GRADE,JULY,LABEL,METHODS,RESULTS,TREATMENT,ZOLEDRONIC
145,300
177,215,AFTER,BASED,FITC,NGO,PEG,PSCA,UPON
BONE,EBRT,HOWEVER,LABEL,OBJECTIVE,PURPOSE,RESULTS,STUDIES,SUMMARY
2000,8202,LABEL,OBJECTIVE,PURPOSE,RESULTS,SUMMARY,VITAMIN,WHETHER
1386,BOTH,GLEASON,GROUP,III,INSTITUTE,LABEL,OBJECTIVE,PR7,PURPOSE,QUALITY,RESULTS,SOUTH,SUMMARY,SWOG,THERE,WEST
001,2007,2012,208,509,743,823,8805,912,AFTER,BETWEEN,BMI,FURTHER,MARCH,OBESE,PCA,PSA,THESE
DU145,HOWEVER,KI67,PTEN,RACK1,THESE
AFTER,D95,DEA,FIVE,GRAY,PTV
100,2043,600,650,BACKGROUND,CASE,CURRENT,INC,LABEL,MATERIALS,METHODS,MODEL,PUBLISHED,RESULTS,SOCIETY,SUO,UOS,UOSS
0001,004,0074,112,169,2007,2011,2012,2014,221,COPYRIGHT,FORCE,INC,JUNE,LABEL,MATERIALS,MAY,METHODS,OBJECTIVE,OBJECTIVES,PCPS,PREVENTIVE,PSA,RESULTS,SINCE,TASK,THERE
001,100,125,131,140,145,150,160,169,189,2014,8805,COPYRIGHT,D90,DAYS,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PUBLISHED,PURPOSE,PVS,RESULTS,SMALL,SMALLER,SOCIETY,V100,V150
169,2004,2012,2013,BACKGROUND,CONTEXT,COPYRIGHT,CURRENTLY,DATA,LABEL,METHODS,OBJECTIVE,PCA,PUBLISHED,RESULTS,SYNTHESIS,TAXANES,THESE,UROLOGY
160,169,177,2013,8804,BOTH,CONCLUSION,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PSA,RESULTS,SIXTY,UNDER
001,1422,160,169,2013,711,CONCLUSION,COPYRIGHT,GLEASON,INC,LABEL,MASTERFILE,MEDICAL,METHODS,OBJECTIVE,PEARSON,RADIATION,RESULTS
160,169,2001,2012,2013,AUS,CONCLUSION,COPYRIGHT,FORTY,INC,JANUARY,LABEL,METHODS,OBJECTIVE,RECORDS,RESULTS,STENT,THERE,UROLUME
169,2013,8804,BLADDER,INDEX,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PERI,PROSTATIC,RESULTS,SCORE,UROLOGICAL
BASED,BAX,BCL,CELL,FLOW,HPLC,IC50,USING,WESTERN
25D3,CACO,CYP27B1,DAB2,DBP,LNCAP,MEGALIN,PREVIOUSLY,TAKEN
100,2001,2004,EIGHT,HOWEVER,PSA
DIFFERENT,FURTHER,SEVERAL,TEA,THERE
DECREASED,FURTHER,HOWEVER,POPULATION
BOTH,CONSISTENT,THESE,USING,VEGF
0003,001,100,1500,169,2013,750,8201,ADC,CANCERS,CONCLUSION,COPYRIGHT,DIFFUSION,DWI,HOWEVER,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PARAMETERS,PURPOSE,RESULTS,ROIS,TES,TESLA,WILEY
AFTER,GLEASON
CAUCASIAN,RCC,SUBSEQUENT
FOCUS,MCGUIRE,MODEL,RESULTS
140,2002,2005,630,8804,8805,BACKGROUND,BIOACTIVE,CIS,CONCLUSION,COX,HRS,KING,LABEL,METHODS,RESULTS,USA,WASHINGTON
018,169,2013,272,641,869,BMI,CIS,COLORECTAL,COX,LUNG,OVARIAN,RRS,SCREENING,THEREFORE,THESE,TRIAL,TVU,UICC
960,BCL,GAL
172,174,186,947,BAX,LNCAP,RADIATION,THESE,WILD,WIP1
398,BACKGROUND,COLORECTAL,CONCLUSION,GREATER,INSTITUTE,LABEL,LUNG,METHODS,OVARIAN,RESULTS,SCREENING,SIMILARLY,SIX,THESE,TRIAL
1126,1170,1315,1338,1447,800,8201,ADPC,CRPC,LABEL,LNCAP,MATERIALS,METHODS,OBJECTIVE,PCA,PURPOSE,RAMAN,RESULTS,SVM,THEN,THERE,THESE
FINALLY,FORM,LABEL,MCS,METHODS,OBJECTIVE,PURPOSE,QOL,RESULTS,SHORT,THESE,TREATMENT
EASTERN,EPITHELIAL,MOST,WEST,WESTERN
100,1400,395,400,500,800,BOTH,CNR,DWI,FORTY,GLEASON,LABEL,MATERIALS,METHODS,NUMERICAL,OBJECTIVE,OBJECTIVES,REGIONS,RESULTS
100,105,124,169,2013,8805,ART,CBCT,CONCLUSION,COPYRIGHT,D99,INC,LABEL,MATERIALS,METHODS,MLC,OBJECTIVE,PLN,PURPOSE,RESULTS
946,GB3,GSL,GSLS,SSEA,THESE
169,2013,223,ALTOGETHER,COPYRIGHT,CRPC,EGF,FER,FINALLY,IGF,IRELAND,LTD,PSA,SH2,SINCE,STAT3
2008,2011,289,8804,8805,954,CONCLUSION,DENMARK,EPE,EXACT,GLEASON,LABEL,METHODS,OBJECTIVE,OPEN,RESULTS,ROBOT,SMS,ST1,ST2,SVI,SWEDISH,UNIVERSITY
001,003,007,014,029,037,198,BCR,FURTHER,HOWEVER,LOG,SPECIALLY
ADM,BAX,BCL,CHINESE,DU145,FAS,HOWEVER,MDR,MDR1,TAKEN,THEREFORE,TPL,TRIPTOLIDE
011,018,109,169,2013,218,236,8201,CHANGES,CONTINENCE,LABEL,METHODS,NONE,OBJECTIVE,OBJECTIVES,RESULTS,SOCIETY,TAMSULOSIN,UROLOGICAL
EXISTENCE,FINALLY,HOWEVER,THESE
169,177,2006,2009,2013,233,2980,3000,8201,HENRI,JANUARY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,RESISTANCE,RESULTS,UROLOGICAL
145,169,2013,61472,945,956,ADP,BAX,C17,CASP,COMPOUNDS,CYP17A1,CYP19,IC50,JOHN,LNCAP,MCF,MOLECULAR,NINE,P450,SONS,THESE,WESTERN,WILEY
169,2013,COPYRIGHT,INC
169,2013,BLADDER,COPYRIGHT,INC,SHORT
169,2012,2013,AUTHORS,BJU,CURRENTLY,FURTHER,GLEASON,THERE,THESE
055,135,172,186,244,530,585,754,BACKGROUND,COMMITTEE,CONCLUSION,FUNDING,GPS,LABEL,METHODS,PATIENT,RESULTS,TRIAL
CASE,GIVEN,LABEL,METHODS,UNLABELLED
001,116,120,131,BPH,BSP,ECLIA,ELISA,MEIER,NBM,PEARSON,PSA,PSA1,PSA2,PSADT,ROC,SERUM,VAS
178,1966,1974,1978,1980,2013,AUTHORS,BACKGROUND,CENTRAL,COLLECTION,CONTROLLED,DATA,DECREASED,ELECTRONIC,FEV1,HRQOL,ISSUE,LABEL,LIBRARY,MAIN,MEDLINE,META,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,OVID,PEDRO,RCTS,RESULTS,SCIENTIFIC,SELECTION,SMD,THREE
169,2013,CIT,COPYRIGHT,COSI,COSY,DUE,EARLIER,EPSI,FURTHER,GLN,GLU,HOWEVER,JOHN,JRESI,LTD,MAS,MRS,MRSI,NUS,PCA,SONS,SPM,WILEY
169,2013,ADT,COPYRIGHT,DATA,HOWEVER,JOHN,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,SONS,THESE,WILEY
029,035,049,177,280,299,309,ADT,BACKGROUND,BMD,HOWEVER,LABEL,METHODS,RESULTS,SERUM,UNLABELLED
2010,BRONJ,CHIBA,COLLEGE,EVENTUALLY,FIVE,ORAL,SURGERY,THREE,TOKYO
100,DATA,GUIDELINES,MEDLINE,PET,THERE
AMONG,BOTH,KLK2,KLK3,MEMBERS,PSA
AKT,AKT1,BACKGROUND,CXCR4,DU145,LABEL,LOSS,METHODS,PC3,PTEN,RESULTS,SDF,THESE
HOWEVER,MAPK,ROS,SMIP004,UPR
160,CMR,EARLY,WHILE
2004,THESE
AFRICAN,AMERICANS
ACHN,CAKI,FINALLY,HOWEVER,MVD,NAFTOPIDIL,NEXT,RCC,RENAL,STUDIES
CELL,CISPLATIN,HOWEVER,JNK,JUN,LNCAP,MTT,PCR,TPA
AFTER,BASED,LN3,LNCAP,MAO,TREATMENT
106,174,176,815,8201,8482,BOTH,HOWEVER,IC50,ICG,PROLONGED
AFRICAN,AMERICANS,CAUCASIANS,GLEASON,IOWA,MEDICAL,METASTASIS,MTA1,NUCLEAR,PCA,UNIVERSITY
CTBP1,EPIGENETIC,FINALLY,FIRST,H3F3A,RNAS,SMARCB1,TET1,TET2,TET3
000,024,065,10Q24,1629,200,20Q11,20Q13,215,2240,2P16,3P14,3Q26,4Q32,5P15,6P22,731,8764,ACYP2,GWAS,MEAN,NAF1,OBFC1,PXK,RTEL1,SNPS,TERC,TERT
AGAINST,BACKGROUND,COLLEGE,CONTEXT,ICCR,KINGDOM,LABEL,METHODS,OBJECTIVE,OBJECTIVES,REPORTING,RESULTS,ROYAL
138,8804,BACKGROUND,CONCLUSION,ENDPOINTS,GLEASON,LABEL,MEIER,METHODS,MRL,OUTCOME,PSA,RESULTS
NWFET,PSA,SINCE,TWEEN,WHILE
001,003,169,177,2013,8804,8805,AIMS,ANXIETY,AVERAGE,BACKGROUND,DESPITE,ICI,INDEX,INJECTION,INVENTORY,LABEL,MAIN,MEAN,MEN,METHODS,OBJECTIVE,OUTCOME,PAIN,RESULTS,SCALE,SOCIETY,THESE,WHILE
947,AIM,CONCLUSION,LABEL,MATERIALS,METHODS,MSNP,MSNPS,OBJECTIVE,RESULTS
100,181,8201,956,BAPTA,BHQ,CONVERSELY,GF109203X,HOWEVER,INHIBITION,PC3,THEREFORE,WST
001,AIM,BACKGROUND,CONCLUSION,HOWEVER,LABEL,MATERIALS,METHODS,OBJECTIVE,PNT2,RESULTS,TRAMP,ZOLEDRONIC
BACKGROUND,CONCLUSION,FBS,FGF1,FISH,HIGH,HMGA2,LABEL,MATERIALS,METHODS,NONE,PDGF,RESULTS
169,CD49F,GPR48,LGR,LGR4,LIN,MECHANISMS,NOTCH,PRESS,PSC,PSCS,SCA1,SONIC,TAKEN,TREATMENT,WNT
1100,BACKGROUND,CROSS,ENGLISH,FLORIDA,HISPANICS,LABEL,METHODS,NOTABLE,POISSON,RESULTS,THERE,WHITE
138,2010,2011,BEDFORD,CONCLUSION,FIFTY,INCREASING,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,PREBIOPSY,PROSTATIC,PSA,PURPOSE,RESULTS,THEREFORE
223,FURTHER,III,LHRH
001,009,1893,2007,2011,4794,625,626,628,8201,8217,BACKGROUND,BOTH,COHEN,DECISIONAL,IDENTIFIER,IMPORTANCE,LABEL,MAIN,METHODS,OBJECTIVE,PCA,RELEVANCE,RESULTS,SCREENING,SETTING,TRIAL
001,035,046,149,290,58102,859,ABOUT,BACKGROUND,CRPC,ECOG,III,LABEL,METHODS,RESULTS,SUMMARY
450K,485,577,58102,8201,946,947,BACKGROUND,BNC1,CONCLUSION,CPG,CXXC5,FOS,FZD1,IFN,IL1,LABEL,LMX1B,METHODS,MYC,PATHWAY,PCA,RESULTS,SYN2,THERE,TNF,TP53
001,004,967,ADT,AFRICAN,BACKGROUND,CAUCASIAN,CHINESE,COX,CRPC,DATA,HAN,LABEL,MEIER,METHODS,OATPS,ORGANIC,RESULTS,SLCO,SLCO1B3,SLCO2B1,SLCO3B1,SLCOS,THESE,TTP
CRPC,CYP17,LNCAP,PSA
ATG16L1,BIOMARKERS,CONVERSELY,SINCE,TAKEN
169,2013,ADT,COPYRIGHT,FOLLOWING,FURTHER,GLEASON,HOWEVER,INCLUSION,LTD,OTHER,PSA
117,169,2013,ADT,ASSESSMENT,BFI,BRIEF,CONCLUSION,COPYRIGHT,EARLY,FATIGUE,GROC,III,INC,INVENTORY,LABEL,LASA,MEAN,METHODS,OBJECTIVE,PROTECT,QOL,RESULTS,SELF,THERE,TREATMENT
169,2013,4664,AMONG,CADT,CONCLUSION,COPYRIGHT,IADT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,RCTS,RESULTS
AIM,BACKGROUND,GLEASON,KAPPA,LABEL,METHODS,OBJECTIVE,RESULTS,THESE
KNOCKDOWN,LNCAP,TCTP,THESE
000,1000,2235,266,3000,3394,401,6000,667,8000,AFRICAN,EACH,GENOMES,KLK,KLK1,KLK15,KLK9,LINE,PCR,THERE
26S,945,954,DU145,EVEN,EXPRESSION,IKK,INHIBITION,PC3
0001,100,1556,1993,1994,1997,1998,2001,2002,2008,3440,4676,6398,732,739,829,GLEASON,HOWEVER,LABEL,METHODS,OBJECTIVE,ONTARIO,RADICAL,RESULTS
119,169,2013,3523,3530,BACKGROUND,COPYRIGHT,DESPITE,END,HISPANICS,LABEL,METHODS,MOST,NONMARRIED,ODDS,OVERALL,PSA,RESULTS,SOCIETY,YEAR
169,2013,8201,BACKGROUND,COPYRIGHT,JOHN,LABEL,LTD,METHODS,MRI,NYQUIST,RESULTS,SIMULATION,SONS,WILEY
169,2013,ADT,COPYRIGHT,FIVE,FRAMEWORK,HOT,HOWEVER,JOHN,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,SEMI,SONS,THERE,THESE,WILEY
EZH2,HIPPO,KNOCKDOWN,LNCAP,MST1,PCA,PRC2,PSA,SAFB1
ADT,PCA,USING
AFRICAN,CAUCASIAN,CURRENT,ERG,KEY
916,956,968,AIM,AKT,AUTOPHAGY,CELL,CONCLUSION,GFP,LABEL,LC3B,LC3BI,LNCAP,LOBARIA,METHODS,MTT,OBJECTIVE,PC3,PCR,PI3K,RAB,RESULTS,RETIGERIC,ROS,SIMILAR,THUS,WESTERN
101,945,946,947,948,956,A66,AIM,AKT,CAL,CCK,CONCLUSION,LABEL,METHODS,MYR,OBJECTIVE,PAN,PI3K,PI3KS,RAJI,RESULTS,RH30,SRB,WESTERN
0001,0017,0034,8201,ADC,AUC,BACKGROUND,CONCLUSION,DCE,DTI,HOWEVER,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,REGIONS,RESULTS,ROC,ROIS,THERE
HOWEVER
169,2013,214,302,CAUCASIAN,CBM,DESPITE,FURTHER,LABEL,MEDLINE,PAT,THEREFORE,UNASSIGNED,UNLABELLED,XPC
169,1990,1991,2008,2012,2013,AARP,ASPARTAME,CALIFORNIA,COPYRIGHT,DENMARK,DIET,HODGKIN,ITALIAN,JANUARY,LOW,LTD,NIH
169,2013,270,ADT,COPYRIGHT,CROWN,INC,LHRHA,MEN,PCA,PRIMARY,PUBLISHED
028,169,172,2013,2696,860,8805,BACKGROUND,COPYRIGHT,GLEASON,LABEL,MEN,METHODS,OBJECTIVE,OUTCOME,PCA,PSA,PUBLISHED,RESULTS,SETTING,SNPS,THERE,UROLOGY
169,2013,99M,ACA,BACKGROUND,BBN,COPYRIGHT,EIGHT,GRPR,HABBN,HYNIC,INC,LABEL,LOW,METHODS,RATIONALE,RESULTS,SPECT,TECHNETIUM,THERE,TPPTS
019,026,125,160,169,177,2013,454,597,8804,8805,CONTROL,COPYRIGHT,DETERMINE,FAT,INC,LABEL,MATERIALS,MEAN,METHODS,NEITHER,OBJECTIVE,PSA,PSAB,PUBLISHED,PURPOSE,RESULTS,SOCIETY,T1C,T2A,THERE,UNIVARIATE
169,2013,222,947,ATM,AUTHORS,COPYRIGHT,H2O2,INC,MRN,NKX3,PUBLISHED,THESE,THUS
169,2013,COPYRIGHT,LTD,MOST,ONJ
111,411,416,COLORECTAL,COX,DIETARY,INC,LABEL,LUNG,METHODS,OBJECTIVE,OVARIAN,PUBLISHED,PURPOSE,RESULTS,SCREENING,THESE,TOTAL,TRIAL
135,138,148,169,177,2013,207,259,2935,351,4478,5137,5787,956,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,RESULTS,THEN,THERE,TURB,TURP
396,8201,ASSAY,BACKGROUND,CPG,DLK1,IGF2,IMPRINTING,LABEL,LOI,METHODS,RESULTS,TFPI2,TP73,USING,WHILE,WT1
064,169,1995,1ST,2010,2013,31ST,8201,ABSTRACTS,ASSESSMENT,AUTHORS,BJU,CONTROLLED,CRI,CURRENT,EFFECTS,INDEX,JANUARY,LABEL,MEDLINE,MEN,METHODS,NIH,OBJECTIVE,OCTOBER,PROCESS,RCT,RCTS,RESULTS,REVIEWS,ROBOTIC,SCIENCE,STUDIES,SURGEON,TECHNOLOGY,THERE
169,2013,8201,945,AUTHORS,BJU,CONCLUSION,DESPITE,DETECTION,LABEL,MEN,METHODS,OBJECTIVE,PSA,RESULTS,UTI
667,BACKGROUND,GLEASON,LABEL,METHODS,MOST,PCA,RESULTS,STUDENT
001,169,1998,2010,2013,4628,8201,8805,AUTHORS,BCR,BJU,CONCLUSION,COX,ESTIMATES,GLEASON,LABEL,MEIER,METHODS,MIRP,NSMS,OBJECTIVE,OTHER,PSA,PSM,PSMS,RESULTS
007,010,015,027,1051,169,1998,2005,2009,2013,470,AIMS,COX,EPE,EPSTEIN,FOCAL,JOHN,LABEL,LTD,METHODS,OBJECTIVE,PATHOLOGY,PNI,RESULTS,SOCIETY,SONS,UROLOGICAL,WHEELER,WILEY
0001,001,0035,009,024,049,2006,2010,344,441,8804,8805,ADVERSE,BETWEEN,COPENHAGEN,DENMARK,FAVOURABLE,GLEASON,LABEL,METHODS,OBJECTIVE,PRIMARY,PSA,RESULTS
22RV1,946,APC,BACKGROUND,BECAUSE,CURRENT,DNMT,DNMT1,DU145,GSTP1,HOWEVER,LABEL,LNCAP,METHODS,PCA,PCR,RAR,RESULTS,RG108
AFTER,ALONG,BMI1,COMPLEXES,CRC,CRCS,H2A,HISTONE,HMS,KDMS,LYS27,PCA,PCG,PCGS,PRC1,PRC2,PRCS,REPRESSIVE,SIMILARLY,SINCE,TIC,TICS
AVAILABLE,CELLS,CONCLUSION,DISORDERS,LABEL,ROLE,UNLABELLED,VITAMIN
0001,002,160,169,183,8804,8805,CONCLUSION,DCE,DTPA,GEORG,GLEASON,III,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PCA,PURPOSE,RESULTS,STUTTGART,THERE,TYPE,USING,WASH,YORK
003,007,009,036,037,117,131,169,183,233,741,AMICO,BACKGROUND,BDFS,CONCLUSION,GEORG,GERMANY,HIFU,LABEL,LYON,MATCHED,METHODS,NADIR,NEITHER,PCA,PSA,RESULTS,STUTTGART,THERE,THESE,TURP,YORK
169,183,DATA,GEORG,IAD,III,STUTTGART,UNTIL,VARIOUS,YORK
494,971,AFRICAN,ASIAN,BACKGROUND,CIS,CYP17,EBSCO,LABEL,METHODS,MSPA1,OBJECTIVE,ODDS,ORS,RESULTS,SCIENCE,THEREFORE,WEB
001,003,011,012,055,086,119,134,147,194,1999,2012,243,262,298,321,407,434,454,471,511,597,644,727,761,776,778,781,801,802,8201,823,846,961,AFRICAN,ASIAN,BIOMEDICAL,CAUCASIAN,CHINESE,GSTM1,GSTT1,HOWEVER,KNOWLEDGE,LITERATURE,MEDLINE,OVERALL,PCA,SCIENCE,WEB,WHILE
169,2013,4606,AACR,INCREASED,INTERPLAY,MDSC,MDSCS,OSTEOLYSIS,RES,THEREFORE,THESE
169,2013,4599,605,AACR,CRPC,GONADAL,RES,THESE
CCAR1,DEPLETION,GATA2,MED1
339,CELL,CONCLUSION,CURRENTLY,DEFINIENS,GLEASON,LABEL,METHODS,OBJECTIVE,PROTEIN,PSA,PURPOSE,RESULTS,TMA,WHILE
145,900,ALTOGETHER,BAX,BESIDES,CCAAT,EBP,EGF,GLUCOSE,GRP78,INSTEAD,PDT,PHOTOFRIN,SUBA,UPR,VAD
0001,041,2006,2009,299,770,9766,AMONG,BACKGROUND,CONCLUSION,DRUG,LABEL,METHODS,ORS,PRESCRIBED,RESULTS,SWEDISH,TNM
0001,001,152,3P13,5Q21,6Q15,7964,8201,945,ERG,GLEASON,INCREASED,KPNA2,PTEN,RESULTS,TMPRSS2
AAH,ERG,FIFTY,TMPRSS2
002,087,180,8232,AMICO,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,SPECIMENS,TESLA,TRUS
169,2013,8482,BASEL,COPYRIGHT,DATA,FURTHER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,QMAX,RESULTS,SPANNER,STENT
116,11R,169,2013,549,945,947,956,COPYRIGHT,DIETHYL,DIVERSE,FEW,HCT,IC50,LTD,LUNG,MICHAEL,MORPHOLINE,THP
946,CL2,CTR1,PET
002,104,169,173,2013,575,COPYRIGHT,COX,GLEASON,INC,INCREASING,LABEL,MATERIALS,MAXIMUM,MEIER,METHODS,MTD,OBJECTIVE,PCSM,PSA,PURPOSE,RESULTS,SRT
001,137,2YL,BACKGROUND,HIGH,LABEL,METHODS,MTT,OPTIMAL,RESULTS,TAKEN,TIM,WESTERN
CXCR4,HOWEVER,SRC,THEREFORE
2001,2010,2015,AGE,BACKGROUND,DIFFERENCE,ESTIMATES,IRAN,ISFAHAN,LABEL,MATERIALS,METHODS,RESULTS
1996,2009,626,BACKGROUND,HOWEVER,LABEL,MATERIALS,METHODS,NHL,RESULTS,THERE
497,BPH,LNCAP,MICRORNAS,RESULTS,RNAS,TAKEN,UTR
MYCOPLASMA,THERE
152,1987,2000,2004,309,8805,956,AFTER,AMICO,LABEL,MEN,METHODS,OBJECTIVE,PCSM,PSA,RADICAL,RESULTS
BACKGROUND,BAND,CONCLUSION,DEPTH,LABEL,RESULTS,THEREFORE
8201,BACKGROUND,CTV,CTVS,DICE,HIGH,IMRT,INCREASING,LABEL,METHODS,OAR,RESULTS,RTOG,SIMILARITY,SMALL
001,005,007,101,158,1973,2004,259,BACKGROUND,CONCLUSION,COX,END,JANUARY,LABEL,METHODS,OLDER,PATIENT,RESULTS,SCCP,SEER,THERE,WHETHER
945,ARID,CHROMATIN,H3K4ME3,H3K9,H3K9ME1,H3K9ME2,H3K9ME3,HYPOXIA,JARID1B,JMJDS,JUMONJI,LNCAP,PSA,THUS,UNDER
ADS,EVENTUALLY,NOTABLY,PCSC,PCSCS,STAGE,THESE,TRAMP
160,1995,2009,477,621,721,8805,BEGINNING,JANUARY,LABEL,METHODS,OBJECTIVE,PURPOSE,RELATIVELY,RESULTS,SRES
000,1991,2009,BACKGROUND,HOWEVER,INCREASED,ITALIAN,LABEL,METHODS,ODDS,ORS,RESULTS,SWISS
175,2536,600,6727,COMBINING,DMSO,DU145,HDAC,HENCE,IC50,IC50S,LNCAP,MTS,PC3,PCR,PLK1,THEREFORE,WHILE
ANTIGEN,EIS,IMPEDANCE,PSA
035,049,055,072,074,177,HCC,IHC,RCC,SIMILARLY,USING
146,2003,2008,2010,278,AFTER,BACKGROUND,BMP,CONCLUSION,DATA,LABEL,LEVEL,METHODS,OBJECTIVE,RESULTS,SUMMARY,THERE
FURTHER
169,2013,961,AACR,FINALLY,PC3,PNKP,PTEN
148,2011,2013,500,INCLUSION,LABEL,MARCH,METHODS,MONITORING,OBJECTIVE,OCTOBER,QUALITY,RESULTS,SAMS,SWEDISH
001,108,1276,1988,2001,239,403,AFTER,COX,HENRI,LABEL,MEIER,METHODS,OBJECTIVE,PSA,PSM,PSMS,RANDOMIZED,RESULTS,RFS
004,665,710,8201,8805,BACKGROUND,BIRC5,CHINESE,CIS,CONCLUSION,IAP,LABEL,METHODS,ORS,PCA,PSA,RESULTS,UTR
176,2011,2012,238,ADT,EVERY,HOWEVER,LABEL,LESS,MAY,METHODS,NINE,OBJECTIVE,OVERALL,RESULTS,SECONDARY,SEPTEMBER
1118,1126,160,ARE1,ARE2,ARE3,ARE4,ARE5,ARES,BESIDES,CACCATGTT,CHIP,CONSENSUS,DU145,EMSA,GNMT,LNCAP,LUCIFERASE,PCA,PCR,PREVIOUSLY,R1881,REAL,THESE,YANG,YIN,YY1
ACP,CENTRAL,CUBA,ENGLISH,FLORIDA,KNOWLEDGE,LATINOS,NINE,SPANISH,USA,VENEZUELA
ADDRESSING,BONFERRONI,BRCA,CORRECTION,CREIGHTON,HEREDITARY,PROTECTIVE,THEREFORE,UNIVERSITY
005,007,009,102,104,142,8805,CONCLUSION,GLEASON,IQR,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PSA,PURPOSE,RESULTS,SVI,USING
1000,177,2000,8201,AREAS,CONCLUSION,DWI,DWIS,FOUR,LABEL,METHODS,MRI,OBJECTIVE,PCA,RESULTS,T2WI
136,BOTH,FXR1,G3BP,GAP,GLEASON,PKP,PKP1,PKP3,RBPS,SH3,UNTIL,UPF1
KNOWLEDGE,NON
145,375,AFA,ANNOTATION,CTCL,FUNCTIONAL,HDAC,HDACI,HDACS,HISTONE,MHC,PC3,THESE
ACTIVATION,HOWEVER,SEVERAL,THEREFORE
201,2010,3514,4176,464,509,ALPHARADIN,ARN,AZD,BESIDES,CYP17,DENOSUMAB,EZN,GALETERONE,ODM,ORTERONEL,SINCE,SIPULEUCEL,UNDER
ACCORDING,CAP,CURRENTLY,EARLY,PSA
8322,CONCLUSION,KNOCKDOWN,LABEL,LNCAP,METHODS,OBJECTIVE,PCA,PCR,PRDX,RESISTANT,RESULTS,TCA
126,177,8201,AFTER,BACKGROUND,CFRT,CRPC,FIFTY,FORTY,LABEL,METHODS,PSA,RADICAL,RESULTS,SIXTY,T1B,T3B,THERE
223,BACKGROUND,CLASS,CRPC,INTUITIVE,LABEL,METHODS,REDUCTION,RESULTS,SCS,TARGETS,THEREFORE,THESE,UDP,UGT,UGT1A
CARCINOMA,HIGH,HOWEVER,INSTEAD,LABEL,NMIBC,OBJECTIVE,PURPOSE,RESULTS,SUMMARY,THERE,THEREFORE
METASTATIC,MOST
177,FDG,HOWEVER,IMAGING,PET,THUS
169,2013,APART,CSCS,FAILURE,MDR
169,2013,6MONTHS,CENTRAL,COPYRIGHT,DCR,GRADE,HOWEVER,III,IQR,LDM,LOW,LTD,MEAN,MEDLINE,META,MTD,PFS,RDI,THUS,WHILE
169,2013,370,8473T,8594,94INS,COPYRIGHT,COX,DIET,IL1B,INC,IRR,NFKB1,NSAID,PPARG
100NM,8201,BACKGROUND,DU145,FINALLY,GHRELIN,GHSR,GOAT,LABEL,LNCAP,METHODS,PC1,PC2,PC3,PCR,REAL,RESULTS,RWPE
001,007,169,2013,263,AUSTRALIA,BJU,CRPC,EBRT,LABEL,LOCAL,METHODS,OBJECTIVE,OBJECTIVES,PATIENT,PRIMARY,RESULTS,RRP
169,2004,2011,2013,3110,AUTHORS,BJU,BMI,DATA,LABEL,LLCS,METHODS,OBJECTIVE,RARP,RARPS,RESULTS,SEVEN,THERE
963,BACKGROUND,CBCT,COM,COV,FIVE,INTER,LABEL,METHODS,PROSTATES,REGARDING,RESULTS,RMS
0001,002,106,178,946,967,AIM,CONCLUSION,HOWEVER,ITC,LABEL,METHODS,OBJECTIVE,PCA,RESULTS,SEVENTY,TGF,VCAM,VEGF,WHILE
8804,BACKGROUND,CONCLUSION,CTS,DEFORMABLE,DIR,DOSE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,VMANUAL,VPROP
001,002,006,162,2008,2010,225,287,459,613,638,735,8805,AGE,BETWEEN,HACM,IIEF,INDEX,LABEL,METHODS,NVB,NVBS,OBJECTIVE,PURPOSE,RARP,RESULTS,SHORT
101,108,2006,2010,477,674,AFTER,CROSS,JANUARY,LABEL,MAIN,METHODS,OBJECTIVE,OBJECTIVES,OUTCOME,OVERALL,RESULTS,SELF,SETTING,SOUTH,THERE,WALES
144,2011,2012,BACKGROUND,CONCLUSION,FOLLOWING,GLEASON,LABEL,MAY,METHODS,MRI,OBJECTIVE,PSA,PURPOSE,RESULTS
001,1176,181,1986,279,550,898,AGAINST,BACKGROUND,CIS,COX,III,LABEL,METHODS,PCA,RESULTS,TOENAIL,UNION
1990,1994,2003,2004,2006,2008,AMONG,APC,ASIAN,BACKGROUND,CHINESE,CIS,DECREASES,END,FILIPINAS,FILIPINOS,INCIDENCE,INDIANS,JOINPOINT,KAMPUCHEAN,KOREANS,LABEL,LAOTIAN,METHODS,PAKISTANI,PAKISTANIS,RATES,RESULTS,SEER,STAT,THESE,VIETNAMESE
001,004,027,100,156,2013,215,8805,ADC,ADCS,AREAS,CONCLUSION,GLEASON,HIPAA,LABEL,LEAST,MATERIALS,MEAN,METHODS,OBJECTIVE,PURPOSE,RESULTS,RSNA,WHOLE
169,2013,AACR,ASC,CCL4,PIN,PTEN,SNAIL,STAT3
169,2013,AACR,APPROACHES,DESPITE,STUDIES
AURKA,CLU1,DESPITE,HPN,NOVEL,PCA,PROMISING,SPARC,WESTERN,WNT5A,WT1
169,2013,7721,COPYRIGHT,ECTOPIC,HCC,HOWEVER,IGF,INC,PCR,RESULTS,SCREENING,SMMC,SND1,THEREFORE,WILEY
011,147,178,180,2003,2010,306,548,993,COX,ECONOMICS,HRS,INITIATORS,JANUARY,LABEL,MEDICAL,METHODS,MORE2,NPH,OBJECTIVE,RESULTS,WHILE
097,174,5T4,PSA,THEREFORE
2009,2011,217,BACKGROUND,EAST,ENTRY,FIFTY,GRADE,JULY,LABEL,MARCH,MBQ,METASTRON,METHODS,NRS,REGARDING,RESULTS,SELF
8209,8710,954,968,AKT,COX,DU145,EVEN,HRPC,LIMITED,PARP,RG003,RG005,THERE
FDG,PET,PRIMARY,SCC,SERUM

730,946,I298T,P261L,T292A
160,8209,LNCAP,MET
IMRT,MLCS,PTV,RTPS,RTPSS
014,1000,8201,AFFYMETRIX,ANIMALS,BACKGROUND,IGF,LABEL,LAPC,METHODS,MICE,OVERALL,PCA,PGE,PSA,RESULTS,SERUM,WESTERN
169,2013,CASTRATION,CCL5,CCR1,COPYRIGHT,CRPC,ELISA,ERK,ERK1,FINALLY,LTD,MEK1,MMPS,PC3,PC3PR,RAC,RAC1,THESE
160,169,2013,COPYRIGHT,D90,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SDREF,SEED,SEVEN,SOCIETY
3T3,C33A,DPPH,HELA,ROS,THESE
1980S,1986,1994,AFTER,BOTH,FDA,HOWEVER,PSA,WHAT
945,946,AMONG,AREAS,BACKGROUND,BESIDES,COVERED,DESPITE,DEVELOPING,LABEL,LXR,LXRS,METHODS,MOST,OPINION,OXYSTEROLS,SLIMS
0001,003,174,8201,AQUILAB,DCE,DIPL,DWI,GTV,KAPPA,LABEL,LESIONS,MASTERPLAN,METHODS,MRI,NET,OBJECTIVE,PURPOSE,RESULTS,SUBSEQUENT,T2W,TESLA,USING
EVEN,HOWEVER
CRPC,DESPITE,FIRST,HOWEVER,III,PHASE,PROMISING
HIGH,HRPC,SELECTION
COA,GOLGI,HBP,HELA,NAD,NADH,NADP,NADPH,PRINCIPAL,UDP
33258,BAX,BCL,FURTHER,HOECHST,HOWEVER,IC50,PARR,THUS,VITAMIN,VK4,VK4S
JUN,LNCAP,THESE
182,ECTOPIC,MICRORNAS,NDRG1,RNAS,RWPE
946,BACKGROUND,BONE,CONCLUSION,HFE,INHIBITION,LABEL,RESULTS,SINCE,THEREFORE,USING
BACKGROUND,CHANGES,GEARRAYTM,LABEL,OBJECTIVE,PRINCIPAL,PSA,PURPOSE,RESULTS,THESE,TRIAL
157,APC,BACKGROUND,CHANGES,COMPARISON,GLEASON,GSTP1,ITALY,LABEL,MARKERS,METHODS,NTAT,PCR,PREVALENCE,RESULTS,TURIN
19Q13,4Q34,CFD,ENSEMBL,KLK,KLK3,KLKB1,KLKS,NCBI,PSA,SEQUENCES
BASED,DESPITE
1048,1564,173,2009,2010,291,292,355,426,587,610,773,BACKGROUND,CRC,DATA,DELAYED,EACH,EHR,FOBT,IDA,JANUARY,LABEL,MARCH,METHODS,OVERALL,PPV,PPVS,PSA,RESULTS
160,METICULOUS
102,178,412,GLEASON,LABEL,MAB,METHODS,OBJECTIVE,PCA,PSA,PURPOSE,PZB,RESULTS,THERE,THUS,TRUS,TZB
ARKO,GENERATION,HOWEVER
2012,SEPTEMBER,THEREFORE

2003,2010,288,AIM,BOTH,BPH,CONCLUSION,DIDN,IPSS,JANUARY,JULY,LABEL,METHODS,OBJECTIVE,PSA,REDUCTASE,RESULTS,SCORE,SYMPTOM
024,2008,2011,AIM,BETWEEN,CONCLUSION,DESPITE,FORM,JANUARY,LABEL,METHODS,OBJECTIVE,OVERALL,PCA,PPI,RESULTS,RRP,SHORT,THERE,URINARY
223,HOWEVER
1979,2000,2013,AFTER,FINALLY,RARP,RRP,SHORT,WALSH
169,2013,COPYRIGHT,IRELAND,LTD,PDT,ROS,THESE
169,2013,ASIAN,COPYRIGHT,CRPC,ISSUE,LTD,SPECIAL,THUS,WESTERN
001,037,1171,1298,150,169,200,2013,CHAIN,CONCLUSION,DUE,GENOTYPES,HAPLOTYPE,INDIANS,LABEL,MATERIALS,METHODS,MMP,MMPS,NORTH,OBJECTIVE,OVERALL,PCA,PCR,POLYMERASE,PURPOSE,RESULTS,RFLP,TIMP,VARIANT
160,169,2013,22B,956,A549,COPYRIGHT,DU145,GES,HEPG2,IC50,MCF,SAS,SORAFENIB,SY5Y
001,002,006,009,100,155,169,171,2014,260,282,734,CAUSE,COPYRIGHT,DOSE,EIGHT,HDR,IGRT,INC,LABEL,MATERIALS,METHODS,NETWORK,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SOCIETY,T2B,THESE
004,125,160,169,2013,423,AUSTRALIAN,COPYRIGHT,CROWN,INC,LABEL,LOW,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,TCP,USING
169,2013,72H,945,956,ADME,AKT,CIP1,COPYRIGHT,DU145,FIRSTLY,LTD,THESE
169,183,2011,2013,278,294,486,492,496,498,APRIL,ATRASENTAN,AVENTIS,BACKGROUND,COPRIMARY,COPYRIGHT,INSTITUTE,LABEL,LTD,METHODS,PFS,RESULTS,THREE,UNASSIGNED
1024,169,2013,8804,CALYPSO,COPYRIGHT,FEWER,INC,LABEL,MATERIALS,MEDICAL,METHODS,OBJECTIVE,PURPOSE,REAL,RESULTS,SEATTLE,WASHINGTON,WAVELET
169,200,2013,956,ASIA,CELLS,COPYRIGHT,HOWEVER,LNCAP,LTD,PCA
945,DU145,HEPG2,HIF,LTD,MAPK,PEITC,PHENETHYL,PI3K,PUBLISHED,SKBR3,TAKEN,U87,VEGF
169,171,187,2013,AEU,BACKGROUND,CONTEXT,COPYRIGHT,FOCAL,GLEASON,LABEL,METHODS,PUBLISHED,RADICAL,RESULTS,SYNTHESIS,TREATMENT
2011,BACKGROUND,CERTAIN,DATA,DESPITE,KAPPA,LABEL,METHODS,OCTOBER,PCA,PURCHASING,RELATIVES,RESULTS,UTAH
169,2013,225,AUSTRALIAN,AUTHORS,BACKGROUND,BLAND,COLLEGE,EBRT,FMS,IMAGING,JOURNAL,LABEL,LOA,LOAS,MEDICAL,METHODS,RADIATION,RESULTS,ROYAL,RTS,SIX,SMALL,TREATMENT,ZEALAND
100,169,2013,8201,AUSTRALIAN,AUTHORS,BACKGROUND,BLADDER,COLLEGE,IMAGING,IMRT,JOURNAL,LABEL,MEDICAL,METHODS,NON,OAR,OVERALL,PPRT,RADIATION,RESULTS,ROYAL,SEVENTY,SUGGESTED,THERE,V40GY,V50GY,V60GY,V65GY,ZEALAND
163,1948,1970,1980,2011,300,5400,700,APRIL,ASSESSMENT,BACKGROUND,BPS,BSC,CONCLUSION,CONFERENCE,COST,DATA,DATABASES,DENOSUMAB,FUNDING,GENERALLY,INSTITUTE,ISSUE,LABEL,LIBRARY,MARCH,MAY,MEDLINE,METHODS,NMA,NSCLC,OBJECTIVE,OBJECTIVES,OSTS,OWING,PAS,QALY,RCTS,RESULTS,SCIENCE,SOURCES,SRE,SRES,STUDIES,SYSTEMATIC,TECHNOLOGY,WEB,WITHOUT
145,181,946,LCLET,THESE,TRITERPENE
123,33258,AIF,ANNEXIN,APOPTOSIS,BAX,BCL,CONCLUSION,HOECHST,LABEL,MCF,METHODS,MMP,MTT,OBJECTIVE,PCR,PHASE,REAL,RESULTS,THEREFORE,WESTERN
169,2013,8201,ACQUIRING,BACKGROUND,BRDU,CRPC,ELISA,HOWEVER,INC,LABEL,MAIN,METHODS,RESULTS,VCAP,WESTERN,WILEY
169,2013,ADENOVIRUS,CAR,CARS,COXSACKIE,CRCA,CRCAS,CTV,FEW,INC,PCS,PHASE,RECEPTORS,USING,WILEY
0003,007,141,169,2011,2012,2013,215,308,8201,8805,AMONG,APRIL,BACKGROUND,CHINA,CHINESE,CONCLUSION,HUASHAN,INC,LABEL,METHODS,PCA,PSA,RESULTS,SNPS,THREE,WILEY
106,1106,2009,235,278,503,845,AIMS,BACKGROUND,CONCLUSION,CONTROL,DATA,FURTHER,IRELAND,JUNE,LABEL,MEN,METHODS,OBJECTIVE,PROGRAMME,PSA,RAPAC,RESULTS,SEVENTY,SIXTY,TRUS,UNIVERSITY
004,007,009,135,168,215,AMONG,CDX2,CIMP,CPG,NONE,PRAC
131,HOWEVER,LNCAP,NIS,SEVERAL
001,009,1997,2011,556,8201,845,BACKGROUND,CONCLUSION,CPRD,LABEL,METHODS,QRESEARCH,RESULTS,THERE
160,169,2013,COPYRIGHT,FURTHER,INC,KNOCKDOWN,MEK1,NKX3,PATHOLOGY,PUBLISHED,RAMP1,SOCIETY,THESE
180,181,223,945,AFTER,DRUG,FOOD
28S,C2848,IRES,PHA,SIMILAR,U50
169,2013,223,CBZ,COPYRIGHT,CRPC,ENZ,IRELAND,LTD
0238,1541,2013,7786,AKT,CHRONIC,IL6,INCREASED,LABEL,LOF,MALIGNANT,MCR,OSM,PIN,PTEN,STAT3,UNLABELLED
169,2013,COPYRIGHT,EGCG,LTD,OTF,SYNTHESIS,THEIR
1089,169,174,2011,2012,2013,AFTER,AGE,BACKGROUND,BLACK,CHI,COPYRIGHT,DATA,FORCE,GFK,INC,JOURNAL,KNOWLEDGE,LABEL,LLC,MARCH,METHODS,OBJECTIVE,OCTOBER,PANEL,PREVENTIVE,PSA,PUBLISHED,PURPOSE,RESULTS,TASK
016,021,027,10TH,111,117,133,1998,2008,ADT,HORMONALLY,ICD,LABEL,METHODS,OBJECTIVE,RESULTS,S72,TAMPERE,UNIVERSITY
2009,2011,220,2500,400,5000,CENTRAL,DALTEPARIN,DATA,INCREASED,LABEL,METHODS,NINE,OBJECTIVE,RALP,RESULTS,THEN,UNIVERSITY,VIII
945,946,947,ACTIVATION,AIM2,ASC,BPH,CASP1,CLOSE,FURTHER,GIVEN,HOWEVER,IFN,IFNS,LABEL,PC3,UNLABELLED,UPON
133,2005,2012,288,355,959,AFRICAN,AMERICANS,AMICO,BMI,CAPRA,CAUCASIAN,CONCLUSION,GEORGETOWN,GLEASON,GSU,JANUARY,JULY,LABEL,METHODS,OBJECTIVE,PCA,PSA,PURPOSE,RACE,RESULTS,TRUS,UNIVERSITY,WASHINGTON,WHILE
946,EVALUATION,HOWEVER,HUR,IGF,INSULIN,PREVIOUSLY,RRM2,RRM3,SP1,UTR
002,137,177,2008,2010,600,BMD,BONE,BPFS,HOWEVER,PSA,SRES,ZOLEDRONIC
166,2000,2009,464,500,644,856,8805,AMONG,CASES,DISULFIRAM,SIMILARLY
AF1,CRPC,FURTHER,MOST,TAU1,TAU5
SPECIAL
DUE,FINALLY,RNAS,SMALL,THESE
027,327,849,863,971,998,LABEL,METHODS,OBJECTIVE,PSAD,RESULTS,TRUS
967,DRAGS,IIEF,III,INDICATORS,PEARSON,PSA,THESE
0001,001,181,ANTI,BACKGROUND,BISPECIFIC,BOM,CARDIOCYTE,COMPLEXES,CONCLUSION,DISCUSSION,DOX,DTPA,H9C2,HOWEVER,IC50,LABEL,METHODS,OBJECTIVE,PC3,PDC,PDCS,PGA,POLYMER,PURPOSE,RESULTS
001,002,223,233,314,528,809,921,BACKGROUND,BAYER,HEALTHCARE,LABEL,METHODS,RESULTS
1600,BETWEEN,BODY,CYBERKNIFE,DISRUPTING,IRIS,IRT,IRTS,LARGE,LIVER,MEAN,SBRT,SERVICE,SPINE,STOP,TBF,TECHNICAL,TIME,TIMES,TOOL,TREATMENT,WEIBULL
ADT,DATA,GETTING,MANEN,THESE,THREE
0001,002,2004,2007,505,AFRICAN,CONCLUSION,LABEL,LOUISIANA,METHODS,NORTH,OBJECTIVE,PATIENT,PROJECT,RESULTS,SEPTEMBER
BESIDES,PSA
LPXN
175,179,BASED,BESIDES,CBR,CONCLUSION,DCS,LABEL,MEDLINE,METHODS,MOST,OBJECTIVE,PSA,RESULTS,SPSS,TEN
000,100,1000,500,AKT,CONCLUSION,GSK3,LABEL,MDM2,METHODS,MTT,OBJECTIVE,PCR,RESULTS,THEN,WESTERN
017,075,100,250,274,425,500,AFTER,CONCLUSION,DU145,LABEL,METHODS,MTT,OBJECTIVE,PCR,RESULTS,TEA,WESTERN
AFTER,CAPE,CONCLUSION,ELISA,LABEL,METHODS,OBJECTIVE,PCR,RESULTS,STAT3,THEREFORE,TNF,WESTERN
0001,0002,0003,0006,002,004,1018,1057,1114,1116,13C,1407,1499,1647,1846,1B1,5438,5807,5999,6380,8202,A119S,AFTER,BACKGROUND,FURTHER,L432V,LABEL,N453S,P450,PCA,PRINCIPAL,R48G,RESULTS,SNPS,STUDIES,THERE
001,247,300,417,673,8202,ANTIGEN,AUC,DCA,DRE,FINALLY,INDEX,PCA,PCA3,PHI,PSA,ROC,THESE
EGF,IGF,IGFBP,INCUBATION,LNCAP,SCID,SERUM
AZD3514,CONTINUED,CRPC,DUNNING,HID28
604,ABC,ABCB1,ATP,DOCETAXEL,HOWEVER,IC50,KNOCKDOWN,TAXR
1482,169,1998,2004,2013,432,475,516,AFFAIRS,AMICO,AMONG,BACKGROUND,COPYRIGHT,LABEL,MEN,METHODS,RESULTS,SOCIETY,USING
1000,1997,2008,2009,232,250,ADT,AKI,CASES,CIS,HOWEVER,IMPORTANCE,JANUARY,LABEL,MAIN,MEN,METHODS,OBJECTIVE,ORS,OVERALL,RELEVANCE,RESULTS,SETTING,STATISTICS,THESE
2002,2009,404,809,AFTER,COMMUNITY,LABEL,METHODS,OBJECTIVE,PRIOR,PURPOSE,RESULTS,WHILE
ARTEMIS,COGNITIVE,MRI,ORGAN,PROS,THREE,TRUS
158,160,1994,2008,2010,222,404,705,802,COX,SERUM,T2DM
CAP,THERE,THESE,WHILE
1982,1993,2609,2615,390,ACAD,ACID,ANN,BASED,EMBO,ETTEN,H2O,LPAP,PAP,PHOSPHATE,RIA,SCHNEIDER,SCI,THEREFORE,THESE,VAN
177,899,BASED,DAILY,HERK,PTV
110,150,BACKGROUND,BOTH,CONCLUSION,LABEL,METHODS,REGRESSION,RESULTS,RISK,THEREFORE,TREATMENT
0042,017,0212,0485,2578A,634C,634CC,634CG,8805,936C,BACKGROUND,BONFERRONI,CONCLUSION,CTX,FORTY,GEHAN,HARDY,LABEL,MEIER,METHODS,OVERALL,PCR,PFS,PRISM,PSA,RESULTS,SNP,SNPS,VEGF
1982,8201,863,ALPHA,BACKGROUND,BETA,CIS,CONCLUSION,COX,HRS,LABEL,MC1R,MEN,METHODS,PREVENTION,RESULTS,SOLAR,TOCOPHEROL
001,054,114,120,169,180,2013,205,280,310,833,BACKGROUND,BASEL,LABEL,LOCALIZED,MATERIALS,METHODS,ORP,ORPS,OVERALL,RARP,RARPS,RESULTS
169,2013,253,BACKGROUND,BASED,CBCT,CONCLUSION,COPYRIGHT,CTV1,CTV2,CTV3,DVH,HERK,LABEL,LTD,METHODS,PTV,PUBLISHED,RESULTS
181,CHONDROSIA,FURTHER,HCA,HOWEVER,IC50,MMPS,PC3,PI3K,PRL,THESE
169,2013,ADT,CHANGES,CRPC,MOST,PCA,THERE,THESE
169,1996,2009,2013,400,631,8805,BETWEEN,COX,HOWEVER
1023,152,160,169,193,2013,563,8805,987,BMI,CONCLUSION,COPYRIGHT,HOWEVER,III,INC,LABEL,MATERIALS,METHODS,OBESE,OBJECTIVE,PSM,RESULTS,WORLD
DESPITE,DU145,EMF,IODOPHENYL,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,WST
CYP11B1,CYP11B2,CYP17,CYP19,DUAL,IC50,THESE,VIA
AKT,DATS,DIALLYL,PNT1A,THESE
100,125,2212,500,8804,ADHERENCE,AFRICAN,AMERICANS,CAUCASIAN,EACH,FUND,GLEASON,LOUISIANA,NORTH,PCAP,PROJECT,RESULTS,TNM,TOTAL,WCRF,WORLD
COMPOSITE,DU145,MTMP,PARP
DESPITE,FINALLY,INCRNAS,PCA,RNAS,THESE
001,185,2005,2008,8804,AMONG,BACKGROUND,CONCLUSION,DRE,GLEASON,LABEL,METHODS,NON,OBJECTIVE,PSA,PURPOSE,RESULTS,THEREFORE,THESE,TRUS,UNDER
0001,595,8201,COLLEGE,CONCLUSION,HOSPITALS,LABEL,LUPUS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SIRS,SLE,THERE,UNIVERSITY,WHEREAS
159,BACKGROUND,BIOMARKER,DECREASED,HOWEVER,LABEL,MALDI,METHODS,PCI,RESULTS,SISCAPA,THESE
169,200,2013,956,GMBH,ISOLATION,KGAA,PCR,SMPS,VCH,WILEY
AFTER,HOWEVER,MOST,PARACRINE,TARGETING
HOWEVER,SEVERAL,THESE
FCH,GLEASON,PET,PSA,T3B
CHOLINE,FCH,PET
0001,169,2013,239,COPYRIGHT,E26,ERG,FUNCTIONAL,INC,TFF3,TREFOIL
169,2013,5426,AACR,AKT,CONVERSELY,ECTOPIC,HOWEVER,PTEN,PTK6,RES,SH4
169,1990,2013,8805,BACKGROUND,COPYRIGHT,EAU,LABEL,MEDLINE,METHODS,OBJECTIVE,PCA,PSA,PUBLISHED,RESULTS,REVIEWS,SYNTHESIS,UROLOGY
045,100,162,169,1ST,200,2010,2011,2013,31ST,BACKGROUND,CLAVIEN,COMPARING,COPYRIGHT,DINDO,DOUGLAS,INDEX,JANUARY,LABEL,METHODS,OBJECTIVE,ONCOLOGIC,OUTCOME,POTENCY,PROCEDURE,PSM,PSMS,PUBLISHED,RARP,RECURRENCE,RESULTS,RETZIUS,ROBOT,SETTING,THERE,UROLOGY
169,2013,COPYRIGHT,DESPITE,IRELAND,LTD,ONCO,RNAS,WHILE
11KETODHT,11KETOT,11KT,11OH,11OHDHT,169,1NM,2013,945,ADRENAL,C19,COPYRIGHT,CRPC,DHEA,DHT,IRELAND,LNCAP,LTD
002,005,ABERRATION,AFTER,BLOOD,BOTH,FISH,IAEA,LABEL,MATERIALS,METHODS,OBJECTIVE,PAINT,PURPOSE,RESULTS,THESE,WHOLE
107,2009,2011,2012,2013,500,8805,AIDS,ANALYSING,ASSESSMENT,BACKGROUND,DISCUSSION,DUE,GUIDELINE,HOSPITALS,HOWEVER,HTA,IMPROVING,ITALIAN,LABEL,LACK,LIBRARY,METHODS,NHS,OBJECTIVE,OBJECTIVES,OUTCOME,PROGRAMME,REGARDING,RESULTS,SINCE,STUDIES,SYSTEMATIC,TAX,TECHNOLOGY,THERE,WHERE
CLEAR,CONCERNING,DOSES,HOWEVER,IMIT,IMPT,ISOE,LOOKING,MEAN,OAR,OARS,PTV,SIMILAR,VMAT
FOUR,INSTEAD,OAR,OARS,PTV,PTVS,SPS,V95
100,160,181,CELLS,CHINESE,CHO,CO2,OER,RAT,RBE
019,BACKGROUND,CONCLUSION,CURATED,EXPRESSION,FAIME,FUNCTIONAL,FURTHER,INDIVIDUAL,KEGG,LABEL,MICROARRAY,MODULES,MOLECULAR,MOTIVATION,RESULTS,VIA

8201,956,AFTER,FLIP,HSP27,TUNEL,WHILE
178,215,956,ADC,CMOS,EACH,FRA
CD99,EWING,FUNCTIONAL,GROSS,IMAGING,OWING,PCR,REVERSE
A11,E1A,E2F,E2F1,FURTHER,INCREASED,KIP1,MAGE,SELECTIVE,THESE
1104,119,1719,315,3524,530,5306,BACKGROUND,DATA,LABEL,METFORMIN,METHODS,ONTARIO,RESULTS,THERE
001,1998,2000,2009,879,BACKGROUND,DESPITE,LABEL,METHODS,NPCR,OVERALL,PHYSICIAN,QUALITY,REPORTING,RESULTS,SINCE,SOCIETY,SWEDISH,THESE,UROLOGICAL
177,EBRT,HDR,LDR,LITERATURE,SIDE
ASIAN,CHINA,RAPIDLY,THESE,WESTERN
239,SINCE,UGSM
BNNT,BNNTS,BORON,LNCAP
ADT,AR3,ASF,HOWEVER,SF2,THESE,UNDER
DICER,DISRUPTING,III,INK4A,KIP1,P16,P27,PTEN,RNASE
ANG,CRITICALLY,CRPC,HOWEVER,LABEL,MOST,RIBOSOMAL,THUS,UNLABELLED,UPON
169,2013,4PG,956,ADT,COPYRIGHT,DHEA,ESI,GNRH,LTD,PATHWAY,SID,SRM,TAPS
169,2013,257,600,746,COPYRIGHT,HODGKIN,HOWEVER,INC,NADPH,NOX5,PUBLISHED,UACC,USING
169,2013,888,COPYRIGHT,EMBEDDING,ESDS,GLEASON,GRAPH,HOWEVER,MACHINE,SUPPORT
169,2013,946,A549,CELASTROL,COPYRIGHT,DARBY,EMT,INC,MADIN,MDCK,MIGRATION,SNAIL,TGF,THESE,THUS
169,2013,COPYRIGHT,ERG,FISH,HOWEVER,INC,SMALL,THEREFORE,TMPRSS2,URINARY
1000,169,2010,2011,2013,BACKGROUND,CDSS,CDSSS,COPYRIGHT,CORRECT,EMR,GPS,IRELAND,JANUARY,JUNE,LABEL,LTD,METHODS,PROVIDING,PSA,RESULTS,THERE
169,2000,2011,2013,4209,7135,BACKGROUND,COPYRIGHT,DATA,EVERY,GLEASON,HOWEVER,LABEL,METHODS,NODAL,OBJECTIVE,OUTCOME,PCA,PLND,PUBLISHED,RESULTS,SETTING,UROLOGY,WHEREAS
169,2003,2009,2012,213,442,8804,AEU,COMPARING,COPYRIGHT,EPSTEIN,GLEASON,KLOTZ,LABEL,METHODS,OBJECTIVE,PSA,PSAD,PUBLISHED,RESULTS,T2A
169,2013,COPYRIGHT,ERG,INC,PCA,TMPRSS2
0052,020,150,169,2013,315,568,8805,BACKGROUND,CONCLUSION,COPYRIGHT,CRPC,DUE,HOWEVER,LABEL,LTD,METHODS,NEPRO,ODDS,RESULTS,THERE,TTP,WESTERN
1024,169,2013,CALYPSO,COPYRIGHT,FIRST,INC,LABEL,LILLIEFORS,MATERIALS,METHODS,OBJECTIVE,PEARSON,PURPOSE,REAL,RESULTS,THEN,THERE
000,0045,014,100,169,2013,COPYRIGHT,CTS,IGRT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THREE
004,100,164,169,192,2003,2009,2013,208,8805,COPYRIGHT,CROWN,CTV,D90,DOSE,ESTIMATES,FFBR,GLAND,HDR,INC,JULY,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,V100
2008,2010,BRAZILIAN,COMPOSITE,EPIC,INDEX,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PORTUGUESE,POST,RESULTS,VALIDATION
0001,005,2004,2007,558,571,652,BRAZILIAN,DRE,DRES,FULL,GLEASON,ILLITERATE,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,PCA,PSA,PSAS,PURPOSE,RESULTS,T2A
023,047,100,111,123,946,INTEGRINS,LABEL,METHODS,PSA,RECURRENCE,RESULTS,THERE,UNLABELLED
143,266,CONCLUSION,GLEASON,INCREASING,LABEL,MATERIALS,METHODS,OBJECTIVE,PSA,RESULTS,THERE
001,003,023,064,135,1991,2009,AFRICAN,AFTER,BACKGROUND,CAUCASIANS,CONCLUSION,COX,EQUAL,LABEL,MATERIALS,METHODS,PSA,RESULTS,UNI,VAS,WHILE
169,2013,BACKGROUND,COPYRIGHT,CRPC,LABEL,MEIER,METHODS,OBJECTIVE,OUTCOME,PSA,PUBLISHED,RESULTS,SETTING,SEVEN,SMALL,UROLOGY
0002,108,125,169,180,2003,2007,2013,20NG,392,615,ADT,ASTRO,BACKGROUND,BETWEEN,CONCLUSION,COPYRIGHT,EBRT,FORTY,GLEASON,GS7,IRELAND,KETTERING,LABEL,LTD,MATERIALS,METHODS,MSKCC,OBJECTIVE,OTHER,PHOENIX,POTENTIAL,PSA,PURPOSE,RESULTS,ROUTINE,SLOAN,T2B
100,169,2003,2005,2013,704,COPYRIGHT,EPIC,ESTIMATING,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PURPOSE,QOL,RESULTS
946,EMT,THESE
BRCA1,BRCA2,PARP
223,DRUG,FOOD
001,003,100,220,303CM,967,ASI,ASIAN,AVERAGE,BACKGROUND,CAU,CAUCASIAN,GLEASON,JAPAN,LABEL,MANN,METHODS,PCA,PROSTATES,RESULTS,RUSSIAN,THREE,TOKYO,WHITNEY
144,1649,1994,2007,BETWEEN,CHANGES,CHASE,COX,FCCC,FOX,GLEASON,HARRELL,HCI,NCCN
HOWEVER,WHICH
1992,2008,238,709,715,790,8805,HOWEVER,IPSS,LUTS,SCORE,SYMPTOM,THUS
145,167,169,2013,945,946,AKT,BAX,BCL,BIOLOGY,CAFFEIC,CAPE,DECREASED,DOC,ERK,LNCAP,MOLECULAR,PTX,SER,SERM,SUBSEQUENT,UNION
946,THESE
141,146B,194,BACKGROUND,BCR,CONCLUSION,COX,GLEASON,LABEL,METHODS,MICRORNAS,MIR,PCR,RECURRENCE,RESULTS,THREE
100,169,1990,2007,2013,2752,8805,ACTUARIAL,ADT,APRIL,CAD,COPYRIGHT,COX,EBRT,INC,LABEL,LOW,MATERIALS,METHODS,OBJECTIVE,OCTOBER,POST,PURPOSE,RESULTS,RV100,TREATMENT,USING
169,2013,294,ADDITIONAL,COPYRIGHT,GUIDELINE,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PHYSICIANS,PRINCIPLES,PSA,PUBLISHED,PURPOSE,RADIATION,RESULTS,SOCIETY,UROLOGICAL
169,2013,945,946,948,BACKGROUND,CCL2,CCR2,CCR4,CHEMOKINE,DU145,GENERAL,HOWEVER,LABEL,LNCAP,MCP,METHODS,PC3,PKC,RESULTS,SRC,TRANSWELL,TREATMENT
160,169,174,2013,COPYRIGHT,EDUCATION,GLEASON,INC,LABEL,MALAT,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THUS,TRANSWELL,UROLOGICAL
160,169,2013,ADT,COPYRIGHT,INC,XAF1,XIAP
169,2013,ALVAREZ,CELL,COPYRIGHT,INC,PAR,WOMEN
169,2013,COPYRIGHT,CTC,CTCS,EPITHELIAL,INC,USING
169,1C3,2013,945,946,COPYRIGHT,CRPC,CYP,DHT,HSD5,HTS,INHIBITION,LTD,ORAL,TYPE
115,169,2006,2012,2013,COPYRIGHT,INC,THESE,TRUS
177,ECLIPSE,PTV,VARIOUS,VMAT
169,177,2013,348,360,451,8201,8804,AIM,AMONG,BACKGROUND,FURTHER,INVENTORY,LABEL,MAIN,MEN,METHODS,OBJECTIVE,OUTCOME,PROPORTION,RESULTS,SHIM,SOCIETY,SPAIN
169,2013,BIOMETRIC,SOCIETY
946,CILIA,HOWEVER,INCREASED,NUCLEAR,PIN,PRIMARY,THEREFORE,THESE,WNT
BACKGROUND,H2S,LABEL,METHODS,NEITHER,PCA,PSA,RESULTS
WACHTEL
1393,156,3PUFA,834,969,BACKGROUND,CASE,LABEL,METHODS,PREVENTION,RESULTS,STUDIES,TRIAL,VITAMIN
000,0001,0042,169,2013,503,5Q21,6Q15,8201,BACKGROUND,DATA,ERG,FURTHER,HOWEVER,INC,KAZAL,LABEL,METHODS,PTEN,RESULTS,THESE,WILEY

227,945,AFRICAN,AMERICANS,CAUCASIANS,CIS,GSTP1,HOWEVER,ILE,ILE105VAL,ILE158VAL,MEDLINE,ORS,PCA,SCIENCE,VAL,WEB
1076,169,2000,2006,2009,2013,3460,850,BACKGROUND,END,FEWER,LABEL,METHODS,RATES,RECEIPT,RESULTS,SEER,SOCIETY
169,2013,AACR,CASTRATION,CDK,CDK4,CRPC,F876L,FINALLY,FUNCTIONAL,LABEL,LNCAP,MDV3100,UNLABELLED
100,108,160,1992,2007,2011,221,2395,3754,598,8201,BACKGROUND,CONCLUSION,IORT,LABEL,MATERIALS,METHODS,RADIATION,RESULTS,SOCIETY,THERAPY
AD5,ONCOLYTIC,TRAMP
945,COMPLEX,THUS
1938,1987,2877,667,8197,9942,BMJ,CLINICIANS,GENERAL,GPRD,GROUP,IQR,LABEL,LIMITED,METHODS,OBJECTIVE,PMR,PUBLISHED,PUBLISHING,RESULTS,THERE
0001,004,169,177,1995,2008,2013,295,827,8805,943,APRIL,COPYRIGHT,F20,F21,F23,F25,GENERALLY,ICD,INC,LABEL,MARCH,METHODS,OBJECTIVE,PHYSICIANS,PLACE,PRESS,RESULTS
IVGGWECEK,L132I,MRM,OTHER,PSA,SNP,SVILLGR,THUS
DUTCH,GIVEN,LRP,RARP,ROBOTIC,RRP
169,2013,HOWEVER,ROBOT,THEREFORE,UROLOGICAL
001,100,160,169,2013,AIM,BRITAIN,COLORECTAL,CONCLUSION,CROHN,DATA,DEFINITIVE,DISEASE,FEW,FIFTY,GREAT,IRELAND,LABEL,METHODS,MOST,OBJECTIVE,PERMANENT,PRIOR,RADIATION,RESULTS,SUCCESSFUL
AFTER,APC,BESIDES,C30,CD3,CD4,CD8,CHINA,CHINESE,CONCLUSION,DIAGNOSIS,GUIDELINES,LABEL,METHODS,OBJECTIVE,PSA,PSS,QLQ,QOL,RESULTS,TCELL,TOTALLY,TREATMENT,UROLOGICAL,WESTERN,YJQR
AKT,DHA,DU145,FURTHER,LC3B,NAC,PC3,RESULTS,ROS,SIMILARLY
ADIS,BAX,BECAUSE,HOWEVER,LAPC4,LNCAP,THUS
946,BMP,BMP4,BMPS,BONE,CAFS,MMP,MMPS,TGF,THESE,TREATMENT
0015,2888,291,BACKGROUND,CELLSEARCH,CTC,CTCS,EPCAM,EPITHELIAL,HOWEVER,LABEL,MCA,METHODS,NSCLC,RESULTS,SCLC
174,AMONG,ARG,BACKGROUND,CRYAB,DISCUSSION,DLX1,EXPRESSION,GIVEN,LABEL,METHODS,OVERALL,PCA,PCA3,PCR,RESULTS,ROC,RWPE,SDPR,SEVERAL,SIMILARLY
1064,169,2013,8322,8323,956,COPYRIGHT,DMSO,GMBH,KGAA,MHZ,RAMAN,SRL,SRS,USING,VCH,WILEY
169,2013,ATTRITION,COPYRIGHT,JOHN,LABEL,LOW,LTD,METHODS,OBJECTIVE,RESULTS,SONS,WILEY
177,1997,2010,8201,8805,ADHERENCE,AMONG,BACKGROUND,CONCLUSION,DAILY,IDENTIFIER,IMPORTANCE,JULY,LABEL,MAIN,MAY,METHODS,OBJECTIVE,OVERALL,PSA,RANDOMIZED,RELEVANCE,RESULTS,SETTING,SOY,SUPPLEMENT,TRIAL
005,007,2002,2011,239,AFTER,BACKGROUND,CONCLUSION,FRANKEL,JUNE,LABEL,METASTATIC,METHODS,OBJECTIVE,PATIENT,RESULTS,YOUNGER
945,946,CAFS,CSCS,EMT,HIF,MOST,NEXT,PCA,SHRNA,SIMILAR,TAKEN,THUS
DNMTS,EOC,ETS,HDACS,MAGEA11,SP1,THUS,TSS
169,2013,BACKGROUND,BASEL,CCR2,CONCLUSION,COPYRIGHT,CXCR4,EFFECTS,FAK,GTPASES,LABEL,METHODS,MOST,PC3,RAB,SIGNALING,THESE
945,BMP5,CD34,EVEN,FGFR2,JUN,K14,LRIG,MYC,NANOG,NANOGP8
002,005,8804,END,HILL,HOWEVER,IARC,JAPAN,REGARDLESS,RESULTS,SEER,THESE,TP53,WESTERN,WORLDWIDE
0001,2ML,ANY,BACKGROUND,LABEL,METHODS,PPNB,RESULTS,THERE,TOPICAL
039,1599,160,169,2013,3198,805,AUC,AUCS,BACKGROUND,CONCLUSION,COPYRIGHT,LABEL,LNMS,LNS,LTD,METHODS,PCA,RESULTS,ROC
169,177,2013,BASEL,COMPARING,CONCLUSION,COPYRIGHT,FOUR,LABEL,MATERIALS,METHODS,OBJECTIVE,PTE,RESULTS,THUS,TRUS
0001,165,169,2013,508,527,947,AACR,CONCLUSION,COX,EGF,ERK,ERK1,ERK2,HOWEVER,INVERSELY,LABEL,MAPK,MEK,METHODS,OBJECTIVE,PCR,PD98059,PURPOSE,RAF,RESULTS,RSK,THEREFORE,THESE,U0126,WESTERN
011,169,2013,946,AACR,CELL,CLUSTERIN,CRPC,EGR,IGF,KNOCKDOWN,LABEL,LOSS,METHODS,MTT,OBJECTIVE,OGX,PCR,PURPOSE,RESULTS,UNTIL,WESTERN,WNT
149,177,178,185,239,8201,8309,AUR,BACKGROUND,D90,GRAYS,LABEL,MEAN,METHODS,PVOL,RESULTS,TRUS
001,121,2001,2009,250,BACKGROUND,C30,COX,DEC,EORTC,EVERY,JAN,LABEL,METHODS,QLQ,QOL,RESULTS,SEVERAL
200,ASSISTANT,CHIEF,COUNCIL,ENDOCRINE,ESTONIA,FELLOWSHIP,GALUKANDE,GUEST,INSTITUTE,INTAS,LABORATORY,LEV,MEDICAL,METABOLISM,NATASHA,PETERSBURG,PHD,RUSSIAN,SOCIETY,TARTU,UICC,UNIVERSITY,USA
946,EGFR,HIP1,HIP1R,HPM,HUNTINGTIN,PDGF,RTK,RTKS,TEL,THESE,Y152
169,2013,ACADEMY,ANDROLOGY,BOTH,CANDIDATE,CD13,CD26,FALL,ORM1,PAP,PSA,SOCIETY,ZAG
169,2013,BACKGROUND,COPYRIGHT,DU145,DUPRO,INC,LABEL,LAPC4,LNCAP,MATERIALS,METHODS,NKX3,PCR,RESULTS,RNAA,THESE,TREATMENT,VEGFC,WILEY

169,2013,BACKGROUND,BPH,CD24,CD49F,COPYRIGHT,INC,LABEL,METHODS,PCA,RESULTS,SUBSETS,TROP,USING,WESTERN,WILEY
0002,CD4,CD8,COHORTS,CSF,FOUR,NGEP,OVERALL,PSA,THERE
160,177,1990,2012,ACROMEGALY,AGE,IGF,MALIGNANCY,RENAL,THEREFORE,THYROID
104,160,8201,CONCLUSION,CT1,CT2,DISTANCES,IMAGING,IMRT,INTENSITY,LABEL,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS,TREATMENT,V50,V60,V70,V75
947,948,BECAUSE,GMP,NBP,PERIPHERAL
120,712,BACKGROUND,CENTERS,CONTROL,DISEASE,LABEL,METHODS,MOST,PREVENTION,PSA,RESULTS,WEB
118,2007,2008,AFTER,AUTHORS,CALIFORNIA,CONTROL,DISEASE,LABEL,METHODS,OBJECTIVE,PREVENTION,PSA,PURPOSE,RESULTS,WEB
2010,427,ABSENCE,INTERVIEW,LABEL,METHODS,MOST,OBJECTIVE,PSA,PURPOSE,RESULTS,SCREENING
160,CSIO,DSIO,FOUR,IMPT,PLANS,SIO,THUS,TPS
0001,015,052,177,8805,ALSO,ARSB,BACKGROUND,C4S,EGFR,FORTY,GLEASON,LABEL,METHODS,PSA,RESULTS,TMA,TMAS,TNM
BLAND,CBCT,COHEN,EPID,LOA
100,D10,DVHO,GRO,HDR,HIPO,PTV,SWIFT,V100
002,006,037,177,6GY,CONCURRENT,DOSES,IMRT,OAR,PTV,PTV1,PTV2,RA1,RA2,SLIDING,TEN,V30,VMAT,VOLUMETRIC
169,2013,ADT,BMD,COPYRIGHT,FORTY,FURTHER,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,RESULTS
6MV,CRT,IMRT,REGARDING,RISPC,THERE,UNTIL,WHETHER
10MV,120,126,136,2012,8201,8482,8804,ACCORDING,ACUTE,ARC,BACKGROUND,CTCAE,EARLY,EPIC,FFF,FLATTENING,FREE,GLEASON,INCLUSION,IPSS,LABEL,LIFE,METHODS,MODULATED,NCCN,NEO,PSA,QUALITY,RESULTS,SBRT,THERAPY,TOXICITIES,TURP,VMAT,VOLUMETRIC
0001,114,277,575,BACKGROUND,COX,HOWEVER,LABEL,MEIER,METHODS,PCSM,PSA,PSADT,RESULTS,SRT,SUFFICIENT
001,002,009,035,100,150,200,2006,2011,BETWEEN,EBL,LABEL,METHODS,OBJECTIVE,PSM,PURPOSE,RARP,RESULTS
169,2013,507,BECAUSE,DIFFERENT,FIVE,JOHN,LTD,SONS,WILEY
169,195,1999,2012,2013,208,CHINA,CHINESE,ENGLISH,HONG,INCLUSION,JANUARY,JOHN,KONG,LTD,MEDLINE,MOST,SCIENCE,SONS,WEB,WEEK,WILEY
DRUG,MICRORNAS
169,2013,AACR,AXL,BCL,CONVERSELY,EACH,HOWEVER,MERTK,TAM,THESE,TYRO3
001,2005,2010,8805,AGE,BACKGROUND,DISCUSSION,EFFORTS,GIVEN,INTERVIEW,LABEL,METHODS,PSA,RESULTS,SDM
152,215,444,776,BACKGROUND,BECAUSE,CAUCASIAN,CERTAIN,FDR,FIVE,LABEL,METHODS,RESULTS,RXRB,SNP,THESE,VDR,VITAMIN
0032,0070,010,019,060,130,155,270,496,819,ASP336ASN,BACKGROUND,BOTH,BTNL2,CANDIDATE,GLY454CYS,HOWEVER,HPC,LABEL,METHODS,RARE,RESULTS,WES
AMONG,CHALLENGES,CRPC,EPOTHILONE,PGP,THUS,VINCA
2004,2011,296,872,8804,AGE,AMONG,EACH,FEW,LABEL,METHODS,MUL,NVB,OBJECTIVE,ODDS,PURPOSE,RESULTS

13TH,2013,APRIL,BERZOFSKY,BIOLOGY,BOONS,CCR,CHAIR,CHIEF,COMPLEX,DEPARTMENT,GEERT,GEORGIA,IMMUNOLOGY,INSTITUTE,JAN,JAY,JEFFREY,LABORATORY,NCI,PARK,PEPTIDE,ROSWELL,THEN,UNIVERSITY,VACCINE,WASHINGTON,WORLD
169,2013,945,946,AHR,ARNT,AUTHORS,COPYRIGHT,HIF,HYPOXIA,INC,LPA,PUBLISHED,SINCE,THESE,VEGF
169,2013,600,956,ADT,COPYRIGHT,DISCOMFORT,FIFTEEN,LTD,PSA,VACCINE
0001,114,145,169,2000,2011,2013,218,279,336,AUS,COPYRIGHT,EDUCATION,INC,JANUARY,LABEL,MATERIALS,MEN,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
169,2013,BIOMARKERS,CHALLENGE,GENERALLY,ISSUE,MALDI,PROTEOMIC,SPECIAL
001,006,160,169,2008,2010,2013,ADVANCE,ATUS,CONCLUSION,COPYRIGHT,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,OVERALL,RESULTS,THUS,XRT
154,160,169,178,2013,ACCORDING,BCR,CONCLUSION,COPYRIGHT,FURTHER,III,INC,LABEL,METHODS,OBJECTIVE,OVERALL,PATIENT,PHOENIX,PRIOR,PSA,RESULTS,STUTTGART,THREE,UNIVERSITY
169,2013,CONVERSELY,COPYRIGHT,DTX,EPIGENETIC,FEDERATION,HDAC2,MTA1,NR4A1,NURD,PCA,PUBLISHED,SOCIETIES,THESE
1226,169,2013,AIMS,COLLEGE,COPYRIGHT,ESTIMATING,LABEL,LARGE,LTD,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,RESULTS,ROYAL
169,2013,390,8805,AFRICAN,AMERICANS,BACKGROUND,CAUCASIAN,CNS,CONCLUSION,COPYRIGHT,CTC,CTCS,HOWEVER,INC,LABEL,METHODS,PFS,PI3,PI3K,PSA,PTEN,RESULTS,TORC1,TOXICITIES
0001,160,169,2002,2007,2013,590,BACKGROUND,CONCLUSION,COPYRIGHT,ECE,INC,LABEL,METHODS,MRI,RESULTS,ROC,SPS,TESLA
169,2013,COPYRIGHT,DERIVED,GIVEN,HOWEVER,HYDN,MOLECULAR,POLG,POLL,SNP,SNPS
000,100,113,151,169,2013,220,462,487PY,982PY,AMONG,BACKGROUND,COPYRIGHT,COX,HRS,LABEL,LTD,METHODS,NPC,NPCS,RESULTS,USING
169,2013,945,946,954,COPYRIGHT,INC,ITGA7,PATHOLOGY,PUBLISHED,SOCIETY,THESE,TIMP3
169,2013,COPYRIGHT,CSCS,CTC,CTCS,EMT,EVEN,IRELAND,LTD
0001,001,006,169,177,2010,2013,ACT,BOTH,COPYRIGHT,INC,INSURANCE,LABEL,MATERIALS,MEAN,METHODS,MRI,OBJECTIVE,OBJECTIVES,OCTOBER,PUBLISHED,RATIONALE,RESULTS,ROI,SNR,SNRS,THEREFORE
120,160,169,177,2013,AUR,BPH,BPHS,COPYRIGHT,FIFTY,INC,LABEL,MATERIALS,METHODS,NIC,NICS,OBJECTIVE,OBJECTIVES,PCA,PUBLISHED,RATIONALE,RESULTS
100,169,191,2013,3DCRT,649,810,8805,ADT,COMPLIANCE,COPYRIGHT,EBRT,HOWEVER,IMRT,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PURPOSE,RESULTS,WHILE
160,169,2013,AFTER,BACKGROUND,CONCLUSION,COPYRIGHT,LABEL,METHODS,PDE5I,RESULTS,SAS,THERE,UNIMPAIRED
169,2012,2013,BACKGROUND,CONCLUSION,COPYRIGHT,JANUARY,LABEL,MEDLINE,METHODS,RELATIONS,RESULTS,SAS,THERE
002,1000,11Q13,1318,169,2013,215,2716,908,AMONG,BACKGROUND,COPYRIGHT,CORRELATED,EMSY,FINNISH,GENOMES,HAPLOTYPES,LABEL,LTD,METHODS,PRCA,PREVIOUSLY,PROJECT,RESULTS,SNPS,THESE
001,169,177,2013,AFTER,BACKGROUND,COPYRIGHT,D35,IMRT,IRELAND,LABEL,LTD,MATERIALS,METHODS,NEXT,OBJECTIVE,PURPOSE,RESULTS,THESE
001,037,113,160,169,176,177,2003,2010,2013,215,342,465,582,753,804,8804,8805,956,APRIL,BCR,CONCLUSION,COPYRIGHT,COX,DATA,FIVE,GLEASON,INC,LABEL,MATERIALS,MEAN,METHODS,OBJECTIVE,PATHOLOGIC,PSA,RESULTS,SRM,T2A,T2B,T2C
A549,BACKGROUND,FURTHER,III,LABEL,PC3,RESULTS,THESE,UPON
001,1998,2007,817,8211,8805,CONCLUSION,HOWEVER,LABEL,LOW,METHODS,OBJECTIVE,RESULTS,SEER,USING
169,2013,COPYRIGHT,HIGH,JOHN,LTD,MRS,NMR,SONS,WILEY
158,160,174,BAP,BONE,BSI,COMPARISON,CONCLUSION,CTP,DUNNETT,EXINI,GROUP,HOWEVER,INDEX,JAPAN,LABEL,LTD,METHODS,OBJECTIVE,PSA,RESULTS,SCAN,TOKYO,TRACP
170,231,956,AFRICAN,BLACK,HOWEVER,IC50,MCF,MDA,MTT,MURASHIGE,NEURO,SKOOG,VERO
290,8201,956,BETA,CHOU,DIFFERENT,DRUG,E162,FOOD,FURTHER,IC50,IC75,IC90,MCF,PACA,SINCE,TALALAY,THESE,UNION
110,2008,2011,750,BARCELONA,COPYRIGHT,DATA,GLEASON,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PSA,RESULTS,SEGURETAT,THERE,TREBALL,UROLOGY
DLBCL,HODGKIN,MRI,NHL,NON,PSA,SINCE
177,65309,BXO,EIGHT
001,169,17A,2013,947,BLADDER,CD4,COPYRIGHT,FURTHER,INC,PBMCS,PUBLISHED,ROR,SOCIETY,TH17,THEREFORE,THESE
169,2013,COLLEGE,COPYRIGHT,LTD,MRI,PUBLISHED,ROYAL
169,2013,AUTHORS,BJU,PDE5I
015,016,017,105,130,169,180,2013,500,8201,8805,AUTHORS,BJU,CATHETERS,CLAVIEN,IIEF,INDEX,INTRA,LABEL,METHODS,OBJECTIVE,PSA,RESULTS,STLRP
169,2012,2013,ADT,APRIL,BJU,CRPC,ENGLISH,EXPLORE,HOWEVER,MEDICAL,MESH,PSA,PSADT,SUBJECT,THERE,USA,WHILE
AAA,ALSO,LABEL,METHODS,NTCP,NTCPAAA,NTCPPBC,OBJECTIVE,PBC,PURPOSE,RESULTS,STUDENT
169,2009,2011,2013,BETWEEN,BJU,CONCLUSION,DVD,III,LABEL,MAY,METHODS,OBJECTIVE,PRIMARY,RESULTS,SABRE,SCREENING,THERE
001,002,038,1026,158,169,2013,247,366,464,489,549,600,733,8804,961,AUC,BJU,GLEASON,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PCA,PHI,PRO,PROMETHEUS,PSA,RESULTS
004,169,2003,2010,2013,8201,BJU,DATA,FUNCTIONAL,GLEASON,LABEL,MARCH,METHODS,OBJECTIVE,OBJECTIVES,PCA,PHOENIX,PSA,RESULTS,SFC,STC
246,BACKGROUND,GRADE,LABEL,MANAGER,MEDLINE,META,METHODS,NORRK,OVID,PSA,RANDOMIZED,RESULTS
HOWEVER,ILC,THESE
125,8805,BACKGROUND,BIOMARKER,EIGHT,EXTENSIVE,GLEASON,IMAP,LABEL,PCA,PRE,PRINCIPAL,RESTRICTED,RESULTS,SEMINAL,SUPPORT
1987,2001,213,545,639,CONCLUSION,EXPRESSION,GLEASON,LABEL,MAYO,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS
008,051,2003,2012,284,8202,848,8804,8805,AGE,ALSO,AREA,AUC,AUCS,BACKGROUND,BETWEEN,CHINA,CHINESE,CONCLUSION,DIGITAL,DRE,GLEASON,HOWEVER,HUASHAN,LABEL,MEN,METHODS,PCA,PSA,PSAD,RESULTS,ROCS,SCORE,SERUM,USA
155,211,215,22Q13,7169,8P11,945,BACKGROUND,INDIVIDUAL,KARMA,LABEL,LIBRO,METHODS,MKL1,RESULTS,SNPS,SWEDISH
1992,2000,2005,2006,DATA,END,LUNG,OTHER,RESULTS
169,2013,945,956,ATF3,CHOP,GADD153,HELA,HNSCC,ISR,MCF,PC3,SALUBRINAL,SCC,SCC25,SCC9,TAKEN,UICC
169,2013,BECAUSE,COPYRIGHT,JOHN,LTD,SONS,USING,WILEY
GENISTEIN
328,CNTO,HOWEVER,LLL12,STAT3,STEM
169,2013,BACKGROUND,CELL,COPYRIGHT,INC,LABEL,METHODS,MTT,PCR,PROTEIN,REAL,RESULTS,SARDH,WESTERN,WHILE,WILEY
169,178,2013,331,AUROC,BACKGROUND,COPYRIGHT,CURRENT,GLEASON,INC,LABEL,METHODS,NAD,RESULTS,THESE,WILEY
001,085,169,2001,2012,2013,527,558,8201,8805,AAS,AFRICAN,ALTOGETHER,AMONG,BACKGROUND,CONCLUSION,COPYRIGHT,GLEASON,HEAVY,INC,LABEL,METHODS,NCCN,PCA,RESULTS,SMOKING,VALIDATED,WILEY
116,1995,2000,695,8804,8805,AUSTRALIA,BCR,GLEASON,LABEL,MARRIAGES,MEN,METHODS,OBJECTIVE,OBJECTIVES,PCSM,POISSON,RADICAL,RESULTS,RPS,VICTORIAN
125,130,2005,2011,8201,CONCLUSION,DOSE,GRADE,LABEL,LOCAL,METHODS,OBJECTIVE,PDR,PET,PSA,PURPOSE,RESULTS,SALVAGE,V100
169,2000,2010,2013,3115,AUC,BACKGROUND,COPYRIGHT,HOWEVER,IRELAND,LABEL,LNI,LTD,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,ROACH,THEREFORE
DWI,KNOWLEDGE,MOLECULAR,MRI,MRL,PET,THEREFORE,THESE
22RV1,AKT,CALORIE,EUTHANASIA,GANITUMAB,IGF,RESULTS
2003,2012,CURRENT,DATA,EVALUATION,HOWEVER,JANUARY,KNOWLEDGE,LABEL,LITERATURE,MARCH,METHODS,NURSING,OBJECTIVE,PROBLEM,SINCE
001,100,236,8201,AFTER,FIVE,GLEASON,LABEL,MEIER,METHODS,MFS,OBJECTIVE,OBJECTIVES,PSADT,RESULTS,SRT,THEREFORE
IMRT,IQM,LABEL,METHODS,MLC,OBJECTIVE,PURPOSE,RESULTS
192,215,BRACHYVIEW,CARLO,HDR,HIGH,LABEL,METHODS,MONTE,OBJECTIVE,PURPOSE,RESULTS,SEVEN,SIMULATION
100,8776,945,946,D100,D95,D97,HOWEVER,ITV1,ITV2,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,V100,V95
8725,BEAMS,EXAMPLE,FUSIONARC,IMRT,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,VMAT,WHILE
100,EACH,IMRT,LABEL,METHODS,MLC,OBJECTIVE,PLAN,PURPOSE,RESULTS,THESE
177,244,376,817,BECAUSE,EPI,FMS,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SINCE,USER
AUSTRALIA,GROUP,IMRT,LABEL,METHODS,OBJECTIVE,PASS,PURPOSE,RADIATION,RESULTS,STRENGTHS,TRANS,TRIAL,ZEALAND
012,036,177,60GY,ESPECIALLY,EXCLUDING,FURTHER,IMRT,IMRTCUT,LABEL,LARGE,METHODS,OAR,OARS,OBJECTIVE,PLANS,PTV,PURPOSE,RESULTS,V60
BMD
119,2013,3359,BACKGROUND,CONCLUSION,GOVERNMENT,HOPKINS,JOHNS,LABEL,LESIONS,METHODS,MRI,PCA,PUBLISHED,RESULTS,THESE,THREE,ULTRASOUND,USA
0001,169,2013,563,575,8201,BACKGROUND,CONCLUSION,FINE,GLEASON,GP5,GRAYS,GS8,LABEL,METHODS,PCSM,PRIMARY,RESULTS,SOCIETY,SRT
124,AMONG,BKV,BPH,FURTHER,JCV,PCA,PCR
160,5223,5232,8805,CLIN,CRPC,DESPITE,LABEL,METHODS,OBJECTIVE,PSA,PURPOSE,RES,RESULTS,SCHER,SECONDARY,TOXICITIES
CTR,EXPRESSION,HIGH,HOWEVER,PCS
001,159,177,2008,2012,314,473,8217,AIM,CONCLUSION,GROUP,LABEL,MANN,MEAN,METHODS,OBJECTIVE,PEARSON,PSA,RESULTS,TRUS,VAS,WHITNEY
174,2011,2012,BACKGROUND,DEPARTMENT,DRE,LABEL,METHODS,ORAL,PBX,PCA,PSA,RESULTS,SEPTEMBER,SPBX,THREE
117,147,2004,2007,650,AFTER,CRUDE,DRE,HGPIN,LABEL,MATERIALS,METHODS,OBJECTIVE,PCA,PSA,PURPOSE,RESULTS,TRUS,WIDESPREAD
121,174,647,ALEXA,DYNAMIC,FLUOR,MICROMIXER,MRI,SUCCESSFUL
102,108,125,437,521,589,623,8201,848,AARP,AMONG,BACKGROUND,COLORECTAL,CONCLUSION,COX,DATA,DIET,INSTITUTES,LABEL,LUNG,METHODS,OVARIAN,RESULTS,RISK,SCREENING,TRIAL,WHILE
001,169,184,186,2003,2012,2014,211,592,609,639,663,8805,940,BMI,CONFIDENCE,COPYRIGHT,HOWEVER,HTN,INC,JULY,LABEL,MARCH,MATERIALS,METABOLIC,METHODS,METS,OBJECTIVE,OBJECTIVES,ODDS,RALP,RATIO,RESULTS,THERE
169,2013,COPYRIGHT,DESCRIBING,HISTORICAL,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE,THEREFORE
001,009,169,2013,276,COPYRIGHT,COX,EDUCATION,ENTRY,EXPECTANT,FURTHER,GLEASON,INC,LABEL,MANAGEMENT,MATERIALS,METHODS,NORTH,OBJECTIVE,OLDER,POST,PUBLISHED,PURPOSE,REDUCTION,RESULTS,T1C,T2A,TIME,UROLOGICAL
001,018,169,2013,338,595,COPYRIGHT,COX,EDUCATION,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THOSE,THUS,UROLOGICAL
396,ANOVA,BM22,BONE,EORTC,FURTHER,HRQOL,ITEMS,KPS,LABEL,LIFE,METASTASES,METHODS,OBJECTIVE,QLQ,QUALITY,RESULTS,THROUGH,TREATMENT
169,174,2013,500,ADDITIONAL,AUTHORS,BJU,COMMITTEE,CONCLUSION,FURTHER,HIFU,INDEX,LABEL,METHODS,MRI,NON,OBJECTIVE,RESULTS,SONABLATE
8594,CTV,DESIRED,DVH,EACH,EUD,IGRT,IMRT,NTCP,PTV,SIXTY,USING
100,2001,2010,819,AMICO,BETWEEN,BOUNDARIES,CONCLUSION,GLEASON,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PSA,PURPOSE,RADICAL,RESULTS
ADC,CONCLUSION,DWI,GLEASON,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,T2WI

2013,APRIL,ENDOCRINE,IGF2,LUBIK,MOLECULAR,RELATED
EPIGENETIC,S100
001,008,009,029,037,169,2013,206,8201,8805,BACKGROUND,CRP,GLEASON,LABEL,METHODS,PSA,RESULTS,SOCIETY,THESE
926,CONCLUSION,GANODERMA,GE132,HOWEVER,LABEL,MCF7,METHODS,MSC,NATURAL,OBJECTIVE,PC3,PURPOSE,RESULTS,ROYAL,SW480
945,HOWEVER,HSP70,HSP90,SGTA,SMALL,STEROID,THERE
169,2013,945,ATP,BACKGROUND,CHRONIC,COPYRIGHT,CYTOCHROME,GLUT1,GLYCOLYTIC,HOWEVER,INC,LABEL,LNCAP,METHODS,PGC,PRE,RESULTS,RWPE,TNF,WARBURG,WILEY
172,175,177,2004,8805,AMONG,BACKGROUND,BAUS,BCRFS,CONCLUSION,CSS,EIGHT,ENDPOINTS,GLEASON,HOWEVER,LABEL,LHRH,MATERIALS,METHODS,OVERALL,RARP,RECORDS,RESULTS,THESE
004,012,026,046,080,113,1143,177,226,423,646,655,BSM,BSMS,CASES,LABEL,METHODS,MRI,OBJECTIVE,PML,PROTRUSION,PURPOSE,RALP,RESULTS,THUS
1303,160,212,331,603,660,738,ALTERED,CONCLUSION,EXPRESSION,HOWEVER,LABEL,LSCC,LSCCS,METHODS,OBJECTIVE,PURPOSE,RESULTS
150,160,2010,2012,BACKGROUND,CAM,DISCUSSION,FOUR,GCP,GERMANY,GGPO,GUIDELINE,HODGKIN,LABEL,LOE,METHODS,MOST,OFTEN,PROGRAM,REGARDING,RESULTS,THERE,THUS
014,018,019,041,095,8209,AFTER,DPD,FIFTY,GROUP,OPRT,PSA,SOA,THERE,TTP
001,007,046,431,675,677,853,876,COCHRAN,GSTM1,GSTS,GSTT,GSTT1,MEDICAL,OVERALL,THERE,WANFANG
001,005,007,177,793,961,ANATOMICAL,CONCLUSION,DESPITE,DIXON,IMAGE,LABEL,MBQ,METHODS,OBJECTIVE,OSEM,OVERALL,PET,PURPOSE,RESULTS,SUVS,THERE,THESE
1CH3,435,A549,CH2,CL2,DU145,MCF,MDA,MTS,NMR,SEVERAL
146,327,BASED,BECAUSE,CHINA,TAX,THUS
223,LABEL,MET,OBJECTIVE,PURPOSE,RESULTS,SUMMARY
GNRH
100,169,2013,211H,253J,5637,786,956,A549,ACHN,BASEL,COPYRIGHT,DU145,H2052,H2452,H28,HEPG2,HUH,LNCAP,MKN,MSTO,NCI,RCC4,SBC,T24,VHL
ERG,ETS,ETV1,PTEN,SIMILARLY,STUDIES
169,2013,947,AACR,ARF,INK4A,LABEL,MEFS,REG,THUS,UNLABELLED
000,0001,301,398,797,BRIEF,CONCLUSION,COU,COX,EASTERN,FORM,GROUP,III,INVENTORY,LABEL,METHODS,OBJECTIVE,PAIN,PURPOSE,RESULTS,SHORT,TREATMENT
AFTER,FCH,GLEASON,PET,PSA,SIX,STAGING
CHANGES,CHIP,CTC,CTCS,FDA,INC,NANOVELCRO,PDMS,PUBLISHED,SINW,VALIDATED,WHILE
001,048,101,112,169,177,184,193,2013,205,220,8804,ALBUMIN,AT101,BACKGROUND,CONCLUSION,COPYRIGHT,COX,CRP,GLASGOW,INC,LABEL,METHODS,NLR,PROGNOSTIC,RESULTS,SCORE
001,10TH,2002,2008,2009,9096,90TH,BACKGROUND,C61,CONCLUSION,ENGLAND,ICD,III,IRELAND,IRISH,JANUARY,LABEL,LOS,METHODS,PATIENT,RADICAL,RESULTS,RPS,THESE,THOSE
169,2013,COPYRIGHT,HOWEVER,IRELAND,LTD
145,169,2013,AIB,COMBINING,COPYRIGHT,DOCKING,ETHYL,GHSR,LTD,THEIR,TRP
AKT,BACKGROUND,COLON,CYQUANT,ERK,FINALLY,FURTHER,HOWEVER,INHIBITION,LABEL,MAP1D,MEK,METHODS,PDF,PI3K,PROTEIN,RESULTS
A10,APT,EPI,EPIRUBICIN,FLOW,LNCAP,PC3,PEG,PSMA
169,183,2013,208,564,802,CONCLUSION,DISCUSSION,EMEA,FDA,FIXED,HEART,JOHN,KNOWN,LABEL,LTD,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,RCT,RCTS,RESULTS,SONS,WHAT,WILEY
CONNECTION,LDL,PSA,THERE,TNF
1000,172,313,ANN,ARTIFICIAL,BACKGROUND,FUZZY,GLEASON,INFERENCE,LABEL,METHODS,NEURO,PSA,RESULTS,SYSTEMS
091,177,1998,2009,220,304,411,ADVERSE,AERS,AKI,BPS,CONCLUSION,DRUG,FDA,FOOD,FOUR,JANUARY,JUNE,LABEL,LITERATURE,METHODS,OBJECTIVE,PURPOSE,REPORTING,RESULTS,ZOL
ADT,ADTS,CASTRATION,CRPC,CRPCS,PCA,PCDH,WHILE
ERG,EST14,ETS,ETV1,ETV4,ETV5,FINALLY,FISH,FLI1,HERVK17,HMG,PCA,PCAS,SLC45A3,TMPRSS2,UBTF
0980,490,980,DCE,GDC,GNE,MICRO,MRI,PI3K,VEGF,VSI
0005,215,301,ADDITIONAL,BCA,BONFERRONI,COLORECTAL,HODGKIN,LUNG,NHL,OVARIAN,SCREENING,TRIAL
1463,2002,2011,BACKGROUND,LABEL,METHODS,POOR,RESULTS,SCIENCE,THERE,WEB
169,2013,231,ADP,AMPK,CONVERSELY,COPYRIGHT,ERK,H460,IIA,JOHN,KBM,LC3,LTD,MDA,NCI,OVERALL,PD98059,RAF,RSK,S6K,SALVIAE,SONS,TAN,THUS,U266,WILEY
169,2013,22RV1,945,BACKGROUND,CELLS,COPYRIGHT,DHT,DIFFERENT,DISRUPTION,H874Y,INC,LABEL,LAPC4,LNCAP,METHODS,MUTATIONS,REGARDLESS,RESULTS,T877A,THESE,VCAP,WILEY
7938,8805,AWARENESS,BACKGROUND,FACTORS,FOBT,LABEL,METHODS,NOW,PAP,POPULATION,PSA,RESULTS,SPAIN
001,842,986,BPH,IPSS,PREVENTION,PSA,SCORE,SYMPTOM,TRIAL,UNIT,USING
169,2013,945,BACKGROUND,DHT,FACTORS,INC,LABEL,METHODS,PCR,RESULTS,WILEY
145,169,2013,BACKGROUND,BPH,CELL,CONCLUSION,FINALLY,INC,LABEL,LNCAP,METHODS,PCA,PCR,PIM,PNT1A,RESULTS,RWPE,SIRNA,THEN,WESTERN,WILEY
030,126,169,171,200,2004,2011,2013,222,327,336,532,8201,8482,873,BBC,CONCLUSION,COPYRIGHT,GREENLIGHT,INC,IPSS,IQR,LABEL,LASER,LUTS,METHODS,NONE,OBJECTIVE,OCTOBER,PRIOR,PVP,PVR,QMAX,QOL,RANK,RESULTS,SIMILARLY,SIX,THERE,TURP,URINARY,WILEY
13Q13,13Q14,169,174,2013,3P13,3P14,AFFYMETRIX,BACKGROUND,CNA,CNAS,COPY,ELF1,GLEASON,INC,LABEL,METHODS,RESULTS,RGC32,RYBP,SCORE,WILEY
132,145,169,2013,APPROACHES,BACKGROUND,BCL,CASPASE,CHOP,COMET,COPYRIGHT,GADD153,HDAC,HDAC1,HISTONE,INC,LABEL,METHODS,PROTEIN,RESULTS,WESTERN,WILEY,WJ25591
DEAF,ENGLISH,GENERAL,KNOWLEDGE,OVERALL,SIGN,TESTICULAR,TOTAL
169,2013,946,ALTOGETHER,CBF,COPYRIGHT,CORE,FB1,HOWEVER,INC,ROS,RUNT,RUNX1,RUNX2,SINCE,WILEY
APR,MRI,PSA
956,A549,BAX,BCL,CDK,ETOH,IC50,MCF,NMR,P21,PC3,TREATMENT
954,KINASES,MECHANISMS,NUCLEAR,PP2C,PPM1A,RELA,S276,S536
100,435S,BACKGROUND,CONCLUSION,CURRENT,G3BP1,HER2,KLAKLAK,LABEL,LTVSPWY,MATERIALS,MDA,METHODS,RAS,RESULTS,THEREFORE,TOX
945,AKT,HIF,MMP,PC3,PI3K,PI3KS,VEGF,ZSTK474
BACKGROUND,DESPITE,LABEL,MEN,METHODS,RESULTS
2002,2012,BACKGROUND,EARLY,FOCAL,LABEL,METHODS,RESULTS
ADDITIONAL,BACKGROUND,CROSS,EVALUATION,IMAGING,LABEL,METHODS,MRI,NOVEL,PERTINENT,RESULTS
EACH,THUS
169,2013,8320,8322,8325,947,956,AFTER,CASPASE,COPYRIGHT,HOWEVER,JUN,LTD,MAPK,MDA,MEKK1,OME,PHOSPHO,PPAR,ROS,SOD,T24,UROLITHINS
PSA
048,169,176,2013,215,427,520,871,8805,906,AACR,BACKGROUND,BMI,GLEASON,GRS,LABEL,METABOCHIP,METHODS,NONE,RESULTS,SNP,SNPS,WHR
100,169,183,2008,2011,2013,300,400,ADP,ANTITUMOUR,BACKGROUND,BETWEEN,BRCA,BRCA1,BRCA2,COPYRIGHT,DOHME,DOSE,EASTERN,EIGHT,ETS,EVALUATION,FUNDING,GROUP,JAN,LABEL,LTD,MERCK,METHODS,NIRAPARIB,PARP,POLY,PTEN,RESULTS,SEPT,SHARP,SOLID,TOXIC,USA
169,2013,COLLEGE,COPYRIGHT,LTD,PUBLISHED,ROYAL
169,2013,COPYRIGHT,LTD,RESULTS
052,169,1997,2010,2014,323,562,885,ACM,AFTER,AMONG,BCR,BESIDES,COPYRIGHT,COX,GLEASON,HOWEVER,HRS,INC,LABEL,MATERIALS,MAYO,MEIER,METFORMIN,METHODS,OBJECTIVE,RESULTS
003,100,169,2012,2013,257,295,AIR,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,MAY,METHODS,OBJECTIVE,PEARSON,PUBLISHED,PURPOSE,RESULTS,SEPTEMBER,STUDENT,UROLOGICAL,WATER
169,2013,BACKGROUND,CONTEXT,COPYRIGHT,GAIT,INC,LABEL,LOCOMOTION,LUC,LUCIFERASE,METHODS,NONE,OBJECTIVE,PC3,PURPOSE,RATS,RESULTS
1046,169,2013,344,8804,8805,AREA,AREAS,BACKGROUND,CONCLUSION,COPYRIGHT,ECE,FOUR,GLEASON,INC,LABEL,LNI,MATERIALS,METHODS,PCA,PCAS,RARP,RESULTS,SIX
169,177,2004,2012,2013,231,233,6MONTHS,CONCLUSION,COPYRIGHT,FIVE,LABEL,MEAN,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SAS,SEPTEMBER,SFRO,SOCI
169,2013,CARLO,COPYRIGHT,DVH,ERGO,LTD,MONTE,NTCP,PLAN,PLANS,PUBLISHED,TCP,TEN,THESE,TPS,VMAT
0001,001,1000,1200,1500,169,177,2013,600,ADC,ADCS,CONCLUSION,COPYRIGHT,ERC,HIPAA,IRELAND,LABEL,LOWER,LTD,MEAN,METHODS,MRI,OBJECTIVE,PAC,PURPOSE,RESULTS,ROI,ROIS,SNR,SNRS
169,1992,2006,2013,814,CONCLUSION,COPYRIGHT,ICERTDT,ICLINDT,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,SETTING,THERE
169,2013,COPYRIGHT,HOWEVER,INC,SRS,SUMO,THESE
169,177,2013,25GY,30GY,41GY,6MM,717,84GY,86GY,COPYRIGHT,CROWN,CYBERKNIFE,D10,D80,D98,HDR,HOWEVER,INC,MEDICAL,OAR,PUBLISHED,V100
215,BACKGROUND,E2F,E2F2,KNOCKDOWN,LABEL,LIVER,LXR,LXRS,METHODS,PCR,PUBLISHED,RESULTS,TAKEN
117,172,216,8201,8482,CONCLUSION,EBL,LABEL,MATERIALS,METHODS,OBJECTIVE,RALP,RESULTS,SAFE
FE3O4,NCS,NPS,PAA,PC3M,SIO2,TEOS
BACKGROUND,CONTEXT,DATA,E26,ETS,IMP3,LABEL,LITERATURE,METHODS,OBJECTIVE,SEVERAL,SOURCES,UROVYSION
1988,BACKGROUND,BASICALLY,DISCUSSION,DOF,ESWL,LABEL,MANAGEMENT,MEDLINE,METHODS,MIS,RESULTS,SMIT,STONE,THERE,TUMOURS,UROLOGY
000,100,1982,1990,1991,1ST,2002,2006,2011,309,31ST,628,JANUARY,LUXEMBOURG,MEIER,PSA,SINCE
ANTIGEN,ARTICLE,DOWN,PSA,TRISOMY
MRI
006,007,136,140,227,248,8804,BACKGROUND,BNS,GLEASON,LABEL,LOWER,LRP,METHODS,PCA,POTENCY,PSA,RALP,RESULTS
002,018,034,065,107,157,2013,267,489,773,798,869,894,922,936,ACCORDING,BSMI,CHINA,CNKI,FOKI,FURTHER,HOWEVER,KNOWLEDGE,MARCH,ORS,OVERALL,PCA,PUBLISHED,SCHOLAR,VDR
000,100,23ANDME,AUC,CONCLUSION,CROHN,LABEL,METHODS,NAVIGENICS,OBJECTIVE,PREDICTED,PREDICTIVE,PURPOSE,RESULTS
001,ADP,AIF,DIFFERENT,HENCE,INHIBITION,PARP,POLY,PROTEIN,THESE
CTC,CTCS,DEP,HELE,J591,LNCAP,PBMC,PBMCS,SHAW
100,169,2013,COPYRIGHT,FITC,FITCS,FPANS,PSA,PUBLISHED,USING
8201,BACKGROUND,BMI,CROSS,FIFTY,LABEL,LOSS,MAXIMAL,METHODS,PHASE,RESULTS,THESE
BONE,HARD,MRI,TURP
0XS,169,2013,946,COPYRIGHT,CURRENT,IRELAND,LTD,THESE,VARIOUS
169,1913,2013,AFTER,COPYRIGHT,DHEA,DHEAS,DHT,IRELAND,LTD,STEROID,STS,THESE
169,2013,COPYRIGHT,EFFORTS,EPIGENETIC,HDACS,INC,ORAL
169,2013,239,99M,COPYRIGHT,CTC,DRUG,EFFECTIVE,FDA,FOOD,GROUP,HOWEVER,III,INC,PATIENT,PCWG2,PROS,WORKING
169,2013,COPYRIGHT,DRUG,FDA,FIRST,FOOD,INC,PUBLISHED
169,2013,BENEFIT,COPYRIGHT,INC,WHERE
169,2013,ADT,COPYRIGHT,CRPC,DESPITE,GNRH,INC,NCPC,THESE
169,2013,COPYRIGHT,HOWEVER,INC,PRIMARY,PSA,THERE,THESE,WESTERN
169,2013,COPYRIGHT,HOWEVER,INC,INCREASED,THERE
169,2013,COPYRIGHT,INC,PUBLISHED,THERE
169,2013,COPYRIGHT,INC,LARGE,LRP,ORP,PUBLISHED,PURE,RALP
169,2013,5ARIS,CONCLUSIVE,COPYRIGHT,DRUG,FDA,FOOD,INC,PCPT
169,2013,COPYRIGHT,INC,PAP,PCA,PSA,THERE
169,2013,CLINICALLY,COPYRIGHT,CRPC,HOWEVER,INC,OVERALL,PCA
160,1778,1990,2009,BCR,CAPSURE,CONCLUSION,COX,CPDR,CURRENTLY,DISEASE,DPC,DUKE,EQUAL,HOPKINS,HOWEVER,INC,JHH,JOHNS,LABEL,METHODS,OBJECTIVE,PCSM,PSA,PSADT,PUBLISHED,RESULTS,STRATEGIC
215
AFRICAN,GEORGETOWN,JACKSON,TWITTER
300MICROG,AFTER,BLACK,CELL,CONCLUSION,FCM,JNK,LABEL,METHODS,MTT,OBJECTIVE,RESULTS,THESE,WESTERN
140,169,2013,204,AACR,BOTH,DESIGNS,DTF,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
169,2013,ARSENIC,BACKGROUND,BCL2,CELL,CHRONIC,INC,INCREASED,LABEL,METHODS,MLH1,MSH4,MSH6,PCR,RESULTS,RWPE,THEREFORE,WESTERN,WILEY
181,183,COMPOUNDS,GEORG,GI50,SIX,STUTTGART,THEIR,YORK
2007,GROUP,HODGKIN,IARC,NHL,THEREAFTER
003,215,451,694,696,935,AMONG,BPI,CD18,CIS,COLORECTAL,INHERITED,ITGB2,LBP,LUNG,MYD88,ORS,OTHER,OVARIAN,SCREENING,SIXTEEN,SNPS,TRIAL
AKT,BRADYKININ,ICAM,PI3K,THUS
BONE,SRE,THEREFORE,THESE
017,BMD,CURRENTLY,FEVER,HOWEVER,INDEX,ISI,LIBRARY,MANAGER,META,RCTS,SCIENCE,SIMILAR,TEN,THERE,THESE,WMD
001,103,212,333,448,946,AIM,BACKGROUND,COX,EXPRESSION,GLEASON,HIGH,LABEL,MATERIALS,MEIER,METHODS,MMP,OBJECTIVE,OVERALL,PSA,RESULTS,THAI
167,196,BACKGROUND,BPH,FURTHER,GP5,GP6,HPV,HPVS,IRAN,IRANIAN,LABEL,MATERIALS,METHODS,MY09,MY11,PCA,PCR,RESULTS
000,007,021,069,117,177,2000,2011,258,718,AMONG,BACKGROUND,CONCLUSION,GLEASON,HOWEVER,JANUARY,LABEL,MATERIALS,MAY,METHODS,NEWLY,NODAL,PATIENT,PSA,RESULTS,UROLOGY
105,2002,2008,BACKGROUND,BLADDER,BLOOD,CASES,DATA,LABEL,LEBANON,METHODS,NAT1,PCR,RESULTS,RFLP
2006,2010,ACCORDING,CHILE,HANGA,MOST,NUI,POLYNESIA,RAPA,ROA
008,013,044,13Q22,266,288,BACKGROUND,BEIJING,C2ORF43,CASE,CHINESE,FOXP4,GLEASON,HOWEVER,KLK3,LABEL,METHODS,OTHER,PCA,PCR,PSA,RESULTS,RFX6,SNPS,TIANJIN
190,2012,595,621,785,AGA,BACKGROUND,BPH,COMMONEST,DEPARTMENT,GLEASON,JULY,KARACHI,KHAN,LABEL,MATERIALS,MEAN,METHODS,OVERALL,PATHOLOGIC,PATHOLOGY,RESULTS,SECTION,THESE,TMAJORITY,TUR,UNIVERSITY
HOWEVER,MMP,PFES,PLS,PLS10,THESE
001,120,COX,ESCC,ESCCS,LABEL,LOW,METHODS,OBJECTIVE,PCR,PROTEIN,REPS2,RESULTS,TNM,WESTERN
100,2010,2011,452,4NG,521,8804,BACKGROUND,DEPARTMENT,DIGITAL,DRE,EASTERN,GENERAL,HOSPITALS,INSTITUTE,JULY,JUNE,KOIRALA,LABEL,MATERIALS,METHODS,NEPAL,OBJECTIVE,OUTPATIENT,PSA,RESULTS,SURGERY
018,029,169,2013,8201,CONTINENCE,GROUP,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THERE,UROLOGICAL
0001,1403,158,183,414,717,ANOVA,ARABIAN,FEW,KING,KSUH,MEN,MUHC,PCA,PSA,SAUD,SAUDI,SERUM,THEREFORE,UNIVERSITY,WESTERN
CIMP,CPG,IDH1,IDH2,MAFUCCI,TET,TET2,THESE
CRITICALLY,CRPC,FHL2,THESE,THUS
221,ARHI,HOWEVER,MCF,MIR,UTR
001,1000,129,2004,2009,2010,244,384,3926,5881,6123,633,8804,AMONG,CONCLUSION,EBRT,END,GLEASON,IMPORTANCE,IMRT,LABEL,MAIN,METHODS,OBJECTIVE,RELEVANCE,RESULTS,SEER,SETTING,T2A,USING


181,CHEST,IGA,LABORATORY,UPON
169,1989,1991,2008,2013,20TH,386,80TH,932,956,AACR,ARIZONA,ARSENIC,BACKGROUND,HEART,HRS,INDIANS,INORGANIC,LABEL,LOW,METHODS,NORTH,RESULTS,SOUTH,THESE
ACCORDING,CONCLUSION,DEPARTMENT,GENERAL,INC,LABEL,MEAN,METHODS,OBJECTIVE,ORAL,PRIMARY,PUBLISHED,PURPOSE,RESULTS,SPAIN,SURGERY,TEN,THERE,UNIVERSITY
169,1966,1981,1985,1988,2007,2013,215,250M,8805,AIM,CHERNOBYL,CONCLUSION,COPYRIGHT,FINLAND,FINNISH,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,THERE
1990,2000,2004,439,BACKGROUND,CONCLUSION,FIVE,JAPAN,LABEL,LIVER,METHODS,OSAKA,RESULTS,THESE
2000S,8764,AFTER,AUSTRALIA,BACKGROUND,CONCLUSION,COUNTRIES,GEOGRAPHIC,ITALY,LABEL,METHODS,RESULTS,THESE,USA,WESTERN
303,AIMS,LABEL,METHODS,OBJECTIVE,PSA,RATES,RESULTS,THERE,UNIVERSITY
146B,181B,361,515,8202,BACKGROUND,BCR,CONCLUSION,CPFS,EXPRESSION,FURTHER,HMGA1,LABEL,MICRORNAS,PCA,PCR,PRINCIPAL,RESULTS,VALIDATION,WHILE
105,160,CALYPSO,IMRT
KLK4,PCA,PI3K,PLZF,THESE,THUS
0001,0035,169,1987,2004,2013,295,741,8201,8805,ADT,BACKGROUND,GLEASON,HOWEVER,LABEL,MEN,METHODS,RESULTS,SOCIETY
169,2013,3000,3640,8201,8805,CONCLUSION,COPYRIGHT,HIGH,INC,LABEL,METHODS,NINE,OBJECTIVE,PURPOSE,RESULTS,T2W,TSE,WILEY
008,108,169,2013,206,8201,AFTER,AMONG,AST,BACKGROUND,COX,DESPITE,ESTIMATES,INCREASING,LABEL,METHODS,OPTIMAL,PSA,RCTS,RESULTS,SOCIETY
150,8201,8764,GRFT,IFP1,PC3,PET,THESE,VALIDATION
1208,170,2000,611,8211,FOUR,HOWEVER,ILLNESS,INSURANCE,INTENSE,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
121,160,8804,AAWD,CAB,PSA,SHORTENING,UNIVARIATE,USING
476,945,AMACR,COA,ERG,FOAMY,GLEASON,LOW
000,001,169,2013,317,CHOLINE,CIS,DMG,HIGH,HOWEVER,JANUS,ORS,SERUM,UICC,USING
0001,11C,177,708,752,BACKGROUND,CANCEROUS,CONCLUSION,DCE,LABEL,METHODS,MRI,OBJECTIVE,PET,PURPOSE,RESULTS,SUV,T2W
223,233,BONE,CRPC,FOUR,TARGETING
605,CONCLUSION,DUE,INCLUSION,LABEL,METHODS,OBJECTIVE,PITX2,PURPOSE,RESULTS,SIXTEEN
177,AMONG,CHOLINE,LABEL,MEAN,METHODS,OBJECTIVE,PET,PSA,PSADT,PURPOSE,RESULTS
945,954,BMI1,CBP,E2F1,IKK,PCA
ARP2,CDC42,FAK,HOWEVER,USING,WASP,WAVE1
10Q,146B,169,2013,COPYRIGHT,HOWEVER,IRELAND,LTD,MMP16,MMP2
1067,169,2013,COPYRIGHT,INC,PUBLISHED,RFID,WEB
111,169,2013,316,357,764,BACKGROUND,COLON,CONCLUSION,COPYRIGHT,FOLLOWING,INC,LABEL,LYNCH,MEIER,METHODS,MLH1,MMR,MSH2,MSH6,PMS2,PUBLISHED,RESULTS,SIR,SIRS
ANDROGENIC,HOWEVER
001,015,032,154,169,194,2008,2010,2013,222,250,383,580,8201,860,941,961,993,ADD,BJU,COMPARING,DIAGNOSIS,DOES,KNOWN,LABEL,MBP,METHODS,OBJECTIVE,PLOS,PROCEDURE,RESULTS,SUBJECT,UNLABELLED,WHAT
169,177,2013,679,AMONG,BJU,CONCLUSION,GREATER,LABEL,METHODS,MIXED,OBJECTIVE,RESULTS,THESE
169,2010,2013,470,8805,AUSTRALIA,BJU,CONCLUSION,LABEL,METHODS,OBJECTIVE,RADIATION,RESULTS
066,169,181,183,1997,2006,2007,2013,8804,BJU,CONCLUSION,LABEL,METHODS,OBJECTIVE,PSA,RESULTS,TCR
001,093,169,188,1992,2008,2013,391,827,ADJUSTING,BJU,CONCLUSION,COX,CRC,DESPITE,END,FINE,GRAY,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,RATES,RATIO,RCC,RESULTS,SEER,SIR,SIRS,USING
001,006,216,835,CLIENTS,FILIPINOS,FIVE,HAWAI,HAWAIIANS,HIGH,KAUA,LANA,MAUI,RANDOMIZED
BONE,OMICS,THESE

AFTER,BACKGROUND,BOARD,CAB,COMMUNITY,FACE,LABEL,LEARNED,LESSONS,METHODS,OBJECTIVE,OBJECTIVES,PSA
413,8197,BRCA1,BRCA2,ELISA,EN2,GLEASON,PSA,THERE,URINARY,URINE
1987,2011,324,BACKGROUND,LABEL,METHODS,MOST,OUTPATIENT,RESULTS,SKIN
169,2013,CAP,COPYRIGHT,ELISA,IHC,INC,LIN28,LNCAP,MYC,NKX3,PATHOLOGY,PCR,PSA,PUBLISHED,SOCIETY,WESTERN
160,169,2009,2013,COPYRIGHT,ISUP,PATHOLOGY,SAS,SOCIETY,UROLOGICAL
169,2013,3068,BLACKWELL,FURTHER,GMBH,HOWEVER,THESE
2006,AGE,BACKGROUND,CONFIDENCE,HODGKIN,HOWEVER,INCREASED,INTERVALS,ITALIAN,LABEL,METHODS,MORTALITY,OBJECTIVE,OBJECTIVES,PCB,PCBS,PLANT,RESULTS,SMR,SMRS,VITAL
ALDI,CURRENTLY,TOF
BACKGROUND,BECAUSE,CBCT,CONCLUSION,DEPARTMENT,EUCLIDEAN,GLIWICE,INSTITUTE,LABEL,METHODS,RESULTS
0001,0015,0125,169,1828,2013,3126,3200,3P13,BRITAIN,COPYRIGHT,ECTOPIC,ERG,FISH,FOXP1,GLEASON,GREAT,IRELAND,JOHN,LTD,PSA,PTEN,PUBLISHED,RYBP,SHQ1,SNP,SOCIETY,SONS,WILEY
169,2013,BACKGROUND,COPYRIGHT,INC,LABEL,LNCAP,METHODS,MT1,MT2,MT3,MT4,NDRG1,RESULTS,WILEY
THERE
FURTHER
CSC,CSCS,THESE
CRPC,SEVERAL,TODAY
EVENTUALLY,SINCE,WILMS
2000,2010,8804,BACKGROUND,GLEASON,HOWEVER,LABEL,METHODS,RESULTS,T1C
169,2013,AUTHORS,COPYRIGHT,CRPC,LTD,ONCE,PUBLISHED,RESULTS
100,HPV,LPIN2,MBP,NB26,NF2,PGC1A,RWPE1,STRUCTURAL,THERE,TRPV6,UGT2B17,WPE1
PKR,RNAS,SMALL,THUS
CCL5,CD133,CHEMOKINE,CXCR4,MECHANISM,MSCS,PCA,THEREFORE,ZEB
AGING,ARS,LNCAP,MMP,MMP9,PC3,PCA,THEREFORE,USING
100,137,169,2003,2006,2009,2012,2013,7GY,8P21,8PTER,8Q23,8QTER,947,BLOOD,COPYRIGHT,FISH,FURTHER,ISIS,METAFER,METAPHASE,MYC,RINGS,ZEISS
0001,100,114,115,169,177,2013,649,COPYRIGHT,DETECTION,EDUCATION,HOWEVER,INC,IQR,LABEL,MATERIALS,MEAN,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL,WHOLE
001,003,169,2013,563,599,697,698,734,750,922,COPYRIGHT,COX,EDUCATION,HARRELL,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,ROC,UROLOGICAL
169,2013,COPYRIGHT,IRELAND,LNCRNAS,LTD,RNAS
169,182,183,2013,AMONG,BLADDER,COPYRIGHT,FURTHER,MIR,THEREFORE
1000S,169,177,2013,215,3000S,ADC,ADCF,ADCS,AUCS,CONCLUSION,COPYRIGHT,DWI,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,ROC
002,1000,1500,169,177,2013,250,500,62242,750,8805,945,ANTITUMOR,BACKGROUND,COPYRIGHT,DLTS,EMD,EMR,FOUR,LABEL,METHODS,OBJECTIVE,OUTCOME,PCA,PSA,PUBLISHED,RESULTS,SECONDARY,SETTING,TEAES,THERE,TREATMENT,TRIAL,UROLOGY
145,169,2013,231,8320,956,COPYRIGHT,JUGLONE,LLL12,LTD,MDA,MENADIONE,MOST,PD10,PD11,PD13,PD14,PD15,PD18,PD9,PLUMBAGIN,PUBLISHED,STAT3
169,1ST,2013,33PCA,3RD,947,ARC,AUTHORS,BIOMARKER,COPYRIGHT,ETB,H2AX,IMRT,INTENSITY,IRELAND,LABEL,LTD,MATERIALS,METHODS,MODULATED,OBJECTIVE,PCA,PUBLISHED,PURPOSE,RADIATION,RESULTS,THERAPY,VMAT,VOLUMETRIC
169,2013,AFTER,BIOLOGY,COPYRIGHT,DESPITE,FEDERATION,INC,PUBLISHED,ULTRASOUND,WORLD
130,150,155,169,2013,833,BACKGROUND,COPYRIGHT,DESPITE,DVH,GTV,GTVS,IRELAND,LABEL,LTD,MATERIALS,METHODS,ONGOING,RESULTS,THERE
109,169,200,2005,2007,2013,2123,532,AFTER,APRIL,BETWEEN,BNC,CAD,CONCLUSION,COPYRIGHT,COST,HOLAP,INC,INDEX,LABEL,MARCH,METHODS,OBJECTIVE,PROCEDURE,PVP,REDO,REGARDLESS,RESULTS,SCORE,SMALLER,SYMPTOM
087,169,181,2007,2009,2012,2013,2016,2020,4874,5537,592,896,AIMS,AUSTRALIA,CARE,COLLEGE,COPYRIGHT,DEVON,ENGLAND,HAMLETS,LABEL,LTD,MALTHUS,MATERIALS,METHODS,OBJECTIVE,PCT,PRIMARY,PROGRAMME,PUBLISHED,RESULTS,ROYAL,SIMILAR,TOWER
169,2006,2010,2013,215,CHRONIC,COPYRIGHT,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PRIMARY,PURPOSE,RADIATION,RADICAL,RESULTS,SECONDARY
169,2013,COPYRIGHT,IC50,LTD
169,2014,COPYRIGHT,INC
169,2013,946,BMDMS,CELL,CONCLUSION,DU145,IFN,JOHN,LABEL,LTD,METHODS,MTT,OBJECTIVE,PC3,PCR,PROBLEM,RESULTS,RWPE,SONS,THESE,TLR7,TLRS,TOLL,TRAMP,TRMAP,WESTERN,WILD,WILEY
169,2013,69A11,954,AKT,BOTH,FINALLY,IKKS,JOHN,SAR,SONS,WILEY
001,002,008,032,1148,125,2013,223,467,739,BACKGROUND,CONCLUSION,DATA,DC1,GLEASON,HIPAA,IMAGING,LABEL,MATERIALS,MAXIMAL,METHODS,OBJECTIVE,PURPOSE,RADS,REPORTING,RESULTS,RSNA,SEVENTY,THREE
169,1G7,2013,AACR,AMD3100,CXCR4,DESPITE,DRD,DTX,DU145,ERK1,LABEL,MYC,PC3,PC3DR,THUS,UNLABELLED
173,2011,282,8805,BLADDER,CIS,ORS,THERE,TOBACCO
001,169,2007,2012,2013,315,582,8804,8805,BACKGROUND,CONVERSELY,COPYRIGHT,GLEASON,LABEL,METHODS,MRI,OBJECTIVE,OUTCOME,PCA,PUBLISHED,RESULTS,SETTING,THERE
AFTER,BACKGROUND,CONTEXT,DESPITE,INFECTIOUS,LABEL,LUTS,METHODS,OBJECTIVE,PAIN,PUBLISHED,RESULTS,SYNTHESIS
169,2014,CONCLUSION,COPYRIGHT,HOWEVER,INC,LABEL,MEDLINE,METHODS,MRI,OBJECTIVE,RESULTS
169,200,2014,215,COPYRIGHT,EXTENSIVE,GLEASON,INC,LABEL,LC3A,LC3B,LDH5,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SIMILARLY,YET
100,106,169,2007,2010,2013,519,643,8804,8805,AIMS,ASSESSMENT,BACKGROUND,CONCLUSION,COPYRIGHT,LABEL,LTD,METABOLISM,METHODS,MINI,MINIGDS,MMMSE,MNA,NUTRITION,OBJECTIVE,ORA,OTHER,RESULTS,SOCIETY
011,AKT,BECAUSE,CLU,CRPC,LNCAP,MAPK,MDV3100,OGX,PSA,THESE
160,AKT,BACKGROUND,DECREASED,DU145,EXPRESSION,FINALLY,ID1,ID4,INHIBITOR,KI67,LABEL,LNCAP,METHODS,MYC,NKX3,PTEN,RESULTS,SOX9
231,945,946,CONVERSELY,DU145,EED,EXCITINGLY,HDAC,HDACI,MCF,MDA,TAM,THESE,VERO
300,500,BACKGROUND,CONCLUSION,DRE,ERSPC,FINNISH,HRQL,ITEM,LABEL,METHODS,PSA,RAND,RANDOMIZED,RESULTS,SCREENING,SHORT,TRUS
233,CYTOTOXIC,NOVEL,SEVERAL
145,181,945,946,AKT,AKT1,CDXR,CHOLESTANE,FAK,FLOW,KIP,LNCAP,MICRO,MYC,ORAL,OXYSTEROLS,PDK1,SKP2,SLUG,TREATMENT,TRIOL,TUNEL,WESTERN
001,002,006,010,053,095,177,AMONG,COMPARISON,CONCLUSION,COX,FDG,GLEASON,LABEL,MEIER,METHODS,PET,RESULTS,SUM,SUV,UNLABELLED
169,2013,COPYRIGHT,COX,III,JOHN,LTD,PROGNOSIS,SONS,WILEY
946,954,A375P,MALIGNANT,THERE,VEGF
EVEN,GLEASON,TNM
146,8201,EBRT,EFFECTS,HALF,STUDIES
119,182,2001,2009,8211,CAUCASIAN,CHINESE,CONCLUSION,GRADE,HISTORICAL,HONG,INTENSITY,KONG,LABEL,MAIN,MAY,METHODS,NETWORK,OBJECTIVE,OUTCOME,OVERALL,RESULTS,SETTING,THESE
160,945,BILE,FXR,TGR5,THESE
023,105,168,423,8201,BACKGROUND,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
8209,AKT,BPH,DEPLETION,DU145,ILK,PCA,THESE,THUS,WESTERN
GNRH
202,BACKGROUND,DISCUSSION,LABEL,MATERIALS,METHODS,PATIENT,RALP,RESULTS,SOCIETY,THERE
ADVANCE,BACKGROUND,CONCLUSION,LABEL,MATERIALS,MEDICAL,METHODS,MINNETONKA,OTHER,RESULTS,SIXTY,SYSTEMS,UNIVARIATE,USA
BACKGROUND,BFW,BWI,DATA,EBL,INDEXES,ISD,LABEL,MATERIALS,METHODS,MRI,NONE,PDI,RESULTS,RRP,RUC,SPSS,SWI
0099,0101,0321,0347,0397,0399,139,141,2008,21210,ACCORDING,BACKGROUND,DATA,ENDPOINTS,ERSPC,LABEL,MATERIALS,MEIER,METHODS,RANDOMIZED,RESULTS,ROTTERDAM,SCREENING
BACKGROUND,BCR,CRPC,EACH,LABEL,MATERIALS,METHODS,PSA,RADICAL,RESULTS,WHILE
BACKGROUND,LABEL,RESULTS,THEREFORE,THUS
160,169,2001,2012,2013,AIMS,ASSESSMENT,BACKGROUND,CONCLUSION,DATA,EIGHT,EVALUATION,GRADE,GRADING,JANUARY,JOHN,LABEL,LTD,MEDLINE,METHODS,OBJECTIVE,RESULTS,SONS,SOURCES,WILEY
FINALLY,LIFESTYLE,SINCE
001,007,032,050,102,116,177,2006,281,321,348,435,470,518,668,763,843,ABDOMINAL,AGE,CONCLUSION,IIEF,INDEX,ITALIAN,LABEL,METHODS,NON,OBESE,OBJECTIVE,RESULTS
2013,MRI
BACKGROUND,DISCUSSION,GPS,LABEL,OBJECTIVE
001,2005,294,BOTH,DRE,E26,ERG,ETS,FFPE,FISH,PCA,PCR,PSA,SERUM,SINCE,TMPRSS2
CRPC,III,PHASE,THESE,UNTIL,YET
177,BALB,CD133,CD44,CSC,CSCS,DU145,FACS,FINDING,HOWEVER,LNCAP,PCA,SFM,THESE,UNDER
000,2013,345,600,AMONG,BACKGROUND,CONCLUSION,GCMAF,HOWEVER,LABEL,MARCH,METHODS,MIRAI,RESULTS
BACKGROUND,CONCLUSION,EHRLICH,GCMAF,HELIX,LABEL,RESULTS
0001,001,039,169,2013,8804,AFTER,LABEL,MANN,METHODS,OBJECTIVE,PFMT,PURPOSE,QOL,RELEVANCE,STUDENT,WHITNEY
2012,821,ADVERSE,ANY,AUTHORS,BACKGROUND,BLACK,CENTRAL,COLLECTION,CVD,DATA,DBP,DIASTOLIC,GREEN,LABEL,LDL,LIBRARY,MAIN,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,OCTOBER,OVID,RANDOMISED,RCTS,RESULTS,REUTERS,SBP,SCIENCE,SELECTION,SEVEN,THERE,THOMSON,WEB
048,137,2004,2009,8804,8805,BETWEEN,ECOG,GBM,NEUTROPHIL,NLR,THESE
001,112,115,177,247,864,8805,910,ALU,AUC,BPH,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PCR,PSA,RESULTS
169,2013,509,AACR,ARN,CRPC,DESPITE,F876L,LABEL,THESE,THUS,UNLABELLED
596,CAS,CURRENT,GIVEN,LABEL,MEN,THESE,THUS,UNLABELLED
048,181,302,374,520,746,8804,894,AMONG,BACKGROUND,BASE,CASE,CONCLUSION,DATA,DEFENSE,DEPARTMENT,FOUNDATION,FUNDING,GLEASON,HORIZON,INSTITUTE,LABEL,LIMITATION,MEN,METHODS,OBJECTIVE,OUTCOME,POPULATION,PRIMARY,QUALITY,RESULTS,SOURCES,T2A,TIME,TREATMENT
017,023,110,153,177,2006,2011,235,243,253,8805,CONCLUSION,GLEASON,LABEL,METHODS,OBJECTIVE,PSA,RESULTS
001,006,025,038,100,BAZ2,BAZ2A,CELL,CONVERSELY,DU145,FGFR3,LABEL,METHODS,MICRORNAS,OBJECTIVE,PC3,PCR,RESULTS,SMARCA5,THAP2,THERE
001,017,036,100,218,253,315,649,BUB1,CELL,CONCLUSION,LABEL,LAMB3,METHODS,MYC,OBJECTIVE,PCR,RAS,RESULTS,SMARCA5
001,133,1499,2007,412,6316,671,735,7815,945,ARI,BASE,DRUG,GLEASON,LABEL,MAIN,MEN,METHODS,NATIONWIDE,OBJECTIVE,OUTCOME,PATIENT,PRESCRIBED,RESULTS,RISK,SETTING
169,2013,22RV1,COPYRIGHT,CPP,LTD,PLK,PSA,PSMA
169,2013,COPYRIGHT,LTD,PSMA,QUANTUM,WHILE
8201,956,ADR,AFTER,BACKGROUND,BAF,CHINESE,CONCLUSION,CONTEXT,DISCUSSION,EAF,FOUNDATION,HARA,HEMSL,LABEL,LAMIACEAE,MATERIALS,MCF,MDR,MDR1,METHODS,MTT,OBJECTIVE,PCR,PEF,RESULTS,RH123,THESE
001,256,473,801,AFRICAN,ASSESSMENT,CAPRA,CONCLUSION,LABEL,METHODS,NETWORK,OBJECTIVE,PCA,POST,PRESENTING,PURPOSE,RESULTS,RISK
8212,CAP,CARCINOMA,CURRENTLY,DOWEX,FE2O3,LOD,THEREFORE
016,031,047,FOUR,FUNCTIONAL,ICIQ,LABEL,METHODS,MRI,MUL,OBJECTIVE,OBJECTIVES,PAD,PCL,QOL,RESULTS,SURGERY,VISIBILITY
THESE
002,169,2013,8201,BACKGROUND,BP3,CHANGES,CONCLUSION,COPYRIGHT,ESTIMATING,IGF,IGFBP,INC,LABEL,MEN,METHODS,OBESE,OTHER,OVERWEIGHT,PCA,POTENTIAL,RESULTS,THERE,THESE,WILEY
169,2013,239,946,BACKGROUND,CONVERSELY,COPYRIGHT,CRPC,HOWEVER,INC,LABEL,LNCAP,METHODS,RESULTS,TAXANES,WESTERN,WILEY
169,2013,ACTIVATION,AKT,BACKGROUND,BOTH,COPYRIGHT,DIFFERENT,ERBB2,EXPRESSION,HOWEVER,INC,LABEL,LN3,LNCAP,METHODS,PC3,RESULTS,RTPCR,SOMATIC,THR1697ALA,WILEY
0001,2006,2012,AIMS,ALSO,CK20,CK7,HMWK,HMWKS,IHC,LABEL,MANN,METHODS,OBJECTIVE,PSA,PSAP,RESULTS,WHITNEY
100,169,177,2013,8201,ADULT,BACKGROUND,BURNS,C57BL,COPYRIGHT,CRPC,CYP17A1,INC,LABEL,METHODS,MOUSE,NOG,RESULTS,THESE,WILEY
169,2013,8201,ADPC,AR9,ARSC,ARSI,BACKGROUND,BPH,CELL,COPYRIGHT,CRPC,DHT,ENTOSIS,HEME,INC,KNOCK,LABEL,LNCAP,METHODS,PC3,PCA,RESULTS,RHO,ROCK,THESE,WILEY
017,169,2013,22RV,8201,BACKGROUND,CELL,CONVERSELY,COPYRIGHT,DU145,GLEASON,HOWEVER,INC,LABEL,LCN2,LIPOCALIN,LNCAP,METHODS,MTT,PC3,PCR,RESULTS,WESTERN,WILEY
784,AFTER,LABEL,MACRO,METHODS,OBJECTIVE,RESULTS,WITHOUT
0001,0002,0004,0005,0015,0030,0036,0043,8201,AGE,ASSESSMENT,BONFERRONI,C30,EORTC,FURTHER,HRQOL,INCREASED,KARNOFSKY,KPS,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,QLQ,RESULTS,UNIVARIATE
879,892,946,ARF,DECREASED,FOXM1,HOWEVER,HSD2,LOX,PCA,PLK,SV40,TRAMP,VEGF,WITHOUT
125,174,787,9089,9335,9728,9977,AFP,CA125,CA15,CA19,CEA,CYFRA,EACH,G1200,LUMIPULSE,PASSING,PSA,SERUM
DESPITE,HIFU,HOWEVER,MRI,ROBOTIC,THESE,USA
RADICAL,WHILE
CURRENT,PCA,THUS
169,2013,239,250,332,BASEL,COPYRIGHT,HUASHAN,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PSA,RESULTS,THESE,TTPN
0876,105,169,2013,BACKGROUND,BASEL,CDC,COPYRIGHT,CRP,DATA,LABEL,LABORATORY,METHODS,ORP,POI,POIS,RALP,RESULTS,ROBOTIC,THERE,WBC
145,169,2013,AKT,COPYRIGHT,ERK1,FGF8B,FGFR,FURTHER,IRELAND,LTD,P38
949,963,964,ETS,ETV1,FINALLY,MMP,NON,NOTABLY,S216,TAKEN
109,BECAUSE,CD31,ERG,EWING,GENERAL,HOWEVER,INI1,OTHER,PROX1,SMARCB1
GLEASON,OVERALL,PCA,PIN4,PROSTATIC,USUAL
945,946,BPH,SERM,SERMS,THERE
169,174,2013,500,8804,8805,BACKGROUND,BOWEL,COPYRIGHT,EARLY,EPIC,FACT,FOCAL,GLEASON,HIFU,IIEF,INC,INDEX,IPSS,LABEL,LARGE,METHODS,MRI,PRIMARY,PSA,PUBLISHED,QOL,RESULTS,SECONDARY,SONABLATE,T2CN0M0,TPM,TREATMENT,UNILATERAL,URINARY
169,2013,ANGELES,BJU,CALIFORNIA,LABEL,LOS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THESE,UNIVERSITY
160,169,2000,2006,2013,8805,ADDITIONAL,ADJUSTING,AGGREGATE,AREA,BACKGROUND,COPYRIGHT,CURRENT,END,ESTIMATES,INC,INSURANCE,LABEL,MATERIALS,METHODS,OVERALL,POPULATION,RESULTS,SMALL,THEREFORE,UNIVARIATE
1000,169,2013,ALSO,COPYRIGHT,DIFFUSION,DTI,FSE,IMAGING,IRELAND,LABEL,LTD,MATERIALS,METHODS,MRI,OBJECTIVE,OBJECTIVES,RESONANCE,RESULTS,THREE
160,945,946,947,BACKGROUND,CXCR4,CXCR5,FINALLY,FURTHER,HOWEVER,INHIBITION,LABEL,LISA,LNCAP,METHODS,PAR,PC3,PCA,RAC,RESULTS,RHOA,RWPE,THESE
169,2005,2013,BACKGROUND,COPYRIGHT,EAU,ESTRO,EXCLUSION,GEC,HDR,HDRBT,IRELAND,LABEL,LTD,METHODS,RESULTS
169,2013,GCPII,GLUTAMATE,JOHN,SONS,THERE,WHILE,WILEY
155,169,195,2013,262T,463A,BJU,CAT,GLEASON,HOWEVER,LABEL,METHODS,MNSOD,MPO,OBJECTIVE,PSA,RESULTS,SIMILARLY,THERE,TURKISH
1013,947,CD3,CD30,CD56,EBV,EXTRANODAL,LABEL,NKTCL,RNAS,TCR,TIA,UNASSIGNED,UNLABELLED,VIRTUAL
001,150,169,200,2013,220,2427,8201,8804,ADT,AMONG,BED,BJU,EBT,FBF,FPF,GY2,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,USING
000,160,169,2013,ACADEMY,AFTER,AUTHORS,CONSISTENT,CTLA,EVALUATION,III,INC,IPILIMUMAB,THESE,WILEY,YORK
2003,2011,2012,752,927,ABOVE,CONVERSELY,DISABILITY,KOREA,OFF,TRADE,VAS
0001,121,177,926,BACKGROUND,CONCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,THEREFORE,THUS
100,110,129,2007,945,946,AIMS,BACKGROUND,BED3,BOARD,CONTEXT,CTV,FIFTY,HARK,IMRT,IRB,LABEL,MATERIALS,METHODS,OBJECTIVE,PSA,PTV,RESULTS,THERE
2641,3255,3259,3654,ACCORDING,AFRICAN,AIMS,ASIAN,ASN,ASP312ASN,BACKGROUND,CAUCASIAN,CAUCASIANS,CONCLUSION,ERCC2,HOWEVER,LABEL,LYS751GLN,MATERIALS,METHODS,OBJECTIVE,RESULTS,STUDIES,THESE,THUS,XERODERMA,XPD
C2C12,CURRENT,PEARSON,USING,VALIDATION
215,CD34,GLEASON,IVD,TEN,THESE
DU145,GST,GSTM1,GSTP1,HOWEVER,LNCAP,MOLECULAR,PCR,THESE,ZEBULARINE
HOWEVER,RECURRENT,THESE
160,CARLO,CLASSIFIER,GATE,MONTE
001,002,003,1988,1991,COLORECTAL,ERSPC,LUNG,OVARIAN,PLCO,PSA,RANDOMIZED,SCREENING,SINCE
221,222,CRPC,HORMONE,LNCAP,MIR,RAB1A
169,2013,AIFM1,AMONG,BIK,CALR,CCND1,CDK2,COPYRIGHT,CYCS,DDIT3,ERN1,FAS,HSPA5,INCREASED,LNCAP,LTD,PCNA,PPP2R1A,PROTEOMIC,SFN
946,ALSO,ALTERED,DHEA,DHEAS,HSD,HSD2,HSD5,LTD,PUBLISHED,TGF,THESE,WHILE
001,002,003,169,174,2014,BLACK,COPYRIGHT,EDUCATION,GLEASON,INC,LABEL,MATERIALS,METHODS,NCCN,NETWORK,OBJECTIVE,PUBLISHED,PURPOSE,RADICAL,RESULTS,UROLOGICAL
001,010,169,2000,2006,2013,219,AUC,COPYRIGHT,EDUCATION,GIVEN,GLEASON,HOWEVER,INC,LABEL,MATERIALS,MAYO,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,ROC,UROLOGICAL
169,181,2014,250,256,308,780,945,AFTER,AUA,COPYRIGHT,EDUCATION,EVEN,INC,LABEL,LOWER,MATERIALS,METHODS,OBJECTIVE,OLDER,PUBLISHED,PURPOSE,RESULTS,STORAGE,THESE,UROLOGICAL
169,2013,COPYRIGHT,INC,LOW,MOST,PAR
107,169,2013,945,946,AIM,AQUEOUS,BACKGROUND,COPYRIGHT,DPPH,EL4,FPR,HOWEVER,IC50,IRELAND,LABEL,LTD,MATERIALS,METHODS,MTT,NADPH,NQO1,OBJECTIVE,PCR,RELEVANCE,RESULTS,ROS,TNF,VIETNAM
116,169,177,181,2013,945,956,COPYRIGHT,GANODERMA,IC50,KNOWN,UVB
100,169,2012,2013,2350,239,BACKGROUND,CONTEXT,COPYRIGHT,DOPPLER,FOCAL,LABEL,MEDLINE,METHODS,MOST,OBJECTIVE,OCTOBER,RESULTS,SCIENCE,STUDIES,SYNTHESIS,UROLOGY,WEB
169,16MM,2013,88MM,945,AKT,AKTI,COPYRIGHT,DLD,EMT,IC50,INC,PI3K,THESE,THUS
169,2013,945,946,954,AKT,CONVERSELY,COPYRIGHT,EMT,EPITHELIAL,ERK,FINALLY,GSK,HOWEVER,MAPK,METASTASIS,PC3,SNAIL,TAKEN,TNF
169,2012,COPYRIGHT,GLEASON,SINCE,SSS
169,2014,CONVERSELY,COPYRIGHT,INC,LABEL,LNS,MATERIALS,METHODS,OBJECTIVE,OVERALL,PET,PPV,RESULTS,THEREFORE
169,2014,500,600,ADT,ANDROGENS,COPYRIGHT,INC,PERSISTENT,SERUM
169,1990,2014,495,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,MORBIDITY,MOUNT,OBJECTIVE,OBJECTIVES,RESULTS,SINAI
169,2013,949,COPYRIGHT,DET,FDA,LTD,PASP,PC3,PCL,PEG,RAP
169,2012,ALZHEIMER,COPYRIGHT,HDL,HOWEVER,INCREASES,PUBLISHED,SEVERAL,THERE
077,169,2002,2011,2013,223,3338,438,BACKGROUND,COPYRIGHT,EPBX,JANUARY,LABEL,METHODS,OBJECTIVE,OCTOBER,OUTCOME,OVERALL,PSA,PUBLISHED,RESULTS,SETTING,SPBX,STRATIFIED,THERE,THESE,UROLOGY,USING
169,2013,CONCLUSION,COPYRIGHT,FOUR,GLEASON,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,RESULTS,THERE
110,114,169,2009,2012,317,AEU,COPYRIGHT,HCT,HOWEVER,LABEL,MAY,METHODS,OBJECTIVE,PUBLISHED,RARP,RESULTS,ROBOTIC
177,AMINO,BOTH,CBT1G,CBT2G,GPI,H2009,H2CBT1G,H2CBT2G,LNCAP,PC3,PET,PSMA
497,8201,ANTIGEN,BACKGROUND,CRP,GLASGOW,GLEASON,LABEL,METHODS,PROGNOSTIC,PSA,RESULTS,RISK,SCORE,SEVEN,THERE,THEREFORE
AKT,BACKGROUND,CLONOGENIC,DUAL,LABEL,METHODS,MTT,NEITHER,NVP,PI3K,RESULTS
2002,2067,946,BACKGROUND,BT474,CONCLUSION,DOWN,FOCAL,IGF,IGF1R,INHIBITORS,INSULIN,KNOCKDOWN,LABEL,MAP,METHODS,RESULTS,WHOLE,WNT
191,BACKGROUND,EXPRESSION,HOWEVER,LABEL,METHODS,MMP,PSA,RESULTS,TOUCH
169,2013,AKT,BACKGROUND,COPYRIGHT,ELISA,EXPRESSION,FOXO,FOXO4,INC,INHIBITION,LABEL,LOSS,METHODS,PI3K,PKB,PTEN,RESULTS,TRAMP,WILEY
1210,169,2013,978,BACKGROUND,CONCLUSION,EGF,EGFR,ERLOTINIB,GEFITINIB,GOVERNMENT,INC,LABEL,METHODS,MOST,PHLORIZIN,PREVIOUSLY,RESULTS,SGLT1,THESE,USA,WILEY
169,2013,946,AKT,BACKGROUND,BPH,BRDU,DKK,DKK3,ELISA,EXPRESSION,FIBROBLAST,INC,KNOCKDOWN,LABEL,LENTIVIRAL,METHODS,PCA,PI3K,PRSC,PRSCS,RESULTS,THEREFORE,THUS,WESTERN,WILEY,WNT
169,2013,AMONG,BACKGROUND,CONSISTENT,COPYRIGHT,HOWEVER,INC,LABEL,METASTASIS,METHODS,PAX,PAX2,PCR,RESULTS,WILEY
945,946,CORE,UDP
100,153,169,2013,8805,945,946,BACKGROUND,COPYRIGHT,EDTMP,LABEL,METHODS,NINE,RESULTS,SOCIETY
DIFFERENT,HOWEVER,HPLC,MALDI,MELDI,SPE,THUS,TOF,TRACING
946,DKK,ENDOGENOUS,TGF,THESE,WNT
169,2013,293,AFFYMETRIX,BACKGROUND,COPYRIGHT,CRPC,FINALLY,HEK,INC,LABEL,LNCAP,MDV3100,METHODS,PSA,RESULTS,THESE,WILEY
169,2004,2006,2013,8201,8804,982,AFRICAN,AMERICANS,BACKGROUND,BETWEEN,CERTAIN,COPYRIGHT,DATA,DEFINITIVE,GEOGRAPHIC,GLEASON,INDIANS,LABEL,LIMITED,METHODS,NATIVES,PSA,RESULTS,RURAL,SEER,SOCIETY,T1C,T2A,T2B,T2C,T2NOS,USING
169,2013,946,ALSO,CPO,INC,JAK1,PSIDIUM,SHP,SRC,STAT3,WILEY
251,295,549,723,BCR,COX,GLEASON,KOREA,LABEL,METHODS,OBJECTIVE,PCA,PSA,RESULTS,SIMILAR,WESTERN
EVIDENTLY,JANUS,KALLIKREIN,KLK,KLKS,MOST,REGARDING
OVERALL,STROMAL,STUMP
685,C685Y,CRAD,CRADS,E1A,E1B,PCA,PCAS
107,124,140,191,8805,AMONG,GLEASON,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,TTMB
2012,ABRF,GROUP,MASS,PSA,THUS
169,2010,2013,3199,3509,6708,BETWEEN,COPYRIGHT,INC,JANUARY,PUBLISHED,SUBMISSION
000,100,112,160,169,178,197,2006,2009,2013,269,288,423,494,734,922,981,ADVERSE,AGE,COPYRIGHT,DEPARTMENT,DUE,EDUCATION,EMERGENCY,INC,LABEL,MATERIALS,METHODS,NATIONWIDE,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THESE,UROLOGICAL
000,139,1970,1980,1989,1990,2007,2008,2009,2010,2020,289,372,717,797,AMONG,APPENZELL,BACKGROUND,DATA,FEDERAL,FSO,GRISONS,INCIDENCE,JOINPOINT,LABEL,METHODS,MODEL,POPULATION,PREVALENCE,RESULTS,SWISS,THERE
169,2013,946,ARRB,ARRBS,COPYRIGHT,INC,NOWHERE,STUDIES
169,2013,COPYRIGHT,ETS,GATA3,INC,PDEF,THESE
169,2013,COPYRIGHT,INC,NETWORK
169,2013,COPYRIGHT,INC,PUBLISHED,SEVERAL,SIMILARLY,SRT
169,2013,BASED,COPYRIGHT,GLEASON,INC,PUBLISHED
169,2013,CAREFUL,COPYRIGHT,ELDERLY,INC,MANAGEMENT,PRCA,PUBLISHED
1500,169,2013,COPYRIGHT,FIVE,INC
169,2013,COPYRIGHT,INC,OVERALL
169,2013,COPYRIGHT,INC,MEN,PUBLISHED,THERE
169,2013,COPYRIGHT,GLEASON,INC
169,2013,AVAILABLE,CARE,COPYRIGHT,HOWEVER,INC,PHYSICIAN,PUBLISHED
4T1,BACKGROUND,BONE,BOTH,CONCLUSION,DU145,EFFECTS,HOWEVER,LABEL,METHODS,MSC,MSCS,PCR,RESULTS,SIMILAR,THESE
100,8764,HOWEVER,IGY14,LOQ,PRISM,PSA,SRM
2012,8804,8805,FORCE,FURTHER,MAY,PREVENTIVE,PSA,TASK,THESE,UROLOGICAL
111,177,8243,ALA,BALB,BB2,BOTH,GLN,GLY,GRPR,IC50,LEU,NH2,NMRI,NOTA,PEG2,PET,PHE,RM26,SPECT,STA,TRP,VAL
000,100,162,182,2009,410,8202,AFTER,CZECH,ERSPC,GLEASON,GRAPH,N0M0,PCA,PLCO,PSA,THERE,TNM
100,171,180,712,931,ACCORDING,CONCLUSION,HIFU,HIGH,HOWEVER,IQR,LABEL,MEAN,METHODS,NHA,OBJECTIVE,OBJECTIVES,PHOENIX,PSA,REGARDLESS,RESULTS,SEVENTY,TURP

0127,8202,CD4,EOSIN,HOWEVER,LYMPHOCYTE,PCA,TRICHROME
NUMERICAL,PEARSON
169,2013,COPYRIGHT,HOWEVER,JOHN,LTD,MRI,MRSI,ROUTINE,SONS,THEREFORE,WILEY
BCL,BID,BOTH,CELL,CONVERSELY,ERK,ERK1,HOWEVER,MAPK,MCF,MCF7,MTT,PAR,PAWR,RELATIVELY
BASED,CBI,HOWEVER,L1210,NOTABLY,PREVIOUSLY
0005,0006,024,036,139,2009,APC,APCS,BRFS,CONCLUSION,EERPE,LABEL,MEIER,METHODS,OBJECTIVE,PATHOLOGY,PPC,PPCS,PSA,PSAD,PSM,PURPOSE,RESULTS
001,163,194,2006,2009,290,591,GLEASON,HOWEVER,MAY,MEDICAL,MRI,PCA,PCA3,RADBOUD,THUS,UNIVERSITY
155,169,186,1994,2007,2013,2802,337,492,916,BACKGROUND,BECAUSE,COPYRIGHT,COX,DATA,END,FOLLOWING,GLEASON,LABEL,METHODS,OBJECTIVE,OUTCOME,PCA,PCSM,PCSS,PROPENSITY,PUBLISHED,RADICAL,RESULTS,SETTING,UROLOGY
169,2013,AKT,BACKGROUND,CONTEXT,COPYRIGHT,ETS,LABEL,MAJOR,METHODS,MOLECULAR,OBJECTIVE,PCA,PUBLISHED,RESULTS,SYNTHESIS,THESE,UROLOGY
004,042,1000,1430,166,169,1993,1999,2013,210,2674,376,392,561,565,765,8805,AFTER,BACKGROUND,COPYRIGHT,ERSPC,GIVEN,LABEL,METHODS,OBJECTIVE,OUTCOME,PCA,PCAS,POISSON,PSA,PUBLISHED,RANDOMIZED,RESULTS,ROTTERDAM,SCREENING,SETTING,SYSTEMATIC,UROLOGY
169,2013,COLLEGE,COPYRIGHT,FOCAL,LTD,PUBLISHED,ROYAL,THERE
021,105,8805,ACUTE,AFTER,BACKGROUND,GRADE,HYRT,IGRT,LABEL,METHODS,PATIENT,PSA,RESULTS,RTOG
169,2003,2012,2013,8201,8805,BJU,EIGHT,JANUARY,LABEL,MARCH,MATERIALS,METHODS,NINE,OBJECTIVE,OBJECTIVES,PSA,RESULTS,TEN
185,270,560,8315,8322,8323,A431,A549,AMONG,BACKGROUND,BRAGG,CALCEIN,CELL,CLSM,DII,FIT,FNTD,FNTDS,GLUT,HDS,HOECHST,LABEL,METHODS,MEV,NEITHER,PC3,RESULTS,SMA,U87,VMDK
103,50E,8805,ARRAY,DENSITY,GLEASON,LOW,SUMMING,THESE,TLDA
76A,AIN,LNCAP,SIMILARLY
A594,MCF
CTLA,DRUG,FOOD
ALGORITHMS,BACKGROUND,BECAUSE,HOWEVER,LABEL,NGS,RESULTS,USING
ALZHEIMER,BACKGROUND,BASED,DIFFUSION,FINALLY,LABEL,RESULTS,THEN
BACKGROUND,HOWEVER,LABEL,RESULTS,SEQ,SEQGSEA
160,ARCAP,DMSO,EGF,EGFR,EPIDERMAL,ERK,GLI,PCA,TRANSWELL
000,169,2013,AUNRS,COPYRIGHT,CSC1,CSC13,DU145,EVEN,GMBH,KGAA,NIR,THEREFORE,VCH,WESTERN,WILEY
8201,8226,8805,954,COHEN,CONCLUSION,DATA,DCE,DWI,ESUR,HISTOLOGY,IMAGING,INTER,KEY,LABEL,METHODS,MRI,OBJECTIVE,OBJECTIVES,RADIOLOGY,RADS,REPORTING,RESULTS,SOCIETY,T2WI,TRUS,UROGENITAL,USING
000,001,024,062,067,180,500,8201,8226,8804,8805,CONCLUSION,DIFFUSION,DWI,FORTY,HOWEVER,KEY,LABEL,METHODS,MRI,OBJECTIVE,OBJECTIVES,PPV,RESULTS
189,BACKGROUND,CONCLUSION,LABEL,METHODS,OVERALL,RESULTS
0017,013,034,141,1991,2006,AFRICAN,AMONG,BCR,CCP,COX,EBRT,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OUTCOME,PHOENIX,PUBLISHED,PURPOSE,RESULTS,THERE
13D,169,2013,A549,COPYRIGHT,DU145,HBA,LTD,ORAL,PDGFR
NOVEL,TREATMENT
8321,AKT,BACKGROUND,FURTHER,LABEL,PRINCIPAL,RESULTS,THERE
MAXIMUM,SINCE,THUS
946,CRE,KLF5,RWPE,TGF,THESE,WHILE
946,FURTHER,PKG,PKG1,WDR77
155,183,189,2009,370,387,405,594,659,727,750,8201,BACKGROUND,BAD,BILATERAL,BOTH,HOWEVER,KKP,LABEL,METHODS,RESULTS,RETENTION,WILDUNGEN
BACKGROUND,DENMARK,INVITATION,LABEL,LACK,METHODS,OBJECTIVE,PATIENT,RESULTS
169,2013,203,571,COPYRIGHT,COX,CRP,FINLAND,FINNISH,HOWEVER,MEN,UICC
256,300,385,LABEL,METHODS,MRI,OBJECTIVE,PCA,PURPOSE,RESULTS,TESLA
238,240,343,596,HOWEVER,LEP,PUBLISHED
169,2013,AAS,AFRICAN,AMERICANS,CAS,CAUCASIANS,EMT,UICC,USING
169,2013,AACR,AKT,EXPECTEDLY,PI3K,PTEN,RAC,REX,REX2,RHO,THESE,THUS

001,1000,1064,1986,2010,315,4577,AMONG,CRUDE,EXPOSURES,IMPORTANCE,LABEL,MAIN,METHODS,OBJECTIVE,RELEVANCE,REPLACING,RESULTS,SATURATED,SETTING
ANTISENSE,ETE,FLAP,LOX,OXER1,SEVERAL,STUDIES
POST,TREATMENT
BONE,PAIN
945,AGGRESSIVE,DOX,THESE,TOPO,VSV
1257,2001,2009,230,8201,AFTER,BACKGROUND,BMI,COX,HIGH,LABEL,METHODS,PCA,PSA,PSAD,RESULTS,WORLD
ADT,CRPC,CYP17A1,DRUG,EARLY,FOOD,III,PCA,PHASE
946,CHIP,DICKKOPFS,DKK1,JUN,PCA,PTHRP,TCF,THESE,WNT,WNTS
ADT,WESTERN
2005,2010,CONCLUSION,CPG,CPGS,GUIDELINES,INSTITUTE,IOM,JANUARY,LABEL,LESS,METHODS,MOST,OBJECTIVE,PURPOSE,RESULTS,TRUST
169,2013,COPYRIGHT,EFFICIENT,FURTHER,HA2,IRELAND,LNCAP,LTD,PSMA,THESE
0001,0002,0003,001,169,2013,220,945,AIM,ANOVA,BASEL,COPYRIGHT,EIGHT,GLEASON,LABEL,MATERIALS,MDA,METHODS,OBJECTIVE,PCA,PSA,RESULTS,SERUM,THERE,UNIVARIATE
147,169,193,2013,AUSTRALIA,AUSTRALIAN,BACKGROUND,COPYRIGHT,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,RTR,THERE
017,024,035,044,169,2013,75TH,961,BACKGROUND,BLINDED,COPYRIGHT,DCE,DUE,GLEASON,KEP,KRUSKAL,LABEL,METHODS,MRI,OBJECTIVE,OUTCOME,P75,PCA,PUBLISHED,RESULTS,ROC,UROLOGY
169,2013,EFFECTIVE,GENOMIC,JOURNAL
ADDITIONAL,CNS,GBM,OUTCOME,RESULTS,SEVERAL,THESE
1996,945,AREAS,BACKGROUND,BPH,COVERED,LABEL,MEDICAL,MEDLINE,METHODS,OPINION
146AG,499A,ASIAN,CHINESE,CIS,CRC,HCC,HOWEVER,INDIA,KOREA,MICRORNAS,NORTH,ORS,RNAS,SNPS,WHEREAS,WHILE
252,272,280,323,331,553,CD8,CTL,CTLS,FIVE,H522,HLA,NCI,POTE,WHILE

177,180,945,946,99M,ARG,ASP,CHANGES,GLY,LINIFANIB,RGD2,SPECT,U87MG
164,191,3TMRI,AIM,BASED,CONCLUSION,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,OVERALL,PSA,RESULTS,THERE
8805,945,946,ACUTE,AFTER,AIM,CONCLUSION,CRT,DOSE,EQD2,EQUIVALENT,FORTY,GRADE,GROUP,IMRT,LABEL,METHODS,OBJECTIVE,RADIATION,RESULTS,RTOG,SIB,THERAPY
004,024,1EC,247,8804,8805,BACKGROUND,CONCLUSION,GLEASON,IEC,IGF,IIB,III,LABEL,MATERIALS,METHODS,RESULTS
169,2010,2011,2013,356,638,ANXIETY,ASSESSMENT,AUSTRALIA,CABRINI,COPYRIGHT,DEPRESSION,ENGLISH,FUNCTIONAL,GUIDELINES,HOSPITALS,INCLUSION,JOHN,LABEL,LATROBE,LOWER,LTD,MEETING,METHODS,NPAGA,OBJECTIVE,PCA,QOL,RESULTS,SCALE,SECONDARY,SONS,THERAPY,THESE,WILEY
HOWEVER,TSP,TSPS,VARIOUS
0001,036,1330,177,189,2007,2011,BEIJING,HOWEVER,MARCH,MEN,PEARSON,PSA,PSAV
229,EXPRESSION,FIVE,OSCC,PAR
231,3ML,ACUTE,CATHEPSIN,CTSL,INCREASES,KGP94,MDA,METASTASIS,NOVEL
100,11A,12A,13A,13I,145,169,176,2013,A549,COPYRIGHT,FURTHER,HELA,MTT,OXO,SAS
169,1C3,2013,945,ALDO,COMPOUNDS,COPYRIGHT,CRPC,CSR,ISSUE,LTD,SELECTIVE,SPECIAL
169,200,2013,COPYRIGHT,LTD,PERVASIVE,ROLES,THESE
ASHKENAZI,BRCA1,BRCA2,ICELANDIC,IGF,JAK,JANUS
169,2013,COPYRIGHT,HENCE,RWPE1,TGF
169,2013,AKT,COPYRIGHT,GFRS,IGF,INC,NTG,RTK,TRAIL,WHILE
169,2013,5MM,COPYRIGHT,CTV,EVEN,IMPT,INC,MFO,PUBLISHED,ROTATIONAL,TEN,V45,V70
000,002,024,102,125,145,169,2013,369,COPYRIGHT,DVHS,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
100,169,2013,947,956,COPYRIGHT,FLOW,HOWEVER,INC,PPAR,TAXOL,THESE,WST
0001,100,169,2013,344,CONCLUSION,COPYRIGHT,CRPC,ERG,FISH,HGPIN,HOWEVER,IHC,INC,LABEL,METHODS,OBJECTIVE,PCA,RESULTS
100,169,2000,2006,2013,406,AES,CONCLUSION,COPYRIGHT,CURRENT,INC,LABEL,METHODS,MINNESOTA,OBJECTIVE,PROCEDURAL,RESULTS,THESE,UNIVERSITY
001,169,2013,2052,22034,57441,6H2,ABM,CAT,CONCERNING,COPYRIGHT,FISH,GMBH,HOMOLOG,MICROARRAY,NB110,PTEN,THERE,WESTERN,Y184
001,004,006,009,1161,169,2013,BJU,CALIFORNIA,FRANCISCO,GLEASON,HOPKINS,JOHN,KETTERING,LABEL,MARSDEN,METHODS,OBJECTIVE,OBJECTIVES,RANDOMIZED,RESULTS,ROYAL,SAN,SLOAN,TORONTO,UNIVERSITY
092,169,1996,2013,293,8201,8804,8805,BJU,COX,FINNISH,LABEL,MATERIALS,METHODS,OBJECTIVE,PCA,PSA,RESULTS,TAMPERE
169,2000,2012,2013,524,8804,8805,BJU,GLEASON,HOPKINS,HOWEVER,JOHN,LABEL,METHODS,OBJECTIVE,PBXZ,REGRESSION,RESULTS
100,169,2013,640,8201,8805,BJU,CONCLUSION,GLEASON,HOPKINS,HOWEVER,IRS,JHAS,JOHNS,LABEL,METHODS,OBJECTIVE,POISSON,PSA,PSAD,RESULTS,RISK
231,CHINESE,IC50,MCF,MDA,MOST,THESE
144,AMONG,DWT,FUZZY,HOS,MACHINE,ORDER,SPECTRA,SUPPORT,THESE,THREE,TRANSFORM,TRUS,ULTRASOUND,WAVELET
100,390,ADENINE,FAD,NADH,TRS
AFTER
003,011,2008,2010,210,300,BONE,CONCLUSION,CREATININE,DIGITAL,GLEASON,LABEL,METHODS,OBJECTIVE,PSA,RESULTS
0001,025,102,185,2006,2011,3N1,CONCLUSION,FOUR,GLEASON,IMMEDIATE,LABEL,LRP,MEAN,METHODS,OBJECTIVE,OCTOBER,PREDICTING,PSA,RAJAVITHI,RESULTS,STAGE,THREE,UNIVARIATE
0001,215,ADT,AKT,AKT1,ANOVA,BODY,ENDURANCE,GLUT4,IMAT,INSULIN,NINE,PRIMARY
239,945,946,ENDOCRINE,ESTROGENS,RELATED,ZELLWEGER
003,051,169,2000,2009,2013,288,381,8201,874,8804,8805,906,ADDITIONAL,BACKGROUND,COPYRIGHT,END,INCIDENCE,LABEL,METHODS,MORTALITY,RESULTS,SIMILARLY,SOCIETY,STATISTICS,STUDIES,THESE,USING,VITAL
169,1997,2013,AML,CSC,CSCS,INC,JOHN,SONS,THESE,WILEY
169,2013,BRITAIN,COPYRIGHT,GIVEN,GREAT,IRELAND,JOHN,LTD,PUBLISHED,SOCIETY,SONS,WILEY
FURTHER,HOWEVER,NIGELLA,PLANT,USING

000,175,1991,1996,1997,2001,2002,2005,2012,379,400,ASAP,DETECTION,DRE,HGPIN,INCIDENCE,JANUARY,LABEL,METHODS,OBJECTIVE,OVERALL,PCA,PSA,PURPOSE,RESULTS,SPBX,TPBX
103,141,169,2013,29B,COPYRIGHT
169,2013,BIR2,BIR3,COPYRIGHT,IAP,LTD,ML183,SAR,SMAC,TRAIL,XIAP
1224,123,169,182,183,187,2007,2010,2013,612,873,AUG,BACKGROUND,BETWEEN,COPYRIGHT,DOCETAXEL,EASTERN,FEB,FUNDING,GROUP,INC,IQR,LABEL,LTD,MEN,METHODS,REGENERON,TREATMENT,VEGF
011,1251,1258,177,2010,2012,963,BACKGROUND,BEAM,BRAGG,FURTHER,HEIDELBERG,HIT,HOUNSFIELD,ION,LABEL,PEAK,PET,RESULTS,THERAPY,TOMOGRAPHY,UNIT
169,1999,2010,2013,267,465,732,8201,AFRICAN,AIM,BACKGROUND,CAUCASIAN,HOWEVER,LABEL,MAIN,METHODS,OBJECTIVE,OUTCOME,PRE,RESULTS,SOCIETY,VCS,XRT
169,2013,ADT,AIMS,BACKGROUND,BOWEL,COMPOSITE,DOMAINS,EACH,EPIC,INDEX,LABEL,MAIN,METHODS,MSHQ,MSM,OBJECTIVE,OUTCOME,PCA,QOL,RESULTS,SCALE,SEVEN,SOCIETY,THERE,URINARY,WHILE
BACKGROUND,GOLGI,GP73,HOWEVER,LABEL,METHODS,PCR,RESULTS,WESTERN
POTENTIAL,TRANSIENT,TRPV2
FASN,FATTY,HOWEVER,INHIBITORS,PET
775,ATLAS,BARR,DETECTION,EBV,EPSTEIN,HEPATITIS,HPV,SEQ,VIRAL,WHILE
215,AFTER,BACKGROUND,EACH,GLEASON,GVAX,LABEL,LNCAP,METHODS,PATHOLOGIC,PSA,RESULTS,SIX,THESE
169,2013,900,945,946,AKT,COPYRIGHT,DHT,HSP70,HSP90,KNOCKDOWN,PATHWAY,PCA,PI3K,SGTA,SOLID,TPR,UICC
136,147,169,174,2013,27632,BACKGROUND,BOTH,CELL,CELLS,COPYRIGHT,DEAD,EDTA,INC,LABEL,LIVE,LUCAP,METHODS,MTS,PCR,R1881,RESULTS,RHO,STEMPRO,STR,WILEY,XENOGRAFTS
007,021,042,088,160,1993,2003,2007,238,258,527,673,734,842,882,907,AMONG,ASIRS,CATALAN,CATALONIA,CONCLUSION,DATA,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SPAIN,TARRAGONA,THESE
991,PATHOLOGIC,RADICAL
101,CD133,CD44,CELL,EZH2,FACS,FINALLY,HOWEVER,LNCAP,MTT,PCSC,PCSCS,SILENCE
145,181,AUC0,BLOOD,CHOLINE,DECREASED,FOURIER,FTIR,GNP,GNPS,GOLD,ICP,LABEL,METHODS,MTT,OBJECTIVE,PEI,PURPOSE,RESULTS,TEM,USING,XPS
169,200BP,2013,COPYRIGHT,FFPE,HOWEVER,INC,MLV,MOLONEY,PCR,RTS,VIRUS
169,177,2013,8194,8197,8201,916,956,968,ANNEXIN,APOPTOSIS,CASPASE,DAD,EPILOBIUM,HPLC,KEY,LABEL,LNCAP,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,ROYAL,SOCIETY,USING
160,169,2006,2009,2010,2012,2013,AIMS,JOHN,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,ROUTINE,SONS,UPON,WHOLE,WILEY
116,ACHE,HCT,HOWEVER,IC50,MCF,NMR,SEVENTEEN
8764,AFTER,AIM,CORE,COX,DIGE,EARLY,ELISA,HDAC1,HOWEVER,LABEL,META,METHODS,OBJECTIVE,PCA,PTEN,REGRESSION,RESULTS,ROC,SFPQ,SVM,THEN,THEREFORE
001,005,177,BACKGROUND,CD31,HPF,HPFS,METHODS,MVD,OBJECTIVES,RESULTS,VEGF
169,2013,COPYRIGHT,COX,GLEASON,MEIER,PCA,UICC,UNIVARIATE
256,311,8805,BOTH,PSA,PVUII,SIMILARLY,XBAI
8320,8325,CNS
160,AFRICAN,BASED,BLACK,DESPITE,EARLY,FIRST,HOWEVER,NON,WHITE
124,160,2005,2009,383,449,506,AFFAIRS,CONCLUSION,FURTHER,JANUARY,LABEL,MEDICAL,METHODS,MPM,MPMS,OBJECTIVE,PURPOSE,RESULTS,SEER
945,AMP,LNCAP,ODNS,PKA,PKARI,WESTERN
AFFYMETRIX,FORTY,FURTHER,SNP

ADDITIONAL,ASX,ASXH,ASXL,ASXL1,ASXL2,ASXL3,ASXM1,ASXM2,ASXN,BAP1,BOHRING,DROSOPHILA,EPC1,GERM,KDM1A,LSD1,MSI,NCOA1,NHR,NHRS,OPITZ,PHD,PRC,PRC2,TRUNCATION
15A,169,2013,COPYRIGHT,LTD,PIM
160,OVERALL
169,1997,2009,2013,272,8804,8805,ASPT,CONCLUSION,COPYRIGHT,GLEASON,INC,LABEL,METHODS,OBJECTIVE,RESULTS,SET
1515,169,2013,8805,BARR,BASED,CD4,CD8,COPYRIGHT,DAVID,EBV,EPSTEIN,ESPECIALLY,FIVE,FOUR,GMBH,HBV,HCV,MANN,NOS,PTCL,TIA,WHITNEY
169,1984,2012,2013,BASEL,COPYRIGHT,ENGLISH,EXPERIENCE,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PSRC,RESULTS
135,169,2013,333,408,702,BASEL,CONCLUSION,COPYRIGHT,GLEASON,LABEL,MATERIALS,MEN,METHODS,OBJECTIVE,PCA,PSA,PSM,RESULTS,TURP,USING
169,2013,COPYRIGHT,LTD,ONCOSTATIN,PC3M,TGFBI,THESE,TREATMENT
13P,169,2013,956,COPYRIGHT,COXS,DU145,IC50,PC3,PCDNA,SAR,SAS,SKP2,STRUCTURE,THEIR
169,1993,2012,2013,ADT,AGE,BACKGROUND,BECAUSE,CONTEXT,COPYRIGHT,CURRENT,INCREASING,LABEL,MEDLINE,METHODS,OBJECTIVE,PCA,PLND,PUBLISHED,RESULTS,SYNTHESIS,THEREFORE,UROLOGY
145,485,945,BACKGROUND,CYTOTOXIC,LABEL,MONITORING,PCS,RESULTS
945,GIVEN,GPCR,GPCRS,HIGH,INCREASED,LIGANDS,RGS,RGS17
001,300,349,BACKGROUND,DISTANT,LABEL,LESS,METHODS,RESULTS,SIMILARLY
AGENT,CURRENT,EXPOSED,VIETNAM,WAR
CELL,MEP50,SMAD1,USING,WD40,WDR77,YEAST
1404,1405,1427,1428,157,176,177,550,99M,CIM,CONCLUSION,FOUR,HIGH,LABEL,LNCAP,METHODS,MIP,PC3,PMPA,PSMA,RESULTS,SPECT,THESE,TIM,UNLABELLED
169,1972,1981,2010,2013,BCC,COPYRIGHT,ICELAND,INCREASED,UICC
CYTOSTATIC,THEIR
109,169,2013,AFRICAN,AMONG,BACKGROUND,COPYRIGHT,LABEL,LACK,LOWER,METHODS,RESULTS,SOCIETY,THESE
181,8209,ACC,BCL,CDK,CDK4,COA,COC1,DDP,IC50,TOFA
ESTIMATES,FIRST,KNOWLEDGE,THIRD
143,8209,DU145,FOLLOWING,MICRORN,MMP,THESE
160,THYROID,TTF1,WORLD
AIM,BACKGROUND,BPH,CHILE,LABEL,METHODS,OBJECTIVE,RESULTS,SPECIMENS,THERE,THESE,VEFG,VEGF
105,1998,2010,422,608,BACKGROUND,INADEQUATE,INDEX,LABEL,MEN,METHODS,OBJECTIVE,RESULTS,SWEDISH
169,175,2013,ASSIA,COPYRIGHT,HRQOL,JANUARY,LABEL,LTD,MEDLINE,MEN,METHODS,OBJECTIVE,PERCEIVED,RESULTS,STUDIES
MRI
MRI
100,BACKGROUND,DISCUSSION,EVEN,FURTHER,HOWEVER,IGF,LABEL,METHODS,MIF,SECONDARY,SEPARATING,TRIAL,VO2
000,127,169,2006,2013,257,AIM,AUSTRALIA,AUTHORS,DALY,DALYS,DUE,LABEL,METHODS,OBJECTIVE,RESULTS,USING
169,2013,FURTHER,JOHN,LTD,SONS,THESE,WILEY
145,946,A2780,ANNEXIN,CELL,H1299,PCDT,POOR,SKOV
160,954,BARRETT,CD4,DESPITE,IMPORTANT,JAK,STAT,THERE,WNT
169,2013,353,ANXIETY,ASIA,ASSESSMENT,CHINESE,DEPRESSION,FUNCTIONAL,FURTHER,GENERAL,HRQOL,LTD,MILD,PTY,PUBLISHING,THERAPY,WILEY,YOUNGER
956,BASED,DOT,DOTS,FURTHER,OPEN,SUSPENDED,USING
001,004,017,1268,2000,2009,8805,AGE,AMICO,CHANGES,DATA,GLEASON,JAPAN,LABEL,METHODS,OBJECTIVE,RESULTS,USA
151,1985,2006,8314,CD1A,CD4,CD8,GLEASON,MEIER,PCA,WHOLE
009,012,169,2013,724,946,947,AKT,BRITAIN,CAV,CONVERSELY,COPYRIGHT,GLEASON,GREAT,IRELAND,JOHN,LTD,PUBLISHED,SILENCING,SNCG,SOCIETY,SONS,TGF,THESE,WILEY,WPMY
169,2013,947,COPYRIGHT,GLEASON,HYPOXIA,LNCAP,OTHER,PCS,UICC
18TH,223,CONFERENCE,JAMES,KANTOFF,NCCN,RAPID
HOWEVER,LOW,MICROARRAY
BBN,GRPR,LNCAP,NINE,PC3,RHD,THESE
526,BACKGROUND,CONCLUSION,CURRENT,LABEL,METHODS,PCA,RESULTS,THESE,TOTAL
169,200,2013,8201,BACKGROUND,CD24,CD44,CK5,CK8,CONCLUSION,INC,INDIVIDUAL,LABEL,LAPC4,LAPC9,LNCAP,METHODS,PCSC,RESULTS,SCID,SOX2,THESE,WILEY
BACKGROUND,DISCUSSION,ELECTRONIC,FURTHER,KINGDOM,LABEL,METHODS,MOST,OBJECTIVE,RESULTS,SCREENING
129,137,1992,2005,AFTER,FOUR,RADICAL,SEVERAL
001,177,BLOOD,CD127,CD25,CD4,HOWEVER,PCA,THEIR,THEN,TREGS
AMONG,CONSISTENT,EGF,EMT,ERG,ETS,SRC,TMPRSS2,VCAP
CAFS,FINALLY,PCA,THESE
207,300,DESPITE,RNAS,THROUGH
H19,MIA,NOTABLY,PICS,PTEN,SOX9,THUS
CONVERSELY,CRPC,NOTABLY,PTEN,THUS,TRP53,XAF1,XIAP
169,2013,COLLEGE,COPYRIGHT,EBRT,HDR,HIGH,LDR,LTD,PUBLISHED,ROYAL,THERE
169,2013,945,ALSO,AMONG,ANXA1,AUTHORS,COPYRIGHT,DA3,EGF,INC,K257,LNCAP,MOUSE,PUBLISHED,SITE,SUMO,SUMOYLATED,THESE,Y21
0001,0003,001,073,169,1987,2011,2013,449,744,COPYRIGHT,CUMULATIVE,EDUCATION,GLEASON,HOWEVER,INC,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RANDOMIZED,RESULTS,THESE,UROLOGICAL
0001,001,169,2013,583,ALSO,ASSESSING,AUC,COPYRIGHT,EDUCATION,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,ROC,UROLOGICAL
169,1998,2007,2011,2013,272,695,713,AGE,COPYRIGHT,EDUCATION,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PRIOR,PUBLISHED,PURPOSE,RESULTS,SINCE,SWEDISH,T1C,UROLOGICAL
169,1987,2012,2013,259,COPYRIGHT,EDUCATION,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THERE,UROLOGICAL
001,014,018,115,169,177,188,2006,2012,2013,319,COPYRIGHT,EDUCATION,GROUP,INC,LABEL,MATERIALS,MEAN,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
169,2013,333,898,AGE,COPYRIGHT,EDUCATION,HOWEVER,IIEF,INC,INDEX,LABEL,MATERIALS,METHODS,OBJECTIVE,PSS,PUBLISHED,PURPOSE,RESULTS,RISK,SCORE,SYMPTOM,UROLOGICAL,WHILE
169,2013,COPYRIGHT,LBP,LNCAP,LTD
169,2013,BAX,BCL2,COPYRIGHT,IRELAND,LTD,MDM2,SALMONELLA,THESE
169,2013,CLOQUET,CONCLUSION,COPYRIGHT,INC,LABEL,LNS,METHODS,OBJECTIVE,PLND,PLNDS,PUBLISHED,RESULTS,RETRACTION
001,1150,1330,160,169,2002,2012,2013,3000,630,8804,915,CONCLUSION,COPYRIGHT,EDV,INC,LABEL,METHODS,OBJECTIVE,OVERALL,PSA,RESULTS,SIDE
169,2013,CONCISE,COPYRIGHT,EDUCATION,FOUNDATION,INC,MAYO,MEDICAL,PHYSICIANS,PUBLISHED
1062,169,174,176,2013,2MM,4MM,6MM,7MM,CONCLUSION,COPYRIGHT,FIVE,GOLD,LABEL,METHODS,OBI,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SAS,TEN
001,169,192,2013,867,AUC,COPYRIGHT,EXAMINING,FURTHER,HOWEVER,LTD,MALAT,PCA,PCA3,PCR,RNAS,ROC
0001,0002,002,004,042,169,1993,1995,1997,1999,2001,2013,22863,584,730,8805,ADT,AFTER,BRITISH,CCI,COPYRIGHT,DISEASE,EARLY,EORTC,GLEASON,IRELAND,LABEL,LATE,LTD,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS,USAGE
AAP,COV,DVHS,IMRT,INC,LABEL,MATERIALS,METHODS,NINE,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,V70
011,169,2013,657,COPYRIGHT,HEART,HOWEVER,HRV,LTD,PUBLISHED,RATE,THESE,WHILE
168,2012,2013S,452,611,938,LABEL,MAIN,METHODS,OBJECTIVE,OBJECTIVES,OUTCOME,PSA,QALY,QALYS,QUALITY,RESULTS
1201,160,2008,2011,2013S,2027,2531,2724,2776,299,594,655,736,8805,AUSTRALIA,CONCLUSION,LABEL,MAIN,MEN,METHODS,MOST,NETWORK,OBJECTIVE,OUTCOME,RESULTS,SETTING,THOSE,TREATMENT
FIRST
1999,1ST,2012,30TH,ASIA,ASIAN,BACKGROUND,ENGLISH,INCLUSION,JANUARY,JAPAN,LABEL,LEVEL,MATERIALS,MEDLINE,METHODS,QOL,RESULTS,SCIENCE,WEB,WEEK
1999,2002,371,850,BACKGROUND,FIVE,INDIA,LABEL,LAR,LOCAL,MATERIALS,METHODS,NON,RESULTS,TATA,TMH,UNDER
008,018,100,132,BACKGROUND,ELISA,HODGKIN,LABEL,MATERIALS,METHODS,NSE,RESULTS
001,103,198,956,ANXIETY,APMRT,BACKGROUND,DASS,DEPRESSION,HOWEVER,KEBANGSAAN,LABEL,MATERIALS,MEDICAL,METHODS,RESULTS,THERE,UKMMC,UMMC,UNIVERSITI,UNIVERSITY
HOWEVER,III,NPC,PHASE,PREVENTION,SURGERY,TRIAL,VITAMIN
35S,ACUTE,BPH,EPIDIDYMO,STI,UTI
ADT,CRPC,DESPITE,EVENTUALLY,LHRH,MEDICAL,MOST,THERE
ADDITIONAL,CURRENT,DEFECTS
002,1420C,2756A,677C,B12,HOWEVER,MECHANISMS,META,MTHFR,MTR,SHMT1,THERE
ACHIEVING,HBP,HORMONE,IGF,INHIBITION,INSULIN,KLK3,RTKS
BACKGROUND,BV2,CONCLUSION,FINALLY,HOWEVER,LABEL,METHODS,RESULTS,SIMILARLY,VPP
945,946,AMONG,PEPTIDE,THUS
2012,3482,4304,5195,5786,8202,A588T,ASIAN,BEGG,CAUCASIAN,HIF1A,LABEL,METHODS,NOV,OBJECTIVE,ODDS,OVERALL,P582S,PURPOSE,RESULTS,STATA,STILL,THEREFORE
2007,2012,ASIAN,CAP,CAPSURE,FRANCISCO,INITIATIVE,JAPAN,JOINT,MEETING,SAN,SEVERAL,SINCE,SIXTH,USA
035,2010,8805,AFTER,AVERAGE,BACKGROUND,EASTERN,FACTORS,GRADE,GROUP,LABEL,MARCH,METHODS,PAIN,PALLIATION,RESULTS,TREATMENT,UPDATED
169,1800,2013,2300,800,ADC,ANOVA,AUC,CONCLUSION,COPYRIGHT,DFAST,DSLOW,DWI,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PCA,PURPOSE,RESULTS,ROC,WILEY
001,017,117,954,AUC,BOTH,CONCLUSION,GLEASON,LABEL,METHODS,OBJECTIVE,ORP,OVERALL,PSA,PURPOSE,RALRP,RESULTS
001,CRPC,EPI,HORMONE,LBD,NTD,THESE
034,163,2003,2009,738,AIMS,DM2,DMP,ENROLMENT,HYPOTHESIS,JUNE,LABEL,METHODS,OBJECTIVE,PANCREATIC,POISSON,RESULTS,RISK,SIR,SIRS,THERE
THEIR
215,SKENE
946,BACKGROUND,BALP,CONCLUSION,COX,CTX,DATA,LABEL,METHODS,OWING,P1NP,PCA,RESULTS,SERUM,SRES
0008,135,185,2907,657DEL5,8315,8805,BACKGROUND,BRCA1,C61G,CHEK2,CONCLUSION,DRE,G84E,I157T,IVS2,LABEL,METHODS,NBS1,PSA,RESULTS,SNP,SNPS,THESE,THREE
2002,2008,5456,8805,AFTER,AGE,BACKGROUND,CLINICALLY,CONCLUSION,GERIATRIC,LABEL,MEN,METHODS,RESULTS,THERE
0001,169,1990,1998,2013,924,ALONG,BACKGROUND,COPYRIGHT,DATA,INCOMPLETE,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,ONTARIO,PURPOSE,RESULTS,TREATMENT
164,1986,2003,279,362,8804,8805,COX,FLAVONOIDS,III
CURRENTLY,LTD,PUBLISHED,WESTERN
1360,168,169,189,2012,2013,AMICO,BACKGROUND,CONTEXT,COPYRIGHT,ELND,FURTHER,GLEASON,INCIDENCE,LABEL,LND,MEDLINE,METHODS,MOST,OBJECTIVE,OCTOBER,OVERALL,PCA,PUBLISHED,RARP,RESULTS,SCIENCE,SHORT,STUDIES,SYNTHESIS,THREE,UROLOGY,WEB
169,2000,2012,2013,BACKGROUND,CONTEXT,COPYRIGHT,DESPITE,DIFFERENT,HIFU,ITEMS,LABEL,META,METHODS,OBJECTIVE,OPTIONS,PCA,PREFERRED,PSA,PUBLISHED,RADIATION,REPORTING,RESULTS,REVIEWS,STUDIES,SYNTHESIS,SYSTEMATIC,UROLOGY
000,169,173,1994,2010,2012,2013,246,371,423,6449,6974,8804,BACKGROUND,COPYRIGHT,INCIDENCE,INSTEAD,JUNE,LABEL,MEIER,METHODS,NINE,OBJECTIVE,OUTCOME,PCA,PSA,PUBLISHED,RESULTS,SETTING,SWEDISH,UROLOGY,WESTERN
169,2013,216,CAREFUL,COPYRIGHT,LTD,MULTI,PUBLISHED
169,2013,48692,COPYRIGHT,LTD
METASTASIS
169,2013,BACKGROUND,CONCLUSION,COPYRIGHT,LABEL,METHODS,PCA,PSA,RESULTS,SAS
BACKGROUND,DESPITE,LABEL,METHODS,RESULTS
100,78000,8764,945,AKT,ANTIBODIES,DESPITE,FINALLY,GRP78,LRP,RBD,SCATCHARD,THESE,THUS
169,191,199,2013,229,237,268,276,947,CD8,CTL,CTLS,FIVE,GLQLGVQAV,HLA,HPN,IFN,JOHN,LNCAP,LTD,PLTEYIQPV,SLLSGDWVL,SONS,THEREFORE,THESE,WILEY
AFTER,CURRENTLY,THEREFORE,WITHOUT
946,BPH,CONSISTENT,IGF,PCA,TGF,USING,WESTERN
169,2012,DESPITE,SOCIETY,THERE,THESE
169,2013,ADT,BACKGROUND,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,PET,RESULTS,SDC,SDCS,WILEY
001,023,129,2005,2011,704,734,742,748,8804,BCR,COX,GLEASON,INCREASING,JULY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
1306,1987,946,GLEASON,HBP,METABOLIC,MICROARRAY,MYC,OGT,SUPPORTING
001,169,2013,3514,5088,8201,8764,8805,BACKGROUND,CALCULATOR,COPYRIGHT,DATA,LABEL,METHODS,PCPT,PREVENTION,PSA,PSAS,RESULTS,RISK,RISKS,SEPARATING,SOCIETY,TRIAL
169,2013,2EHT,410,434,552,622,8201,8805,ADT,BACKGROUND,COPYRIGHT,CRPC,EASTERN,GLEASON,GROUP,LABEL,METHODS,RESULTS,SOCIETY,THERE
HOWEVER,MICRORNAS,MOUSE,TRAMP,TRANSGENIC
THEREFORE,THESE
108,11Q14,169,2013,215,289,453,614,673,BACKGROUND,COPYRIGHT,GWAS,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEVERAL,SNPS,SOMMERS,THESE,TREATMENT
1999,2012,276,65291,925,APRIL,DOCETAXEL,EIGHT,GLEASON,LUTENIZING,MARCH,PACLITAXEL,PSA,SIX,THREE
027,043,65291,65309,CHANGES,EGG,EHS,EIGHT,PDE5,SEAR,SELF,SIX
AFRICAN,AWARENESS,MEN,PROJECT
006,100,8201,ADVERSE,BACKGROUND,BLOOD,CONFIDENCE,FGF2,FOUR,FURTHER,IL8,LABEL,LOW,METHODS,METRONOMIC,MOVIN,NSCLC,OBJECTIVE,PFS,PRIMARY,RESULTS,SEVENTY,TEK,TREATMENT,TRIAL,TTF
169,2013,EGR,EGR1,FEBS,NOTABLY,REMARKABLY,WAALS
0304,381,8201,EIT,EXAMPLE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,STUDENT,THESE,THIN,TRUS
176,177,8201,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
225,4GY,8725,8810,CBCT,CTS,D99,DOSIMETRIC,IMRT,LABEL,METHODS,MLC,MLCS,OAR,OARS,OBJECTIVE,PURPOSE,RESULTS,SELECTIVE,SEVENTY,SIMILAR,USING,V56GY
0001,001,181,AIM,CONCLUSION,COX,DATA,LABEL,MEIER,METHODS,OBJECTIVE,RESULTS,SARCOSINE,SERUM
2011,2012,8805,AIM,CONCLUSION,FORTY,GLEASON,JANUARY,LABEL,MARCH,METHODS,OBJECTIVE,RESULTS,RIONERO,SEVENTEEN,UNIVERSITY,VULTURE
2012,ITALIAN,THERE
2012,ITALIAN,THERE
130,756,DISTANT,ML2,PC3,PCA,WESTERN
101K,2010,91K,94K,956K,AWP,BACKGROUND,CEA,CONCLUSION,DOCETAXEL,EXCELLENCE,ICER,III,INCREASES,INSTITUTE,LABEL,METHODS,MODEL,NEWER,NICE,OBJECTIVE,QALY,RESULTS
148B,152,231,29B,29C,946,ACTIVATION,DU145,MDA,RAR,TLR3,TOLL,TRAMP
LIMITLESS,STRIKINGLY,THESE,WHILE
001,105,169,2004,2007,2013,2506,454,946,AFRICAN,BACKGROUND,CAUCASIAN,COPYRIGHT,DELAY,END,INSTITUTE,LABEL,METHODS,RESULTS,SEER,SOCIETY,TIME,USING
169,2013,350,COMP,CURRENTLY,ELISA,GMBH,KGAA,SINCE,VAP,VCH,WILEY
128,2010,AIRO,DESPITE,GLEASON,ITALIAN,LABEL,METHODS,OBJECTIVE,PURPOSE,RADIATION,RESULTS,SCORE,THESE,THREE,TNM
1880,HOWEVER,IMAGING
909,BFTC,COX,EXPRESSION,HOWEVER,MMP,THUS,UUT,UUTUC
160,ABT,ASSAM,ATP,TAKEN,TFS,YBT
048,133,140,757,824,879,BRFS,GLEASON,HOWEVER,PCA,PSA,THERE
160,8209,945,CIP1,EGR,INHIBITION,JNK,JUN,LNCAP,TNF,TPA
COMPONENTS,HOWEVER,MARIJUANA,STUDIES,THC,USA
213,752,8805,966,BMI,CIS,COLORECTAL,CONCLUSION,DATA,HRS,LABEL,LUNG,METHODS,OBESITY,OBJECTIVE,ORS,OVARIAN,PURPOSE,RESULTS,SCREENING,TRIAL,WHETHER
IC50,LXXLL,PELP1,THESE
048,169,177,2013,8805,AACR,CONCLUSION,EXPANSION,FORTY,IMAGING,J591,LABEL,METHODS,OBJECTIVE,PSA,PSMA,PURPOSE,RESULTS,SITES,THOSE
091,092,106,114,169,2013,270,315,8201,AUR,BJU,COMPARING,GLEASON,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PCA,PSA,PSAD,RESULTS,TTSB
001,008,009,167,169,2013,256,425,681,8201,AMONG,BJU,DATA,DOPPLER,GLEASON,IMAGE,LABEL,METHODS,OBJECTIVE,RESULTS,TRUS
ADT,LARGE
AMONG,DRUG,FOOD,III,PSA,RESULTS
223,427,FURTHER,III,MOST,O11,OGX,THERE
100,600,AMERICANS,DHA,EPA,MOST,OMEGA
EGCG,GREEN,GTP,GTPS,THERE
122,169,183,2008,2012,2013,642,990,BOTH,COPYRIGHT,EDUCATION,INC,INCLUSION,LABEL,MACCONKEY,MATERIALS,METHODS,MILD,OBJECTIVE,POST,PROTECTION,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
169,2013,946,AJCC,ASIA,AUTHORS,BEC,CD31,CD34,GLEASON,III,LEC,LTD,MVED,MVPD,NIH,PATHOLOGY,PDGFR,PTY,PUBLISHING,SOCIETY,THESE,WILEY
AFRICAN,DIFFERENT,PROSTATIC,SINCE
946,956,ARD,ARS,GI50,USING
169,2013,AKT,BACKGROUND,BEIGE,BRITISH,CHOLBUT,CONCLUSION,EFFECTS,KEY,LABEL,LUC,METHODS,OBJECTIVE,PC3,PURPOSE,RESULTS,SCID,SLN,SLNS,SOCIETY,SOLID,THESE,WESTERN
169,2013,207,239,ANXIETY,AUSTRALIA,COPYRIGHT,INTERVIEW,JOHN,LABEL,LTD,MEN,METHODS,OBJECTIVE,REGRESSION,RESULTS,SCALE,SONS,TELEPHONE,WILEY
1984,2010,AFTER,BACKGROUND,ERT,FOUR,FRANKEL,LABEL,MEAN,METHODS,MRI,MSCC,PATIENT,RESULTS,SIXTEEN
169,2013,COPYRIGHT,JOHN,LTD,MRI,SONS,THUS,WILEY
ERSPC,HOWEVER,PSA
8201,BACKGROUND,COX,DATA,ENDORECTAL,LABEL,METHODS,PSA,RESULTS,T2W,TESLA,THERE,THESE,TRIAL
DATA,MRI,MRL,PET,PORT,PSA,SPECT,WPRT
2005,AUTOPSY,GLEASON,HOWEVER,ISUP,PATHOLOGY,PSA,SERUM,SOCIETY,UROLOGICAL
HYPOXIA
2011,2718,IMPORTANCE,INFORMING,KNOWLEDGE,LABEL,MAIN,METHODS,MOST,OBJECTIVE,OVERALL,RELEVANCE,RESPONSES,RESULTS,SETTING
169,2013,954,COPYRIGHT,FURTHER,HT29,LCDAD,LTD,PC3
001,005,006,169,1957,2013,BACKGROUND,COPYRIGHT,LABEL,METHODS,OBJECTIVE,OUTCOME,PCA,PERINEURAL,PUBLISHED,RESULTS,S100,SAS,SETTING,SIMILAR,SPECIMENS,SUBSEQUENT,UROLOGY,WHOLE
124,177,2004,2009,355,398,740,782,BPH,LABEL,M50,METHODS,OBJECTIVE,PVP,RESULTS
169,2013,ABOLISHING,BMP,BONE,CAP,HOWEVER,LNCAP,MDV3100,SUBSEQUENT,TAKEN,TRAMP,USING
BONE
1013,842,945,ACONM,FASN,HIF,HIF1A,HOWEVER,HYPOXIA,LDHA,LNCAP,RESULTS,THESE
CONCLUSION,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS
022,121,126,140,179,2006,2011,247,403,718,APRIL,ASIAN,CONCLUSION,GLEASON,LABEL,MATERIALS,MAY,MEN,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,SMALLER,TRUS
AFFYMETRIX,RMA,RNAS,THESE,WHILE
956,APOPTOTIC,CHROMATIN,DIM,DIMS,DR4,DR5,FAS,FASL,HOECHST,INTRA,LNCAP,PARP,RING
177,945,946,ARG,ASP,BACKGROUND,BBN,CONCLUSION,DO3A,DUAL,GLY,GPRP,LABEL,MATERIALS,METHODS,PC3,RADIATION,RESULTS,RGD
011,2007,2010,BETWEEN,CAA,FURTHER,ISR,JANUARY,ROBOTIC
160,954,EXPRESSION,GFP,INJECTION,KNOCKDOWN,OPG,PC3,PCR,PLAC8,RANK,RANKL,RBP4,THUS,TOXICITIES
ERG,MMP9,PC3C,PCA,TMPRSS2,WESTERN
0332991,CDK,CDK4,FINALLY,PCA,SUBSEQUENT
012,230,300,361,8805,905,ADT,COX,PCA,SERUM
130,2008,2010,2011,8804,EQUAL,JANUARY,MARCH,OPERATIVE,PCA,THERE,THESE,USING
CONCLUSION,DFS,EXPRESSION,GLEASON,HOWEVER,HUNDRED,LABEL,METHODS,MMP,MMPS,OBJECTIVE,PURPOSE,RESULTS,TIMP,TIMPS
AAS,PET,SPECT
PCA,PSA,SINCE
NEXT,RNAS,ULTIMATELY,WHILE
169,187,2013,473,AKT,CDK2,COPYRIGHT,FURTHER,IAA,INC,PTEN,THESE,THUS
169,176,180,200,2013,270,COPYRIGHT,LTD,TLDS,USING
120,169,2013,946,AIMS,BACKGROUND,BPH,COPYRIGHT,DESPITE,GLEASON,IMSS,INC,LABEL,METHODS,OBJECTIVE,PCA,PSA,PUBLISHED,RESULTS,SERUM
001,149,163,169,2013,312,476,753,COPYRIGHT,EDUCATION,HGPIN,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PROSTATIC,PUBLISHED,PURPOSE,RECURRENCE,RESULTS,TEN,UNIVARIATE,UROLOGICAL
169,174,2013,294,ADDITIONAL,ASTRO,AUA,COPYRIGHT,EDUCATION,GUIDELINE,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PHYSICIANS,PRINCIPLES,PUBLISHED,PURPOSE,RAP,RESULTS,UROLOGICAL
100MG,1423,169,2013,956,CCG,CLOGP,COPYRIGHT,IC50,LTD,MKL1,RHO,SRF
100,169,200,2013,COPYRIGHT,HPLC,PC3,PLGA,TAXANES,THESE
169,2013,22043,30041,AFTER,BACKGROUND,COPYRIGHT,DUMMY,EARLY,EORTC,IRELAND,LABEL,LTD,MATERIALS,METHODS,NINE,OAR,OBJECTIVE,PURPOSE,QART,RESULTS,RUN,SIX,VODCA
2008,865,8749,ALZHEIMER,AMONG,CUMULATIVE,GMBH,HODGKIN,INDIANA,MORTALITY,PARKINSON,PCB,PCBS,POISSON,PUBLISHED,THROUGH,YORK
001,100,160,169,1781,2000,2012,2013,857,8804,8805,BCR,BETWEEN,CONCLUSION,COPYRIGHT,EIGHT,GLEASON,INC,JUNE,LABEL,METHODS,OBJECTIVE,OCTOBER,PSA,PSADT,RESULTS,SRT,THERE
169,2013,ADT,ADVERSE,BACKGROUND,CONTEXT,COPYRIGHT,DENOSUMAB,LABEL,METHODS,OBJECTIVE,OSTEOCLAST,PCA,PREVENTION,PUBLISHED,RESULTS,SYNTHESIS,UROLOGY,ZOLEDRONIC
0001,001,149,169,1992,2007,2013,237,354,8805,CONCLUSION,COPYRIGHT,END,INC,LABEL,METHODS,MORTALITY,OBJECTIVE,PROPENSITY,PSA,RESULTS,THROUGH
0001,0GY,113,125,139,142,160,169,1999,2006,2013,248,390,415U,493U,6GY,COPYRIGHT,CROWN,D90,DESPITE,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS
160,169,1999,2001,2008,2011,2013,9572,AFFAIRS,AVERAGE,BETWEEN,CAPSURE,CONCLUSION,COPYRIGHT,DECREASED,GLEASON,INC,LABEL,METHODS,OBJECTIVE,RESULTS,STRATEGIC,VETERAN
160,169,2013,COPYRIGHT,EBRT,INC
BACKGROUND,CONCLUSION,LABEL,LARGE,METHODS,RESULTS,THERE
250,BACKGROUND,BASAL,CONCLUSION,CTL,LABEL,MAST,METHODS,NATURAL,PCR,RESULTS,THESE
520,535,924,CCD,LEDS,PSA,TESTING
ADT,CRPC,HOWEVER,JQ1,MYC,USING
169,2013,504,662,715,834,AACR,ASSOCIATED,BACKGROUND,CRUK,GROUP,HBA1C,HOMA,LABEL,METHODS,OGTT,PRACTICAL,RESULTS,SNP,USING
169,2013,AACR
BLOOD,SEANO
169,2013,COPYRIGHT,JOHN,LTD,MRI,SONS,WILEY
DESPITE,PET
BCL,DU145,EMT,EOTAXIN,MAPK,MMP,MYC,NOTABLY,PCA,THUS,VEGF,ZOL
945,946,954,B16,CD8,IAP,PC3,PCNA,STAT3,SW620,THESE,TNF,XIAP
154,160,270,517,816,8201,CAUCASIAN,ERG,GLEASON,SEVENTY,SPANISH,THREE,THUS
137,145,BACKGROUND,BPH,CONCLUSION,DFS,FOLLOWING,GLEASON,LABEL,METHODS,PCA,PCR,PSA,RESULTS,RNU48,SNORD48,TOTAL,TUMOURS
001,012,022,044,061,064,160,2007,2010,293,8804,8805,946,ADDITIONAL,ADJUSTING,INCREASED,LABEL,METHODS,NUTRITION,OBJECTIVE,PSA,PURPOSE,RESULTS,SERUM,TOTAL,USING
112,160,499,DIETARY,GLEASON,LABEL,MEAN,METHODS,OBJECTIVE,ORS,PURPOSE,RESULTS,RISK
000,100,160,1973,2009,8805,985,991,DESPITE,EBRT,END,FOUR,INCIDENCE,IRR,LABEL,METHODS,OBJECTIVE,POISSON,PURPOSE,RESULTS,SEER
174,1996,2010,AFTER,AIM,ANALYZING,BACKGROUND,BETWEEN,CONCLUSION,HIIA,IIIA,IIIB,LABEL,METHODS,NETS,OBJECTIVE,RESULTS,STAGE
0001,174,1884,319,620,ELISA,NTX,OPG,PCR,RANK,ZOLEDRONIC
ANOTHER,EVEN,EXCELLENT,LABEL,MINIMALLY,OBJECTIVE,PATIENT,PCA,PURPOSE,RADICAL,RESULTS,SUMMARY,SURGERY
API,GENOMIC,GROK,KIT,LUA,OPERATION,SQL,TFS
169,2013,231,233,AFTER,AMONG,CONCLUSION,COPYRIGHT,LABEL,METHODS,OBJECTIVE,PET,PSA,PUBLISHED,PURPOSE,RESULTS,SAS,SFRO,SOCI
144,169,2000,2013,550,AUNPS,BRUST,COPYRIGHT,FINALLY,LNCAP,PEG
129,169,2013,8710,AKT,ALA,ARG25,COPYRIGHT,ERK,ERK1,INC,LNCAP,MEK,PCA,RAF,THESE,USING
169,2013,COPYRIGHT,FINALLY,INC,METABOLIC
169,2013,233,AUTHORS,JOURNAL,MAT,MICROSCOPY,POISSON,ROYAL,SOCIETY,STRAUSS
160,921,ADT,CRPC,DRUG,FDA,FOOD,PSA
945,BCL,CDK,DFMO,DU145,HOWEVER,LNCAP,ODC,PAO,PC3,POLYAMINES,PURVALANOL,SIMILARLY,SMO,SSAT,TARGETING,THEREFORE,TRANSIENT
009,136,169,2013,AIM,CLEAR,ERG,FEWER,FISH,JOHN,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,SEVEN,SONS,TMPRSS2,WILEY
C57BL,ELISA,ELISPOT,HOWEVER,HSP,HSP70,LUC,PSCA
169,1C3,2013,AIMS,ALPHA,BCAR1,CELL,ERA,ERB,JOHN,KI67,LABEL,LTD,METHODS,OBJECTIVE,PSA,RESULTS,SONS,SQLE,SRC,THESE,WILEY
ATTENTION,CONCLUSION,LABEL,OBJECTIVE
145,INHIBITORS,NNAS,SAR
COX,CURCUMA,DESPITE,MMPS,OTHER,PCURC,STAT,TNF
2D3,AFTER,BASED,CASE,LOW,SEVERAL,TESTING,VITAMIN
HOWEVER,ULTRASOUND
167,265,413,511,673,815,901,988,ADPCA,AIPCA,CONCLUSION,EAG1,LABEL,METHODS,OBJECTIVE,PCA,PCR,RESULTS
CGA,CONCLUSION,HOWEVER,III,LABEL,LDL,LNCAP,METHODS,NSE,OBJECTIVE,PCR,RESULTS,SGIII,SREBP,TRANSIENT
231,BECAUSE,DU145,MDA,PEITC
FLAVONOIDS,PCA
9324,III,PSA,SWOG
954,LNCAP,PCR,RESISTANCE,THESE,VCAP,WESTERN
001,010,045,8804,AUSTRALIA,BACKGROUND,DATA,GOLDFIELDS,GREAT,LABEL,METHODS,MIXED,OBJECTIVE,OBJECTIVES,REGIONS,RESULTS,SIXTY,THERE,THESE,WESTERN
ANIMALS,CCL2,PCA,THEREFORE,THESE
100,954,ERBB,FURTHER,KNOCKDOWN,NEU,PACP,PCA,THUS
006,1112,1122,309,813,COLORECTAL,LUNG,OVARIAN,SARCOSINE,SCREENING,TRIAL
1999,DUE,PET
11C,ADT,AIM,CHOLINE,CONCLUSION,FOUR,LABEL,METHODS,OBJECTIVE,PET,PET1,PET2,PSA,PSADT,RESULTS
003,1203,17Q24,215,333,474,4Q34,ADDITIONAL,AGA,CANDIDATE,COLORECTAL,INITIATIVE,LUNG,NEIL3,NONE,OVARIAN,PLCO,SCREENING,SNPS,THEREFORE,THREE,WHI,WOMEN
000,163,1946,1980,1995,2012,3895,4056,ABSTRACTS,ASSESSMENT,BACKGROUND,BIOSCIENCE,CITATIONS,DARE,DATA,DATABASES,DCE,EFFECTS,ENGLISH,FEW,FUNDING,HOWEVER,INDEX,INDEXED,INSTITUTE,ISSUE,LABEL,LIBRARY,MARCH,MEDLINE,METHODS,MRI,MRS,NON,OBJECTIVE,OBJECTIVES,OTHER,PROCESS,PSA,QALY,REFERENCE,RESULTS,REVIEWS,SCI,SCIENCE,SERVICE,SOURCES,TECHNOLOGY,TESTS,TRUS,TYPES,UNDER
CPG,EPIGENETIC,PEPID
BONE,MMP,OPG,RANK,RANKL,THEREFORE,THESE
CONVERSELY,DHEA,GDP,NGF,PC12,RHO,TRK,TRKA
167,216,327,ADIPOKINE,ADIPOKINES,BACKGROUND,BMI,CIS,COLORECTAL,CONCLUSION,LABEL,LUNG,METHODS,MHT,ORS,OVARIAN,RESULTS,SCREENING,THESE,TRIAL
169,2013,EPO,HOWEVER,INC,PCA,WILEY
000,115,169,2013,300,480,AACR,ERG,GLEASON,GP3,GP4,GS6,GS7,LCM,NGS,PTEN,TMPRSS2,WGA
ESPECIALLY
012,215,675,954,BACKGROUND,BOTH,CONCLUSION,FISH,GLEASON,IHC,LABEL,METHODS,PSA,PTEN,RESULTS
2010,790,DRUGS,FIRST,HOWEVER,THEREFORE
PSA
169,2013,COPYRIGHT,HRS,IMPORTANT,IRELAND,LTD,PARTICULAR
169,2013,945,947,ACTIVATION,ATF3,ATM,ATR,BRCA1,CDC25,CHK1,COPYRIGHT,DDIT4,DR5,GADD45A,H2AX,IRELAND,KNOCKDOWN,LTD,MEANWHILE,MICROARRAY,NHEJ,PCA,RETIGERIC,TOPO
169,2012,ATP,COPYRIGHT,DGC,EGFR,GBM,GPCR,GRK,GRK5,GSC,LTD,PDGFR,PUBLISHED,USING
169,2013,AMONG,COPYRIGHT,ISSUE,LTD,SPECIAL,SYNTHESIS
125,580,AHX,BPG,FSQN,PSA
169,1978,2013,BLACKWELL,DEPRESSION,ENDOGENOUS,HEPG2,LNCAP,LTD,MCF,PUBLISHING,REGUCALCIN,RGN,SMP30
169,2006,2013,AUTHORS,BLOOD,BRITISH,DUE,EVER,NOVEL,PCA,SOCIETY,XMRV
945,954,ALPINIA,BECAUSE,BONE,CARDAMONIN,ERK,FINALLY,MAPK,NEMO,RANKL,TNF
2007,347,368,BAYES,FDR,JOURNAL,ODP,ROYAL,SOCIETY,UNDER
BACKGROUND,CONTEXT,LABEL,MEIER,METHODS,NEK2,NR2F2,OBJECTIVE,OVARIAN,PCR,RAI14,RESULTS,SETTING,TARGETING,THESE
004,011,140,177,8804,EARLY,GLEASON,PROTEIN,PSA,PSMA,THERE,THEREFORE
PANCREATIC,PDAC,SEVERAL,SPARC
100,AMONG,BECAUSE,BURKITT,CD99,EFTS,EPR3864,ERG,ETS,EWING,EWSR1,FLI1,PREVIOUSLY
2000,2002,2007,2009,457,557,CIS,CRT,DATA,END,GIVEN,IMPORTANCE,IMRT,LABEL,MAIN,MEN,METHODS,OBJECTIVE,OBJECTIVES,RELEVANCE,RESULTS,RRS,SETTING,THERE
3183,AMONG,BACKGROUND,CONCLUSION,FUNDING,INSTITUTE,LABEL,LIMITATION,METHODS,OBJECTIVE,OLDER,PRIMARY,RESULTS,SETTING
000,0001,169,199,2003,2007,2013,795,COPYRIGHT,EDUCATION,END,INC,LABEL,MATERIALS,METHODS,MINIMALLY,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SEER,UROLOGICAL
001,124,169,2013,945,COPYRIGHT,CYP17,ISSUE,LTD,REDUCTASE,SPECIAL,SYNTHESIS,TOK
0086,100,1006,125,144,169,1998,2003,2013,256,ANEUPLOID,COPYRIGHT,CROWN,D90,DIPLOID,FEULGEN,FORTY,GLEASON,INC,JULY,LABEL,MATERIALS,METHODS,OBJECTIVE,OCTOBER,PUBLISHED,PURPOSE,RESULTS,SEVENTY,TEN,THIONIN,USING,V100
169,2013,600,BOTH,COPYRIGHT,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
177,J591,LNCAP,PSMA,ULTIMATELY
CARS,FIRST,SOLID,THEREFORE
166,209,AMONG,BACKGROUND,CONCLUSION,FSHR,HORMONE,LABEL,METHODS,RESULTS
17A1,20LYASE,945,C17,CYP17A1,CYTOCHROME,FDA,ONGOING,P450,P450C17AND,P450SCCII,THEREFORE,THROUGH
169,2013,946,954,AACR,ELF3,ESE1,ETS,SUPPORTING
174,946,956,ADT,ASC,CASODEX,DESPITE,MDV3100,MECHANISM,MMP9,PCA,PSA,SMAD3,TGF,THESE,USING
ABCG2,AFTER,BACKGROUND,CAD,CSC,CSCS,LABEL,MEC,MECS,MMP,MNU,NSC,NSCS,OBJECTIVE,OCT,PTEN,RESULTS,THESE,THUS,VIM,WNT,WPE
001,002,005,012,019,026,036,042,113,134,153,169,177,2007,2011,2013,236,ACADEMY,ADT,AFTER,ANDROLOGY,BMD,DESPITE,HBA1C,OLDER,OVERALL,PREVALENCE,SOCIETY
169,2013,AKT,AKT1,ANNEXIN,BCL,BSN,COPYRIGHT,FINALLY,JOHN,LNCAP,LTD,PARP,PI3K,S6K1,SONS,TAKEN,TUNEL,WILEY
0051,0084,0209,0224,1202,404,498,7684,AMONG,BPH,CAC,ERG,FOLLOWING,GLEASON,LABEL,METHODS,NINE,OBJECTIVE,OCC,PCA,PEARSON,PSA,PURPOSE,RESULTS,USING
947,948,ABS,B16,CCL2,CCR2,IFN,STRIKINGLY,TCR,TIL,TILS
049,169,2013,269,506,543,824,AFFAIRS,ARB,COMPUTING,DEPARTMENT,DRUG,FOOD,GLEASON,POST,PRCA,THERE
169,2013,COPYRIGHT,FINALLY,HIV,JOHN,LTD,SONS,WILEY
BOTH,ERK,ERK1,ERK2,ERKS,GP130,JAKS,JANUS,LIF,OSM,STATS,U2OS
116,480,945,ANNEXIN,ATM,FIRST,FITC,GENISTEIN,HCT,HOWEVER,PCR,REAL,SOYBEAN,THESE
046,159,967,BACKGROUND,BCRFS,COX,ECE,GLEASON,LABEL,LNI,MANN,MATERIALS,MEIER,METHODS,PCA,PEARSON,RARP,RESULTS,THERE,WHITNEY
160,TCP
177,8804,DUE,NOMINAL,SCANNED
160,A248,DU145,HDAC,HISTONE,MCL,PC3,SINCE,SP1,THESE
169,2013,COPYRIGHT,CROWN,INC,PUBLISHED
11OH,11OHT,169,2013,945,946,ATTENTION,BOTH,CHINESE,COPYRIGHT,CYP11B1,CYP11B2,DOWNSTREAM,H295R,HSD,HSD1,HSD2,LNCAP,LTD,P450,UPLC
169,2013,945,946,956,BPH,COMET,COPYRIGHT,FACSCAN,FOXO,FURTHER,IGF,IRELAND,LTD,OHE2,REDUCED
101,107,116,169,2014,221,8805,AGE,CCI,COPYRIGHT,COX,FURTHER,HTN,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
CRPC,IRELAND,LTD,MOLECULAR,PSO,PUBLISHED
150,169,179,1993,1997,2007,2013,310,31ST,8805,911,AGGRESSIVE,AIM,CASE,COPYRIGHT,DIET,EARLY,GLEASON,LABEL,LTD,METHODS,OBJECTIVE,PSA,RESULTS,TOTAL
010,1301G,500C,AFTER,ARG399GLN,ASN118ASN,BACKGROUND,COX,ERCC1,INC,LABEL,METHODS,N118N,PFS,PUBLISHED,R399Q,RESULTS,SIMILARLY,XRCC1
169,2013,8805,ACUTE,BACKGROUND,CONCLUSION,COPYRIGHT,GRADE,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,ORS,PURPOSE,RESULTS,THESE,VARIATION
003,143,169,2006,2008,2013,243,311,BACKGROUND,CONCLUSION,COPYRIGHT,COX,CTCAEV4,CUMULATIVE,DESPITE,DETAILS,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PATIENT,PHOENIX,PURPOSE,RESULTS,THERE
169,2013,AUS,CONCLUSION,COPYRIGHT,FIVE,HOLMIUM,INC,LABEL,METHODS,OBJECTIVE,RESULTS,THERE,USING,YAG
169,2013,BALLISTIC,COPYRIGHT,PUBLISHED,SAS,TECHNIQUES
2008,603,AMONG,CONCLUSION,LABEL,LIBRARY,MATERIALS,MEDLINE,METHODS,MRI,OBJECTIVE,RESULTS,SYSTEMATIC,THREE
CONCLUSION,DESPITE,LABEL,MATERIALS,METHODS,RESULTS,UNLABELLED
108,168,174,AFTER,ASAP,BPH,CD20,CD3,CD68,CD8,FIRST,IIC,LABEL,LUTS,MATERIALS,METHODS,OBJECTIVE,PCI,PIN,PSA,RESULTS,SERENOA,SPECIMENS
001,164,300,379,421,8805,AFTER,AUC,CONVERSELY,GLEASON,HOWEVER,LABEL,MATERIALS,METHODS,OBJECTIVE,PCA,PSA,PURPOSE,RESULTS,TNM
0005,1000,110,135,169,1994,2004,2013,261,334,392,5CM,8805,AUC,BACKGROUND,COPYRIGHT,GLEASON,LABEL,METHODS,OBJECTIVE,OUTCOME,PCA,PSA,PUBLISHED,RANDOMIZED,RESULTS,ROTTERDAM,SCREENING,SETTING,STEYERBERG,TREATMENT,UROLOGY,WHILE
AIMS,AKT,CONCLUSION,FINALLY,INNOVATION,LABEL,METHODS,MM2,NADPH,OBJECTIVE,ONCOGENIC,PDCD4,RESULTS,ROS,TAIL,THESE,USING
169,2013,ACADEMY,HOWEVER,VDR,YORK
231,AFU,ASCO,BRITISH,EAU,EXCELLENCE,INSTITUTE,NCCN,NETWORK,NICE,SOCIETY,UROLOGICAL,UROLOGY
CSF,DOCETAXEL,THESE
CRT,EBRT,IMRT,NEWER
2011,71000,AMICO,EARLY,MAIN,RADICAL,REGARDING,RISK,THERE
HIGH,LOCALIZED,PSA,SELECTION
DIFFERENT,FLA,HIFU,PDT,PROSTATIC,THESE,THOSE
IMPROVING,MEANWHILE,MRI
DETECTION,MRI,PET,PSA
2012,DRE,FORCE,HOWEVER,MEDIA,MRI,PREVENTIVE,PSA,SCREENING,TASK
003,169,2013,8201,ABILITY,AVERAGE,BODY,CEC,CONCLUSION,COPYRIGHT,FOUR,IMAGE,INC,LABEL,MATERIALS,METHODS,MRI,NVB,OBJECTIVE,PEC,PURPOSE,RESULTS,SNR,WILEY
100,181,OPIOIDS
BIOMARKERS,MMP,MMPS
169,2013,CONCLUSION,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,MRI,MRS,OBJECTIVE,PURPOSE,READERS,RESULTS,WILEY
160,1995,1996,288,335,391,917,927,AARP,CIS,COX,DIET,HRS,INSTITUTES,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
0017,0234,177,CONCLUSION,LABEL,METHODS,NONE,OBJECTIVE,PET,PSA,RESULTS
150NG,169,2013,945,946,COPYRIGHT,LTD,MCF,PROTEIN,T47D,USING
133,160,169,1995,2012,2013,261,890,BASED,COPYRIGHT,EDUCATION,GLEASON,INC,LABEL,MATERIALS,MEN,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
160,169,183,2013,AMICO,COPYRIGHT,EDUCATION,HIGH,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,RESULTS,TESLA,UNIVARIATE,UROLOGICAL
169,2013,BACA,CELL,COPYRIGHT,INC,WIDESPREAD
169,2013,COLLEGE,COPYRIGHT,CURRENT,HOWEVER,LTD,PUBLISHED,ROYAL
1092,169,177,2013,243,8194,8805,AGE,AIMS,BECAUSE,CKD,GFR,GLEASON,HOWEVER,JOHN,LABEL,LTD,MATERIALS,MEAN,METHODS,OBJECTIVE,PSA,RESULTS,SONS,WILEY
ALZHEIMER,BACKGROUND,DIFFERENT,HOWEVER,LABEL,MEDEA,METHODS,RESULTS,SPANISH
005,100,177,2009,2011,823,832,AUC,BACKGROUND,BPH,CONCLUSION,DEPARTMENT,DRE,ELISA,EXPRESSION,FORMATION,INDIA,KGMU,LABEL,LUCKNOW,METHODS,PCA,PSA,RESULTS,ROC,SEPTEMBER,SPSS,THEREFORE,UROLOGY,VEGF
001,003,011,017,020,GLEASON,NR4A,NURR1,THESE
100,AMERICANS,ASIAN,CITY,LIVER,PHYSICIANS,PRIMARY,YORK
025,050,182,375,620,885,909,ALA,ALTERED,MNSOD
AIMS,APOG2,APOPTOSIS,BACKGROUND,BESIDES,HUVEC,LABEL,METHODS,MTT,OBJECTIVE,RESULTS,THESE
A549,APOPTOTIS,CELL,LUNG,MTT,RES,THEREFORE
2008,ALSO,ASSESSMENT,BACKGROUND,DIET,FURTHER,HEART,IRAN,LABEL,MATERIALS,METHODS,RESULTS,SEP,URBAN,VARIATION
AMONG,HOWEVER,THEREFORE
169,177,2013,323,8201,8805,AIM,BACKGROUND,CAVERNOUS,GLEASON,LABEL,MAIN,METHODS,NSS,OBJECTIVE,OUTCOME,PATIENT,PSA,RESULTS,SOCIETY,WHILE
B16,C57BL,GENISTEIN,NON
CHINA,EMT,PCA,WESTERN
016,109,2003,2009,318,400,546,578,8804,923,COX,CRPC,CUMULATIVE,DOCETAXEL,DSS,JULY,JUNE,MEIER,NONE,THERE,THEREFORE,USING
1994,1997,2005,630,BACKGROUND,LABEL,METHODS,NITRATE,RESULTS
ANTISENSE,LNCAP,THOSE,WHILE
0005,022,946,CD27,CD4,CD70,HOWEVER,IIA,PBMCS,TCR
177,2007,2009,956,ARU,BACKGROUND,CONCLUSION,EVERY,JULY,LABEL,MATERIALS,METHODS,OVERALL,PPNB,PSA,RESULTS,SPSS,TRUS,UNIVARIATE,UTI
201,AG490,FIRST,INHIBITION,JAK,JAK2,JANUS,S3I,STAT3,WASF3
169,2013,22RV1,ABNORMALLY,AGAIN,BASAL,COPYRIGHT,GAS5,INDUCTION,RNAS,SIMILAR,THUS,WHILE
2008,2009,924,946,BCL,E12,IPSS,LABEL,METHODS,OBJECTIVE,PSA,RESULTS,SEPTEMBER,TURP
ADT,DISCUSSION,LABEL,METHODS,NED,OBJECTIVE,PSA
100,300,966,CONCLUSION,GLEASON,III,LABEL,LFT,LRP,LRPS,METHODS,OBJECTIVE,OBJECTIVES,PATHOLOGIC,PATIENT,PSA,PSM,PSMS,RESULTS
190,2004,2008,ACCORDING,CONCLUSION,EPSTEIN,GLEASON,HOPKINS,JANUARY,JOHNS,LABEL,MEAN,METHODS,OBJECTIVE,OBJECTIVES,PCA,PSA,RESULTS,TECHNICAL
100,177,282,BOTH,CPC,CPCS,DETECTION,DRE,HOWEVER,INCLUSION,LABEL,MEN,METHODS,OBJECTIVE,OBJECTIVES,P504S,PSA,RESULTS,SERUM,THERE
GIVEN
2010,2011,390,BACKGROUND,CONCLUSION,EPMS,INCREASED,IPMN,IPMNS,ITALIAN,ITALY,JANUARY,LABEL,METHODS,RESULTS
5HMC,THESE,WHILE
ASIAN,BOTANICALS,CURIS,CURRENTLY,DUE,EGCG,FDA,GENENTECH,GLI,SOUTHEAST,THESE
169,1976,2008,2013,HODGKIN,LABEL,MAYO,METHODS,MINNESOTA,MUIR,NON,OBJECTIVE,OBJECTIVES,RESULTS,ROCHESTER,SEBACEOUS,SIX,SKIN,SOCIETY,THEIR,THREE,TORRE,WHITE
947,ATP,GLEASON,H2AX,MTT,THEREFORE,WESTERN
144,239,ADL,ADT,CWR22,FINALLY,HENCE
404,777,8202,946,GLEASON,RAR,RASSF1A,THEREFORE,UNDER
125,135,945,946,ASN,BINDING,GPI,HAI,HGF,HOWEVER,LYS,MATRIPTASE,THESE
945,946,ALTOGETHER,ELEVATION,EZH2,H3K27,HOMOLOG,LIVER,LXR,MSMB,NKX3,PCA,RECEPTORS,ZESTE
EBRT,RADIATION
AAG,DESPITE,HSP90,SUPPORTING
169,2013,AACR,BCL,KEAP1,NADPH,NRF2,PGAM5,ROS,THESE,TRX
ALSO,GIVEN,NVBS,RALRP,RAPID,RESULTS,ROBOT,TRUS,VINCI
0001,177,185,8310,8311,8312,CONCLUSION,FAB,HSG,LABEL,METHODS,OBJECTIVE,PC3,PET,PRIT,PURPOSE,RESULTS,TF12,TROP
095,1995,2005,318,8201,853,BACKGROUND,CIS,CONCLUSION,COX,HRS,JANUARY,JAPAN,LABEL,METHODS,RESULTS,THERE
BACKGROUND,BOTH,CONCLUSION,GLEASON,HARMS,IMMEDIATE,LABEL,MEN,METHODS,RANDOMIZED,RESULTS,SCREENING
FOUR
8805,ADT,EORTC,GROUP,HIGH,III,IMAGE,LABEL,OBJECTIVE,PCA,PURPOSE,RADIATION,RESULTS,SUMMARY,THERAPY,USA
100,AOM,COX,FRUIT,GOLD,HOWEVER,MMP,PMFS,THESE,VEGF
64258,BAX,BCL,HOWEVER,LACK,LNCAP,QUERCETIN
ALSO,BACKGROUND,HIGH,HMW,HMWS,LABEL,METHODS,MMP,MMP9,MMPS,NGAL,RESULTS,THERE,TIMP
006,048,1262,8805,AAG,BACKGROUND,BONE,III,LABEL,METHODS,NUTRITION,RESULTS,SERUM,SHBG,THIRD
224,BCL2,BMI1,CAP,CHIP,LUCIFERASE,NOTABLY,TCF4,USING
5ARI,945,ADT,DHT,HOWEVER,IADT,KI67,LNCAP,LUCAP35,REDUCTASE,THESE
223,MEETING,PRACTICES,TREATMENT
2007,2011,2013,BASED,FEDERAL,GOVERNMENT,JPM,PROCESSING,PUBLISHED,SOCIETY,THESE,USA
141,169,2013,287,8804,8805,BIOMARKERS,CHRT,FOLLOWING,GMBH,KGAA,LABEL,METHODS,MRM,OBJECTIVE,PCA,PURPOSE,RELEVANCE,RESULTS,VCH,WILEY
036,1996,2008,ADT,BACKGROUND,BMD,END,KEY,LABEL,MAIN,METHODS,OBJECTIVE,PCP,RATES,RESULTS,SEER,THERE
185,710,8312,8804,ADT,CONCLUSION,GLEASON,LABEL,METHODS,OBJECTIVE,PDR,PET,PSA,PURPOSE,RESULTS,TRIGGER
ADDRESSING,ALZHEIMER,PARKINSON,PREVENTION,ROS,SIMILARLY,THEREFORE,TRIAL,VITAMIN
946,ALTOGETHER,BACKGROUND,BLM,BRCA1,BRCA2,CCNB2,CIP1,DDB2,DHH,EMT,FEN1,GADD153,GADD45A,GLI1,H3F3B,IHH,LABEL,LNCAP,LOSS,METHODS,PC3,PCA,PCR,PREVIOUSLY,RESULTS,SHH,WAF1
169,2013,2720,459,8804,8805,896,AGENT,AOE,BACKGROUND,COPYRIGHT,GLEASON,HGPCA,HOWEVER,LABEL,LGPCA,METHODS,PCA,RESULTS,RISK,SOCIETY,THESE,VETERAN,VIETNAM
330,DU145,FINALLY,PC3,RNAS,SP1,THESE
427,BCG,HEAT,HSP,HSP27,HSPS,OGX
FINALLY,OVERALL
BPH,INCREASED,INTRA,THUS
ADULT,ALREADY,ASSAY,BACKGROUND,CAUTION,EFFECTIVE,H295R,HORMONE,INHIBIN,KNOWN,LABEL,MAIN,MATERIALS,METHODS,MILD,NCI,OBJECTIVE,PGE2,REASONS,RESULTS,ROLE,SERTOLI,SETTING,SIZE,STUDIES,SUMMARY,TISSUES,WHAT,WIDER
AKT,ATG3,ATG7,AZD5363,DU145,MTOR,PI3K,PTEN,TAKEN
947,CK2,DU145,INCREASED,INHIBITION,LNCAP,NCOR,RWPE1,THESE
466,AUSTRALIA,FIVE,HOWEVER,LABEL,METHODS,NDSS,OBJECTIVE,RESULTS,SELF,THERE
001,006,169,1990,2009,2013,495,COPYRIGHT,COX,EDUCATION,ESTIMATES,EXCLUSION,INC,JUNE,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,OVERALL,PEARSON,PUBLISHED,PURPOSE,RESULTS,THERE,URINARY,UROLOGICAL
000,117,169,2003,2007,2013,373,425,442,485,857,COPYRIGHT,EDUCATION,END,HIGH,INC,INCREASED,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SEER,THEREFORE,UROLOGICAL,WHILE
169,174,2014,216,528,COPYRIGHT,EDUCATION,ERG,EXPRESSED,III,INC,LABEL,MATERIALS,METHODS,NCCN,NETWORK,OBJECTIVE,PCA3,PUBLISHED,PURPOSE,RESULTS,SECRETION,TMPRSS2,UROLOGICAL
0001,001,10TH,169,177,2013,BACKGROUND,BMI,BPH,CAP,COPYRIGHT,HIGH,INDIA,LABEL,LTD,METHODS,RESULTS,SIMILARLY,WHR
001,1002,169,1997,2009,2013,8804,ADT,BACKGROUND,COPYRIGHT,EBRT,HIFU,HIGH,IIEF,INDEX,LABEL,MEIER,METHODS,MFSR,OBJECTIVE,OUTCOME,PCA,PHOENIX,PRIMARY,PSA,PUBLISHED,RESULTS,SALVAGE,SECONDARY,SETTING,SIXTY,UROLOGY,WHOLE
014,125,150,160,169,2003,2010,2013,8805,916,AUR,CONCLUSION,COPYRIGHT,DELTA,EXPERIENCE,GRADE,GROUP,INC,IPPS,IPSS,JULY,LABEL,MATERIALS,MAY,MEAN,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RADIATION,RESULTS,SCORE,SOCIETY,SYMPTOM,THERAPY,URINARY
00001,019,103,169,2014,COPYRIGHT,D90,DOSIMETRIC,FIFTY,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PALLADIUM,PUBLISHED,PURPOSE,RESULTS,SOCIETY,V100,VOLUMES
211,254,304,8201,ACTUARIAL,BACKGROUND,BOWEL,COMPOSITE,CYBERKNIFE,FEWER,FIFTY,FIVE,GRADE,GROUP,HDR,III,INDEX,LABEL,LATE,METHODS,PSA,QOL,RADIATION,RESULTS,SBRT,THERAPY
160,169,2013,4A4,640,ADDITIONAL,AIMS,COA,HOWEVER,JOHN,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,SONS,WILEY
131,155,17Q21,182,215,221,22Q13,337,534,781,9P24,AFFYMETRIX,AFRICAN,AMERICANS,ARAB,ARRAY,BACKGROUND,CONCLUSION,EUROPEANS,GENOTYPING,GWAS,LABEL,LARGE,METHODS,QATAR,RESULTS,SAUDI,SNP,SNPS,THREE,TUNISIANS,USING,WESTERN,WIDE
330,DATA,GWAS,KALLIKREIN,KLK,KLK3,SNP,SNPS

BRDU,CELL,CRPC,CYTOTOXIC,ELISA,LNCAP,PCR,PSA,R1881,RBIC,REAL,SCID,SRB,TIME,VCAP
169,176,2013,AACR,CD133,CD44,CD44S,CONVERSELY,MMP9,NOTABLY,PREC,RBM3
BACKGROUND,BOTH,CONCLUSION,CONTEXT,HOWEVER,LABEL,METHODS,OBJECTIVE,PCR,PRA,PRB,RECIPROCAL,RESULTS,SETTING,WESTERN
023,029,047,113,133,163,177,ADT,ASSESSMENT,FLOW,FMD,GTN,LABEL,REDUCTION,THERE,UNASSIGNED,WHAT
001,004,007,008,009,016,020,031,032,177,AMONG,GLEASON,PCA,PCR,PSA,QRT,SOCS,SOCS2,SOCS6,SOCSS,THUS
137,EFFECTIVE,EIGHT,LABEL,METHODS,OBJECTIVE,PCN,PCNS,PURPOSE,RENAL,RESULTS,THEREFORE
22RV1,945,CALPHOSTIN,CCK,DU145,HOWEVER,PC3,PC3M,PCR,PKC,PMA,RWEP,UNC5B,WESTERN
AIMS,AUSTRALIA,BRAIN,CONCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,THREE

126,169,177,2013,COPYRIGHT,DICE,HOWEVER,LOW
21ST,AGE,HIGH,HOWEVER,STONE
169,2013,945,COPYRIGHT,LNCAP,MTT,SAS,THUS
FINALLY,LABEL,OBJECTIVE,PURPOSE,RESULTS,SEVERAL,SUMMARY,THEREFORE
HENCE,HIGH,LABEL,MANAGEMENT,OBJECTIVE,PURPOSE,RESULTS,SUMMARY,WESTERN,WHILE
ADDITIONAL,HIGH,LABEL,OBJECTIVE,PURPOSE,RESULTS,SUMMARY,VARIOUS
169,2013,8594,945,946,956,COPYRIGHT,DU145,EC50,LTD,LYSIMACHIA,NMR,PC3
ADI,ASS,AUTOPHAGY,HORMONE,USING,WHILE
169,1996,2013,303,COPYRIGHT,CRPC,EDUCATION,ENGLISH,FDA,GIVEN,GUIDELINE,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PRINCIPLES,PUBLISHED,PURPOSE,RESULTS,THESE,UROLOGICAL
0001,0005,001,169,2013,286,561,674,806,952,AUC,COPYRIGHT,EDUCATION,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,ROC,SPON2,UROLOGICAL
0001,169,2013,BACKGROUND,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,RESULTS,THERE,THEREFORE
0006,002,003,137,149,169,1995,2012,2013,286,8804,ABSENCE,BACKGROUND,COPYRIGHT,COX,GLEASON,IQR,LABEL,MEN,METHODS,OBJECTIVE,OUTCOME,PATHOLOGIC,PREDICTORS,PSA,PUBLISHED,RESULTS,SETTING,UNASSIGNED,UROLOGY
00001,169,18GY,1999,2006,2013,253,4GY,COPYRIGHT,EBRT,GRADE,GROUP,LABEL,MARCH,MATERIALS,METHODS,N0M0,OBJECTIVE,PDR,PHOENIX,PURPOSE,RESULTS,SOCIETY,STAGE,TREATMENT
100,125,135,160,162,169,191,194,2013,ATV,COPYRIGHT,CROWN,D90,DESPITE,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,TMS,V100
169,2013,COPYRIGHT,ERG,GLEASON,INC,NONE,TMPRSS2,UNTIL
169,2013,BACKGROUND,BLOT,CONCLUSION,COPYRIGHT,EHM2,FERM,FINALLY,GAPDH,HACAT,IHC,INCREASED,IRELAND,LABEL,LTD,METHODS,NWASP,OBJECTIVE,OBJECTIVES,PCR,PUBLISHED,RESULTS,SOCIETY,THESE,WESTERN
169,2013,946,CDX2,CK20,CK7,COPYRIGHT,GATA3,INC,TUBULAR
169,1995,2011,2013,BACKGROUND,CONTEXT,COPYRIGHT,DUE,FIVE,INCLUSION,JANUARY,LABEL,METHODS,OBJECTIVE,OVERALL,PUBLISHED,RESULTS,STUDIES,SYNTHESIS,UNDENIABLE,UROLOGY
0001,009,055,110,169,175,2013,8804,958,ADT,CMRT,COPYRIGHT,COX,EBRT,GLEASON,IBF,INC,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PCSM,PURPOSE,RESULTS,SHORT
100,160,169,1993,2000,2013,503,8804,8805,AGE,AUHC,BACKGROUND,CONCLUSION,COPYRIGHT,COX,CPE,DVH,INC,LABEL,MATERIALS,METHODS,OVERALL,RESULTS,THERE
1945,742,BACKGROUND,BASED,CLEARLY,DU145,DYZ1,HOWEVER,LABEL,LNCAP,LOSS,MSY,RESULTS,SIMILARLY,SRY,STSS,TTCCA,WORK
2007,2012,251,2N0M0,3N0M0,465,748,EBRT,GENERALLY,GLEASON,HIFU,PCA,PSA,RPE
BACKGROUND,FAITH,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RADICAL,RESULTS,URINARY
CASTRATION,III,PHASE
2009,2012,ACT,CER,INSTITUTE,MAY
EGFR,FINALLY,GEF,HOWEVER,PREVIOUSLY,RHOG,SGEF,SH3
169,2013,208,8201,BACKGROUND,ERG,EVALUATING,FATAL,FISH,HOWEVER,IHC,INC,LABEL,MEFPC,METHODS,MOLECULAR,NUCLEAR,PCR,PERMANENTE,PRIOR,QPCR,RESULTS,TMPRSS2,WILEY
169,170,2013,BACKGROUND,CLIP,COPYRIGHT,CRPC,EXPRESSION,FINALLY,GLUED,INC,LABEL,METHODS,PCA,PLK1,POLO,RESULTS,TAXEL,WILEY
169,2013,CBP,CONCLUSION,EXPRESSION,FUNCTIONAL,GMBH,KGAA,LABEL,LNCAP,METHODS,PCA,PCAF,PEITC,RESULTS,SCOPE,USING,VCH,WILEY
BAG1,DDR1,DU145,ERBB4,ESR1,EXPRESSION,HNF1B,HSPD1,IMPLICATED,KEGG,LNCAP,NR4A1,OMNIBUS,PAWR,PC3,PCR,RAP2A,RWEP,SIX,TPD52
169,2012,2013,223,685,689,BACA,BRITAIN,CAUCASIAN,COPYRIGHT,EXOME,FOXA1,GENET,GREAT,IRELAND,JOHN,LTD,MED12,OVERALL,PUBLISHED,SOCIETY,SONS,SPOP,WILEY
2006,2007,2009,232,245,AIMS,BELLO,BETWEEN,BONE,BONES,CLINICO,CONCLUSION,DEPARTMENT,EDITION,EPI,GLEASON,HIV,INFO,JANUARY,LABEL,MATERIALS,METASTATIC,METHODS,NIGERIA,OBJECTIVE,OBJECTIVES,PSA,RESULTS,THERE,UNIVERSITY,VERSION,VIRCHOW
DCS,FOUR,HENCE,HIFU,MHZ
1980,1990S,2010,BACKGROUND,CONCLUSION,LABEL,METHODS,MODEL,RESULTS,THESE
2007,2010,CONCURRENT,FORTY,SBRT,SEPTEMBER
169,2000,2013,CLEARLY,COLLEGE,COPYRIGHT,III,LTD,MEDLINE,ONCE,OVID,PHASE,PUBLISHED,ROYAL
2003,2006,BETWEEN,EACH,IMRT,QOL,THERE,URINARY
2000,2010,AMERICA,NORTH,THROUGH,WHILE
160,169,2013,BASED,COPYRIGHT,FUNCTIONAL,INC,NUCLEAR,PATHOLOGY,PCA,PCAS,PUBLISHED,SOCIETY,STAT5
169,2013,300,8805,COPYRIGHT,EDUCATION,GUIDELINE,INC,LABEL,MATERIALS,METHODS,MODELED,OBJECTIVE,OUTSIDE,PANEL,PSA,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
169,2013,COPYRIGHT,HMEC,IC50,OVERALL,PC3,PLK1,TREATMENT
169,2011,2013,8805,ADVERSE,BACKGROUND,CONCLUSION,COPYRIGHT,CSF,CUP,DUTCH,FEBRILE,FIFTY,FORTY,GRADE,INC,INSTITUTE,IQR,LABEL,METHODS,OVERALL,PFS,PROGRAM,PSA,RESULTS,SAES,SERIOUS,TEAES,TTPP
1229,169,2005,2009,2013,8201,8804,8805,ACCORDING,AMICO,GLEASON,GUIDELINE,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,PREDICTIVE,PREDICTOR,RESULTS,UROLOGICAL,UROLOGY
130,150,160,210,946,956,CDK4,COA,DU145,HMG,HYDROXY,IC50,LNCAP,TUNEL
954,AKT,HIGH,HOWEVER,LNCAP,PCA,PUFA,STUDIES,TAKEN
CRPC,HOWEVER,LNCAP,PCA,PCR,SNAIL,THESE,WESTERN,ZEB1
34A,8776,946,BETA,CHIP,FACTORS,HIFS,HYPOXIA,INDUCIBLE,LNCAP,NOS,PCA,PEAK,SEQUENCING,SIRT1
152,946,AKT,CDE,CHR,IAP,IGF,MEK,NRP,PI3K,SMAD,SMADS,SURIVIN,TAKEN,TGF,USING
01910,370,60000,8764,IC50,III,PC3,PHASE,PLK1,POLO,XENOGRAFT
300,946,AFRICAN,CAUCASIAN,FURTHER,HOWEVER,PCA,PCR,TAKEN
169,2013,BACKGROUND,CELL,CONCLUSION,COPYRIGHT,EXPRESSION,INC,INHIBITORS,LABEL,LNCAP,METHODS,MTS,PCR,RESULTS,SILENCING,WILEY,WNT
170,ACTIVATING,FGFR3,R3MAB,THEREFORE
169,2013,350,8201,ANOVA,CONCLUSION,COPYRIGHT,GLEASON,INC,LABEL,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS,STUDENT,THERE,TRUS,WILEY
001,015,031,158,169,178,2007,2011,2013,956,CONCLUSION,DIAGNOSTIC,GLEASON,LABEL,MANN,MATERIALS,MEAN,METHODS,OBJECTIVE,OVERALL,PCA,POTENTIAL,PSA,PURPOSE,REAL,RESULTS,RSNA,WHITNEY
001,814,AFRICAN,AMERICANS,AMONG,HOWEVER,IRAK4,IRF3,JAMAICANS,MDR,PCA,SEVEN,SNP,SNPS,THEREFORE,TLR,TLR2,TLR6,TLRS,TOLL
2004,2008,351,ADVERSE,BACKGROUND,BETWEEN,CONSENSUS,GRADE,JANUARY,LABEL,LATE,MARCH,METHODS,PHOENIX,RESULTS
GWAS,NGS,SNP
8764,BOTH,HOWEVER,INCREASING,MOUSE,TRAMP,TRANSGENIC,TREATMENT
0167,019,1995,2009,425,4752,813,974,AFTER,BACKGROUND,CONCLUSION,COX,DIAGNOSIS,JANUARY,LABEL,METHODS,NNEB,NNEH,PRIMARY,RESULTS
BOTH,CAIX,THESE,WARBURG,WHILE
AUSTRALIAN,HOWEVER,MEN,SEMI
HOWEVER,M13,THESE,VII
126,AFRICAN,AMERICANS,BORDERLINE,DATA,NORTH,THERE,THESE,WHITE
114,AGE,BACKGROUND,CPCS,LABEL,MEIER,METHODS,PSA,RESULTS,SECONDARY,THESE
160,207,239,8201,AUSTRALIA,BACKGROUND,CONCLUSION,DESPITE,FIRST,LABEL,METHODS,OBJECTIVE,PSA,PURPOSE,RESPONSES,RESULTS
100,178,179,200,BONE,CONCLUSION,DICHLORIDE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,TEN,URINARY
CXCR4,CXCR6,HOWEVER,TUMOURS
116,AMERICA,CD73,CHINA,GPI,NORTH,PCR,THESE,WESTERN
015,169,2013,8201,AFTER,BACKGROUND,COPYRIGHT,ERG,GLEASON,INC,LABEL,METHODS,PI3,PTEN,RESULTS,TMPRSS2,WILEY
005,015,104,145,BPH,CCK,DVL2,GLEASON,LNCAP,MMP,PCA,PCR,SILENCING,TNM,WNT
102,135,2002,2006,2009,8805,AGES,BACKGROUND,COX,HRS,ICELANDIC,LABEL,METHODS,RESULTS,REYKJAVIK
100,284,945,946,CD40L,CSF2,DASATINIB,DECREASES,FACT,FIVE,GZMB,PSA,SECONDARY,SRC,THERE
176,177,ACCORDING,CBCT,CBCTS,CMD,CTS,CTV,D99,FORTY,ROT_C
125I,192IR,43U1,AAPM,BTPS,CARLO,COMPTON,FMCWS,GROUP,ISA,MONTE,PHYSICISTS,TASK
0001,0003,049,CBCT,CTV,DELIVERED,IGRT,MCNEMAR,PTV,WHILE
018,028,AMONG,DOSIMETRIC,ECLIPSE,IMRT,INTENSITY,MUS,OAR,OPTIMIZED,PLANS,PTV,SEVEN,TPS
100,135,169,177,186,400,671,711,DAO,DMPO,FIVE,HOWEVER,IMRT,MACHINE,MUS,PANTHER,PARAMETER,TPS,TPSS
D30,D50,D99,DOSE,DOSIMETRY,KUTCHER,LYMAN,NTCP,PTV,TCP,THEREFORE,V17GY,V35GY,VMAT
2008,BONE,CURRENTLY,FDA,ONCE,SEVERAL,THESE,WORLDWIDE
160,169,2013,5972,ACM,ADT,AHR,COPYRIGHT,COX,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SOCIETY,T1C,T3B,TESTS
1995,2010,350,8805,BACKGROUND,BETWEEN,CONCLUSION,FUNDING,LABEL,MEIER,METHODS,MORTALITY,OVERALL,RESULTS,TRIAL
169,2013,AACR,CURRENTLY,IGF,INSULIN,IRS,IRS1,IRS2,PLX4032,RAF,SER,TREATMENT,V600E
169,2013,495,510,CAUCASIAN,CONCLUSION,COPYRIGHT,CROSS,DATA,INC,LABEL,MAIN,MEASURE,MEN,METHODS,MOST,OBJECTIVE,OUTCOME,OVERALL,PATIENT,PCA,PUBLISHED,RESULTS,SETTING,SOCIETY
BACKGROUND,CFS,CHANGES,DIRICHLET,HIGH,HILIC,HOWEVER,LABEL,RESULTS
169,2004,2013,223,BJU,CRPC,DRUG,FOOD,HOWEVER,III,INITIAL,MDV3100,PSA,RECURRENCE,USA
169,2013,AACR,AKT,CRPC,FKBP5,MMP10,NOTABLY,PTEN,PTENCKO,RPS6,RPS6KB1,SRC
CPRC,CRPC,DESPITE,GIVEN,WHETHER
169,2013,AXL,UICC
2011,ATLANTA,BACKGROUND,CENTERS,CONFERENCE,CONTROL,DISEASE,EACH,FEDERAL,GEORGIA,JULY,KEY,LABEL,MAIN,METHODS,OBJECTIVE,PANELISTS,PRCS,PREVENTION,RESULTS,SDM,SIXTEEN,THINKTANK,YET
169,1983,1991,1993,1999,2009,2013,8201,APC,BACKGROUND,BETWEEN,BLACK,CONCLUSION,COPYRIGHT,FORCE,INC,INCIDENCE,JOINPOINT,LABEL,METHODS,PRIOR,PROGRAM,PSA,REGRESSION,RESULTS,SEER,STAT,TASK,WHITE,WILEY
IMAGING,MRI,PET
220,642,COX,CRP,LABEL,METHODS,MINIMAL,MORTALITY,OBJECTIVE,OBJECTIVES,PRE,RESULTS,RISK,SIMILAR,SWEDISH,TIBC
113,120,169,2013,AACR,CEA,CONCLUSION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCPC,SERUM,SEVENTY
001,016,023,1000,2007,2010,58102,724,8201,ASIAN,AUR,BACKGROUND,BETWEEN,BPH,CALIFORNIA,CURRENT,LABEL,METHODS,ORADJ,RESULTS,STATEWIDE
169,2013,22863,9904,COPYRIGHT,EBRT,EORTC,FURTHER,GROUP,HDR,HIGH,INSTITUTE,JAPAN,LTD,PAST,PROG,RADIATION,RTOG,SEVERAL,THERAPY,TREATMENT
169,2013,AUTHORS,COPYRIGHT,HOWEVER,IAS,INC,LUIGI,PROFESSOR,PUBLISHED,PWA,RICCIARDI,THEN,THESE
001,003,004,169,197,2013,COPYRIGHT,COX,DIFFERENT,EDUCATION,FREEDOM,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THERE,THESE,THOSE,UROLOGICAL
110,169,2010,2013,661,ASIAN,BACKGROUND,BEHAVIORAL,COPYRIGHT,CURRENT,DIGITAL,DRE,INC,LABEL,MATERIALS,MEN,METHODS,PSA,RESULTS,RISK
14C,169,177,184,196,2013,230,738,8211,956,ANTI,ASCT2,BACKGROUND,BOTH,COPYRIGHT,FACBC,INC,KINETIC,LABEL,LAT1,LAT2,METHODS,MICHAELIS,PET,RESULTS,SNAT2,TRANS,XENOPUS
012,025,164,169,2013,266,COPYRIGHT,DOSE,HIGH,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PRESCRIBED,RESULTS,THERE,TREATMENT
0MM,100,169,1MM,2013,2MM,4MM,6MM,8MM,CBCT,CBCTS,CONCLUSION,COPYRIGHT,CROWN,CTV,FOUR,IGART,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PTV,PUBLISHED,PURPOSE,RESULTS,ROS,RTT,RTTS,USING
169,2012,2013,ADVERSE,BACKGROUND,BIOLOGICAL,COPYRIGHT,GROUP,IRELAND,LABEL,LTD,MATERIALS,MAY,METHODS,OBJECTIVE,PHOENIX,PSA,PURPOSE,RADIATION,RESULTS,SABR,THERAPY
169,2012,COPYRIGHT,HOWEVER,IMMEDIATE,LTD,PKP
946,DHT,EXPRESSION,HSD,HSD1,HSD5,HSDS,MEMBERS,THESE
AFTER,PSA,TNM
23848,2ME,58125,AKT,AMP,CONCLUSION,COX,CPT,EP4,EPAC,EPAC1,LABEL,MAPK,METHODS,OBJECTIVE,PGE2,RAS,RESULTS,RNAI,S473,S505,T389
945,FEW,HIF1,VEGF
007,BACKGROUND,BMP,BMP10,BMPS,BONE,CONCLUSION,EXPRESSION,HOWEVER,LABEL,MATERIALS,METHODS,PCR,RESULTS,T24
0001,004,177,AFRICAN,AIM,AMONG,CAUCASIAN,CAV1,CONCLUSION,CRPC,ELISA,LABEL,LNCAP,MATERIALS,METHODS,OBJECTIVE,PC3,PCR,RESULTS,WESTERN
0201,191C,2402,AIM,AIM1L,BACKGROUND,CONCLUSION,HLA,LABEL,MATERIALS,MESSENGER,METHODS,OBJECTIVE,RESULTS,RLRYT,RNAS,SINCE,SYFPEITHI,TKLSA,TMEM
160,2010,778,APRIL,CONCLUSION,IMPORTANT,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,STUDIES,SURVIVORS
CONCLUSION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,TRUS,ULTRASOUND
004,007,045,125,2009,2010,826,AMP,FOLEY,JANUARY,JAPAN,NONE,SOCIETY
001,150,160
PCA,REMARKABLY,THEREFORE,TRBP,USING
BAK,BAX,BLADDER,BRAZILIAN,CONCLUSION,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PCR,PRIMA,PUMA,RESULTS,RT4,T24
130,169,2013,AACR,CHANGES,JMJD2,KDM4,KDM4A,KDM4B,KDM4C,KDM4D,PHD,THUS,TUDOR,VARIOUS
EZH2,PRC2,SUZ12
CTBP1,HIGH,HOWEVER,PSF,RNAS
013,2001,2008,8807,ACCORDING,AFTER,BACKGROUND,BETWEEN,CONCLUSION,HOWEVER,LABEL,MAY,METHODS,PSA,RESULTS
169,2013,949,COPYRIGHT,HOWEVER,INHIBITION,IRELAND,LOX,LTD,OXER1,PKC,PLC
169,2013,COPYRIGHT,INC,TRUNCATED
169,2013,24H,33342,COPYRIGHT,CROWN,DHT,HOECHST,HOWEVER,JUGLANS,JUGLONE,LNCAP,LTD,MAXIM,MTT,OCCURRENCE,PSA,PUBLISHED,TAKE,THEREFORE,THUS
027,169,193,2013,COPYRIGHT,LABEL,LTD,MEN,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RALP,RESPONSES,RESULTS
153,169,2013,333,486,ADVERSE,AFTER,CANDIDATES,COPYRIGHT,EDUCATION,GLEASON,INC,LABEL,MATERIALS,MEN,METHODS,OBJECTIVE,POISSON,PUBLISHED,PURPOSE,RESULTS,T1C,T2A,THESE,UROLOGICAL
001,032,169,1998,2011,2013,496,735,COPYRIGHT,COX,EDUCATION,INC,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PREDICTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
169,1GY,200,2013,24H,53BP1,6MEV,8764,946,947,956,ATF2,ATM,COPYRIGHT,DDR,DSB,DSBS,H2AX,PC3,PHOSPHO,PREVIOUSLY,PUBLISHED,ROS,SER1981,SMAD,SMAD2,SMAD7,STUDIES,TGF,UNREPAIRED
169,2013,AEU,COPYRIGHT,JANUARY,LABEL,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,SYNTHESIS,VALIDATION
169,2013,BACKGROUND,CHALLENGES,COPYRIGHT,GROWING,LABEL,LTD,METHODS,RESULTS,THERE,WHILE
1000,169,2013,250,500,570,750,956,COMPARABLE,COPYRIGHT,HISTOLOGIC,INC,PUBLISHED
169,2013,300,BIOLOGY,COMBINING,COPYRIGHT,FEDERATION,INC,MHZ,OPTICAL,PUBLISHED,ULTRASOUND,WHOLE,WORLD
0001,169,2013,4609,5718,7478,COPYRIGHT,DAXX,E26,ERG,GLEASON,INC,MOLECULAR,RESULTS,TMPRSS2
169,2013,COPYRIGHT,GLEASON,INC
120,145,BACKGROUND,CCK8,CELL,GLEASON,HOWEVER,LABEL,LNCAP,METHODS,PC3,RESULTS,SATB1,SPECIAL,THESE,WESTERN
DUPA,NIR,PSMA,WHILE
CELL,MRI
2009,2010,500,8201,ANTIBIOTIC,CHRONIC,CONCLUSION,DRE,INDEX,INITIALLY,INSTITUTES,JUNE,LABEL,METHODS,OBJECTIVE,OVERALL,PSA,PURPOSE,RESULTS,SCORE,SYMPTOM,TRUS
2006,2010,648,711,AMONG,AUSTRALIA,BACKGROUND,CROSS,FOBT,HRT,LABEL,METHODS,NSW,PSA,RESULTS,THESE,WHILE
1987,2009,RHODE
4FISH,8P21,8Q24,MYC,NKX3
169,2013,ACC,ADP,AKT,ALSO,AMP,AMPK,BETA,COA,CONVERSELY,COPYRIGHT,JNK,JOHN,JUN,LTD,OVERALL,PARP,ROS,S6K,SONS,THUS,U266,VEGF,WILEY
011,014,022,024,033,039,054,063,076,082,195,203,213,215,238,240,241,256,274,281,309,310,946,ADT,BIO,BMD,BONE,BSAP,BTM,FREE,PCA,THERE,THESE,TRAP
001,007,108,185,355,ALSO,COX,CRC,HOWEVER,PCAT,PCR,RNAS
103,122,125,150,230,956,BED,CARLO,CONCLUSION,DOSE,DVH,DVHS,GBQ,LABEL,METHODS,MONTE,NOTABLY,OBJECTIVE,PURPOSE,RESULTS,SIMILARLY
000,0001,CONCLUSION,CRPC,DRUG,FDA,FOOD,III,LABEL,OBJECTIVE,PHASE,PUBLISHED,PURPOSE,SIPULEUCEL,SUMMARY
BASED,BECAUSE,CARLO,IGRT,MONTE,PLAN,THREE
169,2013,COPYRIGHT,FIRSTLY,INC
169,2013,ANNEXIN,ANXA7,CAP,COPYRIGHT,CRC,GBM,LOH,NPC
169,2013,8710,936,946,ATP,AUTHORS,COPYRIGHT,PUBLISHED,RAPAMYCIN,VARIOUS,WARBURG,WNT
0001,044,158,169,2012,393,452,616,642,658,7447,7796,7854,802,823,8804,8805,897,936,967,AEU,CONCLUSION,COPYRIGHT,LABEL,METHODS,OBJECTIVE,PASSING,PPV,PSA,PSAC,PSACOMPLEX,PSAL,PSAT,PUBLISHED,RESULTS,ROC,THERE
ALTERED,CASODEX,EGF,FBS,LNCAP,PCA,SINCE,THESE,TREATMENTS
AXL,DTCS,GAS6,MER,PCA,THESE,TYRO3
ENGLISH,GNRH
169,2013,ASHKENAZI,BRCA1,ERG,INC,METASTATIC,PBRM1,SIXTY,SNPS,TET2,TMPRSS2,WILEY
145,193,BCRFS,CSCS,GLEASON,IHC,OCT4,OCT4A,OCT4B,PCA,THEIR,THUS
169,2013,946,947,A549,B16,CD40,CD86,DCS,DU145,GMBH,IFN,KGAA,STAT1,THUS,TLR3,VCH,VIRAL,WILEY
FINALLY,THESE
EZH2,THUS
PSA,SOMATIC
210,ASSESSMENT,CHRONIC,CROSS,FUNCTIONAL,GENERAL,HEART,III,IIIB,ILLNESS,LABEL,METHODS,OBJECTIVE,OVERALL,PCO2,PURPOSE,RESULTS,THERAPY,THESE,YORK
169,2013,AACR,HOWEVER,METASTATIC,THUS
169,2013,2G7,AACR,CCL2,DC101,DRUGS,FINALLY,INDIVIDUAL,PC3,THREE,VEGF,VEGFA
ALPHA,EDUCATION,LUTS,PSA
BONE,COXAL,GLEASON,HOWEVER,PAGET,PSA,SERUM
LABEL,MARKERS,METHODS,OBJECTIVE,PURPOSE,RADIOPAQUE,RESULTS,TLD,TLDS
BIOLOGICAL,CARLO,EUD,FTP,HOWEVER,IFD,INCREASED,INVERSE,LABEL,METHODS,MONTE,NTCP,OBJECTIVE,PURPOSE,RBE,RESULTS,STP,TCP
BOTH,FLICE,FLIPS,HOWEVER,INHIBITORY,JNK,JUN,PROTEIN,SHORT,THESE,TRAIL
160,CYS49,FURTHER,GLY50,HOWEVER,NDRG1,PAGE,PCR,PHOS,PRECS,SDS,WESTERN
500,ABCG2,AFTER,BOTH,CD44,DU145,ETBR,NANOG,NANOGP8,OCT3,THERE
945,956,AGP,BSA,ESI,EVALUATION,PEEK
BASED,GIVEN,NAFLD,NASH,OBESE,SCREENING,THERE
239,CRPC,IPILIMUMAB,TREATMENT
186,ASSESSMENT,DOWN,HTA,TECHNOLOGY,WHILE
CONSISTENT,GNMT,PCA,PIPOX,SARDH,TAKEN
153,CEA,EIGHT,FIVE,HOWEVER,PSA,T3BN0M0
000,8806,916,ICER,PSA,QALY,QALYS
969,AKT,BAD,DHA,PIP3,PIPS,PUFA,PUFAS,S241,S473,T308
169,1988,2008,2013,633,8805,BACKGROUND,EBRT,FACTORS,FFBF,LABEL,METHODS,PRIOR,RESULTS,RISK,SOCIETY,TOBACCO
001,123,151,169,2002,2005,2013,289,8201,BACKGROUND,COPYRIGHT,COX,INC,KING,LABEL,METHODS,PCA,PCSM,RESULTS,SEER,WASHINGTON,WILEY
160,OVERALL,PET,WHOLE
1990S,CURRENT,FURTHER,SINCE
1007,1993,2006,243,246,332,350,874,985,AMONG,BACKGROUND,CONCLUSION,EBRT,LABEL,METHODS,POPULATION,RESULTS,SWEDISH,SYMPTOM,TOTAL,UNIVERSITY
122,AFRICAN,BACKGROUND,KNOWLEDGE,LABEL,METHODS,NURSING,OBJECTIVE,PSA,RESULTS,SOUTH,THOSE,TSHWANE,WESTERN
000,001,169,2013,BMI,CIS,COLORECTAL,CONCLUSION,COPYRIGHT,CVD,HRS,INC,LABEL,LUNG,METHODS,OBESITY,OBJECTIVE,OVARIAN,OVERWEIGHT,PLCO,RESULTS,SCREENING,TRIAL
001,119,130,136,169,172,2013,311,385,550,64I,916,975,BPH,CCR2,CCR5,CHEMOKINES,COPYRIGHT,INC,PCA,PSA,PUBLISHED,REMARKABLY,SOCIETY
113,BACKGROUND,LABEL,METHODS,RADAR,RESULTS,SIMILAR,THERE,TROG
ADVANTAGES,BACKGROUND,CONCLUSION,CONTEXT,LABEL,MAKIN,METHADONE,METHODS,OBJECTIVE,OBJECTIVES
BACKGROUND,COURT,CURRENT,DEFENCE,DEVICES,DMRC,EXPLOSIVE,HEADLEY,IEDS,IMPROVISED,LABEL,MEDICAL,METHODS,RCDM,RESULTS,ROYAL,THERE,THEREFORE
004,028,124,167,179,212,221,300,302,395,629,823,826,843,CONCLUSION,LABEL,METHODS,OBJECTIVE,PCR,PTC,RESULTS,RUNX2,TSH
0001,0401,130,173,361,362,390,III,LABEL,METHODS,OBJECTIVE,PHASE,RESULTS
2012,508,CAD,CONCLUSION,IAD,LABEL,LIBRARY,MEDLINE,METHODS,NINE,OBJECTIVE,PURPOSE,RESULTS,SEPTEMBER,THERE
0007,0008,012,169,2013,8201,8804,ATHYMIC,BACKGROUND,BODY,COMBINING,COPYRIGHT,EXERCISING,INC,LABEL,LNCAP,METHODS,PCA,PRESENTLY,RESULTS,STD,SUSTAINED,WESTERN,WILEY
916,ACTIVITIES,K5A,K75A,L9G,MCF,MICROSCOPY,N39,N39A,N39K,PC3,R24A,R25A,R8G,THUS,V10G,W106F,W106G
100,400MG,CQA,DAILY,HIGH,HOWEVER,IC50,SPGE,THESE
160,177,CDF,CDFS,DOT,EVEN,PDT,THREE
215,278,292,8P21,967,BACKGROUND,D8S1734,D8S1742,LABEL,METHODS,MSS,NLCS,RESULTS
1055,11C,169,18F,2013,5117,637,BACKGROUND,CONTEXT,COPYRIGHT,DOR,HOWEVER,LABEL,METHODS,OBJECTIVE,PCA,PET,PUBLISHED,REFERENCE,RESULTS,SCIENCE,SYNTHESIS,UROLOGY,WEB
108,169,2013,4675,ADT,BACKGROUND,CONTEXT,COPYRIGHT,DATA,IAD,LABEL,LIBRARY,MEAN,MEDLINE,METHODS,OBJECTIVE,OTHER,PCA,PSA,PUBLISHED,QOL,RESULTS,SYNTHESIS,UROLOGY
0001,169,2014,344,392,8Q24,BACKGROUND,CAP,CAUCASOID,CONCLUSION,COPYRIGHT,HOWEVER,INC,LABEL,MATERIALS,METHODS,RESULTS,RUSSIAN,SNP,SNPS,THERE,THREE,THUS
169,2013,AUC,AUR,COPYRIGHT,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PSA,PUBLISHED,RATIONALE,RESULTS,SIMULATED,TAMOXIFEN
169,178,1997,2007,2013,305,483,AUC,BOTH,COPYRIGHT,CRT,DESPITE,IMRT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,TOTAL
0087,169,1988,2010,2013,2765,502,AFTER,CONCLUSION,COPYRIGHT,DISEASE,GLEASON,LABEL,METHODS,OBJECTIVE,PSA,RESULTS,SAS,THESE,TNM
169,2013,BLADDER,BOO,COPYRIGHT,MEDLINE,SAS
169,1995,2012,2013,8804,BACKGROUND,CONCLUSION,COPYRIGHT,EBRT,GLEASON,IPSS,LABEL,METHODS,MRI,ONCOLOGIC,PSA,RESULTS,SAS,URINARY
420,ALIGNMENT,ANNOTATION,AUTOMATED,BACKGROUND,BASED,CD3,CD8,CONCLUSION,DIFFERENT,DONOR,EXACT,HOWEVER,LABEL,METHODS,NEXT,RESULTS,TEN,TMA,TOTAL
184,8804,BACKGROUND,CONCLUSION,CONTEXT,GLEASON,LABEL,LNS,METHODS,OBJECTIVE,RESULTS,THERE,THESE
0044,158,183,8202,8805,CCP,GLEASON,HIGH,LCMODEL,MAS,MRS,OVERALL,PLS,SEPARATING
000,100,181,231,320,8764,8804,BETWEEN,CD45,COLO,CTC,EPCAM,MDA,PC3,SKBR,TEM,WHILE
169,2013,AFTER,ANTIGEN,BLOOD,CHANGES,EGFR,ELISPOT,FIFTY,MUC20,NYES,REGULATORY,TAA,TAAS,TEFF,TREG,TREGS,UICC
FULL,URINARY,VCF
8Q24,E26,ETS,GWAS,HOWEVER,SOMATIC
003,011,035,037,140,177,178,188,233,368,466,631,648,697,925,GLEASON,HOWEVER,MVD,PSA,THERE,THEREFORE,VEGF
HOWEVER,PCA,PSA,THUS
ERG,ETS,SINCE,THESE,TMPRSS2,WESTERN
169,2013,8322,APOPTOSIS,BIOLOGY,COPYRIGHT,HOWEVER,INC,MOLECULAR,MSA,ORGANIC,THUS,UNION
100,2007,2010,BACKGROUND,FOUR,HBOT,LABEL,METHODS,OBJECTIVE,RESULTS,THREE
160,1993,1995,2006,2010,283,792,952,AARP,COLORECTAL,COX,DIET,INSTITUTES,LUNG,NIH,OVARIAN,PLCO,SCREENING,SIMILAR,TRIAL,WOMEN
110,125,2006,2011,218,982,ADT,AMONG,CONCLUSION,D90,EBRT,FURTHER,GLEASON,HDPPB,HIPCA,LABEL,MARCH,MEIER,METHODS,OBJECTIVE,PSA,RESULTS,V100
169,2013,COPYRIGHT,CRP,EAC,EMOTION,EMOTIONAL,FORTY,INC,LABEL,METHODS,OBJECTIVE,PROBING,RESULTS,RII,YET
106,140,155,169,2013,997,COPYRIGHT,DISPERSIVE,UNDER
169,2013,945,946,COPYRIGHT,EMT,FURTHER,HIF,IRELAND,LTD,SILENCING,STAT3,STRIKINGLY,TGF
169,2013,24H,ACID,AKT,BAX,BCL,BCL2,BIML,BIMS,BOK,COPYRIGHT,CYR61,HIGH,LTD,MCL,NAC,OVERALL,PARP,PI3K,SILENCING
169,2013,20NG,2YEAR,848,AUSTRALIAN,BACKGROUND,CONCLUSION,COPYRIGHT,EBRT,HOWEVER,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PCSM,PSA,PSAV,PSAVS,PURPOSE,RESULTS,SD1,SOUTH
100,1257,169,1840,2001,2013,3200,4800,583,ACCORDING,AMONG,BETWEEN,COPYRIGHT,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,RESULTS
132,169,2013,COPYRIGHT,IMRT,INC,INTENSITY,KNOWLEDGE,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
169,2013,40GY,65GY,68GY,708,745,COPYRIGHT,IMRT,INC,PLANS,PTV,PUBLISHED,TEN,THERE,V20,V40,V65,VMAT
169,2013,AFTER,AORN,COPYRIGHT,IMMEDIATE,INC,IUSS,PUBLISHED
0001,0007,0138,026,160,169,2013,202,2695,8805,CELLSEARCH,CONCLUSION,COPYRIGHT,CTC,CTCS,DRUG,FOOD,GLEASON,INC,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,RESULTS,VARIABLES
001,111,169,2013,215,5GY,BOTH,COMPARING,COPYRIGHT,DIFFERENCE,DMAX,HDR,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PTV,PUBLISHED,PURPOSE,RESULTS,SBRT,SOCIETY,V100,V150,V200,VIRTUAL
169,2013,COPYRIGHT,INC
169,2013,COPYRIGHT,INC,RADIATION
169,2013,COPYRIGHT,EACH,FIVE,INC,MEAN,PSA,PUBLISHED,SALVAGE,SIR,TECHNICAL
125,135,185,195,2007,2011,320,329,335,8201,BACKGROUND,BOTH,FALSE,HOWEVER,IFS,LABEL,METHODS,RARP,RESULTS,ROBOTIC,UNIVERSITY
007,017,073,207,261,327,402,439,593,608,ADC,ADCS,BACKGROUND,DWI,FOCAL,GLEASON,LABEL,LARGE,METHODS,MRI,RESULTS,THEREFORE
AOX1,CLU,FURTHER,GSTP1,HOWEVER,MOST,SINCE,TPM2,WESTERN
100,106B,1209,1221,146A,193A,425,AIMS,AMONG,AVERAGE,BACKGROUND,IC50,LABEL,MATERIALS,METFORMIN,METHODS,MICRORNAS,OBJECTIVE,RESULTS,RNAS
001,019,517,637,BACKGROUND,DFS,HOWEVER,KAYSERI,LABEL,MATERIALS,MEAN,METHODS,RESULTS,TURKISH
010,029,128,A1A2,A2A2,BACKGROUND,CYP17,IRAN,IRANIAN,LABEL,MATERIALS,METHODS,RESULTS,SBMU,STUDIES,THEREFORE
100,ESPECIALLY,FET,MMP,SILICON,THEREFORE
120,FLT,HENCE,L929,LDH,MTT,NPS,PC3
824NG,C57BL,CAST,CONVERSELY,CROSS,EIJ,FOXA2,HLLTJ,NEPC,NOD,NZO,PHJ,PWK,THESE,TRAMP,WSB
ACTIVATION,CONSISTENT,CONVERSELY,DU145,EGF,EGFR,ERK,ERK1,ERK2,INHIBITION,K97M,MEK,MEK1,MODULATION,PCSC,PCSCS,U0126,WHILE
001,006,023,038,150,169,174,2013,8201,BACKGROUND,COPYRIGHT,COX,HPRT1,INC,KLK15,LABEL,METHODS,PCR,REAL,RESULTS,ROC,SEVERAL,TIME,WILEY
161,413,DOPPLER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PSA,RESULTS
008,169,184,2013,242,2Q31,426,5P15,6Q22,8201,BACKGROUND,BECAUSE,BPH,CHINESE,COPYRIGHT,HOWEVER,INC,IPSS,IRX4,ITGA6,LABEL,METHODS,PCA,PSA,RESULTS,RFX6,SCORE,SNPS,SYMPTOM,WILEY
22RV1,CMV,HRPC,HSP70,HTERT,SHRNA,UTMD
0263,8805,BACKGROUND,BECAUSE,CNS,CORD,FORTY,LABEL,LACK,MATERIALS,METHODS,OBJECTIVE,PRIMARY,PURPOSE,RESULTS
104,169,177,2013,8805,AMONG,BACKGROUND,CAP,CCI,COPYRIGHT,COX,HRS,ILLNESS,INDEX,LABEL,METHODS,PREVIOUSLY,RESULTS,SOCIETY,THEREFORE,THESE,TIBI,TOTAL
160,EPCAM,LABEL,METHODS,NIRF,OBJECTIVE,PCA,PRIMARY,PURPOSE,RESULTS,USING,WIDE
147,264,555,ELISA,FIBROBLAST,MOLECULAR,PCR
CONCERN,LABEL,MEN,OBJECTIVE,PURPOSE,RESULTS,SUMMARY,THERE,VARIATIONS
ADT,LABEL,MOLECULAR,MRI,OBJECTIVE,PSA,PURPOSE,RESULTS,SUMMARY
99M,GLEASON,HIGH,LABEL,MOST,MRI,OBJECTIVE,PCA,PET,PURPOSE,RESULTS,SCORE,SUMMARY,THEREFORE
1800,8764,ALSO,ART,COMPLIANCE,LABEL,OBJECTIVE,ONGOING,PURPOSE,RESULTS,SRT,SUMMARY,THREE
0001,2003,2011,371,424,CONCLUSION,GLEASON,HOWEVER,LABEL,METHODS,OBJECTIVE,OVERALL,PCA,PSA,PURPOSE,RARLP,RESULTS
029,044,127,169,2013,947,954,AFRICAN,CAUCASIAN,COPYRIGHT,ELISA,IIA,INC,MUC1,PUBLISHED,RIIA,RIIIA,SOCIETY,THESE
0001,169,1988,201,2010,2013,369,8804,BACKGROUND,BCR,COPYRIGHT,COX,GLEASON,LABEL,LND,LNM,METHODS,OBJECTIVE,OUTCOME,PCA,PUBLISHED,RESULTS,SETTING,SEVENTY,SIXTY,UROLOGY
AKT,BAXM159,ERK1,INCUBATION,MACROPHAGE,MIF,PC3,TREATMENT
1024,160,215,CARLO,CONCERNING,DIRICHLET,DPGLM,EPID,EPIDS,GOLAY,IMRT,IRON,LASG,MONTE,RMS,SIEMENS
169,2013,COPYRIGHT,HDAC,HDACS,HISTONE,INC,INCREASED,LIVER,LXR,LXRS,PCA,RECEPTORS,TARGETING,THEREFORE
177,8201,ADVERSE,BACKGROUND,CONCLUSION,DOSE,FOUR,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THREE
110,144,169,2004,2011,2012,2013,8804,AEU,COPYRIGHT,GLEASON,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PSA,PUBLISHED,RESULTS,T1C,T2A
169,1996,2000,2013,802,AFTER,BETWEEN,COPYRIGHT,DPS,IRELAND,LABEL,LTD,METHODS,NAS,OBJECTIVE,PSA,PURPOSE,RESULTS,TROG
103,456,8610,ARM,BACKGROUND,COX,FINE,GRAY,III,INTENSITY,LABEL,METHODS,RESULTS,RTOG,SUFFICIENT,THERE,UNIVARIATE,VEGF
001,100,CONCLUSION,HOWEVER,METHODS,PC3,RADIATION,RESULTS
AFTER,CAREFUL,RADICAL,SIDE
ADC,DCE,GTV,MOST,MRI,MRSI,NEXT,OAR,THERE,TPS,WHILE
HOWEVER,IMRT,THEREFORE,TNMU
2013,COLD,COPYRIGHT,MILAN,PROUS,SCIENCE,UROLOGY
131,947,956,CLONOGENIC,CONCLUSION,DISULFIRAM,ESCALATING,LABEL,METHODS,MIBG,NAT,RESULTS,THEREFORE,UNLABELLED,UVW
945,ACT,CANDIDA,COMPARISON,EPITOPE,HUACTN1,SERA,STI,STIS,THERE,THESE
BONE,ZOLEDRONIC
181,CELL,EGCG,GROWING,PC3
ERG,MAST4,NDUFAF2,TMPRSS2,USING,VARIOUS,VCAP
0001,104,1164,1990S,1994,1995,2010,491,568,AFTER,BACKGROUND,EBRT,LABEL,METHODS,MORTALITY,OCTOBER,OVERALL,POPULATION,RESULTS
CORYLOPSIS,DPPH,DU145,FIFTEEN,LNCAP,MEOH,NBT,UYEKI
0067,008,426,ADDITIONAL,BECAUSE,BPH,CHINA,CHINESE,GWAS,PCA,SNP,STRATIFIED
946,BOTH,DEPLETION,EMT,H2O2,IRS,REMARKABLY,ROS,TGF
0001,101,2008,2012,215,ADC,AUC,AUCS,DIAGNOSTIC,DIFFUSION,EXCEPTIONS,FIFTY,GLEASON,HOWEVER,III,LABEL,MATERIALS,METHODS,MIXED,OBJECTIVE,OBJECTIVES,RESULTS,VII
001,169,2013,269,566,628,747,897,BASEL,CONCLUSION,COPYRIGHT,CRUDE,DATA,LABEL,METHODS,OBJECTIVE,OVERALL,PSA,REGARDING,RESULTS
100,BIOSENSING,HIGH,PEDOT,PSMA
GROWING
133,2002,2006,2009,214,2268,ADJUSTING,AGES,AMONG,HIGH,HRS,LABEL,MEN,METHODS,OBJECTIVE,ORS,RESULTS,REYKJAVIK
168,CAP,CONCLUSION,CUT,DETECTION,DRE,GLEASON,LABEL,MATERIALS,MEAN,METHODS,NEITHER,OBJECTIVE,OVERALL,PPVS,PSA,RESULTS,THERE,THEREFORE,TRU
181B,ASO,CHANGES,DOWN,MTT,PCR,TISSUES,TOTAL,TRANSWELL
2001,302,552,575,8805,984,BACKGROUND,CANCERS,CONCLUSION,ESTIMATES,HOWEVER,INCREASES,LABEL,METHODS,OBJECTIVE,PROGRAM,RESULTS,SEPTEMBER,SIR,SIRS,TRADE,WORLD,WTC,YORK
494,538,692,AFTER,BACKGROUND,BODY,LABEL,METHODS,OBESITY,PIN,PSA,RESULTS,RISK,TURP
CONDUCTING,DUE,EVENTUALLY,GFF,INCUBATION,THESE,UPON
EARLY,HOWEVER,LIMA,PERU,PSA,THERE
111,205,BCL2,CONSISTENT,DECREASED,GLEASON,LNCAP,LOWER,MIR,PC3
ANGIOGENIC,HOWEVER,PCA,THEREFORE,THESE
HOWEVER,RNAS,UTR
160,ATR,CDC6,DU145,FINALLY,NCTD,PCA,RCS,THESE
ENDOCRINE,RELATED
2007,2010,9344,958,GENERAL,LABEL,METHODS,MIDLAND,NETWORK,OBJECTIVE,PSA,RESULTS,ZEALAND
1184,1997,2008,4736,ASIAN,BACKGROUND,BOTH,BPH,CONCLUSION,INSURANCE,LABEL,MEDICAL,MEN,METHODS,RESULTS,WESTERN
001,014,2008,2011,240,BACKGROUND,CONCLUSION,EBRT,EPIC,LABEL,METHODS,RESULTS
125,169,2013,ANY,COPYRIGHT,D90,D90S,GIVEN,INC,MEDICAL,MRI,PID,PUBLISHED,TRUS
169,2013,COPYRIGHT,CXC,DOPPLER,FINALLY,IL8,IRELAND,LTD,MAGI,MGT
169,2012,8805,AEU,BACKGROUND,BOTH,CONCLUSION,CONTEXT,COPYRIGHT,FOLLOWING,ISC,LABEL,METHODS,OBJECTIVE,PUBLISHED,SUMMARY,TUMOURS,UNASSIGNED
APPARENTLY,CD16,EPCAM,EPCAM16,STUDIES
439,CANCERS,CONSORTIUM,INSTITUTE,MOUSE,NCI,WHILE
001,2010,777,8804,CONCLUSION,GIVEN,HISPANICS,INTERVIEW,LABEL,METHODS,MOST,NON,OBJECTIVE,PCSG,PURPOSE,RESULTS,SURVIVORS,THESE
125,169,2013,215,333,405,ADAR,AFFYMETRIX,BACKGROUND,CNAS,COPYRIGHT,GENOMIC,GLEASON,LABEL,METHODS,MYC,PCA,PTEN,RESULTS,SOCIETY,TARGETS,THESE,TP53,TPD52,USP10
239,8804,8805,AFTER,AMONG,BACKGROUND,CLASS,CONCLUSION,CSF,DP4,DR4,ELISPOT,ESO,GIVEN,GROUP,HLA,LABEL,METHODS,OWING,PSA,RESULTS,THREE
169,181,2013,842,929,BCL,COPYRIGHT,DIETHYL,GMBH,HREI,INSTITUTE,KGAA,MTT,NCI,NMR,USA,USING,VCH,WILEY
CD133,IC50,IL1RA,KNOCKDOWN,MECHANISM,OCT4,PCA,TR4
AFTER,BPH,DHT,LNCAP,MAZ,MYC,PCA,THESE
GLEASON,HOWEVER,LABEL,MRI,OBJECTIVE,PURPOSE,RESULTS,SCREENING,SUMMARY,THESE
0001,169,2000,2009,2013,226,235,436,437,COMPOSITE,COPYRIGHT,EDUCATION,EPIC,INC,INDEX,INVENTORY,LABEL,MATERIALS,METHODS,OBJECTIVE,PEARSON,PUBLISHED,PURPOSE,RESULTS,SUCCESSFUL,THREE,UIN,URINARY,UROLOGICAL
104,152,169,200,2013,300,347,COPYRIGHT,DIAGNOSIS,EDUCATION,GLEASON,IMAGING,INC,LABEL,MATERIALS,METHODS,NCCN,NETWORK,NONSEPTIC,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,REGARDING,RESULTS,SINCE,SYSTEMATIC,TESLA,UROLOGICAL
001,002,169,2003,2008,2013,484,COPYRIGHT,EDUCATION,GENERAL,HOWEVER,INC,INCREASED,INDEX,JANUARY,KINGDOM,LABEL,MAIN,MATERIALS,MEN,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,TAYSIDE,THERE,UROLOGICAL
AAM,AFRICAN,DESPITE,EARLY,PCA
001,002,004,169,2013,507,565,649,967,CONCLUSION,COPYRIGHT,GRIFFITHS,INC,IPSS,LABEL,LUTS,MANN,METHODS,OBJECTIVE,PEARSON,RESULTS,SCHAFER,SCORE,SYMPTOM,WHITNEY
169,2013,220,257,CONCLUSION,COPYRIGHT,CROWN,DOSES,FEW,FURTHER,IMAGE,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THERE
000,169,177,2013,CINE,CONCLUSION,COPYRIGHT,DIFFERENT,EPID,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,TEN
169,2013,AEU,ANTIGEN,BPH,COPYRIGHT,CURRENTLY,LABEL,METHODS,OBJECTIVE,PSA,PUBLISHED,SUMMARY,UNASSIGNED
169,2013,COPYRIGHT
169,2013,338,382,946,COPYRIGHT,CROWN,ELISA,FURTHER,HOWEVER,MSMB,PUBLISHED,SEMEN,SIXTY,THESE
169,201,2013,231,COPYRIGHT,DRE,MRI,PSA,PUBLISHED,SAS,ULTRASOUND
IMAGING
000,004,153,169,2009,2013,8201,964,BACKGROUND,BEHAVIORAL,CCS,CHI,COPYRIGHT,HRQOL,JOHN,LABEL,LTD,METHODS,OBJECTIVES,PCS,RESULTS,RISK,SHORT,SONS,USA,WILEY
1035,1054,169,2013,ALSO,COPYRIGHT,GIVEN,IMAGING,INC,MAGN,RESON,WILEY
160,169,183,BIOLOGY,DIFFUSE,FEDERATION,GEORG,GUIDELINES,SOCIETIES,STUTTGART,THEN,ULTRASOUND,YORK
002,017,029,078,142,158,166,358,573,618,678,8963,921,ABSTRACTS,AIMS,ALSO,BPS,DONJ,FURTHER,LABEL,METHODS,OBJECTIVE,ONJ,OVERALL,RCTS,RESULTS,SIMILAR
BBN,CONCLUSION,GRP,LABEL,METHODS,OBJECTIVE,PDT,PEG6,PET,PPIX,RESULTS,THEN
MRI
ADT,ALT,FEW,FORTY,GRADE,LABEL,METHODS,OBJECTIVE,PFS,PURPOSE,RESULTS
118,160,2007,2009,8201,ACCURAY,ACTUARIAL,BETWEEN,CBK,CONCLUSION,CSS,CYBERKNIFE,EORTC,EVALUATION,FURTHER,GROUP,INC,INCLUSION,LABEL,MAY,METHODS,OBJECTIVE,PFS,PRIMARY,PURPOSE,RADIATION,RESULTS,RTOG,SCALE,SOLID,SRT,SUNNYVALE,THERAPY,TREATMENT,UPON,USA
160,8201,BACKGROUND,CBCT,CONCLUSION,LABEL,METHODS,OBJECTIVE,OTHER,PSA,PURPOSE,RESULTS,UNDER,VAS
160,2008,2012,8201,ADVERSE,BETWEEN,CONCLUSION,CTCAE,EARLY,EBRT,FURTHER,HDR,IHT,LABEL,METHODS,OBJECTIVE,RESULTS,SEPTEMBER
ALSO,ALTERED,PCA,SRC,TAKEN,TARGETING
CHINA,CHINESE,GWAS,MECHANISMS,NEXT,PCA,RNAS,SNPS
10MG,169,176,2013,8320,8325,AHGDM,BASED,BINDING,CONJUGATES,COPYRIGHT,DOC,DU145,FOLLOWING,GRP78,HPMA,HSP,THESE
169,177,2013,20GBQ,956,AE105,AE152,ALF,CONCLUSION,COPYRIGHT,HPLC,INC,LABEL,METHODS,NOTA,PET,RESULTS,UNLABELLED,UROKINASE
0001,169,2013,8805,CLINICALLY,COPYRIGHT,DIAGNOSTIC,GLEASON,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,OBJECTIVES,RATIO,RESULTS,SEVENTY,TRUS
169,2013,AMINOETHYL,APB,COPYRIGHT,IP3,LTD,ORAI,SERCA,SOCE,TRP,TRPV6,WHEREAS
100,183,496,500,7221,8805,CENTRAL,CONTROLLED,COX,MEDLINE,TRIAL
104,112,115,118,160,169,184,188,193,2008,2013,304,310,468,561,633,727,8805,916,935,ADT,CONCLUSION,COPYRIGHT,FFS,INC,LABEL,MARKETSCAN,METHODS,OBJECTIVE,RESULTS,USING
169,1989,2009,2013,ADULT,AFTER,AGE,CONCLUSION,COPYRIGHT,EARLY,INC,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,RESULTS
169,2013,BASED,CARLO,COPYRIGHT,CTV,HEAD,IRELAND,LABEL,LTD,MATERIALS,METHODS,MONTE,NECK,OBJECTIVE,PTV,PURPOSE,RESULTS
014,100,125,145GY,160,169,176,183,188GY,2010,2012,2013,2GY,CONCLUSION,CONTINENCE,COPYRIGHT,D90,FOCAL,FURTHER,INC,INDEX,LABEL,MARCH,MATERIALS,METHODS,MRI,OBJECTIVE,PATIENT,PUBLISHED,PURPOSE,RESULTS,SCORE,SOCIETY,SYMPTOM,V100
105,112,217,8201,ARM,GRADE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,RTOG,THERE,VARIABLES
169,2013,231,233,COPYRIGHT,PUBLISHED,SAS,SFRO,SOCI,STIC
024,169,2013,BPS,BRONJ,CLINICO,CONCLUSION,COPYRIGHT,DATA,FIFTY,GRAM,HIGH,INC,INFECTION,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PAS,RESULTS
1000,169,2001,2005,2013,244,600,844,BCR,BJU,CONCLUSION,COX,GLEASON,LABEL,LRP,LRPS,METHODS,MOST,OBJECTIVE,OVERALL,PRIMARY,RESULTS,RRP,SRT
013,035,1015,169,181,2003,2010,2013,766,8201,945,946,APOPTOSIS,BCL2,COX,LABEL,METHODS,NAFTOPIDIL,OBJECTIVE,OBJECTIVES,RESULTS,SMAD2,UROLOGICAL
169,2013,8201,HOWEVER,THUS,UROLOGICAL
169,2013,EOS,OCT4,PCA,SOX2,THEREBY,TREATMENT
3RP1,AFTER,FIVE,IGFBP,THESE
AUC,BAYES,CHI2,CONCLUSION,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,ROC,SIX,T1WI,T2WI
ANTISENSE,ASONS,BCL2,BFL,BPH,CONCLUSION,DU145,ISH,LABEL,LNCAP,METHODS,MTT,OBJECTIVE,PCR,RESULTS
INHIBITION,PCA
1091,1973,2006,710,807,876,AIM,BACKGROUND,BARRETT,CAUCASIANS,CHI,CONCLUSION,DATA,EAC,END,HOWEVER,LABEL,METHODS,NIH,OBJECTIVE,OVERALL,RESULTS,SEER,THERE
CONVERSELY,E1A,ERK,ERK1,ERK2,INDIVIDUAL,MAP,MEK,RNAI,SAPD,STAT3
METASTATIC
946,948,ABCA1,CAV1,ERK,EXPRESSION,HOWEVER,PPAR,SMAD,TGF
CELLS,FTIR,PROPIDIUM,RESULTS,WHILE
0002,001,945,946,947,AKT,BACKGROUND,CONCLUSION,FAK,IHC,LABEL,METHODS,PCA,PCR,PP2A,PROTEIN,RESULTS,SIMILAR,THROUGH
169,2013,945,9994,9995,BPH,COPYRIGHT,DHT,DLLME,ENZYMATIC,RIS,VARIABLES
129,169,2002,2005,2013,8805,ADVERSE,COPYRIGHT,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RADIATION,RESULTS,THERE,TREATMENT
18F,BCR,FACBC,IMAGING,PCA,PET,PSA,RESONANCE,TODAY
181,DU145,ERK1,HOWEVER,JNK,MAP,MAPK,NAC,ROS,RWPE,SOD,THESE,U0126
001,2006,2012,350,AMICO,CAP,DEPARTMENT,EVEN,FORTY,LABEL,METHODS,OBJECTIVE,PHOENIX,PSA,RECURRENCE,RESULTS,UNIVERSITY,UROLOGY
10TH,181,1974,246,277,40S,4922,50S,8805,CAREFUL,CASE,CONCLUSION,GIVEN,LABEL,MAIN,MALM,METASTASIS,METHODS,OBJECTIVE,OUTCOME,PREVENTIVE,PROJECT,PSA,RATES,RESULTS,RISK,SETTING,SWEDISH
111,DWI,HOWEVER,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,SPECT
8322,BIOMARKERS,KNOWN,PAO,RADIATION,TPOT
123,134,160,8201,869,901,ACS,AOW,ARMY,AVON,CIS,CONSORTIUM,FOUNDATION,HOWEVER,INADEQUATE,INSTITUTE,LABEL,LOVE,METHODS,OBJECTIVE,OTHER,PURPOSE,RESULTS,SERVICE,SOCIETY,SURVIVORS,SUSAN,WOMEN
0028,003,100,1389,177,BPH,CONCLUSION,LABEL,METHODS,OBJECTIVE,PAI,PCA,PURPOSE,RESULTS,TRIS,UROKINASE,USING
114,160,1981,2003,271,366,DEPENDING,NORWEGIAN,SIR,USING
199B,945,ARTIFICIAL,DU145,HIF,LNCAP,MICRORNAS,PCA,RNAS,UTR
945,946,949,AR47,BACKGROUND,BINDING,CD4,CD8,ELISA,FURTHER,IGE,IGG1,LABEL,LOG,METHODS,PCA,PSA,RANK,RESULTS,THESE
169,1995,2013,288,330,BASEL,COPYRIGHT,EACH,FACT,HOWEVER,JAPAN,KYOTO,LABEL,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS,SHEET
160,177,300,ARP,AUNP,AUNPS,CARLO,CELL,MONTE,SER,SERS
0001,169,2013,8201,BASED,FOLLOWING,LABEL,METHODS,OBJECTIVE,RESULTS,UROLOGICAL
AKT,BMX,TEC,TEL,USING
2012,AFTER,DOCETAXEL,FIRST,HOWEVER,LOW,PRESCRIRE
945,946,954,DOCKING,FINALLY,HOWEVER,IKK,PAF,PMS1077,RAJI,THESE,TNF,WESTERN
040,151,651,CGEMS,CSF1,EGFR,FIVE,FORESTS,MARKERS,MMP16,MOFFITT,REGRESSION,ROBO1,SNP,SNPS,SPLINES,THREE,TRM,USING
003,006,444,776,8202,AFTER,AMONG,CIS,DISCOVERY,EHBP1,FALSE,ORS,RATE,SNP,TET2,UNCOVERING
001,119,215,93G,AIN,C57BL,FVB,MAXIMALLY,PCA,TRAMP
BIOLOGICAL
1995,DENDRITIC,SINCE,WHILE
131,1318,CEACAM6,ETS,FURTHER,HER2,MCF,OVERALL,PDEF,THESE,U133A
BACKGROUND,BCR,CONCLUSION,CONSISTENT,DECIPHERTM,IRB,LABEL,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS,THESE,TREATMENT,UROLOGISTS
100,160,500,956,ANTI,BACKGROUND,CONCLUSION,DISEASE,FURTHER,GX301,IMIQUIMOD,ISA,LABEL,METHODS,MONTANIDE,OBJECTIVE,PROLONGED,RESULTS
CONCLUSION,FACBC,FURTHER,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,TBR
ATF3,CCND,CCND1,DU145,FINALLY,FIRST,HOWEVER,LNCAP,PC3,PREVIOUSLY,SUMO,SUMOYLATED,TAKEN
100,177,BCI,BNC,LABEL,METHODS,MVDC,OBJECTIVE,OBJECTIVES,OVERALL,QMAX,RESULTS,RRP,STUDENT,T2A,T2C
154,EMT,EPITHELIAL,HIGH,HMGA2,HOWEVER,PCA,WESTERN
DESPITE,DU145,HEME,NUCLEAR,PC3,THESE,VEGF
001,007,167,8807,950,BACKGROUND,CD34,CONCLUSION,ECS,GLEASON,LABEL,METHODS,MVD,PCA,PSA,RESULTS,VASH1
111,111IN,176,177,ACA,AFTER,DOTA,GRPR,HIGH,HPLC,MULTIMERIC,NHS,PBS,PREVIOUSLY,RGD,SCID
BAY1075553,BECAUSE,DCFBC,HBED,PCA,PET,PSMA,SEVERAL,THESE
PET
159,185,2009,787,928,ACCORDING,AFRICAN,INSTITUTE,MIGRATION,NIGERIA,SIMILAR,STUDIES,WASHINGTON
17TH,CONCLUSION,LABEL,METHODS,OBJECTIVE,PLAIN,RESULTS,SPANISH,WORLDWIDE
ETS,PTEN,THESE
176,200,BECAUSE,DEGARELIX,JAPAN,P450,UNION
013,116,145,169,2013,209,414,956,A549,AACR,ANTITUMOR,B16,BCA,C38,C51,CAKI,GXF,H460,HCT,IC50,LABEL,LEWIS,MA16,MA17,METHODS,MIA,N87,NCI,OBJECTIVE,P02,P03,PACA,PURPOSE,RESULTS,SR475,TAXANES,THESE,TXT,UISO,XRP6258
001,124,160,224,945,ADDITIONAL,ASSESSMENT,BPI,BRIEF,COHEN,DATA,FACT,FUNCTIONAL,HOWEVER,INTENSITY,INVENTORY,LABEL,MCNEMAR,METHODS,OBJECTIVE,PAIN,PEARSON,PPI,PRESENT,PURPOSE,RESULTS,THERAPY
HIFU,MRG
22RV1,8805,945,BPH,CAFS,ECM,GLEASON,HOWEVER,K14,MFS,MMP,MMPS,PC3,PCA,SMA,THEREFORE,TIMP1,TIMP2,TIMP3,TIMPS
945,BAX,BCL,CCK,CELL,ERP29,FITC,HIF,HOWEVER,INCREASED,MALDI,PARP,PROTEOMICS,ROS,SOD1,THESE,THREE,TOF,WESTERN
001,2003,208,295,4284,468,5220,584,588,645,8313,AFFAIRS,AMONG,DESPITE,DEYO,HOWEVER,IMPORTANCE,INDEX,LABEL,MAIN,METHODS,OBJECTIVE,OUTCOME,PSA,RELEVANCE,RESULTS,SETTING
BACKGROUND,CONCLUSION,HOWEVER,LABEL,LND,LYMPH,METHODS,RESULTS
PTH,PTHRP,RANKL,THESE
041,945,CD31,DCE,GIVEN,GLEASON,HIF,HOWEVER,MRI,MVD,NUCLEAR,PRONOUNCED,THEREFORE
000,001,106,160,181,250,270,500,ABST,ABTS,BRDICKA,DMPD,DPPH,FINALLY,FRAP,MTT,SARCOSINE,THERE
BASED,DESPITE,SILYBUM
8209,CDC2,FLOW,IMIQUIMOD,TLR7,TRAMP,TREATMENT,TRMPA
8910,947,DSBS,H2AX,MCL,PARP
0001,0008,002,007,169,2013,426,5990,706,8805,ADT,AUA,BACKGROUND,COPYRIGHT,DAILY,DATA,FRACTURES,GROUP,INDEX,LABEL,MEN,METHODS,OBJECTIVE,OUTCOME,PCA,PRS,PUBLISHED,RESULTS,SETTING,SYMPTOM,THESE,UROLOGICAL,UROLOGY
169,2001,2011,2013,2670,2892,ASSESSMENT,BACKGROUND,CALIFORNIA,CAPRA,COPYRIGHT,EQUAL,FRANCISCO,HOWEVER,LABEL,MEIER,METHODS,OBJECTIVE,OUTCOME,PREDICTION,PUBLISHED,RESULTS,RISK,SAN,SETTING,STEPHENSON,UNIVERSITY,UROLOGY
169,2004,2013,AIMS,COLLEGE,CONCLUSION,COPYRIGHT,DOCETAXEL,FURTHER,GVAX,LABEL,LIBRARY,LTD,MATERIALS,MEDLINE,METHODS,OBJECTIVE,PROMISING,PUBLISHED,RCTS,RESULTS,ROYAL,SINCE,THESE
001,1617,167,297,464,673,792,825,8805,AMONG,COMPARISON,FURTHER,IPSS,LABEL,MAIN,METHODS,NNT,OBJECTIVE,OUTCOME,PLACEBO,POST,REDUCTION,RESULTS,SCORE,SYMPTOM
0001,115,1988,2003,432,490,922,AJCC,BACKGROUND,CONCLUSION,COX,END,LABEL,MARITAL,MARRIED,MATERIALS,METHODS,RESULTS,SEER,UNMARRIED
1043,147,529,8804,BACKGROUND,EPSTEIN,GLEASON,LABEL,MATERIALS,METHODS,PSA,RESULTS,TRUS,USING
186,BACKGROUND,LABEL,MATERIALS,METHODS,MRI,RESULTS,THERE
2004,2008,AFRICAN,ALSO,AMERICA,AMERICANS,BACKGROUND,DATA,FURTHER,HISPANICS,INDEX,LABEL,LUNG,METHODS,MORTALITY,PARADOX,RESULTS,TEXAS,USA,WELLBEING
AACR,AREAS,ASCO,BACKGROUND,COMPOUNDS,COVERED,HOWEVER,LABEL,METASTATIC,METHODS,OPINION,OTHER
125B,22RV1,346C,ARF,CONVERSELY,LNCAP,MDM2,MICRORNAS,PC3,PUMA,RNAS,THUS
262,324,356,ACTIVATED,ALZHEIMER,NOTABLY,PSK,PSK1,PSK2,PSKS,SER,TAOKS
8805,BACKGROUND,ECOG,LABEL,METHODS,NORTH,OPTIMAL,PRIMARY,PSA,RESULTS,THREE
169,2013,AACR,AKT,PI3K,PIM,RTK,RTKS
169,2013,912,GMBH,KGAA,MVS,NSCLC,PAGE,SDS,THESE,THREE,USING,VCH,WILEY
BOTH,CCL,CCL2,CCR2,DIM,GIVEN,I3C,LNCAP,THESE,THP
ADT,ADVERSE,DENOSUMAB,MULTI,SRE
169,2013,ANDROGENS,ARS,COPYRIGHT,CYTOMETRY,DESPITE,FQNLF,FRET,SOCIETY
166,2013,458,AFRICAN,ASIAN,CAUCASIAN,CHINA,FURTHER,HOWEVER,JANUARY,P450,SCIENCE,SEVENTEEN,WEB
CRPC,FURTHER,THOUGHTFUL,TREATMENT
DEFINITIVE,SEVERAL
169,2013,BASED,COPYRIGHT,EVEN,HOWEVER,INC,RRP,URINARY
169,2013,BCL,CHROMATIN,COPYRIGHT,FUNCTIONAL,H3K4,H3K9,LTD,PAWR,RNAA,RNAS,THESE
169,2007,2008,2013,295,AMBULATORY,ASSURANCE,CARE,COMMITTEE,COPYRIGHT,EDUCATION,FINALLY,HOPES,INC,LABEL,MATERIALS,MEDICAL,METHODS,NAMCS,NCQA,OBJECTIVE,OFF,PUBLISHED,PURPOSE,QUALITY,RESULTS,SUCCESSFUL,UROLOGICAL,UROLOGY,WHILE
001,169,2013,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,MOST,OBJECTIVE,PUBLISHED,PURPOSE,REAL,RESULTS,SMALLER,THREE,UROLOGICAL,WHOLE
169,2013,239,481,7641,785,9295,AFFYMETRIX,ALTERED,AMONG,COPYRIGHT,CPG,INC,METHYLATED,PATHOLOGY,PATHWAY,PUBLISHED,SNP,SOCIETY,THESE
169,173,2009,2013,7500,COPYRIGHT,PUBLISHED,SAS
169,2013,8320,8325,956,ANNEXIN,COPYRIGHT,DU145,HDAC,HDACS,HISTONE,LNCAP,PC3,SAHA,SAS,THESE,WESTERN
169,2013,AIMS,BACKGROUND,COPYRIGHT,EGCG,FURTHER,GREEN,HOWEVER,LABEL,LTD,METABOLISM,METHODS,MOST,NUTRITION,OBJECTIVE,RELEVANCE,RESULTS,SOCIETY
1045,169,200,2013,300,456,462,8804,8805,918,AMONG,BACKGROUND,COPYRIGHT,CPA,FEW,IHT,LABEL,LHRH,MAB,MEN,METHODS,OBJECTIVE,OUTCOME,PCA,PRIMARY,PSA,PUBLISHED,RESULTS,SECONDARY,SETTING,THERE,TIME,UROLOGY
228,CLINICALLY,DENMARK,MOHS,PKMK,RADICAL
10MG,169,2011,2013,47TH,8805,AKT,BACKGROUND,BASEL,CD3,CD4,CD8,CHICAGO,CONFIRMED,COPYRIGHT,COX,EVEROLIMUS,HEMATOLOGY,JUNE,LABEL,MEETING,MEIER,METHODS,OBJECTIVE,OCTOBER,OUTCOME,PFS,PI3K,PSA,PTEN,PUBLISHED,RESULTS,SEPTEMBER,SETTING,SEVERAL,SMALL,SOCIETIES,SOCIETY,SWISS,TIME,TREATMENT,TRIAL,UROLOGY,USA
169,2013,945,BACKGROUND,COPYRIGHT,ESC,IPSCS,KLF4,KRUPPEL,LABEL,METHODS,MYC,OBJECTIVE,OCT4,OUTCOME,POU,PRIMARY,PRO,PUBLISHED,RESULTS,SETTING,SIMILARLY,SOX2,SRY,SUCCESSFUL,THESE,UROLOGY
169,1990,2012,2013,AVAILABLE,BACKGROUND,CONTEXT,COPYRIGHT,HOWEVER,JANUARY,LABEL,MEDLINE,METHODS,OBJECTIVE,OVERALL,PLND,PUBLISHED,RARP,RESULTS,SCIENCE,SYNTHESIS,UROLOGY,WEB
169,2013,957,APT,BAX,BCL2,CASPASE,COPYRIGHT,DOX,H40,LTD,P21,P27,PARP,PEG,PLA,PSMA,THESE
169,2013,600,AFTER,CONCLUSION,COPYRIGHT,ERB,IMRT,INC,LABEL,LAT,MARGINS,MATERIALS,MEAN,METHODS,OBJECTIVE,PATIENT,PURPOSE,RESULTS
001,045,157,1996,2005,8805,FURTHER,GLEASON,HDR,INC,LABEL,MATERIALS,METHODS,NONE,OBJECTIVE,PHOENIX,PSA,PUBLISHED,PURPOSE,RESULTS,THERE,THREE
0001,134,160,169,2013,512,8804,CONCLUSION,COPYRIGHT,COX,ESTIMATED,III,INC,LABEL,MEIER,METHODS,OBJECTIVE,PSA,RESULTS,THESE,TREATMENT
169,2013,233,BACKGROUND,BCG,BLADDER,CONTEXT,COPYRIGHT,EAU,GROUP,GUIDELINES,LABEL,MEDICAL,MEDLINE,METASTATIC,METHODS,OBJECTIVE,PRIMARY,PUBLISHED,RESULTS,RISK,SUBJECT,SYNTHESIS,UROLOGY
10MG,169,177,2013,ACTH,BACKGROUND,CONCLUSION,COPYRIGHT,EPLERENONE,LABEL,LTD,METHODS,PHASE,RESULTS
160,169,1980,1990,2009,2011,2013,AIMS,ALSO,CENTRAL,COLLEGE,CONCLUSION,CONTROLLED,COPYRIGHT,ENROLMENT,III,LABEL,LTD,MATERIALS,MEDLINE,METHODS,MOST,OBJECTIVE,PUBLISHED,REGRESSION,RESULTS,ROYAL,SEPTEMBER,SRE,SRES
ANP,C57BL,NPRA,PCA,THESE,YET
FDA,MONOCLONAL,PSMA
AREAS,BACKGROUND,COVERED,CRPC,DESPITE,LABEL,METHODS,OPINION,VARIATIONS
000,001,002,057,090,131,138,179,1999,2009,8314,AIDS,AUTHORITY,BRESCIA,CD4,HIV,HOWEVER,IRR,LHA,LOCAL,NADCS,POISSON,RISK,SIR,SIRS
1968,1998,1999,2007,HOWEVER,USING
000,001,002,007,167,2006,2012,226,238,426,464,549,8804,BACKGROUND,COMPARING,GLEASON,GROUP,HOWEVER,LABEL,METHODS,RESULTS
2002,2006,221,352,495,BACKGROUND,BASE,BMI,HBA1C,LABEL,METHODS,OBESE,OVERALL,RESULTS,T2DM,THERE
ERG,FURTHER,MOUSE,NKX3,PCA,PTEN,SMAD4,TMPRSS2,TRANSGENIC
0001,001,005,101,107,210,239,945,946,EPITHELIAL,KI67,PCS,SIMILAR,WHILE
169,174,2013,8482,AUTOMATION,CHROMEO,GMBH,HOWEVER,KGAA,LIF,NANOORANGE,P503,PCA,PEAKS,PSA,VCH,WILEY
169,2013,AACR,BAK,BCL,BH3,FINALLY,HRK,JNK,JUN,NH2,THUS
163,174,908,950,APPRAISAL,COMMITTEE,DATA,ERG,EXCELLENCE,GROUP,HOWEVER,III,INSTITUTE,JEVTANA,NHS,NICE,QALY,RELATED,SHEFFIELD,TAG,TECHNOLOGY,UNIVERSITY,UTILITY
169,2013,COPYRIGHT,HIV,MMTV,THERE,UICC
001,00499,7554,DESPITE,DOI,ECTOPIC,F876L,MOLECULAR

18F,BASED,PET
ACCORDING,PET
CHOLINE,HOWEVER,PCA,PET,PSA,REGARDING,WHEREAS
001,2B1B,945,946,DHEA,DR7,HSD1,MANN,SULT,SULT2B1,THESE,WHITNEY
PCA
1922,2294,608,AUSTRALIAN,BACKGROUND,CONCLUSION,COX,LABEL,METHODS,OVERALL,RESULTS,SIR,SIRS,SMR,SMRS,WESTERN
0001,0011,033,2009,2011,954,956,967,AMONG,CLINICALLY,COG,CONCLUSION,FUS,GLEASON,JANUARY,LABEL,MATERIALS,MAY,MEAN,METHODS,NEITHER,OBJECTIVE,PCA,PREBIOPSY,PRIMARY,PURPOSE,RESULTS
169,2013,231,233,AFTERWARDS,COPYRIGHT,FINALLY,III,PUBLISHED,SAS,SFRO,SOCI
169,2013,COPYRIGHT,CROWN,MALIGNANT,PUBLISHED
1008,145,177,230,288,945,AFTER,CK18,CONCLUSION,CSC,CSCS,EMT,EVENTUALLY,FURTHER,HIF,LABEL,LNCAP,METHODS,MMP,MTT,NSP,OBJECTIVE,RESULTS,THROUGH,TRANSWELL,WESTERN
023,028,030,177,181,188,189,200,216,281,323,719,886,BPH,CONCLUSION,ELISA,GLEASON,HOWEVER,III,LABEL,METHODS,OBJECTIVE,PSA,RESULTS,ROC,THERE,TSP
138,2005,2011,501,645,691,813,AUC,CART,CHINESE,CONCLUSION,FUDAN,LABEL,METHODS,OBJECTIVE,RESULTS,SRE,THERE,UNIVERSITY
169,2013,COPYRIGHT,INC,MEDICAL,MPD,PBS,PEARSON,PUBLISHED,STUDIES
169,2013,AFFYMETRIX,BJU,CPRC,ERG,ETS,ETV1,ETV4,ETV5,LABEL,METHODS,OBJECTIVE,REAL,RESULTS,TMPRSS2
0001,2004,2006,371,8201,BACKGROUND,GLEASON,LABEL,METHODS,RESULTS
BACKGROUND,CONCLUSION,DOSE,FOUR,HODGKIN,LABEL,MATERIALS,METHODS,OARS,OBJECTIVE,POTENTIAL,PTVS,PURPOSE,RESULTS,WILM
954,FURTHER,LNCAP,PC3,PTHRP,RANKL,THESE,WHILE
8805,BACKGROUND,CONCLUSION,III,LABEL,MDV3100,METHODS,PFS,PSA,RESULTS,THREE
946,CAP,CHANGES,CNN2,LOSS,RNAS,SDK1,SERUM,SMALL,SRF,TAKEN
169,2013,8201,CBT,COPYRIGHT,JOHN,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,SONS,WILEY
CHOLINE,CONVERSELY,DUE,FURTHER,PET,PRIOR
211,ANTIGEN,BLACK,CAP,CARIBBEAN,DISPARITY,FLORIDA,HOWEVER,INVENTORY,MODEL,ODDS,OVERALL,POWE,PSA,SOUTH,THEREFORE
003,121,169,2013,464,717,CIS,COPYRIGHT,COX,HRS,MELBOURNE,PPL,PPLS,SFA,SFAS,UICC
169,2013,CRPC,DEVELOPING,ECTOPIC,HOWEVER,MDV3100,THESE,UICC
001,004,008,025,055,169,2013,777,8201,AFRICAN,AFTER,AMERICANS,BACKGROUND,CAUCASIAN,COPYRIGHT,EFFORTS,GLEASON,GREATER,HOWEVER,LABEL,METHODS,NCCN,NETWORK,NORTH,RESULTS,SOCIETY
143,169,2013,317,566,945,AACR,CONCLUSION,DISCOVERY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE
948,955,LASSO,USING
126,141,200C,205,MICRORNAS,PCA,PCR,PEARSON,PSA,WHILE
0001,001,002,121,169,2013,242,8Q24,AMICO,COPYRIGHT,GENOMIC,GLEASON,INC,MYC,TNM
000,309,BACKGROUND,DATA,HOWEVER,INSURANCE,LABEL,METHODS,NHI,PHYSICIANS,RESULTS,TAIWANESE

2000,2005,2009,226,825,BACKGROUND,COX,EXCLUDING,FIVE,LABEL,MEIER,METHODS,MOST,RESULTS
336,500,819C,819TT,942,ASIAN,CIS,HOWEVER,ORS,OVERALL
107,126,169,2013,8201,8804,8805,945,946,CONCLUSION,DATA,DESPITE,GLEASON,GROUP,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RADIATION,RESULTS,THERAPY,UROLOGICAL
CD20,CD30,CD45,GLEASON,IMAGING,KI67,MYCOSIS,POST,PSA,S100,SCC
ACTIVATED,BACKGROUND,HOWEVER,LABEL,MEANWHILE,METHODS,RESULTS,SRC,STAT3
CIN3,CINS,GIVEN,HOWEVER,RMP,RPB5,SCC,TMA,URI
002,11Q13,19Q13,251,4Q22,8804,979,ASHKENAZIC,AUC,BACKGROUND,CONCLUSION,FOUR,GWAS,LABEL,MEN,METHODS,ORS,POPULATION,PRCA,RESULTS,SNPS,THESE
174,CELGENE,III,USA
600,PREFERE
205,AGO2,BACKGROUND,CHIP,CONCLUSION,ELISA,ERK,LABEL,MAPK,METHODS,PCA,PCR,RESULTS,RIP,TAKEN,TOLL,UTR
19Q13,KLK,KLK1,KLK3,KLKS,PSA
400,8201,BACKGROUND,CHANGES,FIFTY,FIRST,LABEL,METHODS,MOST,NINE,PFS,PUBLISHED,RESULTS,SIMON,SORAFENIB,TREATMENT
169,2013,ASC,BPH,COPYRIGHT,DATA,INC,PATHOLOGY,PUBLISHED,SOCIETY
2008,245,ADT,DEGARELIX,USA,USING
000,ADT,COST,MOST
100,239,BACKGROUND,EORTC,HDR,HIGH,IPSS,LABEL,METHODS,MRI,PR25,PSA,QOL,RESULTS,RTOG,SBRT,SCORE,THERE
015,021,1050,169,1998,2005,2013,AIMS,BLACKWELL,GLEASON,KAROLINSKA,LABEL,LTD,METHODS,OBJECTIVE,OTHER,PUBLISHING,RESULTS,SEMINAL,SVI,THERE
00003,00005,003,005,009,015,019,8805,940,BRCA,BRCA1,BRCA2,CONCLUSION,COX,CSS,GLEASON,LABEL,MEIER,METHODS,MFS,MVA,OBJECTIVE,PCA,PURPOSE,RESULTS
052,277,280,283,524,528,963,CONCLUSION,CRPC,DOCETAXEL,ENDOTHELIN,ENTHUSE,III,METHODS,PSA,PURPOSE,RESULTS,SECONDARY,THERE
181,8764,946,AAE,ADP,APOPTOSIS,CAP,DELAYED,DU145,LNCAP,NUCLEAR,PIMENTA,POTENTIAL,RESONANCE,SILENCING,THESE,TREATMENT
2006,2011,CASE,CHINESE,ELIZABETH,HONG,JANUARY,KONG,MAIN,OBJECTIVE,OUTCOME,QUEEN,RESULTS,SETTING
035,160,BASED,HOWEVER,MAJOR,MOST,MRGB,PCA
000,FORCE,HOWEVER,PSA,TASK,USING
000,242,USA
001,138,CONCLUSION,HOME,INCREASING,METHODS,PRIMARY,RESULTS
1174,6729,8201,8804,8805,AMONG,BACKGROUND,BMI,GLEASON,LABEL,MEN,METHODS,POST,PSA,RESULTS,STATINS,THUS
ACP,AGREE,APPRAISAL,AUTHORS,COLLEGE,EVALUATION,FORCE,GUIDELINE,GUIDELINES,LABEL,METHODS,PHYSICIANS,PREVENTIVE,PSA,SOCIETY,STATEMENT,TASK,UNASSIGNED,UROLOGICAL
169,176,2013,502,524,923,9968,ABS,COPYRIGHT,PAP,PCA,PSA,PSCA,PSMA,TMS
169,2013,COPYRIGHT,INC,MLR,NSCLC,PCA,PLSDA
GPXS
169,2013,BURKITT,COPYRIGHT,COX,EICOSANOID,EP1,FAS,HHV,INC,KSHV,LANA,MOSBY,PEL,PGE2,TNFRSF6
169,2012,2013,B12,COPYRIGHT,COQ10,DIETARY,EIGHT,FIVE,IRELAND,LTD,NHDS,PSA,RCT,RCTS,THERE
169,2013,AKT,AKT1,AKT2,CDK2,CDK6,COPYRIGHT,HOWEVER,INC,LNCAP,SKP2,TAKEN,THESE
169,2011,2013,ATS,COPYRIGHT,ERS,HISTOLOGIC,IASLC,INC,LUNG,TNM
169,2013,8230,945,946,COPYRIGHT,GIVEN,HOWEVER,MISS,PUBLISHED,SAS,SERMS,THESE,THUS
177,2011,2012,3DCRT,APRIL,BETWEEN,CTS,EORTC,IIEF,IMRT,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,RTOG,SUBJECTIVE,VAS
ADP,AKT,BACKGROUND,BAD,BCL,ERK,JNK,LABEL,LNCAP,METHODS,PI3K,RAC,RESULTS,RHO,THERAPY,VAV,VAV3,XENOGRAFT
129,246,300,945,BACKGROUND,CELL,DHT,FRET,LABEL,LIVE,NRS,PC3,RESULTS,SKI,SKIP,SNW1
0001,007,011,064,141,143,147,159,217,230,628,676,677,954,961,AFTER,KI67,URINARY,VEGF
100,104,177,200,400,956,A431,FOURIER,HOECHST,IC50,PC3,PEG,TRANSFORM
1000,956,A549,BACKGROUND,CONCLUSION,GARCINA,GRAM,HELA,HOWEVER,IC50,LABEL,MCF,MEOH,METHODS,MIC,RESULTS,SRB,THP
ADT,CAP
2ND,CRPC,CYP17A1,EFFORTS,HOWEVER,LBD,NTD,PCA,RATIONALLY,SEVERAL
1940S,ANDROGENS,HUGGINS,SINCE
200,200G,945,BACKGROUND,BPH,CASE,GIANT,GPH,HOWEVER,LABEL,METHODS,PAX2,PROSTATIC,SPAE,TURPS
001,004,006,048,343,BACKGROUND,CHI,CONCLUSION,COX,DSS,LABEL,LOSS,LOW,MEIER,METHODS,PFS,RBM3,REDUCED,RESULTS
HOWEVER,LESS,PROSTATIC
946,967,ABSENCE,ADP,BRCA1,BRCA2,ERG,ETS,H2AX,HOWEVER,III,INCREASED,LDR,LNCAP,PARP,PC3,PCA,PKCS,POLY,PTEN,RAD51,RUCAPARIB,THESE,TMPRSS2,VCAP
HOWEVER,III,KI67,PIM,PIM1,PTEN,WHILE
144,2000,2008,8804,AFTER,AIM,CONCLUSION,DELAYED,JULY,LABEL,METHODS,OBJECTIVE,RESULTS,TREATMENT
100,600,635,700,ALOH,BACKGROUND,CLINICALLY,COMPARISON,CONCLUSION,FIRSTLY,LABEL,LIPOSOMAL,LNCAP,MATERIALS,METHODS,MICE,PC3,PDT,RESULTS,TOPICAL,WHEREAS
8804,954,956,ERK1,FN1,RESULTS,TREATMENT
256,8805,956,AREA,CONCLUSION,GLEASON,LABEL,MATERIALS,METHODS,OBJECTIVE,PRIMARY,PURPOSE,RESULTS,THREE,TTPM
072,1984,2011,BCR,CONCLUSION,HOWEVER,LABEL,LNS,MAIN,MATERIALS,METHODS,OBJECTIVE,OVERALL,RESULTS,THESE
100,125,156,160,585,ASSESSMENT,CONSENTING,FACT,FUNCTIONAL,HUI,HUI2,HUI3,INDEX,LABEL,MEAN,METHODS,OBJECTIVE,ONTARIO,PATIENT,PCI,PURPOSE,QOL,REGRESSION,RESULTS,SCALE,THERAPY,THESE,UTILITIES,UTILITY
160,176,2006,2009,ACT,AFTER,BACKGROUND,BARIATRIC,BMI,CROHN,DVT,INSTITUTE,INSURANCE,LABEL,MARCH,MEAN,METABOLIC,METHODS,RESULTS,SEPTEMBER,THERE
169,2013,COPYRIGHT,COQ10,ECTOPIC,INC,RNS,ROS,SXR,TBL2,TERE1,VITAMIN,WD40,WILEY
169,2013,441,COPYRIGHT,CRPC,DHH,GLI1,GLI2,LNCAP,NHT,PCA,PTCH1,SHH,SMO,SMOOTHENED,SONIC,TAK,THUS,UICC
160,2000,8226,DRUG,FOLLOWING,FOOD,HOWEVER,RARP,RRP,SINCE,WALSH
ANOTHER,AVAILABLE,CHINA,CHINESE,FINALLY,GWASS,MOST,PCA,SNPS,WESTERN
001,261,8805,ASIAN,HOWEVER,MEN,PCA,PSA,PSAS,PVS,THERE,THEREFORE
000,258,890,DESPITE,HOWEVER,PCA,THESE,TP53
239,ADT,CONCLUSION,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RECURRENT,RESULTS,USING
001,006,8201,ADT,AFTER,BACKGROUND,BMD,DECREASED,LABEL,LOSS,MATCHED,MEN,METHODS,RESULTS,SUMMARY,VITAMIN
70S,BILATERAL
1300,1307,1391,1399,17908,17917,1993,1997,1999,2001,2007,2008,2009,2010,274,283,362,5289,5294,5677,5684,581,695,707,847,849,945,968,975,ACTA,ATM,BIOL,BROWN,CELL,CERS,CHEM,COAS,FEBS,INT,LETT,LIAO,LOWE,MESICEK,OLIVE,ONCOL,PKC,RES,SIX,STEEL,THER,THERE,WOUTERS
116,DOC,DU145,HCT,LNCAP,PC3,TAXANES,THESE,WHILE
CRPC,PBMCS,PCR
DATA,FINALLY,FINDR,FOURIER,FTIR,RAMAN,SVM,SVMS,UPON
946,TAU,TIF1,TIF2
169,2013,COPYRIGHT,FDG,FINALLY,HOWEVER,ISSUE,KREBS,LIPID,METABOLISM,PCA,PCAS,PET,SPECIAL,THUS
1107,1195,169,1999,2009,2013,COPYRIGHT,DATA,LTD,METASTASIS,OVERALL,PRIMARY,SURGERY,WHILE
169,2013,BPH,CAFS,CHANGES,COPYRIGHT,CROWN,CRPC,GLEASON,LTD,NPFS,OVERALL,PATIENT,PUBLISHED,STROMAL
141,160,169,2013,370,768,770,8804,CONCLUSION,COPYRIGHT,GLEASON,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,RESULTS,STEYERBERG
0008,015,018,026,100,169,2013,292,8805,AFTER,ASPIRIN,ASSESSMENT,BOWEL,COMPOSITE,CONCLUSION,COPYRIGHT,FINALLY,HOWEVER,HRQOL,INC,INDEX,INTENSITY,LABEL,MATERIALS,METHODS,OBJECTIVE,PROSTQA,PURPOSE,QUALITY,RESULTS,TREATMENT,V70
0001,001,121,129,160,169,2013,250,575,8804,ADT,AFTER,CONCLUSION,COPYRIGHT,COX,IBF,INC,IQR,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PCSM,PURPOSE,RESULTS,SRT,THERE
001,007,012,018,035,048,075,087,091,1029,109,1128,1480,163,169,2004,2011,2013,2608,264,8594,8805,COPYRIGHT,GLEASON,INC,OVERALL,THUS
169,2013,231,264,946,954,CHINESE,COPYRIGHT,LTD,MDA,PC3,RAW,SIX
109,125,1412,169,2003,2004,2005,2008,2011,2013,269,2783,3793,BECAUSE,HOWEVER,JAPAN,PERMANENT
113,884,991,AIM,CONCLUSION,DWI,LABEL,METHODS,MRI,OBJECTIVE,RESULTS
001,138,168,177,185,250,314,ADT,CONCLUSION,FCH,IMAGING,LABEL,MBQ,METHODS,OVERALL,PET,PSA,RESULTS,SCAN,TRIGGER,UNLABELLED,USING
001,006,156,164,169,1987,1999,2000,2008,2013,8201,8520,AMONG,BACKGROUND,COPYRIGHT,END,ESTIMATES,HODGKIN,LABEL,MATCH,METHODS,RESULTS,SOCIETY,SOLID,SUBGROUPS,TRANSPLANT
169,2013,6294,8805,AMONG,BACKGROUND,COLORECTAL,COPYRIGHT,LABEL,LUNG,MEN,METHODS,NON,OVARIAN,PLCO,PSA,RESULTS,SOCIETY
AIB1,NCOA,NCOA3,PCS,POZ,SPOP,SRC,SRCS,THESE
000,0001,AIMS,BACKGROUND,ERG,FOXP1,FOXP2,GLEASON,HIGH,KI67,LABEL,METHODS,OBJECTIVE,RESULTS,THERE,THESE
169,2013,945,946,APART,COPYRIGHT,DUE,FIRST,ICAM,INC,PC3,THIRD,VEGF,WILEY
2010,223,PHASE,SINCE,THESE,UNTIL
945,948,954,ADP,BCL,LNCAP,MCL,PC3,PKC,PTPL1
AFTER,BECAUSE,FGFR,FGFR2,FGFR3,THROUGH
8233,AIMS,BACKGROUND,EGFL7,ELISA,HCC,HER2,LABEL,METHODS,OBJECTIVE,PCR,RESULTS,SIMILARLY,TNM,WESTERN
FRESH,MOST,SVM,THESE
ERG,ETS,ONCOGENIC,TMPRSS2,WIDE
006,169,2014,21MHZ,5MHZ,8805,AMONG,COPYRIGHT,DYNAMIC,FOLLOWING,INC,LABEL,MATERIALS,MCNEMAR,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,TRUS
15MV,169,2013,6MV,CARLO,COPYRIGHT,DOSE,EBT,GAFCHROMIC,HOWEVER,INC,MEDICAL,MONTE,PUBLISHED,THUS,V95
160,ATM,CPT,HOWEVER,LOSS,NEITHER,NK3,NKX3,THEREFORE
000,2012,240,CAP,CHANGES,CHEMOKINE,CHEMOKINES,CONTROL,ERBB
ADDITIONAL,BACKGROUND,CD8,CSF,CTLA,FDA,GEM,GVAX,III,IPLIMUMAB,LABEL,METHODS,PHASE,PRO,RESULTS,THESE,TRAMP
000,200,215,264,376,630,FIRST,HOUGH,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,TRUS
AFTER,BOTH,CSI,HOWEVER,LABEL,METHODS,MIM,OBJECTIVE,PURPOSE,RESULTS,SEVERAL,THREE,VARIOUS
177,BAT,CLARITY,ESPECIALLY,IMRT,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
215,BRACHYVIEW,DOSIMETRIC,INCORRECT,LABEL,METHODS,OBJECTIVE,PERSPEX,PMMA,PURPOSE,RESULTS,THREE,TRUS
1100,931,956,963,CALYPSO,CBCT,HERK,IRB,LABEL,MARGINS,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,SETUP,THESE
D10,FOLLOWING,HDR,HIPO,INVERSE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
A2780,GLI1,HOWEVER,KAAD,OVCAR,OVERALL,REMARKABLY,RESULTS,SKOV
23OP,7OG,7OM,7OP,CLONOGENIC,DHS,DSS,FURTHER,HTB,HTB9,ISOMERS,MILK,NEXT,OVERALL,PC3,SILYBIN
961,BACKGROUND,CPG,ERG,ETV1,GIVEN,LABEL,MEDIP,PCR,PRINCIPAL,RESULTS,SEQ,TDRD1,TMPRSS2,TUDOR
CURRENT,ORTHOTOPIC,PBS,THREE,UC1,UC13,UC3,ULTRASOUND,VSV,XENOGRAFT
032,191,215,376,545,984,AFRICAN,AMERICANS,ANXA4,CASP5,F13A1,GP6,GWAS,HOWEVER,HUMANEXOME,IGF2,INS,LDLRAD1,MMAB,PSA,RARE,SLC16A6,SLC19A1,SNP,SNPS,USING
10Q11,1371,19Q13,946,FIRST,HOWEVER,MEN,PCA,PCA3,REDUCTION,SNPS
CAV1,EVX1,FGF1,MCF2L,NTA,PCA,SEVERAL,THESE
ASM,BISULFITE,CGI,CGIS,CRPC,CRPCS,PCA,REDUCED,SEQUENCING,SNPS,THESE
574,BCL,EGFR,EP300,GENECODIS,GENISTEIN,GLEASON,JAK,LOSS,LOW,LUCIFERASE,PCA,PCR,RAC1,RWPE,STAT,THESE,USING,UTR,WESTERN,WNT
BLARINA,C13,C27,SOR,SORICIDIN,TRPV6
CELASTROL,ERG,PCA,PCAS,THEREFORE,TMPRSS2,VCAP
100,169,2013,8805,AACR,AES,AMONG,BACKGROUND,CTC,CTCS,III,LABEL,MET,METHODS,PRS,RESULTS,SDS,THESE
169,2013,945,ACID,AFTER,ALANINE,COPYRIGHT,GTP,III,INC,LNCAP,PI3K,PI3KS,PI3KSER83,PKA,REGULATORY,RHO,SER,SER83,SH3,THERE,WILEY
100,233,BLOOD,COMBINING,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SELF,SMOKING,TOBACCO
169,2013,215,8201,COPYRIGHT,JOHN,LTD,SONS,WILEY
160,1978,1993,2002,2003,2010,ABOUT,BACKGROUND,EUROPEANS,EUROPREVAL,JANUARY,LABEL,METHODS,RESULTS,SEVERAL
022,027,038,044,155,2003,2011,8805,ADT,BETWEEN,CSS,DMFS,EBRT,GLEASON,LABEL,MARCH,METHODS,OBJECTIVE,PHOENIX,PRE,PRIMARY,PSA,PURPOSE,RESULTS
99M,OH2,SPECT
141,PSA
COX,EP1R,EP2R,EP4R,EPRS,FINALLY,HOWEVER,RCC,THERE
CTC,CTCS,MOST,THEIR
215,POTENTIAL,PREVENTION,TRIAL,VITAMIN
169,200,2013,205,BJU,COX,FACTORS,GLEASON,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,SINCE
090,100,153,169,177,1995,2007,2013,577,8804,977,ART,BJU,END,LABEL,MEN,METHODS,OBJECTIVE,PCSM,PROPENSITY,RESULTS,SEER
1071,1185,169,2013,754,AUSTRALIA,AUSTRALIAN,AUTHORS,BACKGROUND,COLLEGE,CONCLUSION,GROUP,IMAGING,JOURNAL,LABEL,MEDICAL,METHODS,RADIATION,RANDOMISED,RESULTS,ROYAL,TRANS,TREATMENT,ZEALAND
169,2012,2245,3037,810,8201,947,AUSTRALIAN,AUTHORS,BACKGROUND,COLLEGE,CONCLUSION,DATA,FFBF,IMAGING,JOURNAL,LABEL,MEDICAL,METHODS,PHOENIX,RADIATION,RESULTS,ROYAL,STUDIES,TCD50,ZEALAND
001,132,169,2013,8805,AIM,BACKGROUND,BTB,EFD,EFR,INDEX,LABEL,MAIN,MEN,METHODS,OBJECTIVE,OUTCOME,PDE5I,RESULTS,SOCIETY
169,183,2013,946,AIMS,ASSESSING,BACKGROUND,BLACKWELL,FREQUENCY,INDEXES,KEGEL,LABEL,LTD,MANAGEMENT,MEN,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHING,RELEVANCE,RESULTS,SELF,SYMPTOM
0001,169,2013,8201,8804,BLAND,EACH,GRAYSCALE,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,UROLOGICAL
169,2013,AUTHORS,BLACKWELL,FOUNDATION,JOURNAL,LTD,MOLECULAR,PUBLISHED,PUBLISHING,TLR,TLRS,TOLL
150,1655,169,178,1998,2008,2013,236,8804,8805,ACUTE,BJU,COX,CTCAE,EBRT,FORTY,INDEX,JANUARY,KETTERING,LABEL,LATE,MAY,MEIER,METHODS,NETWORK,OBJECTIVE,POTENCY,PSA,RESULTS,RFS,SLOAN,THERE
001,169,2005,2006,2008,2013,232,409,8805,AUSTRALIA,AUSTRALIAN,BJU,CONVERSELY,GIVEN,GLEASON,HAEMATURIA,JUNE,LABEL,METHODS,OBJECTIVE,PSA,RESULTS,SOCIETY,STRATIFIED,TPB,UROLOGICAL,USANZ,ZEALAND
100,116,145,169,2012,2013,BJU,CONFERENCE,CONSENSUS,ERUS,JANUARY,LABEL,METHODS,MINIMISING,NVBS,OBJECTIVE,RARP,RARPS,RESULTS,ROBOTIC,SECTION,THERE,UROLOGY
169,2012,2013,AIMS,ASIA,BEGG,CONCLUSION,EGGER,JUNE,LABEL,LTD,METHODS,OBJECTIVE,PTY,PUBLISHING,RESULTS,THERE,WILEY
001,003,1535,3040,765,770,BACKGROUND,CASTRATION,INSTITUTE,LABEL,MEN,METHODS,PSA,REPLACING,RESULTS,THERE
GNRH,GPR54,KISSPEPTIN
169,2013,AACR,CPG,DMR,DMRS,ERG,FINALLY,GENOMIC,GLEASON,H3K4ME3,LABEL,METHODS,OBJECTIVE,PCG,PURPOSE,RESULTS,SUZ12
125,2008,2010,517,540,AREA,AUC,AUCS,CALCULATOR,CONCLUSION,ERSPC,HOWEVER,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,PCPT,PREVENTION,PSA,PSAD,PURPOSE,RANDOMIZED,RESULTS,RISK,ROC,SCREENING,THEREFORE,TRIAL,WESTERN
MRS,PCA
268,281,288,725,930,934,945,AARP,ALA,AMONG,BACKGROUND,CASES,CONCLUSION,COX,DIET,EPA,HRQ5,HRQUINTILE,LABEL,LINOLENIC,METHODS,NIH,PERSONS,RESULTS,RETIRED,SATURATED,TOTAL
11RA,HIF,IL11,NOTABLY,PC3,SILENCING,STAT1,VHL
001,1317,1990,2000,2009,2010,547,5698,946,990,AVAILABLE,BACKGROUND,CONCLUSION,HOWEVER,INDIRECTLY,LABEL,METHODS,MOM,PYAR,RELEASE,RESULTS,SIR,SIRS,THA,THAS,THESE
AIMS,BACKGROUND,CENTRAL,CONCLUSION,EBRT,LABEL,METASTATIC,METHODS,MRI,OBJECTIVE,PSA,RESULTS,SINCE
001,006,009,021,024,125I,167,2003,2010,8805,AIMS,ASTRO,BACKGROUND,HORMONE,JANUARY,LABEL,METHODS,OBJECTIVE,PHOENIX,PRIOR,PSA,RESULTS,RTOG,SECONDARY,TURIN,UNIVERSITY
ABOUT,EPSTEIN,GLEASON,LABEL,LOW,MOST,OBJECTIVE,PATIENT,PSA,PURPOSE,RESULTS,SUMMARY
169,2012,2013,8473T,BACKGROUND,BASEL,BOTH,CAUCASIANS,CONCLUSION,COPYRIGHT,COX,EGGER,FINALLY,HARDY,LABEL,MEDLINE,METHODS,ODDS,OVERALL,PCA,PTGS2,RESULTS,SCIENCE,UTR,WEB
034,169,2013,588,BACKGROUND,BASEL,CONCLUSION,COPYRIGHT,GLEASON,LABEL,MATERIALS,METHODS,PSA,RESULTS,STATINS,USERS
169,1997,2001,2005,2007,2011,2013,264,BASEL,CHINESE,COPYRIGHT,DCA,ECP,LABEL,LNI,METHODS,OBJECTIVE,OVERALL,PTS,PURPOSE,RESULTS,SVI,THESE
169,177,2011,2012,2013,8805,ALLERGY,BACKGROUND,BASEL,BONN,CONCLUSION,COPYRIGHT,DEPARTMENT,DOPPLER,EARLIER,ELASTICITY,JULY,LABEL,LNS,METHODS,OBJECTIVE,PDS,REAL,RESULTS,UNIVERSITY
1182,1186,1971,285,BASED,CAP,DESPITE,ENGL,FOLKMAN,FORTY,JUDAH,MED
132,169,2002,2009,2011,2013,488,64257,8804,8805,99M,AGE,BACKGROUND,BASEL,BONE,CHINA,CHINESE,EARLY,FURTHER,GLEASON,LABEL,MATERIALS,METHODS,PCA,PSA,RESULTS,ROC,TNM,USING
CINE,HOWEVER,MRI,POIS,SDS,THERE
EPIRUBICIN,FE3O4,FTIR,MAGNETITE,PVP,TEM,TGA,VIS
137G,165,174,211,270,375,400,607C,687,906,CHINESE,HAN,HOWEVER,III,SNPS
WHILE
126,153,1992,2004,287,AFFAIRS,COX,LABEL,MEDICAL,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS
160,174,24H,24N,48H,48N,CMS,EPC,EPCS,HOWEVER,HYPOXIA,PCA,THESE
000,184,1988,2008,2009,503,ADT,ADTS,ANDROGENS,CIS,CONCLUSION,COX,GENERAL,HRS,JANUARY,LABEL,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,SECONDARY,SIMILARLY,TIME
001,006,2005,2011,521,8804,8805,AMONG,BACKGROUND,FORTY,GLEASON,JANUARY,LABEL,METHODS,PSA,PSAD,RESULTS,SEVEN
BACKGROUND,ERG,FIFTY,HOWEVER,IHC,LABEL,METHODS,PTEN,RESULTS,THESE,USING
001,009,103,128,160,1742,177,2004,2008,221,280,565,721,BNS,EHS,IEFF,IIEF,INDEX,JANUARY,RARP,ROBOTIC,RRP,SHORTER
250,945,946,947,CELL,DU145,H2AX,KEV,LNCAP,PC3,PLDR,SIEMENS,STABILIPAN,TP53
169,2013,946,COPYRIGHT,DKK3,DUAL,DVL1,DVL3,EMT,IRELAND,LTD,SOX2,TAKEN,TGF,WNT
169,174,1990,2012,2013,556,AMONG,ASSESSMENT,COPYRIGHT,DIAGNOSTIC,EDUCATION,EVALUATION,GRADE,GRADING,INC,JANUARY,LABEL,MATERIALS,MAY,MEDLINE,METHODS,MOST,OBJECTIVE,PCA3,PUBLISHED,PURPOSE,QUALITY,RESULTS,STUDIES,UROLOGICAL
169,176,195,2013,632,COPYRIGHT,DRE,EIGHT,GLEASON,LABEL,METHODS,OBJECTIVE,PCA,PSA,RADICAL,RESULTS,SAS,T1C
125,300,652,939,946,BACKGROUND,CONTEXT,GENERALLY,HOWEVER,LABEL,METHODS,NUCLEIC,OBJECTIVE,RESULTS
EC50,EXCEL,IC50,OVERALL,THREE
PET,THERE
945,HOWEVER,MRI,SURGERY,TNF,VDA,VDAS
005,031,11C,177,18F,2003,2010,AFTER,AMONG,BACKGROUND,COMBINING,CONCLUSION,HIGH,LABEL,METHODS,NTD,OMS,PET,RESULTS
037,1998,2010,8805,CONCLUSION,GLEASON,IMRT,INITIAL,LABEL,METHODS,NCCN,OBJECTIVE,PSA,PURPOSE,RESULTS,SEVENTY,WPRT
001,004,006,074,DPP4,HAPLOTYPE,JAPAN,MICC,MULTI,PSA,SNPS,THREE
200,945,946,BED,HDR,HIGH,HOWEVER,INDICATION,T3A
10MM,150,169,177,2013,C18,COPYRIGHT,MASS,RPR112698,RPR123142
128,169,2013,259,324,ANY,COPYRIGHT,EDUCATION,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PREBIOPSY,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
FBL,HOWEVER,MDM2,POL,PTB,RNAS
169,2013,945,956,AFP,COPYRIGHT,DETECTION,PSA,PZT
169,2013,COPYRIGHT,DLT,DLTS,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PDGFR,PURPOSE,RESULTS,SEVENTEEN,SUNITINIB,USING,VEGFR,XRT
145,169,177,2013,COPYRIGHT,HRM,INC,LNCAP,PAI,PREC,TREATMENT
100,102,169,2013,3MM,BOTH,CONCERNING,COPYRIGHT,D99,DIL,DILS,EXCEPTING,IMPT,IRELAND,LABEL,LTD,MATERIALS,METHODS,NTCP,OARS,OBJECTIVE,PTV,PURPOSE,RESULTS,TREATMENT,V95
024,104,150GY,169,2013,2CC,8804,BACKGROUND,BETWEEN,BRT,COPYRIGHT,DVH,EBRT,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,POST,PURPOSE,RESULTS
001,169,1826,2013,954,BCR,COPYRIGHT,COX,FURTHER,GLEASON,HARRELL,HOWEVER,LABEL,LTD,METHODS,OBJECTIVE,PCA,PSA,PURPOSE,RESULTS,TMA
001,002,003,014,169,2013,8122,8805,945,BACKGROUND,BMI,COPYRIGHT,LABEL,MEN,METHODS,OBESITY,OBJECTIVE,OUTCOME,PER,PERCENTAGE,REDUCTION,RESULTS,SETTING,TRUS,UROLOGY
0001,0003,0007,002,007,008,1024,169,1992,2007,2013,8805,ADT,BACKGROUND,BETWEEN,COPYRIGHT,COX,EBRT,GLEASON,IRFS,LABEL,METHODS,NETWORK,OBJECTIVE,OUTCOME,PCA,PCSM,PPBC,PRIMARY,PSA,PUBLISHED,RESULTS,RFS,SETTING,SHORT,THESE,UIR,UNIVARIATE,UROLOGY
169,2013,2695,4593,AUSTRALIA,BACKGROUND,COPYRIGHT,CRC,DATA,DISCUSSION,LABEL,LTD,METHODS,RESULTS,THESE
169,2013,COPYRIGHT,EDUCATION,FOUNDATION,INC,MAYO,MEDICAL,PUBLISHED
169,2011,2012,2013,AMONG,CONCLUSION,COPYRIGHT,DATA,IMAGING,INC,LABEL,METHODS,MRI,OBJECTIVE,RADS,RANDOMIZED,REPORTING,RESULTS,TARGETING,TRUS,UROSTATION
102,160,169,1988,2008,2013,626,8804,8805,CONCLUSION,COPYRIGHT,GROUP,INC,LABEL,LATE,MATERIALS,METHODS,NETWORK,OBJECTIVE,RADIATION,RESULTS,THERAPY,UNIVARIATE,USING
AREAS,BACKGROUND,COVERED,GIVEN,LABEL,METHODS,OPINION,PDGF,PDGFR,PHASE
169,2013,COPYRIGHT,INC
169,2013,BOTH,COPYRIGHT,DOSE,EACH,IMRT,INC,MAXIMUM,MCO,MEDICAL,NINE,PUBLISHED,RAYSTATION,TREATMENT,V50,V70
169,1CM,2013,COPYRIGHT,IMRT,INC,MEDICAL,PUBLISHED,SSD,SSDS,TYPICALLY,VMAT,WHETHER
2009,2010,BSMMU,COMFORT,DEPARTMENT,DHAKA,DRE,HOME,JULY,LTD,LUTS,MEDICAL,MUJIB,NPV,NURSING,OCTOBER,PPV,PSA,PVT,ROC,THEREFORE,TRANS,TRUS,UNIVERSITY,UROLOGY
169,2013,AACR,CONCORDANT,EMT,FOXA1,TAKEN,USING
169,2013,AACR,AKT,ERK,MED1,NKX3,NOTABLY,PTEN,WHEREAS
145,146A,183,767,BACKGROUND,CONCLUSION,DKK,INITIALLY,LABEL,LNCAP,METHODS,MIR,PCR,RESULTS,RWPE,SMAD4
169,2013,258,BACKGROUND,COPYRIGHT,DIAGNOSTIC,EACH,GLEASON,LABEL,METHODS,MRI,OBJECTIVE,OUTCOME,RAND,REPORTING,RESULTS,SETTING,STANDARDS,STARD,START,STUDIES,THERE,UCLA,UROLOGY
169,174,2011,2013,AMONG,CDIS,COPYRIGHT,DESPITE,DRUG,FDA,FOOD,JUNE,PUBLISHED,SAS,THUS,VANDETANIB
947,B4RV,BACKGROUND,LABEL,LNCAP,MLV,MLVS,RELATED,RESULTS,SIMILAR,SMC,SUBSEQUENT,THERE,VIRUS,XENOTROPIC,XMRV
221,324,BACKGROUND,CD36,CONCLUSION,EDNRA,GREM1,HOWEVER,INTEGRATED,KPNA2,LABEL,LOX,METHODS,NOTICEABLY,PROTEIN,RESULTS,SCORE,SINCE,TNFAIP6
169,2013,8594,946,AACR,CD31,CD34,MECHANISM,MMP,TGF,THESE
22RV1,945,946,947,CONVERSELY,CXR,HOWEVER,HP1,LNCAP,SIMILARLY,TAKEN,THEREFORE
954,AKT,BONE,CCN,CCN3,HOWEVER,NOV,OPG,PC3,RANKL,THESE,WESTERN
19TH,2012,EACH,FOUNDATION,OCTOBER,PCF,RETREAT,SCIENTIFIC,SEVERAL
169,2013,945,946,AACR,FINALLY,PAK4,RAC1,TROP
169,2013,8805,946,AACR,COX,CXCL6,DESPITE,FINALLY,GCP,GLEASON,KLK3,PI3,PSA,PTGS2
001,105,160,169,2011,2013,269,292,996,ACADEMY,AFTER,ANDROLOGY,ANOTHER,JUNE,MEAN,SERUM,SOCIETY
169,2013,COX,DU145,HENCE,MCTS,OPPOSED,PGE,PGE2,THEREFORE,UICC
177,215,8805,AES,AMONG,BACKGROUND,CTLA,III,LABEL,METHODS,PSA,RESULTS
011,024,1985,2003,273,368,398,463A,641,8805,947,AMONG,BALTIMORE,CALIFORNIA,CARET,FRANCISCO,GLEASON,HAVEN,HOWEVER,III,MPO,OVERALL,PUFAS,RETINOL,SAN,SEATTLE,TRIAL,WASHINGTON
1094,134,301,320,5P15,MASSARRAY,PRACTICAL,PRCA,SNPS,TERT
074,155,211,215,272,8764,CONSORTIUM,PRACTICAL,SNPS,THESE
COGS,FOUNDATION,PHG
COGS
ERG,TMPRSS2,WHILE
160,HOWEVER,PSA
PSA
CLEARLY,COMMITTEE,FEDERAL,FORCE,KINGDOM,PREVENTIVE,PSA,RANDOMIZED,SCREENING,SIMILARLY,SWISS,TASK
169,1998,2005,2013,BACKGROUND,CHANGES,COLORECTAL,COPYRIGHT,CRS,ITALIAN,ITALY,JOINPOINT,JOINPOINTS,LABEL,LTD,METHODS,PERCENT,PROGRAM,REGISTRIES,REGRESSION,RESULTS,SEER,TIME
001,169,177,2013,AAA,AIR,BESIDES,BONE,BOTH,CARLO,COPYRIGHT,ECLIPSE,INC,MAPE,MAPES,MEDICAL,MGS,MONTE,PUBLISHED,SOFT,XIO
169,174,2013,954,ASA,BACKGROUND,BAX,CONCLUSION,COPYRIGHT,COX,DICLO,GMBH,HOWEVER,IBEROGAST,LABEL,LDH,LPS,PMA,RESULTS,SEVERAL,STW,THESE,THP
001,009,011,012,013,017,474,BACKGROUND,HANDE,LABEL,METHODS,MVD,NUCLEAR,RESULTS,SAMPLES
725,AFTER,EIGHT,FURTHER,GEO
2012,338,ASIAN,BACKGROUND,DOSE,LABEL,MEDLINE,METHODS,NEWCASTLE,PRIOR,RESULTS,SPSS,STATA
001,004,172,258,ASIA,ASIAN,BACKGROUND,CAUCASIANS,CI1,CIS,CNKI,EAST,GSTM1,LABEL,METHODS,ORS,OVID,RESULTS,SCIENCE,SIMILAR,WEB
006,012,018,033,040,055,063,097,105,161,170,178,184,194,2012,308,459,519,796,910,925,965,BACKGROUND,CRP,DOSE,FURTHER,LABEL,METHODS,OCTOBER,RESULTS
2008,2012,BACKGROUND,EQUOL,FIVE,LABEL,MATERIALS,METHODS,PCA,RESULTS,STUDIES,WESTERN
001,110,159,165,206,230,254,267,328,ANALYZE,CONCLUSION,EIGHT,LABEL,MATERIALS,MEAN,METHODS,OBJECTIVE,OPERATIVE,RESULTS,THOSE
1995,2009,408,CHINESE,DESPITE,HONG,KONG,LABEL,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS,STEPHENSON,USA
0057,270,536,GLEASON,PCR,PSA
0001,001,003,0038,ADT,BACKGROUND,BMI,BMIS,CHANGES,CONTEXT,IGF,IGFBP,LABEL,METHODS,OBJECTIVE,RESULTS,TREATMENT
169,2013,900,EPS,EXPRESSED,GMBH,KGAA,PCA,THESE,TRANCHE,USING,VCH,WILEY
169,2013,BACKGROUND,COPYRIGHT,INC,LABEL,LDH,MCT,METHODS,RESULTS,TSC,TSCS,WILEY
169,2013,946,AKT,BACKGROUND,COPYRIGHT,DU145,ELISA,HOWEVER,INC,INHIBITED,LABEL,LNCAP,METHODS,PCA,PCASC,PCR,PRSC,REDUCED,RESULTS,SPARC,WILEY
169,1999,2010,2013,374,439,502,COPYRIGHT,FIFTY,GLEASON,HGPIN,HIGH,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PCA,PSA,PURPOSE,RESULTS,RPSS,SEVEN,UPON,WILEY
169,2013,AMONG,BACKGROUND,BECAUSE,COPYRIGHT,CRPC,GENECHIPS,GLEASON,HSPC,INC,LABEL,METHODS,NR6A1,PCA,RESULTS,WILEY
169,2013,AFTER,ATG5,AUTOPHAGIC,BACKGROUND,CELL,CONCLUSION,COPYRIGHT,FINALLY,GFP,HOWEVER,HRPCA,INC,INHIBITION,LABEL,LC3,LNCAP,METHODS,PCA,RESULTS,TAKEN,TREATMENT,WILEY
169,2013,AFTER,BACKGROUND,COPYRIGHT,FATIGUE,INC,LABEL,MEN,METHODS,QOL,RESULTS,WILEY
10001,333,HOWEVER,MEANINGFUL,MECHANISMS,MEDICAL,PUBLISHERS,SEVENTH,USA,YORK
CONCLUSION,INSTITUTE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
174,JEVTANA,PSA,USA
0029,0033,0064,014,100,150,160,8201,8Q24,BPH,HARDY,LOCUS,ODDS,PCA,PCR,RFLP,SERBIAN,SNP,SNPS,THERE
OPTIMAL
001,100,BACKGROUND,CRC,LABEL,MATERIALS,METHODS,RESULTS,THESE
219,318,A49T,AFRICAN,AMERICANS,BACKGROUND,CAG,CYP3A43,EARLY,FRONTAL,GLEASON,LABEL,METHODS,RESULTS,STUDIES,V89L
2258,711,AMONG,GIST,GISTS,NONE,SDH,SDHA,SDHB,THERE,THREE
1996,2005,2006,803,8804,969,CASES,ESTIMATES,LABEL,METHODS,NO2,OBJECTIVE,OBJECTIVES,RESULTS,THERE,THESE
034,153,169,2013,BACKGROUND,COPYRIGHT,END,GLEASON,INC,LABEL,LHRHA,METHODS,PSA,RESULTS,ROC,SERUM,TTP,USING
CD34,GCDFP,LABEL,LESIONS,UNASSIGNED,UNDER,UNLABELLED,VIRTUAL,WHILE
549,IC50,NSCLC,OVERALL,PLK,POLO,REGARDING
145,COMBINING,THESE,ULTRASOUND
019,029,2005,2007,243,273,DIETARY,FOUR,JULY,MARCH,MEN,STUDIES,THESE
0003,013,014,215,BACKGROUND,HAPLOTYPE,IGF,LABEL,MEIER,METHODS,PCA,RESULTS,SNPS
139,AMONG,CXCLS,DECREASED,FURTHER,HIF1A,IL6,IMPDH,NDRG,NRP1,ORIGINALLY,PAI,PDK1,PI3K,SGK1,U87,USING,VEGF
CD45,CTCS,EPCAM,HOWEVER,PCA,POPULAR,PSA,THEREFORE,TRAMP,WITHOUT
127,198,CIS,CONCLUSION,CUMULATIVE,LABEL,LYNCH,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE,WALD
169,2013,COPYRIGHT,HIGH,HRMAS,JOHN,LTD,MRS,PCA,PSA,SONS,STUDIES,WILEY
169,2013,ARCTURUSXT,CHIP,COPYRIGHT,CTCS,GMBH,KGAA,LCM,NANOVELCRO,NGS,VCH,WILEY
184,883,HOWEVER,LABEL,METHODS,MTB,MTBS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,SIXTY,SWISS
005,008,167,229,312,708,AFFAIRS,CAP,DISEASE,FURTHER,LABEL,MATERIALS,MEN,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,SIMILAR
BACKGROUND,DISCUSSION,LABEL,MEN,OBJECTIVE,THESE
DIAGNOSIS
001,028,127,269,3D26PBX,744,CANCERS,GLEASON,INITIAL,LABEL,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS,TP14PBX,TR12PBX
CLINICIANS,SMN,USA
169,2004,2010,2013,BECAUSE,BETWEEN,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,NONE,OBJECTIVE,RESULTS,SURGERY,URF
BECAUSE,CALIF,HOWEVER,INC,INTUITIVE,MINIMALLY,SUNNYVALE,VINCI
105,8805,CTCAE,GRADE,IMRT
046,128,138,177,181,193,200,994,ALP,ALT,AST,BACKGROUND,BATA,CASE,CONCLUSION,CZECH,GGT,INR,LABEL,LABORATORY,METHODS,QUICK,ZLIN
111,117,169,2013,ADC,AIM,COLLEGE,CONCLUSION,COPYRIGHT,DCE,FIVE,LABEL,LTD,MATERIALS,MEAN,METHODS,MRI,NONE,OBJECTIVE,PUBLISHED,RESULTS,ROYAL
111,169,1998,2011,2013,2665,4660,ANZ,AUTHORS,BACKGROUND,COLLEGE,DISCUSSION,JOURNAL,LABEL,METHODS,RESULTS,ROYAL,SURGERY,THERE
169,2010,2013,AIM,BACKGROUND,BLACKWELL,CONNECT,DISCUSSION,ETHICAL,FORTY,LABEL,LTD,METHODS,OBJECTIVE,OUTCOME,PUBLISHING,REASONS
7AU,7BB,DIMN,H12,MOLECULAR,SAR
169,174,2013,AMONG,CASODEX,INTESTINAL,JOHN,KINETIC,LTD,PUBLISHED,SOCIETY,SONS,UDP,UGT,UGTS,WHILE,WILEY
8149,956,CALU,DOX,DU145,INCUBATION,MTS
CA19,CDX,CEA,CK20,CK7,PAS,PSA,PSAP,SRCC
153,BONE,MINIMAL
207,239,CATI,FDRS,GROUP,INTERVIEW,LABEL,MEN,METHODS,OBJECTIVE,PSA,RESULTS,RISK,SEM,TELEPHONE
169,2013,ADAMS,ELISA,FLOW,MHC,MICA,MICB,NKG2D,STUDIES,THESE,THUS,UICC
169,2013,ACTIVATED,FINALLY,HGF,IGF,MET,PC3,SRC,UICC
101,2009,2011,ABOUT,AGENT,BANG,CAT,CONCLUSION,KIM,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PHU,PSA,RESULTS
169,2013,954,AKT,COPYRIGHT,EXOGENOUS,LOX,MMP9,PI3K,UICC,USING
177,2011,2012,956,ADDITIONAL,BACKGROUND,CONCLUSION,DATA,EACH,FIFTY,GLEASON,JULY,LABEL,MAY,METHODS,PCA,PSA,RESULTS,SHEAR,SWI
8209,COPENHAGEN,MRI,PC3,PCA,THESE
160,8209,CEEF,DU145,ERK1,EUPHORBIA,JNK,MAPK,MMP,PI3K,PKC,SOS1,WESTERN
ANOTHER,CONCLUSION,ICE,INITIAL,LABEL,MATERIALS,METHODS,OBJECTIVE,POTENTIAL,PURPOSE,RESULTS,TEN,THEN,THESE
00093,0021,0030,048,241,8804,8805,AGE,FURTHER,GRADE,GROUP,LATE,RADIATION,STUDENT,THERAPY,V20,V40,V60,V70
100,945,946,ADT,DHT,HSD,HSD17B6,THESE
001,160,2005,2007,ASIAN,BCR,BETWEEN,GLEASON,IQR,JULY,PSA,RARP
HOWEVER,PCA,PSA,SEVERAL,SINCE
1865,CELLS,ELISA,TFPI,THERE,THESE
169,2013,COPYRIGHT,HDACI,LNCAP,LTD,RWPE,SMRT,THERE
169,2013,946,A2780,CONSISTENT,COPYRIGHT,DHA,DU145,INC,NEITHER,SNPP,THUS,WHILE,WNT,ZINC,ZNPP
169,2013,COPYRIGHT,IRELAND,LNCAP,LOX,LTD,PCA,TREATMENT
169,2013,COPYRIGHT,DMAB,IRELAND,LTD,NPS,TARGETING,UPON
169,2013,239,COPYRIGHT,HOWEVER,IRELAND,JUN,LTD,MOLECULAR
105,169,2013,8805,ARTEMIS,BACKGROUND,COPYRIGHT,DETECTION,GLEASON,LABEL,MEN,METHODS,MOST,MRI,OBJECTIVE,OUTCOME,PCA,PCAS,PSA,PUBLISHED,RESULTS,SETTING,SEVENTY,SUSPICIOUS,UROLOGY
001,004,009,169,2013,8804,ADT,COPYRIGHT,EBRT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PRE,PSA,PURPOSE,RESULTS
169,2013,8804,8805,945,ARI,CONCLUSION,COPYRIGHT,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PCA,PREVENTION,RESTAGING,RESULTS,T1C,TRIAL
1024,169,2013,8805,BCJ,CONCLUSION,COPYRIGHT,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PBX,PBXS,PCA,PCA3,RAND,REDUCTION,RESULTS,THESE,THREE,UCLA,USING
169,2013,945,946,COPYRIGHT,GIVEN,INC,THERE,WPRT
169,2013,BCL,COPYRIGHT,DEVD,GINKGETIN,LTD,OVERALL,PRAP,THUS
138,160,2004,2010,274,431,503,934,BGM,CONCLUSION,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,ORP,OVERALL,PUBLISHED,RALRP,REGRESSION,RESULTS
0001,110,116,153,169,177,2013,99M,AFTERWARD,CONCLUSION,COPYRIGHT,EDTMP,INC,LABEL,METHODS,MOST,OVERALL,PET,RESULTS,UNLABELLED
169,192,193,2013,262,307,385,60GY,954,AGREEMENT,ARO,AUO,BACKGROUND,COPYRIGHT,COX,EVENT,GLEASON,LABEL,MEIER,METHODS,OBJECTIVE,OUTCOME,PHASE,PSA,PSMS,PUBLISHED,RESULTS,SETTING,SOCIETY,THERE,THESE,UROLOGY
169,2014,218,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,USING
0001,169,2004,2008,2013,268,4GY,ADVERSE,BACKGROUND,CHANGES,COPYRIGHT,COX,CTCAE,EVEN,FIFTY,IMRT,IPSS,JUNE,KRUSKAL,LABEL,LATE,MANN,METHODS,OBJECTIVE,OUTCOME,OVERALL,PCA,PUBLISHED,QOL,RESULTS,SCORE,SETTING,SYMPTOM,TREATMENT,UNIVARIATE,UROLOGY,WHITNEY
160,169,2013,BACKGROUND,BCL,CELL,CLONOGENIC,CONCLUSION,COPYRIGHT,FLIP,HTB,INC,LABEL,MEL,METHODS,QUICK,RESULTS,RSV,THESE,TUNEL,XRT
0001,001,160,169,177,1995,2010,2013,8804,BACKGROUND,COLLEGE,COPYRIGHT,FOUR,HOWEVER,INC,JANUARY,LABEL,METHODS,NTC,NTCS,PAPILLARY,PTC,PUBLISHED,RESULTS,SIXTY,THERE,THESE
0001,146,321,562,8482,947,BACKGROUND,COX,GIVEN,GLEASON,HGPIN,HP1,INCREASED,LABEL,METHODS,PCA,PEARSON,PSA,RESULTS,USING
160,169,2013,8804,ASSESSMENT,CLAVIEN,CONCLUSION,COPYRIGHT,DINDO,FUNCTIONAL,GLEASON,INC,INDEX,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,SCORE,SYMPTOM,T1C,T2A,THERAPY,THREE,TTPB,USING
169,2013,945,946,954,AMPK,ANATOMICAL,IKK,JOHN,LPS,LTD,SOCIETY,SONS,TAKEN,THESE,WILEY
160,8482,BACKGROUND,CISPLATIN,CONCLUSION,HOWEVER,LABEL,MATERIALS,METHODS,MTT,RESULTS
160,169,2013,COPYRIGHT,LTD,M13,PROTEIN,PTD,PTDS,YPEP
169,177,1964,1971,2008,2013,8201,AMONG,EXCLUSION,THUS,UNIVARIATE,UROLOGICAL
169,177,2013,8201,837,AIM,COX,EXCLUSION,GLEASON,LABEL,MEIER,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THERE,UROLOGICAL
ESPECIALLY,FURTHER,HEAT,HSP,HSPS,NOTEWORTHY,PCA,SINCE,THEREFORE
100,CONCLUSION,DCE,DWI,EVEN,LABEL,MATERIALS,METHODS,MRI,MRS,OBJECTIVE,PSA,RESULTS,THREE
015,017,028,041,042,169,200,2009,2011,2013,231,483,532,643,8201,GLEASON,JANUARY,LABEL,LYMPHOCELE,METHODS,OBJECTIVE,OBJECTIVES,OPERATION,PROPENSITY,RESULTS,SEMINAL,THERE,UROLOGICAL
0007,0121,1159,1467,169,2005,2011,2013,308,421,590,8201,8804,8805,AFTER,BETWEEN,CONCLUSION,GLEASON,LABEL,LOWER,METHODS,OBJECTIVE,RESULTS,SCORE,SYMPTOM,UROLOGICAL
150,2006,2010,350,89SR,ALGORITHMS,CONCLUSION,DEPARTMENT,LABEL,MBQ,METHODS,OBJECTIVE,RADIATION,RESULTS,TRT,VARIOUS
100,125,2009,2012,255,CONCLUSION,DOSIMETRIC,HOWEVER,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,PID,POST,RESULTS,SEED,SUBOPTIMAL
INCREASED,THROUGH
186,2013,685,8201,AFRICAN,AMERICANS,CAUCASIANS,CNKI,JANUARY,REVMAN4,STATA,VDR,WANFANG
DATA,DESPITE
160,5ARIS,945,ADVERSE,BACKGROUND,BECAUSE,DUE,END,LABEL,LIBRARY,MEDLINE,METHODS,OBJECTIVE,PCA,PUBLISHED,PURPOSE,QUALITY,RESULTS,SEER,TREATMENT
100,1993,2010,571,856,956,BMI,CONCLUSION,COX,FURTHER,HOWEVER,HRS,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
0001,0023,156,193,234,271,678,935,DIAGNOSIS,DIETARY,FEW,FEWER,LABEL,MEN,METHODS,OBJECTIVE,PURPOSE,RESULTS
166,167,946,FAS,FLIP,HEK293T,HELA,HOWEVER,K167R,LYS,MG132,PPC,ROS,SEVERAL,T166A,THR,TNF,TRAIL
246,A2780,CL2,CONCERNING,DICHROISM,FOUR,HSA,L4AND,MCF7,PC3,PF6,RU2,RUCL2,TSC,WHILE
945,ANOTHER,HOWEVER,III,INSTITUTE,LABEL,OBJECTIVE,PHASE,PURPOSE,RESULTS,SUMMARY,THESE
000,100,1997,1999,2010,AMONG,ASIR,ASMR,AUTONOMOUS,DOLL,EVEN,HERTZEN,INSTITUTE,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OKRUG,OVERALL,RESULTS,SEGI
169,2013,COPYRIGHT,DU145,EDMAN,FROG,LEAF,LNCAP,MALDI,MEXICAN,MTT,PC3,PDT,PST,SKIN,THESE,TOF,TPH,WAXY
169,2013,COPYRIGHT,CRPC,CRPCS,INC,NCOR1,NOTABLY,SIAH2
154,381,763,788,818,8201,CONCLUSION,ECOG,HOME,HOWEVER,LABEL,METHODS,NURSE,OBJECTIVE,PATIENT,PHYSICIAN,PURPOSE,RESULTS,THERE,TREATMENT,ZOL
100,1000,1000S,169,2000S,2013,708,710,751,752,768,779,805,811,ADC,ADC1000,ADC2000,ADCS,AUCS,CONCLUSION,COPYRIGHT,DWI,GLEASON,IRELAND,LABEL,LTD,MATERIALS,METHODS,MRI,OBJECTIVE,RESULTS,ROC,TRUS
005,009,CONCLUSION,D95,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,TOMODIRECT,TREATMENT,V5GY
011,2010,ALPHARADIN,BECAUSE,CRPC,HOWEVER,MDV3100,OGX,P17,SEVERAL,UNTIL
169,2013,ADT,ADVERSE,GROUP,JOHN,LTD,MEANING,SONS,SPOUSAL,WHETHER,WILEY
001,002,006,013,AFTER,ARF,CHANGES,KRAS,MYC,NPM1,P53,P53GENE,PCR,SIMILAR
DWI,MRI,PCI,RPE,T2WI,THUS
100,ANOTHER,ASTRO,ATM,BACKGROUND,CYSTECTOMY,DAILY,HBO,HEMATURIA,HRC,LABEL,METHODS,NONE,OBJECTIVE,OBJECTIVES,RESULTS
2008,BACKGROUND,CABG,DISSONANCE,LABEL,METHODS,RESULTS,SURVEYING
000,100,4T1,ANTI,BXPC,CTC,CTCS,EPCAM,MBS,THERE,USING
CELL,CFGF,CTGF,JUNB,KIT,PCR,SATB1,SILENCING,SPECIAL,U2OS,WESTERN
CRAC,GBM,HPA,ORAI,ORAI1,ORAI3,OVERALL,SOCE,STIM,STIM1,USING,UTILIZING
169,2013,AACR,PRL,PRLR
001,005,169,2013,387,8805,AACR,BIOMARKER,BOTH,ERG,GLEASON,LABEL,METHODS,OBJECTIVE,ORS,PASS,PCA3,PURPOSE,RESULTS,TMPRSS2,URINE,USING
945,946,AH23848,AKT,COX,DU145,EP2,EP4,EXOGENOUS,L161982,LNCAP,PC3,PGE2,PGF2,PI3K,RAPAMYCIN,TGF
132,270,369,517,639,AAM,AFRICAN,BACKGROUND,DESPITE,EAM,FFPE,LABEL,LIMITED,METHODS,PCA,RESULTS
226,420,945,946,BACKGROUND,BCMO1,BPC3,CONSORTIUM,DIETARY,INSTITUTE,LABEL,METHODS,NEITHER,RESULTS,SNP,SNPS
1999,AIM,CONCLUSION,EACH,FATIGUE,LABEL,METHODS,OBJECTIVE,PROTHER,RESULTS,TEXAS,UNIVERSITY
925,BACKGROUND,C30,CONCLUSION,CONTINENCE,EORTC,FUNCTIONAL,INTERVIEW,LABEL,MATERIALS,METHODS,PR25,QLQ,QOL,RADICAL,RARP,RESULTS,ROBOT
CELL,CONCLUSION,DU145,HENCE,LABEL,METHODS,MTT,NAC,OBJECTIVE,PC3,RESULTS,THEN
1139,1993,1994,2009,768,COX,GAZEL,HOSTILITY,HOWEVER,JANUARY,LABEL,LARGE,METHODS,OBJECTIVE,RESULTS,SEVERAL,THESE,TYPE
209,410,BACKGROUND,COLORECTAL,LABEL,LEUKOCYTE,LUNG,METHODS,ORS,OVARIAN,RCC,RESULTS,SCREENING,THERE,TRIAL
945,947,AKT,BINDING,MOLECULAR,VITAMIN
130,169,2013,236,446,495,598,8805,AMONG,BMI,CLEAR,COLORECTAL,CONCLUSION,COPYRIGHT,LABEL,LUNG,METHODS,OBESITY,OBJECTIVE,OVARIAN,PLCO,RESULTS,SCREENING,SOCIETY,TRIAL
ERG,ETS,ETV1,LAST,PTEN,TMPRSS2
001,177,2000,2009,8201,999,BRONJ,CONCLUSION,DMFT,HOWEVER,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PURPOSE,RESULTS,WITHOUT
001,042,048,070,207,231,492,8804,8805,AMICO,EPLND,GLEASON,IQR,KANE,LABEL,METHODS,OBJECTIVE,PATIENT,PLND,PSA,PURPOSE,RALP,RALPS,RESULTS,ROBOTIC,SPLND,THERE
125,186,428,AUC,BOTH,CONCLUSION,CONDUCTING,CYTOMETRIC,FISH,HOWEVER,LABEL,METHODS,OBJECTIVE,PCA,PHH3,PURPOSE,RESULTS,SIMILARLY,WHILE
FOUR,III,IMIDS,LABEL,OBJECTIVE,PURPOSE,RESULTS,SUMMARY
223,700,DENOSUMAB,DOCETAXEL,EARLY,FURTHER,III,LABEL,OBJECTIVE,OTHER,PURPOSE,RESULTS,SRES,SUMMARY,TAK
BACKGROUND,BECAUSE,BRTI,CONCLUSION,DU145,LABEL,PC3,RESULTS,RGD,RGE,SBTI
HOWEVER,MDP
000,007,040,150,169,17BE,2006,2012,2014,894,946,AGE,BETWEEN,CONCLUSION,COPYRIGHT,DRE,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PCA,PSA,RESULTS,SERUM
169,2014,250,25MG,8805,956,BACKGROUND,COPYRIGHT,CRPC,CSF,DCS,GRADE,INC,LABEL,METHODS,OVERALL,PRIOR,PSA,RESULTS,TH1
100,125,150,169,200,2013,6711,9011,COPYRIGHT,D100,D90,GREATER,INC,MEDICAL,PUBLISHED,USING,V100,V150,V20,V200,V50
2006,ADVERSE,C30,CONCLUSION,DATA,EORTC,HIGH,HOWEVER,IMRT,LABEL,METHODS,OBJECTIVE,PATIENT,PHYSICIANS,PR25,QLQ,QOL,RESULTS,THERE
0016,0352,132,180,BACKGROUND,CONTINENCE,ICIQ,IIEF,INDEX,LABEL,LRP,METHODS,OBJECTIVE,PURPOSE,RESULTS,URINARY
2012,398,BACKGROUND,CENTRAL,EARLY,FOUR,HOWEVER,LABEL,MEDLINE,METHODS,RANDOMIZED,RESULTS,THERE
145,200,8243,8776,8811,951,956,BOC,CELL,EMBRYONIC,ESI,HOWEVER,HPLC,IC50,ICP,MALDI,MCF,NMR,PPH3,RUCL,TOF,UNDER
0002,184,8781,GAUCHER,GBA1,GD1,HOWEVER,PATIENT,PMR
H2O2,INTRINSIC,MTDNA,PCR,ROS
250,6729,7959,8201,9188,956,BCAS1,HER2,MYC,PCR,ROC,SEQUENCES,THESE,UCF
COI,FUNCTIONAL,THESE

001,1990,2010,5274,8804,8805,BACKGROUND,BASED,CONCLUSION,LABEL,LNI,LNS,METHODS,OVERALL,PCA,PLND,RESULTS,YEAR
2012,794,BACKGROUND,HOWEVER,HRS,LABEL,METHODS,OVERALL,RESULTS,RFS
1998,2010,2368,515,613,8805,918,BACKGROUND,BMI,JANUARY,LABEL,MATERIALS,METHODS,PCA,RESULTS,SHR,SWEDISH
000,3000,317,677C,677CC,8594,8805,B12,BACKGROUND,CONCLUSION,JANUS,LABEL,METHODS,MMA,MTHFR,RESULTS,USING,VITAMIN
CURRENTLY,FINALLY,LNCAP,MARKERS,OR1D2,PCA3,PSA
ADT,BOTH,HOWEVER,III,STRATEGIES,THESE,ZOLEDRONIC
001,005,2000,2010,3669,676,BACKGROUND,BARRETT,DATA,FURTHER,GOALS,LABEL,MALIGNANCY,METHODS,OBJECTIVE,RESULTS,SEVERAL
17AAG,946,AKT,CONSISTENT,CRM1,EGFR,GSK,HDAC,HDAC6,HDACS,HER2,HOWEVER
103,169,2013,AFTER,ALSO,CONCLUSION,COPYRIGHT,DISCUSSION,FORUM,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,RCT,RESULTS,WEBCHOICE
103,169,2012,2013,239,2PIN,6CC,8482,AEU,COPYRIGHT,GLEASON,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OCTOBER,PIN,PSA,PUBLISHED,RESULTS,RTU,T1A,THERE,THESE
000,169,200,2000,2010,2012,2013,203,2050,216,450,494,ALZHEIMER,AMERICA,AMERICANS,BETWEEN,COPYRIGHT,INC,PUBLISHED,THESE,THROUGHOUT,TODAY,TOTAL
169,2014,BACKGROUND,COPYRIGHT,DOCETAXEL,III,INC,LABEL,METHODS,PHASE,READY,RESULTS,SYNERGY
169,1998,2000,2007,2014,275,831,AFRICAN,AMONG,ANY,CHI,COLON,COPYRIGHT,CORPORATE,COX,DATA,HEALTHCARE,INC,JANUARY,LABEL,LUNG,MATERIALS,METHODS,OBJECTIVE,OCTOBER,OVARIAN,PSA,REGULAR,RESULTS,SCREENING,SEPTEMBER,TRIAL,VHA,WAREHOUSE
169,2012,COPYRIGHT,DESPITE,HOWEVER,KREBS,LTD,PUBLISHED,SLC30,SLC39,ZINC
1261,169,1995,2007,2013,361,4459,6692,972,BACKGROUND,COPYRIGHT,COX,DATA,EBRT,LABEL,LARGE,MEDICAL,METHODS,OBJECTIVE,OUTCOME,PCA,PCM,PUBLISHED,RESULTS,SETTING,THESE,TREATMENT,UNIVARIATE,UROLOGY,USING
169,1990,2006,2013,336,8804,8805,BACKGROUND,BCR,COMPETING,COPYRIGHT,COX,CSM,DATA,GLEASON,LABEL,MEN,METHODS,OBJECTIVE,OCM,OUTCOME,PUBLISHED,RESULTS,SETTING,SHORT,TEN,THESE,UROLOGY
141GG,141T,141TT,156,198,APE1,APEX1,ASP148GLU,BACKGROUND,BER,CHINESE,HAN,HARDY,HOWEVER,LABEL,METHODS,PCA,PCR,RESULTS,RFLP
000,169,185,2013,4000,8309,8315,AFP,CNTS,CONTROL,COPYRIGHT,CRCAS,ELISA,GMBH,KGAA,MWCNT,PSA,THERE,VCH,WILEY
0001,0002,0003,003,1070,169,2013,744,8804,9413,BACKGROUND,COPYRIGHT,CUMULATIVE,GLEASON,GROUP,LABEL,MEIER,METHODS,OTHER,PHOENIX,PSA,RADIATION,RESULTS,SHORT,SOCIETY,THERAPY,UNIVARIATE
124I,250,BASED,BR55,METHODS,MOLECULAR,MRI,PET,SPECT
001,559,563,BACKGROUND,CHINA,LABEL,METHODS,PSA,PSM,RALP,RESULTS,RRP,THEREFORE
1990,CONCLUSION,INITIAL,LABEL,LIBRARY,MATERIALS,MEDLINE,METHODS,OBJECTIVE,PCA,PURPOSE,RESULTS,THUS
169,2013,COPYRIGHT,FEW,INC,MOST,OTHER,SOCIETY,THUS
001,046,169,2013,8201,CIS,CRPC,ENDOTHELIN,HOWEVER,HRS,NINE,PFS,TTP,UICC
FALSE,GLEASON,HOWEVER,PCA3,PSA
CD146,CD34,CD45,CELLSEARCH,CSF,CSFMC,CTC,EPCAM,HMW,MAA,MRI,TUBES,VERIDEX
134,160,ASIAN,CITY,CULTURE,DATA,EAST,EASTERN,FURTHER,HOWEVER,PSA,SOUTH,TANG,YORK
COMPOUNDS
1999,2008,981,CITY,LABEL,METHODS,NYC,OBJECTIVE,PURPOSE,RESULTS,SES,STAGE,STATE,THERE,YORK
125,150,182,241,282,600,778,877,BCRFS,BNSS,ELRP,LABEL,METHODS,OBJECTIVE,OVERALL,PLND,POTENCY,PSA,PURPOSE,RESULTS,UNSS
CHILD,ESOPHAGEAL,VATER
441,8201,FOXA,MRP4,MULTIDRUG,PSA
100,125B,25D,E2F3,MIR,PLK1,PRE,PROSTATIC,RWPE,SIMILARLY,USING
DUE,OFTEN,PET
169,2013,BASEL,COPYRIGHT,DESPITE,OLDER,RESULTS,TREATMENT,WHILE
160,8209,AZA,CAP,CPGS,DU145,NAB,PC3,PCR
125B,99A,EXPRESSION,EZH2,IGF1R,JMJD3,LINC00478,THESE
INCREASING,THEREFORE
169,2013,ALSO,CNS,COMPOUNDS,COPYRIGHT,GI50,SAS,SNB
169,2013,945,946,AKT,COPYRIGHT,DOX,EFIPLADIB,ERK,LNCAP,PTEN,SILENCING,THESE
169,1980,1984,1999,2013,AGILENT,ATCC,CALIFORNIA,CELL,CLARA,COPYRIGHT,CORE,EDUCATION,GENOMIC,HELA,HOPKINS,IBARAKI,INC,JAPAN,JOHNS,KEIO,KU7,KYOTO,LABEL,LINE,MATERIALS,MEDICAL,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,RIKEN,SANTA,TOKYO,UNIVERSITY,UROLOGICAL,VANCOUVER
CHANCES,CONCLUSION,LABEL,LOW,METHODS,OBJECTIVE,RESULTS,UNLABELLED
169,2013,COA,COPYRIGHT,ERK,INC,INSIG,OXYSTEROLS,PERHAPS,THEREFORE
169,2013,215,330MG,96H,CDR,COPYRIGHT,FOLLOWING,INC,J591,METAL,PSMA,SCFV,WESTERN
169,2013,945,946,954,CAP,COPYRIGHT,INC,POST,PTHRP,SINCE,TARGETING,THESE
001,014,020,025,036,169,190,2013,B2M,BECAUSE,COLORECTAL,CONCLUSION,COPYRIGHT,CRC,DUKES,EVEN,INC,KLK10,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PCR,PSA,PUBLISHED,RESULTS,TNM,TOTAL,TUMOURS
169,2013,COPYRIGHT,HOWEVER,LTD,RNAI
000,169,1984,2008,2013,BACKGROUND,CNS,COLORECTAL,COPYRIGHT,EAPC,LABEL,LTD,METHODS,OVERALL,RATES,RESULTS,THERE
169,2012,241,454,COPYRIGHT,EARLY,ESPA,PET
000,1304,1412,1473,150,1516,1595,163,169,1713,200,2013,329,708,8364,894,BACKGROUND,CARE,COPYRIGHT,ICER,LABEL,METHODS,OBJECTIVE,OUTCOME,PUBLISHED,QALY,QALYS,RESULTS,ROBOT,SERVICE,SETTING,UROLOGY
001,174,2008,2010,8201,8805,ADT,AMICO,AUA,BACKGROUND,CTCAE,CYBERKNIFE,FORM,GEORGETOWN,INVENTORY,JUNE,LABEL,LATE,MAY,MEN,METHODS,PHOENIX,PSA,QUALITY,RESULTS,SBRT,SCORE,SHIM,SHORT,SYMPTOM,THERE,TOXICITIES,TREATMENT,UNIVERSITY,UROLOGICAL
AUC,AUCS,BACKGROUND,HISTORICAL,IMRT,LABEL,METHODS,NEXT,RESULTS,TOC
2010,FDA
00001,0001,2012,341,374,507,EPE,FURTHER,MANAGER,MEDLINE,PNI,SCIENCE,STUDIES,WEB
044,106,108,177,DISCOMFORT,LABEL,LEAKAGE,METHODS,OBJECTIVE,RALP,RESULTS
169,2013,AUTHORS,CIL,CONTACT,EPHA,EPHB,JOURNAL,MICROSCOPY,ROYAL,SOCIETY
001,003,109,169,1995,2011,2013,219,328,6489,8804,8805,AALEN,BJU,COX,CUMULATIVE,DENMARK,GLEASON,LABEL,MEIER,METHODS,OBJECTIVE,OBJECTIVES,PSA,RESULTS,RISK,SIX
001,169,1998,2011,2013,206,8805,BCR,BJU,EBRT,GLEASON,LABEL,MEN,METHODS,OBJECTIVE,POST,RESULTS,SRP,SVI,SVS
169,2013,BOTH,COPYRIGHT,GMBH,KGAA,THUS,VCH,WILEY
169,2013,CONSENSUS,COPYRIGHT,DCE,JOHN,LTD,MEETING,MRI,MRSI,PSA,SONS,TRUS,WILEY
012,177,1970,1985,2002,309,8805,CHRONIC,CONCLUSION,DISEASE,EVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCORE
HIGH,MRI,PET
00001,0001,005,100,104,117,130,155,192,214,362,8201,8226,8804,8805,DETECTION,FAS,FIELD,GLEASON,KEY,LABEL,METHODS,MRI,OBJECTIVE,OBJECTIVES,PRE,READERS,RESULTS,SSS
BASED,EARLY,FURTHER,IGF,PCA,WHILE
ANNA,ESPECIALLY,TRUS
508,555,613,651,670,681,705,712,736,779,794,818,8201,883,913,933,941,977,982,AFRICAN,AMERICANS,CAUCASIANS,GSTP1,HENCE,HOWEVER,ILE,ILE105VAL,ILE158VAL,PCA,THERE,VAL
1958,1985,1990S,2000,2003,2004,2007,2011,FUKUI,JAPAN,JOINPOINT,LABEL,MAJOR,METHODS,OBJECTIVE,RESULTS,STOMACH
CXR,DECREASED,EP2,EP3,EP4,FINALLY,L798106,LNCAP,TAKEN
169,2013,945,AACR,BAF57,CELL,CONCLUSION,CRITICALLY,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SNF,SWI,THESE
169,2013,AACR,CRPC,LNCAP,MDV3100,PSA,RESISTANCE,THESE,THUS
169,2013,AACR,ADT,HOWEVER,LNCAP,MDV3100,METASTATIC,PP2A,PPP2R1A,PPP2R2C,RNAI,THESE,VCAP
119,1637,2012,278,4803,DWI,ENGLISH,HOWEVER,LABEL,MAY,METHODS,OBJECTIVE,PURPOSE,RESULTS,STATA,THERE
100,160,DELIVERIES,DMLC,DOSE,IPL,MLC
1017858,144,177,BAY,CONCLUSION,GRPR,LABEL,MBQ,METHODS,PET,RESULTS,RM2,TREATMENT,UNLABELLED
SLN,SLNS
945,ANDROGENS,DRUGS,FOOD,LABEL,OBJECTIVE,PURPOSE,RESULTS,SUMMARY,TREATMENT
AKT,AMONG,BIM,CASEINE,CK2,PML,PROTEIN,SER,THR
169,2013,427,AACR,EMT,HSP27,HSPB1,OGX,OVERALL,STAT3,TWIST
0001,0038,093,5Q21,947,CHD1,DELETIONS,ERG,FISH,FOXO1,FUNCTIONAL,NKX3,PPAR,PSA,RGMB,SNP,USING
004,083,169,1990,2011,2014,568,8804,COPYRIGHT,COX,CSS,HARRELL,INC,JANUARY,JULY,LABEL,LND,MATERIALS,MEIER,METHODS,OBJECTIVE,RESULTS
169,2013,946,967,BACKGROUND,BRESLOW,CDH11,COPYRIGHT,E26,ERG,INHBA,INITIAL,KRUSKAL,LABEL,MANN,MEIER,METHODS,MOST,OBJECTIVE,OUTCOME,PCA,PCAS,PEARSON,PUBLISHED,RESULTS,SETTING,TMPRSS2,UROLOGY,WHITNEY
160,169,2013,215,8805,CONCLUSION,COPYRIGHT,GLEASON,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,SUSPICIOUS,TESLA,THEIR
1000,1071,169,2003,2007,2013,411,ADT,CONCLUSION,COPYRIGHT,INC,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,THROUGH
013,018,023,040,162,169,2001,2011,2013,230,253,433,CONCLUSION,COPYRIGHT,ECE,GLEASON,INC,LABEL,METHODS,NEXT,OBJECTIVE,PPM,PSA,RESULTS
100,109,169,2013,215,800,8201,8804,8805,ADBX,BJU,DETECTION,INCREASING,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,TVOF,USING
120,169,198,1998,2011,2013,8805,BJU,EBRT,GLEASON,LABEL,METHODS,OBJECTIVE,PRB,PRBS,RADIATION,RESULTS,SRP
169,2013,231,233,COPYRIGHT,PUBLISHED,SAS,SFRO,SOCI,TODAY
100,169,2005,2013,8805,BCR,BJU,COLLEGE,EACH,FORTY,JANUARY,LABEL,MAJOR,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,PSM,PSMS,RESULTS,SOCIETY,THERE
169,200,2013,2893,400,699,734,8805,956,ASIA,BACKGROUND,CHANGES,CONCLUSION,CURRENT,DATA,HENCE,LABEL,LTD,METHODS,MIXED,PHASE,PTY,PUBLISHING,RESULTS,SERUM,THESE,UNIVERSITY,WILEY
214,BRAZILIAN,CONCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
945,946,956,EPH,EPHA2,LCA,STRUCTURE,TRP
169,2013,GTPASES,JOURNAL,MICROSCOPY,RHO,RHOA,RHOB,RHOC,ROYAL,SOCIETY
ASIAN,GENISTEIN
945,946,EGL,EGLN1,HIF,LOSS,PHD2,THESE,UTR
ADVOCATES,DETECTION,EARLY,FIRM,GUIDELINES,HOWEVER,NCCN,PSA,SINCE
AMONG,PSA,THESE
100,11C,123,138,155,1555,1703,18F,2000,2012,783,818,869,946,AIM,CHOLINE,EBRT,ENGLISH,KNOWLEDGE,LABEL,MATERIALS,MEDLINE,METHODS,OBJECTIVE,PCA,PET,PSA,RESULTS,REVIEWS,SCHOLAR,WEB
169,2013,491,BACKGROUND,BASEL,CONCLUSION,COPYRIGHT,DATA,DEPRESSION,DEPRESSIVE,DSM,EMOTIONAL,EPISODE,HOWEVER,LABEL,MAJOR,METHODS,RESULTS,SCALE,SELF,SOMATIC,THEREFORE,VALID,ZUNG
169,174,1ST,2006,2012,2013,317,438,4TH,754,967,ACCORDING,AMONG,BACKGROUND,BASEL,BETWEEN,COPYRIGHT,JANUARY,JUNE,LABEL,METHODS,OPEN,RESULTS,SOCIETY,VINCI,WHEREAS
169,174,2012,2013,550,BASED,COPYRIGHT,DATA,EDUCATION,HOWEVER,INC,JULY,LABEL,MATERIALS,METHODS,OBJECTIVE,PLACEMENT,PUBLISHED,PURPOSE,RESULTS,THERE,UROLOGICAL
169,2013,261,COPYRIGHT,EDUCATION,HOWEVER,INC,LABEL,LYMPH,MATERIALS,METASTATIC,METHODS,MOST,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THEREFORE,UROLOGICAL
160,169,2013,7238,COPYRIGHT,EIGHT,IA1,IA2,III,LTD,MALDI,MLST,MOST,MULTILOCUS,PHYLOGROUP,TOF
000,107,131,169,2012,2013,215,353,410,417,447,464,555,707,BACKGROUND,CONCLUSION,COPYRIGHT,ECO,EUCAN,LABEL,LTD,METHODS,NATIONS,RESULTS,THERE,THESE,UNION
012,046,169,2013,AIM,COLLEGE,CONCLUSION,COPYRIGHT,EBRT,FORTY,GLEASON,HIFU,LABEL,LTD,MATERIALS,METHODS,MRI,OBJECTIVE,PHOENIX,PSA,PUBLISHED,RESULTS,ROYAL,THEREFORE
169,177,2013,COPYRIGHT,CRT,FURTHER,IMRT,INSERTION,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,V100,V70,V80,V90
169,2013,ADT,COPYRIGHT,DATA,IRELAND,LTD,PCA
BOTH,CRAD,LTR,MMTV,PSA,PSP
CELL,COMPARING
31P,AFTER,AMYLOID,CDC34,CDC53,EXPRESSION,HSP104P,HSP70,SDS,SEC27,SRP1,USING
2007,2010,4018,472,741,7623,AFTER,INCREASING,NUTRITION,STUDIES,THEREFORE,THESE,THOSE
169,2010,2011,2013,8201,ADT,ANXIETY,ASSESSMENT,AUSTRALIA,COPYRIGHT,DEPRESSION,ENGLISH,FUNCTIONAL,GUIDELINES,JOHN,LABEL,LTD,METHODS,NPAGA,OBJECTIVE,OBJECTIVES,PCA,QOL,RESULTS,SCALE,SONS,THERAPY,THESE,THOSE,WILEY
CURRENTLY,FIRST,HOWEVER,MRI,TRUS
FURTHER,IMAGING,MRI,PET,REGARDING,WHILE
1000,3000,ADC,ADCF,ADCS,AUC,BPH,CONCLUSION,DWI,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS
150,180,945,946,IPT,PROGNOSCAN,PSI,RECEPTEUR,RON,RTK,SIX,SNPS
956,AFTER,AKT,THESE
QUI,WHETHER
2004,2007,686,8211,8805,CONCLUSION,END,LABEL,MATERIALS,MEN,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THERE
2011,2012,AIM,CONCLUSION,GLEASON,JUNE,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PCA,RESULTS,SPBX,T1C,TESLA
008,ADT,AIM,CONCLUSION,LABEL,METHODS,OBJECTIVE,PSA,RESULTS,TREATMENT
0018,0045,033,134,967,AIM,CAV1,CONCLUSION,CONDIFENCE,GLEASON,LABEL,MATERIALS,METHODS,OBJECTIVE,PEARSON,PSA,RESULTS,T29107A
000,945,946,AIM,ASTRO,CONCLUSION,DOES,LABEL,MATERIALS,METHODS,OBJECTIVE,PHOENIX,RESULTS,THESE,THREE
946,A2780,CONSISTENT,CP70,ELEMENE,THESE
211H,945,BACKGROUND,BOTH,CONCLUSION,GF109203X,H2052,H2452,H28,LABEL,MATERIALS,METHODS,MSTO,MTT,NAFTOPIDIL,NCI,PKC,RESULTS,TUNEL
PC3,ROS,SAG,SEVERAL,THUS
AIM,BACKGROUND,BIC,CONCLUSION,DHT,HOWEVER,LABEL,LNCAP,MATERIALS,METHODS,MTT,OBJECTIVE,PCR,POSTN,RESULTS,THROUGH,WHILE
083,116,2002,2007,446,523,630,854,935,971,BACKGROUND,CONCLUSION,COX,END,LABEL,METHODS,RESULTS,SEER,THERE
FURTHER,HOWEVER,SUBPATHWAY,VARIOUS
077,199,1992,2005,418,ALZHEIMER,APC,BESIDES,CARE,CONCLUSION,DECREASES,END,INCIDENCE,LABEL,METHODS,NLTCS,OBJECTIVE,OBJECTIVES,PARKINSON,RESULTS,SEER,TERM,USA
212,940,AM251,AM281,AM630,CB1,CB2,CP55,IC50,INC,PUBLISHED,WIN55
007,034,035,102,125,2012,231,4728,791,AIM,AMONG,ASIATIC,BACKGROUND,ENGLISH,EVERY,HDL,LABEL,LITERATURE,METABOLIC,METHODS,OBJECTIVE,RESULTS,SEPTEMBER
169,2014,BOARD,CONCLUSION,COPYRIGHT,HIGH,HOWEVER,INC,LABEL,MATERIALS,METHODS,MHZ,OBJECTIVE,RESULTS,TRANSVERSE
169,2013,BKV,CK7,CK903,COPYRIGHT,GLEASON,GMBH
169,2013,COPYRIGHT,DESPITE,FEDERATION,GEM,PUBLISHED,SOCIETIES

0001,014,0233,215,8804,954,ADC,AREAS,AUC,AUCS,CONCLUSION,DCE,FIFTY,HIPAA,LABEL,MATERIALS,MEDIANS,METHODS,OBJECTIVE,PCA,PURPOSE,RESULTS
2006,2008,8460,954,AGREEMENT,AMONG,BACKGROUND,CONSENTING,LABEL,METHODS,NOPR,OBJECTIVE,ONCOLOGIC,PET,RESULTS

000,250,BACKGROUND,COLORECTAL,COMPETING,CURRENT,ERSPC,FORCE,LABEL,LUNG,METHODS,OBJECTIVE,OVARIAN,PLCO,POTENTIAL,PREVENTIVE,PSA,RANDOMIZED,RCTS,RESULTS,SCREENING,TASK
145,169,2013,AUTHORS,ECTOPIC,ERG,FEBS,JOURNAL,MICRORNAS,TMPRSS2
CURRENTLY,THREE
3GALNAC,946,BECAUSE,GAL,TFD,THOMSEN
001,1000,1199,144,BACKGROUND,COX,ERSPC,FINNISH,HRS,LABEL,MEN,METHODS,PCS,PSA,RANDOMIZED,RESULTS,SCREENING,TRIAL
HOWEVER,LINAC,MLC,MUS,THEN
BPH,OVERALL
ERG,LABEL,NKX3,OBJECTIVE,PIM,PURPOSE,RESULTS,SUMMARY,TMPRSS2
LABEL,MRI,OBJECTIVE,PURPOSE,RESULTS,SUMMARY
125,169,2013,231,233,COPYRIGHT,DIFFERENT,ESTRO,GEC,HOWEVER,MID,PUBLISHED,SAS,SFRO,SOCI
BASED,FINALLY,HPIN,PIN,PROSTATIC,THERE
129,169,177,1NG,2012,203,20MCI,20NG,223,239,241,99M,9IU,ALP,BACKGROUND,CONCLUSION,COPYRIGHT,ESPA,GLEASON,HOWEVER,LABEL,MDP,METHODS,PSA,RESULTS,SERUM,SPECT,THERE,THREE
003,015,125,160,169,2013,COM,COPYRIGHT,CRANIAL,DAYS,FORTY,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SOCIETY,THERE
0001,100,103,105,125,1251,160,169,200,2013,COPYRIGHT,D90,GROUP,I125,IMPLANT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PSI,PUBLISHED,PURPOSE,RADIATION,RESULTS,RTOG,SOCIETY,STM,THERAPY,V100,V110,V150
169,2013,ADVANCING,AMICO,BMI,CALIFORNIA,CONCLUSION,COPYRIGHT,COUNSELING,GLEASON,GREATER,IMPROVING,INC,LABEL,MATERIALS,METHODS,OBESE,OBJECTIVE,PSA,RESULTS,TREATMENT,UNIVERSITY
2013,ADT,APA,HOWEVER,LABEL,METHODS,OBJECTIVE,OVERALL,RESULTS,RTH
116,165,2008,2011,207,217,226,228,367,APRIL,BACKGROUND,BETWEEN,CGE,CONCLUSION,EQUIVALENT,GRAY,LABEL,METHODS,NONE,OCTOBER,RESULTS,THREE
0058,171,2006,2007,BACKGROUND,CGE,CONCLUSION,CTCAE,FIVE,IPSS,LABEL,LOW,METHODS,MVA,RESULTS,SCORE,SEPTEMBER,SYMPTOM,THERE
125ML,130,26KG,93NG,ASA,BACKGROUND,BMI,CONCLUSION,FINAL,GFR,GLEASON,HEM,LABEL,MATERIALS,METHODS,MRI,POD,PSA,RARP,RENAL,RESULTS,T1C,T2BNX
100,BACKGROUND,CLAVIEN,DATA,EPIC,HRQOL,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RALP,RALPS,RESULTS,THERE
ADAPP,ANDROGENIC
101,102,103,107,109,112,123,132,133,138,146,152,156,157,167,179,BACKGROUND,CLU,FLICE,FLIP,GRP78,HOWEVER,HSP27,LABEL,LNCAP,MATERIALS,METHODS,PCR,RESULTS,WESTERN
CD44,CD44S,CELL,HOWEVER,MMP9,PC3,THESE
AFTER,AIM,AMACR,EXPRESSION,IHC,LABEL,METHODS,OBJECTIVE,PATCH,RESULTS,TMA,TMAS
144,169,2013,233,CONCLUSION,COPYRIGHT,CRAM,GLEASON,INC,LABEL,LASER,LCMODEL,METHODS,OBJECTIVE,PURPOSE,RAO,RESULTS,WILEY
169,2013,946,ADP,CAP,EMT,INC,NAC,OXIDATIVE,PARP,PSO,ROS,SOD1,SOD2,THESE,WILEY
008,BUBR1,EGE,GLEASON,IHC,PHF,REDUCED,TAU,THERE,UNIVERSITY
889,920,APPLIED,ASHKENAZI,BIOSYSTEMS,CITY,G84E,SCREENING,YORK
160,BLOOD,CD105,EWING,INHIBITION,NOVEL
003,1946,1974,1975,1977,509,8201,CAPACITOR,CAPACITORS,ERA,INHALATION,INTENSITY,JEM,PCB,PCBS,USING
MRI
1574,579,CRF,FORMULA,GIVEN,HIGH,RADIATION
0001,160,3DCRT,DSH,DSHS,DVH,DVH10,DVH5,DVH7,DVHS,DWH,IMRT,INC,MRI,MSS,VODCA
001,004,016,024,035,1A1,2012,411,CAUCASIANS,CHINA,CIS,CYTOCHROME,KNOWLEDGE,MSPI,OVERALL,P450,SCIENCE,SEPTEMBER,SIXTEEN,STRATIFIED,WEB
ABOUT,LABEL,LARGE,MEDLINE,METHODS,MTD,OBJECTIVE,OVERALL,PURPOSE,RESULTS,THESE
1940S,HIFU,HIGH
169,2013,947,CBER,CD8,COPYRIGHT,CURRENT,DCS,FDA,FILE,IFN
169,2013,4NG,5MG,945,946,ADT,ANOVA,BLOOD,COPYRIGHT,DHT,FIFTY,HOWEVER,LTD,PSA,STUDIES
1998,2009,ACUTE,ADVERSE,AFTER,FIVE,HDRB,INC,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,OVERALL,PHOENIX,PSA,PUBLISHED,PURPOSE,RESULTS,UNIVARIATE
0001,002,169,2013,468,8805,ADT,COPYRIGHT,DSM,GROUP,HIGH,INC,KI67,LABEL,MATERIALS,METHODS,MVA,MVAS,OBJECTIVE,PURPOSE,RADIATION,RESULTS,RTOG,THERAPY
104,105,106,1301,1385,169,1861,2003,2010,2013,30CM,40CM,4547,ACHIEVING,COMPARISON,CONCLUSION,COPYRIGHT,D90,INC,JANUARY,LABEL,MATERIALS,MEAN,METHODS,OBJECTIVE,OCTOBER,PUBLISHED,PURPOSE,RESULTS,SOCIETY,V100
169,2013,351,COPYRIGHT,EDUCATION,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PRE,PUBLISHED,PURPOSE,RESULTS,THREE,UROLOGICAL
169,2013,COPYRIGHT,HOWEVER,INC
169,2002,2011,2013,471,8804,8805,BACKGROUND,COPYRIGHT,COX,GLEASON,LABEL,MEIER,METHODS,OBJECTIVE,OUTCOME,PPC,PREDICTORS,PSA,PSAV,PUBLISHED,RESULTS,SETTING,THERE,TREATMENT,UROLOGY
001,1121,169,2004,2007,2013,8804,969,ADD,AFTER,AHR,BJU,BOTH,CONCLUSION,DOES,END,FINE,GLEASON,GRAY,KNOWN,LABEL,MEN,METHODS,OBJECTIVE,PCSM,PENDING,PIVOT,PSA,RESULTS,SUBJECT,T1C,TRIAL,UNLABELLED,WHAT,WHETHER
945,946,AFM,COL,FURTHER,LNCAP,PC3,PCR,SCP1,SEMI,TAKEN,USING
27A,8P23,LOH,MCPH1,MUTATIONS,OSCC,THREE,USING,UTR
ATG,DIFFERENT,ERG,ETS,OPEN,READING,TMPRSS2,USAGE,UTR,UTRS
CRE,EVEROLIMUS,FINALLY,PTEN,TAMOXIFEN,USING
956,CGLIIQKNEC,CLT1,CONCLUSION,CY5,DOTA,GFP,KAREC,LABEL,MAESTRO,METHODS,MRI,OBJECTIVE,PC3,PURPOSE,RESULTS,SNR
0001,102,107,CONCLUSION,COX,DESPITE,FIVE,LABEL,MEIER,METHODS,PET,RESULTS,TREATMENT,UNLABELLED
VEGF
169,2013,945,AACR,C17,CRPC,CYP17A1,DHEA
015,177,233,AFTER,BECAUSE,FOURIER,IMPLANTED,POINCAR,THESE
169,2013,299,BPH,COPYRIGHT,CURVE,HOWEVER,INC,NOTABLY,OPERATING,PCA,PCR,PSA,ROC,TMA,TSP2
8764,945,946,BASED,DESPITE,DVH,DVHS,GTV,HOWEVER,LETD,MOST,RBE,RWTD,VARIATIONS
1970,1992,2007,BACKGROUND,FIVE,INCIDENCE,LABEL,METHODS,MONITORING,MORTALITY,RESULTS,WHILE
146,169,2013,8201,8805,BJU,COMPOSITE,EPIC,EXCLUDING,INDEX,INVENTORY,LABEL,MEN,METHODS,OBJECTIVE,PSA,RARP,RESULTS,SCP,SHIM
RNAS
ADT,CAP,FHL2,ISOLATION,RHOA,SERUM,SRF,USING
0001,0002,0003,0006,0007,0008,002,004,006,007,008,009,010,012,015,016,020,021,022,027,029,033,039,044,045,125,2008,2010,50MG,6MG,AFTER,BMD,CHANGES,CONCLUSION,GSRS,HCT,IBS,LABEL,MCH,MCHC,MCV,METHODS,OBJECTIVE,PSA,RBC,RDW,RESULTS,SEPTEMBER,TOTALLY
001,009,132,169,2013,8805,BASED,BJU,COX,GLEASON,LABEL,LOW,MEIER,METHODS,OBJECTIVE,PHOENIX,POST,PSA,RESULTS,RISK,THERE,UNLABELLED,WHAT
178,4N0M0,BASED,CONCLUSION,GLEASON,GROUP,IAD,LABEL,METHODS,OBJECTIVE,PSA,RESULTS,SIX
107,128,365,542,725,CONCLUSION,DRE,LABEL,METHODS,MRI,OBJECTIVE,PSA,RESULTS,ROC,TRUS

2010,2012,BELGIUM,DOCETAXEL,JEVTANA,THREE,UNTIL
ADP,H2AX,HDACI,HISTONE,LNCAP,MMP,OVERALL,PC3,PNT1A,SAHA,TIMP,VAD
ALTOGETHER,MTA1,NURD,PCA,PTER
946,ADRIAMYCIN,FINALLY,LRP5,LRP6,MESD,WHILE,WNT
945,946,CXCR4,DUE,GIVEN,GPCR,NLS,RPRK
005,133,967,AMICO,AMONG,ASSESSMENT,CAPRA,CONCLUSION,EPSTEIN,GLEASON,HIPAA,LABEL,MATERIALS,METHODS,OBJECTIVE,PPV,PURPOSE,RESULTS,RISK
ADDITIONAL,BACKGROUND,BONE,CONCLUSION,DATA,DENOSUMAB,LABEL,METHODS,RANK,RESULTS,SRES,USA
100,125,144,169,2013,ADVERSE,BACKGROUND,BASEL,COPYRIGHT,LABEL,METHODS,RESULTS
163,169,2013,AKT,AVP,COPYRIGHT,ERK1,FGF8,FGF8B,FGFR3,FIBROBLAST,FUNCTIONAL,HSQAAVP,INC,LLAVPAA,P12,PCNA
EGF,HOWEVER,LNCAP,OVERALL
169,2013,412,COPYRIGHT,INC,METAL,MT2A,MTS,PCR,RFLP,SNP
125,169,1CM,2013,961,COMPOSITE,COPYRIGHT,DOSES,EUS,INC,INDEX,IUS,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,R100,RESULTS,URINARY,V100,V150,V200,V240,V265,V285,V35
002,037,043,116,169,2013,211,AUC,CONVERSELY,COPYRIGHT,EDUCATION,INC,INCLUDING,INDEX,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PCA3,PHI,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
169,2013,AZD3514,COPYRIGHT,LTD,PHASE,REMOVAL
019,026,169,2013,COPYRIGHT,FORTY,IRELAND,LABEL,LTD,METHODS,MRI,OBJECTIVE,PURPOSE,PWI,RESULTS,THERE
0001,004,100,104,111,121,138,168,169,183,2013,956,AFTER,BACKGROUND,COPYRIGHT,FUNDING,IQR,LABEL,LHRHA,LTD,MEAN,METHODS,MRC,NINE,OTHER,PARENTERAL,PATCH,RESULTS,UNIT
1186,127,1469,169,2013,8805,BACKGROUND,BECAUSE,COMBINING,COPYRIGHT,LABEL,LNS,METHODS,MOLECULAR,NOTABLY,OBJECTIVE,OUTCOME,PCA,PCR,PLND,PSA,PUBLISHED,RESULTS,SETTING,THESE,TOPOGRAPHY,UROLOGY
169,2013,272,347,BACKGROUND,COPYRIGHT,EACH,GROUP,LABEL,MEN,METHODS,OBJECTIVE,OUTCOME,PCA,PUBLISHED,RESULTS,SETTING,STUDIES,SWEDISH,SYMPTOM,TRADE,UROLOGY,YET
044,169,171,2009,2013,8201,8805,AFTER,BJU,DECLINE,DUTCH,ERSPC,GPS,LABEL,MATERIALS,METHODS,OBJECTIVE,PRIMARY,PSA,RANDOMIZED,RESULTS,SCREENING
001,160,169,1990S,1992,1996,1997,2007,2013,976,AST,CHANGES,CONCLUSION,COPYRIGHT,END,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,USING
169,2013,8805,BMI,CONCLUSION,COPYRIGHT,INC,LABEL,LHRH,MATERIALS,METHODS,OBJECTIVE,RESULTS,THOSE,USING
169,2007,2013,210,ANGELES,CALIFORNIA,CAP,CONCLUSION,COPYRIGHT,FORM,INC,INDEX,LABEL,LOS,LRP,METHODS,NERVE,OBJECTIVE,PCI,QOL,RALP,RESULTS,SHORT,THERE,UCLA,UNIVERSITY
037,046,124,148,160,169,191,196,2013,8805,AFRICAN,AFTER,CALIFORNIA,CONCLUSION,COPYRIGHT,FRANCISCO,GLEASON,INC,LABEL,METHODS,NCCN,NETWORK,OBJECTIVE,PCA,PSA,RESULTS,SAN,THESE,UCSF,UNIVERSITY,WHITE
003,008,1114,169,2007,2010,2013,BJU,BOTH,BRUEL,COPENHAGEN,DENMARK,DRE,G50,GERMANY,JANUARY,KJAER,LABEL,MEDICAL,METHODS,OBJECTIVE,PBX,PPNB,PRIMA,RESULTS,SIEMENS,TRUS
169,2013,215,8201,8805,897,974,ADD,AMONG,BJU,CAP,CURRENTLY,DOES,EPSTEIN,INDEX,KNOWN,LABEL,LESIONS,MATERIALS,METHODS,MRI,OBJECTIVE,PATH,RESULTS,SUBJECT,THESE,UNLABELLED,WHAT
1200,169,2004,2005,2013,8201,ADD,BJU,CALIFORNIA,COA,COX,DOES,HMG,HOWEVER,KNOWN,KPSC,LABEL,METHODS,NEITHER,OBJECTIVE,PERMANENTE,PSA,RESULTS,STATINS,SUBJECT,THESE,UNLABELLED,WHAT
001,169,2009,2011,2013,849,865,ADD,ANY,BJU,DESPITE,DOES,GRAM,INFECTIOUS,KNOWN,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PATIENT,PRE,RESULTS,SUBJECT,UNIVARIATE,UNLABELLED,WHAT
001,169,1982,2004,2005,2011,2013,7869,8804,ADD,BASED,BFS,BJU,DOES,GLEASON,HOPKINS,III,ISUP,JOHNS,KNOWN,LABEL,METHODS,OBJECTIVE,PATHOLOGY,PSA,RADICAL,RESULTS,SOCIETY,SUBJECT,UNLABELLED,UROLOGICAL,WHAT
BACKGROUND,CASE,CONCLUSION,LABEL,METHODS,PHYSICIANS
110,192,ACCORDING,CARLO,COMMISSION,FINALLY,GIVEN,HDR,HOWEVER,ICRP,IMRT,LABEL,METHODS,MONTE,OBJECTIVE,POINT,PROTECTION,PURPOSE,RESULTS,THESE
LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,SPATIAL
100,43U1,6711,9011,CARLO,D10,D2CC,D90,DVH,ISA,LABEL,METHODS,MONTE,OBJECTIVE,PMMA,PURPOSE,RESULTS,V100
CRT,DESPITE,HOWEVER,IMRT,LABEL,METHODS,OBJECTIVE,POISSON,PURPOSE,RADIATION,RESULTS
8804,BIOLOGICAL,LABEL,METHODS,OBJECTIVE,PURPOSE,RESIDUALS,RESULTS
ALTO,DESPITE,ECLIPSE,FIVE,INC,LABEL,LAPLACIAN,MATHWORKS,MEDICAL,METHODS,OBJECTIVE,PALO,PURPOSE,REAL,RESULTS,SYSTEMS,VMAT
BOTH,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIMULATED,SIMULATION
DOSE,FIVE,LABEL,METHODS,MLC,OBJECTIVE,PTV,PURPOSE,RESULTS,THESE
169,198,2005,2010,2013,303,568,8201,AMICO,ANZ,AUTHORS,AVERAGE,BACKGROUND,COLLEGE,CONCLUSION,JOURNAL,LABEL,LIKELIHOOD,METHODS,MRI,MRIS,RESULTS,RISK,ROYAL,SURGERY,THEREFORE
169,2010,2011,2013,556,804,ACTA,BACKGROUND,CONCLUSION,FOUNDATION,FOV,FOVS,LABEL,LIMITED,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SIMILARLY
000,0001,400,BACKGROUND,CONTEXT,GLEASON,HOWEVER,KI67,LABEL,MAIN,METHODS,OBJECTIVE,ORAL,OUTCOME,PCA,PSA,PTH,RESULTS,SETTING,THESE,TORONTO,VITAMIN
136,137,171,873,949,BACKGROUND,COX,FURTHER,GERMANY,HOWEVER,HRS,LABEL,LOW,METHODS,OVERALL,RESULTS,SEVERAL
169,2013,COPYRIGHT,ECTOPIC,INC
18F,2012,DWI,HIGH,HOWEVER,IMAGE,LABEL,MARCH,MATERIALS,METHODS,MRI,OBJECTIVE,OCTOBER,PET,PURPOSE,RESULTS
169,2013,AGING,COPYRIGHT,HOWEVER,INC,RUNNING,WESTERN
640,BACKGROUND,BPH,HIGH,LABEL,MARKERS,MATERIALS,METHODS,PCA,PSA,RESULTS,SUB
129,2011,452,ACADEMY,ALSO,DAKO,ERG,HGPIN,HOWEVER,MARCH,MEETING,PATHOLOGY,TMA,TMPRSS2
1607,2000,2003,2010,FPC,FPCS,NORTH,REGISTRIES,SPC,SPCS
0001,001,002,015,034,160,169,2013,ADT,CONCLUSION,COPYRIGHT,EBRT,FINE,GLEASON,GRAY,INC,LABEL,LTAD,MATERIALS,METHODS,NETWORK,NPCD,OBJECTIVE,PCSM,PURPOSE,RESULTS,STAD
10MG,169,2013,AKT,CAFFEIC,CAPE,COPYRIGHT,HOWEVER,LTD,PI3K,PTEN
169,2013,CARCINOMAS,COPYRIGHT,EMT,EMTS,EPITHELIAL,IRELAND,LOSS,LTD,MALIGNANT,TRANSITION
169,2013,232,775,AFTER,BIOPANNING,CAT12,COPYRIGHT,ELISA,FVPTC,IRELAND,LIGANDS,LTD,NPA,PTC,RAPID,SELECTIVE,THERE,TMAS
167,2000,2009,8804,AVAILABLE,BACKGROUND,CONCLUSION,DENMARK,FOND,FUNDING,GLEASON,HOWEVER,IMK,LABEL,METHODS,PSA,RESULTS,TEN,TRIAL
1055,550,ASIAN,COX,STI,STIS,WESTERN
AFRICAN,BASED,CASE,CHRONIC,CURRENTLY,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,RESULTS,SETTING,ULTIMATELY,WILEY
001,049,075,097,113,130,169,2008,2012,2013,3041,8805,BETWEEN,BJU,BMI,HOWEVER,JANUARY,LABEL,MARCH,METHODS,OBJECTIVE,RARP,RESULTS,THERE

183,657,BACKGROUND,DATA,FORTY,GLEASON,HOWEVER,LABEL,MEAN,MEDLINE,META,METHODS,MRI,OVID,PSA,RESULTS,THERE,THREE,TRUS
2000,2010,485,559,793,CONCLUSION,FURTHER,GAD,HOWEVER,INSURANCE,LABEL,METHODS,OBJECTIVE,RESULTS,SIR,SIRS
413,8804,8805,ASSESSMENT,CAPRA,CCP,COMBINING,CONCLUSION,COX,LABEL,METHODS,OBJECTIVE,PURPOSE,RECURRENCE,RESULTS,RISK
169,1BB,2012,AACR,CTLA,DRUG,FOOD,ODN,PSMA
152,169,2013,945,BACKGROUND,COPYRIGHT,DUAL,GLEASON,HOWEVER,INC,LABEL,METHODS,MICRORNAS,PCA,PCR,RESULTS,RNAS,TGF,UTR,WESTERN,WILEY
045,174,273,818,8804,DATA,DOCUMENTED,GERMANY,GMBH,LABEL,LHRH,METHODS,OBJECTIVE,OBJECTIVES,PSA,RESULTS,SIMILAR,SWITCHING,THESE,TREATMENT,TRENANTONE
160,2008,CARE,CURRENT,FORCE,PREVENTIVE,PSA,TASK,USING
CRPC,CTC,CTCS
000,001,2001,2008,2009,2011,MEN,PSA
007,008,009,104,110,A66G,BACKGROUND,C677T,ECUADORIAN,GLEASON,LABEL,METHODS,MTHFR,MTR,MTRR,REGARDING,RESULTS
8804,8805,ADDITIONAL,BACKGROUND,CHINESE,CIS,GLEASON,HOWEVER,LABEL,METHODS,ODDS,ORS,PCA,PSA,RESULTS
100,121,1734,2001,2010,8201,8805,BACKGROUND,COX,GLEASON,GLUCOSE,LABEL,METHODS,OBESITY,PCA,PSA,RECURRENCE,RESULTS,SERUM,SUM,THOSE
2005,4177,BACKGROUND,ERG,ETS,FURTHER,GLEASON,HOWEVER,LABEL,METHODS,PCA,RESULTS,TATI,TMPRSS2
8805,EXTENSIVE,HOWEVER,THREE,USING
2002,2011,212,8804,8805,BACKGROUND,CONCLUSION,GLEASON,HOWEVER,JANUARY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PCA,RESULTS,SETTING
0001,5HMC,5MC,BCN,BRESLOW,CMD,DCN,SEVERAL,SSM,TET2
107,1950,1998,200,2008,384,AUSTRALIAN,G84E,POPULATION
643,697,BPH,CAUCASIANS,GST,GSTM1,GSTS,GSTT1
GST,INHIBITION,LNCAP,NB7,TRAIL,USING
104,335,8201,DU145,EGFP,GLEASON,HOWEVER,LNCAP,PC3,PCA,PCR,SCORE,TURNING
946
AKT,GIVEN,PI3K
100,956,APOPTOSIS,CAT,CELL,GPX,GPX1,H2O2,HEK293T,HEPG2,MCF,RSV,SOD,SOD1,SOD2,TREATMENT,WESTERN
2002,2011,560,8805,APRIL,BACKGROUND,BETWEEN,CONCLUSION,COX,CRPC,DTX,INCIDENCES,JANUARY,LABEL,METHODS,PSA,RESULTS,THERE
177,945,956,BCL,CELL,CONCLUSION,DU145,EGF,EXPRESSION,FBS,LABEL,METHODS,MRP1,MTT,NED,NSE,OBJECTIVE,PCR,RESULTS,TGF,WESTERN
CONCLUSION,CURRENT,EXTENDING,LABEL,MATERIALS,METHODS,OBJECTIVE,PROLONGED,REGARDING,RESULTS,T1A,TURBT,UTUC
CD99,EWING,PNET
AIM,HELICAL
SNPS,USING
2012,BACKGROUND,FATIGUE,HOWEVER,ISI,JANUARY,KNOWLEDGE,LABEL,MEDLINE,METHODS,PSYCHINFO,RESULTS,SYSTEMATIC,WEB
8805,AREA,DLTS,LABEL,METHODS,MOST,OBJECTIVE,PM00104,PURPOSE,RESULTS,THREE
INCREASING,PCA,PCSC
40S,CONSISTENT,CONVERSELY,COS,HIGH,JUN,PTOV1,RACK1,THESE
169,2013,COA,COPYRIGHT,FEDERATION,GIVEN,INSTEAD,LNCAP,PUBLISHED,SCAP,SOCIETIES,SREBP
103,162,325,6EMEWZIWZ,BACKGROUND,FREQUENTLY,HIGH,HOWEVER,LABEL,LCA,METHODS,OBJECTIVE,RCT,RESULTS,TRIAL,WEB,WEBCHOICE,WEBCITE
032,042,169,2013,965,APMRT,CONCLUSION,COPYRIGHT,FORM,HOWEVER,INC,KEBANGSAAN,LABEL,MCS,MEDICAL,METHODS,OBJECTIVE,PCS,PURPOSE,QOL,RESULTS,SHORT,THERE,UKMMC,UMMC,UNIVERSITI,UNIVERSITY
100,169,2013,COPYRIGHT,HIGH,INHIBITORS,MOST,SAS,STRUCTURE,THERE,VARIATIONS
0037,169,177,2013,222,2MBQ,50MG,947,956,BACKGROUND,COPYRIGHT,DATA,FDG,FFA,FFAS,INC,LABEL,MBQ,METHODS,PC3,PCA,PET,RESULTS
1128,169,2013,BACKGROUND,CONCLUSION,COPYRIGHT,DENMARK,EACH,EARLY,LABEL,LTD,METHODS,RESULTS,THUS
169,2013,945,946,COPYRIGHT,CURRENTLY,HIGH,LTD,WESTERN
169,2013,BACKGROUND,COPYRIGHT,COUNTRY,DENMARK,DISCUSSION,ICELAND,LABEL,LTD,METHODS,RESULTS
125,169,177,2013,ADVERSE,COPYRIGHT,CROWN,DAYS,FIVE,GRADE,INC,INSTITUTE,LABEL,MATERIALS,MEAN,METHODS,OBJECTIVE,PEG,PUBLISHED,PURPOSE,RESULTS,RV100,THERE,TOXICITIES
160,169,177,194,2013,651,AFTER,ANY,COPYRIGHT,CTS,D90,FORTY,HDR,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SOCIETY,USING
001,006,011,015,045,100,169,193,2003,2007,2014,901,COPYRIGHT,INC,INPATIENT,LABEL,MATERIALS,METHODS,NATIONWIDE,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,RPS
001,1342,169,2013,276,533,603,AFTER,BMI,CONCLUSION,COPYRIGHT,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,THESE
001,169,2013,272,BASED,COPYRIGHT,DATA,LABEL,LTD,METHODS,OBJECTIVE,PATIENT,PURPOSE,RESULTS,SCALE,SEEMINGLY,VARIATIONS
008,169,2013,2237,A1C,ADT,AFFAIRS,BACKGROUND,COPYRIGHT,COX,DEPARTMENT,FEW,HBA1C,LABEL,METHODS,OBJECTIVE,OUTCOME,PCA,PUBLISHED,RESULTS,SETTING,STUDENT
169,1981,2009,2012,2013,517,8805,AMICO,BACKGROUND,BCR,CONTEXT,COPYRIGHT,DIAGNOSTIC,FOUR,GLEASON,LABEL,LIMITED,METHODS,MOST,OBJECTIVE,PCA,PUBLISHED,REASONS,RESULTS,SEPTEMBER,SEVENTEEN,STUDIES,SYNTHESIS,TREATMENT,UROLOGY
HOWEVER,INC,PUBLISHED,THUS
169,2013,BCL,COPYRIGHT,EXHIBIT,GMBH,JACARIC,LNCAP,PARP,PLANT,PUBCHEM,RWPE,THESE,THREE
0001,0055,0398,107,160,169,2013,280,ADT,CONCLUSION,COPYRIGHT,CRPC,INC,LABEL,METHODS,OBJECTIVE,PSA,RESULTS,SECONDARY,TREATMENT,TTP
IMRT,LABEL,METHODS,OBJECTIVE,OED,OEDS,ORGAN,PURPOSE,RESULTS,RPLGD,TOMO,VMAT
169,194,2013,451,BJU,GLEASON,LABEL,METHODS,OBJECTIVE,PATIENT,PERCENT,RESULTS,SMALLER,THESE
001,006,008,169,1995,2013,617,ADD,BJU,DOES,EVEN,KNOWN,LABEL,METHODS,OBJECTIVE,PCA,PREDICTIVE,PSA,PSAD,REBIOPSIES,RESULTS,SUBJECT,TIME,UNLABELLED,WHAT
112,169,177,200,2002,2011,2013,233,400,BJU,COX,DESPITE,HOWEVER,LABEL,METHODS,OBJECTIVE,RARP,RECURRENCE,RESULTS,RRP,THERE,UCSF,UNLABELLED,WHAT
100,145,956,BAX,BCL,DAPI,EPFP,FOS,GAE,IC50,JUN,MMP,PNT1A,VEGF
BACKGROUND,BRUNN,CONTEXT,DATA,GLANDULAR,LABEL,LIBRARY,MALIGNANT,METHODS,OBJECTIVE,SOURCES,WORLD
001,037,500,608,8202,8805,900,ASIAN,BACKGROUND,HOWEVER,LABEL,METHODS,RESULTS,THESE
B3GALT1,DRUG,EMPLOYING,FOOD,FURTHER,GOLGI,HOWEVER,LEWIS,LNCAP,MUC1,PC3,RWPE,SAHA,TSA
114,947,CAF,CK8,EPCAM,GLEASON,HPCA,HS5,IL2R,NOD,NSG,SCID,USING
133B,19A,27A,ABCA1,BASED,CPNE3,LNCAP,MICRORNAS,MODULATION,PCA,PDS5B,PSAP,PTPRK,RAB13,SCORE,SINCE,SUZ12
169,2013,ACCA,CD133,CD44,CD49F,CELL,COPYRIGHT,CYTOMETRY,HOWEVER,SOCIETY,TROP
ADDITIONAL,ETS,GIVEN,LOSS,SAM,SPDEF,TAKEN
ARF,ARR2,CONVERSELY,ENDOGENOUS,HDM2,MOST,NKX3,PCA,PSA,TAKEN
946,BRCA1,BRCA2,KALLIKREIN,LABEL,NKX3,OBJECTIVE,PURPOSE,RESULTS,SUMMARY,THERE
12194,4329,4951,COSTS,LABEL,OBJECTIVE,PURPOSE,RESULTS,SUMMARY
ANALYZING,DISC,FADD,RIP1,TLR,TLR3,TRIF
ASPIRIN,BACKGROUND,COLORECTAL,CONCLUSION,HNC,INSTITUTE,LABEL,LUNG,METHODS,OVARIAN,REGULAR,RESULTS,SCREENING,TRIAL,USING
BACKGROUND,CONCLUSION,LABEL,LN3,LN4,LNCAP,METHODS,MIC,PC3,PC3M,RESULTS,THESE
TREATMENT
1000,133,196,1C4D4,2009,2010,AGS,APRIL,BACKGROUND,BETWEEN,EASTERN,ECOG,GROUP,LABEL,MAY,METHODS,PSCA,RESULTS
22RV,ANOVA,ATF4,BACKGROUND,BAG,BAG1,BAG3,BAG5,BCL,BIP,BONFERRONI,CELLS,COMPARISON,FUNCTIONAL,GRP78,HSP70,IRE1,LABEL,MANN,METHODS,PCR,PERK,RESULTS,WHITNEY,XBP1
954,APOPTOTIC
169,2013,246,2914,740,763,766,774,809,8805,BJU,DRE,LABEL,METHODS,OBJECTIVE,PSA,RANDOMIZED,RESULTS,ROTTERDAM,SCREENING,THERE,TRUS,WHETHER
208,340,792,800,AMONG,CONSORTIUM,PROJECT,SELF,SERVICE,THREE
PCA,THESE,THUS,WESTERN
HMGB1,NMR,THUS,USING
169,2013,BRITAIN,COPYRIGHT,ERG,GREAT,HOWEVER,IRELAND,JOHN,LTD,MMEJ,NHEJ,NUCLEOTIDE,PUBLISHED,SOCIETY,SONS,THESE,TMPRSS2,WILEY
169,2013,COPYRIGHT,CTC,CTCS,HOWEVER,PANCREATIC,THERE,UICC
169,2013,231,956,COPYRIGHT,DNMT,DNMT1,EGCG,IC50,JOHN,LNCAP,LTD,MCF,MDA,MOLECULAR,SONS,WILEY
241,270,AGE,AUC,EDIN,IIEF,ROC
CCK,CURRENT,GFP,LNCAP,METASTASIS,PGK,THUS,TRANSWELL
169,2013,COPYRIGHT,PUBLISHED,SAS
169,2012,238,CONCLUSION,COPYRIGHT,DWS,FMRI,LABEL,METHODS,MRI,OBJECTIVE,PCA,RESULTS,SAS,SSECE,SSSVI,UNIVERSITY
169,2004,2011,2012,2196,BACKGROUND,CIS,CONCLUSION,COPYRIGHT,CPT,FORTUITOUS,LABEL,MATERIALS,METHODS,MIBC,OVERALL,PCA,RESULTS,SAS
DOTANOC,NET,NETS,PET
100,130,1500,190,2008,2010,620,BACKGROUND,DIGITAL,INDICATORS,LABEL,MEAN,METHODS,RESULTS,RRP,SANTORINI
00002,005,104,152,169,2013,8201,8805,AGE,AIMS,BACKGROUND,CONCLUSION,EHS,GLS,IAI,IAIS,ICIQ,IIEF,INDEX,INDEXES,ISL,LABEL,LIFE,MAIN,MEAN,METHODS,OBJECTIVE,OUTCOME,PCI,RESULTS,SCORE,SLS,SOCIETY,UCLA,VAS,WOMEN
2000,293T,AFTER,BASED,CONCLUSION,HPAI,ILK,LABEL,METHODS,MTT,OBJECTIVE,PCR,PURO,RESULTS,RNAI,TRANSWELL,WESTERN,XHOI
100,2012,DEGARELIX,FIRST,FLUTAMIDE,OVERALL,PRESCRIRE,PSA,THERE,WHAT
946,CONSISTENT,DKK,DKK3,LOSS,SILENCING,SMAD,TGF,THESE,WNT
001,160,169,2013,945,ACADEMY,ADT,ANDROLOGY,COX,CRPC,DHT,FURTHER,GLEASON,GREAT,PSA,SOCIETY,THESE
345,CONCLUSION,FIVE,IMAGE,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PET,RESULTS
001,0045,051,100,1998,2005,8201,DAC,DACB,DACC,GLEASON,KAROLINSKA,PAC,PCDF,UNIVERSITY
169,2013,AACR,HIGH,LBD,STRUCTURE
CONCLUSION,DISSECTION,GFP,LABEL,METHODS,OBJECTIVE,RESULTS
160,273,8201,8804,ALIGNMENT,CONCLUSION,DAILY,LABEL,MARGINS,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS,RSE,VMAT
2000,2004,2005,2007,AFTER,BACKGROUND,CENTRAL,CSV1,FACTORS,LABEL,METHODS,NORTH,NOS,OVERALL,REGISTRIES,RESULTS,STAGE,SUMMARY,USING,VARIABLES,VERSION
160,58T,AIF,BAX,BCL,HOWEVER,PLATYCODON,PRE,SPG,THESE
024,026,037,088,095,119,122,2003,2012,323,ADT,JANUARY,LABEL,MEIER,MEN,METHODS,OBJECTIVE,PCA,PRE,PSA,PURPOSE,RESULTS
3355,8805,96AI,ACAT1,AFTER,BDH1,FURTHER,GLEASON,HMGCL,HOWEVER,LNCAP,LUCAP,OXCT1,PCR,TAKEN,UTILIZING,WESTERN
DESPITE,MAJOR,URINE
160,DESPITE,FDA,HOWEVER,IPILIMUMAB,KEY,RESULTS
190,AUSTRALIA,AUSTRALIAN,BACKGROUND,DISCUSSION,DISEASE,ENGAGEMENT,GROUP,LABEL,MBCT,METHODS,PRIMARY,QOL,QUEENSLAND,SECONDARY,SOUTH,TRIAL,UROGENITAL,WALES,WESTERN,ZEALAND
2005,2009,AREAS,ASCO,BACKGROUND,COVERED,ESMO,FDA,III,LABEL,MEDLINE,METHODS,OPINION,OUTSIDE,PHASE,PREVAIL,SINCE
231,BAX,BCL,DU145,JQFFP,MDA,MMP,PNT1A,TIMP
CHOU,DIETARY,HOWEVER,TALALAY,THESE
172,200,CD68,CONCLUSION,DIGITAL,LABEL,METHODS,MRI,OBJECTIVE,PSA,RESULTS,SERUM,TAMSULOSIN,TRUS,TURP,URINATION
CONCLUSION,LABEL,METHODS,MSP,OBJECTIVE,PCR,RAS,RESULTS
CONCLUSION,INHIBITION,LABEL,METHODS,MTT,OBJECTIVE,PC3,PCR,PKM2,RESULTS,THREE,WESTERN
CONCLUSION,FOLLOWING,JAMAICA,LABEL,METHODS,OBJECTIVE,RESULTS,THERE,WESTERN
947,ELISA,GCV,HOWEVER,HSV,IFN,NAME,RESULTS,THESE,TRAMP
123,BACKGROUND,BECAUSE,BRITISH,ECOLOGICAL,LABEL,MENDELIAN,METHODS,PROTECT,RESULTS,TESTING,TREATMENT,WHITE
106,2006,2010,2012,341,342,ADVERSE,ANY,AUTHORS,BACKGROUND,CANCERLIT,CENTRAL,COLLECTION,COLORECTAL,CONTROLLED,DATA,DRE,EED,ERSPC,FIVE,HARMS,LABEL,LOCALISED,LUNG,MAIN,MEDLINE,MEN,META,METHODS,NHS,NONE,OBJECTIVE,OBJECTIVES,OVARIAN,PLCO,PSA,RANDOMIZED,RCTS,RESULTS,SCREENING,SELECTION,TRIAL,TRUS,UPDATED
2010,CRPC,DRUG,FOOD,PRIOR,THESE
169,2013,945,946,AACR,CONSISTENT,EXOGENOUS,FGF,FGF19,FGF21,FGF23,FGFR,FGFS,KLB,THERE,THESE
169,2013,296,AACR,KLF4,METASTATIC,NUMBL
003,131,2007,2010,ADDITIONAL,APRIL,AUC,CONCLUSION,CONFIDENCE,DCE,HIPAA,JANUARY,LABEL,MATERIALS,MCNEMAR,METHODS,OBJECTIVE,PURPOSE,RESULTS,SVI
177,AVERAGE,CONCLUSION,GLEASON,HIPAA,IMMEDIATE,INVENTORY,IPSS,LABEL,LESIONS,MATERIALS,MEN,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCORE,SELF,SHIM,SYMPTOM,TREATMENT
000,100,1996,2006,226,334,490,AGE,ARACAJU,BASE,CONCLUSION,JOINPOINT,LABEL,METHODS,MORTALITY,OBJECTIVE,PROGRAM,PSA,RATES,REGRESSION,RESULTS,SERGIPE,THERE

140,164,169,2013,BACKGROUND,BASED,CAUCASIAN,CAUCASIANS,COPYRIGHT,DATA,ELEMENT,EXPRESSION,GENOMIC,HEPATITIS,HOWEVER,IFN,INTERFERON,ISRE,LABEL,METHODS,MXA,MYXOVIRUS,PGA,RESULTS,SNP,STIMULATED
002,036,146,169,183,2013,8804,CD138,CD38,CDN2,ISS,JOHN,LTD,NOTABLY,SONS,STAGING,WILEY
169,2013,946,963,BOTH,BRDU,COPYRIGHT,INC,LEP,PANCREATIC,PATHOLOGY,PDGS,PUBLISHED,S100P,SOCIETY,THESE,TYPE
DIAGNOSIS,DIAGNOSTIC,DWI,MRI,PET,PSA,TRUS,WHOLE
100,COLON,DLBCL,NERVOUS
945,954,AKT,ALPHA,BACKGROUND,BCL,CONCLUSION,CONSISTENT,HOWEVER,IAP1,IAP2,LABEL,NUCLEAR,PRINCIPAL,RESULTS,TNF,XIAP
945,BACKGROUND,CASODEX,CDC6,HOWEVER,LABEL,LNCAP,PCNA,PRINCIPAL,RESULTS,SINCE
169,2013,ATP,COPYRIGHT,GMBH,KGAA,NOTABLY,PC3,PIM,THESE,VCH,WILEY
169,2013,945,956,AHR,COPYRIGHT,EC50,FRUPICA,INC,MCF,RESIDUE,SCALA,STEWARD,WEAK,WILEY
169,2013,956,ANTI,ARS,COPYRIGHT,FURTHER,GMBH,HOWEVER,KGAA,MDV3100,T877A,UNRAVELING,VCH,W741C,WILEY
100,169,177,181,2013,325,8201,956,COPYRIGHT,EPILOBIUM,HOWEVER,IC50,JOHN,LNCAP,LTD,PSA,RESULTS,SONS,UROLITHIN,WILEY
123,153,169,2013,3DCRT,BACKGROUND,CHANGES,CLINICALLY,COPYRIGHT,IMRT,LABEL,METHODS,PBT,QOL,RESULTS,SOCIETY
BAX,FACS,MTT,PCR,TUNEL
000,100,BACKGROUND,BARRETT,DISCUSSION,LABEL
213,229,500,524,LABEL,METHODS,OBJECTIVE,PFS,PHASE,PURPOSE,RESULTS,THERAPY,THERE
006,046,22RV1,895,AFTER,AMONG,DES,DIGE,HSBP1,HSPB1,MOST,OAT,PCR
CONVERSELY,E74,ELF3,ETS,EXOGENOUS,LNCAP,TAKEN
945,IGF,IGFBP,IGFS,NLS,NUCLEAR,PSORT,SHEP,TAKEN,THESE,VEGF,VIA
169,2013,COPYRIGHT,HPV,IRELAND,LTD,P53
001,KDM4B,POST
IAPS,INCREASED,LIVIN
945,946,ATP,DAUNOMYCIN,DUN,KNOCKDOWN,MULTIDRUG,OPN,RGD,THESE

946,AKT,CONCURRENT,ERK,GSK3,OVERALL,PI3K,PP2A,PTEN,RAS,SPRY2
116,169,2013,AMONG,COPYRIGHT,SEQ,TNFSF10
169,2013,2B4,945,947,ALLOFERON,COPYRIGHT,GMBH,HOWEVER,IFN,TNF
0001,012,10NG,169,1999,2008,2014,863,8804,8805,BCR,CONCLUSION,COPYRIGHT,COX,GLEASON,GLS,INC,INCLUDING,LABEL,MATERIALS,MEN,METHODS,OBJECTIVE,PCA,PSA,RESULTS,SMS,STAGE
169,2013,823,956,A549,BGC,COPYRIGHT,IC50,LTD,MCF,MTT,PC3,SAR
169,2013,956,COPYRIGHT,FOUR,IC50,LTD,MCF,RSK2,SAR
169,2013,8243,945,946,COPYRIGHT,DPPH,LTD,MCF,SIX,SRB,THEIR
0001,1149,144,160,169,1976,2013,268,4092,4360,827,ALSO,AMERICA,AMONG,ASAP,CONCLUSION,COPYRIGHT,DRE,HGPCA,HGPIN,INC,LABEL,LGPCA,MEN,METHODS,NORTH,OBJECTIVE,PBX,PCA,PSA,RESULTS,VARIABLES
127,148,160,169,2013,772,828,856,AFTER,AUASS,BASED,BMI,CONCLUSION,COPYRIGHT,DATA,HOWEVER,INC,INCREASED,LABEL,LUTS,METHODS,OBJECTIVE,RARP,RESULTS,SCORE,SYMPTOM,UROLOGICAL
169,178,2014,946,ADV,BMA,CMV,COMBINING,COPYRIGHT,FURTHER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PR1,RESULTS,TSU
169,2014,COPYRIGHT,III,INC,LABEL,MATERIALS,METASTATIC,METHODS,OBJECTIVE,OBJECTIVES,PHASE,RESULTS,SRE,THERE
10MG,169,2014,5MG,5MO,8805,BACKGROUND,COPYRIGHT,CTC,DOCETAXEL,ERCC,ERCC1,GRADE,INC,LABEL,METHODS,RESULTS
169,2013,ADA,COPYRIGHT,GLEASON,NPP,PCA,PLATELETS,SAS
D2B,DESPITE,DUE,EARLY,LTD,PSMA,PUBLISHED
000,169,2002,2010,2013,2060,571,9204,ADT,BACKGROUND,COPYRIGHT,COX,HRS,JANUARY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OUTCOME,PUBLISHED,RESULTS,SETTING,UROLOGY
100,177,400,500,COCL2,CONCLUSION,CUSO4,HDR,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SEVEN,THREE
CBCT,GPU,PUBLISHED
100,112,169,177,2013,8201,ADT,IIEF,INDEX,LABEL,MEAN,MEN,METHODS,OBJECTIVE,OBJECTIVES,PCA,RADICAL,RESULTS,SOCIETY,THREE
100,2010,2011,8804,BACKGROUND,DRE,LABEL,MATERIALS,METHODS,PCA3,PCPT,PREVENTION,PSA,RESULTS,SPBX,TRIAL,USING
2006,2009,3000,BACKGROUND,COLLECTED,DATA,FIVE,INCIDENTAL,LABEL,MATERIALS,METHODS,RESULTS
BACKGROUND,CONCLUSION,EPS,ERG,FIRST,GAPDH,GIVEN,LABEL,MATERIALS,METHODS,PCA3,PCR,PSA,RESULTS,REVERSE,TMPRSS2
BASED,POLYAMINES,UNDER
001,1102,169,2004,2011,2013,3471,544,572,607,613,638,8805,ASIAN,BJU,BMI,BMIS,HOWEVER,JANUARY,LABEL,MAY,METHODS,OBJECTIVE,PSA,RESULTS,UNLABELLED,WHAT
116,2ME,ABZ,AMONG,BACKGROUND,CONSISTENT,DU145,EXPLORING,FINALLY,HCT,HIGH,LABEL,METHODS,RESULTS
100,183,945,CRPC,LNCAP,NADP
FOLLOWING,GASTRIN,GRPR,HOT,LACK,PEPTIDE,PET,RELEASING,SPECT,TOMOGRAPHY,USA
145,A549,CHCL,MCF,MEOH,NMR
945,ALZHEIMER,DESPITE,DHT,DUE,THERE
ANT2,APO2,APO2L,DR5,HOWEVER,SIMILARLY,THESE,TRAIL,USING
AFRICAN,BLACK,BOTH,CERED,FLORIDA,IDM,TAMPA
DEGARELIX,FSH
BLE,CHV,FURTHER,IC50,PIPER,PLANT,THESE
ALSO,CADMIUM,FURTHER,MOST,PARP,ROS,WHETHER,WHILE,XPA
CUMULATIVE,FDG,PET
177,2002,2010,932,CONCLUSION,IBD,IPAA,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OLDER,PATIENT,POUCHITIS,RESULTS,THERE
169,2013,BACKGROUND,BASEL,CONCLUSION,COPYRIGHT,DLS,LABEL,METHODS,MTD,PARTIAL,RESULTS,S60,S70,S80,V60,V80
13C,179,185,2AT6,945,CRPC,DHT,SRD5A,THESE
000,500,CALYPSO,DRUG,FOOD,IGRT,IGRTS,IMRT,RADIATION
13MM,169,177,2013,27MM,700,COPYRIGHT,LTD,MRI,RALP,RESULTS,SDM,SDMS,SEVERAL
000,116,169,1992,2005,2012,2013,310,420,579,932,CONCLUSION,COPYRIGHT,END,EYLL,INC,LABEL,LIVER,METHODS,OBJECTIVE,RESULTS
154,169,2014,BACKGROUND,CAP,CCK,CCND2,COPYRIGHT,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED
AKT,CONVERSELY,GATA3,LOSS,PI3K,PIK3C2A,PTEN,REMARKABLY
001,004,132,169,1989,2009,2012,250,999,AEU,AMICO,COPYRIGHT,GLEASON,LABEL,METHODS,OBJECTIVE,PSA,PUBLISHED,RESULTS,SLPB,SPANISH,THERE
001,1000,169,183,1992,2007,2009,2013,842,ADT,AMONG,BACKGROUND,COPYRIGHT,COX,EACH,END,GNRH,LABEL,METHODS,OBJECTIVE,OUTCOME,PUBLISHED,RESULTS,SETTING,UROLOGY
2009,2010,239,246,2677,283,465,556,8201,AMONG,BACKGROUND,BASE,CONCLUSION,CRPC,LABEL,MAY,METHODS,PCA,RESULTS,SALT,THERE,TREATMENT
10TH,AFTER,CD8,DC6,DCS,DENDRITIC,ECD,FDA,HOWEVER,III,PBMC,SIGN,SIGNS,TAKEN,USING
147,616,AIM,LABEL,METHODS,MRI,OBJECTIVE,PCA,PPV,PRIAS,RESULTS,TRUS
100,140,177,2010,2012,208,268,273,BACKGROUND,DIAGNOSTIC,JANUARY,LABEL,MARCH,METHODS,NPV,PCA,PCA3,PPV,PSA,RESULTS,SPBX,T1C
120,1ST,2011,BACKGROUND,FINALLY,FOLLOWING,GLEASON,LABEL,METHODS,PCA,PSA,RARP,RESULTS,ROBOTIC,SINCE,SURGERY,THEREFORE,TURKISH,VINCI
FDG,GLEASON,PCA,PET,PSA
STEPHEN
0001,002,100,1030,125,139,1478,149,1680,177,205,215,239,300,500,515,526,800,ADC,CONCLUSION,KNOWLEDGE,LABEL,METHODS,MRI,OBJECTIVE,PZFV,RESULTS,T2W
946,CELL,OVERALL,WHILE
CASODEX,ELK1,ELK3,ETS,MOLECULAR
ERG,ETS,EXPRESSION,FINALLY,PCA,RNAI,SOX9,TMPRSS2,VCAP
LABEL,OBJECTIVE,PURPOSE,RESULTS,SUMMARY,THEREFORE
2001,2005,2007,2010,2653,267,5015,7087,8364,885,ADDITIONAL,ALSO,BELGIAN,COSTS,DISEASE,ICD,IMS,INCLUSION,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RELATED,RESULTS,SRE,SRES,VERSION
001,144,2011,202,332,375,797,803,8805,AUC,BACKGROUND,COLORECTAL,COX,LABEL,LUNG,M2012,METHODS,NLST,OVARIAN,PLCO,RESULTS,SCREENING,TRIAL
BETULINIC,DUB,DUBS,HOWEVER,INHIBITION,OVERALL,TRAMP,UPS
0006,001,003,007,200,582,715,8202,945,ARG,ARG2,ARGS,CAFS,COX,DFS,HIF,HOWEVER,PDC,THESE
181,946,DU145,ELISA,ERK1,HOWEVER,MAPK,MMP,PD98059,THESE,WHEREAS
1NM,447,8764,ACK1,AMONG,BRIEFLY,DASATINIB,ESPECIALLY,EXPLOITING,FINALLY,PDB,UNIPROT,UPON
169,2013,ALSO,ARPCA,BRITAIN,CAM,COPYRIGHT,DHT,FGF,FGF2,FGF8B,FGFS,FIBROBLAST,GREAT,IRELAND,JOHN,LNCAP,LTD,NH2,PTX3,PUBLISHED,SOCIETY,SONS,THESE,TRAMP,WILEY
169,2013,945,946,BACKGROUND,BOTH,COPYRIGHT,DHT,INC,LABEL,LAPC,LNCAP,MEC,MECS,METHODS,RESULTS,TCM,THUS,VEGF,WILEY
ACID,ASAH1,FINALLY,THESE,USING
006,015,049,2000,2010,379,3N0,COX,HOWEVER,LABEL,MARTINGALE,METHODS,OBJECTIVE,RESULTS
PREDICTIVE,THESE
005,016,1165,212,274,302,674,HOWEVER,PCR,TERT,VNTR,VNTRS
EFFECTIVE,HOWEVER,LABEL,OBJECTIVE,PURPOSE,RESULTS,SUMMARY,THERE
BONE,BOTH,CRPC,HOWEVER,LABEL,MRI,OBJECTIVE,PET,PURPOSE,RESULTS,SEVERAL,SIMILARLY,SUMMARY,THESE
ANTISENSE,BCL,CD44,CELLS,LNCAP
305,BACKGROUND,CONCLUSION,DESPITE,HOWEVER,LABEL,METHODS,PHYSICIANS,PSA,RESULTS,SWEDISH
169,2013,8201,947,CD11B,CD14,CD33,DRUG,FLOW,FOOD,HLA,HOWEVER,INTERFERON,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRE,RESULTS,UROLOGICAL,USA
169,2013,945,ABOVE,BASED,COPYRIGHT,FIRST,FURTHER,GFP,GSK3,JOHN,LTD,PI3K,PIGEONPEA,SONS,WESTERN,WILEY
169,185,2013,215,8201,ALTOGETHER,BCL,BRITAIN,COPYRIGHT,GREAT,IRELAND,JOHN,LTD,MCL,PUBLISHED,SOCIETY,SONS,THESE,WILEY
160,169,177,178,183,CEUS,CHI,CONCLUSION,DETECTION,DOPPLER,DWI,GEORG,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PATIENT,PSA,PURPOSE,REAL,RESULTS,STUTTGART,T2W,TRUS,YORK
11C,125,18F,AVAILABLE,BOTH,CEA,FDG,MRI,PET,PSA
101,1470,169,1987,2010,2012,AEU,AFTER,AMONG,BFS,COMMITTEE,CONCLUSION,COPYRIGHT,COX,DESPITE,ETHICAL,LABEL,MEIER,METHODS,OBJECTIVE,PSA,PUBLISHED,RESULTS
0001,169,2013,530,8804,CARCINOMAS,COPYRIGHT,GLEASON,GMBH,ISUP,PCA,TNM,USING
100,160,169,176,2013,500,956,COPYRIGHT,FURTHER,LNCAP,LTD,PC3,PMNPS,PMPS,R11,THESE
169,2013,774,CALIFORNIA,COPYRIGHT,COX,IRELAND,LTD
001,130,136,1400,150,15TH,169,200,2013,311,346,500,8201,8776,AMICO,BJU,GLEASON,LABEL,LNI,LRP,METHODS,OBJECTIVE,PLND,PSA,RESULTS,THERE
2013,CONCLUSION,CRPC,DCE,ENDPOINTS,GOVERNMENT,LABEL,METHODS,MRI,OBJECTIVE,PFS,PUBLISHED,RESULTS,SIMON,SIX,USA
001,034,169,2006,2011,2013,244,8201,BETWEEN,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,SEPTEMBER,UNIVARIATE,UROLOGICAL,USING
100,104,169,2002,2010,2013,8201,BACKGROUND,CONCLUSION,FORM,JANUARY,JUNE,LABEL,METHODS,POOR,RESULTS,SHORT,UROLOGICAL
169,1982,1987,2006,2007,2010,2013,700,774,8201,AIHW,AIM,ASIA,AUSTRALIA,AUSTRALIAN,FIVE,HODGKIN,INSTITUTE,LABEL,LIMITED,LTD,METHODS,OBJECTIVE,PTY,PUBLISHING,RESULTS,WELFARE,WILEY
1360,145,2DLC,8804,BAP31,CALPAIN,CENTRAL,EBENFURAN,ERK2,FDR,III,INGENUITY,ONOBRYCHIS,PAR,PATHWAY,QQTOF,RAB,THESE,THROUGH,USING,WESTERN
169,2013,BJU,BOTH,CONTINUED,FSH,LHRH,LRHR,PCA
001,1990S,1991,1996,2003,2004,2007,292,8805,AGE,C61,DESPITE,FURTHER,GENERAL,GLEASON,GRO,ICD,INDEX,KINGDOM,REGISTRAR,RER,SIMD,SOCIO,WEST
001,129,160,8202,8805,BASED,BICYCLE,BLOOD,CYCLING,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PSA,RESULTS,UNIVARIATE
BACKGROUND,BAX,CLU,FINALLY,KU70,LABEL,LNCAP,METHODS,RAD17,RESULTS
ABL1,CD11B,CSF1,CSF1R,EMR1,ITGAM,LY6G,MDSC,MDSCS,TAM,TAMS,THESE,TIM,TIMS
169,2013,22RV1,ARS,BIOLOGY,CELL,CTE,EXPRESSION,FEDERATION,LNCAP,NON,PCR,PRSC,PSA,PSMA,Q640X,WILD
0001,007,160,582,8201,AFRICAN,ASIAN,CALIFORNIA,CVD,LABEL,METHODS,OBJECTIVE,PRIMARY,PURPOSE,RESULTS,SURVIVORS
LIMITED
111,123,2006,ACTH,CUP,FDG,FDOPA,MIBG,NET,PET,PREVIOUSLY,SPECT,THEN,UNION
169,2013,2DE,BPH,GMBH,HOWEVER,ITIL,KGAA,PCA,USING,VCH,WILEY
100,117,118,453,CALIFORNIA,EMR,LABEL,MATERIALS,MEDICAL,METHODS,NATURAL,NLP,OBJECTIVE,PERMANENTE,RESULTS,TRUS
185,CAP,CDC6,CELL,HOWEVER,LNCAP,TARGETS
AIMS,BACKGROUND,CONCLUSION,DATA,GLEASON,LABEL,METHODS,OBJECTIVE,PSA,RESULTS,THESE,UNIVERSITY,VINCENT
002,031,035,105,110,152,2004,2011,240,491,503,801,AFTER,CHINESE,CONCLUSION,GLEASON,JUNE,LABEL,LRP,METHODS,OBJECTIVE,PCA,RESULTS,THERE
004,006,007,010,177,722,723,741,753,956,CELL,GENISTEIN,IC50,LNCAP,SOY,WHILE
169,2013,2MIN,CELL,COPYRIGHT,IRELAND,LTD,RADICAL,TAKEN
ADT,AMONG,BCR,DRUG,FDA,FOOD,PSA
169,174,2013,466,ASSAY,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,MEN,METHODS,OBJECTIVE,PCA3,PUBLISHED,PURPOSE,RESULTS,THUS,URINARY,UROLOGICAL,WHOLE
169,196,2005,2012,2013,226,485,COPYRIGHT,EDUCATION,EPSTEIN,INC,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
169,2013,8805,COPYRIGHT,HISTONE,INC
169,2011,2012,2013,236,COPYRIGHT,EDUCATION,FINAL,GLEASON,INC,JUNE,LABEL,MATERIALS,METHODS,OBJECTIVE,PATHOLOGY,PUBLISHED,PURPOSE,RESULTS,SEPTEMBER,UROLOGICAL
0012,138,169,2000,2005,2013,302,ADVERSE,CHRONIC,COPYRIGHT,EDUCATION,HIGH,INC,JULY,LABEL,LOCAL,MATERIALS,MAY,METHODS,NETWORK,OBJECTIVE,PHOENIX,PUBLISHED,PURPOSE,RADIOLOGY,RESULTS,RISK,SOCIETY,UROLOGICAL
169,174,2005,2013,704,ABLATHERM,AMICO,COPYRIGHT,COX,EDUCATION,EVALUATION,GLEASON,HARLACHING,INC,LABEL,MATERIALS,MEAN,MEIER,METHODS,OBJECTIVE,PHOENIX,PSA,PUBLISHED,PURPOSE,RESULTS,THOSE,UROLOGICAL
001,153,169,2013,208,254,361,ASSESSMENT,BACKGROUND,CAPRA,CONTINENCE,COPYRIGHT,COX,INDEX,LABEL,LOG,METHODS,OBJECTIVE,OUTCOME,PUBLISHED,RESULTS,RISK,SETTING,UROLOGY,YOUNGER
0004,100,125,149GY,161GY,18G,20G,30CC,43CC,ACUTE,D90,DAYS,DOSIMETRY,ENDPOINTS,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,POST,PUBLISHED,PURPOSE,RESULTS,RV100,SCORE,SMALLER,SYMPTOM,THINSEEDS,URINARY,V100,V150
169,2013,945,ANALOGS,CC214,COMPOUNDS,COPYRIGHT,LTD,PC3,PI3K
002,11997,169,2012,2013,BACKGROUND,CONTEXT,COPYRIGHT,ELECTRONIC,EXPERTS,KNOWLEDGE,LABEL,LIBRARY,MEDLINE,METHODS,OBJECTIVE,PCA,PSA,PSAD,PUBLISHED,RESULTS,SATURATION,STUDIES,SYNTHESIS,UROLOGY,WEB
169,2013,8805,COPYRIGHT,FIFTY,INC,INJECTION,INTENSITY,LABEL,MATERIALS,METHODS,OBJECTIVE,PLAN,PTV,PURPOSE,REDUCTIONS,RESULTS,THERE,V70
ASPEN,BEATSON,CHIEF,COMPARZ,FRANCESCA,GLASGOW,III,INSTITUTE,JONES,LAKE,PHASE,PHD,PLUTO,STUDIES,UNIT,UNIVERSITY,WEST
000,009,039,174,300,410,423,44K,739,783,814,8482,875,972,979,ALEXA,AMONG,BACKGROUND,CLUSTER,CTC,DTC,EXPRESSION,FLUOR,LABEL,MICROARRAY,OVATION,PCA,PCR,PEARSON,RESULTS,TEN,USING,WHOLE
BACKGROUND,CONCLUSION,EVX1,FILIP1L,LABEL,MATERIALS,METHODS,NON,RESULTS,THESE,TREATMENT
2012,ASCO,FURTHER,MEETING,SCIENTIFIC,SOCIETY
169,2012,8201,COPYRIGHT,FIRST,JOHN,LTD,SIMULATION,SONS,WILEY
001,002,004,010,026,031,043,109,133,169,2001,2009,2012,319,345,555,ACADEMY,AMONG,ANDROLOGY,CHANGES,COMPOSITE,EPIC,HOWEVER,HRQOL,INDEX,PDE5I,SOCIETY
DMES,FURTHER,MDR1,PXR,RXR
041,129,197,20MM,330,367,423,464,CD20,CD56,CD79A,GIST,GISTS,JAPAN,KIT
2002,2005,863,8804,8805,892,AMONG,CIS,GLEASON,KING,LABEL,METHODS,OBJECTIVE,ORS,PCA,PURPOSE,RESULTS,RISK,TEA,USA,WASHINGTON
CURRENTLY,EMPIRICAL
INDIVIDUAL,RISK
AD5,ADP,HOWEVER,NIS,SPECT,THESE,VIRAL
142,151,152,2000,2011,AIM,BACKGROUND,HEART,HOWEVER,HTX,INCIDENCE,LABEL,METHODS,OBJECTIVE,REGULAR,RESULTS,TEN,WHILE
190,AFTER,EXTENSIVE,PHYSICIANS,PSA,SINCE
001,005,007,158,1975,1990S,2000,2008,223,801,AMONG,DESPITE,HODGKIN,POISSON,THERAPY,USING
8Q24,FURTHER,HEREDITARY
AMD,BACKGROUND,GIVEN,GROUP,LABEL,METHODS,PIVOT,RESULTS,SPCG,TRIAL
169,2013,ASN,BINDING,COPYRIGHT,HSA,LTD
2010,2012,GUIDELINES,HOWEVER,NCCN
169,2012,945,COPYRIGHT,HER2,LTD,PCR,TAKEN,TAP,TOCOPHEROL,TOS
169,200,2013,223,322,8482,899,BILATERAL,CAPSURE,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,MEN,METHODS,NERVE,OBJECTIVE,PCI,PUBLISHED,PURPOSE,RESULTS,STRATEGIC,UCLA,URINARY,UROLOGICAL
000,169,2013,COPYRIGHT,DATA,EARLY,ERG,ETS,INC,PCA,PCAS,REMARKABLE,SRS,TMPRSS2,WHEREAS
169,193,1999,2002,2011,2014,CAP,CAPS,COPYRIGHT,COX,EACH,EBRT,INC,JANUARY,KAMAT,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PHOENIX,PSA,RADIATION,RESULTS,SOCIETY,THUS,VANCOUVER
169,2014,945,CAP,CAPS,CONCLUSION,CONVERSELY,COPYRIGHT,DATA,EXPRESSION,FORSKOLIN,GEO,INC,LABEL,LNCAP,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,OMNIBUS,PC3,PDE4,PKA,PRKAR2B,PSA,RESULTS
169,2000,2013,A549,BALB,BAX,COPYRIGHT,DQA,DRUG,DSPE,EVEN,FDA,FOOD,LTD,MCL,MECHANISM,ONCE,PEG
BESIDES,WESTERN
DSB,ERG,HOWEVER,NHEJ,TMPRSS2
CRPC,PTEN,WHILE
ARV,ARVS,CANONICAL,COOH,CRPC,HOWEVER,LBD,NH2,SINCE
CAGE,CAP
100,HOWEVER,KENNARD,MANN,PCA,PLS,STONE,WHITNEY
1058,106,174,200,283,287,302,363,454,477,481,962,ADDITIONAL,AZA,BACKGROUND,BECAUSE,EXPRESSION,GLEASON,LABEL,LNCAP,METHODS,NANOSTRING,PCR,R1881,RESULTS,RNAS,THESE,UCR,UCRS,USING
CTS,CTV,FOUR,GYE,INTENSITY,LABEL,METHODS,RESULTS,SIB,SIMULATION,UNLABELLED
APOPTOSIS,BACKGROUND,BIRC6,CONCLUSION,GLEASON,IAP,INCREASED,INHIBITORS,LABEL,LNCAP,METHODS,PROTEIN,REDUCTION,RESULTS,WESTERN
104,8482,ADT,CRPC,LNCAP,MALDI,PROT,SWISS,TOF,UNIPROTKB
199,1995,1996,2006,276,295,591,AARP,AFTER,BACKGROUND,CIS,CONCLUSION,CONTEXT,COX,DIET,HOWEVER,HRS,INSTITUTES,LABEL,MAIN,METHODS,NIH,OBJECTIVE,OUTCOME,PERSONS,RESULTS,RETIRED,SETTING,YET
1995,2005,2006,2010,251,293,428,453,464,969,AARP,AHEI,ALTERNATE,AMONG,BETWEEN,COX,DIET,FEW,HEALTHY,HEI,INDEX,INSTITUTES,NIH
100,169,177,2013,300,956,ANOTHER,CONCLUSION,COPYRIGHT,ENDORECTAL,INC,LABEL,MATERIALS,METHODS,MRE,MRI,OBJECTIVE,PURPOSE,RESULTS,SHEAR,TESLA,WILEY
000,956,CONSISTENT,H3K4ME3,IC50,JARID1B,JMJC,KDM5B,PBIT,PLU1,THEREFORE,THESE
169,1988,1999,2013,338,445,BACKGROUND,BECAUSE,COD,COPYRIGHT,CSS,END,FAVORABLE,HOWEVER,LABEL,METHODS,RESULTS,SEER,SIX,SOCIETY
169,2013,BASED,BASEL,COPYRIGHT,FURTHER,LABEL,METHODS,OBJECTIVE,PCA,PURPOSE,RANK,RESULTS,THESE
169,2013,BASEL,CONCLUSION,COPYRIGHT,CYTOLOGIC,HISTOLOGIC,HOPKINS,JOHNS,LABEL,METHODS,OBJECTIVE,PDA,PDAS,RESULTS,SINCE,THERE
0001,108,112,160,169,2013,215,COPYRIGHT,D90,EVALUATED,HGS,INC,LABEL,MASTERPLAN,MATERIALS,METHODS,NUCLETRON,OAR,OARS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SOCIETY,V100,V150,VEENENDAAL
001,125,169,2013,COPYRIGHT,DOSE,DOSIMETRIC,EACH,INC,INDIVIDUAL,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SOCIETY,THERE,USPRE
106,169,2013,BACKGROUND,BASEL,COPYRIGHT,HIFU,LABEL,MATERIALS,METHODS,PCA,PSA,RESULTS,TURP
2013,547,8201,BACKGROUND,CIS,FURTHER,GLEASON,HOWEVER,JANUARY,LABEL,MEDLINE,METHODS,METS,RESULTS,RRS
000,048,100,1996,1998,1ST,2009,287,377,384,504,505,IARC,JANUARY,LYON,THESE
107,2000,841,ABIDJAN,ACCORDING,BURKITT,CANCERS,COTE,PATHOLOGY,THEREFORE,WORLD
945,C13,C15,C18,DU145,IC50,KEY,THESE,WADSWORTH
2005,2011,APRIL,BETWEEN,CONCLUSION,GLEASON,LABEL,LRP,METHODS,OBJECTIVE,RESULTS,TURP
10Q11,22Q13,525,667,8Q24,CHINESE,CONCLUSION,HAN,LABEL,METHODS,OBJECTIVE,PCA,RESULTS,SNP,SNPS,WESTERN
ABCG2,BESIDES,CD133,CD44,CONCLUSION,CSC,CSCS,DU145,EVENTUALLY,FACS,HOECHST,IA8,LABEL,LNCAP,METHODS,NANOG,NSP,OBJECTIVE,OCT4,PCA,PRL,RESULTS,STEM,TSU
DHT,GLEASON
ACCORDING,BACKGROUND,CLOCK,CONCLUSION,GROUP,IARC,LABEL,METHODS,RESULTS
169,2011,2013,AIM,BACKGROUND,LABEL,MAIN,MANNE,MEETING,METHODS,NORTHOUSE,OBJECTIVE,OUTCOME,RESULTS,SOCIETY,VALIDATED
169,2013,AIMS,BACKGROUND,CONCLUSION,CURRENT,ENGLISH,HOWEVER,LABEL,MATERIALS,METHODS,OBJECTIVE,PDE5,RESULTS,SOCIETY,THERE,WHILE
169,2013,ADT,AIM,BACKGROUND,CURRENT,LABEL,MAIN,METHODS,OBJECTIVE,OUTCOME,RESULTS,SOCIETY,TREATMENT,WHERE
169,1990,2013,AIM,BACKGROUND,CONCLUSION,DESPITE,FEW,FOLLOWING,HOWEVER,LABEL,LITERATURE,MAIN,METHODS,OBJECTIVE,OUTCOME,RESULTS,SOCIETY
945,CWR22,DHT,EXPRESSION,LUCIFERASE,THESE,USING,UTR
ABL,ATP,BAX,BCL,CASPASE,CELL,CML,DASATINIB,DDP,HEP,MEASURING,MTT,SRC
160,169,183,8805,CONCLUSION,ESUR,FINALLY,GEORG,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,RADS,RESULTS,STRUCTURED,STUTTGART,THEN,USING,YORK
2000,2006,2011,8805,CONCLUSION,DIAGN,FIFTEEN,GIST,GISTS,KIT,LABEL,METHODS,MIETTINEN,NON,OBJECTIVE,PRESENTING,PRIMARY,PURPOSE,RESULTS,SEMIN,SEVEN,SUCCESSFUL
145,8209,CD44,CSC,EMT,HOWEVER,KLF4,MIR,MYC,OCT4,PCA,THESE,ZEB2
BECAUSE,DUAL,DUOX,DUOX1,DUOX2,H2O2,MAB,NADPH,ROS
FINALLY
255,AUSTRALIA,CONFIDENCE,THESE
169,2014,AKT,COPYRIGHT,HYPOXIA,IMMUNOBLOT,INC,INGENUITY,LABEL,LNCAP,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PATHWAY,RESULTS,VAV3
001,030,041,042,169,2001,2007,2014,CARE,COPYRIGHT,CROWN,GROUP,INC,INPATIENT,LABEL,LVT,MATERIALS,METHODS,NATIONWIDE,OBJECTIVE,OVERALL,PATIENT,PROJECT,PUBLISHED,RCS,RESULTS,THESE,THRESHOLD
169,2013,COPYRIGHT,IRELAND,LARGE,LTD
DEPLETION,DROSOPHILA,FDA,HIPK2,MED19,RNAI,THUS,USING
169,2013,231,233,COPYRIGHT,EVEN,PUBLISHED,SAS,SFRO,SOCI,TREATMENT
169,2013,954,COPYRIGHT,DR5,HIGH,HOWEVER,IRELAND,LNCAP,LTD,RIP1,TRADD,TRAIL
000,100,140,2009,2011,2012,2013,296,314,489,576,737,747,ASRS,BACKGROUND,BETWEEN,ESTIMATED,FAVOURABLE,LABEL,METHODS,PANCREATIC,POISSON,RESULTS,UNION,USING,WORLD
160,280,956,APIOS,COMPOUNDS,ESI,IC50,ISOFLAVONE,LNCAP,MEDIK,NMR,PSA,THEIR
250,400,956,BACKGROUND,CONCLUSION,CRPC,CSF,LABEL,METHODS,PFS,PSA,RESULTS,TID,TREATMENT
BASED,HOWEVER
0001,127,132,149,174,177,185,217,289,486,8201,ADVERSE,DOSE,DVHS,EACH,ERGO,OARS,PTV,TPS,TPSS,VMAT
1348,CURRENT,IGS,PSA,THESE,WESTERN
095,2004,322,366,661,8805,BECAUSE,COLORECTAL,CONCLUSION,END,LABEL,METHODS,OBJECTIVE,PURPOSE,QUALITY,RESULTS,SEER,USING
047,143,164,169,2013,307,8805,AMONG,BACKGROUND,CAP,COPYRIGHT,CRUDE,HOWEVER,LABEL,MET,METHODS,RESULTS,SOCIETY,THERE,USING
0004,122,125,128,153,177,2003,2011,ALSO,BETWEEN,CONCLUSION,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,TUR
0001,054,059,169,177,2013,256,274,534,8201,AFRICAN,AMERICANS,COPYRIGHT,DESPITE,HOWEVER,OVERALL,PHIP,UICC,WHITE
169,2013,AMONG,BACKGROUND,COPYRIGHT,HOWEVER,LABEL,MEN,METHODS,QALE,RANDOMIZED,RESULTS,SOCIETY
001,2011,302,307,911,AUSTRALIA,DIFFERENT,FURTHER,HOWEVER,IMPORTANCE,LABEL,MAIN,METHODS,OBJECTIVE,OCTOBER,OUTCOME,PSA,RANDOMIZED,RELEVANCE,RESULTS,SECONDARY,SETTING,THOSE
169,2013,945,946,COPYRIGHT,ECM,INC,LUMICAN,MMP,MT1,OVERALL,PCR,SLRP,WASP
3864,9FY,EPR,ERG,ETS,HGPIN,PCA,PCAS,TAKEN,TMPRSS2,UNTIL
145,177,6FFF,945,946,CURVE,DU145,FFF,FLATTENING,H460,NYLON
1486,3376,459,541,560,6119,ATP,BACKGROUND,COX,III,LABEL,METHODS,NCEP,RESULTS,THERE
000,063,100,2010,8201,8805,BACKGROUND,BEHAVIORAL,DRE,INDIVIDUAL,LABEL,MEN,METHODS,MSA,PCS,PSA,PSAT,RESULTS,RISK
1990S,ANN,ANNS,ARTIFICIAL,MOST
000,ONCE
169,2004,2006,2007,2013,COINCIDENT,COPYRIGHT,EDUCATION,END,INC,JULY,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SEER,STATISTICS,UROLOGICAL,USING
155,169,184,2013,COPYRIGHT,EDUCATION,FRACTURES,GOTHENBURG,INC,LABEL,MATERIALS,MEN,METHODS,MROS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
169,2013,AKT,COPYRIGHT,INC,LNCAP,PCA,THEREFORE,TMPRSS2,WESTERN
AFRICAN,AMERICANS,ASIAN,ETS,LABEL,OBJECTIVE,PURPOSE,RESULTS,SUMMARY,THESE
001,011,018,025,033,17Q21,193,338,48ULTRA,800,945,ALSO,BACKGROUND,BRFS,CEP17,CONCERNING,DAKO,DIEGO,FISH,FLEX,GLEASON,IHC,LABEL,METHODS,PCA,PLUS,PSA,RESULTS,SAN,TOP2A,USA
0001,001,169,2013,8144,BACKGROUND,CENTRAL,CHINESE,CONCLUSION,CONTROLLED,COPYRIGHT,DATA,ELECTRONIC,ENGLISH,HOWEVER,JADAD,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,PERIODICAL,RESULTS,SERVICE,SOURCES,WANFANG
000,106,128,1658,169,1981,1997,2006,2010,2013,351,441,503,7455,8095,8804,AGE,BACKGROUND,CITY,COPENHAGEN,COPYRIGHT,COX,DENMARK,HEART,LABEL,METHODS,NRI,NRIS,OBJECTIVE,OUTCOME,PCA,PSA,PSAV,PUBLISHED,RESULTS,SETTING,THESE,UROLOGY,USED
001,138,178,875,BACKGROUND,CONTENT,EFFECTS,EORTC,GROUP,HRQOL,INTER,LABEL,LATE,LENT,MANAGEMENT,METHODS,OBJECTIVE,OLAVS,RADIATION,RESULTS,RTOG,SOMA,SPCG,SUBJECTIVE,THERAPY,TREATMENT
215,2NG,3N0M0,8805,ARM,BACKGROUND,BCF,BCFFS,CGE,LABEL,METHODS,NADIR,RADIOLOGY,RESULTS,SOCIETY
169,2013,AKT,AUTHORS,BACKGROUND,ECTOPIC,FAK,FOUNDATION,HOWEVER,INCREASED,JOURNAL,KNOCKDOWN,LABEL,MATERIALS,METHODS,PC3,POTENTIAL,PROTEIN,PTK6,RESULTS,SOCIETY,SRC,STICHTING
BLADDER,CONCLUSION,DATA,FORM,GROUP,ICIQ,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SHORT,SPSS,THERE,UISF,UISFS,URODYNAMIC
2000,2012,8Q24,ARES,CONCLUSION,HIGH,LABEL,LOCALIZED,METHODS,MIBC,MIBCS,OBJECTIVE,PSCA,PURPOSE,RESULTS,SNP,SNPS
028,033,320,8804,BACKGROUND,COX,GLEASON,HOWEVER,IGF1,IGF1R,INSULIN,LABEL,METHODS,PSA,RESULTS,SNPS
015,019,1733,203,5790,CASTRATION,CURRENT,GENOMIC,GLEASON,HCT,PCR,PSA,SHBG
215,665,8804,AFRICAN,AMERICANS,B13,BACKGROUND,G84E,LABEL,METHODS,RESULTS,TESTING
000,385,500,AGE,BACKGROUND,COLORECTAL,CONCLUSION,GIVEN,LABEL,LUNG,METABOLITE,METHODS,OVARIAN,RESULTS,SCREENING,TAKEN,USING
913,945
189,349,397,8201,956,AKT,ERK,IC50,LPA,MLC2,PAK,PDGF,RHO,RKI,RKIS,ROCK,ROCK1,ROCK2
169,2013,COPYRIGHT,EPHS,KINASES,WESTERN
169,2013,COPYRIGHT,FURTHER,IRELAND,LTD,PRATT,SINCE,STEROID,THESE,TOFT
002,004,007,103,169,2013,213,261,302,COPYRIGHT,EDUCATION,HOWEVER,INC,IQR,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,RESULTS,THERE,THUS,UROLOGICAL
169,2013,90CE,AGT,COPYRIGHT,DU145,EMT6,LTD,STUDIES,THESE
169,2013,COPYRIGHT,ENGRAILED,FEDERATION,PARKINSON,PUBLISHED,SOCIETIES
002,169,2012,4078,4916,8994,ACADEMY,AGA,ANY,BACKGROUND,COPYRIGHT,INC,LABEL,MEDLINE,METHODS,MOSBY,OBJECTIVE,PUBLISHED,RESULTS,THERE
011,160,169,1995,2008,2013,329,ADT,APRIL,BETWEEN,COPYRIGHT,CSS,GLEASON,HOWEVER,INC,LABEL,MATERIALS,MEN,METHODS,MOST,NETWORK,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SOCIETY,THERE,XRT
0004,001,006,007,132,169,1987,2009,2014,334,693,COPYRIGHT,COX,ECE,LABEL,LTD,MEANWHILE,MEIER,METHODS,OBJECTIVE,OBJECTIVES,PENDING,RESULTS,THEN
118,160,169,2001,2011,2013,492,AFTER,CONCLUSION,COPYRIGHT,EPSTEIN,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PRIAS,RESULTS,USING
10MM,169,176,1MM,2013,2MM,4MM,5MM,6MM,8MM,BACKGROUND,BASED,CBCT,CONCLUSION,COPYRIGHT,EPID,ESTIMATION,FAST,IRELAND,LABEL,LTD,MAP,MATERIALS,MAXIMUM,METHODS,OBJECTIVE,POSTERIORI,PURPOSE,RESULTS,SHORT,SLOW,STOCHASTIC
154,160,169,2007,2009,2013,8805,AMONG,CONCLUSION,COPYRIGHT,DWI,EST,GLEASON,INC,INCREASED,LABEL,METHODS,MRI,NST,OBJECTIVE,RESULTS,SST,TESLA,THESE,UNIVARIATE
174,97H,97L,BACKGROUND,CONCLUSION,CORE,HCC,HEPG2,L02,LABEL,LM3,LTQ,RESULTS,SIMILARLY,THESE
BONE,EBRT,MFRT,QOL,SFRT,STUDIES,THEREFORE
100,8201,AZA,BACKGROUND,BOTH,DAPI,LABEL,LID,LIM,MEC,METHODS,METHYLIGHT,RESULTS,TREATED,ZEB
BACKGROUND,CONCLUSION,CRPC,EXPRESSION,HAI,HEPATOCYTE,IHC,LABEL,METHODS,PSA,RESULTS
AIM,BACKGROUND,COMBINING,CONCLUSION,DIEGO,DRE,GEN,LABEL,METHODS,OBJECTIVE,OPERATING,PCA,PCA3,PROBE,PSA,PVOL,RESULTS,ROC,SAN,USA
001,ABCC4,ATP,BACKGROUND,CONCLUSION,DOCETAXEL,FUNCTIONAL,LABEL,MATERIALS,MATLYLU,METHODS,MK571,MLL,PC3,R3327,RESULTS,SRB
002,1735,1792,1831,3186,3508,AMERICA,AUSTRALIA,B13,CAUCASIANS,EASTERN,FINLAND,G84E,LATIN,NORTH,PCA,REDUCTION,SOUTH,WESTERN,YEAR
056,1010,116,374,522,5765,865,BMI,COX,DATA,LABEL,META,METHODS,OBJECTIVE,RESULTS,SIMILARLY,THERE,THESE,WORK
159,830,CNS,END,MPNET,RESULTS,SEER,STAT,SUBSEQUENT,VARIATION
2010,AAS,ARRIVAL,BACKGROUND,CONCLUSION,DEPARTMENT,III,JANUARY,LABEL,MEDICAL,METHODS,OCTOBER,RESULTS,STAGE,UNIVERSITY
004,008,104,10TH,177,961,ADC,AUC,CAD,CONCLUSION,GLEASON,HIPAA,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,ROIS,TOFTS
AKT,BIM,CRC,FIRST,HOWEVER,MODULATION,PI3K,PTEN,ROS,SW480,THESE
035,2009,AMONG,AUDIT,BACKGROUND,CARE,CONCLUSION,DEVELOPING,DIAGNOSIS,LABEL,METHODS,PRIMARY,RESULTS
015,035,061,081,169,2013,907,BACKGROUND,BASEL,COPYRIGHT,GLEASON,GS3,LABEL,METHODS,PCA,PSA,RESULTS
169,2013,C57B,COPYRIGHT,HB1,IRELAND,LTD,MNP,MNPS,STEM,THESE
169,2012,2013,COPYRIGHT,INHIBITORS,ISSUE,LTD,OCTOBER,SPECIAL,STS,SYNTHESIS
169,2013,BMP6,COPYRIGHT,FGF,INC,KLK15,KLK2,KLK3,KLK4,LABEL,METHODS,MSMB,OBJECTIVE,OBJECTIVES,PCA3,PCR,PSA,PSCA,PUBLISHED,RESULTS,SOCIETY,SUBSEQUENT,TOTAL,TRPM8,VARIATION
1540,2011,2665,FIFTEEN,LOV,MED,PHYS,SOS,TOF
231,300,945,946,DOTA,ICP,MDA,MRI,OES,POST,T47D
561,AZGP1,EIGHT,ERG,FIRST,FUNCTIONAL,NPY,TFF3
BOTH,CD28,CTLA,CYTOTOXIC,III,INHIBITING
1000,ATTENDEES,CORRECTING,ERSPC,LABEL,METHODS,OBJECTIVE,RESULTS,SETTING,THESE
1000,141,2006,578,8211,ERSPC,FINLAND,ITALY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RANDOMIZED,RESULTS,SCREENING
169,2013,AT1R,AT2R,ATIP,BACKGROUND,C21,COPYRIGHT,GLEASON,INC,LABEL,M024,METHODS,RESULTS,TREATMENT,WESTERN,WILEY
169,200B,2013,ADPC,AIPC,BACKGROUND,CCK,CONCLUSION,COPYRIGHT,DOWN,HOWEVER,INC,LABEL,METHODS,PC3,PCR,RESULTS,THEN,WESTERN,WILEY
GAGE,GSEA,GSEAROT,HOWEVER
169,2013,BACKGROUND,CONCLUSION,COPYRIGHT,FURTHER,INC,JNK,LABEL,MDH2,METHODS,MOLECULAR,NOVEL,PCR,RESISTANCE,RESULTS,RFS,TAKEN,WILEY
169,2013,22RV1,BACKGROUND,COPYRIGHT,ECTOPIC,FOXO1,HOWEVER,INC,LABEL,METHODS,NH2,NTD,PCA,PTEN,RESULTS,SRC,TAU5,WILEY
169,2013,ANIMALS,BACKGROUND,BPH,C57BL,CHRONIC,COPYRIGHT,IHC,INC,LABEL,MAJOR,METHODS,NKX3,PA2,PROSTATIC,RESULTS,WILEY
HOWEVER,THESE
AFTER,CONCLUSION,DIFFERENT,EVEN,GTV,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SHRINKAGE,SUV,THEREFORE
AIMS,APOPTOSIS,BACKGROUND,BAK,BAX,BCL,LABEL,METHODS,OBJECTIVE,RESULTS,THERE
1002,177,1999,2005,AGE,AIMS,BACKGROUND,LABEL,MEAN,MEIER,METHODS,OBJECTIVE,RESULTS,ROC
120,4350,AIMS,BACKGROUND,CRPC,FIFTY,GOLGI,GRADE,LABEL,METHODS,NON,NPLD,OBJECTIVE,PSA,RESULTS,SIXTEEN
177,956,CTC,CTCS,ODEP,OEC,UNDER
ANXIETY,BACKGROUND,DIGITAL,DRE,HOWEVER,LABEL,MEN,METHODS,PRIMING,PSA,RESULTS
17B,37A,37B,AMONG,BACKGROUND,CONCLUSION,DU145,EARTH,HALOMONAS,HELA,HIGH,LABEL,MCF,METHODS,OVERALL,RED,RESULTS,SEA,TOTAL
177,271,LABEL,METHODS,OBJECTIVE,PAA,PATIENT,PURPOSE,RESULTS,SHEAR,TMMS,YOUNG
EXCISED,FURTHER,IMAGING,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE,TRUS
110,177,288,BLADDER,CBCT,CBCTS,COMBINING,COMPARING,D98,DICE,IGRT,LABEL,METHODS,OBJECTIVE,PLAN,PURPOSE,RESULTS,SIX,THESE,THREE,USING
119,177,8725,ECLIPSE,FAST,GAMMA,IMNRT,IMRT,INTENSITY,ION,LABEL,MEAN,METHODS,MONITOR,NEUTRON,OBJECTIVE,PURPOSE,RBE,RESULTS,STATE,THERAPY,THESE,UNIVERSITY,VALIDATION,WAYNE,WHILE
001,120,130,160,177,ASCENSION,HDR,HOWEVER,LABEL,METHODS,MODEL,OBJECTIVE,PURPOSE,RESULTS,TECHNOLOGY
135,DMLC,DVH,FIRST,IMRT,KETTERING,LABEL,METHODS,MSKCC,OAR,OARS,OBJECTIVE,PCA,PURPOSE,RESULTS,ROCO,SLOAN,THIRD,TPS
CTV,DVHS,IMPT,LABEL,METHODS,OAR,OARS,OBJECTIVE,PRV,PRVS,PTV,PURPOSE,RBE,RESULTS,USING
177,INSIGHT,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THREE,TOOLKIT
1268,147,169,2000,2009,2013,222,374,595,8201,8804,GLEASON,JANUARY,LABEL,LYMPH,MEDICAL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,T1C,T2A,UROLOGICAL
169,1828,2007,2011,2013,CYSTOGRAMS,GREENPLAST,HISTOACRYL,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THESE,UROLOGICAL
100,169,2008,2013,487,5496,582,605,639,7160,7624,781,ANZ,AUSTRALIA,AUTHORS,BACKGROUND,BASED,COLLEGE,ESTIMATES,JOURNAL,LABEL,METHODS,QUEENSLAND,RALP,RALPS,RESULTS,ROBOT,ROYAL,RRP,RRPS,SURGERY,THESE,TRANSITION,VINCI,WOMEN
185,460,562,786,8315,8320,8325,956,ADR,ALSO,EAR,HMR,MCF,NCI,OVCAR,PCO,UACC
169,2013,AACR,CRPC,FURTHER,TAKEN,WHILE,WNT7B
0001,109,BACKGROUND,CONTEXT,EACH,GLEASON,KLLN,LABEL,LOSS,METHODS,OBJECTIVE,PTEN,RESULTS,TP53,TP73
1617,174,2004,2009,CONCLUSION,CPF,EXCEL,HEMATOLOGY,LABEL,METHODS,OBJECTIVE,RESULTS,STAGE
CRPC,CYP17A1,LABEL,OBJECTIVE,PURPOSE,RESULTS,SUMMARY,THERE,WHEREAS
LABEL,OBJECTIVE,PURPOSE,RESULTS,STUDIES,SUMMARY,THERE,THESE
ANTISENSE,CRPC,DESPITE,HSP,HSP27,HSP90,HSPS,III,LABEL,NEWER,OBJECTIVE,PURPOSE,RESULTS,SUMMARY
DU145,H3K27,H3K9,H4K20,HOWEVER,MAMMALIAN,USING,YY1
000,206,888,954,CA125,CCL2,CNTO,FORTY,FREE,IGG1,LABEL,METHODS,MTD,OBJECTIVE,PSA,PURPOSE,RESULTS
107,108,126,129,162,1824,196,2004,2007,2008,ADULT,AIMS,BETWEEN,CONCLUSION,EDITION,EPI,INFO,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,ONCOLOGIC,PATTERN,RESULTS,SIMILARLY,VERSION

ALSO,THERE
177,CONCLUSION,CSR,CSRS,LABEL,MATERIALS,MEAN,METHODS,MRGBX,OBJECTIVE,OBJECTIVES,RESULTS,SIDE,SUCCESS
132,160,169,2013,420,AFTER,COMPANY,CONCLUSION,COPYRIGHT,III,JOURNAL,LABEL,LTD,MAINZ,METHODS,OBJECTIVE,PEDIATRIC,PUBLISHED,PURPOSE,RESULTS,RMS,URINARY,UROLOGY
002,160,169,177,2013,215,216,8804,AIM,ASSESSMENT,COLLEGE,COPYRIGHT,EBRT,FACT,FUNCTIONAL,GENERAL,HDR,INDEX,LABEL,LTD,MATERIALS,MEAN,METHODS,OBJECTIVE,OUTCOME,PUBLISHED,QUALITY,RESULTS,ROYAL,THERAPY,THERE,TOI,TRIAL
169,2013,C42,COPYRIGHT,FEDERATION,JMJC,JMJD2,KDM1A,LNCAP,LSD1,PC3,PSA,PUBLISHED,RECURRENT,SOCIETIES,TMPRSS2,VEGF
169,2013,233,AIM,BCG,COLLEGE,CONCLUSION,COPYRIGHT,DWI,LABEL,LTD,MATERIALS,METHODS,MRI,OBJECTIVE,POLYGONAL,PUBLISHED,RESULTS,ROYAL,T1WI,T2WI,TEN,THREE
001,031,032,038,100,100CC,126,148,169,182,2013,2017,2051,205CC,741,935,BFFF,CONCLUSION,COPYRIGHT,GLEASON,INC,LABEL,METHODS,OBJECTIVE,PHOENIX,PUBLISHED,PURPOSE,PV100,RADIATION,RESULTS,SCORE,SOCIETY,SYMPTOM,THERE,URINARY
144,174,2009,2011,BACKGROUND,BLADDER,CONCLUSION,FIVE,LABEL,LITHOCLAST,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SLM,STONE,SWISS,UNDER,WESTERN
143,BACKGROUND,CSCS,III,LABEL,LNCAP,METASTATIC,METHODS,MICRORNAS,MIR,PCR,RESULTS,THERE,THESE
182,AFTER,ALSO,FOXF2,INITIALLY,KNOCK,MTSS1,RECK,UTR,WESTERN
125,ABC,ABCG2,ATP,EPITHELIAL,FUNCTIONAL,HOECHST,STEM,THUS
011,110,121,223,581,633,BACKGROUND,BRMET50,EXALT,LABEL,METHODS,RESULTS,USING,VALIDATION
ADP,ANDRO,DU145,MAD2,SAC,TAXI,TAXIFOLIN
AMONG,MIA,PACA,PEI,SEVEN
434,516,CONCLUSION,COX,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SNP,SNPS,THREE
013,0145,044,086,169,199,2013,502,577,644,678,700,8201,COPYRIGHT,ERG,GLEASON,INDEX,KI67,MALDI,MSI,PSA,THESE,TMA,TMAS,TMPRSS2,UICC
COMPOSITE,EPIC,INDEX,LIFE,PCI,QOL,QUALITY,THERE,UCLA,USING
1421,293,330,589,8201,BACKGROUND,BASED,CRPC,ENDOTHELIN,ENTHUSE,III,LABEL,METHODS,OWING,PFS,PSA,RESULTS,ZIBOTENTAN
0001,001,002,007,1039,8201,8804,8805,AMICO,BACKGROUND,ERG,IHC,LABEL,METHODS,MOST,PCA,PSA,RESULTS,SIMILAR,TMPRSS2
001,004,020,1A1,350,8201,992,CAUCASIANS,ILE,ILE462VAL,P450,VAL,WANFANG
DEVELOPERS,PATIENT
181,BACKGROUND,BASE,CASE,CENTERS,CONCLUSION,CONTROL,DATA,DISEASE,FORCE,FUNDING,HORIZON,INSTITUTE,LABEL,LIMITATION,METHODS,OBJECTIVE,OUTCOME,POPULATION,PREVENTION,PREVENTIVE,PRIMARY,PSA,RESULTS,SOURCES,TASK,TIME,VARYING,WITHOUT
2012,743,ASSESSMENT,EVALUATION,GRADING,LABEL,LIBRARY,META,METHODS,NINE,OBJECTIVE,OCTOBER,PSA,PURPOSE,QUALITY,RCT,RCTS,RESULTS,SYSTEMATIC,WEB
HOWEVER,ILS,ITERATIVE,MLC,SINOGRAMS,VMAT
169,2013,COPYRIGHT,GFP,INC,MCF7,MMP,MMPS,PC3,PRMT6,TAKEN,TSP,WAF1
145,169,2013,945,946,948,949,ACTIVATION,COPYRIGHT,ERK1,GNRH,GNRHR,IRELAND,JNK,LNCAP,LTD,MAPK,PKC,PKCS,PMA,SUSTAINED,THUS
0001,100,125,130GY,152,169,170GY,183,2013,3NG,6GY,9GY,COPYRIGHT,D90,FUSED,HOWEVER,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SOCIETY,V100,VOLUMES
100,148,15NG,169,2003,2008,2013,22GY,4GY,5NG,ACCORDING,APRIL,BED,BETWEEN,COMMITTEE,COPYRIGHT,GLEASON,GROUP,GUIDELINES,HDR,HIGH,IIB,IMRT,INC,JOINT,JULY,LABEL,MATERIALS,METHODS,OBJECTIVE,PATIENT,PHOENIX,PSA,PUBLISHED,PURPOSE,RESULTS,SOCIETY,TREATMENT
169,2013,223,COPYRIGHT,HOWEVER,INC,PCA,TGF,THEREFORE
169,2013,COPYRIGHT,CRPC,FULL,HEAT,HSP90,INC,LBD,LBDS,LNCAP,MJC13,NTD,PCA,THUS,USING
001,011,028,045,1122,169,177,200,2013,8201,AFTER,COX,END,LABEL,METHODS,OBJECTIVE,RESULTS,THERE,UROLOGICAL
10A,145,A221A,BLM,BXPC,CY5,HPV,MCF,SVR,THESE
169,2013,ADD,BJU,CONCLUSION,DOES,FINALLY,HOWEVER,IMAGE,KNOWN,LABEL,METHODS,OBJECTIVE,RARP,RESULTS,SUBJECT,SYSTEMS,THEREFORE,UNLABELLED,WHAT
169,2013,2386,846,ANTIGEN,BIOMETRIC,CARLO,COPYRIGHT,MCMC,MONTE,PSA,SOCIETY
876,BASED,GLEASON,PRACTICAL,PSA
105,320,ACCORDING,PIN,PSA,THUS
CAVEATS
8804,DENOSUMAB,GCT,GCTS,GIANT,IMAGING,LOCAL,MEDICAL,METASTATIC,MONOSTOTIC,MOST,TYPICALLY
169,2010,2013,ACS,ACT,AFFORDABLE,CARE,COPYRIGHT,EACH,INC,INTERVIEW,PATIENT,PROTECTION,SOCIETY
000,2011,2016,AMERICANS,CALIFORNIA,CONCLUSION,DIEGO,ENERGETICS,FOUR,FRED,HARVARD,HOWEVER,HUTCHINSON,INITIATIVE,INSTITUTE,LABEL,LOUIS,METHODS,NETWORK,NIH,OBJECTIVE,PURPOSE,RESULTS,SAN,SCIENCE,TEAM,TREC,UNIVERSITY,WASHINGTON
001,8804,8Q21,E2F5,ESPECIALLY,FAILURE,GLEASON,MYC,PCA,PSA,QPCR,THEN,WESTERN
DIFFERENT,E2F1,E2F1S,E2FS,HOWEVER,MIRS
145,3360,COMPOUNDS,CTAB,NDRG1,PCA,SCREENING
100,13R,17S,23S,24R,25S,49R,99M,CONCLUSION,FDG,LABEL,MDP,METHODS,MRI,NPV,NSCLC,OBJECTIVE,OBJECTIVES,PET,PPV,RESULTS,SEVENTY
000,001,177,392,539,AFRICAN,MEAN,MEN,PCA
000,100,116,126,262,8226,CONCLUSION,DCE,DIFFUSION,DW1,DW3,DWI,KEY,LABEL,METHODS,MRI,OBJECTIVE,OBJECTIVES,PSA,RESULTS
001,012,141,ALP,BPH,GLEASON,KENDALL,NON,PCA,PCR,PEARSON,PSA,SERUM,THERE,USING
HIP,HISTOLOGY,HOWEVER,INITIAL,MRI,PSA,THERE,THR,THREE,TOTAL
AFTER,BACKGROUND,GLEASON,LABEL,MATERIALS,METHODS,PROSTATES,REPORTS,RESULTS
1974,945,DISCOVERY,DRUG,FDA,FOOD
0002,002,003,018,052,BACKGROUND,CONSORTIUM,CYP24A1,DHCR7,INSTITUTE,LABEL,METHODS,NCI,RESULTS,SNP,SNPS,STUDIES
945,DLC1,GTP,PCA,RHO,RHOA,RHOC,RHOGTPASES,ROCK,V14
169,2013,215,723,945,9P21,AUA,COPYRIGHT,EDUCATION,IFNK,INC,LABEL,MATERIALS,METHODS,MYO3B,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SCORE,SEVERAL,SYMPTOM,THESE,UROLOGICAL
169,2013,COPYRIGHT,ISSUE,SECRETOME,SPECIAL,THEREFORE,UPDATED
169,2013,500,946,AFTER,AGA,AIMS,AOM,APC,ATOH1,BACKGROUND,COLON,CONVERSELY,COPYRIGHT,CRC,DSS,ETS,EXPRESSION,INC,INSTITUTE,LABEL,METHODS,MIN,MYC,OBJECTIVE,PUBLISHED,RESULTS,SAM,SPDEF,SW480
116,145,169,2013,231,956,A375,A549,ACETONE,ANTI,ASTERACEAE,BACKGROUND,BENTH,BOTH,COLON,CONCLUSION,COPYRIGHT,HCT,IC50,IRELAND,LABEL,LTD,LUNG,MATERIALS,MCF,MDA,METHODS,MIA,NMR,OVARIAN,RELEVANCE,RESULTS,WST
169,2013,947,COPYRIGHT,DEFECTS,H2AX,HRS,IRELAND,LTD,MRE11,MSH2,PERSISTENT,RAD51
169,2013,COPYRIGHT,IRELAND,LTD
169,2013,511,APC,CCND2,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,MGMT,OBJECTIVE,PUBLISHED,PURPOSE,RARB,RESULTS,UROLOGICAL
169,2013,945,AMACR,COA,COPYRIGHT,COX,FXR,INHIBITORS,LTD,METHYLACYL,OTHER,P504S,PPAR,PROTEIN,SAR,SNPS
001,100,169,2013,264,646,942,BACKGROUND,COPYRIGHT,INDEX,LABEL,METHODS,OBJECTIVE,OUTCOME,PCA,PHI,PSA,PUBLISHED,RESULTS,SETTING,STRATEGIES,UROLOGY
169,2011,2013,628,812,CONCLUSION,COPYRIGHT,CROWN,DETAILS,INC,JUNE,LABEL,MATERIALS,METHODS,NOMOGRAMS,OBJECTIVE,PUBLISHED,RESULTS,THESE
169,2013,CHANGES,COPYRIGHT,DATA,DPPIV,FEDERATION,GLP,PUBLISHED,T2DM,THEREFORE
100,125,169,2005,2011,2013,225,945,AFTER,BACKGROUND,CONCLUSION,COPYRIGHT,INC,IPSS,LABEL,LTURP,LUTS,MEAN,METHODS,PCA,PFR,PVR,QOL,RESULTS,SCORE,SYMPTOM
169,2013,223,COPYRIGHT,III,INHIBITION,IRELAND,LTD,NOVEL
169,2013,COPYRIGHT,INC
169,2013,CONCLUSION,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,POK,POKEMON,RESULTS,RNAI,THEREFORE,WESTERN
134,169,2008,2011,2013,8805,CLAVIEN,CONCLUSION,COPYRIGHT,DISSECTION,GLEASON,INC,JULY,LABEL,MATERIALS,METHODS,OBJECTIVE,RARP,RESULTS
169,2013,AFTER,BECAUSE,COPYRIGHT,DEPENDING,INC,MRI,TESLA,TRUS
CONCLUSION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PSA,PUBLISHED,RESULTS,SIPULEUCEL,USING
001,003,005,008,016,024,036,169,2013,329,343,409,945,946,ADT,AFTER,CONCLUSION,COPYRIGHT,IGF,INC,LABEL,LBM,LBMS,MATERIALS,METHODS,OBJECTIVE,RESULTS,SEX
169,2013,CONCLUSION,COPYRIGHT,EACH,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,THESE,THUS
008,131,169,2013,8804,8805,ADVERSE,CONCLUSION,COPYRIGHT,GROUP,INC,INVENTORY,LABEL,MATERIALS,MEN,METHODS,MOUNT,OBJECTIVE,RADIATION,RESULTS,SCORE,SINAI,SYMPTOM,THERAPY
001,169,1994,2010,2013,3226,AFTER,CONCLUSION,COPYRIGHT,COX,INC,LABEL,MEIER,METHODS,OBJECTIVE,PNI,RESULTS
127,1503,151,2003,2010,CLAVIEN,CONCLUSION,III,INC,JULY,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SURGEON
001,1000,108,169,200,2002,2011,2013,8804,CLAVIEN,CONCLUSION,COPYRIGHT,INC,JUNE,LABEL,METHODS,OBJECTIVE,RARP,RESULTS,THERE
100,102,104,169,2006,2007,2013,3448,CALIFORNIA,CONCLUSION,COPYRIGHT,COX,HISPANICS,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PERMANENTE,PROC,RESULTS,THESE
169,2013,ACR,COLLEGE,COPYRIGHT,IMAGING,INC,MRI,PUBLISHED,RADIOLOGY,THERE,ULTRASOUND
169,2012,8201,AUSTRALIAN,AUTHORS,BACKGROUND,COLLEGE,COMPOSITE,CONCLUSION,HRQOL,IMAGING,IMRT,INDEX,INDIVIDUAL,JOURNAL,LABEL,MEAN,MEDICAL,METHODS,POST,PPRT,PRESCRIBED,RADIATION,RESULTS,ROYAL,THERE,ZEALAND
169,2012,8201,AUSTRALIA,AUSTRALIAN,AUTHORS,BACKGROUND,COLLEGE,CONCLUSION,IIEF,IMAGING,INDEX,JOURNAL,LABEL,MANN,MEDICAL,MEN,METHODS,RADIATION,REGULAR,RESULTS,ROYAL,STUDENT,THERE,WHITNEY,ZEALAND
153SM,154,177,BONE,CRPC,EBRT,MRI,PAIN,THEREFORE,VAS
001,003,006,031,124,170,FORM,HOWEVER,INVENTORY,MEN,SHORT,SIXTY,URINARY,USING
CELL,HOWEVER,LNCAP,M12,PICOGREEN,SEEDING,THESE
2009,2011,999,DATA,DESPITE,GERMANY,ITALY,KEY,KINGDOM,LABEL,MAY,MEN,METHODS,OBJECTIVE,RESULTS,RHYME,SPAIN
2000,2008
145,33342,CDK1,CONCLUSION,IC50,LABEL,MTT,OBJECTIVE,PCR,PLAB,REAL,RESULTS,WESTERN
998,BACKGROUND,CONCLUSION,COX,FURTHER,INCLUDING,LABEL,METHODS,MORTALITY,RESULTS,RISK,SIMILAR
160,169,183,BEST,CONCLUSION,GEORG,HEALTHCARE,INGENIA,LABEL,MATERIALS,METHODS,OBJECTIVE,PHILIPS,PURPOSE,RESULTS,STUTTGART,TESLA,USA,YORK
001,067,1000,169,2000,2013,309,544,8805,ADC,BOTH,CONCLUSION,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,WILEY
169,2013,BACKGROUND,CONCLUSION,COPYRIGHT,CRPC,DASATINIB,ELISA,HENCE,IGF,INC,LABEL,METHODS,RESULTS,SRC,WILEY,XENOGRAFT
700,945,ADRENAL,CRPC,CYP17,III,ONGOING,P450,PSA,TAK
120,177,198,8805,AIM,BACKGROUND,CONCLUSION,GROUP,HOWEVER,INSTITUTES,LABEL,METHODS,NIH,OBJECTIVE,PCA,RESULTS
0001,0108,1125,1198,2289,4699,6Q12,6Q15,ERG,GLEASON,HOWEVER,MAPPING,TAK1,THERE,TMPRSS2
CSCS,PCA,PCSCS
034,074,181,522,MOST,PC3,QSAR
2009,239,510,BACKGROUND,BOARD,CYBERKNIFE,ECE,EPIC,FORTY,GEORGETOWN,GRADE,IRB,LABEL,MEAN,METHODS,PSA,QOL,RADIATION,RESULTS,SBRT,TRIAL
100,169,2009,2011,2012,AIM,ALSO,AUTHORS,BACKGROUND,CURRENTLY,DIGESTIVE,ENDOSCOPY,HOWEVER,JAPAN,JUNE,KOREA,LABEL,METHODS,OBJECTIVE,RESULTS,SOCIETY,STENT,TECH
BACKGROUND,LABEL,R1881,RESULTS,SIMILARLY,SP1,THREE,VEGF
8804,956,AKT,CDKS,CIP1,ERK,ERK1,ITC,ITCS,NEITHER,PC3,WAF1
100,169,174,2013,8804,ACUTE,AFTER,BJU,CURRENT,CYBERKNIFE,DESPITE,FEW,GLEASON,III,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PCA,PSA,RESULTS,SBRT,SUNNYVALE,T2A,USA
158,15D,2009,2010,317,630,BACKGROUND,C30,EORTC,HRQOL,LABEL,LOC1,LOC2,LOC3,MANAGEMENT,METASTATIC,METHODS,PALLIATIVE,PCA,QLQ,RESULTS,SEPTEMBER,UUSIMAA
2010,2011,FDA,MOST,UNTIL

100,2012,FIVE,HOWEVER,LOCALLY,PRESCRIRE,SHORTER,THREE,VARIOUS,WHICH
001,8201,AFTER,ASSESSMENT,BLOOD,CONTROL,EBRT,HDR,PCA,SIXTY,TBARS
006,034,393,459,934,BACKGROUND,BIOMEDICAL,CBM,CHINESE,COLLECTED,CONCLUSION,DATA,DATABASES,ELECTRONIC,FOLLOWING,GSTT1,LABEL,META,METHODS,ORS,OVERALL,RESULTS,SIMILAR,ULTIMATELY
954,ATM,BDEC,BLADDER,CHINA,GENISTEIN,HCPT
000,122,145,160,2009,2010,340,696,700,718,914,AFTER,HOWEVER,JULY,LABEL,METHODS,OBJECTIVE,RESULTS
IFN,IFNS,NKT,STILL,TYPE
0496,CONCLUSION,FIFTY,GROUP,LABEL,MATERIALS,METHODS,NHT,OBJECTIVE,PCA,PSA,PURPOSE,RESULTS,RRP,THERE
169,2013,COPYRIGHT,JOHN,LTD,SONS,WILEY
169,2013,ATP,CD133,CD8,CEA,CERTAIN,COPYRIGHT,CRT,CTL,CTLS,DOCETAXEL,HMGB1,HOWEVER,ICD,KILLING,MDR,MUC,PERK,PSA,THESE,UICC
169,1991,1998,2000,2001,2004,2010,2013,AIDS,COPYRIGHT,HIV,HODGKIN,INCIDENCE,NON,SAHARAN,UICC
100,169,2013,AACR,DU145,EP1,EP2,EP3,EP4,EPR,HPV10,HPV7,IHC,INCREASED,LNCAP,MMP9,PC3,PGE2,RUNX2,THESE,WESTERN
001,039,169,2013,8804,8805,ACHIEVING,ACUTE,ASTRO,BACKGROUND,BASEL,COPYRIGHT,EBRT,HIFU,III,LABEL,LATE,METHODS,PHOENIX,PRIMARY,RESULTS,SALVAGE
OPINION
CASODEX,LNCAP,NOTABLY,TELOMERES
169,2013,AACR,CCL1,CCR8,CD11B,CHEMOKINES,FOXP3,LABEL,METHODS,OBJECTIVE,PRIMARY,PURPOSE,RESULTS,STAT3
169,2013,ALCOHOL,BACKGROUND,BASEL,CAT,COPYRIGHT,GPX,GPX1,HOWEVER,INCREASING,LABEL,METHODS,RESULTS,SEL15,SNPS,THESE,THREE,ZEALAND
169,2013,BACKGROUND,BASEL,CONCLUSION,COPYRIGHT,IMPROVING,LABEL,RESULTS,STRATIFIED,VARIOUS
160,176,177,952,ART,CBCT,D95,EVALUATION,HOWEVER,IGRT,IMRT,OARS,SBRT,THEREFORE
100,155,218,8201,ADVERSE,BACKGROUND,EBRT,INSTITUTE,IPSS,LABEL,METHODS,R100,RESULTS,SCORE,SYMPTOM
100,160,CURRENT,DVH,HDR
160,DMC,GENERALLY,GSI,PLANS,RBE,THUS,V107,V95
001,006,019,027,046,266,277,486,521,AUSTRALIA,BACKGROUND,GEOMETRIC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SIXTY,TDI,THERE,THESE,WESTERN
1164,1655,1994,1995,3533,491,BACKGROUND,FUNCTIONAL,HOWEVER,INSTITUTE,LABEL,METHODS,PCOS,RESULTS,SIMILARLY
DOSE,FRET,MM45,NMR
8805,BOTH,COLOADING,ENTRAPMENT,INSTEAD,NLCS,SGM,SIM,SOLUBILITY
140,160,199,2013,3100,CASTRATION,CLINICALLY,COPYRIGHT,CRPC,CURRENTLY,DRUG,FDA,FOOD,III,MDV,PREVAIL,PROUS,SCIENCE
1290,141,169,2012,AACR,ATRI,BECAUSE,CLIN,CONCLUSION,GLEASON,IGM,III,LABEL,MEIER,METHODS,OBJECTIVE,PSA,PURPOSE,RES,RESULTS,THERE
AMONG,CCL2,CCL5,CD105,CD14,CD20,CD34,CD45,CD73,CD90,CELLS,CHRONIC,CWR22RH,FAP,HLA,MSCS,STEM,THESE
169,2013,945,946,ALSO,BOTH,COPYRIGHT,EGF,EGFR,FGF,FGFR,HOWEVER,INC,INCREASED,STATE,UNIVERSITY,WILEY
205,267,391,838,8805,ALT,AST,ATP,BACKGROUND,BID,CA19,DOSE,FORTY,KX2,LABEL,METHODS,MTD,PHASE,PSA,RESULTS,SRC
10216,630,DEFINIENS,ERG,FURTHER,GERMANY,HOWEVER,IHC,SEVERAL,SLC45A3,STAININGS,TMAS,TMPRSS2
1000,141,188,258,459,8364,BACKGROUND,CONCLUSION,DCE,INCREASING,LABEL,MEN,METHODS,PREFERENCE,RESULTS,SCREENING,TRADE
001,002,004,035,037,103,125,169,200,2013,218,2454,772,ASIAN,BED,BJU,GLEASON,HAEMATURIA,LABEL,LATE,METHODS,OBJECTIVE,PSA,RESULTS
100,2006,2008,382,ASSESSMENT,BACKGROUND,CONCLUSION,FLORIDA,FORTY,FRAX,INSTITUTE,LABEL,METHODS,PER,RESULTS,RISK,THERAPY,THERE,THREE,TOOL,UFPTI,UNIVARIATE,UNIVERSITY
FRET,THEREFORE
132,134,169,2007,2011,2013,396,8201,8805,AMONG,GLEASON,JAPAN,LABEL,METHODS,OBJECTIVE,OCTOBER,RESULTS,TESLA,TOKYO,UROLOGICAL
HOWEVER,SEVERAL
004,169,178,2004,2006,2013,954,ADD,BCR,BJU,BOTH,COX,DOES,ELISA,GLEASON,GREATER,KNOWN,LABEL,MAIER,MANN,METHODS,NEITHER,OBJECTIVE,OPG,RANKL,RESULTS,SUBJECT,THERE,UNLABELLED,WHAT,WHITNEY
945,PC3,TAKEN,USING
001,041,645,8804,ADT,CAG,COX,PCSM
3940,946,954,956,BPH,GASTRIN,GRP,SHRINKAGE,WPMY
945,946,FIRST,FKRP,FUKUTIN,FUNCTIONAL,GTDC2,ISPD,LARGE,MUTATIONS,PC3,POMGNT1,POMT1,POMT2,SEVERAL,THESE,WARBURG,WWS
1423,169,2013,660,ABL,BACKGROUND,CCG,CONCLUSION,COPYRIGHT,FOLLOWING,HOF,HOWEVER,INC,LABEL,LNCAP,METHODS,RESULTS,SRF,TFS,USING,WILEY
169,2013,BACKGROUND,COPYRIGHT,COS,GOLGI,INC,LABEL,MDCK,METHODS,PCR,PSMA,RESULTS,WILEY
169,2013,946,AKT,FAK,FURTHER,INC,LNCAP,LOW,PC3,SMAD2,SMAD3,SRC,TAKEN,TGF,THESE,VEGF,WILEY
015,12P13,1722,19Q13,2899,3192,464,584,642,BACKGROUND,K530R,KLK2,KLK3,LABEL,MATERIALS,METHODS,NEITHER,PERCENTAGE,PSA,REDUCTION,RESULTS,SNP,SNPS,THESE
169,2013,946,AIIB2,COPYRIGHT,FINALLY,IGF,INC,JNK1,JUN,PRCA,TRAMP,WILEY
003,011,013,140,177,1LI,8804,GLEASON,GLUT,MIB,PROTEIN,PSA,THERE
002,004,013,017,018,019,025,089,116,143,160,276,310,370,567,734,8805,945,946,950,ACUTE,EORTC,EQD2,IGRT,LABEL,MATERIALS,MEAN,METHODS,MINIMUM,OBJECTIVE,PURPOSE,RESULTS,RTOG,TURP
BECAUSE,UPS
128,2010,300,AIRO,DESPITE,GLEASON,ITALIAN,LABEL,METHODS,OBJECTIVE,PSA,PURPOSE,RADIATION,RESULTS,THESE,TNM
1980,2012,CONCLUSION,ENGLISH,GIVEN,LABEL,MANAGEMENT,MEDLINE,MEN,METHODS,MINIMALLY,OBJECTIVE,PSA,PURPOSE,RESULTS,SALVAGE,SEPTEMBER,SRP,URINARY
001,003,004,054,8805,CELLSEARCH,CTC,CTCS,LABEL,LAPC,MEIER,METHODS,OBJECTIVE,OVERALL,PSA,PURPOSE,RESULTS
100,169,239,AURKA,CONCURRENT,ERG,HISTOLOGIC,MYCN,NEPC,PCA,PCAS
169,2013,25D,AACR,CK2,CYP24A1,FINALLY,INHIBITION,PC3,TBBZ,THESE,VITAMIN
CEACAM1,ECM,INHIBITION,SINCE
0001,947,AKT,CAP,H2AX,HEAT,HSP90,MYC,PC3,PI3K,TARGETING,THESE
153SM,2001,2011,89SR,AIM,CONCLUSION,EDTMP,FIFTY,FORTY,LABEL,METHODS,MOST,OBJECTIVE,REPORTS,RESULTS
200,945,956,FABP,FURTHER,HOWEVER,MCP,NPC,PREVENTION,TNF,TRIAL,VCAM,VITAMIN
916,945,AD5,CRAD,CRADS,E1A,E3B,IGG1,METASTATIC,OPG,RGD,THESE
169,2012,COPYRIGHT,ERG,ETS,HOWEVER,LTD,TMPRSS2
169,2013,215,543,AFRICAN,CONCLUSION,COPYRIGHT,HOME,INTENTION,IRELAND,LABEL,LTD,MEN,METHODS,OBJECTIVE,RESULTS,SCREENING,THESE
006,009,029,044,047,065,070,072,103,169,177,2007,2012,2013,25TH,ADJUSTMENT,ASSESSMENT,AUC,BACKGROUND,BETWEEN,CHECKLIST,COPYRIGHT,FACTORS,FUNCTIONAL,HRQOL,INFLUENCE,LABEL,LACK,MARCH,METHODS,MINI,OBJECTIVE,OUTCOME,POOR,PRIAS,PUBLISHED,QOL,RESULTS,SEPTEMBER,SETTING,SYMPTOM,THERAPY,UROLOGY
169,2013,AKT,CONCURRENT,COPYRIGHT,GIVEN,OVERALL,PCA
169,1997,2009,2013,538,8201,8764,ADD,BDFS,BJU,DOES,FACTORS,GRADE,HIFU,HIGH,III,KNOWN,LABEL,METASTATIC,METHODS,OBJECTIVE,PCA,PHOENIX,PRESERVED,RESULTS,SEPTEMBER,SEVENTY,SIDE,SUBJECT,THERE,UNLABELLED,WHAT
002,1044,1472,169,2013,215,639,706,785,8201,894,ADD,BJU,COMMITTEE,DOES,EFS,KNOWN,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,SUBJECT,THERE,UNLABELLED,WHAT
169,2012,8201,AUTHORS,BZT,BZTS,JPP,KEY,LABEL,LNCAP,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,ROYAL,SOCIETY,THESE,XTT
126,132,169,199,2013,331,ADD,BJU,DOES,KNOWN,LABEL,METHODS,NODAL,OBJECTIVE,RARP,RESULTS,RRP,SUBJECT,UNLABELLED,WHAT
1454,169,2013,493,8805,961,AUTHORS,BCR,BJU,COX,LABEL,METHODS,NCCN,NETWORK,OBJECTIVE,ORP,OVERALL,PSA,RALP,RESULTS,USING
1998,2005,378,APRIL,AUC,BACKGROUND,COMPARING,DEVELOPED,EVALUATED,FLORIDA,HALEY,HGB,IDENTIFIED,III,JAMES,JANUARY,LABEL,METHODS,PBCDR,PPV,PSA,RBC,RESULTS,ROC,TAMPA,THESE,VETERAN
033,141,169,170,2006,2011,2013,294,497,905,ADD,BJU,CONCLUSION,DOES,GLEASON,JANUARY,JUNE,KNOWN,LABEL,LND,METHODS,OBJECTIVE,PROPENSITY,RESULTS,ROBOT,SUBJECT,UNLABELLED,WHAT
105,169,2002,2011,2013,743,8201,8805,913,AGE,BJU,GLEASON,HOPKINS,HRPC,JOHNS,LABEL,LRP,METHODS,MIRP,OBJECTIVE,OBJECTIVES,ORRP,OVERALL,PSA,RADICAL,RALRP,RESULTS
BACKGROUND,BASED,COLORECTAL,CRC,FOCAL,HYPOTHESIS,LABEL,NOVEL,STAGE,THEN,TLCS,UNASSIGNED
AFRICAN,CONSISTENT,FOUR,HOWEVER
DESPITE,ENGLISH,IDEALLY,MESH,PCA,PSA,RESULTS,SEVERAL
BOTH,DENOSUMAB,DUE,RANKL
169,2013,BRITAIN,COPYRIGHT,EHMT1,GREAT,IRELAND,JOHN,LOW,LTD,MT1H,MTS,PUBLISHED,SCID,SOCIETY,SONS,WILEY
117,169,2013,328,562,644,8201,ADJUSTMENT,BASE,CHILDLESS,CIS,COPYRIGHT,ORS,UICC
169,182,2013,203,COPYRIGHT,EMT,EPT1,FINALLY,KNOCK,MET,MICRORNAS,MIR,PC3,SNAI2,STRIKINGLY,UICC
169,1994,1996,2013,253,656,8805,COPYRIGHT,GENERAL,HOWEVER,OUTCOME,PREVIOUSLY,STRONGEST,THESE,UICC
111,956,9999,HPLC,SARCOSINE,SINCE
028,033,040,041,044,320,8804,8805,AFTER,BACKGROUND,CCND1,CONCLUSION,COX,CTGG,GAGG,GLEASON,LABEL,MEIER,METHODS,PSA,RESULTS
199B,228,AFTER,CACO,CD133,CD15,CSC,CSCS,DAOY,HES,MCF,MDA,NOTCH,ONS,SHH,SNALP,SW480,THESE,THUS
002,010,033,043,047,134,AFTER,AMERICANS,CONCLUSION,ESTRADIOL,III,LABEL,MEAN,METHODS,MEXICAN,NEXT,NUTRITION,OBJECTIVE,RESULTS,SHBG,THIRD
DUE,NOS,PRESENTLY
001,064,2005,2010,335,536,8805,BETWEEN,JANUARY,LABEL,METHODS,OBJECTIVE,PSM,RALP,RESULTS,SHIM
DIFFUSE,FCH,FDG,PET,SIMILAR
AKT,ERK1,JAK2,MCL,MEK,MTT,OBESITY,OVCAR,PI3K,USING
00001,0001,0008,0149,2000,2006,2362,258,2612,AFRICAN,AMERICANS,FURTHER,MEN,PDE,THESE
014,045,221,222,COX,GLEASON
145,169,2013,24H,AKT,BASED,CASPASE,COPYRIGHT,ERK,INC,JNK,MAP,ROS
000,169,2013,500,COPYRIGHT,EPIGENETIC,INC,UROLOGICAL
100,169,2013,COPYRIGHT,CRPC,ERG,FISH,GEN,INC,PROBE,SINCE,SUCCESSFUL,TMPRSS2
169,2012,CONCLUSION,COPYRIGHT,LABEL,METHODS,OBJECTIVE,PATIENT,RESULTS,SAS,SCHWANN,SCHWANNOMA
169,2012,2013,535,636,ACCORDING,ALSO,AMONG,COPYRIGHT,EGGER,ENGLISH,ISI,JUNE,LABEL,LTD,MEDLINE,META,METFORMIN,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCIENCE,SRR,WEB
169,2013,956,COPYRIGHT,INC,PP5,USING
1809,183,1904,2011,2652,500,621,8211,969,BACKGROUND,BRITISH,COUNCIL,FOLIC,FOOD,FOUNDATION,FUNDING,HEART,LABEL,MEDICAL,METHODS,RESULTS,STANDARDS,THERE
001,106,169,194,2013,CONCLUSION,COPYRIGHT,FADD,FAS,GLEASON,INC,LABEL,MATERIALS,MEIER,METHODS,NONE,OBJECTIVE,OVERALL,RESULTS
0002,0093,0094,169,2003,2008,2012,224,AFRICAN,APRIL,CARIBBEAN,CAUCASIAN,CI95,CONCLUSION,COPYRIGHT,COX,GUADELOUPE,LABEL,MEIER,METHODS,OBJECTIVE,OBJECTIVES,PITRE,PSA,PUBLISHED,RESULTS,SALVAGE,SAS,UNIVERSITY,WEST
169,2012,5MM,BACKGROUND,CONCLUSION,COPYRIGHT,GLEASON,LABEL,METHODS,MRI,NPV,PCA3,PPV,PSA,RESULTS,SAS,SIXTY
169,2012,ASSESSMENT,CONCLUSION,COPYRIGHT,HDL,HOMA,LABEL,LDL,MATERIALS,METHODS,MODEL,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,SAS
001,169,2004,2009,2011,2013,3561,571,655,946,ASA,BACKGROUND,BLOCKER,COPYRIGHT,COX,EXCLUSION,GLEASON,LABEL,MANN,METHODS,NORWEGIAN,OBJECTIVE,OUTCOME,PCA,PEARSON,PUBLISHED,RESULTS,SETTING,STUDENT,UROLOGY,WHITNEY
231,BACKGROUND,CHANGES,CYTOSTATIC,LABEL,LNCAP,MDA,METHODS,RESULTS,SKOV,U87MG
001,002,004,169,200,2008,2012,2013,202,204,406,8201,ADD,AMICO,BETWEEN,BJU,CLAVIEN,DOES,ELND,KNOWN,LABEL,LLND,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,SUBJECT,THERE,UNLABELLED,UROLOGY,WHAT,WHILE
170,2012,241,740,COMPOUNDS,CURRENTLY,HERIN,HOWEVER
001,002,008,120,169,175,2013,ADT,BJU,FEW,HBBS,LABEL,METHODS,MODEL,MOST,OBJECTIVE,OBJECTIVES,RESULTS,THESE
169,2000,2011,2012,2013,ADD,ADT,BJU,CONCLUSION,DENOSUMAB,DESPITE,DOES,GABAPENTIN,GIVEN,KNOWN,LABEL,METFORMIN,METHODS,OBJECTIVE,PRESENT,RESULTS,SUBJECT,THERE,TOREMIFENE,UNLABELLED,WHAT
160,169,2013,AUTHORS,DECORIN,FEBS,IGF,JOURNAL
169,174,1987,1991,2007,2010,2013,8804,ADD,BJU,DATA,DEFENSE,DEPARTMENT,DOES,GLEASON,KNOWN,LABEL,METHODS,OBJECTIVE,PSA,RESULTS,SUBJECT,THESE,UNLABELLED,WHAT
131,946,A549,ALSO,BLM,CACO,HUTU,QUALITY
0001,001,012,169,2000,2007,2013,6156,812,8804,8805,APRIL,BJU,CONCLUSION,GLEASON,GS6,LABEL,METHODS,OBJECTIVE,PSA,RESULTS,T1C
1048,169,2013,238,8804,ADD,BJU,COX,DOES,GLEASON,KNOWN,LABEL,MATERIALS,METHODS,OBJECTIVE,PSA,RESULTS,SIMILARLY,SUBJECT,UNLABELLED,WHAT
169,2013,BLACKWELL,FOCUSED,LTD,PUBLISHING,THESE
180,620,CYTOTOXIC,EHRLICH,EUCALYPTUS,FURTHER,HELA,HEP,HOP,IMR,OVCAR,SARCOMA,SIX
BACKGROUND,CELL,CONTROL,LABEL,PAS,PEPTIDE,PRINCIPAL,RESULTS
946,CATENIN,CHIP,CHROMATIN,CRPCA,DDX5,DEAD,LNCAP,PCA,PSA,RNAP,THESE
001,947,AFTER,BECAUSE,BILATERAL,CASTRATION,DSB,DSBS,GNRH,H2AX,KU70,LABEL,METHODS,NHEJ,OBJECTIVE,PSA,PURPOSE,RESULTS
ALTOGETHER,CCND2,PCA,THESE,TRAMP,USING,VPA
AGR2,BASED,CD10,CONVERSELY
0001,111,173,184,203,228,232,284,AUTOMATED,ERG,FISH,FURTHER,PTEN
001,008,012,2003,2008,663,CENTERS,CONCLUSION,CROSS,DISCHARGE,HNCA,INPATIENT,LABEL,METHODS,NATIONWIDE,OBJECTIVE,OBJECTIVES,RESULTS,SETTING,URINARY,UTI,UTIS
946,ERBB2,FINALLY,MET,PTEN,TAG,THESE
551,946,ADRB2,BAD,BCL2,BEHAVIORAL,CONVERSELY,EFFECTS,MYC,PI3K,PKA,PKI,PTEN,THESE
BEHAVIORAL
945,946,ERBB2,JCI,MET,PCSCS,TARGETING,THERE,THESE
FIRST,HOWEVER,III
HIGH,PATIENT
177,22RV1,479,AKT,AMG,CRPC,CWR,GANITUMAB,IGF,THESE,VCAP,WHILE
2011,2GY,BEEKLEY,BOTH,BRAGG,GRADE,HOWEVER,LABEL,METHODS,OBJECTIVE,PATIENT,RBE,RESULTS,SOBP
0001,100,169,2013,259,670,685,8201,8764,8805,ALSO,CONCLUSION,GLEASON,GROUP,HOWEVER,IIA,IIB,IIB1,IIB2,III,IV1,IV2,JAPAN,LABEL,METHODS,OBJECTIVE,OVERALL,PROGNOSTIC,RESULTS,T2C,THUS,TNM,UROLOGICAL
169,1982,2013,ADVERSE,AIM,BACKGROUND,EARLY,LABEL,MAIN,METHODS,OBJECTIVE,OUTCOME,PDE5I,RESULTS,SOCIETY,STUDIES,VED,VEDS
1421,169,2013,8201,ANZ,AUTHORS,BACKGROUND,COLLEGE,CONCLUSION,FORTY,ICU,INFECTIONS,JOURNAL,LABEL,METHODS,RATES,RESULTS,ROYAL,SURGERY,TREATMENT,TRUS,UROSEPSIS
FAK,MMP,MMP1,MT1,PEDF,THESE
BPV,FOLEY,IPSS,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PCA,PVR,QMAX,QOL,RESULTS,SCORE,SYMPTOM,THESE
028,100,179,8201,8805,AFTER,GLEASON,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PCA,REGARDING,RESULTS,RPE,RTE
GIVEN,REGIONS,THESE,WHEREAS
000,2012,ENGLISH,HOWEVER,INVERSE,JUNE,LABEL,MEDLINE,METHODS,OBJECTIVE,RESULTS,RRS,SEVENTEEN,TZD,TZDS
ALSO,CAP,DESPITE,EC50,FURTHER,INDUCTION,NDV,NEWCASTLE,ONCOLYTIC,OVERCOMING,PSA,R1881
946,948,956,ADT,AFTER,C17,HSD3,HSD5,HSDS,THESE
ANNEXIN,BEPT,HPLC,MTT,THESE
000,400,ASSOCIATED,BONE,CARCINOMA,CURRENTLY,RANK,RANKL,TREATMENT,TREATMENTS
001,002,169,2013,648,AFTER,BACKGROUND,BASEL,CAUCASIANS,COPYRIGHT,GSTT1,LABEL,META,METHODS,PCA,RESULTS,SCIENCE,WEB
108,168,180,AE1,AE3,DU145,EGFR,KI67,MIB,NBF,PCNA,PROLONGED,SHORT,SKOV3
AMONG,DOCETAXEL,FIVE,FOUR,PSA,THREE,TUR
GLEASON,THERE
AAT,BOTH,BPH,ELISA
209,326,ACCORDING,BPH,FALSE,GROUP,HIGH,PSA
ID1,ID2,ID3,ID4,PCA
C81,CONVERSELY,HIGH,ID1,ID2,ID3,ID4,LNCAP,PCR
312,COX,MEIER,MMTV,WNT5A
017,021,100,8202,945,BACKGROUND,CRPC,CRPCS,DESPITE,DU145,EXPRESSION,HIF1,INCREASED,LABEL,LNCAP,MEIER,METHODS,MIGRATION,NOTABLY,PC3,RESULTS,TRANSWELL,UTR
000,8202,946,AFFYMETRIX,ATLAS,COX,EGR,EGR3,EVALUATION,IL1,MEMBERS,PREDICTIVE,PROTEIN,SIGNATURES,SPECS,STRATEGIC,THESE
ADAM,ADAM9,CELL,CIP1,MICROARRAY,REG4,WAF1
001,005,053,116,164,1990,2007,366,412,489,579,616,631,795,937,ADDITIONAL,CHRONIC,CLL,CONCLUSION,HOWEVER,LABEL,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,SEER,THESE
ABL1,BACKGROUND,BCR,DETECTION,ERG,FINDING,GENOMIC,LABEL,MOTIVATION,RESULTS,SNP,TMPRSS2
263,737,ABT,ALSO,BAG3,BCL,HSP70,MB231,MCL,MDA,MEMBERS,NAVITOCLAX,PC3,SILENCING,THESE,USING
MDV3100
001,002,169,2013,253,8201,963,AFTER,BPC3,CONSORTIUM,COPYRIGHT,IGF,IGFBP,NCI,NORTH,PER,SEVERAL,SNP,SNPS,SSTR5,TOTAL,UICC
CHINESE,CPG,CXCR7,FINALLY,HIC1,IVIS,LABEL,METHODS,MTT,NOTABLY,OBJECTIVE,PCR,PURPOSE,RESTORING,RESULTS,THESE,WESTERN,XENOGEN
148,169,177,1982,1993,1995,2011,2013,263,421,700,963,BACKGROUND,COPYRIGHT,COX,GLEASON,HPFS,LABEL,MARCH,METHODS,OBJECTIVE,OUTCOME,PCA,PHS,PHYSICIANS,PUBLISHED,RESULTS,SETTING,SEX,SHBG,TNM,UNASSIGNED,UROLOGY,USING
200,239,600,BACKGROUND,CONCLUSION,CRPC,CTC,GROUP,HIGH,LABEL,METHODS,PFS,PPFS,PSA,RESULTS,SECONDARY,WORKING
169,2013,COPYRIGHT,IRELAND,LABEL,LTD,RESULTS
100,153,160,192,242,43U1,AAPM,GADOLINIUM,GBQ,RSBT,SCATTERED,TBQ
145,163,166,183,187,2007,2011,217,404,8201,AFTER,BACKGROUND,BOARD,DESPITE,GLEASON,LABEL,METHODS,PATHOLOGY,RARP,RESULTS,THERE
169,2013,2B4,33B6,946,9EG7,AACR,AKT,FAK,INCREASED,KNOCKDOWN,LNCAP,MECHANISMS,PC3,THUS,Y397
900,AFRICAN,AFTER,CAUCASIAN,PSA,THUS,WHETHER
169,2013,947,BRITAIN,COPYRIGHT,EWING,GPR64,GREAT,INHIBITION,IRELAND,JOHN,LTD,METASTATIC,MICROARRAY,MMP,MMP1,PBX2,PGF,PUBLISHED,RAG2,SLIT,SLIT2,SOCIETY,SONS,THUS,TRAIL,WILEY
056,057,065,084,128,169,2013,228,406,670,800,8201,824,864,8804,930,COPYRIGHT,HOWEVER,OVERALL,THERE,UICC
GLEASON,PSA
0001,0003,0015,0061,0138,1418,228,2883,3000,412,778,ACCORDING,BACKGROUND,CAM,GLEASON,HIGH,LABEL,MEMBRANOUS,METHODS,PSA,RESULTS,TMA
2004,2009,246,267,798,8201,AFRICAN,AMONG,BACKGROUND,CARIBBEAN,END,GLEASON,HOWEVER,JAMAICA,LABEL,MEAN,METHODS,PSA,RESULTS,SAHARAN,SIMILAR,WEST
ANNEXIN,APOPTIN,DAPI,E1A,MTT
109,240,267,8201,C15,C30,CONCLUSION,CORE,EORTC,LABEL,LIFE,METHODS,OBJECTIVE,PAL,PALLIATIVE,QLQ,QOL,QUALITY,RESULTS,SPECIAL,THREE,TREATMENT,UNIVARIATE
169,2013,946,ADVERSELY,COPYRIGHT,FEDERATION,GLI1,GSK3,HOWEVER,KINDLIN,PUBLISHED,SMOOTHENED,SOCIETIES,TAKEN
0042,1200,1970S,945,BASED,BOTH,DRUGS,III,MET,PCA,SINCE,THERE,THESE,VEGF
CRPC,EFFECTIVE,III,LOWER,MET,ONGOING,VEGFR
011,BCL2,HOWEVER,III,IMPORTANT,OGX
153,223,945,946,BONE,CRPC,DATA,III,MOST
223,ABOUT,BIOMARKERS,BONE,DIFFERENT,III,MET,RANK,SRC,TARGETING
945,946,DOCETAXEL,THERE,TUBULIN
ADDITIONAL,ANOTHER,III,PSA,SIPULEUCEL,THERE
509,ARN,CRPC,DRUG,FOOD,PERSISTENT,THESE
001,2011,700,APRIL,DRUG,FOOD,P450,TAK,TOK
CRPC,GIVEN,PREDICTIVE,THERE
1941,DESPITE,FURTHER,SINCE
1173,1630,2005,2007,2010,3148,345,DISCUSSION,FOLLOWING,HCI,LABEL,MARCH,METHODS,OBJECTIVE,OCTOBER,OVERALL,PURPOSE,RESULTS,SEPTEMBER,SIXTY,THESE,TRICARE,USING
160,177,CARLO,CLEARLY,MODULATING,MONTE,SOBP

1000,105,169,1997,2009,2013,528,658,736,BASE,CONCLUSION,COPYRIGHT,LABEL,LTD,METHODS,OBJECTIVE,POISSON,PSA,PURPOSE,RESULTS,RISK
001,160,169,2013,AXIAL,BDI,BENT,BLAND,CONCLUSION,COPYRIGHT,HOWEVER,ICCS,INC,LABEL,MBI,MDI,METHODS,MRI,OBJECTIVE,RESULTS,THEREFORE,THREE,TRUS
ACUTE,BACKGROUND,FURTHER,LABEL,METHODS,MRI,RADIATION,RESULTS,TRIAL
071,174,224,263,452,521,AIM,BACKGROUND,BMI,CONCLUSION,COPD,EARLY,FACTORS,LABEL,METHODS,OBJECTIVE,QRESEARCH,RESULTS,SETTING,THERE
100,176,231,99M,ANOVA,CONCLUSION,DMSA,LABEL,MCF,MDA,METHODS,OBJECTIVE,PCNA,PCR,PURPOSE,RATES,RESULTS
154,1990,2010,223,504,595,CONCLUSION,DATA,JANUARY,LABEL,METHODS,MPMN,MPMNS,NEWLY,OBJECTIVE,PHYSICIANS,PURPOSE,RESULTS,SPCS,THREE
169,2013,ATLAS,COPYRIGHT,HOWEVER,INC,MOLECULAR,PROJECT,RAPID,SEVERAL,WILEY
169,2013,223,945,BACKGROUND,BONE,CARE,COPYRIGHT,IGF,IGFBP,INC,LABEL,MAJOR,METHODS,MIB,PIN,PSA,PTH,RESULTS,TGF,TUNEL,VEGF,VIII,WHETHER,WHILE,WILEY
000,100,152,169,173,1990,1991,2000,2005,2009,2012,2013,215,290,350,580,660,900,CENTERS,CENTRAL,CONTROL,COPYRIGHT,DISEASE,EACH,FURTHER,HODGKIN,INC,INSTITUTE,NORTH,OVERALL,PREVENTION,REGISTRIES,SOCIETY,STATISTICS
169,2013,492,549,8201,8805,BACKGROUND,CONCLUSION,COPYRIGHT,GLEASON,INC,LABEL,METHODS,MOST,PCA,POTENTIAL,REGULAR,RESULTS,THERE,WESTERN,WHETHER,WILEY
169,2013,BACKGROUND,BPH,CONCLUSION,COPYRIGHT,CXCL1,CXCL8,CXCR2,DU145,INC,LABEL,METHODS,OTHER,PC3,PCA,RESULTS,TRAMP,WESTERN,WILEY
169,2013,BACKGROUND,BMP,COPYRIGHT,DKK,EMU1,HOWEVER,INC,LABEL,METHODS,MMP,OPG,PCA,PCR,PGK1,RESULTS,SCLEROSTIN,SUBSTANCE,THREE,TRANSCRIPT,WILEY
169,1995,2009,2013,315,8201,8805,945,ARI,ARIS,BACKGROUND,COPYRIGHT,COX,GLEASON,HRS,INC,LABEL,METHODS,MORTALITY,PSA,RESULTS,RISK,TAMPERE,UNIVERSITY,WILEY
0001,047,169,1991,1997,2013,300,8201,9FY,BACKGROUND,COPYRIGHT,EPR3864,ERG,ETS,INC,LABEL,MASON,MEAN,MEIER,METHODS,NUCLEAR,PCA,PCSM,RECURRENCE,RESULTS,SEATTLE,TMPRSS2,WHILE,WILEY
104,1998,2004,250,BACKGROUND,LABEL,METHODS,RESULTS,SEVERAL,WHERE
005,008,169,2013,416,515,604,8201,AMERICA,BACKGROUND,COPYRIGHT,G84E,INC,LABEL,METHODS,NORTH,ODDS,RESULTS,WILEY
125,EPCAM
239,BECAUSE,CASTRATION,CRPC,III,PHASE
2002,2008,ACCORDING,AMERICA,HOWEVER,IARC,PCA,PCAMR,PSA
FINALLY,PET
BONE,MRI,PET
1295,177,2590,EDTMP,III,KARNOFSKY,LABEL,MBQ,MEAN,METHODS,OBJECTIVE,PAIN,PURPOSE,RESULTS,SIXTEEN
169,2013,945,947,954,AACR,B16,BATF3,CD11C,CD8,CONVERTING,CTLS,DCS,DCT,DTR,FLAGRP170,HYOU1,IFN,PMEL,TRP2
169,2013,COPYRIGHT,FINALLY,GLYOXALASE,LNCAP,LTD,PC3
169,2012,916,AURKA,COPYRIGHT,FEDERATION,HSC70,INHIBITION,MYB,PCA,PUBLISHED,SOCIETIES,SP1,TPX2
169,2013,25D,COPYRIGHT,D3VIA,GENOMIC,ISSUE,LTD,RNAS,SPECIAL,VITAMIN
169,2013,945,COPYRIGHT,EMPLOYING,HOWEVER,IFN,INC,INTERFERON,NOTABLY,NPS,STAT1,VSV
0001,169,177,1H30,2010,2011,2013,226,3MM,4MM,5MM,8482,CI95,CONCLUSION,COPYRIGHT,DAILY,FIVE,LABEL,METHODS,OBI,OBJECTIVE,PUBLISHED,PURPOSE,RADIATION,RESULTS,SAS
169,2013,COPYRIGHT,FEDERATION,LACTATE,PNT1A,PUBLISHED,SOCIETIES
169,2013,COPYRIGHT,MPT,STATINS,THESE
169,177,2000,2012,23B,99M,CIM,COPYRIGHT,DPA,GLU,HOWEVER,LNCAP,LTD,LYS,NMI,PSMA,SAAC,TIM
160,169,2013,CATS,COPYRIGHT,PUBLISHED,SAS
0001,169,187,2009,2013,208,679,6865,8364,8804,BEAM,CBCT,CONE,COPYRIGHT,COSTS,EPI,EUROS,IGRT,IMRT,INCREASING,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PURPOSE,RESULTS,TOMOGRAPHY
100,169,1CM,2012,2MM,3MM,4MM,6MM,8482,8804,BACKGROUND,COPYRIGHT,CT1,CT2,IRELAND,LABEL,LTD,MATERIALS,MEAN,METHODS,OBJECTIVE,PURPOSE,RESULTS
100,169,1CM,2012,2CM,BACKGROUND,CHANGES,COPYRIGHT,CT1,CT2,CT3,CTS,D2CM,DVHS,HOWEVER,IRELAND,LABEL,LTD,METHODS,OARS,OBJECTIVE,PDR,PTV,PURPOSE,RESULTS,V100
169,2012,78GY,8805,CONCLUSION,COPYRIGHT,EORTC,GRADE,IMRT,INTENSITY,IRELAND,LABEL,LTD,METHODS,MODULATED,MRI,OBJECTIVE,PURPOSE,RESULTS,RTOG,SIX,SPACE,THESE
169,1906,2000,2004,2013,AREA,CARE,COMMUTING,CONCLUSION,COPYRIGHT,DATA,HORMONE,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,QUALITY,REGISTRARS,RESULTS,RURAL,URBAN,USING
1011,1034,169,2012,AFRICAN,CAUCASIAN,CONCLUSION,CONTENT,COPYRIGHT,HCP,HCPS,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,REGARDLESS,RESULTS
169,2012,COPYRIGHT,LTD,THESE
001,003,008,169,1997,2006,2013,5077,ACM,AHR,CAD,CHICAGO,COPYRIGHT,COX,FINE,GLEASON,GRAY,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OTHER,PURPOSE,RESULTS,THESE
169,2013,215,945,946,BASED,CIS,CONCLUSION,COPYRIGHT,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
169,176,2013,931,963,CBCT,COPYRIGHT,DAILY,INC,LABEL,MATERIALS,MEAN,METHODS,OBJECTIVE,PURPOSE,RESULTS,SVS,THEREFORE,USING
001,003,169,1992,2008,2013,8805,895,COLORECTAL,COPYRIGHT,HISPANICS,HODGKIN,HOWEVER,MATCH,NHL,SIR,SIRS,SOCIETY,TRANSPLANT
169,2001,2007,2012,BACKGROUND,BETWEEN,CONCLUSION,COPYRIGHT,ECE,GLEASON,LABEL,METHODS,MRI,OCD,OTHERWISE,PCA,PSA,PUBLISHED,RESULTS,SVI,THESE
001,1000,169,2013,75994,8805,ADD,ADT,AMONG,BJU,COX,DOES,END,HOWEVER,KNOWN,LABEL,MEN,METHODS,OBJECTIVE,RECEIPT,RESULTS,SUBJECT,UNLABELLED,WHAT
001,169,2013,264,633,647,742,8805,ADD,ASIAN,BJU,DOES,DRE,KNOWN,LABEL,METHODS,OBJECTIVE,PCA3,PSA,PSAD,RESULTS,SUBJECT,UNLABELLED,URINE,USING,WHAT
015,019,021,169,192,1995,2011,2013,8804,BJU,COX,CSS,GLEASON,GROUP,LABEL,LNS,MAY,MEAN,MEIER,METHODS,OBJECTIVE,OBJECTIVES,PCA,PLND,RESULTS
001,1311,169,2006,2010,2013,8805,ADD,BJU,BMI,DOES,IIEF,INDEX,KNOWN,LABEL,MEIER,METHODS,OBJECTIVE,REGRESSION,RESULTS,SUBJECT,THESE,UNLABELLED,URINARY,WHAT
160,169,2013,CUTANEOUS,MOST,SOCIETY,TREATMENT
8Q24,LOSS,PSCA,SNP,SNPS,THEREAFTER
001,2004,2005,293,ABORIGINAL,ABOUT,APRIL,CONCLUSION,INDEX,INDIGENOUS,LABEL,MAIN,MAY,METHODS,OBJECTIVE,OUTCOME,QUEENSLAND,RESULTS,SETTING,TERRITORY,WHILE
HOWEVER
252,BOZF,BOZF1,BTB,C2H2,POK,POZ,SP1
141,182,200,200A,ECTOPIC,EXPRESSION,GNA12,GNA13,GPCRS,KNOCKDOWN,LNCAP,PC3,RHO,RNAS,THESE,UTR
001,100,116,130,177,2000,2013,215,500,800,ADC,ADCS,CONCLUSION,CSRS,DIFFUSION,GLEASON,LABEL,MATERIALS,METHODS,OBJECTIVE,PCA,PURPOSE,RESULTS,RSNA
169,183,AFTER,GEORG,STUTTGART,YORK
143,204,347,BACKGROUND,GLEASON,GROUP,INSTITUTE,LABEL,MATERIALS,MEAN,METHODS,PSA,RESULTS,WORKING
002,008,293,8804,967,BACKGROUND,CONCLUSION,COX,GLEASON,IHC,LABEL,METHODS,RESULTS,TURP
BCR,DATA,EBL,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,POTENCY,RESULTS,ROBOTIC,SALVAGE
001,178,179,215,8315,ADC,CSR,CSRS,FIFTY,GLEASON,LABEL,LEVEL,MANN,MATERIALS,MEAN,METHODS,MRI,OBJECTIVE,PCA,PURPOSE,RESULTS,WHITNEY
482,967,BACKGROUND,CONCLUSION,DATA,HAROW,HOWEVER,LABEL,MATERIALS,METHODS,PROS,REGARDING,RESULTS,SPECIAL,THEREFORE

100,169,2013,BASEL,CD20,CD204,CD3,CD68,CD79ALPHA,COPYRIGHT,LABEL,MEDIATORS,METHODS,OBJECTIVE,RESULTS,THERE
LUNG,STAGING
SEVERAL,THERE,WNT
002,273,691,APPEARANCE,ASSUMED,FINNISH,GLEASON,LABEL,LOCALIZED,METHODS,MRI,OBJECTIVE,PEARSON,PRIAS,PSA,RESULTS
2004,2011,8482,BACKGROUND,DATA,GREENLIGHT,KTP,LABEL,MATERIALS,MEAN,METHODS,OBJECTIVE,RECURRENCE,RESULTS,SEPTEMBER,THERE
AMS,CATHEPSIN,FURTHER,SELECTIVE
CD133,CWR,DESPITE,FGF5,FIBROBLAST,GLEASON,LAPC,LOSS,MDV3100,RESISTANCE,SCORE,SOX2,SRY,THESE
8764,AFM,FORCE,GNRH,HIGH,LNCAP,MICROSCOPY,PCA,THUS,WESTERN
945,CARCINOMA,FUC,FUT1,GNTV,LNCAP,LYMPH,MGAT5,NODE,USING
KNOCKDOWN,THEREFORE,USING
007,105,126,169,183,231,386,GEORG,GSU,LESIONS,OVERALL,RTE,STUTTGART,SUSPICIOUS,YORK
169,183,2008,2009,2012,APRIL,BASED,GEORG,PET,PSA,SEPTEMBER,STUTTGART,TREATMENT,YORK
001,128,2003,2009,379,8804,ADT,AMONG,BACKGROUND,DATA,EBRT,FFBF,GHANA,GLEASON,LABEL,MEIER,METHODS,PSA,RESULTS,THERE,WEST
147,210,AIMS,BACKGROUND,BREF,COLLEGE,CONCLUSION,DIAGNOSTIC,DSM,EDITION,LABEL,LIFE,METHODS,OBJECTIVE,QOL,QUALITY,RESULTS,UNIVERSITY,WORLD
BACKGROUND,BUM,DEGS,DISCOVERY,FALSE,FDR,HIGH,INFERENCE,LABEL,METHODS,MICROARRAY,NEXT,PREDICTION,RATE,REALITY,RESULTS,USING
001,1000,110,2000,215,300,700,ADC,ADCS,AUC,CONCLUSION,DWI,LABEL,MATERIALS,MEAN,METHODS,MRI,OBJECTIVE,RESULTS
169,2013,COPYRIGHT,HODGKIN,INC,SOCIETY
169,2013,945,946,956,BT549,COPYRIGHT,DU145,EIGHT,GMBH,HEXADECYL,HOWEVER,JIMT1,KGAA,PC3,VCH,WILEY
111,267,278,ANPEP,APN,BACKGROUND,COMBINING,CONCLUSION,CSS,LABEL,METHODS,METHYLIGHT,NOVEL,RESULTS,RFS
CRPC,PREDICTIVE,THESE
DESPITE,III,PREVIOUSLY
1974,ARMED,BRADY,HOPKINS,INSTITUTE,JOHNS,RADICAL,UROLOGICAL,USING
KNOWLEDGE,LABEL,OBJECTIVE,PURPOSE,RESULTS,SUMMARY
DIETARY,LABEL,OBJECTIVE,PDE5,PURPOSE,RADICAL,RESULTS,SUMMARY,THESE
169,2013,289,COPYRIGHT,EDUCATION,GLEASON,INC,IQR,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RADICAL,RESULTS,UROLOGICAL
0001,168,2558,417,530,BACKGROUND,CAP,CONCLUSION,ERK5,GLEASON,LABEL,MEK5,METHODS,RESULTS,STUDIES,THESE,TMA,TMAS
001,019,100,161,515,8804,BACKGROUND,CDK,CDK1,CONCLUSION,ERK1,HIGH,LABEL,LNCAP,METHODS,PSA,RESULTS,S515
ADT,HOWEVER,PSA
169,2013,947,BACKGROUND,COPYRIGHT,DESPITE,DU145,H2AX,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PC3,PI3K,PTEN,PURPOSE,RESULTS
169,2013,BLACKWELL,DESPITE,GERMANY,HOWEVER,ITALIAN,ITALY,LTD,MOST,OVERALL,PUBLISHING,RESULTS,SPAIN,SPANISH
000,100,1999,2008,2009,2010,2014,ASR,BACKGROUND,CENTRAL,CONCLUSION,DESPITE,FINALLY,INCREASING,LABEL,METHODS,RESULTS,SERBIAN,THESE,USING,VOJVODINA
169,2002,2013,8201,AFTER,CWS,UROLOGICAL
001,144,1627,169,1997,2007,2010,2013,285,345,356,616,6TH,7965,7TH,8201,9235,980,ANESTHESIA,DIAGNOSIS,INDEX,PROCEDURE,UROLOGICAL
124,1268,169,2013,211,8804,ADD,BJU,CLOSE,DATA,DOES,GLEASON,GROUP,KNOWN,LABEL,METHODS,MRI,OBJECTIVE,PRIAS,PSA,RESULTS,SUBJECT,UNLABELLED,WHAT
001,169,1998,2007,2013,219,388,727,8804,8805,955,963,AUC,AUCS,BJU,CALIFORNIA,GLEASON,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,PERMANENTE,PSA,RESULTS
145,169,2013,386,471,573,8482,965,BJU,COX,GWAS,LABEL,MARSDEN,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,ROYAL,SNP,SNPS,THERE
169,2013,ADD,BASED,BJU,DOES,KNOWN,MRI,SUBJECT,WHAT
160,169,2005,2008,2013,AIM,AUTHORS,BRITAIN,COLORECTAL,CONCLUSION,DATA,DISEASE,EIGHT,GREAT,IRELAND,LABEL,METHODS,OBJECTIVE,RESULTS,RIHT,TARD,THERE,TRANS,TREATMENT
169,2013,ALDEFLUOR,ALDH1,CICS,CSCS,HEPATOCYTE,HGF,MET,PCR,TAKEN,WESTERN
305,364,BACKGROUND,CONCLUSION,FIRSTLY,GIVEN,LABEL,LNCAP,LXR,OVERALL,PRINCIPAL,RESULTS,SREBP,USING
169,2012,947,AACR,AMONG,BRCA1,EXPRESSION,FOXP3,SITE,SOMATIC
LNCAP,POLYAMIDE,RNAP2,RPB1
2007,2008,246,426,ACADEMY,JANUARY,JULY,LABEL,LEADING,MEMBERS,METHODS,NETWORK,OBJECTIVE,PHYSICIANS,PURPOSE,RESULTS
2D3,CRC,GIVEN,HOWEVER,THEREFORE,WNT
945,946,ALSO,MAPK,SEVERAL,THS,THUS,THYROID,TSH,YET
17A1,17B3,1C3,22RV1,8202,AKR,CYP,HSD,IGF1,IGF1R,IGF2,INHIBITION,INSR,LNCAP,PSA,STAR,TREATMENT
116,169,2013,3OMGA,947,CONCLUSION,DHPAA,EGCG,GMBH,HCT,HPAA,HPLC,KGAA,LABEL,METHODS,RESULTS,SCOPE,SERUM,TEA,URINE,VCH,WILEY
169,2013,500,946,CD127,CD25,CD4,COPYRIGHT,DUSP1,FOS,INCREASED,JUN,PBMC,RESULTS,RGS1,STUDIES,TGF,TREG,TREGS,UICC
128,169,2013,COPYRIGHT,ERG,ETV1,EXPRESSION,MOLECULAR,PCR,TDRD1,TMPRSS2,TUDOR,UICC,VCAP
946,AIM,CONCLUSION,CRC,EST,HOWEVER,HSD,INITIALLY,LABEL,MEDLINE,METHODS,OBJECTIVE,RESULTS,STS
ASAP,LOW,PIN
0488,ADDITIONAL,BACKGROUND,CONCLUSION,CONTEXT,DENMARK,FOLLOWING,LABEL,METHODS,OBJECTIVE,OUTCOME,PRIMARY,RESULTS,SECONDARY,SETTING,SIMILARLY
024,045,AST,BACKGROUND,FIFTY,FOLLOWING,LABEL,METHODS,PR25,QLQ,RESULTS,THERE,TREATMENT
1999,2011,8201,8804,8805,967,BACKGROUND,FIFTY,GLEASON,JANUARY,LABEL,MEAN,METHODS,MOST,POTENTIAL,PSA,RESULTS
EZH2,NOV,THEREFORE,THROUGH
1000,250,AAA,AIR,DOSE,DOSIMETRIC,EBRT,GTV,HOUNSFIELD,IMRT,PTV,RED,THERE,THUS,WHILE
021,177,421,798,DVH,DVHS,EUD,NAGELKERKE,NTCP,NTCPS,PC1,PC2,PCA,PRINCIPAL,TCP,WALD
125I,131,EDEMA,EHL,TCP,THESE
CHANGES,HOWEVER,PSA,RAPID
5857G,BACKGROUND,BRCA1,BRCA2,DIAGNOSIS,DOPPLER,EARLY,ERG,G84E,GLEASON,GLU1953,LABEL,MANAGEMENT,METHODS,PSA,RADICAL,RESULTS
1159,1437,2003,2009,2NG,3MM,8804,8805,AMICO,BACKGROUND,BRFS,COX,FORWARD,GLEASON,IRB,LABEL,MEAN,MEIER,METHODS,MULTIFOCAL,OBJECTIVE,OBJECTIVES,OVERALL,PSA,RALP,RESULTS
223,AREAS,BACKGROUND,BONE,COVERED,CRPC,III,LABEL,METHODS,OPINION,PHASE,UNTIL
2013,APA,HOWEVER,KEY,LABEL,METHODS,MOST,OBJECTIVE,PATIENT,RESULTS,THESE
2013,APA,DISCLOSURE,FIFTY,FOUR,FRAMEWORK,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,WORK
2013,APA,ASPECTS,CMT,DECREASED,EAC,EMOTION,LABEL,LOW,METHODS,OBJECTIVE,RESULTS,SIXTY,WHETHER
467,BACKGROUND,LABEL,METHODS,RESULTS,TSP,UTR
169,2013,ALA,HOWEVER,INC,MANGANESE,MNSOD,PCA,THEREFORE,TURKISH,VAL,WILEY
543,652,ELISA,FURTHER,GLEASON,HOWEVER,IGF,IGF1,IGF2,IGFS,ORS,PCPT,PREVENTION,RESULTS,THESE,TRIAL
002,010,119,146,157,2003,2006,205,227,438,665,776,884,ACUTE,ADVERSE,BETWEEN,CONCLUSION,D10,D90,GLEASON,GRADE,LABEL,LATE,MEAN,METHODS,OBJECTIVE,RESULTS,UNIVARIATE,V100
6583,945,A2A,A2B,AMP,BAY60,CHX,DU145,LDH,LNCAP,NECA,PCR,THUS,TNF,WESTERN
22RV1,945,AKT,CXCR4,DESPITE,FURTHER,HIF1,HOWEVER,PTEN,ROS
128,BPH,KOREA,PSA
129,142,156,239,348,391,8805,ATP,AUC,BAP,BECAUSE,CONCLUSION,CRPC,CTC,CTCS,CTX,KX2,LABEL,METHODS,OBJECTIVE,PFS,PPFS,PSA,PURPOSE,RESULTS,SECONDARY,SRC
BACKGROUND,CONTROL,FINALLY,FURTHER,LABEL,METHODS,MULTI,PSA,QUALITY,RESULTS,TMC
125,945,AFP,BACKGROUND,BOTH,CBS,CEA,FPSA,LABEL,METHODS,PGD,RESULTS,THERE,TPSA
8482,CARCINOMAS,CELLSEARCH,CTCS,DRUG,DUE,FOOD
169,2013,AP3A,C22,COPYRIGHT,FHIT,INC,LNCAP,MYC,NADPH,ROME,S1P,SK1,SK2,SKI,THESE,WARBURG
169,2012,BAYES,COPYRIGHT,LTD,POISSON,THROUGH
155NM,174T,24H,250NM,956,BECAUSE,CACO2,DECREASED,DPI,DRUG,DTI,DU145,H2O2,INC,NADPH,NOX1,PUBLISHED,ROS,THESE
8209,916,CLAUDIN,DATA,NH2,NP63
100,169,1995,2011,2012,768,AIMS,ASSESSMENT,COLLEGE,CONCLUSION,COPYRIGHT,DCE,DIAGNOSTIC,EBRT,JANUARY,LABEL,LTD,MATERIALS,MEDLINE,METHODS,MRI,MRSI,NINE,OBJECTIVE,OCTOBER,PUBLISHED,QUALITY,RESULTS,ROYAL,SEVEN,STUDIES,T2WI
169,2013,COPYRIGHT,FINALLY,FOXP3,IPEX,LTD,WHILE
111,169,2012,ASSESSMENT,BACKGROUND,COPYRIGHT,EPIC,FACT,FORTY,FUNCTIONAL,HADS,LABEL,LTD,MEAN,METHODS,RESULTS,SURVEYS,THERAPY
094,169,2013,232,519,571,958,AUASS,AUC,AUCS,COPYRIGHT,DETECTION,EARLY,EDRN,EDUCATION,EXCLUDING,GLEASON,INC,LABEL,MATERIALS,METHODS,NETWORK,OBJECTIVE,PCPT,PREVENTION,PUBLISHED,PURPOSE,RESULTS,RISK,ROC,TRIAL,UROLOGICAL
000,169,174,2005,2008,2012,2013,213,276,300,426,APRIL,BASED,COPYRIGHT,EDUCATION,INC,INFECTION,INHIBIZONE,JANUARY,JUNE,LABEL,MARCH,MATERIALS,METHODS,OBJECTIVE,PATIENT,PUBLISHED,PURPOSE,RESULTS,THEREFORE,UROLOGICAL
169,2009,2011,2013,339,COPYRIGHT,EDUCATION,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PB12,PB20,PUBLISHED,PURPOSE,RESULTS,SECONDARY,UROLOGICAL
0002,169,2006,2011,2013,337,BETWEEN,C30,COPYRIGHT,EDUCATION,EORTC,GROUP,INC,INDEX,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PATIENT,PR25,PUBLISHED,PURPOSE,QLQ,RADIATION,RESULTS,RTOG,SCORE,SYMPTOM,THERAPY,TREATMENT,UROLOGICAL
169,2013,AFTER,CAP,COPYRIGHT,HOWEVER,INC,INCREASED,LUMINAL,PATHOLOGY,PTEN,PUBLISHED,SMAD4,SOCIETY,SPP1,TAKEN
168,169,1922,1990,2010,2012,621,BACKGROUND,COPYRIGHT,COX,FIFTY,INCREASED,LABEL,LOWER,LUTS,MEN,METHODS,NEITHER,OBJECTIVE,OUTCOME,PCA,PUBLISHED,RESULTS,SELF,SETTING,THESE,UROLOGICAL,UROLOGY
169,2003,2011,2012,239,442,ALP,BACKGROUND,COPYRIGHT,COX,CRPC,DUE,JUNE,LABEL,LDH,METHODS,MVA,OBJECTIVE,OUTCOME,PREDICTED,PROGNOSTIC,PSA,PUBLISHED,RESULTS,SETTING,SMALETZ,UNASSIGNED,UROLOGY
1000,160,169,177,2013,304,318,4406,485,556,700,ACCORDING,CONCLUSION,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PSA,RESULTS,THESE,USING
086,160,169,1998,2008,2013,CONCLUSION,COPYRIGHT,EINDHOVEN,INC,LABEL,METHODS,OBJECTIVE,OVERALL,PSA,RESULTS,SES,TREATMENT,YOUNGER
001,160,169,2012,440,AIMS,ANOVA,COLLEGE,CONCLUSION,COPYRIGHT,GENERAL,INSTITUTE,KRUSKAL,LABEL,LTD,MATERIALS,MEN,METHODS,OBJECTIVE,PUBLISHED,RESULTS,ROYAL
0001,107,169,2012,3MM,8805,8MM,BACKGROUND,CASES,COPYRIGHT,CROWN,IMAGE,KOLMOGOROV,LABEL,METHODS,OBJECTIVE,OUTCOME,PUBLISHED,RESULTS,SETTING,SMIRNOV,SYSTEMATIC,TRUS
001,013,169,2013,8201,CLINICALLY,MEDLINE,UROLOGICAL
1990,2000,AUA,BACKGROUND,BASED,CONCLUSION,LABEL,MEAN,METHODS,PRE,PSA,PSAS,RESULTS,SHIM,SUBJECTIVE,THESE
1996,2005,238,869,AOR,AORS,BACKGROUND,CIS,HODGKIN,LABEL,METHODS,OBJECTIVE,OHIO,PFOA,RESULTS,STRENGTHS,THERE,WEST
DISEASE,DU145,DUPRO,HPV,LNCAP,NUCLEAR,SATB1,SIMILARLY,SPECIAL
100,BACKGROUND,HIGH,HOWEVER,LABEL,MRI,NPV,PPV,PRINCIPAL,RESULTS,SWI
AFRICAN,BACKGROUND,BMI1,BPH,CAP,CAUCASIAN,CAUCASIANS,ELISA,FURTHER,LABEL,LACK,PRINCIPAL,PSA,RESULTS,SEMI,SLOT,THUS,TRAMP
AKT,DAB2,DOC,DSB,HOWEVER,LC3B,PCA,PKCS,RADIATION,RAS,S6K,TAKEN
ADT,AMONG,CRPC,PCA,THESE

100,215,956,AB2,AGCL,CAPTURE,EACH,ECL,PDMS,POTENTIAL,PSA,RUBPY,THEN,TPRA
TOTAL
2012,ADT,ASCO,CASTRATION,CRPC,HOWEVER,MDV3100,MEETING,RESISTANT,THUS
AMONG,ASIA,ASIAN,CHILE,CHILEAN,EAST,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIR,SIRS,SWEDISH,T1C
CASITAS,CBL,DR4,DR5,TRAIL
169,183,192,193,2004,2008,2013,ADT,AFTER,AMGEN,AVENTIS,BACKGROUND,BELGIUM,BETWEEN,COPYRIGHT,DEC,DOCETAXEL,EARLY,FOUR,FUNDING,GLASS,IQR,KARNOFSKY,LABEL,LTD,METHODS,OCT,PHRC,RESULTS
169,2013,8201,MEN,UROLOGICAL
AUSTRALIAN,BACKGROUND,CFS,FFPE,GENOMIC,GLEASON,LABEL,METHODS,MLV,NONE,PCR,R462Q,RESULTS,RNASE,SAMPLES,USING,WHILE,XENOTROPIC,XMRV
001,006,035,037,169,1988,2010,2013,2058,8201,8804,8805,BJU,BMI,BMIS,COX,EQUAL,LABEL,MEN,METHODS,OBJECTIVE,PCA,RESULTS,WHERE
169,174,2009,2011,2013,260,8804,ADD,BETWEEN,BJU,BOARI,CLAVIEN,DINDO,DOES,DUR,IIIB,IVA,JUNE,KNOWN,LABEL,METHODS,OBJECTIVE,OCTOBER,OPEN,PUBLISHED,RESULTS,ROBOT,SUBJECT,THERE,UNLABELLED,WHAT
125,169,180,186,2001,2005,2013,ADD,AFTER,APRIL,BJU,D90,DOES,HOWEVER,IIEF,INDEX,IPSS,KNOWN,LABEL,METHODS,MORBIDITY,OBJECTIVE,RESULTS,SCORE,SUBJECT,SYMPTOM,THERE,UNLABELLED,USING,WHAT
AZIKIWE,BACKGROUND,CONCLUSION,LABEL,MALIGNANT,METHODS,MOST,OBJECTIVE,RENAL,RESULTS,THERE,UNIVERSITY
AZIKIWE,BACKGROUND,CONCLUSION,LABEL,MALIGNANT,METHODS,MOST,OBJECTIVE,RENAL,RESULTS,THERE,UNIVERSITY
BACKGROUND,CFSE,INITIAL,LABEL,METHODS,NPS,RESULTS,USING,WEV
024,054,058,1072,1095,110,123,131,370,BOTH,CONCLUSION,ESTIMATED,EXM,LABEL,MBQ,METHODS,MIP,RESULTS,SEVEN,SPECT,THESE,UNLABELLED,WHOLE
1985,SINGAPORE
2011,CONFERENCE,CONSENSUS,ESMO
CXCR4,CYPD,PPIF,STAT3,THEREFORE,THESE
BACKGROUND,HODGKIN,HOWEVER,LABEL,METHODS,NEWER,PHYSICIANS,RESULTS,RIT,SEVERAL
BACKGROUND,DRUG,DUE,FOOD,INITIAL,LABEL,METHODS,MONOCLONAL,RESULTS,THERE,THEREFORE
BACKGROUND,COMBINING,DATABASES,FINALLY,LABEL,METHODS,RESULTS,SCHOLAR,THERE,THROUGH
BACKGROUND,DATA,DRUG,FOOD,III,LABEL,METHODS,PERIPHERAL,RESULTS,SIPULEUCEL,THERE
201,300,501,799,830,8805,CONCLUSION,GLEASON,LABEL,METHODS,OBJECTIVE,RESULTS
163,177,242,8805,967,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,SPSS
2006,2011,2121,8805,AFRICAN,APRIL,BRAZILIAN,LABEL,MEN,METHODS,OBJECTIVE,PURPOSE,RESULTS,RISK
001,737,CENTRAL,CHI2,CONCLUSION,LABEL,MATERIALS,MEDLINE,METHODS,NNT,OBJECTIVE,RATIO,RESULTS,RISK,SEVERAL,SIPULEUCEL,TTP
149,2001,2010,421,592,BACKGROUND,CONCLUSION,GLEASON,IPC,LABEL,MATERIALS,METHODS,RESULTS,THESE
946,AKT,CAV,DU145,GLUT3,HK2,IGF,LNCAP,LRP6,MYC,OVERALL,THESE,WNT
169,2013,945,AKT,AUTHORS,BLACKWELL,BONE,COMMONS,DU145,ERK,FOUNDATION,HOWEVER,LICENSE,LTD,MOLECULAR,MSCS,PUBLISHED,PUBLISHING,SDF1,USING
169,2012,945,946,AKT,AUTHORS,BLACKWELL,COMMONS,CXC,CXCR4,EGFR,EMT,FOUNDATION,HIF,HIFS,IGF,KIT,LICENSE,LTD,MOLECULAR,NANOG,NOTCH,OCT,PI3K,PUBLISHED,PUBLISHING,SCF,SOX,TGF,THESE,VEGF
2011,8563,BF3,CHEM,FLUTAMIDE,HOWEVER,LNCAP,MED,NILUTAMIDE
160,169,1989,1ST,2013,AIMS,APPRAISAL,BACKGROUND,BLACKWELL,CONCLUSION,DATA,DIEKELMANN,FACE,KNOWLEDGE,LABEL,LTD,MEN,METHODS,NLN,NURSING,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHING,RALP,RELEVANCE,RESULTS,STUDIES,YORK
BACKGROUND,CASE,CLEAR,CONCLUSION,LABEL,METHODS
CONCLUSION,DAB,GLEASON,LABEL,METHODS,OBJECTIVE,PSA,RESULTS,THERE,VORONOI
001,003,009,084,215,BACKGROUND,GWAS,JAK,KEGG,LABEL,NEXT,PATHWAY,RESULTS,STAT
624,8805,ALN,BACKGROUND,COX,FURTHER,INSURANCE,LABEL,METHODS,NHI,RESULTS
945,946,AKT,CAM,CD31,CD34,ERK,GELATIN,MMP,TAKEN,TNF,VEGF,WESTERN
23B,27B,CONVERSELY,HOWEVER,INHIBITION,LNCAP,MICRORNAS,MIRS,RAC1,RNAS,THESE
133,AKT,AKT1,AKT2,ALSO,BACKGROUND,BMS,DUAL,IGF,INSULIN,LABEL,MATERIALS,MDA,METHODS,PCA,RESULTS,SFK,SRC,THESE,THUS,TREATMENT
946,CATENIN,HOWEVER,MYC,NKX3,PTEN,THESE,WESTERN
AKT,CYLD,DUB,K63
001,2012,CRPC,DRUG,FATIGUE,FDA,FOOD,III,MDV3100,MEDIVATION,PSA,SEPTEMBER
2344,APC,COMBINING,PCA,POOLING,PSA
946,A549,ACCORDING,CHIP,CPG,DU145,FIRST,FISH,H3K9ME3,LNCAP,PC3,PCR,RAR,RARA,WESTERN,WHILE
177,2013,202,212,ARSENIC,DESPITE,EPIDEMIOL,GIVEN,TAIWANESE,THERE
154,381,763,788,818,BOTH,ECOG,HOME,HOWEVER,LABEL,METHODS,NURSE,OBJECTIVE,PATIENT,PHYSICIAN,PHYSICIANS,PURPOSE,RESULTS,ZOL
130,177,181,200,246,257,2X2,400,427,547,581,AFRICAN,ALZHEIMER,AMERICANS,BOTH,CERAD,CONCLUSION,CONSORTIUM,ESTABLISH,GROUP,LABEL,METHODS,MIS,MOST,OBJECTIVE,OBJECTIVES,ONCE,PARTNERING,PREADVISE,RCT,RESULTS,SETTING,SEVERAL,SOUTHWEST,STAFF,SWOG,TICS,WHILE
145,177,2005,2011,AES,BACKGROUND,CRPC,CSS,DOC,HOWEVER,LABEL,LEUKOPENIA,METHODS,PSA,RESULTS,SERUM
169,2012,AIM,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,MEDLINE,META,METHODS,NEWCASTLE,OBJECTIVE,OCTOBER,PRIOR,RESULTS,RRS,SCALE,STATA
146,BACKGROUND,CHROMATIN,DU145,GLEASON,LABEL,LNCAP,PC3,PCA,RESULTS,THESE,THUS,TRANSWELL,USING,WT1
DESPITE,INITIAL,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,THROUGH
0001,916,IMRT,LABEL,METHODS,OBJECTIVE,OVH,PTV,PURPOSE,RESULTS,TREATMENT,WHETHER
AAA,BOLTZMANN,CARLO,COMPARING,ECLIPSE,FILM,LABEL,METHODS,MONTE,OBJECTIVE,PURPOSE,RADIO,RESULTS,THESE,USING
8725,945,946,CARE,HOWEVER,ISOEFFECT,LABEL,METHODS,OBJECTIVE,PURPOSE,RBE,RESULTS
DESPITE,EARLIER,PDE5,RADICAL,TADALAFIL
063,138,2002,2011,375,380,518,900,991,CONCLUSION,GLEASON,HAN,HANS,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS,UYGUR
AFTER,BAX,BCL,CONCLUSION,LABEL,METHODS,MTT,OBJECTIVE,PAR,PC3,RESULTS,WESTERN
146,169,2012,AIM,BACKGROUND,COPYRIGHT,DEPARTMENT,LABEL,MEAN,METHODS,OBJECTIVE,PARTNER,PUBLISHED,RESULTS,SOCIETY,URBAN
177,CTV,D2CC,D90,HDRIB,INSTITUTE,PRE
200,CROHN,MSC,SLE,THESE
001,004,154,302,480,658,CHEK2,I157T,IVS2G,MUTATIONS,TRUNCATING
BLADDER,CERTAINLY,EAU,ENDOSCOPIC,ESPU,HOWEVER,INFANTS,MRI,PAEDIATRIC,SOCIETY,THERE,UROLOGY,UTI,VCUG,VUR
160,353,ACCOUNTING,AMONG,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,STUDIES,SWEDISH
GLEASON,PSA,RADICAL
0001,001,036,132,156,177,438,446,8805,ADDICTION,AMONG,GLEASON,HOWEVER,OPIUM,PSA,SERUM,TOTAL
001,019,101,169,2000,2011,2012,480,487,8804,896,BACKGROUND,BASEL,BETWEEN,COPYRIGHT,COVARIATES,EUR,GLEASON,LABEL,LNI,MEAN,METHODS,PCA,PSA,RESULTS,UNI,UROL
916,955
001,002,2007,2011,499,8805,ATTITUDES,CONCLUSION,COST,EVEN,FORTY,LABEL,LOWER,METHODS,OBJECTIVE,PURPOSE,RESULTS,SES,STUDIES
467,CONCLUSION,HGPIN,III,LABEL,MEIER,MEN,METHODS,OBJECTIVE,PCA,PURPOSE,RESULTS
100,2008,2010,AFTER,FORTY,INCIDENTAL,JANUARY,LABEL,MARCH,METHODS,OBJECTIVE,OBJECTIVES,PROSTATIC,RESULTS,SCORE,SYMPTOM
BACKGROUND,CAR,GIVEN,HOWEVER,LABEL,METHODS,MUC1,RESULTS,WESTERN
004,169,2013,270,490,8804,AGE,BASEL,COPYRIGHT,DRE,LABEL,METHODS,OBJECTIVE,PREDICTIVE,PSA,RESULTS,TRUS
169,177,2012,AUC,CAP,COD,COMPARING,COPYRIGHT,DSS,EMBEDDING,EVEN,FIELD,GLEASON,GRAPH,MRI,MRS,MULTI,ROC,SEMI,STEP,SUPERVISED,T2W
946,BPH,CELSIUS,CPG,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PCA,PCR,QMSP,RAR,RESULTS,UNLABELLED
002,014,169,170,176,177,183,184,2004,2009,2013,BACKGROUND,COPYRIGHT,DOCETAXEL,ENROLMENT,FINLAND,FUNDING,GRADE,IRELAND,LABEL,LTD,MARCH,MAY,METHODS,RESULTS,TTTF
115,161,169,174,177,200,2013,ADD,BELGIUM,BJU,CONCLUSION,DOES,GERMANY,KNOWN,LABEL,METHODS,OBJECTIVE,PSA,RESULTS,SEVEN,SIX,SPAIN,SUBJECT,TESTOPATCH,THESE,UNLABELLED,UROLOGY,USA,WHAT
169,2013,8805,AGR,AGR2,AGR3,ANDROGENS,AUTHORS,BOTH,DUCAP,FEBS,FKBP5,JOURNAL,PCR,POL,VCAP
300,8805,ACCORDING,AVOIDANCE,BACKGROUND,DISCUSSION,FACED,FURTHER,IDENTIFIER,LABEL,METHODS,NCT,OTHER,RCT,TRIAL
AREAS,BACKGROUND,COVERED,CURRENTLY,IGF,LABEL,METHODS,OPINION,THESE
1120,460,AFTER,DNMT,DNMTS,DU145,EC50,G9A,PKMT,SSSI,THEIR,YFP
DENDRIMERS,GIVEN,THESE
188,DU145,HER2,HERCEPTIN,HOWEVER,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,RHENIUM,TREATMENTS
125,169,2004,2011,2013,466,8201,ACUTE,APRIL,D90,GRADE,GROUP,JANUARY,LABEL,METHODS,MOST,OBJECTIVE,OBJECTIVES,RADIATION,RESULTS,SCORE,SYMPTOM,THERAPY,UROLOGICAL,V100,V150
001,005,006,169,1997,2008,2013,8805,CONCLUSION,COX,GLEASON,KYOTO,LABEL,MEDICAL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SALVAGE,THUS,UNIVERSITY,UROLOGICAL
001,162,169,2013,8201,ANGELES,CALIFORNIA,HOWEVER,INDEX,LABEL,LOS,METHODS,OBJECTIVE,RESULTS,THERE,UNIVERSITY,UROLOGICAL
BECAUSE,INCREASED,SBE,SBES
CPA
119,169,177,2012,916,BECAUSE,CO2,CONCLUSION,COPYRIGHT,GH3,INC,LABEL,MATERIALS,MEAN,METHODS,MRI,OBJECTIVE,PC3,PURPOSE,RESULTS,WILEY
0001,1000,169,2000,2012,341,AUC,AUCS,CONCLUSION,COPYRIGHT,DWI,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,ROC,T2WI,WILEY
126,141,142,177,1978,2011,244,289,409,830,834,881,93960,AWARENESS,EIGHT,MDACC,MEAN
INC,KIT,MET,RANDOMIZED,VEGF,XL184
8209,ORAL,OSCC,RNAS,THESE,THUS,WHILE
8201,848,872,8805,958,AFRICAN,AMERICANS,END,LABEL,METHODS,NINE,OBJECTIVE,OBJECTIVES,PALLIATIVE,PCN,REASONS,RESULTS,RUS,SIXTEEN,THERE,USING
177,6TH,IPSS,LABEL,MEN,METHODS,OBJECTIVE,PURPOSE,PVR,QOL,RESULTS,TAMSULOSIN,THERE,TRUS,UFM
100,177,270,275,BACKGROUND,CLASICC,CRM,FIFTY,IPSS,LABEL,METHODS,RESULTS,ROBOTIC,SCORE,SYMPTOM,TME
160,380,8209,ESTS,PC3,PCAG1,PCR,REVERSE,SAGE,WHILE
GFM,HGPIN
118,130,8209,8805,AMONG,BASED,BLOOD,C70T,GLEASON,OVERALL,PCR,PSA,RFLP
ADP,APOPTOSIS,BAX,BCL,CORDYCEPIN,CORDYCEPS,HOWEVER,IAP,MMP,ROS
100,120,126,130,156,164,172,194,210,220,245,290,313,6300,BECAUSE,IMPLANT,JAPAN,PERMANENT
HDAC,IGFBP,LNCAP,MICE
038,1998,2007,2009,ADT,BACKGROUND,CONCLUSION,GLEASON,LABEL,MEN,METHODS,RESULTS,THEREFORE,WHILE
000,442,8804,8805,986,BACKGROUND,BPH,BRCA1,CONSORTIUM,COX,CRC,FINLAND,FINNISH,FINNS,G84E,GENOTYPING,ICPCG,LABEL,MASSARRAY,METHODS,PSA,RESULTS,THESE
223,535,AGE,CHINESE,DRE,NOMOGRAMS,PSA,TRUS
AFTER,LABEL,LNCAP,METHODS,OBJECTIVE,PEG,PEI,PSMA,PSMAE,RESULTS,THEIR,THESE
169,2012,223,COPYRIGHT,III,LTD,PUBLISHED,TREATMENT
000,100,2004,2005,2008,297,535,802,BOTH,CHINA,CONCLUSION,DATA,LABEL,METHODS,MORTALITY,OBJECTIVE,PREVENTION,RESULTS,THIRD
0001,0003,002,005,007,026,036,169,2013,COPYRIGHT,CT1,CT2,D10,D15,D20,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,V50,V60,V70,V80,V90
152,169,2012,BASED,COPYRIGHT,CRPC,DOX,GNRH,HOWEVER,III,LTD,LYS,PITUITARY
15I,15J,15M,15N,169,2012,COPYRIGHT,LTD,RENS,SAR
125,128,150,165,181,AFTER,CONCLUSION,LABEL,METHODS,NHT,OBJECTIVE,PSA,RESULTS,T1C,T3B,THEIR
1000,956,BACKGROUND,CLONOGENIC,COX,LABEL,LNCAP,METHODS,NEO,NEXT,PCR,RESULTS,THESE,THUS,TRAIL,TREATMENT
016,049,8197,DESPITE,IMRT,ROIS,THREE
053,1990,1991,1994,1995,2000,2007,393,AFTER,AMONG,BACKGROUND,COX,FINALLY,ICD,LABEL,METHODS,POISSON,RESULTS,SNC,SWISS
HER2
ACTIVATION,CHIP,CHOP,EBP,H2A2,HA2A,ST3,STAT3,THESE,USING
197,46A1,BECAUSE,BIC,BOTH,CYP46A1,CYTOCHROME,DUE,P450
CARCINOMA,OTHER,THYROID
00032,0017,012,027,031,11P15,12Q23,16Q,16Q22,1P31,3P21,7Q32,9P21,D1S2137,FAL,FRACTIONAL,LOH,LOSS,MSI,NIR,PCA,TRUS
GIVEN,HOWEVER
200,AFRICAN,CONSTRUCT,EPCS,HOWEVER
986,AFFYMETRIX,AGILENT,BLOOD,MICROARRAY,NATURAL,THESE,U133,USING,WHETHER
000,100,106,1187,126,2001,2003,2004,2007,2008,253,269,439,748,778,850,928,AMONG,BACKGROUND,CASES,CONTEXT,COX,HODGKIN,LABEL,MAIN,METHODS,OBJECTIVE,OUTCOME,RDS,RESULTS,SEPTEMBER,SETTING,SIR,SIRS,STATE,THERE,TRADE,USING,WORLD,YORK
30962,ANOTHER,BCG,CIS,CUETO,CYSTOSCOPY,DOSE,EMDA,EORTC,FULL,IMMEDIATE,MMC,NMIBC,POSTPONING,RADICAL,RISK,SINCE,SYNERGO,TCC,TUR
AFTER,BESIDES,HIFU
EVEN,HODGE,PBX,PCA,TRUS
ASIAN,DESPITE,FURTHER,HOWEVER,THROUGH
946,AKT,BACKGROUND,CONCLUSION,DU145,EFFECTIVE,ERK,ERK1,LABEL,MAPK,METHODS,NDRG1,PI3K,PROTEIN,PTEN,RAS,RESULTS,SILENCING,TGF
169,2012,AFTER,COPYRIGHT,HOWEVER,PUBLISHED,SAS,SEVERAL,THEREFORE
001,004,008,119,157,162,169,1992,2008,2012,2582,2901,8804,BACKGROUND,COPYRIGHT,COX,CRPC,DATA,DMFS,FINE,FURTHER,GLEASON,GRAY,LABEL,MEIER,METFORMIN,METHODS,OBJECTIVE,OUTCOME,PCSM,PSA,PUBLISHED,RESULTS,RFS,SETTING,UNIVARIATE,UROLOGY
169,2012,COPYRIGHT,DESPITE,HEAT,HSP90
002,025,169,2004,2009,2012,412,AFTER,C30,COPYRIGHT,FSFI,IIEF,JULY,LABEL,LRP,MARCH,METHODS,OBJECTIVE,PARTNER,PR25,QLQ,RALP,RESULTS,SAS,THERE
100,100NG,1447,160,164,169,2004,2010,2012,4NG,57NG,65YEARS,660NG,88NG,96YEARS,AFTER,CONCLUSION,COPYRIGHT,DATA,DIGITAL,HALF,JANUARY,JUNE,LABEL,MATERIALS,METHODS,OBJECTIVE,PSA,PULPECTOMY,RADICAL,RESULTS,SAS,SENEGAL,TREATMENT
0002,160,169,2008,2012,223,3100,CONCLUSION,COPYRIGHT,DENOSUMAB,III,LABEL,MDV,METHODS,OBJECTIVE,RESULTS,SAS,SIPULEUCEL,SOCIETY,UROLOGICAL,UROLOGY
LABEL,OBJECTIVE,PURPOSE,RESULTS,SEVERAL,SUMMARY
HOWEVER,MULTIMODAL,THERE
001,129,BACKGROUND,COMPOSITE,CONCLUSION,EXPRESSION,EZH2,LABEL,METHODS,MYC,NOTABLY,RESULTS,SUBSEQUENT,THERE
000,011,047,100,109,1996,2006,2009,203,250,258,341,355,406,430,459,492,543,572,590,604,605,680,709,719,742,750,794,8201,844,875,8805,912,921,946,958,BACKGROUND,BPH,COX,HOWEVER,INCIDENCES,INSURANCE,JANUARY,LABEL,METFORMIN,METHODS,RESULTS,TAIWANESE
PC3,ZKK
004,028,037,051,134,186,191,8202,961,AFTER,ALA,BMI,DESPITE,HOWEVER,KI67,PROSTATIC,PSA,SERUM,SEVEN,SNPS
HODGKIN,JMJC,L1236,L428,LNCAP,LOX,SMCX,SMYD3,STAT6,TAKEN
AKT,BAD,BAX,BID,FADD,FAS,GTP,HDAC,HOWEVER,JNK,LNCAP,LNCAPSHP53,PARP,PI3K,THESE
00024,001,DTX,MHZ,MPA,PC3,THESE,ULTRASOUND,USMB,USMBS
128,2012,448,928,966,AIM,ASSESSMENT,BIOMEDICAL,CHINESE,CONFIDENCE,EVALUATION,FURTHER,GRADING,INSULIN,LABEL,LIBRARY,LITERATURE,MARCH,MEDICAL,METHODS,OBJECTIVE,ODDS,ORS,RESULTS,SCIENCE,WEB
3T3,BASED,CDC42,GM130,GOLGI,GTPASES,ITSN,RAC,RAC1,RHO,RHOA,SIGNALING,SWISS,THUS
AKT,ANTIBODIES,BP1,DU145,HEAT,HSP90,PROTEIN,S6K,TERT,THESE
120,160,171,177,8201,AUR,GREENLIGHT,HPS,IPSS,MEAN,NINE,PCA,PSA,PVP,PVR,QOL,SCORE,SYMPTOM
001,008,2004,2010,404,495,BETWEEN,COCKCROFT,GAULT,GFR,LABEL,METHODS,OBJECTIVE,PERCENT,PSA,PURPOSE,RESULTS,SCREENING
001,016,160,631,8804,BMI,CONVERSELY,HORMONE,LABEL,METHODS,OBJECTIVE,PCA,PURPOSE,RATE,RESULTS,SHBG,TOTAL
8320,8325,DBNL,MELK,PSMA1
BACKGROUND,CONCLUSION,DUE,EVALUATION,LABEL,METHODS,MRI,OARS,RESULTS,TCP,TCPS,THEN,V100
102,169,1738,1995,2007,2013,202,8805,HOWEVER,INSURANCE,NHIRD,OVERALL,SIR,STUDIES
169,2012,ADIPOSE,ADT,COPYRIGHT,CVD,INCREASES,JOHN,LOW,LTD,OBESITY,SONS,THERE,TRT,WILEY
CDC37,DIMINISHED,DISRUPTION,GST,HSP90,TAKEN,VAV3
0009,2011,3749,4611,8360,BEGG,CAUCASIANS,CBM,CNKI,CONCLUSION,DATA,DATABASES,FOKI,LABEL,MAY,METHODS,OBJECTIVE,RESULTS,STATA,TEN,TOTAL,VDR,VIP,WANFANG
169,2012,CARCINOMA,COPYRIGHT,DU145,J591,JOHN,LNCAP,LTD,MRI,PSMA,SMCC,SONS,WILEY
138,169,188,2012,214,402,489,ACAD8,ACADL,ACADM,ACADS,ACOXL,BIOLOGICAL,COA,FADS1,GWAS,GWASS,INC,LIPC,PDGFC,PON1,PYROXD2,SEVEN,SNPS,SWEDISH,WILEY
169,2013,COPYRIGHT,GMBH,KGAA,MANNICH,MICHAEL,NATURALLY,VCH,WILEY
100,129,169,2012,3N0M0,AE1,AE3,AVAILABLE,COPYRIGHT,DETECTION,DTC,DTCS,PCA,POST,PRE,SPCG,THEREBY,UICC
0001,0031,036,169,2000,2011,2012,8201,8805,AMICO,AMONG,BACKGROUND,BEST,CONSENSUS,COPYRIGHT,EPE,FAILURE,GLEASON,INC,LABEL,METHODS,PATHOLOGIC,PCA,PSAD,RESULTS,WILEY
169,2012,BACKGROUND,COPYRIGHT,HIGH,HPV,INC,LABEL,METHODS,RESULTS,WILEY
169,2012,954,AS5,COPYRIGHT,INCREASED,INGENUITY,LNCAP,PATHWAY,TAKEN,TNFAIP8,UICC
169,2012,945,946,CCN,CCN2,COPYRIGHT,FAK,GDF,HUVEC,INC,THESE,WILEY,WILLEBRAND
104,169,1993,2010,2012,8201,875,8805,BACKGROUND,BMI,CCB,CCBS,CHI,COPYRIGHT,COX,DIAGNOSTIC,INC,INSTITUTE,LABEL,LOUISIANA,MEDICATION,METHODS,NCCN,NORTH,PARK,PCA,PCAP,PFS,PROJECT,PSA,RECURRENCE,RESULTS,ROSWELL,RPCI,WILEY
001,169,2012,961,CCS,COPYRIGHT,GLEASON,JOHN,LCMODEL,LTD,MAS,MRS,MRSI,SONS,THERE,WILEY
169,177,2012,680,8201,AF680,ALEXA,BACKGROUND,BBN,COPYRIGHT,FLUOR,GRPR,INC,LABEL,LUC,METHODS,NEAR,NH2,NIR,NIRF,RESULTS,WILEY
169,2012,ALDH1,BACKGROUND,CD45,COPYRIGHT,CTCS,DESPITE,EGFR,EMT,ESR2,FOXP3,IGF1,IGF2,INC,INCREASED,LABEL,METHODS,PCR,RESULTS,TGFB3,THESE,WILEY,WNT5A
169,2012,247,345,421,616,AML,COPYRIGHT,MDS,RECURRENT,SF3B1,SRSF2,U2AF1,UICC
0001,043,1006,169,2003,2011,2012,348,ADT,BACKGROUND,COPYRIGHT,CSS,DATA,DFS,FINE,GRAY,HOWEVER,LABEL,LDR,METHODS,NETWORK,OCTOBER,PHOENIX,RESULTS,SIXTY,SOCIETY,UNIVARIATE
100,177,CAD,LABEL,MEAN,METHODS,OBJECTIVE,PSA,RESULTS,THERE,THUS
954,AIM,ALSO,BACKGROUND,CAFFEIC,CAPE,FURTHER,LABEL,OBJECTIVE,RESULTS
AFFYMETRIX,AIM,BACKGROUND,DEGS,E2F1,ESCC,LABEL,MATERIALS,METHODS,OBJECTIVE,P53,RESULTS,SP1,SP3,TFS,USF2
169,2000,2010,2012,BACKGROUND,BRAIN,COPYRIGHT,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,SOCIETY
169,2012,21ST,257,ANZ,AUTHORS,COLLEGE,COLORECTAL,JOURNAL,KIMI,PERSISTING,ROYAL,SURGERY,THEN,ZEALAND
169,2012,232,276,8201,901,ADD,BJU,COSTS,DOES,HOWEVER,KNOWN,LABEL,METHODS,OBJECTIVE,RESULTS,SUBJECT,THERE,THESE,UNLABELLED,USA,UTILITIES,WHAT
124,169,2005,2007,2012,218,500,8201,8804,8805,BETWEEN,COX,GLEASON,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PATHOLOGY,RESULTS,SIMILAR,T2A,THERE,UPSTAGING,UROLOGICAL,USING
1247,142,155,169,1988,2004,2012,244,419,861,8805,ADDITIONAL,BACKGROUND,INDEX,LABEL,MEANWHILE,MEIER,METHODS,NETWORK,OVERALL,RESULTS,UROLOGICAL
GIVEN,HBS,PCA,THESE,VIRTUAL
169,2012,946,APMIS,BDS,ELISA,GRAM,JOHN,LTD,NLR,NOD,PUBLISHED,SONS,WILEY
540,CONCLUSION,CONSISTED,CRC,FIRST,INITIATIVE,LABEL,METHODS,NOTABLE,OBJECTIVE,PURPOSE,RESULTS,THESE,THIRD,THREE
946,954,CONVERSELY,IL1,METFORMIN,SRC,STAT3,TAKEN
000,2004,2007,2011,654,ADT,AMICO,BACKGROUND,CONCLUSION,DISCORDANT,END,GLEASON,HOWEVER,NETWORK,RESULTS
1995,385,49A,49T,562,945,A49T,ADDITIONAL,CAUCASIANS,HOWEVER,JANUARY,STEROID,V89L
945,946,LXXLL,MIER1,THESE,WHILE
HOWEVER,JANUS,SOCS,THESE
OBESITY
PCA,WESTERN
101,160,ESCRT,UEV
BOTH,FURTHER,LZTS2,THESE,TREATMENT,USING
000,100,285,591,COSTS,DISEASE,GIVEN,HOWEVER,ICER,IMRT,INTENSITY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PSA,QALY,RESULTS,SBRT,TREATMENT
100,169,2012,AACR,AKT,ATP,CELLS,CG5,DAILY,ERMA,ERMAS,KI67,LNCAP,MICROARRAY,NADH,OSU,PCNA,SRC,THESE,TRAMP,WARBURG,WESTERN
125,5HT3,CONCLUSION,DAYS,FIFTY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE
001,142,1956,201,2146,688,723,CIPC,HOWEVER,THERE,THEREFORE
002,138,2001,2004,2005,AFFAIRS,BACKGROUND,BONFERRONI,DESPITE,LABEL,METHODS,MOST,RATES,RESULTS
001,1672,169,2003,2004,2005,2006,2012,2013,CONCLUSION,COPYRIGHT,COVARIATES,DATA,EDUCATION,FOUNDATION,INC,JULY,LABEL,MAYO,MEDICAL,METHODS,NUTRITION,OBJECTIVE,PSA,PUBLISHED,RESULTS,SEDENTARY,SEPTEMBER
001,002,007,016,161,169,187,2004,2011,2014,603,8805,ADULT,CONCLUSION,COPYRIGHT,DRE,EDUCATION,HGPIN,III,INC,LABEL,MATERIALS,METHODS,METS,OBJECTIVE,OBJECTIVES,ODDS,OVERALL,PANEL,PCA,PROGRAM,PSA,RESULTS,TREATMENT
0002,0348,169,2009,2010,2012,BETWEEN,BOTH,CONCERNING,COPYRIGHT,DEPENDING,GLEASON,IRELAND,JULY,LABEL,LTD,MAY,METHODS,MOST,MRI,MRT,OBJECTIVE,RESULTS,RTE,SCORE
169,2011,COPYRIGHT,IRELAND,LTD,MOST,SELECTING
0008,028,034,037,075,215,949,BCL,CD31,HOWEVER,MMP2,MMP9,NONE,PC3,PCA,PCNA,PKC,PLUMBAGIN,PUBLISHED,RESULTS,STAT3,TAKEN,THESE,THREE,VEGF
420,748,8201,8804,BACKGROUND,BOTH,CONTEXT,DIAGNOSES,DIAGNOSTIC,GRADE,HIGH,LABEL,METHODS,NEOPLASIA,OBJECTIVE,PROSTATIC,RESULTS,SMALL,SUSPICIOUS
000,001,008,BACKGROUND,BOTH,COX,IRS,LABEL,MEIER,METHODS,MULTI,PCA,PEARSON,PERIOSTIN,POSTN,PSA,REGARDLESS,RESULTS,WHILE
003,169,2003,2008,2013,946,AGE,BETWEEN,CALIFORNIA,CONCLUSION,COPYRIGHT,FORM,INC,JULY,LABEL,LEUPROLIDE,METHODS,MINI,OBJECTIVE,RESULTS,SHORT,STATE,TEST
004,0079,016,169,2013,213,225,510,948,ADT,COMPARE,COMPLAINTS,CONCLUSION,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PHYSICIANS,RESULTS
001,169,177,2006,2009,2013,760,770,BETWEEN,CONCLUSION,COPYRIGHT,INC,LABEL,MATERIALS,MEAN,METHODS,OBJECTIVE,OVERALL,RESULTS,TRUS
223,CRPC,FOUR,MDV3100
EGFRS,FGFR,FGFRS,RTKS,SIGNALING
DESPITE,IMRT,IR192,J125,PA103,PSA,TRUS,VMAT
2007,555,ABBOTTABAD,AMONG,ANOTHER,AYUB,BACKGROUND,COMMONEST,CONCLUSION,DATA,DEPARTMENT,HARIPUR,HODGKIN,IEUKAEMIA,INCIDENCE,LABEL,LEUKAEMIAS,LYMPHOMAS,METHODS,RESULTS
CAT,GPX1,GPX4,HOWEVER,OXIDATIVE,ROS,SNPS,SOD1,SOD2,THERE
1034,200,209,367,409,775,AMONG,ENDOSCOPIC
001,007,491,594,BACKGROUND,BOTH,BPH,CONCLUSION,FORTY,LABEL,METHODS,NIGERIA,RESULTS,SINCE,TAUS,THERE,TRANSITION,TRUS,ZONE
ADENOSINE,AMP,AMPK,ATP,BECAUSE,DATA,FURTHER,LKB1,METFORMIN,ONCE,THESE,TORC2,VIRTUALLY
AIM,GLEASON,LABEL,METHODS,OBJECTIVE,PCA,PSA,RESULTS,THERE
1990,2005,2013,347,3756,5672,BASED,CAP,GROUP,LABEL,METHODS,RESULTS,THERE,THESE,TNM,UNLABELLED
AUTOMATIC,FIRST,HOWEVER,LARGE,SDA,THIRD
EFFICIENT,GPUS
ADDITIONAL,BACKGROUND,CONDITIONS,DATA,ELIXHAUSER,FLORIDA,INDEX,LABEL,METHODS,RESULTS,THERE
100,APPEARANCE,ERG4,MUTATIONS,SEVERAL,TEST,TMPRSS2,VHL
945,AIF,BACKGROUND,GIVEN,LABEL,NEXT,PARP1,PC3,PRINCIPAL,RESULTS,ROS,TOS,USING,VK3
4EBP,945,ACTIVATED,AKT,BINDING,CONCLUSION,DOWN,EMPLOYING,GRP78,LABEL,METHODS,OBJECTIVE,RESULTS,RHEB,RNAI,S473,T308,T389,TETRAMERIC,TORC2,TSC2,WESTERN
320,494,536,8202,CLEVELAND,OAS1,OAS2,OHIO,SNPS,TAKEN,TLR1,TLR6
AKT,DU145,ERK,IGF,LNCAP,MIR,MM2,ORAL,PDCD4,PI3,SCID,SHORT,SIMILAR,THESE,USING
1AR,ATM,ATR,CHK1,CHK2,ERG,H2AX,HOWEVER,HPR,NOTABLY,TMPRSS2
1998,200,2006,500,550,555,600,620,630,655,680,900,930,FIVE,RADICAL
BOWEL,FIVE,FURTHER,HRQOL,QUALITY
117,1995,450,AMONG,COX,DEFINITIVE,FIVE,FURTHER,GLEASON,HOWEVER,KLOTZ,MOST,OVERALL,PSA,SINCE,TEN,WOLTERS
347,348,DATA,GROUP,HENCE,SPCG,THESE,TRIAL
THERE
000,100,2004,8232,CARE,CENTERS,CONTROL,DATA,DISEASE,MEN,OLDER,OVERALL,PHYSICIANS,PREVENTION,QUALITY
FINALLY,THESE
CONSISTENT,DESPITE
STUDIES,TREATMENT
1500,CARE,PRESENTING,PROTECT,THESE,TREATMENT
022,1994,2NG,407,5023,731,8NG,AFFAIRS,AFRICAN,COMPARISON,DEPARTMENT,GLEASON,HEALTHCARE,INSTITUTE,PIVOT,PROGRAM,PSA,QUALITY,RESULTS,STUDIES,TRIAL,USING
MEN
CONVERSELY,GLEASON,MEN,PREVIOUSLY,PSA
2011,PSA,THESE,THROUGH
EFFORTS,GLEASON,PATHOLOGIC,PATHOLOGY,SOCIETY,YEARS
170,1975,1980S,1990S,1991,2012,241,740,BOTH,SCREENING,SOCIETY,TODAY
FACTORS,FINALLY,FIRST
1000,400,488,ALEXA,CELLS,FLUOR,PHALLOIDIN
039,160,1997,2000,328,619,8805,947,ALBERTA,ALCOHOL,CASES,CURRENT,GLEASON,III,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,STAGE
ADT,AMONG,OTHER,PSA,THERE
169,177,2012,658,840,956,COPYRIGHT,HOWEVER,ILE,ISOLEUCINE,LAT1,LAT2,PCR,REVERSE
FINALLY,NB2,PRL,PRLR
150,665,956,SUBSEQUENT,THERE,THESE
169,2012,400,436,5584,945,946,947,948,AACR,EGF,PI3K
000,HOWEVER,OVERALL,SPC,SPCS
169,2013,BECAUSE,CARM,CONSISTENT,COPYRIGHT,HBD,HBDS,LNCAP,LTD,PSA,SRC,THESE,THUS,TMPRSS2,UGT2B17,USING
DU145,FLOW,THESE
160,CAREGIVERS,CONTINUOUS,INTERVIEWS,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OUTPATIENT,PURPOSE,RESULTS,SETTING
1970S,2013,EACH,FORUM,NURSING
ACTB,AFTER,ALAS1,B2M,BASED,CELLS,EXPRESSION,GAPDH,HPRT1,NINE,NORMFINDER,REAL,SDHA,SELECTION,TATA,TBP,UBC,YWHAZ
ALU,CELL,HOWEVER,PCR,THEREFORE
2001,2006,792,FUNCTIONAL,HENRI,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PSA,RALRP,RESULTS
10Q11,160,19Q13,1Q32,215,496,999,CHINA,CHINESE,GUANGXI,GWAS,KLK3,MSMB,PSA,SERUM,SLC45A3,SNPS
016,025,047,179,193,223,231,BACKGROUND,FCR,FEAR,HOWEVER,INVENTORY,LABEL,METHODS,RECURRENCE,RESULTS
169,1F5,2012,AACR,FOXA1,HOWEVER,LNCAP,VCAP
BACKGROUND,COLORECTAL,CONTROL,ERSPC,FORCE,LABEL,LUNG,METHODS,OBJECTIVE,OVARIAN,PLCO,PREVENTIVE,RANDOMIZED,RESULTS,SCREENING,TASK
169,2012,AACR,BLADDER,DESPITE
0001,169,2013,4NG,593,AAM,AFRICAN,COPYRIGHT,HOWEVER,IRELAND,LTD,PIN,PSA
12TH,169,2012,ACTIVATION,CALCIUM,CASR,COPYRIGHT,ISSUE,REDUCED,SPECIAL,SYMPOSIUM,WHILE
002,005,044,066,207,549,672,772,858,894,AMONG,AUC,BACKGROUND,CONCLUSION,DRE,EARLY,ERG,ETS,GLUTAHIONE,GSTP1,LABEL,MATERIALS,METHODS,MSP,PCA3,PCR,PSA,RAS,RASSF1A,REAL,RESULTS,SEDIMENTED,TMPRSS2
ART,BOTH,BT474,DU145,ERBB2,HER2,MCF7,MYC,POTENTIAL,WNT
954,ASIAN,DIET,GENISTEIN,HOWEVER,SOY,WESTERN
117,FINALLY,GHRELIN,GHRL,LNCAP,METABOLIC
117,1991,2008,328,332,AMERICANS,ASIA,EAST,EUROPEANS,LABEL,METHODS,NON,NORTH,OBJECTIVE,OLDER,PCA,PSA,PURPOSE,RESULTS,SWEDISH,USING
169,2012,CHANGES,COPYRIGHT,D191V,FOLH1,G206R,G245S,GCPII,H475Y,HAPLOTYPES,P160S,PSMA,R190W,SIX,V108A,Y176H
169,2013,ACTB,BETA,COPYRIGHT,HOWEVER,PUBLISHED
011,ANTISENSE,CUSTIRSEN,HEMISPHERE,OGX,WESTERN
169,1B1,2012,AHR,COPYRIGHT,IMMUNOBLOT,INC,LNCAP,P450,PCR,TCDD,THESE
160,169,2012,293,COPYRIGHT,HCT,HEK,HEPG,HOR,MCF,OCT,SAS,TRI
169,2012,COPYRIGHT,IRELAND,LTD,METASTASIS,PCA,TFF1
1999,2009,946,AMBULATORY,BACKGROUND,CARE,CIS,CROSS,GIVEN,HOWEVER,LABEL,MEDICAL,METHODS,RESULTS,THERE
173,215,278,PSCA
001,003,157,169,2013,523,614,814,BECAUSE,COPYRIGHT,COX,GLEASON,INC,MOLECULAR,PATHOLOGY,PCR,PITX2,PUBLISHED,SOCIETY
169,2012,COPYRIGHT,INC,INCIDENCE,INNOVATIVE,LABEL,MARKERS,OBJECTIVE,PCA,PROTEOMICS,PSA,PUBLISHED,PURPOSE,RESULTS,SEVERAL,SOCIETY
0001,0151,0355,103,169,2002,2012,6MM,CELL,COPYRIGHT,FOXP3,FURTHER,GLEASON,KI67,LTD,PSA,TREGS
169,2013,BEAM,BOWEL,COPYRIGHT,DOSE,FIVE,IMRT,INC,MEDICAL,PTV1,PTV2,PTVS,PUBLISHED,V50GY
169,1989,2008,2012,551,553,9243,BACKGROUND,CIS,COPYRIGHT,DATA,LABEL,LTD,METHODS,OVERALL,RESULTS,SIR,SIRS
169,2012,COPYRIGHT,DESPITE,III,INSTEAD,LTD,MAXILLO,PUBLISHED,RANKL,SINCE,SURGERY
000,100,169,1999,2008,2012,AAPC,ANTALYA,ASRW,AVERAGE,BACKGROUND,CLUJ,COLORECTAL,COPYRIGHT,CROATIA,DATA,EAST,EASTERN,IZMIR,JOINPOINT,LABEL,LTD,MALTA,METHODS,NORTH,PERCENTAGE,RESULTS,ROMANIA,SOUTH,WEST
AREAS,BACKGROUND,COVERED,LABEL,MEDICAL,MEDLINE,METHODS,OPINION,PENDING
169,2013,ACO,ACOS,ACT,AFFORDABLE,CARE,COPYRIGHT,DEBT,FEE,FFS,FINANCIAL,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PBT,PURPOSE,RESULTS
0583,169,177,2004,2007,2013,2485,ADT,BMD,COPYRIGHT,INC,LABEL,MATERIALS,MEAN,METHODS,OBJECTIVE,PURPOSE,RESULTS
0001,0006,015,169,2013,718,8805,CCMI,CHF,COPYRIGHT,COX,EACH,EBRT,EFFECTS,INC,INCREASING,INDEX,LABEL,MATERIALS,MEIER,METHODS,NTCP,OBJECTIVE,PATIENT,PURPOSE,QUANTEC,RESULTS
169,2012,300,956,COPYRIGHT,CROWN,FITC,HOWEVER,LTD,MTT,MYRICETIN,PUBLISHED
1587,15D,169,1706,1998,2000,2004,2011,2012,2200,539,549,7011,756,763,775,777,831,852,866,872,889,892,BACKGROUND,COPYRIGHT,FINNISH,HRQOL,LABEL,METHODS,OBJECTIVE,OUTCOME,PCA,PUBLISHED,RESULTS,SETTING,THESE,UROLOGY
169,2012,BACKGROUND,CDC27,CNA,CNAS,COPYRIGHT,EXOME,INTEGRATED,KDM6A,KIF5A,LABEL,METHODS,MLL3,MULTILEVEL,OBJECTIVE,OUTCOME,PCA,PUBLISHED,RESULTS,SETTING,THERE,UROLOGY
106,1213,169,2009,2011,2012,547,AFTER,AMICO,BACKGROUND,CLAVIEN,COPYRIGHT,DATA,DINDO,FOCAL,GLEASON,HIFU,INDEX,IQR,LABEL,METHODS,OBJECTIVE,OUTCOME,PCA,PSA,PUBLISHED,RESULTS,SCORE,SETTING,SYMPTOM,THERE,UROLOGY,VTP
ASIDE,DNAJC15,LOSS,MCJ,TIM14,TIM23
001,002,003,187,1993,2009,452,495,8804,8805,887,COX,GLEASON,MEIER,PSA,T2A,UNILATERAL
3475,BMS,PROGRAMMED
481,AFRICAN,ANTIGEN,FEAR,INTRINSIC,MEN,SCREENING,TESTING
256,4DCT,8804,CTV,D95,DOSE,PTV,PTV1,PTV2,PTVS,SMALL
215,979,ADHD,MEN,SMOC1
125,COLORECTAL,HIGH,LABEL,LEVEL,LUNG,METHODS,NPV,OBJECTIVE,OVARIAN,PPV,RESULTS,SCREENING,TRIAL
169,177,2012,419,CB1,CB1IR,COPYRIGHT,DATA,FAAH,FATTY,ISSUE,LIPID,METABOLISM,SPECIAL,THUS,USING,WILLEBRAND
FEATURE,NET,NUMERICAL,THUS
133,BECAUSE,EGR,FURTHER,INC,MAPK,MG132,NAG,PROTEASOME,PUBLISHED,TRANSGENIC
169,2012,215,COPYRIGHT,HIGH,HOWEVER,INC,LNCAP,MMP2,MMP9,MMPS,RWPE,THESE,UNTREATED
047,169,200,2013,AFTER,BACKGROUND,CONCLUSION,COPYRIGHT,FRONTLINE,INC,LABEL,LDK,LHRHA,LOW,MEDICAL,METHODS,P17,RESULTS,TTP
169,2013,COPYRIGHT,CRPC,FUNCTIONAL,INC
145,169,2012,2C9,COMPOUNDS,COPYRIGHT,HPLC,HUH7,LNCAP,LTD,P450,SILYBUM
169,1978,2008,2013,8445,997,BACKGROUND,BETWEEN,CONCLUSION,COPYRIGHT,INC,INTENSIVE,LABEL,METHODS,RESULTS,SIR,SIRS
169,2012,COPYRIGHT,LDL,LTD,PLA,SEVERAL
050,108,169,2012,241,525,AEU,BACKGROUND,CHINESE,CONCLUSION,COPYRIGHT,DIEGO,ESPA,GENOTYPING,HAN,INC,LABEL,MASSARRAY,METHODS,MPO,OBJECTIVE,OBJECTIVES,OTHER,PCA,PUBLISHED,RESULTS,SAN,SNP,SNPS,TOTALLY,USA
FLOW,HOWEVER,RAF,RKIP,SGC7901,TAKEN,THESE,WOUND
003,004,031,12P70,945,946,BASED,LABEL,METHODS,OBJECTIVE,PCA,POD1,PURPOSE,RESULTS,SERUM,SEVERAL
DIAGNOSIS,EARLY,PERHAPS

8805,DATA,DEFINITIVE,MRI,PET,PROTONS
HOWEVER,SUI,URINARY
DENOSUMAB,RANK,RANKL,SOLID
HLA,III,PPV,RANDOMIZED
169,2012,AACR,AKT,ATG3,ATG7,AZD5363,CONCLUSION,DU145,HOWEVER,LABEL,METHODS,OBJECTIVE,PC3,PI3K,PTEN,PURPOSE,RESULTS,S6K,TAKEN,THEREFORE,WHILE
160,169,2012,ACADEMY,ADT,ANDROLOGY,CYP17A1,DHT,HENCE,SOCIETY,STS
946,AMONG,EVEN,FINALLY,GTPASES,P21,PAK1,PAK6,PAKS,PC3,RHO,TGF
FINALLY,PRSS3,SILENCING,USING
169,2012,240,BACKGROUND,BASEL,CONCLUSION,COPYRIGHT,DEGARELIX,IPSS,LABEL,LUTS,MEAN,METHODS,MOST,PRCA,RESULTS,SCORE,SYMPTOM
000,100,169,185,2006,2012,8804,8805,APRIL,BACKGROUND,BASEL,COPYRIGHT,LABEL,METHODS,RARP,REGARDING,RESULTS
158G,169,2012,2013,292,485,BACKGROUND,BASEL,CAUCASIANS,COMT,CONCLUSION,HOWEVER,JULY,LABEL,LIBRARY,MEDLINE,METHODS,PCA,RESULTS,STATA,VAL158MET
169,177,1ST,2007,2011,2012,252,31ST,BACKGROUND,BASEL,BETWEEN,CONCERNING,COPYRIGHT,GERMANY,JANUARY,LABEL,LOWER,METHODS,NEITHER,RESULTS,TRACT,URINARY
D1B,FURTHER,NOTABLY,SLUG,SNAI2,WHILE
160,169,177,2012,240,244,8805,ABOUT,AIMS,COLLEGE,COPYRIGHT,GLEASON,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,QUALITY,RESULTS,ROYAL,SCORE,SYMPTOM,T2B,TNM,UICC
1931,8805,CONCLUSION,HODGKIN,LABEL,MAIN,METHODS,NATIONWIDE,OBJECTIVE,OUTCOME,RESULTS,SETTING,SWEDISH
215,AIM,BACTERIAL,BOTH,CD3,CD4,CD8,CONCLUSION,LABEL,METHODS,OBJECTIVE,PSMA,RESULTS,SCID,THEREFORE
237,2806,305,660,8804,8805,MOST,PCA,PHYSICIANS,SKIM,THESE
CVID,DIFFUSE,DNLH,HASHIMOTO,IGG2,NODULAR,THROUGH
CDK1,CELL,EPAC,KH7,LNCAP,PC3,RAF,RAP1,UNTIL
169,2012,8201,AFTER,BACKGROUND,CONCLUSION,COPYRIGHT,FLOW,INC,LABEL,LNCAP,MAPK,METHODS,PSMA,REGULATED,RESULTS,THEN,THESE,TRANSWELL,WESTERN,WILEY
1000,169,2010,2012,458,500,5P15,782,8Q24,BACKGROUND,CONSORTIUM,COPYRIGHT,GENOMES,GWAS,IMPUTATION,INC,LABEL,MAF,METHODS,NCI,PROJECT,RESULTS,SNP,SNPS,WILEY
169,2013,GMBH,KGAA,VCH,WILEY
022,035,070,088,128,1997,2006,252,65309,6TH,905,AGAINST,BCR,CRPC,EBRT,FIFTY,HTX,III,JANUARY,PSA,SEPTEMBER,THERE,UICC,UNION,UNIVARIATE
160,CIII,CONVERSELY,ECM,EGFR,ERBB2,FIVE,HSP,HSP90,IGG,NONE,PSA,RIBOSOMAL,TREATMENT
160,8805,960,BPH,DNMT,DNMT1,GLEASON,GSTP1,LN4,PC3,PC3M,PCA,PRIMARY,WHILE
183,2012,ATTENTION,GEORG,STUTTGART,WHAT,YORK
0001,169,2013,506,512,ADVERSE,CENTRAL,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,MOST,NCT,OBJECTIVE,PERIPHERAL,PUBLISHED,PURPOSE,RESULTS,SIPULEUCEL,TRIAL,UROLOGICAL
001,153,169,174,177,2006,2009,2012,ADD,BJU,DOES,FIFTY,HOWEVER,IIEF,INDEX,JANUARY,KNOWN,LABEL,METHODS,OBJECTIVE,PDE5,RESULTS,RRP,SEPTEMBER,SUBJECT,THERE,UNLABELLED,WHAT
001,169,2006,2007,2008,2013,413,424,837,AFTER,AHA,COPYRIGHT,EDUCATION,INC,INPATIENT,LABEL,MATERIALS,METHODS,NATIONWIDE,NIS,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,RESULTS,THERE,UROLOGICAL
945,CHIRALITY
8804,AMONG,GNRH
3BETA,CONCLUSION,DU145,ETOAC,IC50,LABEL,METHODS,MTT,NMR,OBJECTIVE,PC3,RESULTS
AMTB,INHIBITION,INHIBITORS,RNAI,TRPM8
8226,954,AKT,BAK,BAX,BCL,BIM,CCL,CD54,CFSE,CXC,CXCR4,ERK,MCL,MONITORING,PBMCS,RHO,RPMI,TAKEN,U266,WEV
3357,BACKGROUND,CURRENT,DISULFIRAM,ERG,HOWEVER,LABEL,METHODS,RESULTS,SINCE,TAKEN,TMPRSS2
22RV1,22RV1RD,BACKGROUND,DOCETAXEL,DU145,DU145RD,HORMONE,LABEL,LNCAP,MDR,PRINCIPAL,RESULTS
0019,AIMS,HYPOTHESIS,IGF,INSULIN,IRS,KIP1,LABEL,METHODS,OBJECTIVE,PCR,RESULTS,SINCE,THESE
000,059,100,165,1995,2008,2010,554,781,ADDITIONAL,ARB,ARBS,CASES,CIS,GENERAL,KINGDOM,RRS,THUS
BIOLOGICAL,BIOP,BIOPROP,DVH,FOUR,III,IMRT,LEVEL,NSCLC,NTCP,OARS,SABR,TCP
174,CREMOPHOR,DOCETAXEL,DRUG,DUE,FDA,FOOD,PACLITAXEL,TAXOL,TAXUS,TODAY
160,AKT,ELISA,ERK1,LNCAP,MAPKS,PC3,PSMA,WESTERN
0108,0877,1990,2006,BACKGROUND,LABEL,MATERIALS,METHODS,RESULTS,THERE,UCP
ANDROGENS,FURTHER,HOWEVER,THESE
HOWEVER,OTHER
0001,0016,0156,100,GLEASON,LABEL,METHODS,MTT,OBJECTIVE,PURPOSE,RESULTS,SIXTY,TURBOFLASH
2004,2009,270,342,BACKGROUND,FEW,GLEASON,JANUARY,LABEL,LRP,METHODS,NHT,PSA,RESULTS,SEPTEMBER,THERE
174,8482
126,2010,670,795,8201,ARA,BACKGROUND,CONVERSELY,FURTHER,HOWEVER,LABEL,MAY,METHODS,RESULTS,STUDIES,THERE
1200,125,6159,CHINA,CHROMOSOME,CONSORTIUM,ESI,HPP,INDIA,LIMS,MALDI,MRM,NAPPA,PROJECT,QTRAP,SPAIN,SRM
946,QUESTIONS,THESE
001,100,280,946,956,BLUE,BOTH,CARCINOMA,CONCLUSION,DOX,ETO,GSK,HOWEVER,IC50,LABEL,LICL,LNCAP,LYMPH,MATERIALS,METHODS,MTT,NODE,OBJECTIVE,RESULTS,SUBG1,THIAZOLYL,VIN
8805,AMONG,BAYES,CA125,COLORECTAL,CONCLUSION,LABEL,LUNG,METHODS,OBJECTIVE,OVARIAN,PEB,PLCO,PURPOSE,RESULTS,SCREENING,TRIAL
169,2012,AACR,ANECDOTAL,BP1,C42B,CONSISTENT,DU145,HGPIN,INHIBITION,LNCAP,NAD,PC3,PTEN,RES,RWPE,S6K,SIRT1,THEREFORE,THESE

1440,2004,2007,255,CENTRAL,END,JANUARY,LABEL,MAIN,MAJOR,MARCH,METHODS,OBJECTIVE,OBJECTIVES,OUTCOME,RESULTS,SAHARAN,SETTING
CRPC,CURRENT,HOWEVER,MEN,TARGETING
COLORECTAL,FORCE,HOWEVER,INSTEAD,LUNG,OVARIAN,PREVENTIVE,PSA,RANDOMISED,SCREENING,TASK,TRIAL
160,330,760,ESS,SIMILAR,TRUS
15MIN,169,2012,COPYRIGHT,LNCAP
169,2012,CHOP,COPYRIGHT,DR5,THEREFORE,TRAIL
ADS,CRAD,DTSTA,PCA,TSTA
CHIP,DEPLETION,HSP70,KNOCKDOWN,MDM2,PC3,TARGETING
169,2012,8314,ANTIGEN,APM,CD3,CD38,CD4,CD8,COPYRIGHT,FOXP3,HLA,INC,LENTIVIRUS,MACHINERY,PROCESSING,TAP1,TAPASIN
133,140,169,2012,219,254,CHIP,COPYRIGHT,DU145,EP3,H89,L798106,LTD,NAF,PC3,PGE2,PKA,SDF,SP1,WPMY
169,2013,499,795,797,804,806,COPYRIGHT,COX,EDUCATION,EXAMINING,HARRELL,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PARTIAL,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
169,2013,964,CAUCASIAN,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THEREFORE,UROLOGICAL
1000,500,954,956,BCL,BCLXL,CDDP,INC,LYSATES,MICE,OVERALL,PUBLISHED,THUS,TMA,YANG,YIN,YY1
169,2012,215,COPYRIGHT,CRPC,ELISA,LTD,PSMA,VEE,VENEZUELAN,VRP,WHILE
0001,075,138,169,1997,2006,2013,ABOUT,BACKGROUND,CONCLUSION,COPYRIGHT,INC,INPATIENT,LABEL,METHODS,NATIONWIDE,NINTH,PREVALENCE,PUBLISHED,RELATIVELY,RESULTS
169,2012,AEU,BACKGROUND,BONE,BOTH,COPYRIGHT,CRPC,DENOSUMAB,LABEL,METHODS,PUBLISHED,RANK,RANKL,SRES,SUMMARY,ZOLEDRONIC
097,143,169,2008,2010,2012,346,512,AEU,CONCLUSION,COPYRIGHT,FREE,GLEASON,JUNE,LABEL,LOW,MATERIALS,METHODS,OBJECTIVE,PSA,PUBLISHED,RESULTS,THERE,VARIABLES,VERMEULEN
169,2013,COPYRIGHT,CPG,EPIGENETIC,HOWEVER,INC,LREA,NOTABLY,THESE
001,030,045,100,1009,1377,169,2001,2011,2012,2386,396,BACKGROUND,COPYRIGHT,LABEL,LRP,LRPS,MEAN,MEIER,METHODS,OBJECTIVE,OUTCOME,PATIENT,PUBLISHED,RALP,RALPS,RESULTS,ROBOT,ROBOTIC,SETTING,SHORTER,UROLOGY
001,003,006,223,294,402,ADT,BACKGROUND,CRPC,HOWEVER,LABEL,MEN,METHODS,OBJECTIVE,OUTCOME,PCA,PCSM,PSA,PUBLISHED,RESULTS,SETTING,WHETHER
133,169,183,187,1980,1990,2006,2010,2012,235,AFRICAN,AGE,AIDS,ALZHEIMER,BACKGROUND,BILL,CAUSE,CODEM,COPD,COPYRIGHT,FACTORS,FOUNDATION,FUNDING,GATES,GBD,HIV,ISCHAEMIC,LABEL,LTD,MALARIA,MELINDA,METHODS,MODEL,POPULATION,RESULTS,RISK,SAHARAN,UIS,YLLS
001,0014,169,2013,220,AVERAGE,CALYPSO,COLLEGE,COPYRIGHT,DMLC,IMRT,INC,LABEL,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RADIOLOGY,RESULTS,ROOM,STUDENT,THESE,TREATMENT,VMAT
169,2013,COPYRIGHT,DISCERN,IHI,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PBT,PCA,PROVIDERS,PURPOSE,QUALITY,RESULTS,THERE,THESE
AUTOMATED,CBCT,CONCLUSION,HOWEVER,LABEL,METHODS,MONITORING,PRE,RESULTS,UNLABELLED
0002,0065,0142,143,186,2006,2010,8805,945,ADT,CGE,CONCLUSION,DEFINITIVE,GRADE,IPSS,LARGE,RESULTS,TURP
001,2007,2008,3439,4947,BACKGROUND,BASED,DISCUSSION,EORTC,FURTHER,LABEL,METHODS,OCTOBER,OVERALL,POMS,QLQ,RESULTS,SEPTEMBER,THESE,UNMET
BONE,THESE
CAMELUS,CH1,CURRENTLY,DIFFERENT,DUE,ELISA,GIVEN,HCABS,IGG,PSMA,VHH
169,2005,2013,6TH,COPYRIGHT,EACH,EDUCATION,INC,JUNE,LABEL,MATERIALS,METHODS,OBJECTIVE,PARIS,PUBLISHED,PURPOSE,RESULTS,TREATMENT,UROLOGICAL
169,1995,2000,2001,2007,2013,366,8482,CAPSURE,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PCI,PHYSICIAN,PUBLISHED,PURPOSE,RESULTS,UCLA,UROLOGICAL,UROLOGISTS
111,169,180,2013,COPYRIGHT,EDUCATION,GRADE,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OSTEOCLAST,PUBLISHED,PURPOSE,RANKL,RESULTS,UROLOGICAL
0001,169,2013,638,646,COPYRIGHT,EDUCATION,III,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OTHER,PUBLISHED,PURPOSE,RESULTS,SECONDARY,THERE,TOREMIFENE,UROLOGICAL
169,174,2013,CONSISTENT,COPYRIGHT,EDUCATION,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THUS,UROLOGICAL
111,169,2013,ANECDOTAL,COPYRIGHT,EDUCATION,ENGLISH,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PERTINENT,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL,WORRISOME
169,2009,2013,BEST,COPYRIGHT,DRE,EDUCATION,FIRST,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PSA,PUBLISHED,PURPOSE,RESULTS,THERE,THEREFORE,UROLOGICAL
002,007,169,2013,262,ACTUARIAL,AGE,COPYRIGHT,COX,EDUCATION,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,T2A,UROLOGICAL
0001,169,190,1996,2005,2013,482,508,682,781,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,ONTARIO,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
169,2013,ALSO,CLASSIC,COPYRIGHT,EDUCATION,HOWEVER,INC,LABEL,MATERIALS,METHODS,MOST,OBESITY,OBJECTIVE,PRIOR,PUBLISHED,PURPOSE,RESULTS,SINCE,UROLOGICAL
094,2008,2009,428,553,575,647,BACKGROUND,IMRT,LABEL,METHODS,PRT,RESULTS,THERE
1400,169,2012,AACR,ANEUPLOIDY,CEP57,FGF,FGFR1,HOWEVER,MALIGNANT,RES,TAKEN
945,946,LNCAP,MEN,PCA,TAKEN

CAR,CARS,CCR,CURRENT,HOWEVER,PSCA,PSMA,TCRS,USING
001,185,18FCH,2009,2011,224,233,8312,8805,APRIL,DISEASE,GLEASON,JANUARY,LABEL,METHODS,OBJECTIVE,OVERALL,PET,PSA,PSADT,PURPOSE,RESULTS,SUBSEQUENT,THREE,TRIGGER
250,947,948,JAPAN

8805,BACKGROUND,DETECTION,HOWEVER,LABEL,METHODS,PBL,PCA,PCA3,PCR,PSA,RESULTS
169,2012,ALSO,FOUR,GOLGI,JOHN,LNCAP,PNTA1,SONS,THEIR,WILEY
009,169,2005,2012,337,617,8194,8195,AGREEMENT,AIMS,AMONG,BLACKWELL,ENUP,FIFTEEN,GLEASON,IMAGE,ISUP,LABEL,LIMITED,MEAN,METHODS,MINIMUM,NETWORK,OBJECTIVE,PATHOLOGY,PUBLISHING,RESULTS,SOCIETY,THERE,UROLOGICAL,WHILE
169,2011,2012,ANOTHER,BLACKWELL,COLLEGE,CONSENSUS,III,LIMITED,NHMRC,PUBLISHING,REPORTING,ROYAL,THERE
MEN
8202,CHRONIC,CRP,IGG,LIVE,RAT,RATS,SEVERAL,SPRAGUE
027,032,916,APC,CDC20,CDH1,DAXX,ECTOPIC,GLEASON,MITOTIC
EPIGENETIC,EZH2,HENCE,INSTEAD,PRC2
RARP,WITHOUT
000,132,2004,8805,BPH,COX,ITALIAN,JANUARY,LABEL,MEN,METHODS,OBJECTIVE,OVERALL,PCA,PROPENSITY,PURPOSE,RESULTS,THESE
169,2010,AMONG,DIVERSE,INC,WILEY
956,BAK,BAX,BCL,BIM,CFSE,CKRS,CXCR3,CXCR4,CXCR5,CXCR6,FINALLY,LNCAP,MCL,MTT,PC3,PCA,USING,WEV
156,2002,2009,239,315,3771,BIOLOGICS,BRITISH,CONCLUSION,ENGLAND,ENGLISH,HODGKIN,LABEL,METHODS,OBJECTIVE,OBJECTIVES,POISSON,RESULTS,RISKS,SIR,SIRS,SOCIETY,TNF
100,102,169,2012,8804,ADC,CONCLUSION,COPYRIGHT,DWI,ECE,FIFTY,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,SIDE,T2WI,WILEY
169,2012,COPYRIGHT,GHR,GOLGI,INC,LNCAP,THESE,WILEY
231,HECV,HOWEVER,MATRIPTASE,MDA,TTSP
0001,015,024,1982,1997,2007,5970,AUSTRALIA,BACKGROUND,DATA,HODGKIN,HOWEVER,LABEL,METHODS,OUTCOME,RESULTS,TRANSPLANT,ZEALAND
169,2012,954,956,AKT,COPYRIGHT,GMBH,MAPK,MYC,PACLITAXEL,PGP,TAX
ADT,HRQOL,INTENTION,PCA
169,2012,COPYRIGHT,HODGKIN,LTD,NHL,THESE
002,0059,0137,169,2013,3750,ACUTE,ADVERSE,COPYRIGHT,CRT,DOSE,DOSES,IMRT,INC,MEDICAL,OAR,PTV1,PTV2,PTVS,PUBLISHED,SALVAGE,THERE,THESE,THREE
103,150,1973,1994,2008,4457,8201,BACKGROUND,CANCERS,CONFIDENCE,END,LABEL,METHODS,POISSON,RESULTS,SEER,SIR,THYROID
CURRENTLY,HIFU,IMAGE
100,115,137,169,197,1993,2006,2013,215,222,242,246,268,350,863,8805,985,AMONG,COPYRIGHT,EBRT,GY3,INC,LABEL,MATERIALS,MEN,METHODS,OBJECTIVE,PRESCRIBED,PROSTATIC,PURPOSE,RESULTS,SURVIVORS,UNIVERSITY
00005,00006,0001,0002,004,0058,120,121,191,209,CTVPROS,CTVPVSAPCT,CTVPVSAPMR,CTVPVSSZCT,CTVPVSSZMR,EIGHT,HOWEVER,MEAN,MRI,PTVS,RATIO,STUDENT,VOLUMES
2004,223,700,BASED,CRPC,III,MDV3100,RESULTS,TAK
001,024,040,PEAK,PRE
111,158A,BPH,CHAIN,CONCLUSION,GENOTYPING,LABEL,MATERIALS,METHODS,OBJECTIVE,PCA,POLYMERASE,PSA,PURPOSE,RESULTS,SIMILARLY
177,CONCLUSION,LABEL,MATERIALS,MEAN,METHODS,OBJECTIVE,PURPOSE,RESULTS
000,160,177,190,AFTER,BPH,CONCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,PCA,PSA,PURPOSE,RESULTS,USING
100,107,AIMS,BACKGROUND,HOWEVER,LABEL,METHODS,MYD88,MYELOID,OBJECTIVE,RESULTS,SSCP,THERE
000,010,100,132,144,172,178,2007,2008,2012,500,773,7743,783,AIMS,BACKGROUND,HOWEVER,ITALY,LABEL,METHODS,MORTALITY,OBJECTIVE,OTHER,REDUCED,RESULTS,WORLD
118,132,258,549,IDH1,IHC,WESTERN
ADT,AFTER,BECAUSE,CA19,CEA,MRI,PSA
MRI,PSA,SIX
169,178,185,2012,215,8315,8322,8324,COPYRIGHT,CVS,DPV,ELISA,HRP,NTF,PSA,UNDER
132,148,169,2012,210,227,ADT,BASEL,CHANGES,COPYRIGHT,HDL,LABEL,LDL,LHRH,MAB,METHODS,OBJECTIVE,RESULTS,SERUM,THERE
BONE
ABCA1,AKT,GLEASON,LNCAP,REMARKABLY
E2F1,E2F2,EVEN,EXO1,FOXM1,MCM2,NOTABLY,YET
177,237,946,956,ELISA,ERK1,GELATIN,HOWEVER,MEANWHILE,MMP,PD98059,THESE,THROUGH,U87MG,WESTERN
CAT,GSH,ME45,SOD,THERE
1000,1995,200,2004,FOUNDATION,MICROARRAY,NORTH,TMA,TMAS
000,1000,169,2012,BACKGROUND,CHEMISTRY,DESPITE,LABEL,METHODS,MNAZYME,PCR,RESULTS
169,2012,AUNP,AUNPS,COPYRIGHT,CTT54,GOLD,LNCAP,LTD,PSMA
0057,026,30D,DU145,LNCAP,MIR,MMP,PC3,PCA,PRSC,RWPE,SOCS1,STAT3,TAKEN,USING,UTR,WESTERN
BACKGROUND,DUAL,FINALLY,FIRST,GAMMA,LABEL,LAST,LNCAP,METHODS,RESULTS,SILENCING,SNCG
BRAIN,HOWEVER
945,946,ALDH1,ALDH2,ALDH3,ALDHS,GSH,HNE,MDA,METHIONAL,ROS
100,2010,280,345,698,808,8364,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,OUTCOME,PBX,PCA3,RAM,RAND,RESULTS
3DVH,8725,DICOM,DVH,DVHS,DYK,IMRT,LABEL,MELBOURNE,METHODS,NUCLEAR,OBJECTIVE,PEARSON,PERCENTAGE,PURPOSE,RESULTS,SUN,TPS,VAN
176,180,8725,CHHIP,DIFFERENT,DOSE,EUCLIDEAN,HOWEVER,LABEL,METHODS,OBJECTIVE,PLAN,PLANS,PTV,PURPOSE,RESULTS,THESE,VMAT
176,BACKGROUND,FURTHER,LABEL,METHODS,RESULTS,THESE,ULTIMATELY,USING
003,016,017,025,165,175,340,8201,AFRICAN,BACKGROUND,CAUCASIAN,FORWARD,LABEL,METHODS,NCI,OBJECTIVE,PURPOSE,RESULTS,SERVICE,SURVIVORS,THERE
AFTER,POTENTIAL
169,1964,1990,2008,2013,COPYRIGHT,EDUCATION,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SIR,SIRS,SWEDISH,UROLOGICAL
2008,3355,679,BACKGROUND,CONCLUSION,DESPITE,GUIDELINES,LABEL,MATERIALS,METHODS,RESULTS,TEN,THERE,UROLOGICAL,UROLOGISTS
079,124,139,208,258,377,470,499,514,852,BACKGROUND,COHEN,GLEASON,KAPPA,LABEL,MATERIALS,METHODS,PERINEURAL,PNI,RESULTS
136,290,516,806,BACKGROUND,CONCLUSION,DRE,LABEL,MATERIALS,METHODS,NPV,PNB,PPV,PSA,RESULTS,SERUM,THREE,WHILE
ADDITIONAL,BACKGROUND,EBRT,LABEL,MATERIALS,METHODS,RESULTS
001,1000,1088,BACKGROUND,GRADE,JANSSEN,LABEL,METHODS,RESULTS
001,192,2000,2004,261,332,BACKGROUND,BRFS,COX,DSS,EBRT,GLEASON,HDR,LABEL,METHODS,PSA,RESULTS,THERE
2010,BACKGROUND,DEPARTMENT,ENROLLMENT,LABEL,MEDICAL,METHODS,PILOT,RESULTS,SKCCC,TRIAL
FURTHER,HIGH,HOWEVER,III
1993,2002,464,767,CONCLUSION,FEDERAL,LABEL,METHODS,NORTH,OBJECTIVE,RESULTS,SEVENTY,SOUTH,THERE,THESE,UNLABELLED
0001,20NG,99M,GLEASON,HOWEVER,PET,PSA,SPET,THESE
100,1E8,2B4,AKT,MTA1,PCR,SILENCING,WESTERN
AUNP,AUNPS,FGF1,FGFR,FGFRS,FIBROBLAST,NOVEL,THESE
000,001,8202,91263,BACKGROUND,CLPTM1L,FOLLOWING,LABEL,PRINCIPAL,RESULTS,TERT,THESE
ACTIVATION,DISRUPTION,PC3,PCA,PSA,SEVERAL,STAT3,STRIKINGLY,THESE
BECAUSE,DU145,FURIN,KI67,KIP,LNCAP,PACE4,PC7,PCS,USING,XTT
001,011,2003,2011,368,6TH,7TH,ASIAN,COMMITTEE,JOINT,LABEL,METHODS,OBJECTIVE,RESULTS,TNM
2006,2010,386,AMONG,BETWEEN,CONCLUSION,HOWEVER,KOREA,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
001,011,177,2008,2010,BETWEEN,CONCLUSION,HOWEVER,JULY,JUNE,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,OVERALL,PCA,PURPOSE,RESULTS
0001,1127,1991,2008,2010,973,AIM,EINDHOVEN,GLOBE,HRNO,LABEL,METHODS,OBJECTIVE,QUESTIONS,RESULTS
1995,2011,674,8805,AIM,AMONG,CONCLUSION,GLEASON,GS6,LABEL,LOW,METHODS,OBJECTIVE,PCA,PSA,RESULTS,STRATIFIED
4OHT,BACKGROUND,BCL2,BIC,CONCLUSION,EGF,LABEL,LNCAP,MATERIALS,METHODS,MYC,RESULTS,TAMOXIFEN
224,BACKGROUND,C32,CONCLUSION,DART,FADU,GBM,HCT15,LABEL,MATERIALS,METHODS,RESULTS,U87,WHILE
946,AKT,DPI,DUOX,FAS,GSK3,INHIBITION,PC3,ROS
15TH,2012,209,791,902,CAUCASIANS,HOWEVER,MEDLINE,ODDS,OVERALL,SCIENCE,SIMILARLY,THEREFORE,WANFANG,WEB
160,GLY450VAL,PARK2,SER9THR,SSCP
332,945,946,DESPITE,HOWEVER,LOSS,RNAI
007,2001,2009,311,413,8804,8805,GLEASON,LABEL,METHODS,OBESITY,OBJECTIVE,PROTECT,PSA,PURPOSE,RESULTS,THERE
2000,494,692,AFTER,AMONG,DETROIT,DRE,FURTHER,HOWEVER,LABEL,METHODS,NSESI,OBJECTIVE,PCA,PSA,PURPOSE,RESULTS,SES
CCD
160,IMAGING,ORBITAL,TREATMENT
102,127,CHINESE,CONCLUSION,CROSS,HONG,KONG,LABEL,METHODS,OBJECTIVE,PCA3,PSA,RESULTS,SETTING,UNIT,UROLOGY
111,945,946,FINALLY,GLEASON,GYLTL1B
BASED,SEMINAL
183,196,2002,2010,379,8805,AMONG,HOWEVER,JULY,JUNE,PCA,RADICAL,RRP,T1A,T2C,T3A
2765,954,AGREEMENT,BACKGROUND,CARE,CENTERS,CONTROL,DISEASE,LABEL,METHODS,PREVENTION,PROGRAM,RESULTS
2000,2003,2005,5298,8804,929,BACKGROUND,CANCORS,CRN,HMO,HOWEVER,III,LABEL,METHODS,NETWORK,OBJECTIVE,PPV,RESULTS,SECONDARY
0001,100,CK903,ERG,HOWEVER,PIN,PTEN,RADICAL,WEAK
BRAF,CTLA4,EMT,EPITHELIAL,KNOWLEDGE
SIPULEUCEL
ALIGNMENT,BAM,FASTQ,FURTHER,JAVA,KNOWN,LNCAP,MAP,SAM,TARGETSCAN
CACO2,GPX3,NOTABLY,ROS,TAKEN,WNT
001,514,BACKGROUND,BETWEEN,C30,EORTC,LABEL,METHODS,PCA,QLQ,QOL,RESULTS
169,2012,BASEL,COPYRIGHT,ENCOUNTER,GEQS,IIEF,INDEX,LABEL,LIBRARY,MANAGER,METHODS,OBJECTIVE,PCA,PDE5I,PROFILE,QUESTIONS,RCTS,RESULTS,SEP
021,042,135,169,2012,352,556,946,BACKGROUND,BASEL,CAMS,CD44S,COPYRIGHT,GLEASON,HGPIN,LABEL,MATERIALS,METHODS,PCA,RESULTS,TNM
169,2010,2012,COPYRIGHT,INC,PHYSICIANS,TIO
4000,AFRICAN,CAUCASIAN,CAUCASIANS,ISSUE,LTD,PUBLISHED,SINCE,SPECIAL,THESE,VITAMIN
946,EGR,GSK,INC,LABORATORY,NAG,NSAID,PUBLISHED,STUDIES,TGF,UPON
169,2012,ADJUSTMENT,ADT,ASSESSMENT,COPYRIGHT,COUPLES,INC,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCALE,THERAPY,THOSE,WHILE
169,2012,945,946,948,CAM,COPYRIGHT,CWR22RV,FEDERATION,HIF,PUBLISHED,SOCIETIES,VEGF
001,002,013,10878,169,2012,CDCA3,CHIP,COPYRIGHT,GLEASON,HOX,HOXB3,IRELAND,LNCAP,LTD,MEIER,PSA,THEIR,THESE
169,2012,COPYRIGHT,EARLIER,INC,OPG,PANCREATIC,PDAC,RAS,SILENCING,THESE,TRAIL,WHILE
160,169,2013,947,BECAUSE,BHPRE,COPYRIGHT,HINDGUT,INC,KSM,PATHOLOGY,PPAR,PTEN,PUBLISHED,SOCIETY,STROMAL,THESE,WHEREAS
001,009,169,2011,2013,313,328,422,COPYRIGHT,EDUCATION,INC,INCREASED,LABEL,MATERIALS,METHODS,OBJECTIVE,PEARSON,PHYSICIANS,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL,USING
009,169,2004,2010,2013,309,334,955,BOARD,COPYRIGHT,EDUCATION,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OLDER,PUBLISHED,PURPOSE,RESULTS,THERE,THESE,UROLOGICAL,UROLOGY
100,169,200,2013,298,AFTER,COPYRIGHT,EDUCATION,ENCOUNTER,FOLLOWING,IIEF,INC,INDEX,LABEL,MATERIALS,METHODS,OBJECTIVE,PRIMARY,PROFILE,PUBLISHED,PURPOSE,RESULTS,SEP,SEP2,SEP3,UROLOGICAL
160,169,2013,ADT,ASC,C81,COPYRIGHT,INC,LNCAP,MDM2,PATHOLOGY,PCA,PTEN,PUBLISHED,SOCIETY,THESE,TRAMP,USING
160,169,2013,COPYRIGHT,EVEN,FINALLY,FURTHER,IMAGING,INC,PATHOLOGY,PUBLISHED,SOCIETY
009,078,161,169,2013,913,951,COPYRIGHT,GLEASON,INC,KLF6,KRUPPEL,PATHOLOGY,PCA,PDCD4,PUBLISHED,SOCIETY,THUS
169,1991,2012,BACKGROUND,BMI,CONTEXT,COPYRIGHT,HOWEVER,INCREASING,JULY,LABEL,METHODS,OBESITY,OBJECTIVE,PCA,PUBLISHED,RESULTS,SYNTHESIS,THESE,UROLOGY,WESTERN,WHETHER
169,2012,969,BACKGROUND,BECAUSE,CONTEXT,CONVERSELY,COPYRIGHT,CURRENT,DUE,JUNE,LABEL,METHODS,OBJECTIVE,PCA,PRIMARY,PUBLISHED,RESULTS,SYNTHESIS,UROLOGY,WESTERN
169,2012,501,8805,AIMS,AMONG,COLLEGE,COPYRIGHT,COX,HIGH,HOWEVER,III,LABEL,LTD,MATERIALS,METHODS,NTX,OBJECTIVE,PUBLISHED,RESULTS,ROYAL,THEREFORE,ZOL
104,114,169,2000,2009,2013,AVID,BACKGROUND,CONTEXT,COPYRIGHT,GRADE,HOWEVER,INC,LABEL,METHODS,MRI,OBJECTIVE,OUTCOME,PATIENT,PURPOSE,RCC,RESULTS,SETTING,THERE
169,2012,241,COPYRIGHT,ESPA,PET,PSCC,SMALL
169,2012,241,BACKGROUND,CONCLUSION,COPYRIGHT,DUAL,ESPA,FDG,FIFTY,LABEL,METHODS,PET,RESULTS,THUS
169,2012,COPYRIGHT,CURRENTLY,EBRT,HOWEVER,LTD,SBRT,STUDIES,WESTERN
169,2012,2030,BOTH,COPYRIGHT,FEDERATION,FINALLY,PREVENTION,PUBLISHED,SOCIETIES,THESE,TOBACCO,WIDER
169,2012,COPYRIGHT,INC,SEMINAR,SOCIETY,THERE
001,011,076,130,145,169,172,1999,2009,201,204,213,255,385,405,672,ACP,AMONG,BPH,DATA,JANUARY,LABEL,MANN,MARCH,METHODS,OBJECTIVE,OUTCOME,PROSTATIC,PSA,RESULTS,SERUM,SETTING,STUDENT,WHITNEY
2010,CONCLUSION,LABEL,MARCH,METHODS,OBJECTIVE,PATIENT,PLACE,RESULTS,SEPTEMBER,SHAUKAT
032,035,169,2012,300,332,413,640,739,823,AUC,COPYRIGHT,OPTIMIZING,PSA,PUBLISHED,ROC,THESE
100,AFTER,CD10,CD34,CD56,CD99,EMA,LABEL,MOST,PALLIATIVE,PROSTATIC,SLIDE,UNASSIGNED,UNLABELLED,VIRTUAL
160,169,177,2003,2011,2012,AIM,AUTHORS,BRITAIN,CLOSURE,COLORECTAL,CONCLUSION,DISEASE,GREAT,IRELAND,LABEL,METHODS,OBJECTIVE,RESULTS,RUF,THERE
008,169,2012,ANZ,AUSTRALIA,AUSTRALIAN,AUTHORS,BACKGROUND,BLADDER,CIS,COLLEGE,CONCLUSION,HIGH,JOURNAL,LABEL,LARGE,METHODS,RCP,RESULTS,ROYAL,SOUTH,SURGERY,WALES
102,169,2012,319,ASSESSMENT,GLEASON,HOWEVER,JAPAN,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,RISK,UROLOGICAL
169,1821,2012,207,257,259,453,946,FOLEY,JUDGING,UROLOGICAL
169,2012,ALSO,APMIS,CRC,CUL3,JOHN,LTD,OVERALL,PCA,PHE133LEU,POZ,PUBLISHED,SONS,SPECKLE,SPOP,SSCP,TSG,WILEY
DESPITE,PI3K
800CW,DUAL,EPCAM,FURTHER,IRDYE,MMC,MULTIMODAL,THREE,USING
100,1103,140,258,266,364,482,528,CONCLUSION,DVC,GLEASON,LABEL,METHODS,NVB,OBJECTIVE,POOR,PSA,RESULTS,RRP,THERE,WALSH
001,029,150,AFTER,CCS,CONCLUSION,CPSI,III,IIIA,LABEL,METHODS,NBT,NIH,NINGBITAI,OBJECTIVE,PSA,PSAD,RESULTS
022,035,100,153SM,99MTC,CONCLUSION,EDTMP,LABEL,MBQ,MDP,METHODS,OBJECTIVE,PCA,RESULTS
BMD,CONCLUSION,LABEL,MAB,METHODS,OBJECTIVE,PSA,RESULTS,THERE
008,169,2012,BACKGROUND,BPH,CONCLUSION,FURTHER,LABEL,LINEA,NIGERIA,OBJECTIVE,RESULTS,SOCIETY
001,1503,946,BACKGROUND,GLEASON,HOWEVER,LABEL,METHODS,MSP,PSA,REGARDLESS,RESULTS,WHETHER
2007,2012,784,CONCLUSION,ETHNICITY,FOUR,IMD,INDEX,LABEL,METHODS,OBJECTIVE,ONCE,PHASE,PURPOSE,RESULTS
0001,0018,018,1362,169,2012,215,668,694,8730,8805,956,ACCESS2,AUC,BACKGROUND,BECKMAN,CHEMISTRY,COULTER,GLEASON,LABEL,METHODS,PCA,PHI,PSA,RESULTS,ROC,SERUM,TOTAL
110,136,169,2012,215,246,8730,8805,956,AUC,AUCS,BACKGROUND,BECKMAN,CHEMISTRY,COULTER,DRE,E26,ERG,GEN,HOLOGIC,LABEL,METHODS,NEM,PCA,PCA3,PHI,PROBE,PSA,RESULTS,ROC,SERUM,TMPRSS2
169,2012,A549,AMONG,COCL,COPYRIGHT,HCT,JOHN,LNCAP,LRP1,LTD,ROS,SONS,WILEY
169,2012,BACKGROUND,BRITISH,CONCLUSION,COPYRIGHT,JOHN,JOURNAL,LABEL,LTD,METHODS,PUBLISHED,RESULTS,SCREENING,SOCIETY,SONS,SURGERY,WILEY
100,120,177,300,BACKGROUND,CONTROL,LABEL,LNCAP,MATERIALS,METHODS,PC3,POST,RESULTS,SCID,TEN
001,015,106,159,169,201,2012,231,243,AMICO,CONCLUSION,COPYRIGHT,DALL,DOPPLER,DRE,ERA,LABEL,METHODS,OBJECTIVE,PDS,PSA,PUBLISHED,PURPOSE,RESULTS,SAS,SIXTY,VPN
100,8804,8805,945,COMMITTEE,EASTERN,EIGHT,GAL,GROUP,HAP,HYPERACUTE,IGG,JOINT,NEWLINK,PSA,RESULTS,SERUM,THESE,THREE
169,2012,AUSTRALIAN,AUTHORS,BILATERAL,COLLEGE,HIP,IMAGING,INVERSE,JOURNAL,MEDICAL,RADIATION,ROYAL,ZEALAND
169,2012,ACHIEVA,AUSTRALIAN,AUTHORS,COLLEGE,DWI,IMAGING,JOURNAL,LABEL,MEDICAL,METHODS,MRI,MRS,NPV,OBJECTIVE,PHILIPS,PPV,PSA,RADIATION,RESONANCE,RESULTS,ROYAL,TESLA,ZEALAND
ABDOMINAL,CONCLUSION,EMERGENCY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,ROOM,TRUS,UNIT,UROLOGY
460,ANTIGEN,DRE,LABEL,METHODS,NPV,OBJECTIVE,PPV,PREDICTIVE,PROSTATIC,PSA,RESULTS,SCAN,TRANS,TRUS,ULTRASOUND,VALUE
ADT,ANTIGEN,DEGARELIX,EAU,FSH,GNRH,ITALY,PSA
ADI,AMONG,DHT,LNCAP,RHOB
946,AKT,AMP,F12
105,309,947,DOSIMETRIC,EPID,HOWEVER,IMRT,SEVERAL
120,160,177,418,8201,CONCLUSION,EARLY,FACBC,LABEL,MBQ,METHODS,MRI,OBJECTIVE,PET,PURPOSE,RESULTS,SIX,SUV,SUVS,THERE,URINE
AMP,COA
135,946,AKT,BOTH,CDCP1,COMPLEXING,CUB,FAK,PI3,PI3K,THEREFORE,THUS
DESCRIBED,TAMIS,TRANSANAL
169,2012,BASEL,COPYRIGHT,CTC,CTCS,EGFR,FISH,HER2,KRAS,PCR
ADENOVIRAL,AKT,ALTOGETHER,ERK1,LNCAP,MACROPHAGE,MIF,NED,PCA,THUS,YET
1422,1677,169,186,2004,2010,2012,210,255,ARIZONA,CLAVIEN,CONCLUSION,COPYRIGHT,GLEASON,INC,LABEL,MARCH,MATERIALS,MAYO,MEDICAL,METHODS,OBJECTIVE,OCTOBER,RARP,RESULTS,T3A,UNIVERSITY
145,162,169,2001,2007,2012,2110,500,900,AMONG,AREAS,CONCLUSION,COPYRIGHT,COX,END,HOWEVER,HSA,HSAS,IMRT,INC,LABEL,MARKETS,METHODS,OBJECTIVE,POISSON,RESULTS,SERVICE,THESE
000,100,1623,177,2010,2011,259,BACKGROUND,BETWEEN,DATA,HOWEVER,LABEL,METHODS,PCA,PSM,RESULTS,SSIS,THEREFORE,THESE,UNIVERSITY
001,169,174,2013,215,704,892,AUC,BECKMAN,COPYRIGHT,COULTER,EDUCATION,HYBRITECH,INC,INDEX,LABEL,MATERIALS,METHODS,OBJECTIVE,PSA,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
232,BACKGROUND,CONCLUSION,DIFFERING,DVH,LABEL,METHODS,OBJECTIVE,ORGAN,PURPOSE,RESULTS
169,2012,8226,AUTHORS,BJU,CONCLUSION,LABEL,METHODS,RESULTS,TRUS
002,153,169,1998,2000,2012,243,525,8226,8805,AMONGST,AUTHORS,BFR,BJU,GLEASON,HDRB,INCLUSION,LABEL,METHODS,OBJECTIVE,PFP,PSA,RESULTS,T2B,THERE
004,043,169,2012,8226,AUTHORS,BJU,CONCLUSION,INVENTORY,LABEL,LRP,MEN,METHODS,OBJECTIVE,PSM,PSMS,RALP,RESULTS,SHIM,VINCI
001,169,2012,249,8226,8805,AFTER,AUTHORS,BJU,COX,EPE,GLEASON,LABEL,METHODS,OBJECTIVE,PSA,RESULTS,SVI,TUMOURS
169,2012,8226,AUTHORS,BJU,FRYDENBERG
169,2012,8226,AUTHORS,BJU,CURRENTLY
169,2012,8226,AUTHORS,BJU,HGPIN,HIGH
169,2010,2012,CHRONIC,COPYRIGHT,FATIGUE,FOCI,JULY,MEETING,MICRO,RELATED,SINCE,STILL,TODAY,VIRUS,XENOTROPIC
001,206,AUC,AUCS,CAD,CONCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIX,STAND,WITHOUT
945,946,CTSH
233,945,946,CLIC3,CLT1,HIGH,INCUBATING,WHILE
BASED,INSTEAD,LASSO
ERG,FURTHER,GLEASON,LOW,PTEN,THESE,THUS,TMPRSS2,USING
954,GRP78,PAR,UACA
169,2012,BACKGROUND,CHEMISTRY,CONTENT,CRPC,LABEL,MAJOR,SUMMARY
140,177,340,410,DBR,LABEL,METHODS,OBJECTIVE,RADICAL,RESULTS
177,370,956,CONCLUSION,DCFBC,EXM,FDG,FIVE,LABEL,MBQ,METHODS,MOST,PCA,PET,PREVIOUSLY,PSMA,RADIATION,RESULTS,TIME,UNLABELLED
916,936,AKT,APOPTOSIS,BCL,BID,DADS,DIALLYL,DR4,DU145,ERK,FAS,FASL,HOWEVER,IAP,JNK,JUN,LY29004,MAPK,MAPKS,MMP,PD98059,PI3K,THESE
001,029,032,118,432,BARR,CAV,EBV,EPSTEIN,LC3B,QDS,QUANTUM
946,CPT,HB1,IFN,KIT,LNCAP,SCF,THESE,VEGF
AGAINST,COLLEGE,KINGDOM,REPORTING,ROYAL
BOTH,DESPITE,SUI
LOW
178,DCE,DYNAMIC,EMPIRICAL,EU1,MRI,PUN,TOFTS
LABEL,MINIMALLY,OBJECTIVE,PURPOSE,RESULTS,SUMMARY
946,COUP,HOWEVER,MUTATIONS,NR2F2,PTEN,SMAD4,TFII,TGF,THESE
169,2012,COPYRIGHT,IRELAND,LTD,THERE
169,2012,223,954,BACKGROUND,BETA,BONE,CONTEXT,COPYRIGHT,DENOSUMAB,FURTHER,LABEL,MET,METHODS,OBJECTIVE,OPTIMAL,OSTEOCLAST,PCA,PUBLISHED,RESULTS,SRC,SYNTHESIS,UROLOGY,ZOLEDRONIC
001,002,023,169,196,2012,443,497,799,833,842,AUC,BACKGROUND,BOTH,COPYRIGHT,E26,ERG,ERSPC,GLEASON,LABEL,METHODS,OBJECTIVE,OUTCOME,PCA,PCA3,PUBLISHED,RANDOMISED,RESULTS,SCREENING,SETTING,TMPRSS2,UNIVARIATE,URINE,UROLOGY
169,2012,BASED,COPYRIGHT,DUE,INC,MSNS,NPS,PSA
169,2012,33258,BAX,COPYRIGHT,GST,HOECHST,MTT,RESULTS,SAS,SW620
169,2012,BACKGROUND,COPYRIGHT,GAP,LABEL,LNCAP,PC3,RESULTS,RHO,RHOA,RHOC,RHOGAPS,SEVERAL
169,2012,8230,945,946,COPYRIGHT,ESTROGENS,GIVEN,HOWEVER,INC,MISS,SERMS,THESE,THUS
0126,081,169,177,2012,ASSUMPTION,COPYRIGHT,CTS,CTV,D15,D25,D35,D50,D90,D98,DOSE,EFFECTS,IMRT,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PURPOSE,RESULTS,RMSPE,RTOG
0001,008,464,8211,8216,8217,AFRICAN,LOWER,MEAN,THEIR,THEREFORE
CD25,CD4,DATA,HANAHAN,HOWEVER,IC50S,IDO,METASTASIS,PCR,THESE,TREG,WHILE
169,174,180,2012,24H,652,956,AMONG,BACKGROUND,COPYRIGHT,HOWEVER,LABEL,LNCAP,METHODS,PDT,PEGYLATED,REGARDING,RESULTS,SEVERAL,THPC,USING
169,1747,2011,2012,2013,AGA,AVERAGE,BAY,COPYRIGHT,DEPARTMENT,GLEASON,HIGH,HONG,HOWEVER,INC,JANUARY,JUNE,KARACHI,KHAN,KONG,MOST,PATHOLOGY,PERINEURAL,PSA,SECTION,SPSS,UNIVERSITY
169,2012,956,COLLEGE,COPYRIGHT,DAURICINE,LABEL,MEDICAL,METHODS,MTT,OBJECTIVE,PUBLISHED,RESULTS
169,2012,CONCLUSION,COPYRIGHT,CTV,FIFTY,FIVE,IRELAND,LABEL,LTD,MATERIALS,METHODS,MRL,OBJECTIVE,PURPOSE,RESULTS,RTOG
1000,169,1998,2008,2012,9782,BACKGROUND,COPYRIGHT,EIGHT,GATHERING,INTENTION,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PERFORMING,PURPOSE,RADIATION,RATE,RESULTS,THERE
169,188,2013,945,946,99M,BALB,BBN,COPYRIGHT,FURTHER,GAMMA,GLU,GRPR,INC,MAG,RGD
169,2012,COPYRIGHT,CRPC,LNCAP,LTD,THUS
005,946,AIMS,BME,CONCLUSION,DISCUSSION,ICAM,LABEL,MATERIALS,METHODS,OBJECTIVE,PC3,RESULTS,VCAM
AREAS,BACKGROUND,COVERED,CRPC,LABEL,METHODS,OPINION
500,BOTH,EACH,PC3,PI3,PI3K,SELECTIVE
1E8,390,DT390,EFFICACIES,INCREASED,MKN,PEPTIDE,THUS,TMTP1,TUNEL,USING
2009,AVILA,BMX,EGFR,IRM,MERCK,TEC,THEREFORE,THESE
AFTER,EIT,MREIT,MREPT

000,0001,0013,004,0318,ERG,GLEASON,PTEN,THERE
ADRENAL,ALDO,CRPC,CURRENT,DHEA,DHT,DUCAP,HIGH
169,183,BECAUSE,GEORG,STUTTGART,THESE,YORK
169,2012,CHIP,COPYRIGHT,IRELAND,LTD,SEQ
100,945,AE1,AE3,CD34,CD68,MFS,MIB,RIGHT,SMA,THUS
BOTH,FUNCTIONAL,FURTHER,LBD,PCA,THEREFORE,THUS
003,017,1981,2007,450,5590,962,END,HODGKIN,NHL,POISSON,PROGRAM,RESULTS,SEER,THERE
1923,1945,1991,2005,246,3000,308,3500,4000,4781,637,AMONG,BIRTH,BWS,CRUDE,DIET,LUND,MALM,PRCA,THERE
BACKGROUND,BEOWULF,LABEL,UNLABELLED
001,065,458,526,782,ADCY5,CONSORTIUM,DATA,FTO,HNF1B,INSTITUTE,JAZF1,KCNQ1,PCA,T2D,TEN,THESE
169,2012,BACKGROUND,BLINDED,CHEMISTRY,COLLECTION,CONTENT,DETECTION,EARLY,EDRN,EVALUATION,INSTITUTE,LABEL,NETWORK,PROBE,REFERENCE,SINCE,SUMMARY
1981,1991,2006,2106,BACKGROUND,HOWEVER,HPLC,LABEL,METHODS,NORWEGIAN,OBJECTIVE,PREDEFINED,RESULTS,THERE
15D,916,947,BECAUSE,CHROMATIN,HOWEVER,PGJ,SUMO,TMPRSS2
169,2012,8201,916,936,BAPTA,BAX,COPYRIGHT,DPT,INC,MMP,NAC,ROS,USING,WILEY
169,2012,AFTER,COPYRIGHT,DRUG,DU145,HOWEVER,INC,PCA,SNAIL,THESE,TXR,WILEY,ZEB1
946,COX,EP2,PGE,POPULATION,PTGS2
005,018,039,041,042,122,DU145,IL6,LNCAP,PC3,SHP,SRC
AFTER,DUE,FINALLY,HOWEVER,SIFT
169,2012,ANNEXIN,BACKGROUND,COPYRIGHT,EGFR,IGF,INC,INCREASED,LABEL,LNCAP,METHODS,PARP,PC3,PTHRP,PTPRF,RESULTS,SELECTIVE,SIMILAR,SRC,THESE,WILEY
169,2012,349,946,ALSO,AMACR,BACKGROUND,COA,COPYRIGHT,E12,GLEASON,INC,LABEL,MCT2,METHODS,PIN,RESULTS,TMAS,WILEY
169,2012,ACTIVATION,CCL5,COPYRIGHT,DOCETAXEL,EGFR,INC,INCREASING,MSC,MSCS,PC3,THESE,WILEY
000,100,151,169,2012,AFFYMETRIX,BACKGROUND,BASED,CONCLUSION,COPYRIGHT,COX,E2F3,IGF,IGFBP,INC,LABEL,LAPC,LNCAP,METHODS,MICE,RESULTS,SCID,SERUM,THREE,WESTERN,WILEY
105,1200,150,225,300,600,900,945,ACT,AFTER,INSURANCE,INTRACLASS,KOHLRAUSCH,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS
215,ACADEMY,BEIR,EPA,LSS,PROTECTION,VII
8320,8805,BOTH,HOWEVER
ATRT,ATRTS,BACKGROUND,E2F,EZH2,GIVEN,LABEL,METHODS,MICROARRAY,PRC2,RESULTS,RNAI,SMARCB1,USING,ZESTE
223,CRPC,THESE
244,341,AFP,ANALYZE,CA125,CA153,CA199,CEA,CMIA,CONCLUSION,ECLIA,LABEL,METHODS,OBJECTIVE,PSA,RESULTS,THESE
CLINICIANS,CODE,CONDUCT,ETHICAL,PRINCIPLES,UPON
22R,23R,DEPENDENCE,FBS,IC50,LNCAP,MCF,STUDIES
0345,0845,102,1067,11313,12934,1405,2012,2251,2655,2854,4353,4487,7152,7335,8202,9596,9913,A131G,ACCORDING,BACKGROUND,CHINA,CNKI,FIFTY,FURTHER,GSTM1,GSTP1,GSTT1,HOWEVER,JUNE,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PCA,PUBLISHED,RESULTS,SCHOLAR
004,2003,2007,2011,215,650,8202,AGE,AUC,BACKGROUND,CHINA,CHINESE,DETECTION,DRE,HUASHAN,LABEL,METHODS,OBJECTIVE,OCTOBER,PCA,PREDICTIVE,PSA,RESULTS,SIMILAR,THESE
362,604,EGF,EMT,EPLIN,ERK1,HOWEVER,PCA,USING
945,CCNJ,KNOCKDOWN,LIN,LNCAP,THUS,VDR
169,2012,COPYRIGHT,INC,MRI,MRSI,WILEY
320,946,CD44,PCA,THESE,TIC,TICS,WNT
1975,1983,2012,703,ALSO,HIV,HOWEVER,VIDEO
160,177,236,384,481,668,ADT,BACKGROUND,CLINICALLY,CURRENTLY,DESPITE,FOLLOWING,KI67,LABEL,MESH,OBJECTIVE,RESULTS,UNASSIGNED
22RV,CONVERSELY,DU145,LNCAP,MUTATIONS,THESE
167,169,2012,AMONG,CES,COPYRIGHT,DELAYED,DEPRESSION,DEPRESSIVE,FCS,FOUR,GMM,IL10,IL1R2,LABEL,LTD,METHODS,OBJECTIVE,PEAK,PURPOSE,RESILIENT,RESULTS,SNPS,STUDIES,TNFA,VARIATION,VARIATIONS,WHILE
0014,009,109,215,526,601,8804,AFTER,CAUCASIAN,CAUCASIANS,CONCLUSION,COX,CYP17A1,CYP19A1,DHEA,ESR1,HSD17B2,HSD17B3,LABEL,MEIER,METHODS,OBJECTIVE,PURPOSE,REMARKABLY,RESULTS,SNP,SNPS,TAIWANESE
100,169,2012,435,956,COPYRIGHT,ETG,FINALLY,GMP,HL1,INC,MANNICH,MDA,NMR,PTCL,SEVERAL,THUS,TOPO
169,1992,2009,2012,AGE,AUTHORS,BJU,CONCLUSION,GLEASON,HOWEVER,JANUARY,LABEL,LOCAL,METHODS,MOST,NORTH,OBJECTIVE,PSA,RESULTS,RRP,THERE,UNLABELLED,WHAT
169,177,1997,2007,2011,2012,203,8805,ACCORDING,ADD,AFTER,BJU,DOES,EFRP,EFRPS,FACTORS,FURTHER,GROUP,INVENTORY,KNOWN,LABEL,MEN,METHODS,OBJECTIVE,PRP,PRPS,RARP,RESULTS,SHIM,SUBJECT,TREATMENT,UNLABELLED,USING,VED,VEDS,WHAT
169,2012,HIGH,UROLOGICAL
0001,0002,0039,169,2012,704,8201,ANZ,AUTHORS,BACKGROUND,COLLEGE,CONCLUSION,DATA,FIFTY,JOURNAL,LABEL,MEAN,METHODS,OUTCOME,OVERALL,RESULTS,ROYAL,SCORE,SHORT,SURGERY,SYMPTOM,TURP
169,2012,3966,8805,CAUCASIAN,CAUCASIANS,GLEASON,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERWEIGHT,RESULTS,UROLOGICAL,USING,WORLD
106,169,1997,2011,2012,ANZ,AUTHORS,BACKGROUND,COLLEGE,COLORECTAL,CONCLUSION,EVEN,IQR,JOURNAL,LABEL,LUNG,MANN,METHODS,PATIENT,RESULTS,ROYAL,SURGERY,THERE,WHITNEY,ZEALAND
DRUG
2012,695,ABOUT,AFTER,FURTHER,GLEASON,HORMONE,LOCALISED,MOST,PRESCRIRE,PSA,TRANSIENT,TREATMENT,WHICH,WITHOUT
945,954,CAP,CHRONIC,HIF,INHIBITION,PRX1,STRIKINGLY,TLR4,TLRS,TOLL,VEGF
BACKGROUND,LABEL,PATHVISIO,PRINCIPAL,RESULTS,WORLDWIDE
ARMS,CAV1,CONVERSELY,ECRG4,ERG,ESFT,ETS,EWING,EWSR1,FLI1,KCNN2,LDOC1,NPT,NR0B1,PCA,USING
169,2012,COPYRIGHT,CPLA,CPLAS,GMBH,KGAA,VCH,WILEY
169,2012,BOTH,COPYRIGHT,CRPC,GMBH,IHC,KGAA,PBLS,PCA,SEM,VCH,WILEY
0001,0013,145,169,183,2012,215,827,895,931,AUC,COPYRIGHT,DUTCH,PCR,SWEDISH,THEREFORE,TODAY,UICC
169,2013,680,ALEXA,COPYRIGHT,FLUOR,GMBH,KGAA,LNCAP,MRI,OPTICAL,PSMA,VCH,WILEY
169,182,183,2012,205,221,222,34C,8201,BACKGROUND,COPYRIGHT,EXPRESSION,FFPE,GLEASON,GP4,GPS,HOWEVER,INC,LABEL,LCM,MEANWHILE,METHODS,PCR,REAL,RESULTS,VALIDATION,WILEY
169,16S,2012,BACKGROUND,CC36,CC53,COPYRIGHT,INC,LABEL,METHODS,MLST,OVERALL,RADICAL,RESULTS,STS,THESE,WILEY
169,2013,CALCIUM,COPYRIGHT,DESPITE,GMBH,HOWEVER,KGAA,PEG,PEGYLATED,VCH,WILEY
AFRICAN,AFTER,BALTIMORE,EXPLORING,INTEGRATED,SOUTHWEST,WHITE
0001,005,011,8804,8805,CDR,LABEL,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS,SINCE
002,005,007,126,130,280,300,362,385,470,754,786,799,874,8804,BPH,GGC,PCA,TOTAL
145,205,MICROBIAL,MUCOR
0001,100,129,170,18F,AIM,BASED,CHOLINE,HOWEVER,LABEL,MATERIALS,METHODS,OBJECTIVE,PET,PSA,RESULTS
100,1895
169,2012,AIM,C30,COLLEGE,CONCLUSION,COPYRIGHT,EBRT,EORTC,FORM,HDR,HOWEVER,IIEF,INDEX,LABEL,LTD,MATERIALS,METHODS,MINIMALLY,OBJECTIVE,PR25,PUBLISHED,QLQ,RESULTS,ROYAL,SHORT,THERE,TREATMENT
169,2012,AFP,COPYRIGHT,FISH,HCC,INC,PHA,THESE,THUS,USING
0001,002,1190,169,1989,2011,2013,613,COPYRIGHT,DMFS,EBRT,GLEASON,INC,JANUARY,LABEL,MATERIALS,MAY,METHODS,OBJECTIVE,PCSM,PRIMARY,PURPOSE,RESULTS,USING
0009,027,169,2005,2012,2CM,4FB,BLADDER,COPYRIGHT,CTV,EPNI,HOWEVER,IMRT,INITIALLY,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PURPOSE,RESULTS,RTOG,SHIH,THREE
169,2012,COPYRIGHT,DSH,DVH,DWH,IRELAND,LTD,MRI,PUBLISHED
001,002,104,2006,2009,237,279,8804,8805,AGE,BARCELONA,DRE,FREE,LABEL,LOW,MAY,METHODS,OBJECTIVE,PCA,PSA,RESULTS,SCREENING,SHBG,VERMEULEN
0001,002,003,1148,1995,2011,967,BOTH,CONCLUSION,GLEASON,LABEL,METHODS,NERVE,OBJECTIVE,PPB,PSA,PSM,RESULTS,SURGEON,WALD
001,003,169,2012,950,964,ALPHA,BETA,CIS,COPYRIGHT,DBP,FINNISH,ORS,PREVENTION,SERUM,TOCOPHEROL,UICC
THERE
1300,600,FINALLY,FURTHER,IRE,LNCAP
060,160,1995,2009,2012,BACKGROUND,CLL,FIFTY,FIVE,LABEL,METHODS,MOFFITT,OFTEN,RESULTS,SLNB
100,123,124,131,158,160,224,99M,AHX,CONCLUSION,GLU,HBED,LABEL,LESIONS,LYS,METHODS,OBJECTIVE,PET,PSA,PSMA,PURPOSE,RESULTS,SUVMEAN
111,145,160,177,4551,8201,99M,CONCLUSION,DOTA,IGF,IGF1R,IMAC,LABEL,METHODS,NMRI,OBJECTIVE,PURPOSE,RESULTS,TARGETING
HPE,METHODS,PRIMARY,RETROVIRUS,THESE
156,8805,COLD,LABEL,MEIER,METHODS,OBJECTIVE,OBJECTIVES,PHOENIX,PSA,RESULTS,SALVAGE
160,690,692,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SNP,TLR4,TOLL,WHILE
000,100,122,160,174,1998,2008,GEORGIA,GETIS,LABEL,LIMITED,METHODS,MOST,OBJECTIVE,ORD,POISSON,PRCA,PURPOSE,RESULTS,SATSCAN,SIX,SOUTHWEST
142,147,150,160,2000,2011,BACKGROUND,CAUSE,CLOSE,CONCLUSION,LABEL,METHODS,PATIENT,RESULTS
8226,APART,FIFTY,HISTOLOGY,KEY,LABEL,METHODS,MRGB,MRGBS,MRI,OBJECTIVE,OBJECTIVES,RESULTS,USING
ELISA,HENCE,NATS,TCC
001,004,173,3A4,810,AFRICAN,ASIAN,CAUCASIAN,HOWEVER,HUGE,RESULTS,SEVERAL
EXCELLENT,HDR,HOWEVER,III,LDR,LOW,PHASE
ARCAP,BESIDES,CAMALEXIN,EMT,INCREASED,LNCAP,NAC,NEO,PARP,PREC,ROS,SNAIL,WESTERN
169,2012,2364,ADJUDIN,ATP,CASPASE,COPYRIGHT,FURTHER,HOWEVER,INC,LND,TAKEN
169,2012,BOTH,COPYRIGHT,LNCAP,PC3,RASP,RETINOIDS,THEIR,THESE

169,2012,ATF3,BCA,COPYRIGHT,EGR1,GADD45A,IPO7,IRELAND,LTD,NAG,NSAID,ROS,TAKEN,THESE
160,169,18MM,1MM,2012,4NG,63YEARS,7693,CONCLUSION,COPYRIGHT,GLEASON,LABEL,METHODS,OBJECTIVE,PSA,RESULTS,SAS,SIX
0001,0006,160,169,2005,2010,2012,403,503,52YEARS,99NG,CHI,CONCLUSION,COPYRIGHT,GLEASON,HOWEVER,LABEL,MATERIALS,METHODS,NINE,OBJECTIVE,PCA,PSA,RESULTS,SAS,STUDENT,T1C,T2A,T2B,T2C,THESE
10ML,169,200ML,2012,AIM,BOO,BPH,CONCLUSION,CONTINENCE,COPYRIGHT,FREQUENCY,HOLMIUM,INITIAL,LABEL,LUTS,MEDICAL,METHODS,OBJECTIVE,PSA,RESULTS,SAS,SERUM,SOCIETY,TREATMENT,UROLOGICAL
169,2012,COPYRIGHT,PERMANENT,PSA,PUBLISHED,SAS,WHILE
014,021,114,131,169,2012,ADT,CONCLUSION,COPYRIGHT,FOUNDATION,HOWEVER,INC,LABEL,MATERIALS,METHODS,MOSBY,OBJECTIVE,PUBLISHED,RESULTS,THERE,VOICE
169,2012,237,241,BACKGROUND,CASE,CONCLUSION,COPYRIGHT,DIAGNOSTIC,DUE,ESPA,LABEL,METASTASES,METHODS,MUIR,NEUROCIRUG,PUBLISHED,TORRE
169,2011,241,COPYRIGHT,ESPA,FCH,FDG,HOWEVER,PET
001,107,147,169,187,2012,294,945,AES,BACKGROUND,COPYRIGHT,LABEL,MANAGEMENT,METHODS,OBJECTIVE,OUTCOME,PCA,PSA,PUBLISHED,RANDOMISED,RESULTS,SECONDARY,SETTING,TRIAL,UROLOGY
28TH,AFTER,BACKGROUND,CASE,CONCLUSION,DESPITE,LABEL,METHODS,THEREFORE
MASS
1083,802,8201,837,BACKGROUND,FINNISH,LABEL,METHODS,PCR,RARE,REAL,RESULTS,RISK,TIME
169,2012,ACTA,ATP,P2X3,P2X5,P2X7,SOCIETY,TREATMENT
169,2012,946,AACR,DU145,GIVEN,LNCAP,PC3,RADIATION,TGF
1612,931,963,IGRT,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SEED,SYSTEMATIC,THERE
0001,CHANGES,CONCLUSION,IMRT,INSTEAD,KNOWLEDGE,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,STUDENT,THERE
0001,006,169,174,2013,8482,BISULFITE,COPYRIGHT,CPG,EDUCATION,FILIP1L,INC,ISOFORM,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SENESCENCE,UROLOGICAL
004,177,956,A375,A549,ANILINE,ANTICANCER,BHA,BUTYL,DPPH,EDTA,EXTENSIVE,FIC,FRAP,HOWEVER,HYDROXY,IC50,LINDERA,MCF,NMR,WRL
ABOVE,AIM,CELL,CONCLUSION,DU145,GERMANY,GMBH,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,ROSTOCK,THESE
125,162,2007,BACKGROUND,D90,LABEL,LDR,LIVE,LOW,METHODS,OAR,RAH,RESULTS,ROYAL,SIMILARLY,SMALL,STILL,V100,V150,V200
169,2012,COPYRIGHT,GIVEN,JOHN,LTD,SONS,WILEY
ACTIVATION,AKT,BCL,BITC,HOWEVER,INHIBITION,LC3,PC3,RV1,SER2448,SER2481,THESE,UNC
169,2012,20S,AMONG,APART,COLON,COPYRIGHT,FRESHWATER,JOHN,LEISHMANIA,LTD,PLASMODIUM,SAR,SONS,THEREBY,THESE,THUS,WHILE,WILEY
0001,005,169,2012,COMBINING,CONCLUSION,COPYRIGHT,DCE,GEE,GLEASON,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PEARSON,PURPOSE,RESULTS,SEVENTY,T2W,WILEY
FRONTLINE,THESE
183,A11,AMP,FXXLF,LAPC,MAGE
001,1993,2007,412,919,962,BECAUSE,POISSON,RATE,THREE
024,048,1994,2007,233,512,8805,CASES,CRP,MAX,MIN,SUPPL,THESE,VITAMINES
177,1994,2007,2013,CHRONIC,CONSISTENT,EPIDEMIOL,GIVEN,JOURNAL,MAX,TOUVIER
AFRICAN,FOUR,INSTITUTE,PHOTOVOICE,PRCA,RESULTS,SOUTH
100,176,177,181,8310,8312,8323,FDPM,FINALLY,IRDYE800CW,MHZ,NIRF,OPERATING,PET,SIEMENS,THREE
10Q23,AKT,ALTOGETHER,BACKGROUND,FFPE,FISH,IHC,LABEL,MEIER,METHODS,NORTH,PCA,PIK3,PTEN,RESULTS,SEVERAL,SITU,USING
0000001,BACKGROUND,BPH,CARS,CTC,DETECTION,LABEL,METHODS,RAMAN,RESULTS,RWPE
2012,BEIJING,BIRD,CHINA,CITY,CONTINENCE,CONVENTION,COPYRIGHT,FORBIDDEN,ICS,LOCATED,NEST,OLYMPIC,PROUS,SCIENCE,SOCIETY
145,8320,8321,8322,BAX,BCL,CCK,FLOW,LNCAP,SEPIA,SIO,SUB,THESE
945,AKT,III,INHIBITION,NAD,SIRT1,SIRTUIN,WHETHER
00006,328,AXIN2,FGF10,FGF3,FGFR2,THERE,TOOTH
1997,2007,2010,COMMISSION,NUCLEAR,RADIATION,RP162,RP91
2000,2010,292,355,779,ABDOMINAL,CONCLUSION,HOWEVER,JANUARY,LABEL,MATERIALS,METHODS,N0M0,NOTABLY,OBJECTIVE,RESULTS,STAGING
2000,2007,2009,202,287,299,721,AMONG,CONCLUSION,COSTS,END,HOSPICE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEER
001,100,8805,CONCLUSION,CRPC,LABEL,MET,METHODS,OBJECTIVE,PFS,PRIMARY,PURPOSE,RESULTS,SERUM,SEVENTY,THOSE,XL184
000,169,2012,BACKGROUND,CHEMISTRY,KLK3,LABEL,METHODS,PCA,PROTECT,PSA,RESULTS,SERUM,TESTING,THESE,TREATMENT
112,145,1516,1517,1992,2000,2009,396,432,4623,808,BACKGROUND,CONCLUSION,COX,LABEL,METHODS,RESULTS,SMOKING,UNTIL
001,BACKGROUND,CONCLUSION,CONVERSELY,DUSP1,ERK,GLEASON,LABEL,MAPK,METHODS,PROFILING,RESULTS,SEF,THESE
0002,BACKGROUND,CONCLUSION,CX26,LABEL,MEASURING,MEIER,METHODS,PRCA,RESULTS
0001,169,2012,403,8201,8805,BACKGROUND,BETWEEN,COPYRIGHT,GLEASON,INC,LABEL,LATERALITY,LESIONS,METHODS,PCA,RESULTS,SPECIAL,TPMB,TPMBS,TRUSB,WILEY,WMRP
HOWEVER,LABEL,OBJECTIVE,PURPOSE,RESULTS,SUMMARY,THEREFORE
HOWEVER,LABEL,OBJECTIVE,PPI,PURPOSE,RARP,RESULTS,SUMMARY
001,105,106,120,ALSO,BACKGROUND,BPH,CAP,EXPRESSION,GLEASON,LABEL,METHODS,MMR,MUTATIONAL,OBJECTIVE,OBJECTIVES,PIN,PRO,RESULTS,TP53
ALTOGETHER,ATP,CHANGES,CONSISTENT,TRPM7
160,183,2011,811,DIETS,DRC,MEDLINE,SEPTEMBER
CTC,CTCS,PCR
100,8805,956,CELECOXIB,COX,DU145,EARLIER,EXPRESSION,LNCAP,MTT,PC3,PCA,PCR,PHENOTYPIC,REDUCED,RNAS
AMONG,CD168,CD44,METASTATIC,PCA,RHAMM,STUDIES,THUS
8CPT,945,EPAC,GEF,HOWEVER,PKA,RAP1,SUBSEQUENT,VEGF
945,FBXW7,HOWEVER,LOSS,LUCIFERASE,UTR,UTRS,WESTERN
391,METASTASIS,NETWORK,SBC,SECONDARY,THROUGH,TOWARDS,USING
200,400,FUNCTIONAL,PCA,SIXTEEN,THEIR
100,169,195,2012,288,313,ADC,CONCLUSION,COPYRIGHT,FOUR,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PPVS,PSA,PURPOSE,RESULTS,THERE,WILEY
8209,946,C2GNT,CORE2,HOWEVER,MUC1,POLY,THESE,TRAIL
001,008,033,050,064,128,172,268,271,AIM,AMONG,BACKGROUND,BLOOD,BPH,CHRONIC,FEDERATION,HEART,INSTITUTE,IPSS,LABEL,LUNG,LUTS,MAXIMUM,METHODS,METS,PROSTATIC,RESULTS,SCORE,SYMPTOM
0001,014,100,367,415,BACKGROUND,BPH,CPG,DNAME,GLEASON,HEAT,HSP,HSPB1,LABEL,METHODS,PCA,PCAS,RESULTS
BPH,DESPITE
BCRP,EXPRESSION,FADU,GANODERMA,MRP,MTT,PACLITAXEL,PANAX,PREVIOUSLY,PRIMARY,SPES,WESTERN
CROOK,PSA
000,163,169,2004,2006,2013,382,390,505,BASED,CLINICALLY,COPYRIGHT,EDUCATION,END,GLEASON,HOWEVER,INC,LABEL,LASER,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SEER,T1A,T1B,UROLOGICAL
035,169,1992,1993,2004,2005,2013,781,CONVERSELY,COPYRIGHT,EDUCATION,END,GOING,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,REDUCTIONS,RESULTS,SECONDARY,SEER,SKILLED,UROLOGICAL
001,169,2010,2013,AJCC,CHICAGO,CLEVELAND,COMMITTEE,COPYRIGHT,EDUCATION,INC,IQR,JOINT,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RATES,RESULTS,UNIVERSITY,UROLOGICAL
169,2003,2007,2013,344,770,861,886,AREAS,COPYRIGHT,COX,DESPITE,EDUCATION,END,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,POISSON,PUBLISHED,PURPOSE,RESULTS,SEER,SERVICE,STATE,UROLOGICAL,USING
001,169,2013,COPYRIGHT,EDUCATION,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THEREFORE,UROLOGICAL
001,169,2002,2009,2013,396,541,814,CON,COPYRIGHT,EDUCATION,END,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SEER,THERE,UROLOGICAL,YES
001,100,169,2011,2012,2013,AFTER,BETWEEN,COPYRIGHT,EDUCATION,HOWEVER,IMAGING,INC,JANUARY,JUNE,LABEL,METHODS,OBJECTIVE,PERFUSION,PUBLISHED,PURPOSE,REAL,RESULTS,UROLOGICAL
169,2013,300,COPYRIGHT,COX,EACH,EDUCATION,GLEASON,INC,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PREDICTION,PUBLISHED,PURPOSE,RESULTS,TIME,TOTAL,UROLOGICAL
134,169,2013,904,COPYRIGHT,CUMULATIVE,EDUCATION,END,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RADIATION,RESULTS,SEER,UROLOGICAL
100GY,125,2003,2011,BACKGROUND,BONE,CHANGES,COMPARING,HIP,JUNE,KARNOFSKY,KPS,LABEL,METHODS,MPD,PAIN,RESULTS,ROUTINE,SCALE,SCORE,SIX,THERE,VAS
123,216,BACKGROUND,CHI,COMPOSITE,EPIC,GEE,INDEX,LABEL,METHODS,OVERALL,QOL,RESULTS,SBRT,SPANISH,THESE
169,2012,EARLIER,HOWEVER,MANAGEMENT,UROLOGICAL
155,169,2012,ADT,AIM,AUTHORS,BACKGROUND,BLACKWELL,CONCLUSION,ENGLISH,INDUSTRIAL,LABEL,LHRH,LTD,METHODS,OBJECTIVE,PUBLISHING,RESULTS
THERE
1000,1312,1373,1997,2011,210,2669,329,641,998,BACKGROUND,CONCLUSION,CONTEXT,DAILY,IDENTIFIER,JUNE,LABEL,MAIN,METHODS,OBJECTIVE,OUTCOME,PHYSICIANS,RESULTS,SETTING,THERE,TOTAL,TRIAL
125,168,AVIAN,E26,ERG,FLI1
946,DIFFERENT,GLUCOSE,LIPID
160,177,2010,ANY,BILATERAL,CSE,FOLEY,HDR,LABEL,METHODS,NPB,OBJECTIVE,PURPOSE,REGARDING,RESULTS,THERE,USING,VAS
ANTISENSE,IFN,LNCAP,PSMA,VEGF
700,CRPC,DUE,MDV3100,TAK,TODAY
946,MAPK,PCA,TGF
946,BASED,BPH,BPS,BRITISH,DUE,FURTHER,LUTS,PCA,PICA,PSA,THERE
CIP1,GAL,WAF1
ALPHA,BOTH,HOWEVER,LABEL,OBJECTIVE,PURPOSE,RESULTS,SUMMARY
169,2013,COPYRIGHT,EZH2,H3K27,H3K36,HISTONE,HMTASES,INC,MMSET
169,2001,2012,COPYRIGHT,HOWEVER,INC,SINCE,THESE,TRPM8
169,2012,956,CDK2,CDK4,COPYRIGHT,INC,LNCAP,PARP,ROS
169,2012,CONSISTENT,COPYRIGHT,DOWN,INC,PIRH2,SILENCING
169,2012,946,ACTIVIN,ALVA,COPYRIGHT,DESPITE,EMT,FINALLY,INC,SNAIL,THERE
0001,001,169,174,2013,658,696,702,774,796,898,909,AUC,CAV1,COMPARISON,COPYRIGHT,CPGS,EDUCATION,EVX1,FGF1,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,REGRESSION,RESULTS,UNIVERSITY,UROLOGICAL,WASHINGTON,WISCONSIN
168,169,2013,5P15,8Q24,9Q33,AFTER,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SEVERAL,THESE,UROLOGICAL,WHILE,XP11
169,2012,COPYRIGHT,FIVE,MRI,OVERLAP,PCA,PUBLISHED,UROLOGY
100,1480,169,1718,2012,2494,415,527,8804,ATFS,BACKGROUND,COMPLIANCE,COPYRIGHT,COX,DUTCH,GLEASON,LABEL,MEIER,METHODS,NTR1718,OBJECTIVE,OUTCOME,PCA,PSA,PUBLISHED,RESULTS,SETTING,TRIAL,UROLOGY
001,006,160,169,1970,2008,2013,725,782,802,842,957,COPYRIGHT,COX,EDUCATION,HOWEVER,INC,INCLUSION,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
CASES,GLEASON,HOWEVER,INC,PUBLISHED
120,169,2011,2012,3052,332,947,AIMS,CONCLUSION,COPYRIGHT,DATA,ENGLISH,LABEL,METHODS,OBJECTIVE,PANCREATIC,RESULTS,SAS
100,239,BACKGROUND,BCR,LABEL,METHODS,PSA,RESULTS,RETROPUBIC,RRP,THUS
123,ANNEXIN,BACKGROUND,BAD,BH3,BID,BIM,CELL,CONCLUSION,EXPRESSION,IHC,LABEL,METHODS,MTT,P53,RBM5,RESULTS,RHODAMINE
106,169,171,2013,COPYRIGHT,EDUCATION,GLEASON,INC,LABEL,LESIONS,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,TESLA,UROLOGICAL,WORKING
169,2013,945,AMACR,ATYP,COA,COPYRIGHT,ERG,FINAL,HGPIN,IHC,INC,PCA,PCAS,THREE,TMPRSS2
169,2013,COPYRIGHT,INC
169,1982,2012,ASCO,BOTH,COPYRIGHT,CYP17,IRELAND,LTD,MEDLINE,MEETING,SOCIETY
0001,0007,0258,169,177,2013,438,BLOOD,CELLS,COPYRIGHT,CROWN,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THESE
14S,18S,700,800CW,COMPOUNDS,CY5,CY7,ICG,IRDYE800CW,IRDYE800RS,NIR,PSMA
MICRORNAS,RNAS
142BR,956,A375,ABTS,ACHN,C32,CLOSE,DPPH,HELA,ITALY,LEBANON,LNCAP,MCF,MPLC,NMR,NON,REMARKABLE,SPACH,SRB,TORMENTIC
ANDROGENS,MOST
HOWEVER,THESE
HEALTHY,MALDI,TOF,USING
945,946,AMONG,HOWEVER,MART,THESE
CAG,CHLAMYDIA,CMV,ELAC2,HPV,HSV,MSR1,NEISSERIA,THERE,TREPONEMA
0001,00013,0003,0013,0021,00406,0089,0406,388,8202,BACKGROUND,CONCLUSION,KRUSKAL,LABEL,METHODS,OVARIAN,RESULTS,THESE,TYPICALLY
146AG,149C,499A,ASIAN,CIS,HCC,MICRORNAS,ODDS,ORS,SIMILARLY,SNPS
2002,2011,AFTER,BACKGROUND,CONCLUSION,HODGKIN,LABEL,METHODS,NINE,RESULTS,TREATMENT,USING
0001,001,005,126,945,AIM,ANOVA,CONCLUSION,FSH,GLEASON,LABEL,MATERIALS,METHODS,OBJECTIVE,PRL,PSA,RESULTS,THERE,UNIVARIATE
CONCLUSION,EPHA2,LABEL,METHODS,OBJECTIVE,PTX,PURPOSE,RESULTS,YNH,YSA
100,131,169,2012,AACR,ELP,FADU,THESE
169,2012,COPYRIGHT,GMBH,KGAA,PET,THESE,VCH,WILEY
160,PAT,SEVEN,VMAT
170,227,264,364,CD31
00AM,107,2008,2009,204,491,8804,AGE,CONCLUSION,DIGIT,HIGH,JANUARY,JUNE,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PCA,PSA,RESULTS,SHBG,VARIABLES,VERNIER
1966,2012,APRIL,CONCLUSION,FINALLY,JANUARY,LABEL,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,OPTIMALLY,OTHER,PREDICTIVE,RESULTS,TOOLS,WHILE
035,120,702,811,BACKGROUND,CONCLUSION,CUMULATIVE,DENOSUMAB,FURTHER,INCIDENCE,LABEL,MEIER,METHODS,NSCLC,RANKL,RESULTS,SCLC
AFTER,BACKGROUND,HENCE,INDIVIDUAL,LABEL,MEN,METHODS,OBJECTIVE,OBJECTIVES,PCA,RESULTS
1515,1762,2919,3928,956,DATA,INDEX,PSA,PUBLISHED,SIMILAR,USING
FEW,FURTHER,WORKPLACE
169,2012,COPYRIGHT,INC
001,018,169,2006,2012,2014,ACCORDING,BETWEEN,CAP,CGA,COPYRIGHT,FURTHER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PSA,RESULTS
BLENDED,FOOD,REAL,SCIENCE,WORLD
169,2012,COPYRIGHT,ELEMENT,GST,INC,LINE,LNCAP,NUCLEOTIDE,ORF,PSA,R1881,WIDESPREAD
176,8201,AH2,FDU,I3DC,JBSD,JOURNAL,NETROPSIN,NMR,NOESY,PC3,PCA
105,141,390,BACKGROUND,HCA,HIGH,LABEL,PCA,PRINCIPAL,RESULTS,THREE,USING
946,CD25,CD4,CD8,CTLA,PAP,REGULATORY,TAKEN,TGF,THESE,TREGS,USING
100,956,HOWEVER,MACCONKEY,PRIOR,THERE,THEREFORE
BAK,BAX,BCL,BIM,E2F1,LUCIFERASE,MCL,PCR,THESE
CATHEPSIN,IGF,TAKEN
0001,0075,0155,194,301,398,797,BACKGROUND,BFI,BRIEF,COU,FATIGUE,III,INVENTORY,LABEL,METHODS,PATIENT,RESULTS
1187,1461,1861,1966,1980,1982,1984,1985,2008,2011,4068,ABSTRACTS,AMED,AUTHORS,BACKGROUND,BRITISH,CENTRAL,COLLECTION,CONTROLLED,DATA,FINALLY,FURTHER,INDEX,ISSUE,JANUARY,LABEL,LIBRARY,MAIN,MARCH,MEDLINE,METHODS,NURSING,OBJECTIVE,OBJECTIVES,RCTS,RESULTS,SELECTION,SIGLE,SMD,WHERE
PRIMARY
22RV1,AAG,FURTHER,GANETESPIB,HOWEVER,HSP90,TARGETING

104,157,CHOLINE,CONCLUSION,LABEL,METHODS,OBJECTIVE,PET,PSA,PSADT,PURPOSE,RESULTS,THESE
001,007,116,134,165,184,2001,2007,ANY,BCF,C30,ELECTRONIC,EORTC,GLEASON,NHT,NON,OCTOBER,PRE,PSA,PSADT,QLQ,QOL,SRT,SVI
945,PREVENTION,THESE
1071,169,183,2012,2014,215,267,268,8805,956,AUSTRALIA,BACKGROUND,CALVARY,COPYRIGHT,COUNCIL,FUND,FUNDING,GLEASON,HOWEVER,HTRS,INSTITUTE,ITAS,LABEL,LTD,MATER,MEDICAL,METHODS,NEWCASTLE,OTHER,PRO,PROS,PSA,RADIATION,RESULTS,SOCIETY,STAS,T2A,T2B,THERE,TREATMENT,UNIVERSITY,ZEALAND
155,1988,1994,2006,5204,569,ADDITIONAL,AMERICANS,CADMIUM,COX,DESPITE,HOWEVER,III,NUTRITION,RDA,SIMILAR,THERE,THIRD
AST,BACKGROUND,CODED,CONTROLLED,CURRENT,LABEL,LINE,MEN,METHODS,NONE,RESULTS,STRATEGIES,TRIAL
169,2012,BECAUSE,CD44,COPYRIGHT,CSC,DU145,EVOLUTION,LIGANDS,SELEX,SYSTEMATIC,UICC
HDR,LDR,LOW,PSA
115,160,174,BACKGROUND,LABEL,LNS,MATERIALS,METHODS,RESULTS
169,2012,BACKGROUND,CHEMISTRY,CONTENT,LABEL,SUMMARY,VALIDATION
945,946,BMEC,EXPRESSION,GTPASES,HOWEVER,RAC,RAC1,RAP1,THESE
1386,169,2012,945,AACR,COR,G202,HDAC3,HDAC4,HIF,HOWEVER,III,RES,THROUGH
301,8211,COU
0001,0003,004,008,228,3750,383,3956,657DEL5,8804,BACKGROUND,BRCA1,C61G,CHEK2,CONCLUSION,I157T,IVS2,LABEL,METHODS,MORTALITY,NBS1,RESULTS,THESE,THREE
5HEAD,BDR,COMPARING,CVDR,EPID,INITIALLY,MLC,VMAT,WHILE
177,186,350,963,A12,ALGORITHM,ANALYTICAL,DOSES,EBT,EBT2,GAFCHROMIC,INTENSITY,STORING
DOSIMETRIC,IMRT,INCREASING,LEAF,MAXIMUM,MUS,PLANS,PTV,SYNERGY,THESE,VMAT
2006,2010,5600,657,8764,942,BACKGROUND,EARLIER,EAST,ENGLAND,III,LABEL,METHODS,RESULTS,STAGE,THERE
NETWORK,PRIMARY,THERE,UROLOGICAL
001,002,012,026,033,114,169,2013,4RS,CD34,CONCLUSION,COPYRIGHT,EP1R,EP2R,EP3R,EPR,INC,LABEL,METHODS,OBJECTIVE,RESULTS,SIMILARLY
DU145,PARSIMONY
100,2000,2003,ANTONIO,BEATSON,BONO,DRUG,FOUNDATION,FRANCESCA,FRED,GLASGOW,HUTCHINSON,INSTITUTE,LAKE,MARSDEN,NHS,PHD,ROYAL,SAN,SWOG,USA
128,AFTER,BACKGROUND,HOWEVER,LABEL,METHODS,OVERALL,PHYSICIANS,RESULTS,SDM,TRIAL
169,2012,AACR,DISCOVERY,ERG,TMPRSS2
169,2012,956,BASED,CONCLUSION,ENL,GMBH,KGAA,LABEL,LNCAP,METHODS,NA22,NB11,NB14,NB26,PCR,RESULTS,RWPE,SCOPE,THERE,VCH,WILEY,WPE1
34B,AKT,BIOLOGICAL,CONCLUSION,CPG,FINALLY,LABEL,METHODS,MIR,OBJECTIVE,PCR,PROFILING,PURPOSE,RESULTS,SNAIL,THESE,ZO1
718,ACRE,AMONG,ASR,RIO,STATE,THESE
956
3730,533,LABEL,LIMITED,METHODS,OBJECTIVE,ORS,RESULTS,THERE
001,110,115,8805,ACCORDING,ALP,CHINESE,COX,MEIER,OSS,PSADT
0001,AFRICAN,AMERICANS,BACKGROUND,CAUCASIAN,CAUCASIANS,CONCLUSION,GLEASON,LABEL,METHODS,RESULTS,THERE
003,005,010,019,028,105,313A,313GG,ARGENTINE,BACKGROUND,BRFS,COX,CURRENT,GST,GSTM1,GSTP1,GSTS,GSTT1,ILE,LABEL,MEIER,METHODS,ORGAN,PCA,PCR,RESULTS,RFLP,RRP,THUS,VAL
101,1169,1237,1623,1690,184,2002,2011,2090,3919,4749,830,838,951,984,AMONG,BACKGROUND,COMMERCIAL,ENCOUNTERS,JUNE,LABEL,MARKETSCAN,MEDSTAT,METHODS,RESULTS,SEPTEMBER,SRE,SRES,THOMSON
169,181,2012,BACKGROUND,BASEL,COPYRIGHT,CRPC,DOCETAXEL,LABEL,METHODS,PSA,RESULTS,TREATMENT
034,169,2013,BACKGROUND,COPYRIGHT,INC,LABEL,METASTATIC,METHODS,NSE,PFS,RESULTS,SCC,SCCUT,SERUM,SMALL,THERE
169,2013,CLAVIEN,COPYRIGHT,III,INC
169,2012,AMRT,COPYRIGHT,IRELAND,LTD
ASSESSMENT,DVC,RALP,SSL,TECHNIQUE
954,ALTOGETHER,DNMT1,MCF,RASSF1A,SP1,SSS,TSG,TSGS
001,169,1873,2006,2010,2012,2511,300,638,8201,8804,AUTHORS,BETWEEN,BJU,BMI,CONVERSELY,LABEL,MEN,METHODS,OBJECTIVE,OVERALL,PCA,PLND,RARP,RESULTS,RRP,SIMILAR,THUS
THESE
CELLSEARCH,CTC,CTCS,HOWEVER,LNCAP,MAGSWEEPER,SEQ,THESE
177,945,946,CD133,FLOW,FURTHER,HOWEVER,KLK2,LOW,PSA,STEM,TMPRSS2
416,527,HOWEVER,METASTATIC,SRC,TYR
286,CHIP,CONSISTENT,EEF1A,GAIN,GBX2,HOWEVER,NRP1,ROBO1,SEQ,SEVERAL,SLIT3,TAKEN,USH2A,USHER,USING
384,A2A,AMONG,EGFR,GPCR,GPCRS,H1975,L858R,NHLF,NSCLC,T790M,THERE
115,157,215,726,967,BMI,WHILE
EBRT,FOLEY,RECTO
0001,0002,4409,6387,827,889,BEDSIDE,BIOLOGY,DISCUSSION,ELIMINATE,GRAPHICAL,LABEL,MATERIALS,MEDICAL,METHODS,NLP,OBJECTIVE,OBJECTIVES,PROJECT,RESULTS,TEXT,THESE,UNIFIED
177,CONCERNING
DORMANT,THESE,THUS
169,2012,266,309,BACKGROUND,COPYRIGHT,COX,GPX1,GPX2,GPX3,GPX4,INC,LABEL,METHODS,NONE,PCA,PCSM,RESULTS,SEP15,SEPP1,SNPS,THESE,WHILE,WILEY
946,954,ALT,AST,CROHN,CURCUMA,DOSE,EXTENSIVE,LOX,STAT3,VARIOUS
101,8805,AGE,AIM,CARCINOMA,CIS,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,T1G2,TAG3,TURB
HERTZ,MECHANICAL,SNEDDON,THEREFORE,THESE
1000,1148,197,2012,500,800,ADC,AUC,BACKGROUND,CONCLUSION,DC1,DCE,DETECTION,FOUR,GLEASON,INCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,ROC,ROI,ROIS,RSNA
169,2012,COPYRIGHT,EXSY,GENERALLY,INC,MAD,METABOLIC,MODE,STEAM,STIMULATED
169,2012,20S,231,26S,945,954,BAX,BORTEZOMIB,COPYRIGHT,DOCKING,HOWEVER,INC,MCF,MDA,UPS
0008,100,125,150,168,187,190,2003,2010,223,CONCLUSION,D10,D30,D90,JULY,LABEL,MAY,METHODS,OBJECTIVE,PERI,PPB,PURPOSE,R100,RESULTS,V100,V150
169,2012,945,COPYRIGHT,CYP17A1,HITS,LTD
169,2012,COPYRIGHT,DRUG,EGF,ELISA,ETE,FACS,LNCAP,LYCOPODIUM,MTT,OXE,PC3,PCR
1500,169,2012,2D3,AMONG,COPYRIGHT,IRELAND,LTD,SINCE,THESE,VDR
169,2012,COPYRIGHT,EWING,INC,MICROARRAY,STEAP,TAKEN
0001,0002,0004,0005,0018,0056,100,134,157,163,169,183,2012,223,301,349,BACKGROUND,BONE,BRIEF,COPYRIGHT,COU,EASTERN,FORM,FUNDING,GROUP,INVENTORY,IQR,JANSSEN,LABEL,LTD,METHODS,PAIN,PALLIATION,RESULTS,SHORT
169,2013,COPYRIGHT,FEW,GNRH,INC,LABEL,LESS,LHRH,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SITES,SIXTEEN,STRATEGIES
169,2013,AMONG,COPYRIGHT,ELAC2,GWAS,HPC1,HPC2,INC,MSR1,RNASE,SNP
0043,0056,0070,0092,0368,0513,0613,0623,169,177,2013,956,BACKGROUND,CONCLUSION,COPYRIGHT,EOB,EOS,GBQ,HIGH,INC,LABEL,METHODS,PET,PPIS,RESULTS,SUFFICIENT,YM155
VARIOUS
CARIBBEAN,DISCOVERED,ERICIFOLIN,EUGENOL,JAMAICA,PIMENTA,SYSTEMATIC
IMR90,RRM2B
169,2012,BACKGROUND,BASED,BRDU,CD133,CFSE,CHANGES,COPYRIGHT,FINALLY,HIGH,INC,LABEL,MDV3100,METHODS,R1881,RATES,RESULTS,TREATMENT,WILEY
169,2012,22RV1,945,BACKGROUND,CHIP,COPYRIGHT,HIF1,HRES,HUVEC,INC,LABEL,LNCAP,METHODS,NEP,NEUTRAL,PCR,RESULTS,WESTERN,WILEY
CD31,CWR22,MDAS,ONCOLYTIC,THESE
160,945,946,ARG,ASP,GLY,NPS,PLGA,PLL,SUCCESSFUL,UTMD,VEGF
100,177,600,8202,ARTEMIS,CAP,DRUG,EIGEN,FOOD,GLEASON,LABEL,MRI,OBJECTIVE,PURPOSE,RESULTS,SUMMARY,SUPPORTIVE,THREE,UROSTATION,USA,WORKING
8226,ADC,BOTH,GLEASON,KEY,LABEL,METHODS,MRI,OBJECTIVE,OBJECTIVES,RESULTS,SIMULATED,SIXTY,TRE,TUMOURS
ALPHARADIN,CRPC,III
100,169,177,2013,8804,AMICO,BACKGROUND,BLADDER,CONCLUSION,COPYRIGHT,FIFTY,INC,LABEL,MEIER,METHODS,PCA,PSA,RESULTS,RTUR,WATER
1000,169,1995,2008,2012,AFTER,AGE,AIM,BLACKWELL,CONCLUSION,CPRD,GENERAL,HRS,LABEL,LTD,METHODS,OBJECTIVE,OHA,PUBLISHING,RESULTS,TZDS
100,1989,2001,3791,945,AMONG,COX,DENMARK,LABEL,METHODS,OBJECTIVE,RESULTS,TREATMENT
1360,1529,2008,2010,AGE,LABEL,METHODS,OBJECTIVE,RESULTS,SEPTEMBER,SWEDISH,THESE,URINARY
1990S,AIS,AREAS,ARYL,BACKGROUND,COVERED,DUAL,FURTHER,LABEL,LSDS,METHODS,OPINION,PGL2001,PHASE,SANFILIPPO,STEROID,STS,STX64
BPH1,CAF,CAFS,DLK1,INHIBITION,NEXT,NOTCH,SCID,XIX
1977,2000,2012,ADDITIONAL,CRPC,DATA,EACH,ENGLISH,EXTRACTION,JEVTANA,JUNE,LABEL,LITERATURE,MEDLINE,METHODS,OBJECTIVE,OPTIONS,PHASE,REFERENCE,RESULTS,SELECTION,SIPULEUCEL,SOCIETY,SOURCES,SYNTHESIS,THREE
113,199,2007,BACKGROUND,JULY,LABEL,METHODS,NETWORK,PSA,RESULTS,ROUTINE,SCREENING,THERE
FURTHER,LABEL,LACK,LIMITED,METHODS,MOST,OBJECTIVE,RESULTS
BELL,DOES,LOTS
001,013,017,018,021,139,169,2012,224,314,916,AFTER,BACKGROUND,CHEMISTRY,COX,LABEL,METHODS,PCR,RESULTS,TOTAL,UNIVARIATE
CRPC,HGF,HIGH,LABEL,MET,METHODS,OBJECTIVE,PURPOSE,RESULTS,SOLUBLE,TOTAL,TREATMENT
179,181,183,185,22E,24R,8201,8320,8325,COMPOUNDS,GEORG,NMR,ODYENDYEA,STUTTGART,YORK
INITIAL,NEWER,OPTIMAL,THROUGH,THROUGHOUT,USA
945,946,DHT,HAEC,HAECS,LAPC,LNCAP,PSA,THESE
001,006,023,035,049,268,342,8804,BILATERAL,EBL,EPIC,ERROR,GLEASON,INDEX,LABEL,METHODS,NVB,OBJECTIVE,OBJECTIVES,PARAMETER,PSM,RARP,RESULTS,THERE,WHILE
145,160,ADARB,DGCR8,EPIGENETIC,GLMN,HILS1,IGF2,LNCAP,OLIGO,PC3,PCA,RBM3,TDRD1,THEREFORE,VCAP,WHOLE
101,116,117,139,177,956,BPH,PIN,RA50,SERUM,ZINC
041,1061,962,BACKGROUND,BLOOD,CONCLUSION,EPIC,FATTY,FOUR,LABEL,METHODS,NUTRITION,OBJECTIVE,ORS,PATTERN,PUFA,PUFAS,RESULTS,STUDIES,TREELET
246,8128,817,AFTER,BACKGROUND,COX,DIET,DIETARY,HOWEVER,LABEL,MALM,METHODS,OBJECTIVE,RESULTS
LIMNOTHRIX,LNCAP,ROS,SIMILARLY,SPIRULINA,TAKEN,THEREFORE,TPT
169,2012,BLACKWELL,CEA,CGIN,HPV,KINGDOM,LIMITED,MCCLUGGAGE,PRIMARY,PUBLISHING,SKENE,THERE,WHILE,WORLD
001,150,BACKGROUND,BPH,INDIA,JAK,LABEL,METHODS,RESULTS,SOCS,STAT,STATS,THERE,THESE
THESE
HDR
248,384,492,EPIC,GOLDENGATE,HEIDELBERG,INCREASED,RISK,SELK,SNPS
240,282,473,AKT,BACKGROUND,GLEASON,HOWEVER,KI67,LABEL,PRINCIPAL,RESULTS,SER,UPON
158,186,578,FIRST,MDM2,PAK6,REGULATION,SER,THESE,THR
200,215,8202,8764,946,AFTER,BOTH,CASTRATED,HSD,HSD3,HSDS,LNCAP,MOUSE,SCH,STX1383,STX2171
105,110,137,AAH,BACKGROUND,CONCLUSION,GLEASON,HGPIN,KI67,LABEL,METHODS,NEP,PCA,PTOV1,RESULTS,RPS,SPS
0001,161,169,2000,2007,2012,525,AMONG,BACKGROUND,COPYRIGHT,END,IMRT,LABEL,METHODS,RESULTS,SEER,SOCIETY,SRS
169,2012,AACR,CD151,HOWEVER,LIVER,MICE,MOUSE,THUS,TRAMP,TRANSGENIC,WESTERN
AKT,CELLS,JUN,PDK1,PI3K
002,005,010,021,126,166,282,2ND,350,408,420,445,4TH,544,610,770,847,8805,AMONG,DESPITE,DRE,GLEASON,LABEL,LUTS,MATERIALS,METHODS,OBJECTIVE,PSA,RESULTS,TRUS
174,2010,2011,3RD,AMICO,BACKGROUND,BDFS,BRAZILIAN,CALIFORNIA,CONCLUSION,GLEASON,JUNE,LABEL,MATERIALS,METHODS,OCTOBER,OPERATIVE,PSA,RESULTS,SHORT,TEN
HOWEVER,NEOBLADDER
100,BACKGROUND,CDK1,CDK2,DHT,FGF8,GREB1,LABEL,LNCAP,METHODS,NDRG1,PC3,PCA,PCA3,PCR,PSA,RESULTS,TMPRSS2
ANOTHER,BOTH,CD4,CD8,DCS,DENDRITIC,FDA,FINALLY,HOWEVER
011,CLUSTERIN,III,OGX,PHASE,THESE
107,125,169,2007,2011,2012,800,8805,BJU,CLAIM,GLEASON,GOVERNMENT,LABEL,LESIONS,MARCH,METHODS,MRI,NETWORK,OBJECTIVE,RESULTS,TESLA,THERE,THUS,TRUS,UNLABELLED,WHAT,WORKS
000,153,169,179,1991,2009,2012,280,385,508,556,9TH,AMONG,AREA,BJU,DISEASE,FOLEY,HOWEVER,ICD9,LABEL,MARSHFIELD,MEIER,MESA,METHODS,OBJECTIVE,PATIENT,RESULTS,THERE,THESE,UNLABELLED,USING,WHAT
001,096,140,604,717,857,8804,AFRICAN,AMERICANS,AMONG,BACKGROUND,CDX,CDX2,HIGH,LABEL,LOW,METHODS,RESULTS,SNP,VDR,WHITE
021,169,2012,400,429,559,580,8201,971,AFRICAN,AMERICANS,BACKGROUND,CARIBBEAN,COPYRIGHT,CYP17,EIGHT,INC,LABEL,METHODS,OVERALL,PCA,PSA,RESULTS,USA,WILEY
071,169,2012,352,382,8201,BACKGROUND,COPYRIGHT,INC,LABEL,LOW,METHODS,PCA,PHS,PHYSICIANS,RESULTS,SEPP1,SNPS,THESE,VARIATION,WILEY
169,2012,8201,ADT,BACKGROUND,CASTRATION,CGA,COPYRIGHT,CRPC,EXPRESSION,III,INC,LABEL,MDK,METHODS,NED,RESULTS,T1B,TUBB3,WILEY
169,2012,259,310,8201,BACKGROUND,COPYRIGHT,G84E,GLEASON,INC,LABEL,MATERIALS,METHODS,RESULTS,THERE,THESE,WESTERN,WILEY
169,2012,COPYRIGHT,INC,NCOR,PKA,PROTEIN,RD1,TAKEN,WILEY
169,2012,26S,6258,COPYRIGHT,FURTHER,INC,LOSS,MASS,NKX3,PEST,PIM,THR89,THROUGH,WILEY
169,2012,COPYRIGHT,DISRUPTING,FURTHER,HOWEVER,JNK,JUN,ROS,SMALL,TAP,UICC
ART,BACKGROUND,CONCLUSION,GLEASON,III,LABEL,METHODS,POST,PRESENTLY,PSA,PUBLISHED,RESULTS,SRT,THREE,WHERE
358,CONCLUSION,GIPC1,HOWEVER,LABEL,MATERIALS,METHODS,OBJECTIVE,PROTEIN,PURPOSE,RESULTS,STUDIES,UNI
0001,0002,001,005,169,2012,8804,AGE,AIM,ALSO,ANOVA,BASEL,CONCLUSION,COPYRIGHT,ESR,FSH,GLEASON,HOWEVER,LABEL,METHODS,OBJECTIVE,PRL,PSA,PTP,RESULTS,TRUSB
125B,8209,ANNEXIN,CCK8,HGC,MICRORNAS,PCR,THUS
169,2012,BASEL,BESIDES,COPYRIGHT
001,1071,169,2003,2007,2012,215,BACKGROUND,BETWEEN,CONCLUSION,COPYRIGHT,EBRT,EORTC,HDRB,HOWEVER,IRELAND,LABEL,LTD,METHODS,PR25,PREVALENCE,RADAR,RESULTS,THESE,USING
100,350,450,550,650,CBDCA,CBP,CHINESE,DCP,DLTS,FIBONACCI,GRADE,HOWEVER,LABEL,METHODS,OBJECTIVE,PHASE,PURPOSE,RELEVANCE,RESULTS,THERE,UNLABELLED
BASED,CARLO,EGRT,GATE,GTV,LABEL,LINAC,LOR,METHODS,MONTE,OBJECTIVE,PET,PURPOSE,RESULTS,VMC
160,BOTH,CALYPSO,HEXAPOD,INC,LABEL,MEDICAL,METHODS,MLC,OBJECTIVE,PURPOSE,RESULTS,SIEMENS,THEREBY
177,8804,95TH,CARLO,CHAIN,GEOMETRIC,LABEL,METHODS,MONTE,MRI,OBJECTIVE,POSTERIOR,PURPOSE,RESULTS,TESLA,TRUS,USING
DU145,HOWEVER,LEU,LNCAP,MULTI,PACE4,PCS
169,2012,945,946,947,ANTIGEN,AUTHORS,AUTOLOGOUS,BLACKWELL,CD40L,CRPC,CTL,CTLS,DC1,DC1S,DCS,IFN,IMMUNOLOGY,JOURNAL,LTD,PGE,PUBLISHING,TNF,UVB
GIVEN,IGF,IGFBP
MRI
000,009,2010,2012,ADT,BETWEEN,CONCLUSION,DATA,FBG,HDL,JANUARY,JUNE,LABEL,LDL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THEREFORE
009,113,193,1993,2004,225,244,BACKGROUND,BONY,CASR,FURTHER,LABEL,METHODS,ORS,PCA,RESULTS,SNPS,THERE
TRT,WHILE
223,ALPHARADIN,BONE,HORMONE,III,INTERIM,METASTASES,PSA,REFRACTORY
0269,0302,8805,GLEASON,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PCR,RESULTS,WESTERN
009,054,118,2012,264,637,710,719,727,767,789,790,811,812,825,846,857,890,925,963,BEGG,CENTRAL,CONTROLLED,EGGER,HOWEVER,MAY,RRS,USING
APC,MUTATIONS,WHOLE
169,2012,956,COPYRIGHT,DU145,HELA,MCF,MOST,MTT,SAS
HOWEVER
0001,0004,001,169,2013,500,678,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PATIENT,PUBLISHED,PURPOSE,RESULTS,SURGEON,UROLOGICAL,UTAH
945,946,BOTH,COSY,DESV,FURTHER,HMBC,HRFTESIMS,HSQC,HUH,MCF,MYRICARIA,NMR,PARP
0035,169,176,2007,2010,2013,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,MAYO,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SEPTEMBER,UROLOGICAL,USING
169,2013,945,CELL,COPYRIGHT,EDUCATION,HOWEVER,INC,LABEL,MATERIALS,METHODS,MYOBLASTS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THEREFORE,UROLOGICAL,WESTERN
169,2012,946,COPYRIGHT,LTD,STRUCTURE,VEGF
169,2012,ANG,COPYRIGHT,IRBESARTAN,LTD,RHR,SHR,THEIR,THESE,VALSARTAN
006,1049,169,1998,2008,2012,8804,8805,ART,BACKGROUND,CONVERSELY,COPYRIGHT,COX,CSM,FINALLY,GLEASON,LABEL,METHODS,OBJECTIVE,OUTCOME,PCA,RESULTS,SETTING,THESE,UROLOGY
ALSO,BERBAUM,DORFMAN,FOUR,INC,LABEL,MATERIALS,METHODS,METZ,MRMC,OBJECTIVE,OBJECTIVES,PUBLISHED,RATIONALE,RESULTS
100,169,2013,222,224,446,6541,764,8805,COMPOSITE,CONCLUSION,COPYRIGHT,CUTPOINTS,EPIC,FORM,GLEASON,INC,INDEX,ISI,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,SHORT,THESE,UIN,USING
110,1456,16MIN,1NG,3MIN,50MG,5MIN,60G,8594,956,9MIN,AUC,BECAUSE,BRB,MMIN,PCA,PUBLISHED
169,2012,COPYRIGHT,DIFFUSION,DWI,INC,THERE
169,2012,BOTH,COPYRIGHT,DETECTION,INC,KNOWLEDGE
169,2012,COPYRIGHT,INC,PSA
169,2012,COPYRIGHT,INC,MRI,NEWER,THESE
169,2012,COPYRIGHT,INC,SEQUENCES
169,2012,COPYRIGHT,INC
003,015,038,169,2012,ASIA,AUTHORS,ERG,EXPRESSION,GLEASON,LTD,OVERALL,PATHOLOGY,PCA,PSA,PTY,PUBLISHING,SOCIETY,WESTERN,WILEY,YOUNGER
129,16FR,1997,2006,800,APRIL,BETWEEN,BMI,CVD,FOLEY,GLEASON,LABEL,MARCH,MATERIALS,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS,RISK,RRP,SUI
2003,2005,305,353,CONCLUSION,INDEX,JULY,LABEL,MATERIALS,METHODS,NHT,OBJECTIVE,PCI,POTENCY,PURPOSE,Q26,RESULTS,RRP,SEPTEMBER,THEIR,UCLA
114,8804,946,GLEASON,MFSB,PCA,PIN,PSA,THUS,TZB
2011,BACKGROUND,BASED,CONCLUSION,FORCE,GUATEMALA,GUATEMALAN,INTERNS,LABEL,METHODS,MOH,PREVENTIVE,RESULTS,TASK
122,735,AOX1,CPG,FDR,PCA,SPON2
0001,8805,FCH,LABEL,METHODS,OBJECTIVE,PCA,PET,PROCEDURES,PURPOSE,RESULTS,SUV,TIME
001,8805,CRPC,FIFTY,FOUR,LABEL,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS
006,402,945,946,ALPHA,ATBC,BACKGROUND,BETA,LABEL,MEN,METHODS,ODDS,PREVENTION,RESULTS,TBG,THYROID,TOCOPHEROL,TSH
AIF,APOPTOSIS,DU145,FINALLY,HOWEVER,LNCAP,OVERALL,PC3
CRPC,FURTHER,HOWEVER,MDV3100,OVERALL,PERSISTENT
CANCEROUS,CIP2A,ELK1,ETS1,MYC,THUS
RADICAL,UROLOGIST
001,177,FLOW,IGG,IGG1,IGHG1,LNCAP,MTS,PC3
169,2012,945,AHR,ARS,CAG,COPYRIGHT,INC,INCREASED,PNT1A,TCDD
169,2012,COPYRIGHT,GLEASON,LTD,THESE,VIEW
111,160,169,177,2012,25MG,5MG,970,BACKGROUND,CBZ,COPYRIGHT,CRPC,GERMANY,GRADE,HOWEVER,LABEL,METHODS,OBJECTIVE,OUTCOME,PSA,PUBLISHED,RESULTS,SETTING,THREE,TREATMENT,UROLOGY
005,017,019,047,169,174,176,2012,360,ARC,CONCLUSION,COPYRIGHT,DESPITE,FURTHER,LABEL,LTD,MATERIALS,MEDICAL,METHODS,MLC,MLCI2,MODULATED,OBJECTIVE,PHILIPS,PTVS,PUBLISHED,PURPOSE,RESULTS,SYNERGY,SYSTEMS,THERAPY,TPS,VMAT,VOLUMETRIC
001,114,169,197,2011,2012,212,324,432,8804,BJU,BPH,CONCLUSION,DRE,GRADENIGO,ITALIAN,ITALY,JANUARY,LABEL,METHODS,OBJECTIVE,PCA3,PIN,PSA,RESULTS,TURIN,UNLABELLED,WHAT,WHILE
169,2012,ASSESSMENT,AUSTRALIA,AUTHORS,BJU,COMMITTEE,LABEL,METHODS,NETWORK,OBJECTIVE,OUTCOME,PCR,RESULTS,RISK,SCORE,VICTORIAN
2158,2292,CHI,COMT,FIX,HARDY,LABEL,METHODS,OBJECTIVE,PCA,RESULTS,SCIENCE,THERE,VAL158MET
100,AFTER,BPH,THUS,TURP
125,ANDROLOGY,RETROPUBIC,RMAPE,UROLOGY
169,2013,8201,945,946,954,956,AP1,CSF,CURRENTLY,FURTHER,IGF,INC,OSCAR,PC3,PCA,PTHRP,RANKL,RESULTS,RUNX2,SILIBININ,TAC,TGF,TNF,TRAP,WILEY
APPENDING,LEMUR,LMTK2
2007,2010,209,8201,AMONG,BETWEEN,JANUARY,LABEL,METHODS,MRI,NPV,OBJECTIVE,OBJECTIVES,OVERSTAGED,PCA,PPV,RESULTS
ANOTHER,GIVEN,GOLGI
GEM,SINCE,SV40,THESE
0065,031,554,946,AKT,BOTH,CAV,DU145,FAK,IGG,OVERALL,PDGF,PDGFR,SERUM,SRC,TREATMENT,VEGF
16B,MALIGNANT,MMTV,SUN,WNT
0007,129,8201,947,954,AFRICAN,CAUCASIAN,FCGAMMA,IGG,RIIIA,SINCE,THERE
001,177,8805,ADDITIONAL,DCE,IMAGING,LABEL,METHODS,MRI,OBJECTIVE,PSA,PURPOSE,RESONANCE,RESULTS
8201,ARM,BACKGROUND,DISCUSSION,HELICAL,LABEL,METHODS,TRIAL,WHILE
169,2012,AUTHORS,BACKGROUND,BRITISH,CONCLUSION,FUMONISIN,INHIBITION,JOURNAL,KEY,LABEL,LNCAP,METHODS,OBJECTIVE,PURPOSE,RESULTS,SK1,SKI,SOCIETY,THEREFORE,TREATMENT
0001,169,174,2010,2012,804,822,AACR,BACKGROUND,CONCLUSION,DESPITE,HRQOL,INTERVIEW,LABEL,METHODS,POOR,RESULTS,SCALE,SURVIVORS,THESE
241,AIM,BRITISH,LABEL,METHODS,NETWORK,OBJECTIVE,PBNX,PNBX,RESPONSES,RESULTS,THERE,UROLOGICAL
HOWEVER,RUF,RUFS,VARIOUS
BACKGROUND,GIST,GISTS,LABEL,RESULTS,UNASSIGNED,VIRTUAL
1999,2001,2002,AIMS,DATA,GPS,LABEL,METHODS,OBJECTIVE,RESIDENTS,RESULTS,SIRS,SMRS,THERE,WARD,WEST
2000,214,AUTOMATED,BACKGROUND,CAS,GLEASON,LABEL,OSC,OVA,PIN,PPV,RESULTS
075,184,8201,9480,971,BPI,BRIEF,GROUP,INC,INVENTORY,LABEL,METHODS,OBJECTIVE,PAIN,RESULTS,ROOT,THESE,WHITE,WILEY
169,1992,200,2000,2012,221,231,8226,AUTHORS,BJU,CRPC,DES,GROUP,LABEL,MARSDEN,METHODS,OBJECTIVE,OVERALL,PSA,RESULTS,ROYAL,TREATMENT,UNLABELLED,WHAT,WORKING
169,2012,COPYRIGHT,FORMS,SAS,THERE
169,2012,BASED,COPYRIGHT,FEW,HOWEVER,SAS,THEREFORE,UROLOGISTS
169,2012,COPYRIGHT,SAS
169,2012,COPYRIGHT,HDL,LDL,SAS,THUS
169,2012,BECAUSE,COPYRIGHT,SAS
169,174,2012,ASSESSMENT,COPYRIGHT,FRAX,HOWEVER,RISK,SAS,TOOL
BPH,LUTS,MIRABEGRON,OAB
DESPITE
ALPHA,ARI,AVODART,BPH,CURRENT,CURRENTLY,DRE,DRUGS,INITIAL,IPSS,ONCE,PDE,PROSCAR,PSA,RAPAFLO,SCORE,SYMPTOM
2012,COPYRIGHT,HOWEVER,IDIOPATHIC,IPF,PROUS,SCIENCE
916,CRPCA,DUE,LBD,PCA
CAF,CHROMATIN,NOTABLY,TMA,TMAS
2000,2008,825,CONCLUSION,GENERAL,GPRD,KINGDOM,LABEL,METHODS,OBJECTIVE,OLDER,PURPOSE,RESULTS,WOMEN
001,169,177,2012,8805,946,ANXIETY,COPYRIGHT,DEPRESSION,DUTCH,JOHN,LABEL,LIST,LTD,METHODS,OBJECTIVE,PROBLEM,RESULTS,SCALE,SONS,THESE,UNIVARIATE,WILEY
169,2012,COPYRIGHT,DU145,IMPLANTED,INC,LIGHT,NCR,THESE,WILEY
279,290,336,669,AFTER,DIETARY,DUTCH,LABEL,METHODS,NLCS,OBJECTIVE,PATHOLOGY,PURPOSE,REPORTS,RESULTS
050,133,178,423,482,677,845,888,929,THREE,XRCC7
440,956,BOTH,CFPAC,CPFAC,HPLC,LABEL,METHODS,MTT,NB142,NB165,OBJECTIVE,PANC,PKD,PROTEIN,PURPOSE,RAPID,RESULTS,THEREFORE
COPENHAGEN,DR1,FINALLY,HHDII,HLA,HOWEVER,LBD,TH1,THESE,USING
AFTER,GERMANY,PRIMARY,RESULTS,TECHNICAL,THERE
FRESH,HSP90
945,946,DAMP,DAMPS,HMGB1,HOWEVER,TAKEN
DESPITE,GAL,GALECTINS,GIVEN,SILENCING
CALIFORNIA,COMPONENTS,CULTURALLY,FDMR,FDMRS,INDIVIDUAL,LABEL,LATINOS,MEN,METHODS,OBJECTIVE,OBJECTIVES,PURPOSE,RESPECTFUL,RESULTS,SETTING
MPLUS,MULTILEVEL,SAS,SIMULATED
169,2012,AFTER,COPYRIGHT,INC,INITIAL,LIVER,PRIMARY
000,006,021,022,169,177,2012,495,656,668,721,CONCLUSION,COPYRIGHT,FREE,INC,LABEL,METHODS,OBJECTIVE,PSA,RESULTS
011,169,2012,CONCLUSION,COPYRIGHT,DESPITE,GLEASON,INC,LABEL,METHODS,OBJECTIVE,RESULTS,SIXTY
043,1441,169,2012,807,810,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,MOST,OBJECTIVE,RESULTS
003,005,007,1103,169,1990,2010,2012,AFRICAN,AMICO,CONCLUSION,COPYRIGHT,INC,IQR,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,TIME,TTS,UNIVERSITY
169,2012,945,ACT,COPYRIGHT,FET,HIGH,PSA
169,2012,223,945,AMERICA,COPYRIGHT,DEGARELIX,DENOSUMAB,III,LTD,MDV3100,SEVERAL,UNION,USA
169,197,2012,946,947,AUTHORS,BJU,CONCLUSION,EMT,EXPRESSION,GLEASON,LABEL,METHODS,MMP,OBJECTIVE,RESULTS,SLUG,SMS,SNAIL,SVI,THERE,TWIST,UNIVARIATE,ZEB1,ZEB2
0001,0004,169,2012,304,8804,8805,CONCLUSION,COPYRIGHT,COX,GLEASON,INC,LABEL,MATERIALS,MEIER,METHODS,NADIA,OBJECTIVE,PROSVUE,PSA,RESULTS
001,133,169,2000,2007,2011,2012,309,483,8805,AFRICAN,AFRO,AUTHORS,BCR,BJU,BOTH,CARIBBEAN,CAUCASIAN,FURTHER,GLEASON,JAMAICA,LABEL,MATERIALS,MEDICAL,MEIER,MEN,METHODS,OBJECTIVE,PSA,RESULTS,UNIVERSITY,USA,WEST,YORK
100,176,190,2010,2012,252,300,305,500,BACKGROUND,BMI,CONCLUSION,FINAL,JUNE,LABEL,LESS,METHODS,PARAMETERS,PSA,RESULTS,SEPTEMBER,THERE,VAPS
001,002,023,106,638,ADAM9,BACKGROUND,CONCLUSION,COX,CRPC,HOWEVER,HSPC,LABEL,METHODS,PCR,RESULTS
1997,2000,2001,2007,2012,203,525,608,615,649,726,735,758,788,808,820,875,877,AUC,BACKGROUND,CHINA,CHINESE,ECE,JUNE,LABEL,LNI,MAY,METHODS,RESULTS,SVI,THERE,USING
169,2012,AUTHORS,FEBS,FINALLY,JOURNAL,NLS
169,2012,ADD,AUTHORS,BJU,DOES,FREE,KNOWN,PSA,SUBJECT,WHAT
8202,945,COA,GLEASON,HOWEVER,RADICAL
945,946,AMONG,CYS86,FINALLY,ITG
169,2008,2012,BETWEEN,CURRENT,END,ENGLISH,HOWEVER,JANUARY,JUNE,RISKS,ROBOT,UROLOGICAL
014,018,163,795,8805,AES,BACKGROUND,CONCLUSION,CRPC,CTCS,CTX,GRADE,GREATER,LABEL,METHODS,NTX,PFS,PLACEBO,PSA,RESULTS
004,006,029,041,1042,4439,605,611,614,6807,694,858,862,866,962,978,AUC,BACKGROUND,COLORECTAL,CONCLUSION,LABEL,LUNG,METHODS,NEITHER,OVARIAN,PREDICTORS,RELAPSE,RESULTS,ROC,SCREENING,THESE,TRIAL
174,ASC,LEUCINE,MOST,PCA,PRLZ,TARGETING
0059,215,795,8804,8Q24,ICELANDERS,SEVERAL,WESTERN
HAUSA,NIGERIA,OTHER,RENAL
116,120,160,169,2012,947,COPYRIGHT,CTV,DIFFERENT,DIL,DILS,LTD,NTCP,NTCPS,POISSON,PTV,PUBLISHED,TCP,TD50
125,169,1984,1995,2000,2013,239,313,546,COPYRIGHT,EDUCATION,INC,LABEL,LONGEST,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RECURRENCE,RESULTS,UROLOGICAL
001,169,198,2012,2013,2624,822,AUC,AUR,BEGG,CEUS,CONCLUSION,COPYRIGHT,DOR,EGGER,INC,LABEL,LARGE,LIBRARY,MATERIALS,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,PCA,PUBLISHED,RATIONALE,RESULTS,SIXTEEN,SROC,VARIOUS
010,100,155,1994,2010,215,CONCLUSION,INC,LABEL,MAIN,MEAN,MEASURE,MEN,METHODS,NONE,OBJECTIVE,OUTCOME,PATIENT,PUBLISHED,RESULTS,SETTING,TMC
009,021,037,039,169,196,1990,2007,2013,8805,ADT,AFRICAN,BOTH,COPYRIGHT,FFS,INC,LABEL,MATERIALS,MDV3100,METHODS,OBJECTIVE,PCSM,PSA,PURPOSE,RESULTS,TDM,THESE
001,008,063,13G,14G,15G,169,2013,35G,BACKGROUND,COMMITTEE,CONCLUSION,CONTEXT,COPYRIGHT,ENDOSCOPIC,GRADE,HEMOGLOBIN,HRP,INC,LABEL,METHODS,MOST,O3T,OBJECTIVE,OBJECTIVES,PAIN,PERSISTENT,PUBLISHED,RESULTS
000,087,100,169,2010,2012,237,8804,933,940,AEU,ANDALUS,ANDALUSIA,CATALONIA,COPYRIGHT,GLEASON,LABEL,MEAN,METHODS,OBJECTIVE,OBJECTIVES,PCA,PSA,PUBLISHED,REGIONS,RESULTS,SPAIN,SPANISH
169,2012,AMONG,CONCLUSION,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,MOST,OBJECTIVE,OOPE,RESULTS,UNIVERSITY
001,065,080,105,169,2012,CONCLUSION,COPYRIGHT,HOWEVER,IIEF,INC,INDEX,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS
1104,1624,169,16ML,177,1DAYS,2012,24ML,332,3712,3721,3867,4074,8364,843,880,8DAYS,ASA,BACKGROUND,BPE,BPH,CONCLUSION,COPYRIGHT,DEPARTMENT,LABEL,MEDICAL,METHODS,OBJECTIVE,PVP,RESULTS,SAS,TUR,TURIS,TURP
004,011,029,169,2003,2009,2012,2NG,5NG,70GY,AFRICAN,AMICO,APRIL,CARIBBEAN,CONCLUSION,COPYRIGHT,EIGHT,FIFTY,GLEASON,HRPC,JANUARY,LABEL,METHODS,NADIR,OBJECTIVE,PCA,PHOENIX,PSA,RESULTS,SAS,SIX
003,018,160,169,2012,300,AFTER,CONCLUSION,COPYRIGHT,FIFTY,HOWEVER,LABEL,LRP,METHODS,OBJECTIVE,PURPOSE,RESULTS,SAS
102,160,169,174,2012,BACKGROUND,CONCLUSION,COPYRIGHT,LABEL,MEDLINE,METHODS,MRI,RESULTS,SAS,TRUS
169,2012,COPYRIGHT,HORMONE,SAS,SCREENING,THESE
128,146,202,290,418,BACKGROUND,BASED,CONCLUSION,ERES,ESCC,LABEL,RESULTS,TFBSS,THESE
113,1999,2010,AIM,ANTIGEN,CONCLUSION,DEPARTMENT,DIFFERENT,DRE,GERMANY,JANUARY,JENA,LABEL,MAY,METHODS,OVERALL,PCA,PLOVDIV,PSA,RESULTS,THEREFORE,TURP,UNIVERSITY,UNLABELLED,UROLOGY
3E10,BRCA2,SLE
177,215,485,800,849,948,ABTC,BOTH,CD18,CD27,GAMMA,GDTC,MRI,PERLS,TESLA,THUS,U87,USING,USPIO
000,032,040,143,177,188,2010,2012,2ND,CONCLUSION,JANUARY,JUNE,LABEL,METHODS,OBJECTIVE,RESULTS
169,2012,300,BACKGROUND,BECAUSE,CHEMISTRY,DPP,LABEL,LISAS,METHODS,MULTIPLEX,RESULTS,TIMP,USING
037,082,762,BASED,SEVEN
145,169,2012,231,956,A549,BXPC,COPYRIGHT,HEP,MCF,MDA,MEL,NMR,THEIR
169,2012,2D3,945,CHIP,CHROMATIN,COPYRIGHT,G0S2,H3K9,ISSUE,LTD,NCOR1,RWPE,SPECIAL,SUBSEQUENT,THUS,TIME,VDR,VITAMIN
967,CHINESE,CP3,CURVE,DIFFERENT,DU145,H460,H841,LQL,NCI,NSLC,OVERALL,PADE,PLQ,QUADRATIC,SCLC,SRS,SRT,THEIR,U1690,UNIVERSAL,USC,USING
148,150,301,945,946,AAG,AIMS,CIS,CNV,D85Y,GENOMIC,LABEL,OBJECTIVE,ORS,RESULTS,UGT2B,UGT2B15,UGT2B17,URIDINE,WHILE
217,BACKGROUND,LABEL,METHODS,MMP,QSOX1,RESULTS
2010,CRPC,III,METASTATIC,PHASE,PRIOR
CTBP1,EXPRESSION,TAKEN,TRANSIENT
004,0125,169,2012,ADC,CONCLUSION,COPYRIGHT,IMRT,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,OVERALL,PURPOSE,RESULTS,SEVENTEEN,WILEY
BASIC,INITIALLY,PRIMARY,SINCE,THEREFORE,THESE
169,2012,COPYRIGHT,FUNCTIONAL,INC,NUMA,RIKA,USING,WILEY
ODF,ODF3,ODF4
140,145,1562,165,169,1989,2007,2012,3215,8804,8805,ACCORDING,ADT,BACKGROUND,COPYRIGHT,EDRT,GLEASON,GRAY,LABEL,METHODS,PSA,RANDOMIZED,RESULTS,SDRT,SOCIETY
CONCLUSION,LABEL,MDCT,OBJECTIVE,RALRP
BONE,BOTH,CONCLUSION,DWI,LABEL,METHODS,MRI,NAF,OBJECTIVE,PET,RESULTS,WHOLE
100,177,350,614,618,708,769,BLOOD,BOTH,CONCLUSION,EIGHT,LABEL,MDCT,METHODS,MVD,OBJECTIVE,RESULTS
141,1994,2002,2011,238,241,249,BMS,DEPARTMENT,MEDICAL
000,001,002,011,043,050,057,068,118,138,143,146,158,160,266,272,279,363,517,558,894,932,961,971,975,ASIAN,CAUCASIAN,COMT,HOWEVER,MET,SIX,STATA,SUMMARY,VAL,VAL158MET,VERSION
169,2012,AIMS,ANDROGENS,BACKGROUND,BASEL,C57BL,CHIP,CHROMATIN,COPYRIGHT,DHT,EMSA,LABEL,METHODS,OBJECTIVE,PCA,PCR,PEBP,RAF,RESULTS,RKIP,WESTERN,WHETHER
BACKGROUND,CBP,EXPRESSION,LABEL,METHODS,MTS,PCA,PCAF,PCR,RESULTS,TARGETING,WESTERN,WHETHER
169,2012,960,BACKGROUND,BASEL,CONCLUSION,COPYRIGHT,GLEASON,HOWEVER,LABEL,METHODS,PROSTATIC,RESULTS,USING
100,147,1992,2011,370,617,CURRENTLY,EPE,EPES,METHODS,PARTIAL,PMS,RADICAL
224,AZA,EZH2,FACTORS,HA22T,HCC,HDAC,HEP3B,HEPG2,HOWEVER,RAF,RKIP,SNAIL,VGH
963,FINALLY,INHIBITION,THESE
CTS,HOWEVER,ONCE,PCA,WESTERN
1980,370,BECAUSE,DIAGNOSIS,ECOLOGICAL,HODGKIN,HOWEVER,NHL,SEVERAL,STUDIES,UVA,UVB
CONVERSELY,OHD,VDR
AKT,CAM,MOST,QUERCETIN,RAT,VEGF,WESTERN
BACKGROUND,CONCLUSION,IIB,III,LABEL,METHODS,PSA,RESULTS,THERE
8201,ACID,ALSO,CONCLUSION,INCREASED,LABEL,LNCAP,METHODS,PCA,RESULTS,UNLABELLED,VPA,WHILE
ENDPOINTS,ERSPC,GOTHENBURG,LABEL,METHODS,OBJECTIVE,RANDOMIZED,RESULTS,ROTTERDAM,SCREENING,THEREFORE
0001,001,002,004,005,006,013,017,116,2011,940,ASIA,AVAILABLE,CIS,EVERY,LABEL,METABOLIC,METHODS,OBJECTIVE,OCTOBER,RESULTS
ADDITIONAL,EMSA,ERG,ETS,THESE
0002,8201,AMONG,BELOW,CITY,ENGLISH,FOUR,LIMITED,SIXTEEN,YORK
276,536,945,954,AKT,BACKGROUND,BP65,CELL,CONCLUSION,CRPC,EXPRESSION,GLEASON,HNPC,LABEL,LNCAP,METHODS,MMP,NLS,RESULTS,THESE
EARLY,EXPRESSION,KLKS,PSA
169,2012,AACR,CTC,CTCS,PSA,PSMA
169,2012,AACR,ADT,CRPC,CTC,CTCS,DESPITE,INITIATION,LABEL,MEASURING,UNLABELLED
120,163,169,177,2013,268,956,CONCLUSION,COPYRIGHT,EXCRETION,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,ORGAN,PURPOSE,RESULTS,SPRAGUE,THESE
169,2012,ADT,COPYRIGHT,GNRH,IRELAND,LTD,SINCE
169,2012,8805,BACKGROUND,CONTEXT,COPYRIGHT,ENGLISH,GLEASON,LABEL,MEDICAL,MEDLINE,METHODS,OBJECTIVE,PUBLISHED,RESULTS,RPS,SINCE,SUBJECT,SYNTHESIS,UROLOGY,USING
001,019,024,044,089,145,169,171,172,192,2012,344,457,462,482,514,AFTER,BACKGROUND,COPYRIGHT,FIVE,FUNCTIONAL,INVENTORY,LABEL,MEN,METHODS,OBJECTIVE,OUTCOME,PROCEDURE,PUBLISHED,RARP,REGARDING,RESULTS,SETTING,SHIM
AKT,BACKGROUND,CGA,COMET,DNMT,DU145,ELISA,FINALLY,LABEL,LNCAP,METHODS,NED,RESULTS,THEREFORE,TREATMENT
126,172,A1C,AFTER,BMI,FURTHER,JAPAN,JDS,MULTI,PSA
AFRICAN,LABEL,METHODS,OBJECTIVE,RESULTS,TRUST
003,126,BACKGROUND,BOTH,CAP,CONCLUSION,FATAL,HIGH,LABEL,METABOLIC,METHODS,MORTALITY,OBJECTIVE,OVERALL,RESULTS,SEVENTY,TAB,THERAPY,URINARY
AGE,FINALLY
PDT,STUDIES
PDT
1H109,CELL,GLAF,GLV,OVERALL,VACV,VEGF
BACKGROUND,BPH,ELISA,EXOSOME,GLEASON,LABEL,METHODS,PCA,RESULTS,SMALL,THESE,WESTERN
ALTOGETHER,BOTH,DLX,DLX4,EMT,HOWEVER,TAKEN,TWIST
169,2012,AACR,ANTITUMOR,DOSE,III,OBJECTIVE,OTHER
004,118,177,251,308,346,806,AGE,CONCLUSION,COX,CRS,DATA,DUTCH,LABEL,LYNCH,MEIER,METHODS,MLH1,MMR,MSH2,MSH6,OBJECTIVE,PURPOSE,RESULTS,SEVEN,SEX,SIR,SIRS
001,169,2012,289,6673,866,961,BACKGROUND,BMI,COPYRIGHT,COX,HIGH,LABEL,MEN,METABOLIC,METHODS,PROJECT,RESULTS,RRS,SOCIETY,THERE
004,139,177,1975,1991,2011,BOHAN,CONCLUSION,ENHANCING,LABEL,METHODS,OBJECTIVE,PETER,RESULTS
DU145,GLUCOSE,GRP78,KDEL,NPS,PC3,PNT1B,THEREFORE
160,1973,2007,216,ALS,END,FEW,INCREASING,INSTITUTE,LABEL,METHODS,OBJECTIVE,PARKINSON,PROGRAM,RESULTS,SEER,SMR,THERE,USING
DESPITE,PERHAPS,THESE
115,169,2013,BCR,CAP,COPYRIGHT,DU145,ESPECIALLY,GLEASON,INC,LABEL,LNCAP,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PCR,PIN,RESULTS,RWPE,SENP1,SUMO,THREE,TMA,WESTERN
169,2012,956,ALTERATION,BOTH,CCL2,CCL20,COPYRIGHT,CXCL6,HCC,HCC24,HCC38,HOWEVER,IL6,IL8,KMUH,MT3,QUINONE,SAS,WST
169,2012,404,945,BACKGROUND,BPH,CONCLUSION,COPYRIGHT,FIFTY,HOWEVER,KLF4,LABEL,LTD,METHODS,MYC,NANOG,OCT4A,PCA,PCR,RESULTS,SOX2
110,ADT,BACKGROUND,BLACK,CAUCASIANS,LABEL,METHODS,PCA,QOL,RESULTS,THERE,THESE,THUS
169,2005,2010,2012,CLAVIEN,COPYRIGHT,LRP,MINOR,PUBLISHED,THERE
127,169,185,2013,205,227,330,528,AGA,AIMS,BACKGROUND,COPYRIGHT,CRM,CYS,FOXO,INC,INCREASED,INSTITUTE,KPT,LABEL,METHODS,MUTATIONS,OBJECTIVE,ORAL,PAR,PUBLISHED,RESULTS,SELECTIVE,SINE,SINES
169,2012,AREAS,AUSTRIA,BACKGROUND,BCA,BLADDER,CONTEXT,COPYRIGHT,JUNE,LABEL,METHODS,OBJECTIVE,ONGOING,PATHOLOGY,PUBLISHED,RESULTS,SYNTHESIS,UROLOGY
0001,169,2012,COPYRIGHT,EDUCATION,HOWEVER,INC,LABEL,MATERIALS,METHODS,MOCK,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,ROBOTIC,SYSTEMATIC,UROLOGICAL,UROLOGISTS
100,169,2012,ANOTHER,COPYRIGHT,EDUCATION,ERG,GLEASON,GRADE,HOWEVER,INC,LABEL,MATERIALS,METHODS,NEITHER,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,TMPRSS2,UROLOGICAL
145,169,2012,8482,ANN,ARBOR,ATCC,CELL,CHANGES,COPYRIGHT,EDUCATION,INC,LABEL,LNCAP,MATERIALS,METHODS,OBJECTIVE,PROTEIN,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL,VORINOSTAT
169,2012,LAPRA,REGARDING,UROLOGICAL
945,CHIP,CPG,GADD45A,H3K9ME2,KMT,KMTS,NCOR1,RWPE,TAKEN,THESE,VDR
001,ERG,PCA3,TMPRSS2,URINE
169,2012,COPYRIGHT,INC,OVERALL,PCR,WILEY
124,155,163,165,18F,2006,2009,319,353,396,456,491,912,955,ACCORDING,CANCERS,CONTROL,FDG,HOWEVER,JAPAN,LABEL,METHODS,OBJECTIVE,PET,RESULTS,STAGE,UICC,UNION
ANGELES,BACKGROUND,CALIFORNIA,CONCLUSION,HOWEVER,INDEX,LABEL,LOS,LRP,METHODS,OBJECTIVE,ORP,PCI,QOL,QUALITY,RESULTS,UCLA,UNIVERSITY
160,1999,2009,8804,909,EACH,IGF,IGFBP,IGFS,KINGDOM,LABEL,METHODS,OBJECTIVE,PSA,PSADT,PURPOSE,RESULTS,THERE
181A,199A,30D,C42B,DESPITE,GRP78,THUS
1000,106,123,16511,193,1999,2008,2010,380,905,908,ADULT,BACKGROUND,INCIDENCES,LABEL,LUT,MEIER,METHODS,NETWORK,ORGAN,PTLD,PTM,RESULTS,SEPTEMBER,SHARING,SOT,SOTS,TRANSPLANT
160,169,2012,BOTH,COPYRIGHT,JAPAN,PLM,PRECS,PUBLISHED,SOCIETY
169,2012,5MG,AVODART,CONCLUSION,COPYRIGHT,DISCUSSION,FORTY,GSK,HISTOSCAN,INC,JANUARY,LABEL,MEN,METHODS,MRI,MULTI,OBJECTIVE,PLANNED,PRIMARY
001,004,148,169,2012,300,AMICO,BACKGROUND,BCR,COPYRIGHT,GROUP,III,LABEL,LTD,METHODS,NVB,PSA,RARP,RESULTS,UNDERGOING
145,169,2013,945,954,956,AFTER,ALSO,COPYRIGHT,EDUCATION,INC,LABEL,LUCIFERASE,MATERIALS,METHODS,OBJECTIVE,PC3,PUBLISHED,PURPOSE,RESULTS,REVERSE,THESE,UROLOGICAL,WESTERN,XIAP
032,155,169,2013,261,655,700,COPYRIGHT,COX,EDUCATION,GLEASON,HARRELL,INC,IQR,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
150,169,2009,2013,578,616,COPYRIGHT,EDUCATION,HOWEVER,INC,INPATIENT,LABEL,LOW,MATERIALS,METHODS,NATIONWIDE,NIS,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,RESULTS,THESE,UROLOGICAL,USING,WHILE
169,2012,2993,5MM,AIM,COPYRIGHT,CROSS,FIFTY,LABEL,LTD,LYMPH,METHODS,MRI,NPV,OBJECTIVE,PLND,PPV,RESULTS,SEVENTY,USPIO
169,2012,223,3100,COPYRIGHT,III,INC,MDV,PHASE,PRACTICING,SINCE
169,2012,COPYRIGHT,INC,THESE
169,2012,COPYRIGHT,CURRENTLY,INC
169,2012,COPYRIGHT,INC,SEVERAL,TARGETING,THESE
169,2012,ADT,BONE,COPYRIGHT,INC
169,2012,CLU,COPYRIGHT,CRPC,HSP27,INC,MOST,WESTERN
169,2012,CONVERSELY,COPYRIGHT,HRQOL,INC,THERE,TREATMENT
169,2012,COPYRIGHT,CRPC,INC
169,2012,COPYRIGHT,CRPC,INC,PUBLISHED,TARGETS,THESE
169,2012,ALSO,COPYRIGHT,III,INC,OTHER,PUBLISHED
169,2012,COPYRIGHT,INC,PSA
169,2012,COPYRIGHT,INC
0001,001,1005,169,183,198,2012,232,233,311,502,503,945,956,BACKGROUND,CHARITABLE,COMIT,COPYRIGHT,EORTC,FUNDING,LABEL,LATE,LIGUE,LTD,METHODS,NATIONALE,RESULTS,TREATMENT,TRUST
001,135,169,183,2007,2012,270,BACKGROUND,BASED,COPYRIGHT,DWI,HOWEVER,IMAGING,LABEL,LIC,LNC,LSC,METHODS,NPV,OBJECTIVE,OUTCOME,PBX,PCA,PREDICTIVE,PUBLISHED,RESULTS,SETTING,UROLOGY
1000,169,2012,223,AFTER,BACKGROUND,BASED,CAUSE,COPYRIGHT,GLEASON,HOWEVER,LABEL,METHODS,MOST,OBJECTIVE,OUTCOME,PCA,PUBLISHED,RESULTS,SETTING
169,2012,AUSTRALIA,COPYRIGHT,INC,NMSC
169,2012,COPYRIGHT,MULTIPLEX,PSA
169,195,2007,2011,2012,BETWEEN,COPYRIGHT,EDUCATION,GLEASON,HIGH,HOWEVER,INC,LABEL,MARCH,MATERIALS,MEN,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
169,1993,2011,2012,244,COPYRIGHT,EACH,EDUCATION,GLEASON,INC,LABEL,MATERIALS,MEAN,METHODS,NINE,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,ROUTINE,THUS,TRANSITION,UROLOGICAL
011,021,026,031,039,042,169,2012,BASED,COPYRIGHT,COX,EDUCATION,GLEASON,HOWEVER,INC,LABEL,MATERIALS,MEAN,MEIER,METHODS,MOST,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
0001,092,135,169,1999,2007,2012,233,242,322,334,656,956,BETWEEN,COPYRIGHT,COX,EDUCATION,FEW,GLEASON,INC,LABEL,LIMITED,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THERE,THEREFORE,UROLOGICAL,WHILE
0004,003,005,006,014,015,028,169,2012,257,AGE,COPYRIGHT,EDUCATION,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THREE,UNIVARIATE,UROLOGICAL
169,2012,270,513,AMERICANS,CLINICIANS,COPYRIGHT,EASE,EDUCATION,FEW,INC,KINCAID,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,READING,RESULTS,UROLOGICAL
169,2012,8805,AFFYMETRIX,ARRAY,COPYRIGHT,EXON,FINALLY,GLEASON,IHC,INC,MICROARRAY,PATHOLOGY,PCR,PUBLISHED,SEC14L1,SOCIETY,TCEB1
1034129,169,2003,2010,2011,2012,229,333,337,341,54239,872,BACKGROUND,COPYRIGHT,DETERMINE,LABEL,METHODS,OBJECTIVE,OUTCOME,PCA,PSA,PUBLISHED,RESULTS,SETTING,STOCKHOLM,THERE,THESE,THROUGH,UROLOGY
001,169,177,2002,2006,2012,289,435,BETWEEN,COPYRIGHT,EDUCATION,FIVE,FOUR,GLEASON,INC,JUNE,LABEL,MATERIALS,MEAN,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
169,1982,2011,2012,30TH,478,AMICO,ANATOMICAL,COPYRIGHT,EDUCATION,EXCELLENT,HOPKINS,INC,JOHNS,LABEL,MATERIALS,MEDICAL,METHODS,OBJECTIVE,PCW,PSA,PUBLISHED,PURPOSE,RADICAL,RESULTS,UROLOGICAL
169,2012,703,953,COPYRIGHT,DECISIONAL,EDUCATION,INC,INVENTORY,IQR,LABEL,MATERIALS,MEN,METHODS,OBJECTIVE,PHYSICIAN,PUBLISHED,PURPOSE,RESULTS,SCORE,SYMPTOM,THESE,UROLOGICAL,USING
ACCORDING,BACKGROUND,CONCLUSION,DDC,DOPA,GREEN,HEAD,HNSCC,LABEL,METHODS,PCR,RESULTS,SCCS,SYBR,TNM,TOTAL
001,1301,157,1997,2010,BETWEEN,BMI,BPH,CHRONIC,GLEASON,IRANI,JANUARY,LABEL,METHODS,OBJECTIVE,PSA,RESULTS,RPE,SCORE,SYMPTOM,THERE,TNM,TOTAL,TURP,TVE,UROL
AGE,BACKGROUND,CONCLUSION,GLEASON,LABEL,MATERIALS,METHODS,NIGERIA,OBJECTIVE,PATHOLOGY,PORT,RESULTS,SOUTH,THESE,THOSE,THREE
189,2002,2003,AZIKIWE,BACKGROUND,CONCLUSION,DATA,LABEL,METHODS,NAUTH,NIGERIA,NNEWI,OBJECTIVE,PORT,RESULTS,THESE,THOSE,UNIVERSITY,UPTH,USING
00003,00005,00006,00007,003,177,BACKGROUND,CONCLUSION,HEALTHY,INS,LABEL,METHODS,MM2,MRS,NUDE,OBJECTIVE,PC3,PRESS,PURPOSE,RESULTS,SPRAGUE
ANAL,ANORECTAL,BOWEL,COMPOSITE,EPICB,FECAL,FIQL,INDEX,LABEL,LIFE,METHODS,OBJECTIVE,PURPOSE,QOL,QUALITY,REGRESSION,RESULTS,SIXTY,THEREFORE
169,183,184,2008,2012,AGE,ASIA,BACKGROUND,COLORECTAL,COPYRIGHT,COUNTRY,DALYS,DUTCH,ERASMUS,ESTIMATES,FUNDING,HDI,LABEL,LTD,METHODS,RESULTS,ROTTERDAM,SAHARAN,SCIENTIFIC,SOCIETY,THEREFORE,UNIVERSITY,WORLDWIDE,YLDS,YLLS
AMONG,BACKGROUND,CONCLUSION,ERBB,LABEL,MAPK,METHODS,PGR,RESULTS,TARGETING,THEREFORE,TP53,VEGF,VEGFA
169,2012,500,COPYRIGHT,HGPIN,IRELAND,LTD
169,1995,2002,2012,657,COPYRIGHT,COX,FINLAND,FURTHER,LTD,NSAID
169,2008,2010,2012,2014,8805,AIMS,BRITISH,CG58,COLLEGE,COPYRIGHT,DESPITE,EXCELLENCE,GROUP,HOWEVER,INSTITUTE,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OCTOBER,PUBLISHED,RESULTS,ROYAL,SEPTEMBER,THERE,URO
160,169,2007,2009,2012,321,664,BACKGROUND,CART,COPYRIGHT,LABEL,METHODS,PSA,PSAD,RESULTS,THUS,USING
8805,ASSESSMENT,GLEASON,HOWEVER,INCIDENTAL,INCREASED,PCA,PSA,PSCA,RCP,YET
157,169,2007,2009,2012,430,8226,DESPITE,FACTORS,FOUR,JANUARY,LABEL,LEVEL,MARCHES,METHODS,OBJECTIVE,OBJECTIVES,PGE1,REASONS,RESULTS,STUDENT,THERAPY,TYPE,UNIVERSITY,UNLABELLED,UROLOGY,WHAT
11Q13,1206,612,8Q24,GWAS,SINCE,SNP,SNPS
945,947,APOPTOSIS,BAX,BCLXL,BOTH,FN14,FURTHER,HOWEVER,IFN,LNCAP,TNF,TNFSF12,TWEAK
037,120,177,184,8805,AMONG,DRE,FDG,GLEASON,LABEL,MATERIALS,METHODS,OBJECTIVE,PET,PSA,RESULTS,SECONDARY,THEREFORE
HOWEVER,THERE
160,949,AKT,HOWEVER,JNK,JUN,LOX,PKC,PREC,THESE,THUS,WDL
999,ABOUT,ARIZONA,COPD,DVT,THERE
130,2006,2012,AFTER,BACKGROUND,EORTC,FIRST,HBO,HDR,HYPERBARIC,LABEL,METHODS,PATIENT,RESULTS,RTOG
160,200,ER81,ETS,ETV1,FINALLY,LNCAP,MMP,TRANSGENIC,WHILE
108,549,BLK,DU145,HBCC,HDF,HEAT,HELA,HPCC,HSP70,INITIALLY,LNCAP,MCF7,MTW9,NG108,PC3,SHOCK,TDF,YEARS
CONCLUSION,DOCETAXEL,LABEL,LNCAP,LUCIFERASE,METHODS,OBJECTIVE,PSA,RESULTS,WESTERN
EMT,EPITHELIAL,SNAIL,THUS
160,275,357,945,ADENOSINE,AMP,AMPK,ASPC,ATP,BML,COLO,HOWEVER,MIA,NAC,PACA,PANC,ROS,SMALL,THESE
AMONG,ATG12,ATG5,AUTOPHAGIC,DU145,HOWEVER,LC3,LNCAP,THESE,VPA
10PBX,12PBX,169,2012,253,8805,8PBX,923,AGE,BASEL,CDR,CDRS,CHINESE,CONCLUSION,COPYRIGHT,EACH,HOWEVER,LABEL,METHODS,OBJECTIVE,PCA,PURPOSE,RESULTS,TRUS
ALA,ARG,ASN,FINALLY,ILE,LEU,MYTILUS,PHE,TFF
005,019,029,125,739,967,BACKGROUND,CHINESE,INCIDENCE,LABEL,METHODS,RESULTS,TOTAL,TOTALLY
169,2012,215,698,ADVERSE,ATM,BACKGROUND,COPYRIGHT,CRT,ERCC2,FDR,IRELAND,LABEL,LIG4,LTD,METHODS,MLH1,OBJECTIVE,PURPOSE,RESULTS,SNP,SNPS,THOSE,XRCC3
169,2012,BASEL,BPH,CONCLUSION,COPYRIGHT,LABEL,MATERIALS,METHODS,NORMALIZED,OBJECTIVE,PCA,PCR,RESULTS

AIM,CONCLUSION,LABEL,LNCAP,MATERIALS,METHODS,NPS,OBJECTIVE,RESULTS
CURRENTLY,HOWEVER,THESE
169,2012,IGG4,UROLOGICAL
198,COMPARISON,THUS,TUR
2005,2006,206,619,80W,ASSESSMENT,GREEN,IPSS,LASERSCOPE,LIGHT,MEAN,OLYMPUS,PROSTATIC,QMAX,QOL,RECURRENT,THUS
1990,1994,2003,2009,448,476,BACKGROUND,BOTH,CASES,CUMULATIVE,HRS,LABEL,MELBOURNE,METHODS,RESULTS,VICTORIAN
23B,AKT,DEPLETION,EMT,HIGH,INCREASED,LOSS,SNAIL,SRC,THESE
169,2012,COPYRIGHT,EXCLUSION,HOWEVER,JOHN,LASER,LTD,MRS,MRSI,SONS,TES,THEREFORE,THESE,WILEY
122,2008,2122,8805,CONCLUSION,GLEASON,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PCA,PSA,PURPOSE,RESULTS,SECONDARY,THERE
128,169,183,AFTER,BARTH,CONCLUSION,FINE,GEORG,LABEL,LOW,METHODS,MOST,OBJECTIVE,RESULTS,STIFFNESS,STUTTGART,THYROID,UENO,ULTRASOUND,YORK
000,012,016,024,026,029,038,043,088,10TH,125,169,177,215,250,3RD,495,500,505,CSCS,DISSECTING,FORMULA,HOWEVER,LNCAP,THESE,TSU
174,1800795,1800796,236,357,572,613,636,941,992,ADDITIONAL,DUE,PCA,SNPS,THERE
BACKGROUND,CONCLUSION,CURRENTLY,LABEL,METHODS,PCA,RESULTS,THERE
IMAGE,PSA
BACKGROUND,BCL,CHIP,CONCLUSION,FOLLOWING,HYPOXIA,LABEL,LNCAP,METHODS,PCR,RESULTS,RUNX2
109,169,197,2012,8804,8805,947,AACR,AFRICAN,AMERICANS,APOPTOSIS,CAUCASIAN,CELL,GLEASON,GLUTAMATE,GRM1,H2AX,HOWEVER,IHC,LABEL,METHODS,OBJECTIVE,PARP,PURPOSE,RESULTS,SERUM,UNIVARIATE
NVB,RALP,THESE,WHILE
183,255,8805,AFFYMETRIX,BLOOD,CONCLUSION,CURRENT,DIAGNOSIS,EXPRESSION,FOLLOWING,GLEASON,LABEL,MALAYSIAN,MATERIALS,METHODS,MICROARRAY,NORTH,OBJECTIVE,PCR,PSA,PURPOSE,RESULTS,THUS,U133
412,946,COP9,CSN,CSN5,ERMA,ERMAS,SIRT1,SKP1,SKP2,SP1,THUS,TRCP
001,8202,BACKGROUND,CAUCASIANS,CIS,GSTM1,HOWEVER,LABEL,ORS,PCA,PRINCIPAL,RESULTS
177,AC133,BOTH,CD133,CD44,CD49F,CELL,CFC,CFCS,STEM
100,945,946,CRT,PC3,PKC,SER33,SER37,THEREFORE,WNT
281,294,655,661,679,689,749,AUC,AUCS,HOWEVER,PSA,SNPS
169,2012,AACR,AMONG,ATP,EXPRESSION,IDH1,IDH2,ISOCITRATE,MYC,OTTO,PKM2,SDH,THESE,WARBURG
GLEASON,SERIOUS,T2A
001,005,256,487,503,BECAUSE,CARE,CONCLUSION,GIVEN,LABEL,METHODS,NETWORK,OBJECTIVE,PCPS,PHC,PRIMARY,PURPOSE,RESULTS,USING
169,2012,AFM,ALSO,COPYRIGHT,EVALUATION,FINALLY,HERTZ,HOWEVER,INC,PC3,PNT2,WILEY,YOUNG
946,HEIGHTENED,HOWEVER,THESE,TROP2
169,2012,COPYRIGHT,IMAGING,INC,SOCIETY
2001,2007,2009,300,65291,89SR,GLEASON,MAB,PSA
AKT,APOPTOSIS,BCL,CURRENT,DECADES,EMERGENCE,FOUR,ISSUE,LATER,OTHER,PTEN,SPECIAL,THUS
111,111IN,177,1MBQ,3000,AIM,AMBA,BESIDES,CONCLUSION,GASTRIN,GRPR,HPLC,LABEL,METHODS,NON,OBJECTIVE,PEPTIDE,RELEASING,RESULTS,TYR4,VCAP
ASSESSING,BONE,HOWEVER,PET,SPECT
002,016,11C,124,967,AGE,AIM,CBS,CENTRAL,CONCLUSION,DISEASE,DUTCH,EBRT,LABEL,MANN,METHODS,OBJECTIVE,OVERALL,PET,PSA,PSADT,RCTS,RECURRENT,RESULTS,SIXTY,STATISTIC,TEN,WHITNEY
11C,177,AIM,CHOLINE,CONCLUSION,LABEL,MEIER,METHODS,OBJECTIVE,PET,PSA,RESULTS,ROUGHLY,SRT
HIGH,PET,RADIATION,SALVAGE
FOUR,GTV,MRI,PET,PSA,RECURRENCE,SALVAGE,THERE,THESE
105,145,2005,2011,8804,AMONG,BACKGROUND,BLACK,COX,DUKE,GLEASON,INCLUSION,JANUARY,LABEL,METHODS,PSA,RACE,RESULTS,SEPTEMBER,THERE,TIME
124,CAP,DATA,UNTIL
169,2012,CB1,CB1R,CB2,CB2R,COPYRIGHT,FURTHER,INC
169,198,2012,AMONG,COPYRIGHT,CROWN,DU145,FURTHER,HAIRPIN,LIVIN,LTD,METASTATIC,PCR,PUBLISHED,TARGETSCAN,THEREFORE,THUS,UTR,WESTERN
001,009,169,2000,2005,2007,2008,2013,429,586,AHA,COPYRIGHT,EDUCATION,INC,INPATIENT,LABEL,MATERIALS,METHODS,NATIONWIDE,NIS,OBJECTIVE,OWNERSHIP,PUBLISHED,PURPOSE,RADICAL,RESULTS,SEVERAL,UROLOGICAL
001,047,136,169,2013,303,AUTOMATED,BOTH,CAPISTRANO,CD31,COPYRIGHT,GLEASON,GROUP,IMAGE,INC,JUAN,NEOPLASTIC,SAN,SIMILAR
127,169,2012,208,290,8804,8805,ADT,AMICO,ANTIGEN,CONCLUSION,COPYRIGHT,EBRT,FOCUSED,GLEASON,HIFU,HIGH,III,INTENSITY,IRELAND,LABEL,LOCAL,LTD,MATERIALS,METHODS,OBJECTIVE,PCA,PFSR,PSA,PURPOSE,RESULTS,SALVAGE,ULTRASOUND
169,2012,AMONG,COPYRIGHT,HOWEVER,INC,NEU2,PCR,RUNX2,SNPS,SP3
HOWEVER
169,2012,366,INCREASED,PRECISE,THESE,THUS,TODAY
141,1956,2012,469,498,5615,6704,BACKGROUND,CTD,ENRICHMENT,EXTENSIVE,GENERATION,GWAS,HOMER,HOWEVER,INTEGRATED,IPAD,JAN,KEGG,KNOWLEDGE,LABEL,NCI,NEXT,NGS,PATHGUIDE,PATHWAY,RESULTS,SEQUENCING,STUDIES,SYSTEMATIC,THERE,WIDE
169,2012,8226,ADT,AUTHORS,BECAUSE,BJU,LHRH,SINCE,TREATMENT
169,2012,8226,BJU,CRPC,CYTOTOXIC,MOST
169,2006,2008,2012,8226,BJU,CTC,DRUG,FOOD,GUIDELINES,HOWEVER,OTHER,PSA,SEVERAL,THESE,UROLOGY,USA
162,169,1987,1988,1989,1993,2001,2004,2008,2012,388,693,8226,BJU,COLORECTAL,ERSPC,LUNG,OVARIAN,PSA,RANDOMIZED,SCREENING,TYROL,USA
169,2010,2012,223,COPYRIGHT,DRUG,FDA,FOOD,HOWEVER,INC,MDV3100,SINCE,THERE,THESE,UNTIL
CALABAR,EOSIN,GLEASON,HISTOLOGY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THERE,UNIVERSITY
AA861,AKT,COX,DHA,DU145,FATTY,KNOCKDOWN,LNCAP,LOX,PAN,PC3,PDK,SDC,T308,THESE
0005,536,6692,AFRICAN,AFTER,AMERICANS,CARCINOGEN,INCREASED,PAH,WHITE
946,AKT,DU145,HOWEVER,HUS1,LNCAP,MRAD9,PC3,RAD1,RAD9
169,176,196,2000,2009,2012,238,713,CASES,COPYRIGHT,HOWEVER,ORS,UICC,VKA,VKAS
169,2012,347,367,CHINESE,CRICK,HAN,HOWEVER,HRM,INC,INTEGRINS,ITGAV,SNP,THESE,THUS,UTR,WILEY
121,215,463,5953,BPC3,GWAS,PRACTICAL,PRCA,SNPS
119,125,132,147,169,2012,344,BEST,CA125,COLORECTAL,COPYRIGHT,CURRENTLY,FORTY,HOWEVER,LUNG,OVARIAN,PLCO,ROCA,RRS,SCREENING,STAGE,TRIAL,TVU,UICC,UKCTOCS,UPDATED
001,169,2001,2002,2007,2008,2009,2012,8805,960,ADT,AFRICAN,AMERICANS,AMONG,BACKGROUND,BONE,COPYRIGHT,DATA,END,FEW,GUIDELINES,LABEL,LESS,MEN,METHODS,RESULTS,SOCIETY
1A1,2012,2455A,3801T,640,645,801,959,ASIAN,CRUDE,HARDY,HOWEVER,HWE,ISI,MARCH,OVERALL,P450,THUS,WEB
104,118,12TH,160,2012,318,425,615,751,ACCORDING,ASIAN,CAUCASIAN,CIS,ETHNICITY,FURTHER,HOWEVER,JANUARY,ORS,SUMMARY
150,308,481,945,BPH,PCA,PCR,RISK,TNF
BPH,MOST
2001,2010,BACKGROUND,EARLIER,LABEL,METHODS,RESULTS
231,945,DISCOVERY,MCF7,MDA,SDF1,THESE,USING
000,100,102,108,24H,268,275,8805,AUC,CONCLUSION,HBR,LABEL,MEN,METHODS,OBJECTIVE,PURPOSE,RESULTS
112,137,194,215,382,443,CONSORTIUM,G84E,ICPCG,SNPS,THESE,WHILE
160,282,ASAP,CONCLUSION,GLEASON,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PIN,RESULTS,UROLOGISTS
ADT,E26,ETS,GLEASON,PCA,PSA,THERE,THESE
000,109,2008,2011,2012,215,400,533,569,580,761,APRIL,BACKGROUND,CENTRAL,CFU,COMMITTEE,DATA,DSMC,GLEASON,GROUP,HOWEVER,INSTITUTE,IRBS,LABEL,METHODS,MONITORING,NCI,OBJECTIVE,PREVENTION,PURPOSE,RESULTS,RICO,SINCE,SITE,SITES,SOUTHWEST,SWOG,TRANSITION,TRIAL,VITAMIN,WORKBENCH
000,141,160,224,22RV1,23A,296,320,375,376,8209,BAX,LNCAP,MICRORNAS,MT1A,MT2A,PNT1A,USING,UTR,ZIP
005,046,125,AIMS,ANTIGEN,BOTH,CHI,CONCLUSION,CUT,DIGITAL,DRE,LABEL,MCNEMAR,METHODS,OBJECTIVE,OBJECTIVES,PEARSON,PSA,RESULTS,SEXTANT,TEN,THREE,TRU
CRPC,DOCETAXEL,JAPAN,NOW,PSA
024,103,113,169,174,177,182,2013,CLINICALLY,COLLEGE,COPYRIGHT,EDUCATION,FURTHER,GLEASON,INC,IQR,LABEL,MATERIALS,MCNEMAR,MEAN,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,STRATEGIES,UNIVERSITY,UROLOGICAL
077,169,2005,2006,2007,2008,2013,BOWEL,BRISTOL,COPYRIGHT,EDUCATION,FORM,HARD,INC,LABEL,LOWER,MATERIALS,MEN,METHODS,NUTRITION,OBJECTIVE,PUBLISHED,PURPOSE,REPORTING,RESULTS,SCALE,STOOL,THESE,UROLOGICAL
145,169,2012,AUCL,BAK,CLO,COPYRIGHT,DMSO,HSA,III,INC,MCL,PBMC,TPAN,TPAO,WEAK,WHILE
169,2012,50S,947,ALZHEIMER,AMONG,COPYRIGHT,HUNTINGTON,IDO,INC,INF,INHIBITION,PARKINSON,PCR,TREG
0001,134,169,1991,2007,2013,640,883,977,COPYRIGHT,EACH,EDUCATION,END,HOWEVER,ICD,INC,INITIAL,LABEL,LESS,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SEER,UROLOGICAL,USING
001,104,114,150,154,164,169,2013,207,636,COPYRIGHT,EDUCATION,GLEASON,HOWEVER,INC,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
169,2012,8482,BIC,COPYRIGHT,FOXA1,HOWEVER,IRELAND,LTD,MDV,MDV3100,MMTV,ONCE,SYNTHETIC,XENOPUS
169,2013,BACKGROUND,COPYRIGHT,FORM,GLEASON,INC,INITIAL,LABEL,METHODS,MINEOLA,MORBIDITY,PRESALVAGE,PSA,RESULTS,SBRT,SHORT,THERE,UNIVERSITY,YORK
001,010,049,169,2012,313,709,8794,BACKGROUND,COMPOSITE,CONCLUSION,COPYRIGHT,COX,INC,LABEL,METHODS,MFS,RESULTS,SWOG
001,005,029,169,2012,8805,CELLSEARCH,CONCLUSION,COPYRIGHT,COX,CTC,CTCS,GLEASON,INC,KENDALL,LABEL,MATERIALS,METHODS,OBJECTIVE,PCA,PFS,RESULTS,THESE,TNM
001,103,124,125,160,169,180,2001,2013,304,3760,COPYRIGHT,GLEASON,INC,JANUARY,LABEL,MATERIALS,METHODS,MOST,OBJECTIVE,PSA,PUBLISHED,PURPOSE,RESULTS,SOCIETY
169,2012,ANOTHER,COPYRIGHT,PUBLISHED,QUATERNARY,SEGG,THESE
000PY,135,169,1997,2007,2009,2012,COPYRIGHT,DNCS,HODGKIN,IRR,ITALIAN,ITALY,LTD,NHL,PTLD,SEVEN,SIR,SIRS,THREE
2010,AJCC,COMMITTEE,INC,JOINT,METASTASIS,NODES,PUBLISHED,TNM
169,2012,CAP,COLLEGE,COMMISSION,COMMITTEE,CONTROL,COPYRIGHT,DIAGNOSTIC,FOLLOWING,INC,INSTITUTE,JOINT,PATHOLOGY,PROVIDING,STAGE,THESE,TNM,UNION
AREAS,BACKGROUND,BESIDES,CENTROSOME,COVERED,LABEL,METHODS,OPINION,POLO,STRATEGIES
2008,2009,207,213,220,233,7457,7553,8805,BACKGROUND,INCLUSION,JULY,LABEL,MEAN,METHODS,REOC,REOCS,RESULTS
AREAS,BACKGROUND,COVERED,DESPITE,HOWEVER,LABEL,METHODS,OPINION,PAR,THEREFORE
ADDITIONAL,BONE,EVEN,HOWEVER,LYTIC,MMPS,OPG,OSTEOLYSIS,PTHRP,RANKL,SEVERAL
000,001,173,1997,200,2010,500,600,BMI,CONCLUSION,ESTIMATED,GLEASON,HOWEVER,JANUARY,LABEL,LRP,METHODS,OBJECTIVE,OPEN,PSA,RESULTS,RRP,THERE
DICT,NPS
004,1000,15TH,215,AIM,AMIFOSTINE,CONCLUSION,GRADE,HIGH,HYPOARC,LABEL,METHODS,OBJECTIVE,RESULTS
0001,0006,0008,0009,002,003,004,005,007,008,009,105,8804,AGE,AIM,ANOVA,CONCLUSION,FSH,GLEASON,HOWEVER,LABEL,METHODS,MLRA,NONE,OBJECTIVE,PRL,PSA,RECORDS,RESULTS
ADC,AIM,AREAS,CONCLUSION,DWI,FORTY,LABEL,METHODS,OBJECTIVE,PSA,RESULTS
956,ATP,BACKGROUND,CONCLUSION,CSNK2A2,DRAK1,FLT,FOUR,GAK,LABEL,MATERIALS,MEK5,METHODS,RESULTS,SINCE,TILLANDSIA
946,950,BACKGROUND,CONCLUSION,DESPITE,DU145,EMT,ERK1,FAK,LABEL,PC3,PTEN,RESULTS,RNAI,RPTP,SRC,TAKEN,WHILE
169,2012,946,BACKGROUND,CDKNI,COPYRIGHT,DU145,HOWEVER,HPV7,ID1,ID3,ID4,INC,INHIBITOR,KNOCKDOWN,LABEL,METHODS,PC3,RESULTS,TGF,THESE,WILEY
14Q32,169,16Q23,1P36,2012,8201,AFRICAN,AMERICANS,ARRAY,BACKGROUND,CNV,CNVS,COPYRIGHT,DESPITE,IGHG3,INC,LABEL,METHODS,RESULTS,TEN,THESE,THROUGH,WILEY
169,2012,945,946,BACKGROUND,COPYRIGHT,DHT,FBS,HOWEVER,INC,LABEL,LNCAP,METHODS,PCR,RESULTS,THEREFORE,WESTERN,WILEY
947,ALK,EML4,ERG,ETS,ETV6,NOTABLY,NTRK3,PAX8,PPAR,PTC,RECURRENT,RET,TMPRSS2
ANOTHER,MUCIN,PRIMARY,SECONDARY,THESE
FGF,FGFR,FGFR2,FGFRS,GIVEN,LABEL,METHODS,OBJECTIVE,RESULTS
153,169,2012,AKT,BACKGROUND,CDK,CIP1,COPYRIGHT,FOXO1,FURTHER,HIGH,INC,LABEL,LUCIFERASE,METHODS,MTT,PCR,PTEN,RESULTS,TAKEN,UTR,WILEY
112,169,2012,8201,946,BACKGROUND,CCND1,COPYRIGHT,FORTY,FOS,INC,JUN,LABEL,METHODS,PHTPP,RESULTS,SUBSEQUENT,THESE,WILEY
169,2012,272,309,8201,BACKGROUND,CCL1,CCL11,CCL17,CCL2,CCL5,CCL8,COPYRIGHT,CXCL1,CXCL5,CXCL8,ELISA,EOTAXIN,FORCE,INC,LABEL,METHODS,MULTIPLEX,PCA,PREVENTIVE,PSA,RESULTS,SERUM,TASK,WILEY
169,2012,2D3,CHANGES,CONCURRENT,COPYRIGHT,E2F1,ISSUE,LNCAP,LTD,MYC,PPARA,SPECIAL,THESE,VDR,VITAMIN,WARBURG
0001,0067,140,168,169,183,2006,2008,2009,2012,ABL2,BACKGROUND,C1QA,COPYRIGHT,DANA,FUNDING,INSTITUTE,ITGAL,JUNE,KETTERING,LABEL,LTD,MDX,METHODS,PCR,PERIPHERAL,RESULTS,SLOAN,TIMP1,USA,YORK
0001,001,169,183,2012,AFFYMETRIX,BACKGROUND,BEATSON,BIOMARKERS,CHARITY,COPYRIGHT,EXPRESSION,FOUNDATION,FUNDING,GLASGOW,KETTERING,LABEL,LDP4,LPD,LPD1,LPD2,LPD3,LTD,MARSDEN,METHODS,NHS,PAXGENE,PCR,RESULTS,ROYAL,SLOAN,THESE,TRUST,U133PLUS2,USA,WEST,WHOLE,YORK
169,2011,2012,241,ADCP,AEU,BOTANICAL,BPH,CODE,COPYRIGHT,ENGLISH,ESPA,EXCLUSION,HOWEVER,JANUARY,LABEL,LIBRARY,MEDLINE,METHODS,OBJECTIVE,PUBLISHED,SPANISH,SYNTHESIS,SYSTEMATIC,THERE,UNASSIGNED
PROVIDING,TUR
169,2012,436,559,8594,945,AE1,AE3,CD117,CD34,COPYRIGHT,DISCOVERED,DOG,GAT,GIST,GMBH,GTT,IMAGING,KIT,MITOTIC,S100,SINCE
10Q23,169,1Q22,2012,3Q13,5P13,ASIA,CHINESE,GASTRIC,GWAS,JAPAN,JSNP,KOREA,MUC1,MUCIN,PREVIOUSLY,PSCA,SNP,WHILE
224,BACKGROUND,CFS,HIV,HPV,LABEL,LBC,PCR,RESULTS,THERE,USING,XMRV
AMP,AMPK,DIM,HOWEVER,LNCAP,SCID,THERE,THESE
947,AD5,CD40,CTL,DCS,IFN,MHC,PSMA,TAP,THESE
22RV1,916,947,ADE1A1102,ADE1A1104,ADE1A1108,CBP,CR2,DU145,E1A,NEITHER,NHBE,ONCOLYTIC,THESE,THROUGH,TRRAP,WHILE
COUP,ELEMENT,OCT1,SEVERAL,SOX9,STROMAL,TF1
THESE
181,ALSO,ATM,BASED,HAT,HIGH,KAT5,KLKK,TIP60
169,2012,CACO,COMPOUNDS,COPYRIGHT,GMBH,KGAA,MCF,NOSCAPINE,PAPAVER,PC3,VCH,WILEY
2000,2004,540,8201,ASIAN,CHINESE,VIETNAMESE,WOMEN
005,2005,2008,3DRT,CONCLUSION,DISCUSSION,EPIDS,GLEASON,GREATER,LABEL,MATERIALS,METHODS,OBJECTIVE,PSA,RESULTS,RTOG,SHOW,TNM,TREATMENT,URINARY
ASCT,CERTAIN
001,011,DATA,DIFFICULT,FIFTY,GROUP,ITD,LABEL,METHODS,OBJECTIVE,PDA,PURPOSE,RESULTS,RPP,SPAD,SPBD,THESE,WHILE
008,010,048,077,594,661,8805,AGGRESSIVE,CONCLUSION,DATA,FURTHER,GLEASON,LABEL,METHODS,OBJECTIVE,PATHOLOGIC,PCA,PSA,RESULTS
821,CUMULATIVE,EIGHT,FDR,FDRS,LYNCH,MANCHESTER,MLH1,MSH2,PSA,TIME,UPPER,UROLOGICAL
002,007,009,011,019,027,029,033,195,250,3423,ADDITIONAL,DIPLOTYPES,METHYLENE,MTHFR,NAD,NORTH,NQO1,NQO2,NRH,PCA,PCR,QUINONE,RFLP,SIMILARLY,VARIANT
012,035,149,152,CXCR4,HOWEVER,PCR,RFLP,SDF,SDF1,THERE,TURKISH
0001,CIS,COX,HOWEVER,ORS,OVERALL,PCA
10A,231,MCF,MDA
DONOR
174,223,AFTER,ALPHARADIN,BONE,COMMISSION,CONCLUSION,ICRP,LABEL,MBQ,METHODS,OBJECTIVE,PROTECTION,PURPOSE,RESULTS
100,2012,8804,FACTORS,GLEASON,HOWEVER,JUNE,LABEL,METHODS,OBJECTIVE,OVERALL,PATIENT,PSA,PSADT,PURPOSE,RESULTS
160,8201,CONCLUSION,CRT,DOSE,DVHS,EIGHT,IIEF,INDEX,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
10TH,160,162,21ST,AVPOSPR,CBCT,CONCLUSION,CTV,LABEL,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS,TEN,USING
160,2010,2011,8201,ACUTE,CONCLUSION,CTV,CTV1,CTV2,CTV3,EORTC,LABEL,LOW,MAY,METHODS,OBJECTIVE,PTV,PTV1,PTV2,PTV3,PURPOSE,RESULTS,RTOG,SEPTEMBER,SIB,UNIVARIATE
160,8201,ACUTE,BACKGROUND,CONCLUSION,IMRT,LABEL,LATE,LNPPC,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS,RTOG,TREATMENT
128,160,177,180,1980S,8201,AFTER,BACKGROUND,CONCLUSION,DATA,ENDPOINTS,HAMBURG,LABEL,METHODS,RELATIVELY,RESULTS
000,001,2006,2010,8201,8805,AFTER,APRIL,BACKGROUND,GLEASON,LABEL,MAJOR,METHODS,NVB,RALP,RESULTS
AGE,BASED,BOTH,COMPETING,CONSENSUS,ELDERLY,PCA,PSA,THERAPY
PCA,RPX
THEREFORE,WHILE
160,BALANCING,CHOICES,FURTHER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,STRENGTHS
150,177,180,AFTER,ALERTNESS,ASSESSMENT,BACKGROUND,BLOOD,CAO2,CO2,CVO2,EXAM,FORTY,LABEL,METHODS,MINI,MMSE,OAA,OAAS,PROLONGED,RESULTS,STATE
001,044,129,160,166,1995,2003,2004,2009,295,8201,BETWEEN,INCIDENTAL
ALSO,DATA,DISCUSSION,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,WISCONSIN
018,029,169,195,2005,2010,2012,403,BACKGROUND,BASED,BASEL,COPYRIGHT,DIFFERENT,HOWEVER,LABEL,MATERIALS,METHODS,RESULTS,STATINS
GLEASON,PSA,SIX,T3AN1M0
186,2005,2011,298,BLUNT,BMI,EFFECTS,MARCH,MEIER,RRP,SAITAMA
002,0393,2004,2011,HOWEVER,JANUARY,MARCH,MEYER,OVERALL,RALP,RRP,SIMILARLY,T1A
008,177,178,179,215,8315,ADC,DIFFUSION,DWI,GLEASON,MRI
169,2012,AACR,ERG,III,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,TARGETING,TMPRSS2
FRESH,HSP90,INITIALLY
1950,2011,BACKGROUND,BASED,DATA,DUTCH,ENGLISH,FIFTEEN,GPS,ITALIAN,JANUARY,LABEL,MAY,MEDLINE,METHODS,PSA,PSYCHINFO,RESULTS,SPANISH,STUDIES,THREE
945,947,DY131,ERR,ERRS,FEDERATION,GYNECOLOGY,HEC1A,HOWEVER,LABEL,METHODS,OBJECTIVE,OBSTETRICS,RESULTS
954,ATG7,BCL,BECN1,BIRC2,BIRC3,CFLAR,DISC,FLIP,JNK,KNOCKDOWN,MAPK8,RIPK1,THESE,THUS,TNFSF10,TRAF2,TRAIL,XIAP
ERR,HOWEVER,RRR,VARIOUS,VMAT
160,DIR,DVH,HENCE,LARGE,VARIATIONS
152,169,2008,2011,2012,8201,8805,APRIL,HIGH,LABEL,METHODS,OBJECTIVE,OBJECTIVES,POTENTIAL,RESULTS,RETZIUS,SEPTEMBER,UROLOGICAL
945,CD133,CSC,CSCS,EMT,HIF,HOWEVER,HYPOXIA,PDA,SLUG,THESE,WHETHER,WHILE,ZEB1
1H68,BRDU,CD19,CD68,GLV,MHCII,THEREFORE,THESE,THUS
2010,CELL,DIS,NED,ORAI1,SEP,SOCE,STIM1,TRPC1
001,1993,2011,2012,BACKGROUND,CIS,CUMULATIVE,FURTHER,HOWEVER,LABEL,LAIRD,LITERATURE,METHODS,PCA,RESULTS,THERE
AMINO,BAG,BIP,GRP78,INHIBITION,PARP
954,AMONG,DENOSUMAB,DRUG,FOOD,III,PHASE
TRUS
062,163,2008,500,745,CLEARLY,CURRENT,ENGLAND,FOLLOWING,HOWEVER,OTHER,PCA3,PSA,TGB,TGBS,THESE,WALES
001,AIFM2,ARRAY,BACKGROUND,BCL2,CONCLUSION,CRF,EBRT,FIS1,LABEL,MEAN,METHODS,MIPEP,MSTO1,NEFL,OBJECTIVE,PCR,RESULTS,SELF,SLC25A4,THESE
164,BACKGROUND,CD117,CD133,CD146,CD31,CD45,CECS,CEPS,CONCLUSION,LABEL,METHODS,MVD,RESULTS
AIM,AMONG,BACKGROUND,KEGG,KYOTO,LABEL,MATERIALS,METHODS,NOTCH,OBJECTIVE,PCA,PPI,RESULTS,TOTAL
1106,16357,16S,177,2618,339,473,500,8201,945,956,BENZAMIDES,BLAST,DGC1,DH5,FOUR,H460,KOCURIA,NMR,NRRL,PC3
2003,RARC,ROBOT
140,169,2012,299,8226,BJU,ERG,EXPRESSION,HGPIN,HIGH,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PCA,RESULTS,UNLABELLED,WHAT
001,003,169,2012,8226,AGAIN,AUTHORS,BJU,CCCS,CECS,CLINICALLY,CYCLE,DRUG,FIRSTLY,GPX1,LABEL,MDR1,METHODS,MOLECULAR,OBJECTIVE,OBJECTIVES,OVERALL,PCA,PCR,PREDICTION,RESULTS,SOD2,SW480,TEST,UNLABELLED,WHAT
1000,103,125,169,2012,2046,8194,8226,8805,BJU,CLINICIANS,COX,EBRT,GROUP,LABEL,LIFE,METHODS,MOUNT,OBJECTIVE,OBJECTIVES,RADIATION,RESULTS,RTOG,SCORE,SEVERAL,SINAI,THERAPY,UNLABELLED,WHAT,WHILE
CONCLUSION,LABEL,METHODS,OBJECTIVE,PCSS,QOL,RESULTS,SEVENTY,TIP
BASED,CD4,CD8,GIVEN,HOWEVER,THESE,VEGF
000,0003,001,0017,130,200,2012,235,304,628,993,AACR,BACKGROUND,LABEL,METHODS,NAVIGATION,PATIENT,PROGRAM,RESULTS,TIME
665,703,BACKGROUND,CHINESE,CYR61,GLEASON,IGFBP10,LABEL,MEN,METHODS,PCA,PCR,PSA,RESULTS
169,2012,8804,BACKGROUND,BRM,CHEMISTRY,CURRENT,ERG,GLEASON,LABEL,METHODS,MFC,MICROFOCAL,PCR,RESULTS,THREE,TMPRSS2,URINE
169,1980,2012,2645,752,CONCLUSION,COPYRIGHT,JOHN,LABEL,LTD,METHODS,MOST,OBJECTIVE,QOL,QUALITY,QUESTIONS,RESULTS,SONS,THEREFORE,USING,WILEY
2010,2011,4570,BESIDES,CSF,FURTHER,GRADE,MEIER,THREE,UNIVARIATE,UNIVERSITY
1429,2012,378,450,BACKGROUND,COLORECTAL,GWAS,HOWEVER,LABEL,LUNG,METHODS,NFKB1,ODDS,OVARIAN,PLCO,PUBLISHED,PULMONARY,RESULTS,SCREENING,SNP,SNPS,SOCIETY,TRIAL
1358,160,169,2012,BASED,COPYRIGHT,FIFTY,HELICAL,IEC,LTD,MVCT,NONE,PUBLISHED,THESE
169,2012,BOTH,COPYRIGHT,FURTHER,LTD,SAR,SENP1,SENTRIN,SPECS,SUMO
169,2012,8243,946,956,COPYRIGHT,DEWA,LTD,MAHKOSIDE,MAHKOTA
169,2012,947,954,AUTHORS,BACKGROUND,BRITISH,JOURNAL,KEY,LABEL,LNCAP,METHODS,OBJECTIVE,PC3,PPAR,PURPOSE,RESULTS,SOCIETY,THUS
001,169,2012,376,8194,8226,8805,BJU,CONVERSELY,DIAGNOSIS,ERSPC,GLEASON,LABEL,LEVEL,METHODS,OBJECTIVE,PPV,PPVS,PSA,RANDOMIZED,RESULTS,ROTTERDAM,SCREENING,T2B,TYPE,UNLABELLED,WHAT
223,CRPC,DOCETAXEL,WESTERN,WORLD
182,193,1972,2006,455,585,851,AFTER,AUSTRALIA,BACKGROUND,CONCLUSION,ESTIMATED,FIVE,LABEL,METHODS,RESULTS,SOUTH,THESE,USING,WALES
169,2012,AACR,LABEL,UNLABELLED,VISIBLE
160,662,716,945,CHINESE,GLEASON,HAN,HIF,HIF1A,HOWEVER,PCA,SNPS,THESE
541,945,946,954,AMERICA,COX2,CXCL1,EFEMP,IKK,INHIBITION,SPARC,TREATMENT,WESTERN
160,DECREASED,EMERGENCE,LNCAP,PSMA
261,474,CASES,CD4,HOWEVER,THUS
FURTHER,GFP,HENCE,INCREASED,LBD,MG132,NES,PC3,TREATMENT,USING,WESTERN
169,2012,AMONG,COPYRIGHT,EGCG,GTP,INC,PCA,SEVERAL
CAP,FINALLY,PN1,SHH,SONIC,USING,WHILE
005,212,22RV1,AMG,BAY2010112,BITE,CD3,CHINESE,DU145,LNCAP,MDA,NOD,PCA,PSMA,RAPID,SCID,VCAP
169,2006,2008,2010,2013,ACUTE,BACKGROUND,COPYRIGHT,GROUP,HIGH,IMRT,INC,LABEL,MATERIALS,METHODS,NINE,RADIATION,RADIOLOGY,RESULTS,SOCIETY,THERAPY
009,1338,169,2011,2012,AIMS,COPYRIGHT,ESTIMATES,FURTHER,JUNE,LABEL,METHODS,OBJECTIVE,RCT,RCTS,RESULTS,RISK,SAS,TZD,TZDS
169,200C,2012,205,COPYRIGHT,DOCETAXEL,FUNCTIONAL,HOWEVER,INC,LOW,PATHOLOGY,PUBLISHED,SCREENING,SOCIETY,THEREFORE
TESTICULAR
015,021,038,045,100,118,169,2008,2011,2013,8804,AOR,COPYRIGHT,GLEASON,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,TESLA,THREE
009,010,128,154,169,2008,2010,2013,282,367,COPYRIGHT,CROWN,IGRT,INC,LABEL,MARCH,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SEPTEMBER,URINARY
0001,102,169,186,2012,239,400,510,ADT,BACKGROUND,BMD,BONE,BOTH,BSAP,CHANGES,COPYRIGHT,LABEL,METHODS,NTX,OBJECTIVE,OUTCOME,PCA,PUBLISHED,RESULTS,SETTING
000,163,169,2012,3DCRT,AIMS,COLLEGE,CONCLUSION,COPYRIGHT,FOUR,ICER,IMRT,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OTHERWISE,PUBLISHED,RESULTS,ROYAL,SERVICE
006,169,2012,AFP,CEA,COPYRIGHT,HOWEVER,IRELAND,LTD,PSA,THEREFORE
330,BESIDES,HOWEVER,ITERATIVE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESIDUE,RESULTS,SRC,THEN,THEREFORE
DIR,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,RMM
CLINICALLY,DOSE,DOSIMETRIC,GAMMA,IMRT,LABEL,METHODS,MLC,OAR,OBJECTIVE,PTV,PURPOSE,RESULTS,ROTATIONAL,SLIDING,SYSTEMATIC,UNIFORMLY
931,963,FLORIDA,GAS,HERK,INSTITUTE,LABEL,METHODS,NGR,OBJECTIVE,POPULATION,PTV,PURPOSE,RESULTS,SIMILAR,THEIR,THERAPY,UNIVERSITY
001,044,109,169,2012,COMPOSITE,CONTINENCE,FUNCTIONAL,INDEX,LABEL,METHODS,OBJECTIVE,OBJECTIVES,REGARDING,RESULTS,SIMILARLY,UROLOGICAL
037,169,2004,2006,2012,8201,ADHERENCE,LABEL,METHODS,NETWORK,NONE,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,UROLOGICAL,UROLOGY
1992,2004,AGE,AMERICA,AREAS,CENTRAL,CONCLUSION,FURTHER,HISPANICS,INSTITUTE,LABEL,METHODS,NHB,NHW,NON,OBJECTIVE,POISSON,RESULTS,RICO,SEER,SEP,USH
126,DATA,FINALLY
ASC,CD146,CD31,CD34,CD45,CFD,PRESENT,WHILE
169,2012,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,RESULTS,THESE,THUS,VEGF,VEGFR,WILEY
169,2012,264,8201,945,BACKGROUND,CD68,COPYRIGHT,ELISA,FINALLY,IL10,IL12,INC,LABEL,METHODS,MOST,PCR,PEDF,RAW,RESULTS,THESE,TNF,USING,WESTERN,WILEY
169,2012,BACKGROUND,CONCLUSION,COPYRIGHT,DU145,INC,JNK,LABEL,LNCAP,METHODS,PCA,PCR,RESULTS,SP1,THESE,WESTERN,WILEY
145,145R,169,2012,8201,954,BACKGROUND,COPYRIGHT,CRPC,DESPITE,ELISA,EMSA,HOWEVER,INC,LABEL,METHODS,PCR,RESULTS,THESE,WILEY
169,2012,ANCCA,ANIMALS,BACKGROUND,CHIP,CHROMATIN,CONCLUSION,COPYRIGHT,CRPC,E2F,EED,EZH2,H3K4ME3,HOWEVER,IHC,INC,LABEL,LNCAP,METHODS,MLL1,PCR,PRC2,REGULATION,RESULTS,SUZ12,THEIR,UGS,WESTERN,WHILE,WILEY
000,046,150,160,169,2012,215,8201,AMONG,BACKGROUND,BODY,COPYRIGHT,IGF,IGFBP,INC,LABEL,LAPC,METHODS,NCKD,PCA,RESULTS,SCID,SERUM,WILEY
125,169,177,2012,3327,AIM,COPENHAGEN,COPYRIGHT,DESPITE,DOTA,DUNNING,GRP,HENCE,LABEL,LTD,METHODS,OBJECTIVE,PET,RESULTS,TYR
131,AD5PB_RSV,NIS
0008,0124,145,177,270,AKT,BACKGROUND,BMEC,CAP,CONCLUSION,EPHA2,FAK,GFP,HIGH,LABEL,LNCAP,METHODS,PC3,PUFA,RESULTS,SRC,WESTERN
2329,410,800,8226,8805,AUC,AUSTRALIA,BACKGROUND,CAMBRIDGE,CARE,CONCLUSION,GLEASON,KINGDOM,LABEL,METHODS,PRIAS,PSA,RESULTS,TORONTO
169,174,175,2005,2011,2013,226,301,948,COPYRIGHT,EDUCATION,G84E,INC,JUNE,LABEL,MASSARRAY,MATERIALS,METHODS,NONE,OBJECTIVE,OCTOBER,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
169,2012,549,7402,8320,8325,956,BEL,COPYRIGHT,HCT,HPLC,LTD,NMR,PDA,THEIR,TLC,VALERIANA
109,11C,169,18F,2000,2012,441,773,9446,999,BACKGROUND,CHOLINE,CONTEXT,COPYRIGHT,ENGLISH,JANUARY,KNOWLEDGE,LABEL,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,PCA,PET,PUBLISHED,RESULTS,REVIEWS,SCHOLAR,STUDIES,SYNTHESIS,UROLOGY,WEB
134,8805,LABEL,MATERIALS,METHODS,NNS,OBJECTIVE,OBJECTIVES,PSA,RESULTS,SEVENTY,SIMILARLY,SIXTY
169,2012,8226,AUTHORS,BJU,BRCA2,CONSORTIUM,CUNINGHAM,HGPIN,HIGH,LABEL,LOH,LOSS,METHODS,OBJECTIVE,OBJECTIVES,PCR,RESULTS,TEN,TRUS,UNLABELLED,WHAT
RADICAL
2009,2010,8500,EUB,HITACHI,LABEL,METHODS,OBJECTIVE,PCA3,REAL,RESULTS,RTE,SEPTEMBER,THREE
101,1281,169,180,1875,2010,2011,2012,210,8226,BJU,CLAIM,CLIN,GOVERNMENT,JANUARY,LABEL,METHODS,MRI,OBJECTIVE,PINTO,PSA,RES,RESULTS,SCIARRA,TRUS,UNLABELLED,UROL,WHAT,WORKS
1062,169,2002,2004,2012,3305,8226,AUR,BJU,BPH,CIS,CONCLUSION,INSURANCE,LABEL,LEVEL,METHODS,OBJECTIVE,ORS,PROGNOSIS,RESULTS,STUDENT,THERE,TURP,TYPE,UNIVARIATE,UNLABELLED,UTI,UTIS,WHAT
BESIDES,DGFIT,THERAPY
150,1867,1904,1924,1945,1952,1991,2011,BALTIMORE,DAVINCI,FINALLY,FRIEDRICH,GERMANY,HALLE,HALSTED,HAMPTON,HOPKINS,HUGH,JOHNS,ORIGINALLY,PROF,STEWART,TERENCE,THEODOR,THIERMANN,USA,WILLIAM,YOUNG
137,1979,1985,512,EQUIVOCAL,HODGKIN,NIGHT,RESULTS,THERE
176,2012,751,759,EPIDEMIOL,JOURNAL,STUDIES,THESE
945,954,CANCERS,HIF,MYC,NOTABLY,PTEN,RAS
BACKGROUND,BASE,CHIP,DNASE,EPIGENETIC,LABEL,RESULTS,SP1,THESE
946,AKT,DU145,HOWEVER,LNCAP,MMPS,MYC,REGULATION,TREATMENT
946,III,OXIDATIVE,TAKEN
AUTOCRINE,BACKGROUND,BAP,CONCLUSION,CONVERSELY,LABEL,METHODS,PSA,RESULTS,THESE
DEGARELIX,GNRH,LUTS,THERE,THESE
160,177,5500,8764,AVERAGE,DYNALOG,IMRT,LEAF,MACHINE,MCS,MLC,PLANNED,PPN,RMS,SITE
001,1993,2010,4157,604,8804,AFRICAN,BACKGROUND,DESPITE,FURTHER,GLEASON,LABEL,METHODS,OVERALL,PCA,PSA,RESULTS,THESE
132,1970,2011,331,BACKGROUND,FORTY,HOWEVER,LABEL,METHODS,RESULTS,TYPE

INITIAL,METASTATIC
000,100,1970,1985,1990,1995,2000,2006,2008,400,500,680,8201,AGE,APC,APCS,BACKGROUND,CONVERSELY,EARLY,HOWEVER,INSTITUTE,ITALIAN,LABEL,METHODS,MORTALITY,OVERALL,RESULTS,STATISTICS,THESE,THROUGHOUT
1196,1707,498,696,AMONG,BACKGROUND,CHECKLIST,LABEL,METHODS,PROBLEM,RESOURCES,RESULTS,YOUNG,YOUNGER
BOWEN,EMPD,EXTRA,PAGET,REASONS
169,2012,401,515,882,916,ALLELIC,ALSO,AML,APMIS,ARG,AUTHORS,SOMATIC,SSCP
169,2008,2009,2012,320,458,474,ADD,AUTHORS,BJU,DOES,GLASGOW,GPS,GREATER,KNOWN,LABEL,MEN,METHODS,OBJECTIVE,OBJECTIVES,OLDER,PSA,RESULTS,SUBJECT,UNLABELLED,WHAT
169,177,2009,2012,300,8226,APRIL,ARB,ARBS,AUTHORS,BJU,CONCLUSION,FURTHER,IIEF,INDEX,LABEL,LEVEL,METHODS,OBJECTIVE,PDE5,POTENCY,REGULAR,RESULTS,RRP,SPL,STRETCHED,THERAPY,THERE,TYPE,UNLABELLED,WHAT,WHILE
100,156T,174,AIM,CELLS,CHEMPRO,CONCLUSION,LABEL,LNCAP,MALIGNANT,MATERIALS,METHODS,OBJECTIVE,PROSTATIC,RESULTS
HOWEVER,MDV3100,MEN
169,2012,8804,APMIS,AUTHORS,GLEASON,HISTOLOGY,HOWEVER,INCLUSION,PCA,PSA,THERE,THREE
2012,HOWEVER,JANUARY,UROLOGY
AGR2,APTAMER,BACKGROUND,C14B,C14B1,CONCLUSION,HOWEVER,LABEL,PRINCIPAL,RESULTS,SELEX,STRUCTURAL,THEREFORE,THROUGH
ATO,BLI,DOPPLER,DYNAMIC,FLI,MCF7,PC3,POWER,SIMILAR,SMALL,U87
370,CDK,CIP1,DU145,ECTOPIC,FOXO,FOXO1,KIP1,LNCAP,MICRORNAS,PREC,RNAS,TAKEN,THEREFORE
AMONG,BACKGROUND,CD8,EFFORTS,HLA,LABEL,LNCAP,PBMCS,PRINCIPAL,PSGR,PSGR3,PSGR4,RESULTS,THESE
946,CD24,DIAGNOSTIC,GLEASON,PATHOLOGY,PSA,SIGNALS,URINE,USING
001,100,181,8805,947,DHA,DU145,LNCAP,LOX,PC3,PPAR,THESE
2012,377,385,780,814,929,BACKGROUND,CIS,CONCLUSION,GIVEN,HOWEVER,LABEL,LIBRARY,MEDLINE,METHODS,RCTS,RESULTS,REVIEWS,SCI,SEVENTEEN,SIMILARLY
256,324,CHI,CLASSIFIER,CLUSTER,DATA,GLEASON,MICROARRAY,SAM,SETS,THESE
2006,2009,CFS,CWR22,DESPITE,FISH,HOWEVER,MLV,NOTABLY,PCR,THESE,VP62,XMRV
AUC,AUCS,FLIP,GIVEN,GLEASON,HOWEVER,PREDICTION,PSA,SP1,SP3,THUS
2555,3165,3182,3539,8202,AFRICAN,ASIAN,ASN,ASN312ASP,ASP,BACKGROUND,CIS,CONCLUSION,FURTHER,GLN751LYS,LABEL,MEANWHILE,PCA,PRINCIPAL,RESULTS,SNP,SNPS,STATA10,XPD
AMAZONIAN,DRS,PC3,THESE
22RV1,946,GLEASON,MYC,PC3,RANK,RUNX2,SKP2,SLUG,THUS,USING
AU565,BALB,BN999,FINALLY
0267,2000,BPH,E26,EMT,ERG,ERG3,EXPRESSION,FUNCTIONAL,ILK,LEF,MICROARRAY,PCA,PNT1B,PREC,PRECS,QLT,RWPE,SNAIL,THESE,TMPRSS2,ZEB1,ZEB2
945,954,ACTIVATED,AKT,AKT2,CRPC,CXCL1,DU145,GRO,HDAC1,HOWEVER,IKK,INDUCTION
169,2013,COPYRIGHT,INC,OVERALL,THUS,WILEY
CD133,CD44,CDC2,CHK1,HOWEVER,USING
AKT,AKT1,DISRUPTION,EXPRESSION,FAK,FYN,HOWEVER,KNOCKDOWN,MEFS,PALM,PC3,PROTEIN,PTEN,PTK6,SRC,SW620,SYF,YES
945,BOTH,CRPC,CYP17A1,HOWEVER,III
1367,ACCORDING,ATROPHY,CPSI,NIH,NON,PIA,PIN,THESE
169,2012,AMONG,COPYRIGHT,CPG,ICELAND,JAK,LTD,MAPK,SEVERAL,STAT,STAT3,TFBS
169,2012,ACTIVATED,COPYRIGHT,LTD,PLATELETS,PMP
169,2013,COPYRIGHT,FIVE,GIVEN,GLEASON,INC,PROSTATIC,ROSETTE,SMALL,TTF
0001,012,017,028,034,106,169,2013,562,COPYRIGHT,COX,GLEASON,INC,MOST,PCA,PCAS,THERE
231,555,E3S,FINALLY,KNOCKDOWN,MDA,PC3,SCID,THESE,USING
169,2012,COPYRIGHT,DU145,HORMONE,INC,MET,SU11274
086,177,BACKGROUND,CONCLUSION,IDEALLY,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PSA,PUBLISHED,RESULTS
LNCAP,PSMA,THESE
DU145,LYSOSOMAL,MALIGNANT,POOR
1981,2010,509,571,707,BACKGROUND,CIS,COX,HRS,LABEL,METHODS,RESIDENTS,RESULTS,THERE,THROUGH
CHIP,CSLC,EMT,MET,NANOG,PCA,SAHA,SLUG,SOX2,THEREFORE,TSA,ZEB1,ZEB2
946,ACTIVIN,ALSO,CRPC,INHBA,INHBB,INHIBITION,LNCAP,LOCAL,VCAP
004,169,2012,700,ALCOHOL,BMI,CIS,COPYRIGHT,GLEASON,PROTECT,PSA,RGM,RGMS,RRR,RRRS,UICC
116,169,2012,ALTOGETHER,COPYRIGHT,HCT,HDAC,HDACI,HDACS,INHIBITION,MCF,UICC
AZA,CDR,CPG,DU145,DZNEP,HDAC,LNCAP,PC3,SIMILARLY,TIMP3,TREATMENT,TSA,USING
ADDITIONAL,CRPC,DESPITE,HOWEVER,MDV3100,PREVIOUSLY,THESE,USING
AR3,CONVERSELY,CRPC,DESPITE,RHO,THESE,VAV3
1000,CRPC,PSA,TTPP
19Q13,215,484,934,9Q31,AFRICAN,AMERICANS,CHINESE,GWAS,HAN,THESE
133,22RV1,252,AIM,CELL,CONCLUSION,EIGHT,KLF8,LABEL,LNCAP,LUCIFERASE,METHODS,MTT,OBJECTIVE,PCA,RESULTS,THESE,WESTERN,YEAST
114
ADDITIONAL,ADT,HEALTHCARE
001,463,945,ALPHA,CONCLUSION,D14,D21,D42,D72,EBRT,ELISA,FATIGUE,INC,LABEL,METHODS,MICROARRAY,OBJECTIVE,PARKINSON,PUBLISHED,PURPOSE,RESULTS,SIXTEEN,SNCA
BECAUSE,DIFFUSION,MRI
145,169,2012,3387,946,ABSIDIA,AMONG,COPYRIGHT,THESE
169,200B,2012,34A,504,945,AKT,AURKB,CCNB1,COPYRIGHT,DLBCL,EMT,FOX,FOXA1,FOXE1,FOXF1,FOXM1,FOXN5,FOXO,FOXP1,FOXR1,GLI,HIF1,IRELAND,LTD,MALT,MLL,MYC,PAFAH1B,SKP2,SNP,TEAD,TTF2,UTR,WHOLE,YAP,ZEB1,ZEB2
169,2012,956,ADP,COPYRIGHT,INC,ONCOSOMES,PATHOLOGY,PUBLISHED,SIMILAR,SOCIETY,STRUCTURES,THESE
001,169,2013,233,AFTER,COPYRIGHT,DATA,EDUCATION,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,RESULTS,THEREFORE,UROLOGICAL
026,169,2008,2011,2013,381,645,ACUTE,COPYRIGHT,EDUCATION,INC,JUNE,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THERE,UROLOGICAL
169,2013,751,COPYRIGHT,EDUCATION,FEW,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,REDUCTION,RESULTS,SECONDARY,UROLOGICAL
065,169,2002,2010,2012,BACKGROUND,CAUSE,COPYRIGHT,COX,DVT,LABEL,MAIN,METHODS,OBJECTIVE,OTHER,OUTCOME,PATIENT,PCA,PLND,PUBLISHED,RESULTS,SETTING,SURGERIES,TED,THUS,TURP,UROLOGY,USING
169,2012,ADDITIONAL,BACKGROUND,BECAUSE,CONTEXT,COPYRIGHT,CURRENT,DRE,ENGLISH,HOWEVER,INDICATION,LABEL,MEDLINE,METHODS,OBJECTIVE,OPTIMISED,PCA,PSA,PUBLISHED,RESULTS,SEVERAL,SYNTHESIS,THESE,TRUS,UROLOGY
102,103,128,132,169,2013,215,940,AFFYMETRIX,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,NOTABLY,OBJECTIVE,PURPOSE,RESULTS,SNP,SNPS,SOMMERS,THERE,THESE
169,2012,COPYRIGHT,GLEASON,INC,PSA,USA
169,2012,COPYRIGHT,DESPITE,INC,WHILE
169,176,2013,CALYPSO,CONCLUSION,COPYRIGHT,CTV,DMIN,IMRT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,RIGID,ROTATIONAL,TREATMENT,TREATMENTS,USING
169,2013,269,397,431,448,477,531,537,COPYRIGHT,INC,LABEL,LRT,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,RISK
017,056,169,2013,223,258,476,877,AES,AFTER,BACKGROUND,CONCLUSION,COPYRIGHT,COX,CRPC,ENDPOINTS,INC,LABEL,METHODS,RESULTS,THERE
2007,2009,448,8201,BACKGROUND,ENGLISH,LABEL,LPC,MEN,METHODS,P3P,PATIENT,PROFILE,RESULTS,SPANISH,THERE,TRIAL,USING
001,169,2005,2008,2013,2756,357,694,8805,AFTER,BMI,CAP,COPYRIGHT,GLEASON,INC,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,RARP,RESULTS
010,127,169,177,2012,8226,945,AUC,AUTHORS,BJU,EVEN,FURTHER,LABEL,METHODS,OBJECTIVE,PCA3,PROTEOMICS,PSA,RESULTS,SINCE,THUS,UNLABELLED,URINE,USING,WESTERN,WHAT,ZAG,ZINC
169,2012,HOWEVER,UROLOGICAL
HOWEVER,MDV3100
HOWEVER,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RADIATION,RESULTS
ACCOUNT,FIRST,HOWEVER,MOLECULAR,THROUGH
ANTIGEN,DIGITAL,DRE,FIRST,PSA,SCREENING
100,1040,1988,2005,2009,2180,844,CALIFORNIA,CCB,CCR,DAVIS,LABEL,METHODS,OBJECTIVE,OVERALL,POPULATION,PURPOSE,RESULTS,UCD,UNIVERSITY
CAND1,CUL1,PLK4,POLO,SCF,SKP1,THESE
947,HLA,IFN,PERIPHERAL,TARP,TCR,THESE
CRPC,FOXA1,THESE,TREATMENT,UPON
160,194,1978,2001,AUSTRALIA,AUSTRALIAN,BACKGROUND,BUSSELTON,CANCERS,CONCLUSION,COX,LABEL,METHODS,RESULTS,THERE,USA,WESTERN,WORLD
169,2012,526,ANHEDONIA,BECAUSE,CONCLUSION,COPYRIGHT,DEPRESSION,DEPRESSIVE,DSM,EPISODE,JOHN,LABEL,LTD,MAJOR,MEAN,METHODS,OBJECTIVE,PCA,RESULTS,SCALE,SDS,SELF,SONS,THESE,WILEY,ZUNG
0001,0003,007,215,8805,AE1,AE3,BRE,GLEASON,HIGH,INTER,TNM,USING,WHOLE
001,007,134,139,142,724,DATA,ERG,ETS,GLEASON,HOWEVER,PROSTATIC,PTEN,THREE,TMA,TMAS,TMPRSS2
169,2012,CML,COPYRIGHT,INC,MOLECULAR,WILEY
ENGLISH,FATIGUE,LIFE,MEDLINE,PORTUGUESE,SEX,SPANISH,URINARY
169,2012,388,AUC,COPYRIGHT,EDUCATION,GLEASON,INC,INTER,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,T2A,THREE,UROLOGICAL
057,169,2000,2007,2013,348,BLACK,COPYRIGHT,EDUCATION,END,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OLDER,PUBLISHED,PURPOSE,RESULTS,SEER,SOUTH,URINARY,UROLOGICAL,USING
169,174,2013,BIOMARKER,COPYRIGHT,DETECTING,EDUCATION,ERG,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PCA3,PUBLISHED,PURPOSE,RESULTS,SCIENCE,TMPRSS2,URINE,UROLOGICAL,WEB
035,119,169,2004,2010,2013,ALSO,COPYRIGHT,EDUCATION,FEW,INC,INDEX,LABEL,MATERIALS,MEAN,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THERE,UROLOGICAL
001,016,027,169,2013,208,237,713,COPYRIGHT,EDUCATION,INC,LABEL,LIFE,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,QUALITY,RESULTS,UROLOGICAL
1064,169,2005,2007,2012,8226,ABOUT,ADT,AUSTRALIA,AUTHORS,BJU,DATA,GLEASON,LABEL,MEN,METHODS,OBJECTIVE,PSA,QUEENSLAND,RESULTS,SHARP,THESE,TREATMENT,UNLABELLED,USA,WHAT
002,169,2012,AUTHORS,BASED,BJU,COCHRAN,CONCLUSION,FIVE,HOWEVER,HRS,LABEL,MEDLINE,METHODS,OBJECTIVE,RESULTS,THERE,UNLABELLED,WHAT
169,2012,8194,8195,8226,ADT,BJU,CONCLUSION,DLT,GLEASON,GRADE,HIGH,HOWEVER,IMRT,LABEL,LEVEL,METHODS,OBJECTIVE,PHASE,PRIOR,PSA,RESULTS,SUCCESSIVE,THERAPY,TYPE,UNLABELLED,WHAT
THEIR,THERE
000,1400,2009,2012,300,340,390,ABOUT,BETWEEN,ERSPC,FIVE,GOTHENBURG,HOWEVER,PLCO,PRESCRIRE,PSA,THESE
FURTHER,HOWEVER,STUDIES,WORLDWIDE,ZINC
GRAM,ST131
111,8233,BACKGROUND,FURTHER,GLU298ASP,LABEL,METHODS,PSA,RESULTS,THESE
169,2012,AACR,CONCLUSION,DOWNSTREAM,DU145,HOWEVER,HVJ,JAPAN,KNOCKDOWN,LABEL,MAVS,METHODS,NOD,NOXA,OBJECTIVE,PC3,PNT2,PURPOSE,RESULTS,RIG,SCID,TNF,TRAIL
169,2012,836,AACR,CD45,CTC,CTCS,EPCAM,INFLUENCE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,USING
LABEL,MEETING,METHODS,NINE,OBJECTIVE,RESULTS
11C,18F,FACBC,FDG,FDHT,FLT,FMAU,INITIAL,PET,PSA
11C,18F,239,HOWEVER,OTHER,PCA,PET,PSA,SERUM,STUDIES
11C,18F,HGPIN,HOWEVER,MOLECULAR,MRI,PET,THEREFORE,TRUS
2012,INTENSE,JANUARY,LIBRARY,MEDLINE,MPMRI,MRI,PCA,PUBLISHED
DUE,EVERY,HOWEVER,PCA
124,BACKGROUND,DELAYED,DISCUSSION,HOWEVER,IMMEDIATE,LABEL,METHODS,THERE,TRIAL
AUSTRALIAN,BACKGROUND,COUNCIL,DISCUSSION,DVD,INTENTION,LABEL,METHODS,MINIMAL,SELF,SOUTH,THOSE,TRIAL,WALES,ZEALAND
ARBS,AT1,CRPC,PSA,RAS,THESE
001,047,061,1998,2007,306,572,BACKGROUND,CALIFORNIA,ESTIMATES,LABEL,MEN,METHODS,PERMANENTE,PSA,RESULTS
MECHANISM,PCA,TAKEN,TARGETING
169,2012,ALSO,COPYRIGHT,DUB,DUBS,EPITOPE,GMBH,KGAA,VCH,WILEY
ANNEXIN,ANXA3
226,239,BOTH,HIGH,IGFBP,INSULIN,LOW,PCA,PSA,THERE,TNM
060,1996,2004,528,532,BACKGROUND,CONCLUSION,LABEL,METHODS,MONTEVIDEO,ORS,RESULTS,URUGUAY
160,AMONG,CARE,MVAC,SUPPORTIVE,TIP
001,138,ANY,CONCLUSION,DCE,DWI,FORTY,LABEL,MATERIALS,MEAN,METHODS,MRI,MRSI,OBJECTIVE,OBJECTIVES,RESULTS,ROC,T2W,T2WI
456,5237,COX,DATA,FURTHER,HOWEVER,PRIME
100,169,2013,ADT,ADVERSE,BACKGROUND,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,PCA,RESULTS,SBRT,SECONDARY,TEN
169,174,2013,COPYRIGHT,EDUCATION,INC,KNOWLEDGE,LABEL,LIBRARY,MATERIALS,MEDLINE,METHODS,MOST,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,RIGHT,STATA,UROLOGICAL,WEB,WHILE
169,1998,2011,2013,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SUCCESS,UROLOGICAL
BESIDES,BMC,HOWEVER,RIBEIRO,THEIR
BACKGROUND,BOTH,CFH,CONVERSELY,FADS1,FREQUENTLY,INGENUITY,IPA,LABEL,LEP,METHODS,MIRLET7A2,OBESITY,PATHWAY,PCR,RESULTS
2006,2010,245,546,AFFAIRS,BACKGROUND,CHICAGO,DATES,DISCUSSION,GIVEN,INSTITUTE,LABEL,MEN,METHODS,NAVIGATION,PATIENT,PNRP,PRIMARY,PROGRAM,SECONDARY,WHILE
0188,169,2012,3261,APMIS,AUTHORS,CD20,CD3,ERG,PSA
1120,ACCORDING,BIBF,FGF,FGFR,INHIBITION,NINTEDANIB,PDGF,PDGFR,THERE,VEGF,VEGFR
001,180,2001,2011,252,5XS,7XS,AFTER,AUTOMATIC,BETWEEN,CTV,CTVS,DEVIATIONS,HERK,JANUARY,LAT,MARCH,OVERALL,PROS,PTV,PTVS,PVS,SYSTEMATIC,THESE,VERT
470,769,8804,963,CAPSURE,GLEASON,HOPKINS,JOHNS,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,T2A
ADT,PRIMARY,THERE
LIFESTYLE,OTHER
100,215,7P13,AVERAGE,CYTOTOXIC,DISCOVERY,DU145,FALSE,LNCAP,MOLECULAR,PC3,RAPAMYCIN,RATE,RPM,URGCP,XTT
100,169,181,2012,253J,5637,945,ACHN,BASEL,COPYRIGHT,DU145,LNCAP,NAFTOPIDIL,T24,THUS
GLEASON,MICRORNAS,MIRNA,STUDIES
145,AMONG,MICRORNAS,RETROVIRAL,RNAS
174,CPG,DACOGEN,DNMT1,DNMTI,GSTP1,HOWEVER,NSCLC,PCR,RASSF1A
174,348,8764,COLORECTAL,INVERSE,LUNG,OVARIAN,SCREENING,THESE,TRIAL
117,122,169,2012,ADDITIONAL,AFTER,AIM,APC,AUTHORS,BRITAIN,CHRONIC,CHUTKAN,COLORECTAL,CONCLUSION,DISEASE,GREAT,IRELAND,LABEL,METHODS,OBJECTIVE,RESULTS
0005,012,017,024,027,032,038,342,8201,BACKGROUND,CRPC,DFS,GLEASON,GOLGI,HDPC,LABEL,METHODS,PSA,RESULTS,UNASSIGNED,VIRTUAL
169,2000,2011,2012,BACKGROUND,BCR,EACH,JOHN,LABEL,MATERIALS,MEDLINE,METHODS,RESULTS,SONS,THEREFORE,USING,WILEY
400,956,AREAS,ATP,BACKGROUND,COVERED,HOWEVER,LABEL,LYS67,METHODS,OPINION,PDB,PHE49,PIM1
132,169,2007,2009,2012,8201,BLADDER,JANUARY,LABEL,MEAN,METHODS,NONE,OBJECTIVE,OBJECTIVES,RESULTS,UROLOGICAL
2000,2010,223,8764,CLEARLY,CRPC,III,SINCE,TAKEN,UNTIL
ADT,BECAUSE,CRPC,PSA,SEVERAL
946,AKT,DISTURBED,EMPLOYING,GSK3,MELATONIN,THUS
169,2012,ADC,CHO,CIT,CONCLUSION,COPYRIGHT,DWI,FIFTY,FLDA,HOWEVER,INC,LABEL,MATERIALS,MEAN,METHODS,MMR,MRS,OBJECTIVE,PCA,PURPOSE,RESULTS,ROC,THERE,TRUS,WEIGHTS,WILEY
0001,006,LABEL,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS,THERE
169,1989,2004,2008,2013,387,961,COPYRIGHT,JANUARY,NET,PERME,POHAR,UICC
947,DOSE,EPID,PATIENT
003,169,2012,370,493,AACR,BACKGROUND,COLORECTAL,HOWEVER,HPLC,LABEL,LEUKOCYTE,LUNG,METHODS,ORS,OVARIAN,PLCO,REDUCED,RESULTS,SCREENING,SYSTEMATIC,TRIAL
0001,100,177,500,8804,AMONG,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PAC,RESULTS,WHEREAS
023,049,169,2013,234,ADVANTAGES,AFTER,CLAVIEN,COPYRIGHT,DATA,EACH,EDUCATION,GLEASON,III,INC,LABEL,MATERIALS,METHODS,MOST,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SALVAGE,THERE,UNIVERSITY,UROLOGICAL,VANDERBILT
124R,169,2012,5RS,9S1R,ATP,COPYRIGHT,INC,NCBI,NULLOMERS,NULLOPS,ROS,RRRRRNWMWC,RRRRRWCMNW,RRRRRWFMHW,THESE
169,177,2013,ADT,AFTER,BACKGROUND,BMD,BMI,BODY,CONCLUSION,COPYRIGHT,FOUR,INC,LABEL,METHODS,OVERALL,PCA,RESULTS,SFG,THESE,WHR
014,046,048,052,101,169,2012,221,8804,8805,BACKGROUND,COPYRIGHT,COX,DOCETAXEL,INC,LABEL,MEIER,MEN,METHODS,RESULTS
343,350,3815,4250,693,BACKGROUND,COLORECTAL,CONCLUSION,END,GLEASON,LABEL,LTD,LUNG,MEDICAL,MEIER,MEN,METHODS,OVARIAN,PLCO,PUBLISHED,RESULTS,SEER,THERE
0001,0297,122,169,2012,223,8805,AES,BACKGROUND,COPYRIGHT,CRPC,JONCKHEERE,LABEL,METHODS,OBJECTIVE,OUTCOME,POTENTIAL,PSA,PUBLISHED,RESULTS,SETTING,TRIAL,UROLOGY
169,2013,498,APC,BELGIUM,CONCERN,COPYRIGHT,EDUCATION,GSTP1,INC,KINGDOM,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
169,2012,AUTHORS,CONCURRENT,COPYRIGHT,INC,PUBLISHED,TET1,TIMP,TIMP2,TIMP3,WHETHER
001,100,10A,169,2012,205,COPYRIGHT,EDUCATION,ENDOGENOUS,FOUR,INC,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,RNU,THESE,UROLOGICAL
165,169,177,2012,234,956,CELLS,COPYRIGHT,EGF,HGPS,LNCAP,LTD,OVERALL,PCA,VEGF
1085,169,2001,2007,2012,309,558,683,8805,AMONG,CONCLUSION,COPYRIGHT,COX,END,HOWEVER,HSAS,INC,LABEL,METHODS,OBJECTIVE,POISSON,RESULTS,THESE,USING
169,2012,AEU,BACKGROUND,CONTEXT,COPYRIGHT,CRPC,GROUP,GUO,LABEL,METHODS,OBJECTIVE,ONCOLOGIST,ONCOLOY,PUBLISHED,RESULTS,SCIENTIFIC,SOGUG,SPANISH,SYNTHESIS,TUMOURS,URO,UROLOGIST,UROLOGY,WORKING
002,003,012,100,169,177,2012,COPYRIGHT,ECLIPSE,EIGHT,IMPT,IMRT,INC,INJECTING,LABEL,MATERIALS,MEAN,METHODS,OARS,OBJECTIVE,PLANS,PTV,PURPOSE,REGARDLESS,RESULTS,VMAT
000,169,2012,290,515,570,618,BACKGROUND,CONCLUSION,COPYRIGHT,GIVEN,INC,ISPOR,LABEL,METHODS,PUBLISHED,RESULTS,SOCIETY,STR,STUDIES,USING
169,2012,AMONG,BACKGROUND,CONCLUSION,COPYRIGHT,GLEASON,LABEL,METHODS,PCA,PSA,RESULTS,SAS,THEIR
000,160,169,1997,2006,2007,2011,2012,332,7963,9832,ATIH,BACKGROUND,CONCLUSION,COPYRIGHT,HIFU,LABEL,METHODS,PROSTATIC,RESULTS,SAS,TECHNIQUE,THERE,TURP
001,003,160,169,2005,2009,2012,242,CIS,COPYRIGHT,DIFFERENT,JANUARY,JUNE,LABEL,MATERIALS,METHODS,OBJECTIVE,PSAT,PURPOSE,RESULTS,SAS,STSM,UCB
169,2012,COPYRIGHT,MALIGNANT,POTENTIAL,PROSTATIC,SAS,STROMAL,STUMP,UNCERTAIN
160,169,2005,2012,BACKGROUND,CONCLUSION,COPYRIGHT,FIVE,FURTHER,LABEL,MATERIALS,METHODS,RESULTS,SAS
169,2005,2012,COPYRIGHT,EDUCATION,GIVEN,GLEASON,INC,ISUP,LABEL,MATERIALS,METHODS,OBJECTIVE,PATHOLOGY,PUBLISHED,PURPOSE,RESULTS,RISK,SOCIETY,THESE,UNDER,UROLOGICAL
0005,001,005,169,2012,203,237,264,272,276,311,945,COPYRIGHT,EDUCATION,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,ROC,SELECTIVE,UROLOGICAL
0001,134,169,2012,COPYRIGHT,COX,EDUCATION,GLEASON,INC,LABEL,MATERIALS,MEIER,METHODS,N0M0,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,RESULTS,TEN,UROLOGICAL
001,006,009,023,067,146,169,2005,2011,2012,276,596,791,985,BLADDER,CONTINENCE,COPYRIGHT,COX,DATA,EDUCATION,EPIC,GLEASON,INC,INDEX,LABEL,MATERIALS,MEN,METHODS,OBJECTIVE,OCTOBER,PUBLISHED,PURPOSE,REGARDING,RESULTS,SEPTEMBER,T1C,UROLOGICAL,WHILE
089,169,2012,222,249,300,413,802,889,913,962,COPYRIGHT,EDUCATION,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PCA3,PUBLISHED,PURPOSE,RESULTS,SAMPLES,URINARY,UROLOGICAL
CTV,GTV,HOWEVER
AKT,DIETARY,ITC,ITCS,PI3K,THESE,THROUGH
THUS
ABL1,EPIGENETIC,ERRB2,FOXP3,MMP2,SATB1,SATB1IN,SPECIAL
001,003,005,011,048,1151,169,1993,1999,2012,210,376,420,8226,AFTER,AMONG,AUTHORS,BJU,COX,CSS,ERSPC,GLEASON,HOWEVER,LABEL,LEVEL,MEN,METHODS,MFS,OBJECTIVE,PFS,PSA,RADICAL,RANDOMIZED,RESULTS,ROTTERDAM,SCREENING,THERAPY,TYPE,UNLABELLED,WHAT
169,2012,AUTHORS,BACKGROUND,FOUNDATION,HIGH,JOURNAL,LABEL,METHODS,RESULTS,SOCIETY,STICHTING
100,1000,200,400,ADC,BPH,CONCLUSION,DECAY,DWI,IVIM,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,SDS,THERE,TRACE
001,016,CONCLUSION,FIFTY,GLEASON,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PPV,RESULTS,SIX
070,129,138,2010,215,5892,BASED,CONCLUSION,DWI,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,RESULTS,ROC
CONCLUSION,CURRENTLY,LABEL,MRI,OBJECTIVE,OTHER
2000,AFTER,CONCLUSION,FFP,III,LABEL,LABORATORY,NORMALIZED,OBJECTIVE,PCC,PURPOSE,RATIO,SUMMARY,TREATMENT
169,2012,BACKGROUND,BPH,CAF,CATHD,CATHEPSIN,CD1,COPYRIGHT,INC,KNOCKDOWN,LABEL,METHODS,NPF,RESULTS,STROMAL,WESTERN,WILEY
169,2012,75TH,BACKGROUND,BPH,CD31,CONCLUSION,COPYRIGHT,DCE,INC,LABEL,LARGE,MEAN,METHODS,MRI,NTZ,PZT,RADICAL,RESULTS,SPECIMENS,TZT,WILEY
169,2012,BACKGROUND,CONCLUSION,COPYRIGHT,ERK,GFP,H2B,INC,INTRA,LABEL,METHODS,MICROSCOPY,PLUMBAGIN,PTEN,RESULTS,SYNGENEIC,VIEWING,VITAL,WHEREAS,WILEY
ADT,BACKGROUND,HORMONE,HOWEVER,LABEL,LITERATURE,METHODS,PSA,RESULTS,THEREFORE
169,2012,BACKGROUND,COPYRIGHT,CRPC,DOCETAXEL,DOWN,DU145,HOWEVER,INC,KNOCKDOWN,LABEL,LNCAP,METHODS,PC3,RESULTS,THESE,WESTERN,WILEY
215,UROGENITAL
169,1988,2011,2012,437,561,748,813,8804,AMICO,BACKGROUND,BCR,COPYRIGHT,COX,ECE,EQUAL,GLEASON,INC,LABEL,METHODS,OVERALL,PSA,PSM,RESULTS,WILEY
169,2012,946,BACKGROUND,COPYRIGHT,DU145,INC,INCREASED,LABEL,LNCAP,METHODS,PC3,RESULTS,RNAI,SIMILAR,USING,WHEREAS,WILEY
215,8764,ADC,AFTER,BACKGROUND,DIFFUSION,DISCUSSION,LABEL,METHODS,MRI,PEARSON,RESULTS,TSC
141,169,2012,423,8805,945,946,BAM,BILE,COPYRIGHT,DIAGNOSIS,FIVE,IMRT,INC,INTENSITY,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RADIATION,RESULTS,THREE
0001,1000,1195,147,169,183,2008,2009,2012,235,301,394,398,775,791,797,BACKGROUND,BETWEEN,BRIEF,COPYRIGHT,COU,EASTERN,ECOG,FORM,GROUP,INVENTORY,IQR,JULY,LABEL,LTD,MAY,METHODS,PAIN,PSA,RESULTS,SHORT
169,2000,2010,2012,821,AMONG,BCR,CONCLUSION,COPYRIGHT,COX,GLEASON,INC,LABEL,METHODS,NETWORK,OBJECTIVE,PSA,RESULTS,T3A,USING
100,169,2013,CK14,COPYRIGHT,GATA3,III,INC,PURE,S100P,UROTHELIAL
169,2012,BESIDES,COPYRIGHT,IRELAND,LNCAP,LTD,NAME,NOS,TREATMENT
169,2012,329,8201,8804,ACUTE,AIMS,ASIA,CTCAE,CYBERKNIFE,EIGHT,FURTHER,GRADE,LABEL,LTD,METHODS,OBJECTIVE,PSA,PTY,PUBLISHING,RESULTS,SBRT,THERE,WILEY
CAV
100,CONCLUSION,LABEL,METHODS,MTT,OBJECTIVE,PCR,RESULTS,VEGF,WESTERN
BPH,CONCLUSION,LABEL,LNCAP,MALDI,METHODS,NMPS,OBJECTIVE,RESULTS,THERE,TOF
2008,2011,292,475,665,AUC,BETWEEN,CONCLUSION,JANUARY,LABEL,MARCH,METHODS,OBJECTIVE,PSA,PSAD,RESULTS,THAI,TRUS
ACCORDING,IP6,MOLECULAR,THERE
169,2012,AACR,ADP,FINALLY,LABEL,PARP,THESE,UNLABELLED
946,BACKGROUND,BOTH,CONCLUSION,EVEN,LABEL,MATERIALS,METHODS,MOST,MSMB,RESULTS,THUS
1000,22RV1,ACTIVATION,CHO27,CIP1,PCA
AIM,BACKGROUND,CONCLUSION,ERG,ETS,GDP,LABEL,MATERIALS,METHODS,NEXT,OBJECTIVE,PCR,RESULTS,RHO,RHOGDIB,TMPRSS2,WNT
160,BAX,BCL,EZH2,PCG,THESE,U87,USING
160,ADP,BCL2,BIRC5,DAPK1,F10,LNCAP,PARP
ACTUARIAL,EVALUATION,GROUP,INCLUSION,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,PATTERN,PRIMARY,RADIATION,RESULTS,SBRT,SCALE,SIXTY,SOLID,THERAPY,TREATMENT
0159,0169,018,0197,071,116,393,8320,8325,956,ADR,CNS,HCT,HOP,INSTITUTE,MOST,NCI,RES,RXF,SNB,TGI
GLEASON,HIGH,HOWEVER,LCM,MAPPING,PATTERN,SEQUENCING,WGA
169,1999,1E8,2012,ATP6V0C,BECEF,COPYRIGHT,HOWEVER,INC,LASS2,LOSS,RESULTS,THEIR,THESE,TMSG1,WILEY
137,169,2013,8201,831,8805,902,ADT,ANOVA,AUC,BONE,COPYRIGHT,DUAL,DXA,HIGH,MINERAL,MRI,ROC,SEVEN,SOCIETY,VERTEBRAL,VFA
169,183,AFTER,ANNA,APART,CEUS,GEORG,MRI,STUTTGART,TRUS,YORK
PC3,PC3R,PC3WT,SST,SSTR2,SSTR5
2011,AUTOMATED,COMPOSITE,CONCLUSION,EPIC,FORTY,INC,INDEX,JULY,LABEL,METHODS,OBJECTIVE,PUBLISHED,QOL,RESULTS,TEST
120,169,2010,2011,2012,947,99M,CONCLUSION,COPYRIGHT,EACH,EVERY,FIVE,INC,LABEL,LYMPHATIC,MARCH,METHODS,OBJECTIVE,OCTOBER,RESULTS,USING
ACTIVATION,CONVERSELY,DISEASE,EMT,ERK,HSP90,INITIATION,LAST,PCA
169,2012,946,AKT,COPYRIGHT,INC,JNK,MAPK,PC3,T24,TGF
169,2012,241,AEU,BACKGROUND,BPO,CENTRAL,CONTEXT,CONTROLLED,COPYRIGHT,DEPENDING,EAU,ESPA,GUIDELINES,LABEL,LASER,MEDICAL,MEDLINE,METHODS,OBJECTIVE,PUBLISHED,RESULTS,REVIEWS,STRUCTURED,SUBJECT,SYNTHESIS,SYSTEMATIC,UROLOGY
169,2012,8195,AFFECTION,AIMS,BACKGROUND,CLARK,DATA,DIMINISHED,LABEL,LIFE,MAIN,MARITAL,MASCULINE,METHODS,OBJECTIVE,OUTCOME,PCA,QUALITY,REGARDLESS,RELATED,RESULTS,SELF,SOCIETY
169,2012,8201,FINALLY,MIXED,UROLOGICAL,UROLOGISTS
176,8805,HIFU,HIGH,MORBIDITY,OWING
169,2010,2012,205,211,4087,4933940,8226,8804,CASES,DATA,GLEASON,LABEL,LUTS,MEAN,METHODS,MOST,OBJECTIVE,OBJECTIVES,PCA,PSA,RESULTS,SINCE,SPAIN,SPANISH,UNLABELLED,WHAT
ABAS,CMS,DICE,FIFTEEN,HEAD,LABEL,MATERIALS,METHODS,MIM,NECK,OBJECTIVE,PURPOSE,RESULTS,ROIS,THREE,VELOCITYAI,VOIS
001,176,177,180,1998,2006,270,362,ADVERSE,EBRT,GRADE,JAPAN,LATE,OSAKA,VERSION
004,009,235,AIM,BACKGROUND,CAREGIVERS,CLINICIAN,CLINICIANS,DYADS,GENERAL,LABEL,METHODS,MIXED,OBJECTIVE,RESULTS,SETTING,SUPPORT,THOSE,USING
124,199,2001,2011,206,212,222,325,376,468,479,527,599,609,638,855,8804,882,CALIFORNIA,FRANCISCO,GLEASON,HOPKINS,HOWEVER,JOHNS,KETTERING,LABEL,MEDICAL,METHODS,MIAMI,OBJECTIVE,OVERALL,RESULTS,SAN,SLOAN,UNIVERSITY
169,2012,8201,AFRICAN,COPYRIGHT,JOHN,LTD,SIMULATION,SONS,WILEY

112,169,200,2000,2009,2010,2012,310,800,AMONG,CENTERS,CENTRAL,CONTROL,COPYRIGHT,DISEASE,HISPANICS,HOWEVER,INC,INSTITUTE,LATINOS,NORTH,PREVENTION,REGISTRIES,SOCIETY,STATISTICS,STRATEGIES
169,1994,2006,2009,2012,337,463,50TH,75TH,761,8804,8805,90TH,95TH,99TH,AFTER,AMONG,ASIAN,BETWEEN,COPYRIGHT,PCM,PSA,TAIWANESE,UICC
BROAD,CHANGES,FACE,IRELAND,LABEL,METHODS,OBJECTIVE,OSWS,PURPOSE,RESULTS,THESE
002,003,009,039,046,1995,2010,307,AIM,BETWEEN,CONCLUSION,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,PORT,PSA,RESULTS,SART
001,100,AFTER,DCE,HIFU,LABEL,MATERIALS,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS,SEVERAL,USING
125,145,2003,2008,8805,ASTRO,BETWEEN,BRT,GROUP,JUNE,LABEL,LDR,MATERIALS,METHODS,NCCN,NETWORK,OBJECTIVE,PURPOSE,RADIATION,RADIOLOGY,RESULTS,RTOG,SOCIETY,THERAPY
103,10991,10996,2006,ACAD,DU145,HIGH,INSTITUTE,LNCAP,NATL,PROC,SCI,SEVERAL,THESE,USA
2595,945,AES,BACKGROUND,BPH,DESPITE,FIVE,IPSS,LABEL,LIBRARY,LUTS,MEDLINE,META,METHODS,PRIMARY,QOL,RCTS,RESULTS,SCORE,SILODOSIN,SYMPTOM
ADP,AKT,ANNEXIN,ASSAY,BACKGROUND,BCL,CELL,EFFECTIVE,ETHANOL,HOWEVER,LABEL,LNCAP,METHODS,MTT,PC3,PCA,RESULTS,ROS,TAKEN,THESE,TRAIL
145,3387,945,946,ABSIDIA,AMONG,NMR,SEVEN
BASED,CURRENT,FINALLY,MYC,PTEN,SIMILARLY,SIRT1,THESE
213,HOWEVER,IL6,LNCAP,NKX3,PIM,PIM1,PSA,S213,S213A,THEREFORE,THUS,UPON,VCAP,WILD
106B,22RV1,AFTER,CASP7,DU145,FURTHER,LNCAP,USING
000,169,2000,2009,2012,COPYRIGHT,INC,ROBOTIC,SEVERAL,SINCE
000,003,169,2012,221,AIM,BASEL,COPYRIGHT,DRE,LABEL,METHODS,OBJECTIVE,POD,RESULTS,THERE,TRUS
133,624,CURRENT,EPS,LTQ,MME,PARK7,SFN,SRM,TGM4,THESE,TIMP1,WESTERN
1196,169,1986,2003,2012,279,3451,BOTH,COPYRIGHT,III,INC,LABEL,METHODS,MOST,OBJECTIVE,OBS,OXIDATIVE,PCA,PRO,PURPOSE,RESULTS,TOTAL
169,2012,APRIL,ASSESSMENT,BACKGROUND,COPYRIGHT,HOWEVER,IRELAND,LABEL,LTD,MEDLINE,METHODS,RCTS,RESULTS,REVIEWS,SYSTEMATIC,TEA,THERE
169,2012,CAP,CARLO,CHAIN,COPYRIGHT,HOWEVER,MAP,MONTE,MPM,MRF,MRI,MWMAP,MWMPM,SIMILARLY,TESLA,THUS
169,2012,COPYRIGHT,INC,OLDER
169,2012,668,956,COPYRIGHT,CUB,CUZD1,ELISA,III,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVCA,PUBLISHED,RESULTS,SERUM,SOCIETY
169,17Q12,2012,215,3221,3Q26,5272,5P15,ADD,AFTER,AUSTRALIAN,BJU,BONFERRONI,CASE,CONSORTIUM,CONTROL,DOES,DRB1,GWAS,HLA,HOWEVER,KNOWN,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PRCA,PROXIES,RESULTS,SNP,SNPS,STUDIES,SUBJECT,THERE,THESE,TRUST,UNLABELLED,WHAT,WTCCC
169,2012,8226,ADT,BJU,CASTRATION,DESPITE,MDV3100,WHAT
001,005,169,2012,338,AFRICAN,APPRAISAL,ASSESSMENT,AUTHORS,BJU,CARE,COMMUNITY,DATA,EDUCATION,FOLKMAN,FORM,ILLNESS,LABEL,LAZARUS,LEVEL,MEN,METHODS,OBJECTIVE,OBJECTIVES,PROSTQA,QUALITY,RESULTS,SCALE,SERVICE,STUDIES,THERAPY,THERE,THESE,TREATMENT,TYPE,UNLABELLED,WHAT,YOUNGER
000,006,008,010,013,015,019,023,025,03774,04097,04395,044,045,04545,06278,06698,07211,07241,08377,095,09576,177,305,312,338,4507,4583,5446,6083,7064,7077,7106,7179,8036,855,8750,AMBULATORY,BOARD,BOTH,EDUCATION,EXAMINING,LABEL,NETWORK,OBJECTIVE,OBJECTIVES,PCA,RESULTS,THREE,UNIVERSITY,UROLOGY
119,169,2011,2012,8194,8195,8226,8776,958,AGDAP,AGDAS,ANOGENITAL,BARCELONA,BJU,EACH,EISENBERG,ENVIRON,LABEL,LEVEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PLOS,PROGNOSIS,RESULTS,SPAIN,STUDIES,THERE,TYPE,UNLABELLED,WHAT
HAT,STRUCTURAL,THESE,TIP60
000,100,140,169,2005,2012,666,8194,8226,ACCOUNTING,AUTHORS,BJU,CONCLUSION,ERSPC,LABEL,LEVEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PSA,RANDOMIZED,RESULTS,SCREENING,SWEDISH,THERAPY,TYPE,UNLABELLED,WHAT
DKK,KLAKLAK,THESE,TMTP1
8805,99M,CONCLUSION,FURTHER,LABEL,MDP,METHODS,NONE,OPTIMAL,PARTIAL,PSA,RESULTS,THERE,TKI,TKIS,UNLABELLED
ASSAY,GLUCOSE,KIT
HOWEVER,INCREASING,M13,MOLECULAR,OWING,SPARC,UNTIL
192,232,632,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PATIENT,PEAK,RESULTS,STENT,THESE
53BP1,ADP,BRCA,BRCA1,BRCA2,GIVEN,MRE11,MRN,NBS1,OVERALL,PARP,PARPI,RAD50,RAD51,WHILE
8805,GATA,GATA3,GLEASON,IHC,III,NONE,SCC,SCCS,THROMBO,TMA,TMAS,UCS,WEAK
001,090,151,1999,2008,331,565,624,723,858,899,949,951,A1C,ADDITIONAL,CONCLUSION,CONVERSELY,COX,DATA,EXCLUDING,LABEL,METHODS,OBJECTIVE,OVERALL,PANCREATIC,RESULTS
169,2012,946,BESIDES,COPYRIGHT,INC
0016,0065,127,131,133,169,174,2013,391,COPYRIGHT,EDUCATION,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PATIENT,PUBLISHED,PURPOSE,RESULTS,RIGID,UROLOGICAL
169,2012,COPYRIGHT,PCR,RWPE,THESE,TOTAL
1500,169,2012,ANALYTICAL,COMPARISON,COPYRIGHT,DRUG,FBDR,HIGH,KX01,KX02,LTQ,SRC
169,2012,COPYRIGHT,INC,MANGANESE,MNSOD,THESE,ZNSOD
169,2012,BACKGROUND,BCNAS,COPYRIGHT,FURTHER,HIGH,HPLC,HSV1,IMAGING,INC,LABEL,METABOLISM,METHODS,MICE,PET,PRG,PRGS,PRP,PRPS,PUBLISHED,RESULTS,VZV
020,072,166,169,192,2012,8804,8805,934,AIM,COLLEGE,CONCLUSION,COPYRIGHT,DCE,DWI,EXTENSIVE,FORTY,FURTHER,HOWEVER,LABEL,LTD,MATERIALS,METHODS,MRI,OBJECTIVE,PUBLISHED,RESULTS,ROYAL,T1WI,T2WI,THERE,THREE
001,002,003,004,011,032,128,157,169,176,1992,2005,2013,219,297,347,357,360,380,424,435,516,598,685,710,739,819,841,8804,8805,921,ADT,AHR,COPYRIGHT,COX,DESPITE,GLEASON,INC,LABEL,MATERIALS,MEIER,METHODS,NETWORK,OBJECTIVE,PCSM,PSA,PURPOSE,RESULTS,RFS,SHORT,USING
169,182,2000,2012,3320,900X,945,ATM,BACKGROUND,BRAF,BRCA2,COPYRIGHT,CRPC,CRPCS,E26,ERG,FFPE,HISEQ,LABEL,METHODS,MOST,MYC,NGS,OBJECTIVE,OTHER,OUTCOME,OVERALL,PCA,PTEN,PUBLISHED,RESULTS,SETTING,THERE,TMPRSS2,TP53,UROLOGY
1218,169,2012,4075,5058,6296,806,BACKGROUND,CONTEXT,COPYRIGHT,COST,FEW,HOWEVER,ITEMS,LABEL,LIBRARY,LRP,MARCH,META,METHODS,MINIMALLY,MIRP,OBJECTIVE,PCA,PREFERRED,PUBLISHED,RALP,REPORTING,RESULTS,REVIEWS,ROBOT,RPP,RRP,SCIENCE,SYNTHESIS,SYSTEMATIC,UROLOGY,WEB
169,2012,946,947,AKT,COPYRIGHT,HTS,LTD,PC3,PI3K,PTEN,SAR,THESE
169,2012,AKT,ANNEXIN,CARIBBEAN,CDK,CLUSIACEAE,COPYRIGHT,ERK1,FACS,FITC,GMBH,HPLC,LNCAP,MAJOR,MAPK,MDR1,MEK1,MTT,PKB,PSA,THUS,WESTERN
1360,169,1991,2006,2012,4365,5411,ACM,BACKGROUND,CAD,CHF,COPYRIGHT,COX,EBRT,GLEASON,HOWEVER,LABEL,MEN,METHODS,NHT,OBJECTIVE,OUTCOME,PCA,PSA,PUBLISHED,RESULTS,SETTING,T2A,THESE,UROLOGY,USING
002,162,169,1995,2010,2012,246,439,968,BACKGROUND,COPYRIGHT,COX,FORTY,LABEL,MEIER,MEN,METHODS,OBJECTIVE,OUTCOME,PCA,PUBLISHED,RESULTS,SETTING,UROLOGY
031,115,178,8201,8804,8805,BACKGROUND,CTV,FFF,FORTY,FURTHER,IMRT,LABEL,LATE,METHODS,PCA,PHOENIX,PSA,RESULTS
100,2005,2011,ACCRUAL,AFTER,BACKGROUND,DRUG,EVALUATION,FIRST,FURTHER,III,LABEL,LACK,MAMS,METASTATIC,METHODS,OCTOBER,ORIGINALLY,RESULTS,STAGE,THERAPY,THESE,TRIAL
BONE,DENOSUMAB,RANK
169,2012,212,250,400,8805,AACR,ABOUT,EGF,EGFR,EVALUATION,LABEL,METHODS,OBJECTIVE,PFS,PSA,PTEN,PURPOSE,RESULTS,SEVEN,SWISS,TREATMENT
EPIGENETIC,HOXC,HOXD,PCDH,USING
057,1004,12P11,1562,19P13,209,20Q11,215,2188,2745,3399,4754,519,663,6Q14,6Q25,745,869,8804,902,946,9965,AABC,AFRICAN,BPC3,CONSORTIUM,GWAS,NCI,SIMILARLY,SNP,SNPS,TNBCC
2013,247,256,2MAN,3MAN,4GLCNAC,6GAL,6MAN,945,946,GAL,GLYCOCONJ,KDN,TAKAHASHI,THESE,YABU
169,2012,COPYRIGHT,JOHN,LTD,SONS,WILEY
169,2012,268,8805,COPYRIGHT,IMAT,INC,KEY,KIM,LABEL,MATERIALS,METHODS,MOST,OBJECTIVE,POST,PURPOSE,RESULTS,TEN,VARIOUS
001,052,103,130,169,180,1997,2008,2013,ACP,ACUTE,AEP,COPYRIGHT,COX,EARLY,INC,LABEL,LCP,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,TREATMENTS
ELONGATED,EVERY,IMPLANTING,WHILE
0CC,125,145,160,166,169,180,186,199,1CC,2004,2011,2012,6711,AUSTRALIA,BOTH,COPYRIGHT,D10,D90,D90S,DOSIMETRIC,ESTRO,FTE,GEC,LDR,LOW,RAH,ROYAL,SEPT,SEPTEMBER,THREE,URETHRA,V150
160,169,2012,AKT,BCL,COPYRIGHT,DOCETAXEL,FINALLY,HLA,HLAI,HOWEVER,HRPC,INC,NOTABLY,NOTCH,THESE,USING
169,2012,90S,AMP,COPYRIGHT,INC,THEREFORE
001,169,2012,BACKGROUND,CONCLUSION,COPYRIGHT,DENOSUMAB,DISEASE,END,LABEL,LTD,METHODS,PATIENT,RANK,RANKL,RESULTS,SRE
169,2012,25MG,AIM,BACKGROUND,COPYRIGHT,DLTS,LABEL,LTD,METHODS,MTD,NAIL,OBJECTIVE,PUBLISHED,RESULTS,SECONDARY
169,2012,AUNPS,COPYRIGHT,GOLD,NINPS,PBNPS,PSA
169,2013,ADT,CONTENT,COPYRIGHT,EIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
0001,001,145,169,2012,AFRICAN,COPYRIGHT,EGF,FURTHER,GLEASON,INC,KAISO,NUCLEAR,PATHOLOGY,PUBLISHED,SOCIETY,THERE
110,169,2012,220,250,300,346,387,8226,8804,8805,AUTHORS,BJU,CHINESE,CONCLUSION,GLEASON,LABEL,METHODS,OBJECTIVE,PCA,RESULTS,SETTING,TOTAL,UNLABELLED,WHAT
169,2012,8226,AUTHORS,BJU,BRCA1,BRCA2,CONCLUSION,GWAS,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RARE,RESULTS,UNLABELLED,WHAT
103,137,200,2004,2008,239,BACKGROUND,COX,FIFTY,JULY,LABEL,LDR,METHODS,MINIMAL,PSA,RESULTS
CURRENTLY,GEM,GIST,NON,THESE,WHILE
AKT,BACKGROUND,BAD,BCL,DATA,FAS,LABEL,LHX4,MECHANISMS,METHODS,MOLECULAR,NME5,PC3,PROTEIN,RESULTS,TNF,TRAF1,TUNEL
001,002,015,023,169,173,2012,503,8226,ACT,BOARD,CHANGES,DIAGNOSIS,HIGH,INSTITUTE,INSURANCE,INVENTORY,IPSS,LABEL,LEVEL,MEN,METHODS,MRI,OBJECTIVE,PSA,RESULTS,SCORE,SHIM,SYMPTOM,THERE,THESE,TYPE,UNLABELLED,VARIOUS,WHAT,WHOLE
001,077,BACKGROUND,CONCLUSION,COVARIATE,FORM,LABEL,METHODS,MIXED,PCPT,PREVENTION,RESULTS,SHORT,TRIAL
6009,7827,AUROC,CONSORTIUM,DISCUSSION,FIRST,GWAS,INTEGRATED,LABEL,METHODS,OBJECTIVE,RESULTS,THERE
DATA,FULL,MHZ,OFFLINE,PZT,TRFE,TRUS,VDF,VERASONICS
CONCLUSION,DESPITE,FIFTEEN,LABEL,MAIN,MEN,METHODS,OBJECTIVE,ONT,OUTCOME,PSA,RESULTS,SETTING,SEVENTY,WHETHER
003,023,1998,2008,396,EBRT,FIVE,GRADE,HDR,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,TURP
AD5PB_RSV,CRAD,HOWEVER,LNCAP,NIS,PCR,USING
231,4T1,ANTONIO,BALBC,BONE,GFP,MDA,MUNDY,NEITHER,ONCE,SAN,SEVERAL,THUS,WHILE
9944,FURTHER,LNCAP,PCA,PCR,PSA,PSMA
BASAL,LABEL,METHODS,OBJECTIVE,RESULTS
155,ASA,BMI,LABEL,LRP,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,POTENCY,RADICAL,RESULTS,TURP
0033,014,027,031,2008,2009,ADIPOKINE,AIM,CONCLUSION,FIFTY,LABEL,METHODS,OBJECTIVE,RESULTS,SERUM,THERE,USING
012,178,2006,2011,263,281,345,368,591,CAP,GLEASON,HCT,HGB,PSA,SERUM,SHBG,TRT
231,HOWEVER,MDA,STAT,THESE
156,8805,BACKGROUND,CYP17,LABEL,METHODS,NLR,PFS,PSA,PSADT,RESULTS,RISK,SEVENTY,SIXTY
169,2012,934,AACR,CCR2,CPNI,ERK,GDNF,GFRA1,PDA,PDAS,PERINEURAL,RET,TAKEN,THESE,VIDEO
127,CNA,CNAS,CRPC,CTC,CTCS,CYP17,GNRH,INHIBITION,INSTEAD,METASTATIC,PCA,PCAS,PCR,THESE
169,2012,AIM,APNEA,BACKGROUND,COMMITTEE,ENDOCRINE,ISSM,LABEL,MAIN,MEASURE,MEDICAL,MEN,METHODS,OBJECTIVE,OPERATING,OUTCOME,PROCEDURES,RESULTS,SLEEP,SOCIETY,SOPS,STANDARDS,THERE,TTH,YOUNG
8201,AMONG,ASSESSMENT,CONCLUSION,FIFTY,FUNCTIONAL,GENERAL,HOWEVER,ILLNESS,LABEL,METHODS,OBJECTIVE,PERCEPTION,QOL,RESULTS,SPOUSES,THERAPY
169,2012,AIM,BACKGROUND,DAILY,EARLY,ERECTIONS,LABEL,MAIN,MEASURE,MEDLINE,METHODS,NIGHTLY,OBJECTIVE,OUTCOME,RESULTS,SOCIETY,THERAPY,VARDENAFIL
954,AKT,HES,HEY,LNCAP,MIGRATION,MOUSE,NOTCH,RBP,SFN,STRIKINGLY,THESE,TRANSGENIC
1300,177,8805,ASSESSMENT,GLEASON,KALLIKREIN,KLK4,SNPS,THREE
5AR,945,BPH,DHT,FURTHER,INHIBITION,SEVERAL,THERE,THESE
002,022,037,166,BPH,CAP,HOMA,MEN,THESE
100,BACKGROUND,BASED,CLONOGENIC,DOSE,DU145,HOWEVER,LABEL,LNCAP,METHODS,PC3,PDGFR,RESULTS,SUNITINIB,THEREFORE,VEGFR
231,ADP,AMP,ATP,BASAL,MDA,PC3,PURINERGIC
003,169,2012,64257,CDTE,COPYRIGHT,ECL,ITO,OWING,PSA,QDS,UNDER
120,169,174,2012,203,215,24H,4T1,COPYRIGHT,DTX,IC50,MICE,PC3,PEGYLATED,THESE
CHIP,GIST,GISTS,LABEL,METHODS,MOST,NON,OBJECTIVE,PCA3,PCR,REAL,RESULTS,SEVEN,TIME
ADVERSE,LABEL,METHODS,OBJECTIVE,PURPOSE,RARP,RESULTS,THERE,VAS
000,001,100,1499,2008,2011,2565,946,BACKGROUND,COMMISSION,COST,EVEN,GIVEN,HIGH,HSCRC,LABEL,METHODS,OBJECTIVE,PURPOSE,RALRP,RESULTS,RRP,SERVICE,THERE,THEREFORE
001,155,200,2005,2010,AMICO,BACKGROUND,BCR,BETWEEN,COX,GROUP,JULY,LABEL,MEDIANS,MEIER,METHODS,PLND,RALP,REGARDLESS,RESULTS,THEREFORE,UNIVARIATE
005,BACKGROUND,CONCLUSION,GROUP,LABEL,METHODS,MRI,OBJECTIVE,PCA,PURPOSE,RESULTS,ROI,TESLA,THESE,TRUS
215,GLEASON
024,133,169,178,2007,2010,2012,207,281,8226,AUTHORS,BETWEEN,BJU,FORTY,HOWEVER,IHR,IHS,JULY,LABEL,METHODS,OBJECTIVE,ORRP,OTHER,RESULTS,UNLABELLED,WHAT
1000,106,176,177,99M,BOC,DEMOMEDIN,GRP,GRPR,HEK,NMBR,THUS
945,946,BACKGROUND,BONE,CD44,HOWEVER,LABEL,PC3,RANKL,RESULTS,RUNX2,SIMILARLY,SMAD,SMAD5,THESE
168,2838,330,945,946,LABEL,METHODS,NEGLECTING,OBJECTIVE,PURPOSE,RESULTS,THESE,TREATMENT
106,150,153,180,2011,2012,375,900,AVERAGE,FOLEY,INVENTORY,JUNE,LABEL,MARCH,MEAN,MEN,METHODS,OBJECTIVE,POTENTIAL,PURPOSE,RESULTS,RSP,SCORE,SYMPTOM,THREE,TRUS
BACKGROUND,CONCLUSION,FORTY,INSTITUTE,METHODS,MOST,RESULTS,SURVIVORS,YET
1MET,246,ACUTE,ALT,AML,APR,AST,CONCLUSION,DLTS,HODGKIN,LABEL,METHODS,MTD,OBJECTIVE,PRIMA,PURPOSE,RESULTS
169,2012,BACKGROUND,CELL,CETUXIMAB,COPYRIGHT,EGFR,ELISA,IGG,INC,LABEL,METHODS,PE38,RESULTS,SEVERAL,WESTERN,WILEY,XTT
13910,169,2012,630,873,COPYRIGHT,DAIRY,DENMARK,EPIC,HIGH,LACTASE,LCT,NUTRITION,ODDS,ORS,THESE,UICC
177,CONCLUSION,DEFINITIVE,FSA,LABEL,MATERIALS,METHODS,NONE,OBJECTIVE,PROSTATIC,PURPOSE,RESULTS,SIX,THERE
8230,ASSESSMENT,BACKGROUND,CONCLUSION,DATA,LABEL,METHODS,OBJECTIVE,QUOTATIONS,RESULTS
156,2007,2008,BACKGROUND,BPH,CURRENT,DEVICES,DUNE,FIRST,LABEL,MAY,MEDICAL,METHODS,RESULTS
001,002,009,012,029,169,1993,2009,2012,236,377,495,583,621,8804,AFRICAN,AMONG,BASEL,COPYRIGHT,DATA,GLEASON,LABEL,LOW,MEIER,METHODS,OBJECTIVE,PSA,RESULTS,T2A,THESE
169,2012,BLOT,CELL,COPYRIGHT,GLUT1,GLUT3,HENCE,HOWEVER,LDH,LNCAP,LTD,MCT4,NMR,NUCLEAR,PC3,PCA,PCR,PFK1,RESONANCE,WESTERN
945,ACCORDING,BACKGROUND,CA15,CA27,CEA,CRP,IVC,IVCS,LABEL,METHODS,PSA,RESULTS,RIORDAN,SINCE,THERE,TNF,VITAMIN
169,2012,8804,CBCT,CBCTS,MINIMAL,RADIOLOGY,ULTRASOUND,VETERINARY
AKT,BACKGROUND,CONCLUSION,DEPLETION,ERK,FURTHER,HELA,HOWEVER,LABEL,METHODS,MMP,PAR,PRINCIPAL,RESULTS,SUB,WITHAFERIN
DOPPLER,THEREAFTER,ULTRASOUND,UROLOGICAL

169,2012,299,961,AACR,AFTER,PNKP,PTPN6,ROS,SHP
169,2012,COPYRIGHT,H1299,HOWEVER,INC,NSCLC,NUPR1,RNAI,SILENCING,WILEY
1990,2005,2008,265,8805,986,COX,GLEASON,JANUARY,THERE,TNM
169,2012,316,COPYRIGHT,FRANCIM,HAKULINEN,MEANWHILE,NET,PERME,POHAR,PPE,UICC,USING
169,1986,2004,2012,ALGORITHM,ASIAN,COLORECTAL,COPYRIGHT,ENGLAND,NAMES,OVERALL,POISSON,POPULATION,SOUTH,STUDIES,UICC
160,253J,8243,950,A375P,EACH,ERBB2,PC3M,PC3MLN4,SN12C,SN12PM6,TAKEN,THESE,THUS,USING
405,575,725,DU145,PPIX
125,BOTH,CHI,CONCLUSION,DRE,LABEL,MATERIALS,METHODS,OBJECTIVE,PEARSON,PSA,RESULTS,SEXTANT
161,AMONG,BACKGROUND,BMI,BPH,CONCLUSION,CUT,DEVELOPING,FORTY,FURTHER,HDL,LABEL,LDL,MATERIALS,METHODS,PCA,PRIOR,PSA,RESULTS,ROC,TAS,THERE,VIT
160,169,2012,AIMS,BACKGROUND,COPYRIGHT,E2F3,E2F3A,E2F3B,IMSS,INC,LABEL,METHODS,OBJECTIVE,PCR,PUBLISHED,RESULTS,THEREFORE,THUS,WESTERN
1997,2006,641,CUP,GERMANY,HODGKIN,HOWEVER,RRS,SPCS,SWEDISH
169,2012,A549,AMPK,ATM,COPYRIGHT,FINALLY,IRELAND,LKB1,LTD,THUS
169,2012,216,276,579,617,902,930,AIM,COLLEGE,CONCLUSION,COPYRIGHT,INR,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,REGRESSION,RESULTS,ROYAL,THERE,THESE,TRUS
169,2012,BACKGROUND,CONCLUSION,COPYRIGHT,FEW,FOCAL,INDIVIDUAL,LABEL,MATERIALS,METHODS,ONCOLOGIC,PDT,RESULTS,SERIOUS
050,09443,1008,1388,169,2012,8806,ANOTHER,BACKGROUND,CAT,CHINESE,COPYRIGHT,DIEGO,GENOTYPING,HAN,INC,LABEL,MASSARRAY,METHODS,MPO,OXIDATIVE,PCA,RESULTS,SAN,SNP,SNPS,SOD2
001,10409,11932,169,2006,2008,2012,424,837,8862,9390,9413,AFTER,AHA,BACKGROUND,COPYRIGHT,DESPITE,HOWEVER,INPATIENT,LABEL,METHODS,NATIONWIDE,NIS,OBJECTIVE,ORP,OUTCOME,OVERALL,PUBLISHED,RARP,RESULTS,SETTING,UROLOGY,USING
169,1979,1993,1995,2004,2012,ADDITIONAL,BACKGROUND,CALIFORNIA,CENTRAL,CIS,CONCLUSION,COPYRIGHT,HODGKIN,IDAHO,INDEX,LABEL,LTD,METHODS,NDI,OBJECTIVE,RESULTS,SINCE
169,2012,24H,A2780,COPYRIGHT,LTD,PBS,PC3,RGD,ST7456CL1
169,2012,229,3828,549,8804,8805,AGE,BACKGROUND,CCI,COMPETING,CONVERSELY,COPYRIGHT,CSM,EVEN,GLEASON,HOWEVER,INDEX,LABEL,METHODS,OBJECTIVE,OCM,OUTCOME,OVERALL,PCA,POISSON,PUBLISHED,RESULTS,SETTING,UROLOGY
160,169,2012,COPYRIGHT,FAD,FMN,FTIR,HUVEC,LNCAP,LTD,MRI,RCP,RIBOFLAVIN,SEM,TEM,THEIR,THEREFORE,USPIO
169,2006,2012,6986,CONCLUSION,COPYRIGHT,CROATIA,DATA,GIVEN,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,PSA,RESULTS,SES,SOCIO,UNION,VARIATION
CIN,CIN1,CIN2,CIN3,CXCR4,CXCR6,MEIER,THESE
169,2001,2011,2012,260,592,852,AUR,CANCERLIT,COPYRIGHT,DWI,FURTHER,INC,JANUARY,LABEL,LIBRARY,MATERIALS,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RATIONALE,RESULTS,SIX,SIXTEEN,TEN
169,2012,8226,BJU,COMPARABLE,ONCE,THESE,TODAY,WHAT
169,2007,2010,2012,214,229,APMIS,AUTHORS,MIC,UME
169,2012,34A,CDK,DU145,E2F1,E2F3,HDAC,HOWEVER,MEF,PI3K,THEREFORE,THESE,TSA
8725,945,946,CARLO,HOWEVER,IMPLANTED,LABEL,METHODS,MONTE,OBJECTIVE,PURPOSE,RBE,RESULTS,SFUD,TCP,TCPS,THREE
100,8725,CANCEROUS,EXPECTEDLY,LABEL,METHODS,MEV,OBJECTIVE,PURPOSE,RESULTS,THERE,THESE,ULTIMATELY
8725,FIVE,IMAGING,INSTEAD,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,USING,VMAT
005,113,157,2010,2011,232,366,AIM,APRIL,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS,SUSPICIOUS
945,FOCAL,HELA,MGAT1,ONCOGENIC
8482,LNCAP,MMP,PEG,R1881,RGD,SINCE,TAKEN,THEREFORE
2002,488,AFTER,BACKGROUND,COX,EACH,INDEX,LABEL,LUNG,METHODS,RESULTS,SCORE,SES,THERE
100,HOWEVER
ADT,DESPITE,MINIMIZING
GUIDELINES,NCCN,PANEL,THESE
8000,ABS,AGS,CD4,CSF,CTLA,PAK6,THESE,TREATMENT,USING
2009,2010,2011,345,546,749,BACKGROUND,CONCLUSION,DOSES,JANUARY,LABEL,METHODS,MOST,OBJECTIVE,RESULTS,ZOLEDRONIC
152,2011,767,LABEL,LIBRARY,MEDLINE,META,METHODS,OBJECTIVE,PAIN,PURPOSE,RANDOMIZED,RESULTS,SCIENCE,SRES,STUDIES,TREATMENT,WEB
006,1169,AGING,AMONG,ANXIETY,BACKGROUND,CONVERSELY,LABEL,METHODS,PERCEIVED,PROJECT,PSA,RESULTS
1133,BOTH,ENDORECTAL,ERB,ERBS,FIFTEEN,GAS,THUS
177,AVERAGE,DVHS,IMRT,MACHINE,MLC,MUS,SIXTEEN,THERE,TPS,TPSS
103,125,BED,CURRENTLY,EQUATIONS,THREE
119,AAPM,DOSE,ECLIPSE,IMRT,PLANS,TREATMENT,VMAT
490,CURRENT,PSA,THERE
AFRICAN,CHILEAN,CONTINENTS,FIVE,HODGKIN,INCIDENCE,NAS,NORTH,SWEDISH,TURKISH,TURKS
945,949,954,PKC,PROTEIN,RNAI,TNF
114,120,128,163,177,240,942,956,ACCORDING,AFTER,CONCLUSION,DU145,GFP,GSTP1,LABEL,METHODS,MTT,NEO,OBJECTIVE,RESULTS,TUNEL
ADPC,AIPC,ALTOGETHER,CLAUDIN,CONCLUSION,ER60,LABEL,LNCAP,METHODS,OBJECTIVE,RESULTS,SERUM,WESTERN
0001,0011,169,2001,2006,2013,344,688,COPYRIGHT,CROWN,EBRT,FIVE,HDR,HDRB,HIGH,INC,INITIAL,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RATES,RESULTS,THREE
8805,BOTH,IMPROVING,INCREASING,LABEL,MATERIALS,METHODS,MODEL,NTCP,OBJECTIVE,PRE,PSA,PURPOSE,RESULTS,SIMILAR,SRT,STRATEGIES,TCP
BECAUSE,HOWEVER,OATP1B3,OATP1BS,OATPS,THERE
FOUR,SWEDISH,THEIR,THESE,USING,WESTERN
0003,008,177,8202,ANIMALS,CASTRATED,CWR22,DYNAMIC,FMAU,MIB,PC3,PET
001,003,104,166,169,2004,2007,2012,8226,8804,995,999,AFTER,AHR,AUTHORS,BJU,END,FINE,GLEASON,GRAY,INCREASING,JANUARY,LABEL,LEVEL,METHODS,MRI,OBJECTIVE,PCSM,PROGNOSIS,PSA,RESULTS,TECHNIQUES,THERE,THESE,TYPE,UNLABELLED,USING,WHAT
169,2012,60MIN,COPYRIGHT,DIGESTION,HOWEVER,LNCAP,LTD
11TH,12TH,14TH,15TH,1996,2000,2005,2010,2ND,3RD,6TH,BRCA,EUR,ISRAELI,NUTRITION,PARADOX,PUFA,UNION

CONSISTENT,HOWEVER,MED50,NESS,PRMT5,PROTEIN,SMD3,THESE,WD45,WDR77
CHRONIC,RWPE,THEREFORE,THESE
2008,2009,254,450,520,566,956,ANTIGEN,BLOOD,CONCLUSION,DESPITE,FOUR,GENERAL,INCIDENCE,IRR,LABEL,MAIN,MAMMOGRAMS,METHODS,NETWORK,OBJECTIVE,OBJECTIVES,OTHER,OUTCOME,POISSON,RESULTS,SETTING
CDF,CSC,EMT,EZH2,HIF,HOWEVER,LNCAP,NANOG,OCT4,PCA,TAKEN,VEGF
AMD3100,CXCR4,PC3,SEVERAL,STROMAL,THEREFORE,THESE
169,183,2012,8804,8805,956,CONCLUSION,DIAGNOSTIC,GLEASON,HIPAA,LABEL,MATERIALS,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS,RSNA,WHOLE,WRITTEN
005,271,4282,627,679,695,879,896,BACKGROUND,CONCLUSION,DIET,LABEL,MEAT,MEN,METHODS,OBJECTIVE,RESULTS,THESE
AKT,DESPITE,DU145,FAK,ORAL,OXIDATIVE,PC3,ROS,TRAMP,TRANSGENIC
128,1392,169,179,183,2007,2011,2012,231,233,241,545,818,8364,847,997,CBCT,CONCLUSION,COPYRIGHT,ECONOMICS,IGRT,LABEL,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SAS,SFRO,SOCI
41388,BACKGROUND,BLACK,BRAZILIAN,BROWN,LABEL,META,METHODS,OBJECTIVE,RESULTS,SETTING,WHITE
109,118,140,201,2010,2011,253,634,678,8804,8805,ASAP,AUC,DIAGNOSTIC,DRE,HGPIN,JANUARY,LABEL,MAY,METHODS,NPV,OBJECTIVE,PCA,PCA3,PPV,PSA,PURPOSE,RESULTS,ROC,SPBX,T1C
0001,169,2012,AFRICAN,ALSO,AMERICANS,CAP,CAUCASIAN,CONCLUSION,COPYRIGHT,ERG,ETS,GLEASON,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,ONCOGENIC,RESULTS,WESTERN
169,2010,2012,356,AMONG,CONCLUSION,COPYRIGHT,INC,JULY,LABEL,LYMPH,METHODS,OBJECTIVE,RESULTS,SEPTEMBER,SIMILARLY,THEREFORE,THREE
169,2012,CONCLUSION,COPYRIGHT,ESTERIFIED,INC,LABEL,METHODS,OBJECTIVE,RESULTS,SEVEN,WESTERN
ALA,AMCA,DU145,FUNCTIONAL,GLY,HOWEVER,INHIBITING,LEU,LNCAP,LYS,PCR,PEPT1,PEPT2,PEPTIDE,PHT1,PHT2,SAR,WESTERN
2009,2010,APRIL,AVENTIS,BBB,FDA,JEVTANA,JULY,MARCH
281,8805,BACKGROUND,GLEASON,GS6,GS7,LABEL,LRM,METHODS,ODDS,PCA,PSA,RATIO,RESULTS,USING
DUE
CAM,HOWEVER,OTHER,OVCAR,SKOV
205,218,281,916,EMT,GLEASON,LOSS,NP63,PCA,SIMILARLY,TAP63,THESE,ZEB1
107,1973,1982,2008,2684,306,3187,331,474,504,842,AIMS,BACKGROUND,BOARD,BRAIN,CENTRAL,ENGLAND,GENERATING,LABEL,LEUKAEMIA,METHODS,OBJECTIVE,OBS,OVERALL,RESULTS,SRR,SRRS,WALES
169,2012,ADT,BACKGROUND,COPYRIGHT,ERG,FINALLY,HGPIN,IDC,INC,LABEL,METHODS,PCA,RESULTS,TMPRSS2,WILEY
2002,2008,458,461,8805,956,BAVARIA,CONCLUSION,CURRENT,LABEL,METHODS,OBJECTIVE,POISSON,RESULTS
THERE
GNRH,SVC
143,145,CD133,CD44,CSC,CSCS,KLF4,MYC,OCT4,PCA
169,2012,AIMS,AZGP1,BASEL,CAST,CONCLUSION,COPYRIGHT,DU145,GLEASON,LABEL,METHODS,MSMB,NBL1,OBJECTIVE,PCA,PCR,PSA,RESULTS,WESTERN
216,331,352,393,978,BPH,TEN
006,009,17Q21,18Q12,193,22Q11,2Q37,395,541,651,876,916,FINNISH,HPC,HPC6,HPC9,HPCX1,LOD,OSA,PRCA,USING,XQ26
BACKGROUND,CONCLUSION,HOWEVER,LABEL,METHODS,RESULTS,THEREFORE,WEB
001,002,004,017,026,028,030,037,057,060,102,1225,1636,169,195,1997,2009,2012,231,341,411,526,590,8805,898,984,ASA,AUTHORS,BETWEEN,BFS,BJU,BOTH,CONTINENCE,CSS,GLEASON,HOWEVER,ICS,ICSMALE,JUNE,LABEL,LEVEL,MEIER,METHODS,OBJECTIVE,RESULTS,SEPTEMBER,SOCIETY,THERAPY,THERE,TYPE,UNLABELLED,WHAT
000,2010,275,8805,AIM,BACKGROUND,DISCUSSION,FIVE,GPS,HOWEVER,LABEL,METHODS,OBJECTIVE,PSA,RESULTS,TEN,TESTING,WAIKATO,ZEALAND
169,2012,2DE,954,DU145,GMBH,KGAA,THESE,VCH,WESTERN,WILEY
167,169,179,185,2012,COPYRIGHT,FOLLOWING,JOHN,LTD,MCF,MCT1,MEK,MRS,NADH,PC3,SONS,U0126,WILEY
169,2012,ATPASES,COPYRIGHT,GOLGI,INHIBITION,LNCAP,PCA,PSA,R1881,THESE,TREATMENT,UICC
005,144,8804,8805,AURKB,CCNB2,GLEASON,INCREASED,LNCAP,LOSS,MELK,PC3,RNAI,TOP2A,UBE2C
465,945,AMONGST,ENZYMATIC,FINALLY,LL32,SELECTIVE,THESE
001,110,181,256,371,736,946,CORTACTIN,COX,GLEASON,HDAC6,HDACS,HIGH,HOWEVER,LABEL,METHODS,OBJECTIVE,PCA,PSA,RESULTS,SIRT2
145,169,2012,8320,8325,946,956,ASIA,COPYRIGHT,FOUR,GAL,GLC,HMBOA,LTD,M2BOA,MBOA,SWEET
169,2013,384,462,613,897,945,BIOMARKER,CALIPER,CHICAGO,CLOSE,COA,COPYRIGHT,E26,HOPKINTON,IBM,INC,LIFE,METHYLACYL,SPSS,STATISTICS,THREE
169,196,2012,250,AMONG,AUCS,BACKGROUND,COPYRIGHT,CYFRA,FDP,LABEL,METHODS,NMP22,RESULTS,ROC,UBC,URINARY
015,018,020,024,038,040,1032,121,168,178,2007,2010,323,357,447,511,634,665,833,967,CONCLUSION,DOCETAXEL,JANUARY,LABEL,METHODS,OBJECTIVE,ORR,PSA,RESULTS,THERE
004,005,200,BACKGROUND,CONCLUSION,EARLY,INTERVALS,LABEL,METHODS,MRI,PSA,RAISING,RESULTS
DENOSUMAB,RANKL,THUS
DETECTION,FFPE,LIFE,NEXT,NGS,SEQUENCING,SOLID,THESE
2010,BACKGROUND,CASE,CLINICIANS,LABEL,METHODS,ONJ,RESULTS
002,003,201,247,331,8805,COMPARING,CONCLUSION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THEREFORE,TYPE
2012,CD8,THERE,THESE,UNIVERSITY
100,AFTER,BASED,DKK,FIRST,HEP3B,HEPG2,LNCAP,MOI,PC3,PCR,REGARDING,REIC,THESE
160,267B1,APOPTOSIS,DAPI,DIAMIDINO,FOXO,KOREA,SACCHARINA
954,CX3C,DU145,HIF,HYPOXIA
COMMUNITY,DATA,LABEL,MANEN,METHODS,OBJECTIVE,OBJECTIVES,PURPOSE,RESULTS,SETTING,SEVERAL,SYNTHESIS
169,2012,AKT,COPYRIGHT,INC,LNCAP,M14,PP2A,PTEN,RAC1,THESE,USING,WHEREAS
169,181,2012,ADJUSTING,AFRICAN,CENTRAL,COMPOSITE,CONCLUSION,COPYRIGHT,EPIC,HOWEVER,INDEX,IRELAND,LABEL,LTD,METHODS,MOST,NORTH,OBJECTIVE,PCA,QOL,RESULTS,TDM
169,2012,CACO2,CALCITRIOL,COPYRIGHT,CYP24A1,DAC,HOWEVER,ISSUE,LTD,MED1,RXR,SINCE,SP1,SPECIAL,VDR,VITAMIN
169,2012,ANDROGENS,CONVINCING,COPYRIGHT,DATA,IRELAND,LTD,PUBLISHED
169,2012,COPYRIGHT,IRELAND,LTD,PXR
145,169,2012,BRS,CDK4,CHANGES,COPYRIGHT,FOLLOWING,LNCAP,LTD,TUNEL,WESTERN
169,2012,946,CACO2,COPYRIGHT,CYP3A,IRELAND,LNCAP,LTD,VDR
169,2012,954,AUTOCRINE,BACKGROUND,CHANGES,COPYRIGHT,CXCL8,CXCR,CXCR1,CXCR2,ELISA,HIF,HYPOXIA,INCREASED,LABEL,METHODS,OBJECTIVE,OUTCOME,PCA,PCR,PTEN,PUBLISHED,RESULTS,SETTING,SMALL,TRANSIENT,UROLOGY
100,169,2012,945,946,956,CONCLUSION,COPYRIGHT,DIFFERENT,DPPH,GAS,GMBH,LABEL,METHODS,NMR,OBJECTIVE,PINUS,PURPOSE,RESULTS
169,2011,2012,233,AUSTRIA,BACKGROUND,BCG,BLADDER,CIS,CONTEXT,COPYRIGHT,HOWEVER,LABEL,MARCH,METHODS,OBJECTIVE,ONCE,PUBLISHED,RADICAL,RESULTS,STROMAL,SYNTHESIS,THESE,UROLOGY
CD133,DAOY,EQUALLY,SOX2,THESE,U118,U87
945,AMP,C352G,C81,CELL,DU145,ECTOPIC,EGF,EXPRESSION,LNCAP,OXT,PC3,PERTUSSIS,PTX,RWPE1,THESE
ADAMS,FINALLY,INCREASED,JAGGED1,MMPS,NOTCH,PC3,THESE,ZMP,ZMPS
10Q21,1581,1644,17P13,215,3225,CROSS,D356N,DHT,FAM9B,GWAS,REDUCTION,SHBG,THESE,XP22
2005,2010,560,BACKGROUND,CONCLUSION,CRPC,DOCETAXEL,FOUR,GRADE,JULY,JUNE,LABEL,MEDICAL,METHODS,ORAL,RESULTS,UNIVERSITY
160,2002,2011,AFRICAN,BARBADIAN,BLACK,PCBP,POPULATION,WEST
BCL,CD20,GLEASON,IGH
POWERPOINT
169,2013,661,873,ADT,BONE,BPS,COPYRIGHT,CRPC,MINERAL,OVERALL,SOCIETY
AIMS,GLEASON,INCREASED,LABEL,METHODS,OBJECTIVE,PCA,PSA,RESULTS,RHOC,ZAG
945,JUK,MEK1,PC3,PI3,SPSS,WESTERN
ADDITIONAL,BASED
AKT,HEAT,HSP90,THESE,WEE1
145,169,2012,COPYRIGHT,IRELAND,LNCAP,LTD,ROS
MOST,MPE
005,007,169,1987,1997,2012,223,8226,843,ADT,AUTHORS,BJU,COX,DESPITE,DOWN,EBRT,GLEASON,LABEL,LEVEL,LOCAL,MEIER,METHODS,OBJECTIVE,RESULTS,THERAPY,TYPE,UNLABELLED,WHAT,WHILE
ENRICHMENT
FURTHER,PSA
AFTER,CONCLUSION,EARLY,IIEF,LABEL,METHODS,OBJECTIVE,RESULTS,SIX,THREE,VED
AFTER,CGA,CONCLUSION,LABEL,LACKING,METHODS,NSE,OBJECTIVE,RESULTS,S100
001,002,008,013,024,120,BPH,CONCLUSION,III,LABEL,METHODS,OBJECTIVE,PSA,PSAD,REGARDING,RESULTS
121,122,272,CONCLUSION,DU145,LABEL,METHODS,MTB,MTP,NOS,OBJECTIVE,PCR,RESULTS
2ND,4TH,CCK,CONCLUSION,GLUT,LABEL,METHODS,MYC,OBJECTIVE,PC3,PPAR,PPARGAMMA,RESULTS,RNAI,THEN,THERE,USING
AFTER,BOTH,BRDU,CONCLUSION,KNOCKDOWN,LABEL,METHODS,MTT,OBJECTIVE,PCR,RESULTS,WESTERN
2007,CARE,CHALLENGES,CHRONIC,CONDITIONS,DEPARTMENT,DOH,GCM,GENERIC,LABEL,METHODS,MODEL,MOST,OBJECTIVE,RESULTS,THERE,YORKSHIRE
111,316,357,764,BACKGROUND,COLON,CONCLUSION,FOLLOWING,LABEL,LYNCH,MEIER,METHODS,MLH1,MMR,MSH2,MSH6,PMS2,RESULTS,SIR,SIRS
3DCRT,ADVANTAGES,BACKGROUND,BOWEL,COMPOSITE,CONCLUSION,IMRT,INDEX,LABEL,METHODS,RESULTS,SIMILAR,THERE
215,243,LENS,LPP,MEDIKUS,PEROXIDASE,SPAIN,UNDER
180,215,25C,296,957,BRDU,CDK,CIP1,CONCLUSION,EFFECTS,KCL,LABEL,LICL,METHODS,MTT,NACL,OBJECTIVE,PBS,RESULTS,VALUE,WESTERN
DUOX,DUOXS,NADPH,NEGATIVELY,NOX,NOX1,NOX4,NOX5,NOXS,ROS,THESE,WHILE
1386,256,268,690,696,BACKGROUND,INSTITUTE,LABEL,METHODS,PSA,RESULTS,SECONDARY,SOCIETY,THERE
000,147,169,2012,26A,AACR,ERG,EZH2,LABEL,TMPRSS2,UNLABELLED,USING
946,KEY,WNTS
000,018,146,169,172,2012,256,COPYRIGHT,HOWEVER,HPV,INC,SIMILARLY,VLPS,WHETHER,WILEY
125,150,2009,8805,90TH,CACS,DRUG,HIV,JANUARY,TDM
141,169,2002,2009,2013,226,351,718,ADVERSE,BETWEEN,BRT,CONCLUSION,COPYRIGHT,HDR,INC,IRT,JANUARY,LABEL,LATE,MATERIALS,METHODS,OBJECTIVE,PHOENIX,PURPOSE,RESULTS,THREE,TRUS
143,182,BACKGROUND,FPI,LABEL,RESULTS,SEVERAL
00001,0746,0837,100,1013,179,215,228,286,3310,8308,8309,8310,8764,963,BOTH,DIAGNOSTIC,EIS
169,176,177,2012,3457,5580,8804,956,CONCLUSION,GLEASON,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,RSNA
003,128,169,1994,2007,2012,221,381,509,8226,8804,BJU,COMPETING,DISEASE,ERSPC,FAVOURABLE,GLEASON,HOWEVER,LABEL,LEVEL,LOW,MEIER,METHODS,OBJECTIVE,PCA,PRIAS,PSA,RANDOMIZED,RESULTS,ROTTERDAM,SCREENING,THERAPY,TYPE,UNLABELLED,WHAT
A36,AMI,PRMT,PRMT1,PRMTS,PROTEIN
169,1927,1999,2012,286,3056,843,ANGELES,AUTHORS,BJU,CALIFORNIA,CAPSURE,DESPITE,INDEX,LABEL,LOS,METHODS,OBJECTIVE,PATIENT,RESULTS,UNIVERSITY
169,2012,330,500,8805,AUTHORS,BJU,CONCLUSION,DANUSERTIB,FURTHER,LABEL,METHODS,OBJECTIVE,PHA,PSA,RESULTS,SIXTY
032,169,191,2002,2006,2012,8226,8804,8805,ABLATHERM,AMICO,BJU,CONCLUSION,DURABLE,EDAP,HIFU,HIGH,LABEL,LEVEL,MEIER,METHODS,OBJECTIVE,OCTOBER,PCA,PSA,RESULTS,STRATIFIED,STUTTGART,THERAPY,TMS,TYPE,UNLABELLED,WHAT
121,169,2012,8226,8804,8805,945,AKT,AUTHORS,BJU,CONCLUSION,CRPC,DESPITE,LABEL,LEVEL,METHODS,OBJECTIVE,OBJECTIVES,PI3K,PSA,RESULTS,THERAPY,THERE,THUS,TYPE,UNLABELLED,WHAT
151,181,ARHGDIA,CASZ1,DU145,GENISTEIN,HOWEVER,INHIBITION,LUCIFERASE,MEIER,N4BP1,PC3,PCA,PCR,REAL,RWPE,SOX17,TREATMENT,UTR
145,201T,A549,BACKGROUND,BEAS,CONCLUSION,DOA,DOX,LABEL,LIPOSOMES,MCF,METHODS,MTT,PEG,RESULTS,SV119
15TH,16TH,176,1ST,2011,2ND,FPD,MAY,TOMOGRAPHY
175,955,ACS,AFTER,CONCLUSION,LABEL,METHODS,OBJECTIVE,PCSM,PURPOSE,RESULTS,STRATEGIC
EVALUATION,NOW,SOLID
001,169,1988,1992,1998,2002,2008,2009,2012,837,AACR,ACCORDING,BECAUSE,CONCLUSION,COX,LABEL,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS
HOWEVER,RAS,RHOC,SPARC,SPARCL1,THUS
169,2012,COMPLEX,COPYRIGHT,FINALLY,INC,LNCAP,OVERALL,WILEY
169,2012,22RV1,ACTB,B2M,BACKGROUND,BOTH,COPYRIGHT,DU145,GSTP1,HIF1A,HKG,HKGS,HRES,HYPOXIA,INC,IPO8,LABEL,LNCAP,METHODS,NORMFINDER,PC3,PCR,PGK1,PPIA,PWR1E,RESULTS,RWPE1,UBC,WILEY
006,009,117,169,177,2012,457,567,926,AGSC,BACKGROUND,COPYRIGHT,HOWEVER,INC,LABEL,METHODS,NOCA,NUCLEOLAR,PCA,RESULTS,WILEY
12TH,1TH,3RD,6TH,EPIC,QOL,RADICAL,THESE
433,8805,FEW,GLEASON,HOWEVER,LABEL,METHODS,OBJECTIVE,PROTECT,PSA,PURPOSE,RESULTS,TESTING,THERE,TREATMENT
169,2012,BP1,COPYRIGHT,HOWEVER,INC,RNAI,TREATMENT
169,174,2008,2010,2012,500,BETWEEN,BJU,CALYPSO,CLAVIEN,CONCLUSION,DATA,IIIB,LABEL,MEDICAL,METHODS,OBJECTIVE,OCTOBER,RESULTS,SEATTLE,UNLABELLED,USA,UTI,WHAT
169,2012,COPYRIGHT,HDR,HIGH,PUBLISHED,SAS,WILLIAM
9RR0,ALSO,BACKGROUND,CENTRAL,FOUR,FURTHER,LABEL,MEDLINE,METHODS,RCTS,RESULTS,TAMOXIFEN
139,169,2012,8805,AMICO,CONCLUSION,COPYRIGHT,EPSTEIN,FURTHER,GLEASON,INC,LABEL,METHODS,OBJECTIVE,PATIENT,RESULTS,THERE,THEREFORE
120,169,2012,BOARD,CONCLUSION,COPYRIGHT,DOPPLER,ENDOSCOPE,FIVE,FURTHER,INC,IQR,LABEL,METHODS,OBJECTIVE,RALP,RALPS,RESULTS,THERE,TILEPRO,TRUS,VIKY,VINCI
001,002,005,012,124,169,2012,276,365,765,8805,CONCLUSION,COPYRIGHT,GLEASON,HOWEVER,INC,LABEL,MATERIALS,MEAN,METHODS,OBJECTIVE,RESULTS
8201,ADT,AFFAIRS,AMONG,BACKGROUND,DESPITE,LABEL,METHODS,RESULTS
177,945,949,HIF,HYPOXIA,MDR1,MNP,PC3,PCL,PEG,PPEEA,THEREFORE
124,2005,945,BESIDES,BINDING,CYP17,DOCKING,DRUG,FIT,HANDRATTA,HORMONE,IFD,INDUCED,LBD,PCA,SBDD,STEROID,STRUCTURE
AKT,LEHSSKLQL,ONCE,PI3K,PSA,THEREFORE
BACKGROUND,CASE,CONCLUSION,LABEL,METASTATIC,METHODS,PAGET
BASED,BECAUSE,CURRENT,FURTHER,III,INCREASED
174,BASED,CRPC,CSF,FURTHER,GVAX,III,IPILIMUMAB,LNCAP,PAP,PC3,PSA,USA,USING
0058,027,0401,068,169,177,2012,215,ADC,ADCS,AUC,CONCLUSION,CORRECTING,INTRA,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,RSNA,STAND,WHOLE
AUTOPHAGY,CELLS,CONVERSELY,FLIP,INCREASED,LC3,LNCAP,MG132,PC3,TNF,TUNEL,WESTERN
8209,DESPITE,DIAGNOSING,LUNG,THEREFORE
033,042,043,057,169,2012,215,2Q33,386,3P12,583,854,8804,894,AACR,BACKGROUND,CONCLUSION,EUROPEANS,GWAS,HOWEVER,LABEL,LATINOS,MEC,METHODS,RESULTS,SNP,SNPS,THERE
093,169,2012,215,257,605,AACR,AAS,AFRICAN,AMERICANS,BACKGROUND,CHICAGO,CONCLUSION,IL16,LABEL,METHODS,RESULTS,SNP,SNPS,WASHINGTON,WEST
000,001,003,100,105,125,8804,8805,ACHIEVING,BFS,BRT,DFS,DISEASE,FREE,LABEL,MEIER,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS,TIME
8209,ERG,ETS,ETV,EVEN,PC3,PCA,USING
169,183,2012,3CLHAZA,956,COPYRIGHT,DMF,HOS,INC,LNCAP,MCF7,MTT,PTCL
174,HOWEVER,HPV,SIPULEUCEL
169,2012,ALARA,COPYRIGHT,IMAGE,MOST,PUBLISHED,SAS,SEVERAL,THEN,THESE
001,006,007,043,1038,2001,2010,ADJUSTING,BACKGROUND,BCR,BMI,EQUAL,HOWEVER,INCREASED,LABEL,MEAN,METHODS,OBESE,OBESITY,OBJECTIVE,OUTCOME,PSA,PUBLISHED,RESULTS,SETTING
169,2012,231,233,CBCT,COPYRIGHT,EVEN,IGRT,IMRT,INTENSITY,PUBLISHED,SAS,SFRO,SOCI
000,018,019,1186,160,169,2012,215,468,572,BEIR,COPYRIGHT,HODGKIN,LTD,PERIPHERAL,PUBLISHED,VII
169,2012,295,COPYRIGHT,FREE,LOD,PROSTATUS,PSA,TOTAL
169,2004,2011,2013,COPYRIGHT,FIVE,INC,JULY,LABEL,MAY,METASTATIC,METHODS,OBJECTIVE,ORAL,PRIMARY,PUBLISHED,PURPOSE,RESULTS
0005,169,2012,CONCLUSION,COPYRIGHT,GLEASON,INC,LABEL,LOW,MEAN,METHODS,MOST,OBJECTIVE,PARAMETERS,RESULTS,THESE
169,2012,CHOLINE,COPYRIGHT,INC,PUBLISHED,SOCIETY,TARGETING
001,008,096,169,2012,239,ADJUSTING,BLACK,COPYRIGHT,CURRENT,EDUCATION,HOWEVER,III,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,RESULTS,S8494,S8894,S9346,SUBGROUPS,UROLOGICAL
101,169,2003,2004,2012,AFTER,BIOLOGY,COPYRIGHT,FEDERATION,INC,JANUARY,JULY,PUBLISHED,ULTRASOUND,WORLD
169,2012,AIM,COPYRIGHT,LTD,TLD
169,2012,ADDITIONAL,CONCLUSION,COPYRIGHT,CTCS,FACS,FLOW,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,PCA,RESULTS,SCID
101,INC,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,STAGING,THREE,TRUS
1000,169,2000S,2012,500,AREAS,AUCS,CONCLUSION,COPYRIGHT,DWI,INC,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,SEVENTY,THREE
169,2012,COPYRIGHT,GOSERELINE,SAS
004,169,2012,4MM,COPYRIGHT,GLEASON,LABEL,METHODS,MFC,MRI,OBJECTIVE,PSA,RESULTS,SAS,SEVENTY
169,2012,5ARI,AFTER,BACKGROUND,CONCLUSION,COPYRIGHT,DESPITE,EVEN,FDA,LABEL,METHODS,PCPT,RESULTS,SAS
169,2012,COPYRIGHT,IGRT,IMAGE,IMRT,PUBLISHED,SAS
013,036,8804,954,BLINDED,COX,CTS,INTER,KAPPA,KRUSKAL,LABEL,METHODS,MOST,OBJECTIVE,OBJECTIVES,OVERALL,PCA,READERS,RESULTS
145,177,194,195,956,RED,SEQUENTIAL
COULD,ERG,PERHAPS,SIMILARLY,THESE
169,2012,BACKGROUND,CLAVIEN,CONTEXT,COPYRIGHT,DELAY,FURTHER,LABEL,MEDLINE,METHODS,MIBC,OBJECTIVE,OPEN,PUBLISHED,RESULTS,SYNTHESIS,UROLOGICAL,UROLOGY
169,2012,400,946,ANNEXIN,COPYRIGHT,CPT,CTP,DU145,HOWEVER,HPLC,LNCAP,PROPIDIUM
169,2012,COPYRIGHT,JMJD2,KDM4,KDM4C,LTD,THEREFORE
100,DRUG,OMICS,THESE
1H255,1H68,BACKGROUND,BVD,ECM,GLV,HOWEVER,LABEL,METHODS,MMP,ONCOLYTIC,PBS,RESULTS,TAKEN,VACV
0001,004,105,BACKGROUND,LABEL,MEIER,OVERALL,PCA,PCR,PRINCIPAL,PSA,RESULTS,SERUM,UNIVARIATE
174,945,AKT,CARDURA,CLINICALLY,EPH,EPHA2,EPHA4,ERK,NMR,PI3,RAS,SIMILAR,THESE,THROUGH,TREATMENT
160,176,177,206,247,389,702,956,AFTER,BACKGROUND,BINDING,CONCLUSION,DRUG,LABEL,METHODS,MRI,PSMA,PTX,RESULTS,SIPP,SIPPS,SPM,SPMS
946,ASC,BPH,CD68,EARLY,EMT,MECHANISM,SILENCING,SNAIL,TGF,THESE,THP
160,177,IMRT,NTCP,SUBVOLUME,TCP
PC3,PDZ,RHO,ROCK,THERE,THESE,TRUNCATION
946,EMT,HOWEVER,INITIALLY,INSTEAD,PRIMARY,STMN1,TGF,THESE
160,BACKGROUND,CONCLUSION,FATIGUE,LABEL,METHODS,NETWORK,RESULTS,WHILE
0001,001,0096,116,169,2012,8804,8805,AZA,BPH,CDR,COPYRIGHT,DENSITY,GLEASON,HGPIN,LOW,NOTABLY,OVERALL,RELATED,SFRP1,SFRP2,SFRP4,SFRP5,SFRPS,UICC,USING,WNT,WNTS
169,177,2012,ADT,AQ4N,CELLS,COMBINING,COPYRIGHT,DAYS,DSF,LNCAP,PCR,QPCR,UICC,USING
069,2012,204,327,AACR,BACKGROUND,BECAUSE,COX,FORTY,III,LABEL,MEN,METHODS,NUTRITION,RESULTS,THESE
169,2012,AACR,AD5,AD6,ADENOVIRUS,E1A,ELEVATING,HOWEVER,KUPFFER,ONCOLYTIC,VIRTUALLY
AD5,FDA,GVAX,III,OTHER,PHASE,SIPULEUCEL
145,1522B,53BP1,947,AG0,CELLS,FOLLOWING,H2AX,MODULATED,THERE,THESE
169,2012,945,946,954,FIRST,GPX2,H2AX,IKB,IL1,INC,KLK4,LNCAP,LPS,MDM2,MMP8,MMP9,NEXT,NKX3,PMA,PSA,ROS,S139,THUS,TNF,U937,WILEY
8764,C57BL,CONCLUSION,FOLLOWING,HIFU,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,STAT3,TDLNS
ATX,HOWEVER,HUVEC,LEDGF,LPA,LPA1,LPA3,ROS,THESE,VEGF
000,068,12ADT,131,173,180,206,267,344,543,580,893,913,AMINO,BACKGROUND,BALB,FAP,LABEL,LNCAP,MCF,METHODS,MIXED,RESULTS
GAPDH
169,2012,99M,BACKGROUND,COPYRIGHT,CTT,DBCO,DPA,INC,LABEL,LNCAP,METHODS,PC3,PEG,PSMA,RESULTS,SPECT,WILEY
169,2012,946,947,APOPTOSIS,BACKGROUND,COPYRIGHT,GLB1,HP1,INC,KIP1,LABEL,LNCAP,LUCAP,METHODS,PHENOTYPIC,RESULTS,TUNEL,WILEY
169,2012,8201,8804,AGR2,BACKGROUND,BLOOD,CGA,COPYRIGHT,CRPC,CSPC,CTC,CTCS,ELISA,FURTHER,INC,LABEL,METHODS,NSE,PCR,PSA,RESULTS,WILEY
208,231HM,MDA,PCR,SCID
221,C21,EGFP,EVALUATING,NKX3,P221A,POINT,PRO,PROTEASOME,REDUCED,TREATMENT,USING
8805,GLEASON,HIFU,MRI,REGARDING,THESE,TREATMENT
100,11600,169,1999,2009,2012,3277,AFTER,BACKGROUND,CASTRATION,COPYRIGHT,CRPC,GENERAL,GPRD,LABEL,LTD,MEAN,METHODS,OVERALL,PSA,PUBLISHED,RESULTS,USING
169,2012,AIM,BACKGROUND,CHANGES,CONCLUSION,DOPPLER,FIFTEEN,FLOWMETRY,HOWEVER,LABEL,LASER,MAIN,METHODS,OBJECTIVE,OUTCOME,RESULTS,SOCIETY,TEN,THREE
2008,2010,252,40X,760,DISCUSSION,GLEASON,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,PIN3,PSA,RESULTS,T2A,T2B,T2C,T3A
1382,1425,2000,2242,2295,2916,3620,3624,553,658,6860,ESWL,EURO,HOWEVER,INSTEAD,ITALY,PCNL,STONE,TREATMENT,TURB,UROLOGICAL,WHILE
100,22RV1,8805,DU145,GLEASON,HOWEVER,LNCAP,PC3,PCR,PPC1,PROS1,PROTEIN,RWPE,SIMILARLY,TAKEN,USING,VCAP
182,331,642,DOHH,DU145,FINALLY,PCR,TRANSIENT,USING,UTR
169,177,2004,2009,2011,430,ANGELES,BACKGROUND,CALIFORNIA,COMPOSITE,COPYRIGHT,EXCLUDING,HIFU,INDEX,LABEL,LOS,METHODS,PHOENIX,PSA,RESULTS,SOCIETY,STUTTGART,UNIVERSITY,URINARY,VALIDATED
8805,888,954,956,AES,BACKGROUND,CCL2,CCR2,CNTO,CONCLUSION,CRPC,FORTY,IGG1,LABEL,METHODS,PSA,RESULTS,SAES,SECONDARY,THERE
107,1428,BACKGROUND,BANK,BCR,COMPONENTS,DATA,ELECTRONIC,GIVEN,LABEL,MEDICAL,METHODS,METS,OBESITY,RESULTS,UNIVERSITY
001,019,028,036,250,300,314,8805,AST,BACKGROUND,BODY,IAST,LABEL,LOSS,METHODS,PHASE,POST,PSA,RESULTS,THESE,WAIST
169,2012,COPYRIGHT,DEVELOPING,HOWEVER,LNCAP,MECHANISMS,PPD,TARGETING,THUS,UICC
169,1948,1970,1980,2010,2011,2012,AIM,APRIL,CONFERENCE,COPYRIGHT,CROWN,DATA,DENOSUMAB,LABEL,LIBRARY,LTD,MARCH,MAY,MEDLINE,METHODS,NETWORK,OBJECTIVE,PUBLISHED,QOL,RESULTS,SCIENCE,SECONDARY,SOURCES,SRE,SYNTHESIS,WEB
001,169,2012,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
169,174,2012,ASC,CELL,COPYRIGHT,EDUCATION,GFP,INC,LABEL,LC3,LNCAP,MATERIALS,MECHANISM,METHODS,OBJECTIVE,PC3,PUBLISHED,PURPOSE,RESULTS,SIGMA,TARGETING,UROLOGICAL,USING,WESTERN
169,2012,22RV1,COPYRIGHT,CPG,DU145,EDUCATION,INC,LABEL,LNCAP,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THUS,UROLOGICAL
169,1995,1999,2005,2012,AIM,COPYRIGHT,CRS,FIVE,HODGKIN,ITALIAN,LABEL,LTD,METHODS,OBJECTIVE,REGISTRIES,RESOURCES,RESULTS,SEH,SERTS,SOCIO
169,1792,2003,2006,2012,COPYRIGHT,GMBH,SEMINAL
169,192,2007,2010,2012,ADVERSE,ASSESSMENT,FUNCTIONAL,HIGH,INDEX,JANUARY,JULY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,QUALITY,RESULTS,SCORE,SYMPTOM,T3AN0M0,THERAPY,UROLOGICAL
169,2012,ENGLISH,OTHER,UROLOGICAL
001,169,177,2007,2011,2012,205,361,410,AGE,AMONG,COX,HOWEVER,LABEL,MAY,MEDICAL,METHODS,OBJECTIVE,RESULTS,UROLOGICAL,UROLOGISTS
HIFU,HIGH
177,231,8197,8201,AML,BLOOD,DISRUPTION,HUVEC,KHT,MDA,PC3,RESULTS,S1P,THESE,USING
946,97C1,BCL,FURTHER,HOWEVER,MCL,MET,PCA,PTEN,RESISTANCE,SABUTOCLAX
CACNA1D,CPG,DMB,ERG,ETS,ETV1,GLYATL2,GRPR,HLA,KCNH8,LNCAP,PCA,PDE3B,PLA1A,TDRD1,TMEM45B,VCAP
COMPOUNDS,EZH2,H3K27,HISTONE,HMT,PRC2,SEVERAL
CD141,CD44S,CK20,CK5,CK7,HMWK,PSA,PSAP
169,2012,950,AACR,CHIP,LABEL,LNCAP,METHODS,OBJECTIVE,PCR,PSA,PURPOSE,RESULTS,USING,WESTERN
129,177,ADVERSE,BECAUSE,CONCLUSION,CTCAE,CURRENT,DUTCH,LABEL,METHODS,OBJECTIVE,PHOENIX,PSA,PURPOSE,RESULTS
2004,2007,239,APRIL,BETWEEN,INDEX,LABEL,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS,TPV,TZD
DOWN,DU145,DUCAP,HOWEVER,IGF,IGF1,IGF1R,INS,INSR,INSRA,LNCAP,PC3,RWPE,THESE
BOTH,CAFS,EPC,EPCS,EPHA2
107,137,165,177,696,CONCLUSION,FURTHER,GLEASON,LABEL,MATERIALS,METHODS,OBJECTIVE,PCA,PURPOSE,RESULTS,SERUM,YKL
169,2012,737,ABT,COPYRIGHT,DU145,HOWEVER,JOHN,LNCAP,LTD,PAB,SONS,WILEY
DESPITE,FOLLOWING,ONCE,THERAPY
001,012,017,120,163,200,400,454,605,619,767,865,8805,COX,PFS,PSA,PSADT
DU145,HOWEVER,LNCAP,MHC,NATURAL,THEREFORE,THESE,TRAIL
1003,309G,5151,ASIAN,CAUCASIANS,CIS,MDM2,ODDS,ORS,PCA,T309G
132,169,2012,8764,COPYRIGHT,PCR,SAS,TELOMERASE,THESE,USING,WESTERN
000,169,2013,711,835,AGA,AIMS,BACKGROUND,COLORECTAL,COPYRIGHT,DETECTION,INC,INSTITUTE,LABEL,LOW,LOWER,LUNG,METHODS,OBJECTIVE,OVARIAN,PLCO,PUBLISHED,RESULTS
001,088,114,1327,169,2006,2009,2012,8805,AFTER,BACKGROUND,BETWEEN,BMI,CCI,CONVERSELY,COPYRIGHT,ENOXAPARIN,LABEL,LMWH,LTD,METHODS,RBC,RESULTS,SIMILARLY
HOWEVER,MANAGEMENT,THEREFORE
100,169,1991,2009,2012,437,8804,8805,AMONG,BACKGROUND,CCI,COPYRIGHT,EACH,GLEASON,INDEX,LABEL,LIMITED,METHODS,NPCR,OBJECTIVE,OUTCOME,PCA,PSA,PUBLISHED,RESULTS,SETTING,TEN,UROLOGY
1149,169,177,18F,2005,2011,2012,282,BACKGROUND,COPYRIGHT,FEC,JUNE,LABEL,LNM,LNMS,METHODS,NPV,OBJECTIVE,OUTCOME,PCA,PET,PPV,PSA,PUBLISHED,RESULTS,UROLOGY
169,174,197,2003,2010,2012,398,427,50TH,63RD,80TH,COPYRIGHT,EDUCATION,GLEASON,GUIDELINES,INC,INVENTORY,LABEL,MATERIALS,MEN,METHODS,NCCN,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SEPARATED,SIMILARLY,UROLOGICAL
006,105,112,169,1996,2007,2012,855,972,999,BLACK,COPYRIGHT,COST,DATABASES,DIFFERENCE,EDUCATION,FLORIDA,HEALTHCARE,INC,INPATIENT,LABEL,MATERIALS,METHODS,OBJECTIVE,PROJECT,PUBLISHED,PURPOSE,RESULTS,STATE,UROLOGICAL,USING,YORK
0001,001,067,075,102,1121,169,1712,194,197,2012,218,224,233,242,260,280,281,310,705,711,889,972,988,991,BACKGROUND,BCR,COPYRIGHT,COX,CRPC,DATA,LABEL,MEIER,METHODS,OBJECTIVE,OUTCOME,PCA,PCSM,PSMS,PUBLISHED,RESULTS,SETTING,SIXTY,SRT,TEN,TIME
001,002,111,123,132,141,1417,1546,169,199,2008,2011,2012,277,289,440,791,805,8804,BACKGROUND,COPYRIGHT,DATA,EARLY,INVENTORY,LABEL,LOWER,MEN,METHODS,OBJECTIVE,OCTOBER,OUTCOME,PUBLISHED,RALP,RESULTS,RISK,SCORE,SETTING,SYMPTOM,UNIVARIATE,UROLOGY
AIM,CASE,DISCUSSION,LABEL,OBJECTIVE,PAGET,PSA,PSAP,UNASSIGNED,VIRTUAL
0000001,00001,0001,001,003,135,169,2012,237,401,627,633,685,949,AUC,COPYRIGHT,EDUCATION,INC,INDEX,LABEL,MATERIALS,METHODS,OBJECTIVE,PEARSON,PUBLISHED,PURPOSE,RESULTS,ROC,SIMILAR,THERE,UROLOGICAL
001,169,2012,215,280,729,8730,AUC,BECKMAN,BREA,CALIFORNIA,COPYRIGHT,COULTER,EDUCATION,INC,INCLUDING,INDEX,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PREDICTIVE,PUBLISHED,PURPOSE,REGRESSION,RESULTS,TOTAL,UROLOGICAL
105,169,177,1999,2002,2012,8804,ACCRUAL,COPYRIGHT,DISEASE,EDUCATION,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PHOENIX,PUBLISHED,PURPOSE,RESULTS,THERE,UROLOGICAL
000,001,034,094,100,109,116,136,153,169,2012,215,222,8730,8804,BECKMAN,COPYRIGHT,COULTER,EDUCATION,INC,INDEX,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SERUM,UROLOGICAL
167,169,189,2012,215,ADDITIONAL,BECKMAN,COPYRIGHT,COULTER,COX,EDUCATION,GLEASON,INC,INDEX,LABEL,LESS,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THUS,UROLOGICAL,WHILE
008,169,1997,2007,2012,318,COPYRIGHT,COX,EDUCATION,FURTHER,GLEASON,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,REQUIRING,RESULTS,UROLOGICAL,USING,WHILE
001,003,058,169,2012,401,657,COPYRIGHT,EDUCATION,FOUR,FREE,INC,KLK3,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,ROC,SERUM,UROLOGICAL
000,005,008,055,074,169,2013,3000,483,ANDOVER,COPYRIGHT,GENERATING,HEALTHCARE,IMRT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PHILIPS,PTV,PURPOSE,RESULTS,USING,VMAT
125,160,956,ANIBA,ANIBAMINE,CCR5,PUBLISHED,SAS,THUS
135,2004,2008,633,CHINESE,EACH,EORTC,HRQOL,ITEM,LABEL,METHODS,OBJECTIVE,PR25,QLQ,RASCH,RESULTS,VERSION
BACKGROUND,DALY,DALYS,DISABILITY,HDI,INDIA,LABEL,METHODS,RESULTS,THESE,USING
001,122,169,176,2008,2009,2012,8201,ADD,ALSO,BETWEEN,BJU,DOES,HOWEVER,ITE,ITR,JUNE,KNOWN,LABEL,MAY,METHODS,NST,NSTS,OBJECTIVE,OBJECTIVES,RARP,RESULTS,SUBJECT,THERE,THEREFORE,THUS,UNLABELLED,WHAT
0001,169,2012,8201,ANZ,AUTHORS,COLLEGE,CONCLUSION,CONSORT,DOCTORS,DRE,JOURNAL,LABEL,METHODS,OBJECTIVE,OBJECTIVES,POTENTIAL,PRACTICAL,PSA,RESULTS,ROYAL,SURGERY,THOSE
10Q22,118,200,223,445,945,FISH,TMA
LUNG,OFTEN,THESE
DESPITE,HSP,HSP90
169,174,177,2012,468,8805,956,AFTER,CD44,CELLSEARCH,COPYRIGHT,CTC,CTCS,CYTOMETRY,FCM,FLOW,MDA,SOCIETY,TAKEN,VERIDEX
169,2012,BARR,COPYRIGHT,EPSTEIN,JOHN,LTD,MYC,NEWER,SONS,WILEY
2011,GEORGIA,PROGRAM,SCREENING
103,178,190,480,E26,ERG,TMPRSS2
001,160,177,245,ADT,CHL,CRP,CVR,ELEVATION,FURTHER,HDL,LABEL,LDL,METHODS,OBJECTIVE,PCA,PSA,PURPOSE,RESULTS,SFG,TAG
BPH,DU145,HOWEVER,MTT,PCR,REPRESSION,ZFX,ZINC
2007,2012,956,APRIL,BETWEEN,CHINESE,CONCLUSION,GLEASON,JANUARY,LABEL,LYMPH,METHODS,OBJECTIVE,PSA,RESULTS,THESE
110,149,160,177,200,2006,2011,230,493,BETWEEN,CONCLUSION,CONTINENCE,GROUP,LABEL,LRP,MAY,METHODS,OBJECTIVE,PSM,RESULTS,T2A,T2B,T2C,T3A,T3B,THERE,THIRD,TURP,UNIVERSITY
001,096,177,1994,2005,201,216,338,352,400,443,624,8805,933,956,971,CHINESE,CONCLUSION,DEC,DEPARTMENT,FIRST,GLEASON,JAN,LABEL,METHODS,OBJECTIVE,PSA,RESULTS,ROC,UNIVERSITY,UROLOGY
169,2012,COPYRIGHT,IMAGING,INC,NETWORK,STRATEGIES
169,2012,COPYRIGHT,DCE,FSE,HOWEVER,INC,MRI,SPGR,THERE,VFA,VFAS
169,2013,COPYRIGHT,INC,METABOLIC,METHODS,NOVEL,SSFP
169,2000,2009,2012,215,664,740,APRIL,BRF,CONCLUSION,COPYRIGHT,GYE,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RBE,RESULTS
100,1031,1467,1468,1991,2009,230,2390,3034,326,454,505,767,851,956,BACKGROUND,ITALY,LABEL,METHODS,ORS,RESULTS
1256,169,2001,2006,2012,487,503,ADVERSE,CARE,CONCLUDING,COPD,COPYRIGHT,FEAR,GENERAL,INSIGHT,LTD,NETWORK,PRIMARY,USING
176,177,956,CTC,DU145,HOWEVER,LNCAP,NEXT,PC3,SURFACE,THERE,THESE,WBC,WBCS
169,2012,BASED,TAKEN,UROLOGICAL
169,177,2012,AAT,ADD,AUTOPHAGY,BJU,CONCLUSION,CONSISTENT,DOES,HENCE,HOWEVER,KNOWN,LABEL,LC3,LNCAP,MATERIALS,METHODS,OBJECTIVE,RESULTS,SUBJECT,UNLABELLED,WHAT
169,177,1800,181,2012,2500,2ND,ADVIA,AGREEMENT,AIA,AXSYM,BECKMAN,BJU,BLAND,BLOOD,CALIBRATED,CENTAUR,E170,FOLLOWING,GENERATION,HOWEVER,HYBRITECH,IRELAND,IRISH,LABEL,METHODS,OBJECTIVE,PSA,RESULTS,ROCHE,SIEMENS,TODAY,TOSOH,UNLABELLED,WHAT
169,2012,947,AACR,CD204,CD8,DCS,FURTHER,GIVEN,HOWEVER,IFN,RM1,SRA,THEREFORE,TRAMP,TREATMENT
946,CLU,EMT,HOWEVER,TAKEN,TGF
160,1985,2011,2286,4826,ABSTRACTS,AUTHORS,BACKGROUND,BECAUSE,CCTS,CENTRAL,COLLECTION,CONTROLLED,DATA,EWB,FIVE,FURTHER,HRQOL,LABEL,MAIN,MEDLINE,METHODS,MODE,OBJECTIVE,OBJECTIVES,PEDRO,RCTS,RESULTS,SCIENCE,SELECTION,SIGLE,SINCE,SMD,SMDS,THERE,WEB,WHERE
956,CONVERSION,HMAF,HOWEVER,PTGR1
010,019,094,COX,COXS,DU145,HETE,LNCAP,LOX,LOXS,MDA,PCA,PGE2,RELATIVELY
160,946,947,AMONG,CCAAT,CCND3,CEBPB,ETV4,FLI,FLI1,GADD45G,GSE2514,HOWEVER,KDR,LPL,LUNG,MMP9,NFKB1,PPAR,PPARG,TAL1,TGF,THUS
122,176,177,230,238,575,653,920,ADNEP,AKT,ATHYMIC,BAD,DU145,LACZ,NEP,NEUTRAL,PARP
CYSTOSCOPY,III,MRI,PSA,TOTAL
021,100,1997,2005,208,65309,AMICO,GLEASON,MEIER,PSA,T2B,THEREFORE,USING
0002,003,CHANGES,GLEASON,LDH,MCT,MIB1,TAFS,TAS,THESE,WARBURG
FURTHER,HLA,IGG,III,PPV,SINCE
AMONG,ARSER81,FOLLOWING,HORMONE,PIN1,SINCE
1000,AFTER,BACKGROUND,ERSPC,HOWEVER,LABEL,METHODS,PER,PSA,QALYS,RANDOMIZED,RESULTS,SCREENING,VARIOUS
001,1199,160,399,520,800,BACKGROUND,EASTERN,GROUP,LABEL,MDV3100,MEDIVATION,METHODS,PSA,RATES,RESULTS
1540,8725,AFTER,LABEL,LIVER,METHODS,OBJECTIVE,PURPOSE,RESULTS,SOS
BAO,BEAM,IMPT,IMXT,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THEREFORE,THREE
3DVH,8725,BEAM,DVH,HOWEVER,IMRT,LABEL,METHODS,OAR,OBJECTIVE,PURPOSE,RESULTS,SMALL
100,174,700,AFTER,AMERICA,AMS,BOTH,CALYPSO,LABEL,METHODS,MODEL,MP35N,NORTH,OBJECTIVE,PHANTOM,PURPOSE,RESULTS
000,051,100,1131,1294,1426,1769,1875,1987,1993,2010,2111,2368,2647,309,324,8805,AGE,COMPETING,FDS,FREMANTLE,IRR,IRRS,LABEL,METHODS,OBJECTIVE,PANCREATIC,RESULTS,THERE,TYPE
120,121,241,AFTER,ANESTHESIA,CONCLUSION,CONTROL,EBL,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,TRUS
ESTIMATION,SINCE
100,FINALLY,GRAPH,LIVER,RESULTS
0001,001,003,103,125,169,1995,2010,2012,250,369,474,484,510,958,ADT,BACKGROUND,BETWEEN,CMRT,COPYRIGHT,EBRT,FINE,GLEASON,GRAY,HRS,INCREASING,LABEL,MEIER,METHODS,PCSM,RESULTS,SCHIFFLER,SOCIETY,UNIVERSITY
169,2012,BACKGROUND,COLORECTAL,COPYRIGHT,GLEASON,HOWEVER,LABEL,LUNG,METHODS,OVARIAN,PCPT,PLCO,PREVENTION,PROJECTING,REDUCTION,RESULTS,SOCIETY,TRIAL
427,ASO,CRPC,HEAT,HSP27,OGX,P53,TCTP
0001,005,007,009,011,018,028,037,045,108,148,160,192,300,BACKGROUND,GAL,GLEASON,LABEL,MATERIALS,MEAN,METHODS,RESULTS,TISSUES
160,578,8201,ALT,CIVI,CLCR,CREATININE,III,OTHER,POPULATION,PURPOSE,RESULTS,VERSION,YM155
002,005,982,DIMELQX,HIGH,MELQX

180,SINCE,USING,VMAT
125B,146A,155,181,223,250,BLOOD,CSF,EIGHT,GROUP,INCREASES,SERUM
108,2004,2008,8804,AMONG,END,FACTORS,FIFTY,GLEASON,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SCORE
2009,2010,2040,BACKGROUND,COLORECTAL,CONCLUSION,DIFFERENT,ENGLAND,INCREASING,KINGDOM,LABEL,METHODS,PLANS,RESULTS,THERE,USING
001,835,8805,ADT,AMONG,BACKGROUND,CONCLUSION,IMRT,LABEL,LATE,MATERIALS,META,METHODS,MORBIDITY,MOST,PBRT,RADIATION,RESULTS,RTOG,SCORING,UNIVARIATE
102,254,489,581,719,936,AUC,BACKGROUND,LABEL,MATERIALS,METHODS,OVERALL,PATHOLOGIC,PSA,RESULTS,ROUTINE,T1C
1078,150,2003,2005,436,586,BACKGROUND,IIEF,INACCURATE,INDEX,LABEL,MATERIALS,METHODS,ONCOLOGIC,RESULTS,SEPTEMBER

169,17571,2012,8226,8804,8805,AMONG,AUTHORS,BJU,BRAZILIAN,DRE,LABEL,METHODS,OBJECTIVE,PCA,PSA,RESULTS,TUMOURS,UNLABELLED,USING,WHAT
DESPITE,SUMO,SUMOYLATED
145,8482,DOXIL,FDA,LNCAP,LY3117273,SECRETORY,SPRL,SSL,TREATMENT
169,2012,CONVERSELY,COPYRIGHT,DRAWING,JOHN,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,SONS,WILEY
125,142,2005,2011,280,AMICO,BACKGROUND,EMP,FURTHER,GLEASON,HIGH,IQR,LABEL,LHRH,MARCH,METHODS,PCA,PSA,RADICAL,RESULTS,SECONDARY,SEPTEMBER,SEVEN,SIX,T2C
005,010,014,023,114,8201,825,8805,BACKGROUND,BPH,CAP,GLEASON,HOWEVER,LABEL,METHODS,PCR,PSA,RESULTS,RUNT,RUNX2
CASTRATION,HARNESSING,LIVE,LNCAP,PARP,PCA,PLK1,POLO
AKT,AXL,BCL,CREB,CURRENT,FAK,MAPK,MER,NON,NSCLC,PROMISING,RTKS,THESE
945,EXCELLENCE,FDA,HOWEVER,INSTITUTE,THESE,USING
169,2012,270,765,ASIAN,ASN,ASP,ASP312ASN,BASEL,CAUCASIANS,COPYRIGHT,HOWEVER,LABEL,LYS751GLN,METHODS,OBJECTIVE,ODDS,ORS,PCA,RESULTS,SER326CYS,XPD
BOTH,PET
001,002,052,1348,169,1998,2001,2012,243,2658,413,8226,897,AMONG,BETWEEN,BJU,EBRT,LABEL,LEVEL,MATERIALS,METHODS,OBJECTIVE,RADIATION,RESULTS,SMS,THERAPY,TYPE,UNLABELLED,USING,WHAT
169,1999,2011,2012,8194,8195,8226,8805,BJU,CONCLUSION,DOCETAXEL,LABEL,LEVEL,MEIER,METHODS,OBJECTIVE,PFS,PSA,RESULTS,THERAPY,TYPE,UNLABELLED,WHAT
771,8201,BACKGROUND,BLADDER,LABEL,MARGINS,MATERIALS,METHODS,RESULTS,SYSTEMATIC
0001,514,764,BACKGROUND,CHI,CONCLUSION,CORE,DRUG,LABEL,METHODS,MRI,PC3M,RESULTS
169,2012,ADT,BETWEEN,COPYRIGHT,INDEX,JOHN,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,RTH,SIXTY,SONS,WILEY
113,169,2012,215,8302,871,ELISA,GMBH,KGAA,SAMPLES,THESE,VCH,WILEY
169,2012,ASIDE,COPYRIGHT,DESPITE,FURTHER,LIVER,PATIENT,RECIPIENTS
169,2012,268,323,519,946,GWAS,INC,MSMB,NCOA4,PSP94,SNP,SNPS,TAKEN,THESE,WILEY
OPERATIVE,SEL
169,2012,AKT,ANNEXIN,BACKGROUND,BCL,COPYRIGHT,EMBELIA,IAP,INC,LABEL,LNCAP,METHODS,PARP,RESULTS,S6K1,WILEY
169,181,200,2012,232,233,234,400,699,8201,CONCLUSION,COPYRIGHT,COX,INC,LABEL,METHODS,OBJECTIVE,PHASE,PSA,PURPOSE,RESULTS,WILEY
141,169,2012,375,378,409,APPLIED,BACKGROUND,BIOSYSTEMS,COPYRIGHT,CRPC,INC,LABEL,METHODS,MIR,RESULTS,RNAS,USING,WILEY
169,2012,AMONG,BACKGROUND,BESIDES,BPH,COPYRIGHT,INC,LABEL,METHODS,PCA,PCR,PEPT1,PEPT2,PHT1,PHT2,POTS,RESULTS,RWPE,THESE,THUS,WESTERN,WILEY
169,2012,217,218,460,8201,AUSTRALIAN,BACKGROUND,CONCLUSION,COPYRIGHT,DATA,INC,LABEL,METHODS,RESULTS,THERE,WESTERN,WILEY
0001,0016,0027,0045,0092,0275,0483,169,2012,2448,261,AKT,COPYRIGHT,ERG,ETS,LOSS,MOLECULAR,PREVALENCE,PTEN,SER2448,UICC
169,2012,COPYRIGHT,INC,POSITIONAL,POSITIONS,SYSTEMATIC,WILEY
CHANGES,FAS,FASN,FATTY,FDA,FURTHER,H1975,H3255,H441,LABEL,METHODS,NMR,NSCLC,OBJECTIVE,PC14,PROCEDURES,PURPOSE,RESULTS,TCA,THESE
169,2011,CD44S,DESPITE,DRG,INC,KAI,MKK4,NM23,PIN,PTEN,RKIP,TEN,WILEY
BACKGROUND,HOWEVER,IMMEDIATE,INSTEAD,LABEL,METHODS,NONE,RESULTS,SEVERAL,THERE
001,002,004,009,029,045,155,2007,499,8805,INCREASING,JAPAN,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,UROLOGISTS
956,CELLS,CONCLUSION,DU145,EMT,ERK,ERK1,FBS,FGF8B,GROUP,LABEL,MEK1,METHODS,OBJECTIVE,PD98059,RESULTS,TRANSWELL
BOTH,DETECTION,EACH,GLEASON,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,SEVENTEEN,TRUS
001,FIFTY,GLEASON,LABEL,METHODS,OBJECTIVE,PCA,PURPOSE,RESULTS,TRANSVERSE
169,2012,213,COPYRIGHT,INC,PAGE4,PATHOLOGY,PCA,PUBLISHED,SOCIETY
145,169,2012,956,ANG,ASSAY,AT1,AT2,AUTOMATED,BLOT,BOTH,BRDU,CELL,CHAMBER,CHANGES,COPYRIGHT,COUNTER,HEALING,III,INC,LNCAP,MIGRATION,TEST,THESE,TRANSWELL,WESTERN,WOUND
169,2013,COPYRIGHT,INC,MEDICAL,MVCT,OAR,PTV,PUBLISHED,THEREFORE
169,2012,25D,945,947,AF2,COPYRIGHT,CYP24A1,INC,PPAR,RXR,T47D,VDR,VDRE
006,058,160,169,2013,932,COPYRIGHT,CSS,GLEASON,INC,LABEL,LDR,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SOCIETY,THERE,TREATMENT
169,2012,COPYRIGHT,ESPECIALLY,GMBH,HIFU,MRI,PUBLISHED
110,148,177,1993,2003,2011,310,317,338,347,492,APRIL,BACKGROUND,BETWEEN,CONCLUSION,HOWEVER,LABEL,METHODS,OBS,RESULTS,THREE,THSM
000,177,2006,2010,499,684,8804,GLEASON,JANUARY,LABEL,METHODS,OBJECTIVE,PSA,RESULTS
001,088,189,280,420,8320,8322,8324,8325,8328,956,AFTER,ALSO,HEPG2,HOWEVER,IGG,IGM,INC,MCF7,METHIONINE,NAB,PC3,PLP,PUBLISHED,RABBITS,RBCS,THERE,THUS,UPON,ZEALAND
108,2000,2011,566,AIPC,AMONG,CONCLUSION,FOUR,GLEASON,III,JANUARY,LABEL,METHODS,OBJECTIVE,OCTOBER,PFS,PSA,RESULTS,SPECIAL
001,169,185,2006,2010,2012,2408,581,8201,841,945,ADD,ADULT,BJU,BLOOD,CONCLUSION,DETECTION,DOES,EDUCATION,EVALUATION,GLEASON,HIGH,III,KNOWN,LABEL,METABOLIC,METHODS,OBJECTIVE,PANEL,PROGRAM,PSA,RESULTS,SUBJECT,TREATMENT,UNLABELLED,WHAT
001,169,2008,2011,2012,240,ADD,AGE,AUTHORS,BJU,DOES,KNOWN,LABEL,MEN,METHODS,OBJECTIVE,OBJECTIVES,PREDICTORS,RESULTS,SUBJECT,TREATMENT,UNLABELLED,WHAT
001,169,2012,6082,693,8201,ADD,BJU,CAPRA,DATA,DOES,KNOWN,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,RRS,SEVEN,SUBJECT,UNLABELLED,WHAT
169,2009,2012,8482,8805,BJU,FSS,LABEL,METHODS,NSRP,OBJECTIVE,OCTOBER,RESULTS
145,169,2012,8226,APOPTOSIS,BJU,BOTH,BPS,CALYCULIN,CELL,CONCLUSION,CURRENT,DETECTION,ELISA,KIT,LABEL,MATERIALS,METHODS,NOW,OBJECTIVE,OBJECTIVES,OKADAIC,PLUS,PP1,PP2A,RESULTS,THERAPIES,UNLABELLED,WESTERN,WHAT,XTT,ZOLEDRONIC
111,169,181,2012,214,8226,945,BJU,BPH,CONCLUSION,HEIDELBERG,HOWEVER,LABEL,LEVEL,METHODS,MODIFIABLE,NUTRITION,OBJECTIVE,OXIDATIVE,PROGNOSIS,RESULTS,RISK,THESE,TYPE,UNLABELLED,WHAT
169,2012,COPYRIGHT,JOHN,LEUPROLIDE,SONS,WILEY
SINCE
HOWEVER,LNCAP,RED,THESE,WHILE
CD166,CD49F,CRPC,LIN,LSC,PTEN,SCA1
AIM,BACKGROUND,CONCLUSION,DCN,DECORIN,E17,E19,EXPRESSION,FIVE,FOUR,LABEL,OBJECTIVE,P28,PRINCIPAL,RESULTS,SPARC,SPRY,TSKU
0002,011,016,031,AKT,DEPLETION,FORK,FOXA1,GLEASON,HOWEVER,IGFBP,LNCAP,MAPK,PSA,THESE
AKT,ANTI,BIOLOGICAL,ERK,HORMONE,INCREASED,LHRH,RECURRENT,RELEASING,THERAPIES
452,AMONG,BACKGROUND,CONCLUSION,DATA,FRESH,HYPOTHESIS,LABEL,METHODS,OBJECTIVE,RESULTS,START,THUS
069,2000,2008,2012,AACR,BACKGROUND,LABEL,METHODS,RESULTS,STATINS,THERE
001,2012,553,694,945,946,AACR,AMONG,BACKGROUND,DHT,GLEASON,HIGH,LABEL,LOW,METHODS,NEITHER,PREVENTION,RESULTS,TRIAL
BLOOD,BPH,DATA,DESPITE,GLEASON,HYPOXIA,PSA,WHERE
CD4,CD8,CTLA,CTLA4,GVAX,IRAE,PHENOTYPIC,TREATMENT
1261,1287,25C,365C,8P22,ALA275PRO,BACKGROUND,CHINESE,DEPLETION,FURTHER,LABEL,LAST,LEWIS,MAIN,METHODS,MMP9,OBJECTIVE,OBJECTIVES,RATIONALE,RESULTS
169,2012,CONFERENCE,COPYRIGHT,CURRENTLY,DENIS,IRELAND,JANUARY,KLOTZ,LTD,PCA,ROTTERDAM,SCIENTIFIC,STEYERBERG,TRACK,UOMO
169,177,2012,956,A2780,A2780CISR,ADP,ALBUMIN,ALTOGETHER,CISPT,COPYRIGHT,III,INC,MCF7,PARP,PC3,PPH,RUTHENIUM,TM34
160,174,AMONG,HOWEVER,III,JEVTANA,MDR,STUDIES,TODAY,TREATMENT
169,2012,COPYRIGHT,DESPITE,INC,REMARKABLY,TRIPARANOL
169,2012,COPYRIGHT,CVD,INC
1500,CRYSTAL,SAR,SMALL
2004,2008,AMUR,KHABAROVSK,KOMSOMOLSK
181,AFTER,DAPI,DR5,LABEL,METHODS,MOST,MTT,NUCLEAR,OBJECTIVE,PURPOSE,RESULTS,SMAC
ABS,BASED,CD3,CD4,CD8,HOWEVER,PSCA,THEIR
153,160,169,183,186,223,EDTMP,FURTHER,GEORG,HEDP,III,RHENIUM,STRONTIUM,STUTTGART,YORK
167,169,183,2004,2011,408,AMICO,BACKGROUND,GEORG,HIFU,III,LABEL,METHODS,PFS,RANDOMIZED,RESULTS,SALVAGE,STUTTGART,YORK
DENOSUMAB,OSTEOCLAST,RANK,SEVERAL
DICE,DSC,DSCS,MEAN
GIVEN,GSMTX,HOWEVER,LNCAP,MSCCA,TRPC1,TRPC3
AFTER,BACKGROUND,CLEVELAND,DOUGLAS,FLORIDA,FOUR,LABEL,METHODS,OBJECTIVE,OPERATIVE,OUTCOME,RESULTS,SETTING,THEN
AFTER
0008,2007,2011,CRPC,DOC,GLEASON,HEMOGLOBIN,HOWEVER,THERE
124,150,160,1998,2001,2007,2011,22RV1,ANTIGEN,FURTHER,HOWEVER,KLK10,KLK3,KLK6,KLKS,PC3,PCA
104,99MTC,BACKGROUND,CTS,CTV,CTVS,FCH,LABEL,LNS,METHODS,PET,RESULTS,SNS,SPECT,THESE
001,153,800CW,9601,AFTER,CONCLUSION,DOTA,DSRED,EPCAM,FULLY,IRDYE,LABEL,LNS,METHODS,NIRF,PC3,PET,RATES,RESULTS,SIMILARLY,UNLABELLED,USING
111,ADC,ADCS,CONCLUSION,CONSISTENT,LABEL,LUCAP,METHODS,MMAE,NONLINEAR,OVERALL,RESULTS,SIMILAR,SPECT,TENB2,UNLABELLED
4MM,8MM,GLEASON,MID
AFTER,CELL,MTT,PC3,PITUITARY,PTTG1,RNAI,SIMILARLY,THUS
946,DU145,ELISA,FURTHER,GDF15,HPV,IL6,LNCAP,NDRG1,OTHER,PCR,RESULTS,SOFT
BONE,DRUG,FOOD,LABEL,OBJECTIVE,ONGOING,PCA,PURPOSE,RESULTS,SUMMARY,THESE
LNCAP,SUSTAINED,THEREFORE
0001,005,027,199,219,438,513,8201,943,969,BACKGROUND,CONCLUSION,CRPC,EBRT,HIGH,LABEL,MET,METHODS,OPN,PCA,PSA,RESULTS,ROC
143,154,160,233,8201,DESPITE,GIVEN,HALF,INSTITUTE,LOIRE,RADIATION,SIXTY,USING
169,2012,946,99M,ALA,BBN,COPYRIGHT,HYNIC,KIT,LTD,SEVERAL
0074,036,058,127,144,164,181,2340,241,277,741,7841,8824,9232,9306,963,968,CONCLUSION,DENOSUMAB,HOWEVER,III,LABEL,METHODS,OBJECTIVE,OVERALL,QALY,QALYS,RESULTS,SRE,SRES
GLY,POST,SENP1,SENPS,SMALL,SUMO,THESE,UBIQUITIN
CNS,GKSRS,THERE
CURRENTLY,HOWEVER,RADIATION
AMHR2,AMONG,BHR,CA125,CA15,CEA,GCT,GCTS,HODGKIN,INCREASED,PROTEOMIC,PTEN,THESE,VCP
0001,115,131,AFFYMETRIX,BIOMARKERS,PAM,THESE
AKT,BOTH,CAP,CD147,CD44,DTX,ERK,EXPRESSION,MAPK,MCT4,MRP2,MTT,PI3K,SELECTIVE,WESTERN
AKT,ECM,ERK,HOWEVER,IGFR,IL6,INCREASES,LNCAP,MAPK,MDA,MEK1,MSCS,PCA,PI3K
169,183,BOTH,GEORG,HOWEVER,III,PSA,STUTTGART,YORK
169,173,183,2010,215,330,BACKGROUND,BETWEEN,CLAVIEN,CONCLUSION,DINDO,GEORG,JANUARY,LABEL,METHODS,MIBC,RESULTS,SEPTEMBER,STUTTGART,VINCI,YORK
005,109,149,205,625,LOC642587,MED1,MIR,TRAP220
DETECTION,EARLY,EDRN,FINALLY,HOWEVER,INSTITUTE,NETWORK
11248,160,946,ADVERSE,BALB,BCL,BOTH,CONCLUSION,HOWEVER,KI67,LABEL,LNCAP,METHODS,OBJECTIVE,PDGFR,PURPOSE,RESULTS,SUNITINIB,THEN,VEGFR,VON,WESTERN,WILLEBRAND
169,2012,BACKGROUND,BASEL,CASE,CONCLUSION,COPYRIGHT,COX2,CRPC,CUSHING,LABEL,METHODS,THERE,TREATMENT
108,169,2009,2012,8804,BASEL,COPYRIGHT,GLEASON,JANUARY,LABEL,MARCH,METHODS,OBJECTIVE,PCA,PCA3,PSA,RESULTS,T1C
000,003,0041,0398,0489,100,169,2012,APHRODITE,ARP,ARPS,BASEL,COPYRIGHT,FIFTY,IHC,LABEL,METHODS,OBJECTIVE,OPEN,PURPOSE,RESULTS,VEIL
0167,3135,8253,ADT,BACKGROUND,C30,CRPCA,EORTC,LABEL,LHRHA,METHODS,OVERALL,QLQ,QOL,RESULTS,THERE,WHETHER
068,090,169,2012,296,354,420,522,581,726,730,BASEL,BLOOD,CAP,COPYRIGHT,HOWEVER,HPLC,THEREFORE,THESE
010,047,1500,169,2012,400,588,650,819,961,AFTER,AMONG,COPYRIGHT,INC,ISPOR,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PEARSON,PUBLISHED,RESULTS,SELECTION,SOCIETY,THERAPY,WANTING,WTP
AFTER,CRPC,CURRENTLY,EARLY,EPIGENETIC,FINALLY,HISTONE,KDM,KDM1A,KDM4C,KDMS,MOST,PCA,PHF8,SINCE,TIC,TICS,WHILE
0237,0329,079,956,COMPOUNDS,LNCAP,PC3,THESE
CHK,EACH,PC3,PCA,PSMA,STUDIES
ASSAY,INHIBITION,SELECTIVE
945,946,ARES,CASTRATION,CATENIN,HIF,HOWEVER,HYPOXIA,LNCAP,THESE
00001,0002,002,AIMS,DATA,LABEL,LIBRARY,METHODS,OBJECTIVE,RESULTS,SEVEN
003,25TH,737,75TH,ANTIGEN,APC,APCS,CD54,CONCLUSION,CUMULATIVE,CYTOKINES,FDA,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIPULEUCEL,THESE,TNC
160,1993,1998,293,298,AFTER,CHINESE,FEW,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SINGAPORE,TEA,THERE
2003,2011,218,233,451,BACKGROUND,CONCLUSION,LABEL,METHODS,NONE,PRIMARY,RESULTS
160,1859,2117,2768,706,8Q21,909,HOPKINS,JOHNS,MRE11,NBN,NBS,PROJECT,RAD50,S706X,SEQUENCING,UNIVERSITY,UTRS
AGILENT,BLUNTED,CURRENT,EXPRESSION,INTRA,LRP,ORP,PCR,RALRP,RIN,VOLCANO
001,145,2007,2009,221,COX,EXPRESSION,GLEASON,HOWEVER,MEIER,MICRORNAS,PCR,PSA,RNAS
176,40GY,60GY,8594,CYBERKNIFE,GENERATED,IMRT,MEAN,NCP,OAR,PLANS,PTV,REDUCED,SBRT
169,2012,22RV1,CELL,COPYRIGHT,DHEA,DHEAS,INC,KNOCKDOWN,LNCAP,OATP,OATP1A2,OATPS,SIMILAR,STX64,THUS
CBCT,DIR,IGART,RANDO
16B,954,COMPONENTS,MMTV,THESE,USING,WNT
BACKGROUND,CONTACT,LABEL,METAOMICS,MICROARRAY,SUMMARY
ONCOPHAGE,UNION
169,2012,26RFA,AIM,CAP,CONCLUSION,COPYRIGHT,DU145,LABEL,LTD,METHODS,OBJECTIVE,RESULTS
1242,2007,215,300,400,498,744,9319,BACKGROUND,BRM,DATA,ECOG,LABEL,METASTASES,METHODS,PALLIATIVE,RADIATION,RESULTS,SPAIN,THESE
0907,8805,ANTIGEN,BACKGROUND,DEPOVAX,DPX,HLA,LABEL,METHODS,NATURALLY,RESULTS,TRIAL,TYPE
BACKGROUND,BOXES,CONCLUSION,EXPERIENCE,FIFTEEN,FOLLOWING,HONEYCOMB,LABEL,METHODS,PROTOTYPES,RESULTS,SEVEN,THREE,USER
181,521,8805,BASED,COMPOSITE,EPIC,GLEASON,INCREASING,LABEL,METHODS,OBJECTIVE,PCA,PSM,PSMS,RESULTS,ULP
104,169,175,2004,2009,2012,279,CONCLUSION,GLEASON,JANUARY,LABEL,MARCH,METHODS,MONTSOURIS,OBJECTIVE,OBJECTIVES,PATIENT,RESULTS,UROLOGICAL
ECM,PCA,SRC,THUS,WHILE
EPCAM,ERG,FACS,FINALLY,GENOMIC,PIN,PRIMARY,PTEN,SCA,TAKEN,THESE,TMPRSS2,VCAP
AZD8542,BASED,CONCLUSION,EXPRESSION,FURTHER,GLI1,HPSC,HPSCS,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SMO,SMOOTHENED,SONIC,THESE
007,125,145,150,160,200,2005,2009,8804,ADVERSE,APRIL,BETWEEN,GRADE,PATIENT,POST,RD1,RV100,RV50,SEPTEMBER,T1C,USAGE
2012,404,AACR,ASSESSMENT,BACKGROUND,CONCLUSION,FACTORS,LABEL,METHODS,PSA,PSAS,RESULTS,SIMILAR,SMOKING,THESE
1993,2001,2012,484,AACR,BACKGROUND,CONCLUSION,CRP,GPX1,GSR,GSTP1,IL10,IL1B,IL1RN,IL6,IL8,LABEL,METHODS,MPO,NOS2,NOS3,RESULTS,SNP,SNPS,SOD1,SOD2,SOD3,TLR4,TNF,VARIATION
DHT,FURTHER,HNTEP,SAMPLES
652,CONFIDENCE,DRE,DRES,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PATIENT,REFUSAL,RESULTS
001,007,160,946,HOWEVER,MATRIPTASE,PC3,TTSPS
169,2012,B16,COLON,COPYRIGHT,MXT,P388,PREVIOUSLY,S180,THESE,TREATMENT,UICC
CELL,VNP
169,2012,CNH,CNH3,CNHS,COPYRIGHT,DOCETAXEL,LTD,PAMAM,PCA,RNASE,SYNTHETIC,USING
032,042,169,2012,554,852,8805,ADRS,ADT,AES,BACKGROUND,CAD,COPYRIGHT,HOT,IAD,LABEL,MANN,METHODS,OBJECTIVE,OUTCOME,PCA,PSA,PUBLISHED,QOL,RESULTS,SETTING,TRIAL,UROLOGY,WHITNEY
169,177,2012,8805,AFTER,BMI,BMIS,CALYPSO,CARTESIAN,COPYRIGHT,DATA,HISTOGRAMS,INC,LABEL,MATERIALS,MEAN,MEDICAL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEATTLE,STRATIFIED,THERE
169,2012,AIM,CONTOURING,COPYRIGHT,CTV,D90,ESTRO,GEC,GUIDELINES,IRELAND,LABEL,LTD,MATERIALS,METHODS,MRI,OBJECTIVE,POST,PROBATE,RESULTS,SEED,THREE,TSE
0001,1146,169,1721,1986,1992,1993,1996,2012,575,CAP,CONCLUSION,COPYRIGHT,GLEASON,INC,LABEL,METHODS,OBJECTIVE,POST,PRE,RESULTS,SCREENING,UROLOGICAL
22RV1,BACKGROUND,CELL,CHIP,DU145,EMT,EXPRESSION,KNOCKDOWN,LABEL,LNCAP,METHODS,OVERALL,PCR,RESULTS,SNAIL,THEREFORE
116,169,2012,22RV1,945,954,JOHN,KIP1,LNCAP,MT1,NOTABLY,PKA,PKC,SONS,WILEY
DESPITE
169,2011,2012,994,AFTER,BACKGROUND,COPYRIGHT,LABEL,LTD,METHODS,RESULTS,RIETE,WHILE
165,169,2009,2010,2012,456,BACKGROUND,COPYRIGHT,DATA,GERMANY,HALF,JOHN,LABEL,LTD,METHODS,RESULTS,SONS,WILEY
169,2012,365,ANXIETY,BACKGROUND,CAUCASIAN,COMPOSITE,COPYRIGHT,CSA,FINALLY,INDEX,JOHN,KENDALL,LABEL,LTD,MAX,MEN,METHODS,PCA,PSA,RANK,RESULTS,SCALE,SONS,SUM,WILEY
102,108,2007,8805,BACKGROUND,EBRT,LABEL,MATERIALS,METHODS,RESPONSES,RESULTS,SPAIN,SPANISH
004,048,160,2008,2011,8805,BACKGROUND,CONCLUSION,FURTHER,GRADE,GROUP,JULY,LABEL,MATERIALS,METHODS,RADIATION,RESULTS,THERAPY
ANTIGEN,CURRENT,ETS,HOWEVER,PCA,RNAS,SINCE,TMPRSS2
001,145,177,APOPTOTIC,BACKGROUND,BRDU,CONCLUSION,ELISA,FITC,INHIBITION,LABEL,METHODS,PCR,RESULTS,RNAI,THEREFORE,VEGF
ANXA2
177,956,ANS,CURRENT,SINCE,WGA,WHEAT
ANTIGEN,APART,DISCOVERY
187,205,222,DU145,EXPRESSION,GAIN,PC3,PCA
001,137,169,2012,318,692,8804,8805,AGE,ANY,BACKGROUND,BOOTSTRAP,COPYRIGHT,HGPCA,IBX,LABEL,METHODS,OBJECTIVE,OUTCOME,PCA,PCA3,PUBLISHED,REGRESSION,RESULTS,SETTING,URINARY,UROLOGY
100,150,1991,2011,COMMISSION,ICRP,PROTECTION,THROUGH,TREATMENT
049,169,2012,ACADEMY,COPYRIGHT,DIET,DIETETICS,INC,NUTRITION,PUBLISHED,THESE
130,169,2000,2007,2012,24H,AMICO,ANALYSING,COPYRIGHT,FURTHER,IMAGE,IRELAND,LABEL,LTD,MATERIALS,MEIER,METHODS,OBJECTIVE,PDR,PHOENIX,PSA,PURPOSE,RESULTS,SEVENTY,T1C,THERE
104,125,169,2012,8804,8805,COMPOSITE,EVEN,INDEX,LABEL,LIFE,METHODS,OBJECTIVE,OBJECTIVES,QUALITY,RESULTS,SCORE,SYMPTOM,THEIR,URINARY,UROLOGICAL
008,590,8805,CSS,EBRT,FFBF,FFM,GLEASON,HOWEVER,LABEL,MATERIALS,METHODS,MIBC,NCCN,OBJECTIVE,PCV,PPC,PSA,PURPOSE,RESULTS
169,2012,AMONG,OTHER,QUITE,UROLOGICAL
1252,177,8201,BACKGROUND,CTV,LABEL,METHODS,PTV,RESULTS,STUDIES,SYSTEMATIC
CVD,HOWEVER,SINCE,THERE,THESE
001,2009,701,CONCLUSION,CRUDE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,YET
026,BACKGROUND,BRIEF,CONCLUSION,DENOSUMAB,INVENTORY,LABEL,PAIN,RESULTS,SRE,SRES
169,181,2012,392,783,8201,AFRICAN,AMERICANS,BACKGROUND,CALIFORNIA,COPYRIGHT,FURTHER,HAWAIIANS,HOWEVER,INC,LABEL,LATINOS,METHODS,RESULTS,WILEY
100,192,1994,1995,2002,2006,2009,253,429,594,8805,AFTER,AMONG,BACKGROUND,BETWEEN,DIAGNOSTIC,END,JANUARY,LABEL,METHODS,RESULTS,SEER
169,2012,BACKGROUND,BARR,BECAUSE,BOTH,COPYRIGHT,EBV,EPSTEIN,HPV,INC,LABEL,METHODS,PCR,RESULTS,THESE,WILEY
AUTO,B16F0,B16F1,CONVERSELY,COOH,GRP78,HEP3B,HEPG2,PC3,SUBA,THERE,THESE
946,ACT,BACKGROUND,ELISA,EPIGENETIC,GNMT,LABEL,METHODS,PCA,PCR,RESULTS,SNP,SNPS,TOTAL,VEGF
001,003,004,011,094,132,2012,444,946,AACR,ASIAN,BACKGROUND,BLAND,BMI,BSA,HCT,LABEL,METHODS,PSA,RESULTS,THERE
169,2012,36TH,AACR,ASPO,DRS,FRANK,MARCH,MEETING,PAOLO,PREVENTIVE,REBBECK,SAHARAN,SOCIETY,THERE,TIMOTHY,WASHINGTON
169,2012,ABL,COPYRIGHT,DESPITE,DHA,EPA,HOWEVER,III,LTD,THESE
089,177,1998,2008,2009,3085,326,794,8201,894,956,BACKGROUND,CADMIUM,CONCLUSION,LABEL,MEAN,METHODS,RESULTS,SWEDISH
177,239,8201,8805,ACCORDING,BACKGROUND,CONCLUSION,CRPC,LABEL,MEAN,METHODS,PSA,RESULTS,SAGOPILONE,SIMON
169,2012,AACR,CAF,CAFS,CONVERSELY,EMT,GLUT1,HENCE,HIF1,MCT1,MCT4,METABOLIC,SIRT3,WARBURG
ACC,AICAR,AMPK,BDMC,CBL,COA,CUR,DMC,EGFR,FASN,HSP,HSP70,PC3,PP2A,SHP
2012,916,BECAUSE,BRITISH,CASODEX,GOVERNMENT,JOURNAL,PUBLISHED,THC,USA
111,160,162,311,418,8202,945,AMONG,BACKGROUND,CONTEXT,E26,EPR3864,ERG,FUSIONS,LABEL,METHODS,OBJECTIVE,RESULTS,THUS
BACKGROUND,CHIP,COUPLED,LABEL,RESULTS,SEQ,WHILE
22RV1,CWR,CWR22,IL13,OPN,TIMP2,WHILE,XMRV
169,2012,COPYRIGHT,JOHN,LTD,SONS,WILEY
000,169,1983,1985,2008,2012,2277,739,8000,BACKGROUND,COPYRIGHT,END,LABEL,METHODS,PSA,RESULTS,SEER,SOCIETY
2002,2010,8805,917,AUC,AUCS,BMI,CAP,DRE,ITALIAN,ITALY,LABEL,MEN,METHODS,OBESE,OBESITY,OBJECTIVE,PSA,PURPOSE,RESULTS,ROC,THERE,UNIVERSITY
BACKGROUND,CASE,IMT,LABEL,METHODS
183,CENTRAL,GEORG,PSA,STUTTGART,YORK
169,2012,COPYRIGHT,CUL4,CUL4A,DAMAGED,DDB1,DDB2,HENCE,LNCAP,LTD,PC3,THEREBY
169,2012,946,CD109,COPYRIGHT,INC,INSTEAD,PATHOLOGY,PUBLISHED,SMAD2,SOCIETY,STAT3,THESE
169,2012,AFRICAN,COPYRIGHT,HOWEVER,INC,MEDICINAL,MOST,WEST,WORLD
1994,2007,BACKGROUND,BARCELONA,DP2,FIRST,HOUSING,LABEL,METHODS,POPULATION,RESULTS,SIXTEEN,SPANISH,THIRD
145,169,2012,COPYRIGHT,INC,LNCAP,PCR,PWR,RYR,RYR1,RYR2,RYR3,RYRS,THREE,TOTAL
169,2012,BASEL,CD103,CD20,CD25,COPYRIGHT,FINE,FLOW,HAIRY,HCL,PET
169,2012,COPYRIGHT,ISSUE,LOW,PROTEOMICS,PSA,SPECIAL,SRM,THESE
ADT,ANXIETY,BACKGROUND,COGNITIVE,CONTROL,DEPRESSION,DISCUSSION,GROUP,INVENTORY,LABEL,METHODS,ROSENBERG,SCALE,SELF,STATE,STUDIES,TRAIT,TRIAL
027,029,046,169,2012,708,8805,AMONG,CONCLUSION,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THESE,UROLOGICAL
CANCERS,HOWEVER
100,181,ANNEXIN,BAPTA,BHQ,INCUBATION,INHIBITION,PC3
USA,WHILE

BOTH,HOWEVER
223,CRPC,CURRENTLY,FDA,MDV3100,PSA,THESE
AKT,AKT1,CELLS,FURTHER,HOWEVER,PI3,PIN,SKP2,THESE,TRANSGENIC
001,032,042,601,8804,ACM,ADT,BMP5,CASP3,COX,GWAS,IRS2,MARKERS,MEIER,PCSM,PROGNOSTIC,SEVERAL,SNPS,THREE
167,AMONG,FCS,GENERAL,GMM,GSDS,IL6,KARNOFSKY,NFKB,SCALE,SLEEP,SNPS,VARIATION
1970S,BECAUSE,HOWEVER,NOVEL,TRUS
100,174,BACKGROUND,CONCLUSION,CTCS,EGFR,FIRST,LABEL,METHODS,RATES,RESULTS,TREATMENT
001,025,945,947,APC,BACKGROUND,BPH,CONCLUSION,COX2,FXR,LABEL,LPC,LXR,METHODS,PPAR,RAR,RESULTS,RXR,TMA,TNF
112,115,174,CONCLUSION,GLEASON,LABEL,MATERIALS,METHODS,MRI,NAVIGATION,OBJECTIVE,OBJECTIVES,PRIMARY,RATE,RESULTS,SUSPICIOUS,T2W,THERE,TRUS,UROSTATION
1577,300,956,BACKGROUND,CONCLUSION,CRPC,HOWEVER,LABEL,METHODS,PSA,RESULTS,TRANSIENT
2012,AIM,ASF,BACKGROUND,CONCLUSION,DATA,FOUR,IGF,JANUARY,LABEL,MATERIALS,MEDLINE,METHODS,OBJECTIVE,RESULTS
728,ADT,AIM,BACKGROUND,CONCLUSION,LABEL,METHODS,MOST,OBJECTIVE,RESULTS,THEIR
169,2012,25TH,961,ADC,ADCS,CHO,CIT,CONCLUSION,FIFTY,LABEL,LRM,MATERIALS,MAXIMUM,METHODS,OBJECTIVE,PURPOSE,RESULTS,RSNA,THESE
555,KOLMOGOROV,PATIENT,SINCE,SMIRNOV
2009,2010,5245,CTV,D95,DOSE,HOWEVER,IMRT,INTENSITY,JAPAN,LOW,MEAN,OCTOBER,PTV,REGULAR,THEREFORE,THESE,V95
946,DU145,EXOGENOUS,KNOCKDOWN,LNCAP,NODAL,PC3,REDUCED,RWPE1,SIMILAR,SKI,SMAD2,SMAD3,TGF,WPE
160,177,438,DRR,EUCLIDEAN,THERE
2000,2006,AMONG,BETWEEN,GLEASON,LYMPHATIC,MEANWHILE,PSA
000,113,130,1836,192,2009,201,2010,2011,240,337,3DCRT,529,586,663,816,939,CARE,FTE,GAMMA,IMRT,JANUARY,JAPAN,KNIFE,LINAC,MARCH,PCS,RADIOLOGY,RALS,ROS,SOCIETY,THERE,THESE
INTRA,PAI,THEN,TRUS
100,125,DIGITAL,FIRST,HOWEVER,THEREFORE,THIRD
ALTERED,DU145,LNCAP,RWPE,THESE,VCAP
145,611,8201,8594,945,946,ANEUGENIC,G21,GENISTEIN,GENOTOXIC,H2AX
169,2012,AKT,AMONG,COPYRIGHT,DUAL,FISETIN,INC,PI3K,USING
145,945,946,947,ACTH,AMONG,FURTHER,GPCRS,LNCAP,MC2R,MCR,MCRS,MTT,PC3,SHU9119,THEIR
SIADH
2009,2011,8648,ACUTE,BACKGROUND,BLADDER,COLORECTAL,CONCLUSION,DEC,ESOPHAGEAL,HODGKIN,INCIDENCE,INDIA,JAN,KASHMIR,LABEL,LUNG,MATERIALS,METHODS,MYELOMA,NON,OVARY,PATTERN,RCC,RESULTS,SKIN,STOMACH,URINARY
100,169,2012,400,ALONG,AUC,COPYRIGHT,DIFFERENT,INTEGRATED,ISSUE,SEREX,SERPA,SPECIAL,TAA,THUS
169,2012,ALZHEIMER,COPYRIGHT,EACH,INC,PARKINSON,PATHOLOGY,PUBLISHED,SOCIETY
169,2012,945,946,CONSISTENT,COPYRIGHT,CXCR4,DU145,INC,LNCAP,PC3,PCA,RWPE,THESE
169,2012,791,8804,8805,ADDITIONAL,BACKGROUND,COPYRIGHT,DRE,GLEASON,LABEL,METHODS,OBJECTIVE,OUTCOME,PCA,PSA,PUBLISHED,RANDOMIZED,RESULTS,ROTTERDAM,SCREENING,SETTING,T2B,THESE,UROLOGY
169,2001,2003,2005,2007,2012,4693,5003,B13,BACKGROUND,CAPS,COPYRIGHT,G84E,HAPLOTYPE,LABEL,METHODS,OBJECTIVE,OUTCOME,PUBLISHED,RESULTS,SETTING,STOCKHOLM,SWEDISH,UROLOGY
169,2012,241,AROMATASE,BOTH,COPYRIGHT,EARLY,ESPA
169,2012,COPYRIGHT,INC,MEDLINE,TODAY
150,169,174,200,2012,ANTIGEN,ATTENTION,BACKGROUND,BXT,CASES,CONCLUSION,COPYRIGHT,DOSIMETRY,EACH,GLEASON,IPSS,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PSA,PURPOSE,RADIATION,RESULTS,SCORE,SYMPTOM,THERE
169,2012,22RV1,CONCLUSION,COPYRIGHT,DU145,GOLGI,GOLM1,HOWEVER,INC,LABEL,LNCAP,METHODS,OBJECTIVE,RESULTS,THERE,THESE,WESTERN
169,2012,COPYRIGHT,FINALLY,FUNCTIONAL,HOWEVER,INC,PET,SENSITIVE,SPECT,THERE
020,042,044,120,169,2010,2011,2012,967,AMONG,BACKGROUND,CONTINENCE,COPYRIGHT,FURTHER,JANUARY,LABEL,LRP,MANN,METHODS,OBJECTIVE,OUTCOME,PEARSON,PSA,PUBLISHED,RARP,RESULTS,SETTING,WHITNEY
001,003,012,100,112,169,183,1994,2011,2012,203,212,290,328,396,8804,AFTER,BACKGROUND,COPYRIGHT,DFS,DSS,FIFTY,FOCAL,LABEL,METHODS,OBJECTIVE,OCTOBER,OUTCOME,PSA,PUBLISHED,RESPECTIVE,RESULTS,SALVAGE,SETTING,SUFFICIENT,UROLOGY
ABERRATION,BACKGROUND,CCNE1,CMDS,CNA,CNAS,COPY,KRAS,LABEL,MYC,OPEN,OPERATING,PERL,RESULTS,SAIC,SCA,SCAS,SMART,SOMATIC,STAC,SUPPORTED,SYSTEMATIC,THREE
FINALLY,G202,PSMA,THESE
500,552,956,AFTER,CD31,LABEL,METHODS,MHZ,OBJECTIVE,OBJECTIVES,RESULTS,SIXTEEN,SONOGRAPHY
BACKGROUND,DWI,LABEL,MEDLINE,METHODS,MRI,MRS,OVID,RESULTS,SURFACE,SYSTEMATIC
169,183,BOTH,CONCLUSION,DATA,GENERAL,GEORG,GPS,IDEALLY,IDM,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PSA,RESULTS,STUTTGART,YORK
945,947,948,ACTIVATION,HOWEVER,PPAR,TMT,USING
000,200,500,BACKGROUND,CONCLUSION,LABEL,LOSS,METHODS,RESULTS,WHETHER
025,062,160,169,177,2013,236,300,COMPARISON,COPYRIGHT,DTA,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PEARSON,PTV,PURPOSE,RESULTS
005,169,188,1993,2008,2013,218,274,326,8804,ADT,BASED,COPYRIGHT,FAVORABLE,FFF,GLEASON,INC,LABEL,MEIER,METHODS,OBJECTIVE,PSA,PURPOSE,RECURSIVE,RESULTS,T1C,T2A,T2B,T2C,THREE
169,2012,ADLS,ANAL,COPYRIGHT,CROWN,EACH,EFFECTS,FIVE,INC,LABEL,LATE,MANAGEMENT,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,STUDIES,SUBJECTIVE,THESE,TISSUES,TOTAL
169,2012,241,BOTH,CHOLINE,COPYRIGHT,ESPA,MRI,PET,PSA
112,1961,1973,2008,210,341,490,BACKGROUND,BECAUSE,END,LABEL,METHODS,PROGRAM,RESULTS,SWEDISH
001,016,144,183,327,AMICO,GLEASON,LABEL,LRP,METHODS,NRS,OBJECTIVE,RALRP,THERE,THEREFORE
001,118,18K,2002,2005,2008,2205,266,32K,34K,46K,473,666,AFTER,BACKGROUND,CHARGES,COLLEGE,CRS,HIGH,INCREASING,INPATIENT,LABEL,LOS,MEAN,MEN,METHODS,MIP,NATIONWIDE,NSQIP,OBJECTIVE,PROGRAM,PURPOSE,QUALITY,RESULTS,RRP,THC,ZIP
062,100,1000,110,128,153,200,2011,2012,208,254,BACKGROUND,BETWEEN,JANUARY,JULY,LABEL,LRP,METHODS,OBJECTIVE,PSA,PURPOSE,RADICAL,RALP,RESULTS,THERE
1000,169,2000,2005,2006,2007,2011,2012,629,702,853,917,BJU,BOOTSTRAP,EPE,GLEASON,HOPKINS,JANUARY,JOHNS,JULY,LABEL,MEN,METHODS,MOST,OBJECTIVE,PSA,RESULTS,T1C,T2B,T2C
FOUR,ICP,III,NGF,PKH
177,178,179,8201,946,AFTER,MBQ,PCA,PLLA,SPECT,THESE,WBC
231,945,946,ATTACHMENT,ERK,MCF,MDA,MEK,MLC,RAF,RAS,SKOV3,TEM,THESE
0001,103,169,2013,8201,GSTP1,INC,INDUCTION,LNCAP,LOSS,OHDG,ROS,RWPE1,SILENCING,THESE,WILEY
001,169,200,2012,204,ASIAN,BRAF,CHINESE,COPYRIGHT,EASTERN,ERG,ERK,GLEASON,HIGH,INC,KRAS,MEK,PTEN,RAF,RAF1,RAS,TMPRSS2,USING,V600E,WESTERN,WILEY
0001,178,313,505,8804,AAM,AFRICAN,LOUISIANA,NORTH,PATIENT,PCAP,PROJECT,SINCE
AGGRESSIVE,FOXP3,HOWEVER
006,047,1980,2009,373,A28,AUSTRALIAN,HLA,IIM,SIR,SOUTH,THERE
949,99M,ACA,GRPR,HOWEVER,HYNIC,SPECT
169,2012,945,AKT,CK2,COPYRIGHT,IAP,LNCAP,LTD
CRPC,CSF,PAP,SIP,SIPULEUCEL
169,2012,ALTOGETHER,ATM,BASEL,BRCA1,BRCT,COPYRIGHT,CTIP,E2F1,FINALLY,KU55933,PC3
DRUG,EXTENSIVE,FOOD
1009,1029,1069,1182,1345,1447,1666,1727,1799,1994,1997,2362,309,3341,343,442,5039,628,686,BACKGROUND,DIETARY,FFQ,HODGKIN,LABEL,METHODS,NHL,ODDS,ORS,RESULTS
009,177,181,328,BACKGROUND,BPH,DIAGNOSIS,EXPRESSED,HOWEVER,LABEL,METHODS,PSA,RESULTS,SERUM
947,ADT,ASC,CASODEX,PCA,THEREFORE,USING
001,169,190GY,192,1998,2009,2013,229,4GY,5GY,8805,AMONG,BETWEEN,CONCLUSION,COPYRIGHT,EBRT,GLEASON,GRADE,HDR,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PSA,PUBLISHED,PURPOSE,RESULTS,SEVEN
AKT,CRPC,PARTICULAR,PI3K,THUS
169,2012,ACADEMY,DENOSUMAB,RANK,RANKL,YORK
177,8201,8725,INCREASING,LABEL,METHODS,MHZ,MRI,OBJECTIVE,PURPOSE,REAL,RESULTS,TREATMENT,TREATMENTS
286,5000,948,DOSE,HDR,LABEL,METHODS,NPIP,OBJECTIVE,PURPOSE,RESULTS,THESE
125,218,265,BESIDES,D10,D90,ESTRO,GEC,LABEL,METHODS,NDR,OBJECTIVE,PATIENT,PID,PURPOSE,RESULTS
225,264,8725,ACT,DSS,INSURANCE,IRB,KAPPA,LABEL,LEAVE,METHODS,MRI,OBJECTIVE,PURPOSE,RATER,RESULTS,SEGMENTED,SEVEN,SVM,THERE,THESE,THUS
ADVERSE,CEDIRANIB,STUDIES,VEGF
946,CONSISTENT,TRAMP
946,ACUTE,BCL,CONSISTENT,CRMA,GSK,HOWEVER,MCL,PANC,PARP,PPC,THESE,TRAIL
003,046,106,10Q21,129,12P12,15Q26,17P13,17Q21,1P13,215,2P16,2P23,4Q13,791,7Q21,8Q21,GCKR,GWAS,LHCGR,LOCI,NR2F2,PRMT6,SEX,SHBG,SLCO1B1,SNPS,T2D,TDGF3,THESE,UGT2B15,USING,XQ22
390,524,CONSISTENT,GLY,KENNEDY,PRO,REMARKABLY,SIMILARLY,SUMO
169,2012,COPYRIGHT,GMBH,KGAA,VCH,WILEY
190,193,8805,CONCLUSION,CRPC,DLT,DOSE,GRADE,LABEL,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS,SILTUXIMAB,THESE,TOXICITIES
014,113,139,483,571,60S,897,AIM,AUD,AUD12,AUD17,AUD19,AUD32,COSTS,EUR,FULL,HBOT,LABEL,METHODS,OBJECTIVE,POST,RESULTS,THERE
0055,177,4667,CHI,KAPPA,LABEL,METHODS,OBJECTIVE,PERFORMED,PURPOSE,RESULTS,RTE,THUS
169,2012,946,COPYRIGHT,FOLLOWING,LTD,PEG,VEGF
104,169,177,2001,2004,2010,2012,297,635,AACR,BACKGROUND,FURTHER,LABEL,METHODS,RESULTS,SHBG
BACKGROUND,DESPITE,DISCUSSION,GERMANY,LABEL,METHODS,PROJECT,TRIAL
34A,COMPARISON,DU145,IPA,LNCAP,PC3,PCR,RWPE
000,2010,2030,231,600,700,ACCORDING,ANGOLAN,BACKGROUND,CONCLUSION,DATA,ESPERAN,HOSPITALS,HOWEVER,IMPROVING,LABEL,MALARIA,METHODS,RESULTS,SAGRADA,THUS
FURTHER,GHRELIN,GHSR
1999,2009,620,ABDOMINAL,CONCLUSION,GLEASON,LABEL,MANN,MATERIALS,METHODS,OBJECTIVE,PSA,RESULTS,THERE,WHITNEY
0435,7294,954,AREAS,COHEN,CONCLUSION,FIFTY,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,RESULTS
CONCLUSION,LABEL,OBJECTIVE,PET
2004,2008,BACKGROUND,DENMARK,FRAILTY,LABEL,METHODS,RESULTS,RISK,STATISTICS
490,8201,BACKGROUND,BLACK,LABEL,METHODS,OBJECTIVE,POST,PURPOSE,RESULTS,THERE
169,2012,8201,AMONG,ARG,BSTU1,COPYRIGHT,HPV,INC,IRANIAN,PCR,PCRRFLP,PRO,TP53,WILEY
954,AKT,DU145,EMSA,ERK,JNK,JUN,LNCAP,MAPKS,MMP,MTT,USING
1085949,121,1900,1960,ADULT,AFTER,BACKGROUND,CONCLUSION,HRS,LABEL,METHODS,RESULTS
1987,2000,2007,650,BACKGROUND,CONTINUED,DIAGNOSIS,LABEL,METHODS,MORTALITY,NETWORK,NINTH,ORGAN,RESULTS,SEVERAL,SKIN
AIM,BACKGROUND,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,SCCP,SMALL,THERE
0001,1020,103,2908,ACCORDING,HORMONE,LABEL,METHODS,NCCN,OBJECTIVE,POST,PURPOSE,RAD,RESULTS
000,1985,200,2004,2006,AIMS,BACKGROUND,LABEL,METHODS,OBJECTIVE,RESULTS,TUSCANY
233,ALSO,BCG,CSS,DESPITE,HRBC,LABEL,MEDLINE,OBJECTIVE,PURPOSE,RESULTS,SUMMARY,TUR
0001,CRPC,CURRENT,CYP17,DRUG,FDA,FOOD,III
954,BMAS,CHI,CPCS,DTCS,GLEASON,HOWEVER,MMP,PHENOTYPIC,PSA
SGEF,SH3
000,100,AREA,BACKGROUND,CENTERS,CONCLUSION,CONTROL,DISEASE,FILE,HOWEVER,INSTITUTE,LABEL,METHODS,RESULTS,THERE,USING
CAA,DATA,HGPIN,NEP,PCA,SSTR,SSTRS,TAKEN
169,2012,COPYRIGHT,LTD
388,496,BACKGROUND,CONCLUSION,LABEL,PSCA,RESULTS
169,1996,2012,946,ASIA,COPYRIGHT,INC,WESTERN
124,169,2012,945,946,ACCEPTABLE,COPYRIGHT,CURRENT,ESI,PCA,PEI,PRECISION,PSA,SPE
0001,001,169,2012,358,406,COPYRIGHT,GENOTYPING,INC,MT2A,PCR,RFLP,SNP,SNPS,THREE
001,020,036,100,120,137,169,2010,2011,2012,301,309,369,430,561,760,8805,AKT,AMICO,AMONG,AUTHORS,BJU,HIGH,INVENTORY,IQR,JANUARY,LABEL,LNS,LNY,LNYS,LOW,MAY,MEN,METHODS,OBJECTIVE,OBJECTIVES,PLND,RESULTS,THERE
3591,3799,CAUCASIANS,MED,MEDLINE,OVERALL,PUB,THEREFORE,V109G,WEB
1195,OVERALL,P450,THERE,TREATMENT,UNION
001,004,169,2008,2010,2012,267,8805,AACR,AFRICAN,AMERICANS,ANTONIO,BACKGROUND,COX,HISPANICS,LABEL,METHODS,PSA,RESULTS,SAN,TIME
008,013,023,026,035,1096,1140,717,CALIFORNIA,EPHX1,GSTM1,GSTP1,GSTT1,HCAS,NAT2,PCA,PTGS2,RED,SNP,SNPS
400,792,954,CALIFORNIA,CONCLUSION,DISCUSSION,FAVORABLE,FURTHER,LABEL,MATERIALS,METHODS,OBJECTIVE,PERMANENTE,REPORTS,RESULTS,SAS,SCENT,TRAINED
169,2012,AKT,BACKGROUND,COPYRIGHT,FOXO1,INC,LABEL,LNCAP,METHODS,PI3K,PTEN,RESULTS,RNAI,TRANSITION,WILEY,WORTMANIN
032,122,169,2000,2012,212,263,303,448,6515,655,776,8201,946,ADT,BACKGROUND,COPYRIGHT,COX,DATA,GLEASON,HOWEVER,INC,LABEL,METHODS,NORWEGIAN,OSLO,PCA,PSA,RESULTS,STATISTICS,WILEY
0001,008,046,118,169,173,2007,2011,2012,291,743,8201,8482,BACKGROUND,BETWEEN,COPYRIGHT,DETECTION,ERG,GLEASON,GRADE,INC,LABEL,METHODS,PCA,PCA3,PSA,RESULTS,TMPRSS2,UNIVARIATE,WILEY
169,2012,COPYRIGHT,ERG,ETS,PSA,RESULTANT,SIX,SLC45A3,TMPRSS2,UICC
001,100,169,2012,215,8201,8804,AUCS,BACKGROUND,BECKMAN,COPYRIGHT,HOWEVER,INC,LABEL,METHODS,PCA,PCA3,PSA,RESULTS,ROC,WILEY
002,155,169,2007,2011,2012,282,829,8804,AUC,COPYRIGHT,GLEASON,INC,LABEL,LNI,MATERIALS,METHODS,OBJECTIVE,PCA,PSA,PURPOSE,RESULTS,WILEY
100,169,174,2012,228,CALGARY,COPYRIGHT,DIGITAL,EACH,EIGHT,FOUR,FURTHER,INTERVIEW,JOHN,LABEL,LTD,METHODS,NINE,OBJECTIVE,RECORDING,RESULTS,SEMI,SIXTY,SONS,STRUCTURED,VANCOUVER,WILEY
004,005,006,150,169,1974,1988,2007,2012,568,8805,CIS,COPYRIGHT,COX,HODGKIN,HRS,INVERSE,NHL,NORWEGIAN,PHFO,PHVO,TFA,UICC
001,003,2004,2007,231,552,569,735,8804,BETWEEN,GLEASON,HOWEVER,LABEL,MEN,METHODS,OBJECTIVE,PCA,PSA,PURPOSE,RESULTS
145,169,2012,231,47D,946,COPYRIGHT,FINALLY,INC,LRP6,MDA,SILIBININ,WNT,WNT3A
8212,H3K9ME3,TESTING
169,2012,ANO1,CA2,CACC,CACCS,COPYRIGHT,GLEASON,IRELAND,LNCAP,LTD,PCR,RNAS,THESE,TMEM16A,TNM,WESTERN,WST
169,2012,8467,COPYRIGHT,HOWEVER,LTD
169,2012,ATP,CLQ,COPYRIGHT,INC,LNCAP,MODULATION,PCA,TAKEN
169,176,177,179,2013,360,COPYRIGHT,CTV,D30,D99,DOSE,FIVE,INC,MEDICAL,PTV,PUBLISHED,RESULTS,SOFT,VMAT
100,169,185,190,196,2012,204,220,COPYRIGHT,DWI,INC,PMB,TEN
169,2012,239,252,COPYRIGHT,INC,KLF6,LNCAP,NPS,PATHOLOGY,PCS,PUBLISHED,SIXTEEN,SOCIETY,SVS
1000,169,2008,2011,2012,250,AEU,ASAP,BACKGROUND,COPYRIGHT,HOWEVER,LABEL,METHODS,PUBLISHED,RESULTS,SEVEN,THERE
046,132,169,2012,414,718,AFTER,COPYRIGHT,CURRENT,EDUCATION,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,RADICAL,RESULTS,UROLOGICAL
169,1975,2009,2012,209,379,419,ACTUARIAL,CLOSE,COPYRIGHT,EDUCATION,INC,IQR,LABEL,MATERIALS,MEN,METHODS,MOST,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,RESULTS,STATISTICS,THESE,UROLOGICAL,VITAL
015,169,174,2012,COPYRIGHT,COX,EDUCATION,FAILURE,INC,LABEL,MALIGNANT,MATERIALS,METHODS,NOTABLY,OBJECTIVE,PREDICTORS,PUBLISHED,PURPOSE,RESONANCE,RESULTS,STENT,THREE,UROLOGICAL
169,174,2000,2011,2012,AVERAGE,COPYRIGHT,EDUCATION,EIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PATIENT,PUBLISHED,PURPOSE,REMOVAL,RESULTS,TEN,TREATMENT,UROLOGICAL,UROLUME
100,101,145,150,169,177,2007,2013,3CM,414,4CM,CENTRAL,COPYRIGHT,DOSIMETRIC,INC,LABEL,LOW,MATERIALS,METHODS,MOST,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SCANS,SOCIETY,THERE,THESE
00001,0001,129,1514,169,2012,8805,967,BACKGROUND,COPYRIGHT,DIGITAL,ESUR,IMAGING,LABEL,MANN,METHODS,MRI,OBJECTIVE,OUTCOME,PCA,PEARSON,PUBLISHED,RADIOLOGY,RESULTS,SETTING,SOCIETY,UROGENITAL,WHITNEY,WIDE,YATES
036,042,169,180,2000,2003,2012,360,807,BACKGROUND,BPFS,COPYRIGHT,COX,INC,LABEL,MEAN,METHODS,PLND,RESULTS,THERE
169,2012,945,946,AKT,COPYRIGHT,HENCE,LIVER,LTD,LXR,LXRS,OXYSTEROLS,RECEPTORS,THERE,THESE
001,169,177,2012,800,ADC,CONCLUSION,COPYRIGHT,DIFFUSION,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,USING
169,2012,215,346,500,AUC,COPYRIGHT,EACH,EDUCATION,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,ROC,UROLOGICAL
169,2012,945,946,ARA70,CELL,COPYRIGHT,DU145,DUE,EDUCATION,INC,LABEL,LNCAP,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RC165,RESULTS,RU486,TREATMENT,UROLOGICAL,WESTERN
100,169,176,2012,50MG,945,946,ANDROGENS,BPH,COPYRIGHT,CROWN,DHT,ETOAC,FMP,LLOQ,LOWER,PUBLISHED
10MM,169,2013,CBCTS,COPYRIGHT,CTS,CTV,CTVS,DOSES,EACH,HULL,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PTV,PURPOSE,RED,RESULTS
125,169,179,185,2012,COPYRIGHT,FORTY,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PSA,PSAS,PUBLISHED,PURPOSE,RESULTS,SOCIETY,THERE
1990S,22RV1,PUBLISHED,WHILE,XMRV
169,2012,BASED,COMMITTEE,COMPETENCE,COPYRIGHT,DUE,FEDERAL,FUNDS,GKV,GMBH,HOWEVER,INSURANCE,IQWIG,JOINT,MDK,MDS,PSA,PUBLISHED,STATUTORY
124,169,2012,COPYRIGHT,DEPENDING,EDUCATION,GLEASON,INC,LABEL,MATERIALS,MAXIMUM,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
169,2000,2001,2012,876,ACOS,CENTERS,COLLEGE,COMPLIANCE,COPYRIGHT,EDUCATION,EFFORTS,GIVEN,INC,INSTITUTE,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RAND,RESULTS,THEREFORE,UROLOGICAL,USING
045,069,169,2012,285,372,AFTER,COPYRIGHT,EDUCATION,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,ROUTINE,THERE,UROLOGICAL
009,169,2012,437,446,AMICO,COPYRIGHT,COX,EDUCATION,GLEASON,INC,LABEL,MATERIALS,MEIER,META,METHODS,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,RESULTS,UNIVERSITY,UROLOGICAL,YORK
122,154,169,179,2012,208,276,945,COPYRIGHT,EDUCATION,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
001,002,013,015,022,028,169,2003,2007,2012,732,AMONG,ASIAN,COPYRIGHT,EDUCATION,END,INC,LABEL,MATERIALS,METHODS,MINIMALLY,OBJECTIVE,OBTAINING,PATIENT,PUBLISHED,PURPOSE,RESULTS,SEER,UROLOGICAL,USING
174,2004,327,AMONG,CRPC,DOCETAXEL,HOWEVER,III,SINCE,TAX
123,169,2012,916,99M,BACKGROUND,BOTH,CONCLUSION,COPYRIGHT,CROWN,HOWEVER,INC,LABEL,METHODS,PAI,PEGYLATED,PEGYLATION,PUBLISHED,RESULTS,SPECT,THESE,WHOLE

007,022,029,046,150,239,8202,BACKGROUND,G16129A,GLEASON,LABEL,PRINCIPAL,PSA,RESULTS,T16224C,T16311C,T16356C,THESE,USING
CDK4,CNA,CNAS,EGFR,SCES,SOMATIC
003,022,027,666,708,8202,AKT,AKT2,BACKGROUND,CHINESE,CONCLUSION,GLEASON,LABEL,METHODS,ODDS,PCA,PSA,PTEN,RESULTS,SNPS
CDC42,CONVERSELY,ELECTRICAL,HELA,MIMICKING,NIPP1,NOTABLY,PP1,REMARKABLY,TAKEN,THESE
169,2012,2206,8669,AACR,AKT,CRPC
169,2010,2012,205,217,29B,529,COPYRIGHT,DU145,HOWEVER,IPO7,LNCAP,MOL,PCA,RES,UICC,VEGF
301,BOTH,COU,CRPC,III,MDV3100,SIPULEUCEL
001,102,11C,124,185,354,400,542,721,730,AFTER,ASTRO,AUC,BCR,CHOLINE,DETECTION,EBRT,ECAT,LABEL,MBQ,METHODS,OBJECTIVE,PASW,PET,PSA,PURPOSE,RESULTS,ROC,SIEMENS,STATISTICS,TOTAL
BCG,LABEL,OBJECTIVE,PURPOSE,RESULTS,SUMMARY,THEREFORE
001,100,133,139,161,2000,2010,BACKGROUND,CONCLUSION,LABEL,METHODS,OPHIOLITES,ORS,PPS,RESULTS,SAMPLES,SIVAS
ACTIN,CHINESE,CIP1,DHCF,DU145,LABEL,LNCAP,METHODS,MTS,OBJECTIVE,PC3,PCA,PURPOSE,RESULTS,WHILE
126,169,2006,2012,618,8804,AIM,BACKGROUND,BASEL,CONCLUSION,COPYRIGHT,LABEL,METHODS,NNT,NNTBL,NNTS,OBJECTIVE,PSA,PSAV,RCT,RCTS,RESULTS,THERE,UROL,WHILE
169,1995,2011,2012,BACKGROUND,BASEL,COPYRIGHT,ELECTRONIC,ENGLISH,LABEL,MATERIALS,MEDLINE,METHODS,PBX,PCA,RESULTS,SATURATION,SPBX
0001,009,169,193,2012,AGE,BACKGROUND,BASEL,COPYRIGHT,COX,CUMULATIVE,FACTORS,GLEASON,LABEL,MEIER,METHODS,MORI,PEPE,RESULTS
100,155,169,177,2012,333,438,493,ADRS,ADVERSE,AFTER,AIM,AMERICA,ASIA,ASSESSMENT,AUSTRALIA,BACKGROUND,BLOOD,CONCLUSION,IPASS,LABEL,LATIN,MAIN,METHODS,MORBIDITY,OBJECTIVE,OUTCOME,PARAMETERS,POST,PSA,RESTORING,RESULTS,SOCIETY
ACP,ACPS,PAP,PPE4
176,CLT1,DOTA,III,INNOVATIVE,MRI,PC3
10TH,ATTACHMENT,C3D,EIA,EVALUATION,IGG,IGM,MUC4,THOMSEN
169,2012,AIDS,BACKGROUND,COPYRIGHT,DSI,DSIS,LABEL,METHODS,OVERALL,PATIENT,RESULTS,SOCIETY,STANDARDS
1095,1991,1992,2008,2394,541,636,820,AMONG,ANTI,BACKGROUND,HBSAG,HCV,LABEL,METHODS,MONITORING,RESULTS,THERE
AIM,BACKGROUND,BONE,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS
0001,133A,137,184,194A,26B,34C,375,99A,ALTERED,HNSCC,HOWEVER,PCR
AFTER,COX,STUDIES,THEREFORE
AUTONOMIC,BACKGROUND,LABEL,METHODS,MOST,OBJECTIVE,RESULTS,THEREFORE
160,1997,438,ACCORDING,APC,DNMT,GLEASON,GSTP1,HOWEVER,ITALIAN,LABEL,METHODS,OBJECTIVE,PCR,PURPOSE,RESULTS,RUNX3,SNP,THESE
160,614,616,CASES,CMV,IGG,LABEL,METHODS,OBJECTIVE,PCA,PCPT,PREVENTION,PURPOSE,RESULTS,SERA,TRIAL
001,151,160,205,352,369,503,574,CONCLUSION,LABEL,LIKELIHOOD,METHODS,OBJECTIVE,PURPOSE,RESULTS,RISK,SECONDARY,THERE,TORONTO,TURKU,UUT,UUTR
200,946,AKT,AKT1,AKT2,AKT3,DOWN,EGFR,MET,PC3,SILENCING,TAKEN,VALIDATION
002,0MM,169,2012,5MM,BACKGROUND,COPYRIGHT,DMIN,DOSE,IMRT,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PLANS,PTV,PURPOSE,RESULTS,SWIFTER,VRX
169,2012,947,BACKGROUND,CBCT,COPYRIGHT,DENSITY,DOSE,DVH,HUS,IMRT,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PHA,POP,PTV,PURPOSE,RESULTS,ROI,WAB
003,025,039,047,128,198,393,476,8201,AMONG,HOWEVER,IMPORTANT,USING
GLEASON,PCA
000,100,1943,1947,1978,1982,1990S,1993,1998,2007,2008,2009,AGE,BACKGROUND,CONCLUSION,DENMARK,LABEL,METHODS,POPULATION,PSA,RESULTS,WORLD
104,106,169,2012,BACKGROUND,COX,EPP,FINNISH,JOHN,LABEL,LTD,METHODS,OBJECTIVE,PATIENT,PSA,RESULTS,SONS,THESE,WILEY
171,183,1994,2002,2010,364,367,731,ADVERSE,AFFAIRS,AMONG,BACKGROUND,DEPARTMENT,JANUARY,LABEL,METHODS,PIVOT,PROGRAM,PSA,RADICAL,RESULTS,STUDIES
169,2012,COPYRIGHT,INC,NOVEL
ATRA,BOTH,EZH2,RESULTS
946,CD49F,ESTROGENS,FINALLY,LIN,SCA1,SUBSEQUENT,TROP2,VE2
22RV1,ADP,FINALLY,LNCAP,MAR,MARS,PARP,PC3,SATB1,THESE,VARIATIONS
946,947,950,963,DESPITE,EXPRESSION,PC3,RAC,RAC1,WHILE
GASSIST,INCREASING,MICROARRAY
001,101,103,114,184,8202,8804,CRPC,MEIER,NADIR,PADT,PSA,TTN
10S,12A,12AR,14B,14BS,169,2012,4AS,6AR,6AS,6BR,8AR,945,946,956,A549,APOPTOSIS,ASPC,COPYRIGHT,CYANO,FLIP,GMBH,HEP,KGAA,MCF7,MIA,NOXA,PACA,PANC,SARS,THESE,VCH,WILEY
169,181,2011,786,8201,945,ADR,BAUERENYL,CABR,CNS,COPYRIGHT,GOCHNATIA,H460,JOHN,K562,LESS,LTD,MCF,NCI,OVCAR,RES,SONS,TGI,U251,UACC,VERO,WILEY
001,169,177,2011,956,COPYRIGHT,ESTIMATED,GLEASON,INC,TEN,WILEY
169,177,2012,945,ACT,BACKGROUND,COMPLEX,COPYRIGHT,FREE,GLEASON,HOWEVER,INC,LABEL,METHODS,PLA,PSA,RESULTS,THESE,WILEY
150,169,181,2012,215,300,BACKGROUND,COPYRIGHT,INC,LABEL,LEAVING,METHODS,RADICAL,RESULTS,RIN,USING,WILEY
150,AFRICAN,PRCA,SOUTH
023,069,239,399,537,645,703,761,804,823,8804,945,BACKGROUND,IPSS,LABEL,METHODS,POD,QAVG,QMAX,RESULTS,SCORE,SYMPTOM
1256,29A,BLOT,LUC,PCA,PCR,PGK,UTR,WESTERN
INDIA
954,963,BACKGROUND,CELL,CONCLUSION,DHMEQ,INDUCIBLE,LABEL,LNCAP,METHODS,RESULTS
005,284,300,400,9027,BACKGROUND,CONCLUSION,CRPC,DL0,DL1,DLT,DOSE,LABEL,MAXIMUM,METHODS,MTD,REFRACTORY,RESULTS,SEVENTEEN,TEN
BACKGROUND,CONCLUSION,LABEL,MEN,METHODS,PSA,RESULTS,SCREENING,THESE,USING
008,044,1346,1993,2008,2009,AMONG,BACKGROUND,CONCLUSION,INCLUDING,JUNE,LABEL,MARCH,MEIER,METHODS,PAGET,PDB,RESULTS,UNTIL
169,2012,BONE,GROUP,HOWEVER,UROLOGICAL,WORKING
169,2012,231,233,CELLULAIRE,COPYRIGHT,DESPITE,DUE,EWING,FRANCAISE,SOCI,STEAP
169,2012,683,ADVERSE,AIMS,BRITISH,FURTHER,JOURNAL,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,SOCIETY,TAK
285,371,ALLELIC,MTR,SHMT1,SIBERIA,WEST
AKT,ASIA,M93,RED,RYR,THESE,WENT
1100,198,946,AUNP,AUNPS,EGCG,LAMININ67R,SCID
2011,2012,ADVERSE,ASCO,CONTEXT,DATA,HEALTHCARE,LABEL,MARCH,METHODS,OBJECTIVE,PCO,PSA,PURPOSE,QUALITY,RESULTS,SOCIETY
2005,2011,BACKGROUND,LABEL,METHODS,PSA,RESULTS,THESE,TREATMENT
000,145,HDAC,HDAC3,HDAC4,LNCAP,MTT,OBVIOUSLY,PRESUMABLY,THEREFORE,WESTERN
2008,FORCE,LABEL,METHODS,PREVENTIVE,PSA,TASK
BONE,LABEL,OBJECTIVE,OTHER,PURPOSE,RESULTS,SUMMARY,THESE
132,145,AIM,CELLS,CONCLUSION,EXPRESSION,HOWEVER,INCREASING,LABEL,METHODS,OBJECTIVE,PCA,RESULTS,SLUG,T286A,WESTERN
169,2012,946,AMP,AMPK,COPYRIGHT,HOWEVER,IMPORTANT,IRELAND,LTD,OBESITY
0017,002,007,009,032,2000,2004,358,AFRICAN,AFTER,AIMS,BACKGROUND,EIGHT,GIVEN,LABEL,METHODS,PCA,RESULTS,SNP,SNPS,UNIVERSITY,WEST
14TH,21ST,35TH,615,7TH,DU145,PBS
1990S,8722,PCA,PSA,SINCE
152,2005,2010,BACKGROUND,CHINA,CHINESE,COX,ELRP,GLEASON,JANUARY,LABEL,MARCH,METHODS,PSM,RESULTS,TNM
DECREASES,DIM,HDAC,HDAC1,HDAC2,HDAC3,HDAC4,HDAC6,HDAC8,HDACS,HISTONE,I3C,INC,INCREASED,LNCAP,PUBLISHED,TAKEN
BACKGROUND,DALY,DISABILITY,IDEALLY,INSTITUTE,LABEL,LIFE,LOST,METHODS,NCI,RESULTS,THESE,YEARS,YLL
001,150,2006,2011,351,400,440,904,AFTER,BACKGROUND,BETWEEN,BOTH,CLAVIEN,CONCLUSION,DINDO,III,IIIB,LABEL,LND,MANN,METHODS,NODAL,OVERALL,RALP,RESULTS,UROLOGY,WHITNEY
945,AMACR,BACKGROUND,BLINDED,BOTH,COA,LABEL,METHODS,RESULTS,SIXTY,THERE,UNASSIGNED,VIRTUAL
1985,2010,8201,APPRAISAL,BLACK,CENTRAL,COGNITIVE,CONTROLLED,DATA,DOWNS,DVD,ENGLISH,FIVE,IDM,KNOWLEDGE,LABEL,MEDLINE,MESH,METHODS,OBJECTIVE,OBJECTIVES,PCA,QOL,RESULTS,REVIEWS,SOURCES,SUBJECT,SYNTHESIS,SYSTEMATIC,WEAK
121,2007,2011,883,KUB,LABEL,MARCH,MATERIALS,METHODS,MIGRATION,OBJECTIVE,PRE,PURPOSE,RESULTS,SEED
AT3,CONSISTENT,CWR22RV,DIMN,DU145,FLEXX,HOWEVER,LNCAP,PPC,R3327,TAKEN,THROUGH
2012,ADDITIONAL,AFTER,DEFINITIVE,EBRT,HOWEVER,IMAGING,KEY,LABEL,MEDLINE,METHODS,MRI,NON,OBJECTIVE,OBJECTIVES,PCA,RESULTS,STS,THEREFORE
946,954,CONVERSELY,ENDOGENOUS,HDAC1,IKK,MMP9,PAI,PKD,PKD2,PKD3,PLAU,SILENCING,TAKEN,THESE
BONE,MOST
0005,001,169,177,2012,AFTER,BASEL,COMPARISON,COPYRIGHT,EARLY,HBO,HIGH,JAPAN,LABEL,METHODS,OBJECTIVE,RESULTS
169,1993,2011,2012,AIM,BACKGROUND,BASEL,COPYRIGHT,CRYO,CURRENTLY,FOCUSED,HIFU,HIGH,HOWEVER,INTENSITY,LABEL,LOCAL,MATERIALS,METHODS,OBJECTIVE,RADIO,RECURRENT,RESULTS,SALVAGE,ULTRASOUND
193B,CFTR,FINALLY,TAKEN
AMONG,CHROMATIN,CONVERSELY,DEPLETION,DU145,EMT,EPIGENETIC,KNOCKDOWN,MMSET,MYELOMA,PCA,RWPE,SET,WHSC1
001,043,169,2003,2007,2012,594,AFTER,BACKGROUND,BASEL,COPYRIGHT,DIETARY,LABEL,MEN,METHODS,PSA,RESULTS,THERE
BENZO,CUMULATIVE,FFS,LABEL,METHODS,OBJECTIVE,PAH,PAHS,RESULTS
0009,0090,0297,169,2012,945,946,ADT,ADTS,BPH,COPYRIGHT,CYP11A1,CYP17A1,HSD17,HSD3,IHC,INC,LNMS,MALIGNANT,PATHOLOGY,PCA,PROTEIN,PUBLISHED,RECURRENT,SIX,SOCIETY
169,2012,916,AKT,ATP,COPYRIGHT,INC,INHIBITION,KNOCKDOWN,NADPH,O3A,PC3,POTENTIAL,PRODH,PROLINE,TREATMENT,WM35
169,2012,945,946,CNS,COPYRIGHT,ERE,LTD,MCF,SERM,TAKEN,THESE
169,2012,BASED,CNR,COPYRIGHT,DCE,FLASH,GIVEN,HOWEVER,INC,MRI,SNR
169,2012,COPYRIGHT,HOWEVER,INC,MRI,PET,THESE
001,003,004,008,033,1002,169,1997,2008,2013,317,427,587,ACTUARIAL,BETWEEN,COPYRIGHT,GLEASON,IMRT,INC,LABEL,LATE,MATERIALS,METHODS,NETWORK,OBJECTIVE,PCSM,PURPOSE,RESULTS
120,169,176,180,2013,240,AVERAGING,CALYPSO,COPYRIGHT,CORRECTION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,USING
0001,0052,169,2012,5597,8764,COPYRIGHT,DOSE,EARLY,INC,LABEL,LEVEL,MATERIALS,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS,RFS,SALVAGE,SRT,THERE
169,2011,2012,371,470,8804,8805,99M,AFTER,BACKGROUND,COPYRIGHT,IQR,LABEL,LND,LNS,METHODS,NOTE,OBJECTIVE,OUTCOME,PUBLISHED,RESULTS,SETTING,SEVENTY,SNS,THEN,UROLOGY
001,026,050,169,1988,2010,2013,280,300,563,621,778,8804,8805,COPYRIGHT,DATA,ESTIMATED,GLEASON,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,PATIENT,PCA,PSA,RESULTS
169,2013,CAP,COMPARISON,COPYRIGHT,DIFFERENT,FLA,HIFU,INC,LABEL,LASER,MATERIALS,METHODS,OBJECTIVE,PDT,PROSTATIC,PURPOSE,RADIO,RESULTS,SEVERAL,THOSE
169,2013,COPYRIGHT,DRE,HOWEVER,INC,PSA
169,2012,COPYRIGHT,INC
0001,003,1439,169,2012,AIM,ASSESSMENT,COLLEGE,CONCLUSION,COPYRIGHT,ESAS,GREATER,HOWEVER,KARNOFSKY,KPS,LABEL,LTD,MANAGEMENT,MATERIALS,METHODS,OBJECTIVE,PROGRAM,PUBLISHED,RAPID,RESULTS,ROYAL,SYMPTOM
177,AUNP,AUNPS,HRP,MWCNT,PSA,UNDER
001,003,317,337,967,ANOVA,BACKGROUND,COMPONENT,CONCLUSION,CURRENT,EPIC,LABEL,MCS,METHODS,PCS,QOL,RESULTS,SUMMARY,WHILE
174,194,262,308,55208,700,814,8594,BACKGROUND,CONCLUSION,ESI,FDA,LABEL,LLOQ,ORTERONEL,RESULTS,TAK
AGE,BPH,DIGITAL,DRE,LUTS,MEN,PSA
HOWEVER,QOL,THUS
160A,160AA,160C,160CA,194,2012,207,BACKGROUND,BECAUSE,EUROPEANS,HOWEVER,LABEL,MARCH,METHODS,NORTH,RESULTS,USING
0001,680,8202,824,945,947,BACKGROUND,CIS,COLORECTAL,LABEL,LUNG,METHODS,OVARIAN,RESULTS,SCREENING,SERUM,TRIAL,VITAMIN
001,1006,8805,ADIPOKINE,FEW,GLEASON,PSA,SEVEN,SNP,SNPS,THESE
120,8201,916,BIOLOGICAL,ESTIMATED,EUD,FIVE,KNOWLEDGE,LABEL,MAXIMUM,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SIB,VMAT
000,218,945,ABOUT,ADT,MEANWHILE,POPULATION,PSA,TNF
946,CHANGES,EMT,EMTS,ERK2,FIBROBLAST,GLEASON,MEK1,MEK2,MMP,MMP1,PROTEIN,RAF,RAS,SLUG,TGF
174,DOX,DOXIL,MDR,NDC,NOTABLY,WHILE
PATIENT,USING
012,024,2005,2008,BACKGROUND,CRPC,FIFTY,FURTHER,HOWEVER,LABEL,METHODS,PFS,RESULTS,THERE
1987,2302,2306,ACAD,BARRANDON,DU145,GREEN,LNCAP,NATL,PRIMARY,PROC,SCI,UNDER
ALSO,WHILE
039,169,2001,2007,2012,6976,ADT,BACKGROUND,BECAUSE,CONVERSELY,COPYRIGHT,COX,CRT,END,IMRT,INTENSITY,LABEL,METHODS,OBJECTIVE,OUTCOME,RESULTS,SETTING,UROLOGY
013,034,042,119,145,170,946,CK34,E12,ESCC,ESOPHAGEAL,HOWEVER,THESE
AFTER,CTAP,CTHA,HEPATIC,MHV,RHV
HOWEVER,RARP,ROBOT
169,2012,22R,956,957,COMPOUNDS,COPYRIGHT,OME,RESULTS,SAS
169,200,2012,BESIDES,CONVERSELY,COPYRIGHT,GASTRIN,INC,MCF
001,169,182,2012,229,640,COPYRIGHT,GEOGRAPHIC,HOWEVER,INC,INTEGRATED,LABEL,MANN,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,TEXAS,WHITNEY
169,2012,533,AFRICAN,AFRO,CARIBBEAN,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,OVERALL,PSA,RESULTS,STRATIFIED,THOSE,TOBAGONIAN,YORK
EBRT
22RV1,916,AD5,DU145,THESE
169,2012,8226,8764,AUTHORS,BJU,DIFFERENT,INJECTION,LABEL,METHODS,OBJECTIVE,PROCEDURE,RESULTS,SPACING,THERE,THESE,UNLABELLED,V70,WHAT
001,036,1351,169,187,1982,2011,2012,260,2834,4461,4569,462,8226,8804,8805,AUTHORS,BETWEEN,BJU,CONCLUSION,COX,DIAGNOSTIC,GLEASON,LABEL,LEVEL,METHODS,OBJECTIVE,PCSM,PSA,PSM,PSMS,RESULTS,TYPE,UNLABELLED,WHAT
0157,0182,0375,169,2004,2011,2012,621,660,8226,AUTHORS,BASED,BJU,BSI,COX,CRPC,FORTY,LABEL,MARCH,METHODS,OBJECTIVE,PSA,RESULTS,UNLABELLED,WHAT
169,2012,7696,8226,AUC,BJU,CONCLUSION,LABEL,LIBRARY,METHODS,OBJECTIVE,PCA,RESULTS,TRSE,UNLABELLED,WHAT
0005,002,146,178,184,185,DATA,DVC,EBL,IMMEDIATE,LABEL,METHODS,NONE,OBJECTIVE,OPERATIVE,PLND,PURPOSE,RARP,RESULTS,THERE
106A,169,2012,LABEL,METHODS,NORMFINDER,OBJECTIVE,OBJECTIVES,REFERENCE,RESULTS,RNU1,RNU6,SERUM,SNORD43,SNORD44,SNORD48,UROLOGICAL
CCCTC,ELK4,SLC45A3,USING,ZHANG
169,2012,343,445,788,8805,AFRICAN,BACKGROUND,CAUCASIAN,COPYRIGHT,GREATER,LABEL,METHODS,RESULTS,SOCIETY
169,2012,240,295,299,594,8805,ADVERSE,BACKGROUND,CARDIAC,COPYRIGHT,ENDOTHELIN,LABEL,METHODS,PERIPHERAL,RESULTS,SECONDARY,SOCIETY,ZIBOTENTAN
EMT,LUNG,MMP,RAC1B
8764,CENTROSOME,HOWEVER,RED,ROS
20A,945,CX43,MDA,PCA
169,177,2012,30S,COPYRIGHT,FIRST,HOWEVER,SINCE,TRUS
169,2012,AACR,GLEASON,S1P,SPHK1,SPL,TMA
176,2009,8201,BACKGROUND,BALANCING,CONCLUSION,LABEL,MASTERPLAN,METHODS,NUCLETRON,PLANS,RESULTS,SINCE,VMAT
103,104,105,8201,BACKGROUND,CELL,LABEL,LABELLING,METHODS,MNCL2,MNCL2IN,MRI,NOD,RESULTS,SCID,SPIO,SPIOS
8764,COMPOUNDS,EFFECTIVE,SEVERAL,SH2,SRC
8201,BACKGROUND,CPG,G2M,HP1,LABEL,LBR,LNCAP,MECP2,MUTATIONS,NIH,PROTEIN,RESULTS
169,2012,HOWEVER,MIGRATION,NOD,PC3,PTN,SCID
ABI,III,NOVEL,PGP
169,17AAG,2012,BLACKWELL,CONCLUSION,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHING,RESULTS
008,2007,2010,ANXIETY,EMOTIONAL,JULY,LABEL,MARCH,METHODS,OBJECTIVE,RESULTS,SUPPORT,THREE,WAITING
AFTER,BACKGROUND,BIOSPEC,C57,CONCLUSION,III,LABEL,MATERIALS,METHODS,MNTE,MNTNHEX,MRI,OBJECTIVE,OBSERVABLE,PARAVISION,PHANTOM,PURPOSE,PYP,RESULTS,THESE
052,071,127,131,142,169,2012,626,722,8482,8804,8805,BACKGROUND,COPYRIGHT,DATA,GLEASON,GPTV,INC,LABEL,MEAN,METHODS,PCA3,PSA,REGRESSION,RESULTS,STRATIFIED,THUS,TOTAL,TVS,WILEY
169,174G,2012,6331,6331T,732,745,818,8201,825,BACKGROUND,COPYRIGHT,DENSITY,FACTORS,INC,LABEL,LOW,MCCS,MELBOURNE,METHODS,PCA,RESULTS,RFPCS,RISK,WHILE,WILEY
0015,002,0028,169,2012,252,BACKGROUND,CONCLUSION,COPYRIGHT,INC,KLF,KLF6,LABEL,LNCAP,METHODS,MOUSE,MSP,OVERALL,PCR,QPCR,RESULTS,TRAMP,TRANSGENIC,TREATMENT,WILEY
021,3761,4087,700,BASED,CAUCASIANS,CIS,HOWEVER,ORS,PTGS2,SIMILARLY
160,DIFFERENT,WHILE
945,946,ACTIVATION,AKT,BACKGROUND,CHRONIC,CONCLUSION,EGFR,ERK1,HOWEVER,INHIBITORS,LABEL,METASTATIC,METHODS,PC3,PCR,RESULTS
001,007,157,1966,1998,2004,2011,2012,569,726,CIS,DATA,FDA,HER2,III,INCIDENCE,OVERALL,PERTUZUMAB,PREVENTION,RASH,SCIENCE,SOCIETY,WEB
EFFD,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE
473,AGC,AKT,ANTITUMOR,AT13148,ATP,BT474,CCT128930,HER2,INDUCTION,IRS2,LABEL,MES,METHODS,OBJECTIVE,PC3,PIK3IP1,PKA,PTEN,PURPOSE,RESULTS,RHO,ROCK,SGK
1525,1757,1843,215,2225,G84E
1989,1994,214,525,ADDITIONAL,AMONG,C10,COX,DIETARY,SWEDISH
100,160,169,2012,562,956,ADP,COPYRIGHT,HUVEC,LNCAP,LTD,THREE,VLAIP
177,954,DU145,LABEL,LNCAP,LOW,METHODS,OBJECTIVE,RELA,RELB,RESULTS,WESTERN
185,2000,2011,368,BETWEEN
BENEFITING,CTLA,DESPITE,FDA
001,005,083,432,514,683,732,845,IHC,PSCA,QDS,QUANTUM
MRI
PC3,RESULTS
AMP,CAM,CAMKI,CAMKS,CELL
945,ACCORDING,ACTIVATION,BASED,GNRH,THESE
047,162,177,2008,2012,496,533,566,657,708,786,847,99M,AUC,CONCLUSION,DIAGNOSTIC,GLEASON,JANUARY,LABEL,MDP,MEAN,METHODS,MRI,OBJECTIVE,PLND,PSA,RESULTS,SUR,WHOLE
BMI,CONVERSELY,IGF,INHIBITION,JUN,NRP2,PTEN,VEGF
132,169,2012,945,946,956,AFTER,COPYRIGHT,ELISA,GHRH,HIF,JMR,MMP,MMPS,PC3,SEVERAL,THESE,UICC,VEGF,WESTERN
104,125,203,219,2900,323,8201,956,AUC,BACKGROUND,LABEL,MEN,METHODS,PSA,PSAD,RESULTS,WBC,WHITE
000,100,118,142,300,600,700,800,8201,BACKGROUND,BPH,GLEASON,ICER,ICERS,INITIATING,LABEL,METHODS,PATIENT,QALY,RESULTS
CTC,CTCS,CURRENT,DTCS,MRD
AREAS,BACKGROUND,COVERED,HOWEVER,LABEL,METHODS,ONGOING,OPINION,OVERALL,QUESTIONS,VEGF
100,125,181,235,250,295,786,8320,8325,ADR,AMPHIBIAN,ANURA,BACKGROUND,BUFONIDAE,CONTEXT,HOWEVER,K562,LABEL,MCF,MDR,METHODS,NCI,OBJECTIVE,OBJECTIVES,OVCAR,PCO3,RESULTS,STEVAUX,UACC
100,164,181,407,500,8320,8321,8322,8323,8325,AMONG,BACKGROUND,COMPOSITAE,CONCLUSION,CONTEXT,DISCUSSION,DPPH,HELA,ISOLATION,LABEL,LINN,MATERIALS,METHODS,MTT,NMR,OBJECTIVE,RESULTS,TAGETES
DEP,HOWEVER,LNCAP,SEPARATION
169,2012,ALZHEIMER,AUTHORS,BPH,FURTHER,III,JPP,KEY,LABEL,MEGESTROL,NETA,OBJECTIVE,OBJECTIVES,PHASE,RESULTS,ROYAL,SOCIETY,STUDIES,SUMMARY
169,2012,945,954,ADP,AUTHORS,BCL,BRITISH,CELL,COMPLEMENT,DU145,IMMUNOLOGY,PARP,SOCIETY,TNF,UPON
100,107,BALB,CONCLUSION,LABEL,METHODS,MTT,OBJECTIVE,PCA,PR7,RESULTS,THERE,TRANSWELL
100,BPH,CONCLUSION,ELIVISION,GLEASON,LABEL,METHODS,OBJECTIVE,PCA,PSA,RESULTS
2011,ACUTE,BACKGROUND,BOLOGNESE,COMPLIANCE,DERMA,FARMA,FURTHER,ITALY,JANUARY,LABEL,MATERIALS,METHODS,OCTOBER,RESULTS,RTOG,SALA,TIME
1992,1993,2003,2004,415,4680,8805,AFTER,BACKGROUND,DEPRESSION,LABEL,METHODS,RESULTS,SCALE,STUDIES,WISCONSIN,WLS
64CU,AHX,AIM,BASED,BBN,CONCLUSION,CONJUGATES,DPHE6,GRPR,LABEL,MATERIALS,MAXIMUM,METHODS,NH2,NHET,OBJECTIVE,RESULTS,TOMOGRAPHY
79NG,ACID,ANTIGEN,PAP,PROSTATIC,PSA
108,110,1998,2011,CAP,CIS,CONCLUSION,GLEASON,INCIDENTAL,LABEL,METHODS,OBJECTIVE,PIN,PRE,PROSTATIC,PURPOSE,RESULTS,TCC
343,ALZHEIMER,ARVC,DISEASE,ENRICHMENT,FIRSTLY,GSEA,HCM,HUNTINGTON,KEGG,KNOWLEDGE,MEANWHILE,PARKINSON,SET,THIRDLY
1113,1852,739,764,AUC,BMI,BPH,CIH,INSTITUTE,MEDICAL,PREDICTIVE,PSA,TMDU,TOKYO,TPV,UNIVERSITY
001,004,014,032,041,045,8804,IDH1,III,INCREASED,KPNA,KPNA2,MIB1,RECURRENT
101,177,2008,2009,212,216,315,392,612,676,677,718,824,830,956,ACCORDING,BACKGROUND,BPH,DRE,HOWEVER,IPSS,LABEL,MATERIALS,METHODS,OCTOBER,PSA,QOL,RESULTS,SCORE,SUSPICION,SYMPTOM,THEREFORE,TRUS,USG
100,154,181,CONCLUSION,ECE,EPC,EPED,GLEASON,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,OBJECTIVES,PATHOLOGY,PSA,RESULTS,RRP,SVI,TESLA
HOWEVER
2010,2011,MET,MOLECULAR,RET,SRC,UNTIL
THESE
GLEASON,ISUP,MOST,SOCIETY,UROLOGICAL
176,408,DIFFERENT,HIFU,HIGH,MRI,PRFS,REFERENCE,T1W,T2W,TFE,THEREFORE,WAC,WHILE
8805,BACKGROUND,CONCLUSION,DOCETAXEL,GROUP,III,LABEL,METHODS,PSA,RESULTS,WORKING
ARBS,ATAD2,E2F1,MYC,USING
169,2012,ADDITIONAL,ASSESSMENT,BACKGROUND,COMMITTEE,CONCLUSION,CONTEXT,COPYRIGHT,DESPITE,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PAIN,PUBLISHED,RADIATION,RESULTS,SCALE,SYMPTOM
032,169,2012,ADJ,BACKGROUND,COMMITTEE,CONCLUSION,CONTEXT,COPYRIGHT,EIGHT,FORTY,INC,LABEL,METHODS,MP3,OBJECTIVE,OBJECTIVES,PAIN,PUBLISHED,RESULTS,SYMPTOM,TIME
169,2012,COPYRIGHT,FABRY,FPI,PEROT,PSA
169,2012,231,945,946,BASE,COMPOUNDS,COPYRIGHT,HELA,JONES,MCF,MDA,MRC,NABH,NAOH,OPPENAUER,REDUCTION,SAS,SEO
169,2008,2012,COPYRIGHT,IMAGING,INC,INSTITUTE,NETWORK,QIN
169,2012,COMPLEX,COPYRIGHT,DYNAMIC,INC,MRI,SEVERAL,THESE
169,2003,2008,2012,785,919,CLINICO,CONCLUSION,COPYRIGHT,DESPITE,GLEASON,INC,JANUARY,LABEL,MEAN,METHODS,OBJECTIVE,PATHOLOGIC,PSA,RESULTS,T1C,THERE
001,002,133,169,2010,2012,CONCLUSION,COPYRIGHT,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,PCA,RESULTS,THEREFORE
169,2012,BACKGROUND,BPH,CONCLUSION,COPYRIGHT,DATA,GUANOSINE,LABEL,LUTS,MATERIALS,MEDLINE,MESH,METHODS,OXIDE,PCA,PSA,RESULTS,RHO,RHOA,RISK,ROCK,SAS
177,BALB,BBN,FINALLY,GRPR,NOTA,PC3,PEG,PET,T47D
044,100,105,124,128,141,2003,2008,8805,ADVERSE,BACKGROUND,CSS,GLEASON,HOWEVER,IMRT,LABEL,METHODS,NETWORK,PHOENIX,PSA,RESULTS,SEVERAL,THERE,THESE
169,2012,CDH1,COPYRIGHT,INC,K68,K71,NLS,SIRT3,SKP2,THUS
170,200,282,317,470,475,5000,BACKGROUND,BMI,CLINICALLY,III,LABEL,METHODS,OBJECTIVE,PURPOSE,RARP,RESULTS,SERUM
00001,0001,169,2012,2508,ADT,ARR,BCF,CANCERLIT,CDRT,COPYRIGHT,DESPITE,FIVE,HDRT,INC,LABEL,LIBRARY,MATERIALS,MEDLINE,METHODS,OBJECTIVE,PCSM,PURPOSE,RESULTS,THERE
COLLOIDAL,DESPITE,FURTHER,THESE
ADT,AST,REGARDING,SINCE,THEREFORE
ATF3,INTEGRATED,THESE,VALIDATION
ACC,ALTOGETHER,AMP,AMPK,ATP,COA,DU145,HOWEVER,INHIBITION,LNCAP,NAD,NAMPT,PCA,SIRT1,SIRT3
106B,141,191,19B,330,620,622,8764,92A,92B,ABOUT,EACH,KEGG,MPC,MPS,PPC,TGF,THESE,UTR
33342,34A,CYA,DRUG,DU145,HOECHST,PC3,POST,PTX,STUDIES,TREATMENT,TXR
181,4000,ASTERACEAE,BOTH,BR3,CACO,GNAPHALIUM,LNCAP,MCF,MCF7,MIA,MTT,PACA,PANC,PC3,THESE
145,177,947,BACKGROUND,DROSOPHILA,H2AX,HITS,LABEL,METHODS,MS0017509,MS0019266,RESULTS
THEIR
169,2012,AACR,ANTIBODIES,CD105,CHINESE,CONCLUSION,FIFTY,IGG1,LABEL,METHODS,MTD,OBJECTIVE,ONGOING,PURPOSE,RESULTS,VEGF
PROSTATIC,STUMP
BONE,DIC,PSA,SEVERAL,THEREFORE
087,BOTH,CASE,FURTHER,LHRH,MAB,NINE,PSA
134,160,967,CASTRATION,ERG,SAMPLES,TMPRSS2
001,007,083,806,8201,967,GLEASON,HOWEVER,STUDIES
609,945,946,ACTIVATION,AKT,AKT1,AP7,BACKGROUND,CONCLUSION,HOWEVER,LABEL,METHODS,PC3,RESULTS,TRAMP,USING
100,300,400,600,ECLIPSE,IMRT,MUS,THESE,TREATMENT
CBCT,CTDI,DEFORMABLE,DICOM,FBCT,IGART,IRB,LINAC,THEREFORE,THESE,THREE,USING
CLARITY,DESPITE,MEDICAL,SEVENTEEN,SUBSEQUENT,ULTRASOUND,VARIATIONS
001,007,025,8201,ADOBE,AGE,BIOIMAGENE,CS3,FREQUENCY,HOWEVER,MAGIC,PAX2,PAX2P,PHOTOSHOP,PIXEL,SCOUT,WAND
BOTH,ERG,ETS,EWING,EWR1,EWSR1,FLI1
22RV1,954,BCL,FOS,HOWEVER,JUN,PNT1A,SEVERAL,THEREFORE
AFTER,BCL,CELL,JNK,JUN,MTT,PCR,VEGF,XIAP
169,182,2012,400,COPYRIGHT,EZH2,FEDERATION,HER2,KI67LOW,PRC2,PUBLISHED,SOCIETIES
125,169,2012,946,COPYRIGHT,INC,LABEL,LNCAP,MCF,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,RM2,THEREFORE
106G,180,4MG,4NG,5MG,60G,64Y,APPLIED,BODY,BPH,CONCLUSION,FOLEY,GEL,INDEX,IPSS,JLS,LABEL,LUTS,MASS,METHODS,OBJECTIVE,PATIENT,POINT,PORT,PSA,PURPOSE,RESULTS,USA
240,25NG,520,GLEASON,LABEL,MATERIALS,METHODS,NEITHER,OBJECTIVE,PSA,PURPOSE,RESULTS,SURGERY,T2C
177,2001,2009,8805,GLEASON,III,LABEL,MATERIALS,METHODS,OBJECTIVE,PCR,PSA,PURPOSE,RESULTS,THERE
1988,2008,2010,2011,600,ASSESSMENT,CAYNE,LECHNER,MAY,MEN,NURSING,SOCIETY,THESE,UPON
A549,AG494,AKT,ATP,BOTH,DMEM,DU145,EGFR,ERK,F12,INHIBITION
COX,GLEASON,HOWEVER,PCR,PSA,SIMILAR,THERE,VASOACTIVE,VIP,VPAC,VPAC1,VPAC2
016,018,027,028,038,043,047,049,137,160,193,2011,2012,8804,8805,956,CONVERSELY,GLEASON,LABEL,LOW,METHODS,NON,OBJECTIVE,PSA,PURPOSE,RESULTS,ROC,SHBG,ULM,UNIVERSITY
000,0001,001,032,160,177,1886,1985,2004,2499,873,AAS,AMERICANS,ARAB,CAS,CAUCASIAN,ETHNICITY,FORMULA,ODDS,PSA,THERE,WHILE
169,2012,AVAILABLE,BACKGROUND,CALIFORNIA,CITY,CONTEXT,COPYRIGHT,FURTHER,HOPE,ITEMS,KEY,LABEL,META,METHODS,OBJECTIVE,PCA,PREFERRED,PUBLISHED,RADICAL,RARP,REPORTING,RESULTS,REVIEWS,ROBOTIC,RRP,SECTION,SURGEON,SYNTHESIS,SYSTEMATIC,UROLOGY
169,2012,BIOLOGY,COPYRIGHT,FEDERATION,INC,PUBLISHED,TRUS,ULTRASONIX,ULTRASOUND,USA,WORLD
000,100,169,2012,ATM,CLEARLY,COPYRIGHT,ERG,FEDERATION,PUBLISHED,SOCIETIES,THEREFORE,TMPRSS2
169,2012,AKT,AUTHORS,BASIC,LNCAP,PC3,PI3K,RAPAMYCIN,SOCIETY,TOXICOLOGY
116,169,2000,2009,2012,CONCLUSION,INDICATION,JANUARY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OCTOBER,OVERALL,RESULTS,ROUGHLY,TIS,UROLOGICAL
RAMAN,SHM,TRM
169,2002,2010,2012,233,8805,ADVERSE,CONCLUSION,EARLY,JANUARY,LABEL,LATE,METHODS,MINIMALLY,OBJECTIVE,OBJECTIVES,OCTOBER,OVERALL,PATHOLOGY,PSA,RESULTS,UROLOGICAL,UROLOGISTS
2005,2011,AREAS,ASCO,ASH,BACKGROUND,COVERED,LABEL,METHODS,OPINION,SCLEROSTIN
1300,231,8805,BCR,CONCLUSION,COX,EBRT,EXCLUDING,LABEL,MEIER,METHODS,OBJECTIVE,PCA,RESULTS,SUPPORTED,UNIVARIATE
945,BACKGROUND,E74,ETS,LABEL,RESULTS
295,9873,AIM1,BASED,ERG,LNCAP,PSA,RNAI,TMED3,TPX2,VCAP
CELLS,EXOCYST,METASTASIS,RALA,REGULATION
100,181,ABCA1,CELL,CELLS,CHANGES,HMGCR,LDL,LDLR,LNCAP,P96E,P97E,PCR,PWR,RWPE,THESE,TREATMENT,VCAP
650,673,BASED,CIT,CONSISTENT,DGKD,GALK2,HOWEVER,ICK,KNOCKDOWN,LNCAP,MAP3K11,MOST,PSKH1,SER,THUS
7721,7F5,ANTI,BACKGROUND,CONCLUSION,FIRST,GOLDMAG,LABEL,METHODS,MRI,NEXT,PCA,PSCA,RESULTS,SMMC,TAS
169,2012,AACR,POLY,THESE
ETS,FURTHER,HOWEVER,LNCAP,LUC,MMP13,MMP9,PC3,SAM,SPDEF,THESE,USING,UTILIZING
0002,169,2012,542,AACR,BACKGROUND,CONCLUSION,EPIC,HIGH,IGF,LABEL,METHODS,NUTRITION,ORS,RESULTS
ABROGATION,DUE,EXPRESSION,MYC,SIMILARLY,SOX9,TRAMP
100,BOTH,IAT,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE,WHILE
160,215,300,ACTIVATION,CONCLUSION,HOWEVER,INJECTION,LABEL,METHODS,OBJECTIVE,PNP,PURPOSE,RESULTS
169,2012,ADIPOSE,AIMS,BACKGROUND,BASEL,BPH,BPPAT,CELL,COPYRIGHT,HOWEVER,LABEL,LNCAP,METHODS,MMP,OBJECTIVE,PC3,PCA,PPAT,PPATS,RESULTS,TPPAT,ZYMOGRAMS
000,001,100,169,1764,1991,1998,2003,2007,2012,519,BACKGROUND,CARSTAIRS,CONCLUSION,GLEASON,INCIDENCE,LABEL,MEN,METHODS,RESULTS,SOCIO,WEST
1993,2003,471,735,AMONG,ARTHRITIS,BPH,CONTROL,NSAID,PREVENTION,PSS,SCORE,SYMPTOM,TRIAL
128,177,FIRST,SEED
001,169,1994,2009,2012,2866,8804,8805,ADD,AUTHORS,BCR,BJU,CONCLUSION,COX,DOES,GLEASON,KNOWN,LABEL,MEIER,METHODS,NSM,NSMS,OBJECTIVE,PSA,PSM,RESULTS,SUBJECT,UNLABELLED,WHAT
169,2012,670,674,708,728,763,784,817,ADD,AUC,AUTHORS,BGLAP,BJU,CURRENTLY,DESPITE,DOES,EBCR,FOUR,GLEASON,HOSPITALS,INTEGRATED,KLK2,KLK3,KNOWN,LABEL,METHODS,NET,OBJECTIVE,OBJECTIVES,PCA,RESULTS,SNPS,SUBJECT,SULT1A1,UNIVARIATE,UNIVERSITY,UNLABELLED,VICKERS,WHAT
100,169,174,2012,215,8201,BJU,DESPITE,FURTHER,INCREASED,INDEX,PSA,STUDIES,THERE,THUS
100,169,1900,1956,1992,1998,2001,2010,2012,5FR,8226,ALA,AUTHORS,BJU,FLEX,FOLLOWING,KARL,LABEL,METHODS,OBJECTIVE,OLYMPUS,ORAL,PDD,RESULTS,SIMILARLY,SINCE,STORZ,TCC,UNLABELLED,WHAT,WHILE
0075,956,CELL,FURTHER,H460,KY40,PC3
001,003,169,2012,984,ADD,AGE,BJU,CAD,DOES,KNOWN,LABEL,METHODS,NSS,OBJECTIVE,RESULTS,SUBJECT,UNLABELLED,VRFS,WHAT
100,169,1996,2008,2012,380,8201,8462,8804,ADD,BJU,CAUSE,CONCLUSION,COX,DATA,DOES,FOLLOWING,GLEASON,KNOWN,LABEL,MATERIALS,METHODS,OBJECTIVE,PATIENT,PCA,PSA,RESULTS,SUBJECT,THERE,TREATMENT,UNLABELLED,WHAT
001,006,027,104,166,169,2004,2007,2012,685,8226,ACM,BJU,BOTH,CLINICALLY,COX,DRE,END,FINE,GLEASON,GRAY,LABEL,LEVEL,METHODS,OBJECTIVE,PCSM,PROGNOSIS,PSA,RESULTS,THERE,TYPE,UNLABELLED,USING,WHAT,WHITE
001,100,169,1999,2012,370,500,BCRFS,BJU,COX,DATA,GLEASON,HEILBRONN,HIGH,LABEL,LRP,MEIER,METHODS,OBJECTIVE,OBJECTIVES,PSA,RESULTS
001,1575,169,2000,2005,2009,2012,2N0M0,370,499,8226,8804,AUTHORS,BASED,BJU,CCL,CONCLUSION,CONFERENCE,CONSENSUS,GLEASON,ICS,ISUP,LABEL,METHODS,OBJECTIVE,PATHOLOGY,PSA,RESULTS,SOCIETY,T2A,UNLABELLED,UROLOGICAL,UROLOGISTS,WHAT
169,2011,2012,8226,ADC,BJU,DIFFUSION,JANUARY,LABEL,MCNEMAR,METHODS,MRI,OBJECTIVE,RESULTS,TUR,UNLABELLED,USING,WHAT
169,2012,BECAUSE,HOWEVER,IMRT,LABEL,METHODS,OBJECTIVE,PHYSICISTS,PURPOSE,RESULTS,SALO,THROUGH,TREATMENT
103,125,131,169,2012,DUE,FIVE,HOWEVER,LABEL,LOSS,LOW,METHODS,OBJECTIVE,PALLADIUM,PHYSICISTS,PROWESS,PURPOSE,RESULTS,SEED
169,2012,945,946,PHYSICISTS,SINCE
169,2012,BOS,BRAGG,DET,DOSE,IMPT,LABEL,LSFUD,METHODS,OBJECTIVE,PHYSICISTS,PURPOSE,RESULTS,SPOTS
169,177,2012,ARW,BASED,BLA,CBCT,D95,DAILY,DICE,DVH,ERB,IMAGE,IRB,LABEL,METHODS,OBJECTIVE,PHYSICISTS,PTV,PURPOSE,RESULTS,SBRT,T1CN0M0
169,2012,8805,947,EPID,IMRT,LABEL,METHODS,OBJECTIVE,PHYSICISTS,PTV,PURPOSE,RESULTS,TPS,VMAT
2SO4,HRPC,NH4,THEREFORE
567,658,715,793,978,988,COMFA,FIELD,INDICES,MOLECULAR,QSAR,SIMILARITY,THESE
956,CTCS,GFP,MTT
945,ADP,AMONG,BAX,BCL,BT474,GNM,HELA,MAA,OEC,OVCAR,PANC,PARP,TSCCA,U2OS
1200,A549,ACTIVATING,ATF3,BACKGROUND,CHIP,CHOP,CONCLUSION,LABEL,MATERIALS,MCF7,METHODS,MTT,PC3,RESULTS,WI38
AKT,BACKGROUND,CHINESE,CONCLUSION,DME25,EXTRACT,FURTHER,LABEL,MATERIALS,METHODS,PI3K,RESULTS,YANGZHENG
ANP,ERK,ERK1,JUN,MAPK9,MAPKS,MEK1,RAS,RAT,THEIR,THESE
DENOSUMAB,SRE,SRES
169,2012,916,946,956,AACR,ABI,CRPC,CYP17A1,DHEA,DHT,FKBP5,HSD,HSD1,HSD2,LABEL,LAPC4,LNCAP,METHODS,OBJECTIVE,PURPOSE,RESISTANCE,RESULTS,TMPRSS2,TREATMENT
169,2012,BACKGROUND,BASED,CHANGES,CONCLUSION,COPYRIGHT,CYP17,EXPRESSION,FOUR,INC,KI67,LABEL,METHODS,RESULTS,THESE,WILEY
102,169,1998,2007,2012,8805,AGE,AMICO,BACKGROUND,COPYRIGHT,DESPITE,GLEASON,HIGH,INC,LABEL,LOW,MATERIALS,MEDIANS,METHODS,PSA,RESULTS,RISK,SEVENTY,STUDIES,T1C,THREE,WILEY
169,2004,2008,2012,AMERICA,ASIA,CHINA,CLOSE,COPYRIGHT,EASTERN,NORTH,OCEANIA,SAHARAN,STOMACH,SUB,UICC,WESTERN
100,2006,2010,241,ADT,DFS,GRADE,GROUP,JUNE,LABEL,METHODS,MOST,OBJECTIVE,PHOENIX,PURPOSE,RADIATION,REGULARLY,RESULTS,THERAPY
8226,BLADE,FOUR,FREE,FURTHER,GLEASON,HIGH,KEY,LABEL,MEAN,METHODS,MRI,OBJECTIVE,PSA,RESULTS
000,0031,0040,0102,160,AFTER,CYCLE,CYP17,ECG,ECGS,LABEL,METHODS,OBJECTIVE,PURPOSE,QTC,QTCF,RESULTS,THERE
001,043,174,185,2008,2011,235,BACKGROUND,CONCLUSION,FUNCTIONAL,INC,INDEX,INTUITIVE,ISR,JULY,LABEL,MARCH,METHODS,RESULTS,ROBOT,SCORE,SUNNYVALE,SYMPTOM,USA,VINCI
160,200,239,400,8805,BID,CONCLUSION,DLT,DLTS,FOLLOWING,HFS,HOWEVER,LABEL,MAXIMAL,METHODS,MTD,OBJECTIVE,PSA,PURPOSE,RESULTS,SIX,THREE
106B,169,2012,20A,946,AACR,CDODA,DU145,PC3,SP1,SP3,SP4,ZBTB4
BONE,EFFECTS,III,THESE
CELL,CONVERSELY,JNK,JUN,S120,S120A,S120D,T148,T148A,T148D,T183,T183A,T183D
000,FINALLY,FIRST,GCPII,GLUTAMATE,HTS,NEXT,TMR,USING
ADT,AES,ALSO,DEGARELIX,GNRH,III,PCA,PHASE,PSA,STRATEGIES
CRPC
HDAC3,HOWEVER,INCREASED,KNOCKDOWN,PC3,PROTEIN,USING
ADDITIONAL,HOWEVER,PATENTING,PSA

177,185,200,8315,CARLO,DYNAMIC,EACH,ECLIPSE,FIVE,MONTE,PLDR,PTV,THERE
00001,005,110,152,166,169,2008,2011,2012,582,BACKGROUND,BLOOD,CONTEXT,COPYRIGHT,CUMULATIVE,JANUARY,LABEL,LRP,LYMPHOCELE,MANAGER,MEDLINE,METHODS,OBJECTIVE,OVERALL,PUBLISHED,RARP,RESULTS,RRP,SCIENCE,SYNTHESIS,WEB
006,100,169,2008,2011,2012,AGE,BACKGROUND,CONTEXT,COPYRIGHT,CUMULATIVE,HOWEVER,JANUARY,LABEL,LRP,MANAGER,MEDLINE,METHODS,OBJECTIVE,POSTERIOR,PUBLISHED,RARP,RESULTS,REVIEWS,ROBOT,RRP,SCIENCE,SYNTHESIS,WEB
141,169,2008,2011,2012,526,BACKGROUND,BCR,COLLEGE,CONTEXT,COPYRIGHT,DESPITE,FINALLY,JANUARY,LABEL,LRP,MANAGER,MEDLINE,METHODS,OBJECTIVE,PSM,PSMS,PUBLISHED,RARP,RESULTS,RRP,SCIENCE,SEVERAL,STATA,STATACORP,STATION,SYNTHESIS,USA,WEB
002,100,169,2011,2012,AGE,AVAILABLE,BACKGROUND,COPYRIGHT,CUMULATIVE,DATA,LABEL,LRP,MANAGER,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RARP,RESULTS,REVIEWS,RRP,SCIENCE,SYNTHESIS,WEB
000,001,002,005,006,008,028,050,062,169,2000,2011,2012,210,AMONG,COPYRIGHT,DPPC,LABEL,MCP,METHODS,OBJECTIVE,OBJECTIVES,OTHER,RESULTS,SAS,THERE,TOTAL
129,160,169,200,2013,COPYRIGHT,FURTHER,HDR,INC,LABEL,MATERIALS,METHODS,MOSFETS,OBJECTIVE,PBC,PURPOSE,RESULTS,SIXTEEN,SPC,THERE,VYSE
169,2012,8805,COMPOSITE,CONCLUSION,COPYRIGHT,IIEF,III,IMRT,INC,INDEX,INVENTORY,LABEL,MEN,METHODS,NOCTURNAL,OBJECTIVE,PHASE,RESULTS
169,2009,2010,2012,AFTER,BECK,CONCLUSION,COPYRIGHT,DEPRESSION,INC,INVENTORY,KEGEL,LABEL,MAY,MEDICAL,METHODS,OBJECTIVE,RESULTS,THESE
169,1981,1990S,2012,BEND,BIG,COPYRIGHT,FLORIDA,LTD,PSA
169,2011,CAR,CLASSICAL,COPYRIGHT,LIMBURG,LTD,POISSON
0004,006,169,2012,CONCLUSION,COPYRIGHT,DTI,EIGHT,GOLD,INC,LABEL,METHODS,MRI,OBJECTIVE,RARP,RESULTS,THERE,TRACT,VARIATION
160,169,2012,240,CONCLUSION,COPYRIGHT,CS21,DATA,HOWEVER,III,INC,LABEL,METHODS,OBJECTIVE,PSA,RESULTS,THERE,TREATMENT
001,008,133,142,169,177,2009,2011,2012,339,396,8805,APRIL,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,OPIUM,PSA,RESULTS
108,120,147,169,2006,2009,2012,AMONG,BONE,CHART,CONCLUSION,COPYRIGHT,DATA,INC,JULY,LABEL,METHODS,NETWORK,OBJECTIVE,PATIENT,RESULTS,SEVENTY
05NG,0NG,115GY,15CC,169,2000,2008,2011,2013,43NG,4600,ACUTE,COPYRIGHT,DOSE,FINAL,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SIX,SOCIETY,STAGING,T2A
145,169,2012,956,COMPOUNDS,JOHN,MCF,MTT,SONS,THESE,WILEY
2010,2011,CHALLENGES,MEN,WHILE
169,2012,945,ADP,ATP,BOTH,CL1,EVEN,ROS,UDP,UTP
170,2012,CRPC,MOST,ONCE,PCA,THUS
ANGELES,CALIFORNIA,DATA,DVD,EVEN,FORM,HRQOL,INDEX,LABEL,LOS,MCS,METHODS,OBJECTIVE,OLAVS,PCI,PCS,PFMT,RESULTS,SHORT,TRONDHEIM,UCLA,UNIVERSITY
PRIMARY
174,2011,998,CENTRAL,DATA,GREY,HEALTHCARE,KEY,KQ2,KQS,LABEL,MEDLINE,METHODS,NONE,OBJECTIVE,OBJECTIVES,OCTOBER,PANEL,QUALITY,QUESTIONS,RESULTS,REVIEWS,SNP,SNPS,SOURCES,SYSTEMATIC,TECHNICAL,THREE
BONE,GAS6,NONE,PC3,PCA,RM1,USING
99M,BONE,CAP1,CXCR4,HBB,IGR,MMP,RUNX2,TECHNETIUM
APOPTOTIC,AUTOPHAGY,AVOS,BACKGROUND,BLOT,CCK,DAPI,EXPRESSION,FACS,HOWEVER,HPC,LABEL,LC3,LNCAP,MDC,METHODS,ORI,P21,PROMOTING,RESULTS,TEM,WESTERN
G202,PSMA,SERCA
194,SOMATIC,TES
963,CGRS,COMPLEX,FINALLY,HCC1954,SINCE,WGSS
CRPC,MOST,OVERALL,PCA,SLUG,SNAIL
DESPITE
158,174,740,BONE,BSI,BSIS,CONCLUSION,DWASS,EACH,EOD,LABEL,LTD,MATERIALS,MBQ,METHODS,OBJECTIVE,RESULTS,ROC,STEEL,THERE,THEREFORE
108,160,169,183,312,AFTER,CONCLUSION,DCE,DWI,FUNCTIONAL,GEORG,KAPPA,LABEL,MATERIALS,METHODS,MRI,MRSI,OBJECTIVE,PURPOSE,RESULTS,STUTTGART,YORK
181,231,8320,8325,ACCORDING,DPPIV,HELA,HOWEVER,LCK,MDA,NEXT,PC3,TEBROPHEN,U2OS,ZAP
2012,BRITISH,INSTITUTE,INTEGRATED,MARCH,RADIOLOGY,SPECT,THERE
169,2011,2012,222,236,237,248,374,4222,555,599,BACKGROUND,BOTH,CONTEXT,COPYRIGHT,FIFTY,FOUR,LABEL,METHODS,MRI,OBJECTIVE,PUBLISHED,RESULTS,SYNTHESIS,TECHNICAL,THERE,THOSE,UROLOGY,WHERE
2010,8805,AMONG,III,PFS,THESE
116,169,177,2012,8320,8325,956,BESIDES,COPYRIGHT,ESI,FTMS,HACAT,HCT,HUH,MCF,NMR,ORAC,REAUMURIA,THREE
BACKGROUND,BRUNN,CONTEXT,DATA,ECTOPIC,LABEL,METHODS,OBJECTIVE,SOURCES,SPECIMENS
181,A2058,AMONG,DMF,DU145,MCF,RESULTS,TCT
124,138,BMI,CHINESE,CONCLUSION,GLEASON,HOWEVER,LABEL,MDR,METHODS,NKX3,OBJECTIVE,PCA,PSA,RESULTS,SLC22A3,THERE
CURRENTLY,PML
ANALYZING,ATTENTION,AUGMENTED,CENSORING,CONTROLLED,DEFICIT,HIV,INVERSE,IPCW,METHODS,RANDOMIZED,SEQUENTIAL,SRCT,SRCTS,TMLE
169,2012,AII,BPH,DIAGNOSIS,GMBH,KGAA,PCA,VCH,WILEY
169,2012,GMBH,KGAA,MALDI,PROFILING,VCH,WILEY
00001,1624,1640,3264,CAB,CALCULATED,CHINESE,CONCLUSION,ENGLISH,FINALLY,HOWEVER,IAB,LABEL,METHODS,OBJECTIVE,PCA,PURPOSE,QOL,RCT,RCTS,RESULTS,THEN,THERE,USING,WMD
BACKGROUND,CLASS,HYPOTHESES,LABEL,METHODS,OBJECTIVE,RESULTS,YOGA
BASED,IOPN
946,ADT,AFRICAN,APC,CURRENT,DESPITE,FORM,HRQOL,MEASURE,MEDICAL,MOS,NON,PERCEIVED,REGRESSION,SCALE,SHORT,THESE,TREATMENT,WHITE
NCS,NUMB
169,2012,24H,956,ADME,AKT,BAD,BAX,BCL,CONCLUSION,COPYRIGHT,DADS,DIALLYL,DISCOVERY,DISULFIDE,EXCEL,FIT,FURTHER,GMBH,IC50,IGF,INSULIN,LABEL,METHODS,MTT,NFKB,OBJECTIVE,PACKAGE,PCR,PI3K,PURPOSE,RESULTS,SINCE
169,2012,COPYRIGHT,FINALLY,HOWEVER,IRELAND,LOW,LTD,TRUS
169,2012,946,COPYRIGHT,LNCAP,PBMC,SAS
001,002,100,125,177,179,184,197,200,2007,2010,206,218,230,D90,DU30,SUFFICIENT,THERE,V100,V200,VR100
007,169,186,2012,338,443,791,936,BACKGROUND,BASEL,CONCLUSION,COPYRIGHT,INS,LABEL,MATERIALS,METHODS,RALRP,RECURRENCE,RESULTS
169,2012,250,309,425,890,BASEL,CLAVIEN,CONCLUSION,COPYRIGHT,CORE,CUT,LABEL,METHODS,OBJECTIVE,OVERALL,PAIN,PBX,RESULTS,THREE,TRU,TRUS
169,2012,COPYRIGHT,JAPAN,PLM,PRECS,PUBLISHED,SOCIETY,TIME
125,144GY,160,169,2013,3200,8805,ACUTE,COPYRIGHT,CROHN,CROWN,GRADE,GROUP,IBD,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RADIATION,RESULTS,RTOG,SEVEN,TEN,THERAPY,THERE
161,169,183,2012,235,396,8804,8805,AIM,BACKGROUND,BNSRP,CONVERSELY,COX,HOWEVER,IIEF,INDEX,LABEL,MAIN,MEASURE,METHODS,OBJECTIVE,OUTCOME,OVERALL,PLND,RESULTS,SOCIETY,THEREFORE,THESE
169,2012,BECAUSE,FINALLY,HOWEVER,JOHN,MELATONIN,SONS,THUS,TNF,TRAIL,WILEY
AKT,AMPK,INDUCTION,LNCAP,PI3K
049,074,131,169,180,1983,2005,2012,266,623,8805,AACR,AMONG,BACKGROUND,COX,E26,ERG,LABEL,METHODS,PHYSICIANS,RESULTS,STUDIES,THESE,TMPRSS2,WHETHER
0001,031,112,135,139,169,2012,247,8805,BACKGROUND,COPYRIGHT,COX,GLEASON,HOWEVER,LABEL,METHODS,NEITHER,OVERALL,PBRT,PSA,RESULTS,SOCIETY,SRT,SUCCESS,WPRT
2007,2011,329,386,715,954,APRIL,BACKGROUND,CENTRAL,COMMUNITY,CONCLUSION,CROSS,EIGHT,HIGH,HOWEVER,INDEX,LABEL,METHODS,MOST,NONE,RESULTS,SEPTEMBER,TAYSIDE,THERE,TOPAS,TRUS,VALIDATION
000,100,169,2012,BACKGROUND,BECAUSE,COLORECTAL,COPYRIGHT,DATA,DIFFERENT,LABEL,LUNG,METHODS,OVARIAN,PLCO,REGRESSION,RESULTS,SCREENING,SOCIETY,TRIAL,USING
1018,1027,2005,2010,881,893,894,904,945,946,AKT,BACKGROUND,CELL,CHINESE,ELEMENE,HIF,KNOCKDOWN,LABEL,LIFE,MOL,PHARM,PHARMACOL,PI3K,RESULTS,ROS,SCI,WANG
CFS,ENV,GAG,HIV,HOWEVER,HTLV,MLV,PBMCS,POL,RESULTS,THESE,XMRV
AGR3,AMACR,ANDROGENS,DUSP1,HOXC6,LNCAP,PCA3,SAMPLES,SLC14A1,THESE
160,8710,954,968,ANNEXIN,APOPTOSIS,ARTEPILLIN,BRAZILIAN,CASPASE,DEPSIPHER,DR4,DR5,ELISA,FITC,HOWEVER,LDH,LNCAP,MTT,NATURALLY,THESE,TRAIL,TRANSAM
177,400,AIM,AKI,CONCLUSION,COX,GFR,HIGH,LABEL,MEAN,METHODS,MONTHLY,OBJECTIVE,PHASE,RESULTS,SERUM,THERE
DESPITE
001,103,1063,125,169,1990,2007,2012,8226,ADT,AUTHORS,BJU,CONCLUSION,COX,EBRT,FIVE,INCREASING,LABEL,LEVEL,METHODS,MOUNT,MSEFS,OBJECTIVE,OBJECTIVES,PREVIOUSLY,RESULTS,SCORE,SINAI,THERAPY,THERE,TYPE,UNLABELLED,WHAT
1573,2007,2012,2298,ANTIGEN,ERSPC,GIVEN,IRELAND,LABEL,LIFESTYLE,LTD,METHODS,NUTRITION,OBJECTIVE,OBJECTIVES,PRESS,PSA,RANDOMISED,RESULTS,ROYAL,SCREENING,SLAN,SOCIETY,THERE
945,ENO1,HOWEVER,PCA
001,110,201,207,514,529,COLORECTAL,CONCLUSION,FINALLY,LABEL,LUNG,METHODS,OBJECTIVE,OVARIAN,PCA,PLCO,PROPENSITY,PURPOSE,RESULTS,SCREENING,SURVIVORS,TRIAL,WEIGHTS
2001,2011,627,CANCERLIT,CONCLUSION,DWI,HIGH,JANUARY,JULY,LABEL,LIBRARY,MATERIALS,MEDLINE,METHODS,OBJECTIVE,OVERALL,RESULTS,T2WI
169,2012,210,750,CDR1,COPYRIGHT,HPCX1,INC,SDS,SEVERAL,SPANX,TAR,WILEY,XQ27
160,8805,ADT,BACKGROUND,CONCLUSION,CRPC,LABEL,LHRH,MEAN,MEDICINAL,METHODS,PFS,PSA,PSADT,PSAV,RESULTS
001,023,120,177,8804,956,BACKGROUND,BPO,IPSS,LABEL,MEAN,METHODS,PATIENT,PSA,PVR,QMAX,QOL,RESULTS,THULIUM,WATT,YAG
100,1000,109,115,25MG,BACKGROUND,CAD,EC507,IAD,III,LABEL,METHODS,OTT,PSA,RESULTS,SERUM,THERE
125,247,274,BACKGROUND,BOTH,BPH,FOUR,INCREASED,LABEL,METHODS,PCA,POTENTIAL,RESULTS,SERUM,SNP,SNPS
AST
150,945,HIF1,MMP2,MMP9,MODULATING,PIN,SENP1,SILENCING,SUMO,WHEREAS
012,COX,DCDC2,DCX,EHF,ESE3,ETS,LOGRANK,THESE
000,001,005,019,374,AIMS,BACKGROUND,DISCUSSION,IFG,INSULIN,LABEL,METHODS,OBJECTIVE,OGTT,RESULTS,SPAIN,THERE
154,1979,AMONG,CUP,EVALUATION,HODGKIN,MAHA,THERE,THESE,TTP
HIFU,HIGH,HOWEVER,THUS
CONCLUSION,CURRENTLY,GOING,LABEL,METHODS,OBJECTIVE,OBJECTIVES,THERE,VARIOUS
169,177,2012,774,956,COPYRIGHT,PCR,PKC,PTK,REVERSE,SMVT,THEREFORE
169,2012,AFTER,COPYRIGHT,DETECTION,HOWEVER,INVADED,LIMITED,LYMPH,PSA,RMI,SAS,THEREFORE
101,169,2012,ASIAN,BACKGROUND,BPH,CHINESE,COLO320,COPYRIGHT,EASTERN,FFPE,G12D,GAT,GGT,GLEASON,LABEL,METHODS,PCA,PSA,RAS,RESULTS,WESTERN
125,169,2012,COPYRIGHT,INC,LABEL,LACK,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SEVENTY,SOCIETY
001,002,004,009,016,018,031,105,106,120,158A,8804,A2A2,A2A3,BPH,CAG,CAP,CYP19,KLK3,P450,PSA,SNP,USING,WHILE
947,AFTER,AIPC,FLOW,IFN,NGF,PRESENT,TUNEL
000,2007,AFFAIRS,BLACK,CENTRAL,DATA,LABEL,METHODS,OBJECTIVE,RESULTS,VACCR,WHITE
110,1980,2004,2007,666,6820,BRITISH,COLORECTAL,OVERALL,RISK,THERE
EVEN,HOWEVER,THESE
001,103,123,127,233,255,407,483,662,8804,AFRICAN,AMERICANS,BECAUSE,GWAS,HNF1B,MSMB,NCOA4,PREVIOUSLY,SLC22A3,TAKEN
100,169,2012,CAM5,COPYRIGHT,GLEASON,HMB,INC,MALIGNANT,MELAN,SUBSEQUENT,URINE,WILEY
117,118,159,8805,CRPC,FOLLOWING,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PSA,RESULTS,THESE
2001,2011,309,GREEK,INDICATION,JANUARY,JULY,JUNE,LABEL,METHODS,OBJECTIVE,PSA,RESULTS,SEVEN,TEN
00248,0223,0417,CD4,CD8,DOM,HLA,PSA,PSMA
121,BACKGROUND,LABEL,MEN,METHODS,OBJECTIVE,OBJECTIVES,QOL,RESULTS,THERE,YOUNGER
2007,ALSO,GROUP,HOWEVER,IARC,MONOGRAPHS,PROGRAMME,PUBLISHED,SINCE,WORKING
017,028,077,080,141,177,CONCLUSION,LABEL,MBQ,METHODS,NAF,PET,RESULTS,SIXTY,SUV,SUVS,UNLABELLED
169,2012,AH23848,BPH,CCAAT,CHROMATIN,COPYRIGHT,EP2,EP4,H89,HOWEVER,KNOCKDOWN,LTD,PROSTANOID
001,120,169,1992,2008,2012,207,252,2754,356,4045,4824,4962,514,869,938,COPYRIGHT,HDR,IMRT,INC,JANUARY,LABEL,LDR,MATERIALS,METHODS,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,RESULTS,SOCIETY
169,2012,AEU,COPYRIGHT,LABEL,LIBRARY,MEDLINE,MESH,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,THERE,THEREFORE
111,169,177,2012,215,5MM,8805,AIMS,AUC,BACKGROUND,COPYRIGHT,DYNAMIC,IRELAND,LABEL,LESIONS,LTD,MEAN,METHODS,MRI,NINE,OBJECTIVE,PCA,RESULTS,ROC,STUDENT,WASH
001,116,117,125,150,160,169,200,2013,526,901,COPYRIGHT,HOWEVER,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PTV,PUBLISHED,PURPOSE,RESULTS,SOCIETY,STAGING,TREATMENT,TREATMENTS,TRUS
100,125,144GY,169,2013,COPYRIGHT,DOSIMETRIC,FOLEY,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SOCIETY,TRUS
003,017,100,121,169,2000,2001,2012,279,371,AFTER,BRFS,COPYRIGHT,DISEASE,EXCELLENT,FIVE,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SOCIETY,T1A,T2C,UPGRADING
169,1997,2002,2011,2013,4000,450,ASSURANCE,BCCA,BRITISH,COPYRIGHT,CROWN,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PROGRAM,PROVINCIAL,PUBLISHED,PURPOSE,QUALITY,RESULTS,YUKON
169,178,2012,8805,COPYRIGHT,EORTC,IRELAND,LABEL,LATE,LTD,MATERIALS,MAXIMUM,METHODS,OBJECTIVE,PURPOSE,RESULTS,RTOG,USING
014,017,018,169,2012,8805,BACKGROUND,COPYRIGHT,ENDOSCOPY,IRELAND,LABEL,LATE,LTD,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RECTOSCOPY,RESULTS,ROC,SCORE,SIMILAR,VRS
001,003,1249,169,2003,2010,2012,8804,993,ADD,AUTHORS,BJU,COX,DOES,GLEASON,INDEX,KNOWN,LABEL,METHODS,NSRP,OBJECTIVE,OVERALL,PSA,RESULTS,SUBJECT,THEREFORE,UNLABELLED,URINARY,WHAT,WHILE
169,2012,233,COPYRIGHT,FDG,INC,PET
169,2012,BONE,COPYRIGHT,DYNAMIC,INC,KETY,PCA,PERFUSION,PIXEL
001,014,025,029,046,054,081,084,116,126,146,169,171,2012,220,261,338,440,464,538,729,8804,958,969,981,ADD,BJU,CONCLUSION,CONTINUOUS,DESPITE,DOES,KNOWN,LABEL,MANN,METHODS,NPP,OBJECTIVE,PEARSON,PSA,RESULTS,SUB,SUBJECT,TRUSP,UNLABELLED,WHAT,WHITNEY
052,169,2012,405,AUTHORS,BJU,BMI,INDEX,LABEL,LUTS,MET,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SYMPTOM,UROLOGICAL
005,008,017,129,169,1991,2010,2012,281,312,626,8804,BFS,BJU,COX,EVEN,GLEASON,JANUARY,LABEL,MEIER,METHODS,OBJECTIVE,PREDICTIVE,PREDICTORS,PRIAS,PSA,PSAD,RESULTS,T1C,THERE
169,2012,293,COPYRIGHT,FURTHER,INC,PSEUDOGENE,SEQ,TAKEN
EPIGENETIC
169,2001,2005,2006,2012,APRIL,BLADDER,FOUR,GLEASON,JANUARY,PATHOLOGY,URINARY,UROLOGICAL
946,DEPLETION,GEF,RAC,RHO,RHOB,RNAI
BCL,EGFR,ERK,HOWEVER,MCL,MIAPACA,PANC,PI3K,STAT3,THEREFORE,WESTERN,XIAP,YM155
489,5ARI,5ARIS,945,BACKGROUND,BPH,INSURANCE,LABEL,METHODS,NHIRD,REDUCTASE,RESULTS,TAIWANESE
172,CONCLUSION,DERIVED,EACH,GLEASON,HOX,HOXA9,LABEL,MEIS1,MEIS2,METHODS,OBJECTIVE,PBX1,PURPOSE,RESULTS,THESE
2010,217,730,BECAUSE,EUKARYOTIC,GOLGI,IMPROVING
CLINICIANS,DATA,FURTHER,INITIATIVE,LABEL,METHODS,OBJECTIVE,PROMS,PURPOSE,RESULTS
147,ASXL1,CHD1,CRPC,CRPCS,ERG,ETS,ETS2,FOXA1,HOWEVER,KDM6A,MLL,MLL2,PTEN,SIMILARLY,TMPRSS2,UTX
1993,2001,2009,3575,450,8805,AFTER,BACKGROUND,COLORECTAL,CONCLUSION,DAILY,HRS,LABEL,LUNG,MEN,METHODS,OVARIAN,RESULTS,SCREENING,TRIAL
169,2012,COPYRIGHT,HOWEVER,PSA,SEVERAL
100,169,2012,8482,BACKGROUND,BECAUSE,BIO,BIOMARKER,COPYRIGHT,GLEASON,LABEL,LOQS,METHODS,PANEL,PLEX,PRO,RESULTS
223,ADT,CASTRATION,DEPENDING,DRE,GLEASON,PSA,SEVERAL
2011,ASCO,BONE,DENOSUMAB,FINALLY,III,RANK,SRES
169,2012,CERTAIN,COPYRIGHT,GOLGI,LTD,THUS
0126,0172,122,169,177,180,2012,8804,BACKGROUND,CONCLUSION,COPYRIGHT,DAYS,GENERALLY,LABEL,METHODS,PSA,PUBLISHED,RESULTS,SERUM,TAIWANESE
174,177,2006,250,900,BACKGROUND,BLAND,CALYPSO,CBCT,DAILY,DRR,LABEL,MEDICAL,METHODS,OBI,PEARSON,RESULTS
1997,1999,2009,476,8804,BACKGROUND,COMPARING,COX,HBA1C,HRS,LABEL,METHODS,RESULTS,SIMILARLY,SWEDISH
000,001,149,176,2000,2008,204,262,389,406,583,61777,784,805,8805,AFTER,INSTITUTES,LABEL,METFORMIN,METHODS,OBJECTIVE,RESULTS,TAIWANESE,THOSE,USING
106A,141,169,2012,301,34A,452,945,946,AACR,CD133,CD44,PCR,TAKEN
CCCTC,CTCF,ELK4,LABEL,SLC45A3,UNLABELLED
174,8211,BACKGROUND,BLOOD,FREE,GNRH,IQR,LABEL,METHODS,PRIOR,PSA,RESULTS,THEREFORE
CAP,CD326,CRPC,CURRENT,DESPITE,EPCAM,EPITHELIAL,FINALLY
169,174,2012,8805,BACKGROUND,BASED,CD45,CELLSEARCH,COPYRIGHT,DAPI,EPCAM,FIBROBLAST,INC,LABEL,METASTATIC,METHODS,RESULTS,VERIDEX,WILEY
027,169,2012,536,575,671,751,BACKGROUND,CAUCASIANS,CHINESE,CONSISTENT,CONSORTIUM,COPYRIGHT,G135E,G84E,HAPLOTYPE,HOWEVER,INC,LABEL,METHODS,PCA,RESULTS,WILEY
0001,170,AIM,AMACR,BASED,CONCLUSION,LABEL,METHODS,OBJECTIVE,PCA,PCR,PSA,RESULTS,TRUS
2008,BACKGROUND,C18,C19,C21,C33,C34,C50,C61,C66,C68,CRN,DATA,LABEL,METHODS,NORWEGIAN,NPR,PATIENT,REGULAR,RESULTS
169,2007,2011,2013,8804,BETWEEN,COPYRIGHT,ENDORECTAL,FURTHER,INC,LABEL,LOCAL,MATERIALS,METHODS,MRI,OBJECTIVE,PSA,PURPOSE,RECURRENCE,RESULTS
100,183,945,956,AKT,DU145,EGF,ERK,HIF,MMP,PD98059,TIMP,VEGF
1005,119,130,169,2012,309,872,CAUCASIANS,CRUDE,LABEL,METHODS,OBJECTIVE,OVERALL,RESULTS,UROLOGICAL
8201,ATS,BACKGROUND,LABEL,METHODS,PHANTOM,RESULTS,SPLITTING,THRESHOLD,TPS,TPS1,TPS2,TPSS,TREATMENT
169,2012,383,946,AFTER,ALSO,APMIS,AUTHORS,FOS,JUN,SEVERAL,TGF,THERE
0001,0016,007,140,169,2012,BMNCS,BOTH,BPH,CD271,COPYRIGHT,DISCUSSION,ELISA,HOWEVER,INC,LABEL,METHODS,MSCS,OBJECTIVE,OBJECTIVES,OPG,RANKL,RESULTS,THESE,WILEY
001,160,176,236,268,368,504,8804,HOWEVER,LYNCH,MEN,MLH1,MSH2,MSH6,OVERALL,PMS2,THESE
1977,2012,ABSTRACTS,DATA,DESPITE,DRUG,ENGLISH,EXTRACTION,FOOD,LABEL,LITERATURE,MEDLINE,METHODS,NETWORK,OBJECTIVE,PHASE,PSA,REFERENCES,RESULTS,SELECTION,SOURCES,STUDIES,SYNTHESIS,TREATMENT
169,2012,ANALYSING,COPYRIGHT,HOWEVER,JOHN,LTD,SONS,WHERE,WILEY
0062,169,17Q21,2012,268,8805,928,930,AACR,BACKGROUND,G84E,LABEL,METHODS,NASHVILLE,RESULTS,UNIVERSITY,VANDERBILT
AFTER,BACKGROUND,CONCLUSION,COX,CRPC,CYP17A1,HORMONE,LABEL,MEIER,METHODS,PCR,RESULTS,SNPS
254,266,AKT,CBR3,PIP3,PTEN,SUMO1
169,2012,COPYRIGHT,GLEASON,HOWEVER,INC,MYC,PATHOLOGY,PUBLISHED,SOCIETY,THESE
ASSESSMENT,CELL,GNRH,IN3,MOST,MTT,PCA,THEREFORE
BACKGROUND,CASE,CLINICALLY,CONCLUSION,LABEL,MARY,METHODS,OBJECTIVE,RESULTS,SMJN
1775,719,CHK1,OVCAR,TARGETING,THESE,TREATMENT,WEE1
135,1400,800,BACKGROUND,DATA,DOSE,DRRS,HOUNSFIELD,IMAGE,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,SINCE
169,2012,223,BJU,CRPC,MDV3100
134,138,323,BACKGROUND,CONSORTIUM,CURRENT,FULL,HLOD,ICPCG,LABEL,LOD,META,METHODS,PARAMETRIC,RESULTS,XQ27
1000,169,2012,244,542,8201,8805,AMONG,CONCLUSION,COPYRIGHT,JOHN,LABEL,LTD,METHODS,OBJECTIVE,ONJ,PURPOSE,RESULTS,SONS,WILEY
0001,125,169,2012,957,ADC,AMONG,CONCLUSION,COPYRIGHT,DCE,DTI,FORTY,GLEASON,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PCA,PURPOSE,RESULTS,ROC,THEREFORE,UNDER,WILEY
169,2012,231,AIF,ANNEXIN,APOPTOSIS,DU145,EXPRESSION,FURTHER,INC,MCL,MDA,MSEA,WESTERN,WILEY
101,169,177,182,2012,BACKGROUND,BMI,CIGARETTE,COLORECTAL,COPYRIGHT,ESTIMATION,INC,LABEL,LUNG,METHODS,OVARIAN,PLCO,RESULTS,THESE,WILEY
TAKOTSUBO
BASED,DZNEP,EZH2,HIGH,PRC2,PRE,THUS,USING
001,073,2002,CLINICALLY,CONCLUSION,GLEASON,LABEL,MDA,METHODS,OBJECTIVE,OBJECTIVES,PCA,PSA,RESULTS,RRP,THERE,TISSUES,TNM
1950,2011,234,600,634,945,ALSO,DATA,JANUARY,LABEL,MEAN,MEDLINE,META,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,SAS,THERE,TURB,TURBT,TURP
167,1974,4117,6091,816,983,AFRICAN,ASSESSMENT,BACKGROUND,FINE,GRAY,LABEL,METHODS,PCSM,RESULTS,RISK,STRATEGIC
106,1977,1983,1999,2004,362,832,945,CYP24A1,CYP27A1,CYP27B1,GLEASON,LABEL,METHODS,OBJECTIVE,PHS,PHYSICIANS,PURPOSE,RESULTS,RXR,SWEDISH,VARIATION,VDR,WAITING
012,022,160,196,1ST,2ND,353,3RD,4TH,731,AGE,BACKGROUND,BMI,CONCLUSION,COX,LABEL,METHODS,MORTALITY,PCA,RESULTS,RISK,SWEDISH
153,166,946,FAK,LYLU,MAT,METASTATIC,SRC,Y925
474,BCL,CREB,DECREASED,DU145,FGC,FINALLY,H89,LNCAP,PAK4,PKA,S133,S474,THEREFORE,THESE
946,ACTIVATION,HOWEVER,LEF,TCF,WNT,WNTS
00185,2004,223,552,695,8202,875,ALPHARADIN,BONE,CRPC,FURTHER,LABEL,OBJECTIVE,PURPOSE,RESULTS,SUMMARY
CONTINUED,CONVERSELY,CRPC,CRPCS,EXPRESSION,LBD,MDV3100,UBE2C,WHILE
8209,BAK,BAX,BCL,EXPRESSION,HOWEVER,MCL,MESO,PC3,SEVERAL,THEREFORE,THESE

169,2012,23B,COPYRIGHT,CROWN,DU145,III,PCA,PRDX3,PUBLISHED
750,860,956,MIE,OPTICAL,RESULTS
DIAMOND,MDS,RIBOSOMAL,RIBOSOMES,RPS14,SHWACHMAN,THESE
169,2012,729,8805,ACADEMY,AMONG,BACKGROUND,BMI,COPYRIGHT,DIETETICS,ENHANCE,GREATER,INC,LABEL,METHODS,NUTRITION,OBJECTIVE,OBJECTIVES,OLDER,PRINCIPAL,PUBLISHED,REACH,RENEW,RESULTS,SURVIVORS,URBAN
169,2012,947,APC,COPYRIGHT,CPG,CTL,MHC,ODN,PLGA,SINCE,TLR,TRAMP
2009,BACKGROUND,CONCLUSION,DISCUSSION,HIV,III,LABEL,NMR,RESULTS,ROD,VARIOUS
956,A2058,ACRONYCHIA,DU145,NHDF,THREE
029,175,2012,228,272,354,AFRICAN,AMERICANS,APA,CALIFORNIA,FACTORS,LABEL,LATINOS,LESS,METHODS,OBJECTIVE,PSA,RESULTS,TELEPHONE
169,2012,BRMS1,COPYRIGHT,EMBO,MB49,MECHANISMS,MEFS,MODULATION,MOLECULAR,S1P,S1PR2,SK1,SPHINGOMAB,THUS,TRAMP
000,001,159,169,2000,2008,2012,233,284,773,BACKGROUND,BASE,BETWEEN,COMMITTEE,COPYRIGHT,DATA,JOINT,LABEL,LOG,METHODS,NSCLC,PRS,REASONS,RESULTS,SOCIETY
AKT,CHINESE,DR5,HDM2,HOWEVER,TAKEN,TRAIL,TRIPTOLIDE
946,AMONG,BMP,BMPS,MAD,MH2,SMAD,SMAD8,SMADS,TGF,THUS
160,BONE
048,106,160,246,25OHD,ALBUMIN,BMI,DIET,LABEL,MALM,METHODS,NINE,OBJECTIVE,PTH,RESULTS
CHOCHRANE,HOWEVER,LABEL,LIBRARY,MATERIALS,MEDLINE,METHODS,OBJECTIVE,OVID,PURPOSE,RESULTS,TURP
0001,005,2000,2007,BACKGROUND,CONCLUSION,COX,GLIOMAS,JANUARY,KETTERING,LABEL,METHODS,OBJECTIVE,OVERALL,RESULTS,SDH,SDHS,SIXTY,SLOAN,THERE
160,176,8400,CBCT,IMAGE,OUTCOME
AFTER,XELOX
PREVENTION,QOL,SINCE,SRE,THEREFORE
165,946,ACTIVATION,ALK5,CONVERSELY,DU145,ERK1,FLK,FLT,HPV7,HYPOXIA,KDR,PC3,RWPE1,TGF,THESE,VEGF,VEGFA,VEGFR,WHEREAS
004,169,177,2012,980,COPYRIGHT,DICE,HAUSDORFF,HOWEVER,THEREFORE
169,2001,2004,2012,BACKGROUND,CONCLUSION,COPYRIGHT,EDUCATION,FURTHER,HOWEVER,JULY,LABEL,LITHUANIA,LITHUANIAN,LOWER,LTD,METHODS,POISSON,RESULTS,STATISTICS,STRIKINGLY
023,1019,169,2012,3DCRT,402,621,768,AIMS,COLLEGE,CONCLUSION,COPYRIGHT,IMRT,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,QALY,RESULTS,ROYAL
169,2012,COPYRIGHT,DESPITE,IRELAND,LTD,THERE
0001,0002,0158,027,149,169,2012,2266,239,458,4699,COPYRIGHT,ERG,GLEASON,INC,PATHOLOGY,PTEN,PUBLISHED,SOCIETY,TMAS
117,169,2009,2010,2012,2030,6484,BACKGROUND,CONCLUSION,COPYRIGHT,DATA,HBCR,I77,JANUARY,LABEL,LTD,MATERIALS,METHODS,NIGERIA,RESULTS,SAHARAN
169,2010,2011,2012,521,702,ANTIBIOTIC,BACKGROUND,CAUSATIVE,COPYRIGHT,DESPITE,GPIU,INFECTION,INFECTIONS,INFECTIVE,LABEL,MANN,MEN,METHODS,OBJECTIVE,OUTCOME,PREVALENCE,PUBLISHED,RESULTS,SETTING,STUDENT,UROLOGY,UTI,WHITNEY
00001,0001,169,2012,777,ADT,ARR,CANCERLIT,COPYRIGHT,INC,LABEL,LIBRARY,MATERIALS,MEDLINE,METHODS,NNT,OBJECTIVE,PURPOSE,RCTS,RESULTS,SIX,TMX
0001,169,2012,AIP,COPYRIGHT,HOWEVER,IMRT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PLAN,PTV,PURPOSE,RESULTS,VMAT
169,2012,28KDA,30KDA,41KDA,CATHEPSIN,COPYRIGHT,GMBH,HOS,THESE,U937
169,200,2012,C57BL,COPYRIGHT,EDUCATION,HYPOXIA,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PRIOR,PUBLISHED,PURPOSE,RESULTS,TRAMP,UROLOGICAL
169,2012,945,946,947,COPYRIGHT,EDUCATION,EPITHELIAL,HOWEVER,INC,LABEL,MATERIALS,METHODS,MTT,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL,WESTERN
0001,001,100,1000,169,2012,256,36270,40543,410,666,813,AALEN,AFTER,BACKGROUND,COPYRIGHT,DATA,ERSPC,HOWEVER,LABEL,METASTATIC,METHODS,OBJECTIVE,OUTCOME,PCA,POISSON,PSA,PUBLISHED,RANDOMIZED,REGULAR,RESULTS,SCREENING,SETTING,UROLOGY
PATHOLOGIC,PERITONEAL,PSA,RALRP,THERE
149,150,153,180,1992,2009,443,AFTER,BACKGROUND,GLEASON,HIFU,HOWEVER,JULY,JUNE,LABEL,MATERIALS,METHODS,PRIOR,PSA,RESULTS,THEIR
001,147,1592,177,1992,2011,2166,507,684,BACKGROUND,BETWEEN,CONCLUSION,DESPITE,JANUARY,LABEL,MATERIALS,METHODS,RESULTS
151,2003,BACKGROUND,CONCLUSION,ECE,ESTIMATING,GLEASON,HOWEVER,LABEL,LOG,MATERIALS,METHODS,PNI,RESULTS,SCORE,WHILE
0001,0002,169,1993,2006,2012,282,346,703,COPYRIGHT,CUMULATIVE,EDUCATION,FACTORS,INC,INCREASING,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,ONTARIO,PUBLISHED,PURPOSE,RESULTS,URINARY,UROLOGICAL
169,2012,ADT,COPYRIGHT,EBRT,LTD,PET,PSA,SPECT,THESE
100,169,2012,956,ANP,AUTHORS,BACKGROUND,CONCLUSION,FLK,FOUNDATION,FOUR,JOURNAL,KDR,LABEL,LANP,MATERIALS,METHODS,RESULTS,SOCIETY,STICHTING,THESE,VEGF,WESTERN
0001,BACKGROUND,CONSISTENT,GLEASON,LABEL,LNCAP,METHODS,PCA,PCR,POTENTIAL,PSA,QRT,RESULTS,SOX,SOX10,SOX7,SOX9,SOXS
169,2012,250,8804,ADD,AUC,AUTHORS,BJU,CHANGES,DOES,GLEASON,HOWEVER,KNOWN,LABEL,METHODS,OBJECTIVE,PSA,PSADT,PSAV,REGULAR,RESULTS,SUBJECT,T2A,UNLABELLED,WHAT
027,105,142,169,1998,2010,2012,247,567,8226,AFTER,BJU,COX,LABEL,METHODS,OBJECTIVE,RECORDS,RESULTS,THERE,UNLABELLED,WHAT
2010,2012,AREAS,BACKGROUND,COVERED,LABEL,MAO,METHODS,MONOAMINE,OPINION
004,345,457,992,AIMS,CONCLUSION,INCREASED,INCREASES,LABEL,METHODS,OBJECTIVE,RESULTS,TYPE
BACKGROUND,CELL,CONCLUSION,DESPITE,GOLD,LABEL,METHODS,RESULTS,WESTERN
954,BONE,DENOSUMAB,HOWEVER,UNTIL,USA
264,956,CORPORA
AKT,AMONG,CONVERSELY,LNCAP,MMTV
100,2012,2022,AMERICANS,BASE,DATA,END,INC,INSTITUTE,JANUARY,PUBLISHED,RESULTS,SEER,SOCIETY
000,001,040,139,177,230,GLEASON,HOWEVER,LABEL,LESIONS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,ULTRASOUND
EGGER,GPX1,PRO198LEU,STATA
116,540,746,946,AKT,LNCAP,MAPK,PKA,SRC,USP10
169,200,2009,2012,239,442,8805,ALSO,BACKGROUND,BASEL,BETWEEN,BPS,COPYRIGHT,CRPC,EAU,JUNE,LABEL,MARCH,MATERIALS,METHODS,PCA,RESULTS
051,053,109,1982,2008,222,243,831,AMONG,BMI,COX,LABEL,METHODS,OBJECTIVE,PREVENTION,RESULTS,RRS
169,176,2012,24H,8764,COPYRIGHT,DMSO,DYNAMIC,ETO,ETOPOSIDE,PBS,RUB,UNDER
169,177,2012,8776,956,CK2,COPYRIGHT,LNCAP,LTD,TBI,TIBI
064,169,2000,2010,2011,2012,COPYRIGHT,EDUCATION,HOWEVER,INC,LABEL,MATERIALS,METHODS,NCCN,NETWORK,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
001,004,036,169,2012,2753,503,BACKGROUND,COPYRIGHT,LABEL,MCNEMAR,METHODS,OBJECTIVE,OUTCOME,PCA,PREDICTIVE,PSAD,PUBLISHED,RESULTS,SETTING,UROLOGY
100,169,1980,2011,2012,BACKGROUND,CONTEXT,COPYRIGHT,DATA,INCLUSION,LABEL,METHODS,MOST,OBJECTIVE,PCA,PUBLISHED,RESULTS,SYNTHESIS,UROLOGY
169,199,2006,2007,2012,217,259,CENTRAL,CONCLUSION,COPYRIGHT,GLEASON,GSU,INC,LABEL,METHODS,OBJECTIVE,RESULTS
169,2000,2010,2012,BNC,CONCLUSION,COPYRIGHT,DESPITE,INC,JANUARY,LABEL,METHODS,OBJECTIVE,PVF,RESULTS
016,1970,1973,2007,8805,COX,FURTHER,GLEASON,HOWEVER,MEN,TEA,THREE
001,002,003,004,020,025,120,124,BACKGROUND,CONCERNING,GLEASON,LABEL,METHODS,PNI,PSM,RESULTS,SVI,UNASSIGNED,VIRTUAL
001,103,143,162,361,523,8805,ERG,FISH,HGPIN,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SAMPLES,THERE
001,124,169,183,1831,1992,2010,2012,AMONG,BACKGROUND,BRITISH,CONCLUSION,COPYRIGHT,COX,ESTIMATED,FIFTY,FIVE,JOHN,JOURNAL,LABEL,LTD,METHODS,PUBLISHED,RESULTS,SOCIETY,SONS,SURGERY,THERE,WILEY
PSA
100,250,300,345,440,510,600,8201,916,955,I297,I307,I345,NADH,PAIRS
BECAUSE
12H,169,2012,24H,60S,880,COPYRIGHT,LNCAP,MHZ,NEXT,TATA
109,169,2012,442,BACKGROUND,BASED,COPYRIGHT,CRPC,EIGHT,EVALUATION,FEW,INC,LABEL,METHODS,RESULTS,SERUM,SOLID,TREATMENT
169,2007,2012,BACKGROUND,CITED,CONTEXT,COPYRIGHT,DESPITE,E26,ERG,HOWEVER,JANUARY,LABEL,MASSIVE,METHODS,OBJECTIVE,PCA,PCA3,PUBLISHED,RESULTS,SYNTHESIS,TMPRSS2,WESTERN
169,2012,BOTH,CAP,COPYRIGHT,CWR22,HOWEVER,INC,LNCAP,NCOR,PRIMARY,PSA,SIMILAR,SMRT,SRC,THUS,TIF
003,005,012,015,026,048,8201,BACKGROUND,BLADDER,CONCLUSION,LABEL,METHODS,MMP,MMPS,MOST,PCR,RECK,REGARDING,RESULTS,TIMP
1970,1973,2007,31ST,6017,BACKGROUND,BODY,CONCLUSION,COX,GLEASON,HAZARDS,INDEX,LABEL,MASS,MEN,METHODS,PCS,RESULTS,THEREFORE
169,2013,CAP,COPYRIGHT,EXPRESSION,IHC,INC,KNOCKDOWN,LABEL,MATERIALS,METHODS,MMPS,OBJECTIVE,OBJECTIVES,PCR,PSORIASIN,RESULTS
0001,101,169,2012,258,2591,294,345,6057,8648,AIMS,COPYRIGHT,COSTING,CROWN,EPI,IGRT,KVI,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,RESULTS,TIME,TREATMENT
CALCIUM,LATER
000,152,431,CARLO,IMRT,LABEL,MATERIALS,METHODS,MONTE,OBJECTIVE,OBJECTIVES,QALY,QALYS,RESULTS,SBRT
001,131,3PB,AD5,ADP,CRAD,LNCAP,NIS,PCA,SPECT,THESE
169,2012,COPYRIGHT,LMWH,LTD,LUNG,THERE,VTE
169,2012,AUTHORS,BJU,FINALLY,NOVEL,OTHER,UROLOGY
169,2012,ALSO,AUTHORS,BJU,CRPC,FURTHER,HOWEVER,III,MDV3100,SIPULEUCEL,THESE
169,2012,954,ADT,AUTHORS,BJU,BONE,DENOSUMAB,IAD,PSA,UROLOGY
169,2012,ADT,APPROACHES,AUTHORS,BJU,HUGGINS,LHRH,PSA,SINCE,WHILE
150,300,8202,AMP,CXCR4,LNCAP
22RV1,5MG,CAUCASIAN,CDKIS,CONSISTENT,DGA,LNCAP,OVERALL,PCA,PCNA,PSA,SYMPHYTUM,THUS
134,169,2012,244,429,793,8201,888,890,BACKGROUND,BPH,COPYRIGHT,GSTM1,GSTT1,INC,LABEL,META,METHODS,NULL,RESULTS,UPON,WILEY
001,160,174,5T4,945,CRP,IFN,III,MCHC,MVA,RCC
235,AAT,CONCLUSION,LABEL,MEAN,METHODS,OBJECTIVE,PET,RESULTS,RPE,THROUGH
160,1998,2001,2007,236,241,8805,AJCC,GLEASON,HDL,HOWEVER,III,LABEL,LDL,METHODS,NEITHER,NUTRITION,OBJECTIVE,PREVENTION,PURPOSE,RESULTS,THESE
215,ERG,EVEN,HGPIN,IDC,SINCE
GLEASON,THESE
HOWEVER,PCA,PCAS,THUS
IGF,IGFBP,POPULATION
072,18F,FDG,LABEL,METHODS,NAF,OBJECTIVE,PET,PSA,PURPOSE,RANK,RESULTS,STUDIES,TRUE
AFRICAN,RESULTS
0609,8804,931,FIVE,TRP,TRP_MIN,TST
001,003,177,2004,2010,403,8201,AFTER,AMONG,APC,ARGON,BACKGROUND,BETWEEN,DEPENDING,EACH,EVEN,FORTY,FREQUENCY,GRADE,HOWEVER,IMRT,LABEL,METHODS,RADIATION,RBS,RESULTS,SCORE,THEIR
131,BALB,BLEOMYCIN,BLM,BLMG,CACO,QUALITY,RESULTS,THEREFORE,XENOGRAPHY
215,253,302,945,BACKGROUND,CYP24A1,CYP27B1,DTC,FTC,LABEL,METHODS,PTC,RESULTS,THERE,THESE
PART
CAREFUL,III,MEDICINES
DIFFERENT,DUE
ESCC,PBMC,PBMCS,PDCD4,PPP2R2A,SCC,SCCS,USING,ZINC
ALTERATION,BACKGROUND,BASED,CONTAINING,DISCOVERY,DISSECT,EVENT,LABEL,MOTIVATION,RESULTS,SEQ,STRUCTURAL
945,946,AUTOCRINE,JNK,NH2,PDGF,PDGFD,PDGFR,TAKEN,USING
001,100,104,554,8805,BACKGROUND,DECLINING,GLEASON,ITT,LABEL,METHODS,OVERALL,POMX,PSA,PSADT,RESULTS
ATP,CDC42,E329,E329K,HEPATOCYTE,HGF,LIM,LIMK1,MET,PAK4,RNAI
BIP,CLU,EXPRESSION,GRP78,MG132,TAKEN
001,177,1993,2009,237,274,632,723,8805,ASSESSMENT,CASES,GLEASON,LOW,MEIER,PSA,PTI,THESE
280,8805,AMONG,BACKGROUND,CRPC,FIFTEEN,FORTY,LABEL,METHODS,PSA,RESULTS,SEVENTY
169,2012,22E,945,946,956,BAX,BCL,COMMIPHORA,COPYRIGHT,COSY,DU145,FURTHER,HMBC,HMQC,K562,LTD,MCF,NMR,NOESY,PC3,THEIR
169,2012,304,75TH,8804,ANALYTICAL,COPYRIGHT,FURTHER,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,PROSVUE,PSA,PUBLISHED,RESULTS,SOCIETY,THESE,USING
169,183,2013,340,8805,AMONG,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PLND,PURPOSE,RESULTS,SOCIETY,UROLOGICAL
169,2013,AMERICA,BACKGROUND,CAP,CHILEAN,COPYRIGHT,DRE,HOWEVER,INC,LABEL,LATIN,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PCA3,PSA,RESULTS,ROC,SIXTY,USING
BACKGROUND,CBT,DISCUSSION,LABEL,METHODS,NETWORK,POST,PRIOR,RCT,SEVENTY,TRIAL,UKCRN10904
169,2012,AMPRENAVIR,BAX,COPYRIGHT,HIV,MLV,PREXMRV,PTEN,XENOTROPIC,XMRV
169,2012,AUTHORS,COLLEGE,JOURNAL
945,946,ARG,ASP,CELL,CONVERSELY,ECM,GLY,PRO,RGD,SER,SINCE
HIFU,HIGH,THERE
150,945,946,EFFECTS,HOWEVER,LABEL,OBJECTIVE,PROTECTION,PURPOSE,RESULTS
945,AAA,CD151,CELL,ERK,GFP,MTT,PC3,TAKEN,THEN,WESTERN
4TH,BALB,CELLS,HOWEVER,ID1,MICE,PC3,PTHRP,THESE
AKT,CELLS,DU145,DUERR,EGF,EGFR,HER2,HER3,HER4,HOWEVER,PC3,PCA,PCR,PI3K,PTEN
001,107,319,4028,8805,BCR,COX,INTENSIVE,LABEL,METHODS,OBJECTIVE,PCA,PSA,PURPOSE,RESULTS
954,FURTHER,MEK,RAF,RKIP,TAKEN
ACID,ALSO,HOWEVER
125,272,320,945,BOTH,CHANGES,LOWER,QOL,TAMSULOSIN,THESE
451,8201,CASES,GLEASON,MEN,ODDS,PTEN,RECURRENCE,THUS
EGF,ELK1,ERK,FOS,MAPK,NUCLEAR,THUS,WHILE
160,CARLO,FINALLY,FIRST,GATE,IBA,MONTE,PBS,TPS,TPSS,XIO
169,2012,513,572,8P21,APOPTOSIS,BOTH,COPYRIGHT,CSR1,HOWEVER,INC,INHIBITOR,PATHOLOGY,PROTEIN,PUBLISHED,SOCIETY,THESE,THROUGH,THUS,XIAP
001,1426,169,2012,ANONYMOUS,COPYRIGHT,LABEL,LTD,METHODS,MOST,OBJECTIVE,RESULTS
169,2012,COA,COLLEGE,COPYRIGHT,ERG,LTD,PCA3,PUBLISHED,ROYAL,TMPRSS2
141,169,1997,2001,2012,276,ADT,AGE,BACKGROUND,COPYRIGHT,EBRT,FREEDOM,GROUP,HOWEVER,ICORG,IRELAND,IRISH,LABEL,LTD,MATERIALS,METHODS,NAD,NEO,OBJECTIVE,PURPOSE,RESULTS
004,026,169,2012,202,221,CHINESE,COPYRIGHT,GENOTYPING,HAN,INC,LYS939GLN,PAT,PCA,PCR,RFLP,XPC
169,2012,206,232,300,469,AIMS,BACKGROUND,COLLEGE,COPYRIGHT,DATA,DRE,EDINBURGH,IRELAND,IVU,IVUS,LABEL,LTD,METHODS,OBJECTIVE,PSA,PUBLISHED,RESULTS,ROYAL,SUBSEQUENT
009,017,169,2012,ADDITIONAL,BACKGROUND,COPYRIGHT,CTC,III,LABEL,LAHNC,LTD,MATERIALS,METHODS,NED,OBJECTIVE,PARTIAL,PURPOSE,RESULTS,SNUC,THESE
149,301,BACKGROUND,DRE,LABEL,METHODS,PCS,PSA,RESULTS
215,EARLY,HENCE,PSA,QCM,SPR
169,2012,COPYRIGHT,CROWN,FDG,INC,PET,PSA,PUBLISHED
177,2004,2006,ACUTE,BACKGROUND,EBRT,EPIC,HRQOL,IMRT,INDEX,JUNE,LABEL,LIFE,LOW,MEAN,METHODS,MRI,NCCN,NETWORK,PCA,PSA,QUALITY,RESULTS,SINCE
145,AT1,AT2,BACKGROUND,FINALLY,LABEL,LIMITED,LNCAP,MATERIALS,METHODS,MTT,RESULTS,THESE,USING
169,2012,8201,BACKGROUND,COPYRIGHT,DOF,JOHN,LABEL,LTD,METHODS,MRI,RESULTS,SOFT,SONS,STD,SUPER,WILEY
176,177,4MM,5MM,8MM,DOF,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS
946,AKT,BASED,BOTH,NON,PC3,PI3,SMAD3,TGF
ASSESSMENT
AMONG
101,945,954,BACKGROUND,CONCLUSION,FURTHER,LABEL,LMP2,METHODS,RESULTS,THESE,TNF
169,2012,BACKGROUND,BASEL,COPYRIGHT,FUNCTIONAL,LABEL,METHODS,MRI,PCA,PSA,RESULTS,TRUS
0003,0353,10Q11,128,169,2012,8P21,8Q24,946,BASED,CELLS,COPYRIGHT,GWAS,MSMB,SNPS,THESE
001,169,2012,BACKGROUND,BFFS,COPYRIGHT,INC,LABEL,LHRHA,METHODS,NEITHER,PHOENIX,PRPH,PSA,RESULTS,SIXTY,THERE
160,169,2012,BATHO,BEAMNRC,BOTH,CARLO,COPYRIGHT,DOSXYZNRC,DVH,ECLIPSE,IMRT,LAW,LTD,MONTE,PBC,POWER,PUBLISHED,TPS,WHEREAS
169,1993,2006,2008,2012,414,8805,985,COPYRIGHT,EXAMINING,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
113,169,2012,8805,COPYRIGHT,DEVIATION,FIVE,GROUP,INC,LABEL,LATE,MATERIALS,METHODS,OBJECTIVE,PHOENIX,PURPOSE,RADIATION,RESULTS,RISK,THERAPY,THREE,TREATMENT
002,005,009,032,169,177,2013,AFTER,BEAM,COMMISSION,CONCLUSION,CONVERSELY,COPYRIGHT,D50,D98,DICE,DSC,INC,LABEL,MATERIALS,METHODS,OAR,OBJECTIVE,PLAN,PLANS,PURPOSE,RADIATION,RESULTS,UNITS,V20,V50,V60,V70,V75,VMAT,WPRT
160,169,2012,COPYRIGHT,CTV,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS,THEIR,WITHOUT
946,ADDITIONAL,ANALOGS,LNCAP,LTD,PUBLISHED
169,2012,291,301,945,BACKGROUND,CASTRATION,CONCLUSION,COPYRIGHT,CRPC,FIVE,III,LABEL,LTD,METHODS,PSA,RESISTANT,RESULTS,THERE,TTP
001,169,1995,2006,2012,832,AFTER,BCR,CONCLUSION,COPYRIGHT,EDUCATION,FOUNDATION,GLEASON,INC,JANUARY,JULY,LABEL,MAYO,MEDICAL,METHODS,OBJECTIVE,PSA,PUBLISHED,RESULTS,THESE
427,HOWEVER,HSP27,OGX,THESE
451,PLND,SUBMISSION,THERE,THREE
BCR,BOTH,MRI,ORGAN,PET,PSA,REGARDLESS,SALVAGE
001,035,169,2012,8805,AKT,BACKGROUND,COPYRIGHT,ERG,FIFTY,GLEASON,KI67,LABEL,LOSS,METHODS,MYC,PFS,PSA,PTEN,RESULTS,SOCIETY,TAX2501,UNIVARIATE
100,131,169,177,2012,209,721,884,COPYRIGHT,HOWEVER,JOHN,LTD,MRI,SONS,WILEY
138,169,2012,5230,613,6829,8240,BACKGROUND,COPYRIGHT,DETECTION,FIVE,LABEL,METHODS,NPCR,PCA,RESULTS,SOCIETY
DUE,FDG,MRI,PET,SUBSEQUENT,WHILE
089,1995,1996,2006,523,AARP,AFRICAN,AMERICANS,AREA,CAUCASIAN,CAUCASIANS,CERTAIN,CIS,COX,DIET,FILE,HRS,LABEL,LIFESTYLE,METHODS,MINIMIZING,MULTILEVEL,NIH,OBJECTIVE,OBJECTIVES,RESULTS
605,697,ASIAN,CONCLUSION,DATA,LABEL,METHODS,NUTRITION,OBJECTIVE,PURPOSE,RESULTS,RRS,THERE
145,169,2012,916,936,AIF,AKT,BACKGROUND,BCL,CELL,CFSE,COPYRIGHT,HRPC,HRPCS,IAP,INC,INCREASING,LABEL,METHODS,PROTEIN,RESULTS,ROS,THEREFORE,WESTERN,WILEY
169,2012,225,618,BACKGROUND,CALIFORNIA,COPYRIGHT,COX,FRANCISCO,GLEASON,LABEL,METHODS,RESULTS,ROC,SAN,SOCIETY,UNIVERSITY,USING
169,2012,BACKGROUND,BPH,COPYRIGHT,ERG,INC,LABEL,METHODS,PCA,PCA3,RESULTS,THERE,TMPRSS2,WILEY
169,2012,239,723,BACKGROUND,COPYRIGHT,ENDOCRINE,ERG,FORTY,FRESHLY,GOSERELIN,INC,LABEL,LNCAP,METHODS,RESULTS,TMPRSS2,VCAP,WILEY
183,200,946,954,CERTAIN,CLEVENGER,COX,DPPH,FORTUNELLA,FRESH,FURTHER,GEORG,KUMQUAT,LNCAP,NMR,RTX,SIL,STUTTGART,WAX,YORK
169,2012,3DCRT,4559,COPYRIGHT,CROWN,GIVEN,IMRT,INTENSITY,LTD,PUBLISHED,THERE,THREE
169,177,2012,BACKGROUND,COPYRIGHT,IRELAND,LABEL,LTD,MATERIALS,MEAN,METHODS,OBJECTIVE,PURPOSE,RESULTS,THREE,VOLUNTARY
024,169,2012,509,8805,ACUTE,BACKGROUND,COPYRIGHT,DVH,GRADE,GROUP,IRELAND,KUTCHER,LABEL,LKB,LTD,LYMAN,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RADIATION,RESULTS,RTOG,THERAPY,THESE,VARIATIONS
0001,10NG,15MM,169,2013,3MM,5MM,75MM,8805,9NG,COPYRIGHT,EPE,GLEASON,INC,INCREASING,LABEL,MATERIALS,METHODS,OBJECTIVE,PSA,PUBLISHED,PURPOSE,RESULTS,SOCIETY,T1C,T2A,T2B,T2C,THESE
169,2012,COPYRIGHT,INC
172,188,1973,2006,755,783,8201,BACKGROUND,BASED,BOTH,DATA,INCIDENCE,LABEL,METHODS,POISSON,RESULTS,SINGAPORE
169,2012,956,AMONG,COPYRIGHT,DMC,LNCAP,LTD
169,2013,CEA,CK903,COPYRIGHT,HIGH,INC,NAS,NUCLEAR,PAX8,PSA
100,103,125,132,144,169,2003,2009,2013,8805,ADVERSE,ASTRO,COPYRIGHT,FOCAL,FULL,GLEASON,INC,LABEL,MATERIALS,METHODS,MRI,MRS,OBJECTIVE,PFS,PHOENIX,PPI,PSA,PURPOSE,RADIATION,RESULTS,SOCIETY,TREATMENT,V100
169,2012,212,966,AIM,BACKGROUND,DIAGNOSIS,DRE,INITIATING,LABEL,MAIN,METHODS,OBJECTIVE,OUTCOME,PCA,PSA,RESTANDOL,RESULTS,SOCIETY,TIME,TRT
001,153,169,1995,2005,2012,576,8804,8805,AIM,BACKGROUND,END,LABEL,MAIN,METHODS,NORTH,OBJECTIVE,OUTCOME,OVERALL,PCA,RESULTS,SOCIETY,TREATMENT
001,002,169,1845,1999,2007,2012,8226,8805,AMICO,AUTHORS,BCR,BECAUSE,BJU,COX,GLEASON,LABEL,LEVEL,LRP,MATERIALS,MEIER,METHODS,OBJECTIVE,ORGAN,RALP,RESULTS,THERAPY,THERE,THESE,TYPE,UNLABELLED,URINARY,WHAT
001,011,101,168,169,2012,348,361,373,8226,BCR,BJU,COX,DU145,GLEASON,HMGB1,HOWEVER,LABEL,LNCAP,MEIER,METHODS,OBJECTIVE,RESULTS,RWPE,THERE,UNLABELLED,WHAT
956,APC,BACKGROUND,BIOMARKERS,EPIGENETIC,FFPE,GSTP1,INCREASING,LABEL,MSP,PCR,PSA,RESULTS
169,2000,2011,2012,8226,BJU,ENGLISH,GLEASON,HIFU,HIGH,HOWEVER,JANUARY,LABEL,MATERIALS,MEDLINE,METHODS,MOST,NOVEL,OBJECTIVE,OBJECTIVES,OVID,PSA,RECTO,RESULTS,TREATMENT,TURP,UNLABELLED,WHAT
169,2004,2006,2012,771,AES,AUTHORS,BJU,BRIEF,COMPOSITE,EDMED,FIFTY,INDEX,INVENTORY,IRRITATIVE,LABEL,MEN,METHODS,OBJECTIVE,OBJECTIVES,OCTOBER,PCA,QOL,RAD,RESULTS
ACC,AMPK,COA,FASN,HOWEVER,LNCAP,PC3,USING,WESTERN
384,393,8Q24,CAUCASIAN,COMPELLING,META,RUSSIAN,SIBERIA,SNPS
169,2011,8201,99MTC,BACKGROUND,CTT,DTPA,IC50,INC,LABEL,LNCAP,METHODS,PERCENT,PSMA,RESULTS,SPECT,WHILE,WILEY
100,HOWEVER,VIRTUALLY
AFRICAN,BARBADIAN,KEY,WEST
174,177,ABAS,AUTOMATIC,BACKGROUND,CBCT,CBCTS,CONCLUSION,CTS,DEMO,DICE,DSC,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
JAK,MAPK,OBESITY,PI3,PROMINENT,PSA,STAT,THESE
125,945,946,956,ACTIVATED,AIM,APTT,B16,BALB,BRDU,CONCLUSION,F10,HCS,HEPARIN,KI67,LABEL,METHODS,MTS,OBJECTIVE,PCR,RESULTS,TGF,WESTERN
CLAUDIN,EMA,GCT,GCTS,GLUT,HOWEVER,MOST,PNI,SCHWANN,THESE,THREE,THUS
169,17A,18A,18I,18J,18L,2012,956,CLAISEN,COPYRIGHT,H460,LTD,NCI,NMR,SCHMIDT,THREE
111,206,ACE,BACKGROUND,CONCLUSION,LABEL,MATERIALS,METHODS,PSA,RESULTS
TEA,WESTERN
171,187,EYE,HOWEVER,UNKNOWN
945,954,BCL,C57BL,DU145,HOWEVER,LPS,PC3,PCA,PREVIOUSLY,RELA,THEREFORE
449,8Q24,BACKGROUND,CI95,HOWEVER,IBC,LABEL,MYC,PRINCIPAL,REPLICATED,RESULTS,SNPS
CELASTROL,CHINESE,GOD,GONG,HOOK,JUN,LEI,LNCAP,MEANWHILE,PARP,PCA,SENP1,SUMO,TAKEN,TENG,THUNDER,TRIPTOLIDE,UNBALANCE,VINE
FOLLOWING
BOTH,MRI,SVM
ACTIVATING,ATF3
130,17Q24,8764,FOXA1,GWAS,PCA,SNP,SNPS,SOX9
223,240,BACKGROUND,GLEASON,HPN,LABEL,METHODS,RESULTS,SNPS
1E8,2B4,DU145,ERK1,GDP,GTP,HOWEVER,PAG,RAS,TAKEN
169,177,1994,2011,2012,836,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,RESULTS,THEREFORE
169,2012,220,300,AFTER,COPYRIGHT,GLEASON,INC,LABEL,LYMPH,METHODS,OBJECTIVE,PCA,PROCEDURES,PURPOSE,RALP,RESULTS
1998,2001,2006,2007,AGE,BESIDES,CANCERS,INUIT,LABEL,METHODS,OBJECTIVE,OBJECTIVES,POPULATION,RESULTS
174,DIET,HDT,HORMONE,PRC,ZYFLAMEND
100,200,231,400,956,BBI,BIRK,LNCAP,MDA,PIC,PICS,THESE
40PATIENTS,GALAL,HOSPITALS,HUSSEIN,NONE,SAYED,TRANS,TRUS,ULTRASOUND,UNIVERSITY
169,215,483,686,8202,ASIAN,BACKGROUND,C2ORF43,CHINESE,EASTERN,FOXP4,FURTHER,GWAS,HAN,HANS,LABEL,METHODS,PHASE,RESULTS,RFX6,RS9600079,SNPS,THEN
236,ALU,BETA,BOTH,GWAS,MSMB,MSP,NCOA4,PCA,UTR
945,BGP,LNCAP,MCF,VDR
2008,ASIA,CONTINENTS,EAST,EASTERN,FIVE,INCIDENCE,ISLANDS,LARGE,MOST,PACIFIC,SOUTH,THEREFORE
108,160,8226,DCE,DIAGNOSTIC,ECE,ENDORECTAL,ERC,HIGH,IRB,KEY,LABEL,METHODS,MRI,OBJECTIVE,OBJECTIVES,RESULTS,T2W
135,AUC,BACKGROUND,CONCLUSION,GRADE,LABEL,METHODS,RESULTS,TTP
AMONG,CLINICALLY,EPHA2,IIB,RAC1,REDUCTION,VAV3,WESTERN,YET
AIMS,CONCLUSION,DATA,GLEASON,HIFU,HIGH,LABEL,METHODS,OBJECTIVE,POST,PSA,RESULTS,STROMAL,TREATMENT
0011,0012,0273,BACKGROUND,CONCERN,CONTEXT,DHT,DMPA,LABEL,MAIN,METHODS,MHC,OBJECTIVE,OUTCOME,RESULTS,SERUM,SETTING
169,2012,947,956,COPYRIGHT,DSBS,DU145,H2AX,HT29,INC,MCF,ROS,SUPEROXIDE,THEIR
1072,1095,111,123,169,2013,AMERICA,CAP,COPYRIGHT,DESPITE,GIVEN,INC,J591,MIP,NORTH,PET,PSMA,SPECT,UREA,WHILE
169,2005,2013,211,293,666,959,COPYRIGHT,DESPITE,GLEASON,INC,ISUP,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PATHOLOGY,PSA,RESULTS,SOCIETY,THERE,UROLOGICAL
006,169,2012,3255,4073,8122,831,8805,ALSO,ANDROGENS,BACKGROUND,COPYRIGHT,DHT,GLEASON,GOV,IDENTIFIER,KEY,LABEL,METHODS,OBJECTIVE,OUTCOME,PCA,PER,PSA,REDUCTION,RESULTS,SETTING,UROLOGY
169,183,184,1988,2002,2008,2012,2030,BACKGROUND,CONTINENTS,COPYRIGHT,FIVE,FUNDING,HDI,INCIDENCE,INDEX,LABEL,LTD,METHODS,NINE,NONE,RESULTS
0005,102,169,2013,8804,CONCLUSION,COPYRIGHT,COX,EARLY,GROUP,INC,IRISH,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,OS1,OS2,PSA,PURPOSE,RESULTS
001,005,010,10780,169,2013,322,509,800,946,AFTER,COPYRIGHT,DATA,FIVE,IMRT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RADICAL,RESULTS,TGF,THESE
001,002,014,169,2012,BOTH,COPYRIGHT,DOSE,IMRT,INC,LABEL,MATERIALS,METHODS,NTCP,NTCPS,OBJECTIVE,PET,PLAN,PURPOSE,RESULTS,SUV,TCP,TCPS,THERE,THREE
006,2012,236,296,ADVERSE,AMONG,ANTI,BACKGROUND,BMS,BRISTOL,CUMULATIVE,GRADE,LABEL,METHODS,MYERS,RESPONSES,RESULTS
LNCAP,LXR,OVERALL,SREBP,THERE,USING,WHEREAS
169,2012,206,232,233,234,CONCLUSION,COPYRIGHT,FOCH,GEORGES,LABEL,METHODS,OBJECTIVE,PARIS,PCA,PITI,PLAN,RCC,RCP,RESULTS,SALP,SAS,THESE,THREE
169,1999,2008,2012,BACKGROUND,CONCLUSION,COPYRIGHT,GLEASON,LABEL,METHODS,MULTIFOCAL,PUBLISHED,REGARDING,RESULTS,SAS
169,2012,AFTER,COPYRIGHT,GIVEN,GROSS,INC,METASTATIC,PSA
169,2012,CONCLUSION,COPYRIGHT,CURRENTLY,INC,LABEL,METHODS,OBJECTIVE,PORT,RESULTS,VINCI
025,087,099,106,110,119,169,2012,2038,213,606,735,836,8804,8805,ALSO,CONCLUSION,COPYRIGHT,GLEASON,HOWEVER,INC,LABEL,METHODS,OBESITY,OBJECTIVE,PCA,PSA,RESULTS
119,139,169,200,2012,205,207,286,291,316,574,954,COHEN,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,MRI,OBJECTIVE,PBX,RESULTS,THERE,THESE,UNILATERAL
223,ALPHARADIN,AMONG,CRPC
137,FINDING,MIDAS,THEREFORE,VXEF
CONVERSELY,KNOCKDOWN,LNCAP,PCA,RNAI,TRAMP
ACTIVATING,DIFFERENT,FURTHER,LBD,PCA
169,2012,BACKGROUND,CELL,COPYRIGHT,GLOI,GLYOXALASE,INC,LABEL,LNCAP,METHODS,PC3,REAL,RESULTS,WESTERN,WILEY
169,2012,948,954,BACKGROUND,BRADYKININ,COPYRIGHT,INC,LABEL,METHODS,MMP,PKC,PP2,RESULTS,SRC,TRANSWELL,WESTERN,WILEY
000,001,95TH,AGE,DRE,FPSA,HOWEVER,PSA,SERUM,SYRIA,THESE,TPSA
408,483,BPH,CAG,GGC,HOWEVER,PCR,PSA,RFLP,TURKISH
038,043,251,273,5P15,CHINESE,FURTHER,GENOTYPES,PCR,RFLP,SNP,SNPS
ERK,ETS,MEK,RAF,RAS,THUS
169,2012,COPYRIGHT,HOWEVER,INC,PCR,RNAS
0016,024,105,1094,1287,2102,2105,2200,366,553,576,707,980,ALTOGETHER,BACKGROUND,FINNISH,LABEL,METHODS,RESULTS
169,2012,COPYRIGHT,HOWEVER,LTD,WHAT
001,002,1654,169,2012,215,25TH,75TH,8805,AMONG,AREA,AUC,BACKGROUND,COPYRIGHT,DCA,GLEASON,LABEL,METHODS,NET,NRI,OBJECTIVE,OUTCOME,PCA,PREDICTIVE,PUBLISHED,REDUCTION,RESULTS,SETTING,SEVERAL,SIMILAR,SNPS,UROLOGY
001,037,049,169,1994,2000,2013,210,502,ADT,AGAIN,COPYRIGHT,EBRT,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PCSS,PSA,PSAHT,PSAS,PURPOSE,RESULTS,SEVENTY
101,102,105,107,108,109,115,118,156,169,177,2013,208,COPYRIGHT,CTV,CUMULATIVE,D90,DOSE,DOSIMETRIC,HDR,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE,URETHRA,V100,V150,V200,V90
0001,0002,0006,0008,0012,008,052,160,169,172,1989,2006,2012,2051,328,465,529,967,974,BETWEEN,COPYRIGHT,FURTHER,GLEASON,IBF,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PATIENT,PURPOSE,RESULTS,UNIVARIATE
160,169,1965,2013,808,945,946,CIS,COPYRIGHT,DETAILS,FIVE,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,STUDIES
169,192,2013,CBCT,CHANGES,COPYRIGHT,INC,IPSS,LABEL,MATERIALS,METHODS,MIGRATION,OBJECTIVE,PATIENT,PURPOSE,REALEYE,RESULTS,SCORE,SYMPTOM
169,2012,COPYRIGHT,LTD,TELOMERES
169,2012,COPYRIGHT,LTD,STAT3,THERE,THEREFORE,THESE
126,8805,BACKGROUND,CONCLUSION,GLEASON,HOWEVER,LABEL,RESULTS,URINARY
452,BMI,COMPOSITE,GLEASON,INDEX,INVENTORY,LABEL,MEN,METHODS,OBJECTIVE,PURPOSE,RARP,RESULTS,SHIM,URINARY,YOUNGER
194,385,579,CONCLUSION,LABEL,METHODS,OBJECTIVE,PSA,RESULTS
126,2008,2010,GLEASON,GPC,JANUARY,PCA,PPV,PREDICTIVE,PSA,SIXTY,T1C,TPC,VALUE
144,1440,1537,2008,2010,COLOR,CONCLUSION,DOPPLER,DRE,GROUP,JANUARY,LABEL,METHODS,OBJECTIVE,PCA,PSA,RESULTS,TRUS,ULTRASOUND
001,002,123,2000,2005,306,CGA,COMPARISON,CONCLUSION,KRUSKAL,LABEL,MANN,MATERIALS,MEIER,METHODS,OBJECTIVE,PATIENT,PSA,RESULTS,STAGE,STUDIES,WHITNEY
132,150,176,180,1995,200,AIMS,BLADDER,FOLLOWING,LABEL,MATERIALS,METHODS,OBJECTIVE,PSA,RESULTS,THREE,URINARY
001,035,0645,120,127,132,168,205,248,252,8804,8805,ADT,CONCLUSION,LABEL,LBM,MEAN,MEN,METHODS,OBJECTIVE,PURPOSE,RESULTS
169,2012,COPYRIGHT,JOHN,LTD,MICROSCOPY,NMR,NMRD,QUANTUM,SONS,SQUID,TEM,WILEY
100,169,2012,ASAP,BASED,BECAUSE,CONCLUSION,COPYRIGHT,FIVE,HGPIN,INC,LABEL,MATERIALS,METHODS,MRI,NPV,OBJECTIVE,PSA,PURPOSE,RESULTS,TESLA,WILEY
169,2012,AKT,COPYRIGHT,EGFR,EMBO,ERBB,FINALLY,HER2,HOWEVER,LOSS,MAPK,MOLECULAR,PI3K,PTEN,REDUCTION,SPRY2
ADP,AKT,BAX,BCL,LPS,PI3,THEREFORE,TLR4,TLRS,TOLL
000,0094,146,169,2012,945,946,ALSO,BPH,COMMITTEE,COPYRIGHT,DECREASED,DGS,HGPIN,IGF,IGFR,INC,LABEL,LAM,METHODS,MMPS,OBJECTIVE,OBJECTIVES,RESULTS,SAMPLES,SHRS,SIXTY,STATE,UNICAMP,UNIVERSITY,WESTERN,WILEY
170,2010,254,5007,956,BACKGROUND,CONCLUSION,CONTINUOUS,DOSE,FUND,INSTITUTE,LABEL,META,METHODS,OBJECTIVE,PROJECT,RESULTS,SEPTEMBER,SEVERAL,THREE,WORLD
FOURIER,MRSI,PHANTOM,PSF,SNR
000,GERMANY,MRI,PCA
004,019,143,145,169,2012,30A,34A,8201,AIMS,AVAILABLE,BACKGROUND,BLOOD,CONCLUSION,COPYRIGHT,EXPRESSION,INC,LABEL,METHODS,MICRORNAS,MIR,MOST,OBJECTIVE,PCR,RESULTS,WILEY
229,239,BACKGROUND,CONCLUSION,DATA,KARNOFSKY,LABEL,METHODS,OBJECTIVE,PSA,RESULTS,SUMMARY,THREE,UME,UNIVERSITY
AKT,BAX,BCL,BCL2,CONVERSELY,DU145,ERK1,HSP27,LEDGF,LENS,LNCAP,PCS,SILENCING,THESE
8805,946,BARR,BKV,CD103,CD127,CD25,CD28,CD3,CD4,EPSTEIN,FOXP3,IGG,PBMC,PCA,TAG
945,EXPRESSION,HENCE,HIF,HYPOXIA,MUTATED,THEREFORE,THESE
AMONG,EACH,LABEL,MRI,MRIS,OBJECTIVE,PURPOSE,RESULTS,SUMMARY
001,101,152,169,2012,564,COPYRIGHT,DOPPLER,IRELAND,LABEL,LTD,METHODS,MFI,NPV,OBJECTIVE,OBJECTIVES,PPV,PSA,RESULTS,TRUS
COMPELLING,III
137,151,2011,ABOUT,FINE,HALF,HOWEVER,LABEL,LOCAL,METHODS,MOST,NETWORK,OBJECTIVE,RESULTS,SUNE,SWEDISH,THERE,UROLOGY
1563,159,1621,179,1800,2006,2008,423,600,763,LABEL,METHODS,NPCR,OBJECTIVE,PSA,RESULTS,T1C
AFP,BACKGROUND,CASE,CASES,CONCLUSION,DISCUSSION,LABEL,METHODS,RESULTS
AREAS,BACKGROUND,BETWEEN,COVERED,HOWEVER,LABEL,MEDLINE,METHODS,OPINION
946,MMP,PCA,TGF,THESE
BACKGROUND,CA19,CAM,CDX2,CEA,CK17,CK19,CK20,CK7,CONTEXT,DPC4,IMP,LABEL,METHODS,MOC31,MUC1,MUC2,MUC4,MUC6,OBJECTIVE,PSCA,RESULTS,S100P,SMAD4
014,1977,2004,337,343,538,604,763,8211,AGE,BETWEEN,EAC,END,ESCC,ESOPHAGEAL,RESULTS,SEER9,SIR,SIR0,THERE
200,2008,2009,400,558,625,COMMENCING,MEROPENEM,OFLOXACIN,OVERALL,REGIMEN,THERE,TRUSGBP,TRUSGPB
8764,ARNT,CREB1,FFL,FFLS,LITERATURE,MYC,NETWORK,TFS
945,954,ANCCA,ATAD2,BCL,CRPC,HOWEVER,MMSET,NSD2,THESE,TNF,VEGFA,WHSC1
99M,CONCLUSION,ICG,LABEL,LNS,METHODS,RESULTS,SNS,SPECT,THESE,UNLABELLED
169,177,2012,AVERAGE,CONCLUSION,COPYRIGHT,DEFORMABLE,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,WILEY
257,375,451,956,ASP312ASN,GROUP,HOWEVER,LABEL,LYS751GLN,METHODS,OBJECTIVE,PURPOSE,RESULTS,XERODERMA,XPD
169,2012,ANG,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,PC3,PRE,RESULTS,SCID,THESE,TRAP,VEGF,WILEY
169,2012,ANG,BACKGROUND,COPYRIGHT,ERK1,FURTHER,INC,KI67,LABEL,LNCAP,MAP,METHODS,PLGF,RESULTS,VEGF,WILEY
1EMA,2011,945,A498,A549,MEL,MKN45,THEREFORE,WON
001,058,1993,1997,2000,2002,426,488,914,946,BACKGROUND,BMI,BODY,CONCLUSION,LABEL,MEN,METHODS,RESULTS
946,950,953,BACKGROUND,HOWEVER,HYDROPATHY,LABEL,METHODS,NCBI,PCR,PKC,PRC,PREVIOUSLY,PRKCZ,RESULTS,THEREFORE
DUE,ENDOGENOUS,GREEN,METHODS,MICRORNAS,PCR,REVERSE,RNAS,RNU44,RNU48,RNU6B,SYBR,TOTAL,UNIVERSAL,WIDESPREAD
401,632,967,BETWEEN,EGGER,FIXED,LABEL,MATERIALS,MEDLINE,METFORMIN,METHODS,OBJECTIVE,ORAL,RESULTS,SEVENTEEN,THERE
946,HER2,HOWEVER,NODAL,STRIZZI
ASODN,BOTH,DRUG,QRS,THUS
025,145,BACKGROUND,LABEL,MATERIALS,METHODS,MMP,MMP9,PCA,PCR,PROGNOSIS,PSA,RECK,RESULTS
001,169,178,2012,955,BASED,COPYRIGHT,ERG,FISH,FURTHER,HOWEVER,INC,ISH,MOLECULAR,PATHOLOGY,PCA,PEARSON,PUBLISHED,SOCIETY,TMPRSS2
1997,2000,2003,AMERICA,BACKGROUND,DATA,DELAYED,DEPARTMENT,HISPANICS,INDEX,LABEL,METHODS,RESULTS,STATE,TEXAS,TOBIT,USA,WELLBEING
EARLY,SLIT
DU145,SEM
105,125,169,2012,AIM,BACKGROUND,LABEL,MAIN,METHODS,MRI,OBJECTIVE,OUTCOME,RESULTS,SOCIETY
0001,009,213,945,AIM,CONCLUSION,LABEL,MATERIALS,METHODS,MICE,OBJECTIVE,ORTHOTOPIC,PC3,RESULTS
123,128,351,378,474,8805,COMPARING,CONCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,PCA,PSA,PURPOSE,RESULTS,THERE
101,CONCLUSION,GLEASON,INTER,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THEREAFTER
0001,2010,755,AES,BECAUSE,DRUG,FOOD,III,JUNE,MOST
CURRENT,INTENSE,PSA,SEVERAL,USED
0001,309,734,ADT,BACKGROUND,BMD,DENOSUMAB,LABEL,LOWER,MEN,METHODS,RANK,RESULTS

CRPC,FDA,SIPULEUCEL,WESTERN
124,239,AUC,BASED,BAYES,CADX,MRI,ROC,ROIS,SVM,USING
014,169,2012,BIND,COPYRIGHT,DOCETAXEL,ENGINEERED,HOWEVER,INC,THERE
AMONG,MOST,TRP,TRPC,TRPC1,TRPC3,TRPC6,TRPM,TRPM7,TRPM8,TRPV,TRPV6
169,2012,ATP,COPYRIGHT,HOWEVER,INHIBITION,PROTEIN,RHO0,ROS,SFN,SKBR
169,2012,BPC,BPCS,BPS,COPYRIGHT,EXPRESSION,HOWEVER,INC,MOST,PATHOLOGY,PATHWAY,PCA,PCAS,PCR,PUBLISHED,RNAS,SOCIETY,THESE
001,003,134,169,2008,2011,2012,ADDITIONAL,AFTER,AUA,AUTHORS,BJU,IIEF,INDEX,LABEL,LUTS,METHODS,OBJECTIVE,PCA,PNBX,QOL,RESULTS,SYMPTOM,THERE,UROLOGICAL
AKT,BACKGROUND,BECAUSE,BMS,CELL,DU145,HGF,LABEL,MET,METHODS,MTT,PCR,RESULTS,SRC,THESE,WESTERN
SOPS,SRM,THREE
169,183,945,EFFECTIVE,GEORG,SERMS,STUTTGART,YORK
1992,2002,2005,930,ADT,BACKGROUND,END,INDICATION,LABEL,METHODS,RESULTS
55KD,BEL7404,E1B,TRAIL,ZD55
215,8201,HOWEVER
8320,8325,A549,MCF,MOST,PC3,ROS,SEVERAL,WRL
1989,2009,MEDLINE
169,2012,ATP,COPYRIGHT,FINGOLIMOD,LNCAP,LTD,S1P,SK1A,SK1B,SKI,THEREFORE,THUS
1995,1999,2000,2003,6493,8331,BACKGROUND,CONCLUSION,COUNTRY,LABEL,METHODS,NAVARRA,POISSON,PSA,RESULTS,SPAIN,SPANISH
169,2012,COPYRIGHT,IRELAND,LTD
1113,169,1996,2012,CONCLUSION,COPYRIGHT,ESTIMATES,INC,LABEL,METHODS,NAMBOUR,OBJECTIVE,PERSONS,PUBLISHED,RESULTS,SUN,WEARING
169,178,2012,8314,8323,946,AKT,AMP,AMPK,CAMKK,COPYRIGHT,CSA,EGF,EGFR,HOWEVER,INC,PIP,THESE
001,130,169,2012,C30,COPYRIGHT,EFFECTS,EORTC,FFQ,FOOD,FREQUENCY,GISEQ,HRQOL,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PR25,PURPOSE,QLQ,RESULTS,SIDE,THERE
169,2012,225,390,500,8804,8805,890,BACKGROUND,BCR,COPYRIGHT,COX,HOWEVER,LABEL,MEIER,METHODS,OBJECTIVE,OUTCOME,OVERALL,PCA,PROPENSITY,PSA,PUBLISHED,RESULTS,SETTING,SIMILAR,THEREFORE,THESE,UROLOGY,USING
169,2012,COPYRIGHT,HIV,INC,MOST,SMI,THESE
160,169,2012,8805,COPYRIGHT,IMAGE,IMRT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,USING
051,084,169,2012,9406,ASTRO,CONCLUSION,COPYRIGHT,CRT,DOSE,GROUP,III,INC,LABEL,MATERIALS,METHODS,NHT,OBJECTIVE,PHASE,PHOENIX,PURPOSE,RADIATION,RESULTS,RTOG,SOCIETY,THERAPY
169,2011,2012,COPYRIGHT,ECCO,ESMO,FGF,MEDICAL,OTHER,SAS,SEPTEMBER,SOCIETY,STOCKHOLM,TARGETING,VEGF
169,2002,2006,2012,8805,944,BACKGROUND,BCR,BRFS,COPYRIGHT,COX,FURTHER,GLEASON,JANUARY,KAROLINSKA,LABEL,MEIER,METHODS,NINE,OBJECTIVE,OUTCOME,PCA,PSA,PUBLISHED,RARP,RESULTS,ROBOT,SETTING,STOCKHOLM,UNIVERSITY,UROLOGY
0001,0010,0074,0079,169,2012,202,434,643,BACKGROUND,BDP,COPYRIGHT,CRPC,LABEL,METHODS,OBJECTIVE,OUTCOME,PSA,PUBLISHED,RESULTS,SETTING,SRE,SRES,UROLOGY,ZOL,ZOLEDRONIC
169,2012,AMED,BACKGROUND,BPH,COPYRIGHT,EIGHT,GIVEN,IRELAND,LABEL,LIBRARY,LTD,MEDLINE,META,METHODS,PSA,RCTS,RESULTS
117,169,1998,2010,2012,967,COPYRIGHT,GLEASON,LVI,MEIER,PSA,PUBLISHED,THEREFORE
188,ASSAY,IFAST,PSA,USING
200,400,AUSTRALIA,BACKGROUND,COST,DISCUSSION,HOWEVER,LABEL,METHODS,NON,OPEN,QOL,ROBOTIC,TRIAL,WESTERN,WHILE
169,2012,BLACKWELL,GROUP,LTD,MALIGNANCY,PUBLISHING,THROUGH,ULTIMATELY
7F5,ANTI,BACKGROUND,CONCLUSION,FIRST,GOLDMAG,IGG,LABEL,MATERIALS,METHODS,MRI,NEXT,PSCA,RESULTS
004,DEP,FURTHER
477,AIP5,GIVEN,HECT,HEPATOCYTE,HGF,MET,PPVY,TAKEN,TIUL1,WWP1
CFS,LNCAP,MLV,PBMC,PBMCS,PCR,STATE,USING,WHILE,YORK
2003,PSE,RUBIN,ZHANG
145,8320,8325,956,AMONG,BACCAUREA,DCM,DIFFERENT,GAE,H460,IC50,MCF,MEOH,MTS,TOTAL,TPC

001,169,2012,BACKGROUND,BIGH3,BPH,CARCINOMA,CD147,CELL,CONCLUSION,COPYRIGHT,ECM,ELISA,HOC,LABEL,METHODS,MOLECULAR,PCR,POST,RESULTS,ROC,SERUM,STMN1,TCC,UROTHELIAL
001,169,2005,2009,2012,237,687,739,768,784,837,AUC,BASEL,CALCULATOR,CANCEROLOG,CITY,COPYRIGHT,GLEASON,HGPCA,INSTITUTO,LABEL,METHODS,MEXICAN,NET,OBJECTIVE,OBJECTIVES,PCA,PREVENTION,RATES,RESULTS,RISK,TRIAL
150,169,2012,220,ABLATHERM,CLAVIEN,CONCLUSION,COPYRIGHT,EDAP,FOUR,GLEASON,HIFU,INC,LABEL,LYON,MEAN,METHODS,NONE,OBJECTIVE,PSA,PSMS,RESULTS,THERE,TMS
153,169,2012,BASED,CHOP,COPYRIGHT,GADD153,GREEN,IRELAND,JAPAN,LTD,TRAIL
169,2012,ANALYZING,COPYRIGHT,HOWEVER,INC,S1PR1,STAT3,TARGETING
400,800,BASED,CDS,CDTE,ECL,MWNTS,NPS,NTS,PSA,TIO
1997,LHERMITTE,PHTS,PROTEUS,PTEN,RILEY,RUVALCABA,SINCE,SOMATIC
001,22RV1,946,CONCLUSION,CONVERSELY,CRPC,FADD,FAS,FLICE,FLIP,HDACI,HOWEVER,LABEL,LNCAP,MAXIMAL,METHODS,OBJECTIVE,PARP,PURPOSE,RESULTS,SAHA,VCAP
169,177,2012,AACR,BACKGROUND,COLORECTAL,CONCLUSION,DBP,FURTHER,LABEL,LUNG,METHODS,ORS,OVARIAN,PLCO,RESULTS,SCREENING,THESE,THREE
CONCLUSION,DCE,LABEL,MRI,OBJECTIVE,PERFORMING
169,2012,8764,AT713,EXPRESSION,GMBH,IQCAT,KGAA,QCONCAT,VCH,WILEY
169,189,2012,22RV1,254,DOCETAXEL,DU145,GMBH,KGAA,RESISTANCE,THESE,VCH,WHILE,WILEY
BASED,BLADDER,EVEN,GOALS,HOWEVER,NMIBC,POSTULATED,TURB
109,250NG,AFRICAN,BACKGROUND,DRE,GLEASON,HOWEVER,LABEL,LOW,MATERIALS,METHODS,OBJECTIVE,PSA,RESULTS,SOUTH,STATA,STUDIES,THERE,TNM,V10
123,169,2012,3NG,AIM,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OVERALL,PET,PSA,RESULTS,VALIDATION
1128,1155,130,138,169,2009,2010,2012,2238,3393,389,768,ABCR,ABUJA,ASR,BACKGROUND,BASED,CONCLUSION,COPYRIGHT,DATA,DESPITE,IBCR,LABEL,LTD,MATERIALS,MEAN,METHODS,NIGERIA,PBCR,POPULATION,RESULTS,SAHARAN,SSA
169,2012,COPYRIGHT,FINALLY,HIV,MULTIFOCAL,SAS
003,100,2008,2010,8201,BACKGROUND,CONCLUSION,CTCAE,CTV,D75,ERB,IMRT,INFIELD,IPSS,LABEL,MAXIMUM,MEAN,METHODS,RESULTS,SCALE,SYMPTOM,V20,V30,V40
33342,8201,956,ADT,AHS,AUC,BACKGROUND,CTRL,CWR22,DCE,EXTRACTED,FIVE,HOECHST,LABEL,METHODS,MRI,RESULTS,USING
CTLA4,III,MDV3100,MET,METASTATIC,NOVEL,OPTIMAL,SRC
DUE,HOWEVER,PSA
2007,3PUFA,969,ALA,FAO,FISH,HOWEVER,OMS,PUFA,RCT,THERE
100,145,176,177,300,CONCLUSION,DOX,DRUG,DSPC,DTPA,HIGH,INCUBATION,LABEL,LIPOSOMES,METHODS,MONY,OBJECTIVE,OBJECTIVES,RESULTS
1080,ACPP,ACPPS,CPP,DOX,ENZYMATIC,FLOW,MCF,MMP,MMPS,THESE
150,174,177,500,947,ANTIGEN,ARTIFICIAL,ASSAY,BURLINGAME,CTL,CTLS,CYTOTOX,DCS,ELISPOT,FITCHBURG,MOST,NON,NPS,PLGA,PROMEGA,THESE
2011,946,ADDITIONAL,ANTONIO,DATA,DRUG,E7389,ENGLISH,EXTRACTION,FOOD,HALAVEN,LABEL,METHODS,OBJECTIVE,OVID,PHASE,RESULTS,SAN,SCHOLAR,SOCIETY,SOURCES,SYNTHESIS
215,219,BASED,EPIGENETIC,THESE
120,183,779,CCI,HOWEVER,KU0063794,LNCAP,MST1,PHOSPHO,PI3K,RNAI,STK4,THR
30G,530,EACH,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,TRUS
097,177,317,695,AFRICAN,BASAL,BMI,COX,FASTING,LABEL,LESS,METHODS,NORTH,OBJECTIVE,RESULTS,TOTAL
169,1990,2009,2012,747,AFRICAN,BRAY,COMPARISON,COPYRIGHT,EUR,GNCR,HOWEVER,INCIDENCE,MOST,SAHARAN,UICC,WEST
110,169,1994,2010,2012,8201,BACKGROUND,COPYRIGHT,HOWEVER,INC,LABEL,METHODS,OVERALL,PHOENIX,PSA,RESULTS,ROC,THESE,UNIVERSITY,VARIOUS,WILEY
CAM,CAMS,PCA
1981,2004,245,366,BOTH,CONTINUED,HEPATITIS,HOWEVER,HPV,IMPORTANT,LABEL,METHODS,OBJECTIVE,OTHER,PACIFIC,PURPOSE,RESULTS,ZEALAND
CBCT,CBCTS,HOWEVER,RESULTS,THESE,VMAT
100,AIM,CONCLUSION,LABEL,METHODS,OBJECTIVE,PCA,RESULTS,RRP
1905,CURRENTLY
RARP
001,006,046,093,169,2012,291,COPYRIGHT,COX,GLEASON,HOWEVER,INC,MEIER,THERE,THESE
C11,F18,FDG,LABEL,MOLECULAR,OBJECTIVE,PET,PURPOSE,RESULTS,SEVERAL,SUMMARY,THERE
CURRENT,LABEL,OBJECTIVE,PURPOSE,RESULTS,SUMMARY,THESE
AMONG,GLEASON,HOWEVER,LABEL,MRI,OBJECTIVE,PURPOSE,RESULTS,SCREENING,SUMMARY
CURRENTLY,HOWEVER,LABEL,MRI,OBJECTIVE,PURPOSE,RESULTS,SUMMARY,THUS
141,169,2012,2278,525,737,8653,BJU,DIAGNOSTIC,DOR,HOWEVER,HSROC,QUALITY,SROC,THERE,TRES,TRUS,USING
001,169,2012,244,285,AIMS,ANGELES,BACKGROUND,CALIFORNIA,CHANGES,FIFTY,FORM,GENERAL,HOWEVER,HSD,INDEX,LABEL,LOS,LSD,MAIN,MEASURE,METHODS,OBJECTIVE,OUTCOME,PCI,QOL,RESULTS,SHORT,SOCIETY,THERE,UNIVERSITY
BACKGROUND,FEW,LABEL,MEDLINE,METHODS,NINE,RESULTS,SECONDARY,SIXTEEN,THERE
150,290,309,32G,399,403,528,660,739,8202,887,BACKGROUND,CAUCASIANS,EX5,HOWEVER,LABEL,OVERALL,PRINCIPAL,RESULTS,THROUGH,WHILE
22RV1,BACKGROUND,DERSE,INFECTIOUS,LABEL,OVERALL,RESULTS,SINCE,XENOTROPIC,XMRV
BACKGROUND,CHINESE,CONCLUSION,ELISA,GLEASON,LABEL,PCA,PRINCIPAL,PSA,RESULTS,ROC,SPON2,USING
BACKGROUND,CFS,HOWEVER,LABEL,METHODS,NINE,PCR,RESULTS,XMRV
1990,22RV1,CWR22,MLV,PCR,THESE,WHILE,XMRV,XMRV1
23B,916,BURKITT,FURTHER,GLS,GLUTAMINE,LESS,MIR,MYC,P493,P5C,PC3,POX,PRODH,PROLINE,USING
BECAUSE,END,GENOMES,KYOTO,PATHWAY,RESULTS
945,ERG,EWS,FLI1,MYC,PML,RAR
119,159,173,CONCLUSION,FIVE,LABEL,METHODS,OBJECTIVE,ONTARIO,RESULTS,VARIATIONS,WITHOUT
12Q24,169,2011,2P16,8201,AFRICAN,AMERICANS,BACKGROUND,COPYRIGHT,HLOD,INC,LABEL,LOUISIANA,METHODS,RESULTS,SNP,THESE,THUS,WILEY
001,150,2005,2007,641,8805,BETWEEN,BMI,CONCLUSION,DIET,ENHANCE,FORM,JULY,KINGDOM,LABEL,MAY,METHODS,OBJECTIVE,OLDER,OVERALL,PURPOSE,REACH,RENEW,RESULTS,SHORT,THESE
181,946,ADME,IC50,OVCAR,U251
2005,246,5893,908,BASED,BIOL,IMRT,MED,NTCP,PCA,PHYS,TCP
786,946,A549,AKT,ERK1,HOWEVER,LIPUS,LM8,LOW,MC3T3,METASTATIC,SAOS2,VEGF
11C,PET
160,AKT,DUAL,PSA,PTEN,TAKEN
001,005,BACKGROUND,BCL,BOTH,COMBINING,FOLLOWING,LABEL,LNCAP,METFORMIN,METHODS,MICROMOLAR,OBESITY,PC3,RESULTS,USING,WESTERN
3DCRT,BACKGROUND,COMPARISON,CONCLUSION,DOSE,KAS,LABEL,METHODS,OARS,OBJECTIVE,PTVS,PURPOSE,RESULTS,TREATMENT
BMM,BMMS,BONE,CCL2,COX,CTSK,MOST
BTG2,DESPITE,EMT,FINALLY
169,2012,BACKGROUND,BASEL,CELLS,CONCLUSION,COPYRIGHT,GTPASES,HELA,INCREASED,LABEL,MB231,MDA,METHODS,RAB11,RAB25,RESULTS,TAKEN
MICRORNAS,RNAS
233,AKT,BCG,CURRENTLY,MCF,MYCOPLASMA,PI3K,PTEN,THESE
169,2012,AUTHORS,BLK,DU145,FEBS,GRP78,HSP70,JOURNAL,LNCAP,NG108,ORF,PC3,TDF,THEREFORE,THESE
116,169,2012,8195,BACKGROUND,BANKS,BLOOD,CONCLUSION,GLEASON,HOWEVER,ICS,LABEL,METHODS,PAD,RESULTS,THERE,VARIABLES
169,2012,AUTHORS,BJU,FURTHER,MICRORNAS,RNAS,THESE
001,002,004,005,010,022,028,030,039,152,156,2518,64I,64V,916,CCR2,CCR5,GENOTYPING,HOWEVER,MCP,PCR,RFLP,TURKISH,V64I
293,BALB,CELL,EGFP,HEK,HOWEVER,LNCAP,PSMAE,RESULTS,RNAI,THEN,THESE
135,CENTERS,COMMITTEE,CONTROL,DISEASE,FORCE,LIPID,MEN,PRACTICES,PREVENTION,PREVENTIVE,SCREENING,TASK,THERE,ULTRASOUND
1246,CONCLUSION,IDEAL,ITALIAN,LABEL,METHODS,OBJECTIVE,PCA3,PSA,RESULTS,UNIVARIATE,VARIOUS
APOPTOTIC,CELL,CONCLUSION,FIFTY,GLEASON,HISTOLOGIC,KI67,LABEL,METHODS,MIB,OBJECTIVE,PEARSON,RESULTS,SEVENTY,STUDENT,THERE
2005,2010,407,4407,457,950,AMONG,APRIL,DEPARTMENT,INDIA,JANUARY,KASHMIR,MEDICAL,MRD,RECORDS,SKIMS,STOMACH
174,945,AFTER,AIM,ALSO,BONT,BOTULINUM,LABEL,LNCAP,MATERIALS,METHODS,OBJECTIVE,PLA2,RESULTS,SV2
000,10Q23,112,250,8P21,ETS,FOXA1,MED12,NKX3,PTEN,RECURRENT,SPOP,THUS
002,021,497,760,765,936,CALIFORNIA,CASE,CONTROL,COOKING,EPHX1,GSTT1,HOWEVER,LEU432VAL,PCA,PTGS2,THESE,THREE,THUS,TYR113HIS
DISCUSSION,JAPAN,LABEL,METHODS,OBJECTIVE,RESULTS,THESE,WHILE
169,2012,COPYRIGHT,DIVERSILAB,LTD,MLST,PCR,SUBTYPING,TC12S,THUS
051,169,2012,AUSTRALIA,BRIEF,COMPOSITE,COPYRIGHT,CROWN,HIGH,HOWEVER,INDEX,KEY,LABEL,LOW,LTD,METHODS,MULTI,NURSE,OBJECTIVE,PSA,PUBLISHED,PURPOSE,RESULTS,SCALE,THERE
169,2010,2011,2012,20TH,363,411,422,865,872,AIDS,BEGINNING,BLACK,COPYRIGHT,DESPITE,DREICER,ENGL,FERRARI,FIRST,IMMUNOL,KANTOFF,KBMA,LTD,MANDL,MED,NAT,REDFERN,REV,SHORE,SIMS,SIPULEUCEL,SMALL
005,169,2006,2010,2012,812,8804,8805,ADDITIONAL,CONCLUSION,COPYRIGHT,GLEASON,HOWEVER,INC,ITALIAN,LABEL,METHODS,MOST,OBJECTIVE,PCA,RESULTS,THESE
169,174,2012,ADENOSINE,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SIGMA,THUS,UROLOGICAL,WESTERN
001,003,008,169,172,2012,344,825T,946,C825,C825T,COPYRIGHT,DUE,EDUCATION,GLEASON,GNB3,INC,LABEL,MATERIALS,MEN,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL,USING
169,174,2012,22RV1,8482,ALDEFLUOR,ALDH1,ATCC,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,NKX3,NOD,OBJECTIVE,PROM1,PUBLISHED,PURPOSE,RESULTS,SCID,UROLOGICAL
169,2012,494,CONCLUSION,COPYRIGHT,DECISIONAL,EPIC,IRELAND,LABEL,LPC,LTD,METHODS,OBJECTIVE,P3P,PATIENT,PHYSICIAN,PRIOR,PROFILE,RESULTS,WHILE
169,2013,AIPC,CAP,CONCLUSION,COPYRIGHT,DOCETAXEL,EGFR,INC,LABEL,METHODS,MICE,OBJECTIVE,OBJECTIVES,PC3,PC3R,PC3WT,PRESENT,RESULTS,RET,VEGFA,VEGFR,XENOGRAFT
2003,2010,595,AFRICAN,AMERICANS,ANOVA,BECAUSE,BOWEL,COMPOSITE,COUNSELING,DESPITE,DISEASE,EBRT,EPIC,ESTIMATES,FORM,HRQOL,INC,INDEX,JUNE,LABEL,MATERIALS,MEDICAL,METHODS,OBJECTIVE,PUBLISHED,RADICAL,RESULTS,SHORT,STUDENT
169,2012,640,A172,BASED,COPYRIGHT,GRI,LTD,NCI,PUBLISHED,RGD,THESE
169,1992,2002,2003,2006,2009,2012,775,8805,AMONG,BACKGROUND,BECAUSE,CONFIDENCE,COPYRIGHT,DESPITE,EARLY,END,GLEASON,LABEL,METHODS,OBJECTIVE,OUTCOME,PADT,PCA,PUBLISHED,RESULTS,SEER,SETTING,UROLOGY
169,2012,COPYRIGHT,CRPC,INC,THALIDMIDE,THESE
10NM,169,2012,COPYRIGHT,CTT54,CY5,LTD,PEG,PSMA
170,400,EIGHT,FRANKEL,LABEL,METHODS,MINIMALLY,OBJECTIVE,RESULTS,TEN,THESE
223,CONCLUSION,GLEASON,LABEL,METHODS,OBJECTIVE,POD,RESULTS
AGILENT,CONTROL,CROHN,FOLH1,IBD,SET,THESE,WHOLE
AKT,ALSO,BACKGROUND,BCL,EGF,ERBB,HOWEVER,JNK,LABEL,LC3,LNCAP,NAC,NRG,PI3K,PREVIOUSLY,PRINCIPAL,RESULTS,ROS,S6K,THESE,THUS
169,1990S,1991,2005,2012,BACKGROUND,CAPSURE,CHANGES,COPYRIGHT,END,LABEL,METHODS,PRIMARY,RESULTS,SOCIETY,STRATEGIC,THESE
169,2012,924,COPYRIGHT,CYTOMETRY,DIGITAL,FEULGEN,HOWEVER,SOCIETY
KALLIKREIN,KLK2,KLK3,KLKP1,LNCAP,LTR,MOST,THEREFORE,THESE,THREE
916,956,BACKGROUND,CONCLUSION,FAK,FIRST,LABEL,METHODS,MRI,NON,PC3,REPORTING,RESULTS,SRC,THERE,TREATMENT
AZAC,BACKGROUND,BISULPHITE,CONCLUSION,EVEN,EVX1,GIVEN,HIGH,LABEL,METHODS,METHYLIGHT,PCA,RESULTS,TSA
1000,HSV,HSV1716,IMMEDIATE,ING4,PCR,SCC,USING
DOPPLER,ESPECIALLY,GLEASON,HOWEVER,LABEL,MRI,OBJECTIVE,PCA,PRESENT,PURPOSE,RESULTS,SHEAR,SUMMARY,TECHNICAL,THREE,VARDENAFIL,WAVE
169,2012,COPYRIGHT,INC
CEA,INC,MUC,MUC1,PSA,PUBLISHED
169,2012,COPYRIGHT,CRPC,III,INC,SIPULEUCEL
169,2011,ALSO,BACKGROUND,COPYRIGHT,IPDT,LABEL,METHODS,PDT,PINUS,RESULTS,SCID,TREATMENT
169,2012,954,BAX,BCL,CADMIUM,CDS,COPYRIGHT,CROWN,HOWEVER,LNCAP,LTD,NAC,PROTECTION,PUBLISHED,QDS,RESULTS,ROS
145,169,181,2012,22RV1,916,AUTHORS,BACKGROUND,BDS,BRITISH,CBD,CHOP,FACS,JOURNAL,KEY,LABEL,LNCAP,METHODS,MTT,OBJECTIVE,OTHER,PCC,PUMA,PURPOSE,RESULTS,SEVERAL,SOCIETY,THC,THESE,TRPM8,TUNEL
001,2000,2006,2010,8804,AFTER,APRIL,BACKGROUND,CONCLUSION,GLEASON,LABEL,METHODS,NVB,ORGAN,RARP,RESULTS
001,118,147,2000,2006,2010,AFTER,APRIL,BACKGROUND,CONCLUSION,GLEASON,LABEL,METHODS,ORGAN,PSA,PSM,RARP,RESULTS
001,2000,2006,2010,8805,AFTER,APRIL,BACKGROUND,CONCLUSION,GLEASON,LABEL,MAJOR,METHODS,NVB,ORGAN,RARP,RESULTS
001,114,162,1623,169,2000,2006,2010,220,AFTER,APRIL,BACKGROUND,CONCLUSION,GLEASON,LABEL,METHODS,NVB,ORGAN,PSA,RARP,RESULTS
8226,BACKGROUND,CELLS,CONCLUSION,CYTOCHROME,GSH,INCREASED,LABEL,LNCAP,MATERIALS,METHODS,NAC,RESULTS,ROS
145,AFTER,BACKGROUND,BOTH,CONCLUSION,LABEL,LNCAP,MATERIALS,METHODS,RESULTS
0001,100,956,CAM,CTC,CTCS,ECM,EMBRYOS,GFP,IMAGING
ACTIN,AFTER,BACKGROUND,CONCLUSION,DIFFERENT,FUNCTIONS,GLEASON,HOWEVER,LABEL,MATERIALS,METHODS,RESULTS,SEVERAL
946,BOTH,CHROMATIN,COX,DU145,PCA,TGF,THESE,WPMY
13Q,169,2012,COPYRIGHT,DIAPHANOUS,EGFR,EMBO,ERK,MEK,MOLECULAR,RB1,SILENCING,THERAPIES,THESE,WHILE
169,1INTEGRIN,2012,945,946,BPH,CAFS,CD133,COPYRIGHT,PRESS,PROSTATIC,SINCE,THESE
119,160,169,2012,204,297,680,ALPHA,AMACR,BACKGROUND,COA,COPYRIGHT,HGPIN,HOWEVER,INC,LABEL,METHODS,RESULTS,SIXTY,THREE,WESTERN,WILEY
169,2012,BACKGROUND,BLUE,CELLTITER,COPYRIGHT,DCFDA,EXPRESSION,INC,LABEL,METHODS,NATURAL,PIPER,RESULTS,ROS,WILEY
005,100,150,8201,956,AFTER,GSH,GSSG,IMPEDANCE,MT1,MT2,MTT,OXIDATIVE,PC3,PNT1A
003,1240,2005,806,8804,CONFERENCE,CONSENSUS,GLEASON,ISUP,PATHOLOGY,SOCIETY,THESE,UROLOGICAL
2007,355,386,ADHERENCE,AICR,BACKGROUND,CONCLUSION,COX,EPIC,FUND,INSTITUTE,LABEL,METHODS,NUTRITION,OBJECTIVE,RESULTS,WCRF,WORLD
0005,008,036,169,2004,2010,2012,366,936,ABU,AMONG,ANNUALIZED,ARTIFICIAL,BOARD,CHI,COPYRIGHT,EDUCATION,ENDOSCOPIC,FURTHER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SEVERAL,UROLOGICAL,UROLOGY
0001,011,169,1996,2000,2013,427,8804,8805,BACKGROUND,COPYRIGHT,DRE,GROUP,HOWEVER,INC,JANUARY,LABEL,METHODS,PSA,RESULTS,THERE
169,2013,CASE,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OXIDATIVE,RESULTS,VEGF
001,169,1998,2010,2013,503,8804,BACKGROUND,BCR,COPYRIGHT,COX,HARRELL,INC,LABEL,MATERIALS,METHODS,PREDICTIVE,RESULTS,TNM
BACKGROUND,BOTH,CHESS,FOCUS,INC,LABEL,METHODS,PUBLISHED,RESULTS,SUPPORT
0001,069,1180,1368,169,2002,2011,2012,5392,BACKGROUND,BCR,COPYRIGHT,EPPENDORF,HAMBURG,JANUARY,JUNE,LABEL,MEDICAL,MEIER,METHODS,NEUROSAFE,NSM,OBJECTIVE,OUTCOME,PROCEDURE,PSM,PSMS,PUBLISHED,RESULTS,RPS,SECONDARY,SETTING,SMS,SYSTEMATIC,UNIVERSITY,UROLOGY
169,177,2011,2012,207,258,BACKGROUND,COPYRIGHT,DUOROTATE,FIVE,GERMANY,GMBH,JANUARY,KEYPORT,LABEL,LESS,LYMPH,MAJOR,METHODS,OBJECTIVE,OBJECTIVES,OCTOBER,OUTCOME,PROCEDURE,PUBLISHED,RESULTS,RICHARD,SETTING,UROLOGY,WOLF
200,231,468,8201,ADNA,ALUJ,ARRAY,BACKGROUND,BLOOD,CTC,CTCS,EGFR,EMT,EPCAM,EPITHELIAL,FURTHER,KPL,LABEL,MDA,METHODS,PCR,PHENOTYPIC,RESULTS,TEST,THESE,TRANSITION,TWIST
001,AZ10397767,BACKGROUND,BCL,CAP,CONSISTENT,CXCL8,CXCR1,CXCR2,ELISA,LABEL,METHODS,PARP,PC3,PCR,PEMETREXED,RESULTS,SUBSEQUENT,TOMUDEX
000,160,CPIC,LAPC,LNCAP,PSA,T877A
123,169,198,2012,238,495,946,AACR,AFTER,CRIP1,FLNC,GROUP,GSTP1,HAAO,HIF3A,LABEL,METHODS,MICROARRAY,OBJECTIVE,PURPOSE,RAR,RASGRF2,RESULTS,RUNX3,TNFRSF10D,UNIVARIATE,VALIDATION
169,2012,292,AACR,ADT,BIOMARKERS,EXTRACTED,FASTING,GNRH,LABEL,MARKERS,METHODS,MOST,NOTABLE,OBJECTIVE,PURPOSE,RESULTS,STEROID
001,006,155,169,2012,251,318,724,8804,946,AACR,BOTH,LABEL,LOW,METHODS,NETWORK,OBJECTIVE,PURPOSE,RESTRICTED,RESULTS,SERUM,SHBG,THESE
169,2012,AACR,CCL,CCL2,PRIMING,SHORTLY,THESE,USING,VEGF
169,2012,252,ACTA,CHIMICA,COPYRIGHT,HELVETICA,HOWEVER,RNAS
150,180,230,298,800,CONCLUSION,GLEASON,LABEL,METHODS,OBJECTIVE,PSA,RESULTS,RLRP,SIXTEEN
11TH,6TH,LABORATORY,TLS
0001,0076,106,BACKGROUND,BPH,CROSS,EASTERN,EZH2,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SERUM,SETTING,UPON
CARLO,LOW,MONTE,THERE,THREE,TRACE
009,017,019,022,023,034,039,177,259,299,8201,ADT,BACKGROUND,BMD,FRACTURES,LABEL,METHODS,RESULTS,SHBG,SUMMARY
DVHS,RMS,SIMILARLY
228,252,AFTER,BACKGROUND,BESIDES,CARE,DISCUSSION,EFFICIENCY,INSTITUTE,IQWIG,LABEL,METHODS,QUALITY,RESULTS
129,169,2007,2012,2041,804,809,838,889,ASIAN,ASSESSMENT,CONCLUSION,GLEASON,HEAD,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,RISK,T1C,T3A,THESE,UROLOGICAL,WESTERN
169,2012,916,947,AACR,CHK2,EX3,H2AX
GTPASES,HOWEVER,RAL,RALA,RALB
END,PSA,RESULTS,SEER
240,4Z1,CDH1,GLEASON,HEY2,MOST,STMN1
169,2012,34B,AACR,LABEL,MDM2,MYC,THESE,TRANSGENIC,UBIQUITIN,UNLABELLED,USP2A
169,2012,AACR,MDM2,MYC,UBIQUITIN
138,241,280,575,610,694,ADDITIONAL,AGE,AUC,CONCLUSION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SNP,SNPS,USEFULNESS
0001,162,167,169,2012,2013,2488,456,500,512,552,605,726,772,959,AUC,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,PCA3,PSA,RESULTS,WILEY
016,098,107,169,2004,2011,2012,465,642,8805,931,BACKGROUND,COPYRIGHT,DRES,HOWEVER,INC,IPSS,JANUARY,LABEL,LUTS,MAY,METHODS,PCA,PSA,RESULTS,SCORE,SYMPTOM,TRUS,WILEY
113,188,205,211,BNM,BNS,CONCLUSION,DATA,GLEASON,LABEL,METHODS,OBJECTIVE,PAE,PERI,PSA,PURPOSE,RESULTS,RRP,SIXTEEN,THERE,TNM
2011,BACKGROUND,CONCLUSION,DRUG,FDA,FOOD,III,LABEL,METHODS,MONITORING,OCTOBER,ONGOING,RESULTS
125,169,2012,945,BASEL,CLINICALLY,COPYRIGHT,HERCEPTIN,KRAS,THESE
177,181,8482,APATONE,BOTH,BRQ,GSH,H2O2,HOWEVER,PART,VK3
213,850,MDM2,PIM,REGULATION,RNF6,SER,THR
BECAUSE,BOTH,C81,DU145,LNCAP,MODULATING,PACLITAXEL,PGP,THESE,WILD
D100,D95,DAILY,EACH,EVEN,PTV,V70S
1261,176,177,3504,85MM,CBCT,CORRECTION,FORTY,IGRT,IMRT,LIMITED,NOVALIS
176,177,43U1,6711,8804,8805,920,923,952,992,AAPM,BECAUSE,CARLO,CURRENTLY,HOWEVER,MCNP5,MONTE,PHYSICISTS
106,CTV,D98,DMIN,EUD,HOWEVER,MEANWHILE,PBS
945,946,CISPLATIN,INTEGRINS,NPS,PEG,PLGA,RGD,RGDFK
137,169,2007,2009,2012,8226,AGE,AGING,AMICO,ANDROLOGY,BJU,CONCLUSION,FREE,GLEASON,HIGH,LABEL,LOW,METHODS,OBJECTIVE,OBJECTIVES,PCA,PSA,RESULTS,SOCIETY,THESE,UNLABELLED,UROLOGY,VERMEULEN,WHAT
001,022,169,194,2012,8Q24,AGC,ASIAN,BJU,CTA,CTC,LABEL,METHODS,OBJECTIVE,RESULTS,SNP,SNPS,THREE,UNLABELLED,WHAT
006,027,125,169,176,181,2012,AUTHORS,BJU,DENMARK,ELISA,EN2,EPSTEIN,GIVEN,GLEASON,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRE,PROJECT,PSA,RESULTS,THERE,UNLABELLED,URINARY,WHAT
169,2012,AUTHORS,BJU,DESPITE,OCCURRENCE,WHAT
155,169,2012,350,577,COPYRIGHT,EDUCATION,ENDOTHELIN,ENTHUSE,III,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OPTIMAL,PUBLISHED,PURPOSE,RESULTS,SCREENING,UROLOGICAL
22RV1,A10,BACKGROUND,CONSISTENT,DISCUSSION,LABEL,LAPC,LNCAP,MATERIALS,METHODS,RESULTS,THESE,UPON
103,109,154,169,193,2008,2012,205,425,8364,COPYRIGHT,DATA,FCA,HCA,INC,IRELAND,ISPOR,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,REDUCED,RESULTS,SOCIETY
AGN,ASIAN,BESIDES,CHINA,DOH,KOREA,NAKAI
0001,0003,0047,110,169,2012,APMIS,ASSESSMENT,AUTHORS
2008,2011,ADT,AREAS,BACKGROUND,COVERED,CRPC,LABEL,MDV3100,METHODS,NOVEL,OPINION,SARD,SEPARATELY
2012,ANOTHER,HOWEVER,RSNA,STUDIES,SUSPICIOUS
1998,8200,859,8805,883,885,888,976,AIM,BACKGROUND,BASED,CONCLUSION,COX,FCD2010,FDR,LABEL,METHODS,OBJECTIVE,RESULTS,SPECIFIED,SWEDISH
169,200,2012,AACR,CYP1A,FOLLOWING,GSTP1,HGPIN,PHIP,PIN,PTEN,SIMILAR,THESE
169,177,2012,ADC,CHO,CIT,CONCLUSION,COPYRIGHT,DWI,GLEASON,INC,LABEL,MATERIALS,METHODS,MRI,MRSI,OBJECTIVE,PURPOSE,RESULTS,ROC,WILEY
EXTENSIBLE,SWAN,THESE,VARIATIONS
484,668,8209,945,AGS,AZAC,CPG5,FSH,III,KATO,LOH,SNU,TAKEN,THESE,TREATMENT,UTR
000,177,ADC,DIFFUSION,DWI,FORTY,HISTOLOGY,LABEL,MATERIALS,METHODS,NINE,OBJECTIVE,PURPOSE,RESULTS,ROI,TESLA,THUS
653,8805,ALIGNRT,COMPARING,CRT,DPI,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SETUP
GRIM,PERSISTENT,RNAS,SALMONELLA,THEN,THEREFORE
183,AKT,EP2,EP4,GTP,HK2,INCIDENCE,PGE2,RAL,RALA,RGC2,SN12C
954,BCL,MICROARRAY,PCA,STAT3
169,2012,8804,CLAS,CONFORMAL,COPYRIGHT,EASTERN,FIVE,GROUP,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PAIN,PURPOSE,RADIATION,RESULTS,SCALE,THERAPY,TREATMENT
169,2012,COPYRIGHT,HOWEVER,INC,MENTHOL,PLK1,SUBSEQUENT
169,2012,3AO,COPYRIGHT,IRELAND,LLDT,LTD,NOTABLY,PHASE
001,113,124,169,177,1872,2012,237,3120,345,946,BONE,COPYRIGHT,CTX,INC,P1NP,PAGET,SCLEROSTIN,SERUM,THESE
169,2008,2012,946,COPYRIGHT,CROWN,FINALLY,HOWEVER,LTD,OPG,PIVONKA,PTH,PTHRP,PUBLISHED,RANK,RANKL,SEVERAL,WNT
001,004,005,006,012,024,027,116,169,2012,264,2PG,300,302,316,328,329,333,344,388,3NMOL,408,519,597,6MONTHS,956,9NMOL,ADT,AFTER,BAP,BMD,COPYRIGHT,COUPLED,DELTA,DHEA,DPD,IGF,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,SERUM,THESE
169,2013,COPYRIGHT,INC,P501S,THESE
169,1996,2000,2009,2012,647,COPYRIGHT,COX,EACH,FURTHER,ICD,INC,INSURANCE,LABEL,METHODS,OBJECTIVE,PHYSICIANS,PRESS,RESULTS,TAIWANESE
169,2012,946,ACTIVIN,ADT,COPYRIGHT,FSH,LTD,PCA,PSA,TGF,THEREFORE,THUS,TREATMENT
001,041,051,169,185,2012,295,297,300,412,519,730,831,942,972,973,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,RESULTS,THEREFORE
001,169,1992,2005,2012,694,COMPETING,COPYRIGHT,EDUCATION,END,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SEER,UROLOGICAL
001,100,169,195,1993,1999,2012,644,894,COPYRIGHT,CUMULATIVE,CURRENT,EDUCATION,FURTHER,GLEASON,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
169,173,177,2012,550,COPYRIGHT,EDUCATION,GLEASON,INC,LABEL,MATERIALS,MEN,METHODS,OBJECTIVE,OVERALL,PREDICTORS,PUBLISHED,PURPOSE,RESULTS,THOSE,UROLOGICAL
169,1993,2008,2012,COPYRIGHT,EDUCATION,FOCAL,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SALVAGE,THESE,UROLOGICAL
169,174,1994,2011,2012,COPYRIGHT,CTC,EDUCATION,FINALLY,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SCIENCE,SOON,TECHNICAL,UROLOGICAL,WEB
169,2012,916,964,COPYRIGHT,DCE,DYNAMIC,EES,INC,MODEL,MRI,SINCE,USING
097,099,119,120,150,169,1990,2004,2013,398,605,ASSESSMENT,BACKGROUND,BMI,CKD,COPYRIGHT,COX,EPI,ESTIMATED,GLEASON,HOWEVER,INC,LABEL,MATERIALS,METHODS,PSA,RESULTS,THEREFORE,WHILE
1018,169,2012,ALTOGETHER,AUR,AUTOMATED,COPYRIGHT,FIRST,INC,LABEL,MATERIALS,METHODS,MRSI,NUMBERS,OBJECTIVE,OBJECTIVES,PUBLISHED,RATIONALE,RESULTS,SPATIAL,THEN,THREE
169,2012,BIOMETRIC,CVPOL,EPOCE,PROGNOSTIC,SOCIETY,THESE
169,2012,AUTHORS,BJU,CRPC,DES,LHRH,LOW,PSA,THESE,WHAT
001,008,009,011,019,030,037,039,044,1000,111,169,181,2006,2011,2012,254,471,611,795,8194,8226,AMONG,AUTHORS,BJU,CONCLUSION,LABEL,MARCH,MATERIALS,METHODS,NINE,OBJECTIVE,ONJ,RESULTS,SEPTEMBER,TAX,TOOTH,UNLABELLED,USING,WBC,WHAT
181,8201,CACO,COMPOUNDS,HALICLONA,HCT,IC50,INDONESIAN,LNCAP,MCF,U937
108,152,AEZS,APART,AREAS,BACKGROUND,COVERED,EARLY,GNRH,III,LABEL,LHRH,LYS,METHODS,ONGOING,OPINION,PHASE,RECEPTORS,RESULTS,SIDE,THUS
CPU,GHZ,INTEL,MAPK
3MM2,AFTER,FIFTY,SIMILARLY,TREATMENT
001,327,469,ANXIETY,ASIA,AUSTRALIAN,DEPRESSION,FURTHER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCALE
145,169,2012,BACKGROUND,BAX,BCL,CONCLUSION,COPYRIGHT,INC,LABEL,LNCAP,METHODS,NIS,NON,PCR,RESULTS,RWPE,WILEY
001,160,2009,313,632,670,761,859,AUC,BMS,EAU,GLEASON,LABEL,MDP,METHODS,OBJECTIVE,PCA,PSA,PURPOSE,RESULTS,UROLOGY
0001,001,002,003,004,010,031,1999,2007,845,BCR,COX,FIVE,GLEASON,LABEL,LRP,METHODS,OBJECTIVE,PREDICTORS,PSA,PSM,PURPOSE,RESULTS
800,945,ACUTE,CRP,FURTHER,PCA,PSA,THESE,UNIVERSITY
1501,CD8,CERTAIN,CMV,DRB1,HLA,MOUSE,PSA,TRAMP,TRANSGENIC,UPON
222,AMONG,DEPLETION,LABEL,PFK2,TAKEN,TARGETING,UNLABELLED,USING
5A10,DESPITE,FINALLY,LABEL,PSA,THEREFORE,UNLABELLED
222,NADPH,ROS,USING
HOWEVER,PSA,SERUM
COLORECTAL,GWA,LUNG,OVARIAN,SCREENING,TRIAL
001,100,169,2002,2009,2010,2011,2012,5798,AMONG,BACKGROUND,CASES,COPYRIGHT,CROWN,CRUDE,GRAM,LABEL,METHODS,NOVEL,OBJECTIVE,OUTCOME,PNB,PNBS,PUBLISHED,RESULTS,SETTING,UTI,UTIS
169,2011,2012,BACKGROUND,CONTEXT,CONVERSELY,COPYRIGHT,DESPITE,ENGLISH,HOWEVER,LABEL,METHODS,OBJECTIVE,PCA,PUBLISHED,RESULTS,SYNTHESIS,UROLOGY
169,2011,2012,BACKGROUND,CONTEXT,COPYRIGHT,ENGLISH,LABEL,METHODS,OBJECTIVE,PATIENT,PCA,PUBLISHED,RESULTS,SYNTHESIS,THEREFORE,UROLOGY
169,177,2012,BOTH,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,MEAN,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,RPM,TPS,TRUS
169,1992,2002,2007,2013,317,431,881,COPYRIGHT,END,GIVEN,INC,LABEL,MATERIALS,MEN,METASTATIC,METHODS,OBJECTIVE,OBJECTIVES,PROPENSITY,PUBLISHED,RESULTS,SALVAGE,WHILE
001,004,012,169,1988,200,2007,2013,275,CAB,CAP,CIS,COPYRIGHT,DIAGNOSIS,END,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SEER,WHILE
FET,FETS,OPN,THESE
1000,106,146,169,2012,202,251,5841,AIMS,AUTHORS,BPH,BRITISH,GENERAL,IRS,JOURNAL,LABEL,METHODS,OBJECTIVE,RESULTS,RISK,RISKS,SOCIETY,THERE
001,169,1992,2005,2012,665,8805,COMPETING,CONVERSELY,INDEX,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PROPENSITY,RATES,RESULTS,UROLOGICAL
169,1993,2009,2010,2012,505,GENERAL,HOWEVER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RECURRENCE,RESULTS,RULES,STUDIES,THUS,UROLOGICAL
169,2012,690,BLACKWELL,LTD,MEN,MOST,PUBLISHING,SINCE
CHINA,CONCLUSION,LABEL,METHODS,OBJECTIVE,REJECTION,RESULTS
100,200,22RV1,400,CONCLUSION,LABEL,METHODS,MTT,OBJECTIVE,RAPAMYCIN,RESULTS,S6K1
BPH,CONCLUSION,GLEASON,III,LABEL,MEIER,METHODS,OBJECTIVE,PCA,PIM,PSA,RESULTS
001,012,116,136,CONCLUSION,LABEL,METHODS,OBJECTIVE,PCA,PSA,RESULTS,THERE,TRUS
170,AUC,CHINESE,CONCLUSION,DRE,LABEL,METHODS,OBJECTIVE,PIN,PSA,RESULTS,ROC
110,2009,2010,BACKGROUND,BETWEEN,BNS,BPH,BPV,IPSS,LABEL,MATERIALS,MAY,METHODS,QMAX,QOL,RESULTS,SCORE,SECONDARY,SYMPTOM,TURP
100,2006,2009,2010,2011,6400,750,ABOUT,BACKGROUND,DEPENDING,DETECTION,DISCUSSION,EBRT,GLEASON,LABEL,MARCH,METHODS,OBJECTIVE,OCTOBER,PSA,RATIONALE,REGARDING,RESULTS,T3B,TUR
169,1999,2012,2B4,COPYRIGHT,HOMO,INC,LAG1,LASS2,MMP,PCR,REAL,RFQ,THERE,THUS,TMSG,TMSG1,WESTERN,WILEY
169,2012,3Q25,COPYRIGHT,EPIGENETIC,ETS,HOWEVER,INCREASING,LXN,RARRES1,SNP,TIG1,UICC
169,2012,500,AACR,AAG,HSP70,HSP90,LABEL,LNCAP,METHODS,NVP,OBJECTIVE,PURPOSE,RESULTS,TARGETING,VCAP
100,EFFECTS,ERK,EXTENSIVE,FGFR,FGFRS,FINALLY,LABEL,METHODS,OBJECTIVE,PNT1A,PURPOSE,RESULTS,TARGETING,TREATMENT,VCAP
BRAGG,HOWEVER,JAPAN,THESE
169,2012,COPYRIGHT,LNCAP,LTD,RWPE,THESE,VIS
160,169,174,176,200,2012,215,360,600,8275,CONCLUSION,COPYRIGHT,FFF,INC,LABEL,MATERIALS,MEAN,METHODS,OBJECTIVE,PRESCRIBED,PTV,PURPOSE,RESULTS,THERE,USING,VMAT,VOLUMETRIC,X10,X6FFF
100,169,2013,209,228,CONCLUSION,COPYRIGHT,DICE,III,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PHASE,PRE,PURPOSE,RESULTS,STUDENT
110,141,160,169,182,1998,2007,2012,402,8805,ACUTE,BETWEEN,COPYRIGHT,GRADE,HORMONE,III,INC,LABEL,LATE,MATERIALS,METHODS,OBJECTIVE,PRE,PSA,PURPOSE,RESULTS,THERE
169,2012,945,956,APOPTOSIS,CASPASE,COPYRIGHT,DAPI,ELISA,GMBH,LNCAP,PARP,TREATMENT
011,169,2012,427,ASO,ATP,BOTH,CLU,COPYRIGHT,HSP27,HSPS,ISSUE,LTD,OGX,SMALL
015,021,036,169,177,2012,8805,BJU,BPH,COX,DDC,DFS,GLEASON,GREEN,LABEL,MEIER,METHODS,OBJECTIVE,PCA,PSA,RESULTS,SYBR,TIME,TOTAL,UNLABELLED,WHAT
169,1990,2008,2012,208,300,352,560,8226,AUTHORS,BJU,GLEASON,LABEL,LEVEL,METHODS,OBJECTIVE,OBJECTIVES,PROGNOSIS,PSA,RESULTS,T1B,T1C,T2A,T2B,T2C,THERE,THESE,TYPE,UNLABELLED,WHAT
169,2007,2009,2012,8194,ANZ,AUSTRALIA,AUTHORS,BACKGROUND,BETWEEN,COLLEGE,CONCLUSION,EETS,JANUARY,JOURNAL,JUNE,LABEL,METHODS,RESULTS,ROYAL,SURGERY,WELLINGTON,ZEALAND
946,ADJUSTMENT,ANXIETY,BEHAVIORAL,DEPRESSION,DIAGNOSTIC,FINALLY,FRAGILITY,HRQOL,MANAGEMENT,MBMD,PESSIMISM,PSYCH,TENSION,THESE,WHITE
169,2012,946,AUTHORS,CDS,JPP,KEY,LABEL,METHODS,MOLECULAR,NEITHER,NMR,OBJECTIVE,OBJECTIVES,OVERHAUSER,PC3,REGARDLESS,RESULTS,ROYAL,SOCIETY
1036,1385,169,2004,2010,2012,267,727,CANDIDATE,COPYRIGHT,DATA,EMR,JOHN,LABEL,LTD,METHODS,NINTH,OBJECTIVE,PPV,PURPOSE,RESULTS,SONS,WHILE,WILEY
2014,2015,202,638,CA125,COLORECTAL,KINGDOM,LUNG,OVARIAN,SCREENING,THERE,TRIAL
COLORECTAL,EOC,LUNG,MOST,OVARIAN,SCREENING,TARGETING
001,029,945,ALTERED,BECAUSE,BOTH,EDI3,GPC,HOWEVER,MCF,MEIER,METASTASIS,OVERALL,PKC,SILENCING
100,177,956,AOC,BBN,CONCLUSION,GBQ,GRPR,GRPRS,LABEL,METHODS,NOTA,PET,RESULTS,SMALL,UNLABELLED
017,030,033,036,062,079,082,105,229,246,CONCLUSION,FCH,LABEL,MALM,MBQ,METHODS,PET,RADIATION,RESULTS,UNIVERSITY,UNLABELLED
005,009,036,047,052,100,105,109,123,130,161,169,2012,969,ADJUSTMENT,ANOVA,ANXIETY,CONCLUSION,COPYRIGHT,DCS,DECISIONAL,DEPRESSION,DOES,JOHN,LABEL,LTD,METHODS,OBJECTIVE,POST,RESULTS,SCALE,SECONDARY,SONS,THERE,WILEY
169,2012,BACKGROUND,BECAUSE,COPYRIGHT,END,HOWEVER,LABEL,METHODS,NOMOGRAMS,POPULATION,PROGRAM,QUERY,RESULTS,SEER,SOCIETY,WEB
ABS,AUTO,CAON,CAR,CAUCASIAN,CRAO,ERG,ERGS,GVFS,IVFA,OCT,OCTS,PVEPS,RPE,THESE
BASIC,CELLSEARCH,DESPITE,FDA,FURTHER,MOST,PSA,THOSE,VERIDEX
169,2012,COPYRIGHT,ELK,ERG,ETS,ETV,HOWEVER,INC,SEVERAL,USING
001,003,015,041,104,169,2012,241,AFFYMETRIX,CNV,COPYRIGHT,INC,PATHOLOGY,PSA,PSADT,PUBLISHED,SNP,SOCIETY
946,HENCE,HOWEVER,TAKEN
34BETAE12,CEA,CK20,CK7,CONCERNING,CONCLUSION,KI67,LABEL,METHODS,OBJECTIVE,P504S,PAP,PROSTATIC,PSA,RESULTS,TUVP
CONCLUSION,GLEASON,LABEL,METHODS,OBJECTIVE,POST,PSAD,RESULTS
AFTER,CDM,CELL,CONCLUSION,EGF,LABEL,METHODS,MTT,OBJECTIVE,PDGF,RESULTS,THEN
BASIC,CHANG,CMV,CONCLUSION,LABEL,METHODS,OBJECTIVE,PCR,PSMA,RESULTS,S2PRO
PARTICULAR,TREATMENT
100,267,ACK1,AIM,ATM,CRPC,CRPCS,HOWEVER,MICE,NOTABLY,THUS,TNK2,TYR
169,2011,231,468,COPYRIGHT,DOX,F127,FREE,FURTHER,HOWEVER,INC,LNCAP,MDA,NPS,PF127,PLGA,PLURONICS,PVA,RELEASE,THESE,WILEY
169,2012,933,954,AACR,AKT,BCL,CREB,FAS,NR4A,NUCLEAR,PPAR,RXR,THESE,TRAIL,VEGF,WNT
169,2012,COPYRIGHT,INC,MRI,THERE,WILEY
1800,2012,BRAIN,FDG,FEW,FIFTY,HCC,JANUARY,LIMITED,MEDLINE,PET
120,BACKGROUND,C75,CONCLUSION,FASN,FATTY,HOWEVER,HSV1,INHIBITION,LABEL,LNCAP,METHODS,RESULTS
8482,CTC,CTCS,HOWEVER,PC3,PDMS,QGEL
BACKGROUND,CONCLUSION,FOUR,HEALTHCARE,LABEL,METHODS,OBJECTIVE,RESULTS,SPOUSES,THERE,THOSE,WHEREAS
169,2012,AACR,DISRUPTION
169,2012,BASED,COPYRIGHT,DU145,E2A,GIVEN,ID1,ID3,INC,MYC,PC3,SILENCING,TCF3,THESE
001,169,180,2012,726,763,8226,825,857,899,924,BJU,CONCLUSION,HOWEVER,LABEL,LEVEL,METHODS,MRI,OBJECTIVE,PCA3,PSA,RESULTS,TRUS,TYPE,UNLABELLED,WHAT
100,161,169,2012,ADD,AUTHORS,BJU,CONCLUSION,COX,DOES,FURTHER,GLEASON,HARRELL,HOWEVER,KNOWN,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,SUBJECT,THESE,THREE,UNLABELLED,WHAT
001,169,1996,2005,2012,221,252,8226,8804,8805,AHR,AUTHORS,BJU,CAB,CONCLUSION,COX,FACTORS,GLEASON,INCREASING,LABEL,LEVEL,METHODS,OBJECTIVE,PCA,PSA,RESULTS,THERAPY,THESE,TYPE,UNLABELLED,WHAT
169,2012,BJU,CYP,FURTHER,HOWEVER,HRQL,METASTATIC,THERE,WHAT
001,048,11752,169,1998,2007,2012,2196,8226,BJU,BRITISH,EARLY,INTERIM,LABEL,LHRH,METHODS,NEITHER,OBJECTIVE,OBJECTIVES,PSA,RESULTS,UNLABELLED,VARIOUS,WHAT,YOUNGER
204,215,360,DESPITE,DIETARY,DIMEIQX,GSTM1,GSTT1,HCA,HEIDELBERG,MEIQX,MNSOD,NUTRITION,PCA,PHIP,RISK
049,083,AAS,AFRICAN,CAP,CAS,CAUCASIAN,DIETARY,HISTORY,LOUISIANA,NCI,NORTH,PCAP,PROJECT,RESULTS
133,ASSESSING,CLAVIEN,LABEL,METHODS,OBJECTIVE,RESULTS,THUS
177,179,210,8201,BACKGROUND,BOO,CHINA,FORTY,IPSS,LABEL,MEAN,METHODS,OBJECTIVE,PCA,PURPOSE,PVP,PVR,QMAX,QOL,RESULTS,SCORE,SYMPTOM,THERE
129S,129S4,8764,AKT,CAP,CRE,EMT,FURTHER,FVB,HOWEVER,LSL,MMS,NKX3,PIN,PTEN,R270H,R273H,THESE,TP53,TRP53
169,2012,22RV1,945,AACR,AFTER,AKT,ERK,FIFTY,HOWEVER,IGF,KI67,TEN,TNF,WHEREAS
000,001,067,100,1997,1998,2006,2007,597,894,BACKGROUND,LABEL,METHODS,PSA,RESULTS
109,150,160,297,406,8805,ADHERENCE,AGE,AMONG,CUMULATIVE,DRUG,FACTORS,FIRST,LABEL,MEN,METHODS,OBJECTIVE,OFF,PATIENT,PRESCRIBED,PURPOSE,RESULTS,SIXTY,SWEDISH
145,954,AKT,AKT1,CAFFEIC,CAPE,LNCAP,MYC,PCR,USING,WESTERN
169,177,2012,956,CHINA,COMPARISON,COPYRIGHT,DU145,HOWEVER,LNCAP,PC3,SEA,THEIR,TYDEMANIA
2009,2011,495,831,852,BOTH,CHINESE,ERSPC,GLEASON,HOWEVER,JANUARY,MARCH,MOST,OVERALL,PCPT,PREVENTION,PSA,RANDOMIZED,SCREENING,SEVERAL,THEREFORE,TRIAL,WESTERN
1987,1998,2008,BASE,EAST,GLEASON,NPCR,OTHER,PCA,PSA,SINCE,SOUTH,SWEDISH
DESPITE,PSA
1221,1222,169,2012,CONVERSELY,COPYRIGHT,DESPITE,ERBB,EXPRESSION,FURTHER,INC,INCREASED,PCA,ROS,STEROID,THESE,W134F
169,1B1,2012,947,CANCERS,COPYRIGHT,CYTOCHROME,GIVEN,HOWEVER,IRELAND,LTD,P450,STUDIES
000,190,BACKGROUND,CENTERS,COLORECTAL,INC,INDEX,LABEL,LSS,LUNG,METHODS,OVARIAN,PLCO,PUBLISHED,RESULTS,SCREENING,TELEPHONE,TEN,TRIAL
169,18GY,1998,19GY,2008,2013,20GY,AALEN,COPYRIGHT,HIGH,INC,LABEL,MATERIALS,METHODS,MOST,OBJECTIVE,POTENTIAL,PUBLISHED,PURPOSE,RESULTS,SOCIETY,THERE,THREE,WILLIAM
102,129,134,169,1999,2002,2006,2011,2012,219,CONSISTENT,COPYRIGHT,FAS,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SOCIETY
169,2002,2007,2012,2584,BACKGROUND,BRIER,CONVERSELY,COPYRIGHT,ESUO,GALLINA,LABEL,METHODS,NORTH,OBJECTIVE,OBJECTIVES,OUTCOME,PRIMARY,PUBLISHED,RESULTS,ROBOT,ROC,SOCIETY,SVI,THREE,UROLOGICAL,UROLOGY,USING
0001,0002,041,077,134,144,169,17Q,2013,289,412,8805,8Q24,ASIAN,CAP,CAPS,CAUCASIANS,CHINESE,COPYRIGHT,GLEASON,INC,INDIANS,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PSA,RESULTS,SNPS
169,2011,ACHE,BCHE,COPYRIGHT,GLEASON,PCA,SAS,THESE,THUS
100,125,145,169,185,186,2006,2009,2012,CONSISTENT,COPYRIGHT,D90,INC,PUBLISHED,V100
169,2012,945,946,ALDH,ALTOGETHER,CD44,COPYRIGHT,INC,PCA,PSA
007,021,168,169,1A1,2012,6TAA,8TAA,COPYRIGHT,INC,MACEDONIAN,URIDINE
176,177,246,765,780,810,BOTH,ICG,PC3,PIN,PLGA,SUCCESSFUL
8725,ANOTHER,DOSE,IMRT,LABEL,MAGIC,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE,TPS
176,177,2000,8201,956,ANIMALS,DOX,FINALLY,FIRST,FUS,INCREASED,INSIGHTEC,LABEL,LNCAP,METHODS,MHZ,OBJECTIVE,OPTIMAL,PARAMETRIC,PURPOSE,RESULTS,THERE,THIRD
8201,956,CUSUM,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
103,EDITING,LABEL,METHODS,OBJECTIVE,PURPOSE,RBF,RBFS,RESULTS,STRUCTURES,STUDIES,SURFACE,THESE
AKP2,BACKGROUND,GLI1,HOWEVER,INDUCTION,LABEL,LNCAP,LNSHH,MC3T3,PTC1,RESULTS,SHH,SONIC,THEREFORE
100,757,911,AUC,BACKGROUND,CONCLUSION,CURRENT,DIAGNOSTIC,GLEASON,LABEL,MEIER,METHODS,PCA,PCR,PSA,RESULTS,ROC,SINCE,THEREFORE,USING
AFTER,FOLLOWING,THOSE
066,AMONG,BACKGROUND,COX,DESPITE,INSURANCE,LABEL,METHODS,NHI,RESULTS,TAIWANESE
271,641,895,927,954,AP1,ASSESSING,CAUCASIANS,MDM2,SNP285G,SNP309G,SNP309T,SNP344A,SNP344T,SP1,SPIB,THUS,WHILE
174,400,CD45,CELLSEARCH,CRPC,CTCS,ERG,GEDI,HOWEVER,ISOLATION,MOLECULAR,PSMA,T868A,THESE,TMPRSS2
LOUISIANA,SEER,USA
2011,FORCE,OCTOBER,PREVENTIVE,PSA,TASK,THESE
205,332,916,945,946,HENCE,LACK,NP63,PCA,THEREFORE
PIONEER
105,2008,2009,ATLAS,BOTH,CONSORTIUM,NEXT,PATHOLOGY,PROGRAM
129,160,175,185,360,CONCLUSION,COX,DIFFUSE,GROUP,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PURPOSE,RESULTS,T1C
021,048,8805,BPH,CONCLUSION,GLEASON,LABEL,MATERIALS,METHODS,MMP,MMPS,MT1,OBJECTIVE,PCA,PCR,PSA,RESULTS,TIMP
001,082,1026,1915,2004,2005,BETWEEN,BRAZILIAN,DATA,GLEASON,LABEL,MATERIALS,METHODS,OBJECTIVE,PAULO,PSA,RESULTS,SAO,SECTION,SEPTEMBER,SOCIETY,STATE,UROLOGY
001,177,BPH,CONCLUSION,DOPPLER,DRE,IPSS,LABEL,LUTS,MATERIALS,METHODS,OBJECTIVE,POWER,PSA,PUD,RESISTIVE,RESULTS,SCORE,THERE,ULTRASOUND
0126,169,2013,COPYRIGHT,D95,DAILY,INC,INTENSITY,LABEL,LARGE,MATERIALS,METHODS,OBJECTIVE,PTV,PURPOSE,REAL,RESULTS,RTOG,THESE,V79
169,2012,428,COPYRIGHT,END,EXPRESSION,GLEASON,INC,PERCENTAGE
AKT,BACKGROUND,BALB,CD31,E804,IDR,INTRATUMOR,LABEL,METHODS,RESULTS,SRC,THESE,VEGF,VEGFR
169,2012,AACR,III,LABEL,METHODS,OBJECTIVE,PEC,PURPOSE,RATES,RESULTS,SEMINAL,THREE
0001,169,2012,350,492,8804,8805,956,AACR,ACTIVATION,GLEASON,IGF,III,LABEL,MEAN,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS,SIXTEEN,THESE
AGS,BACKGROUND,DOSE,DRUG,IIA,LABEL,METHODS,PKS,PRIMARY,PSCA,RESULTS
169,2012,BRITAIN,COPYRIGHT,FINALLY,GREAT,HOWEVER,IRELAND,JOHN,LTD,MPS,PUBLISHED,REST,SOCIETY,SONS,WILEY
FURTHER,HOWEVER,INCREASING
160,PART,TYPE
160,231,CELL,CONCLUSION,DER,ICG,LABEL,MDA,MET,METHODS,OBJECTIVE,OPTICAL,PC3,PURPOSE,RESULTS
160,2009,ISUP,PATHOLOGY,SOCIETY,UROLOGICAL
181,BAX,EGCG,GTP,GTPS,HDAC1,HDACS,HISTONE,LNCAP,LYS,TREATMENT

001,1205,1387,300,370,401,AHR,AMONG,COLORECTAL,DIETARY,EPHX1,GSTM3,HCAS,LUNG,MEAT,MEIQX,NAT1,NOCS,OVARIAN,PAHS,SCREENING,SNPS,TRIAL,UGT1A,USING,XME
100,793,798,8804,BACKGROUND,GROUP,LABEL,METHODS,PSA,RESULTS,SERUM,THERE,THREE
CASE,CONCLUSION,FGF23,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,TIO
0001,001,002,177,181,6993,EAU,FINALLY,GLEASON,GUIDELINES,PCA,PEARSON,PROMISING,PSA,RRP,STUDENT,THEREFORE,THESE
CUR,DMC,DMSO,HOWEVER,MMP,MTT,THEREFORE,THESE
708,AKT2,CD44,CLINICALLY,CONVERSELY,FUNCTIONAL
BPS,LOSS,REMARKABLY,TOP,TORIN,YBX1
101,169,2013,220,AFTER,BOTH,COPYRIGHT,COX,CYP17,DRUG,GIVEN,HRS,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,ORR,OVERALL,PFS,PSA,RESULTS,SIMILAR
021,169,2013,AFRICAN,CALCULATOR,CAP,CAUCASIAN,COPYRIGHT,INC,KING,LABEL,MATERIALS,METHODS,PREVENTION,RESULTS,RISK,RISKS,TRIAL,USA
329,AGE,EORTC,INDEX,INSTEAD,PR25,QLQ,REGARDLESS,THESE
117,169,2012,956,COMPOUNDS,COPYRIGHT,E10,F10,FN1,FN2,INHIBITORY,MTT,PANC,SAS,SIXTY
169,2012,947,BACKGROUND,CELL,COPYRIGHT,DSB,DSBS,DU145,H2AX,HOMOLOGOUS,IGF,IRELAND,LABEL,LNCAP,LTD,METHODS,OBJECTIVE,PC3,PURPOSE,RADIATION,RESULTS,THESE
016,069,116,1998,2002,220,AIM,ASTRO,BFFS,DATA,FIVE,GLEASON,LABEL,LDRB,LOW,METHODS,OBJECTIVE,PHOENIX,PSA,RESULTS
145,215,946,BLI,INCUBATION,MICE,RFC,RIIFC,SMAD2,SMAD3,TAD,TGF,THESE
001,004,010,023,169,177,2000,2012,8804,ADC,CONCLUSION,DATA,FORTY,GLEASON,HIPAA,LABEL,MATERIALS,METHODS,OBJECTIVE,PARAMETRIC,PURPOSE,RESULTS,RSNA,SEVENTY
AFRICAN
169,2012,8201,ADT,BACKGROUND,CONVERSION,COPYRIGHT,DHT,FINALLY,GFP,HOWEVER,INC,INDUCTION,LABEL,LNCAP,METHODS,PCA,RESULTS,SCID,WILEY
001,060,087,169,19Q13,2012,3P12,536,8Q24,AFRICAN,BACKGROUND,CAP,COPYRIGHT,FOUR,GWAS,HOWEVER,INC,KLK3,LABEL,LOUISIANA,METHODS,NORTH,PCAP,PROJECT,PSA,RESULTS,SNP,SNPS,TESTS,WILEY
169,1962,2012,CHARLES,COPYRIGHT,GOODWIN,HUGGINS,INC,NOBEL,PRIZE,UCLA,WILEY,WILLARD
8804,CONCLUSION,FCH,LABEL,METHODS,OBJECTIVE,PET,PSA,PURPOSE,RESULTS,THESE
006,008,042,106,169,2012,344,368,372,8201,BACKGROUND,COPYRIGHT,HOWEVER,JOHN,LABEL,LTD,METHODS,OUTCOME,PHASE,RESULTS,SEVEN,SONS,WESTERN,WILEY,YOUNGER
169,2012,266,304,ADDITIONAL,BACKGROUND,COPYRIGHT,CYP19A1,ESR1,ESR2,INC,LABEL,MATERIALS,METHODS,PCA,RESULTS,THERE,THROUGH,WILEY
100,956,BACKGROUND,CELL,ELISA,IGG,IL8,LABEL,LNCAP,METHODS,RESULTS,VEGF
HOWEVER
PCA,PDT,PPP,PPPS
1975,2008,2009,2011,HOWEVER,SPANISH
945,ANDROGENS,CONSISTENT,CONVERSELY,DHT,FURTHER,HOWEVER,KLK,KLK14,KLK4,KLKS,LG4,SHBG
AFTER,NAVIGATION,SPECT
DETERMINED,HOWEVER,SIX
1980,1990,2000,ALABAMA,BLACK,GEORGIA,LABEL,LOUISIANA,METHODS,NORTH,OBJECTIVE,PCA,PURPOSE,RESULTS,SOUTH,WASHINGTON
8P23,BACKGROUND,FDFT1,FINALLY,LABEL,METHODS,RESULTS,RS2645429
006653848,100,8804,AES,BACKGROUND,ECOG,GLEASON,GROUP,HOWEVER,LABEL,METHODS,NTC,OTHER,OTHERWISE,PSA,RADICAL,RESULTS
145,1522,185,225,8315,AG0,CELL,DOSE,IMRT,RAD,THESE,UNIFORM
000,011,111,172,175,488,688,8805,AKT3,BACKGROUND,CGEMS,FOLLOWING,GLEASON,HOWEVER,III,LABEL,MAIN,MARKERS,MDR,METHODS,MOLECULAR,NCI,PCA,PLCO,PRIOR,PRKCQ,RESULTS,SEN,SNP,SNPS,YET
169,2000,2004,2010,2012,8364,CONCLUSION,COPYRIGHT,DISCHARGE,INC,LABEL,MARCH,METHODS,OBJECTIVE,RESULTS
0001,001,007,008,103,119,123,125,169,1996,2002,2012,242,BRFS,CONCLUSION,COPYRIGHT,COX,EBRT,GLEASON,GROUP,HOWEVER,INC,LABEL,LATE,METHODS,OBJECTIVE,PHOENIX,RADIATION,RESULTS,THERAPY,TREATMENT
169,2012,700,CAM,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,RESULTS,SELECTION,THERAPY
145,ASS,BACKGROUND,BP1,CELL,CONCLUSION,DECREASED,INHIBITION,LABEL,LNCAP,OCT,PCR,RESULTS
103,177,1994,2004,206,945,ADT,ANDROGENS,BETWEEN,CAIX,EGF,EGFR,FIFTY,GLEASON,HIF1,LABEL,MATERIALS,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS,VEGF
000,100,200,233,325,911,BACKGROUND,CHIP,FDR,HOWEVER,HPEAK,KBP,LABEL,MCF7,METHODS,POLII,RESULTS,THEN
CAM,HSA,MMP,MT1,PECAM,THESE,TIMP
AFTER,HOWEVER,KLF,MTM,SDK,SP1,SP3,SP4,TAKEN,TFS
006,007,009,169,177,2012,AJCC,BACKGROUND,COMMITTEE,CONVERSELY,COPYRIGHT,CPE,HOWEVER,JOINT,LABEL,MEIER,METHODS,NCCN,NETWORK,RESULTS,SOCIETY,STAGING,THERE
169,1998,2003,2012,2225,445,8805,AFTER,BACKGROUND,COPYRIGHT,DATA,END,FEW,FORM,HOWEVER,HRQOL,LABEL,MEDICAL,METHODS,MHOS,RESULTS,SHORT,SOCIETY
169,2012,543,8201,BACKGROUND,BECAUSE,CHANGES,COPYRIGHT,FINALLY,FRESH,JOHN,LABEL,LTD,METHODS,RESULTS,SONS,START,WILEY
AFRICAN,AMERICANS,CONCEPTUAL,DIVERGENT,FERRELL,INSTITUTE,LIFE,MODEL,QUALITY,THESE
169,2012,8201,AFTER,BACKGROUND,COPYRIGHT,JOHN,LABEL,LTD,METHODS,RESULTS,SONS,THESE,WILEY
233,326,652,DATA,LABEL,METHODS,OBJECTIVE,ODDS,RESULTS
WHETHER
169,179,2012,CBCT,COPYRIGHT,DOSE,FOUR,INC,LABEL,MATERIALS,MEAN,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE,XVI
AFTER,CONCLUSION,LABEL,METHODS,OBJECTIVE,PCR,RAGE,RESULTS,VC1,WESTERN
001,009,100,125,169,200,2012,299,300,399,400,495,499,967,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SOCIETY,THERE
169,2000,2007,2013,251,ADT,COPYRIGHT,DUE,GLEASON,INC,INJECTING,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PSA,PUBLISHED,PURPOSE,RESULTS,SALVAGE,SOCIETY,T3A
1351,1458,187,ANDROGENS,BACKGROUND,CYP17A1,GWAS,HSD17B3,HSD17B4,JAK2,KLK3,LABEL,LTD,METHODS,NCOA4,NKX3,PUBLISHED,RESULTS,SNP,SNPS,STAT3,SULT2A1,THESE
032,110,169,2012,916,963,AUNPS,COPYRIGHT,ELISA,LOD,PSA,RLS,UNDER
000,1000,169,2012,5000,ANALYTICAL,BACKGROUND,BPSA,CLSI,COPYRIGHT,EP17,EP5,FREE,HYBRITECH,LABEL,LOB,LOD,LOQ,METHODS,PSA,RESULTS,THERE,TOTAL
001,169,2012,251,BECKMAN,COPYRIGHT,DRE,HGPIN,INDICATION,PCA,PCA3,PHI,PSA,ROC
946,CFC,CRYPTIC,EGF,EMT,EPITHELIAL,FRL,INC,NODAL,PUBLISHED,SNAIL,TGF,THEREFORE
169,2012,AFTER,ASC,BACKGROUND,CONCLUSION,COPYRIGHT,FDG,FMA,INC,INHIBITION,LABEL,METHODS,PET,POTENTIAL,RESULTS,THREE
169,2012,COPYRIGHT,INC,MRI,RADICAL
160,169,187,2012,ADT,COPYRIGHT,DXA,INC,INITIAL,PUBLISHED,SIXTEEN,SOCIETY
169,177,2012,281,ADT,CONCLUSION,COPYRIGHT,EBRT,FMS,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE,THREE
160,169,177,2013,8721,947,963,CALYPSO,COPYRIGHT,CRT,FILM,HEXAPOD,IMRT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,REAL,RESULTS,VMAT,WITHOUT
169,2012,695,BACKGROUND,COMPETING,CONVERSELY,COPYRIGHT,GLEASON,GROUP,LABEL,METHODS,OBJECTIVE,OUTCOME,PUBLISHED,RESULTS,SETTING,SPCG,UROLOGY
169,2012,COPYRIGHT,INC,PUBLISHED,SOCIETY,THERE
MV4,PIM1,THESE
001,169,1988,1991,2005,2008,2009,2012,21ST,285,372,8805,AJCC,AST,BJU,CENTURY,CHICAGO,CMT,COMMISSION,CONCLUSION,DUKE,EBRT,FACTORS,FINE,GLEASON,GRAY,INITIAL,JANUARY,JOINT,LABEL,MEN,METHODS,OBJECTIVE,OCTOBER,OPTIONS,PSA,RCT,RCTS,RESULTS,T1C,T2B,THERE,THESE,TREATMENT,UNIVERSITY,UNLABELLED,WHAT,WHILE
000,001,169,1720,1930,1944,1995,2010,2012,2353,2590,633,8805,AUTHORS,BETWEEN,BJU,CONCLUSION,GOTHENBURG,LABEL,LUTS,MEN,METHODS,OBJECTIVE,ORS,PSA,RANDOMIZED,RESULTS,SCREENING,T2B,THERE,TRIAL,TRUS,UNLABELLED,WHAT
169,2012,ATF6,BECKMAN,CITY,EGFP,FEBS,HOPE,INHIBITION,INSTITUTE,JOURNAL,NELFINAVIR,RNAS,S1P,S2P,SREBP,THESE,WESTERN
001,169,1773,2012,257,274,2741,694,8226,8804,AUTHORS,BJU,HOWEVER,INDEX,LABEL,LEVEL,LRP,METHODS,OBJECTIVE,RALP,RESULTS,RRP,THERAPY,TYPE,UNLABELLED,WHAT
200,215,946,956,EM011,FOURIER,HOWEVER,NMR,NOS,OCH,PHASE
FURTHER,HOWEVER,OVERALL
002,044,048,169,201,2012,505,8226,8805,ACCORDING,ALSO,AUTHORS,BJU,CONCLUSION,EVEN,GLEASON,HOWEVER,LABEL,METHODS,OBJECTIVE,PREVIOUSLY,PSA,PSAD,RESULTS,UNLABELLED,WHAT
EMA,FDA,ZOLEDRONIC
447,532,FURTHER,INTER,POTENTIAL,THESE,WBV
0001,169,2012,2182,366,BASED,CNR,COPYRIGHT,FIFTY,JOHN,LTD,MRI,NMR,OVERLAP,SNR,SONS,TSE,ULTRASMALL,USPIO,WILEY
169,177,2012,800CW,BIOLOGICAL,COPYRIGHT,DOTA,IRDYE,JOHN,LTD,NHS,NIR,PRIOR,SONS,WILEY
III,LABEL,OPINION,STATEMENT,THESE,UNASSIGNED
169,2012,224,BACKGROUND,BASP1,CD44,COPYRIGHT,DNMT,DNMT1,E2F1,ERMA,ERMAS,GADD45A,GADD45B,GPX3,GSTP1,INC,LABEL,LAMB3,LNCAP,METHODS,MICROARRAY,PCR,RESULTS,SIRNA,SP1,TACSTD2,TARGETING,THESE,THUS,WESTERN,WILEY
169,2012,22RV1,945,946,ACUTE,AKT,CHIR99021,COPYRIGHT,FINALLY,GLEASON,GSK,GSK3A,GSK3B,MDV3100,UICC
001,169,2000,2012,450,917,934,AARP,CIS,COPYRIGHT,COX,DIET,ESTIMATED,HODGKIN,HRS,INSTITUTES,MAPPING,NASA,NIH,OZONE,RESTRICTED,TOMS,TOTAL,UICC,UVR
BACKGROUND,CLINICIANS,CRITICALLY,LABEL,MEDLINE,METHODS,NNT,RESULTS,SRE,SRES
100,169,185,1982,1998,2012,COPYRIGHT,CURRENT,DATA,DSM,HRS,UICC
106,169,185,1992,2007,2012,8805,ADT,AHR,AMONG,BACKGROUND,COPYRIGHT,COX,LABEL,METHODS,OBJECTIVE,OUTCOME,PCA,PUBLISHED,RESULTS,RISKS,SETTING,STRATEGIES,UROLOGY
000,001,181,1960,1970,1993,2000,2003,2009,385,AGE,CONCLUSION,DATA,ELECTRONIC,LABEL,MARSHFIELD,METHODS,OBJECTIVE,PSA,RESULTS,SETTING,THERE,WISCONSIN
169,2012,CLINICALLY,COPYRIGHT,HAND,HOWEVER,INC,METASTASIS,PUBLISHED,SOCIETY,SURGERY
168,169,2012,945,946,AMONG,CONCLUSION,COPYRIGHT,FFBF,FFDF,FFLF,FREEDOM,GLEASON,HIGH,HOWEVER,III,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
169,2013,945,BOTH,CCK,CELLS,COPYRIGHT,DU145,GLUT,HIF,HOWEVER,IGF,INC,KIT,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PC3,POTENTIAL,RESULTS,WESTERN,ZNSO4
169,2012,961,AUTHORS,CONCLUSION,COPYRIGHT,IGF,INC,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SETTING
169,2012,JOHN,SONS,THERE,WILEY

ANTIGEN,CELL,INCREASED,PIN,PSCA,STEM,THESE,THUS,YANG,YIN,YY1
BACKGROUND,CONCLUSION,EVALUATION,HOWEVER,LABEL,METHODS,MRI,OBJECTIVE,OVERALL,PURPOSE,RESULTS,T1A,T1B,T2B,T2W,T3A,TNM,TSE
169,2012,BOARD,CONCLUSION,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,MRI,MRSI,OBJECTIVE,PURPOSE,RESULTS,ROC,WILEY
169,2012,COPYRIGHT,DRUG,FOOD,INC,SOCIETY,THERE,WHILE
000,001,100,119,180,185,1997,2005,296,497,ASIAN,BETWEEN,INSURANCE,VTE
142,176,1966,2006,2007,800,AMONG,COX,DUTCH,IMS,KTRS,SCCS,SMRS,TIME
2009,367,BETWEEN,MAY,MEN,RARP
169,2012,BOTH,COPYRIGHT,CROWN,DCA,HYBRIDARC,IMRT,INC,MUS,PLANS,PUBLISHED
0001,001,002,1200,169,177,2000,2012,7303,7844,8089,8100,8228,COPYRIGHT,D35,D95,EACH,ECLIPSE,FURTHER,IMRT,INC,MEDICAL,PTV8100,PUBLISHED,THERE,THREE,V95
169,176,2005,2009,2012,993,BODY,COPYRIGHT,COUCH,EXACT,GERMANY,INC,MEDICAL,NOVALIS,OVERALL,PUBLISHED,ROBOTIC,ROTATIONAL,TILT
001,003,162,169,1993,2010,2013,794,8804,BCR,COPYRIGHT,COVARIATES,COX,GLEASON,INC,JUNE,LABEL,LIFE,MATERIALS,MEIER,METHODS,OBJECTIVE,OBJECTIVES,PSA,PSM,RESULTS,RPP
2000,945,946,BOTH,COPOLYMERS,CPOX,EDA,FLUTAMIDE,LNCAP,PEG,PHEA,PPOX,SIZE
BACKGROUND,DRUG,FEDERAL,LABEL,METHODS,MOST,NOTABLY,RESULTS,THESE,WHILE
ATP,BAF,BIOGRID,GENEMANIA,GILFORD,HGPS,HUTCHINSON,INDEX,LAMIN,LMNA,SNF,SWI,THESE
133B,945,CD95,DESPITE,EXPRESSION,FAIM,FAS,GSTP1,HELA,PC3,SIMILARLY,THESE,TNF,TRAIL
001,100,135,270,525,630,690,967,AFFYMETRIX,BACKGROUND,CONCLUSION,CRC,FURTHER,GENOTYPING,GWAS,INDIVIDUAL,LABEL,METHODS,PCA,PLINK,PREVIOUSLY,RESULTS,SEVEN,SNP,SNPS,WIDE
701,APPLIED,BACKGROUND,BASED,CEP,FINDING,LABEL,PKC,PKN1,PRINCIPAL,PRK1,RESULTS,THUS,USING
0980,169,2012,AACR,AKT,GDC,GSK690693,HOWEVER,PI3K,PTEN
169,2012,945,AACR,DESPITE,FURTHER,GRO,MMP,PKD,PKD3,PROTEIN,THESE,USING
945,ACTR,BMP,BMPS,EGF,FGF,FUNCTIONAL,IIB,LNCAP,MC3T3,SHH,SMAD,SMAD1,SONIC,TAKEN
946,COOH,DESPITE,HOWEVER,HSP90,NLS,PCA,SYNTHESIS,THEREFORE,WHEREAS
945,ASIAN,DESPITE,HOWEVER,THESE
CURRENT,DESPITE,EIT,TREIT,ULTRASOUND,WHILE
945,946,AKT,ALOE,MAMMALIAN,PC3,PI3,PKC,PROTEIN,PRR5,PTEN,PULL
181,AIM,CONCLUSION,DOSE,FURTHER,LABEL,MCP,METHODS,OBJECTIVE,PROSTACAID,RESULTS,SECRETION,WESTERN
1000,203,377,649,ACE,BMI,COX,EFFECTS,GENERAL,LABEL,MAIN,METHODS,OBJECTIVE,OBJECTIVES,OUTCOME,POISSON,RESULTS,SETTING,THERE
CHIP,ERG,EZH2,HDAC1,HDAC2,HDAC3,HDACS,HOWEVER,SEQ,TAKEN,USING
169,2008,2010,2011,2012,260,3081,BACKGROUND,COPYRIGHT,EAU,GERMANY,LABEL,LNI,LTD,METHODS,OVERALL,PLND,PLNDS,RESULTS,UROLOGY
169,2012,ADDITIONAL,COPYRIGHT,FURTHER,LTD,PC3,TAKEN,THUS,ZKSCAN3
2000,2007,800,ADVANTAGE,BACKGROUND,DATA,END,ENROLLEES,LABEL,MEDICAL,METHODS,MOST,NETWORK,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,SMALL,VDW,VIRTUAL,WAREHOUSE
169,2006,2011,2012,BRE,CRC,FACTORS,GLEASON,III,METASTASIS,MOST,NODE,PROGNOSTIC,REGARDLESS,TNM,UICC,UNION
0019,0055,0058,012,122,177,8201,956,BACKGROUND,BMS,BONE,CAP,CONCLUSION,GGPP,LABEL,LIPOPHILIC,METHODS,RESULTS,STATINS
169,2006,2012,CFS,COPYRIGHT,HOWEVER,PCA,SEVERAL,SINCE,XMRV
000,123,2005,8804,GLEASON,HOWEVER,ISUP,LNS,PATHOLOGY,SOCIETY,UROLOGICAL
AREA,BACKGROUND,COVERED,DESPITE,HGF,LABEL,MET,METHODS,OPINION,PHASE,UNDER
GDI,GDP,HOWEVER,PROTEIN,RHO,SINCE,TMA
169,2012,945,946,COPYRIGHT,EPH,EPHA2,GMBH,KGAA,PC3,SURFACE,THESE,VCH,WILEY
169,2011,BACKGROUND,COPYRIGHT,CRPC,CXR,H89,HOWEVER,HPR50,INC,LABEL,LNCAP,METHODS,OXIDATIVE,PDE4B,PKA,RESULTS,THEN,WESTERN,WILEY
0101,161,175,181,191,195,2011,205,351,365,947,BACKGROUND,CD4,CD8,DR1,DRB1,ELISPOT,HLA,IFN,INC,LABEL,METHODS,MHC,PAP,PROSTATIC,PUBLISHED,RESULTS,WILEY
AAS,AFRICAN,BASED,COMMUNITY,PRCA,SOUTH,VESEY
690,DATA,MOST,SEX,WOMEN
FIFTY,RESULTING,SEVEN,THESE
016,182,198,1995,2004,2005,2006,2007,319,413,457,474,611,793,804,818,EACH,FEULGEN,JANUARY,JULY,LABEL,METHODS,OBJECTIVE,OCTOBER,PURPOSE,RESULTS,TOTAL,URINE
043,085,2011,562,CIS,FIFTEEN,INSULIN,JANUARY,RRS,SUMMARY,THESE,USA
153,223,ALSO,DECISIONS,EDTMP,GIVEN,LABEL,MET,OPINION,SRC,STATEMENT,UNASSIGNED
197,256,945,ALSO,CAUCASIAN,CYP17,CYTOCHROME,PCR,PSA,RFLP
945,946,CCK,CD133,CD44,MACS,NANOG,PC3,WESTERN
100,200,AFTER,FITC,IAPS,MTT,P20,SMAC,TRAIL,WESTERN,XIAP
8201,BASIC,CONFERENCE,CURRENT,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,STRATEGIES,SUCCESSFUL,SURVIVORS,THERE
PSA,THEREFORE
512,8805,AFRICAN,AUC,CALCULATOR,CLEVELAND,GLEASON,GRADE,HIGH,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PREVENTION,RESULTS,RISK,TRIAL
061,086,160,177,240,CONCLUSION,DEGARELIX,GNRH,LABEL,MEAN,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS,THREE
CASE,CONCLUSION,LABEL,METHODS,THESE
001,177,800,8226,8804,961,ADC,ADCS,ANOVA,DIFFERENT,FORTY,GLEASON,KEY,LABEL,MAPS,MEAN,METHODS,MINIMUM,MRI,OBJECTIVE,OBJECTIVES,PCA,RESULTS,SUBJECTIVE
METASTASES
160,2002,2006,2009,268,347,8804,8805,AGES,CONCLUSION,DAILY,DIETARY,HIGH,HRS,LABEL,METHODS,MIDLIFE,OBJECTIVE,ORS,PCA,RESULTS,REYKJAVIK,THROUGH
160,798,BACKGROUND,DIET,IGF,IGFBP,IGFS,LABEL,METHODS,RESULTS,THERE
114,121,160,1990,1994,230,514,620,COX,DIETARY,HRS,LABEL,MELBOURNE,METHODS,OBJECTIVE,PURPOSE,RESULTS,WEAK
160,1993,1999,2007,588,814,BASED,FURTHER,LABEL,METHODS,OBJECTIVE,POISSON,PURPOSE,RESULTS,SMALL
100,BECAUSE,C2ORF40,ECRG4,HEK,NACL,PC3,WHEREAS
8201,947,950,CAR,CARS,CD28,CD3,ERBB2,LABEL,METHODS,MUC1,NOTABLY,OBJECTIVE,PURPOSE,RESULTS,SFG,THESE
946,BONE,CELL,E26,MVS,PCA,THERE
ASIA,BAK,BAX,BCL,BETA,BETULINIC,CNE2,EAST,FURTHER,HOWEVER,NPC,THESE
0001,218,436,BACKGROUND,BECAUSE,EIGHT,FACTORS,LABEL,METHODS,MSCC,RESULTS,TOTAL
1980S,ANATOMICAL,CURRENTLY,HOWEVER,THESE,WALSH
DESPITE,GLEASON,HOWEVER,PSA
THERE
HOWEVER,LRPE,REPORTS
025,046,1304G,1304T,160,222,244,441,452,647,670,948,993,CONCLUSION,ELISA,HOWEVER,LABEL,METHODS,MKK4,OBJECTIVE,PCA,PURPOSE,RESULTS,SNP
032,160,2004,2006,AGE,AVERAGE,LABEL,MEIER,METHODS,OBJECTIVE,PURPOSE,RESULTS,TOKUHASHI,TRUE
001,003,100,102,639,AUSTRALIA,CRC,CRCS,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SIR,SIRS,SIX,THERE,USA,ZEALAND
2008,2010,OVERALL,PSA
116,145,169,2000,2012,350,5000,CELL,COPYRIGHT,DARK,GOLGI,HCT,HOWEVER,PDT,PEG,THPP
169,2012,262T,COPYRIGHT,GPX1,OTHER,PRO197LEU,SNP,SNPS,SOD,SOD2,THUS
139,177,2002,2006,278,286,BACKGROUND,CONCLUSION,FAILURE,LABEL,LRP,MEIER,METHODS,NONE,OBJECTIVE,PLND,PURPOSE,RESULTS,THESE
001,215,8201,BACKGROUND,CELL,CONCLUSION,HOWEVER,ICCM,ICMM,IRRADIATED,LABEL,METHODS,NON,PC3,RESULTS
946,MODULATION,OVERALL,PKD1,PROTEIN,THEREFORE
744,ARG,ASN,ASP,BACKGROUND,CONCLUSION,CURRENT,EACH,GLY,LABEL,METHODS,NGR,RGD,THESE,TUMORHOPE
946,CHIP,EMSA,H3K4,LNCAP,SOX9,SRY,THESE,WDR5
0001,388,CONTIGUOUS,DPC,EPE,GLEASON,NPC,PNI,PSA,SVI,TRUS
006,040,045,065,151,448,643,BACKGROUND,LABEL,METHODS,PTH,RESULTS,SECONDARY,SERUM
10Q26,2000,800,8805,945,946,FGFR2,GWAS,HIF1,IL10,META,MMP,NOS2A,NOS3,RESULTS,SNPS,TGF,THUS,TNF
000,100,1988,1992,1995,1997,2002,2004,2008,AFFAIRS,AGE,AIM,AVERAGE,CONCLUSION,CROATIA,DEPARTMENT,EAPC,INCIDENCE,JOINPOINT,LABEL,METHODS,MORTALITY,NATIONS,OBJECTIVE,POPULATION,RESULTS,TREND,WORLD
2004,CONCERNING,FINALLY,RANK
8804,BRCA,BRCA1,BRCA2
BPH,PCA,ROS
2010,2011,797,824,APRIL,AUC,BACKGROUND,DCE,ECE,FIRST,HISTOLOGIC,IMAGING,LABEL,MATERIALS,MAY,METHODS,MRI,NPV,PCA,PPV,RADICAL,RESONANCE,RESULTS,SVI,THEN,THEREFORE
EWING,OVERALL,STEAP,STILL
HOWEVER,PSA,ZEALAND
1505,169,2008,2010,2011,241,COPYRIGHT,ESPA,LABEL,MCC,METHODS,OBJECTIVE,OBJECTIVES,ORA,PUBLISHED,RESULTS,SPAIN,THESE
153,169,2009,2011,2012,281,290,AEU,CONCLUSION,COPYRIGHT,LABEL,MEAN,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RESPONSES,RESULTS,SPAIN,SPANISH,THESE,TREATMENT
169,176,1MM,2012,4DCT,5MM,AFTER,BACKGROUND,COPYRIGHT,DRRS,EVEN,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,TEN,THERE
002,003,004,006,0102,016,037,074,169,2012,718,ACTUARIAL,AMONG,CONVERSELY,COPYRIGHT,DIFFERENT,IRELAND,LABEL,LTD,METHODS,MVA,OBJECTIVE,PURPOSE,RESULTS,SURG,UNIVARIATE,UVA,V75
107,160,169,2012,215,BACKGROUND,CONCLUSION,COPYRIGHT,DEFAULT,EACH,EUD,FINALLY,FWS,HENCE,LABEL,LTD,METHODS,MFS,OARS,OBJECTIVE,PFS,PTV1,PTV2,PUBLISHED,PURPOSE,RESULTS,TEN,THERE,TREATMENT
169,2012,BILATERAL,COPYRIGHT,FIVE,MEDICAL,PSA,PUBLISHED,RAP,ROBOTIC,TEN,TRUS,UROLOGY,VIKY
153,169,186,2012,223,BONE,COPYRIGHT,CRPC,IRELAND,LTD
169,2012,ATP,COPYRIGHT,COX,DU145,P2Y,PKC,PLA,PREVIOUSLY,SAS,SRC,UPON
169,177,2004,2010,2012,CONCLUSION,COPYRIGHT,EBRT,INC,JUNE,LABEL,MAY,MEAN,METHODS,OBJECTIVE,OVERALL,PATIENT,RESULTS,STRICTURE,TIME,TREATMENT
169,201,2012,231,ABSCESSES,CHRONIC,COPYRIGHT,DOPPLER,ENDORECTAL,MRI,PUBLISHED,SAS
001,134,169,200,2008,2010,2012,210,8226,ACCEPTABLE,AFTER,AUTHORS,BJU,DIAGNOSTIC,DUE,FCH,HOWEVER,JANUARY,LABEL,LEVEL,LND,LNE,LNS,METHODS,MRI,NPV,OBJECTIVE,OBJECTIVES,OTHER,PET,PPV,RESULTS,SEVERAL,STAGING,THEREFORE,TYPE,UNLABELLED,WHAT
002,101,169,2012,205,220,603,623,8226,8804,BCL,BECAUSE,BJU,COX,CURRENT,GIVEN,LABEL,METHODS,OBJECTIVE,OVERALL,PFS,RESULTS,SERUM,UNLABELLED,WHAT
169,2012,220,2937,530,8226,8805,ASSESSMENT,BCR,BJU,CAPRA,DESPITE,DIFFERENT,GRAPHICAL,HOWEVER,INCREASING,LABEL,LEVEL,MEIER,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,PROGNOSIS,RESULTS,RISK,SCORE,THEREFORE,TYPE,UNLABELLED,USA,WHAT
169,2012,AUC,AUCS,CONCLUSION,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,MRL,OBJECTIVE,PSA,PURPOSE,RESULTS,ROC,SIXTY,STEPHENSON
169,2012,388,COPYRIGHT,DOSE,DSH,DSHS,DVH,DVHS,HOWEVER,IRELAND,LABEL,LKB,LTD,MATERIALS,METHODS,MOST,NEXT,NTCP,OBJECTIVE,OUTCOME,PURPOSE,RESULTS,RT01,SUBJECTIVE
169,2011,2012,AHMED,AUTHORS,BJU,GIVEN,LABEL,MATERIALS,MEDLINE,METHODS,OBJECTIVE,OCTOBER,RESULTS,THERE,THREE
001,004,042,047,053,169,2001,2009,2012,2345,329,354,676,8226,AFRICAN,AMERICANS,AMONG,BJU,CLINICIANS,COMPOSITE,CONVERSELY,EPIC,INDEX,LABEL,LEVEL,METHODS,NOTABLY,OBJECTIVE,OBJECTIVES,PDE5I,PSA,RESULTS,THERAPY,THERE,THOSE,TYPE,UNLABELLED,VED,WHAT
169,1985,2011,2012,AEU,BCG,CARCINOMA,COPYRIGHT,LABEL,METHODS,NMIBC,OBJECTIVE,OBJECTIVES,PROSTATIC,PUBLISHED,RESULTS,STROMAL,UROTHELIAL
169,2011,AEU,BACKGROUND,CONCLUSION,COPYRIGHT,LABEL,METHODS,OBJECTIVE,PUBLISHED,SUMMARY
169,2012,8804,AEU,ASCO,ASTRO,AUA,COPYRIGHT,DISSECTION,EAU,END,ESTRO,FORUM,LABEL,METHODS,OBJECTIVE,PCA,PIVOT,PSA,PUBLISHED,RESULTS,SEER
110,1500,2000,2006,8805,956,AAP,BOTH,DAP,GLEASON,LABEL,METHODS,OBJECTIVE,RESULTS,THREE
031,034,060,185,1991,2009,230,294,326,390,468,505,607,767,852,ITALY
ADC,DIFFUSION,INITIAL
2011,ASPIRIN,BACKGROUND,LABEL,METHODS,REGULAR,RESULTS,SEPTEMBER
141,169,2012,BACKGROUND,BIVARIATE,BLACK,COPYRIGHT,LABEL,METHODS,PROVIDERS,PSA,RESULTS,SOCIETY
ANTIGEN,MOST,OWING,THEN
120,178,185,215,406,BASED,IMAGING,IMRT,MINIMUM,SBRT,T1C,TAILORING,VMAT
001,027,055,079,208,230,8805,956,BEIJING,CONCLUSION,LABEL,METHODS,OBJECTIVE,PSA,RESULTS,SERUM
160,200,3600,MLC,MLCS,THREE
460,8211,913,BACKGROUND,BRCA1,CONCLUSION,LABEL,METHODS,MULTIPLEX,PRCA,RESULTS,THERE,USING
169,174G,2011,2012,361,959,ADDITIONAL,AFTER,BASEL,CAUCASIANS,COPYRIGHT,JUNE,LABEL,LIBRARY,METHODS,OBJECTIVE,PCA,RESULTS,STATA
001,003,004,040,150,169,1988,2008,2013,487,CAP,COPYRIGHT,COX,INC,LABEL,LNS,LOG,MATERIALS,MEIER,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,PLND,PSA,RESULTS,TOTAL
GLEASON,MODALITIES,THREE
CASTRATION,FDA,III,NEOPLASIC,SIPULEUCEL,THESE
DOCETAXEL,OTHER,PREDICTIVE,UNTIL
223,BOTH,III,MDV3100,OTHER
1459,169,1988,2003,2012,676,783,AUC,AUCS,CONCLUSION,COPYRIGHT,GLEASON,INC,LABEL,METHODS,OBJECTIVE,PSA,RADICAL,RESULTS,ROC,STAGE,T1C
2012,945,AACR,AXL,COCL,DU145,GAS6,HIF,KNOCKDOWN,LNCAP,PC3,SLUG,SNAIL
0001,169,174,2011,208,215,243,2PRO,452,AIM,BACKGROUND,BECKMAN,CONCLUSION,COPYRIGHT,COULTER,EARLY,INDEX,LABEL,METHODS,OBJECTIVE,PCA,PSA,RESULTS,SAS,SERA,SERUM,WHETHER
003,009,036,169,177,2004,2008,2011,377,AFTER,AMICO,CHI,CONCLUSION,COPYRIGHT,GLEASON,GROUP,LABEL,MEAN,METHODS,OBJECTIVE,OVERALL,PSA,RESULTS,SAS
169,177,1ST,2008,2011,30TH,CONCLUSION,COPYRIGHT,COTONOU,JANUARY,JUNE,LABEL,METHODS,OBJECTIVE,RESULTS,SAS
ALKB,CRPC,DU145,PNT2,THEREFORE,THESE
169,2012,HOWEVER,THUS,UROLOGICAL,UROTHELIAL
BACKGROUND,CURRENT,LABEL,METHODS,RESULTS,THERE,USING
100,945,AKT,CD31,DU145,FURTHER,HIF,HUVEC,MILK,OVERALL,PCA,RESULTS,THESE,THISTLE,THREE,VEGF
ANTIGENIC,BACKGROUND,CD44,CD49F,EPCAM,EPITHELIAL,EVALUATION,FACS,FURTHER,LABEL,LCS,NON,PCR,PCS,PRINCIPLE,PSA,RESULTS,SCS
FINALLY,GAP,LNCAP,THUS,VITAMIN
FIRST,IGF,IGF1,MEN,METABOLIC,PCA,WHILE
001,003,024,025,033,169,2012,8201,AKT,BACKGROUND,CCR2,COPYRIGHT,DIETARY,HCD,HFD,HOWEVER,INC,LABEL,LNCAP,MCP,METHODS,PCA,RESULTS,WILEY
169,2012,600,BRCA1,BRCA2,BRITAIN,COMPARISON,COPYRIGHT,GREAT,HIGH,IRELAND,JOHN,LTD,PUBLISHED,RECURRENT,SOCIETY,SOMATIC,SONS,THESE,TSHZ3,UTILIZING,WILEY
152,169,1987,2003,2012,8201,8804,BACKGROUND,BCR,CIS,COPYRIGHT,COX,INC,JULY,LABEL,MDM2,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS,RRS,SRT,THESE,WILEY
169,2012,BACKGROUND,COPYRIGHT,CSC,CSCS,DESPITE,INC,LABEL,METHODS,RESULTS,THESE,WILEY
CARLO,GENERAL,MGH,MONTE,PBS
144,541D
169,2013,COPYRIGHT,FSH,FSHR,INC,WHILE
169,2013,215,4500,BRITISH,COPYRIGHT,ECHO,ETL,FAST,FOV,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SEVERAL,SOCIETY,SPIN
169,2013,8MM,COPYRIGHT,FACTORS,FIRST,HIGH,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,ONCE,PUBLISHED,PURPOSE,RESULTS,SOCIETY,THREE
169,18P9,1977,2012,CONCLUSION,COPYRIGHT,CTL,CTLS,DNASE,EXPRESSING,HLA,INC,LABEL,METHODS,OBJECTIVE,PSCA,RESULTS
1952,BIPOLAR,ELECTRODE,OLYMPUS,TURBT,USA
1900,1921,1930,246,293,BACKGROUND,DUE,EBRT,LABEL,MAPS,MATERIALS,METHODS,RESULTS,REVENUE,SEVENTY,USING
100MG,169,2012,946,COPYRIGHT,HDS3,HSD3,LTD,PUBLISHED,SAR,SUBSEQUENT
003,026,041,042,045,060,113,169,183,2007,2010,2012,257,454,644,655,8200,8804,AFTER,ASSESSMENT,BACKGROUND,COMPOSITE,COPYRIGHT,COUNCIL,EPIC,FACT,FOCAL,FOUNDATION,FUNCTIONAL,FUNDING,GENERAL,GLEASON,IIEF,INDEX,IPSS,IQR,JUNE,LABEL,LTD,MEDICAL,MEN,METHODS,MRI,NINE,PELICAN,PRIMARY,PSA,RADICAL,RESULTS,SCORE,SYMPTOM,THERAPY,THERE,TRIAL,TRUST,UCLA,URINARY
947,CD8,HLA,IFN,LOCAL
381,8217,AMONG,IMMIGRANT,INSURED,PAP
197,946,ABC,GOLGI,PKD1,PROTEIN,S37,T120,T41,TGN,THESE,WHEREAS,WHILE,WNT
487,501,AGC,FINALLY,GTPASES,HOWEVER,PDK1,PRK2,PRKS,PROTEIN,RHO
100,1368,2000,2008,2009,976,AMONG,BACKGROUND,CONTEXT,END,IMRT,INTENSITY,LABEL,MAIN,METHODS,OBJECTIVE,OUTCOME,POPULATION,RATES,RESULTS,SETTING,THERE
001,100,149,942,954,983,APC,BPH,GSTP1,PCA,PSA,ROC
FINALLY,HOWEVER,III,PSA
CGA
ANATOMICAL,AUTOMATIC,FIRST,REGIONS,THIRD
1998,2011,FOUR,HOPKINS,JOHNS,LPUC,NONE,PATHOLOGY,RECURRENT,THREE,TYPICALLY
001,002,003,133,8805,945,ACLY,ACON,CHKA,CHOCC,FOLLOWING,FRESH,GLEASON,INTEGRITY,LABEL,LOW,MAS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SAMPLES,VII
169,175,2009,2010,2012,288,440,AMICO,ANZ,AUSTRALIA,AUTHORS,BACKGROUND,COLLEGE,CONCLUSION,CONTINENCE,DATA,FELLOWSHIP,FORTY,JOURNAL,LABEL,LRP,MEAN,METHODS,OCTOBER,PATIENT,RESULTS,ROYAL,SEPTEMBER,SURGERY,THERE,USING
A300E,BITE,CD3,USING
101,BINDING,CAV,CSD,ELISA,FURTHER,GSH,GST,N32,POTENCY
BIOACTIVE,CERTAIN,LNCAP,THESE
22RV1,916,CL1,CTGVT,D55,DD3,DU145,E1A,E1B,PCA,PTEN,TARGETING,THERAPY,THEREFORE,TUNEL,VIRO,WESTERN,WPRE
AKT,AKT1,INHIBITION,LNCAP,PI3K,PSMC1,THERE,TTK
E2F,E2F1,E2F4,HDAC3,HOWEVER,PCA,PPAA,SMRT,THUS,UPON
002,023,026,123,670,CONCLUSION,LABEL,METHODS,MOST,OBJECTIVE,OTHER,PAIN,PROVIDERS,PURPOSE,RESULTS,THERE,THESE
001,290,578,611,647,722,8804,CONCLUSION,IBF,LABEL,METHODS,OBJECTIVE,PCM,PURPOSE,RESULTS,SEVENTEEN,THERE
916,CHROMATIN,DHS,DNASE,ESR1,THESE,WHILE
4000,839,ADVERSE,AFFAIRS,BACKGROUND,CHARLESTON,CONCLUSION,CONTEXT,DRUG,FIFTY,GLEASON,HOWEVER,JOHNSON,LABEL,MAIN,MEDICAL,METHODS,OBJECTIVE,OBJECTIVES,OTHER,OUTCOME,PSA,RALPH,RESULTS,SETTING,SOUTH,UNIVERSITY
000,104,8805,AFRICAN,AVERAGE
169,2012,COPYRIGHT,CTC,DTC,EACH,FURTHER,GFP,HOWEVER,INC,WILEY
169,183,2012,2311,945,956,ADENIJI,AKR1C,CHEM,COPYRIGHT,CRPC,INHIBITION,LTD,MED,NADP
365,CARLO,CHAIN,EARLY,HOWEVER,MONTE
100,123,140,169,190,200,2012,390,470,956,BACKGROUND,COPYRIGHT,DU145,F11,FEMX,GENERAL,GREEN,HOWEVER,LABEL,LNCAP,METHODS,RESULTS,ROS,SINGLET,TC10,TC50,TC90,TOXIC,U87,UNDER
244,300,III,OVERALL,SIMILARLY
169,2012,AUTOPHAGIC,AUTOPHAGY,BECAUSE,INC,NVP,PDT,PI3K,SOCIETY,SVEC,WILEY
169,2012,COMPOUNDS,ESIMS,HPLC,KUNTH,PC3,ROS,SOCIETY,TEAC
169,1C3,2012,946,956,AKR,AKR1C,BRAZILIAN,MOLECULAR,PC3,SOCIETY
169,2012,AACR,ADDITIONAL,BMI1,CSC,EHF,EMT,ESE3,ETS,LOW,ZEB2
101,EPIGENETIC,EXPRESSION,EZH2,K27,PRC2,RAF,RKIP,SUZ12,THESE,USING
27A,ANDROGENS,HOWEVER,INCREASING,MICRORNAS,PHB,PROHIBITIN
1200,1300,8805,GIVEN,GLEASON,KALLIKREIN,KLK,KLK14,KLKS,USING
143,331,DECREASED,EIGHT,KALLIKREIN,KLK,KLK10,KLK4,KLKS,PCA,PCR,THESE
EPIGENETIC,KLK,KLKS,REPORTS,RNAS
BOTH,KLK,KLK1,KLK2,KLKS
BOTH,CONVERSELY,EMT,MALIGNANT,SNAI1,TIC,TICS
AKT,ARF,BMI1,EPIGENETIC,INK4A,PCA,PI3K,PTEN
145,169,2012,945,BINDING,BPH,COPYRIGHT,DESPITE,FUNCTIONAL,HIF,HYPOXIA,S100,UICC
2C4,ERB,ERBB2,HERCEPTIN,THUS
0001,003,014,016,022,117,158,169,179,2012,COPYRIGHT,ERG,INC,PCA,PCR,REAL,TERT,TMPRSS2,WILEY
169,2012,956,COPYRIGHT,INC,USING,WILEY
181,EGC,EGCG,HAT,THESE
FOURIER
1B1,2788,2968,4326C,4326G,CIS,ODDS,ORS,P450,PCA
PCA,THESE
ETS
HOWEVER,PSA
100,103,115,1997,2009,ALP,COX,GLEASON,MEIER,PCA,THESE
AAD,ANNEXIN,APOPTOSIS,BAX,BCL,CASPASE,GAPDH,HMGN5,INFECTION,LNCAP,PCR,TUNEL,WESTERN

000,1954,2011,AUTOPSY,DIAGNOSES,HOWEVER,ILIC,THUS
149,178,2008,2010,8804,8805,ADRS,FURTHER,HOWEVER,INFECTION,MAY,PSA,SEPTEMBER,THERE
169,188,2012,AMP,CONSISTENT,CONVERSELY,COPYRIGHT,INC,LNCAP,PKA,RHO,RHOA,ROCK,SER188ALA,THESE
120,169,2012,CONCLUSION,COPYRIGHT,FDG,LABEL,LTD,METHODS,OBJECTIVE,PERHAPS,PET,RESULTS,SUV
169,2012,CONCORDANT,COPYRIGHT,HENCE,INC,THESE
169,2012,375,400,8805,BAX,CAP,CONCLUSION,COPYRIGHT,EXISULIND,GLEASON,INC,LABEL,MEN,METHODS,OBJECTIVE,PTEN,PUBLISHED,RESULTS,THERE
169,2012,COPYRIGHT,DESPITE,INC,MINOR
0001,001,053,169,1991,2005,2013,215,318,410,564,622,642,650,756,765,801,811X,8804,891X,960,AVERAGE,CAP,COMPARISON,COPYRIGHT,DATA,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,OBJECTIVES,PEARSON,PSA,RESULTS,RRP,TRUS,UNIVERSITY,UPON
167,169,1995,2008,2012,2024,546,603,838,8804,APRIL,CONCLUSION,COPYRIGHT,HIGH,INC,JUNE,LABEL,MATERIALS,MEIER,MEN,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE
169,2012,COPYRIGHT,HOWEVER,LTD,OVERALL,PSA,THEREFORE,ULTIMATELY
169,174,2012,250,C30,COPYRIGHT,EDUCATION,EULEXIN,FLUTAMIDE,INC,LABEL,MATERIALS,METHODS,MONITORING,OBJECTIVE,ONPHASE,PR25,PUBLISHED,PURPOSE,QLQ,RESULTS,THERAPY,UROLOGICAL
169,2012,AUTHORS,BJU,GLEASON,LABEL,METHODS,NONE,OBJECTIVE,PET,PSA,RESULTS
169,2012,BACKGROUND,CNA,CNAS,COPYRIGHT,HOWEVER,LABEL,METHODS,OBJECTIVE,OUTCOME,PCA,PUBLISHED,RESULTS,SNV,SWE,TEN,UROLOGY
0001,0011,018,130,133,169,2000,2003,2012,25MG,264,750,ADT,ASTRO,BACKGROUND,COPYRIGHT,COX,FLUTAMIDE,LABEL,MARCH,MEIER,METHODS,OBJECTIVE,OUTCOME,OVERALL,PFS,PHOENIX,PUBLISHED,RADIOLOGY,RESULTS,SECONDARY,SETTING,SOCIETY,UROLOGY
042,169,173,2012,383,8226,ADT,AUTHORS,BJU,C30,LABEL,LEVEL,METHODS,OBJECTIVE,PCA,PSA,QLQ,RCT,RESULTS,SECONDARY,THERAPY,TYPE,UNLABELLED,WHAT
0001,001,169,2012,AFTER,BACKGROUND,BES,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,NEITHER,OPTIMAL,PERSISTING,PSA,RESULTS,TAM,TAMOXIFEN
100,169,2012,8226,8805,ACUTE,BJU,BONFERRONI,CUMULATIVE,EACH,INDICES,LABEL,LEVEL,METHODS,OBJECTIVE,OVERALL,PATIENT,QOL,RESULTS,SYMPTOM,THERAPY,THESE,TYPE,UNLABELLED,URINARY,WHAT
169,2000,2009,2012,ABSTRACTS,ADDITIONAL,AUTHORS,BJU,DARE,EFFECTS,JANUARY,KNOWLEDGE,LABEL,LVI,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,OVID,PSA,RESULTS,REVIEWS,SCHOLAR,SYSTEMATIC,WEB
001,169,2004,2006,2012,366,373,8226,95TH,AFRICAN,BECKMAN,BJU,CAUCASIAN,CONCLUSION,COULTER,DEFENSE,DEPARTMENT,DIAGNOSTIC,HYBRITECH,LABEL,LEVEL,MATERIALS,METHODS,OBJECTIVE,PSA,RESULTS,TYPE,UNLABELLED,USING,WHAT
2013,FOUR,FURTHER,GERMANY,MEANWHILE,QALY,SRE,SRES,THESE,WHILE,ZOLEDRONIC
169,175,177,182,2012,240,8226,8805,ADT,BJU,BOTH,DECREASES,DEGARELIX,GHRH,GNRH,INDEX,IPSS,KEY,LABEL,LEVEL,LHRH,LUTS,MEDICAL,METHODS,OBJECTIVE,PCA,PSA,QOL,RCT,RESULTS,SCORE,SYMPTOM,THERAPY,TPV,TYPE,UNLABELLED,WHAT,WHILE
169,2012,AFRICAN,BLACKWELL,DIGITAL,FVIII,LTD,PSA,PUBLISHING,VIII
AFTER,BLP,EGF,III,PHASE,THUS
HOWEVER,MEN
223,AACR,AREAS,ASCO,AUA,BACKGROUND,BONE,COVERED,ESMO,HOWEVER,III,LABEL,METHODS,OPINION,PHASE,THEREFORE
946,ACTIVATION,ADRENERGIC,ARRESTIN2,ARS,RHOA,THESE,UPON
AFP,GOLGI,GP73,HCC,HOWEVER
008,114,1260,1331,1993,1995,2011,BACKGROUND,CONCLUSION,CYP24A1,CYP27A1,CYP27B1,LABEL,MARCH,MEN,METHODS,PATHWAY,RESULTS,RXRA,SNP,SNPS,TESTS,VDR
101,169,2012,ACTIVATED,AMONG,BACKGROUND,COPYRIGHT,ESI,HOWEVER,IONIZATION,JOHN,LABEL,LTD,MASS,METHODS,NIST,PSA,RATIONALE,RESULTS,SACI,SONS,SURFACE,THEREFORE,WILEY,XCMS
169,2012,COLLEGE,COPYRIGHT,DWI,LTD,MRI,PUBLISHED,ROYAL,THERE
100,ASM,ASMS,ROUSSON
3LN5,8201,945,BACKGROUND,CONCLUSION,HIF,HYPOXIA,INCREASED,LABEL,METHODS,MYC,NSC,ORTHOTOPIC,RESULTS,TREATMENT
117,131,169,186,1997,2003,2012,206,248,274,280,298,392,554,852,BETWEEN,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,MAY,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THERE,UROLOGICAL
169,2004,2010,2012,308,374,413,709,961,BOARD,COPYRIGHT,EDUCATION,INC,IQR,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THESE,TOTAL,UROLOGICAL,UROLOGY,WHILE
001,169,2002,2010,2012,212,255,298,414,687,COPYRIGHT,EDUCATION,GLEASON,GRADING,INC,KAPPA,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THERE,THUS,UPGRADING,UROLOGICAL
169,2002,2009,2012,427,642,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
137,169,2012,257,265,775,95TH,COPYRIGHT,EDUCATION,INC,LABEL,LOWER,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
001,017,123,169,1988,2010,2012,211,251,365,739,COPYRIGHT,COX,EDUCATION,EQUAL,GLEASON,INC,LABEL,MATERIALS,MEIER,MEN,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THEREFORE,UROLOGICAL
015,169,177,2012,245,331,COPYRIGHT,CORE,EDUCATION,HOWEVER,INC,INCREASING,LABEL,MATERIALS,MEAN,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THUS,UROLOGICAL
0005,001,002,045,049,169,2012,204,ADULT,COPYRIGHT,COX,EDUCATION,EVALUATION,FINE,GLEASON,GRAY,INC,LABEL,MATERIALS,MEN,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,T2BN0M0,UROLOGICAL
027,160,169,175,178,2012,353,COPYRIGHT,EACH,EDUCATION,IMAGING,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,REAL,RESULTS,SIX,SUSPICIOUS,UROLOGICAL
132,169,2004,2006,2012,606,AMICO,COPYRIGHT,EDUCATION,END,EXCLUSION,GLEASON,INC,LABEL,MATERIALS,MEN,METHODS,OBJECTIVE,PSA,PUBLISHED,PURPOSE,RESULTS,SEER,THERE,THOSE,UROLOGICAL
0001,0077,0094,0103,01876,0212,0245,0499,169,2012,8804,COPYRIGHT,EDUCATION,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SIZE,THERE,UROLOGICAL
101,169,2002,2007,2012,AUSTRALIAN,AUTHORS,BACKGROUND,BETWEEN,COLLEGE,EBRT,HDR,IMAGING,JOURNAL,LABEL,MEDICAL,METHODS,MOST,POTENCY,RADIATION,RESULTS,ROYAL,SIXTY,ZEALAND
169,2012,AUSTRALIAN,AUTHORS,COLLEGE,IMAGING,IMRT,JOURNAL,LABEL,MATERIALS,MEDICAL,METHODS,OAR,OBJECTIVE,PLANS,PURPOSE,RADIATION,RESULTS,ROYAL,THERE,VMAT,ZEALAND
169,2012,COPYRIGHT,INC,RELATED,THROUGH,UNDER
PSMA,RBI1033,REMOVAL
145,169,2012,945,954,BMS345541,COPYRIGHT,FINALLY,HOWEVER,IKK,IKK1,IKK2,INC,NEOPLASIA,PC3,PCA,PRESS,SIMILAR,TAKEN
006,026,12Q21,15Q21,215,800,903,945,946,ANTIGEN,BECAUSE,CAUCASIAN,CHROMOSOME,CNVS,COPY,PSA,SCREENING,THESE,TYROL
0001,008,100,1031,2001,2002,2005,250,398,8804,AFFAIRS,AFTER,BACKGROUND,CONTEXT,COX,HOWEVER,JANUARY,LABEL,LARGE,LOW,MAIN,MEASURE,METHODS,NORTHWEST,OBJECTIVE,OUTCOME,RESULTS,SETTING,THESE,TOTAL
169,2012,AACR,ARS,CURRENT,FKBP5,MEL,PSA,T877A,W741C
946,APC,BINDING,CELL,GSK,HOWEVER,SMAD7,TGF
102,169,183,191,297,AZA,EPIGENETIC,FUNCTIONAL,GEORG,IGF,M12,P69,PITX2,STUTTGART,YORK
169,2012,BACKGROUND,COPYRIGHT,INC,INHIBITION,LABEL,METHODS,MMP,OPN,OPNA,OPNB,OPNC,PCA,PCR,PI3K,RESULTS,THESE,VEGF,WILEY
169,181,2012,BASED,COPYRIGHT,HOWEVER,III,INC,LNCAP,NAD,WILEY
004,037,052,101,325,ADDITIONAL,ASSESSMENT,BACKGROUND,CONCLUSION,GROUP,LABEL,METHODS,OBJECTIVE,RESULTS,SCALE,SYMPTOM,THERE,URLS,WEB,WEBCHOICE
244,248,AFRICAN,AMERICANS,BACKGROUND,CONCLUSION,FACTORS,KEY,LABEL,MEASURING,METHODS,MHQOL,OBJECTIVE,OTHER,PHQOL,QOL,RESULTS,TELEPHONE
100,177,181,183,8320,8325,A459,A549,CANDIDA,GEORG,H37RV,HELA,MCF,MIC,MRSA,PLA,PLA1,PLA2,PLA3,PLA4,POLYGONUM,STUTTGART,THP,VRE,YORK
100,945,AMACR,BESIDES,CD10,KIT,KSP,NAS,OTHER
166,TMEM166,VARYING
EARLY,MINIMALLY,NOTES,WHILE
1990,2004,HODGKIN,MORTALITY,THERE

001,0047,215,65285,65308,65309,951,ADC,DIFFUSION,DWI,MEAN,MRI,T2WI
000,2011,241,956,ALSO,AMONG,ARCAP,BACKGROUND,CONCLUSION,CPG,EMT,GENISTEIN,H3K9,HAT1,LABEL,METHODS,RESULTS,TNF,USING,WNT
169,2012,ASA,COPYRIGHT,GLUCOSE,LTD,PANC,PC3,SKBR3
009,100,103,110,125,145,169,185,1998,2003,2012,204,239,8804,CITY,COPYRIGHT,D90,GLEASON,INC,LABEL,MARY,MATERIALS,MEDICAL,METHODS,NCCN,NETWORK,OBJECTIVE,PNI,PRFS,PSA,PURPOSE,RECORDS,RENO,RESULTS,TAHOE,TREATMENT,VARIABLES
0001,0002,002,003,005,169,179,2012,238,8805,COPYRIGHT,EXPRESSION,GLEASON,HIGH,INC,KI67,KU70,KU80,LABEL,METHODS,OBJECTIVE,PHOENIX,PKCS,PURPOSE,RESULTS
221,946,PCL,PEG,PI3K,PSMA,PSMAA10,PTEN,TGX,THESE
22RV1,8764,946,ELISA,PSMA,PTPRF,THESE
945,AFP,CDS,CEA,ECL,ITO,PDMS,PSA,RET,USB
CONTROL,DTX,HPMA,PSMA
465,788,795,885,DESI,DESORPTION,PCA,THESE
239,BACKGROUND,CD25,CD4,CD8,DBY,FINALLY,FURTHER,LABEL,MHC,PRINCIPAL,RESULTS,SPAS,TRAMP
0066,19A,727,8202,BACKGROUND,LABEL,MEANS,PCR,PRINCIPAL,RESULTS,RING,SAMPLES,TRANSCRIPT
552,946,CHIP,CHROMATIN,DU145,EGFR,ERK1,GSK3,HOWEVER,SER,STAT3,WNT
001,002,100,ADT,AFTER,BMD,CONCLUSION,DUAL,DXA,FIFTY,FRACTURES,IAD,LABEL,MEN,METHODS,OBJECTIVE,PURPOSE,RESULTS,SUBSEQUENT
104,2007,2009,ASOC,BACKGROUND,CONCLUSION,LABEL,METHODS,PCEA,POTENTIAL,RESULTS
0001,0008,003,007,008,8804,AIM,BECAUSE,CONCLUSION,EMPIRICAL,FSH,GLEASON,HOWEVER,LABEL,METHODS,OBJECTIVE,PRL,PSA,RESULTS,TRUSB
BACKGROUND,CONCLUSION,EXPRESSION,FURTHER,HTR1A,HTR1B,HTR2B,HTR4,LABEL,MATERIALS,METHODS,RESULTS
BRCA1,FINALLY,LIMK2,MOST,S283,T494,T505
000,2001,2004,2007,IMRT
2007,FEDERAL,THESE
2004,2005,HOWEVER,SIMILARLY
173,1983,1999,598,627,THESE
FORTY,SIX
169,2012,8201,BACKGROUND,COPYRIGHT,JOHN,LABEL,LTD,METHODS,MRI,RESULTS,SNR,SONS,WILEY
FINALLY,THESE
017,035,044,BACKGROUND,FORTY,INITIAL,LABEL,LHRH,MAB,MANN,METHODS,PSA,RESULTS,THERE,TTP,WHITNEY,ZOL
100,DTXL,FINALLY,NPS,TNP
000,169,2012,AACR,AKT,ATG12,ATG5,BECLIN1,HOWEVER,LC3,PI3K,THESE,THROUGH
248,361,576,995,ENGLAND,EQUIVALENT,INCIDENCE,JOINT,LABEL,LINKAGE,MAIN,METHODS,NHS,NJR,OBJECTIVE,OUTCOME,RESULTS,SETTING,SIMILARLY,THESE,WALES
169,2012,947,948,ATM,BAD,BAX,COPYRIGHT,H2A,HRPC,HRPCS,INC,PKC,ROTTLERIN,SER1981,USING
945,947,948,DOES,HOWEVER,PREVENTION,TRIAL,VITAMIN
177,207,369,400,419,737,ABT,APOPTOSIS,BAX,BCL,CELL,DAPI,DOCETAXEL,LABEL,MCL,METHODS,MTT,OBJECTIVE,RESULTS,WESTERN
002,012,023,029,068,149,177,181,200,2006,2011,205,380,707,749,766,8805,AFTER,AUC,CHINESE,CRPC,LABEL,LOW,METHODS,OBJECTIVE,PSA,RESULTS
100,945,CONCLUSION,GRADE,LABEL,METHODS,OBJECTIVE,RESULTS,SMA
100,141,181,2009,2010,8804,8805,BETWEEN,CONCLUSION,JANUARY,LABEL,MDWI,METHODS,MRDWI,OBJECTIVE,PSA,RESULTS,THEN,TRUS
0002,001,0016,0027,0037,1103,144,174,177,2008,2010,217,333,357,616,636,CLAVIEN,CONCLUSION,GLEASON,JULY,LABEL,MEAN,METHODS,OBJECTIVE,OPERATIVE,PURPOSE,RALP,RESULTS,RRP,SOCIETY,TURP
APY,EPH,EPHA4,ISOTHERMAL,KYL,NMR,THUS,VTM
CAP,SCANO
125,168,312,DAR,DIGITAL,FDG,HENCE,LNCAP,MICE,PCA,PSA,PSA30
AIM,CONCLUSION,LABEL,METHODS,MRI,OBJECTIVE,PSA,RESULTS
ADDITIONAL,HIGH,S100
169,2012,945,946,957,AAZTA,BECAUSE,COPYRIGHT,DB58,DOA3,DOTA,DPTA,GMBH,KGAA,MOLECULAR,MRI,PET,RGD,THESE,VCH,WILEY
169,2012,AFTER,AIMS,COMPARING,COPYRIGHT,INC,LABEL,METHODS,MUCP,NON,OBJECTIVE,PFME,RESULTS,RRP,SIXTY,UPP,WILEY
169,2012,COPYRIGHT,DCE,HOWEVER,INC,IVIM,MRI,THERE,THESE,THUS,WILEY
015,047,169,2012,8201,CONCLUSION,COPYRIGHT,DOA,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,PFME,PRPI,QMAX,RESULTS,RRP,SIXTY,THEREFORE,URA,WILEY
160,COLORECTAL,LABEL,LUNG,METHODS,OBJECTIVE,OVARIAN,PLCO,PURPOSE,RESULTS,SIMULATED,UNDER,WHILE
CHINESE,LABEL,METHODS,MODEL,OBJECTIVE,PCA,RESULTS
021,255,945,946,ABHD4,AFTER,FAK,FLIP,HOWEVER,INDUCTION,NP69,PARP,RWPE,SRC,THUS
AFTER,CHANGES,COX,HIGH,LABEL,MEIER,METHODS,MULTI,OBJECTIVE,PAGE,PCA,PSA,PURPOSE,RESULTS
169,2012,8201,BACKGROUND,COPYRIGHT,CTT,DECREASING,HIGH,INC,LABEL,LNCAP,METHODS,PCTCS,PEG,PSMA,RESULTS,WBCS,WILEY
152,1997,2002,2003,2008,AIM,CD117,CONCLUSION,EARLY,GIST,GISTS,JANUARY,KIT,LABEL,METHODS,OBJECTIVE,POST,PRE,RESULTS,SURGERY,THESE
120,182,1994,2009,226,356,8804,ABLATHERM,ACTUARIAL,AMICO,BACKGROUND,CENTRES,DISEASE,EDAP,HIFU,LABEL,METHODS,PHOENIX,PSA,RESULTS,TMS,WHOLE
DATA,GREATER,HOWEVER,QOL,THESE
130,169,2012,GLEASON,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RADICAL,RESULTS,T3A,T3B,THUS,UROLOGICAL
001,004,010,049,169,1996,2009,2012,286,8804,8805,CONCLUSION,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SHORTER,STRATIFIED,UROLOGICAL
001,012,119,124,150,169,1710,1988,2010,2012,226,238,275,281,330,580,8805,ACCORDING,ADD,APRIL,AUTHORS,BCR,BJU,CONCLUSION,COX,CSS,DOES,GLEASON,HOWEVER,JULY,KNOWN,LABEL,LNS,MEIER,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,PLND,PSA,RESULTS,SIMILARLY,SUBJECT,UNLABELLED,WHAT
169,185,2012,A11,BLACKWELL,BW4,HLA,KIR,LTD,NATURAL,PCR,PUBLISHING,SSP
SECONDARY,THESE,TREATMENT
1342,144,18F,2003,2010,2115,241,532,AMONG,BACKGROUND,BNC,LABEL,MEAN,METHODS,MIRP,OBJECTIVE,PCA,PURPOSE,RESULTS,THEIR,TURP,VAN,VELTHOVEN,VVT
003,008,015,1732,1780,215,ASIAN,BACKGROUND,BMAL1,CRY1,CRY2,DIAGRAM,DISRUPTION,KINGDOM,LABEL,META,NEITHER,NONE,PER2,PRINCIPAL,PUNJABI,RESULTS,SAT2D,SNP,SNPS,SOUTH
100,1128,177,376,CRANIAL,CTV,D100,D90,HDR,HOWEVER,ISBT,USING
BAX,BCL,CDK4,DU145,ETHANOL,EUR,LNCAP,PCNA,RCM,RUBUS
4T1,945,946,954,AKT,BALB,CCL2,CHEMOKINES,IKB,LUC,LUC2,MCP,OVERALL,TGF
CHIP,FURTHER,HOWEVER,MYC,NKX3
ATM,ATR,HOWEVER,NKG2D
169,2012,946,COPYRIGHT,PCR,POTENTIAL,SEVERAL,THUS
COMPETING,DIC,GIBBS,LPML,VARIOUS
169,2012,CD44,COPYRIGHT,CSC,CSCS,FURTHER,GENISTEIN,GLI1,IRELAND,LTD,PCA,TCS,THEREFORE
16Q23,A549,HOWEVER,THESE,WWOX
947,BPH,CURRENTLY,DU145,LNCAP,OLEA,OLEUROPEIN,OXIDATIVE
100,1534,169,192,1990,2001,2012,207,332,449,497,8378,8805,995,AMONG,COPYRIGHT,CSS,EVEN,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS
169,177,2012,486,AFTER,COPYRIGHT,CTV,DOSIMETRIC,IMRT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SNS
169,2012,ANORECTUM,BLADDER,COLON,CONSENSUS,COPYRIGHT,FEMUR_L,FEMUR_R,GROUP,IMAGE,INC,LABEL,MATERIALS,MESORECTUM,METHODS,NOS,OBJECTIVE,PENILEBULB,PURPOSE,RADIATION,RESULTS,RTOG,SMALLBOWEL,THERAPY,THESE,WEB
169,2011,241,AEEH,AEG,COPYRIGHT,DIAGNOSIS,ESPA,FEW
169,2012,BECAUSE,COPYRIGHT,LTD
004,10NG,169,2011,215,2424,25067,8804,AEU,AGE,COPYRIGHT,GLEASON,HOWEVER,LABEL,METHODS,OBJECTIVE,PSA,PUBLISHED,RESULTS,SCORE,T1C,THESE
048,160,166,169,200,2013,250,335,555,562,738,811,956,ACE,BACKGROUND,CONCLUSION,COPYRIGHT,CWR22,DM738,DUKE,FIVE,INC,LABEL,MANN,METHODS,MICE,RESULTS,RESV,SERUM,TREATED,WESTERN,WHITNEY
FIRST,HAAR,HENCE,LABEL,LSSM,LSSMS,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,SOI,SSM,SSMS
125,177,508,6711,774,8201,9011,ARLINGTON,AUTOMATED,CNR,HEALTHCARE,HEIGHTS,IMAGE,INC,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,ROIS,SEED,ULTRASOUND
1380,176,177,8201,AFTER,CONCLUSION,FIRST,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,PVC,RESULTS
300,ANOTHER,CBCT,HOWEVER,IGRT,LABEL,LARGE,METHODS,OBJECTIVE,PROMISING,PURPOSE,RESULTS,ROIS,SINCE,SNU
8201,CONVERSELY,DOSE,EACH,HOWEVER,IMRT,ION,LABEL,METHODS,MLC,OBJECTIVE,OFFSETS,PTV,PTVS,PURPOSE,RESULTS,SYSTEMATIC,TEN
001,100,125,145,150,200,8201,ALSO,DOSE,LABEL,LDR,METHODS,OBJECTIVE,PARAMETERS,PURPOSE,REDUCTION,RESULTS
ANOVA,EFFECTS,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
AIM,APOPTOSIS,CONCLUSION,E2F1,LABEL,LC3B,LNCAP,METHODS,OBJECTIVE,PCR,RESULTS,TFDP3,WESTERN
200,945,947,HPLC,LCMS,PARTIAL,PC3,THERE,TLC,TNF,TOF
TREATMENT
101,2010,ACCORDING,AGE,CONCLUSION,JUNE,LABEL,LRP,MARCH,METHODS,OBJECTIVE,OBJECTIVES,ORP,RESULTS,SCAR,THESE,THREE
123,158,746,CIS,CONCLUSION,EUROPEANS,LABEL,METHODS,OBJECTIVE,ODDS,ORS,PSCA,PURPOSE,RESULTS,SIMILAR,THESE,UNASSIGNED
177,956
169,2012,COPYRIGHT,OPERATIVE,OTHER,PUBLISHED,ROBOT,ROBOTIC,SAS
160,169,2012,ASP,BOTH,COPYRIGHT,GLP,GLY,GNRH,III,LNCAP,LYS,MAC,MCF,MONO,PRO,SAS,SER,THEIR,THESE,TRP
293,CHO,ENV,HIV,HOWEVER,MOMLV,NOTICEABLY,XENOTROPIC,XMRV,XPR1
CRPC,EXPRESSION,LABEL,LENTIVIRAL,LIN28,METHODS,OBJECTIVE,PCA,PCR,PURPOSE,RESULTS,THESE
001,002,106,2063,AAS,ACCURATELY,AFRICAN,ASIAN,BACKGROUND,BLACK,CAJUN,CAP,CAUCASIAN,INDIVIDUAL,LABEL,LOUISIANA,MEAN,METHODS,NORTH,PCAP,PRINCIPAL,PROJECT,RACE,RESULTS,THESE,WHITE
174,2011,AVENTIS,COMMISSION,JEVTANA,MARCH,MEDICINES,PARIS,UNION,WEB
MOST,PSA,THEREFORE
ALP,BM22,C30,CONCLUSION,EORTC,LABEL,MATERIALS,MBQ,METHODS,OBJECTIVE,PSA,PURPOSE,QLQ,QOL,RESULTS,VAS
151,2005,2010,BETWEEN,BOTH,CONCLUSION,HOWEVER,JANUARY,LABEL,MATERIALS,MAY,METHODS,MRI,OBJECTIVE,OVERALL,PURPOSE,RESULTS,SEVERAL,TESLA,THERE
001,1302,1582,1995,2003,2004,2007,280,8804,CONCLUSION,GLEASON,GROUP,HOWEVER,KOREA,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,WESTERN
ADT,THERE,THESE
CHOLINE,DESPITE,PET,SENSITIVE
8805,AFTER,BACKGROUND,LABEL,LESIONS,METHODS,MRI,RESULTS
1985,2011,240,40S,50S,720,890,BACKGROUND,CONCLUSION,END,INSTITUTE,LABEL,MAJOR,METHODS,OUTCOME,PROGRAM,PSA,RESULTS,SINCE,SOCIETY,WHILE
99M,BECAUSE,BONE,EXTENSIVE,FDG,LIVER,PET
141,152,183,192,22RV1,425,CURCUMA,DDX39,DIGE,DUE,FKBP4,FURTHER,HMGB1,MALDI,NPM1,PPP2R1A,RBM17,TAKEN,TOF
169,174,2012,308,511,8804,ADT,BACKGROUND,COPYRIGHT,FATIGUE,IL1B,IL6,INC,LABEL,METHODS,RESULTS,SNPS,THESE,TNFA
154,169,2012,BECAUSE,COPYRIGHT,FINALLY,KENNARD,LARGE,PCA,STONE
027,1482,175,327,573,CKLF,CMTM5,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,VEGF
184,189,292,CONCLUSION,HIPAA,LABEL,MATERIALS,METHODS,OBJECTIVE,POSTBIOPSY,PPV,PURPOSE,READERS,RESULTS
BOARD,CONCLUSION,LABEL,MATERIALS,MEANS,METHODS,OBJECTIVE,ONTARIO,PURPOSE,RESULTS,RIGID,UNIVERSITY,WESTERN
1990S,8Q21,HOWEVER,SNP,SNPS,THEIR
947,CD122,CD25,CD4,CD8,COMBINING,CTLA,FINDING,HOWEVER,IFN,THUS,TRAMP

117,161,340,435,945,946,AJS,BINDING,DLC1,GAP,GTP,GTPASES,MALIGNANT,RHO,THEIR,THESE
000,169,2012,8201,BACKGROUND,COPYRIGHT,FURTHER,INC,KI67,LABEL,METHODS,NRBP1,RESULTS,RNAI,TMA,TMAS,TSC,WILEY
169,2012,945,BACKGROUND,BCL,CONCLUSION,COPYRIGHT,EXPRESSION,HIF,HOWEVER,IHC,INC,LABEL,LNCAP,MATRIGELS,METHODS,PARP1,PCR,RESULTS,THESE,VEGF,VETSPON,WILEY
135B,169,2012,203,BACKGROUND,CELLS,CHIP,COPYRIGHT,DBD,EFFECTS,EMT,HOWEVER,INC,LABEL,LAPC4,LNCAP,METHODS,MUC1,PCR,PSA,RESULTS,THESE,WILEY
169,2012,572,8201,AMINE,BACKGROUND,CAUCASIAN,COPYRIGHT,INC,LABEL,MAOA,METHODS,PCA,RESULTS,VNTR,WILEY
169,2012,945,BACKGROUND,CALCIUM,CALPAIN,COPYRIGHT,FAK,FOCAL,GAP,INC,IONOMYCIN,LABEL,LPA,METHODS,NCK,PKC,RAS,RAT,RESULTS,WILEY
099,160,169,183,2635,8364,AUSTRIA,CONCLUSION,GEORG,GERMANY,LABEL,MATERIALS,METHODS,OBJECTIVE,PCA,PURPOSE,QALYS,RESULTS,STUTTGART,YORK
145,169,200,2012,8201,945,946,AKT,COPYRIGHT,FINALLY,HDAC,IFNA,INC,LNCAP,MOLECULAR,MTT,NOD,SCID,VPA,WILEY
169,2012,BACKGROUND,COPYRIGHT,HMW,INC,LABEL,METHODS,NRS,NUCLEAR,RESULTS,STRIKINGLY,VDR,VITAMIN,WILEY
ARI,ARIS,DRUG,FOOD,LABEL,OBJECTIVE,PCA,PURPOSE,RESULTS,SUMMARY,THESE
BECAUSE,LABEL,OBJECTIVE,PURPOSE,RESULTS,SCREENING,SUMMARY
CRPC,DRUG,FOOD,LABEL,NOVEL,OBJECTIVE,PURPOSE,RESULTS,SIMILARLY,SUMMARY
III,LABEL,MDV3100,NOVEL,OBJECTIVE,PURPOSE,RESULTS,SUMMARY
2011,946,CARDIOL,CELL,HIC,HOWEVER,KIM,MOL,THUS
8804,ARSENIC,BACKGROUND,CSC,CSCS,INORGANIC,LABEL,MALIGNANT,MEC,MECS,METHODS,MMP,MMPS,NONCONTACT,NSC,NSCS,OBJECTIVE,PTEN,RESULTS,TRANSWELL,WESTERN,WPE
169,2012,CELL,COPYRIGHT,CROWN,EIT,EPITHELIAL,HOWEVER,PUBLISHED,THERE,TRANSITION
177,641,ART,BACKGROUND,IMRT,INTENSITY,LABEL,METHODS,RADIATION,RESULTS,SYSTEMATIC,THERAPY
240,BACKGROUND,DISCUSSION,HIT,LABEL,METHODS,PET,TOMOGRAPHY,TRIAL
1434,155,2005,2007,293,5TH,695,8805,95TH,AUSTRALIAN,CHINA,CONCORD,DRE,IRELAND,ITALY,JANUARY,JUNE,KINGDOM,LABEL,MAIN,MEN,METHODS,OBJECTIVE,OUTCOME,PROJECT,PSA,RESULTS,SERUM,SETTING
AIMS,BACKGROUND,BOTH,INDEX,LABEL,METHODS,OBJECTIVE,POPULATION,RESULTS,SOUND,UPDB,UTAH
2010,DEPARTMENT,THERE
100,DESPITE,HPV16,SERUM,THEREFORE,XMRV
946,ABR,ALSO,C57BL,CD11B,CD68,DELAYED,EL4,PCR,RAGE,TGF,THUS,TLR4,TRAMP
945,BACKGROUND,BIP,CDK,CHOP,GADD153,GRP78,IRE1,JNK,JNK1,LABEL,LNCAP,METHODS,NOD,PRINCIPAL,RESULTS,SCID,SEVERAL,THUS
946,956,HEP,HOWEVER,ORAL,SIMILAR,VEGF
169,2008,2011,2012,ABOL,CCD,CONCLUSION,COPYRIGHT,ENEIN,GHONEIM,HOWEVER,ILEAL,INC,LABEL,METHODS,MONTI,OBJECTIVE,RESULTS,WALLACE,YANG
001,003,169,1999,2008,2012,621,699,APV,CONCLUSION,COPYRIGHT,FIRST,FLORIDA,INC,LABEL,METHODS,OBJECTIVE,RESULTS
169,2012,COPYRIGHT,FLORIDA,LTD,NORTH,ZIP
169,174,2012,ACR,COLLEGE,COPYRIGHT,GUIDELINES,IMAGE,INC,PUBLISHED,RADIOLOGY
ADIPOCYTE,BACKGROUND,CONVERSELY,LABEL,LNCAP,METHODS,MMP2,MMP9,MMPS,OBESITY,RESULTS,SVF,THUS,VIS
169,2012,BLACKWELL,GIVEN,LTD,PSA,PUBLISHING,TFNAB,THERE,THESE,THUS
169,2012,945,AKT,BLACKWELL,CHANGES,CONVERSELY,DU145,EGFR,EXPRESSION,LABEL,LTD,MATERIALS,METHODS,MTT,OBJECTIVE,OBJECTIVES,PCR,PI3K,PUBLISHING,RESULTS,RNAI,SOX2,TGF
169,2012,239,289,AUSTRALIA,AUTHORS,BJU,CROSS,DRE,LABEL,MEN,METHODS,MOST,OBJECTIVE,PSA,QUEENSLAND,RESULTS,THERE
165,169,2012,236,AUTHORS,BJU,BLAND,CALCULATED,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,TRUS
169,2012,AUTHORS,BJU,LABEL,MEN,METHODS,OBJECTIVE,PATIENT,PSA,RESULTS,TRUS
169,200,2000,2005,2012,8805,AUSTRALIAN,AUTHORS,BJU,GLEASON,LABEL,METHODS,OBJECTIVE,OVERALL,PLND,PPC,PSA,RESULTS,TREND
154,169,2012,ACTUARIAL,AUSTRALIAN,AUTHORS,BJU,CONCLUSION,GLEASON,LABEL,MEN,METHODS,OBJECTIVE,PSA,RESULTS,WHILE
169,1990,2012,945,ALSO,AMACR,AUTHORS,BJU,HGPIN,MOST,PIN,WHAT
001,8211,8804,8805,982,AUC,BACKGROUND,CART,GLEASON,HIGH,LABEL,LNI,LOW,LYMPH,MATERIALS,METHODS,PCA,PLND,PSA,RESULTS
1000,118,11Q13,122,166,2010,642,644,690,755,765,8212,8805,BACKGROUND,CEPH,GENOMES,INCREASING,LABEL,METHODS,OCTOBER,PILOT,RESULTS,SNP,SNPS,YRI
231,CDC42,ERM,EZRIN,GEF,GEFS,MDA,PC3,RAC,RAC1,RADIXIN,RHOA,SIMILAR,VAV
147,160,324,756,DIAGNOSIS,HIGH,LABEL,METHODS,OBESITY,OBJECTIVE,RESULTS
946,947,AGR2,AKT,CHINESE,CIP1,DU145,ERK,FURTHER,GAL,H2AX,HAN,INK4A,KIP1,KNOCKDOWN,LNCAP,PC3,PCA,PI3K,PTEN,SENESCENT,THUS
169,2012,6Q15,800,946,AACR,GLEASON,TAK1,TGF
662,680,685,689,719,725,732,8226,859,8804,8805,887,954,ADC,AUCS,DATA,DIAGNOSTIC,DWI,FIFTY,GLEASON,KEY,LABEL,METHODS,MRI,OBJECTIVE,OBJECTIVES,RESULTS,T2WI
BISCHIP,CPG,NOTABLY
AMAZINGLY,BECAUSE,EXPRESSION,NKX3,PCA,PECS,PTF,T164A,TFS,THESE
004,019,043,142,169,2012,247,AACR,GLEASON,HYPOXIA,LABEL,METHODS,OBJECTIVE,PROSTRATE,PURPOSE,RESULTS
145,169,2012,COPYRIGHT,DMPC,DSC,INC
169,201,2012,231,ANTIGEN,COPYRIGHT,MRI,PROSTATIC,PSA,PUBLISHED,SAS,USING
169,201,2012,231,COPYRIGHT,MRI,PUBLISHED,SAS
001,002,003,004,100,142,145,169,177,2012,233,251,253,275,316,425,452,613,630,641,701,710,763,956,ANTI,AQUEOUS,ASTERACEAE,AT3B,BACKGROUND,BENTH,CONCLUSION,COPYRIGHT,DOCETAXEL,IRELAND,LABEL,LTD,MATERIALS,METHODS,PACLITAXEL,RELEVANCE,RESULTS,WST
169,2012,945,ADT,ALSO,ARI,BPH,CASTRATION,COPYRIGHT,CTP17A1,DHT,EVERY,GNRH,HOWEVER,IAD,INCREASING,IRELAND,LTD,MAB,MDV3100,PSA,PUBLISHED,REDUCTASE,THERE
169,201,2012,231,COPYRIGHT,PUBLISHED,SAS,URO
169,201,2012,231,2NG,COPYRIGHT,MRI,PSA,PUBLISHED,SAS,SINCE,THERE
10NG,128GY,169,2001,2006,2012,32NG,4GY,6GY,70GY,8804,8805,945,946,9GY,COPYRIGHT,GLEASON,GRADE,HDR,IMRT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PHASE,PHOENIX,PSA,PUBLISHED,PURPOSE,RADIOLOGY,RESULTS,SOCIETY,T2B,THERE,TREATMENT
072,100,169,2013,COPYRIGHT,FORTY,GLEASON,HOWEVER,INC,LABEL,MATERIALS,METHODS,MRI,NPV,OBJECTIVE,PPV,PSA,RESULTS,THERE,THESE
169,2011,231,AEU,BOTH,COPYRIGHT,D541E,GLEASON,I97L,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PSA,PUBLISHED,R462Q,RESULTS
101,109,150,169,2011,241,561,750,937,945,AEU,COPYRIGHT,ESPA,LABEL,MEAN,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,SOCIO,SPANISH,TNM,VALIDATION
1386,2001,2002,940,AMONG,CAPS,FFQ,FOUR,INDIVIDUAL,LABEL,METHODS,NNR,NUTRITION,OBJECTIVE,POPULATION,RESULTS,SETTING,SWEDISH,USING
100,132,169,2012,483,8886,AIMS,BLACKWELL,ERG,ETS,LABEL,LTD,METHODS,OBJECTIVE,PUBLISHING,RESULTS,TMPRSS2,WEAK
0001,0408,256,2593,2862,3208,3642,464,5847,6990,8805,AMONGST,LABEL,METHODS,OBJECTIVE,PPPM,RESULTS,TOTAL
22RV1,ASSAY,BACKGROUND,CRPC,DBD,EFFECTS,EOS,GENERATION,INHIBITION,LABEL,LNCAP,METHODS,MODULATION,MTT,PCA,RESULTS,WNT
169,2012,8226,AMERICA,AUTHORS,BJU,CONSENSUS,CURRENTLY,DOPPLER,FOCAL,HOWEVER,NEWER,NORTH,SYSTEMATIC,TRUS,UROLOGICAL,WHAT
ABL,BACKGROUND,BCR,CELL,COLON,CRK,JNK,K562,LABEL,LNCAP,MAPK,METHODS,MTT,NEXT,PC3,PROTEIN,RESULTS,SW480,THROUGH,TNF,TRAIL,WESTERN
000,001,100,195,2011,390,AGE,ASIAN,BACKGROUND,CONCLUSION,DATA,FARMERS,INMOL,INSTITUTE,LABEL,LADY,LEVEL,METHODS,NUCLEAR,OCTOBER,ODDS,PAKISTANI,READING,RED,RESULTS,SHAUKAT
2012,AGING,CONGRES,COPYRIGHT,EAU,FOUR,PARIS,PROUS,SCIENCE,UPON,UROLOGY
HOWEVER,PSA,SINCE,YET
BOTH,DU145,EXPRESSION,GPX3,HOWEVER,OPAL,PC3,PIG3,RWPE,SCID,TAKEN,THESE
AKT,EGF,ERBB2,LNCAP,OTHER,PI3K,THESE,UNDER
2009,CRR,DISEASE,GRM,GWAS,HOPKINS,INSTITUTE,JOHNS,MARKERS,SNPS,THESE
150,187,ERG,FISH,PTEN,THERE
1990,2002,574,6692,CLINICIANS,HGPIN,PSA
0001,007,COX2,HIGH,PSMA,USING
150,169,1975,1990S,1992,1999,2000,2004,2008,2012,ACS,BACKGROUND,CDC,CENTERS,CENTRAL,CONTROL,COPYRIGHT,DATA,DISEASE,INCIDENCE,INSTITUTE,LABEL,LUNG,METHODS,NCI,NORTH,PREVENTION,REGISTRIES,RESULTS,SOCIETY,STATISTICS
945,947,ACTIVATION,EFFECTS,FLOW,PC3,TG2,THESE
159,AFTER,AMONG,BPFS,CONCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS,SALVAGE,SRT,UNIVARIATE
170,5030,BACKGROUND,GIVEN,LABEL,METHODS,NINE,PSA,RESULTS,THERAPY,THESE
001,1000,169,2012,8805,9253,AFTER,BACKGROUND,BPH,COPYRIGHT,COX,DATA,DESPITE,HRS,IPSS,LABEL,MEAN,METHODS,OBJECTIVE,OUTCOME,PREVENTION,PUBLISHED,RESULTS,SCORE,SETTING,SYMPTOM,THESE,TRIAL,UROLOGY
169,2011,2013,ADDITIONAL,BACKGROUND,BARR,CANDIDA,CAP,COPYRIGHT,DESPITE,EPSTEIN,INC,LABEL,MATERIALS,MEDLINE,METHODS,RESULTS
125,169,185,187,2012,947,99M,CONCLUSION,COPYRIGHT,CYS,GLY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCID,THEIR,TYR
CTC,CTCS,THEREFORE
003,005,006,008,043,11Q13,478,AFTER,CONSORTIUM,CTBP2,GWAS,IGF,IGFBP,MSMB,SHBG,SNP,SNPS,THERE,USING
125,132,169,2000,2010,2012,961,ALSO,BETWEEN,C30,CES,CONCLUSION,COPYRIGHT,CURRENT,DEPRESSION,EORTC,FORM,HRQOL,INC,JUNE,LABEL,LIST,MATERIALS,METHODS,OBJECTIVE,PR25,PUBLISHED,PURPOSE,QLQ,RAND,RESULTS,SCALE,SHORT,SOCIETY,STUDIES,TREATMENT,UTRECHT
143,1982,2003,745,BACKGROUND,CIS,COX,CUTANEOUS,HODGKIN,LABEL,METHODS,MRR,MRRS,NHL,OVERALL,RESULTS,SCC,USING
169,1990,2011,2012,AIM,BACKGROUND,JANUARY,LABEL,MAIN,MEASURE,MEDLINE,METHODS,OBJECTIVE,OUTCOME,PSYCHINFO,RESULTS,SEPTEMBER,SOCIETY,THERE
2005,BACKGROUND,CONTEXT,DATA,GLEASON,HISTOLOGIC,ISUP,LABEL,METHODS,OBJECTIVE,PATHOLOGY,SOCIETY,SOURCES,SUBSEQUENT,UROLOGICAL
BACKGROUND,CONTEXT,DATA,HOWEVER,IDC,LABEL,METHODS,OBJECTIVE,SOURCES
BACKGROUND,CONTEXT,DATA,LABEL,LIBRARY,METHODS,MOLECULAR,OBJECTIVE,SOURCES
BACKGROUND,CAREFUL,CONTEXT,DATA,LABEL,METHODS,OBJECTIVE,OBJECTIVES,SEVERAL,SOURCES
BACKGROUND,DISCUSSION,DUAL,HOWEVER,LABEL,METHODS,PEPC,STUDIES,TRIAL
149,169,177,2006,2007,2012,AIM,BACKGROUND,BETWEEN,BLACKWELL,CONCLUSION,HOWEVER,LABEL,LTD,MEN,METHODS,OBJECTIVE,PR25,PUBLISHING,RESULTS,SEPTEMBER,TREATMENT
207,495,8202,GLEASON,PSA,Q22FS,S32X,SINCE
266,AMONG,CD151,CONCERNING,CUB,FURTHER,HOWEVER,RAB,SEVERAL,USING
0001,032,100,102,106,189,378,8805,AMONG,GLEASON,LABEL,METHODS,OBJECTIVE,RADICAL,RESULTS
160,240,273,8804,AFTER,BEST,BOTH,DEGARELIX,DOSE,III,LABEL,METHODS,OBJECTIVE,PHASE,RESULTS
0001,0366,800,8587,BONE,CONCLUSION,DWI,LABEL,METHODS,MRI,OBJECTIVE,OBJECTIVES,RESULTS,STIR
CONCLUSION,DOSE,KEEPING,LABEL,METHODS,OBJECTIVE,RESULTS
100,169,2012,8801,916,COPYRIGHT,FXL,FXR,INC,MRI,PARAMETER,PARAMETRIC,PATHOLOGY,WILEY
0449,118B,169,2012,BACKGROUND,COPYRIGHT,GDC,GLI1,INC,KI67,LABEL,MDA,METHODS,PCA,PTCH1,REDUCTION,RESULTS,SCID,SMOOTHENED,SONIC,WILEY
169,2012,ATHYMIC,BACKGROUND,BAX,BCL,CHANGES,COPYRIGHT,COX,IGFBP,INC,INCREASES,LABEL,METHODS,PCA,PGDH,RESULTS,SINCE,SOY,TRPV6,WILEY
1990,2011,900,AMONG,AUS,FIFTY,KOCK,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIGMOID,THERE,THOSE,USC
0001,042,135,175,186,1999,2005,404,533,930,AMONG,CARE,COX,LABEL,MEAN,METFORMIN,METHODS,OBJECTIVE,PCA,RESULTS,VETERAN
APOPTOSIS,LABVIEW,PC3,RELATED,TNF,TRAIL
ARBS,CHIP,CRPC,DESPITE,NOTABLY,TACC2,TAKEN,USING
FHL2,MAL,PCA,RHO,RHOA,ROCK,SILENCING,SRF,TAKEN,THUS
945,BOTH,FK506,FKBP,FKBPS,RAPAMYCIN
MALDI,MASS,PSA,TAKEN,TOF
001,0013,005,050,181,8804,CONCLUSION,DESPITE,EASTERN,GRADE,GROUP,LABEL,METHODS,OBJECTIVE,PFS,PURPOSE,RESULTS
001,1973,2007,2424,8331,AMONG,COX,END,MEIER,OVERALL,RESULTS,SIC,SICS,SMALL
ALZHEIMER,BACKGROUND,CONDITIONS,INCHIANTI,LABEL,METHODS,MOST,RESULTS,STUDIES,SUCCESSFUL
160,169,183,GEORG,STUDIES,STUTTGART,YORK
141,ALSO,CROSS,EFFECTS,PFE,RESULTS,SELF
AFTER,FULLY,SIPULEUCEL
025,1000,5000,945,956,BECAUSE,BOTH,CALCITRIOL,CYP27B1,DIETARY,MCF,THESE
001,230,CIN,HEPARANASE,HPSE2,IMAGE,LAB,LABEL,MATERIALS,METHODS,OBJECTIVE,THERE
945,954,AKT,APOPTOSIS,BAX,BCL,DU145,FURTHER,IAP,IETD,IKK,LEHD,PARP,PP2A,TUNEL
117,1995,450,8202,AMONG,DEFINITIVE,FIVE,FURTHER,GLEASON,HOWEVER,LABEL,MOST,OBJECTIVE,OVERALL,PSA,PURPOSE,RESULTS,SINCE,SUMMARY,TEN
223RADIUM,LABEL,OBJECTIVE,PURPOSE,RADIATION,RANDOMIZED,RESULTS,SUMMARY
100,2000,2006,INCLUSION,LABEL,OBJECTIVE,PRIAS,PURPOSE,RESULTS,RISK,SUMMARY,WEB
169,2012,COPYRIGHT,INHIBITING,IRELAND,LTD
169,176,2012,AUTHORS,BLACKWELL,FDA,FOUNDATION,GENISTEIN,JOURNAL,LNCAP,LTD,MOLECULAR,MTT,PUBLISHING,ROS,RPMI,TOPOTECAN,TREATMENTS
003,005,015,169,2012,219,8804,967,AACR,COX,CYP26A1,ERG,GLEASON,HOXD3,III,LABEL,METHODS,METHYLIGHT,OBJECTIVE,PSA,PURPOSE,RESULTS,TBX15,TMPRSS2
123,169,183,2005,2011,2012,2043,209,291,305,400,584,ACCRUAL,AVENTIS,BACKGROUND,CELECOXIB,CONTROLLED,COPYRIGHT,COUNCIL,CURRENT,FFS,FUNDING,HORMONE,JAN,LABEL,LTD,MEDICAL,METHODS,OCT,PSA,RESULTS,THERE
0063794,2012,354,AACR,BMP,BMPRI,ID1,LDN,LNCAP,PC3,SMAD1,SMAD8,SMADS,SMALL,TAKEN,WYE
8243,COMT,EGCG,INCUBATION,LNCAP,QUERCETIN
1975,1990,295,ADDITIONAL,AFTER,COX,GLEASON,KI67,LABEL,MEN,METHODS,OBJECTIVE,RESULTS,TMAS,VIII
169,2012,AACR,CYP17,III,MDV3100,P450,THESE,TREATMENT
2000,2011,EBRT,LABEL,METHODS,OBJECTIVE,OPERATIVE,PURPOSE,RESULTS,THERE,THREE,TREATMENT
8776,956,CBDIV17,EMBELIN,LABEL,LNCAP,METHODS,OBJECTIVE,PEG,PURPOSE,RESULTS,SER,THEREFORE,THESE,XIAP
2001,2011,GROUP,JAPAN,JCOG,KENICHI,LABOR,NOW,UNIVERSITY,UOSG,YOSHIYUKI
145,946,BACKGROUND,HOWEVER,LABEL,LNCAP,METHODS,RESULTS
ADDITIONAL,AGGRESSIVE,LABEL,OBJECTIVE,PURPOSE,RESULTS,SCREENING,SUMMARY
169,2012,CIP1,COPYRIGHT,EXPRESSION,INC,PATHOLOGY,PIAS,PIAS1,PROTEIN,PUBLISHED,SOCIETY,TAKEN,WAF1
105,140,169,2012,5854,5855,BACKGROUND,BICA,CASODEX,COPYRIGHT,DEPENDING,DHEA,DHT,FLU,GNRH,LABEL,LNCAP,LTD,MATERIALS,MDV3100,METHODS,PSA,R1881,RESULTS,THESE,WHILE
001,002,004,005,169,1988,2006,2012,8226,859,ACM,BCSM,BJU,COX,END,LABEL,LEVEL,MARRIED,MATERIALS,METHODS,NEVER,NOCD,OBJECTIVE,OBJECTIVES,PROGNOSIS,RESULTS,SDW,SEPARATED,TYPE,UCUB,UNLABELLED,WHAT
0001,007,100,125I,198,1999,8805,AFTER,AGE,BOUNCES,CONCLUSION,HIGH,LABEL,MATERIALS,MEN,METHODS,OBJECTIVE,PHOENIX,PSA,PURPOSE,RESULTS
063,169,2006,2008,2010,2012,782,8805,9033,BEHAVIORAL,BJU,BRFSS,CONCLUSION,DATA,FORCE,LABEL,MATERIALS,MEN,METHODS,OBJECTIVE,PREVENTIVE,PSA,RESULTS,RISK,TASK,USA
22RV1,CADMIUM,CDCL,CELLS,CTPE,CWR,DU145,LNCAP,RWPE
100,2008,2009,215,8805,ADC,AIM,BASED,CANDIDATES,CONCLUSION,DWI,GLEASON,JULY,LABEL,MEAN,METHODS,MRI,OBJECTIVE,PCA,PSA,RESULTS,TRUS
2006,2009,234,611,747,911,APRIL,CED,CENTERS,CONCLUSION,FDG,LABEL,METHODS,ONCOLOGIC,PET,RESULTS,SINCE,THERE,THESE,UNLABELLED
471,511,945,ARIOL,AUTOMATED,BACKGROUND,BOTH,CONCLUSION,CRI,DESPITE,LABEL,METHODS,OVERALL,RESULTS,THESE,TMA
209,3200,33342,800,8000,8764,APOPTOSIS,HOECHST,MEV,UVC
PLK,PLK1,POLO,PTEN
IMPLANTED,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
169,2012,947,COPYRIGHT,INHIBITION,LSD1,POST,THUS,UICC
ASIAN,CAUCASIANS,FIRST,FURTHER,HOWEVER,JAPAN
161,AIM,AMONG,BACKGROUND,EXPOSED,LABEL,METHODS,OBJECTIVE,RESULTS,ROC,THERE,TPSA
100,120,121,156,1997,2008,AIM,BACKGROUND,CHILE,COMMISSION,IMRT,INTENSITY,JANUARY,JUNE,LABEL,LATE,METHODS,OBJECTIVE,OVERALL,RESULTS,STAGING,THEIR,URINARY
177,956,AADAC,CES,CES2,FLU,FLUTAMIDE,HOWEVER,THESE,THUS,USING
169,1988,2012,287,8805,CONCLUSION,COPYRIGHT,FURTHER,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,OVERALL,PCA,PSA,PSADT,RESULTS,SRT,THERE
169,2012,945,COPYRIGHT,INC,SEVERAL,THUS
215,293T,945,CONCLUSION,DU145,EF1,EGFP,GFP,HEK,IRES,LABEL,MAPK,METHODS,OBJECTIVE,RESULTS,WESTERN
001,100,169,2002,2011,2012,BACKGROUND,CLOSE,COPYRIGHT,DOPPLER,EVOLUTION,GLEASON,LABEL,MARCH,MATCHED,METHODS,OBJECTIVE,OUTCOME,POST,PRIMARY,PSA,PUBLISHED,RESULTS,SEPTEMBER,SETTING,TRUS,UROLOGY
169,2012,391,8804,8805,BACKGROUND,CALIFORNIA,COPYRIGHT,EPSTEIN,FRANCISCO,GLEASON,KETTERING,LABEL,METHODS,MIAMI,OBJECTIVE,OUTCOME,PRIAS,PUBLISHED,RADICAL,RESULTS,SAN,SLOAN,THESE,UNIVERSITY,UROLOGY
169,2012,COPYRIGHT,GIVEN,HOWEVER,INC
001,169,2012,AFTER,CONCLUSION,COPYRIGHT,CRT,CTV,CTVS,DESPITE,DOSE,DVH,DVHS,EFFECTS,FACULTY,FOUR,GROUP,IMRT,INC,LABEL,LOCAL,MATERIALS,METHODS,OAR,OBJECTIVE,PURPOSE,QUANTEC,RADIATION,RESULTS,SURGERY,THERAPY,TREATMENT,URINARY,USING
AIMS,BACKGROUND,KHYG,LABEL,METHODS,MICE,MRI,OBJECTIVE,RESULTS
COLLECTION,GAS,LABORATORY,LOUIS,MINUTES,POSTMORTEM,SAINT,SPECIMENS,THESE,TOXICOLOGY,UNIVERSITY
AMONG,BIO,BOULDER,CRPC,CSCS,DIM,EZH2,GLEASON,PCA,THESE,UTR,ZESTE
BOTH,FOLLOWING,INSTITUTE,KABAT,LABEL,MBSR,METHODS,MOFFITT,OBJECTIVE,PURPOSE,QOL,RESULTS,SIMILAR,WEEK,WEEKS,ZINN
ACPP,ATLAS,CDX2,CEACAM5,KLK3,KRT7,NCBI,PAP,PROTEIN,PSA,SLC45A3,THBD,THUS,UPK3A,VIL1
1973,2006,3795,BACKGROUND,END,HOWEVER,LABEL,RCC,RESULTS,SEER,SOLID,SPCS
002,006,160,177,2006,2010,731,862,APRIL,CONCLUSION,DVC,HOWEVER,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS
001,160,605,8804,8805,946,BCR,BMI,CONVERSELY,COX,CURRENT,EARLY,GLEASON,LABEL,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS,SEX,SHBG
169,2012,825,9463,ASP299GLY,CIS,COPYRIGHT,FURTHER,GRAM,HOWEVER,ODDS,ORS,THR399ILE,TLR4,TOLL
AUTOPHAGY,BECAUSE,BMSC,FINALLY,HS27A,HS5,LC3,NED,PCA,STAT3,THUS
169,1995,2008,2012,503,673,ASSESSMENT,BASEL,BCR,CAPRA,CAPSURE,COPYRIGHT,COX,LABEL,MEIER,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,RISK,STRATEGIC,WESTERN
028,036,042,112,121,160,169,194,2000,2009,2012,281,511,8805,967,BACKGROUND,BETWEEN,CONCLUSION,COPYRIGHT,FORTY,GENERAL,GLEASON,HOWEVER,LABEL,MARCH,METHODS,PUBLISHED,RESULTS,SEPTEMBER,TAIWANESE
2011,BACKGROUND,CONCLUSION,LABEL,PSA,RESULTS,THESE
125,2012,340,BACKGROUND,CAB,DISCUSSION,EBRT,GLEASON,III,LABEL,METHODS,PCA,PRIOR,PSA,RCT,SECONDARY,SEPTEMBER,THESE,THOSE,TRIAL,TRIP
AREAS,HOWEVER,IHC,MOLECULAR
193A,BACKGROUND,BLOOD,CFS,DISCUSSION,DU145,E1245,LABEL,LNCAP,MDM,MDMS,METHODS,MICRORNAS,PBL,PERIPHERAL,RESULTS,TOTAL,WHILE,XMRV
945,947,DISEASE,KENNEDY,NRS,NUCLEAR,PPAR,PTM,PTMS
0001,001,005,106,2001,2004,492,8805,GLEASON,JANUARY,LABEL,MEDICAL,METHODS,OBJECTIVE,RESULTS,T1C,T2A,T2B,T3A,TIME,TNM
169,1A1,2012,ADAPTATION,BM18,CARN,CARNS,CASTRATION,CK18,COPYRIGHT,CRPC,HOWEVER,NANOG,NK3,NKX3,PRESS,STEM,THESE
169,2012,231,8322,BUOH,COPYRIGHT,DU145,EOH,ETOAC,JAK1,JAK2,JOHN,LTD,MCI,MDA,OVERALL,SONS,SRC,STAT3,SUDACHITIN,U266,WILEY
BASED,CXC,HOWEVER
2001,2004,ATLAS,BACKGROUND,DARTMOUTH,DISCUSSION,END,III,LABEL,METHODS,MOST,OBJECTIVE,RESULTS,SEER
AIPC,CELL,DU145,MENTHOL,MTT,TRPA1,TRPM8
CAD,FOUR,IRELAND,LTD,PUBLISHED
100,109,160,169,2006,2008,2011,2012,BETWEEN,CANCEROUS,CONCLUSION,COPYRIGHT,EBRT,GLEASON,INC,LABEL,LOCAL,MATERIALS,METHODS,MRSI,OBJECTIVE,PSA,PURPOSE,RESULTS,TEFRT
ACTIVITIES,ADT,ASSESSMENT,BACKGROUND,BALANCE,BATTERY,CHRONIC,CONFIDENCE,CONTROL,DISCUSSION,FATIGUE,FORM,FUNCTIONAL,GROUP,HOWEVER,ILLNESS,LABEL,MEDICAL,METHODS,SCALE,SHORT,SIX,SIXTY,TEST,THERAPY,TRIAL,VERSION,WALK
103,110,120,125,137,145,169,1CM,2012,50D,BED,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,PLANS,PUBLISHED,PURPOSE,RESULTS,SOCIETY,TEN
169,178,185,2012,5MM,8309,8776,8MM,COPYRIGHT,FURTHER,HOWEVER,INC,INSTITUTE,JAMES,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SOCIETY
0NG,100,121,169,2012,20NG,40NG,8805,COPYRIGHT,EBRT,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PERMANENT,PSA,PUBLISHED,PURPOSE,RESULTS,SOCIETY
169,2012,AFM,BASED,COPYRIGHT,CURRENT,HOWEVER,LTD,THEIR,THERE,THESE,YOUNG
AFRICAN,AMERICANS,LABEL,METHODS,OBJECTIVE,RESULTS,SEVENTY,SPSS
11356,11641,202,BACKGROUND,BASED,CAUCASIANS,CIS,CONCLUSION,COX,HOWEVER,LABEL,METHODS,ORS,PCA,RESULTS,STATA
169,1990S,2012,QUALITY,UROLOGICAL
169,2012,BACKGROUND,LABEL,METHODS,PREBIOPSY,REFERENCES,RESULTS,THERE,UROLOGICAL
0001,104,177,946,956,IC50,SEVERAL,SULT1A1,SULT1E1,SULTS,TAM,THERE,THESE,TOR,TOREMIFENE,VMAX
11R,169,177,2012,754,8201,99M,CGRRAGGSC,COPYRIGHT,DTPA,JOHN,LTD,SONS,WILEY
HOWEVER
RADIOGRAPH,THERE,THESE
036,067,075,177,269,908,916,IIEF,IPSS,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THEIR,TME
0001,040,169,177,2006,2007,2012,323,8805,AMONG,BASEL,CARE,COPYRIGHT,CTPP,GENOTYPING,JAPAN,KLK3,LABEL,METHODS,MICC,MULTI,OBJECTIVE,OBJECTIVES,PCR,PREVENTIVE,PSA,RESULTS
001,169,194,2003,2007,2012,424,669,998,BACKGROUND,CONCLUSION,COPYRIGHT,COSTS,COX,INC,ISPOR,LABEL,LOWER,METHODS,MIRP,PLAN,PUBLISHED,RESULTS,RRP,SIMILAR,SOCIETY
000,159,2002,2008,259,892,BASED,BAVARIA,CHANGES,GERMANY,POPULATION,SIR,SPC,UTILIZING
100,169,2012,BIACORE,COPYRIGHT,ELISA,IMPROVING,INC,INDIVIDUAL,PSA
945,946,BACKGROUND,CELL,CELLS,ECM,FNMA,LABEL,METHODS,RESULTS,USING
ACTIVATED,CLCA2,HOWEVER,THROUGH,THUS
ALTOGETHER,BAX,BCL,BCL2,DU145,IMMUNOBLOT,LNCAP,MYB,NOTABLY,PC3,RWPE1,RWPE2,USING
150,169,200,2012,916,936,956,AIF,ATF,BAX,BCL,CDK2,CELLS,CHINESE,COMET,COPYRIGHT,DAPI,FLOW,GADD153,GRP78,INC,QUERCETIN,THESE,WESTERN,WILEY
CD68,CLINICIANS,SECONDARY,TUR
128,169,2012,BRITAIN,COPYRIGHT,ENDOCRINE,ERG,FRESHLY,GNRH,GREAT,IRELAND,JOHN,LTD,PUBLISHED,SOCIETY,SONS,TMPRSS2,WILEY
170,ALSO,HBA1C,HOWEVER,UNTIL
17A1,CYP,CYP17A1,HOWEVER,III,P450,UNTIL
005,169,2012,290,312,535,668,8201,AUC,BACKGROUND,COPYRIGHT,DRE,INC,LABEL,METHODS,NEM,PCA,PSA,RESULTS,ROC,SARCOSINE,TRUS,WILEY
169,2012,8764,BACKGROUND,COPYRIGHT,HIGH,INC,KLK3,LABEL,METHODS,PSA,RESULTS,USING,WILEY
169,2012,8201,946,ARB,ARBS,BACKGROUND,CONCLUSION,COPYRIGHT,CRPC,FURTHER,INC,LABEL,LNCAP,MAPK,METHODS,PSA,RESULTS,THESE,TRANSGENIC,TRAP,WILEY
001,169,2011,8201,947,954,APOPTOSIS,BACKGROUND,CONCLUSION,COPYRIGHT,GLEASON,IGG,INC,LABEL,LOCALLY,METHODS,MTS,PCA,PCR,RESULTS,WESTERN,WILEY
BCR,HIFU,HOWEVER,PCA,PSA,RADIATION,RECURRENCE
169,2012,COPYRIGHT,GENERAL,GTPASES,INC,RAC1,RHO,RHOA,ROCK1,TARGETING,TIAM1
AMONG,BRCA1,BRCA2,MRI,THESE
1338,169,2000,2008,2012,AFRICAN,AMERICANS,ANGELES,AUA,BETWEEN,BJU,CALIFORNIA,CAUCASIAN,CAUCASIANS,CONCLUSION,HRQL,INDEX,JULY,LABEL,LOS,METHODS,OBJECTIVE,OCTOBER,PCI,RESULTS,SCORE,SYMPTOM,THERE,UCLA,UNIVERSITY,UNLABELLED,URINARY,UROLOGICAL,WHAT
126,169,189,2010,2012,8804,ADDITIONAL,AUTHORS,BJU,BRITISH,CRPC,FEW,GROUP,III,LABEL,MATERIALS,MDV3100,METHODS,MOST,OBJECTIVE,OBJECTIVES,RESPONDERS,RESULTS,SEPTEMBER,TREATMENT,UNLABELLED,URO,WHAT
043,169,2006,2008,2012,4771,8226,8805,AUTHORS,BJU,BPH,COLORECTAL,CONCLUSION,DRE,DRES,GENERALLY,LABEL,LEVEL,LUNG,LUTS,MEN,METHODS,NSAID,OBJECTIVE,OLMSTED,OVARIAN,PSA,RESULTS,SCREENING,THERAPY,THEREFORE,TRIAL,TYPE,UNLABELLED,URINARY,WHAT
169,2012,946,CALLICARPA,COMPOUNDS,PC3,SOCIETY
169,2012,8805,DU145,III,INC,MCF7,MTT,SOCIETY,TAM,WILEY

CHIP,NEDD,PROTEASOME,PTEN,TPR,UBIQUITIN,UPS,WWP2,XIAP
169,2012,AACR,COMPETING,MEIER
1000,2007,2011,214,441,ACCORDING,BACKGROUND,BETWEEN,DRE,EAU,LABEL,LOW,MARCH,METHODS,PCA,PSA,RESULTS,TRUS
145,954,IAPS,LIVIN,PCA,THESE,THUS
BASAL,CD104,CD13,CD44,CD49F,CD9,SINCE,THEIR,THESE,VARIOUS
ADP,DR5,TAKEN,TRAIL
000,1994,2003,2011,BASED,CHIBA,CIRT,HEAVY,HIMAC,ION,JAPAN,MAY,MEDICAL,SINCE,THESE
125,945,954,956,AFTER,AIM,AKT,CHIP,CONCLUSION,LABEL,METHODS,OBJECTIVE,PC3,PCR,PI3K,RESULTS,SNAIL,TNF,WESTERN
169,2012,954,BLT2,COPYRIGHT,DESPITE,INC,LNCAP,NADPH,NOX4,ROS,TAKEN,THESE
1000,169,200,2012,956,AQP1,COPYRIGHT,HOWEVER,MAPK,RG3
060,158,2011,2976392,746,824,BACKGROUND,CAUCASIANS,CIS,EXTENSIVE,LABEL,METHODS,NINE,ORS,PSCA,RESULTS
169,2012,22RV1,COPYRIGHT,DELETED,DLC1,HDAC,INC,LNCAP,PCA,PCAS,RHOA,RHOGTPASE,SAHA,SP1,THESE,TREATMENT,TSA
169,2012,COMPLEX,COPYRIGHT,ETS,ETV1,ETV4,ETV5,EWING,MODULATION,PEA3
001,007,009,021,061,169,2012,250,300,400,BACKGROUND,COMPOSITE,COPYRIGHT,GREATER,HOWEVER,INDEX,LABEL,METHODS,OBJECTIVE,OUTCOME,PROCEDURE,PUBLISHED,RARP,RARPS,RESULTS,SETTING,UROLOGY,WHILE
169,200,2012,COPYRIGHT,PHEC
001,002,003,004,005,169,2000,2008,2012,279,BETWEEN,COPYRIGHT,ECE,ENDORECTAL,GLEASON,IMAGE,IMAGING,INC,LABEL,MATERIALS,METHODS,MRI,NETWORK,OBJECTIVE,PSA,PURPOSE,RESULTS
111,140,169,174,177,2008,2010,2012,207,CLAVIEN,COPYRIGHT,EDUCATION,FOUR,INC,LABEL,MATERIALS,MAY,MEAN,MEDICAL,METHODS,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL,VINCI,WIDESPREAD
001,169,2012,BOTH,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,MEDICALLY,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SERUM,UROLOGICAL,USING
0006,0014,0096,0119,0195,0258,100,169,1989,2008,2012,237,329,COPYRIGHT,EDUCATION,GLEASON,HIGH,INC,LABEL,MATERIALS,METASTASIS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RATE,RESULTS,UROLOGICAL,USING
000,100,101,169,2012,8805,BASED,COPYRIGHT,EDUCATION,EXACT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESECTION,RESULTS,THESE,UROLOGICAL
169,1994,2012,249,272,BLACK,CHANGES,COPYRIGHT,COX,EDUCATION,GLEASON,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,T2A,UNIVARIATE,UROLOGICAL
000,169,1983,2010,2012,560,AFTER,COPYRIGHT,DESPITE,EDUCATION,FEWER,GLEASON,GROUP,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,TREATMENT,UROLOGICAL
109,169,177,1999,2007,2010,2012,329,386,804,965,COPYRIGHT,DATA,EDUCATION,INC,JANUARY,KINGDOM,LABEL,MALIGNANT,MATERIALS,METHODS,OBJECTIVE,OCTOBER,PUBLISHED,PURPOSE,RECURRENT,RESULTS,SEPTEMBER,THERE,THEREFORE,UROLOGICAL,VISIBLE
169,2011,2012,AMONG,COPYRIGHT,PET,PUBLISHED,SAS
125,169,2012,COPYRIGHT,EACH,EDUCATION,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THUS,UROLOGICAL
169,1985,2008,2012,AMERICA,BACKGROUND,CARIBBEAN,CONTEXT,CONTINENTS,COPYRIGHT,ESTIMATED,FIVE,INCIDENCE,INCREASING,LABEL,METHODS,MORTALITY,NORTH,OBJECTIVE,OCEANIA,PCA,PUBLISHED,RESULTS,SAHARAN,SOUTH,SYNTHESIS,UROLOGY,WIDE,WORLD
CONCEPT,DIGE,DU145,ERG,FCA,FUNCTIONAL,LNCAP,PCA,PRDX3,PRDX4,REVERSE,RPPA,TMPRSS2
000,100,151,169,1999,2002,2007,2010,946,AGE,AMONGST,BACKGROUND,CENTRAL,HODGKIN,LABEL,LTD,METHODS,MSYAMBOZA,NATIONWIDE,OCTOBER,RESULTS,SEPTEMBER,WHILE
2011,HOWEVER,MAST,NOTCH,SEVERAL
169,2012,AACR,USING
169,2012,8201,8805,ALSO,COPYRIGHT,HOWEVER,JOHN,LABEL,LTD,METHODS,MOST,OBJECTIVE,QOL,RESULTS,SONS,USA,WILEY
001,002,011,26S,AMONG,ICP,THESE
169,2012,COPYRIGHT,III,JOHN,LTD,SONS,WILEY
CUL4A,ECTOPIC,ERK,FINALLY,NOTABLY
AKT,ENDMT,ERK1,ERK5,HOWEVER,SLUG,TIE1,TIE2
100MG,STAGE
169,2012,COPYRIGHT,ERG,INC,STEM,TMPRSS2,ULTIMATELY
169,2011,2012,BACKGROUND,CONTEXT,COPYRIGHT,ELECTRONIC,GLEASON,LABEL,METHODS,OBJECTIVE,PCA,PUBLISHED,RESULTS,SEPTEMBER,SYNTHESIS,UROLOGY,WHILE
169,1991,2012,ADDITIONAL,BACKGROUND,BECAUSE,CONTEXT,COPYRIGHT,ENGLISH,LABEL,MEDLINE,METHODS,OBJECTIVE,PCA,PSA,PUBLISHED,RESULTS,SCA,SYNTHESIS,UROLOGY
1135,169,2000,2011,2012,8805,BACKGROUND,COPYRIGHT,COX,CUMULATIVE,INDEX,JANUARY,JUNE,LABEL,MEIER,METHODS,NSRP,OBJECTIVE,OUTCOME,PCA,PUBLISHED,RESULTS,SETTING,SIMILARLY,UROLOGY
023,177,945,946,997,AFTER,BMI,COX,DISEASE,FINNISH,HEART,ISCHAEMIC,KIHD,RESULTS,RISK,RRS,SERUM,TOCOPHEROL
169,2012,769,956,AUTHORS,DESPITE,DYNAMIC,FEBS,H3K4,H3K4ME2,H3K4ME3,H3K9,HDM,HDMS,HOWEVER,INHIBITION,JARID1B,JHDMS,JMJC,JOURNAL,K4ME3,KDM4A,KDM4C,KDM5B,MICHAELIS,PDCA,PHD,PLU1,SEVERAL,STRUCTURE
005,008,010,017,018,028,035,036,050,052,1997A,BACKGROUND,BPH,HEKAL,HIGHEST,HT1B,LABEL,PCA,PSA,RESULTS,UNIVARIATE
005,8804,8805,ADC,CHOL,CONCLUSION,DATA,FIFTY,GLEASON,LABEL,METHODS,MRI,PET,RESULTS,TBRS,UNLABELLED,VOLUMES
131,2006,2010,258,BACKGROUND,FURTHER,INFECTING,JANUARY,LABEL,METHODS,MOLECULAR,PATIENT,RESULTS,ST131,TRUS
1996,2004,640,AFRICAN,AMERICANS,GLEASON,HISPANICS,HOUSTON,HOWEVER,MEDICAL,PCA,TEXAS,THREE
2004,2009,AFTER,APRIL,JULY,LABEL,METHODS,OBJECTIVE,PSA,RESULTS,SINCE,TURP
6C4,945,DIAGNOSES,GLEASON,MALIGNANT,TEN,WHILE
0001,001,002,132,151,169,2012,738,CONCLUSION,COPYRIGHT,GROUP,INC,LABEL,LNS,MATERIALS,METHODS,MRL,OBJECTIVE,PCA,PET,PURPOSE,RADIATION,RESULTS,THERAPY,THEREFORE
169,2012,BACKGROUND,CASES,COPYRIGHT,IGFR,LABEL,LTD,METHODS,PCA,RESULTS,TZDS
000,CURRENTLY,MICRORNAS,PCA,RNAS,THEREFORE,THESE,THUS,UTR
001,003,1000,1055,160,162,182,388,AFTER,BACKGROUND,CONTROLLED,CURRENT,LABEL,MEN,METHODS,PSA,RANDOMIZED,RESULTS,SCREENING,SEVERAL,THERE
169,602,HRQOL,LABEL,METHODS,MID,OBJECTIVE,RESULTS,SETTING,TRUST
169,2012,AKT,FAS,H2A,INCREASED,PCA,RADIATION,RSV,SAFE,THESE,TOXICITIES,TRAILR1,XRT
009,049,149,177,2906,8805,956,ADULT,ATP,EDUCATION,FEDERATION,IDF,III,PANEL,PROGRAM,RAHE,SERUM,TREATMENT
026,119,169,2012,347,402,479,749,8226,BJU,CONCLUSION,LABEL,LEVEL,METHODS,MOST,OBJECTIVE,RESULTS,TYPE,UNLABELLED,WHAT
169,2012,OTHER,THERE,UROLOGICAL
169,2012,BLACKWELL,FIFTEEN,FRAMEWORK,LTD,NVIVO,PUBLISHING,QSR6,THESE
001,169,2004,2006,2012,789,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,UROLOGICAL
0007,0054,0155,035,100,215,324,393,642,652,8Q24,PSCA,SNP,SNPS
009,169,2012,207,8201,8805,BACKGROUND,COPYRIGHT,GROUP,HOWEVER,INC,LABEL,METHODS,OTHER,RESULTS,SEVEN,THESE,WILEY
169,2012,231,COPYRIGHT,FOLLOWING,IAP,INC,MDA,N4PY,ROS,THEREFORE,THESE,WILEY,XIAP
169,2012,AUC,BACKGROUND,CD14,CONSORTIUM,COPYRIGHT,ECE,GLEASON,IGF,INC,IRISH,LABEL,METHODS,PCA,PCRC,PEDF,RESULTS,VEGF,WILEY
169,1966,2011,2012,AIMS,BASED,COPYRIGHT,GIVEN,INC,JANUARY,LABEL,LUTD,MAY,MEDLINE,METHODS,OBJECTIVE,ONCE,RESULTS,WILEY,YES
169,AIMS,DATA,GRANADA,LABEL,METHODS,OBJECTIVE,RESULTS,SPAIN,THESE
108,110,156,CONCLUSION,GLEASON,INITIAL,LABEL,MEAN,METHODS,OBJECTIVE,PET,PSA,PURPOSE,QUESTIONS,RESULTS
006,009,018,035,145,169,2012,22RV1,8201,ABSENCE,BACKGROUND,BPH,COPYRIGHT,INC,LABEL,LNCAP,METHODS,PCA,PCR,POTENTIAL,RAS,RASSF,RASSF10,RESULTS,WILEY
169,2012,945,ANDROGENS,BACKGROUND,COPYRIGHT,DHT,ERG,ETS,FINALLY,INC,LABEL,METHODS,PREVIOUSLY,PSA,RESULTS,TMPRSS2,VCAP,WILEY
001,009,040,048,051,059,169,1989,2010,2012,2502,8804,8805,BACKGROUND,BCR,BLACK,CAP,COPYRIGHT,COX,CRUDE,DATA,EQUAL,EVEN,GLEASON,HOSPITALS,LABEL,LOW,METHODS,PSM,RESULTS,SES,SOCIETY,ZIP
0449,169,2012,5E1,926,AACR,FURTHER,GDC,GLI,IPI,SMO
169,2012,AIMS,AQP1,AQUAPORIN,BACKGROUND,BASEL,COCL,CONCLUSION,COPYRIGHT,HOWEVER,LABEL,MAPK,METHODS,OBJECTIVE,PKC,RESULTS,THESE
169,2012,AIMS,BACKGROUND,BASEL,CONCLUSION,COPYRIGHT,ELISA,HOWEVER,LABEL,METHODS,NOTABLY,OBJECTIVE,PC3,PCA,PPAT,PRIMARY,RESULTS,SVF,SVFS
945,AMACR,CK7,COA,HOWEVER,NAS,PAX2,PAX8,SOLID
EPIGENETIC,HOWEVER,THERE
1984,2011,CURRENTLY,DESPITE,EVEN,LABEL,MED,METHODS,MOST,OBJECTIVE,POST,PUB,RESULTS,UUTT,UUTTS
182,2007,2010,262,BACKGROUND,GLEASON,LABEL,METHODS,RALP,RESULTS,ROBOTIC,RRP,T2C,UNASSIGNED,VIRTUAL
131,945,946,AMONG,BACKGROUND,BED,DOSES,EBRT,GY2,LABEL,LOCAL,MEAN,METHODS,OVERALL,PMAX,RESULTS,SBRT,THERE
COA,HMG,RANDOMIZED,WHILE
AREAS,BACKGROUND,COVERED,III,LABEL,METHODS,OPINION,PHASE,THESE,VEGF,WHILE
113,BACKGROUND,CRPC,GLEASON,H4K20,HOWEVER,LABEL,METHODS,PCA,PSA,RESULTS,SIMILAR
AREAS,BACKGROUND,COVERED,III,LABEL,METHODS,OPINION,PHASE,PSA
001,002,186,239,894,926,FURTHER,NBS1,PSA,REGARDING
BECAUSE,HES
0007,004,016,147,279,8202,BACKGROUND,CAIR,COX,EGFR,LABEL,LRC,PRINCIPAL,PTEN,RESULTS,THESE
92A,AKT,DIM,EMT,HOWEVER,MITF,NKX3,PCA,PSA,RANKL,RUNX2,THEREFORE
AD5,ONCOLYTIC,SPECT
169,2012,AACR,CRPC,CYP17A1,MDV3100,THEREFORE
169,2012,654,8201,ANXIETY,BACKGROUND,COPYRIGHT,DEPRESSION,FINANCIAL,IRELAND,JOHN,LABEL,LTD,METHODS,RESULTS,SIMILAR,SONS,WILEY
1645,169,1754,2012,BACKGROUND,COPYRIGHT,DATA,LABEL,METHODS,PCA,RESULTS,SELF,SEVERAL,SOCIETY,STI,STIS,THEREFORE,THESE
945,954,AKT,AXL,HOWEVER,IKK,TAKEN
169,2012,4000,COPYRIGHT,HOWEVER,IRELAND,LTD,MEDLINE
ATC,HOWEVER,III,LABEL,MOLECULAR,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SUMMARY,TARGETING,THEIR,VDAS
DRUG,FINALLY,FOOD,LABEL,NEXT,OBJECTIVE,PURPOSE,RESULTS,SUMMARY
169,2012,BA20,BA24,BA33,BIGINELLI,COPYRIGHT,FOUR,LTD,RNS,ROS,THESE
169,2012,COPYRIGHT,DRUG,FOOD,FURTHER,HOWEVER,INC,THERE,WESTERN
CRP,IEF,PSA
CTC,CTCS,PSA
3000,5T4,III,MVA,PHASE,STUDIES
169,2012,BACKGROUND,CRNM,III,LABEL,METHODS,OBJECTIVE,OBJECTIVES,SECONDARY,SOCIETY,THERE,THESE,THREE,THROMBOSIS,VTE
956,ELISA,EPH,EPHA2,FINALLY,FUNCTIONAL
405,513,557,8567,915,931,CONCLUSION,COSTS,CRPC,DENOSUMAB,DRUG,LABEL,METHODS,MORTALITY,NSCLC,OBJECTIVE,PHASE,QALY,QALYS,RESULTS,SRE,SRES
0001,032,035,114,160,8805,BACKGROUND,BPS,FPPS,FURTHER,GLEASON,INCREASED,IRS,LABEL,MEAN,METHODS,REMMELE,RESULTS,STEGNER
133,133A,133B,8209,AFTER,DU145,ECTOPIC,EGFR,PC3,PCR,THESE
ADDITIONAL,MCT,MCT1,MCT4,MCTS,MOST,SLC16,THUS
DFS,GLEASON,MMP,PCA,PSA,PSADT,RESULTS,UNIVARIATE
956,DHT,LNCAP,LUC,LUCIFERASE,PC3,SINCE,TAKEN,THEREFORE
169,2012,629,634,650,COPYRIGHT,IRELAND,LTD,PUBLISHED
145,169,2012,946,954,COPYRIGHT,GSK3,HOWEVER,HRM,IRELAND,LNCAP,LTD,PREC,SEQUENCING,SP1
155,177,2012,332,8202,AIMS,COLLEGE,CONCLUSION,GLEASON,LABEL,METHODS,OBJECTIVE,PSA,RESULTS,ROYAL
2012,AIMS,COLLEGE,CONCLUSION,INTENSITY,LABEL,MEAN,METHODS,OBJECTIVE,RESULTS,ROYAL,SEVENTEEN
0003,001,002,005,154,169,2012,536,954,COPYRIGHT,DESPITE,INC,NEITHER,NUCLEAR,S536,THESE
169,2012,293T,8804,AKT,BPH,CONSISTENT,DU145,GLEASON,HOWEVER,LNCAP,LOSS,PC3,PCS,PIN,TAKEN,THEREFORE,WHILE
169,2008,2011,2012,320,8805,AUC,BACKGROUND,CALCULATOR,COPYRIGHT,DESPITE,DRE,DUTCH,ERSPC,GLEASON,LABEL,LTD,METHODS,OBJECTIVE,PCA,PREDICTION,PSA,RANDOMISED,RESULTS,RISK,SCREENING,TRUS,UNDER
001,002,003,015,169,1995,2008,2012,2057,APRIL,COPYRIGHT,CURRENT,INC,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SEVERAL,SMOKERS,SOCIETY,THERE
169,2012,BIOLOGICAL,COPYRIGHT,HOWEVER,LTD,PUBLISHED,RESULTS
169,2007,2009,2012,ASTRO,CNS,COPYRIGHT,CURRENT,DATA,FORCE,IRELAND,LTD,PBT,RADIATION,SOCIETY,TASK
0001,007,018,118,132,169,2012,22863,AIM,COPYRIGHT,CROWN,EORTC,GLEASON,IDC,III,LABEL,LTAD,LTD,MEIER,METHODS,OBJECTIVE,PUBLISHED,RESULTS
169,2012,COPYRIGHT,GTP,GTPS,INC,LAPC4,SCID,THERE
167,169,184,1990,2002,2010,2012,286,303,389,400,876,AFTER,BACKGROUND,CONTEXT,COPYRIGHT,LABEL,LRP,METHODS,OBJECTIVE,ORP,PSM,PUBLISHED,RADICAL,RALP,RATES,RESULTS,SECONDARY,SUMMARY,SYNTHESIS,TOTAL,UROLOGY
ANOVA,ASSAY,BACKGROUND,CONCLUSION,CURRENTLY,GLEASON,GRADE,HOWEVER,IGG,LABEL,MANN,METHODS,MOLECULAR,RESULTS,SCORE,STUDENT,WHITNEY
BACKGROUND,ERBB2,LABEL,MET,NONE,PAK1,PDZRHOGEF,RAC,RESULTS,RHOA,RHOD,SOMATIC
169,2005,2009,2010,2011,2012,2260,8226,BJU,ITALY,LABEL,LEVEL,MARCH,MATERIALS,METHODS,MILAN,NAZIONALE,OBJECTIVE,OBJECTIVES,PROGRAMME,RESULTS,THERAPY,TYPE,UNLABELLED,WHAT
954,BACKGROUND,CONCLUSION,HOWEVER,LABEL,LNCAP,PC3,PCA,PRINCIPAL,PSA,RELB,RESULTS,RNAI
DESPITE,GLEASON,MUTATIONS,THEREFORE
916,BOTH,FIRST,INSTEAD,PML,ROS,WHILE
100,120,177,202,273,300,328,501,8804,8805,BMI,MEAN,MEN,OPTIMAL,SERUM
946,FORMATION,KNOCKDOWN,OVERALL,PCA,PELP1,THESE
11C,509,739,ACCORDING,AIM,CONCLUSION,EBRT,FORTY,LABEL,METHODS,OBJECTIVE,PET,PSA,RESULTS,STUDENT,SUV
ANTICANCER,DOX,LNCAP,THESE
176,177,2500,FURTHER,MLC,VMAT,VOLUMETRIC
HOWEVER,III,PATIENT,SIPULEUCEL,VITAL
ADTS,DESPITE,PCA,WESTERN,WHILE
CSC,CSCS,PCA
2002,2011,941,963,AFRICAN,BACKGROUND,BLACK,JANUARY,JULY,LABEL,METHODS,ORS,POPULATION,RESULTS,SIMILARLY,THESE,TRAINED,WEST
169,2012,29B,AACR,BETWEEN,EARLY,EPITHELIAL,LNCAP,PC3,SNAIL,THEREFORE,THUS,TWIST
169,2012,COPYRIGHT,CURRENTLY,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PET,PSA,PURPOSE,RESULTS
169,176,2012,8805,BECAUSE,CBCT,CBTS,CONCLUSION,COPYRIGHT,DAVID,IGRT,INC,KRESS,LABEL,MATERIALS,METHODS,OBJECTIVE,PROJECTION,PURPOSE,RESULTS,SCANS,USING
169,2012,947,CONCLUSION,COPYRIGHT,DMLC,DYNAMIC,HOWEVER,IMAGE,IMAT,INC,INTENSITY,LABEL,METHODS,MLC,OBJECTIVE,PURPOSE,RESULTS
000,013,048,169,191,1987,2007,2012,8804,ADT,COPYRIGHT,GLEASON,HOWEVER,INC,INDEX,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE,UNIVERSITY
013,059,169,2012,ADDITIONAL,AVERAGE,COPYRIGHT,DICE,DUE,EXCLUDING,FIFTEEN,INC,INSTITUTES,LABEL,MATERIALS,MEAN,METHODS,OBJECTIVE,PURPOSE,RESULTS,VODCA
002,1128,169,2012,CONCLUSION,COPYRIGHT,ENGAGEMENT,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,SEEKING,USING
111,169,2012,ASSESSING,BACKGROUND,CGA,CONCLUSION,COPYRIGHT,CRPC,DTPA,FORTY,FURTHER,HAZELWOOD,INC,LABEL,METHODS,NED,OCTREOSCAN,PHE,RESULTS,SSTR2
AE1,CD56,KI67,KIT,LCNEC,NCAM,TTF
8805,AIM,BACKGROUND,CONCLUSION,DUE,EIGHT,HOWEVER,LABEL,METHODS,MRI,OBJECTIVE,PSA,RESULTS,SUSPICIOUS,TESLA,TRUS
BACKGROUND,CONCLUSION,LABEL,METHODS,RESULTS
194,206,207,506,ATLAS,BACKGROUND,CONCLUSION,GBM,KLK,KLK1,KLKS,LABEL,MATERIALS,METHODS,OVERALL,RESULTS,THERE
012,109,1490,158,1701,176,1948,2004,2009,360,487,567,956,BACKGROUND,CONCLUSION,DOCETAXEL,HOWEVER,HRPC,LABEL,MARCH,MAY,METHODS,ORAL,PSA,RESULTS,SERIOUS,THEREFORE,TTF,ULTIMATELY
AIM,BACKGROUND,CONCLUSION,GADD45A,JNK,JUN,LABEL,LNCAP,MATERIALS,METHODS,OBJECTIVE,RESULTS,SAPK,THESE
VITAMIN
0001,ANP,BACKGROUND,CONCLUSION,FOUR,JNK2,JUN,LABEL,LANP,MATERIALS,METHODS,RESULTS,THESE
MRI
CRPC,LHRH,PCA,UNTIL
492,AFRICAN,BLACK,BLOOD,CHICAGO,RACE,VITAMIN
103,142,169,2012,295,8211,956,BACKGROUND,BASED,BASEL,CONCLUSION,COPYRIGHT,LABEL,METHODS,RESULTS
PSA
111,139,169,2005,2010,2012,739,BACKGROUND,BASEL,COPYRIGHT,FOUR,LABEL,LND,MEAN,MEIER,METHODS,PRIMARY,PSA,RESULTS
105,125,144,150,169,184,1998,2008,2012,289,601,890,ADDITIONAL,AIM,COPYRIGHT,EBRT,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PHOENIX,PSA,PURPOSE,RESULTS,UTRECHT,YEAR
001,006,085,169,2011,8805,945,AEU,BMI,COPYRIGHT,EXCLUSION,FORTY,LABEL,MEAN,METHODS,MEXICAN,OBJECTIVE,OVERWEIGHT,PCA,PSA,PUBLISHED,REDUCTASE,RESULTS
033,160,183,BCL,CIP1,CLL,FURTHER,GENISTEIN,GLEASON,KI67,KIP1,KLK4,LUMINAL,NK3,NORWEGIAN,PCA,PCR,THERE,WAF1
BACKGROUND,HDR,LABEL
HOWEVER,REASONS
HTS,PERUVOSIDE,THESE
AFRICAN,BACKGROUND,END,FIVE,GREATER,HISPANICS,HODGKIN,LABEL,LESS,METHODS,NHL,RESULTS
169,2012,BAT,CELL,COPYRIGHT,CRPC,CRPCS,INC,ORS,THESE,WILEY
169,2012,8201,BACKGROUND,CIC,CICS,CONCLUSION,COPYRIGHT,DMEN,F12,GFD,INC,LABEL,METHODS,RESULTS,THUS,WILEY
CONCURRENT,DRUG,FDA,FOOD,III
014,015,025,169,2012,8226,8805,BJU,COVARIATES,DIAGNOSTIC,GLEASON,LABEL,LEVEL,MEN,METHODS,MOST,OBJECTIVE,PSA,PSADT,PSAV,RESULTS,TTSB,TYPE,UNLABELLED,WHAT
001,026,120,169,2012,215,8226,945,981,AGAIN,BJU,CHC,HOWEVER,KRUSKAL,LABEL,LAPC,MATERIALS,MCT1,METHODS,MICE,NCKD,OBJECTIVE,RESULTS,THERE,UNLABELLED,VEH,WESTERN,WHAT
107,149,169,1999,2001,2012,500,665,8776,8805,AUC,AUTHORS,BJU,CONCLUSION,LABEL,METHODS,OBJECTIVE,OVERALL,PSA,RESULTS,TPM,TRUS,UNLABELLED,WHAT
NMR
176,AMONG,EARLIER,SKOV
BAK,BCL,BCL2,BIK,BORTEZOMIB,DILTIAZEM,DU145,GRP78,HOWEVER,LNCAP,PRESUMABLY,THUS,VELCADE
ARKO,ARS,CK5,CK8,EARLY,THESE,USING
169,2012,AACR,AUTOLOGOUS,COHORTS,CRPC,CTC,CTCS,DOSE,LABEL,METHODS,NONTAXANE,OBJECTIVE,PSA,PURPOSE,RESULTS,TREATMENT
001,169,2001,2007,2012,BACKGROUND,CARE,COPYRIGHT,INDEX,INPATIENT,LABEL,LOS,LVT,LVTS,METHODS,NATIONWIDE,NIS,OVERALL,PROJECT,RESULTS,RPS,SOCIETY
169,2012,ACCORDING,DRUG,FOOD,INC,MOST,NETWORK,OVERALL,SOCIETY,THREE,THUS
PICO,USING
0001,2005,2009,300,946,ALTERED,BMI,CONCLUSION,DMR,DMRS,ELISA,H19,IGF2,INSULIN,LABEL,LOWER,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE,UCB
11C,170,177,LABEL,MATERIALS,METHODS,OBJECTIVE,PCA,PET,PSA,PSADT,PSAV,PURPOSE,RESULTS
8201,8805,ACTUARIAL,BACKGROUND,EBRT,GROUP,LABEL,METHODS,MIU,PSA,RADIATION,RESULTS,SEVEN,THERAPY,THERE,VACCINE
000,130A,203,205,8201,8764,AGO2,ARGONAUTE,BOTH,HRAS,LNCAP,MAPK,PCA,USING
5HMC,5MC,945,ASSOCIATED,IDH1,TET,TET2
AFTER,HOWEVER,SEVERAL,UROGENITAL,WEGENER
169,2012,8482,COPYRIGHT,IGG1,LRP,LTD,LUNG,PEARSON
AKT,ANOTHER,CDK7,CDK9,CTD,HOWEVER,PC3,T98G,THUS
169,2012,COPYRIGHT,EPIGENOME,HOWEVER,IRELAND,LTD
169,200,2012,CAD,HESSIAN,INSTITUTE,NEXT,PHYSICS
169,2012,44B,COMPOUNDS,COPYRIGHT,CRPC,LNCAP,LTD,SIMILARLY,THESE
169,2012,ADT,PCA,SINCE
169,2012,INSTITUTE,PHYSICS,RBF
945,946,DHA,EMT,PC3,PUFA,SMA,TGF,THESE,THUS
001,362,749,799,893,BACKGROUND,BECAUSE,CLAVIEN,CONCLUSION,III,LABEL,MEAN,METHODS,OBJECTIVE,PSM,PURPOSE,RALP,RESULTS,RRP
800,945,956,BACKGROUND,CDCP1,CUB,G418,GFP,HIF,HOWEVER,HYPOXIA,KAI1,LABEL,METHODS,PC3,PROTEIN,RESULTS,SRC,TEM,THESE,TM4SF,VEGF,VHL
AKT,GAP,GGAP2,GTP,INCREASED,MUTATIONS,NFKB,OVERALL,RAS,SIMILAR,WESTERN
BECAUSE,DESPITE,MCF10AT,THESE,USING
946,ALTOGETHER,CD9,CELL,MMP8
CXCR2,IL8,P53,SCNC,SMALL,THEREFORE,TP53,WHILE
169,2012,CHROMATIN,COPYRIGHT,CSF2,CST7,FRAP,G9A,GST,INC,MMP13,MMP9,PIP,RUNX2,RX2,SDF1,SINCE,TRANSIENT,USING,WHEREAS,WILEY
000,2002,378,508,553,810,8364,ASSESSMENT,BACKGROUND,BEP,BREAK,DATA,DIAGNOSIS,DRG,EVEN,GROUP,HEATH,HTA,ITALIAN,LABEL,MATERIALS,METHODS,POINT,RELATED,RESULTS,ROBOTIC,TECHNOLOGY,UNIVERSITY,VINCI
169,2012,CDC2,COPYRIGHT,HDAC,HISTONE,HOWEVER,INC,JUMONJI,LNCAP,THR34,TSA,WILEY
EVALUATING,LABEL,OBJECTIVE,PHYSICIAN,PURPOSE,RESULTS,SUMMARY
CURRENT,HENCE,LABEL,MRI,OBJECTIVE,PURPOSE,RESULTS,SUMMARY,UPON
LABEL,MRI,OBJECTIVE,PURPOSE,RESULTS,SEVERAL,SUMMARY,THERE
185,8315,956,CDK4,CHANGES,DU145,FOLLOWING,INK4A,THESE,VACCINIUM,WCE
169,2012,BPH,CONVERSELY,COPYRIGHT,ECM,IRELAND,LNCAP,LTD,PCA,THESE,USING
132,169,177,2012,48H,956,ANNEXIN,BCL,CCK,CELL,CHINESE,COPYRIGHT,DU145,FITC,HOWEVER,HRPC,JIN,LTD,NAC,PAB,ROS,TAKEN,WESTERN
035,215,323,8Q24,9Q34,ABO,JAPAN,PSCA,THROUGH
000,100,1976,1987,2008,4042,685,8052,9615,AGE,CUP,HOWEVER,INCREASING,LIVER,MALIGNANT,OVERALL,SITE,SWEDISH
169,194,2012,BACKGROUND,CONCLUSION,COPYRIGHT,CRPC,DOCETAXEL,HOWEVER,INC,LABEL,METHODS,MTS,PC3,PROTEIN,RESULTS,THERE
169,2012,956,ABNORMALLY,BACKGROUND,CK2,COPYRIGHT,GENERAL,IC50,INCUBATION,LABEL,LNCAP,METHODS,RESULTS,THEREFORE,WESTERN
169,2012,8804,BACKGROUND,BECAUSE,CONTEXT,COPYRIGHT,EVALUATION,HIGH,HOWEVER,LABEL,MEDLINE,METHODS,MOST,OBJECTIVE,PCA,PUBLISHED,RESULTS,REVIEWS,SCIENCE,SYNTHESIS,SYSTEMATIC,WEB
169,2012,776,790,AE37,ANOTHER,CD4,CD8,COPYRIGHT,HER2,HOWEVER,INTERIM,KEY,LRMK,LTD,MHC,PEPTIDE
000,100,128,135,144,158,169,1990,1995,2005,2013,567,BANK,COLLECTION,COPYRIGHT,HEIDELBERG,INC,INSTITUTE,LABEL,MATERIALS,METHODS,MORAL,OBJECTIVE,OBJECTIVES,PATHOLOGY,PROGRAM,REGARDING,RESULTS,SINCE,THEIR,TNM,WHEREAS
001,1000,150,169,194,2007,2009,2012,231,250,8804,8805,CONCLUSION,CONTINENCE,COPYRIGHT,ENDOPELVIC,FUNCTIONAL,GLEASON,IIEF,INC,INCLUSION,JANUARY,LABEL,METHODS,OBJECTIVE,OIF,PATHOLOGIC,PRESERVING,PSA,RESULTS,THERE
169,194,1990,2012,25TH,75TH,BPSA,CAP,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,MINNESOTA,MIXED,OBJECTIVE,OLMSTED,PSA,RESULTS,THESE
169,194,2012,CONCLUSION,COPYRIGHT,CRPC,FORTY,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PSA,RESULTS,SEVERAL
169,194,2012,8804,8805,9109,ADT,AMONG,CASES,COPYRIGHT,FIFTY,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PFS,RESULTS,SIXTY,SWOG
001,133,169,194,2011,2012,8805,CONCLUSION,COPYRIGHT,INC,IQR,JANUARY,LABEL,METHODS,OBJECTIVE,OVERALL,RESULTS,SUBJECTIVE
169,186,194,2012,210,BASED,CIS,CONCLUSION,COPYRIGHT,FOUR,INC,LABEL,METHODS,OBJECTIVE,PFMT,RESULTS,THREE
169,173,194,2007,2012,CAGIANNOS,CONCLUSION,COPYRIGHT,EPLND,INC,LABEL,LNI,METHODS,OBJECTIVE,RESULTS
1000,169,1997,2006,2012,600,BACKGROUND,BASE,CONCLUSION,CONFIDENCE,COPYRIGHT,DATA,EFFECTS,GNRH,LABEL,LTD,MEN,METHODS,OLDER,RESULTS,SIR,SWEDISH
169,2005,2010,2011,241,5MG,8805,AEU,AFTER,APRIL,BACKGROUND,COPYRIGHT,CRPC,DOCETAXEL,ESPA,FIVE,LABEL,MAY,METHODS,PSA,PUBLISHED,RESULTS
160,169,194,2012,COPYRIGHT,PIM,SAS
109,124,169,2012,BMS,CONCLUSION,COPYRIGHT,CRPC,EVALUATION,GRADE,GROUP,INC,LABEL,METHODS,OBJECTIVE,PCWG,PUBLISHED,PURPOSE,RESULTS,SECONDARY,SOLID,TAX,TCX,UNLABELLED,WORKING
169,2012,COPYRIGHT,LTD,PAGET,SINCE
009,169,2012,930,AMONG,BACKGROUND,BASE,CIS,COPYRIGHT,DATA,GLEASON,LABEL,METHODS,OBJECTIVE,OUTCOME,POISSON,PUBLISHED,RESULTS,SETTING,SIR,STUDIES,THESE,UROLOGY
001,002,008,169,2012,304,680,746,ADT,CONCLUSION,COPYRIGHT,EDUCATION,FALSE,FDR,FDRS,FOUNDATION,INC,LABEL,MAYO,MEDICAL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SNP,SNPS
169,194,2012,AGENT,CAP,COPYRIGHT,INC,SEVERAL,THESE
169,2012,413,946,BACKGROUND,CODOMINANT,COPYRIGHT,CRT,IRELAND,LABEL,LATE,LTD,MATERIALS,METHODS,NEITHER,OBJECTIVE,PURPOSE,RESULTS,SNPS,TGF
100,473,954,ALSO,CD133,EGF,EGFR,MIC,NB26,PCS,SER,THESE,WPE1
8202,956,AKT,APOPTOSIS,MCL,MOST,SORAFENIB
CHIP,CRPC,FOXA1,FURTHER,INHIBITION,LNCAP,OVERALL
001,145,ANOVA,DU145,FLOW,LABEL,MANN,MATERIALS,METHODS,MHC,MICA,OBJECTIVE,PC3,PDE,PDE11,PDE5,PDES,RESULTS,THESE,TREATMENT,WHITNEY
160,302,H460,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SEVEN,THESE
064,107,144,AFTER,AUSTRALIA,IQR,LABEL,MEN,METHODS,OBJECTIVE,OUTCOME,QUEENSLAND,RESULTS,TREATMENT
091,AMONGST,BMI,CONCLUSION,FEW,HOWEVER,LABEL,METHODS,OBJECTIVE,PROTECT,PSA,PURPOSE,RESULTS
HCT,PTA,RBCS,VARIOUS
8Q24,DG8S737,MYC,PCA,SNPS
169,2012,BASED,CBCT,COPYRIGHT,CTV,IGRT,INC,INTER,LABEL,MARGINS,MATERIALS,METHODS,OBJECTIVE,PBM,PTV,PURPOSE,RESULTS
169,2012,COPYRIGHT,FORTY,IMRT,INC,LABEL,MATERIALS,METHODS,MOST,OBJECTIVE,PBT,PCA,PURPOSE,RCT,RESULTS,SEVENTEEN,WTP
169,2012,231,99M,AMONG,ASP,BALB,COPYRIGHT,GRP,INC,LABEL,MAG,MCF,MDA,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SEVERAL,T47
169,1990,2008,2012,AGE,COPYRIGHT,DETECTION,EARLY,EPCDP,FURTHER,LITHUANIA,LITHUANIAN,LTD,POPULATION,PROGRAMME,PSA,PUBLISHED,ROYAL,SOCIETY,THERE
1100,169,1986,2009,2012,382,BACKGROUND,BASED,BCA,COPYRIGHT,DFS,DSS,JANUARY,LABEL,METHODS,OBJECTIVE,PATHOLOGIC,PLND,PRIMARY,PUBLISHED,RESULTS,RFS,SETTING,UROLOGY
169,2012,364,BRCA,BRCA1,COPYRIGHT,HADS,LTD,THUS
169,2012,231,233,CONCLUSION,COPYRIGHT,DISCUSSION,FOUR,LABEL,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SAS,SFRO,SOCI
FDA,FINALLY
2008,801,ADVERSE,AMONG,BACKGROUND,DESPITE,GERMANY,ITALY,JUNE,LABEL,METHODS,OBJECTIVE,RESULTS,SIGNS,SPAIN,TDS,TREATMENT
ARTIFACTS,CALYPSO,CRAWLEY,KINGDOM,LABEL,MEDICAL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEATTLE,SYNERGY,THESE,XVI
100,8201,BASED,CALYPSO,DIL,DOSE,GAMMA,IMRT,LABEL,MEDICAL,METHODS,OBJECTIVE,PLANS,PTV,PURPOSE,RESULTS,SEATTLE,USA,VMAT
8201,CARLO,LABEL,LARGE,LDR,METHODS,MONTE,OBJECTIVE,PURPOSE,RESULTS,THERE,THEREFORE,THREE
120,8201,931,963,BECAUSE,IMRT,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SDS,SGT,WITHOUT
8201,8804,916,963,BEAMS,IMPT,LABEL,METHODS,OARS,OBJECTIVE,PTV,PURPOSE,RESULTS,THREE,TPS
949,BLANK,GOS,GOSERELIN,LNCAP,PCL,PEG,SERUM
001,020,036,038,1994,2007,233,408,760,BACKGROUND,CASES,CIS,CONCLUSION,LABEL,METHODS,MIN,OBJECTIVE,ORS,PUFA,PUFAS,RESULTS,SUPPL,THESE,VITAMINES
AMONG,ANALYZING,ETS,HOWEVER,PC3,PDEF,SIMILAR,STMN,TET,THESE,USING
169,2012,AUC,AUCS,CARLO,ELTEREN,GMBH,KGAA,MONTE,ROC,STRATUM,VCH,WILEY
CTLA4,CYTOTOXIC
169,2012,945,946,COPYRIGHT,EPCAM,FAK,HOWEVER,IGF,INC,PRCA,RACK1,SRC,THESE,TROP,USING,WILEY
169,2012,COPYRIGHT,LBD,LTD
001,169,200,2012,FCH,GSTP1,HRPC,INC,LABEL,METHODS,OBJECTIVE,PCR,PET,PURPOSE,RARB2,RESULTS,THESE,WILEY
169,2012,945,ATHYMIC,BRDU,CD31,DIGOXIN,HIF,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PCR,PURPOSE,RESULTS,WESTERN,WILEY
169,2012,945,946,HOWEVER,UROLOGICAL
LATER,RECURRENCE
001,007,013,015,029,048,049,053,092,128,19E,218514200,220,251,318,486,491,534,653,965,C30,EORTC,LABEL,LITHUANIA,METHODS,OBJECTIVE,ORS,QLQ,QOL,QUALITY,RESULTS
946,AMONG,INCREASED
CRPC,ONCE,PCA,WESTERN
011,015,018,1306,1306C,1306T,169,190,200,2012,303,303C,303T,418,418G,735,735C,AIMS,BACKGROUND,COPYRIGHT,GENOTYPING,HAPLOTYPE,HOWEVER,IMSS,INC,INDIA,LABEL,METHODS,MMP2,MMPS,NORTH,OBJECTIVE,PCA,PCR,PUBLISHED,RESULTS,THESE,TIMP2,TIMPS
IGRT,IMAGE,MRI,PET,THESE
2011,223,945,CRPC,CYP17,DENOSUMAB,MDV3100,OVERALL
000,100,101,139,2007,2012,283,398,565,703,717,APART,BACKGROUND,CONCLUSION,ESTIMATING,LABEL,MATERIALS,METHODS,POISSON,RESULTS,UNION,USING,WORLD,YOUNGER
8482,BACKGROUND,CELLSEARCH,COMPARISON,CRPC,CTCS,FACS,GENOMIC,HIGH,HOWEVER,LABEL,METHODS,RESULTS,WGA
001,015,169,1982,2010,2012,656,842,8804,8805,AMONG,AUTHORS,BFS,BJU,BOARD,CSS,GLEASON,LABEL,MEIER,MEN,METHODS,MFS,OBJECTIVE,PSA,RESULTS,T2B,THERE,UNLABELLED,WHAT
169,1997,2007,2012,2663,AIMS,BLACKWELL,CASES,DESPITE,GLEASON,LABEL,LNS,LTD,METHODS,MOST,OBJECTIVE,PCA,PSA,PUBLISHING,RESULTS,SEVEN
169,2012,218,434,8226,8805,931,ADIPOSE,AUC,AUCS,BJU,CONCLUSION,GLEASON,INCREASING,LABEL,LEVEL,METHODS,OBJECTIVE,PPF,PROGNOSIS,RESULTS,TRUS,TYPE,UNLABELLED,WHAT
169,2012,ASIA,ASIAN,CALIFORNIA,CHANGES,NORTH,WEST
174,17A1,CRPC,ORAL,P450
169,177,183,2005,2010,2012,219,402,447,8804,AMICO,BCF,BJU,DATA,HIFU,HORWITZ,LABEL,MAY,MEAN,METHODS,NORTH,OBJECTIVE,OVERALL,PRE,PRIMARY,PSA,RESULTS,STUTTGART,TURP,UNLABELLED,WHAT
033,1000,169,2000,2012,323,341,731,857,877,889,896,937,ADC,ADCS,CONCLUSION,COPYRIGHT,GLEASON,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,ROC,TESLA,WEAK,WILEY
001,1178,133,148,157,182,201,460,731,BACKGROUND,CATS,HIGH,INCREASED,LABEL,METHODS,RESULTS,THROMBOSIS
2009,2010,447,AEROMONAS,BETWEEN,DESPITE,EARLY,JANUARY,LABEL,MDRO,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEPTEMBER,SIX,UROSEPSIS
DCIS,DRUGS,MAME,OPTICAL,OTHER
001,169,1992,2005,2011,736,AFTER,BACKGROUND,COPYRIGHT,EFFORTS,END,FRAGMENTED,HERFINDAHL,HIRSCHMAN,INDEX,LABEL,METHODS,PSA,RESULTS,SEER,SOCIETY,USING
2008,BACKGROUND,FEE,FEW,LABEL,MAIL,MAIN,METHODS,MOST,OBJECTIVE,OBJECTIVES,RESULTS,WHILE
946,GDF,HOWEVER,PCA,TGF
016,033,2847,3657,5872,6255,677T,BACKGROUND,C677T,CIS,LABEL,METHODS,MTHFR,NEITHER,ODDS,ORS,OVERALL,RESULTS
2011,ADT,BPS,DENOSUMAB,IGG,OSTEOPENIA,RANKL,SRES
200,946,DEPLETION,EMT,EPITHELIAL,MIR,PTEN,SLUG,THUS,TP53,VARIOUS
169,2012,ADULT,COPYRIGHT,LTD,SMOKERS
ADVERSE,DRUG,FOOD,SERIOUS,SIPULEUCEL,TREATMENT
HOWEVER,SIPULEUCEL
FASN,HOWEVER,HU1,MDM2,MDMX,TRT,USP2A
AKT,DIMINISHED,DL100,ERK1,HIV,HOWEVER,LNCAP,SAQ,SAQUINAVIR,TNF,TRAIL,TREATMENT,XIAP
129SV,169,2012,COPYRIGHT,ELISA,ENDOCAN,HOWEVER,MOUSE,PUBLISHED,THESE
CSCS,THEREFORE
169,195,2012,A375,B16,BOTH,COPYRIGHT,COSY,ESI,HMBC,HSQC,INC,NMR,PC3,TAKEN,U251
169,2012,AHX,DOTA,GLU,HBED,III,LNCAP,LYS,PET,PSMA,SOCIETY,UREA
2012,APA,CONGRUENCE,FIFTY,THOSE,USING
169,2012,ASIA,AUSTRALIAN,BLACKWELL,DRUG,FOOD,III,LTD,PTY,PUBLISHING,SINCE
100,140,169,2012,280,ADMT,AUTHORS,BJU,CAB,CONCLUSION,CRPC,CSS,FIFTY,GLEASON,LABEL,METHODS,OBJECTIVE,PFS,PSA,RESULTS,THERE,UNLABELLED,WHAT
169,2012,AACR,ALSO,AMONG,BOTH,DIGOXIN,ERS,HOWEVER,OTHER,THESE,WOMEN
169,176,2012,8201,COPYRIGHT,INC,TECHNIQUE,USING,WILEY
0003,AREA,BONE,CAD,CONCLUSION,COUNT,INTENSITY,LABEL,MET,METHODS,OBJECTIVE,RESULTS,SCAN,USING
008,125,155,2006,2009,BETWEEN,CHI,CONTINUOUS,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,VAN,VELTHOVEN
ATP,HOWEVER,RNAS,USING
000,101,172,176,325,500,964,BOOLEAN,CGEMS,GWAS,HOPKINS,HOWEVER,INSTITUTE,JHH,JOHNS,MARKERS,OPERATION,PCA,SCREENING,SIXTEEN,SNP,SNPS,TESTING
160,ACUTE,ADVERSE,CONCLUSION,CTCAE,DVH,GRADE,IMRT,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIB,V65,V70,V75
005,2005,268,ADDITIONAL,GLEASON,HIGH,ILL,ISUP,PATHOLOGY,SOCIETY,THESE,THREE,UROLOGICAL
ADT,BASED,COLLEGE,CROSS,DESPITE,PCA,STUDIES
AKT,EPIGENETIC,EZH2,IGF2,INSTEAD,PI3K,WHEREAS
DUE,GREATER,HOWEVER
DTCS,HSC,HSCS,PCA
ETS
003,10Q26,11Q12,141,215,2P11,3P11,557,804,FAM111A,FAM111B,GWAS,SNPS
169,2012,CARLO,COPYRIGHT,DRE,INC,MONTE,ORS,PSA,USING
169,2012,AFM,BACKGROUND,CELL,COPYRIGHT,DESPITE,GENERAL,LABEL,LNCAP,MAJOR,METHODS,SCOPE,THESE
946,AKT,GTPASES,RAC1,RHO,RHOB,RNAI,UROKINASE
143,169,2010,2011,2012,ANALYZE,BACKGROUND,CLAVIEN,CLOQUET,COPYRIGHT,LABEL,LIMITED,LYMPH,METHODS,OBJECTIVE,PLA,PROCEDURE,PSA,PUBLISHED,RESULTS,ROBOTIC,SEPTEMBER,SETTING,UNDER,UROLOGY
100,169,177,2012,99M,AUC,BACKGROUND,BASED,BVC,COPYRIGHT,FOUR,HOWEVER,LABEL,METHODS,MRI,OBJECTIVE,PCA,PUBLISHED,RESULTS,SETTING,TECHNETIUM,TXR,UROLOGY,WBMRI
169,2012,COPYRIGHT,HOWEVER,IRELAND,JEGHERS,LTD,PEUTZ
169,2012,COPYRIGHT,IMAGING,INC,MEDICAL,PUBLISHED,STRUCTSURE,THEREFORE,THESE,UPON
169,177,198,2012,BLADDER,CONCLUSION,COPYRIGHT,DAILY,DOME,FOUR,ISOTROPIC,LABEL,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SAS,SEVENTEEN,SIX
169,194,2011,945,COPYRIGHT,HYDROXY,LTD,SEEBACH,USING,VOLTAGE
169,194,2011,CONCLUSION,COPYRIGHT,LABEL,MEAN,METHODS,MRI,OBJECTIVE,POSTERIOR,PTV,PURPOSE,RESULTS,SAS,TDM,TEN
169,2012,BMP,BMP6,EC109,HOWEVER,INSTEAD,KNOCKDOWN,SOST
108,144,1989,2004,ANOTHER,BETWEEN,BPFS,COX,CPFS,CSS,GLEASON,IQR,JANUARY,LABEL,MEIER,METHODS,OBJECTIVE,PCA,PSA,RESULTS
154,260,ACCRUAL,BACKGROUND,LABEL,METHODS,RESULTS,TRIAL
AKT,ATO,LNCAP,ROS,THESE
101,115,134,155,174,ACH3,ARGONAUTE,CPG,H3K9ME2,HEPARANASE,HPA,INSTEAD,PCR,RNAS,SP1,TFIIB,TGS,THESE,TSS
0001,108,239,8202,CRPC,EXPRESSION,GLEASON,KNOCKDOWN,MCAK
2006,2009,22RV1,234,293T,8202,CFS,MLV,MLVS,THESE,URISMAN,XENOTROPIC,XMRV
BTG1,CDK6,CHIP,FOUR,HOWEVER,RAR,RARE,SAMD3,TGM4
CONCLUSION,HEAT,HSP,HSP27,LABEL,LNCAP,METHODS,MOST,OBJECTIVE,PCR,PURPOSE,RESULTS,TREATMENT,WESTERN
916,ACTIVATION,CRPC,LABEL,LBD,METHODS,OBJECTIVE,PCA,PURPOSE,Q640X,RESULTS,THESE
169,2012,CHEMISTRY,PSA,ROYAL,SOCIETY
000,100,102,115,119,152,996,AFTER,BACKGROUND,COMPARISON,DESPITE,LABEL,METHODS,PCR,PSA,RESULTS,SERUM,THERE,TOTAL
017,215,349,BACKGROUND,CCP,CONCLUSION,GLEASON,LABEL,METHODS,PSA,RESULTS,TOTAL
100,169,2012,8804,8805,AFTER,COMPARISON,COPYRIGHT,EARLY,GROUP,INC,LABEL,LATE,MATERIALS,MEIER,METHODS,MUCOSAL,OBJECTIVE,PURPOSE,RADIATION,RECTOSCOPY,RESULTS,SCORE,THERAPY,TREATMENT,VRS
169,194,197,2012,945,AFRICAN,ATTENDING,CONCLUSION,COPYRIGHT,FURTHER,HIV,INC,INDEX,LABEL,LIFE,MEAN,METHODS,OBJECTIVE,QUALITY,RASCH,RESULTS,SETTING,SOUTH,SPIRITUAL,SWB,TRANSLATED,UGANDAN,VITAS
169,2012,300,316,660,685,ACCORDING,BOTH,LNCAP,MG132,NH1,THESE
100,11P13,12P12,169,1P36,2012,945,AFTER,ARRAY,ASIA,AUTHORS,BLACKWELL,CD10,CD34,CGH,EGFR,LTD,MIB,PATHOLOGY,PSA,PTY,PUBLISHING,SMA,SOCIETY,WT1
169,1994,1999,2003,2012,8236,8804,9995,ASIA,AUTHORS,BLACKWELL,DEPARTMENT,DESPITE,GENERAL,GLEASON,HGPIN,LTD,PATHOLOGIC,PATHOLOGY,PTY,PUBLISHING,SOCIETY,TAIWANESE,THERE,WESTERN
AMD3100,CD133,CD44,CXCL4,CXCR4,HOWEVER
PANDA,THZ
169,2012,AIC,BIC,COPYRIGHT,CRITERION,JOHN,LTD,SONS,WILEY
160,177,181,264,324,A549,HEPG2,IC50,MTT,ORAC,PC3,RAW,WRL
BESIDES,PET
APART,PET
100,165,252,AFTER,AIM,BACKGROUND,C30,CONCLUSION,CONCORDANT,EORTC,GIVEN,LABEL,METHODS,MOST,OBJECTIVE,PF2,QLQ,QOL,RADICAL,RESULTS,SCALE
125,177,CONCLUSION,DCE,EIGHT,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PSA,RESULTS
100,1216,130,215,300,500,800,992,ADC,ADCS,CONCLUSION,DWI,LABEL,MATERIALS,METHODS,MRI,NPV,OBJECTIVE,PPV,RESULTS,ROI,SIXTEEN,TRUS
163,169,2012,600,CONCLUSION,HIPAA,LABEL,MATERIALS,METHODS,NAA,OBJECTIVE,PURPOSE,RESULTS,RMSE,RSNA,SIMILAR
127,169,2007,2010,2012,795,APAS,BETWEEN,CONCLUSION,DIAGNOSTIC,JULY,LABEL,MATERIALS,METHODS,NINE,OBJECTIVE,OVERALL,PURPOSE,RALP,RESULTS,RSNA
169,170,177,2012,211,ADC,AREA,CANCERS,CONCLUSION,GLEASON,HIPAA,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,RSNA,WHOLE
2006,2009,2011,NAMED,SUBSEQUENT,XMRV
1950,1958,1960,1963,1985,1988,1993,2000,2006,8764,ASIA,CHINA,DATA,EAST,HONG,JAPAN,JOINPOINT,KONG,KOREA,SINGAPORE,THERE,THEREFORE,THESE
100,125,18F,8805,BACKGROUND,DOSE,FIFTY,LABEL,LIMITED,METHODS,MTD,NINE,PDS,PI3K,RESULTS,SEVENTEEN,THREE,TIW
FIRST,LABEL,OBJECTIVE,ONCE,PURPOSE,RESULTS,SUMMARY,SUPPORTIVE
004,006,009,380,636,75GY,874,8805,ADT,BACKGROUND,CONCLUSION,COX,DOSE,FFS,FORTY,GLEASON,LABEL,MEIER,METHODS,PRCA,RECURSIVE,RESULTS
110,140,281,282,292,318,LABEL,MEAN,METHODS,NPV,OBJECTIVE,PATHOLOGIC,PCS,PPV,PURPOSE,RESULTS,SHEAR,SIX,SWE,TRUS,YOUNG
956,CASPASE,CELL,DU145,FACS,LNCAP,PC3,THESE
105,107,139,204,410,462,HBV,HIV,HTLV,SPAIN,THERE,THUS
AREAS,BACKGROUND,COVERED,DESPITE,FDA,III,LABEL,METHODS,OPINION,PHASE,SERM,SERMS,THUS,TOREMIFENE
013,2005,2006,8201,ALSO,PREFERENCE,SES
169,2011,2012,ADDITIONAL,APRIL,AUTHORS,BJU,CONFERENCE,MAY,THESE,ULTIMATELY,UNTIL,WESTERN
169,2012,8194,AUTHORS,BJU,CONFERENCE,DIAGNOSIS,HOWEVER,THESE
945,954,ADCK2,AMONG,HIF,HYPOXIA,IKK,JNK,PRKAR2B,RELB,TAKEN,THESE,TNF,TRIB2,TRPM7
001,0353,122,8202,BPH,MANN,MAPPING,OVERALL,WHITNEY
145,BPH,GLEASON,HOWEVER,LNCAP,PSA,RWPE,SERUM,TAKEN
0215,ADJUSTMENT,GROUP,LABEL,LOCKE,MARITAL,METHODS,OBJECTIVE,PURPOSE,RADIATION,RESULTS,RTOG,TEST,THERAPY,THERE,TREATMENT
169,177,181,183,946,AMONG,BENTH,GEORG,NFF,NMR,PC3,STUTTGART,YORK
32D,8314,950,CD28,CD3,ERBB,ERBB1,ERBB2,OWING,T1E,T1E28,USING
ACA,BBN,GRPR,NBBN,NHET
1996,2006,6325,AIMS,BACKGROUND,CCI,COLORECTAL,CONCLUSION,COX,ELDERLY,JANUARY,LABEL,METHODS,POPULATION,PREVALENCE,RESULTS
280,BACKGROUND,CRPC,DTX,EMP,LABEL,METHODS,PSA,RESULTS,THERE,TTP
006,158,174,181,2003,2006,COMPOSITE,CONCLUSION,DOSE,INDEX,LABEL,METHODS,MOST,NONE,OBJECTIVE,PAINFUL,RESULTS,SEVEN,SWEDISH
948,C1B,DBL,GLU,PKC,PKCS,THR,TYR,VAV,VAV1
2753,8805,AFTER,AUSTRALIAN,BACKGROUND,CONCLUSION,CRC,HOWEVER,LABEL,METHODS,NSCLC,OLDER,RESULTS,THUS
2011,BACKGROUND,CONCLUSION,DATA,EXTRACTION,FUNDING,GLEASON,HEALTHCARE,LABEL,MEDLINE,METHODS,OBJECTIVE,PREDICTORS,PRIMARY,PSA,PUBLISHED,PURPOSE,QUALITY,RESULTS,SELECTION,SIXTEEN,SOURCES,SYNTHESIS
10TH,DESPITE
000,132,240,302,311,503,542,814,BACKGROUND,CFS,GERMANY,HIV,HOWEVER,HVS,LABEL,METHODS,PBMC,PCR,RESULTS,XENOTROPIC,XMRV
CD44,FITC,HMW,HPMA,LABEL,LMW,METHODS,OBJECTIVE,PACLITAXEL,POLYMER,PTX,PURPOSE,RESULTS
1993,1998,372,500,8Q24,CAGCT,CGGCT,CGTCG,MYC
001,002,208,946,AMACR,BOTH,E12,HIFU,LABEL,MEAN,METHODS,MIB,OBJECTIVE,PURPOSE,REFERRING,RESULTS,THESE
100,169,2012,AACR,AKT,EMT,G12D,HOWEVER,MAP,MAPK,MEK,PI3K,PTEN,RAS
160,ARD6562,ARD6563,BACKGROUND,CRPC,DOSE,FIVE,LABEL,METHODS,RESULTS,THERE,THEREFORE
644,8805,BACKGROUND,BEDOK,CONCLUSION,HOWEVER,IPSS,LABEL,LUTS,LUTSS,METHODS,NORTH,QOL,RESULTS,SCORE,SINGAPORE,SYMPTOM,THERE
125,144,1973,2008,AFRICAN,AGE,AJCC,BACKGROUND,CASES,CAUCASIAN,COMMISSION,EACH,END,IRS,JOINT,LABEL,METHODS,PSA,RESULTS,SEER,THERE,THESE
IMAGING,ISSUE,LABEL,METHODICAL,METHODS,MONITORING,MRI,OBJECTIVE,PRACTICAL,PSA,RADIATION
246,431,8201,CCAAT,E2F,E2F1,FINALLY,INCREASING,LNCAP,NUSAP,PC3,TRANSIENT
001,002,125,144,148,160,170,1998,2008,252,667,8201,919,CONCLUSION,EBRT,GLEASON,LABEL,LOW,MATERIALS,METHODS,OBJECTIVE,PHOENIX,PSA,PURPOSE,RESULTS,UTRECHT
GJIC,HOWEVER
CONVERSELY,LOSS,STUDIES,THROUGH
160,287,574,BACKGROUND,CONCLUSION,DAH,DOSE,DOSES,EACH,EBT,FOUR,LABEL,METHODS,PTV,RESULTS
0102,636,655,704,714,718,8805,ANN,ANNS,AUC,AUCS,DVH,EUD,FIVE,FOLLOWING,LATE,THESE
CHINESE,ERG,FURTHER,KHDRBS3,NOTABLY,RNAS,THERE,THREE,TMPRSS2,USP9Y
169,2012,246,COLLECTION,COPYRIGHT,LTD,ORAL,THERE,THEREFORE
136,169,194,2012,COPYRIGHT,CTV,DAILY,FOUR,IGRT,IMAGE,INC,INTER,LABEL,MATERIALS,METHODS,MVISION,OBJECTIVE,PTV,PURPOSE,RESULTS,SIEMENS,SYNERGY
11195,ANT,CONTROL,HENCE,MPTP,PBR,SEVERAL,TSPO,VDAC
AFTER,DRR,DRRS,HDR,IMRT,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THEREFORE,THREE,VMAT
947,ANNEXIN,BACKGROUND,BLOOD,H2A,H2AX,HENCE,LABEL,MATERIALS,METHODS,RESULTS,THERE
169,2012,499,AIMS,ALLELIC,BIALLELIC,BLACKWELL,KEAP1,LABEL,LTD,METHODS,NAD,NRF2,OBJECTIVE,PUBLISHING,RESULTS,SOMATIC
169,2012,GENERAL,JOURNAL,MICROSCOPY,NMF,ROYAL,SOCIETY
179,239,BACKGROUND,BASED,DETECTION,HCV,HIV,HOWEVER,LABEL,PBMCS,PCR,PRINCIPAL,RESULTS,SERA,WESTERN,XENOTROPIC,XMRV
PNT2,SNOM
945,946,AKT,AKT1,AKT2,AKT3,BCL,CAFFEIC,CAPE,CIP1,ERK1,GSK3,KLF6,MICROARRAY,MYC,PDK1,SKP2
SIX
945,946,954,CPG,DU145,GD1A,HOWEVER,LNCAP,PC3,RELB,ST3GALS,THEREFORE
22RV1,AUSTRALIA,DU145,EXPRESSION,FIJI,HOWEVER,LAPC,LNCAP,MEN,PCA,PSA,SP1,THESE,TMPRSS2,WPMY
AKT,IHC,PI3K,PTEN,TFA,TFAS,TFS
945,946,AQUA,AUTOMATED,DESPITE,ESTROGENS,EXOGENOUS,USING
AMONG,FDA,FDR,THESE
945,946,954,AKT,CCN,CCN3,FINALLY,ICAM,ILK,NOV,TAKEN
169,2012,COPYRIGHT,GMBH,INHIBITED,KGAA,VCH,WILEY
169,2012,252,956,ACTA,CHIMICA,COMPOUNDS,COPYRIGHT,FIVE,HELVETICA,THEIR,U937
183,2011,GEORG,STUTTGART,YORK
160,AFFYMETRIX,CNA,CNAS,DFS,DNAS,IHC,LNM,NKX3,OSCC,PCR,PRIMARY,THROUGH
CCCTC,CTCF,FOXA1,H3K4,H3K4ME2,HOWEVER,UNDER
0004,704,BACKGROUND,CTC,CTCS,LABEL,METHODS,RESULTS,SAMPLES
CONCLUSION,LABEL,OBJECTIVE,PURPOSE,SUMMARY
422,897,BACKGROUND,GLASGOW,GLEASON,LABEL,METHODS,NLR,OUTCOME,PROGNOSTIC,RER,RESULTS,SCORE,THERE
152,2010,3010,946,ALSO,BACKGROUND,COLORECTAL,ERSPC,FACTORS,FIFTY,FORCE,HALF,JULY,LABEL,LUNG,MEDICAL,METHODS,OVARIAN,PCPS,PLCO,PSA,RANDOMISED,RESULTS,SCREENING,TASK
0006,110,803,AUC,BACKGROUND,CAP,FURTHER,GLEASON,LABEL,METHODS,MOST,PCR,RESULTS,SPARC,THEREFORE,VALIDATION
204,BACKGROUND,CONCLUSION,HOWEVER,LABEL,MCC,MCV,METHODS,PCR,RESULTS,SAMPLES,WHAT,XMRV
169,2012,BASEL,COPYRIGHT,PSA,USA
001,177,CONCLUSION,LABEL,METHODS,MRI,PCA,PET,RESULTS,UNLABELLED,WHOLE
1990S,ADT,CRITICALLY,DESPITE,MOST,OVERALL,PSA
ADT,INSULIN,PCA
HOWEVER,PSA
1980S,BECAUSE,CTAS,HOWEVER,PSA,THUS
CONSIDERED,CYR61,FURTHER,PCA
001,100,169,2012,COPYRIGHT,INC,LAMP,PCR,PLA,PSA,SENSITIVE,USING
161,177,908,DICE,HOWEVER
134,143,167,169,189,2006,2011,2012,8804,8805,BACKGROUND,COPYRIGHT,GLEASON,JULY,LABEL,METHODS,MOST,OBJECTIVE,PATHOLOGY,PCA,PRIAS,PSA,PUBLISHED,RESULTS,SETTING,UROLOGY
169,2012,916,945,AF4,COLLECTED,COPYRIGHT,IEF,WHILE
169,2012,COPYRIGHT,LTD
11C,169,2012,AFTER,COPYRIGHT,IMAGE,IRELAND,LABEL,LTD,METHODS,MRI,OBJECTIVE,OBJECTIVES,PET,RESULTS
125,169,2003,2008,2012,714,715,ACUTE,AUR,COMPARISON,CONCLUSION,COPYRIGHT,INC,JANUARY,JULY,LABEL,MATERIALS,MEDICAL,METHODS,OBJECTIVE,PREDICTIVE,PUBLISHED,PURPOSE,RESULTS,SOCIETY,STILL,THEREFORE,TORONTO,UNIVERSITY,UTRECHT
1570,169,2012,553,643,COPYRIGHT,GLEASON,LTD,PSA,THESE
077,1009,169,2012,8805,COPYRIGHT,COX,DATA,DOSES,FIRST,GRADE,GROUP,INC,INSTEAD,KUTCHER,LABEL,LKB,LYMAN,MATERIALS,METHODS,NEXT,NTCP,OBJECTIVE,PURPOSE,RADIATION,RESULTS,THERAPY,THERE,THIRD,V75,VDOSE
169,2000,2008,2012,COMPLIANCE,COPYRIGHT,INC,LABEL,LOCAL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SECONDARY,TREATMENT
0001,0005,002,0067,008,035,100,169,2012,223,CONCLUSION,COPYRIGHT,CRPC,LABEL,LTD,METHODS,OBJECTIVE,PAIN,PURPOSE,RESULTS,THERE,VAS
169,194,2012,COPYRIGHT,COX,DU145,EDUCATION,GLEASON,HOWEVER,INC,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THUS,UROLOGICAL
108,110,169,1997,2005,2012,218,ADT,BACKGROUND,BTB,COPYRIGHT,EBRT,GLEASON,HDR,III,INCIDENCE,IRELAND,LABEL,LTD,METHODS,PSA,RESULTS,RFS,SECONDARY
014,169,2012,BIND,COPYRIGHT,DOCETAXEL,ENGINEERED,HOWEVER,IRELAND,LTD,THERE
169,194,2012,946,COPYRIGHT,INC,PTEN,SMAD4,TGF,THUS
100,104,150,169,2013,208,462,ACCORDING,ADT,BACKGROUND,BASED,CAP,COPYRIGHT,GEE,INC,LABEL,METHODS,MOST,PBS,PCI,RAD,RALP,RESULTS,UCLA
157,169,2012,AUR,AXIAL,COPYRIGHT,DWI,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,OTHER,PUBLISHED,RATIONALE,RESULTS,THUS
001,004,008,169,194,2012,258,COPYRIGHT,CURRENTLY,EDUCATION,GROUP,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PATIENT,PCI,POST,PUBLISHED,PURPOSE,RESULTS,THESE,UCLA,UROLOGICAL,USING
169,194,2012,947,COMPARING,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PERIPHERAL,PUBLISHED,PURPOSE,REGULATORY,RESULTS,SINCE,UROLOGICAL
169,194,196,2012,AFTER,COPYRIGHT,EDUCATION,GANGNAM,HEALTHCARE,INC,LABEL,MATERIALS,MEN,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SCORE,SEOUL,SYMPTOM,UNIVERSITY,UROLOGICAL,USING
0001,116,169,2012,243,264,447,470,977,AMONG,BACKGROUND,CANCERS,COLORECTAL,COPYRIGHT,DIAGNOSIS,ENDOSCOPY,FSG,INC,LABEL,LUNG,MAIN,METHODS,MOSBY,OBJECTIVE,OUTCOME,OVARIAN,PLCO,PREVALENT,PUBLISHED,RESULTS,SCREENING,SETTING,SOCIETY,THESE,TRIAL
169,2012,AKT,AUTHORS,FEBS,JOURNAL,MST1,ORIGINALLY,PHLPP,PI3K,PTEN
004,115,169,2012,250,400,CETUXIMAB,CMP,COPYRIGHT,CRPC,EGFR,INC,KEY,LABEL,MATERIALS,METHODS,OBJECTIVE,PSA,PURPOSE,RADIOLOGIC,RESULTS,THERAPY,TTP
110,169,2012,AUTHORS,BH10,FEBS,FORWARD,HIV,HOWEVER,JOURNAL,MOLONEY,MOMLV,RTS,XMRV
169,2012,8194,8226,BJU,EBRT,HIFU,HOWEVER
120,150,8776,LOD,LPNE,M13,PBF,PEDOT,PSMA
ACL,ACLY,ATP,COA,THEREFORE
1022,ATLAS,BPH,DRE,EPS,FINALLY,PCA,PROTEIN,TECHNOLOGY,URINARY,WESTERN
169,2012,BASEL,CAM,COPYRIGHT,MAXIMUM,SYSTEMS
0001,931,963,DESPITE,IGRT,LABEL,METHODS,OBJECTIVE,POPULATION,PTV,RESULTS,SYSTEMATIC,TCP,TREATMENT
110,169,2012,CAP,CONCLUSION,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,OPERATING,PURPOSE,QDA,QISES,QUADRATIC,RESULTS,ROI,T2W,TESLA,WILEY
PATHOLOGIC,RANKL,THERE,WHILE
8594,916,945,ACADEMY,CHANG,CRPC,DHT
ALSO,COMMENTARY,DUE,GIVEN,HOWEVER,SIPULEUCEL,TODAY
DRUG,FOOD,HOWEVER
169,177,1987,2007,2012,2675,8805,ADT,AMONG,BACKGROUND,CONCLUSION,COPYRIGHT,LABEL,LOW,LTD,METHODS,NCCN,NETWORK,PCSM,PSA,RESULTS
169,1990S,2009,2010,2012,COPYRIGHT,FORCE,PREVENTIVE,PSA,SAS,SCREENING,TASK,YET
0001,169,2004,2010,2012,7643,BACKGROUND,COPYRIGHT,DESPITE,GLEASON,HALF,LABEL,METHODS,OBJECTIVE,PRIOR,PUBLISHED,RESULTS,SETTING,STUDENT,UROLOGY
169,182,1992,2007,2012,757,8805,ADDITIONAL,ADT,BACKGROUND,COPYRIGHT,COX,GNRH,HOWEVER,LABEL,METHODS,OBJECTIVE,PAD,PCA,PUBLISHED,RESULTS,UROLOGY
000,100,150,169,194,200,2012,CARLO,COPYRIGHT,EDUCATION,HOWEVER,INC,INCREASED,LABEL,MATERIALS,METHODS,MONTE,OBJECTIVE,OLDER,PATIENT,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
016,169,194,2012,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UPON,UROLOGICAL
001,041,169,194,2012,264,429,485,680,AFTER,COPYRIGHT,EDUCATION,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PROPENSITY,PUBLISHED,PURPOSE,RADICAL,RESULTS,THESE,UROLOGICAL,USING
169,194,2000,2005,2007,2012,290,ASIAN,COPYRIGHT,EDUCATION,END,GLEASON,INC,INTENSITY,LABEL,MATERIALS,METHODS,MOST,OBJECTIVE,PATIENT,PUBLISHED,PURPOSE,RESULTS,SEER,THREE,UROLOGICAL
169,194,2001,2006,2012,820,COPYRIGHT,CURRENT,EDUCATION,GIVEN,HIGH,INC,LABEL,MATERIALS,METHODS,NUTRITION,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THERE,UROLOGICAL
001,169,194,2012,795,AUC,BLACK,COPYRIGHT,EDUCATION,FURTHER,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OLDER,PUBLISHED,PURPOSE,RESULTS,ROC,UROLOGICAL
BMI,OBESITY
CURRENTLY,IMAT,IMRT,INTENSITY,TOWARDS
AREA,BACKGROUND,BOTH,COVERED,DUE,LABEL,LEUPROLIDE,METHODS,OPINION
000,100,169,2000,2010,2012,AUTHORS,BJU,EBRT,GROUP,PSA,RESULTS,TECHNICAL,WHAT
169,2012,AUTHORS,BJU,LOW,WHAT,WHOLE
120,ADDITIONAL,FEW,LABEL,METHODS,OBJECTIVE,OUTPATIENT,PHYSICIANS,PROVIDERS,PURPOSE,RATES,RESULTS
089,2000,2007,BACKGROUND,COLORECTAL,FACTORS,FIRST,HMOS,III,JANUARY,LABEL,LMWH,METHODS,OVERALL,RESULTS,USING,VTE
10Q23,169,16Q22,16Q23,2012,21Q22,6Q15,8P21,8Q24,AFFYMETRIX,COPYRIGHT,HGPIN,IDENTICAL,INC,MICROARRAY,THESE,USING,WILEY
029,159,169,2004,2012,605,AIS,CAP,INC,LSDB,OPEN,SOCIETY,VARIATION,WILEY
MICRORNAS
1974,945,BPH,CURRENTLY,NEITHER,THREE
120,2010,ADT,BASED,DENOSUMAB,RANKL,SRE
169,177,200,2012,BACKGROUND,COPYRIGHT,DEFORMABLE,DISCUSSION,ENDORECTAL,GHZ,INTEL,IRELAND,LABEL,LTD,METHODS,MRI,MRIS,RAM,REFINEMENT,RESULTS,TPS,USING
002,169,2012,8226,AFTER,ANGELES,AUTHORS,BFB,BJU,BLADDER,CALIFORNIA,ICIQ,INDEX,IPSS,KEGEL,LABEL,LEVEL,LIFE,LOS,METHODS,OAB,OBJECTIVE,OVERACTIVE,OVERALL,PCI,PERI,QOL,QUALITY,RCT,RESULTS,SCORE,SYMPTOM,THERAPY,TYPE,UCLA,UNIVERSITY,UNLABELLED,URINARY,WHAT
001,116,2006,2010,BACKGROUND,BETWEEN,COMPOSITE,EPIC,INDEX,LABEL,METHODS,OBJECTIVE,PCA,PURPOSE,RALP,RESULTS,RRP
100,125,169,175,177,183,2003,2009,2012,216,8226,8804,8805,AUTHORS,BJU,D90,GROUP,IPSS,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,PATIENT,PERSISTENT,PSA,RADIATION,RESULTS,SCORE,SYMPTOM,THERAPY,THERE
041,070,ADH1B,ALCOHOL,COLORECTAL,LUNG,OVARIAN,PLCO,SCREENING,SNPS,THREE,TRIAL
8194,DUE,FURTHER,TRP,TRPV6
228,252,CONCLUSION,FEBRILE,FIRST,LABEL,MAIN,METHODS,OBJECTIVE,PSA,RESULTS,TECHNISCHE,UNIVERSIT
ERG,ONCOGENIC,WESTERN
FDA,YET
124,169,194,1996,2012,COMMITTEE,COPYRIGHT,HIPAA,INC,LABEL,LOCAL,MATERIALS,METHODS,NINE,OBJECTIVE,PURPOSE,RECURRENT,RESULTS
169,194,1999,2002,2007,2012,918,BETWEEN,COPYRIGHT,INC,INTENSITY,LABEL,MATERIALS,METHODS,MINIMALLY,OBJECTIVE,PURPOSE,RESULTS,THERE
108,125,131,169,194,2012,ASTRO,CONCLUSION,CONSENSUS,COPYRIGHT,GROUP,INC,LABEL,LATE,MATERIALS,METHODS,OBJECTIVE,PHASE,PHOENIX,PURPOSE,RADIATION,RADIOLOGY,RESULTS,SOCIETY,THERAPY,THERE,TREATMENT
160,169,186,190,2006,2007,2008,2009,2012,BETWEEN,COPYRIGHT,IGRT,IMRT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCORE,SYMPTOM,THESE
169,177,2012,CHI,COPYRIGHT,CROWN,DICE,DOSE,DRR,DSC,HOUNSFIELD,INC,LABEL,MATERIALS,MEAN,METHODS,MRI,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SCANS,WHOLE
169,1992,2005,2012,797,COMPETING,CONVERSELY,COPYRIGHT,CSM,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,PCA,PROPENSITY,PURPOSE,RESULTS,THESE
169,2012,652,CALYPSO,CHASE,CONCLUSION,CONFORMAL,COPYRIGHT,FIFTEEN,FOX,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SET
122,132,134,169,1998,2009,2012,375,BAP,COPYRIGHT,FOUR,INC,LABEL,MARCH,METHODS,NTX,OBJECTIVE,ONJ,ORAL,OVERALL,PUBLISHED,PURPOSE,RESULTS,SEPTEMBER,SIMILARLY,USING
0001,DEPLETION,EPIGENETIC,EZH2,H3K27,H3K9,HMT,RING,SET,SUV39H1,UHRF1
169,1998,2010,2012,ABS,COMPLIANCE,CONCLUSION,COPYRIGHT,INC,LABEL,LDR,MATERIALS,METHODS,MICK,MOUNT,NUCLEAR,OBJECTIVE,PUBLISHED,PURPOSE,RADIO,RESPONSES,RESULTS,SIXTY,SOCIETY,THERE,USA
169,194,2012,BASIC,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RADIATION,RESULTS,SOCIETY
100,113,115,125,150,169,2012,245,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SOCIETY,T1WI
EPHA2,HENCE
169,2012,DU145,EACH,HRMS,NMR,SOCIETY,STRUCTURES
946,CD24,CD44,CSC,DU145,HOWEVER,THESE
1031,1294,1468,185,230,2390,3034,326,367,492,505,767,852,BACKGROUND,CONCLUSION,ITALY,LABEL,METHODS,RESULTS
CHOP,DR5,DU145,HOWEVER,HRPC,PC3,ROS,THESE,TRAIL
001,008,100,169,195,2001,2003,2007,2009,2012,8201,8805,BACKGROUND,CONCLUSION,COPYRIGHT,DESPITE,FURTHER,GLEASON,INC,INDIVIDUAL,LABEL,METHODS,RESULTS,THERE,WILEY
169,183,AKT,BAX,BCL2,ERK1,GEORG,IGF1,IGF1R,LNCAP,MAPK,MCF,PI3K,STUTTGART,THUS,TRIFOLIUM,YORK
169,2012,COPYRIGHT,ELECTRODES,GMBH,KGAA,VCH,WILEY
CLINICALLY,CTC,HOWEVER,LABEL,OBJECTIVE,OVERALL,PURPOSE,RESULTS,SUMMARY
DRUG,FOOD,III,IPILIMUMAB,LABEL,NOVEL,OBJECTIVE,PURPOSE,RESULTS,SUMMARY,THESE
2009,AFTER,APRIL,BETWEEN,COUCH,CTV,EACH,LABEL,MATERIALS,METHODS,OBJECTIVE,ORGAN,PTV,PURPOSE,RESULTS,SYSTEMATIC
ADT,CRPC,LABEL,OBJECTIVE,PTEN,PURPOSE,RESULTS,SUMMARY
945,CRPC,CYP17,FDA,LABEL,MDV3100,NOVEL,OBJECTIVE,PURPOSE,RESULTS,SUMMARY,THESE
004,1B1,221,447,668,CYTOCHROME,HOWEVER,ISI,LEU,LEU432VAL,OVERALL,P450,SNP,STATA,TEN,VAL
169,2012,215,BACKGROUND,CD80,COPYRIGHT,FUNDING,GRADE,INSTITUTES,IPILIMUMAB,LABEL,LTD,METHODS,PSA,RANDOMISED,RESULTS
169,183,2006,2012,215,3697,AMSTERDAM,BACKGROUND,CELL,COPYRIGHT,DUE,DUTCH,FOUNDATION,FUNDING,FURTHER,GENESYS,GVAX,INC,KWF,LABEL,LTD,MEDICAL,METHODS,RESULTS,SOCIETY,STICHTING,UNIVERSITY,VUMC
102,169,2012,283,286,CONCLUSION,COPYRIGHT,CUES,EMOTIONAL,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,OPNC,RESULTS,SEQUENCES
169,2012,COPYRIGHT,PCR,SAS
037,125,140,150,1500,169,1998,2006,2012,20TH,362,439,791,7TH,8804,8805,ADT,BACKGROUND,BETWEEN,BRITISH,COPYRIGHT,D90,ESTIMATED,GENERALLY,GLEASON,IRELAND,JULY,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PHOENIX,PURPOSE,RESULTS,THERE
10A,145,169,2012,956,ALSO,COPYRIGHT,LNCAP,LTD,MCF,MTT,SIX,SULFIDE,THESE
169,194,2012,CAR,COPYRIGHT,DMES,DRUG,FURTHER,HOWEVER,INC,MDR,NR1I2,NR1I3,NUCLEAR,PXR
108,117,169,2008,2011,2012,265,438,844,AMICO,BACKGROUND,CLINICALLY,COPYRIGHT,CSRS,DETERMINE,EPSTEIN,EXCLUSION,GLEASON,LABEL,MARCH,METHODS,MRGB,MRI,OBJECTIVE,PCA,PSA,PUBLISHED,RESULTS,SETTING,TRUS,UROLOGY
169,2012,CGD,CHRONIC,COPYRIGHT,INC
169,2012,945,ANOTHER,COA,COPYRIGHT,INC
11A,12A,BOTH,CNS,HUVEC,OVERALL,P388
169,2012,20S,AKT,BAD,CENTRAL,LABEL,LNCAP,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THESE,THUS,UROLOGICAL
ADIPOSE,DIET,INCREASING
5P15,GWAS,IRX4,KNOCKDOWN,THESE,THROUGH,VDR
001,005,2003,2010,280,560,8805,ARMSTRONG,BETWEEN,CRPC,EMP,JULY,MARCH,PSA,PSADT,RATES,TREATMENT
946,ADDITIONAL,ADT,CRPC,DOCETAXEL,DRUG,FDA,FOOD,RANKL,SEVERAL,SRC,VACCINE
111,130,140,145,177,342,AFTER,CONCLUSION,DOTA,ESI,HER2,LABEL,METHODS,NOTA,OBJECTIVE,PURPOSE,RESULTS,SINCE,SPR
100,160,A549,ASP,BLOCK,CONCLUSION,DOX,DU145,IONIC,LABEL,METHODS,OBJECTIVE,PC3,PEG,POLYMER,PURPOSE,RESULTS
160,8209,CROSS,LNCAP,PCR,PSM,PSMA,THESE,THREE,TRANSWELL,WESTERN
169,2012,COPYRIGHT,ETS1,S1P,THESE,THROUGH,UICC
073,130,135,192R,260,268,520,55M,ASIAN,CAUCASIAN,CIS,HDL,HOWEVER,L55M,ODDS,ORS,PON1,Q192R,SIMILARLY
177,212PB,3MM2,BUN,HER2,SGPT,TCMC,THESE,TREATMENT
ESUR,KEY,LABEL,MRI,RADIOLOGY,RADS,SOCIETY,TRUE,UNLABELLED,UROGENITAL
160,169,180,188,2012,CHROMOSOME,COPYRIGHT,EXPRESSION,KRC,NOTI,PCR,RCC,SAS
169,2012,946,COPYRIGHT,FEDERATION,PUBLISHED,SMAD,SMAD2,SMAD4,SMADS,SOCIETIES,TGF
001,007,019,169,1998,2007,2012,225,391,941,BASED,BJU,ESRD,HOWEVER,INPATIENT,LABEL,LOS,METHODS,MOST,NATIONWIDE,OBJECTIVE,OVERALL,PROPENSITY,RCC,RESULTS,UNLABELLED,WHAT
076,140,169,176,2012,MONOCLONAL,SNO,SOCIETY,TIN
169,2012,ACADEMY,ANDROLOGY,ASA,AUTHORS,BPH,ELISA,EVEN,HSE,IBT,JOURNAL,LIS,PSA,SERA,SIT,TAT,THERE,YLP
0001,605,BRFS,CONCLUSION,GLEASON,LABEL,MEIER,METHODS,NON,OBJECTIVE,PSA,PSM,PSMS,RESULTS,RRP,UNIVARIATE
1000,1100,169,175,1994,1995,2000,2003,2011,2012,9402,9703,9904,APRIL,BETWEEN,CHIBA,HEAVY,INSTITUTE,ION,JULY,JUNE,LABOR,MARCH,MEDICAL,OCTOBER,SINCE,TECHNOLOGY,UROLOGICAL,WELFARE
177,8201,IMRT,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,WITHOUT
0001,0010,0126,8201,CTV,LABEL,METHODS,OAR,OBJECTIVE,PHYSICIAN,PLANS,PTP,PTV,PURPOSE,RESULTS,RTOG
177,8201,CTV,IMPT,INTENSITY,LABEL,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS
103,176,BOTH,COMMISSION,DMPO,ICRP,IMRT,LABEL,METHODS,OBJECTIVE,PROTECTION,PURPOSE,RANDO,RESULTS,RISK,ROTATIONAL,SIEMENS,TLD,VMAT
CONCERN,DOSE,HDR,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
100,137,176,177,8201,CLINICALLY,D2CC,D30,D90,DOSE,HOWEVER,INSTEAD,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEVEN,THESE,USING,V100,V150,V200
181,PC3,PCM
169,183,2009,8202,ACCORDING,BMD,DVO,GEORG,HISTORY,SECONDARY,STUTTGART,THEREFORE,YORK
091,103,384,AFTER,CONCLUSION,DIAGNOSIS,EPSTEIN,GLEASON,IPCA,KOREANS,LABEL,MATERIALS,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS
001,002,004,006,031,169,177,2013,340,786C,ASP,CAP,COPYRIGHT,G894T,GENOTYPING,INC,NEITHER,NOS,PCR,RLFP,SEVERAL,STUDIES
021,036,114,1983,2010,BACKGROUND,CONCLUSION,EWING,HIGH,LABEL,MEMBRANOUS,METHODS,RESULTS
1058,2007,2009,425,633,BACKGROUND,CITY,DVC,ENDOSCOPIC,GLEASON,HOPE,HOWEVER,JUNE,LABEL,MATERIALS,MEIER,METHODS,OCTOBER,OPERATIVE,PSA,RALRP,RECURRENCE,RESULTS
OCCURRENCE,PATHOLOGY,THREE,TPNB
945,AREAS,BACKGROUND,BPH,COVERED,DHT,LABEL,METHODS,OPINION
200,BACKGROUND,BAGGING,COMPONENT,EMBEDDING,GRAPH,HOWEVER,LABEL,LOCALLY,MRI,PRINCIPAL,RESULTS
ARD1,BECAUSE,CASODEX,DEPLETION,DISRUPTION,GIVEN,NOTABLY,PCA,R1881,SCID
169,1986,2006,2008,2012,229,918,AACR,BACKGROUND,CIS,COX,DATA,HRS,LABEL,MEN,METHODS,RESULTS,WHETHER
007,169,2012,547,729,AACR,AMONG,BACKGROUND,CAD,LABEL,MEN,METHODS,OVERALL,PCA,PSA,RESULTS,WHETHER
ABL,HSP70,HSP90,KNOCKDOWN,MASS,THESE,WASF3
001,0022,0047,0054,0063,037,116,200,646,8211,8804,ADJUNCTIVE,CONCLUSION,COX,ECE,LABEL,LOWER,MEIER,METHODS,OBJECTIVE,OBJECTIVES,PATIENT,PCA,PSA,RESULTS
8804,GROUP,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE
0001,0013,0019,0439,110,177,ANOVA,BACKGROUND,BPH,CONCLUSION,CURRENT,LABEL,METHODS,PCA,PSA,RESULTS,S1P,SPHK1
8217,AMICO,HIGH,HOWEVER,LEVEL,PCA
141,169,2012,BACKGROUND,COPYRIGHT,INC,LABEL,LNCAP,METHODS,PCA,PHENETHYL,RESULTS,SHP,WILEY
169,2012,BACKGROUND,CD90,COPYRIGHT,INC,LABEL,LIN28,METHODS,NANOG,RESULTS,SOX2,THEIR,WILEY
111,8211,AOC,BB2R,BBN,DOTA,LABEL,METASTATIC,METHODS,MICE,MICRO,MICROCT,MICROSPECT,OBJECTIVE,PROCEDURES,PURPOSE,RESULTS,SPECT
0311,100,BACKGROUND,BRCA1,BRCA2,CNV,CNVS,LABEL,METHODS,RESULTS,SEVERAL,USING
1070,169,1745,2008,2011,2012,578,8776,8804,BJU,EXCLUSION,FINAL,GLEASON,JANUARY,LABEL,MARCH,METHODS,NPV,OBJECTIVE,PPV,RESULTS,RRP,STUDIES,UNLABELLED,WHAT
169,181,200,2012,220,413,AE1,AE3,AUTHORS,BJU,CURRENT,DEPENDING,GLEASON,HOWEVER,KNOWLEDGE,LABEL,LNS,METASTATIC,METHODS,OBJECTIVE,PSA,RESULTS,THREE,UNLABELLED,WHAT
169,2012,338,8226,995,AUTHORS,BCR,BJU,COX,GLEASON,INSTEAD,LABEL,LEVEL,MEAN,MEIER,METHODS,OBJECTIVE,OLDER,PROGNOSIS,PSA,RADICAL,RESULTS,TYPE,UNLABELLED,WHAT
1000,169,2012,8226,AUTHORS,BJU,LABEL,METHODS,OBJECTIVE,PATIENT,PNBX,RESULTS,THESE,TRUS
169,1993,2005,2012,689,729,773,8226,872,AFTER,AIKAIKE,AUC,BEGG,BJU,GREENES,LABEL,METHODS,OBJECTIVE,OLMSTED,PCA,PSA,RESULTS
047,169,2012,BJU,BLOOD,CRPC,CYTARABINE,ERG,FIVE,GRADE,KAZAL,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PSA,RESULTS,SPINK,TEN,THERE,TMPRSS2,UNLABELLED,WHAT
100,169,2012,BJU,CONCLUSION,DEBULKING,EXCELLENT,FINALLY,LABEL,METHODS,OBJECTIVE,PCA,PSA,RADICAL,RESULTS,SALVAGE,SURGERY,THERE,UNLABELLED,WHAT
001,002,042,169,2012,233,341,704,8194,8226,ALSO,AUTHORS,BCG,BJU,BNI,CENTRAL,DATA,DYSURIA,FINALLY,HOWEVER,MEDLINE,MMC,NMIBC,SCIENCE,SIX,THREE,WEB
001,016,023,086,169,1999,2008,2012,571,699,8805,943,ASC,AUTHORS,BETWEEN,BJU,CCI,CONVERSELY,COVARIATES,FINALLY,FLORIDA,INDEX,LABEL,METHODS,MIRP,MORTALITY,OBJECTIVE,RESULTS,RPS,SEVERAL,UNLABELLED,VTE,WHAT
169,2012,BIOMETRIC,CARLO,HOWEVER,MONTE,SOCIETY
183,BZDH,COMPLEXES,COMPOUNDS,COX,DU145,ETOH,HT29,MCF,MEOSALH,STRUCTURES
1BB,1BBL,945,947,CTL,CTLA,IFN,THESE,TNF
120,174,8805,AMONG,CEUS,CLOSE,LABEL,METHODS,OBJECTIVE,PCA,PSA,PURPOSE,RESULTS,SBX,SEVENTY,TBX,THERE
002,100,166,179,238,378,616,8804,CHINESE,LABEL,METHODS,OBJECTIVE,OVERALL,PCA,PSA,PSAD,PURPOSE,RESULTS,ROC,TRUS,TZI,USING
040,1377C,174,195,196,250,DEL,FUNCTIONAL,HOWEVER,INS,NORTH,PCA,SNP,TLR2,TLR3,TLR9,TLRS,VARIANT
169,2012,8805,946,947,CBS,CELL,CONCLUSION,COPYRIGHT,CSE,ENDOGENOUS,INC,LABEL,LNCAP,METHODS,OBJECTIVE,RESULTS,WESTERN
001,003,015,040,119,169,1998,2007,2012,966,ABT,AHC,CENTERS,CONCLUSION,CONVERSELY,COPYRIGHT,HBT,INC,INDEX,INPATIENT,IOBCT,LABEL,METHODS,MIRP,NATIONWIDE,OBJECTIVE,ORP,OVERALL,RESULTS
005,045NG,1561,169,177,194,2012,85NG,945,947,AXYSM,CAD,COPYRIGHT,DESPITE,FGCP,FURTHER,GCPII,GENOTYPING,GLUTAMATE,H475Y,HOWEVER,NAALADASE,PCR,PSMA,PYMOL,RFLP
108,169,177,2012,BACKGROUND,BASEL,CONCLUSION,COPYRIGHT,CURE,LABEL,LOW,MAIN,METHODS,METRONOMIC,RESULTS,TIME
132,148A,18B,34B,450A,542,650,AFTER,AZA,CPG,EXPRESSION,GLEASON,PC3,PCA,PCR,SILENCING
LTD,MDV3100,PUBLISHED
PSA,TRUS
169,2011,COPYRIGHT,DUE,LOD,PSA,PSAS,QDS,SIO,SPCE
169,2012,802,ADDITIONAL,BASEL,COMPETING,CONCLUSION,COPYRIGHT,LABEL,MEN,METHODS,NADT,OBJECTIVE,RESULTS,THESE,TROG
169,2012,947,ALZHEIMER,COPYRIGHT,LTD,MUTATIONS,NOTCH,SEVERAL
100,169,2011,8764,AUTHORS,BOTH,DSPE,H446,HOWEVER,JPP,KEY,L1210,LABEL,LEWIS,METHODS,OBJECTIVE,OBJECTIVES,PEG,PEGYLATED,RESULTS,ROYAL,SOCIETY,TOPOTECAN,TYPICALLY
169,2012,HOWEVER,JOURNAL,LARGE,THEIR,THERE
169,181,2012,BIO,COPYRIGHT,INC,PHENETHYL,WILEY
169,190,1999,2008,2012,692,CAUSE,COPYRIGHT,DISCHARGE,HDR,NEITHER,SIMILARLY,SWEDISH,UICC
KIT,OTHER,STEM
132,AKT,CRPC,ERK,GHRH,JMR,MEK,NOVEL,PCR,PI3K,RAF,SV1,WESTERN
169,2012,945,AKT,COPYRIGHT,DU145,LNCAP,PCK,UICC,XSC
100,182,2010,INCREASED,LABEL,MARCH,MDC,METHODS,NCCN,NETWORK,OBJECTIVE,OBJECTIVES,RESULTS,SIMILAR,UROLOGISTS,WILLIAM
8805,EACH,EPSTEIN,GLEASON,HOWEVER,LABEL,MEAN,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SIXTY,TEN,TRUS,TTMB
032,051,120,169,2012,24C,93RD,956,AACR,ABCC2,AUC,AUCS,DRUG,ENZYMES,FIVE,INHIBITION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEVERAL,SORAFENIB,TOTAL,UGT
145,DBD,ETS,HOWEVER,III,LNCAP,PC3,PCA,PCR,THEREFORE,USING,VCAP,VII
177,178,185,239,442,515,8315,CTC,CTCS,EXTENSIVE,HOWEVER,III,NSCLC
AFTER,ASIA,ASIAN,BPH,PCA,PSA,THROUGH,WESTERN,WESTERNERS
APPROACHES,FFPE,HOWEVER,SINCE
945,947,CTLA,TAKEN,TH1,TH17,TH2
CTC,CTCS
CTC,CTCS,LNCAP
BOTH,CELLS,CTC,CTCS,NUCLEAR,THUS,VTE
0001,100,169,2012,384,702,727,754,768,794,795,825,837,860,8804,8805,881,961,AUTOMATED,BACKGROUND,BONE,BSI,COPYRIGHT,DEVELOP,GLEASON,INDEX,LABEL,METHODS,OBJECTIVE,PCA,PEARSON,PREDICTIVE,PUBLISHED,RESULTS,SCAN,SETTING,THERE,UROLOGY
001,169,2005,2009,2013,237,766,779,785,823,826,8805,AUC,CALCULATOR,CANCEROLOG,CAP,CONTINUED,COPYRIGHT,DRE,FOUR,GLEASON,HGCAP,INC,INSTITUTO,JANUARY,LABEL,LACK,MATERIALS,METHODS,MEXICAN,OBJECTIVE,OBJECTIVES,PREVENTION,PSA,RATES,RESULTS,RISK,TRIAL
000,169,2013,COPYRIGHT,FDA,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PRODUCTION,RESULTS,THERE
169,177,2013,COPYRIGHT,ELECTRONIC,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PSA,RESULTS,TUR
001,013,044,10NG,169,2012,2NG,45GY,526,8805,COPYRIGHT,COX,GLEASON,INC,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SOCIETY,SVB,T2B,T3B,THREE
BACKGROUND,COMPONENT,HOWEVER,ICA,IPCA,LABEL,PCA,PRINCIPAL,RESULTS
123,124,125,127,131,169,2012,JOHN,SONS,SULF1,WILEY
1A1,450,624,CYP,CYTOCHROME,GLEASON,P450,PCA
001,039,105,140,500,576,AAS,AFRICAN,ANGELES,BACKGROUND,CALIFORNIA,CONCLUSION,FURTHER,INDEX,LABEL,LOS,METHODS,OBJECTIVE,PURPOSE,RARP,RESULTS,SIMILAR,SIMILARLY,UNIVERSITY
174,CELLSEARCH,CTC,CTCS
2011
2011,ALZHEIMER,GLIPTINES,PREVENTIVE,PSA
8202,929,946,BACKGROUND,CONCLUSION,DEPRESSIVE,DIVERSE,INCREASES,LABEL,METHODS,RESULTS
181,BACKGROUND,CAP,ENTINOSTAT,FACS,FOXP3,HDAC,HISTONE,INOCULATED,LABEL,LOW,METHODS,MYC,PCR,REAL,RENCA,RESULTS,STAT3,SURVAXM,TEFFS,THESE,TREGS,WESTERN
945,CAP,DAYS,HOWEVER,SCID,SMA,VEGF
169,2012,259,386,452,520,BACKGROUND,BMI,BRITISH,CONCLUSION,COPYRIGHT,DHEA,JOHN,JOURNAL,LABEL,LTD,MAIN,METHODS,OBESE,PSA,PUBLISHED,RESULTS,ROUX,RYGB,SERUM,SOCIETY,SONS,SURGERY,THERE,WILEY
PSA,QALYS,USING
28TH,500,7TH,CONCLUSION,CRP,LABEL,MATERIALS,METHODS,NONE,OBJECTIVE,PURPOSE,PZFX,RESULTS,THERE,URINALYSIS,WBC
239,945,946,ADT,AMONG,BACKGROUND,DISCUSSION,GNRH,LABEL,MATERIALS,METHODS,NONE,PLGF,PSA,RESULTS,SAMPLES,SDF,THESE,TNF
001,002,111IN,177,185,8242,8313,99MTC,AFTER,BISPECIFIC,BOM,BOMANTI,BOTH,CONCLUSION,DSPL,DTPA,EXQUISITE,FAB,LABEL,LABELED,MBQ,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCID,SPECT
169,2012,205,3444,395,491,BACKGROUND,BASEL,COMPARISON,COPYRIGHT,DATA,GROUP,LABEL,METHODS,MRI,PBX,PCA,RESULTS
174,BACKGROUND,BLOOD,CELLSEARCH,CTC,CTCS,HOWEVER,LABEL,MATERIALS,METHODS,PCA,PSA,RESULTS,SAMPLES
AKT,DU145,FURTHER,GLEASON,LAMIN,LNCAP,PC3,PI3K,PTEN,WESTERN
INCLUDING,RADIATION,THUS
013,025,046,169,2013,300,8804,CAP,COPYRIGHT,GLEASON,INC,LABEL,MATERIALS,MEAN,METHODS,OBJECTIVE,PSA,PSAD,RESULTS,T1C,THESE
169,2012,5MM,8805,BACKGROUND,COMPOSITE,COPYRIGHT,FIFTY,FOLEY,INDEX,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PLACEMENT,PPB,PURPOSE,RESULTS
0001,169,194,2012,293,312,BACKGROUND,CONCLUSION,COPYRIGHT,COX,ERG,ETS,GLEASON,HIGH,HOWEVER,LABEL,LOW,LTD,MEN,METHODS,OVERALL,PCA,RESULTS
001,1124,160,169,194,1991,2007,2012,2234,229,424,457,8805,AHR,AST,COMPETING,COPYRIGHT,EBRT,GLEASON,INC,LABEL,MATERIALS,MEN,METHODS,OBJECTIVE,PCSM,PURPOSE,RESULTS,T2C
100,169,2012,8320,8321,8327,8805,COPYRIGHT,EACH,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIMILARLY,SIX,TEN
160,169,1988,2007,2012,205,285,8805,CONCLUSION,COPYRIGHT,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS,SALVAGE,SEVEN,SRT,THERE
157,169,2004,2008,2012,371,BECAUSE,COPYRIGHT,END,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE
100,125,129,145,169,194,2012,COPYRIGHT,D10,D20,D33,D50,D75,D90,DECLINE,ERECTIONS,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,V100,VARIABLES
105,135,169,1995,2006,2012,8805,AGE,BJU,COX,EVEN,FURTHER,HOWEVER,INSULIN,LABEL,METHODS,OBJECTIVE,RESULTS,UNLABELLED,WHAT
954,A549,AMONG,BESIDES,CXC,CXCR4,DU145,HER2,HOWEVER,OVERALL,THUS
1988,2011,6555,BACKGROUND,BASED,DATA,DATABASES,DESPITE,LABEL,LHRH,LOCALLY,MEDLINE,METHODS,OCTOBER,RESULTS,THERE
001,BACKGROUND,IPS,LABEL,LUNG,PRINCIPAL,RESULTS
056,118A,118B,946,CATENIN,CONCLUSION,CRPC,CRPCS,D32G,FINALLY,HAS2,LABEL,MDA,METHODS,OBJECTIVE,PURPOSE,RESULTS,TEN,THESE,TOP,WNT
073,1000,223,443,447,8201,AMONG,BACKGROUND,COLORECTAL,DIAGNOSTIC,FSG,FSGS,LABEL,LUNG,METHODS,OVARIAN,PLCO,RESULTS,SCREENING,TRIAL
BECAUSE,FOCAL
215,955,COOH,LSPR,OCH,PSA,THESE
002,011,023,039,047,145,169,2012,20A,221,595,623,801,8201,824,AMICO,AUC,BACKGROUND,CAPRA,COPYRIGHT,EXPRESSION,FOUR,FURTHER,INC,LABEL,METHODS,PCA,PCR,RESULTS,THESE,WILEY
169,2012,860,924,AFTER,AUC,BACKGROUND,BPH,CAP,CHINESE,COPYRIGHT,FIVE,INC,LABEL,METHODS,PCR,PSA,RESULTS,ROC,WILEY
125,1GB,2301,BEST,CARLO,CORE2,D10,D2CC,D90,DUO,GHZ,INDUSTRIES,INTEL,LDR,MONTE,RAM,V100,V150,V90
252,CRF,EMOTIONAL,FATIGUE,OVERALL,PIPER,REVISED,SCALE,USING
RETURNING,TIME
111,BB2R,CONJUGATES,HOWEVER,HPLC,PROTEIN
001,031,1125,169,1989,2001,2012,214,625,725,8194,8226,8804,AFTER,AUTHORS,BJU,GLEASON,LABEL,METHODS,OBJECTIVE,PSA,PSAV,RESULTS,ROC,SUSTAINED
137,169,2012,BACKGROUND,CONCLUSION,DISCUSSION,HEURISTIC,JOHN,LABEL,LTD,MEN,METHODS,MODEL,OBJECTIVE,PCA,PROCESSES,RESULTS,SONS,SYSTEMATIC,WILEY
1980S,758,945,ADT,EFFECTIVE,GTX,HOWEVER,LHRH
169,182,18F,2012,946,956,AACR,AKT,AZD5363,CELL,CHRONIC,FDG,GSK3,HER2,ORAL,PTEN,RAS,THERE,U87
945,AIM,AMACR,BACKGROUND,CONCLUSION,CRUSH,LABEL,METHODS,OBJECTIVE,RESULTS
169,2012,ATG5,AUTOPHAGY,BACKGROUND,CONCLUSION,COPYRIGHT,INC,LABEL,LAPC4,LDS,LNCAP,METHODS,OIL,PCA,RED,RESULTS,WILEY
169,2012,COPYRIGHT,CORRECTING,DESPITE,INC,PATTERN,WILEY
100,132,150,169,177,2012,948,956,COPYRIGHT,EACH,INC,MRI,NMR,THESE,WILEY
169,2012,BRITAIN,COPYRIGHT,DESPITE,GREAT,IRELAND,JOHN,LTD,MSI2,MYC,NEXT,OVERALL,PUBLISHED,REMARKABLY,SOCIETY,SONS,WILEY
169,186,2003,2007,2012,419,533,ADDITIONAL,AGE,ATLANTA,BACKGROUND,COPYRIGHT,DATA,DISTRICTS,GEORGIA,LABEL,LARGE,METHODS,MIRS,RECORDS,RESULTS,SOCIETY,VITAL
001,100,1024,177,200,234,378,400,749,ALT,AST,IGF2,NR2F2,PCR,PLAU,PROSTACAID
DESPITE,GLEASON,PSA,THERE
246,ADULT,HSP,SCH,THEREFORE,THESE
002,177,215,8804,ADC,ANTIGEN,BACKGROUND,DIFFUSION,DWI,GLEASON,LABEL,MANN,MATERIALS,METHODS,PSA,RESULTS,WHITNEY,WHOLE
000,102,144,2000,249,550,571,578,876,903,912,967,99MTC,ABOUT,BONE,CONCLUSION,LABEL,MATERIALS,METASTATIC,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
000,014,019,020,025,110,125I,145,177,197,BACKGROUND,CONCLUSION,CTC,LABEL,MATERIALS,METHODS,OBJECTIVE,POST,PURPOSE,RESULTS,THERE,THESE
CURRENT,MOST,SIMILARLY
CRPC,CYP17,MEDICAL,P450
945,ACE,AMONG,CONVERSELY,DESPITE,LNCAP,NLS,PCR,PTHLH,PTHRP,REDUCTION,TNF
946,CXCL1,CXCL5,LOSS,RII,TGF,THESE
169,2012,291,ANAL,AUSTRALIA,BACKGROUND,CLEAR,COPYRIGHT,HIV,JOHN,LABEL,LIMITED,LTD,METHODS,RESULTS,SCREENING,SELF,SONS,THOSE,WILEY
169,2012,302,484,BACKGROUND,BOTH,COPYRIGHT,DATA,EFFECTS,FEW,FOCUS,JOHN,LABEL,LTD,MANCOVA,METHODS,MOST,PATIENT,PROGRAM,QOL,RESULTS,RISK,SONS,WILEY
169,2012,COPYRIGHT,DU145,EGF,EGFR,ELISA,ERBB2,INC,JDF12,LABEL,LNCAP,METHODS,MTZ,OBJECTIVE,PCA,PURPOSE,RESULTS,SRB,UNDER,WILEY
169,2012,BACKGROUND,COPYRIGHT,ECTOPIC,EFFECTS,GPNMB,HPV,INC,LABEL,LNCAP,METHODS,NDRG1,PCR,PSA,R1881,RESULTS,WILEY
169,2012,945,946,BACKGROUND,CHICAGO,CK2,COPYRIGHT,FURTHER,INC,LABEL,LUCIFERASE,METHODS,PCR,RESULTS,SPSS,TBCA,WILEY
169,2012,22RV1,ADP,ATM,BACKGROUND,CHK2,COPYRIGHT,H2AX,INC,KU55933,LABEL,LNCAP,METHODS,PARP,RESULTS,SUSTAINED,WILEY
8201,BACKGROUND,LABEL,LOW,METHODS,PCA,PSA,RESULTS,STUDIES,THUS,USING
228,322,ADT,AFRICAN,ASIAN,BACKGROUND,COMPOSITE,CONCLUSION,FORM,HISPANICS,HRQOL,INDEX,LABEL,MEDICAL,MEN,METHODS,OTHER,RAND,RESULTS,SHORT,UCLA
178,2GY,76GY,80GY,8804,BACKGROUND,EPIC,GTV,HOWEVER,LABEL,METHODS,PET,PTV,QOL,QUALITY,RESULTS,SIB,SUV,TREATMENT,WHOLE
169,2012,587,945,ARI,ARIS,AVODART,BECAUSE,BJU,CAREFUL,CHI,CONCLUSION,DRUG,FOOD,LABEL,LUTS,MEN,METHODS,OBJECTIVE,PROSCAR,PSA,RESULTS,TREATMENT,UNLABELLED,WHAT
169,2012,ADT,COPYRIGHT,CRPC,INC,RESULTS
009,033,102,169,1993,2001,2007,2012,381,8226,BASED,BJU,CODC,INCREASED,LABEL,LEVEL,MEN,METHODS,OBJECTIVE,PROGNOSIS,RANDOMIZED,RESULTS,SCREENING,THESE,TREATMENT,TYPE,UNLABELLED,WHAT
001,006,007,845,AIMS,LABEL,OBJECTIVE,PCA3,RESULTS,THESE
239,327,8805,BACKGROUND,CONCLUSION,DATA,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PSA,RESULTS,TAX,TFI,THERE,TOT,TREATMENT
946,THUS
001,189,1998,2007,669,DEVELOPING,END,FORCE,LABEL,PREVENTIVE,RESULTS,TASK,UNLABELLED,USING
156,BETWEEN,CONCLUSION,DECISIONAL,LABEL,METHODS,OBJECTIVE,OUTCOME,PURPOSE,RESULTS,SCALE
169,2012,COPYRIGHT,INC,RMS,WILEY
169,2011,ABR,ANIMALS,BACKGROUND,BOTH,COPYRIGHT,CXCR4,FURTHER,INC,LABEL,LOX,METHODS,RESULTS,SDF,THEREFORE,THUS,VEGF,WILEY
001,002,149,169,1934,1944,2012,221,975,AMONG,COPYRIGHT,FINLAND,FOUR,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THESE,USING,WILEY
169,189,2012,COPYRIGHT,ELISA,FORUM,INC,JAPAN,JOURNAL,PETR,PROF,WILEY,ZUMAN
ADT,WHILE
001,177,BMS,KHT,MET,WHILE
001,002,003,006,018,022,169,2012,954,BACKGROUND,BASEL,CD10,CONCLUSION,COPYRIGHT,DECREASED,GLEASON,LABEL,LOW,METHODS,PCS,PSA,RESULTS
0035,105,112,ASIAN,BASED,BOTH,BRIER,EASTERN,GROUP,ISHII,LABEL,MEIER,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
169,2012,BASEL,COPYRIGHT,DESPITE,HOWEVER,THUS
005,169,2006,2008,2012,260,BACKGROUND,BASEL,BETWEEN,COPYRIGHT,GLEASON,LABEL,METHODS,PATIENT,PHOENIX,POST,PSA,RESULTS,THERE
169,2012,COPYRIGHT,CRPC,EACH,GROUP,HOWEVER,IRELAND,LTD,SOGUG,SPANISH
0529,169,176,2007,2008,2012,365,8805,CONVERSELY,COPYRIGHT,DAILY,FAVORABLE,GROUP,IGRT,INC,LABEL,MARCH,MATERIALS,METHODS,MVCT,OBJECTIVE,PTV,PURPOSE,RADIATION,RESULTS,THERAPY,V10,V15,V45,WITHOUT
169,173,176,2012,COPYRIGHT,EXPANDING,FALSE,FPS,IMAGE,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,ROBUSTNESS,TDPS,TOTAL,VARIATIONS
160,169,2012,AGO1522,CARLO,COPYRIGHT,DU145,INC,LABEL,MATERIALS,METHODS,MONTE,OBJECTIVE,PURPOSE,RESULTS
100,169,2000,2007,2012,239,264,AFTER,BETWEEN,COPYRIGHT,EBRT,HDR,INC,JULY,LABEL,MATERIALS,METHODS,OBJECTIVE,PHOENIX,PURPOSE,RADIATION,RESULTS,SEVEN,SOCIETY,TOXICITIES,TREATMENT
169,194,2012,BACKGROUND,BPO,CENTRAL,CONTEXT,CONTROLLED,COPYRIGHT,DEPENDING,EAU,GUIDELINES,LABEL,LASER,MEDICAL,MEDLINE,METHODS,OBJECTIVE,PUBLISHED,RESULTS,REVIEWS,STRUCTURED,SUBJECT,SYNTHESIS,SYSTEMATIC,UROLOGY
169,2013,ADT,BOTH,CAP,CONCLUSION,COPYRIGHT,CROWN,INC,LABEL,LHRH,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SEVENTY,THERE
000,169,2013,203,334,CANDIDA,COPYRIGHT,CULTURE,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,THERE,UTI
0001,0362,169,176,177,2012,3003,8805,COPYRIGHT,FORTY,GLEASON,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PET,PURPOSE,RESULTS,SUV,SUVS,T2W
121,147,169,1996,2006,2011,8805,AFTER,COPYRIGHT,GLEASON,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PSA,RESULTS,SAS,SEMINAL
076,1990,2005,2011,542,BACKGROUND,BOTH,FEW,LABEL,METHODS,NONE,OVERALL,RESULTS,SEVERAL,THREE
007,013,014,100,169,200,2001,2007,2012,3DCRT,8805,ADT,AFTER,BETWEEN,COPYRIGHT,CTV,GLEASON,GRADE,HDR,INC,LABEL,LATE,MATERIALS,METHODS,OBJECTIVE,PHASE,PRIOR,PURPOSE,RESULTS,T2C,TREATMENT
0001,145,169,1997,2009,2012,246,8805,COPYRIGHT,FORTY,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PCA,PCL,PREDICTION,PURPOSE,RESULTS,SITES
169,2012,945,AFTER,AMONG,BACKGROUND,BECAUSE,BILATERAL,COPYRIGHT,CURRENTLY,GNRH,HIF,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
154,169,2012,598,AGE,ALZHEIMER,AUTHORS,CARE,CONCLUSION,COPYRIGHT,END,FILES,GERIATRICS,INDIVIDUAL,JOURNAL,LABEL,METHODS,MFSU,NLTCS,OBJECTIVE,OBJECTIVES,PARKINSON,RESULTS,SEER,SERVICE,SETTING,SOCIETY,TERM
2006,2009,498,8804,BACKGROUND,BLADELESS,BOTH,CONCLUSION,FASCIAL,LABEL,METHODS,OBJECTIVE,PORT,PURPOSE,RARP,RESULTS,ROUTINELY,SEVERAL,SPLITTING
0001,220,AMONG,BPH,CLSS,CONCLUSION,CORE,IIEF,INDEX,IPSS,LABEL,LOWER,LUTS,METHODS,OAB,OBJECTIVE,RESULTS,SCORE,SYMPTOM,TRACT,URINARY
HIGH,HOWEVER,PTP1B,PTPN1
169,2012,AACR,COMPETING,GROUP,LABEL,METHODS,OBJECTIVE,PURPOSE,RADIATION,RESULTS,RTOG,THERAPY
169,2012,8805,ALSO,BACKGROUND,COPYRIGHT,FORTY,GLEASON,GRADE,LABEL,METHODS,MRI,PSA,RESULTS,SOCIETY,TREATMENT
BACKGROUND,CONCLUSION,CROSS,HIGH,HOWEVER,INTER,JACCARD,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THUS
0001,0004,005,10Q,126,169,2012,CNAS,COPYRIGHT,DESPITE,FISH,GLEASON,MYC,PGA,PSA,PTEN,SOCIETY
8776,CASODEX,CONCLUSION,IIA,LABEL,LNCAP,METHODS,OBJECTIVE,ORAL,PCA,PURPOSE,RESULTS,TIIA
169,2012,AUTOPHAGY,BECN1,COPYRIGHT,LTD,PYMT,RAS
160,169,176,2012,COPYRIGHT,EPID,IMRT,INTENSITY,LTD,MLC,MODULATED,PUBLISHED,QCS,RADIATION,TEN,THERAPY,THEREFORE
1434,1659,183,403,CELL,COWS,MCF,MILK,THERE,WHEY
100,169,1980,2011,2012,BACKGROUND,CLAVIEN,CONTEXT,COPYRIGHT,CSS,ENGLISH,GLEASON,ITEMS,JANUARY,JUNE,LABEL,MAJOR,MEDLINE,META,METHODS,MOST,OBJECTIVE,OCD,OPEN,PCA,PRE,PREFERRED,PUBLISHED,REPORTING,RESULTS,REVIEWS,SALVAGE,SCIENCE,SRP,SYNTHESIS,SYSTEMATIC,URINARY,UROLOGY,WEB
169,2004,2006,2012,AFTER,COPYRIGHT,IGRT,IRELAND,JUNE,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PATIENT,PHASE,PSA,PURPOSE,RESULTS,SEPTEMBER
945,946,COMPOUNDS,DHT,LBD,LBP,PCA,PROLONGED,THESE
945,946,AKT,BESIDES,CPO,GHF,MAPK,OVERALL,S6K1
178,179,2779,326,3484,8202,8310,CYS,FURTHER,HOGG1,HOWEVER,SER,SEVERAL
0023,0049,025,3957,4073,8202,ADT,CRPC,HOWEVER,LNCAP,PCA,SINCE,USING
8Q24,ACP10,CARN,CASTRATION,NKX3,REGIONS,SNP,THESE
22RV1,AKT,BAD,BCL,BIM,CAFS,ERK,MCL,MEK,NOTABLY,PC3,SORAFENIB,SRC,STAT3
ACCORDING,BACKGROUND,BECAUSE,CONCLUSION,HIGH,LABEL,LESS,METHODS,RESULTS,SCIENTIFIC
000,345,8805,ASSESSING,BACKGROUND,BOTH,C30,EACH,EORTC,HOWEVER,LABEL,MATERIALS,METHODS,OVIS,PHYSICIANS,PSA,QLQ,QOL,RESULTS,SCHLESWIG,SELF,VERSION
CIS,DAYTIME,ESPECIALLY,PATIENT,STROMAL,THEREFORE
HOWEVER
169,2012,863,945,BACKGROUND,C30,COMMITTEE,CONCLUSION,CONTEXT,COPYRIGHT,EORTC,HOWEVER,INC,LABEL,LIFE,METHODS,OBJECTIVE,OBJECTIVES,PAIN,PUBLISHED,QLQ,QOL,QUALITY,RESULTS,THESE,TREATMENT
252,CDH1,CIP1,CONSISTENT,CTBP1,CTBPS,HDAC,HDACS,KLF6,LCOR,SUBSEQUENT,WAF1
009,144,145,169,183,194,2006,2007,2012,289,302,8805,945,AMERICA,AUG,BACKGROUND,BETWEEN,COPYRIGHT,EIGHT,FUNDING,GLEASON,INCIDENCE,LABEL,LTD,MARCH,METHODS,NORTH,RESULTS
006,145,2780,956,ABZ,ADDITIONAL,BOTH,CMC,MAA,NILE,OVCAR,PEGMEMA,PMMA,POLY,RAFT,THREE,WHILE
001,1049,169,2002,2010,2012,305,333,411,8195,AIMS,BLACKWELL,DRS,JANUARY,LABEL,LTD,METHODS,OBJECTIVE,PIS,PUBLISHING,RESULTS,SRS,TBSRS,TNM
945,946,ABL,BACKGROUND,HIF,HOWEVER,HRE,LABEL,MCL,PCA,PDGF,PDGFR,PRINCIPAL,RESULTS,USING

1220,1735,235,985,AIDS,HIV,IHC,LEDGF,OXIDATIVE,PANEL,PCR,PROTEIN,THESE,TISSUESCAN,TMAS,TRANSCRIPT
1971,ACT,BACKGROUND,HOWEVER,LABEL,METHODS,MOST,RESULTS,SURVIVORS
AIDS,CR1,DFS70,HIV,HSP27,HSP27PR,LEDGF,MECP2,PC3,PWWP,THESE,U2OS
001,116,GLEASON,LABEL,LOH,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,STIM2,THESE
CDK1,CDK9,CHIP,CONVERSELY,FINALLY,PCA,PSA,S81A,SER,THESE,TMPRSS2,W741C
ACTIVATING,ALZHEIMER,AMP,ATF2,CRM1,FURTHER,JUN,MKFKLHV,NES,NESS,THESE,THUS
003,120,128,157,169,2012,344,452,8Q24,CASE,COPYRIGHT,FDR,HOWEVER,HYPOTHESIS,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OTOLOGICAL,PTC,RESULTS,SNP,SNPS,SOCIETY
038,169,2011,ADM,COPYRIGHT,E231G,ID4,LNCAP,MICE,MUTATIONS,NR2F1,PTGDS,T857A,T877A,THREE,UICC
001,115,160,169,183,8202,BASED,CONCLUSION,DRE,FALSE,GEORG,IMAGING,LABEL,MATERIALS,METHODS,MRI,NPV,OBJECTIVE,PCA,PPV,PSA,PURPOSE,RESULTS,ROC,STUTTGART,T1W,T2W,TRUS,YORK
104,169,2004,2008,2012,AFTER,APRIL,CONCLUSION,CONTINUOUS,HIPAA,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,PEARSON,PURPOSE,RALP,RESULTS,RSNA,SEVEN
945,DU145,PAI,PC3,PCNA,PCR,PTPL1,PTTG1,THESE
169,194,2012,AML,CD33,COPYRIGHT,GFP,INC,PSCA,THERE,THESE,UNTIL
106,1381,357,839,ADT,BACKGROUND,CONCLUSION,CONTROLLED,DCE,LABEL,LPC,MEN,METHODS,MILD,RESULTS,THESE,URINARY
IMAGING,LABEL,OBJECTIVE,PURPOSE,RAMAN,RESULTS,SUMMARY
BOARD,FOCAL,HOWEVER,LABEL,METICULOUS,OBJECTIVE,PURPOSE,RESULTS,SUMMARY
CONSISTENT,DCF,DU145,JANUS,NOBILETIN,OVERALL,RWPE,SRC,STAT,STAT3
169,2012,ALONE,DESPITE,JOURNAL,THERE
ECM,EZH2,H3K27,MMP,MMPS,THESE,TIMP,TIMP2,TIMP3,TIMPS
142,337,916,BACKGROUND,CAP,CONCLUSION,CONTINUED,CWR,DHT,EXPRESSION,FINDING,LABEL,MASS,PRINCIPAL,RESULTS,TARGETING,THERE
109,1463,169,2010,263,ALZHEIMER,COPYRIGHT,CORRECTION,EACH,JOHN,LTD,SONS,WILEY,WTP
169,2012,945,954,CHINA,COPYRIGHT,CXCR4,HOWEVER,IAP,IAPS,INC,LIVIN,LNCAP,PCA,WESTERN,WILEY
010,012,078,597,686,734,815,995,ASHKENAZI,COMPARING,E1B1B1C,FINNS,N1C,POPULATION
115,160,1995,2008,8805,ADT,AFTER,BCR,BETWEEN,COX,GLEASON,LABEL,METHODS,OBJECTIVE,OVERALL,PSA,PURPOSE,RESULTS,RRP
169,1988,1992,1998,2002,2012,745,CONCLUSION,COPYRIGHT,EBRT,END,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PCSM,PURPOSE,RESULTS,THERE
100,125,145,169,176,2012,8804,CONCLUSION,COPYRIGHT,FIRST,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBL,PAI,PNT,PROSTATES,PURPOSE,RADIOLOGY,RESULTS,SOCIETY,TRUS
169,2012,COPYRIGHT,CTV,CTVS,CURRENT,FOUR,GROSS,INADEQUATE,INC,LABEL,MATERIALS,METHODS,MRI,MRIS,OBJECTIVE,PTVS,PURPOSE,RESULTS,THREE,XRT
0022,012,017,105,141,142,152,169,172,2012,381,ACS,BOTH,CONCLUSION,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,NETWORK,OBJECTIVE,PCA,PSA,PURPOSE,RESULTS,STATINS,UNIVARIATE
RADICAL,THUS
169,2012,ASPIRIN,HOWEVER,LIMITED,MACMILLAN,PUBLISHERS,THUS
169,2012,ADT,COPYRIGHT,DHT,III,LOW,LTD,NOTABLY,PCA,SEVERAL
134,144,169,2012,287,BASEL,COPYRIGHT,ESBL,GRAM,KLEBSIELLA,LABEL,METHODS,OBJECTIVE,RESULTS,TRUSB
169,1996,1999,2011,241,278,416,427,544,862,8805,939,AEU,COPYRIGHT,DATES,ERSPC,ESPA,LABEL,MEAN,MEIER,METHODS,MOST,OBJECTIVE,PCA,PSA,PUBLISHED,RANDOMIZED,RESULTS,SCREENING,SPANISH,THESE
2005,2010,AFTER,BACKGROUND,CASE,CLINICALLY,CONCLUSION,ERK,FURTHER,GNRH,LABEL,LUNG,MEK,METHODS,RAF,SINCE,THEREFORE,TUR
169,194,2011,946,ADT,COPYRIGHT,IRELAND,LTD,MECHANISMS,RII,SINCE,TGF,THERAPY
1400,169,2012,950,956,M13,NIR,SOCIETY,SWNT,SWNTS
1048,160,169,2012,ACADEMY,THREE
169,2011,2012,APRIL,BJU,CONFERENCE,MAY
169,2011,2012,8194,APRIL,AUTHORS,BJU,CONFERENCE,DOCETAXEL,HUNGARY,MAY,PARTICULAR,PROGNOSTIC,PSA,RESULTS,THESE,USA
003,100,1500,177,197,198,3064,3167,3674,3761,6923,CONCLUSION,COPENHAGEN,DYNAMIC,LABEL,MAT,MATERIALS,METHODS,MRI,OBJECTIVE,RESULTS
028,120,147,432,8804,8805,ADT,AFTER,BONE,CRPC,DENOSUMAB,DROR,III,MICHAELSON,PSA,RESTAGING,SRES,UNTIL
100,192,2000,THESE
2ND,3RD,LABEL,METASTATIC,METHODS,OBJECTIVE,PURPOSE,RESONANCE,RESULTS
AVAILABLE,BACKGROUND,CRPC,LABEL,MATERIALS,MET,METHODS,MOST,RESULTS,SRC
CA2,HSC3,HSC4,MENTHOL,MMP,PCR,SCC,SEVERAL,THESE,TRP,TRPM8
169,2012,BASED,CONCLUSION,COPYRIGHT,DYNAMIC,GLEASON,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,ROC,SUPPORT,WILEY
001,176,17A1,202,946,BOTH,CYP17A1,CYTOCHROME,DRUG,FOOD,NOTABLY,P450,P450C17,TOK,WHEREAS
100,150,160,945,946,CD31,CONSISTENT,LNCAP,PECAM,PEITC,PHENETHYL,THUS
22RV1,8579,ADT,AR3,COOH,CRPCA,CWR,LUCAP,PCA,PCR,SIMILARLY
0001,148A,221,590,99A,99B,ALSO,BPH,BTG2,CHIP,CRPC,CRPCS,EXPRESSION,FINALLY,LNCAP,PIK3IP1,SEVEN,THUS,UTR
112,1990,2009,350,392,408,COX,DATA,JANUARY,LABEL,METFORMIN,METHODS,MORTALITY,OBJECTIVE,RESULTS,TYPE
286,8594,8764,945,946,AKT,GSK,IMMUNOBLOT,NQO2,SER21,T286
169,194,2012,BMLE,CDK2,CDK4,COPYRIGHT,KUJ,LTD,MMP,MOMORDICA,MT1,PC3
169,2012,945,COPYRIGHT,DHT,HIF,HYPOXIA,INC,LNCAP,THESE,VEGF
169,2005,2010,2011,AEU,BLADDER,BOARI,COPYRIGHT,DATA,LABEL,MEAN,METHODS,OBJECTIVE,OVERALL,PROLONGED,PUBLISHED,RESULTS,SINCE
100,509,ARN,CONTINUED,CRPC,MAXIMAL,MDV3100,THUS,WHILE
169,194,2012,COPYRIGHT,INC,PSA,UNDER
169,2012,COPYRIGHT,IRELAND,LOW,LTD,RAP,RAP1,RAP1GAP,RCC,RESCUED,SN12C,THESE
053,066,100,169,177,2012,CIRS,COPYRIGHT,EACH,IMAGING,INC,LABEL,MATERIALS,METHODS,NORFOLK,OBJECTIVE,PUBLISHED,PURPOSE,REFERENCE,RESULTS,SYSTEMS,THREE,TRANCHE,UROSTATION
169,2011,916,945,946,COPYRIGHT,CRPC,HOWEVER,LNCAP,LTD,PCA,TREATMENT,TYPE
169,2011,BACKGROUND,BASED,COPYRIGHT,DCE,DIFFERENT,DOES,DWI,IRELAND,LABEL,LTD,MATERIALS,METHODS,MRI,OBJECTIVE,PROLONGED,PURPOSE,RESULTS,USING
000,169,1990S,2012,385,458,556,BACKGROUND,CONTROLLED,COPYRIGHT,FINNISH,HOWEVER,III,LABEL,METHODS,NUMBERS,OBJECTIVE,PARAMETERS,PCA,POPULATION,PSA,PUBLISHED,RANDOMISED,REDUCTION,RESULTS,SETTING,THOSE,TRIAL,UROLOGY
169,2013,AFTER,BPH,CAP,CAPS,CCK,COPYRIGHT,INC,LABEL,LNCAP,MATERIALS,METHODS,OBJECTIVE,PC3,PCR,PLNCRNA,PWR,RESULTS,RNAS,RWPE,SILENCING,TUNEL,WESTERN
169,2001,2004,2012,587,600,634,967,AUC,BETWEEN,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,MEMBRANOUS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SOFT,UROLOGICAL
0002,0003,0004,0005,004,169,2012,617,COPYRIGHT,DATA,EDUCATION,FIVE,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
0012,112,122,152,177,BACKGROUND,C30,CMF,EORTC,FEC,GOSERELIN,IIIA,INCREASED,INSURANCE,LABEL,LIFE,MEIER,METHODS,NHI,QAS,QLQ,QUALITY,RESULTS,TEC,TOTAL,TREATMENT
1C3,945,946,ALDO,COX,CRPC,LEAD,LNCAP,SAR,SELECTIVE,STRUCTURE,THESE,USING
177,409,421,435,956,ABC,ASSESSMENT,GLC14,MDA,SILA,THUS
169,2012,AFTER,CD4,CD8,COPYRIGHT,CTLA,CUREVAC,IIA,JOHN,LTD,NSCLC,PCA,PHASE,SONS,THEREFORE,THESE,WILEY
085,145,946,CONCLUSION,LABEL,LNCAP,LUCAP,METHODS,OBJECTIVE,PCR,PHA,PHASEOLUS,PURPOSE,RESULTS
150,176,180,2007,2009,ACID,AFTER,INFECTIOUS,JUNE,MAGP,MAY
169,2012,947,ATM,COPYRIGHT,H2A,IRELAND,KU70,KU80,LTD,NHEJ,PIM,PKCS
169,194,2012,29KD,946,947,948,CATENIN,COPYRIGHT,HOWEVER,LEF,MMP,TAKEN
125I,169,2012,64CU,AOC,BACKGROUND,COPYRIGHT,GRPR,IC50,INC,LABEL,METHODS,NOTA,RESULTS,SCN,THESE,TYR4
ALA,BBN,CONCLUSION,GLN,GLY,GRPR,INC,LABEL,LEU,METHODS,MICRO,NHET,NO2A,NOTA,OBJECTIVE,OBJECTIVES,PET,PHE,PUBLISHED,RESULTS,TRP,VAL
001,169,2012,664,785,AIMS,AUC,EXPRESSION,IHC,JAK,LABEL,LTD,METHODS,OBJECTIVE,PCA,RESULTS,ROC,STAT,STAT3
100,101,200,2005,201,2011,300,8804,AGE,APRIL,BACKGROUND,CDS,CLAVIEN,CONCLUSION,DINDO,III,JANUARY,LABEL,LRP,METHODS,OBJECTIVE,PURPOSE,RESULTS,SOCIETY,THERE,THREE,USING
001,002,005,169,2012,8195,AIMS,BLACKWELL,CONCLUSION,CRPC,ERG,ETS,HOWEVER,KAZAL,LABEL,LTD,METHODS,NONE,OBJECTIVE,PCA,PTEN,PUBLISHING,RESULTS
119,1970,1976,2007,2ND,31ST,650,8805,926,BACKGROUND,COX,GLEASON,HAZARDS,HIGH,LABEL,MEN,METHODS,MIDSPAN,RATIO,RESULTS
200,PEG,PEGYLATED,PEGYLATION,SCID,THREE,WHILE
016,047,169,2009,2010,2012,ANGELES,BJU,CALIFORNIA,CONCLUSION,INDEX,JULY,LABEL,LOS,METHODS,OBJECTIVE,OTHER,RALP,RESULTS,SEVERAL,THERE,UNIVERSITY,UNLABELLED,URINARY,WHAT
145,956,AMYRISINS,POLYGAMAIN,THREE
169,2012,8226,ANXIETY,AUTHORS,BJU,DEPRESSION,FORM,INVENTORY,LABEL,LEVEL,MEN,METHODS,OBJECTIVE,PCA,RANDOMIZED,RESULTS,SCREENING,SHORT,STATE,STUDIES,THESE,TRAIT,TYPE,UNLABELLED,WHAT
BELFAST,FURTHER,MLST
2009,8805,BEHAVIORAL,BRFSS,CONDITION,COVERED,FIVE,GUAM,ISLANDS,LABEL,LIMITED,METHODS,OBJECTIVE,OVERALL,PAP,PROBLEM,REPORTING,RESULTS,RICO,RISK,USING
BIOLOGICAL,CBP,FOXA1,GATA2,HISTONE,NUCLEAR,THESE,THUS
AKT,CHANGES,COA,ERK,HMGR,HYPOXIA,LOSS,RAS,REDUCTION,THEREFORE
ARG,CDR,DESPITE,FAB,FAB25,ISOTHERMAL,LYS,THEREFORE
007,013,018,036,177,2007,2009,231,346,384,BMI,EAU,GUIDELINES,ISA,ISSAM,MEAN,PREVALENCE,SEPTEMBER,TDS,VARIABLES
108,169,194,2011,5NG,AEU,AFTER,BACKGROUND,CHRONIC,COPYRIGHT,CPSI,INDEX,INSTITUTES,IPSS,LABEL,METHODS,NIH,PSA,PUBLISHED,RESULTS,SCORE,SYMPTOM,TPSA
169,2011,COPYRIGHT,IRELAND,LTD,SBRT
BACKGROUND,LABEL,PC3,REDUCTION,REF52,RESULTS,SM22,THESE
000,008,014,016,017,030,033,039,044,052,074,081,1057,135,272,402,946,974,995,998,999,BACKGROUND,BIA,BMI,BODY,FFM,GLEASON,HOWEVER,IGF1,LABEL,MEN,METHODS,RESULTS,SEVERAL
169,2007,2009,2012,630,690,745,777,950,981,BJU,HGPIN,HIGH,LABEL,MEN,METHODS,OBJECTIVE,OTHER,PATIENT,PCA,PSA,RESULTS,SEPTEMBER,SHBG,UNLABELLED,WHAT
001,151,1514,165,169,2012,276,370,477,761,8804,BJU,GLEASON,LABEL,MATERIALS,METHODS,OBJECTIVE,PSA,PSM,PSMS,RESULTS,SUFFICIENT,UNLABELLED,WHAT
234,BAKER,CONCLUSION,GRADE,HAEMATURIA,LABEL,MEAN,METHODS,MOST,OBJECTIVE,OBJECTIVES,OVERALL,PAIN,RESULTS,WONG
100,954,CONCLUSION,DCE,HIFU,LABEL,METHODS,MRI,OBJECTIVE,PSA,RESULTS,ROC,THERE,THREE
005,139,169,2012,606,AACR,AFTER,BACKGROUND,DATA,EPIC,ESTIMATES,HRS,LABEL,METHODS,NUTRITION,RESULTS,THERE
001,0073,038,169,2012,215,331,501,882,AACR,ADA,ARTP,BACKGROUND,CDO1,COLORECTAL,LABEL,LOW,LUNG,METHODS,OVARIAN,PLCO,PRODUCT,RANK,RESULTS,SCREENING,SEVERAL,SNP,TRIAL,TRUNCATED
945,AMONG,CDAF,COMPARISON,ECM,HOWEVER,MMP,SEVERAL
001,008,169,2004,2010,2012,8201,BACKGROUND,BCR,BETWEEN,COPYRIGHT,COX,HIFU,INC,LABEL,MEIER,METHODS,PREDICTORS,PSA,RESULTS,THERE,THEREFORE,WILEY
012,015,017,169,2006,2010,2011,262,8804,8805,BACKGROUND,BETWEEN,COMPOSITE,COPYRIGHT,EPIC,IIEF,INDEX,JANUARY,LABEL,METHODS,POTENCY,RESULTS,SOCIETY,YOUNG
9P21,ARF,BOTH,CDKN2,CRPC,DECREASED,MTAP
171,187,PCA,PSA,THUS
ABCG2,BONE,CD117,CD44,CSF,DU145,NANOG,NANOGP8,OCT3,PCR,SCF,STEM,UPON
000,169,2008,2012,542,715,ABOUT,AFRICAN,COPYRIGHT,SAHARAN,SOCIETY,SUB
400,543,EACH,FEW,FRESH,LABEL,METHODS,MVPA,OBJECTIVE,PURPOSE,RESULTS,START,WHILE
AKT,ANTI,DESPITE,GRP78,QDOT,QDOTS,QDS,QUANTUM
DIGITAL,LABEL,MOLECULAR,MRI,OBJECTIVE,PURPOSE,RESULTS,SUMMARY,USES
190,2007,2009,215,AFTER,CLAVIEN,CONCLUSION,GRADE,JUNE,LABEL,MEAN,METHODS,MOST,OBJECTIVE,PURPOSE,RESULTS
2004,2008,294,385,AMICO,ECE,LABEL,METHODS,MRI,NVB,OBJECTIVE,OVERALL,PCA,PURPOSE,RESULTS,STAGING
CONCLUSION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE
145,22RV1,BACKGROUND,CONCLUSION,LABEL,LOWER,METHODS,NADPH,NORMALITY,NOX,NOX4,OXIDATIVE,RESULTS,SHAPIRO,WILK
EGF,EMT,FINALLY,HPV,SIRT1,ZEB1
169,2012,LIMITED,MACMILLAN,MRI,PUBLISHERS,T2W,VALIDATION
169,2012,ABOVE,COPYRIGHT,DESPITE,EXTENSIVE,INC,THEREFORE
169,1972,2006,2012,235,733,COPYRIGHT,EDUCATION,END,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,POTENTIAL,PUBLISHED,PURPOSE,RESULTS,SEER,THERE,UROGENITAL,UROLOGICAL
169,2004,2005,2012,215,531,720,CENTRAL,COPYRIGHT,DECREASING,EDUCATION,INC,LABEL,MATERIALS,METHODS,NORTH,OBJECTIVE,PUBLISHED,PURPOSE,RACE,RESULTS,UROLOGICAL
176,COOH,EPEG,LOW,NEXT,PSMA,PTX
169,1969,2011,2012,ADT,AIM,BACKGROUND,HOWEVER,LABEL,MAIN,MEASURE,MEDLINE,METHODS,OBJECTIVE,OUTCOME,PHYSICIANS,RESULTS,SEPTEMBER,SOCIETY,THERE
BACKGROUND,BAX,CLONING,H358,HOWEVER,INSTEAD,LABEL,LIC,LNCAP,PCR,RESULTS,THUS,UTILIZING
169,2012,THERE,THESE,UROLOGICAL
125,169,2012,2012THE,8482,AUTHORS,BJU,FEWER,HOWEVER,PSA,RAPID,SALVAGE,SPAIN,WHAT
005,049,100,1000,143,153,169,2011,8195,ALSO,AUTHORS,BJU,IPSS,MEAN,SCORE,SEATTLE,SYMPTOM,THERE,WHAT
BACKGROUND,CXCL9,ELISA,FOUR,IHC,LABEL,METHODS,RESULTS,SEVEN,SIXTEEN
001,1448,169,2012,558,890,ADC,AMONG,CDR,CONCLUSION,COPYRIGHT,ESPECIALLY,GLEASON,GROUP,INC,LABEL,MATERIALS,METHODS,NPV,OBJECTIVE,PPV,PSA,PURPOSE,RESULTS,WILEY
000,038,100,1320,169,1995,2005,2012,769,BACKGROUND,COPYRIGHT,END,LABEL,METHODS,OVERALL,RESULTS,SOCIETY,USING
169,2012,226,AACR,AFTER,BACKGROUND,BCR,BPH,CONCLUSION,CPG,EXPRESSION,FOLLOWING,FURTHER,LABEL,LNCAP,METHODS,PC3,PGP9,RESULTS
0007,005,101,126,177,478,BPH,CONVERSELY,HOWEVER,LATIN,NAT,NAT2,NAT2A803G,NAT2G857A,NAT2T481C,PCA,SLOW
AKT,CORDYCEPIN,CORDYCEPS,LNCAP,MMP,MMPS,PI3K,TER,THESE,TIMP,TJS
603,APAF,CELL,HIGH,MAPK,PC3,RSK
ABOUT,BACKGROUND,INSTITUTE,LABEL,MANAGEMENT,METHODS,OBJECTIVE,OBJECTIVES,PIES,RESULTS,ROM,TAILORING
169,2012,BECAUSE,COPYRIGHT,CRPC,CRPCS,FURTHER,GAIN,IRELAND,KNOWN,LTD,PCS,THEREFORE
169,194,2012,COPYRIGHT,CXCR4,GPCR,GPCRS,IRELAND,LTD,MAPK,MOLECULES,P13K,PSA,SRC,TAKEN,THESE
001,005,007,012,017,169,171,2008,2010,2012,8804,8805,AFTER,COPYRIGHT,EDUCATION,GLEASON,INC,INDEX,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
130,169,174,180,1999,2012,COPYRIGHT,EDUCATION,ERG,ETS,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PCA3,PUBLISHED,PURPOSE,RESULTS,SERUM,TMPRSS2,UROLOGICAL,WIDESPREAD
001,169,177,2012,448,516,AFRICAN,CAUCASIAN,CHANGES,COPYRIGHT,DESPITE,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THERE,UROLOGICAL,USING,WHETHER
001,169,194,2001,2004,2012,AFFAIRS,ALSO,AMONG,CENTRAL,COPYRIGHT,END,FACILITIES,INC,LABEL,METHODS,OBJECTIVE,RESULTS,VHA
001,169,194,1988,2008,2012,2487,AMICO,BCR,BCRFS,CONCLUSION,COPYRIGHT,COX,INC,JULY,JUNE,LABEL,LOCAL,MEIER,METHODS,OBJECTIVE,PCA,PLND,PSA,RESULTS,RRP
169,194,2012,COPYRIGHT,DIGITAL,INC,SPHENOIDAL
002,008,012,019,022,023,055,078,123,138,159,169,173,2012,296,8805,ADT,BFFS,COPYRIGHT,GLEASON,HDRT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PPC,PURPOSE,RESULTS,T2B,UNIVARIATE
169,194,2012,CONCLUSION,COPYRIGHT,EACH,GROUP,HOWEVER,IMRT,INC,LABEL,MATERIALS,METHODS,OARS,OBJECTIVE,PTV,PURPOSE,RADIATION,RESULTS,RTOG,THERAPY,VMAT
169,2012,CONCLUSION,COPYRIGHT,CURRENT,GOLD,INC,LABEL,MATERIALS,METHODS,MRSI,OBJECTIVE,PURPOSE,RESULTS,SPECTRA,TESLA
169,194,2012,8320,8322,8325,956,A549,COMPOUNDS,COPYRIGHT,DIGITALIS,ESI,MCF,NMR,T98G,THEIR
145,169,194,2012,462,AFTERWARD,ANOVA,COPYRIGHT,CTAB,DDAB,DIFFERENT,DOTAP,PIT,SAS,SLN
125,169,1999,2009,2012,COPYRIGHT,GROUP,IIB,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OCTOBER,PUBLISHED,PURPOSE,RESULTS,SOCIETY,STAGE,TREATMENT
169,2013,BCR,COPYRIGHT,ENGLISH,GLEASON,INC,LABEL,METHODS,OBJECTIVE,PSM,PSMS,RESULTS,THEREFORE
001,025,1455,169,2001,2012,2657,395,434,468,810,AVERAGE,BACKGROUND,COMMITTEE,COPYRIGHT,ETHICAL,KNOWLEDGE,LABEL,LITERATURE,METHODS,MREC,MULTITRAIT,OBJECTIVE,PCA,PREDICTORS,PSA,PUBLISHED,RESULTS,SETTING,TRENT,UROLOGY
169,1993,2008,2011,392,474,9198,9241,BACKGROUND,BEGINNING,CONSISTENT,COPYRIGHT,EXAMINE,FEBRILE,FEVER,LABEL,METHODS,OBJECTIVE,PNB,PNBS,PUBLISHED,RANDOMIZED,RESULTS,ROTTERDAM,SCREENING,SETTING,STUDIES,UROLOGY
100,169,2011,ASIA,AUTHORS,BLACKWELL,GLEASON,HISTONE,LNCAP,LTD,PATHOLOGY,PC3,PTY,PUBLISHING,SILENCING,SOCIETY,THESE
CLI,CONCLUSION,FDG,FLT,H460,LABEL,METHODS,MODERATELY,PC3,PET,RESULTS,UNLABELLED
169,2012,737,ABT,ASSESSMENT,BH3,COPYRIGHT,GIVEN,HCQ,INC,INDUCTION,LABEL,LNCAP,METHODS,OBJECTIVE,PURPOSE,RESULTS,ROS,TARGETING,THESE,WILEY
001,004,121,169,1C3,200,2012,8201,AMONG,BACKGROUND,BCAR1,BECAUSE,BOTH,COPYRIGHT,INC,KI67,LABEL,METHODS,RESULTS,SINCE,WILEY
945,AMACR,COA,LNCAP,ZNSE
BMP,HPC,HPCS,HSC,HSCS,LNCAP,PART,PC3,THESE
107,141,375,574,742,BACKGROUND,CONCLUSION,LABEL,METHODS,REAL,RESULTS,THESE
123,137,169,200,2001,397,AMONGST,CONCLUSION,DEPARTMENT,KINGDOM,LABEL,METHODS,OBJECTIVE,RESULTS,THERE
169,194,2011,COPYRIGHT,ERG,EZH2,MAJOR,NGS,THESE,TMPRSS2
001,105,169,2012,293,8804,8805,AIM,BACKGROUND,BNSRP,CCI,COX,FINALLY,IIEF,INDEX,LABEL,MAIN,MEASURE,MEIER,METHODS,OBJECTIVE,OUTCOME,OVERALL,PDE5,RESULTS,SEVERAL,SIMILARLY,SOCIETY,THEREFORE
108,161,2007,2010,237,8805,AFFAIRS,CALCIUM,CIS,CONCLUSION,GLEASON,HARVARD,LABEL,MEDICAL,METHODS,OBJECTIVE,ORS,RESULTS,TOTAL
AKT,AREAS,BACKGROUND,COVERED,LABEL,METHODS,NSCLC,OPINION,PI3K,SMALL,TARGETABLE
169,2012,354,BACKGROUND,BANKS,BLOOD,CONCLUSION,HOWEVER,INFECTION,LABEL,METHODS,MLV,MLVS,RENO,RESULTS,SEVERAL,TAHOE,WESTERN,XENOTROPIC,XMRV
8764,CLASSIC,INTRAGENIC,MICRORNAS
945,946,FER,GLYCANS,HOWEVER,LAMININ,LOSS,STAT3,THESE
119,200,8804,BOTH,CONSISTENT,FOLLOWING,GIVEN,SEQUENCING,SIMILARLY,THESE,XMRV
2012,BACKGROUND,CODE,LABEL,OPEN,PROCESSING,UNITS,UNLABELLED,URL
945,LABEL,METHODS,NEITHER,OBJECTIVE,OBJECTIVES,PIN,PRIMARY,PSA,RESULTS
009,10TH,169,2012,509,642,652,679,90TH,AACR,BACKGROUND,BPC3,CONSORTIUM,INSTITUTE,LABEL,METHODS,RESULTS,SEER
2005,2009,257,HOWEVER,SELF,SIMILARLY,THEREFORE,THESE
22RV1,ABCG2,ALSO,BMI,CD44,CSC,CSCS,DU145,GLI1,LABEL,LNCAP,METHODS,OBJECTIVE,PCA,PURPOSE,RESULTS
8805,DEPENDING,EPNI,HOWEVER
001,169,2010,2012,307,AGE,CONCLUSION,COPYRIGHT,EDUCATION,FOUNDATION,INC,JANUARY,LABEL,MAY,MAYO,MEDICAL,MEIER,METHODS,OBJECTIVE,PUBLISHED,RESULTS,ROCHESTER,SIR,SIRS,THERE
145,946,956,BACKGROUND,CARCINOMA,CONCLUSION,CXCL4,CXCR3,INSTEAD,IP10,LABEL,LNCAP,PF4,PLC,RESULTS,RWPE,THESE,WHILE
1134,1996,2010,AIMS,BECAUSE,CONCLUSION,FALSE,GLEASON,LABEL,METHODS,OBJECTIVE,OVERALL,PROGNOSIS,RESULTS,SINCE,UNLABELLED
0X10,1401,17Q21,200,5083,5X10,BACKGROUND,G84E,INSTITUTES,LABEL,LINKAGE,METHODS,RESULTS
001,005,169,177,2012,227,277,3212,352,3969,413,8194,BACKGROUND,BLACKWELL,EBRT,INFERENCES,KEY,LABEL,LATE,LTD,METHODS,PUBLISHING,RESULTS,SENSORY,SIXTEEN
12TH,7TH,HEY,HRMS,MTT,NMR,STRUCTURAL,STRUCTURES
169,2012,945,A375,AACR,CHOLINE,CONCLUSION,IMAGING,LABEL,METHODS,OBJECTIVE,OXIDATION,PC3,PET,PURPOSE,RAPID,RESULTS
169,2012,308,380,469,8201,886,8Q24,AFRICAN,AMERICANS,BACKGROUND,CAP,CARIBBEAN,COPYRIGHT,HOWEVER,INC,JAMAICA,LABEL,LEONE,METHODS,MOST,NIGERIA,RESULTS,RISK,SNP,SNPS,TEN,WEST,WILEY
169,2012,AMERICA,COPYRIGHT,GOVERNMENT,HARE,INC,PUBLISHED,UICC,WILEY
169,2012,CHEMISTRY,DESPITE,FURTHER,ROYAL,SOCIETY
169,194,2011,945,COPYRIGHT,GPER,IRELAND,LTD,P450
169,2011,2012,AUTHORS,BJU,HOWEVER,MOST,PATIENT,SEVERAL,THERE,THEREFORE,THESE,TREATMENT,WHAT
ADT,AKT,CRPC,CURRENT,E26,ETS,ETS1,GLEASON,INCREASED,PROTEIN,THESE
107,ABL,PSA,PTEN,TYR
000,001,1085,111,1142,1147,119,124,148,172,1753,1999,2006,2008,213,227,271,297,352,356,429,550,605,642,646,653,851,951,958,964,967,976,977,981,984,985,BETWEEN,CONCLUSION,CONTROLLED,CURRENT,EFFECTS,FEWER,GRADE,KENDALL,LABEL,MAY,METHODS,OBJECTIVE,OBJECTIVES,OUTCOME,PAIN,PROBE,PROTECT,PSA,PURPOSE,RESULTS,TESTING,THESE,TREATMENT,TRIAL
277,423,BACKGROUND,COLORECTAL,COX,ESTROGENS,HRS,LABEL,LUNG,METHODS,OVARIAN,PLCO,RESULTS,SCREENING,TRIAL
2010,APRIL,BECAUSE,DRUG,FOOD,HOWEVER,PAP,PATIENT,PREVIOUSLY,SIPULEUCEL
2011,OPTIONS,PSA,THESE
954,DENOSUMAB,III,RANKL,SUBSEQUENT
001,81G,AFRICAN,ASIAN,CAUCASIAN,CONSISTENT,HAPLOTYPES,OCT3,SLC22A3,STUDIES
ADT,AWARENESS,HOWEVER,QOL,WHILE
ANDROGENS,NEWER
ADT,PROVIDING
ADT,FIFTY,FURTHER,NOW,PCA,QOL,THERE
HOWEVER,PCA
169,2006,2012,CWR22,HOWEVER,LIMITED,MACMILLAN,PUBLISHERS,THESE,THUS,XMRV
001,002,0089,012,013,226,298,368,BSI,CONCLUSION,CRMPC,LABEL,LOG,METHODS,OBJECTIVE,PRIOR,PSA,PURPOSE,RESULTS,THERE,THESE
1125,1240,1458,1582,1982,1997,2002,2009,284,3726,6447,684,688,741,8805,917,999,BACKGROUND,CONCLUSION,ITALY,LABEL,METHODS,ORS,RESULTS,THESE
8804,CONCLUSION,DETECTION,LABEL,METHODS,OBJECTIVE,PET,PSA,PSADT,PSAVE,PURPOSE,RESULTS
001,108,133,140,165,169,194,2011,266,8805,BACKGROUND,BECAUSE,COPYRIGHT,LABEL,METHODS,NSS,NSSS,OBJECTIVE,OVERALL,PROCEDURE,PSM,PSMS,PUBLISHED,RARP,RESULTS,SETTING,SIDE,UROLOGY
169,2012,CLEAR,COPYRIGHT,DES,EPR,EXHAUSTIVE,NMR,PGSE,SANS,THESE
AREAS,BACKGROUND,COVERED,DRUG,FULL,LABEL,MDV3100,METHODS,OPINION
CD3,EPCAM,EPCAMXCD3,ESA,LABEL,METHODS,MOST,OBJECTIVE,PURPOSE,RESULTS,TRAIL
EGFR,HER2,HER3,HIGH
001,009,033,080,130,2011,7067,790,BACKGROUND,BMI,LABEL,MATERIALS,MEDLINE,METHODS,OCTOBER,PCA,RESULTS,THEREFORE
001,002,003,004,169,177,2012,324,945,946,ALUI,COPYRIGHT,GENOTYPES,INC,IRANIAN,PCA,PCR,PVULL,RFLP,RSAI,SERUM,THERE,WILEY,XBAI
169,174,2004,2009,2012,613,620,740,752,8201,830,837,860,911,923,AUC,AUCS,BACKGROUND,COPYRIGHT,CTC,CTCS,DATA,INC,LABEL,METHODS,NINTY,PCR,PSA,PSAR,PSM,PSMA,PSMAR,RESULTS,RFS,ROC,WILEY
000,108,1993,2001,2006,2009,340,345,3815,4250,685,8201,AFTER,BACKGROUND,CIS,COLORECTAL,CUMULATIVE,DRE,JULY,LABEL,LUNG,METHODS,MORTALITY,OCTOBER,OVARIAN,PLCO,POISSON,PSA,RESULTS,RRS,SCREENING,TRIAL
169,2012,318,8201,AFRICAN,AMERICANS,BACKGROUND,COPYRIGHT,GLEASON,INC,LABEL,METHODS,RESULTS,SIXTY,USING,WILEY
169,2012,954,ACTIVATION,BACKGROUND,BOTH,CONCLUSION,COPYRIGHT,COX,DAP,DU145,ELISA,INC,LABEL,MAPK,MDP,METHODS,NOD1,NOD2,PC3,PCR,PIN,RESULTS,THESE,TLR,TRAMP,TRI,WILEY
169,2012,8201,946,ALK,BACKGROUND,BOTH,CDK,COPYRIGHT,INC,INCREASED,INK4B,KIP,LABEL,LNCAP,METHODS,RESULTS,SMAD,SMAD2,SMAD3,TGF,THEREFORE,WESTERN,WILEY
GIVEN,HODGKIN,LABEL,LUNG,LUPUS,NHL,OBJECTIVE,PURPOSE,RESULTS,SLE,SUMMARY
008,118,134,163,2301,233,2331,407,8201,8226,FAS,KEY,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,USING
169,194,2000,2011,COPYRIGHT,EUPATORIN,FINALLY,INC,SAC
001,169,194,2012,916,COPYRIGHT,INC,KFM,KISS1,PATHOLOGY,PCA,PCAS,PUBLISHED,SOCIETY
138,169,194,2012,2AT6,8804,8805,AKT,ANGII,ARB,AT1R,CAP,CCL2,COPYRIGHT,GLEASON,HIGH,INC,LNCAP,MCP,PATHOLOGY,PI3K,PSA,PUBLISHED,SOCIETY,SPECIMENS
169,177,2011,265,AIMS,COLLEGE,COPYRIGHT,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,RESULTS,ROYAL,THERE
169,2013,AKT,CAP,CHRONIC,COPYRIGHT,HIF,INC,JAK,LABEL,LNCAP,MATERIALS,METHODS,OBJECTIVE,PI3K,PURPOSE,RESULTS,STAT,THESE,WESTERN
169,2011,CCKRA,COPYRIGHT,FACS,LORGLUMIDE,MRI,PC3,U2OS,U373,WHILE
169,2012,330,3510,8195,9TH,BLACKWELL,CASE,END,HOWEVER,LTD,OVERALL,PROGRAM,PUBLISHING,RESULTS,SEER
ANNEXIN,BACKGROUND,CELL,CX43,FITC,GCV,HSV,LABEL,METHODS,MTT,NUDE,PAMAM,PCR,RESULTS,WESTERN
945,946,AHX,ALA,ARG,ASP,BACKGROUND,BASED,BBN,GLN,GLU,GLY,GRPR,INC,LABEL,LEU,MET,METHODS,MICRO,NO2A,NOTA,PET,PUBLISHED,RESULTS,RGD,TRP,VAL
001,133,169,195,2011,266,BACKGROUND,CNS,COPYRIGHT,FINE,JANUARY,LABEL,METHODS,OBJECTIVE,PROCEDURE,PUBLISHED,RARP,RESULTS,SETTING,UROLOGY
169,2011,945,AKT,AMPK,ATM,CHK2,COPYRIGHT,EBP1,H2AX,HISTONE,IRELAND,LABEL,LTD,MATERIALS,MEFS,METHODS,OBJECTIVE,PCR,PURPOSE,RESULTS,S6K,THESE,UNTREATED,WORK
AKT,AXII,AXIIR,ERK1,FINALLY,HSC,OCL,PCA,THESE
BIP,BORTEZOMIB,CHIP,CHOP,CPDA,DU145,ERS,GADD153,HSPA5,LNCAP,OVERALL,PC3,PCA,SGK1,USING
169,183,8198,BRUCHOVSKY,CAB,GEORG,HOWEVER,IAB,III,MOST,STUTTGART,YORK
169,2011,3000,ADT,ASA,COPYRIGHT,INC,METABOLISM,NSAID,TAKEN
2005,2010,AIS,ALONE,AROMATASE,ATAC,CRPC,CYP17A1,SINCE,TAMOXIFEN
001,419,444,967,AXIS,DISORDERS,DSM,INTERVIEW,LTD,MAJOR,MIXED,PTSD,PUBLISHED,REGARDLESS,STRUCTURED,WOMEN
041,169,1999,2010,2013,357,669,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,RALP,RESULTS,RRP,SHORT,UTILIZING
100,130,151,169,2012,408,477,COPYRIGHT,FOAMY,GLEASON,INC,LIMITED,THERE,TIME
160,169,2012,8482,8805,AFTER,AUC,BJU,DIAGNOSTIC,DRE,GLEASON,LABEL,LEVEL,METHODS,OBJECTIVE,PCA3,PROBE,RESULTS,THERE,THESE,TYPE,UNLABELLED,WHAT
169,2011,BACKGROUND,BIO,CBRT,COPYRIGHT,D10,D90,DMAX,HDR,HIGH,LABEL,LTD,MATERIALS,METHODS,OAR,OBJECTIVE,PTV,PUBLISHED,PURPOSE,RESULTS,TREATMENT,V100,V200
169,2012,UROLOGICAL
003,100,101,102,103,104,105,1362,169,183,2012,BLACKWELL,CONCLUSION,LABEL,LTD,METHODS,OBJECTIVE,PUBLISHING,RESULTS
215,4723,4792,8764,ADDITIONAL,GWAS,HOPKINS,IGF2,JOHNS,MARKERS,META,MYEOV,PCA,SNPS,SYK,TET2,THOSE
AES,ATTENTION,CRPC,RESULTS
5637,BIU87,E1A,HOWEVER,HUC,LUC,PSCAE,R1881,T24,UPII
2000,ANIMALS,DOCETAXEL,INSIGHTEC,LNCAP,MRI,RESULTS
2007,2011,5TH,ASIAN,CAP,CAPSURE,CHINA,FIFTH,INDONESIA,INITIATIVE,JAPAN,JOINT,JULY,KOREA,MEETING,SINCE,TOKYO,USA
1P36,1PTER,1Q42,1Q43,3141,890,CHROMOSOME,DELETIONS,RECOGNIZED
189,2008,220,406,522,593,607,685,797,COMPLETED,CONCLUSION,LABEL,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,RISKS,ROBOTIC
0001,954,BOTH,FHRA,HOWEVER,NAVIGENICS,OVERALL,PGS,SCREENING,SNP,THERE
1207,555,652,8804,8805,AMONG,DEGS,DIGE,ELISA,INOSINE,PCA,SIXTY,THESE
2008,2010,EACH,INDIA,MARCH,OVERALL
2003,2006,BACKGROUND,CERTAIN,FIVE,FURTHER,KEY,LABEL,MAIN,METHODS,OBJECTIVE,RESULTS,SECONDARY,THERE,USING,WHILE,WISCONSIN
001,145,8320,8321,8322,8325,BASED,BCL,DOX,LNCAP,PCA,TREATMENT
169,2012,AFTER,APT,APTS,NPS,PCA,SOCIETY,USING
001,002,003,004,006,009,036,169,2011,205,305,335,343,349,351,380,384,8201,ADT,AFTER,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,RESULTS,SEVENTY,WILEY
169,2012,ABCC2,ABCG2,AIB1,AKT,BCL,CCA,CDK1,CONCLUSION,COPYRIGHT,DOWN,HOWEVER,LABEL,LIVER,NRF2,ROS,UNLABELLED
169,2008,2010,2011,283,384,667,708,8201,AUC,BACKGROUND,COPYRIGHT,CRC,DRE,HOWEVER,INC,JANUARY,LABEL,METHODS,PCA,PCPT,PRI,PSA,RESULTS,SEVERAL,SWOP,TRUS,WILEY
169,2011,BACKGROUND,COPYRIGHT,DU145,EXPRESSION,HMGA1,INC,LABEL,LNCAP,METHODS,PCA,RESULTS,THESE,WESTERN,WILEY
169,2011,8201,AZD2171,BACKGROUND,CEDIRANIB,CONCLUSION,COPYRIGHT,DU145,INC,LABEL,METHODS,PCA,PDGF,PDGFR,RESULTS,THESE,VEGFR,WILEY
169,2011,218,802,BACKGROUND,CDK4,COPYRIGHT,HOWEVER,INC,LABEL,LNCAP,METHODS,NEXT,PTEN,RESULTS,SNVS,WILEY
169,2011,954,AKT,BACKGROUND,BOTH,CIS,COPYRIGHT,CRPC,ERK1,INC,JAK1,JAK2,JAK3,LABEL,LNCAP,METHODS,NED,RESULTS,S17,SH2,SOCS1,SOCS6,SOCS7,STAT3,TYK2,USING,WILEY
00269,031,126,131,169,2011,8201,ADT,ALLELIC,BACKGROUND,COPYRIGHT,GLEASON,HSD17B2,IGRT,INC,LABEL,METHODS,RESULTS,STAR,WILEY
169,2011,ASO,BACKGROUND,COPYRIGHT,CRPC,FINALLY,INC,LABEL,LNCAP,METHODS,RESULTS,THESE,TREATMENT,WILEY
045,139,169,2011,374,410,514,8805,BMI,CIS,COPYRIGHT,COX,FEW,HRS,MELBOURNE,UICC,USING
169,2011,ABD,ANTIGEN,BACKGROUND,CALBIOCHEM,COPYRIGHT,FITZGERALD,INC,LABEL,METHODS,PSA,RESULTS,SEROTEC,THESE,WILEY
100,169,2011,8201,ACH3,ARHI,ARMO,BACKGROUND,CASTRATION,CELLS,CHIP,CHROMATIN,COPYRIGHT,CRPCS,DHT,INC,K14,LABEL,LNCAP,METHODS,PCR,POL,PSA,RESULTS,THESE,TMPRSS2,UPON,WILEY
ANXIETY,CONFUSION,DEPRESSION,IMPOTENCE,VARIOUS
CARE,CONCURRENT,CONVERGENT,DIVERGENT,FORM,FURTHER,LABEL,METHODS,NEEDS,OBJECTIVE,PRINCIPAL,PURPOSE,RESULTS,SCNS,SF34,SHORT,SUPPORTIVE
169,2012,6415,AMERICA,AMONG,BACKGROUND,BCA,DATA,JOURNAL,LABEL,METHODS,NORTH,PCA,PSA,RESULTS,ULTIMATELY
169,2011,LABORATORY,UROLOGICAL
CELL,UTR
150,206,675,CTLA,DOSE,PSA,SECONDARY
733,AUC,AUCS,CALCULATOR,ERSPC,GOETEBORG,KINGDOM,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PREVENTION,PSA,RESULTS,RISK,ROUND,SABOR,THERE,TRIAL,TYROL
CYBERKNIFE,HOWEVER,IMAGE
11A,11L,169,2011,956,A549,ANNEXIN,COPYRIGHT,FITC,HOECHST,HRMS,LTD,MTT,NMR,PBD,SUBG1,THESE
169,194,2012,946,AKT,AKT3,AMONG,COPYRIGHT,INC,PATHOLOGY,PDGF,PDGFR,PTEN,PUBLISHED,SIMILAR,SOCIETY,TAKEN
05GY,169,2013,2CC,2GY,2ML,4GY,5GY,945,946,94GY,CONCLUSION,COPYRIGHT,HGI,INC,LABEL,MATERIALS,METHODS,PUBLISHED,PURPOSE,RESULTS,SOCIETY,UNLABELLED
100,169,2011,223,3100,BACKGROUND,CONTEXT,COPYRIGHT,LABEL,MDV,MDV3100,MEDICAL,MEDLINE,MET,METHODS,MOLECULAR,OBJECTIVE,OCTOBER,PUBLISHED,RESULTS,SOCIETY,SRC,SYNTHESIS,UROLOGICAL,UROLOGY
00002,00005,003,004,020,025,036,169,2011,213,526,AFTER,BACKGROUND,BCR,CAUCASIAN,CAUCASIANS,COPYRIGHT,COX,DETERMINE,FOUR,HSD17B1,HSD17B2,HSD17B3,HSD17B4,HSD17B5,LABEL,MEIER,METHODS,OBJECTIVE,PCA,PUBLISHED,RESULTS,SETTING,SNPS,THESE,UROLOGY
1013,169,176,177,2012,833,ADDRESSING,CONCLUSION,COPYRIGHT,IMPLANTED,IMRT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THREE
001,002,005,009,030,100,169,194,2003,2007,2012,594,638,8805,BACKGROUND,CONVERSELY,COPYRIGHT,DECREASED,LABEL,LATE,METHODS,MIRP,OBJECTIVE,RESULTS,RRP,SETTING,UROLOGY
169,194,2012,20NG,COPYRIGHT,FURTHER,GLEASON,GRADE,IMRT,INC,LABEL,LATE,LTAS,MATERIALS,METHODS,OBJECTIVE,PHASE,PURPOSE,RESULTS,T1C,T2B
001,169,1998,2006,2012,400,562,8805,962,BETWEEN,COPYRIGHT,CSA,ELECTRONIC,EPID,IGRT,INC,LABEL,MATERIALS,MAXIMUM,METHODS,NCCN,NETWORK,OBJECTIVE,PATIENT,PTV,PURPOSE,RESPECTIVE,RESULTS,SVP
PAMAM,RNAS,SUCCESSFUL,TEA
1997,2001,784,838,946,AHR,AMONG,ASSOCIATED,BACKGROUND,BECAUSE,COLORECTAL,CONCLUSION,CONFIDENCE,DEFINITIVE,DUAL,ENROLLMENT,INCIDENCE,LABEL,LIKELIHOOD,LOWER,METHODS,ODDS,OHIO,RATIO,RECEIVE,RESULTS,TREATMENT
160,CELLSEARCH,CSS,CTCS,DETECTION,DRUG,FDA,FOOD
160,CADMIUM,CHANGES,OHDG,ROS,ZINC
ADDRESSING,CER,DEPARTING,USA,USING,WITHOUT
CDDO,HOWEVER,LNCAP,PINS,TERT,THESE,TRAMP
001,040,096,140,160,717,CALIFORNIA,HOWEVER,LABEL,METHODS,OBJECTIVE,PCA,PURPOSE,RESULTS,STUDIES
945,946,DHEA,DPN,EPI,LAPC,LTD,METABOLISM,PPT,PSA,PUBLISHED,R1881,STROMAL,STUDIES,TGF,USING
169,1700,2011,602,610,656,662,675,679,AUC,AUCS,BAUS,BAYES,BNS,BRITISH,COMPARING,CONCLUSION,COPYRIGHT,FINALLY,HEURISTIC,HOWEVER,INFIRMARY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PREDICTION,RESULTS,ROC,ROYAL,SUBSETS,UROLOGICAL,USING
169,2011,COPYRIGHT,INC,INHIBITION,PSS,RNAS,THESE,TIC,TICS,USING
169,2011,COPYRIGHT,LABORATORY,LTD
169,194,2008,2009,2011,462,7389,889,BACKGROUND,COPYRIGHT,INPATIENT,LABEL,LRP,LRPS,METHODS,MIRP,NATIONWIDE,OBJECTIVE,OCTOBER,ORP,ORPS,PRIOR,PUBLISHED,RARP,RARPS,RELYING,RESULTS,RPS,SETTING,UROLOGY
169,2012,COPYRIGHT,DESPITE,INC,PUBLISHED
169,2011,COPYRIGHT,ETS,ETS1,INC,MDR1,MMP1,MMP3,MMP9,PC3,PC3PR,TAKEN
145,169,2011,COPYRIGHT,DR4,DR5,EXPRESSION,HMGB1,HOWEVER,INC,LNCAP,PSA,RAGE,RNAI,THEREFORE
169,2001,2010,2013,463,493,543,836,AFTER,CAP,COPYRIGHT,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,OLDER,PSA,RESULTS,UPGRADING
1103,149,246,437,ANOTHER,ANTIBODIES,FOUR,HBV,HCV,HIV,HTLV,OVERALL,PBMCS,SPAIN,XMRV
1989,2010,306,AGE,COX,HRS,LABEL,MEIER,METHODS,OBJECTIVE,PURPOSE,RESULTS
500,800,8805,BACKGROUND,BECAUSE,CONCLUSION,DOSE,LABEL,METHODS,RESULTS,TEN
ASCORBATE,ATP,H2O2,HOWEVER,IC50,LAPC4,TAKEN,THROUGH,WHEREAS
2004,ENDOTHELIN,UNTIL,WESTERN
300,AUC,AUCS,DRE,ERSPC,LABEL,METHODS,MISSING,OBJECTIVE,OBJECTIVES,PSA,RANDOMIZED,RESULTS,RISK,RISKS,SCREENING,TRUS
AFTER,CDDP,HRPC,IFM
946,BPH,EMT,EPITHELIAL,EXPRESSION,FOXA1,HOWEVER,KLF4,SLUG,SNAIL,TGF
AOS,ATM
0088,160,400,GLEASON,HOWEVER,INCLUDING,OVERALL,THERE
AKT,AMONG,AMPK,HOWEVER
945,EGFR,ERK,FURTHER,HOWEVER,MEK,MMP,PCA,PD98059,TACE,TGF,THESE
DEPLETION,FINALLY,FIRST,HOWEVER,KDM6A,MTDH,NEXT,NUCLEIC,RAD51,TAKEN
CURRENTLY,GIVEN,PET
10Q11,11Q13,160,17Q12,17Q24,3P12,730,8Q24,979,CONSORTIUM,GWAS,HOWEVER,HPC,PCA,SNPS,XP11
LABEL,METHODS,MPH,NERVE,OBJECTIVE,PURPOSE,RARP,RESULTS,THESE
2011,LABEL,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,OVID,RESULTS,SEPTEMBER,THERE
169,2011,COPYRIGHT,HOWEVER,IRELAND,LTD
BECAUSE,PSA
946,BECAUSE,PROMISE,WNT
169,2012,COPYRIGHT,CYP17,III,LTD,PHASE
003,169,2011,BMD,BMDL,CANDIDATE,COPYRIGHT,INC,PBPK,RDX,RFD,RFDS
169,2011,BACKGROUND,COPYRIGHT,EVALUATION,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
169,2011,ADME,COPYRIGHT,HIGH,LTD,REFINEMENT
100,169,173,2005,2010,2012,215,5TH,8804,ADVERSE,COMMITTEE,COPYRIGHT,FAVORABLE,FOLEY,GLEASON,GRADE,HDR,HOWEVER,INC,INSTITUTE,IRB,JOINT,JULY,LABEL,MATERIALS,METHODS,MOST,NONE,OBJECTIVE,PURPOSE,RESULTS,STAGE,T2B,ULTRASOUND
169,2012,215,AFTER,COPYRIGHT,CTV,GTV,INC,LABEL,MATERIALS,METHODS,MODEL,OBJECTIVE,PURPOSE,RESULTS
169,177,18ML,1ML,2012,2ML,9ML,COPYRIGHT,HOWEVER,JACCARD,LABEL,LOCAL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SOCIETY
169,174,2011,945,956,COPYRIGHT,INC,LNCAP,PEG,THESE
001,014,056,159,169,184,2013,673,917,COPYRIGHT,FINALLY,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PEARSON,PSA,PSAD,RESULTS,TAUS,TRUS
139,169,177,194,2012,426,471,495,945,CONCLUSION,COPYRIGHT,FLOW,HIF,INC,LABEL,METHODS,OBJECTIVE,PC3,RESULTS,SILENCING,WESTERN
0001,002,004,1038,169,2001,2009,2012,707,COMPOSITE,CONCLUSION,COPYRIGHT,EPIC,INC,INDEX,LABEL,METHODS,MOST,OBJECTIVE,OPEN,PREDICTORS,PSA,PUBLISHED,RARP,RESULTS,RRP,THERE,VUAS
103,115,125,169,1999,2004,2012,247,8804,994,BETWEEN,CONCLUSION,COPYRIGHT,EBRT,GLEASON,HOWEVER,INC,JUNE,LABEL,MATERIALS,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS
158,197,AFTER,AMONG,BACKGROUND,DETECTION,LABEL,METHODS,PAC,RESULTS,THESE
007,CLINICALLY,EGFR,NOTABLY,SRC,STAT,STAT1,STAT3
945,ADDITIONAL,HDAC,HISTONE,MRS,SAHA
2000,2009,216,243,459,DUTCH,GEP,NET,POISSON
NOD,SCID,THESE,VEGF
023,043,050,160,601,ADT,APAI,BSMI,CDX2,FOKI,GLEASON,HOWEVER,LABEL,METHODS,MOLECULAR,OBJECTIVE,PURPOSE,RESULTS,TRU9I,VDR
00001,ACCORDING,AUC,DRE,ECE,LABEL,MATERIALS,MEAN,METHODS,MRI,NPV,OBJECTIVE,OBJECTIVES,OVERALL,PCA,PPV,PRE,PSA,RESULTS,ROC,T3A,T3B
AFTER,C4A,HSA,IGG,ITIH,MALDI,PSA,REVERSE,SELECTIVE,THREE
169,2011,8482,8805,ASSAY,AUTHORS,BJU,DUE,ENGLISH,HOWEVER,MRI,OPTIMISING,PCA3,SCORE,STRATEGIES,WHAT
104,169,2011,215,345,8226,8804,AUTHORS,BJU,CANCERS,CASES,CONCLUSION,LABEL,METHODS,OBJECTIVE,OVERALL,RESULTS,UNLABELLED,WHAT
001,007,100,169,2001,2005,2011,629,8805,887,928,943,9985,ADT,AUTHORS,BJU,BLACK,CONVERSELY,DESPITE,END,FINALLY,LABEL,MEN,METHODS,OBJECTIVE,RESULTS,SEER,UNLABELLED,USA
046,100GY,103,110GY,125,129,169,199,2002,2008,2012,259,4GY,8805,BETWEEN,CONCLUSION,COPYRIGHT,CTCAE,GRADE,INC,INDEX,IPSS,LABEL,LATE,MATERIALS,METHODS,OBJECTIVE,OCTOBER,OVERALL,PUBLISHED,PURPOSE,RESULTS,SCORE,SOCIETY,THERE,TOXICITIES
125,169,2012,COPYRIGHT,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SOCIETY,SUBSEQUENT,T1C
954,BONE,DENOSUMAB,RANKL
DESPITE,URINARY
130,2003,2009,560,8201,8804,AFRICAN,AMERICANS,BACKGROUND,BMI,FINALLY,GLEASON,IQR,LABEL,METHODS,OBJECTIVE,OVERALL,PERIPHERAL,PSA,PSM,PURPOSE,RALP,RECORDS,RESULTS,THESE,WHILE

169,2011,AFTER,AVOS,BLOT,COPYRIGHT,INC,LC3,MAP1,ORI,PCR,SEM,TEM,UNDER,WESTERN,WILEY
001,006,012,022,100,120,169,183,2011,AMONG,BACKGROUND,BRITISH,CONCLUSION,COPYRIGHT,JOHN,JOURNAL,LABEL,LTD,METHODS,OPEN,OPERATIONS,OUTCOME,PIHR,PUBLISHED,RESULTS,RRP,SIXTY,SOCIETY,SONS,SURGERY,WILEY
123,1907,1920,1935,1967,1987,2002,2006,2009,268,371,894,DAILY,ICELAND,THESE,THROUGH
BPH,CRP,GLEASON,IIA,PCA,PSA
169,2012,215,27632,CONTINUED,COPYRIGHT,CRC,CRCS,HOWEVER,INC,PATHOLOGY,PRIMARY,PUBLISHED,RHO,SOCIETY
115,136,147,169,184,193,2004,2008,2011,435,8804,8805,AIM,BACKGROUND,BNSRP,CCI,CONCLUSION,CONVERSELY,IIEF,INDEX,LABEL,MAIN,MEASURE,MEIER,METHODS,OBJECTIVE,OUTCOME,PDE5,RESULTS,SIMILARLY,SOCIETY
169,2011,C12,COPYRIGHT,CRD,FINALLY,GAL,HPMA,LTD
169,177,2012,8805,AFTER,COPYRIGHT,CTV,FSV,HOWEVER,IMRT,INC,MEDICAL,MINIMUM,PSV,PSVS,PTV,PUBLISHED,SVS
014,029,047,091,169,2001,2010,2011,333,343,676,8195,8805,AFTER,AIM,BACKGROUND,BCR,COX,CRUDE,EPIC,LABEL,MAIN,MEIER,METHODS,OBJECTIVE,OUTCOME,RESULTS,SOCIETY,THESE
BAK,BCL,BH3,DU145,III,MCL,PCS,THESE,ULTIMATELY
103,122,169,2007,2009,2012,8804,ANGELES,CALIFORNIA,CONCLUSION,COPYRIGHT,HOMME,INC,INDEX,JUNE,LABEL,LOS,MARCH,METHODS,MINIMALLY,MODULAR,OBJECTIVE,PATIENT,PHASE,RESULTS,STOP,TOMS,TREATMENT,UNIVERSITY,WOUND
169,2011,AEU,BACKGROUND,CONTEXT,COPYRIGHT,HOWEVER,LABEL,METHODS,OBJECTIVE,ONCE,PUBLISHED,RESULTS,SYNTHESIS
134,138,169,2000,2010,2011,AEU,BETWEEN,COPYRIGHT,DIAGNOSTIC,GLEASON,LABEL,METHODS,OBJECTIVE,PSA,PSAD,PUBLISHED,RESULTS,TRUS
001,100,169,2011,ACCORDING,AEU,COPYRIGHT,GLEASON,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PIN,PUBLISHED,RESULTS,SPAS,THESE,WINDOWS
DETECTION,PCA3,PSA
169,1996,2006,2011,9028,BLACKWELL,EINDHOVEN,ELDERLY,LTD,PUBLISHING
169,1940S,2011,DRUG,FOOD,HIGH,HOWEVER,JAPAN,UROLOGICAL,USA
1975,2005,222,268,359,BRCA1,BRCA2,OCCR,THERE
1603,8201,CHIP,CSF2,ETS,GATA,KLK2,PAGE,PCA,R2ORS,RUNX,RUNX2,SDS,TFS,THUS,TSSS,USING
169,194,2011,945,946,AML,ATP,CK2,CML,COPYRIGHT,INC,PML,SER,SEVERAL,THR
169,200,2011,280,8764,COPYRIGHT,HOWEVER,INTERFRIN,PEG,PEGYLATED,PEGYLATION,PLL,PLLS
145,231,956,CELL,III,MDA,MEL,OVCAR,RESULTS,TIME
2007,2010,440,555,8805,965,BLOOD,CONCLUSION,CRPC,CYP17,ERG,LABEL,MARCH,MAXIMAL,METHODS,OBJECTIVE,OCTOBER,PERSISTENT,POTENTIAL,PURPOSE,RESULTS,TMPRSS2
131,8595,945,954,CASPASE,D131A,EEPD,MCF,PAR,SITE,UPON
AFTER,ATP,BACKGROUND,BLUE,BPH,CELL,HPEC,HPECS,LABEL,METHODS,RESULTS,VEGF
BACKGROUND,BMI,BPH,DOSE,FURTHER,HOWEVER,LABEL,LUTS,METHODS,RESULTS
ACTIVATED,THESE,THUS
001,1990,2008,396,BACKGROUND,CONTEXT,GLEASON,IGF,IGFBP,IGFS,LABEL,LARGE,MAIN,METHODS,OBJECTIVE,OUTCOME,RESULTS,SETTING,THERE
169,194,2011,CA125,COLORECTAL,COPYRIGHT,LTD,LUNG,OVARIAN,SCREENING,TRIAL
100,169,2003,2009,2011,8226,BJU,DATA,ENGLISH,LABEL,MATERIALS,MEDLINE,MEN,METHODS,OBJECTIVE,RESULTS
169,2011,8Q24,FURTHER,HOWEVER,THERE
2008,BACKGROUND,BEHAVIORAL,DATA,DESPITE,LABEL,METHODS,RESULTS,RISK,SMOKERS,STUDIES,THESE,WHILE
000,039,042,046,120,169,2011,9941,9944,9948,ADDITIONAL,BACKGROUND,COPYRIGHT,ESTIMATED,LABEL,METHODS,RESULTS,SOCIETY,THESE
101,169,1NG,2011,215,250,8805,ASSESSMENT,BACKGROUND,BECAUSE,COPYRIGHT,FUNCTIONAL,FURTHER,INDEX,LABEL,METHODS,OUTCOME,PERIPHERAL,PSA,RESULTS,SOCIETY,THERAPY,THERE,TREATMENT
104,123,1999,2000,2003,223,262,622,8201,8805,AMONG,BACKGROUND,CARE,KEY,LABEL,MAIN,MEDICAL,MEN,METHODS,OBJECTIVE,PRACTICES,PRIMARY,PSA,RESULTS,SOUTH,VAS,WEST
0001,169,1997,2000,2011,380,387,553,718,AFTER,BACKGROUND,CASES,COPYRIGHT,HOWEVER,LABEL,MEDICATION,METHODS,RESULTS,SOCIETY,STATINS,THERE
001,1581,169,2011,ADULT,AFTER,AMONG,BACKGROUND,BIVARIATE,COMPONENT,COPYRIGHT,DATA,FORM,GENERAL,HRQOL,LABEL,LOUISIANA,MCS,METHODS,NORTH,PCAP,PCS,PROJECT,RAPID,REALM,RESULTS,SF12,SHORT,SOCIETY,SUMMARY,THESE,YET
EZH2,H3K4ME3,THROUGH
CRPC,FURTHER,HOWEVER,PCS,PHB,PSA,RNAI,USING
135,8594,948,AKT,CDCP1,CUB,PARP1,PKC,PREVENTING,SRC
5Q21,AMONG,CGH,CHD1,EXON,EXPRESSION,LAPC4,OPCN2,RWPE,TAKEN,TOWARDS
112,136,231,737,ABT,ANNEXIN,BAD,BAX,BCL,DU145,FITC,HOWEVER,MCL,MDA,MSEA,PARP,RNAI
200,215,GLEASON,HIGH,OVERALL,THEREFORE
169,2011,AACR,HOWEVER,PARP,PTEN,RAD51
AKT,CONVERSELY,ERK,FADD,FAS,HEAT,HSP27,LNCAP,PEA,PTEN,THESE
AKT,ELK,ERK,ERK1,IGF,MAPK,MTT,NKX3,PC3,PCR,WESTERN
EERPE,ENDOSCOPIC
124,133,160,8805,CPS,LABEL,METHODS,OBJECTIVE,PCA,PSA,RESULTS,RTE,TRUS
100,160,AMONG,BALB,BAX,BCL,HEPG2,NSAID,ORAL,THEREFORE,THESE
169,2011,BACKGROUND,COPYRIGHT,GENERAL,ISSUE,LABEL,MAJOR,METHODS,MOST,NON,SCOPE,SPECIAL,THEREFORE
127,129,169,177,194,2001,2008,2011,212,339,636,AEU,BETWEEN,COPYRIGHT,HDL,LABEL,LDL,LHRH,MEAN,METHODS,OBJECTIVE,PUBLISHED,RESULTS
169,1990,2010,2011,AEU,BACKGROUND,CONCLUSION,COPYRIGHT,LABEL,LIBRARY,MEDLINE,MEGA,MESH,METHODS,OVID,PUBLISHED,RESULTS,SCIENCE,SPT,STP,THERE,TRIP
169,2011,AKT,ATG5,COPYRIGHT,INHIBITION,LC3,PC3,PTEN,SEVERAL,TAKEN
169,180,2011,AVAILABLE,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,TDM
100,1200,169,2009,2010,2011,257,429,8226,ACCORDING,BETWEEN,BILATERAL,BJU,CLAVIEN,GRADE,LABEL,LNS,METHODS,NVB,OBJECTIVE,PATIENT,RARC,RESULTS,STUDIES
169,174,2010,2011,512,AFTER,APRIL,AUTHORS,BJU,CENTERS,CONCLUSION,CYP17A1,DRUG,FOOD,LABEL,MEDICAL,METHODS,OBJECTIVE,PAP,PSA,REFERENCE,RESULTS,SEATTLE,SINCE,SIPULEUCEL,SOCIETY,UNLABELLED,USA
169,2008,2009,2011,293,339,8226,AUTHORS,BETWEEN,BJU,CLASS,CLAVIEN,FOLEY,FUNCTIONAL,INITIAL,IQR,JANUARY,LABEL,LEVEL,METHODS,OBJECTIVE,OBJECTIVES,OCTOBER,PST,RARP,RESULTS,SPLINTING,THERAPY,TYPE,UNLABELLED,URINARY,WHAT
169,2012,22RV1,COPYRIGHT,DCFDA,EDUCATION,HNE,INC,LABEL,LNCAP,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL,WESTERN
169,2003,2009,2012,611,752,8804,AGE,COPYRIGHT,COX,EDUCATION,INC,INDEX,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PROSTATIC,PUBLISHED,PURPOSE,RESULTS,SCORE,UNIVARIATE,URINARY,UROLOGICAL
169,2000,2010,2012,295,398,582,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,ORS,PUBLISHED,PURPOSE,RESULTS,SEVERAL,T1C,UROLOGICAL
1170,169,2007,2009,2011,AIMS,BACKGROUND,BLACKWELL,CONCLUSION,DATA,KAOHSIUNG,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHING,QUALITY,RELEVANCE,RESULTS,SEVENTY,SIXTY,UROLOGICAL
ARS,CLINICALLY,EXPRESSION,IIA,LNCAP,SYNTHESES
001,4EBP1,CYP17,HASS,HOWEVER,LAPC,LNCAP,R1881,THUS,TOK,W741C,W741L
CBP,CHROMATIN,LYS,PSA,TATA,TBP,THUS,TMPRSS2
945,946,CONSISTENT
169,178,183,242,253,BESIDES,BOTH,CONCLUSION,FURTHER,GSE,HADS,ILLNESS,LABEL,METHODS,NON,OBJECTIVE,PURPOSE,RESULTS,SSUK,STUTTGART,SUFFERING,THEREFORE,TPF,YORK
169,2011,231,A253,COPYRIGHT,ERK,INC,JNK,JNKI,MAP,MAPKS,MDA,OVERALL,PC3,RNAS,SKOV,USING,WILEY
169,183,COMPOUNDS,GEORG,HELA,KNOWN,PC3,STUTTGART,THEIR,VITRO,YORK
169,2011,AUSTRALIA,COPYRIGHT,FURTHER,GIVEN,HIGH,HODGKIN,NSW,SOUTH,UICC,WALES
169,2011,308,609,AKT,BAD,CAM,COPYRIGHT,INC,LNCAP,STO,TAKEN,WILEY
169,2011,2ME,473,4EBP1,945,AKAP,AKT,BENZ,COPYRIGHT,CPT,CREB,EPAC1,GRP78,INC,PDE3B,PDE4D,PKA,RNAI,S473,SER,SILENCING,T308,THESE,WILEY
169,2011,COPYRIGHT,GASTWIRTH,JOHN,LTD,SONS,WILEY
100,169,194,2003,2010,2012,CONCLUSION,COPYRIGHT,CRYOPROBE,INC,IPP,IPPS,LABEL,METHODS,OBJECTIVE,OCTOBER,RESULTS
169,2012,8805,CASES,CONCLUSION,COPYRIGHT,GLEASON,INC,LABEL,METHODS,OBJECTIVE,RESULTS,THESE
169,194,2011,946,COPYRIGHT,HISTOLOGIC,INC,LY2109761,MDA,MRI,PCA,PMO,PMOS,SCID,SMAD2,TGF,THUS
004,030,037,169,1998,2000,2001,2012,310,413,897,AMONG,BETWEEN,COPYRIGHT,EBRT,END,INC,INSTITUTE,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SMS,USING
008,009,169,1999,2008,2012,225,ADT,AFTER,ART,BETWEEN,COPYRIGHT,GLEASON,GRADE,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SVI
169,196,2011,24NM,946,AKT,AKT1,AKT2,AKT3,COPYRIGHT,GSK3,LTD,MDM2
100,169,2011,956,COPYRIGHT,GSTP1,PCR
169,2011,946,AACR,BECAUSE,CURRENTLY,DU145,HES1,HEY1,HYPOXIA,LABEL,LNCAP,NED,NOTCH,RESULTS,UNLABELLED
14TH,1950,2003,611,DS02,EFFECTS,ERR,FOUNDATION,LIFE,LSS,POISSON,RADIATION,SPAN,THERE
001,024,103,170,191,2009,2011,225,276,281,BLOOD,BMI,GLEASON,HOWEVER,JULY,LABEL,LND,MARCH,METHODS,OBJECTIVE,OTHERWISE,OWING,RARP,RESULTS,ROBOTIC,THERE,TIME,WHEREAS
167,215,FUNCTIONAL,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THESE
233,244,2B15,ANDROGENS,BACKGROUND,BOTH,BRITISH,CONTEXT,DIEU,FINALLY,GLEASON,HOWEVER,LABEL,LAVAL,MAIN,METHODS,OBJECTIVE,OUTCOME,PCR,RESULTS,SETTING,UGT,UGT2B15,UGT2B17,UNIVERSITY,VANCOUVER
17A1,945,ACTH,BACKGROUND,CONCLUSION,CONTEXT,CYP17A1,HOWEVER,LABEL,METHODS,OBJECTIVE,P450,RESULTS,TREATMENT,URINARY
169,2011,8805,AUA,BACKGROUND,BOWEL,COMPOSITE,COPYRIGHT,CYBERKNIFE,EPIC,INDEX,INVENTORY,LABEL,MEN,METHODS,NETWORK,NINE,PSA,RESULTS,SHIM,SOCIETY,THERE,UROLOGICAL
169,2011,4BIS,COPYRIGHT,GNR,GNRS,GOLD,INC,PAE,SUB,WILEY
169,2011,COPYRIGHT,DATA,ERGONOMICS,LTD,RESULTS,RISK,SOCIETY
169,194,1980,2011,BACKGROUND,CONTEXT,CONTINUED,COPYRIGHT,CRITICALLY,LABEL,MEDLINE,METHODS,OBJECTIVE,PUBLISHED,QOL,RESULTS,SYNTHESIS,THESE,UROLOGY,WEB,WHILE
956,BAPTA,CELECOXIB,CONVERSELY,GF109203X,INHIBITION,PC3,PMA,THESE
954,PC3,THESE
000,1970S,1971,1990S,2002,AMONG,BACKGROUND,CONCLUSION,EVEN,INDEX,INEQUALITY,KNOWLEDGE,LABEL,METHODS,NORWEGIAN,RESULTS
071,1154G,693,CAUCASIANS,PUBLISHED,VEGF
DUE,GCE,HRP,HSMS,NANOPOROUS,NPG,PSA
169,194,2011,231,252,ADP,APPPI,ATOR,ATP,COPYRIGHT,EXPRESSION,GGPP,INC,IPP,KLF,KLF2,KLF6,LNCAP,MCF,MDA,MICROARRAY,PC3,PERMANENT,PUBLISHED,T47D,THESE,WESTERN,ZR75
072,1008,AMONG,BACKGROUND,CIS,COLORECTAL,CONCLUSION,GRILLED,LABEL,LUNG,METHODS,MOST,ORS,OVARIAN,PHIP,RESULTS,SCREENING,TOTAL,TRIAL
169,2011,LIPID,NONWETTING,PLGA,PRINT,SOCIETY,TEMPLATES
3100,BACKGROUND,CONTEXT,LABEL,MDV,METHODS,NEWER,PATIENT,T1C
160,1600,169,2011,215,8764,956,ADC,COPYRIGHT,EPITHELIUM,GLEASON,INC,SIMILAR,STROMAL,WILEY
169,200,200A,2011,BACKGROUND,COMPARING,CONCLUSION,COPYRIGHT,GLEASON,INC,LABEL,METHODS,PSA,RADICAL,RESULTS,STAGE,TRANSIENT,WILEY
003,005,015,169,2003,2010,2011,204,528,8201,8805,945,ALSO,ARI,BACKGROUND,COPYRIGHT,COX,GLEASON,HOWEVER,INC,LABEL,METHODS,PCA,RESULTS,WILEY
004,129,169,179,2004,2008,2011,431,8201,BACKGROUND,BETWEEN,COPYRIGHT,GLEASON,HEMI,INC,LABEL,METHODS,MOST,PBX,PCA,PSA,RESULTS,SIXTY,SPECIMENS,UNILATERAL,WILEY
146A,169,2011,ADPC,ALSO,BACKGROUND,CASTRATION,COPYRIGHT,CRPC,EFFECTS,EGFR,ERK,FUNCTIONAL,GIVEN,INC,LABEL,METHODS,MMP2,MTT,PCR,RESULTS,WILEY
169,2011,BACKGROUND,COPYRIGHT,DETECTION,EPIGENETIC,GSTP1,INC,LABEL,METHODS,PSA,RESULTS,THEREFORE,THESE,WHILE,WILEY
169,2000,2011,COPYRIGHT,CX43,GCV,HSV,INC,LNCAP,PAMAM,PSMA,PSMAE,WILEY
169,2011,BACKGROUND,CELL,COPYRIGHT,IAP,INC,LABEL,LNCAP,METHODS,PCR,PEITC,RESULTS,TRANSWELL,WESTERN,WILEY,XIAP
10A,169,2011,22RV1,COPYRIGHT,EPHB4,ERK1,HOWEVER,MCF,THESE,UICC
169,2011,826,COPYRIGHT,COX,DATA,GENERAL,HOWEVER,HRS,OVERALL,UICC
000,100,125,150,200,240,280,350,471,500,600,711,900,DEPARTMENT,GGT,THERE
001,171,1999,2008,333,350,490,ASC,BETWEEN,CCI,COVARIATES,FIRST,FLORIDA,IHP,INDEX,LABEL,LOS,METHODS,MORTALITY,OBJECTIVE,PURPOSE,RESULTS,RPS
109,2010,300,CGS,DUTCH,ERSPC,GPS,HENCE,JANUARY,KNOWLEDGE,MOST,PCA,PSA,RANDOMIZED,REMARKABLY,SCREENING
160,956,EFFECTS,FACS,TREATMENT
205,4F2HC,A431,ASCT,COLO,CONCLUSION,EXPRESSION,LABEL,LAT,LAT1,MET,METHODS,OBJECTIVE,PC3,PCR,PET,PURPOSE,RESULTS
045,174,947,ASIA,CD4,CD8,COMBINING,FOXP3,HOWEVER,IFN,NOVEL,PSK,TRAMP,YAC
8209,ANNEXIN,BASED,BAX,BCL,CHINESE,CURRENT,FLOW,MATRINE,SOPHORA,THERE
004,028,160,CAV,CRO,CURRENT,DMPD,DPPH,FRAP,FRK,GSH,HOWEVER,TEAC,THESE,TNM
100,1190,22RV1,410,945,ATHYMIC,CDK4,CDKS,FURTHER,PCA,THERE,THROUGH,USING
CELL,DESPITE,DIETARY,KNOCKDOWN,MG132,OMEGA,PTEN,PUFA
169,2012,495,AACR,CPG,CRPC,HSD17B2,PTEN,RB1
1550,2339,945,946,CHIP,FAK,PTK2,RUNT,RUNX,RUNX1,RUNX2,RUNX3,SAOS,TGF,THUS,TLN1,TNF,U2OS,WNT
APPRAISAL,BACKGROUND,EIGHT,EVALUATION,FRAMEWORK,GUIDELINES,LABEL,METHODS,RESULTS
946,CUB,LNCAP,PCA,PDGF,PDGFR,RANK,RANKL,TAKEN
DEPLETION,E2F,E2F3,E2F3A,E2F3B,HELLS,MLL1,SNF2,STRIKINGLY,USING
100,177,193,871,FINALLY,FIRST,THEN
BACKGROUND,DISCUSSION,EVALUATING,LABEL,METABOLITE,METHODS,OBJECTIVE,RESULTS
CCND1,CONCLUSION,CPG,CRPC,LABEL,LCNEC,METHODS,OBJECTIVE,PURPOSE,RB1,RESULTS,SCPC,SMALL,UBE2C
169,2011,BOTH,CHROMATIN,COPYRIGHT,H2B,IRELAND,K120,LNCAP,LTD,PSA,RNF20,RNF40,SINCE
169,2011,210,AKT,ARES,COPYRIGHT,DU145,EGF,EGFR,ERK,EXPRESSION,HN1,IRELAND,KLK3,KLK4,KNOCKDOWN,LNCAP,LTD,NKX3,PD98059,PI3K,R1881,S213,S473,THEREFORE
001,015,111,166,16792,169,2011,25TH,7054,835,9738,BESIDES,CHINESE,CNKI,COPYRIGHT,CROWN,EASTERN,HCC,KOREANS,MAY,MEDLINE,ODDS,PCC,PHCC,PSCA,PUBLISHED,THROUGH
169,2011,945,954,COPYRIGHT,DIM,HIF,HOWEVER,I3C,INCREASED,IRELAND,LTD,PCA,PHASE,PSA,THESE
109,123,169,197,2008,2011,215,8805,AGE,ANGELES,BACKGROUND,BNVBP,CALIFORNIA,COPYRIGHT,DETERMINE,GLEASON,HAR,IIEF,INDEX,LABEL,LOS,MEAN,METHODS,OBJECTIVE,ORRP,PDE5I,PUBLISHED,RESULTS,SETTING,UNIVERSITY,UROLOGY
001,003,005,017,169,2012,215,ADC,COPYRIGHT,DWI,EIGHT,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PRETX,PSA,PURPOSE,RESULTS,SERUM
169,2011,COPYRIGHT,IRELAND,LTD,MOST,SELECTING
169,2011,945,956,ANTI,CHINESE,COPYRIGHT,CTS,DHT,IRELAND,LNCAP,LTD,PCA,PSA,TMPRSS2
169,2011,BACKGROUND,CONTEXT,COPYRIGHT,ENGLISH,LABEL,MARCH,MEDLINE,METHODS,OBJECTIVE,PERFORM,PUBLISHED,RESULTS,SCIENCE,SCP,SYNTHESIS,THESE,TITLE,TNM,UROLOGY,WEB
001,1366,169,1987,200,2009,2011,505,8804,BACKGROUND,BCR,COPYRIGHT,CSS,GLEASON,LABEL,MEIER,METHODS,OBJECTIVE,OVERALL,PCA,PLND,PREDICTION,PSA,PUBLISHED,RESULTS,ROUGHLY,SETTING,THESE,UROLOGY
169,2013,228,266,494,ADDITIONAL,BORDERLINE,CAP,CONCLUSION,COPYRIGHT,INC,LABEL,MEN,METHODS,OBJECTIVE,P3P,PATIENT,PROFILE,RESULTS,TIME
169,2011,BLACKWELL,LTD,NORTH,NRW,PUBLISHING,RHINE,SIR,SIRS,WESTPHALIA
169,2011,945,946,BASED,CURRENT,D351,E709,H874Y,HOWEVER,IKK,JOHN,L354,L712,LBD,SONS,T877A,W741C,WILEY
169,2010,2011,BIOMETRIC,EXTENDING,SAHA,SOCIETY,THESE
DAN,DESPITE,LABEL,MEIER,METHODS,OBJECTIVE,PARAMETERS,PROSTATIC,PSS,RESULTS,SCORE,SEVENTY,SYMPTOM
007,100,1000,116,2004,2009,500,8805,BACKGROUND,CLAVIEN,JANUARY,JUNE,LABEL,METHODS,OBJECTIVE,PURPOSE,RALP,RESULTS
2008,BRAWLEY,COKKINIDES,CONCLUSION,EXPERIMENT,LABEL,METHODS,OBJECTIVE,RESULTS,SMITH,STATEMENT
GLEASON,H3K27,PCA
087,088,107,108,150,8764,956,ACTIVATOR,INHIBITORS,K562,LEAD,MCL,MYC,SH2,STAT,STAT1,STAT3,STAT5,THUS,TRANSDUCER
AF1,ASSAY,BIOLOGICAL,CLICK,CRPC,LNCAP,MICHAEL,NMR,NTD,PC3,SAR
169,2011,COPYRIGHT,LTD,METABOLISM,MOUSE
169,2011,AUC,BACKGROUND,BPH,BRIEFLY,CALD1,COMBINING,CONCLUSION,COPYRIGHT,CY3,IGGS,LABEL,LEDGF,METHODS,PARK7,PSA,PSIP1,RESULTS,SERUM,TLN1,USING
169,194,2011,COPYRIGHT,CRPC,FINALLY,HRPC,OTHER,RECURRENCE,SEVERAL
005,025,169,2011,ASSESSMENT,BLACKWELL,EACH,GPS,HOWEVER,LAP,LEICESTER,LTD,PACKAGE,PUBLISHING,SIX,THERE,THESE,THREE
0001,001,1567,169,2000,2008,2011,3500,742,AUA,AUASS,BCR,BETWEEN,BJU,BLOOD,DELTA,HCT,INDEX,INTRA,LABEL,LEVEL,LOS,METHODS,OBJECTIVE,ORRP,QOL,RALP,RESULTS,SCORE,SYMPTOM,THUS,TYPE,UCLA,UNLABELLED,URINARY,VALIDATED,WHAT
176,956,CELL,COMET,H2O2,HOWEVER,LNCAP,MMS,OVERALL,P53,THEREFORE,UVA,UVC
169,2007,2008,2011,945,BJU,CERTAIN,FIFE,FIVE,FOUR,ILLNESS,INDEX,LABEL,MEANING,MEN,METHODS,OBJECTIVE,PEARSON,PRIMARY,RESULTS,SCALE,UNLABELLED
AGC,AKT,MST1,PHLPP,PKC,PRECISE,SER,THR
0001,007,032,169,2011,655,AACR,AKT,ARR,CAV,HGPIN,MYC,OVERALL,PIN,PREVIOUSLY,VEGF
169,183,1990,2010,8202,ABOVE,BACKGROUND,CONCLUSION,DRE,ESPECIALLY,GEORG,JANUARY,LABEL,MARCH,MEDLINE,METHODS,OVERALL,RESULTS,SIX,STUTTGART,UAP,WITHOUT,YORK
169,2011,BACKGROUND,CONCLUSION,COPYRIGHT,JOHN,LABEL,LTD,METHODS,PEER,PEERS,RESULTS,SONS,TEN,WILEY
TRAIL
EPCAM,J415,J591,PSMA
33342,8776,956,BAX,BCL,DATS,DBTS,DHTS,DPTS,HOECHST,MEANWHILE,TYPICAL
370,387,425,4987,8804,BACKGROUND,FURTHER,GLEASON,LABEL,METHODS,PSA,RESULTS,THERE,THOSE
1059,2002,2010,210,849,AUC,BACKGROUND,BETWEEN,DATA,DRE,GUNMA,INDICATOR,LABEL,METHODS,PSA,RESULTS,RISK,TRUS,UNIVERSITY
132,160,2007,2009,269,8804,AMICO,AMONG,BECAUSE,GLEASON,JANUARY,LABEL,MEAN,METHODS,MRI,OBJECTIVE,OVERALL,PSM,PURPOSE,RESULTS
FOLEY,NEXT
171,AUC,BACKGROUND,CONCLUSION,ELASTICITY,GLEASON,III,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SPS,TRTE,TRUS
160,ADC,ALSO,AMICO,BOTH,DWI,GLEASON,MRI,REAL,THREE,THUS,TRUS
100,160,CGLIIQKNEC,CLT1,CNR,CONCLUSION,CY5,DOTA,KAREC,LABEL,METHODS,MRI,OBJECTIVE,ORTHOTOPIC,PURPOSE,RESULTS
244,ANALYZING,CHD1,EFFORTS,HODS,INDICATING,LOSS,PCA,PTEN
145,169,2011,AACR,ADC,REPRIMO
038,8804,ADT,DIETARY,FIFTY,LABEL,MEN,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIXTY,TOTAL
169,2012,ARS,COPYRIGHT,FINALLY,FOXA1,GLEASON,HOWEVER,INC,PATHOLOGY,PSA,PUBLISHED,SOCIETY,THESE
000,100,3242,362,605,AMONG,BACKGROUND,DALYS,ENGLAND,HIGHEST,LABEL,METHODS,MORTALITY,RESULTS,THERE,WALES,WORLD
169,192,2004,2009,2012,215,256,275,ADT,AFTER,BETWEEN,BFS,CONCLUSION,COPYRIGHT,CSS,DESPITE,DFS,FIVE,GLEASON,GRADE,GROUP,HDR,HIGH,INC,LABEL,METHODS,N0M0,NONE,OBJECTIVE,PSA,PURPOSE,RADIATION,RESULTS,THERAPY
169,2011,AQP4,COPYRIGHT,CRMP5,CV2,ENGLISH,IGG,NMO
160,169,2011,92A,COPYRIGHT,CSC,CSCS,HPMA,LTD,RAFT,TARGETING
0001,100,102,125,133,169,2012,965,COPYRIGHT,COX,DESPITE,DISCUSSION,GROUP,INC,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PSA,PUBLISHED,RESULTS
169,2011,COPYRIGHT,CURRENT,MRI,PRIOR,PUBLISHED,THESE,UROLOGY
169,200,2010,2011,2012,293,514,ACT,AFTER,CLINICIANS,COPYRIGHT,HRQOL,INC,INSURANCE,LABEL,MARCH,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
169,2012,945,947,956,ABCA1,ATP,COPYRIGHT,CROWN,DU145,GGPP,HOWEVER,INC,LIVER,LNCAP,LXR,PPAR,PUBLISHED,THESE
169,2012,8322,8324,COPYRIGHT,EXPERIMENT,INC,SEO,TAKEN
001,169,180,181,1990,2007,2012,360,887,COPYRIGHT,ESTIMATED,FFDM,GLEASON,INC,JUNE,LABEL,MARCH,MATERIALS,METASTASES,METHODS,MOUNT,OBJECTIVE,PSA,PURPOSE,RESULTS,SINAI,UNIVARIATE
169,2012,8804,AWALL,BASED,COPYRIGHT,DOSE,EAS,FINALLY,IAS,INC,LABEL,LAM,MATERIALS,METHODS,OBJECTIVE,PRM,PURPOSE,RESULTS,RWALL,SEVERAL
169,2012,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,MICHAELIS,PET,RESULTS,SAAM,TEN,THEREFORE
ACY1,AMONG,AXL,MERTK,PSMA1,TAM,TYRO3
181,578T,625,945,946,ASSAY,BACKGROUND,CELL,CONCLUSION,CONTEXT,DON,DUNAL,INHIBITORY,LABEL,METHODS,MIC,MINIMUM,NON,OBJECTIVE,RESULTS,SOLANACEAE,SOLANUM,TITRE
5P15,MISU,NSUN2,PROTEIN,SAKI
DAPK1,GLEASON,HIC1,MGMT,SCORE,SFRP2
001,007,169,2011,215,285,561,786,879,ADT,AFTER,ANTIGEN,AREAS,COPYRIGHT,IAUGC,IMAGING,INC,MRI,POST,PSA,THESE,WILEY
118B,169,2011,3MM2,BONE,COPYRIGHT,DESPITE,HOWEVER,JOHN,LTD,MDA,MRI,PCA,SONS,SU10944,WILEY
AFTER,CD68,CEA,HENCE,M30,THESE
177,2007,2010,AMONG,APRIL,CRPC,CTX,LABEL,METHODS,OBJECTIVE,PROSTATIC,PURPOSE,RESULTS,THESE
181,22RV1,AKT,BCL,BCL2,BELINOSTAT,HDAC,HDACI,HISTONE,IAPS,IC50,LAPC,PC3,THESE
003,007,100,1425,1624,168,199,1995,2006,960,APRIL,CAUSE,COX,CSS,GLEASON,HOWEVER,LABEL,MATERIALS,MAY,METHODS,OBJECTIVE,PURPOSE,RESULTS
169,194,2011,AFTER,BACKGROUND,CONTEXT,COPYRIGHT,ESPECIALLY,FURTHER,HOWEVER,LABEL,MEDLINE,METHODS,OBJECTIVE,PCA,PSA,PUBLISHED,RESULTS,SYNTHESIS,THEREFORE,UROLOGY,WIDESPREAD
002,160,169,176,2012,8764,ARW,BILATERAL,COPYRIGHT,DOSE,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PLAN,PLANS,PURPOSE,RESULTS,TEN,THESE,THREE
945,FAB,HGFA,KINETIC
100,130,150,177,203,214,266,8807,BACKGROUND,BLADDER,CTV,HOWEVER,LABEL,MEAN,METHODS,PTV,RESULTS,THERE,TREATMENT
169,2011,COPYRIGHT,INC,PROTEIN,THESE,WILEY
169,2011,ARM,CELL,COPYRIGHT,DHH,DHT,GLI,IHH,KAAD,LNCAP,PCA,PNT2,PTCH,SHH,UICC,VCAP
145,AKT,DASATINIB,FAK,INHIBITION,LNCAP,SRC,STAT3,THEREFORE,WESTERN
549,GRP78,HDF,HELA,HSP70,MCF7,TDF,THESE,WESTERN
008,100,120,160,177,200,956,AFTER,ANATOMICAL,CALCULATED,ESPECIALLY,INDIVIDUAL,LABEL,MEAN,METHODS,NSRP,OBJECTIVE,PURPOSE,RESULTS,SPECIMENS
0014,027,029,041,095,168,169,1997,2007,2012,807,8804,882,AST,CONCLUSION,COPYRIGHT,EBRT,FINE,GLEASON,GRAY,INC,LABEL,METHODS,OBJECTIVE,PCSM,PSA,PURPOSE,RESULTS,SEPTEMBER,T2BNXM0,TREATMENT
169,2013,22RV1,945,AEROBIC,BACKGROUND,CAP,CONCLUSION,COPYRIGHT,DU145,HIF,INC,LABEL,LACK,METHODS,OBJECTIVE,RESULTS,THESE
169,2011,8226,ADT,BJU,CONCLUSION,CRPCA,IAD,INSTEAD,LABEL,MEDLINE,METHODS,OBJECTIVE,PCA,RESULTS
945,946,HOWEVER,TRP,TRPM8
1890,491,5210,526,AAF,AFA,AFRICAN,AMERICANS,CD36,FURTHER,HBB,HOWEVER,IAF,LATINOS,SEVERAL,SNPS,THERE,UYGHURS,WORLD
169,2011,215,BACKGROUND,COPYRIGHT,EGR,FAS,FIELD,HOWEVER,INC,LABEL,METHODS,RESULTS,SIMILARLY,WILEY
009,130,169,2011,503,642,686,706,8201,BECAUSE,CD56,COPYRIGHT,GLEASON,INC,KIT,P504S,PCR,PSA,SCNEC,TTF,WILEY
169,2011,945,AUC,BACKGROUND,BORTEZOMIB,CONCLUSION,COPYRIGHT,EGF,EGFR,GLEASON,HER2,HER3,HEREGULIN,IIA,INC,LABEL,LAPATINIB,METHODS,REGULATION,RESULTS,ROC,WESTERN,WILEY
169,2011,COPYRIGHT,DCI,DIAGNOSTIC,DRE,DWI,IMAGING,INC,MRI,PSA,WESTERN,WILEY
169,2011,8201,AIM1,BIOMARKER,CDH1,COPYRIGHT,COX,GLEASON,INC,KIF1A,LABEL,LOG,METHODS,MT1G,OBJECTIVE,OLDER,PAK3,PCR,PSA,PURPOSE,QMSP,RBM6,RESULTS,THESE,TIME,USING,WILEY
15A,169,2011,203,221,222,239,23B,27B,8764,BACKGROUND,COMPARISON,COPYRIGHT,CRPC,FUNCTIONAL,HOWEVER,INC,LABEL,LNCAP,METHODS,RESULTS,WILEY
169,174,2011,945,946,BACKGROUND,CAM,CAMS,COPYRIGHT,ECFP,FUNCTIONAL,INC,LABEL,LNCAP,METHODS,PCA,RESULTS,VOLTAGE,VSSC,VSSCS,WILEY
049,050,062,067,072,083,094,099,169,2011,215,241,283,292,337,361,371,407,415,ADC,ANISOTROPY,BLAND,CONCLUSION,COPYRIGHT,DTI,INC,INTRA,LABEL,MATERIALS,MEAN,METHODS,MRI,OBJECTIVE,OBTURATOR,PURPOSE,RESULTS,WILEY
169,2011,956,ALTOGETHER,BECAUSE,BOTH,COPYRIGHT,INC,MRI,WILEY
10P14,8Q24,COLORECTAL,CRC,MYC,SNP,SNPS,THEREFORE
169,2011,231,435S,468,945,946,AACR,GRO,HMVEC,MDA,MOST,THEREFORE
120,130,215,981,CIVCO,CNR,ESE,IBA
169,2011,239,AIM,HOWEVER,SEQUENTIAL,UROLOGICAL,ZOLEDRONIC
1649,1657,1665,1671,2001,2004,2005,2006,2008,2010,2011,243,258,440,448,753,764,8253,8261,BEST,BRADLEY,CHARLES,CHEN,CLIN,CRPC,CURR,ENDOCRINOL,FELDMAN,HUGGINS,MDV3100,METAB,MOSTAGHEL,NAT,ONCOL,OPIN,PHARMACOL,PRACT,RES,REV,SAWYERS,SCHER
500,650,AAG,DMSO,DOCETAXEL,DOSE,FORTY,LABEL,METHODS,MINOR,MTD,OBJECTIVE,PURPOSE,RESULTS,SERUM
APART,BACKGROUND,CONTACT,FINDING,HOWEVER,LABEL,PATHVAR,SINCE,SUMMARY
945,CRPC,P450,UNTIL
169,2011,ADVERSE,APC,APCS,COPYRIGHT,CSF,DRUG,FOOD,LTD,PAP,PHASE,SERIOUS,SIPULEUCEL,TREATMENT
012,149,518,903,GLEASON,LABEL,METHODS,MRI,OBJECTIVE,PCA,PSA,PURPOSE,RESULTS
293,478,BECAUSE,HOWEVER,PEBBLES,THESE
169,2011,BECAUSE,CONCLUSION,JUNE,LABEL,METHODS,OBJECTIVE,RESULTS,SEVEN,UROLOGICAL
NONE,THEREFORE
194,1972,2009,8804,OVERALL,POPULATION,REGISTRIES,SIR,SWEDISH,TP53,WHETHER
615,GLEASON,JARID1B,JMJC,KDM3A,KDM3B,KDM4A,KDMS,PHD,PHF8,PLANT,PRCA
946,ANEUPLOIDY,LOSS,RAB21,SPATIAL,THEREFORE,THESE
032,1995,2009,794,AIMS,AMONG,HYPOTHESIS,LABEL,METHODS,OBJECTIVE,POISSON,RESULTS
111,151,169,2011,276,438,929,ALPHA,BETA,COPYRIGHT,DIET,FINNISH,PREVENTION,SINCE,TOCOPHEROL,UICC
180MV,500,87MV,956,AFTER,CELLS,CYS,CYSS,GLEASON,GSH,INC,KNOCKDOWN,MMP,MODULATION,NADPH,PC3,PREC,PRECS,PUBLISHED,RNAS
160,177,956,ALA,ALSO,ASA,CARDIAC,CHANGES,CONTROL,FURTHER,LABEL,MAP,METHODS,OBJECTIVE,PURPOSE,RESULTS,RRP,TEN
101,1421,169,2011,233,583,905,ANOVA,ARRANGING,COPYRIGHT,HSD,PC3,SAS,SQL,THUS,TUKEY
150,151,169,2011,301,8764,8804,COPYRIGHT,HOWEVER,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS,SALVAGE,SRT
10MM,165,169,2001,2007,2011,5MM,BETWEEN,COPYRIGHT,CTC,CTV,GRADE,IMRT,IRELAND,LATE,LTD,PHOENIX,PTV
169,2011,388,BACKGROUND,BOOTSTRAP,COPYRIGHT,GRADE,IRELAND,KUTCHER,LABEL,LKB,LTD,LYMAN,MATERIALS,METHODS,MRC,NTCP,OBJECTIVE,PARAMETER,PURPOSE,RESULTS,RT01,TD50,THEREFORE
169,2012,BECAUSE,COPYRIGHT,DESPITE,INC,OWING
140,169,2011,309G,438,472,666,BACKGROUND,CONCLUSION,CONFIDENCE,COPYRIGHT,ERE,ERES,LABEL,LTD,MDM2,METHODS,ODDS,OR1,OR2,RATIO,RESULTS,SNP285C,SNP285G,SNP309G,SNP309T,SP1
169,1995,2011,ADDITIONAL,BACKGROUND,BPH,CENTRAL,COMPARISON,CONTEXT,COPYRIGHT,DATA,FURTHER,LABEL,METABOLIC,METHODS,METS,NCBI,OBJECTIVE,OUTCOME,PATIENT,PCA,PICO,RESULTS,SEPTEMBER,SYNTHESIS,UROLOGY
169,2012,COPYRIGHT,INC,SOCIETY,STATE,UROLOGY,WASHINGTON
AGE,CUMULATIVE,FINALLY,HRS,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OBVIOUSLY,OTHER,RESULTS,SWEDISH
001,2001,2009,332,443,AMONG,BETWEEN,GLEASON,LABEL,MATERIALS,METHODS,OBJECTIVE,PCA,PFS,PURPOSE,RESULTS,TRUS
000,COLON,DEFINITIVE,EACH,ERSPC,LABEL,LUNG,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,OVARIAN,OVID,PCA,PLCO,PSA,RANDOMIZED,RESULTS,SCREENING,TRIAL
150,751,BLOOD,GLN,HYPER,INDIA,LYS,NORTH,RISK,XERODERMA,XPD
034,085,ACEI,ACEIS,ARB,ARBS,CONCLUSION,LABEL,MEDLINE,METHODS,OBJECTIVE,PFS,PSA,RESULTS,SCIENCE,TEN,THERE,USING,WEB
1960,1990,2006,BETWEEN,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
BAYES,SEVERAL
945,BTG2,HIF,IMMUNOBLOT,KNOCKDOWN,LNCAP,NDRG1
169,2011,AKT,CHIP,COPYRIGHT,EARLY,EGR,ERK,IGF,IRELAND,LTD,RESULTS,TAKEN
008,061,CONCLUSION,ERB,IMS,INC,KOLMOGOROV,LABEL,LARGE,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,REAL,RESULTS,SMIRNOV
169,2012,8764,BOUND,COPYRIGHT,CTC,CTCS,INC,PCA3,THERE
169,2012,COPYRIGHT,DESPITE,GLEASON,INC,PATHOLOGIC,RECEIPT,SEMINAL,THERE,TOTAL
945,FOXA1,GIVEN,HNF3
169,2011,559,5900,619,622,8804,BJU,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,RISK,THREE,TRUS,UNIVERSITY,UNLABELLED
125,169,2011,747,AMONG,ASTRO,AUTHORS,BFFF,BJU,BOTH,D90,GLEASON,LABEL,LEVEL,MEIER,METHODS,NEITHER,NOMOGRAMS,OBJECTIVE,PHOENIX,PREDICTIVE,PROGNOSTIC,PSA,RADIATION,RESULTS,SOCIETY,THEIR,TYPE,UNLABELLED,WHAT
1195,1204,308,473,8201,945,954,956,ADP,AIM,AKT,CONCLUSION,FMK,INNOVATION,KIP1,LABEL,METHODS,OBJECTIVE,PCA,POLY,REDOX,RESULTS,SER,THR,TREATMENT,VAD,WAF1
169,2011,22RV1,AACR,BRCA1,CLONOGENIC,DECREASED,DU145,H1299,LABEL,METHODS,MRE11,OBJECTIVE,PARP,PARPI,PC3,PRIMARY,PTEN,PURPOSE,RAD51,RESULTS,SIMILAR,THESE,TP53
13Q22,1524,215,2169,5P15,6Q22,CHINESE,CONSORTIUM,GLEASON,HOWEVER,RFX6,THESE
956,BAX,GREEN,GTP,GTPS,HDAC,HDACS,LNCAP,MG132,THESE
1989,2001,946,AGE,AIC,BACKGROUND,CONCLUSION,GIVEN,GLEASON,LABEL,MATERIALS,METHODS,PCR,PSA,RESULTS,SINCE,TGF
001,700,ALTOGETHER,FURTHER,III,INHIBITORS,MDV3100,TAK,TOK
000,EVERY,GERMANY,INCREASING,PSA
100,150,160,200,8201,AFTER,CELL,RM1,RM1CELL,THESE
101,ADP,BACKGROUND,BCL,GRADE,LABEL,MEN,METHODS,RESULTS,SECONDARY
0001,0012,0016,017,169,183,1996,2001,2012,734,8805,AFTER,BACKGROUND,COPYRIGHT,DEC,EARLY,FEB,FUNDING,LABEL,LTD,MEN,METHODS,NONE,PCSM,PSA,RESULTS,THEREFORE,THUS,USA
2001,2002,2004,2006,2008,APC,BACKGROUND,BEHAVIORAL,DECREASING,END,GRADE,INFLATION,LABEL,LTD,METHODS,PROGRAM,PUBLISHED,REGISTRIES,RESULTS,RISK,SEER,SIMILAR,STAT,THERE
169,2011,385,500,554,6496,7084,AIM,BACKGROUND,BMI,COLORECTAL,COPYRIGHT,FSG,INADEQUATE,LABEL,LTD,LUNG,METHODS,OBESITY,OBJECTIVE,OVARIAN,RESULTS,SCREENING,TRIAL
001,169,185,2008,2011,240,8226,8804,8805,AFTER,ANOTHER,BJU,DUTCH,EIGHT,GLEASON,INCLUSION,LABEL,LEVEL,METHODS,MOST,OBJECTIVE,OBJECTIVES,PCA,PROGNOSIS,PSA,RANDOMIZED,RESULTS,SCREENING,T2A,THESE,THOSE,TYPE,UNLABELLED,WHAT
169,2011,JOURNAL,RELEASE,THESE
BEE,PLA2,SEVERAL
NONE
000,CURRENTLY,PREVALENCE,TREATMENT
EMT,EPITHELIAL,HOWEVER,LUCAP35,ZEB1
169,2011,946,AFFYMETRIX,CHIP,COPYRIGHT,IRELAND,LTD,PCR,SINCE,USING
000,001,110,2002,2009,8805,AFTER,IGF,IGFBP,IGFS,OVERALL,PSA
145,169,181,2012,8226,COPYRIGHT,GMBH,INSTITUTE,KGAA,NCI,RPMI,THREE,VCH,WILEY
AFRICAN,BAY,FLORIDA,FORUM,LATER,MEN,TAMPA
1288,133,177,2008,2010,2011,8201,8804,BACKGROUND,EACH,JANUARY,LABEL,MEAN,MEDICAL,METHODS,OCTOBER,PHASE,PSA,RESULTS,UNIVERSITY,VANDERBILT,VARIOUS
ART,CBP,LABEL,METHODS,MOST,OBJECTIVE,OBJECTIVES,RESULTS,SRC,TIF,TIP60
104,169,170,1981,1983,2011,4383,8805,BACKGROUND,CITY,COPENHAGEN,COPYRIGHT,DETERMINE,EQUALLY,HEART,LABEL,MEIER,METHODS,OBJECTIVE,PCA,PSA,PUBLISHED,RESULTS,SETTING,UROLOGY
0001,0075,169,2010,2011,2896,322,3624,547,8805,885,AREAS,AUC,AUCS,BACKGROUND,COPYRIGHT,DATA,DEVELOP,DRE,ERSPC,FURTHER,GLEASON,LABEL,METHODS,OBJECTIVE,PCA,PCPT,PREDICTIVE,PREVENTION,PSA,PUBLISHED,RANDOMIZED,RCS,REPLACING,RESULTS,ROTTERDAM,SCREENING,SETTING,SIMILAR,T2B,TRIAL,TRUS,UROLOGY
125,159,160,169,2001,2012,612,8804,ALTOGETHER,BACKGROUND,COPYRIGHT,GLEASON,GROUP,INC,LABEL,METHODS,OVERALL,RESULTS,SCORE,T2A
001,003,110,169,193,1999,2009,2012,ACUTE,CD4,COPYRIGHT,EBRT,GLEASON,HIV,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PRE,PURPOSE,RESULTS
169,172,2012,AFTER,COPYRIGHT,D9602,GIRLS,GROUP,IIA,III,INC,INTERGROUP,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,RMS,THREE
169,2011,215,CAM5,CD10,COPYRIGHT,GMBH,MULLERIAN
169,2011,241,AMONG,COPYRIGHT,ESPA,IBD,INFLIXIMAB
001,002,169,2011,APRIL,EIGHT,EXCLUDING,MEDLINE,SCIENCE,SCREENING,UROLOGICAL,WEB
0001,105,129,169,2011,968,CONCLUSION,GLEASON,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,UROLOGICAL
0005,135,169,184,2011,211,CAPILLARY,COST,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,UROLOGICAL,WHEREAS
946,954,AKT,LNCAP,PSA,WESTERN
1444,215,324,776,CDK7,ERCC1,FDR,GIVEN,MEN,NER,SNPS,WHILE
CCS,DRE,LIBRARY,META,PCA,PSA,RCTS,THERE
AFTER,ALPHARADIN,APART,CRPC,DOCETAXEL,III,MDV3100
HOWEVER,MEN,NEITHER,PSA,PSAS,YET
1000,160,ASIA,BPH,GIVEN,KOREA,PANAX,RG3,SINCE,WKRG
02E,09E,148,177,17E,251,73E,74E,951,BACKGROUND,HGPIN,HOWEVER,IHC,INC,LABEL,METHODS,PSA,PUBLISHED,RESULTS,THERE,TMA
169,194,2004,2011,AREG,CMV,COPYRIGHT,COX,EGFR,ERK,GIVEN,IE1,INC,KOCH,MEC,MECS,POSTULATES,PUBLISHED,THUS
169,2011,COPYRIGHT,DETERMINE,EXERCISING,EXPLORE,INC,PCS
113,169,2008,2011,216,3092,3547,BETWEEN,CONCLUSION,COPYRIGHT,INC,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS,SCREENING
001,169,1991,1996,2005,2011,246,2829,8805,943,BACKGROUND,BLOOD,COCHRAN,COPYRIGHT,DIET,FOUR,GLEASON,LABEL,MALM,METHODS,OBJECTIVE,PSA,PUBLISHED,RESULTS,SETTING,SEVEN,SNPS,UROLOGY,WORLD
0003,001,004,146,169,2011,233,81MG,BACKGROUND,BCA,BCG,CIS,CONNAUGHT,COPYRIGHT,COX,HRS,LABEL,METHODS,NMIBC,OBJECTIVE,PUBLISHED,RESULTS,SETTING,SIXTY,T1G3,TIME,TUR
15MM,169,17AAG,1MM,2011,20MM,231,24H,2DG,500NM,ALLYLAMINO,BSO,COPYRIGHT,GSH,HMEC,INC,INCREASES,INHIBITORS,MDA,NAC,THESE,TRX
001,169,2001,2003,2006,2007,2013,400,442,883,ADD,AHC,COPYRIGHT,DISCHARGE,INC,INPATIENT,LABEL,LOS,METHODS,NATIONWIDE,OBJECTIVE,OVERALL,RESULTS,RPS,SIMILARLY
169,2002,2004,2013,911,AES,BACKGROUND,BETWEEN,BMI,CONCLUSION,COPYRIGHT,GRADE,INC,JANUARY,LABEL,METHODS,PFMT,RADICAL,RESULTS,THESE
1611,169,2011,879,CHINA,CHINESE,COPYRIGHT,COX,DEBULKING,FIVE,III,IRELAND,LABEL,LTD,MEIER,METHODS,OBJECTIVE,PCA,PROGNOSTIC,PSA,RESULTS,SEVEN
169,2011,223,BACKGROUND,CONTEXT,COPYRIGHT,CRPC,GIVEN,LABEL,MDV3100,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SEPTEMBER,SYNTHESIS,UROLOGY
1541,169,2003,2010,2011,8805,BACKGROUND,COPYRIGHT,LABEL,LACK,LNI,METHODS,NCCN,NETWORK,OBJECTIVE,OVERALL,PCA,PLND,PUBLISHED,RESULTS,SETTING,SIMILARLY,THEREFORE,UROLOGY
169,1999,2010,2011,8805,BACKGROUND,BING,CONCLUSION,COPYRIGHT,DESPITE,INTERVIEW,JANUARY,LABEL,LTD,MAY,METHODS,RESULTS,RRS,USING
056,169,1993,2004,2012,8804,BETWEEN,COMBINING,COPYRIGHT,COX,GLEASON,INC,LABEL,MATERIALS,METHODS,NETWORK,OBJECTIVE,PNI,PPC,PURPOSE,RESULTS,STAGE,T1C,WILLIAM
169,2012,500,8805,CONCERNING,COPYRIGHT,DEPARTMENT,INC,LABEL,MAGNESIUM,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SECONDARY
150,169,2012,207,567,576,600,AFTER,COPYRIGHT,CTV,ERB,ERBS,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS,THESE
0001,0012,141,169,2012,221,362,8805,BFF,BFFR,COPYRIGHT,GLEASON,GRADE,GROUP,IGRT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PHOENIX,PURPOSE,RADIATION,RADIOLOGY,RESULTS,RTOG,SOCIETY,THERAPY,THESE
001,040,046,103,125,169,1993,2003,2009,2012,291,521,812,8805,967,AFTER,APRIL,COPYRIGHT,CRT,EBRT,GRADE,GROUP,IMRT,INC,LABEL,LATE,MARCH,MATERIALS,METHODS,MORBIDITY,OBJECTIVE,PEARSON,PURPOSE,QOL,RADIATION,RESULTS,SCORE,SCORING,SYMPTOM,THERAPY,TREATMENT,URINARY
111,115,169,2000,2010,2012,311,336,541,ACCORDING,BASED,COPYRIGHT,HOWEVER,INC,LABEL,LNI,MATERIALS,METHODS,OBJECTIVE,PCA,PLND,PURPOSE,RESULTS,ROACH
0139,100,169,177,192,2011,339,960,COIN,COPYRIGHT,HWL,IRELAND,LABEL,LTD,METHODS,NUCLETRON,OBJECTIVE,OBJECTIVES,PTV,RESULTS,SCATTER,TPS,TRAK,USING
169,2011,COPYRIGHT,FIRSTLY,LTD,THESE
8764,9459,ANALYTE,CHIP,ELISA,IEF,IGG,PCA,PROTEIN,PSA,QQQ,SRM
DU145,PCA,RSV,THESE,THUS,TYPICALLY,WESTERN,XRT
001,169,2011,207,271,AFRICAN,AMERICANS,BACKGROUND,COPYRIGHT,FIFTY,GUIDELINES,JOHN,LABEL,LTD,METHODS,PCA,REASONS,RESULTS,SONS,WILEY
169,2011,COPYRIGHT,DLIN,DMA,KC2,LAPC,LNCAP,LNP,LNPS,PSA,SILENCING,UICC
169,2011,BACKGROUND,COPYRIGHT,EMT,ENDOCRINE,EXPRESSION,GTPASES,INC,LABEL,METHODS,NET1,RESULTS,RHO,RHOC,TREATMENT,WILEY
169,2011,946,BACKGROUND,CDK9,CONCLUSION,COPYRIGHT,HEXIM,HOWEVER,INC,LABEL,METHODS,RESULTS,SMAD,TGF,THUS,TRAMP,WILEY
169,2011,945,946,COPYRIGHT,HOWEVER,INC,MC10,TAKEN,WILEY
2010,8804,8805,899,ENGLISH
DESPITE,THESE,TPS,VITAMIN
0016,114,115,169,194,2011,8804,BACKGROUND,BOTH,CONCLUSION,COPYRIGHT,COX,EBRT,GLEASON,LABEL,LTD,METHODS,PSA,RESULTS
027,063,119,169,1988,2009,2011,287,403,8226,8805,ADT,AMONG,BJU,BMI,BODY,FINALLY,LABEL,LEVEL,MEN,METHODS,OBESE,OBJECTIVE,PROGNOSIS,PROGNOSTIC,RESULTS,THESE,TYPE,UNLABELLED,USA,WHAT
162,169,2011,8482,8805,AFTER,AUTHORS,BJU,HISTOLOGY,HOWEVER,LABEL,METHODS,NOVEL,OBJECTIVE,PATIENT,PHS,RESULTS,THREE,TRUS,UNLABELLED,WHAT
001,169,2011,8805,ADT,BJU,CONCLUSION,DOPPLER,GLEASON,IIEF,INDEX,LABEL,LEVEL,MEDICAL,METHODS,OBJECTIVE,PSA,RESULTS,THERAPY,TYPE,UNLABELLED,WHAT
114,141,169,176,2011,8226,AUTHORS,BJU,FSH,GNRH,LABEL,LEVEL,LHRH,MEAN,METHODS,OBJECTIVE,PSA,RESULTS,THERAPY,TREATMENT,TYPE,UNLABELLED,WHAT
007,169,2011,283,8226,8776,BJU,EPSTEIN,ERSPC,HOWEVER,LABEL,LEVEL,LOW,METHODS,MOST,OBJECTIVE,PCA,PSA,RANDOMIZED,RESULTS,SCREENING,THERAPY,THESE,TYPE,UNLABELLED,WHAT
1098,1568,167,169,1990,2009,2011,2739,303,8226,8804,AFRICAN,BCR,BJU,COX,GLEASON,LABEL,LEVEL,MEIER,MEN,METHODS,OBJECTIVE,PSA,RESULTS,THERAPY,TYPE,UNLABELLED,WHAT
001,131,169,2011,287,8226,AGING,AUTHORS,BALTIMORE,BJU,BLSA,CLINICIANS,HOPKINS,JOHNS,LABEL,LEVEL,MATERIALS,METHODS,OBJECTIVE,PROGNOSTIC,PROGRAM,PSA,PSAYV,RESULTS,THERE,THESE,TYPE,UNLABELLED,WHAT
028,032,120,1432,169,183,2012,319,716,8804,8805,956,AMGEN,BACKGROUND,BONE,COPYRIGHT,DENOSUMAB,FUNDING,INC,LABEL,LTD,METHODS,OVERALL,PSA,RANKL,RATES,RESULTS
169,2007,2011,405,547,585,599,631,641,689,701,730,755,775,8226,8804,8805,AUC,BJU,CRBX,ECE,IBX,LABEL,METHODS,OBJECTIVE,RESULTS,SRBX,SVI
001,102,164,169,2011,2431,565,638,8804,8805,AUTHORS,BJU,CONCLUSION,LABEL,MEANWHILE,METHODS,OBJECTIVE,PREDICTIVE,PSA,RESULTS,UNLABELLED
002,047,056,169,200,2002,2009,2011,321,8805,BJU,EVEN,FOCAL,GLEASON,HOWEVER,LABEL,METHODS,OBJECTIVE,PREDICTIVE,PSA,RESULTS,THESE,UNLABELLED
169,2007,2009,2011,229,8805,ALSO,AUTHORS,BJU,GLEASON,JULY,LABEL,METHODS,NORWEGIAN,OBJECTIVE,PSA,RESULTS,SEVERAL,UNLABELLED
1275,169,2011,659,BLACKWELL,COMPLETED,DESPITE,DISCHARGE,HOWEVER,LTD,PUBLISHING,SURVIVORS
169,2004,2005,DATA,END,LABEL,METHODS,OBJECTIVE,PRINCIPAL,RESULTS,SIMILARLY,SUBGROUPS,THERE,TRUST,USING
945,954,AYURVEDIC,BONE,CHITRAK,EXTENSIVE,OVERALL,PLUMBAGIN,RANKL
946,AMP,CFS,GPCR,MCF,SEVERAL,SY5Y,WHILE,XENOTROPIC,XMRV,XPR1

160,MALIGNANT,MARIE
DIFFERENT,PCR,TG2,TGM2
4TH,5TH,SCLEROTIC
8209,ECTOPIC,EXPRESSION,FINALLY,HOWEVER,MICRORNAS,PCR,RNAS,U251
001,083,088,1000,169,1745,177,2000,2008,2011,231,233,272,278,339,343,355,361,471,694,8805,943,AFTER,CONCLUSION,COPYRIGHT,COX,DATA,FEW,GOUT,INSURANCE,LABEL,MEAN,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SAS,SOCI
169,2012,COPYRIGHT,INC,NINE
100,99M,CONCLUSION,DETECTION,GAMMA,IHC,LABEL,LIMITED,LYMPH,MBQ,METASTATIC,METHODS,OBJECTIVE,PURPOSE,RESULTS,SLN,SUP
071,818,AUC,CONCLUSION,LABEL,METHODS,OBJECTIVE,PET,PSA,PURPOSE,RESULTS,ROC
954,ADT,AFTER,CRPCA,DESPITE,FINALLY,HOWEVER,PCA
AFRICAN,AMERICANS,ASIA,ASIAN,CAUCASIANS,EAST,GSTP1,HOWEVER,MOST,OTHER,PSA,SEVERAL,SOMATIC,SOY,WEST,WESTERN
169,2011,25D,BECAUSE,CONSISTENT,CONVERSELY,COPYRIGHT,CYP27B1,INC,VDR
1060,1486,169,1998,2003,2005,2011,3095,461,8226,8805,ADT,AFRICAN,AUTHORS,BJU,END,LABEL,LAPC,LEVEL,METHODS,OBJECTIVE,RESULTS,SEER,THERAPY,TREATMENT,TREATMENTS,TYPE,UNLABELLED,WHAT
019,022,038,048,124,169,2011,237,410,795,8226,AMONG,AOR,BJU,COMPARE,LABEL,LEVEL,MEN,METHODS,OBJECTIVE,RESULTS,THERAPY,THESE,TREATMENT,TYPE,UNLABELLED,WHAT,WHITE
001,002,1516,169,2011,435,669,AUC,BJU,DIAGNOSTIC,DUE,GIVEN,GLEASON,HOWEVER,LABEL,LEVEL,METHODS,OBJECTIVE,OBJECTIVES,PSA,PSAD,RESULTS,ROC,THERE,TYPE,UNLABELLED,WHAT
665,715,CHINESE,FURTHER,PCA,PSA,UTR,VHL,VON
945,AKT,BACKGROUND,BP1,CCK,CYTOTOXIC,GIVEN,HIF,HYPOXIA,LABEL,LUCIFERASE,METHODS,P276,PCR,RESULTS,UNDER
100,231,3130,967,ABI,AFRO,AMERICANS,ASHKENAZI,BACKGROUND,CARLO,CAUCASIANS,COMMITTEE,D541E,GLEASON,I97L,JEWS,LABEL,METHODS,MONTE,PRISM,PSA,R461Q,R462Q,RESULTS,SPSS
120,1988,2003,2006,392,8804,8805,AMONG,BACKGROUND,CAUSE,END,FOLLOWING,GLEASON,LABEL,METHODS,RESULTS,SEER,STAGE
CVD,LDL,LIMITED,TAG
001,003,031,064,169,2011,476,597,622,661,844,954,ANXIETY,BACKGROUND,COPYRIGHT,HOWEVER,JOHN,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,SONS,THERE,WILEY
169,2012,COPYRIGHT,GMBH,KGAA,PDA,VCH,WILEY
001,007,015,169,200,2011,BESIDES,COPYRIGHT,ERG,ETS,ETV1,ETV4,ETV5,FISH,FLI1,INC,MYC,OUTLIER,PCA,PCR,PTEN,SLC45A3,TLDAS,WILEY
CX43,HOWEVER,LNCAP,PCA,SINCE,THUS
001,003,011,021,024,284,481,8201,8804,E26,ERG,ETS,EXPRESSION,GLEASON,INCREASING,PSA,RANDOMIZED,SCREENING,SINCE,STUDIES,THERE,TMPRSS2
169,2004,2007,2012,8805,ADDITIONAL,COMPOSITE,COPYRIGHT,DAILY,EPIC,GLEASON,HOWEVER,INC,INDEX,LABEL,MATERIALS,METHODS,OBJECTIVE,PHASE,PUBLISHED,PURPOSE,QOL,QUALITY,RESULTS,STAGE
169,2012,383,AFTER,CONCLUSION,COPYRIGHT,COX,GLEASON,INC,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PHS,PHYSICIANS,PURPOSE,RESULTS
169,2012,636,AFTER,COPYRIGHT,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
001,002,005,033,060,100,10Y,125,169,176,2012,ACTUARIAL,CONCLUSION,COPYRIGHT,COX,CROWN,INC,INDEX,LABEL,MATERIALS,MEIER,METHODS,NETWORK,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UNIVARIATE
169,184,2004,2005,2012,339,8805,897,CONCLUSION,COPYRIGHT,DETROIT,EBRT,END,INC,JANUARY,LABEL,MATERIALS,MEN,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE
001,006,169,2006,2010,2011,385,588,8804,AUC,BACKGROUND,BASED,BECAUSE,COPYRIGHT,FEW,GLEASON,LABEL,LNI,METHODS,MVA,OBJECTIVE,OCTOBER,PCA,PUBLISHED,RESULTS,SEPTEMBER,SETTING,UROLOGY,USING,UVA
001,169,2011,350,8805,BACKGROUND,CONVERSELY,COPYRIGHT,CURRENTLY,GLEASON,INDEX,LABEL,METHODS,OBJECTIVE,OPEN,PCA,PHI,PSA,PUBLISHED,RESULTS,SETTING,TEST,UROLOGY
169,1762,2010,2011,257,5001,6763,AML,APRIL,BACKGROUND,CML,COPYRIGHT,CROSS,HODGKIN,IRELAND,LABEL,LTD,MEDLINE,METHODS,NHL,RESULTS
000,1199,169,200,2009,2011,443,8226,8805,BECKMAN,BJU,CONCLUSION,COST,COULTER,DIAGNOSTIC,FEE,INDEX,LABEL,METHODS,OBJECTIVE,PHI,PSA,RESULTS,USA
001,004,11Q13,169,17Q24,2011,263,3Q21,8226,8804,8805,8Q24,9Q33,BJU,CAP,CONCLUSION,GLEASON,LABEL,METHODS,OBJECTIVE,RESULTS,T1C
169,2005,2011,275,700,8804,AMERICA,AUTHORS,BJU,BRITAIN,BRITISH,ECE,ENGLAND,EXCELLENCE,GLEASON,INSTITUTE,LABEL,LEVEL,METHODS,NICE,NORTH,OBJECTIVE,PSA,RALP,RESULTS,SVI,THERAPY,THERE,TYPE,UNLABELLED,WHAT
169,2011,APC,AUTHORS,BJU,COMBINING,DIAGNOSTIC,GSTP1,LABEL,LEVEL,METHODS,NPV,OBJECTIVE,RESULTS,TYPE,UNLABELLED,WHAT
169,2011,BJU,DIAGNOSTIC,EVEN,HOWEVER,LABEL,LEVEL,METHODS,OBJECTIVE,PATHOLOGY,PSA,RESULTS,SIXTEEN,THERE,TRUS,TYPE,UNLABELLED,WHAT
001,169,2011,2997,988,BASED,CONTINUOUS,COX,GENERAL,HRS,JOHN,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SONS,WILEY
263,EPS,EXPRESSED,PC3,PCA,SILAP
001,006,008,009,013,015,020,024,036,169,2011,232,BJU,CONCLUSION,DISEASE,GLEASON,IMP3,INSULIN,IQR,LABEL,LEVEL,METHODS,NONE,OBJECTIVE,PROGNOSIS,PSA,RESULTS,SIMILARLY,TYPE,UNLABELLED,WHAT
169,2011,AMERICA,AUTHORS,BJU,BREAK,CONCLUSION,CONSENSUS,EARLY,FOCAL,GROUP,LABEL,METHODS,NORTH,OBJECTIVE,PRECISE,RESULTS,THERE,THESE,UNLABELLED,WHAT
BMP,BMP7,BMPS,EXPRESSION,FURTHER,GPI,ID1,KNOCKDOWN,PCR,REPULSIVE,RGM,RGMA,RGMB,RGMC,RGMS,SMAD,WESTERN
181,22RV1,CELL,DU145,HPV,LNCAP,SIMILAR,SOLANUM,VIRALLY
0001,006,019,041,056,074,CAV1,CD105,CD144,CD146,CD31,CD34,COMPARING,EXPRESSION,GLEASON,HOWEVER,MVD,SOLID,THERE
1018,177,956,EGF,ERK1,IC50,LDH,MICROSCOPY,MTT,THUS,WESTERN
169,2011,8201,AFRICAN,AMERICANS,BACKGROUND,BINDING,CONCLUSION,COPYRIGHT,DATA,GLEASON,GPX,INC,LABEL,METHODS,PROTEIN,RESULTS,SBP1,THESE,WESTERN,WILEY
169,2011,8201,AFTER,BACKGROUND,CARBIDOPA,COPYRIGHT,CRPC,INC,LABEL,LNCAP,METHODS,PSA,RESULTS,SERUM,WILEY
0001,154,169,1999,2005,2011,466,611,7121,8829,950,ADT,BACKGROUND,COPYRIGHT,END,LABEL,MEDICAL,MEN,METHODS,RESULTS,SOCIETY,TES
100,119,120,177,189,1ST,8201,862,8805,AUC,CEA,CONCLUSION,DLT,DOSE,FULL,HODGKIN,KOS,LABEL,METHODS,MTBF,OBJECTIVE,PBMC,PBMCS,PURPOSE,RESULTS
169,2011,947,ATM,BACKGROUND,COPYRIGHT,DDR,DISCUSSION,H2AX,HPEC,HSVEC,INC,LABEL,METHODS,PREVIOUSLY,RESULTS,WEE1A,WILEY
100,169,181,2011,8201,ADDITIONAL,AGR2,BACKGROUND,COPYRIGHT,ELISA,IGG1,IGG2A,INC,LABEL,METHODS,MONOCLONAL,P1G4,P3A5,RESULTS,WESTERN,WILEY
169,2011,946,ADDITIONAL,BRITAIN,CD280,COPYRIGHT,DU145,ENDO180,GREAT,IRELAND,JOHN,LTD,MRC2,ONCE,PC3,PUBLISHED,RECIPROCAL,SOCIETY,SONS,TGF,THESE,WILEY
169,2011,300,900,AMONG,BACKGROUND,BECAUSE,COPYRIGHT,LABEL,METHODS,MICROARRAY,PBMC,PBMCS,PERIPHERAL,RESULTS,SOCIETY,THERE,THESE
001,169,2004,2009,2011,500,AFTER,ASTRO,BACKGROUND,CLAVIEN,COPYRIGHT,GLEASON,HIFU,INDEX,LABEL,MEAN,METHODS,PHOENIX,PSA,RAND,RESULTS,SALVAGE,SCORE,SF36,SOCIETY,SONABLATE,WHOLE
169,2004,2010,2011,APRIL,CALIFORNIA,FRANCISCO,GLEASON,HOPKINS,HOWEVER,JOHNS,MEDICAL,MEN,SAN,SEPTEMBER,TORONTO,UNIVERSITY,UROLOGICAL
100,215,8805,AMONG,CLEVELAND,FDG,GLEASON,HEALTHCARE,KRUSKAL,LABEL,MET,METHODS,OBJECTIVE,PET,PHILIPS,RESULTS,ROC,TUKEY
0001,016,169,2008,2011,400,700,ACT,ADC,ADCS,AREAS,AUC,AUCS,BOARD,CONCLUSION,COPYRIGHT,HIPAA,INC,INSURANCE,LABEL,LISS,MATERIALS,MAY,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,ROIS,WILEY
960,AFTER,CCRF,CLPY,COMPLEXES,DENSITY,DEPENDENT,DFT,FUNCTIONAL,MCF7,MEPY,MLCT,PALLADIUM,PC3,PDCL,TIME,VIS,XPY
CULTURING,TIC,TICS
133A,BACKGROUND,DU145,LABEL,METHODS,MOLECULAR,PC3,PCA,PNP,RESULTS,SILENCING,THEREFORE
206,AIMS,BPH,LABEL,METHODS,OBJECTIVE,PREDICTIVE,PSA,PURPOSE,RESULTS
0077,0088,0173,0205,117,118,151,293,370,515,566,867,8805,903,ADT,BACKGROUND,CONCLUSION,CRPC,DOC,EFFECTIVE,GLEASON,GRADE,LABEL,METHODS,PSA,RESULTS,SECONDARY,TREATMENT
078,080,160,2009,211,235,351,436,695,732,8201,951,BACKGROUND,BEHAVIORAL,LABEL,LEAST,METHODS,MIE,RESULTS,RISK,SELF,USING
160,183,ASIA,BBP,CDC6,CDK,EAST,LNCAP,MCM7,MDA,PCA,TREATMENT
150,ASSESSING,BACKGROUND,HISB,LABEL,METHODS,OBJECTIVE,RESULTS,TDM
1086,314,AMONG,CD34,EWING,FOUR,HOWEVER,KAPOSIFORM,PROX1,THERE
169,1973,2007,2011,557,AUTHORS,COPYRIGHT,END,ESOPHAGUS,INC,JOURNAL,PROGRAM,RESULTS,SEER,SIR,SIRS,SOCIETY,THESE,THUS,WILEY
101,294,AMONG,BACKGROUND,LABEL,METHODS,NPV,PPV,RESULTS,THERE,THUS,TUPB
916,945,CRPC,CYP17A1,DHT,EVENTUALLY,FURTHER
169,194,2011,ATP,CLINICALLY,COPYRIGHT,FDA,HEAT,HER2,HSP90,ISSUE,PROTEIN,SEVERAL,SHOCK,SPECIAL,THERE,ULTIMATELY
956,ACE,MIXED,PDT,UNTREATED,WHILE
160,AIM,BACKGROUND,CONCLUSION,IRELAND,IRISH,LABEL,METHODS,OBJECTIVE,RESULTS,THERE,TREATMENT,TRUS
007,008,022,403,967,AUSTRALIA,BACKGROUND,CAM,CAMS,DATA,LABEL,METHODS,PEARSON,RESULTS
001,169,1779,1994,2008,2011,267,506,8041,AMICO,CAP,COCHRAN,CONCLUSION,COPYRIGHT,DATA,FIVE,GERMANY,HOWEVER,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,RESULTS
019,032,037,169,2011,2014,2760,613,7942,AIMS,AMONG,ANALYSING,BASE,CARE,CONTINUOUS,COPYRIGHT,DIAB,LABEL,LTD,METHODS,OBJECTIVE,PRIMARY,PUBLISHED,RESULTS,RISK
001,003,005,008,020,165,169,192,2013,245,AVERAGE,BACKGROUND,BLADDER,CIS,COPYRIGHT,COX,CSS,DESPITE,INC,IQR,LABEL,LVI,MATERIALS,METHODS,PROGNOSIS,RESULTS,SEVENTEEN,UCB
0035,014,169,2012,599,COPYRIGHT,GLEASON,INC,LABEL,MATERIALS,METHODS,NETWORK,OBJECTIVE,PCV,PURPOSE,RESULTS
1000,150,169,2012,300,450,600,750,900,ADC,BOTH,COPYRIGHT,ECHO,EIGHT,EPI,FOURIER,HASTE,INC,SIEMENS
169,2011,COPYRIGHT,H2A,IRELAND,LNCAP,LTD,MYC,PSA,TREATMENT,WHILE
169,194,2011,240,241,99M,CONCLUSION,COPYRIGHT,ESPA,LABEL,LYMPHATIC,MBQ,METHODS,OBJECTIVE,PURPOSE,RESULTS,SLN,SLNS,SPECT,THREE

169,1958,2008,2011,8805,AMONG,COPYRIGHT,IMMIGRANTS,SWEDISH,UICC
141,169,2011,298,346,375,8804,COPYRIGHT,FOUR,MOUSE,THREE,TRAMP,TRANSGENIC,UICC
169,2011,COPYRIGHT,H3K9,HISTONE,LSD1,THESE,UICC
000,100,109,128,169,2011,774,COPYRIGHT,FINNISH,NSO,PCA,PCAS,UICC
BAX,BCL,CELL,KIT,SAC,WESTERN
561,956,CAM,III,PSA,SUBSEQUENT
001,160,946,CONFIDENCE,CONTROL,MASCULINE,RALP,SELF,WORRY
169,2011,COPYRIGHT,PSA
945,954,CK2,DMAT,IRELAND,LTD,NUCLEAR,PUBLISHED,SER,TBG,THR
005,015,126,2010,323,330,8805,BACKGROUND,GLEASON,INDIVIDUAL,JANUARY,LABEL,LNI,LNY,LRP,METHODS,OBJECTIVE,ORP,PLND,PSA,PUBLISHED,PURPOSE,RALP,RATES,RESULTS,SEPTEMBER,THERE,VARIATION
0001,007,046,106,169,2011,293T,8805,CYP,FLAG,P450,STAINED,SXR,TOTAL,WESTERN
169,2011,AUTHORS,B7H,BACKGROUND,BRITISH,CHOLBUT,CONCLUSION,ERK,EXPRESSION,HUVEC,JOURNAL,KEY,MAPK,MIGRATION,PCR,PURPOSE,RESULTS,SLN,SOCIETY,THESE,WESTERN
231,946,956,AHR,AMP,BBP,CREB1,DBP,HDAC6,LEF1,MDA,MYC,PKA,TCF4,WHILE
2011,AMONG,BACKGROUND,CASTRATION,HOWEVER,LABEL,METHODS,RESULTS
02GY,100GY,169,194,1GY,2012,3GY,64GY,ADAPTED,BACKGROUND,CARLO,CONCLUSION,COPYRIGHT,DMCO,DOSE,EBT,FILM,FUNCTIONAL,GAFCHROMIC,GMBH,IMRT,LABEL,MATERIALS,METHODS,MONTE,NUMBERS,PET,PUBLISHED,RESULTS,TCP,USING
EARLY
100,10Q23,125,132,169,182,2011,311,330,414,8764,940,AKT,COPYRIGHT,FAS,INC,LISS,PI3K,PTEN,SD17,SD18,WILEY
169,2011,800,AACR,COMPELLING,FOLLOWING,GLEASON,POLYPHENON
100,169,2011,AMONG,BRCA,BRCA1,BRCA2,COLOMBIAN,CONCLUSION,COPYRIGHT,FIFTEEN,FIVE,INC,LABEL,METHODS,MUTATIONS,OBJECTIVE,RESULTS
169,1992,2005,2011,2205,8226,8804,8805,AUTHORS,BJU,CLINICIANS,CONCLUSION,DEPENDING,LABEL,LEVEL,METHODS,OBJECTIVE,RESULTS,SEVERAL,TYPE,UNLABELLED,WHAT
169,2000,2010,2011,680,AUTHORS,BJU,GIVEN,LABEL,METHODS,OBJECTIVE,PATIENT,PSA,RESULTS,TRUS,UNLABELLED
010,105,121,124,142,154,169,2011,583,8194,AUTHORS,BJU,FINNISH,GENERAL,HRQL,IIEF,INDEX,IPSS,ITEM,LABEL,LEVEL,METHODS,NONE,OBJECTIVE,PEARSON,PRIAS,PSA,RAND,RESULTS,SCORE,SYMPTOM,THERAPY,TYPE,UNLABELLED,WHAT
001,003,177,498,ANXIETY,CONCLUSION,INVENTORY,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCALE,SIXTY,STATE,TRAIT
1997,2002,490,796,AVOIDANCE,BACKGROUND,DENMARK,FINLAND,ICELAND,LABEL,METHODS,RESULTS,WORK,WORKING
103,AUC,BACKGROUND,DRE,LABEL,MEN,METHODS,PCA3,PSA,PSAD,RESULTS,TRUS
169,2011,COPYRIGHT,CRPC,NOVEL,SIMILARLY,SOCIETY
ANTISENSE,CELLS,IGF1,LNCAP
444,8804,8805,ACID,BOTH,CELL,CHINESE,COMPROMISE,CONNECTIVE,CYCLE,DISORDERS,FOLD,IPA,METABOLISM,MYC,NETWORK,NUCLEIC,PCR,REGULATION,THESE
160,BUNGE,CELL,HOWEVER,IIA,MTT,STUDIES,TANSHINONE
AKT,CELL,DU145,IMMUNOBLOT,LNCAP,MYC,NOXA,PC3,PI3K,POLY,TLR,TLR3,TLRS,TOLL
MRGB,TRUS
ELF,ERG,ETS,ETV,FEV,PCA,THESE,TMPRSS2
169,2011,22911,8794,ARO,BACKGROUND,BCR,CONTEXT,COPYRIGHT,EORTC,GIVEN,GROUP,HOWEVER,LABEL,METHODS,OBJECTIVE,PCA,PSA,PUBLISHED,RESULTS,SOCIETY,SOUTHWEST,SWOG,SYNTHESIS,THERE,THREE,TREATMENT,UROLOGY
169,194,2010,2011,700,8015,APC,BACKGROUND,CONTEXT,COPYRIGHT,CRITICALLY,CSF,FURTHER,JUNE,LABEL,MDV3100,MEDLINE,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SIPULEUCEL,SYNTHESIS,TAK,UROLOGY
169,2007,2009,2011,500,8805,BACKGROUND,COPYRIGHT,HIGH,IMA,JANUARY,LABEL,LND,METHODS,OBJECTIVE,PLND,PROCEDURE,PUBLISHED,RESULTS,SEPTEMBER,SETTING,SOCIETY
169,18F,2011,COLLEGE,COPYRIGHT,FURTHER,LTD,MEDLINE,MRI,PUBLISHED,ROYAL,THERE
101,169,2011,334,860,ADVERSE,AUSTRALIA,AUTHORS,BJU,CONCLUSION,CTCAE,DOSES,HIGH,IGRT,IMRT,IPSS,LABEL,LEVEL,METHODS,MOST,OBJECTIVE,RESULTS,SCORE,SYMPTOM,THERAPY,THERE,TYPE,UNLABELLED,WHAT
162,169,2011,8805,AFTER,BJU,BMAP,CIS,CONCLUSION,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,UNLABELLED
169,2011,8776,AUTHORS,BJU,CRPC,DOCETAXEL,III,MDV3100,PROMISING,PSA
1160,164,169,1997,1999,2005,2007,2011,567,5853,8194,8195,8226,ASTRO,AUTHORS,BJU,COLD,FOCAL,LABEL,LEVEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PROLONGED,RESULTS,SELECTIVE,THERAPY,TYPE,UNLABELLED,URINARY,WHAT
169,2011,COPYRIGHT,HIGH,HOWEVER,HUS1,INC,MRAD9,RAD1,RAD9,THESE,WHICH,WILEY
153,169,2011,447,449,469,8805,CIS,COPYRIGHT,FRACTIONAL,GLEASON,ORS,PROTECT,THERE,UICC
101,125,174,BACKGROUND,CLAVIEN,DINDO,FOCUS,IRELAND,LABEL,MATERIALS,MEAN,METHODS,RALRP,RESULTS,VINCI
160,2008,223,8201,920,AFTER,AMACR,CONCLUSION,E12,GLEASON,HGPIN,HIGH,LABEL,METHODS,OBJECTIVE,P504,PSA,RESULTS
169,2011,215,AIMS,COPYRIGHT,DISCARDING,FOUR,GWA,LABEL,LTD,LUNG,METHODS,OBJECTIVE,RESULTS,SIRS,SWEDISH,THREE,YET
169,2011,BCL,CDK1,COPYRIGHT,HRPC,IRELAND,LTD,MCL,PROTOPINE
169,2011,COPYRIGHT,HOWEVER,IRELAND,LTD
CONSISTENT,EXPRESSION,GOLGI,POLYMERASE,PTRF,TAKEN
145,145R,243,946,BONFERRONI,CDH1,CHANGES,CRPC,DOCETAXEL,FFPE,FURTHER,HOWEVER,IFIH1,INGENUITY,PCR,RESULTS,TGF,TGFB1,THESE,WHOLE
169,2011,AKT,ATP,BOTH,CELL,COPYRIGHT,DU145,ERK,HOWEVER,INHIBITORS,LNCAP,MPTP,OVERALL,PARP,PC3,PCA,PKC,ROS,RWPE1,TPEN,ZINC,ZNSO4
169,2011,536,8201,AMONG,BACKGROUND,CAG,CAUCASIAN,COPYRIGHT,GGN,INC,LABEL,METHODS,OBESITY,RESULTS,THEREFORE,WILEY
031,116,140,169,177,2011,8201,BACKGROUND,COPYRIGHT,CYR61,ELISA,INC,LABEL,METHODS,PCA,PKA,PREVIOUSLY,RESULTS,SERUM,THERE,THESE,WILEY
169,2011,916,BOTH,CHIPS,COPYRIGHT,CRPC,CYP17A1,CYP19A1,DHEA,FINALLY,GLI,GLI1,GLI2,HOWEVER,INC,PCR,PRSCS,PTCH1,SAG,WILEY
169,2011,BACKGROUND,CASTRATION,CLASS,COPYRIGHT,HDL,INC,LABEL,LNCAP,METHODS,PSA,RESULTS,SCAVENGER,SILENCING,SRBI,TYPE,WILEY
001,002,145,169,2011,8201,BACKGROUND,BASED,BPH,COPYRIGHT,FUNCTIONAL,INC,LABEL,LNCAP,METHODS,MMP,RECK,RESULTS,WESTERN,WILEY
169,2011,BACKGROUND,BPH,COPYRIGHT,CYTOGLOBIN,HGPIN,IHC,INC,LABEL,METHODS,MICROARRAY,NABE,PIA,PIN,PROSTATIC,RESULTS,SEVERAL,WILEY
169,2012,ARES,BRITAIN,BRU,CAP,COPYRIGHT,DHT,GLEASON,GREAT,IIO,IRELAND,JOHN,LDMD,LDMDS,LNCAP,LTD,PCR,POL,PUBLISHED,REAL,SOCIETY,SONS,THESE,WILEY
151,8804,ADVERSE,AES,BACKGROUND,INJECTION,LABEL,LEUPROLIDE,MEAN,METHODS,PSA,RESULTS,THERE
1200,169,2003,2006,2011,4454,5445,692,919,991,BACKGROUND,COPYRIGHT,END,FIRST,LABEL,MEAN,METHODS,MRP,NORTHEAST,ORP,RESULTS,SEER,SOCIETY,TOTAL
0001,0114,169,2011,239,261,8201,BACKGROUND,BCL,CANCERS,CONCLUSION,COPYRIGHT,FISH,GLEASON,INC,KI67,LABEL,METHODS,RESULTS,TMA,WILEY
169,2011,80KDA,AREG,BPH,COPYRIGHT,ECAD,EGF,EGFR,ERK,IGG,INC,PRE,PREC,THESE
169,2012,330,369,647,8805,AFTER,COPYRIGHT,GRADE,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THREE
100,1000,169,2012,311,642,BACKGROUND,BANKS,BASED,BLOOD,CMIA,CMIAS,HTLV,IDR,INSPECTION,LABEL,METHODS,RESULTS,TYPE,WESTERN,XENOTROPIC,XMRV
001,169,1990,2005,2011,518,AFRICAN,BACKGROUND,CAUCASIAN,COPYRIGHT,GLEASON,INCLUSION,LABEL,MEDICAL,METHODS,PCA,PSA,RESULTS,SOCIETY,VAMC,YORK
187,BPH,GLEASON,HOWEVER,NH2,PC3,PCA,SINCE,WESTERN
215,8201,BECAUSE,CD25,CD4,CD8,DIETARY,FIFTEEN,SEO,TAKEN
AKT,CELL,CELLS,DATS,JNK,LABEL,METHODS,OBJECTIVE,PREVIOUSLY,PURPOSE,RESULTS,ROS
160,8209,8482,AFTER,SONOVUE,ULTRASOUND
AP1,BTG,BTG3,E2F1,ERK,INK4A,JMJD3,KDM6B
160,1C4D4,8805,ADVERSE,AGS,ANTI,CHINESE,CHO,CONCLUSION,DESPITE,DISEASE,HOWEVER,LABEL,METHODS,OBJECTIVE,PHASE,PRIMARY,PSA,PSCA,PURPOSE,RESULTS,SECONDARY,SIMILAR,SIX
001,006,017,028,031,169,195,2011,212,250,APE1,ARMS,BER,COPYRIGHT,EXON,HAPLOTYPE,HOWEVER,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,OGG1,PCA,PCR,PURPOSE,RESULTS,RFLP,SIMILARLY,SNPS,VARIANT,VARIATIONS,XRCC1
001,108,169,177,2012,931,956,963,CONCLUSION,COPYRIGHT,FORTY,INC,LABEL,MATERIALS,MEAN,METHODS,OBJECTIVE,PURPOSE,RESULTS
160,169,2012,3MM2,ADENOVIRAL,COPYRIGHT,INC,LABEL,LM3,LNM35,M4A4,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RADIATION,RESULTS,TREATMENT
169,2011,BORIS,BROTHER,CCCTC,COPYRIGHT,CTCF,CTCFL,HIGH,LOWER,LTD
0001,169,194,2000S,2011,218,AMONG,BACKGROUND,CONCLUSION,COPYRIGHT,DIET,INTENTION,LABEL,LTD,METHODS,PRCA,PSA,RESULTS,SFA
003,100,118,169,174,1983,2003,2011,354,5544,8226,8804,AUTHORS,BJU,CAP,CSS,GLEASON,HIGH,LABEL,LEVEL,MEIER,METHODS,MFS,OBJECTIVE,PFS,PSA,RESULTS,THERAPY,TYPE,UNLABELLED,WHAT
169,2011,239,946,AKT,COPYRIGHT,CURRENT,LNCAP,NED,TRAMP,UICC
169,2012,AUTOMATIC,BLAND,CBCT,CIGARETTE,CONCLUSION,COPYRIGHT,FIVE,FURTHER,GFM,GFMS,HOWEVER,INC,IPL,LABEL,MATERIALS,METHODS,OBJECTIVE,PAIN,PEARSON,PURPOSE,RESULTS,XVI
CAP,FDA,HOWEVER,INC,PUBLISHED,WHILE
CRPC,EXCRETION,PHASE,TOTAL,ZIBOTENTAN
000,169,2011,408,AUC,BACKGROUND,CONCLUSION,COPYRIGHT,DAVID,FUNCTIONAL,INC,LABEL,METHODS,PSA,RESULTS,ROC,SERA,SERUM,WILEY
CDC2,FURTHER,ROS,TYR
100,175,176,189,190,233,355,362,364,365,366,368,375,383,388,ADS,BACKGROUND,CFT,CLEAR,COLLEGE,CONCLUSION,EMERGENCY,LABEL,METHODS,RESULTS
103,166,COMMISSION,CONCLUSION,DOSE,IMRT,LABEL,METHODS,NTCP,NTCPS,OBJECTIVE,ORGAN,PROTECTION,RESULTS,RISK,THERE
169,2011,257,8805,ADT,AMONG,BACKGROUND,CONCLUSION,COPYRIGHT,DEPRESSION,GDS,GERIATRIC,LABEL,METHODS,RESULTS,SCALE,SOCIETY,THREE
001,1096,167,169,2003,2007,2011,215,312,759,BACKGROUND,CARE,COPYRIGHT,EVEN,INPATIENT,INSURANCE,LABEL,METHODS,NATIONWIDE,NIS,OVERALL,PRIVATE,PROJECT,RESULTS,RPS,SIMILARLY,SOCIETY
0001,0027,149,169,177,1998,2008,2011,710,8805,ADT,AFTER,BACKGROUND,BECAUSE,COPYRIGHT,CSS,EBRT,FURTHER,HOWEVER,LABEL,METHODS,PHOENIX,RESULTS,SOCIETY,THERE,UNIVERSITY
BACKGROUND,CRPC,ETS,LABEL,MECHANISMS,METHODS,RESULTS,SEMINAL
160,486,956,BCL,CAKI,CHOP,DOWN,DR5,FLIP,LOW,RU486,TAKEN,TRAIL
160,198,ADT,AFTER,ANXIETY,BACKGROUND,BRIEF,CRF,DEPRESSION,EIGHT,FATIGUE,INVENTORY,LABEL,LIFE,MANAGEMENT,METHODS,PAIN,QUALITY,RESULTS,SCALE,SCORE,SYMPTOM,THERE,TREATMENT
169,181,2011,22RV1,8201,COPYRIGHT,HDAC,HDAC1,HDAC3,HDACS,INC,STUDIES,TREATMENT,WILEY
945,946,BASED,CARLO,CATCHESIDE,HENCE,LEA,MINERBO,MONTE,POISSON,POISSONIAN,SEVERAL,TCP,THERE,THESE,TYPICALLY
001,169,188,2011,3833,635,AGE,AUC,BACKGROUND,COPYRIGHT,DETECTION,DRE,EARLY,INSTITUTE,LABEL,LIMITED,METHODS,MODEL,NETWORK,PREVENTION,PSA,PSAD,RESULTS,SOCIETY,TRIAL,UNDER
0001,0003,133,BACKGROUND,CELL,FGF9,FIBROBLAST,GLEASON,LABEL,LNCAP,METHODS,MTT,RESULTS,THESE,TISSUES
800,BACKGROUND,BECAUSE,IAS,LABEL,MEN,METHODS,PSA,RESULTS
169,1998,2007,2011,464,8805,918,AWARENESS,BACKGROUND,COPYRIGHT,END,GRAY,LABEL,METHODS,RECORDS,RESULTS,SEER,SOCIETY
015,169,174,2011,AN3CA,COPYRIGHT,EMCA,FOUR,FURTHER,INC,KLE,LABEL,METHODS,NANOSTRING,OBJECTIVE,OBJECTIVES,PCR,PTEN,RESULTS
169,1960S,2011,947,COPYRIGHT,INC,NIGELLA,PPAR,PTEN,ROS,STAT3
169,2011,BIOMETRIC,MOST,SOCIETY
136,169,2012,945,AUTHORS,BLACKWELL,FOUNDATION,HDM2,HIF,JOURNAL,LNCAP,LTD,MOLECULAR,MST,PUBLISHING,STAT3,THESE,VEGF
145,AICAR,AMP,AMPK,COMP,HENCE,INCUBATION,INHIBITION,JNK,JUN,NADPH,NMPG,ROS,VAS2870
0061,032,125,169,1995,2010,2011,239,512,737,APRIL,BACKGROUND,CONTEXT,COPYRIGHT,D9901,DATA,DRUG,EVALUATION,FOOD,GVAX,HEADING,JANUARY,LABEL,MEDICAL,METHODS,NOTABLY,OBJECTIVE,OCTOBER,OTHER,PCA,PSA,PUBLISHED,RESULTS,SUBJECT,SYNTHESIS,THREE,TREATMENT,UROLOGY
169,2011,BACKGROUND,CONTEXT,COPYRIGHT,CURRENT,DIAGNOSIS,DIFFUSION,LABEL,MEDLINE,METHODS,MRI,OBJECTIVE,PUBLISHED,RESULTS,SYNTHESIS,UROLOGY
169,194,2011,BACKGROUND,CONCLUSION,COPYRIGHT,FINNISH,HOWEVER,LABEL,LTD,METHODS,RESULTS
001,169,200,2011,701,8226,8804,954,AUTHORS,BJU,HARM,LABEL,LEVEL,METHODS,MPP,OBJECTIVE,PPNB,PSA,RCT,REDUCTION,RESULTS,TPB,TYPE,UNLABELLED,VAS,WHAT
169,2011,246,ANGELES,AUTHORS,BJU,BOTH,CALIFORNIA,DISEASE,INDEX,LABEL,LEVEL,LOS,METHODS,OBJECTIVE,PCI,PDEI,RESULTS,THERAPY,TYPE,UNIVERSITY,UNLABELLED,WHAT
169,2011,453,8226,ANOTHER,ASSESSMENT,AUTHORS,BJU,COMPOSITE,CONCLUSION,HOWEVER,INDEX,LABEL,LEVEL,METHODS,OBJECTIVE,RESULTS,THERAPY,TYPE,UNLABELLED,WHAT
169,2011,BRDU,CDK2,CDK4,CONVERSELY,COPYRIGHT,HOWEVER,IIA,JOHN,LNCAP,LTD,PSA,SER,SONS,TAKEN,TANSHINONE,WILEY
946,ANTI,BMP,BMP4,FINALLY,FLAG,GST,HIC,ID1,IGG1,LIM,LIM3,MH2,MYC,PC3,SMAD1,SMADS,WPMY
946,GSK3,KLC2,LMTK2,PP1C,SMAD2,TGF,THUS
945,ACINI,KI16425,LPA,LPAR1,PRCA,RAC1,RHO,RHOA,ROCK1,S1P
156,169,2012,COPYRIGHT,INC,IPSS,LABEL,MATERIALS,METHODS,OBJECTIVE,PBT,PUBLISHED,PURPOSE,QOL,RESULTS,SCORE,SOCIETY,SYMPTOM,VAS
AIMS,ANTI,CONCLUSION,LABEL,MAPK,METHODS,OBJECTIVE,RESULTS
2001,2006,2010,HOWEVER,MRI,PRE,RARP
001,169,2005,2008,2009,2011,2119,8226,AUTHORS,BJU,DATE,LABEL,LEVEL,METHODS,OBJECTIVE,PLND,RESULTS,SEPTEMBER,THERAPY,TYPE,UNLABELLED,WHAT,WITHOUT
001,003,009,169,1997,2003,2011,285,8226,940,BJU,CONCLUSION,GLEASON,HENCE,LABEL,LEVEL,METHODS,NHMRC,OBJECTIVE,PATHOLOGY,PROGNOSIS,PSM,PSMS,RESULTS,SOCIETY,TYPE,UNLABELLED,UROLOGICAL,VARIOUS,WHAT
00024,001,100,169,2011,8226,ACCUPSA,AUTHORS,BCR,BJU,COX,DIAGNOSTIC,HOPKINS,JOHNS,LANGONE,LEVEL,MEAN,MEDICAL,MEIER,METHODS,NADIR,OBJECTIVES,OVERALL,PSA,RESULTS,SPECIMENS,THOSE,TYPE,UNIVERSITY,USING,WHAT,YORK
001,057,058,100,117,1480,160,169,177,2003,2010,2011,8226,8805,ADT,AUTHORS,BETWEEN,BJU,CONTROL,GLEASON,LABEL,METHODS,NETWORK,OBJECTIVE,OBJECTIVES,OVERALL,PSA,RALP,RESULTS,SEPTEMBER,SERUM,TREATMENT
001,003,049,169,2011,ASIAN,AUTHORS,BJU,BMI,CONCLUSION,GROUP,HIGH,LABEL,METHODS,OBJECTIVE,OPERATING,RARP,RESULTS,RETRO,TURP,UNLABELLED
133,169,183,2011,8226,AUTHORS,BJU,COLD,CRYO,DATA,GLEASON,HOWEVER,LABEL,LEVEL,LINE,METHODS,MOST,OBJECTIVE,OBJECTIVES,PSA,RESULTS,THEREFORE,TYPE,UNLABELLED,WHAT
169,2011,CECT,COGNITIVE,COPYRIGHT,INTERVIEWS,JOHN,LABEL,LTD,METHODS,OBJECTIVE,PCA,RESULTS,SEMI,SONS,THERAPY,WILEY
2002,2010,BLM,CENTRAL,CRPC,NOW
10A,11A,12A,13A,13B,14A,14B,169,181,2012,8201,ANTI,BASED,CNS,CONVERSELY,COPYRIGHT,EIGHT,FURTHER,GMBH,KGAA,MICHAEL,PASS,VCH,WILEY
BACKGROUND,BASED,CURRENT,DISCUSSION,LABEL,METHODS,RESULTS,STUDIES,URINARY
169,2011,COPYRIGHT,IRELAND,LTD
100,1992,2002,440,8804,ACCORDING,ALP,BACKGROUND,BETWEEN,COX,DRE,EOD,EVEN,GLEASON,LABEL,METHODS,PSA,RESULTS,STEP,T1C,VARIOUS
159,1990,2008,8201,BACKGROUND,BOTH,HIGH,JANUARY,LABEL,METHODS,MORTALITY,MULTILEVEL,RESULTS
CDH1,FZR1,MAK,POLO,TAKEN,TDY
169,201,2011,343,395,441,472,507,567,601,619,693,BACKGROUND,BPH,CONCLUSION,COPYRIGHT,HP1,LABEL,METHODS,OVERALL,OXIDATIVE,PCA,PSA,RESULTS,SERUM
169,2011,CASTRATION,COPYRIGHT,CRPC,CYP17,CYTOCHROME,DESPITE,HEAT,HSP,HSPS,III,IRELAND,LTD,MDV3100,P450,SEVERAL
015,043,046,169,2012,516,8805,ASTRO,COPYRIGHT,COX,EPPENDORF,HYPOXIA,INC,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PHOENIX,PURPOSE,RADIATION,RESULTS,SOCIETY
0005,103,125,126,169,177,2012,775,779,840,8804,ABSENCE,AMONG,BECAUSE,COPYRIGHT,FFBF,GLEASON,INC,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS,T2A,T2B
0001,0003,0009,008,0102,169,197,2012,550,586,8804,8805,COPYRIGHT,C_INC,GRADE,INC,ITALIAN,LABEL,MATERIALS,METHODS,M_INC,NOMOGRAMS,OBJECTIVE,PURPOSE,P_INC,RADIATION,RESULTS
113,134,146,393,ADVERSE,AGREEMENT,CONCLUSION,CTCAE,GYN,INTRACLASS,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE
160,516,8804,BACKGROUND,CARE,ENGLISH,FORM,GREATER,HISPANICS,LABEL,LATINOS,METHODS,NEEDS,OVERALL,RESULTS,SCNS,SF34,SHORT,SNCS,SPANISH,SUPPORTIVE,SURVIVORS,THERE,THESE
169,2011,COPYRIGHT,DORMANT,LTD,ONGOING
001,1668,169,1720,2013,C57BL,CAP,CD40,CD86,COPYRIGHT,CPG,CTL,FDA,HCIRNKSVI,INC,INDUCTION,LABEL,MATERIALS,METHODS,NOVEL,OBJECTIVE,ODN,PSA,PUBLISHED,RESULTS,SIPULEUCEL,THEREFORE,TREATMENT
033,148,169,178,2012,208,214,AMONG,BACKGROUND,BOARD,COPYRIGHT,COX,ELBOW,INC,JOURNAL,LABEL,MATERIALS,METHODS,MOSBY,PATHOLOGIC,PUBLISHED,RESULTS,SURGERY
004,100,169,177,1998,2007,2011,313,8226,8805,ADVERSE,APRIL,AUTHORS,BJU,CONCLUSION,COX,EBRT,EVENT,GLEASON,GRADE,HDR,JUNE,LABEL,LEVEL,METHODS,OBJECTIVE,PSA,RESULTS,THERAPY,TYPE,UNLABELLED,WHAT
BACKGROUND,HOWEVER,LABEL,RESULTS
0001,1088,333,448,640,CONCLUSION,EPI,IGRT,KVI,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THERE
100,8201,BACTERIAL,CPE,EXPRESSION,MCF,SKMEL
160,2GLCN,956,BOTH,CONCLUSION,GLCN,GLUCOSE,LABEL,METHODS,NEAR,NIRF,OBJECTIVE,PC3,PROCEDURES,PURPOSE,RESULTS,SIMILARLY
000,0001,173,177,239,256,270,338,500,736,8201,8226,8805,ADC,BEST,CNR,CONCLUSION,DWI,FORTY,IMAGING,KEY,LABEL,METHODS,MRI,OBJECTIVE,RESONANCE,RESULTS
0001,0007,003,0061,0371,103,160,210,8805,EXPRESSION,GLEASON,LABEL,MATERIALS,MEAN,MEIER,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS,SEMI,THERE,THYMIDINE,XPA
001,169,2011,8201,APOPTOSIS,BACKGROUND,BAD,COPYRIGHT,CRPC,DU145,INC,LABEL,LNCAP,METHODS,PC3,RESULTS,WESTERN,WILEY
100,177,1999,2003,AHT,BACKGROUND,CRT,FIFTY,JANUARY,LABEL,METHODS,NAHT,PHOENIX,PSA,RESULTS,SEVENTY,SHT,T1C,WESTERN
106A,125B,169,2011,221,410,8194,AUTHORS,BACKGROUND,BJD,BRITISH,HOWEVER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,REGARDING,RESULTS,RNAS
1985,1989,1990,1994,2002,2006,BACKGROUND,CONCLUSION,END,INCIDENCE,LABEL,METHODS,MORTALITY,OVERALL,PSA,RESULTS,TEN,USA,USING
169,2002,2009,2011,334,349,503,820,8201,8804,BACKGROUND,COPYRIGHT,EVEN,GLEASON,HOWEVER,INC,LABEL,MATERIALS,METHODS,OVERALL,PCA,PSA,RESULTS,THREE,WILEY
BACKGROUND,BECAUSE,FORTY,FOUR,HIV,LABEL,METHODS,MLV,RESULTS,THESE,XENOTROPIC,XMRV
CONSEQUENT,H1299,H460,LOSS,XXIII
100,169,194,2011,ANTIGEN,BPH,COPYRIGHT,GLEASON,HIGH,INC,OPN,OPNA,OPNB,OPNC,PCA,PCR,PROSTATIC,PSA,ROC,SCORE
100,102,177,2003,2005,BACKGROUND,CONCLUSION,DOSIMETRIC,HOWEVER,IMRT,INTENSITY,LABEL,METHODS,PTV,REPORTS,RESULTS,SEPTEMBER,SEVENTY,V40,V60,V70
169,171,177,2011,956,AUC,CAP,COPYRIGHT,EIGEN,GABOR,HAAR,HOWEVER,IMAGING,JOHN,LTD,MAWERIC,MRI,MRS,RESONANCE,RESULTS,SONS,WILEY
146,224,AFTER,ATN,BACKGROUND,COX,HOWEVER,LABEL,MEIER,METHODS,MFS,PSA,PSADT,RESULTS,SEVERAL
293T,BECAUSE,CFS,HOWEVER,LACZ,QN10S,XENOTROPIC,XMRV,XMRVS
169,194,2011,AEU,CANCERLIT,COPYRIGHT,DIET,FACTORS,FURTHER,INDEX,LABEL,LITERATURE,MEDLINE,METHODS,OBJECTIVE,PREVENTION,PRIMARY,PUBLISHED,RESULTS,SCIENCE,WESTERN
169,2009,2010,2011,236,342,AUTHORS,HENCE,INFECTION,INFECTIOUS,JULY,SOCIETY
145,A2780,DRUG,MTX,NLCS
LABEL,MEAN,METHODS,MRI,OBJECTIVE,OBJECTIVES,RESULTS
0034,053,169,2011,261,8201,BACKGROUND,COPYRIGHT,FISH,GLEASON,INC,LABEL,LOSS,METHODS,PSA,RESULTS,TMA,WILEY
169,2011,AKT,BACKGROUND,COPYRIGHT,INC,LABEL,LNCAP,METHODS,PCR,PRCA,PSA,R1881,RESULTS,SILENCING,SIMILAR,SRC,VCAP,WILEY
169,2011,264,945,947,954,AUTHORS,BACKGROUND,BRITISH,IKK,INHIBITION,JOURNAL,KEY,LABEL,METHODS,MOST,OBJECTIVE,PURPOSE,RANKL,RAW,RESULTS,SOCIETY,THUS
095,169,2011,8201,COPYRIGHT,CURRENT,JOHN,LTD,MRSI,PHASE,SONS,THESE,THREE,THUS,WILEY
001,034,115,169,177,2011,ADJUSTMENT,AFTER,BACKGROUND,BRIEF,COPYRIGHT,COUPLES,FSFI,IIEF,INDEX,INVENTORY,LABEL,METHODS,NEITHER,RESULTS,SCALE,SOCIETY,SYMPTOM,WEB1,WEB2
169,2011,946,BASED,COPYRIGHT,COULD,DICKKOPF1,DKK1,HOWEVER,THUS,UICC,WNT
001,012,016,116,169,2011,303,482,761,8804,ADT,AIP,COPYRIGHT,COX,GLEASON,MEIER,PCA,PCR,PSCA,UICC
007,025,033,169,2011,389,8226,AUTHORS,BJU,C30,CHANGES,CONTINENCE,LABEL,LEVEL,LOOKING,METHODS,OAB,OBJECTIVE,PERSISTENT,QLQ,RESULTS,SOCIETY,THERAPY,TREATMENT,TYPE,UNLABELLED,WHAT,WHEREAS
169,2011,8226,ADT,AUTHORS,BJU,BOTH,CRUCIALLY,EBRT,HOWEVER,PUBLISHED,THERE
169,2011,BLACKWELL,LTD,PUBLISHING
2005,2008,7332,8805,BACKGROUND,JAPAN,LABEL,MEAN,METHODS,PREVENTIVE,PSA,RESULTS
146A,160,2010,496,885,CAUCASIAN,HOWEVER,INCREASED,MAY,OVERALL,STRATIFIED
022,160,8805,AFTER,GLEASON,GSTP1,HOWEVER,LABEL,METHODS,MSP,OBJECTIVE,PCA,PCR,PSA,RESULTS,THESE
1999,2009,BACKGROUND,CONCLUSION,EARLY,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,SYSTEMATIC
007,102,167,227,BACKGROUND,CONCLUSION,FORM,GENERAL,HRQOL,LABEL,METHODS,NHS,OBJECTIVE,RESULTS,SHORT,STUDIES
1000,102,169,194,1997,2007,2011,432,526,642,BACKGROUND,BETWEEN,COPYRIGHT,COX,CROWN,DISCHARGE,LABEL,MEN,METHODS,NPCR,OBJECTIVE,PCA,PUBLISHED,RESULTS,SETTING,TED,THUS
169,2011,203,CONCLUSION,COPYRIGHT,GIVEN,IRELAND,LABEL,LTD,MAIN,METHODS,OBJECTIVE,PHYSICIANS,RESULTS,THEREFORE,THEREIN
001,010,012,169,2011,70GY,8805,CONCLUSION,COPYRIGHT,FIVE,GLEASON,LABEL,LATE,LTD,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS,SCORE,SRT,STUDIES,UNIVARIATE
169,1996,2004,2011,223,239,COPYRIGHT,CRPC,III,LTD,PHASE,PUBLISHED,SINCE
100,140,169,177,2013,4MIN,57S,600,BRITISH,COPYRIGHT,DICE,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SOCIETY
001,003,169,1991,2010,2012,330,AFRICAN,AOR,BETWEEN,CONCLUSION,COPYRIGHT,GLEASON,HOWEVER,INC,LABEL,MATERIALS,MEN,METHODS,OBJECTIVE,PCA,PENDING,PSA,PURPOSE,RESULTS,TYPE
10000,129,169,194,1996,2008,2011,2171287,745,BACKGROUND,COPYRIGHT,CPA,JANUARY,JUNE,LABEL,LTD,METHODS,NETWORK,ODDS,ORS,RESULTS,THERE,WHILE
013,029,169,2011,AFTER,BACKGROUND,FEW,JOHN,LABEL,LSCC,LSCCS,METHODS,RESULTS,SONS,THERE,WILEY
001,8804,BACKGROUND,CONCLUSION,DATA,FIFTY,GLEASON,LABEL,METHODS,OBJECTIVE,PCA,PSAR,PURPOSE,RESULTS,WHILE
BECAUSE,CAG
127,169,174,2011,8804,8805,AFTER,ASAPS,AUC,AUTHORS,BJU,DIAGNOSIS,DRE,FINALLY,HGPIN,HOWEVER,LABEL,LEVEL,METHODS,NPV,OBJECTIVE,PAB,PCA,PCA3,PPV,PSA,PSAV,RESULTS,RISK,TOTAL,TYPE,UNLABELLED,WHAT,WHILE
001,002,031,150,169,2011,383,AUTHORS,BJU,CEUS,CNTI,DIAGNOSTIC,DOPPLER,GLEASON,LABEL,LEVEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,TYPE,UNLABELLED,WHAT
001,120,169,2002,2008,2011,257,715,8226,8804,AUTHORS,BETWEEN,BJU,CANCERS,CONCLUSION,GLEASON,LABEL,METHODS,OBJECTIVE,RESULTS,TR12
169,18F,2011,CAP,COPYRIGHT,GLUT,GLUT1,GLUTS,HGPIN,HOWEVER,INC,LOW,WILEY
0321,100,101,104,125,160,169,2012,45GY,5GY,BLADDER,BOTH,COPYRIGHT,DOSE,FIFTEEN,GROUP,INC,IPSA,LABEL,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RADIATION,RESULTS,RTOG,SOCIETY,SRP,THERAPY,UDS
100,121,169,1998,2011,2012,258,945,COPYRIGHT,HOWEVER,INC,LABEL,LTURP,LUTS,MATERIALS,MEAN,METHODS,OBJECTIVE,PCA,PLANNED,PUBLISHED,PURPOSE,RESULTS,SCORE,SOCIETY,SYMPTOM,TUIP
126,127,150,169,194,2012,492,COPYRIGHT,DATA,DOSIMETRIC,INC,INTERPLANT,MEDICAL,PUBLISHED
169,2012,COPYRIGHT,ERG,GLEASON,HOWEVER,INC,TMPRSS2,USING
169,2011,954,BCL,BECAUSE,COPYRIGHT,COX,CXCR4,IAP,ICAM,MMP,OVERALL,UICC,VEGF,WESTERN,WHETHER,ZYFLAMEND
031,1997,2004,2010,ADVANCING,AFFAIRS,ANGELES,BACKGROUND,BEACH,CENTERS,CONCLUSION,GREATER,LABEL,LOS,MEDICAL,MEN,METHODS,OBJECTIVE,RESULTS
160,175,665,8804,BMI,CONVERSELY,GLEASON,LABEL,METHODS,OBJECTIVE,PSA,PSM,PSMS,PURPOSE,RESULTS,RRP,SERUM,SHBG
231,474,956,ACID,ACTIVATION,ANNEXIN,APOPTOSIS,BAX,BCL,CELL,DM102,MCF,MDA,NOE,PARP,ROS,THESE
1733,239,271,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PANCREATIC,PDAC,RECORDS,RESULTS
161,165,1993,2005,589,872,AGE,DATA,LABEL,METHODS,MINNESOTA,OBJECTIVE,OLMSTED,OPTIMAL,OUTCOME,PSA,QALYS,RESULTS,SOURCES
001,169,2009,2010,2011,325,712,931,AIM,BACKGROUND,BECAUSE,BETWEEN,CONCLUSION,IIEF,INDEX,LABEL,MAIN,MARCH,METHODS,OBJECTIVE,OUTCOME,PEARSON,RESULTS,RLRP,SOCIETY,THERE
169,181,2007,2011,786,8226,8804,AUTHORS,BASED,BJU,GLEASON,INT,LABEL,LEVEL,METHODS,MRI,MRSI,NOMOGRAMS,OBJECTIVE,OBJECTIVES,PCA,PREDICTION,PROGNOSIS,PSA,RESULTS,T1C,T2A,THERE,TYPE,UNLABELLED,UPON,WHAT
001,169,174,2008,2011,257,269,368,443,8805,ANXIETY,AUTHORS,BETWEEN,BJU,BOTH,CALCULATOR,COMPLIERS,DECISIONAL,DIAGNOSTIC,DUTCH,ERSPC,FORM,INVENTORY,ITEM,LABEL,LEVEL,METHODS,OBJECTIVE,OBJECTIVES,PSA,RANDOMIZED,RESULTS,RISK,SCALE,SCREENING,SHORT,STATE,TRAIT,TYPE,UNLABELLED,UROLOGISTS,WHAT
001,002,006,108,148,151,169,189,1985,2006,2011,AUTHORS,BJU,CONCLUSION,COX,FURTHER,GLEASON,LABEL,LEVEL,MEIER,METHODS,OBJECTIVE,PROGNOSIS,RESULTS,TGG,TYPE,UNIVARIATE,UNLABELLED,WHAT
169,2011,8226,AUTHORS,BJU,CONCLUSION,KEY,LABEL,METHODS,OBJECTIVE,RESULTS,THESE,TREATMENTS,UNLABELLED,WHAT
001,169,2011,ADT,AFTER,AUTHORS,BJU,FURTHER,LABEL,LEVEL,MEN,METHODS,OBJECTIVE,RCT,RESULTS,THERAPY,TYPE,UNLABELLED,WHAT
005,007,025,169,174,175,2011,AUTHORS,BJU,COMPOSITE,EPIC,HRQOL,INDEX,LABEL,LRP,METHODS,OBJECTIVE,RALP,RESULTS,SCORE,SUBSCALES,SUMMARY,THERE,URINARY,USING
0GY,169,177,2006,2009,2011,8194,AUTHORS,BJU,CONCLUSION,HDR,HORMONE,JANUARY,LABEL,METHODS,OBJECTIVE,PSA,RESULTS,SEVEN,T1C,TEN
001,003,078,100,105,1064,1147,169,1991,2008,2011,373,AUTHORS,BJU,FIVE,LABEL,LEVEL,METHODS,OBJECTIVE,RESULTS,THERAPY,TYPE,UNLABELLED,WHAT
169,181,2011,8201,916,945,ADT,ANTI,BACKGROUND,CELL,COPYRIGHT,DHT,DU145,IC50,INC,LABEL,LNCAP,METHODS,MTT,PCA,PCR,PSA,PTS33,RESULTS,TMPRSS2,WESTERN,WILEY
169,2011,AKT,AKT2,BACKGROUND,CLONING,CONCLUSION,COPYRIGHT,DU145,ERBB,INC,LABEL,LNCAP,METHODS,PCR,RESULTS,WILEY
001,0011,0161,024,068,1656,169,2011,212,499,661,8201,BACKGROUND,CONTROL,COPYRIGHT,CRPC,CYTOKINES,DBC,DOCETAXEL,FURTHER,INC,LABEL,METHODS,MST,PPV,RESULTS,WILEY
169,2011,26S,BACKGROUND,CLONOGENIC,COPYRIGHT,DU145,INC,LABEL,METHODS,PROTEASOME,RESULTS,WHILE,WILEY
169,2011,BACKGROUND,COPYRIGHT,DOWNSTREAM,EVEN,HOWEVER,INC,KIP1,LABEL,METHODS,MMP,MTT,PCR,RESULTS,SEVERAL,THEREFORE,WESTERN,WILEY,XENOTROPIC,XMRV
002,169,2011,764,775,COPYRIGHT,IGF,IGF1,IGF2,ORS,SERUM,UICC
169,2011,257,946,AFTER,CBSM,COPYRIGHT,HOWEVER,JOHN,LABEL,LTD,MEN,METHODS,OBJECTIVE,RESULTS,SONS,WILEY
AFTER,GRA,GRB,IMAB,LABEL,MAB,METHODS,OBJECTIVE,PCA,PSA,PURPOSE,QOL,RESULTS,TESTS,TIP,TIP1,TIP2,TOP,TOP1,TOP4,TREATMENT
8805,AMONG,BACKGROUND,CRPC,FURTHER,LABEL,METHODS,PSA,RESULTS,TTP
ASPIRATION,DIAGNOSES,FRESH,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SUTURELESS,THREE
BOTH,BPH,CHANGES,DOES,PCA,SEVERAL,THUS
125,169,2003,2010,2012,427,COMMISSION,COPYRIGHT,DATA,EARLY,HOWEVER,INC,JAPAN,JUNE,LABEL,MATERIALS,METHODS,OBJECTIVE,PROTECTION,PUBLISHED,PURPOSE,RESULTS,SEPTEMBER,SOCIETY
001,103,125,125GY,140GY,144GY,169,192,2012,715,COPYRIGHT,COX,GLEASON,INC,IRIDIUM,LABEL,MATERIALS,METHODS,NINE,OBJECTIVE,PALLADIUM,PSA,PUBLISHED,PURPOSE,RESULTS,RFS,SOCIETY
001,003,026,033,102,110,136,169,2008,2011,2013,246,8804,8805,BETWEEN,BMI,CAP,COPYRIGHT,CRUDE,DRE,GLEASON,INC,ITALY,LABEL,MATERIALS,MEN,METHODS,OBESITY,OBJECTIVE,PSA,RESULTS,SIX,TRUS
169,194,2012,COPYRIGHT,DOSIMETRIC,HOWEVER,IMRT,INC,MEDICAL,PTV,PUBLISHED,SEVEN,V20,V70
169,2011,COPYRIGHT,III,IORT,IRELAND,LTD,THEREFORE,TREATMENT
169,2011,COPYRIGHT,FUS,HIFU,HIGH,LTD,MRI
155,156,169,2013,273,CONCLUSION,COPYRIGHT,DATA,DRE,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PSA,RESULTS,UNIVARIATE
001,002,169,2011,COPYRIGHT,CROWN,DISCUSSION,EBR,HDR,LABEL,LTD,METHODS,OBJECTIVE,ONTARIO,POST,PUBLISHED,PURPOSE,QOL,RESULTS,THEREFORE
169,2011,BACKGROUND,COPYRIGHT,ERAL1,GENERAL,ISSUE,LABEL,MAJOR,MAMMALIAN,METHODS,SCOPE,SPECIAL,TFAM
BCL2,CD10,FISH,GCS,IMPORTANT,THESE
169,2011,329,BACKGROUND,CASTRATION,CGH,COPYRIGHT,CRPC,CRPCS,ECTOPIC,FAM110B,INC,LABEL,LAS1L,METHODS,MYC,RESULTS,SIX,WILEY,YIPF6
169,2011,APOPTOSIS,BACKGROUND,COPYRIGHT,GRB,INC,INHIBITION,LABEL,LNCAP,METHODS,RESULTS,THESE,WILEY
0022,0027,0047,0093,169,2011,8201,BACKGROUND,BINDING,BPH,CONCLUSION,COPYRIGHT,GHRELIN,GHS,GHSR,IMAGING,INC,LABEL,LNCAP,METHODS,PCA,PCAS,PIN,RESULTS,WILEY
169,2011,AFTER,AREAS,AUC,BACKGROUND,BTA,CEA,COPYRIGHT,EGF,FORWARD,LABEL,METHODS,NMP22,PPP,RESULTS,ROC,SOCIETY,WALD
AAV,BAC,BARR,EBNA1,EPSTEIN,GIVEN,ITR,ITRS,T2HEA,THESE
050,100,169,194,2008,2010,2012,ACUTE,ADVERSE,APRIL,BETWEEN,COPYRIGHT,EVENT,GRADE,HDR,INC,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SOCIETY,VERSION
169,194,2011,COPYRIGHT,EDC,EDCS,ENDOCRINE,ERS,FURTHER,IRELAND,LTD,SINCE,THESE
2000,2006,2010,APRIL,CONCLUSION,LABEL,METHODS,OBJECTIVE,PURPOSE,RALP,REGARDING,RESULTS,TURP
042,048,1000,178,500,8201,8226,ADC,ADCS,AUC,DIFFUSION,DWI,GLEASON,KEY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PEARSON,RESULTS,ROC
945,946,DECREASED,DGS,FGF,GLEASON,IGF,MMP,MOST,THUS,WEAK
8201,8805,950,ACCRA,AFRICAN,AMERICANS,BACKGROUND,BPH,DRE,FURTHER,GHANA,HOWEVER,IPSS,LABEL,LUTS,METHODS,PSA,RESULTS,SCORE,SYMPTOM,WEST,WESTERN
ADT,COUPLES,THESE
ALSO,OVERALL,PREVIOUSLY,RETRACTION,THESE
1998,2003,8805,AIMS,BACKGROUND,FIFTY,GLEASON,HENCE,HOWEVER,LABEL,MEDICAL,METHODS,NINE,OBJECTIVE,OVERALL,PSA,RADICAL,RESULTS,SIXTY,STAGE
215,AT6,AZI,HIGH,LN4,ODC,PC3M,PCR,THESE
100,ARBSS,CHIP,CRPC,CRPCS,FEN1,FINALLY,LNCAP,SKP2,SNAI2,ZWINT
2TCR,947,948,ACT,CDR3,HOWEVER,OEC,PBLS,PBMC,TCR,THESE
112,169,179,192,2001,2004,2011,697,CONCLUSION,COPYRIGHT,CROWN,ENGLAND,LABEL,LTD,METHODS,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,RESULTS
0001,004,0053,134,169,2004,2007,2013,397,467,967,COPYRIGHT,CSM,CUMULATIVE,DESPITE,END,GRAY,HGT1,HIGH,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SEER,USING
106,12TH,169,2013,BACKGROUND,CAP,COPYRIGHT,DCE,DIAGNOSTIC,DYNAMIC,FLASH,GERMANY,GLEASON,IMAGING,INC,LABEL,MEN,METHODS,MRI,MRSI,OVERALL,PITTSBURG,PSA,RESULTS,SIEMENS,THREE,TIM
169,2013,CAP,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,OBJECTIVES,RARP,RESULTS,ROBOT
000,026,200,703,858,8804,AGE,DATA,GLEASON,HENCE,ICER,LABEL,METHODS,OBJECTIVE,PSA,QALY,RESULTS,SEK,SPCG,SWEDISH,USING
169,2011,257,330,BACKGROUND,COPYRIGHT,DATA,HOWEVER,JOHN,LABEL,LTD,MATCHED,METHODS,MOST,OBJECTIVE,OBJECTIVES,RESULTS,SONS,STRATEGIES,THERE,WILEY
169,2011,AFRICAN,BACKGROUND,BLACK,CARIBBEAN,CONCLUSION,COPYRIGHT,ENGLISH,FOUR,FURTHER,JOHN,LABEL,LTD,METHODS,NON,RESULTS,SONS,USA,WHITE,WILEY
169,193,2007,2011,COPYRIGHT,DATA,IRELAND,IRISH,JOHN,LTD,PARTICULAR,SCREENING,SONS,WILEY
DISCUSSION,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PAGET,RESULTS
001,004,009,016,037,177,199,299,311,349,508,OPG,SERUM
CRPC,ENHANCING,FINALLY,PCA,TAKEN
105,108,8805,BACKGROUND,CONCLUSION,CRPC,E7389,GRADE,LABEL,MEN,METHODS,PSA,RESULTS,TREATMENT
169,2011,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,MOST,OBJECTIVE,PHYSICIANS,REQUESTING,RESULTS
001,007,148,169,2001,2005,2006,2007,2011,3581,AFRICAN,AFTER,AMERICANS,BACKGROUND,BETWEEN,CAUCASIAN,CAUCASIANS,COPYRIGHT,COST,HEALTHCARE,INDEX,INPATIENT,LABEL,METHODS,MIRP,MIRPS,NATIONWIDE,NIS,ORP,PROJECT,RACE,RESULTS,SOCIETY
BKPYV,LACK,XMRV
001,007,115,169,1998,2007,2011,2109,554,8226,8805,ADVERSE,AHC,AUTHORS,BJU,CARE,INPATIENT,LABEL,LEVEL,METHODS,MOST,NATIONWIDE,OBJECTIVE,ORP,ORPS,PROJECT,RESULTS,SIMILARLY,THERAPY,TYPE,UNLABELLED,USA,WHAT
169,2011,8226,AUTHORS,BJU,HBO,LABEL,METHODS,OBJECTIVE,RESULTS
001,005,017,027,029,048,169,201,2011,262,298,684,8226,AUTHORS,BJU,GLEASON,LABEL,METHODS,OBJECTIVE,RESULTS,SIMILARLY,SURROGATE,TUMOURS,UNDER
001,012,013,031,041,108,115,147,154,169,1998,2007,2011,262,8226,8804,AUTHORS,BJU,DIAGNOSTIC,HGPIN,LABEL,LEVEL,METHODS,OBJECTIVE,OVERALL,PBX,PCA,PIN,PLURIFOCAL,PSA,RESULTS,TYPE,UNLABELLED,WHAT
1000,1500,169,2011,418,AUTHORS,BJU,CIS,CONFIDENCE,LABEL,MEN,METHODS,OBJECTIVE,OBJECTIVES,PARTNERED,RESULTS
169,2000,2007,2011,AUS,AUTHORS,BETWEEN,BJU,LABEL,METHODS,OBJECTIVE,OCTOBER,QOL,RESULTS,WHETHER
111,169,2011,233,5531DELTT,BRCA,BRCA1,BRCA2,COSTA,FOUR,JOHN,JOS,MUTATIONS,OTHER,RICA,RICAN,SAN,SONS,THESE,WILEY
2000,2009,3162,8805,AFFAIRS,ATLANTA,BACKGROUND,GLEASON,JANUARY,JULY,LABEL,MEDICAL,MEN,METHODS,ORS,PSA,RACE,RESULTS,SEVERAL
00001,005,177,2634,ADT,BMD,CANCERLIT,MEDLINE,NNT,NTT,SOCIETY,TREATMENT,ZOLEDRONIC
BINDING,EZH2,HOMOLOG,KLF,KLF2,KRUPPEL,MOST,UPON,ZESTE
169,1CM,2011,364,5MM,6MM,8MM,COPYRIGHT,IGRT,IMRT,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS,SEVENTEEN,THREE,V65
169,2012,603,COPYRIGHT,DTX,INC,LABEL,MESO,NPS,PCL,PEO,UNASSIGNED,UNLABELLED
169,194,2012,COPYRIGHT,FIVE,FOUR,IMRT,INC,MEDICAL,PHILIPS,PINNACLE3,PUBLISHED,RESULTS
169,177,2011,20NG,4NG,954,AIM,BP50,BP65,BPH,CONCLUSION,COPYRIGHT,DIFFERENT,LABEL,METHODS,OBJECTIVE,PSA,RESULTS,SAS,SERUM
100,169,200,2011,8310,956,COPYRIGHT,HOWEVER,INC,RAD3,TAKEN,THESE,WILEY
000,012,169,191,1973,2003,2011,239,241,278,323,AUTHORS,BJU,COX,END,LABEL,MEIER,METHODS,OBJECTIVE,RESULTS,SCC,SEER,USING
169,1970,2011,693,BJU,CLAIM,COMPARING,DESPITE,END,GLEASON,GOVERNMENT,LABEL,MEN,METHODS,OBJECTIVE,PCA,RESULTS,SEER,WORKS
169,2011,8194,ADT,AUTHORS,BJU,CONTROL,CPS,DECISIONAL,DRS,ENGLISH,HOT,LABEL,LEVEL,MEAN,METHODS,NEEDS,OBJECTIVE,RESULTS,SCALE,SEVERAL,SWD,THERE,THREE,TREATMENT,TYPE,UNLABELLED,WHAT
169,2011,365,ADT,AFTER,AUTHORS,BJU,CHINESE,CONCLUSION,COX,INSURANCE,LABEL,METHODS,OBJECTIVE,RESULTS,THERE,THESE
0001,116,128,169,2011,515,8194,AUTHORS,BJU,BPH,CLSS,CONCLUSION,CORE,HOWEVER,INDEX,IPSS,LABEL,LEVEL,LOWER,LUTS,METHODS,OAB,OBJECTIVE,QOL,RESULTS,SCORE,SYMPTOM,THERAPY,TRACT,TYPE,UNLABELLED,URINARY,WHAT
000,163,169,2011,AUTHORS,BJU,CONCLUSION,COSTS,DEGARELIX,EXCELLENCE,ICER,INSTITUTE,LABEL,METHODS,OBJECTIVE,OUTCOME,QALY,QALYS,RESULTS
106,169,2002,2010,2011,8194,AUTHORS,BJU,INVENTORY,IPSS,LABEL,MEN,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SCORE,SYMPTOM,THERE
169,176,2011,AUTHORS,BJU,CAP,CASPASE,CELL,LABEL,LNCAP,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,VITAMIN
1009,169,174,175,2011,348,8804,8805,AUTHORS,BJU,EPSTEIN,FIRST,GLEASON,LABEL,METHODS,OBJECTIVE,PCA3,RESULTS,T1C,T2A,T2C,T3A,T3B,TREATMENT
1120,142,1434,155,169,1750,2005,2006,2007,2008,2009,2011,914,AUTHORS,BJU,INDEX,LABEL,MEAN,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
169,2008,2010,2011,APRIL,AUTHORS,BETWEEN,BJU,GLEASON,LABEL,METHODS,OBJECTIVE,PSA,RESULTS,SEPTEMBER,THERE,TRUS
001,169,1992,1998,1999,2004,2005,2011,444,8201,BACKGROUND,COPYRIGHT,EACH,GLEASON,INC,LABEL,METHODS,RESULTS,WILEY
105,109,122,169,2011,BACKGROUND,BONE,CONCLUSION,COPYRIGHT,INC,LABEL,MEIER,METHODS,RESULTS,SAMPLES,THERE,WILEY
ID4,LABEL,METHODS,OBJECTIVE,PCR,PURPOSE,RESULTS,WEAK
100,143,145,146A,15A,169,191,199A,2013,206,218,7500,916,ABI,BACKGROUND,CAP,CONCLUSION,COPYRIGHT,FAST,HGPIN,INC,ISOLATION,LABEL,METHODS,MICRO,MIX,PCR,REAL,RESULTS,REVERSE,RNAS,RNU43,SIXTY,THROUGH,TIME,UNIVERSAL
169,2004,2006,2010,2011,877,8805,AUTHORS,BJU,CONVERSELY,END,FINALLY,HOWEVER,LABEL,LNI,METHODS,NCCN,NETWORK,OBJECTIVE,OBJECTIVES,OVERALL,PLND,PLNDS,RESULTS
004,169,173,1992,2000,2001,2010,2011,494,598,667,717,764,AMICO,AUTHORS,BFS,BJU,BOARD,CPE,CSS,EARLY,EPE,ERA,GLEASON,LABEL,METHODS,MFS,OBJECTIVE,PSA,RADICAL,RESULTS,T2B,YEAR
169,2011,BLACKWELL,HOWEVER,LTD,PUBLISHING
001,169,2011,601,ACM,ADT,ALPK1,BACKGROUND,BASED,BNC2,CONCLUSION,COX,ERE,ERES,JOURNAL,LABEL,MEIER,METHODS,PCSM,RESULTS,SNPS,TACC2,THEREFORE,THESE
197,1993,2008,298,AUTHORS,BACKGROUND,GUIDELINES,III,LABEL,LEVEL,METHODS,OBJECTIVE,PATHOLOGIC,PRIMARY,QUESTIONS,RESULTS,TREATMENT
169,2011,ADDITIONAL,COMPOUNDS,COPYRIGHT,FDA,HOWEVER,IRELAND,LBD,LTD,NRS,NUCLEAR,SEVERAL,STRUCTURAL,THEIR
169,194,2011,ASSOCIATED,COPYRIGHT,FRESH,HEAT,HSP90,ISSUE,PROTEIN,SHOCK,SPECIAL,TRAP
001,008,012,037,098,160,205,AGE,DRE,LABEL,METHODS,OBJECTIVE,PCA,PCA3,PIN,PREDICTIVE,PSA,PURPOSE,RESULTS,THEREFORE,TRUS
BPS,LATER,ZOL
169,2011,COLLEGE,COPYRIGHT,LTD,PUBLISHED,RADIOLOGY,UPON
2005,2007,CORRECTED,END,FIVE,PROGRAM,RESULTS,THESE
001,014,037,169,180,189,194,214,272,290,304,421,513,515,547,711,8805,965,CHINA,GLEASON,HAN,PSA,STRATIFIED,THEREFORE
0201,CD8,CTL,HLA,KLK4,PAP,PSA,PSMA,THESE
0001,0084,110,194,1989,2009,252,324,650,770,938,AMICO,CAP,COX,DISEASE,INC,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,THERE
169,178,1MM,2011,5MN,AMICO,COPYRIGHT,ECE,HISTOLOGY,IRELAND,LABEL,LTD,MATERIALS,METHODS,MRI,OBJECTIVE,PCA,PURPOSE,RESULTS,SPACE,SVI,T2W
169,1705,177,2011,487,8226,AUTHORS,BJU,CONCLUSION,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,VAS
CASODEX,DPTC,HOWEVER,LNCAP,NAKAI,NKX3,OVERALL,PCA,PSA,TARGETING,VCAP
001,100,110,131,169,177,2012,4MM,COPYRIGHT,FIFTEEN,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,POSTERIOR,PUBLISHED,PURPOSE,RESULTS,SOCIETY
169,1996,2008,2013,8805,BCG,CAP,CONCLUSION,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,NMIBC,OBJECTIVE,OBJECTIVES,RESULTS,THOSE
111,169,189,1999,2009,2013,370,463,500,569,702,730,854,AUCS,CAP,CHINESE,COPYRIGHT,INC,LABEL,MATERIALS,MEN,METHODS,OBJECTIVE,OBJECTIVES,PSA,RESULTS,ROC,THOSE,USING
169,2011,A549,BOTH,CELASTROL,COPYRIGHT,FURTHER,HELA,HSP90,INC,LC3,LC3II,MAPK,MEK,WILEY
169,1986,1990,1994,1998,2002,2006,2011,5025,642,896,ACRYLAMIDE,COPYRIGHT,COX,HIGH,IARC,PSA,RESULTS,THERE,UICC
1996,946,ALZHEIMER,INCREASING,SINCE,ZNT3
BONE,NOTABLY,THESE
ANTICANCER,HOWEVER,ZOL,ZOLEDRONIC
CELL,DATS,ITCH,JNK,JNK1,LABEL,LIP,METHODS,OBJECTIVE,PURPOSE,RESULTS,ROS,THESE
AWARENESS
DEFICIENCY,ERK,MYC,PIM,PIM1,THESE
236,306,BACKGROUND,BOARD,DRE,LABEL,METHODS,RESULTS
168,8805,BACKGROUND,BASED,CRPC,LABEL,METHODS,PFS,PSA,RESULTS,YM155
ESTROGENS,NOVEL,PHASE,STS,THESE
169,2011,947,CD4,COPYRIGHT,DRB1,ELISPOT,HLA,IFN,THEREFORE,THUS,UICC
STEROID,STRIKINGLY
HOWEVER,OTHER,RNS,ROS,STUDIES
169,172,177,1991,2007,2012,CONCLUSION,COPYRIGHT,GLEASON,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PSA,RESULTS,T2W
169,2008,2011,5CM,ADDITIONAL,BOTH,COLLEGE,COPYRIGHT,CURRENT,FURTHER,IGRT,LARGE,LTD,MEDLINE,NINE,PUBLISHED,ROYAL,STUDIES,SUGGESTED,THERE
101,169,2011,8804,AUTHORS,BJU,GLEASON,LABEL,METHODS,OBJECTIVE,PSA,RESULTS,THERE
003,169,174,1999,2004,2011,226,8805,APRIL,AUTHORS,BJU,BXT,C30,CONCLUSION,INDEX,IPSS,LABEL,LDR,MARCH,METHODS,OBJECTIVE,PR25,QLQ,QOL,RESULTS,SCORE,SYMPTOM,THERE,TREATMENT,URINARY
169,2006,2012,391,BACKGROUND,BANKS,BLOOD,BOTH,CFS,CHINA,CHINESE,CONCLUSION,HOWEVER,LABEL,LNCAP,METHODS,PCR,RESULTS,SUBSEQUENT,XENOTROPIC,XMRV
1123,169,1998,2007,201,2011,204,232,405,899,ACP,AUTHORS,BJU,BPH,COMPARING,JUNE,LABEL,MANN,METHODS,OBJECTIVE,PROSTATIC,PSA,RESULTS,SEPTEMBER,STUDENT,TYGERBERG,UTI,WHITNEY
169,2011,8226,AUTHORS,BJU,BPH,CONCLUSION,EXPRESSION,FULL,GLEASON,INCREASED,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,T21,TAKEN,TMA
001,169,170,2011,220,276,678,692,AUTHORS,BASED,BJU,EACH,IIEF,INDEX,KETTERING,LABEL,METHODS,MSKCC,OBJECTIVE,RESULTS,SLOAN
001,152,169,184,198,2005,2007,2011,224,273,301,408,708,8194,8226,8804,AGE,AUTHORS,BETWEEN,BJU,BNS,JANUARY,JUNE,LABEL,MEN,METHODS,OBJECTIVE,POTENCY,RALP,RESULTS
120,169,2011,8194,8226,AUTHORS,AVERAGE,BJU,GLEASON,LABEL,METHODS,OBJECTIVE,RESULTS
169,2011,227,8194,8226,AUTHORS,BJU,CONCLUSION,GLEASON,LABEL,LOW,METHODS,OBJECTIVE,PRIMARY,PSA,RESULTS,RRP,TOTAL
001,169,185,199,1994,2008,2011,310,4090,8194,8226,ADT,AFTER,AUTHORS,BETWEEN,BJU,EXCLUSION,GLEASON,LABEL,METHODS,OBJECTIVE,RESULTS,SVI,THEREFORE
100,160,MOST,REMARKABLY
169,2011,BLACKWELL,FOUNDATION,HOWEVER,ILLNESS,LTD,PSA,PUBLISHING,SOCIOLOGY
169,2011,BLACKWELL,BRITISH,EACH,LTD,MOST,PUBLISHING,THOSE
2005,2010,247,AIM,GLEASON,INDICATION,JULY,LABEL,METHODS,NCCN,OBJECTIVE,PGU,PPB,PRIMARY,RESULTS,SIX
107,160,323,395,592,697,862,892,AMICO,BCR,IOCS,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE,WHILE
1244,2001,2011,ALTERED,BACKGROUND,DEGRADO,FCH,GLEASON,JANUARY,LABEL,METHODS,PCA,PET,POTENTIAL,PSA,RESULTS,STUDIES
EVEN,HOWEVER,LRP,PART,RARP,ROBOT,TURP
RADIATION,WHILE
100,169,2009,2011,AIMS,APRIL,BACKGROUND,BLACKWELL,DATA,FINNISH,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,OCTOBER,PERSONS,PUBLISHING,RELEVANCE,RESPONSES,RESULTS,SUPPORT
100,177,2002,2007,582,CONCLUSION,DATA,DEPARTMENT,FIVE,GLEASON,LABEL,LRP,MEAN,METHODS,OBJECTIVE,OSLO,PFS,PSA,PSM,RESULTS,THESE,UNIVERSITY,UROLOGY
603,BECAUSE,DU145,FOXO,FOXO3,K242,K259,K290,K569,PC3,PROTEASOME,SCF,SIRT1,SIRT2,SIRTUIN,SKP2,TAKEN
169,2012,AMONG,COPYRIGHT,FURTHER,INC,OCCURRENCE
169,2011,BACKGROUND,CHIP,CHROMATIN,CONCLUSION,COPYRIGHT,E2F,E2F3,E2F3A,ERK1,EXPRESSION,INC,LABEL,METHODS,PCR,RESULTS,THESE,WESTERN,WILEY
169,2011,8201,BACKGROUND,BASED,COPYRIGHT,III,INC,LABEL,METHODS,PHASE,RESULTS,SINCE,WILEY
169,172,2011,251,602,AREA,ASIAN,AUC,BACKGROUND,CALCULATOR,COPYRIGHT,DATA,DUTCH,ERSPC,INC,KPCRC,LABEL,METHODS,PCA,PRC,PSA,RANDOMIZED,RESULTS,RISK,SCREENING,WILEY
169,2011,8201,COPYRIGHT,HEPG2,I3C,INC,NAD,NQO,NRF2,TRAMP,TREATMENTS,WESTERN,WILEY
169,1990,2003,2011,AFTER,AUTOMATED,BACKGROUND,COPYRIGHT,DEFENSE,DEPARTMENT,DOD,LABEL,METHODS,RESULTS,SOCIETY
147,169,1995,1998,2003,2011,4285,8201,COPYRIGHT,COX,DEPRESSION,END,JOHN,LABEL,LTD,METHODS,NINTH,OBJECTIVE,POISSON,RESULTS,SONS,THESE,WILEY
000,004,160,167,169,177,2007,2010,235,270,437,449,557,AGE,AIM,BACKGROUND,BMI,DRE,INDICATION,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,PCA,PSA,RESULTS,SEPTEMBER,SERUM,SHBG
160,COMPOUNDS,CRPC,CURRENT,CURRENTLY,LABEL,LBD,METHODS,NTD,OBJECTIVE,OBJECTIVES,RESULTS,SMALL,THESE
8805,APC,GLEASON,GSTP1,HOWEVER,III,LINE,MEDICAL,PCA,THESE,UNIVERSITY
004,016,169,1989,2005,2013,309,321,630,8805,BACKGROUND,COPYRIGHT,COX,HEAVY,INC,LABEL,METHODS,PATHOLOGIC,PSA,RESULTS,SMOKING,THERE,UNIVARIATE
500,ADENOVIRAL,ALSO,E1A,FOUR,LNCAP,MTS,OFF,PPT,PRIMARY,THUS
003,134,169,171,2004,2009,2011,560,COPYRIGHT,MEN,STRATEGIC,THEREFORE,UICC
000,001,030,169,183,2004,2005,2011,BACKGROUND,COPYRIGHT,END,IMAGING,LABEL,METHODS,RESULTS,SOCIETY
001,009,102,126,292,457,502,738,8805,916,COX,LABEL,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS,UNIVARIATE
231,954,A431,CAPC,CONVERSELY,CSF,CSF2,CST1,CXCL1,ECM,IL8,KNOCKDOWN,LNCAP,LTB1,MDA,PRSS3
18S,28S,45S,BISULFITE,CPG,CPGS,FURTHER,HOWEVER,MYC
AMONG,BACKGROUND,CONCLUSION,FORTY,LABEL,METHODS,PSA,RESULTS,RP2D
542,AFTER,HYPOTHESES,INCREASING,LABEL,MEN,METHODS,OBJECTIVE,OVERALL,RESULTS,STRATEGIES
10MIN,169,194,2012,2CC,945,946,BACKGROUND,CONCLUSION,COPYRIGHT,GRADE,GYE,INC,LABEL,LQ2,MATERIALS,METHODS,PUBLISHED,RESULTS,SOCIETY
169,2012,COPYRIGHT,INC,MRI
001,014,160,169,177,2012,50MG,5MG,AFTER,COPYRIGHT,GLEASON,GREATER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PPB,PPBS,PUBLISHED,PURPOSE,RESULTS,SOCIETY,TTMB,UNIVARIATE
001,169,2007,2012,8804,COPYRIGHT,GLEASON,INC,STUDIES,TOTAL
104,169,1997,1998,2009,2012,343,815,967,985,AFTER,COPYRIGHT,COX,INC,INSURANCE,STUDIES,TAIWANESE,THERE,WESTERN
169,2011,COPYRIGHT,IRELAND,LTD,PUBLISHED,REGULATION
0001,012,177,183,1995,2007,250,393,567,641,681,778,842,8804,899,BACKGROUND,BCR,CONCLUSION,GLEASON,LABEL,MEAN,METHODS,PSA,PTV,RESULTS,SERUM
006,032,150,169,2013,224,239,300,8805,ATN,COPYRIGHT,ENDPOINTS,HOWEVER,INC,LABEL,LOW,METHODS,OBJECTIVE,PRE,PSA,PSADT,RESULTS,SERUM,SOD1
169,2013,567,AVERAGE,CAP,COPYRIGHT,FIFTY,GLEASON,IMMEDIATE,INC,LABEL,MEAN,METHODS,NINE,NOTABLY,OBJECTIVE,PSA,PSAD,PUBLISHED,RESULTS,TRUS
001,002,039,150,169,185,2011,528,8194,8226,8804,8805,905,AUTHORS,BJU,BMI,DATA,GLEASON,HIGH,LABEL,METHODS,OBJECTIVE,PEARSON,PSA,RESULTS,USING
169,2011,BLACKWELL,FOUNDATION,ILLNESS,INCIDENCE,LTD,PSA,PUBLISHING,SOCIOLOGY
016,250,AMONG,ASIAN,INDIANS,INITIATIVE,SATHI,SOUTH,TOTAL
169,2011,786,8201,A375,A549,COPYRIGHT,LUC,MANAGEMENT,MB231,MDA,PC3,RCC,SOCIETY,THESE
169,2011,239,ADT,ANG,BACKGROUND,COPYRIGHT,ELISA,INC,LABEL,METHODS,MVD,RESULTS,STILL,THREE,VEGF,WILEY
169,2011,BACKGROUND,CONCLUSION,COPYRIGHT,DU145,H6D,IGF,INC,LABEL,METHODS,MICE,NAG,NON,RESULTS,SERUM,WILEY
104,150,169,2011,254,8201,ADT,BACKGROUND,CHANGES,COPYRIGHT,EBRT,ESTIMATING,GEE,INC,LABEL,METHODS,PBS,PCI,RALP,RESULTS,UCLA,WILEY
169,2011,AMONG,BACKGROUND,COPYRIGHT,DUNNING,GST,INC,LABEL,LNCAP,METHODS,PC3,PCR,PIN1,PRO,RESULTS,SER,TFG,THESE,THR,TOF,TRK,WILEY
169,2011,8764,BCA,CHIP,CHROMATIN,COPYRIGHT,DHT,FASN,FKBP5,HOWEVER,INC,INDUCED,PCA,PIP,PROLACTIN,PROTEIN,PSA,RUNX2,SGK1,T47D,USING,WILEY
319,401,481,542,576,735,FEW,FIFTY,FORTY,IPSS,MEN,NINE,PCA,SEVENTY
1990,2008,2895,749,BACKGROUND,COX,GLEASON,LABEL,MEIER,METHODS,PSM,RESULTS,RRP,THESE
001,174,177,8805,ADT,ASSESSMENT,BOARD,CONCLUSION,DATA,DEXA,DUAL,FOUNDATION,FRAX,LABEL,LHRH,METHODS,NETWORK,OBJECTIVE,PURPOSE,RESULTS,RISK,THERE,TOOL,WORLD
8322,DHPEA,HL60,LABEL,LNCAP,MCF,MDA,METHODS,MTT,OBJECTIVE,PC3,PURPOSE,RESULTS,SEVERAL,SW480
356,671,ASPN,CAF,CAFS,CAV1,CFH,COMPARISON,CTSK,DCN,EMT,FBLN1,FHL1,MESENCHYME,NKTR,NPFS,OGN,PARVA,SPARC,STC1,TAG,ZEB1
0001,169,2013,8805,COPYRIGHT,COX,GLEASON,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,UNIVARIATE
169,19TH,2013,500,8805,COPYRIGHT,CRPC,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PSA,RESULTS
169,2012,22RV1,BPH,CONCLUSION,COPYRIGHT,DU145,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,PCR,RESULTS,ZIP4
0004,100,136,150,169,175,200,2001,2009,2013,202,8805,ACTUARIAL,AMICO,APRIL,BETWEEN,CAP,COPYRIGHT,EBL,FUNCTIONAL,GLEASON,HIGH,INC,IPSS,IQR,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PSA,RARP,RESULTS,ROBOTIC,SHIM,THERE
169,2013,BACKGROUND,CASES,COPYRIGHT,ERG,INC,LABEL,METHODS,OBJECTIVE,PCR,PITX2,PSA,RESULTS
0001,001,002,103,169,2013,ADT,ANXIETY,ASSESSMENT,BODY,COPYRIGHT,DEPRESSION,FUNCTIONAL,GLEASON,GROUP,IMAGE,INC,INDEX,LABEL,LEGS,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PITTSBURGH,QUALITY,RESULTS,SCALE,SLEEP,THERAPY
169,2013,916,936,954,BIOCHANIN,COPYRIGHT,DR5,DU145,INC,INDUCTION,LNCAP,SOLUBLE,THEN,TRAIL
003,008,169,2001,2010,2011,230,8804,8805,950,BACKGROUND,BMI,COPYRIGHT,GLEASON,JANUARY,LABEL,MEAN,METHODS,OBESE,OBJECTIVE,PSA,PUBLISHED,RESULTS,SETTING,T1C,UROLOGY
169,2011,2MIN,COPYRIGHT,PEG,PLNP,PLNPS,RAK
169,2011,BASAL,COPYRIGHT,CSC,CSCS,IRELAND,LTD
169,2012,CHANGES,COPYRIGHT,EXPRESSION,GLEASON,INC,LOSS,PERCENTAGE
169,2011,ANXIETY,AUSTRALIAN,CARE,COMPOSITE,CONSISTENT,COPYRIGHT,DEPRESSION,FOUR,INDEX,JOHN,LABEL,LTD,METHODS,NEEDS,OBJECTIVE,RESULTS,SCALE,SCNS,SF34,SNCS,SONS,SUPPORTIVE,THREE,WILEY
1016,105,123,169,2011,BACKGROUND,COPYRIGHT,COX,DISCHARGE,EARLIER,HRS,LABEL,METHODS,RESULTS,SOCIETY,SWEDISH,T2DM,THERE,TNM
145,DU145,HOWEVER,LNCAP,NEITHER,ODC,THESE
004,160,955,AFRICAN,AFTER,AMERICANS,CRC,INSTEAD,NORTH,OBESE,PSA
169,183,2011,ACUTE,BLACKWELL,DECREASED,FASTING,FOLLOWING,GROUP,LABEL,LTD,METHODS,OBJECTIVE,PLACEBO,PUBLISHING,RESULTS
169,1C1,2011,8201,BACKGROUND,COPYRIGHT,FURTHER,INC,LABEL,LAPC,LNCAP,METHODS,NAD,NRF2,RESULTS,ROS,SINCE,THEREFORE,WILEY
169,2011,ALB,BACKGROUND,COPYRIGHT,CYGB,CYTOGLOBIN,INC,IPCEF,LABEL,LEDGF,LENS,METHODS,PCA,PIP3,PRDX6,PRDXS,RESULTS,SOD3,TPO,VALIDATION,WILEY
108,169,2011,215,525,604,617,631,8201,AUC,AUCS,BACKGROUND,CHINESE,CONCLUSION,COPYRIGHT,GWAS,HOWEVER,INC,LABEL,METHODS,ORS,PCA,RESULTS,ROC,SNPS,WILEY
169,2011,ALSO,COPYRIGHT,ETS,INC,MOST,PDEF,WILEY
169,2011,945,946,947,BACKGROUND,CD4,COPYRIGHT,DENDRITIC,DPI,HOWEVER,IFN,INC,LABEL,LNCAP,METHODS,NADPH,RESULTS,SOD,TH1,TH17,TNF,WILEY
138,145,169,2011,BACKGROUND,BLOT,CETRORELIX,COPYRIGHT,GHRH,INC,LABEL,LHRH,MDA,METHODS,NUDE,PCA,RESULTS,WESTERN,WILEY
0001,0003,0011,0032,0385,1990,1992,2005,2009,448,AMONG,BACKGROUND,BOTH,CONCLUSION,DATA,LABEL,METASTASES,METHODS,NBG,NEITHER,OBJECTIVE,PREDICTIVE,RESULTS,SUMMARY,T12,T15,THERE,TOKUHASHI,UNIVERSITY
169,2012,2N0M0,370,869,CES,COPYRIGHT,DEPRESSION,DEPRESSIVE,EBRT,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PRCA,PSA,PURPOSE,QOL,RESULTS,SAQ,SCALE,STUDIES,UROLOGICAL
169,2013,945,BFA,COPYRIGHT,DHT,EFFECTS,INC,LABEL,LNCAP,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PSA,RESULTS,THEREFORE,UNDER
001,143,159,169,2013,352,477,8804,AFTER,BILATERAL,COPYRIGHT,GLEASON,INC,LABEL,METHODS,OBJECTIVE,PSA,RALP,RESULTS,SEVENTEEN,T2A
008,021,105,169,2001,2009,2013,494,599,BETWEEN,CONCLUSION,COPYRIGHT,FIFTY,INC,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PERINEURAL,PNI,PSA,RESULTS,STAGE
169,2013,CELL,COPYRIGHT,EGF,INC,LABEL,MATERIALS,MDR1,METHODS,OBJECTIVE,PC3,PC3R,PC3WT,RESULTS,VEGF,VEGFR
169,2013,8805,ADDITIONAL,COPYRIGHT,CRPC,DES,DVTS,INC,LABEL,LOW,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PSA,RESULTS,SECONDARY,TTP
169,2011,945,INC,THESE,WILEY
169,1989,2011,AMONG,COPYRIGHT,HODGKIN,INCIDENCE,OPTIMAL,STATISTICS,UICC
169,2003,2007,2011,3018,75TH,8228,853,BACKGROUND,COPYRIGHT,HEALTHCARE,LABEL,LOS,METHODS,PSIS,QUALITY,REPORTING,RESULTS,SOCIETY,STATE,WASHINGTON
ENGLISH,PSA
ACCORDING,CANINES,THERE
H2A,HISTONE,NOTABLY,TSS,TSSS,USING
016,115,169,2011,893,987,BACKGROUND,BCC,COPYRIGHT,LABEL,LTD,METHODS,ORS,RESULTS,SWEDISH
169,2011,946,COPYRIGHT,IRELAND,LTD,TGF,THERE
003,023,050,055,239,8201,BASED,BOTH,COX,GLEASON,HIGH,HOWEVER,PCA,PSA,SEVERAL,TTBF
239,400,8201,8805,CRPC,GRADE,LABEL,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS,SORAFENIB,STRATEGIES
169,1973,1999,2013,289,ADDITIONAL,COMPARISON,COPYRIGHT,END,INC,INSTITUTE,LABEL,LOWER,MATERIALS,METHODS,OBJECTIVE,OLDER,RESULTS,SEER,SIR,WHITE
006,169,2013,500,ACTIVATION,ADDITIONAL,CONCLUSION,COPYRIGHT,EGFR,FORTY,INC,KRAS,LABEL,LAPATINIB,METHODS,OBJECTIVE,OUTCOME,PFS,PRIMARY,PSA,PSADT,PURPOSE,Q787Q,RESULTS
100,121,169,194,2012,AFTER,AMONG,CONCLUSION,COPYRIGHT,GRADE,HDRB,III,INC,LABEL,LATE,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE
169,2013,CAP,CONCLUSION,COPYRIGHT,IIB,IMAGE,INC,ITALIAN,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS
169,2011,COPYRIGHT,IRELAND,LTD,SINCE
137,143,169,193,2007,2010,2013,205,257,8805,APRIL,COPYRIGHT,INC,LABEL,MARCH,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,ONCOLOGIC,PSA,RESULTS
169,2011,COPYRIGHT,IRELAND,LTD,PUBLISHED
169,2011,956,BTG2,COPYRIGHT,ETS,HIGH,IMMUNOBLOT,LNCAP,NDRG1,PDEF,PSA,RESULTS,THESE,TRANSIENT,UICC
001,019,020,021,2002,2010,563,579,640,717,773,828,8804,883,AUC,BONE,GLEASON,HOWEVER,LABEL,METHODS,OBJECTIVE,PCA,PSA,PURPOSE,RESULTS
1500,BACKGROUND,BASED,CONCLUSION,DOSE,FIFTY,LABEL,METHODS,PATIENT,PTEN,RESULTS
001,1275,169,2011,327,8226,AUTHORS,BJU,BMI,BODY,CONCLUSION,GLEASON,LABEL,MEAN,METHODS,OBJECTIVE,RESULTS,TVS
0003,001,101,169,2013,555,599,687,728,791,819,857,895,954,999,AUC,CAP,CONCLUSION,COPYRIGHT,DRE,GLEASON,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,OVERALL,PSA,RESULTS
169,2006,2013,902,ATTITUDES,CLEAR,COPYRIGHT,DETECTION,EARLY,HOWEVER,INC,INSTITUTE,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRIMARY,PROVIDERS,RESULTS,SCREENING
169,2013,ADDITIONAL,COPYRIGHT,GLEASON,INC,MEDLINE,PSA,SURGERY,WHILE
BCL,DOCETAXEL,DU145,FIRSTLY,HDAC,HDACI,HRPC,LNCAP,MCL,NAPHTHALEN,NEXT,PC3,THESE
100,169,2011,8226,AUTHORS,BJU,CELLS,CONCLUSION,DU145,LABEL,LNCAP,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THESE
169,2004,2009,2011,2219,4206,5429,8032,AUTHORS,BAUS,BJU,BRITISH,COMPLEX,GLEASON,HIGH,IMPROVING,JANUARY,LABEL,MATERIALS,MEAN,METHODS,OBJECTIVE,OPEN,OPERATIONS,PATIENT,PSA,PSM,RESULTS,SECTION,SEPTEMBER,TNM,UROLOGICAL
001,002,004,005,038,169,2006,2010,2011,381,774,AFRICAN,BACKGROUND,BETWEEN,BIOMARKER,BMI,CAUCASIAN,COPYRIGHT,EACH,EVALUATION,FREQUENCY,INDIANA,LABEL,METHODS,PSA,RESULTS,RISK,SNPS,SOCIETY,THESE,UNIVERSITY
102,BESIDES,BOTH,CURRENT,PCA,PCR,RNAS,WESTERN
CRPC,ECTOPIC,GEF,INCREASED,RHO,THESE,VAV3
0074,015,027,030,036,05CC,100,1006,100CC,150,150CC,169,1998,2003,2012,50CC,8805,ACUTE,COPYRIGHT,COX,CROWN,GROUP,INC,INCREASED,LABEL,LATE,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,RADIATION,RESULTS,RTOG,THERAPY,UNIVARIATE
007,011,033,035,041,116,169,177,194,1988,2002,2012,226,8805,ADT,CONCLUSION,COPYRIGHT,COX,DOSE,FINE,GLEASON,GRAY,HOWEVER,INC,LABEL,MATERIALS,MEN,METHODS,OBJECTIVE,PCA,PURPOSE,RADIATION,RESULTS,THERE
2000,2010,ADDITIONAL,CLA,DHA,EPA
169,2011,AMONG,BACKGROUND,CONCLUSION,COPYRIGHT,FOUR,III,IIIA,IIIB,INC,LABEL,METHODS,NIH,PCA,PCA3,PSA,RESULTS,WHETHER,WILEY
BACKGROUND,BETWEEN,LABEL,METHODS,MOOD,OBJECTIVE,OBJECTIVES,RESULTS,SEXUALITY,THERE
158,169,2011,8226,AMONG,ASHKENAZI,AUTHORS,BJU,BRCA,BRCA1,BRCA2,CONCLUSION,INITIAL,LABEL,METHODS,OBJECTIVE,OVERALL,RESULTS
001,HOWEVER,LASS2,PCR,THUS
011,035,053,169,2011,AFRICAN,ASSESSMENT,BACKGROUND,CHASE,COPYRIGHT,CRC,DESPITE,FOX,LABEL,METHODS,PREDICTORS,PROGRAM,RESULTS,RISK,SCREENING,SOCIETY
001,010,157,169,1816,1998,2006,2011,259,2919,312,493,536,648,655,696,744,774,955,BACKGROUND,CASES,COPYRIGHT,FAILURE,HARRELL,INCLUSION,INSTITUTE,LABEL,MEDICAL,METHODS,PSA,RESULTS,SEATTLE,SOCIETY,UNIVERSITY,UTRECHT
001,169,2011,8804,893,AREA,AUC,BACKGROUND,BERGH,COPYRIGHT,DATA,GLEASON,LABEL,METHODS,PCA,RESULTS,SOCIETY,THEN
0005,001,009,169,2011,8201,BACKGROUND,CD74,COPYRIGHT,EGF,EGFR,ERBB3,GLEASON,HRG,INC,KI67,LABEL,METHODS,MIF,PNI,RESULTS,THESE,TISSUES,TMA,WILEY
169,2011,945,946,957,BACKGROUND,COPYRIGHT,HOWEVER,INC,LABEL,LNCAP,MESSENGER,METHODS,NTRS1,NTSR1,PSCA,PSMA,RESULTS,WILEY
169,2011,BACKGROUND,CHANGES,COPYRIGHT,DISEASE,ESTIMATES,INC,LABEL,METHODS,REGRESSION,RESULTS,THESE,TREATMENT,WILEY
15Q11,169,17Q21,2011,22Q12,233,4Q13,5Q12,6000,762,8201,8805,8Q24,BACKGROUND,CONSORTIUM,COPYRIGHT,HLOD,ICPCG,INC,LABEL,LOD,METHODS,MYC,RESULTS,SNP,THESE,WILEY
169,2011,223,700,ADDITIONAL,BACKGROUND,COPYRIGHT,CRPC,DRUG,FOOD,III,INC,LABEL,MDV3100,METHODS,MOST,RANK,RESULTS,SRC,TAK,VARIOUS,WILEY
INHIBITORY,LNCAP,MMP,QUINOLINES
001,002,037,8804,916,BACKGROUND,III,LABEL,METHODS,NHS,PRIVATE,RESULTS,SERVICE
155,APPROACHES,FOXP3,SATB1,UTR
EVEN
169,2011,AEU,COPYRIGHT,HOWEVER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS
000,018,153,169,199,2013,300,309,844,886,AUSTRALIA,AUSTRALIAN,CONSORTIUM,COPYRIGHT,DATA,GENOTYPING,INC,KALLIKREIN,KINGDOM,KLK12,KLK13,KLK5,KLK6,PRACTICAL,SNP,SNPS
AMONG,FDA,HSV,HSVS,SIPULEUCEL
169,2011,BACKGROUND,BPH,CHRONIC,COPYRIGHT,INC,LABEL,METHODS,MPO,RESULTS,SEVERAL,TURP,WILEY
169,2011,530,BACKGROUND,COPYRIGHT,GLEASON,GRPR,INC,LABEL,METHODS,MEYER,PSA,RESULTS,THESE,WILEY
151,312,7TH,9TH,BACKGROUND,CONCLUSION,FURTHER,GLEASON,LABEL,MATERIALS,METHODS,NOTES,OVERALL,POTENTIAL,PSA,RESULTS
100,125,160,169,2012,2MM,5CM,5MM,8764,CARLO,COPYRIGHT,DOSXYZNRC,EBT,FILM,INC,INCREASING,KODAK,LABEL,MATERIALS,METHODS,MONTE,OBJECTIVE,OTHER,PUBLISHED,PURPOSE,RESULTS,SIMILAR,SOCIETY,XV2
145,169,2011,CLU,COPYRIGHT,INC,INFECTION,MDA,SIMILARLY,WILEY
0625,169,2011,300,480,956,COPYRIGHT,ETS,LNCAP,MTD,PIM,REMARKABLY,UICC
169,2011,263,301,319,637,647,814,8804,8805,942,AUC,BACKGROUND,CAPITANIO,CHUN,COPYRIGHT,DCA,GLEASON,LABEL,LRPC,METHODS,PREDICTIVE,RESULTS,ROC,SEVERAL,SOCIETY
967,ELISA,FATTY,III,INCREASED,KRUSKAL,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SERUM,THERE
007,100,145,169,1998,2008,2012,25CC,341,6NG,8CC,9GY,ABOUT,BCF,BECAUSE,COPYRIGHT,COX,GLEASON,INC,LABEL,MEIER,METHODS,NETWORK,OBJECTIVE,PHOENIX,PUBLISHED,PURPOSE,REAL,RESULTS,SOCIETY,T1C,USING
160,183,8201,ALCOHOL,AMONG,BACKGROUND,LABEL,LUNG,METHODS,MOST,NSCLC,OPTIMAL,REGARDING,RESULTS,STAGE,SURVIVORS
169,2012,COPYRIGHT,INC
8804,8805,ASSAY,BASED,DRE,LABEL,METHODS,OBJECTIVE,PCA,PCA3,PSA,PURPOSE,RAND,RESULTS,SCORE,T1C,THESE,UCLA,USING
210,520,BPH,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,URINARY,UROLOGICAL,UTI
570,BACKGROUND,CONGRUENT,COX,DFS,FINE,GLEASON,GRAY,LABEL,MEIER,METHODS,PSA,RACE,RESULTS,RTOG,SCORE,SURVIVORS,USA,WHITE
001,002,021,026,035,050,169,2013,404,8804,BCR,COPYRIGHT,GLEASON,INC,JYR,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PERCENT,PSA,PTV,RECURRENCE,RESULTS
166,169,184,2012,COPYRIGHT,EERPE,EORTC,INC,LABEL,METHODS,OBJECTIVE,PR25,QLQ,RESULTS,RRPE,THREE,URINARY
169,2013,500,8805,AGE,CONCLUSION,COPYRIGHT,HOWEVER,ICS,IIEF,INC,LABEL,MATERIALS,MEN,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,PREDICTIVE,PSA,RALRP,RESULTS
021,114,169,177,2002,2006,2007,2008,2011,BACKGROUND,BECAUSE,COPYRIGHT,DESPITE,LABEL,METHODS,OVERALL,RESULTS,ROBOTIC,SOCIETY,WISCONSIN
101,166,169,2011,205,220,327,332,BACKGROUND,COPYRIGHT,LABEL,MEN,METHODS,OBJECTIVE,PSA,PUBLISHED,RESULTS,SETTING,SIX,TAX,UROLOGY
003,169,2011,8201,920,945,AMACR,BACKGROUND,COA,COPYRIGHT,COX,GLEASON,INC,LABEL,LOW,METHODS,METHYLACYL,PHYSICIANS,RESULTS,WILEY
177,CONCLUSION,CRAWLEY,FITCHBURG,HOWEVER,IMRT,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PHILIPS,RESULTING,RESULTS,VMAT,VOLUMETRIC
112,213,229,269,CANCERS,CONCLUSION,DOPPLER,GLEASON,HOWEVER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PDS,PSA,RESULTS,TRUS
006,028,147,169,175,2002,2007,2011,289,354,8194,8226,880,945,AUTHORS,BJU,ECE,LABEL,METHODS,NSS,OBJECTIVE,OVERALL,PSA,PSM,PSMS,RESULTS,RISK,THERE
107,132,2001,2008,464,673,C30,COX,EORTC,III,JANUARY,LABEL,MEAN,METHODS,OBJECTIVE,PATIENT,PURPOSE,QLQ,QOL,RESULTS,THESE,UNIVARIATE,WHILE
0001,012,019,075,160,169,194,1991,2006,2012,378,594,ACM,ADT,AHR,AMONG,CHF,COPYRIGHT,COX,III,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PHASE,PURPOSE,RESULTS,T3AN0M0
039,177,943,DICE,DSC,ERROR,HAUSDORFF,IMAGING,LABEL,LOW,METHODS,MRI,NMI,NORMALIZED,OBJECTIVE,PURPOSE,RESONANCE,RESULTS,SIMILARITY,STUDENT,TRE,TRUS,ULTRASOUND
2005,303,750,8805,CURRENT,GLEASON,JAN,LABEL,LOW,MATERIALS,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS,SEVEN
040,2006,2011,319,337,AMMAN,BACKGROUND,DATA,DUE,HUSSEIN,JUNE,KING,LABEL,MARCH,METHODS,RECORDS,RESULTS,THERE
007,036,560,ABCB1,AUC,CONCLUSION,CRPC,DEC,DOCETAXEL,LABEL,LDH,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SERUM,SNP,SNPS,TREATMENT
CLEC14A,FINALLY,FUNCTIONAL,TEM,TEMS
169,177,194,2011,687,786,ALSO,COPYRIGHT
001,004,169,2013,385,476,CHICAGO,COPYRIGHT,GLEASON,HGPIN,INC,LABEL,LGPIN,MATERIALS,MEIER,METHODS,NONE,OBJECTIVE,PCTS,RESULTS,SPSS
002,003,015,163,169,2011,594,757,8804,8805,BACKGROUND,COPYRIGHT,DATA,GLEASON,LABEL,METHODS,OBJECTIVE,PCA,PSA,PUBLISHED,RESULTS,SETTING,THESE,UROLOGY
169,2011,ANDROGENS,COPYRIGHT,HOWEVER,IRELAND,LTD
0147,0342,049,0615,125,169,1KG,2012,47KG,50NG,5NG,8804,8805,BMI,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PSA,PUBLISHED,PURPOSE,RESULTS,SOCIETY,THESE,UNIVARIATE
169,191,2011,209,3305,3424,8231,AUTHORS,BJU,CONCLUSION,GLEASON,LABEL,MEN,METHODS,NETWORK,OBJECTIVE,OBJECTIVES,PSA,REDUCTION,RESULTS,USING
001,003,011,014,038,2000,2009,232,405,8804,BFSR,DATA,LABEL,LRP,METHODS,NSM,OBJECTIVE,OVERALL,PSM,PURPOSE,RESULTS,THESE,THREE
160,18G,ALSO,CONCLUSION,DOF,FREEDOM,IMAGING,LABEL,METHODS,MRI,OBJECTIVE,PHANTOM,PURPOSE,RESONANCE,RESULTS,STD,THESE
177,8201,880,LNCAP,TATA,THESE
169,2000,2006,2011,BACKGROUND,COPYRIGHT,CROATIA,EASTERN,LABEL,LTD,METHODS,OUTCOME,RESULTS,SOUTH
169,2011,BETWEEN,COPYRIGHT,JOHN,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,SONS,THERE,WILEY
8805,ADT,GLEASON,HOWEVER,SCORE,T2C
001,002,006,8805,AFRICAN,DESPITE,GLEASON,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,REGARDLESS,RESULTS,SIMILAR,THREE,WHITE
169,2011,ARS,COPYRIGHT,IRELAND,LTD,REGARDLESS
114,129,169,1999,200,2010,2011,215,400,8201,8805,ADRENAL,BACKGROUND,COMPOUNDS,COPYRIGHT,CYP,DATA,FACTORS,GNRH,INC,LABEL,METHODS,PRIOR,PSA,PSADT,RESULTS,SIXTY,WILEY
169,2011,22RV1,8201,8764,945,ALA,ANNEXIN,ARG,BACKGROUND,COPYRIGHT,CPD,DAF2,FAR,INC,LABEL,LNCAP,MDA,METHODS,MTS,PCA,PRL,QPCR,REGULATION,RESULTS,WILEY
MYC,PTEN,USING
146,EACH,ESTIMATES,IDM,LABEL,METHODS,OBJECTIVE,PHYSICIANS,PURPOSE,RESULTS
100,169,194,2012,8804,8805,AFTER,CONCLUSION,COPYRIGHT,D90,EVEN,INC,LABEL,MATERIALS,METHODS,NEEDLES,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SOCIETY,V100,V115
153,169,186,189,1970,2009,2011,ACCORDING,BONE,COPYRIGHT,JADAD,KEY,LARGE,LTD,REPORTING,SCIENCE,SEPTEMBER,THERE,WEB
169,2011,22RV1,BACKGROUND,COPYRIGHT,ERK,FINALLY,GPCR,INC,INCREMENTS,LABEL,LNCAP,METHODS,RESULTS,RUNX2,RWPE,THESE,TRAMP,WILEY
169,2011,945,BACKGROUND,CAP,COPYRIGHT,CRPC,EXPRESSION,GDI,HOWEVER,IL6,INC,LABEL,LNCAP,MALDI,METHODS,PMF,RESULTS,THESE,TREATMENT,WILEY
169,177,2011,215,336,8201,8804,AAS,AFRICAN,AMERICANS,ANC,BACKGROUND,BEN,CBC,COPYRIGHT,COX,FURTHER,GLEASON,INC,LABEL,MEAN,MEIER,METHODS,PCA,RESULTS,SINCE,WILEY
169,2011,BACKGROUND,COPYRIGHT,EXPRESSION,INC,KATANIN,LABEL,METHODS,RESULTS,STRIKINGLY,WILEY
1530,169,2011,215,411,ANTIGEN,ASIAN,CAUCASIANS,CELL,COPYRIGHT,EPIC,HAPLOTYPE,MET1THR,NUTRITION,PSCA,SIX,SNP,STEM,THESE,UICC
1970,1988,1989,1993,2004,2008,AUSTRIA,HOWEVER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PCA,POISSON,PSA,RESULTS,TYROL
189,251A,251T,828,AFRICAN,ASIAN,RESULTS,THESE
CURRENT,EACH,HOWEVER
169,194,2011,COPYRIGHT,CTC,CTCS,CURRENTLY,DISSECTING,DTC,DTCS,GLEASON,HOWEVER,INITIALLY,IRELAND,LTD,PCA,PCR,PSA
1229,169,2011,268,471,525,913,AMONG,BRIEF,COPYRIGHT,GENERAL,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,RESULTS
160,169,194,197,2012,8805,COPYRIGHT,GRADE,INC,INCIDENCE,IPSS,LABEL,LATE,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCORE,SYMPTOM,THERE
008,2000,2010,237,372,609,APRIL,BACKGROUND,BCR,BETWEEN,CONCLUSION,DESPITE,GLEASON,INSIGCA,LABEL,MAY,METHODS,PSA,RESULTS,SIXTY,SVCA,UNIVERSITY
117,126,169,2003,2009,2011,BACKGROUND,CONCLUSION,COPYRIGHT,DEPARTMENT,DESPITE,DISCUSSION,GERMANY,LABEL,LTD,MAXILLO,METHODS,ONJ,ORAL,PUBLISHED,RESULTS,SURGERY,UNIVERSITY
124,169,2011,AUTHORS,INFECTION,INFECTIOUS,PCR,SOCIETY,THESE,USING,XMRV
ADIPOSE,ASC,CXCR4,EXPRESSION,MDA,MDA7,PC3,PEDF,RAS,THESE,TRAMP
169,2011,447,ANDROGENS,BACKGROUND,CGEMS,CHIP,COPYRIGHT,DESPITE,GWAS,HOPKINS,HOWEVER,INC,JOHNS,LABEL,MARKERS,PCA,PRINCIPAL,RESULTS,SNPS,THESE,WILEY
031,032,033,1104HIS,150,ARG309GLN,ASP,BPH,GLN,THERE,XPG,XRCC1
039,076,2631,2972,3372,3792,3835,4908,508,681,8805,AFTER,ASIA,CAG,DATA,EGGER,HOWEVER,META,TAKEN,THERE,USA
169,2003,2008,2013,309,8805,COMPARING,COPYRIGHT,ECE,ENDORECTAL,GLEASON,INC,LABEL,LAD,MATERIALS,METHODS,MRI,MRIS,OBJECTIVE,PSA,RESULTS,RRP,SVI
001,106,169,177,1996,2013,8804,8805,CASES,CGA,COPYRIGHT,CRPC,GLEASON,IAD,INC,LABEL,MEAN,METHODS,OBJECTIVE,PSA,RESULTS,SCORE
0001,006,160,169,194,1996,2008,2010,2012,585,8805,ADT,CLEVELAND,COMPARING,CONCLUSION,COPYRIGHT,DMFS,EBRT,FHR,GLEASON,INC,LABEL,MATERIALS,METHODS,NETWORK,OBJECTIVE,PCSM,PSA,PURPOSE,RESULTS,UHR
169,2011,739,902,905,AF2,COPYRIGHT,FUNCTIONAL,FXXLF,H874Y,HIGH,IRELAND,LBD,LTD,LXXLL,LYS,Q902A,Q902K,Q902R,STRUCTURAL,TYR
001,102,157,169,174,1982,2010,2013,394,515,552,779,8805,BACKGROUND,BFS,COPYRIGHT,CSS,GLEASON,HIGH,INC,LABEL,MATERIALS,MEIER,METHODS,PNI,PSA,RESULTS,THEIR
169,2011,COPYRIGHT,EXPRESSION,HIGH,IRELAND,LNCAP,LTD,MDA,PCA,RESULTS,SEVERAL,SOCS,STAT,STAT3
001,160,169,193,194,2006,2009,2012,274,678,8805,ADT,CONCLUSION,COPYRIGHT,DESPITE,DMIN,GLEASON,GRADE,IMRT,INC,JANUARY,LABEL,MATERIALS,MAXIMUM,METHODS,OBJECTIVE,PCA,PSA,PURPOSE,RESULTS,V20,V65
001,169,1995,2007,2012,289,658,670,840,893,901,ALONG,APRIL,CAUSE,COPYRIGHT,COX,CSS,EXCELLENT,GLEASON,INC,JUNE,LABEL,MATERIALS,METHODS,MFS,NETWORK,OBJECTIVE,PURPOSE,RESULTS,RISK,SUBGROUPS,THESE,XRT
003,006,011,012,013,016,039,048,169,2012,228,284,512,ANAL,AUC,COMPARABLE,COPYRIGHT,DUTCH,DVHS,HIGH,INC,INCLUDING,KUTCHER,LABEL,LKB,LYMAN,MATERIALS,METHODS,NTCP,OBJECTIVE,PURPOSE,RESULTS,SERIALITY
BALB,LABEL,LNCAP,METHODS,OBJECTIVE,PC3,PURPOSE,RESULTS
2010,6023,8794,983,ART,BACKGROUND,COST,GROUP,LABEL,METHODS,PRIMARY,PSA,RESULTS,SOUTHWEST,SWOG
169,2013,ADT,COPYRIGHT,CRPC,HSPC,IGF,INC,TARGETING,USING
001,002,009,169,2013,406,658,668,ACCORDING,AMONG,BCR,COPYRIGHT,ECE,GLEASON,HOWEVER,INC,LABEL,MEANWHILE,METHODS,NSM,NSMS,OBJECTIVE,PSM,PSMS,RESULTS
169,2011,AUTHORS,BACKGROUND,BRITISH,CAM,GST,HUVEC,JOURNAL,KEY,LABEL,MEK,METHODS,OBJECTIVE,PLUMBAGIN,PURPOSE,RAC,RAS,RESULTS,SOCIETY,VEGF,VEGFR,WESTERN
001,003,229,239,8804,8805,BACKGROUND,KARNOFSKY,KPS,LABEL,METHODS,MORTALITY,OBJECTIVE,PURPOSE,RESULTS,UME,UNIVERSITY
145,169,2011,33258,916,936,ADENOSINE,APOPTOSIS,BACKGROUND,BAX,BCL,BRDU,CDK4,CONCLUSION,COPYRIGHT,FGC10,HOECHST,INC,LABEL,LNCAP,METHODS,MMP,MRS1220,MTT,PC3,RESULTS,ROS,THESE,WILEY
169,2011,22RV1,BACKGROUND,CLDN,CLDN3,CLDN4,CONCLUSION,COPYRIGHT,CPE,CYTOTOXIC,DU145,INC,LABEL,METHODS,PC3,PREC,PRECS,REDUCED,RESULTS,THESE,WILEY
169,2011,22RV1,BACKGROUND,BCL,BCLXL,CAP,COPYRIGHT,DHT,ELISA,INC,LABEL,LNCAP,METHODS,NKX3,PARP,PCR,POTENTIAL,PSA,RESULTS,SEMI,THESE,WESTERN,WILEY,ZYF,ZYFLAMEND
169,2011,368,372,451,711,CHINA,CHINESE,CLEARLY,COPYRIGHT,EAST,FGFR4,HBV,HCC,HOWEVER,INC,PVTT,SNP,SNPS,WILEY
ARG,ARG462GLN,ASP,ASP541GLU,CAUCASIAN,CAUCASIANS,CIS,GLN,GLU,HOWEVER,ORS,OVERALL,PCA
001,601,ACM,ACTIVATED,ADT,AFTER,ARES,BACKGROUND,CONCLUSION,COX,FLT1,LABEL,MEIER,METHODS,PCSM,RESULTS,SKAP1,SNPS
100,1439,169,1999,2009,2011,967,ADDITIONAL,AIMS,ASSESSMENT,COLLEGE,CONCLUSION,COPYRIGHT,DESPITE,ESAS,FIFTY,HOWEVER,JANUARY,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OCTOBER,ORDINAL,PEARSON,PRIMARY,PROGRAM,PUBLISHED,RAPID,RESULTS,ROYAL,RRRP,SYMPTOM
100,169,2011,ADP,ARFGAP3,COPYRIGHT,DHT,FLAG,GOLGI,LNCAP,PSA,SMALL,THUS,UICC
AFTER,CAM,CD56,FIVE,FOLLOWING,TTF
1000,169,194,1970,1987,2012,BASIL,COPYRIGHT,HILARIS,INC,LABEL,LITERATURE,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SOCIETY,THEIR,UROLOGISTS,YORK
169,2013,3E6,CAP,CLONE,COPYRIGHT,DAKO,FOCAL,INC,LABEL,MATERIALS,METHODS,MOST,NONE,OBJECTIVE,PSMA,RESULTS
0001,125,169,2004,2009,2012,414,468,576,597,BCR,COPYRIGHT,COX,D90,GLEASON,INC,JANUARY,LABEL,MATERIALS,MEIER,METHODS,NCCN,NETWORK,OBJECTIVE,PHOENIX,PPB,PSA,PURPOSE,RESULTS,THEREFORE
0008,169,2006,2010,2012,BETWEEN,CONCLUSION,COPYRIGHT,FIRST,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS,THESE,USING
0102,169,194,2012,718,COPYRIGHT,DOSES,INC,LABEL,LINC,MATERIALS,METHODS,NOMOGRAMS,OBJECTIVE,PREDICTION,PURPOSE,RESULTS,THREE,V75GY
007,009,160,169,194,2012,CONCLUSION,COPYRIGHT,CTV,GROUP,INC,LABEL,MATERIALS,METHODS,MRL,OBJECTIVE,PSA,PURPOSE,RADIATION,RESULTS,RTOG,SEVENTY,TEN,THERAPY,THERE
0049,160,169,194,2012,945,COPYRIGHT,FORTY,FURTHER,INC,LABEL,LIF,MATERIALS,METHODS,MIP,OBJECTIVE,PURPOSE,REGARDING,RESULTS,TNF
0001,0006,003,105,125,169,177,194,2003,2006,2012,ARLINGTON,COPYRIGHT,D90,HEIGHTS,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PROSTATES,PURPOSE,RAPID,RESULTS,SEPTEMBER
003,078,169,177,2012,287,653,CENTRAL,COPYRIGHT,DAILY,DATA,HOWEVER,IGRT,IMAGE,INC,IPC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,USING
0001,001,002,240,8805,GLEASON,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PERSISTENT,PSA,RESULTS
233,244,984,AMONG,DIEU,FACTORS,FIVE,LABEL,METHODS,OBJECTIVE,OVERALL,RESULTS,THESE
169,2011,AGED,COPYRIGHT,IRELAND,LTD,SERTOLI,TESTICULAR
169,2011,COPYRIGHT,HOWEVER,IRELAND,LTD
002,112,150,169,2011,8201,ADT,COPYRIGHT,HOT,JOHN,LTD,QOL,SONS,TEN,THERE,TREATMENT,WILEY
169,2004,2011,2161,2176,ANDROGENIC,ANDROGENS,BACKGROUND,CELL,COPYRIGHT,E1A,FACS,HOWEVER,INC,LABEL,LNCAP,METHODS,PCA,RESULTS,SKP2,THESE,USING,WESTERN,WILEY
143,169,2011,BACKGROUND,BCR,COPYRIGHT,GLEASON,GPSM,HOWEVER,INC,LABEL,METHODS,NOMOGRAMS,PSA,PSADT,RESULTS,SEMINAL,SINCE,WILEY
001,016,106,109,169,177,2011,305,8201,BACKGROUND,COPYRIGHT,EARLY,ELISA,EPCA,HAZARDS,INC,LABEL,METHODS,PCA,RATIO,RESULTS,SERUM,WILEY
154,169,2011,266,ADDITIONAL,BACKGROUND,CONCLUSION,COPYRIGHT,ELISA,GLEASON,III,INC,LABEL,METHODS,PCA,PSAP,REGARDLESS,RESULTS,UNIVARIATE,WILEY
169,2011,8764,945,946,CAC,CN2,COPYRIGHT,FUNCTIONAL,NCC,PCR,UICC,VGSC
CRPC,ESSENTIAL,FIVE,SECONDARY
0001,126,8551,8805,8808,CAP,CONCLUSION,DRE,GROUP,HOWEVER,III,LABEL,MEAN,METHODS,MOST,OBJECTIVE,OBJECTIVES,PAIN,RESULTS,THREE,TRUS,TYPE,VAS
019,027,032,062,LABEL,MEN,METHODS,OBJECTIVE,PEER,PURPOSE,RESULTS
109,ASSOCIATED,PFE,RESULTS
169,2012,COPYRIGHT,HIGH,INC,LABEL,MEN,METHODS,OBJECTIVE,OBJECTIVES,OID,PATIENT,QOL,RESULTS,SYMPTOM,THESE
169,194,2012,ARC,CBCT,CONCLUSION,COPYRIGHT,IMRT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS,STOCKHOLM,WHEREAS,XIO
169,196,2012,215,216,BED,COPYRIGHT,EBRT,GRADE,HDR,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,UNIVARIATE
001,0141,0196,123,160,169,184,2004,2008,2011,945,ACADEMY,BACKGROUND,CONCLUSION,COPYRIGHT,DIFFERENT,INC,JORGE,LABEL,METHODS,MOSBY,MSH,NODULAR,NPY,OBJECTIVE,PUBLISHED,RESULTS,SAN,SPAIN
043,061,084,116,117,154,169,2013,209,284,300,308,360,374,730,732,761,762,824,953,969,COPYRIGHT,DESPITE,EBRT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PSA,RADICAL,RARP,RESULTS,RRP,WHILE
001,650,8805,ACM,ADT,COX,GLEASON,LABEL,MEIER,METHODS,OBJECTIVE,PCA,PCSM,PSA,RESULTS,SCORE
498,BACKGROUND,GLEASON,LABEL,METHODS,PSA,RESULTS,SEVEN
169,2010,ADVANTAGES,COPYRIGHT,DESPITE,IRELAND,LTD,PSA,TREATMENT
142,169,2003,2011,BACKGROUND,BONJ,CLINICIANS,CONCLUSION,COPYRIGHT,DESPITE,LABEL,LTD,MAXILLO,METHODS,PUBLISHED,RESULTS,SURGERY
KRAS
0001,001,169,2012,218,591,926,ANALYZABLE,APF,COPYRIGHT,DESPITE,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PREDICTED,PSA,PURPOSE,RESULTS,WEB
169,2011,COPYRIGHT,DESPITE,EGFR,ERBB,HER2,INC,LAPATINIB,NK1,NOW,SUBSTANCE,THESE,THUS,WILEY
001,169,2013,8805,AUC,COMBINING,COPYRIGHT,DRE,ERG,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PCA3,PCR,POST,PSA,RESULTS,SERUM,TMPRSS2
120,169,2013,2215,BRFS,COPYRIGHT,DD3,EXPRESSION,GLEASON,INC,LABEL,LNS,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PCR,PSA,PSCA,PSMA,RESULTS,UNIVARIATE
001,004,013,027,035,042,169,1CTP,2011,AUTHORS,BAP,BJU,CONCLUSION,LABEL,METHODS,OBJECTIVE,OVERALL,PSA,RESULTS,SERUM,SRE
000,2010,559,8364,ABSTRACTS,ASSESSMENT,DOWN,EFFECTS,EU27,EURONHEED,EVALUATION,FURTHER,LABEL,LITERATURE,MARCH,METHODS,NHS,OBJECTIVE,RESULTS,REVIEWS,STATE,TECHNOLOGY,UNIVERSITY,YORK
1997,2000,2002,2006,8764,BACKGROUND,END,EXCEPTIONS,FIVE,FURTHER,GERMANY,HODGKIN,LABEL,METHODS,RESULTS,UNTIL,USA
1067,2003,2009,2281,329,425,642,AAC,AFRICAN,ARAB,CBPP,CBPPS,COUNCIL,DATA,FOLLOWING,FURTHER,INSTITUTE,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SOCIETY
026,2003,2009,BACKGROUND,BMI,JUNE,LABEL,MEAN,METHODS,PSA,RESULTS
947,ANTISENSE,EMPLOYING,EXPRESSION,HLA,IFN,LNCAP,PAP,PCR,PSA,PSMA,THESE,WHILE
169,176,2012,356,BIOLOGICAL,COPYRIGHT,DIS,DVH,FIFTEEN,INC,LABEL,MATERIALS,METHODS,MONITOR,OBJECTIVE,PURPOSE,RESULTS,THREE,VMAT
1336,150,153,1669,169,171,1935,2006,2007,2012,340,348,353,357,369,375,6996,7317,BETWEEN,CONFORMAL,COPYRIGHT,FLORIDA,INC,INSTITUTE,LABEL,MATERIALS,METHODS,OBJECTIVE,OCTOBER,PR01,PR02,PURPOSE,RESULTS,THERAPY,THESE,THREE,UNIVERSITY
169,2011,BAX,BCL,BH3,CC2,CLU,CLUSTERIN,COPYRIGHT,INC,THESE,WILEY
169,183,1982,2004,2011,248,267,286,306,8201,BACKGROUND,COPYRIGHT,COX,GLEASON,INC,LABEL,METHODS,PHYSICIANS,RESULTS,SNPS,TLR4,TOLL,WILEY
001,032,047,100,169,2011,215,8201,BACKGROUND,CONCLUSION,COPYRIGHT,EXPRESSION,FES,GLEASON,HOWEVER,INC,IRS,KIMAP,LABEL,METHODS,PIN,PTK,RESULTS,WILEY
002,003,034,077,138,169,2011,8201,BACKGROUND,CONVERSELY,COPYRIGHT,FURTHER,HIGH,HOWEVER,INC,LABEL,LOW,METHODS,RESULTS,SERUM,SGK1,UNIVARIATE,WILEY
001,006,169,173,193,2013,500,8804,8805,ADT,AFTER,CAD,COPYRIGHT,IAD,III,INC,LABEL,LOW,MATERIALS,MEIER,METASTATIC,METHODS,OBJECTIVE,OBJECTIVES,PSA,QOL,RESULTS,THEREFORE,UNIVARIATE,WITHOUT
153,177,647,EDTMP,LABEL,MEAN,METHODS,OBJECTIVE,PSA,RESULTS,THUS
156,169,2011,BIOMEDICAL,COPYRIGHT,JOHN,LABEL,LTD,MEDICAL,METHODS,MIPS,OBJECTIVE,POST,PROCESS,RESULTS,SONS,WILEY
005,009,223,240,463,CHRONIC,GLEASON,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SNP,SNPS,TLR4,TLRS,TOLL,UTR
169,194,2011,CONCLUSION,COPYRIGHT,ENDOCRINE,EVENTUALLY,INITIALLY,LABEL,LTD,METHODS,OBJECTIVE,PURPOSE,RESULTS,YET
001,007,169,177,194,2012,COMPARING,COPYRIGHT,D90,DOSIMETRY,FACTORS,GIVEN,INC,INTER,LABEL,MATERIALS,METHODS,OBJECTIVE,PID,PURPOSE,RESULTS,V100
169,194,2003,2008,2012,ACUTE,ADVERSE,AMONG,BETWEEN,COMPOSITE,COPYRIGHT,CROWN,EPIC,FURTHER,GLEASON,GROUP,HDR,HIGH,INC,INDEX,LABEL,MATERIALS,METHODS,OBJECTIVE,PHASE,PSA,PUBLISHED,PURPOSE,RADIATION,RATES,RESULTS,T2B,T2C,THERAPY,THERE,THREE,TREATMENT
001,046,169,2012,441,630,ADT,COPYRIGHT,COX,GLEASON,INC,LABEL,LOW,MATERIALS,METHODS,OBJECTIVE,PFS,PSA,PURPOSE,RESULTS
000,169,2011,COPYRIGHT,CSC,CSCS,ISOLATION,UICC,WHILE
1009,1029,1069,1182,1345,1447,1666,1727,1799,1994,1997,2362,3341,442,5039,628,686,BACKGROUND,DIETARY,HODGKIN,LABEL,METHODS,NHL,ODDS,ORS,RESULTS
169,2011,AMONG,BECAUSE,COMPANY,COPYRIGHT,ENDOSCOPIC,EUS,FNA,INC,MESOTHELIN,PSCA,S100P,SIXTY,USING,WILEY
169,2011,8201,8805,BACKGROUND,COPYRIGHT,GLEASON,INC,LABEL,MATERIALS,METHODS,OVERALL,PCA,PSA,RESULTS,WILEY
169,2000,2007,2011,BACKGROUND,CONCLUSION,COPYRIGHT,END,INC,LABEL,METHODS,RAIRS,RESULTS,RISK,SEER,WILEY
030,169,2011,8201,8804,8805,997,AFRICAN,BACKGROUND,CAUCASIAN,CHINESE,COPYRIGHT,FOUR,INC,LABEL,METHODS,PSA,RESULTS,THESE,WILEY
169,2011,ALTERNARIA,AMP,AMPK,BACKGROUND,BCL,CELL,COPYRIGHT,INC,INHIBITION,LABEL,LC3I,LC3II,METHODS,MTT,PROTEIN,RESULTS,RWPE,THESE,WESTERN,WILEY
000,0003,10Q11,10Q26,11Q13,163,169,17Q12,17Q24,190,19Q13,2011,215,3P12,6Q25,713,754,7P15,7Q21,8201,8764,8804,8Q24,9Q33,BACKGROUND,BASED,CAUCASIAN,CGEMS,COPYRIGHT,INC,LABEL,MARKERS,METHODS,NOTABLY,PCA,PROJECT,RESULTS,SNPS,THESE,WILEY,XP11
169,181,2011,800CW,8201,BACKGROUND,CONCLUSION,COPYRIGHT,DOTA,DSRED,DUAL,FURTHER,INC,IRDYE,LABEL,LNS,METASTASIS,METHODS,NIR,PC3,PCA,PET,RESULTS,THESE,WILEY
169,2011,AMICO,ASO,BACKGROUND,CONCLUSION,COPYRIGHT,GLEASON,INC,LABEL,LNCAP,METHODS,PIN,RESULTS,THERE,TREATMENT,WHEREAS,WILEY
001,003,006,013,8804,ADT,AEROBIC,BODY,CHANGES,CONCLUSION,DXA,LABEL,METHODS,OBJECTIVE,PURPOSE,RESISTANCE,RESPONSES,RESULTS,THERE
0001,0003,0004,0010,0056,0078,0185,100,179,1999,2009,397,ASSESSMENT,BACKGROUND,CONCLUSION,ESAS,FATIGUE,JANUARY,KARNOFSKY,KPS,LABEL,MATERIALS,METHODS,OCTOBER,ORDINAL,PROGRAM,RAPID,RESULTS,SIMILAR,SINCE,SYMPTOM
169,177,194,2012,8805,961,BLADDER,COPYRIGHT,CTV,IMRT,INC,INCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS
160,169,2011,CHANGES,CONCLUSION,COPYRIGHT,KEY,LABEL,LTD,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS,TURKISH,WEB
0001,023,177,CONCLUSION,FIFTY,GROUP,LABEL,MANN,METHODS,NONE,OBJECTIVE,PATIENT,PSA,RARP,RESULTS,THEREFORE,VUA,WHITNEY
BLADDER,COMPOSITE,EARLY,FORM,INDEX,INVENTORY,LABEL,MEN,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SHORT
169,181,2011,8201,8805,BASED,COPYRIGHT,DIM,HOWEVER,I3C,INC,THESE,WILEY
7500,CHI,EUB,HITACHI,JAPAN,LABEL,MEDICAL,METHODS,OBJECTIVE,PURPOSE,RESULTS,RTE,SYSTEMATIC,SYSTEMS,TOKIO
016,025,165,8805,BMI,GLEASON,HOWEVER,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS
005,017,045,266,326,BACKGROUND,CAP,CYS,GLEASON,LABEL,METHODS,PCR,RESULTS,SER,THESE
169,194,2012,COPYRIGHT,IMRT,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,USING
169,194,2012,AFTER,COPYRIGHT,DESPITE,FIFTY,HOWEVER,INC,LABEL,MATERIALS,MEN,METHODS,OBJECTIVE,PSA,PURPOSE,RESECTION,RESULTS,SEMINAL,SRT
001,002,004,009,102,169,2013,BACKGROUND,BCR,CONCLUSION,COPYRIGHT,EPCAM,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,SEVERAL,UNIVARIATE
169,194,2012,CONCLUSION,COPYRIGHT,FIVE,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,THREE
100,183,LABEL,METHODS,MRI,OBJECTIVE,PCA,PSA,PURPOSE,RESULTS,TESLA,TRUS
000,169,1962,1993,1995,2006,2011,202,215,3011,323,617,8194,8226,8804,8805,AFTER,AUTHORS,BJU,FINNISH,GLEASON,HOWEVER,LABEL,METHODS,OBJECTIVE,PCA,PIRKANMAA,PSA,RESULTS
169,2011,AKT,COPYRIGHT,DCB,ENHANCING,HOWEVER,INC,NAC,POLYPLOIDY,ROS,TREATMENT,WILEY
169,2011,945,COPYRIGHT,DU145,GLUT1,HIF,MSEA,PAIII,TREATMENT,UICC,VEGF
169,2006,2011,3719,AZA,CAO,COPYRIGHT,CPG,GPCR,GPCRS,PCR,RGS,RGS2,TARGETING,THUS,UICC
106,169,2013,AFTER,ASA,COMPARING,CONCERNING,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,SOCIETY,THERE
169,2012,COPYRIGHT,DU145,EGF,INC,MAT,MLL,PC3,RHEUM,STAT,STAT3,THESE,TRAMP,VEGF
005,008,095,102,169,2013,ACCORDING,AMICO,CAP,COPYRIGHT,FIFTY,GROUP,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,RESULTS,SBX,SEVEN,THERE,TRUS,TURBP,UTI
169,2011,DRUG,FOOD,IRELAND,LTD
114,140,2007,2008,8805,ANONYMIZED,ASSESSMENT,AVERAGE,BONE,HOWEVER,LABEL,MEDICATION,METHODS,OBJECTIVE,PURPOSE,RESULTS,SYMPTOM
221,ADPC,AIPC,CAP,CCK,CELL,DVL2,LNCAP,MIR,NSE,PC3,PCR,WESTERN
ALCOHOL,KRUSKAL,PSA,SERUM
169,2013,COPYRIGHT,EIGHT,FORTY,INC,LABEL,MATERIALS,MEAN,MEIER,METHODS,MRI,OBJECTIVE,OVERALL,PET,PSA,RESULTS,SEVENTY,SRS
169,177,2013,239,BACKGROUND,BASED,CONCLUSION,COPYRIGHT,CRPC,CSF,DLT,DLTS,DOCETAXEL,GCSF,INC,LABEL,METHODS,RESULTS
160,216,8201,CONCLUSION,HAROW,LABEL,METHODS,OBJECTIVE,PROS,PURPOSE,RESULTS,THERE,THEREFORE
160,246,738,8201,CONCLUSION,LABEL,LUNG,METHODS,OBJECTIVE,PURPOSE,RESULTS,SICK,USING
169,2013,202,8804,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,UCSF
169,176,194,2012,360,CBCT,COPYRIGHT,DAVIS,DTS,FDK,INC,KRESS,LABEL,LUNG,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
169,194,2012,BACKGROUND,BOTH,CONCLUSION,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,MRI,RESULTS,THESE
114,160,169,2012,945,946,COPYRIGHT,DISCUSSION,INC,LABEL,MATERIALS,METHODS,NOW,OBJECTIVE,PURPOSE,RESULTS
169,2011,COPYRIGHT,LTD,RESULTS,SINCE
169,174,194,2012,AFTER,COPYRIGHT,DOSIMETRY,IBA,ICA,INC,LABEL,MATERIALS,MATRIXX,METHODS,OBJECTIVE,PURPOSE,RESULTS,THREE,VMAT
100,169,174,194,2012,ADDITIONAL,CALYPSO,CHANGES,COPYRIGHT,IMRT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS,SMLC,TREATMENT
169,200,2011,33342,956,BHM,CI90,COPYRIGHT,HOECHST,MRI,PC3,TREATMENT,UICC,USPIO
169,2011,946,AKT,COPYRIGHT,DESPITE,DHT,IGF,IGFI,INC,PREVIOUSLY,R1881,SINCE,UPON,WILEY
001,112,169,194,2012,BECAUSE,COPYRIGHT,CROWN,INC,PLANS,PROTOCOLS,PUBLISHED
169,2013,8805,COPYRIGHT,DLT,DOSE,GRADE,IMRT,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PATHOLOGIC,RESULTS,RTOG,SIB,STEP
001,002,169,177,2012,354,367,370,691,956,ACTH,ADT,ASSESSMENT,BACKGROUND,COPYRIGHT,DESPITE,DHEA,GLEASON,GNRHA,IGF,INC,INSULIN,LABEL,METHODS,PSA,RESULTS,SEVENTY
169,2001,2009,2012,599,8805,BECAUSE,CONCLUSION,COPYRIGHT,FIFTY,FORTY,GLEASON,INC,LABEL,METHODS,OBJECTIVE,PSA,RESULTS,T1C,T2A,THERE,TRUS
133,169,2003,2009,2012,577,BMI,COPYRIGHT,FOUR,GLEASON,INC,LABEL,METHODS,OBESITY,OBJECTIVE,OVERALL,PERCENTAGE,PSA,PSM,RECORDS,RESULTS,RLRP,THERE
169,2011,956,AMONG,AUTHORS,BECAUSE,BLACKWELL,FOUNDATION,INITIAL,JOURNAL,LTD,MCF,MOLECULAR,PRE,PUBLISHING,SIX,STATINS,STRE,STRE1,STRE6
009,024,132,169,199,2011,615,COPYRIGHT,FINALLY,GLEASON,PRIMARY,PSA,REDUCED,UICC
002,003,005,017,038,169,2011,601,ACM,ADT,COPYRIGHT,COX,MEIER,PCSM,UICC
FURTHER,GLEASON,PCA,THEREFORE
0001,0002,049,169,170,2003,2007,2013,8805,ACCRA,AGE,CONCLUSION,COPYRIGHT,GHANA,GLEASON,HIGH,INC,KNOWN,KORLE,LABEL,MEAN,METHODS,OBJECTIVE,PSA,RESULTS,SCREENING,THERE,THESE,VARIOUS
135,2004,2005,3476,446,AMICO,COMPARISON,DATA,END,GLEASON,LABEL,MEN,METHODS,NODAL,OBJECTIVE,OBJECTIVES,PATHOLOGIC,PROGRAM,REPLACING,RESULTS,ROACH,THREE
169,2013,CAP,CELL,COPYRIGHT,GPI,INC,LABEL,MATERIALS,METHODS,MTT,OBJECTIVE,OBJECTIVES,PCR,PSCA,RESULTS,SILENCING,WESTERN
001,013,015,028,177,190,2003,2007,576,BRONJ,COX,INCREASED,INSTITUTE,JANUARY,LABEL,MASONIC,METHODS,MINNESOTA,OBJECTIVE,PARK,RESULTS,TEN,TYPE,UNIVERSITY
PSA
169,2012,COPYRIGHT,CTV,INC,LABEL,MATERIALS,METHODS,MINIMAL,MRI,OBJECTIVE,PURPOSE,RESULTS,TREATMENT
169,194,2012,COPYRIGHT,GLEASON,HOWEVER,INC
0001,001,002,013,169,2013,3W6,947,969,C20,CONCLUSION,COPYRIGHT,FRESH,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PUFA,RESULTS,THESE
169,2011,CD4,CD8,CHP,COPYRIGHT,CT10,CT45,CT46,CT7,EIGHT,ELISA,ESO,EXPRESSION,HIS6,HORMAD1,MAGE,SOX2,SSX2,THUS,UICC,WESTERN
169,2011,946,947,AKT,BLACKWELL,CONCLUSION,DISCUSSION,DMEM,GSK3,HOWEVER,INHIBITION,KNOWN,LABEL,LNCAP,LTD,METHODS,MTT,OBJECTIVE,PPAR,PUBLISHING,RESULTS,TZDS,WESTERN,WHAT
143,145,169,2011,375,810,COPYRIGHT,MICRORNAS,MIRNA,PCR,UICC
169,2011,947,COPYRIGHT,LNCAP,THESE,UICC
002,1263,1263A,165,169,19G,2007,2009,2012,205,652,ALSO,CAP,CASP,CONCLUSION,COPYRIGHT,D302H,DESPITE,INC,INDIA,INSTITUTE,IVS12,LABEL,MATERIALS,MEDICAL,METHODS,NORTH,OBJECTIVE,POST,RESULTS,SCIENCE,THESE,USING
005,0277,133A,169,2013,960,BCS,CELL,CONCLUSION,COPYRIGHT,GSTP1,INC,LABEL,METHODS,MIR,OBJECTIVE,PCR,RESULTS,WESTERN,XTT
169,2012,CAP,COPYRIGHT,DCEMR,INC,LABEL,MATERIALS,METHODS,MRI,MRSI,OBJECTIVE,PSA,PURPOSE,RESULTS,SERUM,THERE
0001,169,177,2013,COPYRIGHT,FOUR,GROUP,INC,LABEL,LIDOCAINE,MATERIALS,METHODS,MPP,OBJECTIVE,OBJECTIVES,PILP,PPNB,PSA,RESULTS,THESE,THREE,TPB,VAS
169,2013,500,COPYRIGHT,EGFR,EPIDERMAL,INC,LABEL,LAPATINIB,METHODS,OBJECTIVE,OBJECTIVES,PSA,RESULTS,SEVEN,TREATMENT
003,016,021,122,143,169,2012,8804,8805,987,BMI,CALCULATED,CONCLUSION,COPYRIGHT,DIFFERENCE,GLEASON,INC,LABEL,METHODS,MEYER,MRI,OBESE,OBJECTIVE,RESULTS,RRP,THESE
169,2013,490,510,938C,ALA7VAL,ASP302HIS,ATM,BACKGROUND,BCL2,BID,CASP8,COPYRIGHT,EIGHT,GERMANY,GLEASON,HDM2,HIS64,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SER133ALA,SNP,SNPS,THESE,TP53,VAL410ILE
169,2007,2009,2013,228,258,AFP,AMONG,COPYRIGHT,INC,JULY,JUNE,LABEL,LYMPH,METHODS,OBJECTIVE,PAFP,PAFPS,PSA,RARP,RESULTS,SINCE,THERE
003,140,169,2011,ASPIRIN,AUTHORS,BACKGROUND,COLLEGE,CURRENT,JOURNAL,LABEL,METHODS,PCA,PHYSICIANS,PSA,RESULTS,ROYAL,THESE
109,169,174,2011,819,COPYRIGHT,JOHN,LABEL,LTD,METHODS,MOST,OBJECTIVE,PATIENT,RESULTS,SONS,THERE,THOSE,WILEY
8201,HIGH,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE,TRAIT
169,177,2011,ASI,AUC,CONCLUSION,COPYRIGHT,GLEASON,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PCA,PSI,RESULTS,ROI,SRA,SRB,THEN,THERE,TRTE,TRUS
169,2013,COPYRIGHT,ESPECIALLY,EVEN,HGPIN,INC,PET,PRIMARY,PROMISING,PSA
0001,0042,012,102,169,2011,COPYRIGHT,GLEASON,LNCAP,OCT1,OCTAMER,POU,THESE,UICC
014,051,168,169,2011,883,COPYRIGHT,COX,HOWEVER,IHD,REGARDLESS,UICC
BONY,CONCLUSION,DOSIMETRIC,EACH,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,USED
148,169,2013,BPH,CAP,COPYRIGHT,HIGH,INC,LABEL,MATERIALS,METHODS,MMP,OBJECTIVE,OBJECTIVES,RESULTS,SDF,UNIVARIATE,VEGF
169,2011,946,947,AICD,APART,APP,AZAC,COPYRIGHT,HOWEVER,NEP,UICC
LABEL,LRP,MEDLINE,METHODS,NEITHER,NON,OBJECTIVE,OBJECTIVES,RALP,RESULTS,RRP,UNTIL,WHILE
169,2012,347,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PTV,PTVS,PURPOSE,RESULTS,RMS,ROOT,SBRT
0129,169,2011,954,BACKGROUND,BOTH,COHEN,COPYRIGHT,EVALUATION,IRELAND,LABEL,LTD,METHODS,MRI,RESULTS,T3B,THESE,WHILE
169,2013,COPYRIGHT,INC,PCR,TELOMERASE
169,2011,ADPC,COPYRIGHT,CRPC,DOC,LNCAP,SPECIMENS,UICC
169,2011,253J,946,BBN,CONVERSELY,COPYRIGHT,EMT,FINALLY,GSK3,ILK,MMP,TMA,UICC,ZEB1
169,2011,AUC,BOTH,CANCEROUS,CONCLUSION,COPYRIGHT,CPEAK,DCE,DESPITE,FIFTY,IRELAND,LABEL,LTD,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,ROC,TTP,WASH
169,2011,BCL,CELECOXIB,COPYRIGHT,COX,HOWEVER,INDUCTION,IRELAND,LTD,MCL
169,2011,969,BRAFO,COMMISSION,COPYRIGHT,FRAMEWORK,ILSI,LTD,PCBS,PUBLISHED,SIXTH,SOY,THERE,THESE
HOWEVER,MOLECULAR
8805,ACUTE,FORTY,LABEL,LATE,MATERIALS,MEIER,METHODS,N0M0,OBJECTIVE,OBJECTIVES,PROLONGED,RESULTS,ROACH,TREATMENT
00MM,100,169,2011,2MM,2NG,4MM,562,6MM,833,837,971,AREAS,AUC,AUCS,CONCLUSION,COPYRIGHT,CSI,DCE,DCEMR,GRE,GROUP,IRELAND,LABEL,LTD,MATERIALS,METHODS,MRI,MRSI,OBJECTIVE,OBJECTIVES,PET,PPV,PSA,RESULTS,ROC,RRP,TSE
169,2011,240,BOTH,CD147,COPYRIGHT,COX,GLEASON,INCREASED,MEIER,NOVEL,PCA,PSA,UICC
160,167,169,2011,ADDITIONAL,ANXIETY,COPYRIGHT,FCS,GMM,HIGH,INVENTORY,LABEL,LOW,LTD,METHODS,OBJECTIVE,PURPOSE,RESULTS,STAI,STATE,SUBGROUPS,USING,YOUNGER
001,003,169,2013,331,8804,ACCORDING,BRFS,CONCLUSION,COPYRIGHT,COX,GLEASON,INC,LABEL,MEIER,METHODS,OBJECTIVE,OBJECTIVES,PSA,RESULTS,TGC
0001,013,021,038,100,155,169,2007,2009,2012,CONCLUSION,CONFORMITY,COPYRIGHT,CTV,IMRT,INC,JANUARY,LABEL,MARCH,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS,RISK
169,2011,394,404,452,507,C30,CHANGES,CONCLUSION,COPYRIGHT,EORTC,JOHN,LABEL,LTD,METHODS,OBJECTIVE,POMS,QLQ,RESULTS,SONS,WILEY
100,186,2005,2010,357,633,672,BONE,CONCLUSION,GLEASON,JANUARY,LABEL,MARCH,METHODS,NONE,OBJECTIVE,OBJECTIVES,PSA,RESULTS,STAGING,UROLOGY
022,169,1993,2001,2009,2012,215,8804,CONCLUSION,COPYRIGHT,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PSA,PURPOSE,RESULTS,ROACH,T1C
125,169,1992,2006,2012,8804,975,ADDITIONAL,COPYRIGHT,COX,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PHOENIX,PSA,PURPOSE,RESULTS,STAGE,TEN
001,007,102,169,177,2003,2009,2012,CONCLUSION,COPYRIGHT,CYBERKNIFE,DYSURIA,GRADE,GROUP,INC,LABEL,LOW,MATERIALS,MEIER,METHODS,OBJECTIVE,PATIENT,PERSISTENT,PSA,PURPOSE,QOD,RADIATION,RESULTS,RTOG,SBRT,THERAPY,THERE,TREATMENT,URINARY
ADT,HOWEVER
177,1995,2007,314,ASTRO,JULY,LABEL,MARCH,METHODS,OBJECTIVE,OBJECTIVES,PHOENIX,RADIATION,RESULTS,SOCIETY,WHILE
169,2012,BACKGROUND,COPYRIGHT,GLEASON,INC,LABEL,METHODS,OBJECTIVE,PSA,RECURRENCE,RESULTS,THOSE
013,169,2012,8804,8805,BCR,CAP,COPYRIGHT,FAILURE,FOUR,GLEASON,HIFU,INC,LABEL,MAB,MATERIALS,METHODS,OBJECTIVE,PRE,PSA,RESULTS,SALVAGE,SRT,SUCCESS,TRUS
2000,BACKGROUND,DIFFERENT,DISCUSSION,LABEL,ONCOLOGIC,RARP,ROBOT
169,2007,2009,2010,2012,ACCURAY,ACUTE,BETWEEN,CBK,COPYRIGHT,CYBERKNIFE,DISEASE,FURTHER,GRADE,INC,LABEL,LATE,MATERIALS,MAY,METHODS,OBJECTIVE,PURPOSE,RESULTS,SRT,SUNNYVALE
956,LNCAP,PC3
009,160,1980,2006,249,258,395,8805,BCR,CONCLUSION,GLEASON,INCREASING,LABEL,METHODS,OBJECTIVE,PSA,PSM,PSMS,PURPOSE,RESULTS
169,2012,8805,ADDITIONAL,ADVERSE,COPYRIGHT,GLEASON,GRADE,GROUP,IMAGE,INC,INSTITUTE,LABEL,MATERIALS,METHODS,OBJECTIVE,PHASE,PHOENIX,PURPOSE,RADIATION,RESULTS,STAGE,THERAPY
169,2010,3546,654,AFTER,BACKGROUND,COPYRIGHT,EGFR,EMMPRIN,HER2,IRELAND,LABEL,LITERATURE,LTD,MATERIALS,METHODS,RCC,RESULTS
100,169,194,2010,COPYRIGHT,EACH,RMS,TRUS,USING
131,146,169,185,2004,2008,2010,772,791,APRIL,BASED,COPYRIGHT,GLEASON,IRELAND,LABEL,LTD,METHODS,MRS,OBJECTIVE,RESULTS,ROC
150,COX,INSURANCE,SLE,TAIWANESE
001,056,438,AUC,BILATERAL,COX,LABEL,MEIER,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS,ROC,USING
2005,354,856,8805,954,DFS,GLEASON,ISUP,KAPPA,LABEL,METHODS,OBJECTIVE,PATHOLOGY,PSA,PURPOSE,RESULTS,SOCIETY,UROLOGICAL
223,945,BPH,DHT,EGF,FAS,FASL,FIN,IGF,MODULATION,OHT,ORM,PARP,SERM,SERMS,TAM,TAMOXIFEN,TGF,USING
169,2012,22RV1,945,946,BASAL,CONCLUSION,COPYRIGHT,DU145,FURTHER,HIF1A,HOWEVER,HYPOXIA,HYPOXIC,III,INC,LABEL,METHODS,OBJECTIVE,PC3,RESULTS,THESE,TUBB3
160,231,A21,CVA21,DAF,FLOW,ICAM,MDA,OVERALL,SCID,THROUGH
100,169,194,2010,COPYRIGHT,DOD,INTRA,LABEL,LARGE,MAX,METHODS,OBJECTIVE,PHASE,PURPOSE,RESULTS,SEEDS,STD,TECHNICAL,TRUS
169,2012,BONE,COPYRIGHT,CTX,DISRUPTED,INC,LABEL,LATER,LOW,METHODS,NTX,OBJECTIVE,OBJECTIVES,PSA,PUBLISHED,RESULTS,SEVERAL
EVALUATION,THERE,TRT
169,2010,COPYRIGHT,GLEASON,III,IRELAND,LTD,PHASE
BACKGROUND,CASE,DISCUSSION,LABEL,METASTATIC,METHODS,TMD,TMJ
37LRP,CPP,GAGS,HOWEVER,PENTS,R11,R13
FURTHER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SALVAGE,SRALP
169,2010,AIM,BACKGROUND,CONCLUSION,CURRENTLY,LABEL,OBJECTIVE,RESULTS,SOCIETY,THERE,VED,VEDS
169,2010,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,ORM,PRO,PROS,QOL,RESULTS,WEB
000,148,8805,945,946,BACKGROUND,CEC,CECS,CTC,CTCS,GLEASON,INTEGRINS,LABEL,LOW,METHODS,PRIMARY,PSA,RESULTS,SECONDARY,THERE,TREATMENT,TTP
CIP1,HDAC,HISTONE,K320,K373,K382,K382R,MDM2,RC10,RKO,TAKEN,THEREFORE,WAF1
NUMERICAL,ROC
169,198,2004,2009,2012,651,8804,ACUTE,AMONG,AUR,BPH,CAP,COPYRIGHT,INC,JULY,JUNE,LABEL,MATERIALS,MEN,METHODS,OBJECTIVE,OTHER,OVERALL,PSA,RESULTS,TRUS
001,022,120,159,169,2012,442,601,8805,ALP,COPYRIGHT,COX,CRPC,GIVEN,INC,LABEL,LIKELIHOOD,MATERIALS,MEIER,METHODS,OBJECTIVE,OBJECTIVES,PSA,REDUCTION,RESULTS,SURROGACY
108,132,169,2012,207,495,8804,CONCLUSION,COPYRIGHT,GLEASON,GROUP,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PSA,RESULTS,T1C,T2A,T2B,THEREFORE
169,1997,2001,2003,2007,2008,2012,687,COPYRIGHT,DCA,EPE,FINALLY,INC,LABEL,LNI,METHODS,OBJECTIVE,OVERALL,RESULTS,SVI
169,2012,COPYRIGHT,CRPC,INC,KNOWLEDGE
046,162,169,2012,ACCRUAL,AFTER,BACKGROUND,CHANGES,COPYRIGHT,CRPC,IGF,IGFBP,INC,INSULIN,LABEL,METHODS,OCTREOTIDE,PSA,RESULTS,WHILE
CASES,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PSA,PUBLISHED,RESULTS,SERUM,SKENE
169,16S,2012,215,220,230,BCA,CAP,CELL,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,NEITHER,OBJECTIVE,PCR,RCC,RESULTS,SERUM
001,002,006,009,012,031,169,2005,2010,2012,356,8804,8805,AGE,COPYRIGHT,ESPECIALLY,INC,JANUARY,JULY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THERE
169,1990S,2000,2013,ACCORDING,COPYRIGHT,GIVEN,INC,RALP,SINCE,WHILE
103,115,169,1983,2012,285,673,COMPARING,COPYRIGHT,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,SINCE
169,2012,BACKGROUND,CD133,CD44,CONCLUSION,COPYRIGHT,HOWEVER,INC,LABEL,METHODS,PC3,RESISTANCE,RESULTS,STEM,SUSPENSION,THESE
0001,169,2012,ANOTHER,CISH,CONCLUSION,COPYRIGHT,ECD,FISH,GLEASON,INC,ISH,LABEL,LVD,MER,METHODS,MMP,OBJECTIVE,RESULTS,THEREFORE,VEGF
005,169,2012,8805,945,ARI,ARIS,BPR,CAP,COPYRIGHT,GLEASON,INC,IQR,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,POST,PSA,PSADT,RESULTS,TUPSA
018,024,041,169,192,2012,224,309GG,A670G,CAP,CCND1,CCND1AA,CONCLUSION,COPYRIGHT,FAS,G309T,G670A,G870A,INC,INDIA,LABEL,MDM2,METHODS,OBJECTIVE,PCR,RESULTS,RFLP,THEREFORE,WHEREAS
169,2003,2009,2012,764,8805,990,ASSESSMENT,CALIFORNIA,CAPRA,CAPSURE,COPYRIGHT,FRANCISCO,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PFS,RESULTS,RISK,RRP,SAN,UCSF,UNIVERSITY
001,003,017,020,044,169,2003,2007,2012,457,831,AFTER,COPYRIGHT,HOWEVER,INC,LABEL,MATERIALS,MEN,METHODS,MIRP,OBJECTIVE,ORP,RESULTS,SEER,SIMILARLY
169,2012,ANNEXIN,APOPTOSIS,BAX,BCL,COPYRIGHT,INC,LABEL,LNCAP,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PCR,RESULTS,THERE,ZINC,ZNT
100,261,956,ABCB1,COMBINING,EXCELLENT,GI50,HUVEC,LNCAP,NCI60,ORAL,PC3,SCREENING,SW620
169,2010,INC,METASTATIC,WILEY
169,2010,BRCA1,INC,WILEY
945,946,FOUR,IIA,P450,PHASE
169,194,2012,AFRICAN,CONFIDENCE,COPYRIGHT,EIGHT,FORCE,GIVEN,INC,LABEL,METHODS,MOST,OBJECTIVE,PCPS,PHYSICIAN,PSA,RESULTS,TASK
001,169,194,2012,8804,8805,ANTIGEN,COPYRIGHT,ENTRY,GLEASON,GROUP,INC,IRB,LABEL,METHODS,OBJECTIVE,PRE,PSA,PSADT,RESULTS,THESE,WORKING
00001,001,009,150,169,2010,235,264,376,405,426,477,AIX75,BACKGROUND,CONCLUSION,LABEL,METHODS,POTENTIAL,PSA,PWVC,RESULTS,SOCIETY
100,200,8201,8804,8805,BACKGROUND,CRM,CRPC,DLT,DLTS,DOSE,FIVE,LABEL,METHODS,NSCLC,OTHER,RESULTS,SINCE,TITE,VORINOSTAT
AFTER
174,BACKGROUND,CASES,DISCUSSION,GIST,LABEL,METHODS
GOD,SIXTY,SPANISH,UTILIZING
169,2012,COPYRIGHT,INC,UPS
100,900,AUC,BBMR,CAP,DIAGNOSIS,GABOR,GLEASON,REGIONS
169,2010,COPYRIGHT,IRELAND,LTD
169,2010,BLACKWELL,GIVEN,LTD,PSA,PUBLISHING,WHILE
145,169,2012,215,ANIMALS,AUTOPSY,COPYRIGHT,HOWEVER,INC,LABEL,MATERIALS,METHODS,MN1,OBJECTIVE,OBJECTIVES,ORTHOTOPIC,RESULTS,ULTRASOUND
001,007,015,107,146,169,194,2006,2007,2012,AGE,CAB,CHINESE,COPYRIGHT,GLEASON,INC,LABEL,MATERIALS,MEDICAL,METHODS,OBJECTIVE,OBJECTIVES,PSA,RESULTS,TURP
000,002,101,169,177,2008,2010,2011,2433,8364,9990,CONCLUSION,COPYRIGHT,DAKAR,FCFA,GLEASON,JANUARY,JUNE,LABEL,METASTASIS,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS,SAS,THREE
169,2012,ARCANGELI,CLEVELAND,COPYRIGHT,FOUR,SAS
119,169,194,2005,2007,2012,204,228,233,ANN,APRIL,AUC,BACKGROUND,BECKMAN,CAP,COPYRIGHT,DEPARTMENT,DIAGNOSTIC,DRE,INC,INSTITUTE,LABEL,MATERIALS,MAY,MEDICAL,METHODS,OVERALL,PSA,RESULTS,ROC,TOTAL,TRUS,UNIVERSIT,UROLOGY
169,194,2012,COPYRIGHT,END,INC,RESULTS,SEER
0001,001,100,105,125,169,180,2012,8805,AVAILABLE,COPYRIGHT,DOSIMETRY,INC,IOP,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PSA,RESULTS
111,169,194,2012,627,754,947,CAP,COPYRIGHT,GLEASON,HIGH,INC,LABEL,MATERIALS,METHODS,MOST,OBJECTIVE,OBJECTIVES,REGRESSION,RESULTS,SPECT,SVI,T1C
